PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bottner, M; Barrenschee, M; Hellwig, I; Harde, J; Egberts, JH; Becker, T; Zorenkov, D; Schafer, KH; Wedel, T				Boettner, Martina; Barrenschee, Martina; Hellwig, Ines; Harde, Jonas; Egberts, Jan-Hendrik; Becker, Thomas; Zorenkov, Dimitri; Schaefer, Karl-Herbert; Wedel, Thilo			The GDNF System Is Altered in Diverticular Disease - Implications for Pathogenesis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; MICE LACKING GDNF; NEUROTROPHIC FACTOR; RET PROTOONCOGENE; NEURITE OUTGROWTH; MYENTERIC PLEXUS; CELL-DEATH; C-RET; NEURONS; EXPRESSION	Background & Aims: Absence of glial cell line-derived neurotrophic factor (GDNF) leads to intestinal aganglionosis. We recently demonstrated that patients with diverticular disease (DD) exhibit hypoganglionosis suggesting neurotrophic factor deprivation. Thus, we screened mRNA expression pattern of the GDNF system in DD and examined the effects of GDNF on cultured enteric neurons. Methods: Colonic specimens obtained from patients with DD (n = 21) and controls (n = 20) were assessed for mRNA expression levels of the GDNF system (GDNF, GDNF receptors GFR alpha 1 and RET). To identify the tissue source of GDNF and its receptors, laser-microdissected (LMD) samples of human myenteric ganglia and intestinal muscle layers were analyzed separately by qPCR. Furthermore, the effects of GDNF treatment on cultured enteric neurons (receptor expression, neuronal differentiation and plasticity) were monitored. Results: mRNA expression of GDNF and its receptors was significantly down-regulated in the muscularis propria of patients with DD. LMD samples revealed high expression of GDNF in circular and longitudinal muscle layers, whereas GDNF receptors were also expressed in myenteric ganglia. GDNF treatment of cultured enteric neurons increased mRNA expression of its receptors and promoted neuronal differentiation and plasticity revealed by synaptophysin mRNA and protein expression. Conclusions: Our results suggest that the GDNF system is compromised in DD. In vitro studies demonstrate that GDNF enhances expression of its receptors and promotes enteric neuronal differentiation and plasticity. Since patients with DD exhibit hypoganglionosis, we propose that the observed enteric neuronal loss in DD may be due to lacking neurotrophic support mediated by the GDNF system.	[Boettner, Martina; Barrenschee, Martina; Hellwig, Ines; Harde, Jonas; Wedel, Thilo] Univ Kiel, Inst Anat, Kiel, Germany; [Egberts, Jan-Hendrik; Becker, Thomas] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany; [Zorenkov, Dimitri] Univ Hosp Schleswig Holstein, Dept Neurol, Kiel, Germany; [Schaefer, Karl-Herbert] Univ Appl Sci, Dept Informat & Microsyst Tech, Kaiserslautern, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kaiserslautern	Bottner, M (corresponding author), Univ Kiel, Inst Anat, Olshausenstr 40, Kiel, Germany.	m.boettner@anat.uni-kiel.de	Egberts, Jan-Hendrik/E-3211-2015; Barrenschee, Martina/AAS-9945-2020; Barrenschee, Martina/E-7688-2015; Wedel, Thilo/B-1247-2010	Barrenschee, Martina/0000-0002-6569-5603; Wedel, Thilo/0000-0002-8146-2711; Barrenschee, Martina/0000-0002-0244-9333	Deutsche Forschungsgemeinschaft (DFG) [WE 2366/4-2]; Faculty of Medicine, Christian-Albrechts-University of Kiel [F347022]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Faculty of Medicine, Christian-Albrechts-University of Kiel	The study was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG, WE 2366/4-2) and the Faculty of Medicine, Christian-Albrechts-University of Kiel (F347022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Attie-Bitach T, 1998, AM J MED GENET, V80, P481, DOI 10.1002/(SICI)1096-8628(19981228)80:5<481::AID-AJMG8>3.0.CO;2-6; Bassotti G, 2001, DIS COLON RECTUM, V44, P1814, DOI 10.1007/BF02234460; Bottner M, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01424.x; Bottner M, 2012, DIGEST DIS, V30, P19, DOI 10.1159/000335699; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Bottner M., 2010, NEUROGASTROENT MOTIL, V22, pe152; Brose N, 2010, BIOCHEM SOC T, V38, P443, DOI 10.1042/BST0380443; Burgoyne RD, 2011, NAT CELL BIOL, V13, P8, DOI 10.1038/ncb0111-8; Burke RE, 2006, J NEURAL TRANSM-SUPP, P41; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Deduchovas O, 2008, ANN ANAT, V190, P525, DOI 10.1016/j.aanat.2008.09.002; Du F, 2009, NEUROGASTROENT MOTIL, V21, P1229, DOI 10.1111/j.1365-2982.2009.01379.x; Durbec PL, 1996, DEVELOPMENT, V122, P349; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Golder M, 2003, LANCET, V361, P1945, DOI 10.1016/S0140-6736(03)13583-0; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Humes DJ, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01863.x; Iwase H, 2005, J CLIN GASTROENTEROL, V39, P674, DOI 10.1097/01.mcg.0000173856.84814.37; Jun S, 2002, BEST PRACT RES CL GA, V16, P529, DOI 10.1053/bega.2002.0328; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Knowles CH, 2010, GUT, V59, P882, DOI 10.1136/gut.2009.200444; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rodrigues DM, 2011, NEUROGASTROENT MOTIL, V23, pe44, DOI 10.1111/j.1365-2982.2010.01626.x; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Schafer KH, 1997, BRAIN RES PROTOC, V1, P109, DOI 10.1016/S1385-299X(96)00017-7; Schafer KH, 1999, J INTERF CYTOK RES, V19, P527, DOI 10.1089/107999099313974; Schafer KH, 1999, EXP BRAIN RES, V125, P447, DOI 10.1007/s002210050702; Shen L, 2002, AM J HUM GENET, V70, P435, DOI 10.1086/338712; Simpson J, 2009, NEUROGASTROENT MOTIL, V21, P847, DOI 10.1111/j.1365-2982.2009.01308.x; Simpson John, 2002, Clin Evid, P436; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Uesaka T, 2007, DEVELOPMENT, V134, P2171, DOI 10.1242/dev.001388; von Boyen GBT, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-3; Wedel T, 2010, NEUROGASTROENT MOTIL, V22, P407, DOI 10.1111/j.1365-2982.2009.01445.x; Zeng FN, 2010, GASTROENTEROLOGY, V138, P1491, DOI 10.1053/j.gastro.2009.11.048; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015	45	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66290	10.1371/journal.pone.0066290	http://dx.doi.org/10.1371/journal.pone.0066290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805210	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500038
J	Li, XR; Zhang, FX; Song, GX; Gu, WJ; Chen, ML; Yang, B; Li, DF; Wang, DW; Cao, KJ				Li, Xiaorong; Zhang, Fengxiang; Song, Guixian; Gu, Weijuan; Chen, Minglong; Yang, Bing; Li, Dianfu; Wang, Daowu; Cao, Kejiang			Intramyocardial Injection of Pig Pluripotent Stem Cells Improves Left Ventricular Function and Perfusion: A Study in a Porcine Model of Acute Myocardial Infarction	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; IPS CELLS; GENERATION; FIBROBLASTS; HEARTS; TRANSPLANTATION; ENGRAFTMENT; DERIVATION; INDUCTION; SURVIVAL	Induced pluripotent stem (iPS) cells have the potential to differentiate to various types of cardiovascular cells to repair an injured heart. The potential therapeutic benefits of iPS cell based treatment have been established in small-animal models of myocardial infarction (MI). We hypothesize that porcine iPS (piPS) cell transplantation may be an effective treatment for MI. After a 90-minute occlusion of the left anterior descending artery in a porcine model, undifferentiated piPS cells or PBS were injected into the ischemic myocardium. Cardiac function, myocardial perfusion and cell differentiation were investigated. One week after piPS cell delivery, global left ventricular ejection fraction (LVEF) significantly decreased in both the iPS group and the PBS group compared to the Sham group (p<0.05, respectively). Six weeks after piPS cell delivery, LVEF of the iPS group significantly improved compared to the PBS group (56.68% vs. 50.93%, p = 0.04) but was still lower than the Sham group. Likewise, the piPS cell transplantation improved the regional perfusion compared to the PBS injection (19.67% vs. 13.67%, p = 0.02). The infarct area was significantly smaller in the iPS group than the PBS group (12.04% vs. 15.98% p = 0.01). PiPS cells engrafted into the myocardium can differentiate into vessel cells, which result in increased formation of new vessels in the infarcted heart. Direct intramyocardial injection of piPS cells can decrease infarct size and improve left ventricular function and perfusion for an immunosuppressed porcine AMI model.	[Li, Xiaorong; Zhang, Fengxiang; Song, Guixian; Gu, Weijuan; Chen, Minglong; Yang, Bing; Li, Dianfu; Wang, Daowu; Cao, Kejiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Cao, KJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	kjcao@njmu.edu.cn	Zhang, Fengxiang/Z-2807-2019		National Natural Science Foundation of China [81170160, 30871077, 30800464]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talents Peak Project of Jiangsu Province [DG216D5044]; Postgraduate research and innovation project in Jiangsu province, China; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talents Peak Project of Jiangsu Province; Postgraduate research and innovation project in Jiangsu province, China; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU	This work was supported by grants from the National Natural Science Foundation of China (Grant no. 81170160, 30871077, 30800464) (http://www.nsfc.gov.cn/Portal0/default152.htm), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Six Talents Peak Project of Jiangsu Province (Grant no. DG216D5044), the Postgraduate research and innovation project in Jiangsu province, China, and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Ahmed RPH, 2011, REGEN MED, V6, P171, DOI 10.2217/RME.10.103; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Chang HJ, 2009, JACC-CARDIOVASC IMAG, V2, P412, DOI 10.1016/j.jcmg.2008.12.019; Cheng L, 2009, REGEN MED, V4, P787, DOI 10.2217/RME.09.56; Chiang CH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/219060; Dai B, 2011, J AM COLL CARDIOL, V58, P2118, DOI 10.1016/j.jacc.2011.06.062; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Lee AS, 2011, J BIOL CHEM, V286, P32697, DOI 10.1074/jbc.M111.235739; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Pasha Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023667; Qu XK, 2012, EUR J RADIOL, V81, pE431, DOI 10.1016/j.ejrad.2011.03.062; Roberts RM, 2009, CELL CYCLE, V8, P3078, DOI 10.4161/cc.8.19.9589; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Singla DK, 2011, MOL PHARMACEUT, V8, P1573, DOI 10.1021/mp2001704; So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108; Telugu BPVL, 2010, STEM CELL REV REP, V6, P31, DOI 10.1007/s12015-009-9101-1; Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yan BB, 2011, MOL PHARMACEUT, V8, P1602, DOI 10.1021/mp2003576; Yang YJ, 2008, EUR HEART J, V29, P1578, DOI 10.1093/eurheartj/ehn167; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019012; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	35	27	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66688	10.1371/journal.pone.0066688	http://dx.doi.org/10.1371/journal.pone.0066688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805264	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500092
J	Schuldiner-Harpaz, T; Coll, M				Schuldiner-Harpaz, Tarryn; Coll, Moshe			Effects of Global Warming on Predatory Bugs Supported by Data Across Geographic and Seasonal Climatic Gradients	PLOS ONE			English	Article							THRIPS FRANKLINIELLA-OCCIDENTALIS; BODY-SIZE; ORIUS-LAEVIGATUS; O-ALBIDIPENNIS; ANTHOCORIDAE; TEMPERATURE; INSECTS; REPRODUCTION; HETEROPTERA; LEPIDOPTERA	Global warming may affect species abundance and distribution, as well as temperature-dependent morphometric traits. In this study, we first used historical data to document changes in Orius (Heteroptera: Anthocoridae) species assemblage and individual morphometric traits over the past seven decades in Israel. We then tested whether these changes could have been temperature driven by searching for similar patterns across seasonal and geographic climatic gradients in a present survey. The historical records indicated a shift in the relative abundance of dominant Orius species; the relative abundance of O. albidipennis, a desert-adapted species, increased while that of O. laevigatus decreased in recent decades by 6 and 10-15 folds, respectively. These shifts coincided with an overall increase of up to 2.1 degrees C in mean daily temperatures over the last 25 years in Israel. Similar trends were found in contemporary data across two other climatic gradients, seasonal and geographic; O. albidipennis dominated Orius assemblages under warm conditions. Finally, specimens collected in the present survey were significantly smaller than those from the 1980's, corresponding to significantly smaller individuals collected now during warmer than colder seasons. Taken together, results provide strong support to the hypothesis that temperature is the most likely driver of the observed shifts in species composition and body sizes because (1) historical changes in both species assemblage and body size were associated with rising temperatures in the study region over the last few decades; and (2) similar changes were observed as a result of contemporary drivers that are associated with temperature.	[Schuldiner-Harpaz, Tarryn; Coll, Moshe] Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Schuldiner-Harpaz, T (corresponding author), Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel.	tarryn.harpaz@gmail.com			Chief Scientist of the (Israeli) Ministry of Agriculture and Rural Development; Israel Science Foundation; Academy of Science and Humanities (ISF) [574/07]	Chief Scientist of the (Israeli) Ministry of Agriculture and Rural Development; Israel Science Foundation(Israel Science Foundation); Academy of Science and Humanities (ISF)	This study was supported in parts by grants from the Chief Scientist of the (Israeli) Ministry of Agriculture and Rural Development, and from the Israel Science Foundation, founded by the Academy of Science and Humanities (ISF grant 574/07 to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Azevedo RBR, 1998, EVOLUTION, V52, P1353, DOI [10.1111/j.1558-5646.1998.tb02017.x, 10.2307/2411305]; Bahsi SU, 2008, BIOCONTROL SCI TECHN, V18, P767, DOI 10.1080/09583150802302215; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Baniameri V, 2005, APPL ENTOMOL ZOOL, V40, P545, DOI 10.1303/aez.2005.545; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Bosco L, 2008, B INSECTOL, V61, P209; Calder WA., 1984, SIZE FUNCTION LIFE H; Carayon J., 1959, CAHIERS NATURALISTES, V15, P53; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; CHYZIK R, 1995, PHYTOPARASITICA, V23, P147, DOI 10.1007/BF02980974; Chyzik R, 2002, PHYTOPARASITICA, V30, P335, DOI 10.1007/BF02979681; Cocuzza GE, 1997, ENTOMOL EXP APPL, V85, P189, DOI 10.1023/A:1003127310860; Coll M, 2005, P 2 INT C BIOL CONTR; DAVID JR, 1994, GENET SEL EVOL, V26, P229, DOI 10.1051/gse:19940305; Ferragut F., 1994, Boletin de Sanidad Vegetal Plagas, V20, P89; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Gilchrist GW, 2004, INTEGR COMP BIOL, V44, P461, DOI 10.1093/icb/44.6.461; Goldreich Y., 2012, CLIMATE ISRAEL OBSER; Groenteman R, 2004, THESIS HEBREW U JERU; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; HORTON D. R., 2008, ENCY ENTOMOLOGY, P2402, DOI DOI 10.1007/978-1-4020-6359-6_4633; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Johnson C.G., 1969, MIGRATION DISPERSAL; JORDANO D, 1991, J BIOGEOGR, V18, P637, DOI 10.2307/2845545; Krasnov B, 1996, J ARID ENVIRON, V34, P477, DOI 10.1006/jare.1996.0126; Lacasa A., 1996, Folia Entomologica Hungarica, V57, P67; Lattin JD, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P607; LINNAVUORI R., 1961, ANN ZOOL SOC ZOOL BOT FENNICAE VANAMO", V22, P1; Menendez Rosa, 2007, Tijdschrift voor Entomologie, V150, P355; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PERICART J, 1989, PHYTOPARASITICA, V17, P91, DOI 10.1007/BF02979516; Pericart J, 1972, HEMIPTERES ANTHOCORI; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Sanchez JA, 2002, B ENTOMOL RES, V92, P77, DOI 10.1079/BER2001136; SAS Institute, 2007, JMP VERS 7; Scharf I, 2009, ZOOLOGY, V112, P139, DOI 10.1016/j.zool.2008.05.004; Schuldiner-Harpaz T, 2012, J ECON ENTOMOL, V105, P1520, DOI 10.1603/EC12068; Shahami D, 2009, ISRAELI METEOROLOGIC, V1, P57; SHOUSTER I, 2003, THESIS HEBREW U JERU; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Tommasini Maria Grazia, 2004, Bulletin of Insectology, V57, P65; Wilson RJ, 2011, J INSECT CONSERV, V15, P259, DOI 10.1007/s10841-010-9342-y; Wilson Robert J., 2007, Symposia of the Royal Entomological Society of London, V23, P245, DOI 10.1079/9781845932541.0245; Ziv B, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022796	49	11	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66622	10.1371/journal.pone.0066622	http://dx.doi.org/10.1371/journal.pone.0066622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805249	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500077
J	Vogt, H; Braback, L; Zetterstrom, O; Zara, K; Falth-Magnusson, K; Nilsson, L				Vogt, Hartmut; Braback, Lennart; Zetterstrom, Olof; Zara, Katalin; Falth-Magnusson, Karin; Nilsson, Lennart			Asthma Heredity, Cord Blood IgE and Asthma-Related Symptoms and Medication in Adulthood: A Long-Term Follow-Up in a Swedish Birth Cohort	PLOS ONE			English	Article							SERUM IMMUNOGLOBULIN-E; ALLERGEN-SPECIFIC IGE; GENDER-DIFFERENCES; CHILDHOOD ASTHMA; NATIONAL COHORT; ATOPIC DISEASE; YOUNG-ADULTS; AGE; SENSITIZATION; CHILDREN	Cord blood IgE has previously been studied as a possible predictor of asthma and allergic diseases. Results from different studies have been contradictory, and most have focused on high-risk infants and early infancy. Few studies have followed their study population into adulthood. This study assessed whether cord blood IgE levels and a family history of asthma were associated with, and could predict, asthma medication and allergy-related respiratory symptoms in adults. A follow-up was carried out in a Swedish birth cohort comprising 1,701 consecutively born children. In all, 1,661 individuals could be linked to the Swedish Prescribed Drug Register and the Medical Birth Register, and 1,227 responded to a postal questionnaire. Cord blood IgE and family history of asthma were correlated with reported respiratory symptoms and dispensed asthma medication at 32-34 years. Elevated cord blood IgE was associated with a two- to threefold increased risk of pollen-induced respiratory symptoms and dispensed anti-inflammatory asthma medication. Similarly, a family history of asthma was associated with an increased risk of pollen-induced respiratory symptoms and anti-inflammatory medication. However, only 8% of the individuals with elevated cord blood IgE or a family history of asthma in infancy could be linked to current dispensation of anti-inflammatory asthma medication at follow-up. In all, 49 out of 60 individuals with dispensed anti-inflammatory asthma medication at 32-34 years of age had not been reported having asthma at previous check-ups of the cohort during childhood. Among those, only 5% with elevated cord blood IgE and 6% with a family history of asthma in infancy could be linked to current dispensation of anti-inflammatory asthma medication as adults. Elevated cord blood IgE and a positive family history of asthma were associated with reported respiratory symptoms and dispensed asthma medication in adulthood, but their predictive power was poor in this long-time follow-up.	[Vogt, Hartmut; Falth-Magnusson, Karin] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Pediat,Pediat & Adolescent Clin,Cty Council O, Linkoping, Sweden; [Braback, Lennart] Vasternorrland Cty Council, Dept Res & Dev, Sundsvall, Sweden; [Braback, Lennart] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Zetterstrom, Olof; Zara, Katalin; Nilsson, Lennart] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Allergy Ctr, Linkoping, Sweden	Linkoping University; Umea University; Linkoping University	Vogt, H (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Pediat,Pediat & Adolescent Clin,Cty Council O, Linkoping, Sweden.	hartmut.vogt@liu.se	Braback, Lennart/A-3793-2015	Braback, Lennart/0000-0001-9930-7755; Nilsson, Lennart/0000-0002-5680-6367	Umea SIMSAM Node (Microdata research on childhood for lifelong health and welfare); Swedish Research Council; Swedish Asthma and Allergy Association (Stockholm, Sweden)	Umea SIMSAM Node (Microdata research on childhood for lifelong health and welfare); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Asthma and Allergy Association (Stockholm, Sweden)	LB was supported by the Umea SIMSAM Node (Microdata research on childhood for lifelong health and welfare) financed by the Swedish Research Council. KFM was supported by the Swedish Research Council. LN and HV were supported by The Swedish Asthma and Allergy Association (Stockholm, Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Andersson M, 2010, PEDIAT ALLERG IMM-UK, V21, P859, DOI 10.1111/j.1399-3038.2010.01055.x; Arbes Jr SJ, 2012, J ALLERGY CLIN IMMUN; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Bjerg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016082; Bonnelykke K, 2010, J ALLERGY CLIN IMMUN, V126, P657, DOI 10.1016/j.jaci.2010.06.027; CRONER S, 1992, ALLERGY, V47, P150, DOI 10.1111/j.1398-9995.1992.tb00956.x; CRONER S, 1982, ARCH DIS CHILD, V57, P364, DOI 10.1136/adc.57.5.364; CRONER S, 1990, PEDIATR ALLERGY IMMU, V1, P14, DOI DOI 10.1111/J.1399-3038.1990.TB00003.X; Crump C, 2011, PEDIATRICS, V127, pE913, DOI 10.1542/peds.2010-2603; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Ferguson A, 2009, PEDIAT ALLERG IMM-UK, V20, P710, DOI 10.1111/j.1399-3038.2009.00869.x; Furu K, 2007, EUR J CLIN PHARMACOL, V63, P693, DOI 10.1007/s00228-007-0301-9; Furu K, 2011, J CLIN EPIDEMIOL, V64, P878, DOI 10.1016/j.jclinepi.2010.10.014; Hansen L G, 1993, Pediatr Allergy Immunol, V4, P34, DOI 10.1111/j.1399-3038.1993.tb00063.x; HANSEN LG, 1992, ALLERGY, V47, P397, DOI 10.1111/j.1398-9995.1992.tb02079.x; Hoffmann F, 2010, EUR J CLIN PHARMACOL, V66, P307, DOI 10.1007/s00228-009-0755-z; Kamemura N, 2012, J ALLERGY CLIN IMMUN, V130, P113, DOI 10.1016/j.jaci.2012.02.023; Kirkwood BR, 2003, ESSENTIAL MED STAT; KJELLMAN NIM, 1984, ANN ALLERGY, V53, P167; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Leynaert B, 2012, THORAX, V67, P625, DOI 10.1136/thoraxjnl-2011-201249; Lotvall J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-94; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Pesonen M, 2009, PEDIAT ALLERG IMM-UK, V20, P12, DOI 10.1111/j.1399-3038.2008.00736.x; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Remes ST, 2002, THORAX, V57, P120, DOI 10.1136/thorax.57.2.120; Sadeghnejad A, 2004, THORAX, V59, P936, DOI 10.1136/thx.2004.024224; Shah PS, 2011, ANN ALLERG ASTHMA IM, V106, P245, DOI 10.1016/j.anai.2010.12.006; Tollefsen E, 2007, RESP MED, V101, P896, DOI 10.1016/j.rmed.2006.09.022; Vogt H, 2011, PEDIATRICS, V127, P1052, DOI 10.1542/peds.2010-3083; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	34	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66777	10.1371/journal.pone.0066777	http://dx.doi.org/10.1371/journal.pone.0066777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805276	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500104
J	Ball, ST; Kelly, ML; Robson, JE; Turner, MD; Harrison, J; Jones, L; Napper, D; Beechey, CV; Hough, T; Plagge, A; Cattanach, BM; Cox, RD; Peters, J				Ball, Simon T.; Kelly, Michelle L.; Robson, Joan E.; Turner, Martin D.; Harrison, Jackie; Jones, Lynn; Napper, Diane; Beechey, Colin V.; Hough, Tertius; Plagge, Antonius; Cattanach, Bruce M.; Cox, Roger D.; Peters, Jo			Gene Dosage Effects at the Imprinted Gnas Cluster	PLOS ONE			English	Article							XL-ALPHA-S; PSEUDOHYPOPARATHYROIDISM TYPE-IB; ALBRIGHTS HEREDITARY OSTEODYSTROPHY; EXTRA-LARGE VARIANT; MOUSE-CHROMOSOME 2; G-PROTEIN; CONTROL REGION; GS-ALPHA; HORMONE RESISTANCE; EPIGENETIC DEFECTS	Genomic imprinting results in parent-of-origin-dependent monoallelic gene expression. Early work showed that distal mouse chromosome 2 is imprinted, as maternal and paternal duplications of the region (with corresponding paternal and maternal deficiencies) give rise to different anomalous phenotypes with early postnatal lethalities. Newborns with maternal duplication (MatDp(dist2)) are long, thin and hypoactive whereas those with paternal duplication (PatDp(dist2)) are chunky, oedematous, and hyperactive. Here we focus on PatDp(dist2). Loss of expression of the maternally expressed Gnas transcript at the Gnas cluster has been thought to account for the PatDp(dist2) phenotype. But PatDp(dist2) also have two expressed doses of the paternally expressed Gnasxl transcript. Through the use of targeted mutations, we have generated PatDp(dist2) mice predicted to have 1 or 2 expressed doses of Gnasxl, and 0, 1 or 2 expressed doses of Gnas. We confirm that oedema is due to lack of expression of imprinted Gnas alone. We show that it is the combination of a double dose of Gnasxl, with no dose of imprinted Gnas, that gives rise to the characteristic hyperactive, chunky, oedematous, lethal PatDp(dist2) phenotype, which is also hypoglycaemic. However PatDp(dist2) mice in which the dosage of the Gnasxl and Gnas is balanced (either 2: 2 or 1:1) are neither dysmorphic nor hyperactive, have normal glucose levels, and are fully viable. But PatDp(dist2) with biallelic expression of both Gnasxl and Gnas show a marked postnatal growth retardation. Our results show that most of the PatDp(dist2) phenotype is due to overexpression of Gnasxl combined with loss of expression of Gnas, and suggest that Gnasxl and Gnas may act antagonistically in a number of tissues and to cause a wide range of phenotypic effects. It can be concluded that monoallelic expression of both Gnasxl and Gnas is a requirement for normal postnatal growth and development.	[Ball, Simon T.; Kelly, Michelle L.; Robson, Joan E.; Turner, Martin D.; Cattanach, Bruce M.; Cox, Roger D.; Peters, Jo] MRC, Mammalian Genet Unit, Harwell, Oxon, England; [Harrison, Jackie; Jones, Lynn; Napper, Diane; Beechey, Colin V.; Hough, Tertius] MRC, Mary Lyon Ctr, Harwell, Oxon, England; [Plagge, Antonius] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Peters, J (corresponding author), MRC, Mammalian Genet Unit, Harwell Sci & Innovat Campus, Harwell, Oxon, England.	j.peters@har.mrc.ac.uk	Plagge, Antonius/AAH-3877-2019	Plagge, Antonius/0000-0001-6592-1343; Cox, Roger/0000-0001-7170-5014	UK Medical Research Council; Medical Research Council [MC_UP_1502/1, MC_U142661184, MC_U142636336] Funding Source: researchfish; MRC [MC_U142636336, MC_U142661184, MC_UP_1502/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Aydin C, 2009, ENDOCRINOLOGY, V150, P3567, DOI 10.1210/en.2009-0318; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2012, HORM METAB RES, V44, P732, DOI 10.1055/s-0032-1316331; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Bastepe M, 2011, BONE, V48, P659, DOI 10.1016/j.bone.2010.10.168; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; Cattanach BM, 2006, CYTOGENET GENOME RES, V113, P17, DOI 10.1159/000090810; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Cattanach BM, 1990, DEV S, V1990, P63; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Chillambhi S, 2010, J CLIN ENDOCR METAB, V95, P3993, DOI 10.1210/jc.2009-2205; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; CRAWFORD JA, 1993, J BIOL CHEM, V268, P9879; de Nanclares GP, 2007, J CLIN ENDOCR METAB, V92, P2370, DOI 10.1210/jc.2006-2287; Dixit A, 2013, J CLIN ENDOCR METAB, V98, pE103, DOI 10.1210/jc.2012-2639; Eaton SA, 2012, MOL CELL BIOL, V32, P1017, DOI 10.1128/MCB.06174-11; Fernandez-Rebollo E, 2012, P NATL ACAD SCI USA, V109, P6638, DOI 10.1073/pnas.1117608109; Fernandez-Rebollo E, 2010, EUR J ENDOCRINOL, V163, P953, DOI 10.1530/EJE-10-0435; Frohlich LF, 2010, P NATL ACAD SCI USA, V107, P9275, DOI 10.1073/pnas.0910224107; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Kelly ML, 2009, INT J OBESITY, V33, P507, DOI 10.1038/ijo.2009.30; Kelsey G, 2010, AM J MED GENET C, V154C, P377, DOI 10.1002/ajmg.c.30271; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Krechowec SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029753; Lecumberri B, 2010, J MED GENET, V47, P276, DOI 10.1136/jmg.2009.071001; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Mantovani G, 2010, J CLIN ENDOCR METAB, V95, P651, DOI 10.1210/jc.2009-0176; Mariot V, 2008, J CLIN ENDOCR METAB, V93, P661, DOI 10.1210/jc.2007-0927; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Peters J, 2008, ADV EXP MED BIOL, V626, P16; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; SEARLE AG, 1971, GENET RES, V18, P215, DOI 10.1017/S0016672300012611; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Unluturk U, 2008, AM J MED SCI, V336, P84, DOI 10.1097/MAJ.0b013e31815b218f; Williamson CM, 1998, GENET RES, V72, P255, DOI 10.1017/S0016672398003528; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	52	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65639	10.1371/journal.pone.0065639	http://dx.doi.org/10.1371/journal.pone.0065639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822972	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400015
J	Bianchelli, S; Pusceddu, A; Canese, S; Greco, S; Danovaro, R				Bianchelli, Silvia; Pusceddu, Antonio; Canese, Simone; Greco, Silvio; Danovaro, Roberto			High Meiofaunal and Nematodes Diversity around Mesophotic Coral Oases in the Mediterranean Sea	PLOS ONE			English	Article							LIGURIAN SEA; VERTICAL CLIFF; ORGANIC-MATTER; BIODIVERSITY; ASSEMBLAGES; ECOSYSTEM; SEDIMENTS; HABITAT; BAY	Although the mesophotic zone of the Mediterranean Sea has been poorly investigated, there is an increasing awareness about its ecological importance for its biodiversity, as fish nursery and for the recruitment of shallow water species. Along with coastal rocky cliffs, isolated coralligenous concretions emerging from muddy bottoms are typical structures of the Mediterranean Sea mesophotic zone. Coralligenous concretions at mesophotic depths in the South Tyrrhenian Sea were investigated to assess the role of these coralligenous oases in relation to the biodiversity of surrounding soft sediments. We show here that the complex structures of the coralligenous concretions at ca. 110 m depth influence the trophic conditions, the biodiversity and assemblage composition in the surrounding sediments even at considerable distances. Coral concretions not only represent deep oases of coral biodiversity but they also promote a higher biodiversity of the fauna inhabiting the surrounding soft sediments. Using the biodiversity of nematodes as a proxy of the total benthic biodiversity, a high turnover biodiversity within a 200 m distance from the coralligenous concretions was observed. Such turnover is even more evident when only rare taxa are considered and seems related to specific trophic conditions, which are influenced by the presence of the coralligenous structures. The presence of a high topographic complexity and the trophic enrichment make these habitats highly biodiverse, nowadays endangered by human activities ( such as exploitation of commercial species such as Corallium rubrum, or trawling fisheries, which directly causes habitat destruction or indirectly causes modification in the sedimentation and re-suspension rates). We stress that the protection of the coralligenous sea concretions is a priority for future conservation policies at the scale of large marine ecosystems and that a complete census of these mesophotic oases of biodiversity should be a priority for future investigations in the Mediterranean Sea.	[Bianchelli, Silvia; Pusceddu, Antonio; Danovaro, Roberto] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Canese, Simone; Greco, Silvio] ISPRA, Ist Super Ric Ambientale, Rome, Italy	Marche Polytechnic University; Italian Institute for Environmental Protection & Research (ISPRA)	Pusceddu, A (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	a.pusceddu@univpm.it	Canese, Simonepietro/AAA-5499-2019; Bianchelli, Silvia/F-3954-2018	Canese, Simonepietro/0000-0001-6049-4506; Bianchelli, Silvia/0000-0002-1957-3269	Calabrian Regional Council for the Environment; EU project HERMIONE [226354]; National Flag Project RITMARE (Marine Italian Research); Department of Life and Environmental Sciences (Polytechnic University of Marche) [327 MoBioMarCal]; Institute for Environmental Protection and Research ISPRA) [327 MoBioMarCal]	Calabrian Regional Council for the Environment; EU project HERMIONE; National Flag Project RITMARE (Marine Italian Research); Department of Life and Environmental Sciences (Polytechnic University of Marche); Institute for Environmental Protection and Research ISPRA)	This study was supported by Project no. 327 MoBioMarCal financed by the Calabrian Regional Council for the Environment, EU project HERMIONE (grant agreement n. 226354), and National Flag Project RITMARE (Marine Italian Research) coordinated by the CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was carried out in the framework of a collaboration between the Department of Life and Environmental Sciences (Polytechnic University of Marche) and the Institute for Environmental Protection and Research ISPRA), in the framework of the project no. 327 MoBioMarCal. This study is a contribution to the EU project HERMIONE and National Flag Project RITMARE (Marine Italian Research) coordinated by the CNR.	Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; BAVESTRELLO G, 1995, J COASTAL RES, V11, P690; BAVESTRELLO G, 1991, MAR ECOL-P S Z N I, V12, P281, DOI 10.1111/j.1439-0485.1991.tb00259.x; Bianchelli S, 2010, DEEP-SEA RES PT I, V57, P420, DOI 10.1016/j.dsr.2009.12.001; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bo M, 2009, MAR ECOL PROG SER, V397, P53, DOI 10.3354/meps08185; Bo M, 2012, PLOS ONE IN PRESS; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; Bruno JF, 2000, OECOLOGIA, V122, P98, DOI 10.1007/PL00008841; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Canals M, 1997, DEEP-SEA RES PT II, V44, P611, DOI 10.1016/S0967-0645(96)00095-1; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Danovaro R., 2010, METHODS STUDY DEEP S; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; DEPREZ T, 2005, NEMYS; Emig C.C., 1997, PUBL ESPEC I ESP OCE, V23, P23; Feller R.J., 1988, P181; Ferdeghini F, 2000, HYDROBIOLOGIA, V440, P27, DOI 10.1023/A:1004124423718; Gambi C, 2003, DEEP-SEA RES PT I, V50, P103, DOI 10.1016/S0967-0637(02)00143-7; Gambi C., 2010, ADV OCEANOGR LIMNOL, V1, P167, DOI [10.4081/aiol.2010.5299, DOI 10.4081/AIOL.2010.5299]; Gambi C, 2009, BIODIVERS CONSERV, V18, P33, DOI 10.1007/s10531-008-9433-1; Gorley C.K., 2006, GETTING STARTED PRIM; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Hasemann C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029152; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kiriakoulakis K, 2004, DEEP-SEA RES PT I, V51, P1937, DOI 10.1016/j.dsr.2004.07.010; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LEVIN LA, 1991, AM ZOOL, V31, P886; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mirto S, 2010, MAR ENVIRON RES, V69, P38, DOI 10.1016/j.marenvres.2009.07.005; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Platt HM., 1983, SYNOPSIS FREE LIVI 1; Platt HM, 1988, SYNOPSIS FREE LIVI 2; Powers SP, 2005, MAR ECOL PROG SER, V302, P233, DOI 10.3354/meps302233; Previati M, 2010, J EXP MAR BIOL ECOL, V390, P39, DOI 10.1016/j.jembe.2010.04.025; Pusceddu A, 2000, POLAR BIOL, V23, P288, DOI 10.1007/s003000050446; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Pusceddu A, 2009, MAR ECOL PROG SER, V375, P41, DOI 10.3354/meps07735; Raes M, 2008, J BIOGEOGR, V35, P2207, DOI 10.1111/j.1365-2699.2008.01945.x; Schottner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032093; Seinhorst J. W., 1959, Nematologica, V4, P67; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Warwick RM, 1998, SYNOPSIS FREE LIVI 3; WIESER W, 1960, LIMNOL OCEANOGR, V5, P121, DOI 10.4319/lo.1960.5.2.0121; WIESER W., 1953, ARKIV ZOOL, V4, P439	58	18	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66553	10.1371/journal.pone.0066553	http://dx.doi.org/10.1371/journal.pone.0066553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823621	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400127
J	Kono, T; Korenaga, H				Kono, Tomoya; Korenaga, Hiroki			Cytokine Gene Expression in CD4 Positive Cells of the Japanese Pufferfish, Takifugu rubripes	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; MOLECULAR-CLONING; T-CELLS; TELEOST FISH; MESSENGER-RNA; TGF-BETA; FUGU; HOMOLOG; ACTIVATION; INTERFERON	CD4(+) T (Th) cells are a central component of the adaptive immune response and are divided into distinct sets based on their specific cytokine production pattern. Several reports have suggested that fish possess Th subset activity similar to that of mammals. The aim of the present study was to isolate CD4(+) T cells from the blood of Japanese pufferfish, Fugu rubripes, and to characterize their cytokine expression profile. We produced a specific antibody against Fugu CD4 and performed cell sorting with the magnetic activated cell sorting system. Sorted Fugu CD4(+) cells were characterized by morphology and expression analysis of cell marker genes. Fugu CD4(+) cells expressed T-cell marker genes but not macrophage or B-cell marker genes. In addition, peripheral blood lymphocytes were stimulated with lipopolysaccharide (LPS), polycytidylic acid (polyI: C), concanavalin A ( ConA) prior to sorting, and then Multiplex RT-PCR was used to examine the expression of Th cytokines by the stimulated Fugu CD4(+) cells. LPS and polyI: C stimulation upregulated the expression of Th1, Th17 and Treg cytokines and downregulated the expression of Th2 cytokines. ConA stimulation upregulated the expression of all Th cytokines. These results suggest that fish exhibit the same upregulation of Th-specific cytokine expression as in mammals.	[Kono, Tomoya] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Korenaga, Hiroki] Miyazaki Univ, Interdisciplinary Grad Sch Agr & Engn, Miyazaki, Japan	University of Miyazaki; University of Miyazaki	Kono, T (corresponding author), Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan.	tkono@cc.miyazaki-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [23780199]; University of Miyazaki	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Miyazaki	TK was supported financially by the Improvement of Research Environment for Young Researchers program of the Japanese Ministry of Education, Culture, Sports, Science and Technology, a Grant-in-Aid for Young Scientists (23780199) and a grant for Scientific Research on Priority Areas from the University of Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejo A, 2011, DEV COMP IMMUNOL, V35, P1215, DOI 10.1016/j.dci.2011.03.011; Alisa A, 2008, J IMMUNOL, V180, P5109, DOI 10.4049/jimmunol.180.7.5109; Annunziato F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2843; Araki K, 2008, DEV COMP IMMUNOL, V32, P850, DOI 10.1016/j.dci.2007.12.005; Bialecki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026919; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Boschi I, 2011, FISH SHELLFISH IMMUN, V31, P655, DOI 10.1016/j.fsi.2010.10.001; Buonocore F, 2008, MOL IMMUNOL, V45, P3168, DOI 10.1016/j.molimm.2008.02.024; Castro R, 2011, FISH SHELLFISH IMMUN, V30, P215, DOI 10.1016/j.fsi.2010.10.010; Corripio-Miyar Y, 2007, MOL IMMUNOL, V44, P1361, DOI 10.1016/j.molimm.2006.05.010; Edholm ES, 2007, DEV COMP IMMUNOL, V31, P172, DOI 10.1016/j.dci.2006.05.012; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Gibbings D, 2009, J LEUKOCYTE BIOL, V86, P251, DOI 10.1189/jlb.0109040; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; HAANEN JBAG, 1991, J EXP MED, V174, P583, DOI 10.1084/jem.174.3.583; Harms CA, 2000, FISH SHELLFISH IMMUN, V10, P61, DOI 10.1006/fsim.1999.0230; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Igawa D, 2006, MOL IMMUNOL, V43, P999, DOI 10.1016/j.molimm.2005.05.009; Kitao Y, 2009, MOL IMMUNOL, V46, P2548, DOI 10.1016/j.molimm.2009.05.012; Kobayashi I, 2006, DEV COMP IMMUNOL, V30, P1034, DOI 10.1016/j.dci.2006.01.005; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; Kono T, 2013, VET IMMUNOL IMMUNOP, V151, P90, DOI 10.1016/j.vetimm.2012.10.012; Korenaga H, 2012, TAKIFUGUM RUBRIPES G; Korenaga H, 2010, FISH SHELLFISH IMMUN, V28, P809, DOI 10.1016/j.fsi.2010.01.016; Kuo CH, 2011, J MOL MED, V89, P29, DOI 10.1007/s00109-010-0694-2; Laing KJ, 2006, J IMMUNOL, V177, P3939, DOI 10.4049/jimmunol.177.6.3939; Laing KJ, 2011, DEV COMP IMMUNOL, V35, P1282, DOI 10.1016/j.dci.2011.03.004; Laurent C, 2010, HAEMATOL-HEMATOL J, V95, P356, DOI 10.3324/haematol.2009.019133; Li J, 2004, DEV COMP IMMUNOL, V28, P1005, DOI 10.1016/j.dci.2004.03.004; Lynch GW, 2006, IMMUNOL CELL BIOL, V84, P154, DOI 10.1111/j.1440-1711.2005.01403.x; Malmhall C, 2007, ALLERGY, V62, P1007, DOI 10.1111/j.1398-9995.2007.01420.x; Nonaka S, 2008, FISHERIES SCI, V74, P341, DOI 10.1111/j.1444-2906.2008.01530.x; Odaka T, 2011, FISH SHELLFISH IMMUN, V30, P682, DOI 10.1016/j.fsi.2010.12.018; Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x; Ozdemir C, 2009, CLIN EXP ALLERGY, V39, P626, DOI 10.1111/j.1365-2222.2009.03242.x; Patel S, 2009, FISH SHELLFISH IMMUN, V26, P377, DOI 10.1016/j.fsi.2008.11.013; Pouw N, 2010, MOL IMMUNOL, V47, P1411, DOI 10.1016/j.molimm.2010.02.022; Rendon JL, 2012, J LEUKOCYTE BIOL, V92, P529, DOI 10.1189/jlb.0212083; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Savan R, 2005, IMMUNOGENETICS, V57, P140, DOI 10.1007/s00251-005-0768-4; Savan R, 2006, COMP BIOCHEM PHYS D, V1, P89, DOI 10.1016/j.cbd.2005.08.005; Hernandez AS, 2009, REUMATOL CLIN, V5, P1, DOI 10.1016/j.reuma.2008.11.012; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Suetake H, 2004, IMMUNOGENETICS, V56, P368, DOI 10.1007/s00251-004-0694-x; Sugamata R, 2009, J IMMUNOL, V182, P6799, DOI 10.4049/jimmunol.0803371; Sun XF, 2007, FISH SHELLFISH IMMUN, V23, P1242, DOI 10.1016/j.fsi.2007.06.004; Takizawa F, 2008, MOL IMMUNOL, V45, P127, DOI 10.1016/j.molimm.2007.05.005; Takizawa F, 2011, MOL IMMUNOL, V48, P1360, DOI 10.1016/j.molimm.2011.02.014; Toda H, 2011, DEV COMP IMMUNOL, V35, P650, DOI 10.1016/j.dci.2011.01.013; Venkatesh B, 1996, J MOL BIOL, V259, P655, DOI 10.1006/jmbi.1996.0347; Wang TH, 2013, MOL IMMUNOL, V53, P398, DOI 10.1016/j.molimm.2012.09.008; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031809; Wen Y, 2006, COMP BIOCHEM PHYS B, V144, P159, DOI 10.1016/j.cbpb.2006.02.012; Wen Y, 2011, CELL MOL LIFE SCI, V68, P2615, DOI 10.1007/s00018-010-0574-5; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Yamaguchi T, 2011, DEV COMP IMMUNOL, V35, P193, DOI 10.1016/j.dci.2010.09.007; Yang H, 2010, INFLAMM RES, V59, P197, DOI 10.1007/s00011-009-0087-6; Yang Jing, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P213; Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667; Yu YM, 2002, CELL IMMUNOL, V215, P78, DOI 10.1016/S0008-8749(02)00003-5; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Zou J, 2004, FISH SHELLFISH IMMUN, V17, P403, DOI 10.1016/j.fsi.2004.04.015	65	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66364	10.1371/journal.pone.0066364	http://dx.doi.org/10.1371/journal.pone.0066364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823320	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400092
J	Zhang, T; Watson, DG; Wang, LJ; Abbas, M; Murdoch, L; Bashford, L; Ahmad, I; Lam, NY; Ng, ACF; Leung, HY				Zhang, Tong; Watson, David G.; Wang, Lijie; Abbas, Muhammad; Murdoch, Laura; Bashford, Lisa; Ahmad, Imran; Lam, Nga-Yee; Ng, Anthony C. F.; Leung, Hing Y.			Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery	PLOS ONE			English	Article							PROFILING PROCEDURES; GAS-CHROMATOGRAPHY; SERUM SARCOSINE; DEFICIENCY; ACCURACY; MARKER; DAMAGE; ACID	Human exhibit wide variations in their metabolic profiles because of differences in genetic factors, diet and lifestyle. Therefore in order to detect metabolic differences between individuals robust analytical methods are required. A protocol was produced based on the use of Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) in combination with orthogonal Hydrophilic Interaction (HILIC) and Reversed Phase (RP) liquid chromatography methods for the analysis of the urinary metabolome, which was then evaluated as a diagnostic tool for prostate cancer (a common but highly heterogeneous condition). The LC-HRMS method was found to be robust and exhibited excellent repeatability for retention times (<+/- 1%), and mass accuracy (<+/- 1 ppm). Based on normalised data (against creatinine levels, osmolality or MS total useful signals/MSTUS) coupled with supervised multivariate analysis using Orthogonal Partial Least Square-Discriminant Analysis (OPLS-DA), we were able to discriminate urine samples from men with or without prostate cancer with R2Y(cum) >0.9. In addition, using the receiver operator characteristics (ROC) test, the area under curve (AUC) for the combination of the four best characterised biomarker compounds was 0.896. The four biomarker compounds were also found to differ significantly (P<0.05) between an independent patient cohort and controls. This is the first time such a rigorous test has been applied to this type of model. If validated, the established protocol provides a robust approach with a potentially wide application to metabolite profiling of human biofluids in health and disease.	[Zhang, Tong; Watson, David G.; Wang, Lijie; Abbas, Muhammad] Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Ahmad, Imran; Leung, Hing Y.] Gartnavel Royal Hosp, Dept Urol, Glasgow, Lanark, Scotland; [Bashford, Lisa; Ahmad, Imran; Leung, Hing Y.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Murdoch, Laura] Glasgow Clin Res Facil, Glasgow, Lanark, Scotland; [Lam, Nga-Yee; Ng, Anthony C. F.] Chinese Univ Hong Kong, Dept Urol, Hong Kong, Hong Kong, Peoples R China	University of Strathclyde; Gartnavel Royal Hospital; Beatson Institute; Chinese University of Hong Kong	Zhang, T (corresponding author), Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	tong.zhang.101@strath.ac.uk	Ahmad, Imran/GRJ-0536-2022; Chi-fai, NG/AAV-8270-2021; Ng, Chi-Fai/E-5134-2011	Ng, Chi-Fai/0000-0002-1723-9646; Leung, Hing Y./0000-0002-3933-3975; Ahmad, Imran/0000-0002-4404-1926	Cancer Research UK [15151] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Abdenur JE, 2006, MOL GENET METAB, V87, P48, DOI 10.1016/j.ymgme.2005.09.007; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Bohm L, 2012, SAMJ S AFR MED J, V102, P677, DOI 10.7196/SAMJ.5768; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cavaliere B, 2011, ANAL BIOANAL CHEM, V400, P2903, DOI 10.1007/s00216-011-4960-0; Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375; Chen J, 2009, ANAL CHIM ACTA, V650, P3, DOI 10.1016/j.aca.2009.03.039; Claudino WM, 2012, CRIT REV ONCOL HEMAT, V84, P1, DOI 10.1016/j.critrevonc.2012.02.009; Darbon JM, 2009, B CANCER, V96, P355, DOI 10.1684/bdc.2009.0849; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Ganti S, 2011, UROL ONCOL-SEMIN ORI, V29, P551, DOI 10.1016/j.urolonc.2011.05.013; Huang Z., 2012, METABOLOMICS; IDE H, 1991, J BIOL CHEM, V266, P1469; Issaq HJ, 2008, J UROLOGY, V179, P2422, DOI 10.1016/j.juro.2008.01.084; Issaq HJ, 2011, J SEP SCI, V34, P3619, DOI 10.1002/jssc.201100572; Issaq HJ, 2011, J SEP SCI, V34, P3484, DOI 10.1002/jssc.201100528; Jentzmik F, 2011, J UROLOGY, V185, P706, DOI 10.1016/j.juro.2010.09.077; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; Kim K, 2009, MOL CELL PROTEOMICS, V8, P558, DOI 10.1074/mcp.M800165-MCP200; Kuhara T, 2009, J MASS SPECTROM, V44, P214, DOI 10.1002/jms.1500; Lucarelli G, 2012, PROSTATE, V72, P1611, DOI 10.1002/pros.22514; Marklova E, 1999, AMINO ACIDS, V17, P401, DOI 10.1007/BF01361665; Martinez-Lozano P, 2011, METABOLOMICS; Palacios DA, 2012, BIOMARK MED, V6, P513; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; Schalken JA, 2010, EUR UROL, V58, P19, DOI 10.1016/j.eururo.2010.02.025; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Struys EA, 2010, ANN CLIN BIOCHEM, V47, P282, DOI 10.1258/acb.2010.009270; Theodoridis G, 2011, MASS SPECTROM REV, V30, P884, DOI 10.1002/mas.20306; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; Trock BJ, 2011, UROL ONCOL-SEMIN ORI, V29, P572, DOI 10.1016/j.urolonc.2011.08.002; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007; Woo HM, 2009, CLIN CHIM ACTA, V400, P63, DOI 10.1016/j.cca.2008.10.014; Wu H, 2011, ANAL BIOANAL CHEM, V401, P635, DOI 10.1007/s00216-011-5098-9; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738	40	42	42	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65880	10.1371/journal.pone.0065880	http://dx.doi.org/10.1371/journal.pone.0065880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823321	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000320576400027
J	Ren, G; Beech, C; Smas, CM				Ren, Gang; Beech, Cameron; Smas, Cynthia M.			The Immunoglobulin Superfamily Protein Differentiation of Embryonic Stem Cells 1 (Dies1) Has a Regulatory Role in Preadipocyte to Adipocyte Conversion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; PPAR-GAMMA; SIGNALING PATHWAY; GENE-EXPRESSION; TNF-ALPHA; FAT; ADIPOGENESIS; METABOLISM; COMMITMENT	Differentiation of Embryonic Stem Cells 1 (Dies1) was recently identified as a novel type I immunoglobulin (IgG) domain-containing plasma membrane protein important for effective differentiation of a murine pluripotent embryonic stem cell line. In this setting, Dies1 enhances bone morphogenetic protein 4 (BMP4) signaling. Here we show Dies1 transcript expression is induced similar to 225-fold during in vitro adipogenesis of 3T3-L1 murine preadipocytes. Immunocytochemical imaging using ectopic expression of Flag-tagged Dies1 in 3T3-L1 adipocytes revealed localization to the adipocyte plasma membrane. Modulation of adipocyte phenotype with with tumor necrosis factor-alpha (TNF alpha) treatment or by siRNA knockdown of the master pro-adipogenic transcription factor peroxisome proliferator activated receptor gamma (PPAR gamma) resulted in a 90% and 60% reduction of Dies1 transcript levels, respectively. Moreover, siRNA-mediated Dies1 knockdown in 3T3-L1 preadipocytes inhibited adipogenic conversion. Such cultures had a 35% decrease in lipid content and a 45%-65% reduction in expression of key adipocyte transcripts, including that for PPARc. The standard protocol for full in vitro adipogenic conversion of committed preadipocytes, such as 3T3-L1, does not include BMP4 treatment. Thus we posit the positive role of Dies1 in adipogenesis, unlike that for Dies1 in differentiation of embryonic stem cells, does not include its pro-BMP4 effects. In support of this idea, 3T3-L1 adipocytes knocked down for Dies1 did not evidence decreased phospho-Smad1 levels upon BMP4 exposure. qPCR analysis of Dies1 transcript in multiple murine and human tissues reveals high enrichment in white adipose tissue (WAT). Interestingly, we observed a 10-fold induction of Dies1 transcript in WAT of fasted vs. fed mice, suggesting a role for Dies1 in nutritional response of mature fat cells in vivo. Together our data identify Dies1 as a new differentiation-dependent adipocyte plasma membrane protein whose expression is required for effective adipogenesis and that may also play a role in regard to nutritional status in WAT.	[Ren, Gang; Beech, Cameron; Smas, Cynthia M.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43606 USA; [Smas, Cynthia M.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Smas, CM (corresponding author), Univ Toledo, Coll Med, Dept Biochem & Canc Biol, 2801 W Bancroft St, Toledo, OH 43606 USA.	cynthia.smas@utoledo.edu		Ren, Gang/0000-0002-2555-7804	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by funding from NIH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Aloia L, 2010, J BIOL CHEM, V285, P7776, DOI 10.1074/jbc.M109.077156; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; BORTELL R, 1994, J CELL BIOCHEM, V54, P256, DOI 10.1002/jcb.240540214; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Demeulemeester D, 2005, BIOCHEM BIOPH RES CO, V329, P105, DOI 10.1016/j.bbrc.2005.01.103; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V16, P16; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Parisi S, 2012, FASEB J, V26, P3957, DOI 10.1096/fj.12-211607; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen E, 2009, EXPERT OPIN THER TAR, V13, P975, DOI 10.1517/14728220903039706; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319; Sakr MA, 2010, CANCER SCI, V101, P2368, DOI 10.1111/j.1349-7006.2010.01675.x; Sul HS, 2000, INT J OBESITY, V24, pS15, DOI 10.1038/sj.ijo.0801494; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Van Hul M, 2011, ENDOCR J, V58, P101, DOI 10.1507/endocrj.K10E-267; Wang L, 2011, J EXP MED, V208, P577, DOI 10.1084/jem.20100619; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wu Y, 2008, AM J PHYSIOL-ENDOC M, V295, pE205, DOI 10.1152/ajpendo.90316.2008; Wu Yu, 2008, BMC Res Notes, V1, P85, DOI 10.1186/1756-0500-1-85; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	43	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65531	10.1371/journal.pone.0065531	http://dx.doi.org/10.1371/journal.pone.0065531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799023	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800011
J	Crangle, CE; Perreau-Guimaraes, M; Suppes, P				Crangle, Colleen E.; Perreau-Guimaraes, Marcos; Suppes, Patrick			Structural Similarities between Brain and Linguistic Data Provide Evidence of Semantic Relations in the Brain	PLOS ONE			English	Article							WAVE REPRESENTATIONS; RECOGNITION; INVARIANCE; COMPONENT; MEANINGS	This paper presents a new method of analysis by which structural similarities between brain data and linguistic data can be assessed at the semantic level. It shows how to measure the strength of these structural similarities and so determine the relatively better fit of the brain data with one semantic model over another. The first model is derived from WordNet, a lexical database of English compiled by language experts. The second is given by the corpus-based statistical technique of latent semantic analysis (LSA), which detects relations between words that are latent or hidden in text. The brain data are drawn from experiments in which statements about the geography of Europe were presented auditorily to participants who were asked to determine their truth or falsity while electroencephalographic (EEG) recordings were made. The theoretical framework for the analysis of the brain and semantic data derives from axiomatizations of theories such as the theory of differences in utility preference. Using brain-data samples from individual trials time-locked to the presentation of each word, ordinal relations of similarity differences are computed for the brain data and for the linguistic data. In each case those relations that are invariant with respect to the brain and linguistic data, and are correlated with sufficient statistical strength, amount to structural similarities between the brain and linguistic data. Results show that many more statistically significant structural similarities can be found between the brain data and the WordNet-derived data than the LSA-derived data. The work reported here is placed within the context of other recent studies of semantics and the brain. The main contribution of this paper is the new method it presents for the study of semantics and the brain and the focus it permits on networks of relations detected in brain data and represented by a semantic model.	[Crangle, Colleen E.] Univ Lancaster, Sch Comp & Commun, Lancaster, England; [Crangle, Colleen E.] Converspeech LLC, Palo Alto, CA USA; [Perreau-Guimaraes, Marcos; Suppes, Patrick] Stanford Univ, Ctr Study Language & Informat, Suppes Brain Lab, Stanford, CA 94305 USA	Lancaster University; Stanford University	Crangle, CE (corresponding author), Univ Lancaster, Sch Comp & Commun, Lancaster, England.	crangle@converspeech.com						Ballatore Andrea, 2012, Advances in Conceptual Modeling. Proceedings ER 2012 Workshops: CMS, ECDM-NoCoDA, MoDIC, MORE-BI, RIGiM, SeCoGIS, WISM, P231, DOI 10.1007/978-3-642-33999-8_29; Baroni M, 2010, COGNITIVE SCI, V34, P222, DOI 10.1111/j.1551-6709.2009.01068.x; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Borovsky A, 2012, LANG LEARN DEV, V8, P278, DOI 10.1080/15475441.2011.614893; Brants T., 2006, WEB IT 5 GRAM VERSIO; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; Budanitsky A, 2001, P NAACL 2001 WORKSH; Chan AM, 2011, NEUROIMAGE, V54, P3028, DOI 10.1016/j.neuroimage.2010.10.073; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Crestani F, 1997, ARTIF INTELL REV, V11, P453, DOI 10.1023/A:1006569829653; Devereux Barry, 2010, P NAACL WORKSH COMP, P70; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Guimaraes MP, 2007, IEEE T BIO-MED ENG, V54, P436, DOI 10.1109/TBME.2006.888824; Henkin L., 1974, P TARSK S, VXXV, P465; Hirst G, 1988, LEXICAL AMBIGUITY RE, P73; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Jelodar Ahmad Babaeian, 2010, P NAACL HLT 2010 1 W, P18; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Karp R. M., 1972, P COMPL COMP COMP, P85; Kelly C., 2010, P NAACL HLT 2010 1 W, P61; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; LUCE RD, 1956, ECONOMETRICA, V24, P178, DOI 10.2307/1905751; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Martin P, 2003, LECT NOTES ARTIF INT, V2746, P160; Matsunaga T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-205; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Murphy B., 2009, P 2009 C EMP METH NA, P619, DOI [10.3115/1699571.1699594, DOI 10.3115/1699571.1699594]; Murphy B., 2010, P NAACL HLT 2010 1 W, P36; Murphy B, 2012, P 1 JOINT C LEX COMP, V2, P114; Murphy B, 2011, BRAIN LANG, V117, P12, DOI 10.1016/j.bandl.2010.09.013; Murphy Brian, 2012, P 1 JOINT C LEX COMP, P114; Patwardhan S, 2004, P 19 NAT C ART INT I; Pereira F.B., 2010, P 2010 IEEE C EV COM, P1, DOI DOI 10.1109/ICCCN.2010.5560019; Princeton University, WORDNET; Scott D., 1958, J SYMBOLIC LOGIC, V23, P113, DOI [DOI 10.2307/2964389, 10.2307/2964389]; Sudre G, 2012, NEUROIMAGE, V62, P451, DOI 10.1016/j.neuroimage.2012.04.048; Suppes P, 1997, P NATL ACAD SCI USA, V94, P14965, DOI 10.1073/pnas.94.26.14965; Suppes P, 1998, P NATL ACAD SCI USA, V95, P15861, DOI 10.1073/pnas.95.26.15861; Suppes P, 1999, P NATL ACAD SCI USA, V96, P14658, DOI 10.1073/pnas.96.25.14658; Suppes P, 1999, P NATL ACAD SCI USA, V96, P12953, DOI 10.1073/pnas.96.22.12953; Suppes P, 2000, P NATL ACAD SCI USA, V97, P8738, DOI 10.1073/pnas.140228397; Suppes P., 1972, AXIOMATIC SET THEORY; Suppes P, 2009, NEURAL COMPUT, V21, P3228, DOI 10.1162/neco.2009.04-08-764; Wong DK, 2008, NEUROIMAGE, V39, P1051, DOI 10.1016/j.neuroimage.2007.07.064; Wong DK, 2006, NEUROCOMPUTING, V70, P373, DOI 10.1016/j.neucom.2006.01.020; Wong DK, 2004, NEUROCOMPUTING, V61, P479, DOI 10.1016/j.neucom.2004.06.004; Woods W.A., 1975, REPRESENTATION UNDER, P35	54	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65366	10.1371/journal.pone.0065366	http://dx.doi.org/10.1371/journal.pone.0065366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799009	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300016
J	Crowe, TP; Cusson, M; Bulleri, F; Davoult, D; Arenas, F; Aspden, R; Benedetti-Cecchi, L; Bevilacqua, S; Davidson, I; Defew, E; Fraschetti, S; Gollety, C; Griffin, JN; Herkul, K; Kotta, J; Migne, A; Molis, M; Nicol, SK; Noel, LMLJ; Pinto, IS; Valdivia, N; Vaselli, S; Jenkins, SR				Crowe, Tasman P.; Cusson, Mathieu; Bulleri, Fabio; Davoult, Dominique; Arenas, Francisco; Aspden, Rebecca; Benedetti-Cecchi, Lisandro; Bevilacqua, Stanislao; Davidson, Irvine; Defew, Emma; Fraschetti, Simonetta; Gollety, Claire; Griffin, John N.; Herkuel, Kristjan; Kotta, Jonne; Migne, Aline; Molis, Markus; Nicol, Sophie K.; Noel, Laure M-L J.; Pinto, Isabel Sousa; Valdivia, Nelson; Vaselli, Stefano; Jenkins, Stuart R.			Large-Scale Variation in Combined Impacts of Canopy Loss and Disturbance on Community Structure and Ecosystem Functioning	PLOS ONE			English	Article							BIODIVERSITY LOSS; MARINE BIODIVERSITY; DIVERSITY; ASSEMBLAGES; PRODUCTIVITY; STABILITY; IDENTITY; ALGAE; REDUNDANCY; PATTERNS	Ecosystems are under pressure from multiple human disturbances whose impact may vary depending on environmental context. We experimentally evaluated variation in the separate and combined effects of the loss of a key functional group (canopy algae) and physical disturbance on rocky shore ecosystems at nine locations across Europe. Multivariate community structure was initially affected (during the first three to six months) at six locations but after 18 months, effects were apparent at only three. Loss of canopy caused increases in cover of non-canopy algae in the three locations in southern Europe and decreases in some northern locations. Measures of ecosystem functioning (community respiration, gross primary productivity, net primary productivity) were affected by loss of canopy at five of the six locations for which data were available. Short-term effects on community respiration were widespread, but effects were rare after 18 months. Functional changes corresponded with changes in community structure and/or species richness at most locations and times sampled, but no single aspect of biodiversity was an effective predictor of longer-term functional changes. Most ecosystems studied were able to compensate in functional terms for impacts caused by indiscriminate physical disturbance. The only consistent effect of disturbance was to increase cover of non-canopy species. Loss of canopy algae temporarily reduced community resistance to disturbance at only two locations and at two locations actually increased resistance. Resistance to disturbance-induced changes in gross primary productivity was reduced by loss of canopy algae at four locations. Location-specific variation in the effects of the same stressors argues for flexible frameworks for the management of marine environments. These results also highlight the need to analyse how species loss and other stressors combine and interact in different environmental contexts.	[Crowe, Tasman P.; Cusson, Mathieu; Nicol, Sophie K.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Cusson, Mathieu; Bulleri, Fabio; Benedetti-Cecchi, Lisandro; Vaselli, Stefano] Univ Pisa, Dept Biol, Consorzio Interuniv Sci Mare, Pisa, Italy; [Cusson, Mathieu] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Davoult, Dominique; Gollety, Claire; Migne, Aline; Noel, Laure M-L J.] Univ Paris 06, Stn Biol Roscoff, Roscoff, France; [Davoult, Dominique; Gollety, Claire; Migne, Aline; Noel, Laure M-L J.] CNRS, Stn Biol Roscoff, Roscoff, France; [Arenas, Francisco; Pinto, Isabel Sousa; Vaselli, Stefano] Univ Porto, Lab Coastal Biodivers, Ctr Marine & Environm Res, P-4100 Oporto, Portugal; [Aspden, Rebecca; Davidson, Irvine; Defew, Emma] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Bevilacqua, Stanislao; Fraschetti, Simonetta] Univ Salento, Dept Biol Environm Sci & Technol, Consorzio Nazl Interunv Sci Mare, Lecce, Italy; [Griffin, John N.; Noel, Laure M-L J.; Jenkins, Stuart R.] Marine Biol Assoc UK, Plymouth, Devon, England; [Herkuel, Kristjan; Kotta, Jonne] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia; [Molis, Markus; Valdivia, Nelson] Alfred Wegener Inst Polar & Marine Res, Biol Anstalt Helgoland, Sect Funct Ecol, Helgoland, Germany; [Valdivia, Nelson] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Lab Costero Recursos Acuat Calfuco, Valdivia, Chile; [Jenkins, Stuart R.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales; [Griffin, John N.] Swansea Univ, Dept Biosci, Swansea, W Glam, Wales	University College Dublin; University of Pisa; University of Quebec; University of Quebec Chicoutimi; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universidade do Porto; University of St Andrews; University of Salento; Marine Biological Association United Kingdom; University of Tartu; Estonian Marine Institute; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Universidad Austral de Chile; Bangor University; Swansea University	Crowe, TP (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	tasman.crowe@ucd.ie	Jenkins, Stuart R/D-2032-2010; Davoult, dominique/D-5932-2012; Gollety, Claire/D-6743-2011; Arenas, Francisco/M-6367-2013; Arenas, Francisco/M-7095-2015; Cusson, Mathieu/A-3026-2014; Kotta, Jonne/B-5542-2009; Fraschetti, Simonetta/R-8716-2019; Bevilacqua, Stanislao/I-1393-2019; Pinto, Isabel Sousa/W-1591-2019; Valdivia, Nelson A/C-3613-2009; Benedetti-Cecchi, Lisandro/J-8225-2019; Herkül, Kristjan/G-5791-2016	Jenkins, Stuart R/0000-0002-2299-6318; Davoult, dominique/0000-0001-8678-3998; Arenas, Francisco/0000-0001-6925-3805; Arenas, Francisco/0000-0001-6925-3805; Kotta, Jonne/0000-0002-4970-6755; Fraschetti, Simonetta/0000-0002-1780-1651; Bevilacqua, Stanislao/0000-0002-6417-7134; Pinto, Isabel Sousa/0000-0002-9231-0553; Valdivia, Nelson A/0000-0002-5394-2072; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Herkül, Kristjan/0000-0002-4356-8152; Cusson, Mathieu/0000-0002-2111-4803; Griffin, John/0000-0003-3295-6480; Bulleri, Fabio/0000-0002-7335-6791	European Community [GOCE-CT-2003-505446]; Irish Research Council for Science, Engineering and Technology; Natural Environment Research Council [NE/B504649/1] Funding Source: researchfish	European Community(European Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project was carried out within the framework of the MarBEF Network of Excellence 'Marine Biodiversity and Ecosystem Functioning' which was funded by the Sustainable Development, Global Change and Ecosystems Programme of the European Community's Sixth Framework Programme (contract no. GOCE-CT-2003-505446). Additional funding was provided by participating institutions and the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson M. J., 2005, PERMANOVA FORTRAN CO; Araujo R, 2012, MAR BIOL, V159, P697, DOI 10.1007/s00227-011-1847-8; Atalah J, 2010, J EXP MAR BIOL ECOL, V388, P51, DOI 10.1016/j.jembe.2010.03.005; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BELL EC, 1993, MAR BIOL, V117, P337, DOI 10.1007/BF00345679; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; BENEDETTICECCHI L, 1992, MAR ECOL PROG SER, V90, P183, DOI 10.3354/meps090183; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Bertocci I, 2010, MAR ECOL PROG SER, V414, P107, DOI 10.3354/meps08729; BIDWELL RGS, 1985, J EXP MAR BIOL ECOL, V86, P15, DOI 10.1016/0022-0981(85)90040-1; Biles CL, 2003, J EXPT MARINE BIOL E, P285; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Bulleri F, 2002, J EXP MAR BIOL ECOL, V267, P89, DOI 10.1016/S0022-0981(01)00361-6; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crowe TP, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P185; Crowe TP, 2009, ECOL STUD-ANAL SYNTH, V206, P375, DOI 10.1007/978-3-540-92704-4_27; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duffy JE, 2001, ECOLOGY, V82, P2417; Dyson KE, 2007, P ROY SOC B-BIOL SCI, V274, P2547, DOI 10.1098/rspb.2007.0922; European Union, 2008, OFF J EUR UNION L, VL164, P19; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Foster MS, 2003, J EXP MAR BIOL ECOL, V289, P15, DOI 10.1016/S0022-0981(03)00035-2; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gollety C, 2008, THESIS UPMC U PARIS, P+4; Gollety C, 2008, J PHYCOL, V44, P1146, DOI 10.1111/j.1529-8817.2008.00569.x; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Griffin John n., 2009, P78; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Jenkins SR, 1999, MAR ECOL PROG SER, V188, P81, DOI 10.3354/meps188081; Jenkins SR, 2008, ECOLOGY, V89, pS3, DOI 10.1890/07-1155.1; JOHNSON WS, 1974, ECOLOGY, V55, P450, DOI 10.2307/1935235; JOHNSTON AM, 1986, OECOLOGIA, V69, P288, DOI 10.1007/BF00377636; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS, DOI DOI 10.1017/CBO9780511623370; Leonard GH, 2000, ECOLOGY, V81, P1015; Maggi E, 2009, MAR ECOL PROG SER, V381, P39, DOI 10.3354/meps07949; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Migne A, 2002, MAR BIOL, V140, P865, DOI 10.1007/s00227-001-0741-1; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Nielsen KJ, 2001, ECOL MONOGR, V71, P187, DOI 10.1890/0012-9615(2001)071[0187:BUATDF]2.0.CO;2; Noel LMLJ, 2010, ESTUAR COAST SHELF S, V88, P153, DOI 10.1016/j.ecss.2010.03.005; O'Connor NE, 2005, ECOLOGY, V86, P1783, DOI 10.1890/04-1172; O'Connor NE, 2008, ECOLOGY, V89, P428, DOI 10.1890/06-2029.1; O'Connor NE, 2007, OIKOS, V116, P2027, DOI 10.1111/j.2007.0030-1299.16085.x; Paine R. T., 1977, ACAD NAT SCI SPEC PU, V12, P245; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Reynolds PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036196; Schiel DR, 2007, MAR ECOL PROG SER, V339, P1, DOI 10.3354/meps339001; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Underwood A, 1997, EXPT ECOLOGY THEIR L; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; WALKER B, 1995, CONSERV BIOL, V9, P747, DOI 10.1046/j.1523-1739.1995.09040747.x; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Whittaker K, 1975, PRIMARY PRODUCTIVITY, V14, P306; Williams SL, 2005, ECOLOGY, V86, P2373, DOI 10.1890/04-1569; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	77	40	40	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66238	10.1371/journal.pone.0066238	http://dx.doi.org/10.1371/journal.pone.0066238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799082	Green Published, Green Accepted, gold			2022-12-27	WOS:000320363300067
J	Leko, V; Park, GJ; Lao, U; Simon, JA; Bedalov, A				Leko, Vid; Park, Gemma J.; Lao, Uyen; Simon, Julian A.; Bedalov, Antonio			Enterocyte-Specific Inactivation of SIRT1 Reduces Tumor Load in the APC(+/min) Mouse Model	PLOS ONE			English	Article							BETA-CATENIN; C-MYC; INTESTINAL NEOPLASIA; POLYP FORMATION; POOR-PROGNOSIS; CELL-SURVIVAL; STEM-CELLS; EXPRESSION; P53; GROWTH	SIRT1 is a mammalian NAD(+)-dependent histone deacetylase implicated in metabolism, development, aging and tumorigenesis. Prior studies that examined the effect of enterocyte-specific overexpression and global deletion of SIRT1 on polyp formation in the intestines of APC(+/min) mice, a commonly used model for intestinal tumorigenesis, yielded conflicting results, supporting either tumor-suppressive or tumor-promoting roles for SIRT1, respectively. In order to resolve the controversy emerging from these prior in vivo studies, in the present report we examined the effect of SIRT1 deficiency confined to the intestines, avoiding the systemic perturbations such as growth retardation seen with global SIRT1 deletion. We crossed APC(+/min) mice with mice bearing enterocyte-specific inactivation of SIRT1 and examined polyp development in the progeny. We found that SIRT1-inactivation reduced total polyp surface (9.3 mm(2) vs. 23.3 mm(2), p = 0.01), average polyp size (0.24 mm(2) vs. 0.51 mm(2), p = 0.005) and the number of polyps >0.5 mm in diameter (14 vs. 23, p = 0.04), indicating that SIRT1 affects both the number and size of tumors. Additionally, tumors in SIRT1-deficient mice exhibited markedly increased numbers of cells undergoing apoptosis, suggesting that SIRT1 contributes to tumor growth by enabling survival of tumor cells. Our results indicate that SIRT1 acts as a tumor promoter in the APC(+/min) mouse model of intestinal tumorigenesis.	[Leko, Vid; Park, Gemma J.; Lao, Uyen; Simon, Julian A.; Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Simon, Julian A.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Bedalov, Antonio] Univ Washington, Dept Med, Seattle, WA USA; [Bedalov, Antonio] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bedalov, A (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	abedalov@fhcrc.org			National Institutes of Health (NIH) [CA 129132]; NATIONAL CANCER INSTITUTE [R01CA129132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH), CA 129132, to AB. (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Eads CA, 2002, CANCER RES, V62, P1296; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Herranz D, 2012, ONCOGENE; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Holloway KR, 2010, P NATL ACAD SCI USA, V107, P9216, DOI 10.1073/pnas.0911325107; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahajan Sumit S, 2011, Handb Exp Pharmacol, V206, P241, DOI 10.1007/978-3-642-21631-2_11; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Menssen A, 2012, ONCOTARGET, V3, P112, DOI 10.18632/oncotarget.440; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Song NY, 2012, ANN NY ACAD SCI, V1271, P10, DOI 10.1111/j.1749-6632.2012.06762.x; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu YP, 2002, CANCER RES, V62, P1030; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	63	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66283	10.1371/journal.pone.0066283	http://dx.doi.org/10.1371/journal.pone.0066283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799088	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300072
J	Ndeledje, N; Bouyer, J; Stachurski, F; Grimaud, P; Belem, AMG; Mbaindingatoloum, FM; Bengaly, Z; Alfaroukh, IO; Cecchi, G; Lancelot, R				Ndeledje, Noel; Bouyer, Jeremy; Stachurski, Frederic; Grimaud, Patrice; Belem, Adrien Marie Gaston; Mbaindingatoloum, Fidele Molele; Bengaly, Zakaria; Alfaroukh, Idriss Oumar; Cecchi, Guiliano; Lancelot, Renaud			Treating Cattle to Protect People? Impact of Footbath Insecticide Treatment on Tsetse Density in Chad	PLOS ONE			English	Article							RESTRICTED APPLICATION; FLIES; POPULATION; TRYPANOSOMOSIS; IDENTIFICATION; PYRETHROIDS; LIVESTOCK; IMPROVE; RISK	Background: In Chad, several species of tsetse flies (Genus: Glossina) transmit African animal trypanosomoses (AAT), which represents a major obstacle to cattle rearing, and sleeping sickness, which impacts public health. After the failure of past interventions to eradicate tsetse, the government of Chad is now looking for other approaches that integrate cost-effective intervention techniques, which can be applied by the stake holders to control tsetse-transmitted trypanosomoses in a sustainable manner. The present study thus attempted to assess the efficacy of restricted application of insecticides to cattle leg extremities using footbaths for controlling Glossina m. submorsitans, G. tachinoides and G. f. fuscipes in southern Chad. Methodology/Principal Findings: Two sites were included, one close to the historical human African trypanosomiasis (HAT) focus of Moundou and the other to the active foci of Bodo and Moissala. At both sites, a treated and an untreated herd were compared. In the treatment sites, cattle were treated on a regular basis using a formulation of deltamethrin 0.005% (67 to 98 cattle were treated in one of the sites and 88 to 102 in the other one). For each herd, tsetse densities were monthly monitored using 7 biconical traps set along the river and beside the cattle pen from February to December 2009. The impact of footbath treatment on tsetse populations was strong (p < 10(-3)) with a reduction of 80% in total tsetse catches by the end of the 6-month footbath treatment. Conclusions/Significance: The impact of footbath treatment as a vector control tool within an integrated strategy to manage AAT and HAT is discussed in the framework of the "One Health" concept. Like other techniques based on the treatment of cattle, this technology should be used under controlled conditions, in order to avoid the development of insecticide and acaricide resistance in tsetse and tick populations, respectively.	[Ndeledje, Noel; Bengaly, Zakaria] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso; [Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal; [Bouyer, Jeremy; Stachurski, Frederic; Lancelot, Renaud] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, Montpellier, France; [Bouyer, Jeremy; Stachurski, Frederic; Lancelot, Renaud] INRA, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34060 Montpellier, France; [Belem, Adrien Marie Gaston] Univ Polytech Bobo Dioulasso UPB, Bobo Dioulasso, Burkina Faso; [Cecchi, Guiliano] UN, Food & Agr Org, Anim Prod & Hlth Div, Rome, Italy	CIRAD; INRAE; Food & Agriculture Organization of the United Nations (FAO)	Bouyer, J (corresponding author), Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal.	bouyer@cirad.fr	Lancelot, Renaud/HGE-1086-2022; Bouyer, Jérémy/AAK-7370-2020	Lancelot, Renaud/0000-0002-5826-5242; Bouyer, Jérémy/0000-0002-1913-416X	Project "Pole Regional de Recherche Appliquee au developpement des Systemes Agricoles d'Afrique Centrale" (PRASAC); French Embassy in Chad; Government of Italy through the FAO Trust Fund for Food Security and Food Safety; FAO, in the framework of the Programme against African Trypanosomosis (PAAT), through the project "Improving food security in sub-Saharan Africa by supporting the progressive reduction of tsetse-transmitted trypanosomosis in the framework of the NEPAD" [GTFS/RAF/474/ITA]	Project "Pole Regional de Recherche Appliquee au developpement des Systemes Agricoles d'Afrique Centrale" (PRASAC); French Embassy in Chad; Government of Italy through the FAO Trust Fund for Food Security and Food Safety; FAO, in the framework of the Programme against African Trypanosomosis (PAAT), through the project "Improving food security in sub-Saharan Africa by supporting the progressive reduction of tsetse-transmitted trypanosomosis in the framework of the NEPAD"	CEVA Sante Animale provided the insecticide (VectocidND) used in this study, and the field work was funded by the Project "Pole Regional de Recherche Appliquee au developpement des Systemes Agricoles d'Afrique Centrale" (PRASAC) and the French Embassy in Chad. FAO, in the framework of the Programme against African Trypanosomosis (PAAT), provided technical assistance to this research, in particular through the project "Improving food security in sub-Saharan Africa by supporting the progressive reduction of tsetse-transmitted trypanosomosis in the framework of the NEPAD" (GTFS/RAF/474/ITA), funded by the Government of Italy through the FAO Trust Fund for Food Security and Food Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The boundaries and names shown and the designations used on the maps presented in this paper do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The views expressed in this paper are those of the authors and do not necessarily reflect the views of FAO.	Adam Y, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002135; [Anonymous], 2005, AFRICA BUSINESS APR; [Anonymous], WORLD FACTB; Bates D, 2011, IME4 LINEAR MIXED EF; Bourn D., 2005, ASPECTS APPL BIOL, V75, P1; Bouyer F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001276; Bouyer J, 2007, PREV VET MED, V78, P223, DOI 10.1016/j.prevetmed.2006.10.008; Bouyer J., 2008, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V61, P161; Bouyer J, 2009, MOL ECOL, V18, P2787, DOI 10.1111/j.1365-294X.2009.04233.x; Bouyer J, 2009, VET PARASITOL, V161, P187, DOI 10.1016/j.vetpar.2009.01.018; Bouyer J., 2010, INFECT PARASITIC DIS, P1936; Bouyer J, 2008, REV ELEV MED VET PAY, V61, P153; Bouyer J, 2006, VET RES, V37, P633, DOI 10.1051/vetres:2006025; Camara M, 2005, Med Trop (Mars), V65, P155; Cecchi Giuliano, 2009, P1; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Core R Team, 2013, R LANG ENV STAT COMP; De Deken R, 1998, ANN NY ACAD SCI, V849, P450, DOI 10.1111/j.1749-6632.1998.tb11095.x; de l'ElevageduMinistere Tchad, 2002, RAPP STAT; Desquesnes M, 2001, ANN TROP MED PARASIT, V95, P141, DOI 10.1080/00034980120050251; Dyer NA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001266; Eisler MC, 2003, TRENDS PARASITOL, V19, P341, DOI 10.1016/S1471-4922(03)00164-8; Funk S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002855; Goldstein H., 1999, MULTILEVEL STAT MODE; Grady SC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000957; Gruvel J, 1966, Rev Elev Med Vet Pays Trop, V19, P169; Habtewold T, 2004, MED VET ENTOMOL, V18, P408, DOI 10.1111/j.0269-283X.2004.00525.x; Hargrove JW., 2003, TSETSE ERADICATION S; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Pagabeleguem S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049762; Rayaisse JB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001491; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; ROGERS DJ, 1990, INSECT SCI APPL, V11, P331, DOI 10.1017/S1742758400012753; ROGERS DJ, 1988, PARASITOLOGY, V97, P193, DOI 10.1017/S0031182000066853; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Stachurski F, 2000, MED VET ENTOMOL, V14, P391, DOI 10.1046/j.1365-2915.2000.00246.x; Stachurski F, 2006, MED VET ENTOMOL, V20, P402, DOI 10.1111/j.1365-2915.2006.00648.x; Tibayreac R, 1977, Revue Elev Med vet Pays trop, V30, P31; Tibayrenc R, 1977, PROSPECTIONS PULVERI, V20, P19; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Torr SJ, 2000, MED VET ENTOMOL, V14, P400, DOI 10.1046/j.1365-2915.2000.00257.x; Vale GA, 2004, B ENTOMOL RES, V94, P273, DOI 10.1079/BER2004300; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Wint W, 2000, PREDICTED DISTRIBUTI; Wint W., 2007, GRIDDED LIVESTOCK WO	48	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67580	10.1371/journal.pone.0067580	http://dx.doi.org/10.1371/journal.pone.0067580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799148	Green Published, gold			2022-12-27	WOS:000320363300111
J	Lewinsohn, DM; Swarbrick, GM; Cansler, ME; Null, MD; Rajaraman, V; Frieder, MM; Sherman, DR; McWeeney, S; Lewinsohn, DA				Lewinsohn, David M.; Swarbrick, Gwendolyn M.; Cansler, Meghan E.; Null, Megan D.; Rajaraman, Veena; Frieder, Marisa M.; Sherman, David R.; McWeeney, Shannon; Lewinsohn, Deborah A.			Human Mycobacterium tuberculosis CD8 T Cell Antigens/Epitopes Identified by a Proteomic Peptide Library	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; DENDRITIC CELLS; INFECTED-CELLS; HIV-INFECTION; HLA-B; LYMPHOCYTES; VACCINES; ANTIGEN; MICE; VACCINATION	Identification of CD8(+) T cell antigens/epitopes expressed by human pathogens with large genomes is especially challenging, yet necessary for vaccine development. Immunity to tuberculosis, a leading cause of mortality worldwide, requires CD8(+) T cell immunity, yet the repertoire of CD8 antigens/epitopes remains undefined. We used integrated computational and proteomic approaches to screen 10% of the Mycobacterium tuberculosis (Mtb) proteome for CD8 Mtb antigens. We designed a weighting schema based upon a Multiple Attribute Decision Making: framework to select 10% of the Mtb proteome with a high probability of containing CD8(+) T cell epitopes. We created a synthetic peptide library consisting of 15-mers overlapping by 11 aa. Using the interferon-gamma ELISPOT assay and Mtb-infected dendritic cells as antigen presenting cells, we screened Mtb-specific CD8(+) T cell clones restricted by classical MHC class I molecules (MHC class Ia molecules), that were isolated from Mtb-infected humans, against this library. Three novel CD8 antigens were unambiguously identified: the EsxJ family (Rv1038c, Rv1197, Rv3620c, Rv2347c, Rv1792), PE9 (Rv1088), and PE_PGRS42 (Rv2487c). The epitopes are B5701-restricted EsxJ(24-34), B3905-restricted PE9(53-67), and B3514-restricted PE_PGRS42(48-56), respectively. The utility of peptide libraries in identifying unknown epitopes recognized by classically restricted CD8(+) T cells was confirmed, which can be applied to other intracellular pathogens with large size genomes. In addition, we identified three novel Mtb epitopes/antigens that may be evaluated for inclusion in vaccines and/or diagnostics for tuberculosis.	[Lewinsohn, David M.; Frieder, Marisa M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lewinsohn, David M.; Rajaraman, Veena; Frieder, Marisa M.] Portland VA Med Ctr, Portland, OR USA; [Swarbrick, Gwendolyn M.; Cansler, Meghan E.; Null, Megan D.; Lewinsohn, Deborah A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Rajaraman, Veena; McWeeney, Shannon] Oregon Hlth & Sci Univ, Oregon Canc Inst, Portland, OR 97201 USA; [Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Center for Infectious Disease Research	Lewinsohn, DM (corresponding author), Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	lewinsde@ohsu.edu	Nikitchina, Tatiana/P-6814-2015; Lewinsohn, David/I-4936-2013	Nikitchina, Tatiana/0000-0002-1034-3483; McWeeney, Shannon/0000-0001-8333-6607; Lewinsohn, David/0000-0001-9906-9494	VA Merit Review Grant; Portland VA Medical Center, US National Institutes of Health [HHSN266200400081C (NO1-A1-400081), R01AI48090]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048090] Funding Source: NIH RePORTER	VA Merit Review Grant(US Department of Veterans Affairs); Portland VA Medical Center, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a VA Merit Review Grant and the Portland VA Medical Center, US National Institutes of Health HHSN266200400081C (NO1-A1-400081), and R01AI48090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; Day CL, 2001, J VIROL, V75, P6279, DOI 10.1128/JVI.75.14.6279-6291.2001; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gold MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000957; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Hoang TTKT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005928; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lambert PH, 2009, CLIN CHEST MED, V30, P811, DOI 10.1016/j.ccm.2009.08.014; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Lewinsohn DA, 2002, AM J RESP CRIT CARE, V166, P843, DOI 10.1164/rccm.2110094; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DA, 2011, IMMUNOL REV, V240, P25, DOI 10.1111/j.1600-065X.2010.00997.x; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; Lewinsohn DM, 1998, J IMMUNOL, V160, P2374; Lewinsohn DM, 2001, J IMMUNOL, V166, P439, DOI 10.4049/jimmunol.166.1.439; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Moss P, 2004, HUM IMMUNOL, V65, P456, DOI 10.1016/j.humimm.2004.02.014; Oldstone M B, 1994, Curr Top Microbiol Immunol, V189, P1; Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426; Organization WH, 2008, WHO VACCINE PREVENTA; Reed S, 2005, MICROBES INFECT, V7, P922, DOI 10.1016/j.micinf.2005.03.011; RIDDELL SR, 1992, SCIENCE, V257, P238; ROBERTS AD, 1995, IMMUNOLOGY, V85, P502; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Skjot RLV, 2001, SCAND J INFECT DIS, V33, P643, DOI 10.1080/00365540110026971; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30; World Health Organization, 2008, GLOBAL TUBERCULOSIS	41	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67016	10.1371/journal.pone.0067016	http://dx.doi.org/10.1371/journal.pone.0067016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805289	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500117
J	Zhang, CM; Yang, C; Wang, RF; Jiao, Y; Ampah, KK; Wang, XG; Zeng, XL				Zhang, Chunmei; Yang, Chao; Wang, Ruifei; Jiao, Yang; Ampah, Khamal Kwesi; Wang, Xiaoguang; Zeng, Xianlu			c-Abl Kinase Is a Regulator of alpha(v)beta(3) Integrin Mediated Melanoma A375 Cell Migration	PLOS ONE			English	Article							TYROSINE KINASE; F-ACTIN; ACTIVATION; GROWTH; CANCER; PDGF; METASTASIS; EXPRESSION; APOPTOSIS; INVASION	Integrins are heterodimeric transmembrane receptors that physically link the extracellular matrix (ECM) to the intracellular actin cytoskeleton, and are also signaling molecules that transduce signals bi-directionally across the plasma membrane. Integrin regulation is essential for tumor cell migration in response to growth factors. c-Abl kinase is a nonreceptor tyrosine kinase and is critical for signaling transduction from various receptors. Here we show that c-Abl kinase is involved in A375 cell migration mediated by alpha(v)beta(3) integrin in response to PDGF stimulation. c-Abl kinase colocalizes with alpha(v)beta(3) integrin dynamically and affects alpha(v)beta(3) integrin affinity by regulating its cluster. The interaction between c-Abl kinase and alpha(v)beta(3) integrin was dependent on the activity of c-Abl kinase induced by PDGF stimulation, but was not dependent on the binding of alpha(v)beta(3) integrin with its ligands, suggesting that c-Abl kinase is not involved in the outside- in signaling of alpha(v)beta(3) integrin. Talin head domain was required for the interaction between c-Abl kinase and alpha(v)beta(3) integrin, and the SH3 domain of c-Abl kinase was involved in its interaction with talin and alpha(v)beta(3) integrin. Taken together, we have uncovered a novel and critical role of c-Abl kinase in alpha(v)beta(3) integrin mediated melanoma cell migration.	[Yang, Chao; Wang, Ruifei; Jiao, Yang; Ampah, Khamal Kwesi; Zeng, Xianlu] NE Normal Univ, Inst Cytol & Genet, Changchun, Jilin Province, Peoples R China; [Zhang, Chunmei] Jilin Univ, Dept Cell Biol, Norman Bethune Coll Med, Changchun 130023, Jilin Province, Peoples R China; [Wang, Xiaoguang] Changchun Teachers Coll, Dept Biosci, Changchun, Jilin Province, Peoples R China	Northeast Normal University - China; Jilin University	Wang, XG (corresponding author), Changchun Teachers Coll, Dept Biosci, Changchun, Jilin Province, Peoples R China.	wangxiaoguang58@sina.com; zengx779@nenu.edu.cn			National Nature Science Foundation of China [81071726, 81172014]; specialized Research Fund for the Doctoral Program of Higher Education [20100043110007]; Fundamental Research Funds for the Central Universities [10SSXT129]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Nature Science Foundation of China (81071726, 81172014), the specialized Research Fund for the Doctoral Program of Higher Education (20100043110007), and the Fundamental Research Funds for the Central Universities (10SSXT129). The funders had a role in decision to publish.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Askari JA, 2009, J CELL SCI, V122, P165, DOI 10.1242/jcs.018556; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Cui LL, 2009, J IMMUNOL, V182, P3233, DOI 10.4049/jimmunol.0802621; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Kerbel RS, 1995, CANCER METAST REV, V14, P259, DOI 10.1007/BF00690597; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lewis JM, 1998, J BIOL CHEM, V273, P14225, DOI 10.1074/jbc.273.23.14225; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; O'Donovan M, 1999, J CLIN PATHOL-MOL PA, V52, P341, DOI 10.1136/mp.52.6.341; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Renshaw MW, 2000, ONCOGENE, V19, P3216, DOI 10.1038/sj.onc.1203667; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Singer CF, 2004, ENDOCR-RELAT CANCER, V11, P861, DOI 10.1677/erc.1.00801; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Uhm Joon H., 1999, Frontiers in Bioscience, V4, pD188, DOI 10.2741/Uhm; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Verbisck NV, 2009, CANCER RES, V69, P5546, DOI 10.1158/0008-5472.CAN-08-2976; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Woodard AS, 1998, J CELL SCI, V111, P469; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xu JY, 2010, BLOOD, V115, P2709, DOI 10.1182/blood-2009-05-223776; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576	41	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66108	10.1371/journal.pone.0066108	http://dx.doi.org/10.1371/journal.pone.0066108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805201	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500029
J	Pereiro, C; Pino, C; Florez, G; Arrojo, M; Becona, E				Pereiro, Cesar; Pino, Carlos; Florez, Gerardo; Arrojo, Manuel; Becona, Elisardo		COPSIAD Grp	Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; SEVERE MENTAL-ILLNESS; ANTISOCIAL PERSONALITY-DISORDER; DSM-IV DISORDERS; DUAL DIAGNOSIS; COOCCURRING DISORDERS; BORDERLINE PERSONALITY; SURVEY REPLICATION; ALCOHOL-ABUSE; PREVALENCE	The objective of this study is to assess the prevalence of psychiatric comorbidity in patients under treatment within the addictive disorders assistance units of Galicia (Spain). Material and Methods: A total of 64 healthcare professionals performed clinical diagnosis of mental disorders (on DSM IV-TR criteria) in 2300 patients treated throughout March 2010 in 21 addictive disorders assistance units. Results: 56.3% of patients with substance abuse/dependency also showed some other mental disorder, 42.2% of patients suffering from at least an Axis I condition and 20.2% from some Axis II condition. Mood and anxiety disorders and borderline and antisocial personality disorders were the most frequent disorders in both axes. Conclusions: A high comorbidity was found between mental and substance use disorders (SUD) in patients seen at the addictive disorders assistance units of Galicia.	[Pereiro, Cesar] Drug Dependency Unit, La Coruna, Spain; [Pino, Carlos] Drug Dependency Unit, Pontevedra, Spain; [Florez, Gerardo] Addict Behav Unit, Orense, Spain; [Arrojo, Manuel] Galician Hlth Serv, Mental Hlth & Drug Dependency Assistance Serv, Direct Sanit Assistance, Galicia, Spain; [Becona, Elisardo] Univ Santiago Compostela, Fac Psychol, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Pereiro, C (corresponding author), Drug Dependency Unit, La Coruna, Spain.	cesar.pereiro.gomez@sergas.es	Arrojo, Manuel/AAA-2163-2019; lopez-duran, ana/ABE-1205-2021; lopez-duran, ana/N-1645-2014; fraga, jaime/C-4791-2013; Becoña, Elisardo/F-9716-2010	lopez-duran, ana/0000-0001-7661-8972; lopez-duran, ana/0000-0001-7661-8972; Becoña, Elisardo/0000-0002-6639-3834; Arrojo-Romero, manuel/0000-0002-5609-7134; Carou, Maria/0000-0002-3162-1382				ABRAM KM, 1991, AM PSYCHOL, V46, P1036, DOI 10.1037/0003-066X.46.10.1036; Aharonovich E, 2002, AM J PSYCHIAT, V159, P1600, DOI 10.1176/appi.ajp.159.9.1600; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANTHENELLI RM, 1994, PSYCHIAT ANN, V24, P407, DOI 10.3928/0048-5713-19940801-08; Baena M. R., 2006, TRASTORNOS ADICTIVOS, V8, P176, DOI DOI 10.1016/S1575-0973(06)75118-2; Barea J, 2010, ADICCIONES, V22, P15, DOI 10.20882/adicciones.210; BARTELS SJ, 1992, AM J PSYCHIAT, V149, P394; Bornovalova MA, 2005, CLIN PSYCHOL REV, V25, P790, DOI 10.1016/j.cpr.2005.05.005; Cohen WR, 2007, UPPERS DOWNERS ALL A; CUFFEL BJ, 1994, J NERV MENT DIS, V182, P704, DOI 10.1097/00005053-199412000-00005; Darke S, 2004, DRUG ALCOHOL DEPEN, V74, P77, DOI 10.1016/j.drugalcdep.2003.12.002; Drake RE, 2007, WORLD PSYCHIATRY, V6, P131; Goodman LA, 2001, J TRAUMA STRESS, V14, P615, DOI 10.1023/A:1013026318450; Grant BF, 2004, J CLIN PSYCHIAT, V65, P948; Griffin ML, 2009, ADDICT BEHAV, V34, P826, DOI 10.1016/j.addbeh.2009.03.002; Gual A, 2007, DRUG ALCOHOL REV, V26, P65, DOI 10.1080/09595230601037000; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim T, 2003, DHA GUIDE EFFECTIVE; Madden P, 2007, BRIT J PSYCHIAT, V183, P304; Martin-Santos R, 2006, EUR J PSYCHIAT, V20, P147, DOI 10.4321/s0213-61632006000300002; McHugo GJ, 2006, SCHIZOPHRENIA BULL, V32, P655, DOI 10.1093/schbul/sbl009; Mueser KT, 1997, J ABNORM PSYCHOL, V106, P473, DOI 10.1037/0021-843X.106.3.473; Mueser KT, 2001, SCHIZOPHR RES, V48, P93, DOI 10.1016/S0920-9964(00)00065-7; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rosenberg SD, 2001, COMPR PSYCHIAT, V42, P263, DOI 10.1053/comp.2001.24576; ROSS HE, 1994, J NERV MENT DIS, V182, P556, DOI 10.1097/00005053-199410000-00005; ROUNSAVILLE BJ, 1987, ARCH GEN PSYCHIAT, V44, P505; Rounsaville BJ, 2003, DRUG ALCOHOL DEPEN, V70, P117, DOI 10.1016/S0376-8716(03)00033-4; Rush B, 2008, CAN J PSYCHIAT, V53, P810, DOI 10.1177/070674370805301207; Rush B, 2013, J SUBST ABUSE TREAT, V44, P375, DOI 10.1016/j.jsat.2012.08.221; Salyers MP, 2001, SCHIZOPHR RES, V48, P109, DOI 10.1016/S0920-9964(00)00063-3; SATEL SL, 1991, AM J PSYCHIAT, V148, P1708; STOWELL RJA, 1991, PSYCHIAT ANN, V21, P98, DOI 10.3928/0048-5713-19910201-09; Bolotner NS, 2011, ADICCIONES, V23, P249, DOI 10.20882/adicciones.149; Tiet QQ, 2007, ALCOHOL CLIN EXP RES, V31, P513, DOI 10.1111/j.1530-0277.2007.00336.x; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; Torrens Melich Marta, 2008, Adicciones, V20, P315; Volkow ND, 2007, NIDA NOTES, V21, P2; Watkins KE, 2004, AM J DRUG ALCOHOL AB, V30, P749, DOI 10.1081/ADA-200037538	41	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66451	10.1371/journal.pone.0066451	http://dx.doi.org/10.1371/journal.pone.0066451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823135	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400110
J	Zhang, W; Nie, L; Wang, Y; Wang, XP; Zhao, H; Dongol, S; Maharjan, S; Cheng, L				Zhang, Wen; Nie, Lin; Wang, Yan; Wang, Xu-ping; Zhao, Hua; Dongol, Samina; Maharjan, Sailendra; Cheng, Lei			CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues	PLOS ONE			English	Article							INTERVERTEBRAL DISC; T-CELLS; NITRIC-OXIDE; TNF-ALPHA; EXPRESSION; INTERLEUKIN-17; DISTINCT; PROFILE; IL-17; INFLAMMATION	Background: Studies elucidated that Th17 cells are important contributors to the pathogenesis of many immune-mediated diseases, and IL-17A is present in pathologic intervertebral disc (IVD) tissues. However, the mechanisms, how these cells traffic into the degenerate discs are not clear. Materials and Methods: The samples collected from 53 patients had been divided into 3 groups: Group P (annulus fibrosus was intact), Group E (annulus fibrosus was reptured) and normal control. Immunohistochemistry was used to detect the expression of CCL20, CCR6, IL-17A, TNF-alpha and CD4 in IVD tissues. Moreover, nucleus pulposus (NP) cells had been cultured in the presence and absence of Th17 associated cytokines. The supernatants were detected for CCL20 concentrations by ELISA, and the NP cells for the expression of CCL20 mRNA. Additionally, peripheral blood (PB) samples had undergone detection for the expression of CCR6 mRNA and the proportion of IL-17-producing cells, including the surface expression of CCR6. Results: Immunohistochemistry revealed that CCL20 and TNF-alpha were expressed in degenerated NP cells. Double-labeled immunofluorescence elaborated, IL-17-producing cells (CD4(+)IL-17A(+) and CD4(+)CCR6(+)) appeared in the Group E samples, but no traces or expression in Group P and normal control. IL-17A and TNF-alpha, alone or combined, could enhance CCL20 secretion in a dose-dependent manner, which was obtained through RT-PCR results. There was a notable difference of CCR6 mRNA expression between patients and normal controls. In comparison to controls, flow cytometry data indicated that the proportion of IL-17- producing cells and the CCR6 expression in PB were significantly increased. Conclusion: Our results provide a potential explanation for involvement of the CCL20-CCR6 system in the trafficking of IL-17-producing cells to degenerated IVD tissues. Additionally, our results explain the contribution of Th17 associated cytokines to the development of degenerated discs via the up-regulation of CCL20 secretion from NP cells, which forms a positive chemotactic feedback loop.	[Zhang, Wen; Nie, Lin; Zhao, Hua; Maharjan, Sailendra; Cheng, Lei] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Shandong, Peoples R China; [Wang, Yan] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Wang, Xu-ping] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Shandong, Peoples R China; [Wang, Xu-ping] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Dongol, Samina] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Cheng, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Shandong, Peoples R China.	chengleiyx@126.com			Ministry of education of new funds for teachers [20110131120079]; Independent Innovation Foundation of Shandong University [2009TS004]; natural science foundation of Shandong Province [Q2008C09]; National Nature Science Foundation of China [80200212]; Department of Science and the Technology of Shandong Province of China [ZR2012HQ029]	Ministry of education of new funds for teachers; Independent Innovation Foundation of Shandong University; natural science foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and the Technology of Shandong Province of China	This study was partially supported by research funding from The Ministry of education of new funds for teachers (20110131120079), Independent Innovation Foundation of Shandong University (2009TS004), the natural science foundation of Shandong Province (Q2008C09), the National Nature Science Foundation of China (80200212) and the Department of Science and the Technology of Shandong Province of China (ZR2012HQ029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Awad JN, 2006, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000198724.54891.3a; BOBECHKO W P, 1965, J Bone Joint Surg Br, V47, P574; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Gabr MA, 2011, J ORTHOP RES, V29, P1, DOI 10.1002/jor.21206; GRONBLAD M, 1994, SPINE, V19, P2744; Haro H, 2002, J ORTHOP RES, V20, P409, DOI 10.1016/S0736-0266(01)00150-4; Haro H, 1996, SPINE, V21, P1647, DOI 10.1097/00007632-199607150-00006; Haro H, 2000, J CLIN INVEST, V105, P133, DOI 10.1172/JCI7090; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Kawaguchi S, 2002, SPINE, V27, P1511, DOI 10.1097/00007632-200207150-00006; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NAYLOR A, 1975, ORTHOP CLIN N AM, V6, P51; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Studer RK, 2011, SPINE, V36, P593, DOI 10.1097/BRS.0b013e3181da38d5; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Wang F, 2011, ASIAN SPINE J, V5, P73, DOI 10.4184/asj.2011.5.2.73; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zhang ZL, 2007, INT IMMUNOPHARMACOL, V7, P409, DOI 10.1016/j.intimp.2006.09.024	40	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66286	10.1371/journal.pone.0066286	http://dx.doi.org/10.1371/journal.pone.0066286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823618	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400078
J	Eren, AM; Vineis, JH; Morrison, HG; Sogin, ML				Eren, A. Murat; Vineis, Joseph H.; Morrison, Hilary G.; Sogin, Mitchell L.			A Filtering Method to Generate High Quality Short Reads Using Illumina Paired-End Technology	PLOS ONE			English	Article							RARE BIOSPHERE; MICROBIAL DIVERSITY; SEQUENCES; WRINKLES	Consensus between independent reads improves the accuracy of genome and transcriptome analyses, however lack of consensus between very similar sequences in metagenomic studies can and often does represent natural variation of biological significance. The common use of machine-assigned quality scores on next generation platforms does not necessarily correlate with accuracy. Here, we describe using the overlap of paired-end, short sequence reads to identify error-prone reads in marker gene analyses and their contribution to spurious OTUs following clustering analysis using QIIME. Our approach can also reduce error in shotgun sequencing data generated from libraries with small, tightly constrained insert sizes. The open-source implementation of this algorithm in Python programming language with user instructions can be obtained from https://github.com/meren/illumina-utils.	[Eren, A. Murat; Vineis, Joseph H.; Morrison, Hilary G.; Sogin, Mitchell L.] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA USA	Marine Biological Laboratory - Woods Hole	Sogin, ML (corresponding author), Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA USA.	sogin@mbl.edu	Eren, A. Murat/J-3408-2014; Sogin, Mitchell/AAE-7186-2019; Eren, A. Murat/Q-5497-2019	Eren, A. Murat/0000-0001-9013-4827; Eren, A. Murat/0000-0001-9013-4827; Morrison, Hilary/0000-0003-0281-326X	National Institutes of Health [1UH2DK083993]; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [1UH2DK083993 to M.L.S.] and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	13	192	192	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66643	10.1371/journal.pone.0066643	http://dx.doi.org/10.1371/journal.pone.0066643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799126	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800045
J	Dobbs, KB; Rodriguez, M; Sudano, MJ; Ortega, MS; Hansen, PJ				Dobbs, Kyle B.; Rodriguez, Marlon; Sudano, Mateus J.; Ortega, M. Sofia; Hansen, Peter J.			Dynamics of DNA Methylation during Early Development of the Preimplantation Bovine Embryo	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IN-VITRO; MAMMALIAN DEVELOPMENT; NUCLEAR TRANSFER; PATERNAL GENOME; MOUSE; SEX; DEMETHYLATION; EXPRESSION; PATTERNS	There is species divergence in control of DNA methylation during preimplantation development. The exact pattern of methylation in the bovine embryo has not been established nor has its regulation by gender or maternal signals that regulate development such as colony stimulating factor 2 (CSF2). Using immunofluorescent labeling with anti-5-methylcytosine and embryos produced with X-chromosome sorted sperm, it was demonstrated that methylation decreased from the 2-cell stage to the 6-8 cell stage and then increased thereafter up to the blastocyst stage. In a second experiment, embryos of specific genders were produced by fertilization with X-or Y-sorted sperm. The developmental pattern was similar to the first experiment, but there was stage x gender interaction. Methylation was greater for females at the 8-cell stage but greater for males at the blastocyst stage. Treatment with CSF2 had no effect on labeling for DNA methylation in blastocysts. Methylation was lower for inner cell mass cells (i.e., cells that did not label with anti-CDX2) than for trophectoderm (CDX2-positive). The possible role for DNMT3B in developmental changes in methylation was evaluated by determining gene expression and degree of methylation. Steady-state mRNA for DNMT3B decreased from the 2-cell stage to a nadir for D 5 embryos > 16 cells and then increased at the blastocyst stage. High resolution melting analysis was used to assess methylation of a CpG rich region in an intronic region of DNMT3B. Methylation percent decreased between the 6-8 cell and the blastocyst stage but there was no difference in methylation between ICM and TE. Results indicate that DNA methylation undergoes dynamic changes during the preimplantation period in a manner that is dependent upon gender and cell lineage. Developmental changes in expression of DNMT3B are indicative of a possible role in changes in methylation. Moreover, DNMT3B itself appears to be under epigenetic control by methylation.	[Dobbs, Kyle B.; Rodriguez, Marlon; Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Dobbs, Kyle B.; Rodriguez, Marlon; Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Sudano, Mateus J.] Univ Estadual Paulista, Fac Med Vet & Zootecnia, Dept Reprod Anim & Radiol Vet, Sao Paulo, Brazil	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidade Estadual Paulista	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Ortega, Sofia/ABA-3654-2020; , M/AAZ-7804-2020; Hansen, Peter/AAI-4693-2021; Alizadeh/AAK-1398-2021; Sudano, Mateus J/D-7614-2013	Ortega, Sofia/0000-0003-4027-7314; , M/0000-0002-7699-4449; Hansen, Peter/0000-0003-3061-9333; Sudano, Mateus J/0000-0002-7699-4449	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2011-67015-30688]	Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2011-67015-30688 from the USDA National Institute of Food and Agriculture (http://www.csrees.usda.gov/fo/agriculturalandfoodresearchinitiativeafri.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY B, 1992, MOL REPROD DEV, V32, P265, DOI 10.1002/mrd.1080320312; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Block J, 2009, THERIOGENOLOGY, V71, P1063, DOI 10.1016/j.theriogenology.2008.11.007; Block J, 2003, J ANIM SCI, V81, P1590; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; CAMOUS S, 1986, BIOL CELL, V58, P195, DOI 10.1111/j.1768-322X.1986.tb00506.x; Canovas S, 2012, P NATL ACAD SCI USA, V109, P2400, DOI 10.1073/pnas.1119112109; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; Chen T, 2004, FEBS LETT, V578, P69, DOI 10.1016/j.febslet.2004.10.073; de Moraes AAS, 1999, J REPROD IMMUNOL, V42, P135, DOI 10.1016/S0165-0378(98)00075-8; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; deMoraes AAS, 1997, BIOL REPROD, V57, P1060, DOI 10.1095/biolreprod57.5.1060; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Fulka J, 2006, HISTOCHEM CELL BIOL, V126, P213, DOI 10.1007/s00418-006-0153-x; Gebert C, 2006, GENOMICS, V88, P222, DOI 10.1016/j.ygeno.2006.03.011; Giraldo AA, 2008, BIOL REPROD, V78, P832, DOI 10.1095/biolreprod.107.066662; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; GutierrezAdan A, 1997, MOL REPROD DEV, V48, P246, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;246::AID-MRD12&gt;3.0.CO;2-W; GutierrezAdan A, 1996, THERIOGENOLOGY, V46, P515, DOI 10.1016/0093-691X(96)00173-2; Hou J, 2007, SCI CHINA SER C, V50, P56, DOI 10.1007/s11427-007-0003-7; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Lonergan P, 1999, J REPROD FERTIL, V117, P159, DOI 10.1530/jrf.0.1170159; Loureiro B, 2009, ENDOCRINOLOGY, V150, P5046, DOI 10.1210/en.2009-0481; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Ozawa M, 2012, BMC DEV BIOL, V12, P1, DOI 10.1186/1471-213X-12-33; Ozawa M, 2011, FERTIL STERIL, V95, P799, DOI 10.1016/j.fertnstert.2010.10.006; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Shi W, 2004, BIOL REPROD, V71, P340, DOI 10.1095/biolreprod.103.024554; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	47	81	82	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66230	10.1371/journal.pone.0066230	http://dx.doi.org/10.1371/journal.pone.0066230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799080	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300065
J	Ripoll, E; Merino, A; Goma, M; Aran, JM; Bolanos, N; de Ramon, L; Herrero-Fresneda, I; Bestard, O; Cruzado, JM; Grinyo, JM; Torras, J				Ripoll, Elia; Merino, Ana; Goma, Montse; Aran, Josep M.; Bolanos, Nuria; de Ramon, Laura; Herrero-Fresneda, Immaculada; Bestard, Oriol; Cruzado, Josep M.; Grinyo, Josep M.; Torras, Juan			CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms	PLOS ONE			English	Article							NZB/W F-1 MICE; NF-KAPPA-B; COSTIMULATORY BLOCKADE; CHEMICAL-MODIFICATION; ERYTHEMATOSUS SLE; INFLAMED KIDNEYS; CELL ACTIVATION; ANIMAL-MODELS; MURINE LUPUS; PLASMA-CELLS	Lupus nephritis (LN) is an autoimmune disorder in which co-stimulatory signals have been involved. Here we tested a cholesterol-conjugated-anti-CD40-siRNA in dendritic cells (DC) in vitro and in a model of LPS to check its potency and tissue distribution. Then, we report the effects of Chol-siRNA in an experimental model of mice with established lupus nephritis. Our in vitro studies in DC show a 100% intracellular delivery of Chol-siRNA, with a significant reduction in CD40 after LPS stimuli. In vivo in ICR mice, the CD40-mRNA suppressive effects of our Chol-siRNA on renal tissue were remarkably sustained over a 5 days after a single preliminary dose of Chol-siRNA. The intra-peritoneal administration of Chol-siRNA to NZB/WF1 mice resulted in a reduction of anti-DNA antibody titers, and histopathological renal scores as compared to untreated animals. The higher dose of Chol-siRNA prevented the progression of proteinuria as effectively as cyclophosphamide, whereas the lower dose was as effective as CTLA4. Chol-siRNA markedly reduced insterstitialCD3+ and plasma cell infiltrates as well as glomerular deposits of IgG and C3. Circulating soluble CD40 and activated splenic lymphocyte subsets were also strikingly reduced by Chol-siRNA. Our data show the potency of our compound for the therapeutic use of anti-CD40-siRNA in human LN and other autoimmune disorders.	[Ripoll, Elia; Merino, Ana; Bolanos, Nuria; de Ramon, Laura; Herrero-Fresneda, Immaculada; Bestard, Oriol; Cruzado, Josep M.; Grinyo, Josep M.; Torras, Juan] IDIBELL Hosp Univ Bellvitge, Lab Expt Nephrol, Barcelona, Spain; [Goma, Montse] Hosp Univ Bellvitge, Dept Pathol, Barcelona, Spain; [Aran, Josep M.] IDIBELL, Med & Mol Genet Ctr, Barcelona, Spain	CIBERNED; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Torras, J (corresponding author), IDIBELL Hosp Univ Bellvitge, Lab Expt Nephrol, Barcelona, Spain.	15268jta@comb.cat	Merino, Ana/L-8347-2017; Aran, Josep M./R-9093-2019; Torras, Joan/AAH-8131-2021	Aran, Josep M./0000-0003-2827-9392; Torras, Juan/0000-0002-1135-7588	Instituto de Salud Carlos III/FIS [PS09/00897, PS09/00107, PI10/2991]; European Union Grant SYSKID Framework Programme; IDIBELL; ISCIII; Societat Catalana de Transplantament; Dpt. Salut Generalitat Catalunya; Insitituto de Salud Carlos III, programa Sara Borrell	Instituto de Salud Carlos III/FIS(Instituto de Salud Carlos III); European Union Grant SYSKID Framework Programme; IDIBELL; ISCIII(Instituto de Salud Carlos III); Societat Catalana de Transplantament; Dpt. Salut Generalitat Catalunya; Insitituto de Salud Carlos III, programa Sara Borrell	This study was supported by grants from Instituto de Salud Carlos III/FIS (PS09/00897, PS09/00107, PI10/2991), European Union Grant SYSKID Framework Programme 7 (FP7). Nuria Bolanos is a technician from 'Contratos de tecnico de apoyo en el sistema nacional de la salud' financed by ISCIII. Elia Ripoll was a fellowship from IDIBELL and from Societat Catalana de Transplantament. Josep M. Aran and Immaculada Herrero are a researchers from 'Programa Estabilizacion Investigadores' financed by ISCIII and Dpt. Salut Generalitat Catalunya, and Ana Merino was supported by a contract from Insitituto de Salud Carlos III, programa Sara Borrell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Bagavant H, 2009, CURR OPIN RHEUMATOL, V21, P489, DOI 10.1097/BOR.0b013e32832efff1; Berden JHM, 2003, NETH J MED, V61, P233; Borchers A, 2000, SEMIN ARTHRITIS RHEU, V29, P385, DOI 10.1053/sarh.2000.7173; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049; CONNOLLY K, 1992, J IMMUNOL, V149, P3083; Corey DR, 2007, J CLIN INVEST, V117, P3615, DOI 10.1172/JCI33483; Cunnane G, 2004, ARTHRITIS RHEUM-US, V50, P1539, DOI 10.1002/art.20147; Davidson A, 2003, ANN NY ACAD SCI, V987, P188, DOI 10.1111/j.1749-6632.2003.tb06048.x; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; Espeli M, 2011, J AM SOC NEPHROL, V22, P296, DOI 10.1681/ASN.2010050515; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hahn BH, 2001, LUPUS, V10, P589, DOI 10.1191/096120301682430140; HUSTON DP, 1979, YALE J BIOL MED, V52, P289; Ioannidis JPA, 2000, KIDNEY INT, V57, P258, DOI 10.1046/j.1523-1755.2000.00832.x; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; KLINMAN DM, 1990, J CLIN INVEST, V86, P1249, DOI 10.1172/JCI114831; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Park YB, 1998, CLIN EXP RHEUMATOL, V16, P283; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Pluvinet R, 2008, BLOOD, V112, P3624, DOI 10.1182/blood-2008-03-143305; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Ripoll E, 2011, GENE THER, V18, P945, DOI 10.1038/gt.2011.39; Robles-Carrillo L, 2010, J IMMUNOL, V185, P1577, DOI 10.4049/jimmunol.0903888; Robson MG, 2001, CLIN EXP ALLERGY, V31, P678, DOI 10.1046/j.1365-2222.2001.01147.x; Russell P J, 1966, Lancet, V1, P1280; Sang A, 2012, PROG MOL BIOL TRANSL, V105, P321, DOI 10.1016/B978-0-12-394596-9.00010-X; Schiffer L, 2003, J IMMUNOL, V171, P489, DOI 10.4049/jimmunol.171.1.489; Sekine H, 2011, MOL IMMUNOL, V49, P317, DOI 10.1016/j.molimm.2011.09.015; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Starke C, 2011, EUR J IMMUNOL, V41, P2107, DOI 10.1002/eji.201041315; Tang S, 1999, J IMMUNOL, V162, P4336; Vowinkel T, 2006, AM J PHYSIOL-HEART C, V290, pH631, DOI 10.1152/ajpheart.00733.2005; Wang XB, 2002, J IMMUNOL, V168, P2046, DOI 10.4049/jimmunol.168.4.2046	43	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65068	10.1371/journal.pone.0065068	http://dx.doi.org/10.1371/journal.pone.0065068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799000	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300008
J	Wen, ZZ; Cai, MY; Mai, Z; Jin, DM; Chen, YX; Huang, H; Geng, DF; Wang, JF				Wen, Zhu-zhi; Cai, Mu-yan; Mai, Zun; Jin, Dong-mei; Chen, Yang-xin; Huang, Hui; Geng, Deng-feng; Wang, Jing-feng			Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction	PLOS ONE			English	Article							GROWTH-FACTOR-I; ACE-INHIBITION; RENAL-FUNCTION; HEART-FAILURE; EXPRESSION; ACTIVATION; DAMAGE; CONTRIBUTES; MECHANISMS; MODEL	The mechanisms and mediators underlying common renal impairment after myocardial infarction (MI) are still poorly understood. The present study aimed to test the hypothesis that angiotensin II type 1 receptor blockers (ARBs) provides renoprotective effects after MI by preventing augmented intrarenal renin-angiotensin-system (RAS)-induced podocyte injury. Sprague-Dawley rats that underwent ligation of their coronary arteries were treated with losartan (20 mg/kg/d) or vehicle for 3 or 9 weeks. Renal function, histology and molecular changes were assessed. The current study revealed that MI-induced glomerular podocyte injury was identified by increased immunostaining for desmin and p16(ink4a), decreased immunostaining for Wilms' tumor-1 and podocin mRNA expression, and an induced increase of blood cystatin C at both 3 and 9 weeks. These changes were associated with increased intrarenal angiotensin II levels and enhanced expressions of angiotensinogen mRNA and angiotensin II receptor mRNA and protein. These changes were also associated with decreased levels of insulin-like growth factor (IGF-1) and decreased expressions of IGF-1 receptor (IGF-1R) protein and mRNA and phosphorylated(p)-Akt protein at 9 weeks, as well as increased expressions of 8-hydroxy-2'-deoxyguanosine at both time points. Treatment with losartan significantly attenuated desmin- and p16(ink4a)-positive podocytes, restored podocin mRNA expression, and decreased blood cystatin C levels. Losartan also prevented RAS activation and oxidative stress and restored the IGF-1/IGF-1R/Akt pathway. In conclusion, ARBs prevent the progression of renal impairment after MI via podocyte protection, partially by inhibiting the activation of the local RAS with subsequent enhanced oxidative stress and an inhibited IGF-1/IGF-1R/Akt pathway.	[Wen, Zhu-zhi; Chen, Yang-xin; Huang, Hui; Geng, Deng-feng; Wang, Jing-feng] Sun Yat Sen Univ, Dept Cardiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Zhu-zhi; Chen, Yang-xin; Huang, Hui; Geng, Deng-feng; Wang, Jing-feng] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guandong Prov Key Lab Arrhythmia & Electrophysiol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Mu-yan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Mai, Zun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Jin, Dong-mei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, JF (corresponding author), Sun Yat Sen Univ, Dept Cardiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	syswjf@hotmail.com	wang, jing/GRS-7509-2022		National Natural Science Foundation of China [30971262/81270212]; Academic Scholarship of Ministry of National Education for Doctoral Candidates [81000-3191001]; Doctoral Student Innovation Personnel Training Projects of Sun Yat-sen University; Guangdong Province Natural Science Fund [S2011010002650]; Guangdong Provincial Science and Technology Projects [2012B031800293]; PhD Start-up programme of Guangdong Province Natural Science Fund [S2012040008047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Scholarship of Ministry of National Education for Doctoral Candidates; Doctoral Student Innovation Personnel Training Projects of Sun Yat-sen University; Guangdong Province Natural Science Fund(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Science and Technology Projects; PhD Start-up programme of Guangdong Province Natural Science Fund	This work was supported by the National Natural Science Foundation of China (No: 30971262/81270212), the Academic Scholarship of Ministry of National Education for Doctoral Candidates (No: 81000-3191001) and the Doctoral Student Innovation Personnel Training Projects of Sun Yat-sen University. This work was also supported by the Guangdong Province Natural Science Fund (S2011010002650), Guangdong Provincial Science and Technology Projects (No. 2012B031800293) and the PhD Start-up programme of Guangdong Province Natural Science Fund (S2012040008047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia DM, 2004, J AM SOC NEPHROL, V15, P949, DOI 10.1097/01.ASN.0000118528.00817.8E; Bock JS, 2010, CIRCULATION, V121, P2592, DOI 10.1161/CIRCULATIONAHA.109.886473; Bridgewater DJ, 2008, GROWTH HORM IGF RES, V18, P26, DOI 10.1016/j.ghir.2007.06.003; Bridgewater DJ, 2005, KIDNEY INT, V67, P1308, DOI 10.1111/j.1523-1755.2005.00208.x; Cai MY, 2011, MOL MED, V17, P12, DOI 10.2119/molmed.2010.00103; Carubelli V, 2012, HEART FAIL REV, V17, P271, DOI 10.1007/s10741-011-9265-z; Chertin B, 2004, PEDIATR SURG INT, V20, P283, DOI 10.1007/s00383-003-1127-x; Dean RG, 2003, J HISTOCHEM CYTOCHEM, V51, P831, DOI 10.1177/002215540305100614; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; Efrati S, 2012, NEPHROL DIAL TRANSPL, V27, P136, DOI 10.1093/ndt/gfr256; Fujinaka H, 2010, NEPHROLOGY, V15, P700, DOI 10.1111/j.1440-1797.2010.01285.x; Gonzalez A, 2008, CIRC RES, V102, P597, DOI 10.1161/CIRCRESAHA.107.165464; Hillege HL, 2003, EUR HEART J, V24, P412, DOI 10.1016/S0195-668X(02)00526-2; Homma T, 2012, AM J PHYSIOL-RENAL, V302, pF750, DOI 10.1152/ajprenal.00494.2011; Hsu HH, 2011, KIDNEY INT, V80, P959, DOI 10.1038/ki.2011.250; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Lai KN, 2011, CONTRIB NEPHROL, V170, P135, DOI 10.1159/000325649; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; Liang Kelly V, 2008, Crit Care Med, V36, pS75, DOI 10.1097/01.CCM.0000296270.41256.5C; Liebau MC, 2006, AM J PHYSIOL-RENAL, V290, pF710, DOI 10.1152/ajprenal.00475.2004; Mashima Y, 2013, CLIN NEPHROL, V79, P15, DOI 10.5414/CN107645; Niizuma S, 2011, RENAL FAILURE, V33, P847, DOI 10.3109/0886022X.2011.605531; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; Schulze PC, 2003, BASIC RES CARDIOL, V98, P267, DOI 10.1007/s00395-003-0411-1; SCHUNKERT H, 1993, CARDIOVASC RES, V27, P731, DOI 10.1093/cvr/27.5.731; van Dokkum RPE, 2004, J AM SOC NEPHROL, V15, P3103, DOI 10.1097/01.ASN.0000145895.62896.98; Wang CT, 1997, J AM SOC NEPHROL, V8, P535; Wen ZZ, 2013, RENAL FAILURE, V35, P766, DOI 10.3109/0886022X.2013.780561; Windt WAKM, 2006, J AM SOC NEPHROL, V17, P3059, DOI 10.1681/ASN.2006030209; Xu XH, 2008, CARDIOVASC RES, V78, P523, DOI 10.1093/cvr/cvn028	31	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67242	10.1371/journal.pone.0067242	http://dx.doi.org/10.1371/journal.pone.0067242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799145	gold, Green Submitted, Green Published			2022-12-27	WOS:000320363300108
J	Zhao, W; Huang, Y; Liu, Z; Cao, BB; Peng, YP; Qiu, YH				Zhao, Wei; Huang, Yan; Liu, Zhan; Cao, Bei-Bei; Peng, Yu-Ping; Qiu, Yi-Hua			Dopamine Receptors Modulate Cytotoxicity of Natural Killer Cells via cAMP-PKA-CREB Signaling Pathway	PLOS ONE			English	Article							ACTIVATED T-CELLS; PROTEIN-KINASE-A; FACTOR-KAPPA-B; MEDIATED MECHANISM; NUCLEAR-FACTOR; EXPRESSION; D2; LYMPHOCYTES; SECRETION; PROLIFERATION	Dopamine (DA), a neurotransmitter in the nervous system, has been shown to modulate immune function. We have previously reported that five subtypes of DA receptors, including D1R, D2R, D3R, D4R and D5R, are expressed in T lymphocytes and they are involved in regulation of T cells. However, roles of these DA receptor subtypes and their coupled signal-transduction pathway in modulation of natural killer (NK) cells still remain to be clarified. The spleen of mice was harvested and NK cells were isolated and purified by negative selection using magnetic activated cell sorting. After NK cells were incubated with various drugs for 4 h, flow cytometry measured cytotoxicity of NK cells against YAC-1 lymphoma cells. NK cells expressed the five subtypes of DA receptors at mRNA and protein levels. Activation of D1-like receptors (including D1R and D5R) with agonist SKF38393 enhanced NK cell cytotoxicity, but activation of D2-like receptors (including D2R, D3R and D4R) with agonist quinpirole attenuated NK cells. Simultaneously, SKF38393 elevated D1R and D5R expression, cAMP content, and phosphorylated cAMP-response element-binding (CREB) level in NK cells, while quinpirole reduced D3R and D4R expression, cAMP content, and phosphorylated CREB level in NK cells. These effects of SKF38393 were blocked by SCH23390, an antagonist of D1-like receptors, and quinpirole effects were abolished by haloperidol, an antagonist of D2-like receptors. In support these results, H89, an inhibitor of phosphokinase A (PKA), prevented the SKF38393-dependent enhancement of NK cells and forskolin, an activator of adenylyl cyclase (AC), counteracted the quinpirole-dependent suppression of NK cells. These findings show that DA receptor subtypes are involved in modulation of NK cells and suggest that D1-like receptors facilitate NK cells by stimulating D1R/D5R-cAMP-PKA-CREB signaling pathway and D2-like receptors suppress NK cells by inhibiting D3R/D4R-cAMP-PKA-CREB signaling pathway. The results may provide more targets of therapeutic strategy for neuroimmune diseases.	[Zhao, Wei; Huang, Yan; Liu, Zhan; Cao, Bei-Bei; Peng, Yu-Ping; Qiu, Yi-Hua] Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China	Nantong University	Peng, YP (corresponding author), Nantong Univ, Sch Med, Dept Physiol, Nantong, Jiangsu, Peoples R China.	yppeng@ntu.edu.cn; yhqiu@ntu.edu.cn	peng, yu/GXW-2071-2022		National Natural Science Foundation of China [30870929, 81271323]; Natural Science Foundation of Jiangsu Province of China [BK2010278, BK2011386]; Nantong Applied Research Program of China [CP12012003, BK2012014, BK2012015]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Nantong Applied Research Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants 30870929 and 81271323 from the National Natural Science Foundation of China, BK2010278 and BK2011386 from the Natural Science Foundation of Jiangsu Province of China, CP12012003, BK2012014 and BK2012015 from the Nantong Applied Research Program of China, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2002, J IMMUNOL, V169, P802, DOI 10.4049/jimmunol.169.2.802; BASU S, 1992, BIOGENIC AMINES, V8, P191; Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Carr L, 2003, J NEUROIMMUNOL, V137, P87, DOI 10.1016/S0165-5728(03)00047-X; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; Harada Y, 1999, BIOCHEM BIOPH RES CO, V266, P129, DOI 10.1006/bbrc.1999.1783; Hasko G, 2002, J NEUROIMMUNOL, V122, P34, DOI 10.1016/S0165-5728(01)00459-3; Hershfield MS, 2005, EUR J IMMUNOL, V35, P25, DOI 10.1002/eji.200425738; Huang Y, 2010, NEUROENDOCRINO LETT, V31, P101; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Ilani T, 2004, FASEB J, V18, DOI 10.1096/fj.04-1652fje; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jimenez JL, 2001, J PHARMACOL EXP THER, V299, P753; Kavelaars A, 2005, J NEUROIMMUNOL, V161, P162, DOI 10.1016/j.jneuroim.2005.01.004; Kipnis J, 2004, J NEUROSCI, V24, P6133, DOI 10.1523/JNEUROSCI.0600-04.2004; Kirillova GP, 2008, J NEUROSCI METH, V174, P272, DOI 10.1016/j.jneumeth.2008.07.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meredith EJ, 2006, P NATL ACAD SCI USA, V103, P13485, DOI 10.1073/pnas.0605993103; Mignini F, 2009, J NEUROIMMUNOL, V206, P5, DOI 10.1016/j.jneuroim.2008.09.018; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; Nakano K, 2008, BIOCHEM BIOPH RES CO, V373, P286, DOI 10.1016/j.bbrc.2008.06.012; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Ramstad C, 2000, CELL SIGNAL, V12, P557, DOI 10.1016/S0898-6568(00)00097-8; Robinson SW, 1997, MOL PHARMACOL, V52, P508, DOI 10.1124/mol.52.3.508; Saha B, 2001, NEUROIMMUNOMODULAT, V9, P23, DOI 10.1159/000049004; Santanavanich C, 2005, J PINEAL RES, V38, P170, DOI 10.1111/j.1600-079X.2004.00189.x; Teunis MAT, 2004, PSYCHONEUROENDOCRINO, V29, P1058, DOI 10.1016/j.psyneuen.2003.09.007; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Watanabe Y, 2006, J IMMUNOL, V176, P848, DOI 10.4049/jimmunol.176.2.848; Yang M, 2003, MOL PHARMACOL, V64, P447, DOI 10.1124/mol.64.2.447; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103; Zawilska Jolanta B, 2003, Postepy Hig Med Dosw, V57, P293	41	47	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65860	10.1371/journal.pone.0065860	http://dx.doi.org/10.1371/journal.pone.0065860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799052	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300046
J	Elhebir, ES; Hughes, JD; Hilmi, SC				Elhebir, Elsamaul S.; Hughes, Jeffery D.; Hilmi, Samantha C.			Calcium Antagonists Use and Its Association with Lower Urinary Tract Symptoms: A Cross-Sectional Study	PLOS ONE			English	Article							BLADDER SMOOTH-MUSCLE; DETRUSOR HYPERACTIVITY; ENTRY BLOCKADE; PREVALENCE; INCONTINENCE; WOMEN; MEN; COMMUNITY; OLDER; CONTRACTION	Background: Lower urinary tract symptoms (LUTS) have been reported amongst the side effects of calcium antagonists (CA). CAs act on the bladder by affecting the ability of the detrusor muscle to create enough contractile force to overcome obstruction to normal voiding. We aimed to determine the relationship between CA use and LUTS in general medical inpatients. Methods and Findings: In this cross-sectional study we recruited 278 medical inpatients (including 85 CA users) aged >= 40 (72.1 +/- 13.7) years. LUTS was assessed using the International Prostate Symptoms Score (IPSS) questionnaire. A Logistic regression model using a 'backwards-elimination' strategy was used to identify variables associated with LUTS and for calculating the adjusted odds ratios and the 95% confidence intervals (CI). After adjusting for other risk factors and drugs, patients on amlodipine/nifedipine and diltiazem/verapamil (compared to non-users) were more likely to suffer from severe LUTS [Males: 12.45(CI: 1.57-98.63) and Females: 7.75(CI: 0.94-63.94)] and moderate-to-severe LUTS [Males: 17.43(CI: 2.26-134.39) and Females: 47.8(CI: 6.22-367.37)]. Patients on felodipine/lercanidipine were less likely to suffer from either severe or moderate-to-severe LUTS. Further, 19 (22.4%) CA-users were on treatment for LUTS compared to 18 (9.3%) of the non-users group, p = 0.003. Both male and female CA-users were three times more likely to be on alpha-blockers than non-users, p<0.001. CA-users were more likely to have undergone urinary tract-related surgery (Males: two times, p = 0.07 and females: nine times, p = 0.029). The study was limited by the fact that a causal relationship could not be established between CA use and LUTS. Conclusions: Our results demonstrate an association between CA use and an increasing severity of LUTS. They also demonstrate that CA-users are more likely to have medical or surgical treatment for LUTS. However, these CA's effects on LUTS vary, and the use of highly vascular selective agents does not appear to pose significant risk.	[Elhebir, Elsamaul S.; Hughes, Jeffery D.] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia; [Hilmi, Samantha C.] Royal Perth Hosp, Dept Pharm, Perth, WA, Australia	Curtin University; Royal Perth Hospital; University of Western Australia	Elhebir, ES (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA 6845, Australia.	E.Elhebir@curtin.edu.au; J.D.Hughes@curtin.edu.au		Hughes, Jeffery David/0000-0003-0040-4753				American Urological Associaation, 2006, AUA GUID MAN BEN PRO; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Andersson KE, 1999, BJU INT, V84, P923; Antonelli D, 1984, BR MED J, V288; Araki I, 2003, J UROLOGY, V170, P1901, DOI 10.1097/01.ju.0000092942.87643.27; Australian Government: Department of Health and Ageing, 2009, AUSTR STAT MED 2008, P74; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; CHANCELLOR MB, 1993, J UROLOGY, V150, P1706, DOI 10.1016/S0022-5347(17)35872-X; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; FAUSTINI S, 1989, ARZNEIMITTEL-FORSCH, V39-2, P899; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Frohlich G, 1998, ARZNEIMITTEL-FORSCH, V48, P486; GEYSKES GG, 1992, TOHOKU J EXP MED, V166, P135, DOI 10.1620/tjem.166.135; Guarneri L, 1996, ARZNEIMITTELFORSCH, V46, P15; Hall SA, 2012, BJU INT, V109, P1676, DOI 10.1111/j.1464-410X.2011.10593.x; HARARI D, 1993, J AM GERIATR SOC, V41, P1130, DOI 10.1111/j.1532-5415.1993.tb06463.x; Homma Y, 1997, Int J Urol, V4, P40, DOI 10.1111/j.1442-2042.1997.tb00138.x; Hughes Jeffery D, 2011, Qual Prim Care, V19, P223; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Ito H, 2012, NEUROUROL URODYNAM, V12, P22267; Kakizaki H, 2002, UROLOGY, V59, P58, DOI 10.1016/S0090-4295(01)01487-X; KRUSELL LR, 1987, HYPERTENSION, V10, P577, DOI 10.1161/01.HYP.10.6.577; Masters JG, 1999, BRIT J PHARMACOL, V127, P996, DOI 10.1038/sj.bjp.0702640; MATTIASSON A, 1989, J UROLOGY, V141, P174, DOI 10.1016/S0022-5347(17)40635-5; Muscatello DJ, 2001, INTERN MED J, V31, P151, DOI 10.1046/j.1445-5994.2001.00035.x; Naglie G, 2002, J UROLOGY, V167, P586, DOI 10.1016/S0022-5347(01)69090-6; Naslund MJ, 2007, INT J CLIN PRACT, V61, P1437, DOI 10.1111/j.1742-1241.2007.01508.x; NORMAN RW, 1994, BRIT J UROL, V74, P542, DOI 10.1111/j.1464-410X.1994.tb09181.x; Pinnock CB, 1997, MED J AUSTRALIA, V167, P72, DOI 10.5694/j.1326-5377.1997.tb138783.x; SLUITER HE, 1985, DRUGS, V29, P26, DOI 10.2165/00003495-198500292-00006; Terai A, 2004, UROLOGY, V63, P487, DOI 10.1016/j.urology.2003.09.070; Walsh K, 2004, BJU INT, V94, P272, DOI 10.1111/j.1464-410X.2003.04961.x; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; WILLIAMS G, 1986, LANCET, V1, P738; Young MA, 1985, BR J CLIN PHARM, V20	35	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66708	10.1371/journal.pone.0066708	http://dx.doi.org/10.1371/journal.pone.0066708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805268	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500096
J	Hsu, WY				Hsu, Wei-Yen			A Practical Approach Based on Analytic Deformable Algorithm for Scenic Image Registration	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE	Background: Image registration is to produce an entire scene by aligning all the acquired image sequences. A registration algorithm is necessary to tolerance as much as possible for intensity and geometric variation among images. However, captured image views of real scene usually produce unexpected distortions. They are generally derived from the optic characteristics of image sensors or caused by the specific scenes and objects. Methods and Findings: An analytic registration algorithm considering the deformation is proposed for scenic image applications in this study. After extracting important features by the wavelet-based edge correlation method, an analytic registration approach is then proposed to achieve deformable and accurate matching of point sets. Finally, the registration accuracy is further refined to obtain subpixel precision by a feature-based Levenberg-Marquardt (FLM) method. It converges evidently faster than most other methods because of its feature-based characteristic. Conclusions: We validate the performance of proposed method by testing with synthetic and real image sequences acquired by a hand-held digital still camera (DSC) and in comparison with an optical flow-based motion technique in terms of the squared sum of intensity differences (SSD) and correlation coefficient (CC). The results indicate that the proposed method is satisfactory in the registration accuracy and quality of DSC images.	Natl Chung Cheng Univ, Dept Informat Management, Chiayi Cty, Taiwan	National Chung Cheng University	Hsu, WY (corresponding author), Natl Chung Cheng Univ, Dept Informat Management, Chiayi Cty, Taiwan.	shenswy@gmail.com			National Science Council, Taiwan [NSC101-2221-E-194-066]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The author would like to express his sincere appreciation for a grant from NSC101-2221-E-194-066, National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022835; Caskey CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027372; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Daubechies I, 1992, CBMS NSF LECT NOTES, V61; Heeger DJ, 1996, PSYCH 267 CS 348D EE; Hsu WY, 2008, J MICROSC-OXFORD, V231, P408, DOI 10.1111/j.1365-2818.2008.02052.x; Hsu WY, 2013, INT J NEURAL SYST, V23, DOI 10.1142/S012906571350007X; Hsu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040558; Hsu WY, 2012, CLIN EEG NEUROSCI, V43, P87, DOI 10.1177/1550059412445051; Hsu WY, 2012, CLIN EEG NEUROSCI, V43, P32, DOI 10.1177/1550059411429528; Hsu WY, 2012, INT J NEURAL SYST, V22, P51, DOI 10.1142/S0129065712002979; Hsu WY, 2011, MICROSC RES TECHNIQ, V74, P523, DOI 10.1002/jemt.20942; Khalifa F, 2011, MULTI MODALITY STATE-OF-THE-ART MEDICAL IMAGE SEGMENTATION AND REGISTRATION METHODOLOGIES, VOL 1, P235, DOI 10.1007/978-1-4419-8195-0_9; Magara F, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0014094; Mann S, 1997, IEEE T IMAGE PROCESS, V6, P1281, DOI 10.1109/83.623191; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Sighoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018415; Viergever RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014701; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	19	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66656	10.1371/journal.pone.0066656	http://dx.doi.org/10.1371/journal.pone.0066656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805257	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500085
J	Luo, N; Kumar, A; Conwell, M; Weinreb, RN; Anderson, R; Sun, Y				Luo, Na; Kumar, Akhilesh; Conwell, Michael; Weinreb, Robert N.; Anderson, Ryan; Sun, Yang			Compensatory Role of Inositol 5-Phosphatase INPP5B to OCRL in Primary Cilia Formation in Oculocerebrorenal Syndrome of Lowe	PLOS ONE			English	Article							SYNDROME PROTEIN OCRL1; POLYPHOSPHATE 5-PHOSPHATASE; BINDING DOMAIN; CILIOPATHIES; MEMBRANE; POLYPHOSPHATE-5-PHOSPHATASE; DEFICIENT; MUTATIONS; CELLS; MICE	Inositol phosphatases are important regulators of cell signaling, polarity, and vesicular trafficking. Mutations in OCRL, an inositol polyphosphate 5-phosphatase, result in Oculocerebrorenal syndrome of Lowe, an X-linked recessive disorder that presents with congenital cataracts, glaucoma, renal dysfunction and mental retardation. INPP5B is a paralog of OCRL and shares similar structural domains. The roles of OCRL and INPP5B in the development of cataracts and glaucoma are not understood. Using ocular tissues, this study finds low levels of INPP5B present in human trabecular meshwork but high levels in murine trabecular meshwork. In contrast, OCRL is localized in the trabecular meshwork and Schlemm's canal endothelial cells in both human and murine eyes. In cultured human retinal pigmented epithelial cells, INPP5B was observed in the primary cilia. A functional role for INPP5B is revealed by defects in cilia formation in cells with silenced expression of INPP5B. This is further supported by the defective cilia formation in zebrafish Kupffer's vesicles and in cilia-dependent melanosome transport assays in inpp5b morphants. Taken together, this study indicates that OCRL and INPP5B are differentially expressed in the human and murine eyes, and play compensatory roles in cilia development.	[Luo, Na; Kumar, Akhilesh; Conwell, Michael; Sun, Yang] Indiana Univ Indianapolis, Dept Dermatol, Dept Biochem & Cell Biol, Glick Eye Inst,Dept Ophthalmol, Indiana, PA USA; [Weinreb, Robert N.] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Anderson, Ryan] Indiana Univ Indianapolis, Dept Pediat, Indiana, PA USA	University of California System; University of California San Diego	Luo, N (corresponding author), Indiana Univ Indianapolis, Dept Dermatol, Dept Biochem & Cell Biol, Glick Eye Inst,Dept Ophthalmol, Indiana, PA USA.	sunyo@iupui.edu	Luo, Na/L-4228-2014	Luo, Na/0000-0002-8046-9372; Conwell, Michael/0000-0003-1562-2729	National Institutes of Health [NEI K08 22058-01]; NATIONAL EYE INSTITUTE [K08EY022058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the National Institutes of Health NEI K08 22058-01. http://projectreporter.nih.gov/project_info_details.cfm?aid = 8223419&icde = 15619386 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RRD, 2005, SHIELDS TXB GLAUCOMA, P11; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Bernard DJ, 2010, MAMM GENOME, V21, P186, DOI 10.1007/s00335-010-9255-9; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bothwell SP, 2011, J AM SOC NEPHROL, V22, P443, DOI 10.1681/ASN.2010050565; Bothwell SP, 2010, MAMM GENOME, V21, P458, DOI 10.1007/s00335-010-9281-7; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Conduit SE, 2012, FEBS LETT, V586, P2846, DOI 10.1016/j.febslet.2012.07.037; Coon BG, 2012, HUM MOL GENET, V21, P1835, DOI 10.1093/hmg/ddr615; Coon BG, 2009, HUM MOL GENET, V18, P4478, DOI 10.1093/hmg/ddp407; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Faucherre A, 2005, HUM MOL GENET, V14, P1441, DOI 10.1093/hmg/ddi153; GAARY EA, 1993, J ULTRAS MED, V12, P234; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Hellsten E, 2002, BIOL REPROD, V66, P1522, DOI 10.1095/biolreprod66.5.1522; Hichri H, 2011, HUM MUTAT, V32, P379, DOI 10.1002/humu.21391; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Hyvola N, 2006, EMBO J, V25, P3750, DOI 10.1038/sj.emboj.7601274; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; JEFFERSON AB, 1995, J BIOL CHEM, V270, P9370, DOI 10.1074/jbc.270.16.9370; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Luo N., 2012, HUMAN MOL GENETICS; Luo N, 2012, VISION RES IN PRESS; Luo N, 2012, HUM MOL GENET, V21, P3333, DOI 10.1093/hmg/dds163; Matzaris M, 1998, J BIOL CHEM, V273, P8256, DOI 10.1074/jbc.273.14.8256; MITCHELL CA, 1989, J BIOL CHEM, V264, P8873; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Rbaibi Y, 2012, TRAFFIC, V9999; Richardson MR, 2010, MOL VIS, V16, P2376; Russell-Randall KR, 2011, INVEST OPHTH VIS SCI, V52, P5233, DOI 10.1167/iovs.10-6613; Sarmah B, 2007, P NATL ACAD SCI USA, V104, P19843, DOI 10.1073/pnas.0706934104; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Schneider I, 2008, DEVELOPMENT, V135, P75, DOI 10.1242/dev.004713; Schurman SJ, 2009, NAT REV NEPHROL, V5, P529, DOI 10.1038/nrneph.2009.124; Ungewickell A, 2004, P NATL ACAD SCI USA, V101, P13501, DOI 10.1073/pnas.0405664101; Walton DS, 2005, J GLAUCOMA, V14, P181, DOI 10.1097/01.ijg.0000158850.07732.05; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	47	32	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66727	10.1371/journal.pone.0066727	http://dx.doi.org/10.1371/journal.pone.0066727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805271	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500099
J	Okada, K; Venezia, JH; Matchin, W; Saberi, K; Hickok, G				Okada, Kayoko; Venezia, Jonathan H.; Matchin, William; Saberi, Kourosh; Hickok, Gregory			An fMRI Study of Audiovisual Speech Perception Reveals Multisensory Interactions in Auditory Cortex	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; VISUAL SPEECH; INTEGRATION; FACES; ACTIVATION; VOICES	Research on the neural basis of speech-reading implicates a network of auditory language regions involving inferior frontal cortex, premotor cortex and sites along superior temporal cortex. In audiovisual speech studies, neural activity is consistently reported in posterior superior temporal Sulcus (pSTS) and this site has been implicated in multimodal integration. Traditionally, multisensory interactions are considered high-level processing that engages heteromodal association cortices (such as STS). Recent work, however, challenges this notion and suggests that multisensory interactions may occur in low-level unimodal sensory cortices. While previous audiovisual speech studies demonstrate that high-level multisensory interactions occur in pSTS, what remains unclear is how early in the processing hierarchy these multisensory interactions may occur. The goal of the present fMRI experiment is to investigate how visual speech can influence activity in auditory cortex above and beyond its response to auditory speech. In an audiovisual speech experiment, subjects were presented with auditory speech with and without congruent visual input. Holding the auditory stimulus constant across the experiment, we investigated how the addition of visual speech influences activity in auditory cortex. We demonstrate that congruent visual speech increases the activity in auditory cortex.	[Okada, Kayoko; Venezia, Jonathan H.; Matchin, William; Saberi, Kourosh; Hickok, Gregory] Univ Calif Irvine, Dept Cognit Sci, Ctr Cognit Neurosci, Irvine, CA 92717 USA	University of California System; University of California Irvine	Hickok, G (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Ctr Cognit Neurosci, Irvine, CA 92717 USA.	greg.hickok@uci.edu	Saberi, Kourosh/GXG-0944-2022; Venezia, Jonathan/AAD-1296-2019	Matchin, William/0000-0002-2530-8429	National Institutes of Health [DC003681]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009659, R01DC003681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was funded by National Institutes of Health (DC003681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer ET, 2007, J SPEECH LANG HEAR R, V50, P1157, DOI 10.1044/1092-4388(2007/080); Balk MH, 2010, NEUROREPORT, V21, P822, DOI 10.1097/WNR.0b013e32833d138f; Beauchamp MS, 2010, J NEUROSCI, V30, P2414, DOI 10.1523/JNEUROSCI.4865-09.2010; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bernstein LE, 2002, NEUROREPORT, V13, P311, DOI 10.1097/00001756-200203040-00013; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Falchier A, 2002, J NEUROSCI, V22, P5749; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Hertrich I, 2011, J COGNITIVE NEUROSCI, V23, P221, DOI 10.1162/jocn.2010.21421; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Joassin F, 2011, CORTEX, V47, P367, DOI 10.1016/j.cortex.2010.03.003; Joassin F, 2011, NEUROIMAGE, V54, P1654, DOI 10.1016/j.neuroimage.2010.08.073; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; MacSweeney A, 2000, NEUROREPORT, V11, pCOVER3; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Mottonen R, 2004, NEUROSCI LETT, V363, P112, DOI 10.1016/j.neulet.2004.03.076; Nath AR, 2012, NEUROIMAGE, V59, P781, DOI 10.1016/j.neuroimage.2011.07.024; Nath AR, 2011, J NEUROSCI, V31, P1704, DOI 10.1523/JNEUROSCI.4853-10.2011; Okada K, 2009, NEUROSCI LETT, V452, P219, DOI 10.1016/j.neulet.2009.01.060; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; Strelnikov K, 2009, SCAND J PSYCHOL, V50, P437, DOI 10.1111/j.1467-9450.2009.00741.x; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Szycik GR, 2008, BRAIN RES, V1220, P142, DOI 10.1016/j.brainres.2007.08.027; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4	44	36	36	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e68959	10.1371/journal.pone.0068959	http://dx.doi.org/10.1371/journal.pone.0068959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805332	gold, Green Published			2022-12-27	WOS:000320846500161
J	Sipiczki, M; Pfliegler, WP; Holb, IJ				Sipiczki, Matthias; Pfliegler, Walter P.; Holb, Imre J.			Metschnikowia Species Share a Pool of Diverse rRNA Genes Differing in Regions That Determine Hairpin-Loop Structures and Evolve by Reticulation	PLOS ONE			English	Article							LARGE-SUBUNIT RDNA; SP-NOV.; SACCHAROMYCES-CEREVISIAE; INTERSPECIES HYBRIDIZATION; CONCERTED EVOLUTION; SECONDARY STRUCTURE; DNA REPEATS; ACTIN GENE; YEAST; SEQUENCE	Modern taxonomy of yeasts is mainly based on phylogenetic analysis of conserved DNA and protein sequences. By far the most frequently used sequences are those of the repeats of the chromosomal rDNA array. It is generally accepted that the rDNA repeats of a genome have identical sequences due to the phenomenon of sequence homogenisation and can thus be used for identification and barcoding of species. Here we show that the rDNA arrays of the type strains of Metschnikowia andauensis and M. fructicola are not homogenised. Both have arrays consisting of diverse repeats that differ from each other in the D1/D2 domains by up to 18 and 25 substitutions. The variable sites are concentrated in two regions that correspond to back-folding stretches of hairpin loops in the predicted secondary structure of the RNA molecules. The substitutions do not alter significantly the overall hairpin-loop structure due to wobble base pairing at sites of C-T transitions and compensatory mutations in the complementary strand of the hairpin stem. The phylogenetic and network analyses of the cloned sequences revealed that the repeats had not evolved in a vertical tree-like way but reticulation might have shaped the rDNA arrays of both strains. The neighbour-net analysis of all cloned sequences of the type strains and the database sequences of different strains further showed that these species share a continuous pool of diverse repeats that appear to evolve by reticulate evolution.	[Sipiczki, Matthias; Pfliegler, Walter P.] Univ Debrecen, Dept Genet & Appl Microbiol, Debrecen, Hungary; [Holb, Imre J.] Hungarian Acad Sci, Inst Plant Protect, Debrecen, Hungary; [Holb, Imre J.] Univ Debrecen, Debrecen, Hungary	University of Debrecen; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Debrecen	Sipiczki, M (corresponding author), Univ Debrecen, Dept Genet & Appl Microbiol, Debrecen, Hungary.	gecela@post.sk	Sipiczki, Matthias/R-1496-2019; , lipovy/AAT-5960-2021; Pfliegler, Walter P./D-1114-2018	Pfliegler, Walter P./0000-0001-6723-4416; Sipiczki, Matthias/0000-0002-1059-1305	Hungarian Scientific Research Fund [OTKA-81792]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the grant OTKA-81792 provided by the Hungarian Scientific Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper I, 2011, FUNGAL BIOL-UK, V115, P1259, DOI 10.1016/j.funbio.2011.09.002; [Anonymous], 2011, PHYLOGENETIC NETWORK; [Anonymous], 2013, MOL PHYL EV IN PRESS; Balazs A, 2012, FUNGAL GENET BIOL, V49, P235, DOI 10.1016/j.fgb.2012.01.003; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Daniel HM, 2001, INT J SYST EVOL MICR, V51, P1593, DOI 10.1099/00207713-51-4-1593; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Dress AWM, 2004, IEEE ACM T COMPUT BI, V1, P109, DOI 10.1109/TCBB.2004.27; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Ganley ARD, 2011, MOL BIOL EVOL, V28, P2883, DOI 10.1093/molbev/msr117; Gordon JL, 2008, YEAST, V25, P449, DOI 10.1002/yea.1598; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Kurtzman Cletus P., 2006, Mycoscience, V47, P65, DOI 10.1007/s10267-006-0280-1; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Kurtzman CP, 2001, SYST APPL MICROBIOL, V24, P395, DOI 10.1078/0723-2020-00045; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2003, FEMS YEAST RES, V4, P253, DOI 10.1016/S1567-1356(03)00113-2; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P575, DOI 10.1016/B978-0-444-52149-1.00046-X; Lachance MA, 2010, ANTON LEEUW INT J G, V97, P155, DOI 10.1007/s10482-009-9399-3; Lott M, 2009, BIOINFORMATICS, V25, P1199, DOI 10.1093/bioinformatics/btp133; Louis VL, 2012, G3-GENES GENOM GENET, V2, P299, DOI 10.1534/g3.111.000745; Makarenkov V, 2006, APPL MYCOL BIOTECH, V6, P61; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Molnar O, 2005, SYST APPL MICROBIOL, V28, P717, DOI 10.1016/j.syapm.2005.05.009; Morales L, 2012, MICROBIOL MOL BIOL R, V76, P721, DOI 10.1128/MMBR.00022-12; Moret BME, 2004, IEEE ACM T COMPUT BI, V1, P13, DOI 10.1109/TCBB.2004.10; Naumov GI, 2011, MICROBIOLOGY+, V80, P135, DOI 10.1134/S0026261711020111; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pfliegler WP, 2012, FEMS YEAST RES, V12, P703, DOI 10.1111/j.1567-1364.2012.00820.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SACCONE C, 1990, METHOD ENZYMOL, V183, P570; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Sipiczki M, 2006, APPL ENVIRON MICROB, V72, P6716, DOI 10.1128/AEM.01275-06; Sipiczki M, 2012, INT J SYST EVOL MICR, V62, P3099, DOI 10.1099/ijs.0.044974-0; Solieri L, 2005, INT J BIOTECHNOL BIO, V1, P11; Suh SO, 2004, INT J SYST EVOL MICR, V54, P1883, DOI 10.1099/ijs.0.63152-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; Xue ML, 2006, INT J SYST EVOL MICR, V56, P2245, DOI 10.1099/ijs.0.64391-0	60	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67384	10.1371/journal.pone.0067384	http://dx.doi.org/10.1371/journal.pone.0067384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805311	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500139
J	Tulloch-Reid, MK; Younger, NO; Ferguson, TS; Francis, DK; Abdulkadri, AO; Gordon-Strachan, GM; McFarlane, SR; Cunningham-Myrie, CA; Wilks, RJ; Anderson, SG				Tulloch-Reid, Marshall K.; Younger, Novie O.; Ferguson, Trevor S.; Francis, Damian K.; Abdulkadri, Abdullahi O.; Gordon-Strachan, Georgiana M.; McFarlane, Shelly R.; Cunningham-Myrie, Colette A.; Wilks, Rainford J.; Anderson, Simon G.			Excess Cardiovascular Risk Burden in Jamaican Women Does Not Influence Predicted 10-Year CVD Risk Profiles of Jamaica Adults: An Analysis of the 2007/08 Jamaica Health and Lifestyle Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; EUROPEAN-SOCIETY; HEART-DISEASE; CASE-FATALITY; PREVALENCE; PREVENTION; POPULATION; INCOME	Background: Black Caribbean women have a higher burden of cardiovascular disease (CVD) risk factors than their male counterparts. Whether this results in a difference in incident cardiovascular events is unknown. The aim of this study was to estimate the 10 year World Health Organization/International Society for Hypertension (WHO/ISH) CVD risk score for Jamaica and explore the effect of sex as well as obesity, physical activity and socioeconomic status on these estimates. Methods and Findings: Data from 40-74 year old participants in the 2007/08 Jamaica Health and Lifestyle Survey were used. Trained interviewers administered questionnaires and measured anthropometrics, blood pressure, fasting glucose and cholesterol. Education and occupation were used to assess socioeconomic status. The Americas B tables were used to estimate the WHO/ISH 10 year CVD risk scores for the population. Weighted prevalence estimates were calculated. Data from 1,432 (450 men, 982 women) participants were analysed, after excluding those with self-reported heart attack and stroke. The women had a higher prevalence of diabetes (19% W; 12% M), hypertension (49% W; 47% M), hypercholesterolemia (25% W; 11% M), obesity (46% W; 15% M) and physical inactivity (59% W; 29% M). More men smoked (6% W; 31% M). There was good agreement between the 10-year cardiovascular risk estimates whether or not cholesterol measurements were utilized for calculation (kappa -0.61). While 90% had a 10 year WHO/ISH CVD risk of less than 10%, approximately 2% of the population or 14,000 persons had a 10 year WHO/ISH CVD risk of >= 30%. As expected CVD risk increased with age but there was no sex difference in CVD risk distribution despite women having a greater risk factor burden. Women with low socioeconomic status had the most adverse CVD risk profile. Conclusion: Despite women having a higher prevalence of CVD risk factors there was no sex difference in 10-year WHO/ISH CVD risk in Jamaican adults.	[Tulloch-Reid, Marshall K.; Younger, Novie O.; Ferguson, Trevor S.; Francis, Damian K.; McFarlane, Shelly R.; Wilks, Rainford J.] Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica; [Abdulkadri, Abdullahi O.] Univ W Indies, Dept Econ, Kingston 7, Jamaica; [Gordon-Strachan, Georgiana M.] Univ W Indies, Fac Med Sci, Deans Off, Kingston 7, Jamaica; [Cunningham-Myrie, Colette A.] Univ W Indies, Dept Community Hlth & Psychiat, Kingston 7, Jamaica; [Anderson, Simon G.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Mona Jamaica; University West Indies Mona Jamaica; University of Manchester	Tulloch-Reid, MK (corresponding author), Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica.	marshall.tullochreid@uwimona.edu.jm	Ferguson, Trevor/Q-7209-2019; McFarlane, Shelly/AFU-7579-2022; Anderson, Simon G/AGM-2359-2022; Gordon-Strachan, Georgiana/AAS-5589-2021	Ferguson, Trevor/0000-0002-2393-1452; Anderson, Simon G/0000-0002-8896-073X; 	National Health Fund; National Institute for Health Research [ACF-2008-06-003, CL-2012-06-001] Funding Source: researchfish	National Health Fund; National Institute for Health Research(National Institute for Health Research (NIHR))	The project was funded by the National Health Fund (http://www.nhf.org.jm/). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funders did request that questions to evaluate the efficacy of a medication subsidy programme be included in the survey questionnaire. These questions were designed by the investigators. The funders had no role in the decision to use the survey design, sampling or how additional data were collected.	Ataman SL, 1996, J CLIN EPIDEMIOL, V49, P869, DOI 10.1016/0895-4356(96)00111-4; Berger JS, 2010, J AM COLL CARDIOL, V55, P1169, DOI 10.1016/j.jacc.2009.09.066; Block Robert C, 2012, Prev Chronic Dis, V9, pE90; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2011, CURR OPIN CARDIOL, V26, P429, DOI 10.1097/HCO.0b013e3283499f06; Corbin DOC, 2004, STROKE, V35, P1254, DOI 10.1161/01.STR.0000127371.24658.df; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Ferguson TS, 2011, W INDIAN MED J, V60, P422; Ferguson TS, 2010, W INDIAN MED J, V59, P265; Ferguson T, 2010, CURR CARDIOVASC RISK, V4, P76, DOI 10.1007/s12170-009-0076-x; Ferguson TS, 2010, RES REP CLIN CARDIOL, V1, P23, DOI 10.2147/RRCC.S13649; Ferguson TS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-307; Kaduka LU, 2012, DIABETES CARE, V35, P887, DOI 10.2337/dc11-0537; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leeder S, 2004, RACE TIME CHALLENGE; Marmot M, 1997, IARC SCI PUBL, V207-228; Mendis S., 2011, GLOB ATL CARD DIS PR; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Mendis S, 2011, J CLIN EPIDEMIOL, V64, P1451, DOI 10.1016/j.jclinepi.2011.02.001; Molokhia M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014588; Morales A, 2011, MEDICC REV, V13, P23, DOI 10.37757/MR2011V13.N4.6; Ndindjock R, 2011, B WORLD HEALTH ORGAN, V89, P286, DOI 10.2471/BLT.10.082370; Njelekela MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-30; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; The Statistical Institute of Jamaica, 2009, DEM STAT 2008; The Statistical Institute of Jamaica, 1991, JAM STAND OCC CLASS; Vaccarino V, 2011, CARDIOVASC RES, V90, P9, DOI 10.1093/cvr/cvq394; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; Wilks R, 1998, W INDIAN MED J, V47, P40; Wilks R, 2008, TECHNICAL REPORT; World Health Organization, 2011, 317 WHO	35	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66625	10.1371/journal.pone.0066625	http://dx.doi.org/10.1371/journal.pone.0066625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805252	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500080
J	Chen, XL; Lei, YH; Liu, CF; Yang, QF; Zuo, PY; Liu, CY; Chen, CZ; Liu, YW				Chen, Xing-Lin; Lei, Ying-Hong; Liu, Cun-Fei; Yang, Qun-Fang; Zuo, Pei-Yuan; Liu, Cheng-Yun; Chen, Chang-Zhong; Liu, Yu-Wei			Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; PHASE-III; CARDIOVASCULAR COMPLICATIONS; 1ST-LINE CHEMOTHERAPY; SYSTEMATIC REVIEWS; RANDOMIZED-TRIAL; CLINICAL-TRIALS; DOUBLE-BLIND	Concerns have arisen regarding the risk of ischemic heart disease with the novel antiangiogenic agent bevacizumab, a recombinant humanised monoclonal antibody to the vascular endothelial growth factor that is widely used in cancer treatment. Currently, the role of bevacizumab in ischemic heart disease is controversial. This meta-analysis was therefore performed to assess the overall risk of ischemic heart disease associated with the use of bevacizumab. The databases of PubMed, EMBASE and Web of Science were searched for English language studies of randomised controlled trials comparing bevacizumab with control therapy published through October 25, 2012. Summary incidence rates, relative risks (RRs) and 95% confidence intervals (CIs) were calculated using random-effects or fixed-effects models based on the heterogeneity of the included studies. A total of 4,617 patients from 7 randomised controlled trials were identified and included for analysis. Among those patients receiving bevacizumab, the summary incidence of ischemic heart disease was 1.0% (95% CI, 0.6%-1.4%). Patients treated with bevacizumab had a significantly increased risk of ischemic heart disease with an RR of 2.49 (95% CI, 1.37-4.52) compared with controls. In addition, both high doses and low doses of bevacizumab increased the risk of cardiac ischemia (low dose at 2.5 mg/kg per week: RR, 2.14 [95% CI, 1.09-4.19]; high dose at 5 mg/kg per week: RR, 4.81 [95% CI, 1.03-22.42]). Bevacizumab was also found to significantly increase the risk of cardiac ischemia in patients with colorectal cancer (RR, 2.13; 95% CI, 1.11-4.06) compared with controls. This meta-analysis shows the use of bevacizumab was associated with an increased risk of developing ischemic heart disease in colorectal cancer patients receiving this drug. Our conclusions are limited by the available data. Further evaluations of high-quality RCTs are needed.	[Chen, Xing-Lin; Lei, Ying-Hong; Zuo, Pei-Yuan; Liu, Cheng-Yun; Liu, Yu-Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Geriatr,Hlth Minist,Dept Geriatr, Wuhan 430074, Peoples R China; [Liu, Cun-Fei] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Geriatr, Shanghai 200030, Peoples R China; [Yang, Qun-Fang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hyperbar Oxygen Ctr, Wuhan 430074, Peoples R China; [Chen, Chang-Zhong] Dana Farber Canc Inst, Microarray Core Facil, Boston, MA 02115 USA	Huazhong University of Science & Technology; Shanghai Jiao Tong University; Huazhong University of Science & Technology; Harvard University; Dana-Farber Cancer Institute	Liu, CY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Key Lab Geriatr,Hlth Minist,Dept Geriatr, Wuhan 430074, Peoples R China.	lcyun@medmail.com.cn	Yang, Quanjun/D-4657-2013	Yang, Quanjun/0000-0003-0279-8784; Chen, Xinglin/0000-0002-5820-9224	Health Department of Hubei Province [JX4C47]	Health Department of Hubei Province	This study was supported by a grant from Health Department of Hubei Province (No. JX4C47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P3385, DOI 10.1200/JCO.2009.21.9220; [Anonymous], 2011, COCHRANE HDB SYSTEMA; Cella D, 2011, BREAST CANCER RES TR, V130, P855, DOI 10.1007/s10549-011-1725-6; Cohen MH, 2007, ONCOLOGIST, V12, P356, DOI 10.1634/theoncologist.12-3-356; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; des Guetz G, 2011, TARGET ONCOL, V6, P197, DOI 10.1007/s11523-011-0204-7; Ederhy S, 2011, CRIT REV ONCOL HEMAT, V80, P369, DOI 10.1016/j.critrevonc.2011.01.009; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Gordon MS, 2005, ONCOLOGY-BASEL, V69, P25, DOI 10.1159/000088481; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kemeny NE, 2011, ONCOLOGY-BASEL, V80, P153, DOI 10.1159/000324704; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Macedo LT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-89; Meyerhardt JA, 2012, J CLIN ONCOL, V30, P608, DOI 10.1200/JCO.2011.38.9650; Moehler M, 2009, WORLD J GASTROENTERO, V15, P449, DOI 10.3748/wjg.15.449; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Price TJ, 2012, ANN ONCOL, V23, P1531, DOI 10.1093/annonc/mdr488; Ranpura V, 2010, ACTA ONCOL, V49, P287, DOI 10.3109/02841860903524396; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Senkus E, 2011, CANCER TREAT REV, V37, P300, DOI 10.1016/j.ctrv.2010.11.001; Snoeren N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-545; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stone JR, 2002, ENDOTHELIUM-J ENDOTH, V9, P231, DOI 10.1080/10623320214733; Su Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035629; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	40	31	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66721	10.1371/journal.pone.0066721	http://dx.doi.org/10.1371/journal.pone.0066721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818962	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800099
J	Huibers, RP; Loonen, AEHM; Gao, DL; Van den Ackerveken, G; Visser, RGF; Bai, YL				Huibers, Robin P.; Loonen, Annelies E. H. M.; Gao, Dongli; Van den Ackerveken, Guido; Visser, Richard G. F.; Bai, Yuling			Powdery Mildew Resistance in Tomato by Impairment of SlPMR4 and SlDMR1	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; DISEASE RESISTANCE; ARABIDOPSIS MUTANTS; TARGETED MUTAGENESIS; GENE; PLANTS; PATHOGENESIS; MUTATION	Genetic dissection of disease susceptibility in Arabidopsis to powdery and downy mildew has identified multiple susceptibility (S) genes whose impairment results in disease resistance. Although several of these S-genes have been cloned and characterized in more detail it is unknown to which degree their function in disease susceptibility is conserved among different plant species. Moreover, it is unclear whether impairment of such genes has potential in disease resistance breeding due to possible fitness costs associated with impaired alleles. Here we show that the Arabidopsis PMR4 and DMR1, genes encoding a callose synthase and homoserine kinase respectively, have functional orthologs in tomato with respect to their S-gene function. Silencing of both genes using RNAi resulted in resistance to the tomato powdery mildew fungus Oidium neolycopersici. Resistance to O. neolycopersici by SlDMR1 silencing was associated with severely reduced plant growth whereas SlPMR4 silencing was not. SlPMR4 is therefore a suitable candidate gene as target for mutagenesis to obtain alleles that can be deployed in disease resistance breeding of tomato.	[Huibers, Robin P.; Loonen, Annelies E. H. M.; Gao, Dongli; Visser, Richard G. F.; Bai, Yuling] Univ Wageningen & Res Ctr, Lab Plant Breeding, Wageningen, Netherlands; [Van den Ackerveken, Guido] Univ Utrecht, Dept Biol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University	Bai, YL (corresponding author), Univ Wageningen & Res Ctr, Lab Plant Breeding, Wageningen, Netherlands.	Bai.Yuling@wur.nl	Visser, Richard GF/B-3423-2012; Van den Ackerveken, Guido/B-8568-2011	Visser, Richard GF/0000-0002-0213-4016; Van den Ackerveken, Guido/0000-0002-0183-8978				Bai YL, 2005, MOL PLANT MICROBE IN, V18, P354, DOI 10.1094/MPMI-18-0354; Bai YL, 2008, MOL PLANT MICROBE IN, V21, P30, DOI 10.1094/MPMI-21-1-0030; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Gollner K, 2008, NEW PHYTOL, V177, P725, DOI 10.1111/j.1469-8137.2007.02339.x; GREENBERG JT, 1993, PLANT J, V4, P327, DOI 10.1046/j.1365-313X.1993.04020327.x; Heilersig HJB, 2006, PLANT MOL BIOL, V60, P647, DOI 10.1007/s11103-005-5280-6; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Humphry M, 2011, MOL PLANT PATHOL, V12, P866, DOI [10.1111/J.1364-3703.2011.00718.X, 10.1111/j.1364-3703.2011.00718.x]; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; Lyngkjaer MF, 2000, AGRONOMIE, V20, P745, DOI 10.1051/agro:2000173; Lyznik LA, 2012, METHODS MOL BIOL, V847, P399, DOI 10.1007/978-1-61779-558-9_32; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Pavan S, 2011, THEOR APPL GENET, V123, P1425, DOI 10.1007/s00122-011-1677-6; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Stuttmann J, 2011, PLANT CELL, V23, P2788, DOI 10.1105/tpc.111.087684; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; van Damme M, 2009, PLANT CELL, V21, P2179, DOI 10.1105/tpc.109.066811; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107	29	59	63	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67467	10.1371/journal.pone.0067467	http://dx.doi.org/10.1371/journal.pone.0067467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818978	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800135
J	Maekawa, R; Sato, S; Yamagata, Y; Asada, H; Tamura, I; Lee, L; Okada, M; Tamura, H; Takaki, E; Nakai, A; Sugino, N				Maekawa, Ryo; Sato, Shun; Yamagata, Yoshiaki; Asada, Hiromi; Tamura, Isao; Lee, Lifa; Okada, Maki; Tamura, Hiroshi; Takaki, Eiichi; Nakai, Akira; Sugino, Norihiro			Genome-Wide DNA Methylation Analysis Reveals a Potential Mechanism for the Pathogenesis and Development of Uterine Leiomyomas	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; GLUTATHIONE-S-TRANSFERASE; GENE-EXPRESSION; X-CHROMOSOME; EPIGENETIC REGULATION; RISK-FACTORS; INACTIVE-X; FIBROIDS; IRS-1	Background: The pathogenesis of uterine leiomyomas, the most common benign tumor in women, remains unclear. Since acquired factors such as obesity, hypertension and early menarche place women at greater risk for uterine leiomyomas, uterine leiomyomas may be associated with epigenetic abnormalities that are caused by unfavorable environmental exposures. Principal Findings: Profiles of genome-wide DNA methylation and mRNA expression were investigated in leiomyomas and in myometrium with and without leiomyomas. Profiles of DNA methylation and mRNA expression in the myometrium with and without leiomyomas were quite similar while those in leiomyomas were distinct. We identified 120 genes whose DNA methylation and mRNA expression patterns differed between leiomyomas and the adjacent myometrium. The biological relevance of the aberrantly methylated and expressed genes was cancer process, including IRS1 that is related to transformation, and collagen-related genes such as COL4A1, COL4A2 and COL6A3. We also detected 22 target genes of estrogen receptor (ER) alpha, including apoptosis-related genes, that have aberrant DNA methylation in the promoter, suggesting that the aberrant epigenetic regulation of ER alpha-target genes contributes to the aberrant response to estrogen. Conclusions: Aberrant DNA methylation and its related transcriptional aberration were associated with cancer processes, which may represent a critical initial mechanism that triggers transformation of a single tumor stem cell that will eventually develop into a monoclonal leiomyoma tumor. The aberrant epigenetic regulation of ER alpha-target genes also may contribute to the aberrant response to estrogen, which is involved in the development of uterine leiomyomas after menarche.	[Maekawa, Ryo; Sato, Shun; Yamagata, Yoshiaki; Asada, Hiromi; Tamura, Isao; Lee, Lifa; Okada, Maki; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan; [Takaki, Eiichi; Nakai, Akira] Yamaguchi Univ, Dept Biochem & Mol Biol, Grad Sch Med, Ube, Yamaguchi 755, Japan	Yamaguchi University; Yamaguchi University	Sugino, N (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan.	sugino@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X	Japan Society for the Promotion of Science KAKENHI [23791846, 23890140, 24592471]; Ministry of Education, Science, and Culture, Japan [24791704]; Grants-in-Aid for Scientific Research [24791704] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant Number 23791846, 23890140, 24592471, and 24791704 for Scientific Research from the Ministry of Education, Science, and Culture, Japan (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada H, 2008, MOL HUM REPROD, V14, P539, DOI 10.1093/molehr/gan045; Bajekal N, 2000, HUM REPROD UPDATE, V6, P614, DOI 10.1093/humupd/6.6.614; Bell A, 2011, CANCER-AM CANCER SOC, V117, P2898, DOI 10.1002/cncr.25818; Bernard D, 2010, AGING-US, V2, P317, DOI 10.18632/aging.100153; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cesarone G, 2006, J CELL BIOCHEM, V98, P440, DOI 10.1002/jcb.20817; Chiaffarino F, 1999, OBSTET GYNECOL, V94, P395, DOI 10.1016/S0029-7844(99)00305-1; Claus R, 2012, INT J CANCER, V131, pE138, DOI 10.1002/ijc.26429; DAMBROSIO C, 1995, CELL GROWTH DIFFER, V6, P557; DeAngelis T, 2006, ONCOGENE, V25, P32, DOI 10.1038/sj.onc.1209013; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Esposito DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036190; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Faerstein E, 2001, AM J EPIDEMIOL, V153, P11, DOI 10.1093/aje/153.1.11; Faerstein E, 2001, AM J EPIDEMIOL, V153, P1, DOI 10.1093/aje/153.1.1; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; Gilden M, 2012, FERTIL STERIL; Greathouse KL, 2012, MOL CANCER RES, V10, P546, DOI 10.1158/1541-7786.MCR-11-0605; Hitchler MJ, 2006, EPIGENETICS-US, V1, P163, DOI 10.4161/epi.1.4.3401; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Iwatani M, 2006, STEM CELLS, V24, P2549, DOI 10.1634/stemcells.2005-0427; Kawakami T, 2004, ONCOGENE, V23, P6163, DOI 10.1038/sj.onc.1207808; Kearns PR, 2003, BRIT J HAEMATOL, V120, P80, DOI 10.1046/j.1365-2141.2003.04039.x; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lieb JD, 2006, CYTOGENET GENOME RES, V114, P1, DOI 10.1159/000091922; Maekawa R, 2011, J REPROD DEVELOP, V57, P604, DOI 10.1262/jrd.11-035A; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Missaoui N, 2011, PATHOL RES PRACT, V207, P37, DOI 10.1016/j.prp.2010.11.001; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Morelli C, 2003, ONCOGENE, V22, P4007, DOI 10.1038/sj.onc.1206436; Navarro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033284; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Reiss K, 2012, J CELL PHYSIOL, V227, P2992, DOI 10.1002/jcp.24019; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Shiota K, 2002, DIFFERENTIATION, V69, P162, DOI 10.1046/j.1432-0436.2002.690406.x; Sirchia SM, 2005, CANCER RES, V65, P2139, DOI 10.1158/0008-5472.CAN-04-3465; Skubitz KM, 2003, CANCER, V98, P1029, DOI 10.1002/cncr.11586; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Sun M, 2001, CANCER RES, V61, P5985; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Valentinis B, 1999, J BIOL CHEM, V274, P12423, DOI 10.1074/jbc.274.18.12423; Vanharanta S, 2005, ONCOGENE, V24, P6545, DOI 10.1038/sj.onc.1208784; Weston G, 2003, MOL HUM REPROD, V9, P541, DOI 10.1093/molehr/gag066; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wu Q, 2004, BIOL REPROD, V70, P1790, DOI 10.1095/biolreprod.103.025387; Yamagata Y, 2009, MOL HUM REPROD, V15, P259, DOI 10.1093/molehr/gap010; Zhang P, 2006, HUM PATHOL, V37, P1350, DOI 10.1016/j.humpath.2006.05.005	56	71	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66632	10.1371/journal.pone.0066632	http://dx.doi.org/10.1371/journal.pone.0066632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818951	gold, Green Submitted, Green Published			2022-12-27	WOS:000322342800087
J	Lu, P; Xia, HC; Gao, L; Pan, Y; Wang, Y; Cheng, X; Lu, HG; Lin, F; Chen, L; Yao, Q; Liu, XY; Tang, Q; Chen, KP				Lu, Peng; Xia, Hengchuan; Gao, Lu; Pan, Ye; Wang, Yong; Cheng, Xin; Lu, Honggang; Lin, Feng; Chen, Liang; Yao, Qin; Liu, Xiaoyong; Tang, Qi; Chen, Keping			V-ATPase Is Involved in Silkworm Defense Response against Bombyx mori Nucleopolyhedrovirus	PLOS ONE			English	Article							H+-ATPASE; ANTIVIRAL ACTIVITY; BACULOVIRUS; MEMBRANE; CELLS; GENE; LOCALIZATION; RESISTANCE; PHYSIOLOGY; SUBUNIT	Silkworms are usually susceptible to the infection of Bombyx mori (B. mori) nucleopolyhedrovirus (BmNPV), which can cause significant economic loss. However, some silkworm strains are identified to be highly resistant to BmNPV. To explore the silkworm genes involved in this resistance in the present study, we performed comparative real-time PCR, ATPase assay, over-expression and sub-cellular localization experiments. We found that when inoculated with BmNPV both the expression and activity of V-ATPase were significantly up-regulated in the midgut column cells (not the goblet cells) of BmNPV-resistant strains (NB and BC8), the main sites for the first step of BmNPV invasion, but not in those of a BmNPV-susceptible strain 306. Furthermore, this up-regulation mainly took place during the first 24 hours post inoculation (hpi), the essential period required for establishment of virus infection, and then was down-regulated to normal levels. Amazingly, transient overexpression of V-ATPase c subunit in BmNPV-infected silkworm cells could significantly inhibit BmNPV proliferation. To our knowledge this is the first report demonstrating clearly that V-ATPase is indeed involved in the defense response against BmNPV. Our data further suggests that prompt and potent regulation of V-ATPase may be essential for execution of this response, which may enable fast acidification of endosomes and/or lysosomes to render them competent for degradation of invading viruses.	[Lu, Peng; Wang, Yong; Cheng, Xin; Chen, Liang; Tang, Qi; Chen, Keping] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China; [Lu, Peng; Xia, Hengchuan; Lu, Honggang; Yao, Qin; Liu, Xiaoyong; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Gao, Lu] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Pan, Ye] Jiangsu Univ, Lab Anim Res Ctr, Zhenjiang, Jiangsu, Peoples R China; [Cheng, Xin] Jiangxi Agr Univ, Nanchang Key Lab Appl Fermentat Technol, Nanchang, Peoples R China; [Lin, Feng] Zhejiang Inst Freshwater Fisheries, Huzhou, Zhejiang, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University; Jiangsu University; Jiangxi Agricultural University	Chen, KP (corresponding author), Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang, Jiangsu, Peoples R China.	kpchen@ujs.edu.cn	Xia, hengchuan/GQB-2955-2022; Xia, Hengchuan/AAB-1301-2020; cheng, xin/AAN-2326-2020	Xia, hengchuan/0000-0002-5701-6092; Chen, Liang/0000-0001-7371-3130	National basic Research Program of China "973" [2012CB114604]; National Natural Science Foundation of China [31101673, 31272507]; Postgraduate Research and Innovation Project of Jiangsu Province [CXLX12-0671]	National basic Research Program of China "973"(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research and Innovation Project of Jiangsu Province	This work was supported by the National basic Research Program of China "973" under Grant No. 2012CB114604, the National Natural Science Foundation of China (No. 31101673, No. 31272507) and Postgraduate Research and Innovation Project of Jiangsu Province (No. CXLX12-0671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YY, 2008, INSECT BIOCHEM MOLEC, V38, P853, DOI 10.1016/j.ibmb.2008.06.004; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Chen HQ, 2007, FEBS LETT, V581, P5836, DOI 10.1016/j.febslet.2007.11.059; Chen K.P., 1991, ACTA SERICOL SIN, V17, P45; Du J, 2006, J CELL SCI, V119, P2542, DOI 10.1242/jcs.02983; Elandalloussi LM, 2005, MOL BIOCHEM PARASIT, V141, P49, DOI 10.1016/j.molbiopara.2005.02.001; Forgac M, 1999, J BIOENERG BIOMEMBR, V31, P57, DOI 10.1023/A:1005496530380; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; HARVEY WR, 1992, J EXP BIOL, V172, P1; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Lee KS, 2005, INSECT BIOCHEM MOLEC, V35, P73, DOI 10.1016/j.ibmb.2004.09.008; LEIKINA E, 1992, FEBS LETT, V304, P221, DOI 10.1016/0014-5793(92)80623-O; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; LuPeng, 2007, International Journal of Industrial Entomology, V15, P115; Maeda S, 1989, GENE TRANSFER VECTOR, P167; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Selot R, 2007, BIOSCI BIOTECH BIOCH, V71, P200, DOI 10.1271/bbb.60450; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMMERS MD, 1978, VIROLOGY, V84, P390, DOI 10.1016/0042-6822(78)90257-X; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Watanabe H, 2002, CURR SCI INDIA, V83, P439; Weng XH, 2003, J EXP BIOL, V206, P2211, DOI 10.1242/jeb.00385; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yang HJ, 2009, Z NATURFORSCH C, V64, P899; Yao Q, 2003, J APPL ENTOMOL, V127, P134, DOI 10.1046/j.1439-0418.2003.00741.x; Zhao GL, 2008, GENE EXPR PATTERNS, V8, P254, DOI 10.1016/j.gep.2007.12.006	36	19	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e64962	10.1371/journal.pone.0064962	http://dx.doi.org/10.1371/journal.pone.0064962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823190	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400003
J	Jacob, RE; Carson, JP; Thomas, M; Einstein, DR				Jacob, Richard E.; Carson, James P.; Thomas, Mathew; Einstein, Daniel R.			Dynamic Multiscale Boundary Conditions for 4D CT of Healthy and Emphysematous Rats	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; IMAGING TELL US; COMPUTED-TOMOGRAPHY; REGIONAL VENTILATION; PARTICLE DEPOSITION; SURFACE-TENSION; VOLUME CHANGE; LUNG INJURY; B-SPLINE; REGISTRATION	Changes in the shape of the lung during breathing determine the movement of airways and alveoli, and thus impact airflow dynamics. Modeling airflow dynamics in health and disease is a key goal for predictive multiscale models of respiration. Past efforts to model changes in lung shape during breathing have measured shape at multiple breath-holds. However, breath-holds do not capture hysteretic differences between inspiration and expiration resulting from the additional energy required for inspiration. Alternatively, imaging dynamically - without breath-holds - allows measurement of hysteretic differences. In this study, we acquire multiple micro-CT images per breath (4DCT) in live rats, and from these images we develop, for the first time, dynamic volume maps. These maps show changes in local volume across the entire lung throughout the breathing cycle and accurately predict the global pressure-volume (PV) hysteresis. Male Sprague-Dawley rats were given either a full- or partial-lung dose of elastase or saline as a control. After three weeks, 4DCT images of the mechanically ventilated rats under anesthesia were acquired dynamically over the breathing cycle (11 time points, <= 100 ms temporal resolution, 8 cmH(2)O peak pressure). Non-rigid image registration was applied to determine the deformation gradient - a numerical description of changes to lung shape - at each time point. The registration accuracy was evaluated by landmark identification. Of 67 landmarks, one was determined misregistered by all three observers, and 11 were determined misregistered by two observers. Volume change maps were calculated on a voxel-by-voxel basis at all time points using both the Jacobian of the deformation gradient and the inhaled air fraction. The calculated lung PV hysteresis agrees with pressure-volume curves measured by the ventilator. Volume maps in diseased rats show increased compliance and ventilation heterogeneity. Future predictive multiscale models of rodent respiration may leverage such volume maps as boundary conditions.	[Jacob, Richard E.; Carson, James P.; Thomas, Mathew; Einstein, Daniel R.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Jacob, RE (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	richard.jacob@pnnl.gov		Carson, James/0000-0001-9009-5645	National Heart, Lung, and Blood Institute [R01HL073598]; PNNL through internal Laboratory Directed Research and Development LDRD [DE-AC05-76RL01830]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073598] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PNNL through internal Laboratory Directed Research and Development LDRD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by Award Number R01HL073598 from the National Heart, Lung, and Blood Institute and by PNNL through internal Laboratory Directed Research and Development LDRD DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonet J., 1997, NONLINEAR CONTINUUM; Cai J, 2009, INT J RADIAT ONCOL, V75, P276, DOI 10.1016/j.ijrobp.2009.03.051; Carney DE, 1999, AM J RESP CRIT CARE, V160, P1697, DOI 10.1164/ajrccm.160.5.9812031; Carson JP, 2010, COMPUT MED IMAG GRAP, V34, P572, DOI 10.1016/j.compmedimag.2010.03.001; Carson JP, 2010, BIOMECH MODEL MECHAN, V9, P187, DOI 10.1007/s10237-009-0170-5; Castillo R, 2010, PHYS MED BIOL, V55, P4661, DOI 10.1088/0031-9155/55/16/004; Chen Q, 2001, MAGNET RESON MED, V45, P24, DOI 10.1002/1522-2594(200101)45:1<24::AID-MRM1004>3.0.CO;2-6; CILLEY RE, 1993, J PEDIATR SURG, V28, P488, DOI 10.1016/0022-3468(93)90253-H; Corley RA, 2012, TOXICOL SCI, V128, P500, DOI 10.1093/toxsci/kfs168; Ding K, 2009, LECT NOTES COMPUT SC, V5761, P739, DOI 10.1007/978-3-642-04268-3_91; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Einstein DR, 2008, ANAT REC, V291, P1628, DOI 10.1002/ar.20771; Emami K, 2010, MAGN RESON MED, V63, P137, DOI 10.1002/mrm.22186; Fouras A, 2012, ANN BIOMED ENG, V40, P1160, DOI 10.1007/s10439-011-0493-0; Fuld MK, 2008, J APPL PHYSIOL, V104, P1177, DOI 10.1152/japplphysiol.00212.2007; Guerrero T, 2006, PHYS MED BIOL, V51, P1101, DOI 10.1088/0031-9155/51/5/003; Guerrero T, 2007, INT J RADIAT ONCOL, V67, P879, DOI 10.1016/j.ijrobp.2006.10.037; HILDEBRANDT J, 1972, B PHYSIO-PATHOL RESP, V8, P337; Hsia CCW, 2012, J APPL PHYSIOL, V113, P937, DOI 10.1152/japplphysiol.00289.2012; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Jacob RE, 2008, J APPL PHYSIOL, V105, P1291, DOI 10.1152/japplphysiol.90375.2008; Jacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027577; Jiao XM, 2009, MED BIOL ENG COMPUT, V47, P989, DOI 10.1007/s11517-009-0501-9; Kreck TC, 2001, J APPL PHYSIOL, V91, P1741, DOI 10.1152/jappl.2001.91.4.1741; Kuprat AP, 2009, J COMPUT PHYS, V228, P619, DOI 10.1016/j.jcp.2008.09.030; Kuprat AP, 2012, J COMPUT PH IN PRESS; Lee EY, 2009, J THORAC IMAG, V24, P110, DOI 10.1097/RTI.0b013e3181909f4a; Luo HY, 2007, J BIOMECH, V40, P3096, DOI 10.1016/j.jbiomech.2007.03.027; Ma B, 2009, ANN BIOMED ENG, V37, P271, DOI 10.1007/s10439-008-9620-y; Mathew L, 2011, EUR J RADIOL, V79, P140, DOI 10.1016/j.ejrad.2009.10.028; Minard KR, 2012, J MAGN RESON, V221, P129, DOI 10.1016/j.jmr.2012.05.007; Mistry NN, 2010, MAGN RESON MED, V63, P658, DOI 10.1002/mrm.22311; Namati E, 2008, AM J RESP CELL MOL, V38, P572, DOI 10.1165/rcmb.2007-0120OC; Nazridoust K, 2008, INHAL TOXICOL, V20, P595, DOI 10.1080/08958370801939374 ; Nyeng TB, 2011, ACTA ONCOL, V50, P897, DOI 10.3109/0284186X.2011.577096; OTIS DR, 1994, J APPL PHYSIOL, V77, P2681, DOI 10.1152/jappl.1994.77.6.2681; PALECEK F, 1969, J APPL PHYSIOL, V27, P149, DOI 10.1152/jappl.1969.27.1.149; Plathow C, 2009, KOREAN J RADIOL, V10, P559, DOI 10.3348/kjr.2009.10.6.559; Porra L, 2004, J APPL PHYSIOL, V96, P1899, DOI 10.1152/japplphysiol.00866.2003; Rasband W., 2006, IMAGEJ; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Robertson HT, 2010, J APPL PHYSIOL, V108, P1395, DOI 10.1152/japplphysiol.01161.2009; Schmidt-Richberg A, 2012, MED IMAGE ANAL, V16, P150, DOI 10.1016/j.media.2011.06.007; Schroeter JD, 2008, INHAL TOXICOL, V20, P227, DOI 10.1080/08958370701864235 ; Shackleford JA, 2010, PHYS MED BIOL, V55, P6329, DOI 10.1088/0031-9155/55/21/001; Simon BA, 2000, J CLIN MONITOR COMP, V16, P433, DOI 10.1023/A:1011444826908; Simon BA, 2012, J APPL PHYSIOL, V113, P647, DOI 10.1152/japplphysiol.00353.2012; SOBIN SS, 1988, J APPL PHYSIOL, V64, P1659, DOI 10.1152/jappl.1988.64.4.1659; STAMENOVIC D, 1986, J APPL PHYSIOL, V60, P1358, DOI 10.1152/jappl.1986.60.4.1358; van Ertbruggen C, 2005, J APPL PHYSIOL, V98, P970, DOI 10.1152/japplphysiol.00795.2004; Walker MG, 2011, RESPIRATION, V81, P333, DOI 10.1159/000323609; Wu ZJ, 2008, MED PHYS, V35, P775, DOI 10.1118/1.2828378; Yamamoto T, 2011, PHYS MED BIOL, V56, P2279, DOI 10.1088/0031-9155/56/7/023; Yin Y, 2011, MDCT BASED DYNAMIC S; Yin YB, 2009, MED PHYS, V36, P4213, DOI 10.1118/1.3193526	55	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65874	10.1371/journal.pone.0065874	http://dx.doi.org/10.1371/journal.pone.0065874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799057	gold, Green Submitted, Green Published			2022-12-27	WOS:000320363300049
J	Lohberger, B; Rinner, B; Stuendl, N; Kaltenegger, H; Steinecker-Frohnwieser, B; Bernhart, E; Rad, EB; Weinberg, AM; Leithner, A; Bauer, R; Kretschmer, N				Lohberger, Birgit; Rinner, Beate; Stuendl, Nicole; Kaltenegger, Heike; Steinecker-Frohnwieser, Bibiane; Bernhart, Eva; Rad, Ehsan Bonyadi; Weinberg, Annelie Martina; Leithner, Andreas; Bauer, Rudolf; Kretschmer, Nadine			Sesquiterpene Lactones Downregulate G2/M Cell Cycle Regulator Proteins and Affect the Invasive Potential of Human Soft Tissue Sarcoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEHYDROCOSTUS LACTONE; APOPTOSIS; COSTUNOLIDE; INHIBITION; ARREST; LINE; OSTEOSARCOMA; ACTIVATION; EXPRESSION	Soft tissue sarcomas (STS) represent a rare group of malignant tumors that frequently exhibit chemotherapeutic resistance and increased metastatic potential. Many studies have demonstrated the great potential of plant-derived agents in the treatment of various malignant entities. The present study investigates the effects of the sesquiterpene lactones costunolide and dehydrocostus lactone on cell cycle, MMP expression, and invasive potential of three human STS cell lines of various origins. Both compounds reduced cell proliferation in a time-and dose-dependent manner. Dehydrocostus lactone significantly inhibited cell proliferation, arrested the cells at the G2/M interface and caused a decrease in the expression of the cyclin-dependent kinase CDK2 and the cyclin-dependent kinase inhibitor p27(Kip1). In addition, accumulation of cells at the G2/M phase transition interface resulted in a significant decrease in cdc2 (CDK1) together with cyclin B1. Costunolide had no effect on the cell cycle. Based on the fact that STS tend to form daughter cell nests and metastasize, the expression levels of matrix metalloproteinases (MMPs), which play a crucial role in extracellular matrix degradation and metastasis, were investigated by Luminex (R) technology and real-time RT-PCR. In the presence of costunolide, MMP-2 and -9 levels were significantly increased in SW-982 and TE-671 cells. Dehydrocostus lactone treatment significantly reduced MMP-2 and -9 expression in TE-671 cells, but increased MMP-9 level in SW-982 cells. In addition, the invasion potential was significantly reduced after treatment with both sesquiterpene lactones as investigated by the HTS FluoroBlock (TM) insert system.	[Lohberger, Birgit; Stuendl, Nicole; Kaltenegger, Heike; Weinberg, Annelie Martina; Leithner, Andreas] Med Univ Graz, Dept Orthoped Surg, Graz, Austria; [Rinner, Beate] Med Univ Graz, Med Res Ctr, Graz, Austria; [Steinecker-Frohnwieser, Bibiane] Ludwig Boltzmann Inst Rehabil Internal Dis, Saalfelden, Austria; [Bernhart, Eva] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Rad, Ehsan Bonyadi] Med Univ Graz, Dept Dermatol, Canc Biol Unit, Graz, Austria; [Rad, Ehsan Bonyadi; Weinberg, Annelie Martina] Med Univ Graz, Dept Pediat & Adolescence Surg, Graz, Austria; [Bauer, Rudolf; Kretschmer, Nadine] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmacognosy, Graz, Austria	Medical University of Graz; Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Graz	Lohberger, B (corresponding author), Med Univ Graz, Dept Orthoped Surg, Graz, Austria.	birgit.lohberger@medunigraz.at	Bauer, Rudolf/F-8468-2010	Bauer, Rudolf/0000-0002-0057-5547; Steinecker-Frohnwieser, Bibiane/0000-0001-6852-4466; Rinner, Beate/0000-0002-6340-4905; Kretschmer, Nadine/0000-0001-9823-6166	Austrian Science Fond (FWF) [P21114]; Medical University of Graz	Austrian Science Fond (FWF)(Austrian Science Fund (FWF)); Medical University of Graz	Financial support by the Austrian Science Fond (FWF, P21114) and the Medical University of Graz is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2004, J GENE MED, V6, P1216, DOI 10.1002/jgm.616; Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Bongiorno MR, 2010, DERMATOL THER, V23, pS33, DOI 10.1111/j.1529-8019.2010.01297.x; BORDEN EC, 1990, CANCER, V66, P862, DOI 10.1002/1097-0142(19900901)66:5<862::AID-CNCR2820660509>3.0.CO;2-R; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Choi EJ, 2009, INT J MOL MED, V23, P211, DOI 10.3892/ijmm_00000119; Choi JH, 2002, JPN J CANCER RES, V93, P1327, DOI 10.1111/j.1349-7006.2002.tb01241.x; Choi SH, 2005, CANCER LETT, V227, P153, DOI 10.1016/j.canlet.2005.01.011; Chugh R, 2005, J CLIN ONCOL, V23, P3597, DOI 10.1200/JCO.2005.02.170; Dobashi Y, 2001, INT J CANCER, V94, P353, DOI 10.1002/ijc.1479; Duan JA, 2010, NAT PROD COMMUN, V5, P1531; Duke JA, 1985, MED PLANTS CHINA, V1; Ferrari C, 2004, ACTA ORTHOP SCAND, V75, P487, DOI 10.1080/00016470410001295-1; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; JESSUS C, 1992, CELL, V68, P323, DOI 10.1016/0092-8674(92)90473-P; Jiang XL, 2005, J CELL PHYSIOL, V202, P723, DOI 10.1002/jcp.20162; Jiang XL, 2003, J ORTHOP RES, V21, P1063, DOI 10.1016/S0736-0266(03)00079-2; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim EJ, 2008, FOOD CHEM TOXICOL, V46, P3651, DOI 10.1016/j.fct.2008.08.038; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Ko SG, 2005, CANCER LETT, V220, P11, DOI 10.1016/j.canlet.2004.06.026; Kretschmer N, 2012, PLANTA MED, V78, P1749, DOI 10.1055/s-0032-1315385; Mannello F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-95; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Pandey MM, 2007, J ETHNOPHARMACOL, V110, P379, DOI 10.1016/j.jep.2006.12.033; Pazzaglia L, 2004, ANTICANCER RES, V24, P967; Roomi MW, 2007, MED ONCOL, V24, P394, DOI 10.1007/s12032-007-0022-z; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sun CM, 2003, J NAT PROD, V66, P1175, DOI 10.1021/np030147e; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Yamazaki T, 2003, IN VITRO CELL DEV-AN, V39, P337; Yuan J, 2005, J ORTHOP RES, V23, P1467, DOI 10.1016/j.orthres.2005.04.004; Zhang Siyuan, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P239, DOI 10.2174/1568011053765976	41	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66300	10.1371/journal.pone.0066300	http://dx.doi.org/10.1371/journal.pone.0066300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799090	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300074
J	Beyeler, A; Retailleau, A; Molter, C; Mehidi, A; Szabadics, J; Leinekugel, X				Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Szabadics, Janos; Leinekugel, Xavier			Recruitment of Perisomatic Inhibition during Spontaneous Hippocampal Activity In Vitro	PLOS ONE			English	Article							GUINEA-PIG HIPPOCAMPUS; INTERNEURON DIVERSITY SERIES; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; NETWORK OSCILLATIONS; SYNAPTIC PLASTICITY; NEURONS; MEMORY; POTENTIALS; CIRCUITS	It was recently shown that perisomatic GABAergic inhibitory postsynaptic potentials (IPSPs) originating from basket and chandelier cells can be recorded as population IPSPs from the hippocampal pyramidal layer using extracellular electrodes (eIPSPs). Taking advantage of this approach, we have investigated the recruitment of perisomatic inhibition during spontaneous hippocampal activity in vitro. Combining intracellular and extracellular recordings from pyramidal cells and interneurons, we confirm that inhibitory signals generated by basket cells can be recorded extracellularly, but our results suggest that, during spontaneous activity, eIPSPs are mostly confined to the CA3 rather than CA1 region. CA3 eIPSPs produced the powerful time-locked inhibition of multi-unit activity expected from perisomatic inhibition. Analysis of the temporal dynamics of spike discharges relative to eIPSPs suggests significant but moderate recruitment of excitatory and inhibitory neurons within the CA3 network on a 10 ms time scale, within which neurons recruit each other through recurrent collaterals and trigger powerful feedback inhibition. Such quantified parameters of neuronal interactions in the hippocampal network may serve as a basis for future characterisation of pathological conditions potentially affecting the interactions between excitation and inhibition in this circuit.	[Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Leinekugel, Xavier] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Leinekugel, Xavier] Inst Malad Neurodegenerat, CNRS, UMR 5293, Bordeaux, France; [Beyeler, Anna; Retailleau, Aude; Molter, Colin; Mehidi, Amine; Leinekugel, Xavier] European Network Inst, Bordeaux, France; [Szabadics, Janos] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Leinekugel, X (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France.	xavier@arcadi.eu	Leinekugel, Xavier/F-4034-2014; Leinekugel, Xavier/ABD-8347-2021; Beyeler, Anna/V-9934-2019	Leinekugel, Xavier/0000-0003-2878-3791; /0000-0003-2371-5706; Szabadics, Janos/0000-0002-4968-2562; Retailleau, Aude/0000-0001-6367-1889	INSERM; FRM; CNRS; Region Aquitaine; ENI-Net; French Ministry of Research and Education; ANR; Wellcome Trust [087497]; Lendulet initiative of the Hungarian Academy of Sciences	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FRM(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Aquitaine(Region Nouvelle-Aquitaine); ENI-Net; French Ministry of Research and Education; ANR(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); Lendulet initiative of the Hungarian Academy of Sciences	This worked was performed thanks to the following funding sources: INSERM (XL), FRM (XL), CNRS (XL), Region Aquitaine (XL), ENI-Net (XL), French Ministry of Research and Education (AR), ANR (XL, AB, CM), Wellcome Trust #087497 (JS), and Lendulet initiative of the Hungarian Academy of Sciences (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKRI N, 1994, J NEUROSCI METH, V52, P87, DOI 10.1016/0165-0270(94)90060-4; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bazelot M, 2010, J PHYSIOL-LONDON, V588, P2077, DOI 10.1113/jphysiol.2009.185918; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G., 2006, RHYTHMS BRAIN; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 1999, CURR OPIN NEUROBIOL, V9, P184, DOI 10.1016/S0959-4388(99)80025-7; Hebb Donald O., 1949, ORG BEHAV; Kanerva P., 1988, SPARSE DISTRIBUTED M; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maccaferri G, 2003, TRENDS NEUROSCI, V26, P564, DOI 10.1016/j.tins.2003.08.002; MACVICAR BA, 1980, BRAIN RES, V184, P220, DOI 10.1016/0006-8993(80)90602-2; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1984, J PHYSIOL-LONDON, V356, P97, DOI 10.1113/jphysiol.1984.sp015455; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Palm G, 2009, NEURAL ASSEMBLIES; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Pawelzik H, 1999, EUR J NEUROSCI, V11, P3552, DOI 10.1046/j.1460-9568.1999.00772.x; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Racz A, 2009, J NEUROSCI, V29, P2563, DOI 10.1523/JNEUROSCI.5036-08.2009; Singer W, 1997, TRENDS COGN SCI, V1, P252, DOI 10.1016/S1364-6613(97)01079-6; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	49	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66509	10.1371/journal.pone.0066509	http://dx.doi.org/10.1371/journal.pone.0066509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805227	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500055
J	Jacobson, A; Bell, F; Lejarcegui, N; Mitchell, C; Frenkel, L; Horton, H				Jacobson, Amanda; Bell, Frank; Lejarcegui, Nicholas; Mitchell, Caroline; Frenkel, Lisa; Horton, Helen			Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; REPLICATION IN-VITRO; UMBILICAL-CORD BLOOD; DENDRITIC CELLS; HIV-1 INFECTION; INDIVIDUALS; EXPRESSION; TRANSPLANTATION; DISEASE	Background: Neonatal Natural Killer (NK) cells show functional impairment and expansion of a CD56 negative population of uncertain significance. Methods: NK cells were isolated from cord blood and from adult donors. NK subpopulations were identified as positive or negative for the expression of CD56 and characterized for expression of granzyme B and surface markers by multi-parameter flow cytometry. Cell function was assessed by viral suppression and cytokine production using autologous lymphocytes infected with HIV. Activating (NKp30, NKp46) and inhibitory (Siglec-7) markers in healthy infants and adults were compared with viremic HIV-infected adults. Results: Cord blood contained increased frequencies of CD56 negative (CD56neg) NK cells with reduced expression of granzyme B and reduced production of IFNc and the CC-class chemokines RANTES, MIP1 alpha and MIP1 beta upon stimulation. Both CD56pos and CD56neg NK subpopulations showed impaired viral suppression in cord blood, with impairment most marked in the CD56neg subset. CD56neg NK cells from cord blood and HIV-infected adults shared decreased inhibitory and activating receptor expression when compared with CD56pos cells. Conclusions: CD56neg NK cells are increased in number in normal infants and these effectors show reduced anti-viral activity. Like the expanded CD56neg population described in HIV-infected adults, these NK cells demonstrate functional impairments which may reflect inadequate development or activation.	[Jacobson, Amanda; Bell, Frank; Lejarcegui, Nicholas; Horton, Helen] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Bell, Frank; Frenkel, Lisa] Seattle Childrens Hosp, Seattle, WA USA; [Bell, Frank; Frenkel, Lisa] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mitchell, Caroline; Horton, Helen] Univ Washington, Dept Med, Seattle, WA USA; [Mitchell, Caroline] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Frenkel, Lisa] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Frenkel, Lisa; Horton, Helen] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horton, H (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	Helen.horton@seattlebiomed.org		Frenkel, Lisa M/0000-0001-9566-8959; Bell, Frank/0000-0001-7281-516X	National Institutes of Health (NIH) [R01 AI100018, P30 AI027757]; University of Washington Center for AIDS Research (CFAR); NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NCCAM); Seattle Biomedical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100018, P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Seattle Biomedical Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by R01 AI100018 from the National Institutes of Health (NIH), the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM) and startup funds awarded to H. Horton by Seattle Biomedical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1996, AIDS, V10, P143, DOI 10.1097/00002030-199602000-00003; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2011, TRENDS IMMUNOL, V32, P219, DOI 10.1016/j.it.2011.02.003; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Bernstein HB, 2004, AIDS RES HUM RETROV, V20, P1189, DOI 10.1089/aid.2004.20.1189; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Bonaparte MI, 2003, AIDS, V17, P487, DOI 10.1097/00002030-200303070-00003; BRADSTOCK KF, 1993, IMMUNOL CELL BIOL, V71, P535, DOI 10.1038/icb.1993.59; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Dalle JH, 2005, PEDIATR RES, V57, P649, DOI 10.1203/01.PDR.0000156501.55431.20; De Angelis C, 2011, ACTA HAEMATOL-BASEL, V126, P13, DOI 10.1159/000323661; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003; Dominguez E, 1998, IMMUNOLOGY, V94, P109; GADDY J, 1995, J INTERF CYTOK RES, V15, P527, DOI 10.1089/jir.1995.15.527; Gaddy J, 1997, CELL IMMUNOL, V180, P132, DOI 10.1006/cimm.1997.1175; Gonzalez VD, 2008, CLIN IMMUNOL, V128, P46, DOI 10.1016/j.clim.2008.03.521; Gonzalez VD, 2009, J IMMUNOL, V183, P6612, DOI 10.4049/jimmunol.0901437; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; Guilmot A, 2011, J INNATE IMMUN, V3, P280, DOI 10.1159/000323934; Hermann E, 2006, PEDIATR RES, V60, P38, DOI 10.1203/01.pdr.0000220335.05588.ea; Le Garff-Tavernier M, 2010, AGING CELL, V9, P527, DOI 10.1111/j.1474-9726.2010.00584.x; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu E, 2001, BRIT J HAEMATOL, V113, P240, DOI 10.1046/j.1365-2141.2001.02720.x; Lu X, 2008, EUR J HAEMATOL, P81; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Zarife MAS, 2009, J MED VIROL, V81, P49, DOI 10.1002/jmv.21340; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; Verneris MR, 2009, BRIT J HAEMATOL, V147, P185, DOI 10.1111/j.1365-2141.2009.07768.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wang YY, 2007, CELL MOL IMMUNOL, V4, P377; Wiesmayr S, 2012, EUR J IMMUNOL, V42, P541, DOI 10.1002/eji.201141832; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zucchini N, 2008, EXPERT REV ANTI-INFE, V6, P867, DOI 10.1586/14787210.6.6.867	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67700	10.1371/journal.pone.0067700	http://dx.doi.org/10.1371/journal.pone.0067700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805324	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500152
J	Li, D; Lei, Y; Deng, J; Zhou, CJ; Zhang, Y; Li, WJ; Huang, HG; Cheng, SG; Zhang, HZ; Zhang, L; Huang, RZ; Liu, X; Ma, LH; Wang, X; Li, J; Xie, P				Li, Dan; Lei, Yang; Deng, Jing; Zhou, Chanjuan; Zhang, Yong; Li, Wenjuan; Huang, Hua; Cheng, Shigang; Zhang, Hongzhi; Zhang, Liang; Huang, Rongzhong; Liu, Xia; Ma, Lihua; Wang, Xiao; Li, Juan; Xie, Peng			Human but Not Laboratory Borna Disease Virus Inhibits Proliferation and Induces Apoptosis in Human Oligodendrocytes In Vitro	PLOS ONE			English	Article							INFECTION; CELLS	Borna disease virus (BDV) is a neurotropic virus that produces neuropsychiatric dysfunction in a wide range of warm-blooded species. Several studies have associated BDV with human psychiatric illness, but the findings remain controversial. Although oligodendrocytes are a major glial component of brain white matter and play a pivotal role in neuronal cell function, BDV's effects on human oligodendrocytes have not been clarified. Here, the effects of two BDV strains, Hu-H1 (isolated from a bipolar patient) and Strain V (a laboratory strain), on the proliferation and apoptosis of human oligodendrocytes were investigated. Three experimental cell lines were constructed: Hu-H1-infected oligodendroglioma (Hu-H1) cells, Strain V-infected oligodendroglioma (Strain V) cells, and non-infected oligodendroglioma (control) cells. BDV infection was assayed by BDV nucleoprotein (p40) immunofluorescence, cell proliferation was assayed by Cell Counting Kit-8 (CCK8), and cell cycle phases and apoptosis were assayed by flow cytometry. Expressions of the apoptosis-related proteins Bax and Bcl-2 were measured by Western blotting. p40 expression was confirmed in Hu-H1 and Strain V on and after day three post-infection. Strain V cells showed significantly greater cellular proliferation than Hu-H1 cells on and after day three post-infection. In Hu-H1 cells, Bax and Bcl-2 expression were significantly increased and decreased, respectively, on and after day three post-infection. In contrast, in Strain V cells, Bax and Bcl-2 expression were significantly decreased and increased, respectively, on and after day three post-infection. In conclusion, Hu-H1 inhibits cellular proliferation and promotes apoptosis in human oligodendrocytes via Bax upregulation and Bcl-2 downregulation. In contrast, Strain V promotes cellular proliferation and inhibits apoptosis in human oligodendrocytes via Bax downregulation and Bcl-2 upregulation. The effects of the Hu-H1 strain (isolated from a bipolar patient) are opposite from those of Strain V (a laboratory strain), thereby providing a proof of authenticity for both.	[Li, Dan] Chongqing Med Univ, Fac Basic Med, Dept Pathol, Chongqing, Peoples R China; [Li, Dan; Lei, Yang; Deng, Jing; Zhou, Chanjuan; Zhang, Yong; Li, Wenjuan; Huang, Hua; Cheng, Shigang; Zhang, Hongzhi; Zhang, Liang; Huang, Rongzhong; Liu, Xia; Ma, Lihua; Wang, Xiao; Li, Juan; Xie, Peng] Ctr Neurosci, Key Lab Neurobiol Chongqing, Chongqing, Peoples R China; [Lei, Yang; Zhou, Chanjuan; Huang, Hua; Zhang, Hongzhi; Zhang, Liang; Huang, Rongzhong; Liu, Xia; Ma, Lihua; Li, Juan; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Deng, Jing] Chongqing Zhongshan Hosp, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Ctr Neurosci, Key Lab Neurobiol Chongqing, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300), National Natural Science Foundation of China (Grant No. 31271189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode L, 2003, CLIN MICROBIOL REV, V16, P534, DOI 10.1128/CMR.16.3.534-545.2003; Bode L, 1996, MOL PSYCHIATR, V1, P200; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Carbone KM, 2001, CLIN MICROBIOL REV, V14, P513, DOI 10.1128/CMR.14.3.513-527.2001; Clemente R, 2007, J VIROL, V81, P5968, DOI 10.1128/JVI.02426-06; Das S, 2011, NEUROCHEM INT, V59, P357, DOI 10.1016/j.neuint.2011.02.020; de la Torre JC, 2001, VIRUS TAXONOMY, P531; delaTorre JC, 1996, VIRUS RES, V44, P33, DOI 10.1016/0168-1702(96)01338-X; Elder RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD349, DOI 10.2741/elder; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; Hans A, 2001, J BIOL CHEM, V276, P7258, DOI 10.1074/jbc.M005107200; Huang RZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044665; Ikuta K, 2002, FRONT BIOSCI-LANDMRK, V7, pD470, DOI 10.2741/ikuta; Kamitani W, 2001, J VIROL, V75, P8742, DOI 10.1128/JVI.75.18.8742-8751.2001; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li Q, 2009, EUR J NEUROL, V16, P399, DOI 10.1111/j.1468-1331.2008.02516.x; Lipkin WI, 2007, FIELDS VIROLOGY, VII, P1829; Ludwig H, 1993, Arch Virol Suppl, V7, P111; Ludwig H, 2000, REV SCI TECH OIE, V19, P259, DOI 10.20506/rst.19.1.1217; Ovanesov MV, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-50; Ovanesov MV, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-16; Planz O, 2003, J VIROL, V77, P11186, DOI 10.1128/JVI.77.20.11186-11192.2003; Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08; Thakur R, 2009, INDIAN J MED MICROBI, V27, P191, DOI 10.4103/0255-0857.53200; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Nunes SOV, 2008, J CLIN LAB ANAL, V22, P314, DOI 10.1002/jcla.20261; Watanabe Y, 2007, MICROBES INFECT, V9, P417, DOI 10.1016/j.micinf.2006.12.015; Williams BL, 2008, J VIROL, V82, P1748, DOI 10.1128/JVI.02014-07; Wu YJ, 2013, P NATL ACAD SCI USA, V110, P1899, DOI 10.1073/pnas.1214939110; Zhao JF, 2011, J CLIN NEUROSCI, V19, P60	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66623	10.1371/journal.pone.0066623	http://dx.doi.org/10.1371/journal.pone.0066623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805250	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500078
J	Petri, G; Scolamiero, M; Donato, I; Vaccarino, F				Petri, Giovanni; Scolamiero, Martina; Donato, Irene; Vaccarino, Francesco			Topological Strata of Weighted Complex Networks	PLOS ONE			English	Article							SYNCHRONIZATION; LINKS	The statistical mechanical approach to complex networks is the dominant paradigm in describing natural and societal complex systems. The study of network properties, and their implications on dynamical processes, mostly focus on locally defined quantities of nodes and edges, such as node degrees, edge weights and -more recently- correlations between neighboring nodes. However, statistical methods quickly become cumbersome when dealing with many-body properties and do not capture the precise mesoscopic structure of complex networks. Here we introduce a novel method, based on persistent homology, to detect particular non-local structures, akin to weighted holes within the link-weight network fabric, which are invisible to existing methods. Their properties divide weighted networks in two broad classes: one is characterized by small hierarchically nested holes, while the second displays larger and longer living inhomogeneities. These classes cannot be reduced to known local or quasilocal network properties, because of the intrinsic non-locality of homological properties, and thus yield a new classification built on high order coordination patterns. Our results show that topology can provide novel insights relevant for many-body interactions in social and spatial networks. Moreover, this new method creates the first bridge between network theory and algebraic topology, which will allow to import the toolset of algebraic methods to complex systems.	[Petri, Giovanni; Scolamiero, Martina; Donato, Irene; Vaccarino, Francesco] ISI Fdn, Turin, Italy; [Scolamiero, Martina] Politecn Torino, Dipartimento Ingn Gest & Prod, Turin, Italy; [Donato, Irene; Vaccarino, Francesco] Politecn Torino, Dipartimento Sci Matemat, Turin, Italy	Polytechnic University of Turin; Polytechnic University of Turin	Petri, G (corresponding author), ISI Fdn, Turin, Italy.	giovanni.petri@isi.it	vaccarino, francesco/I-5636-2012; Vaccarino, Francesco/T-5098-2019; Petri, Giovanni/K-5335-2016	vaccarino, francesco/0000-0002-0610-9168; Vaccarino, Francesco/0000-0002-0610-9168; Petri, Giovanni/0000-0003-1847-5031	TOPDRIM; Future and Emerging Technologies program of the European Commission [IST-318121]; Project Lagrange Ph.D. Grant; PRIN "Spazi di Moduli e Teoria di Lie"	TOPDRIM; Future and Emerging Technologies program of the European Commission; Project Lagrange Ph.D. Grant; PRIN "Spazi di Moduli e Teoria di Lie"	GP is supported by the TOPDRIM project funded by the Future and Emerging Technologies program of the European Commission under Contract IST-318121. ID and MS are partly supported by Project Lagrange Ph.D. Grant. FV is partially supported by PRIN 2009 "Spazi di Moduli e Teoria di Lie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioni A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.037101; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Barrat A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05003; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Barthelemy M, 2011, PHYS REP, V499, P1, DOI 10.1016/j.physrep.2010.11.002; BAUER U., 2013, ARXIV13030477; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna Marian, 2010, Nat Commun, V1, P62, DOI 10.1038/ncomms1063; Carlsson G, 2009, DISCRETE COMPUT GEOM, V42, P71, DOI 10.1007/s00454-009-9176-0; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chalupa J, 1979, J PHYS C; Cohen-Steiner D, 2007, DISCRETE COMPUT GEOM, V37, P103, DOI 10.1007/s00454-006-1276-5; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Conradi C, 2007, P NATL ACAD SCI USA, V104, P19175, DOI 10.1073/pnas.0705731104; de Silva V, 2004, TOPOLOGICAL ESTIMATI; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Farkas IJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026704; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gea Palla, 2007, NEW J PHYS, V9; Gfeller D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038701; Ghrist R, 2008, B AM MATH SOC, V45, P61, DOI 10.1090/s0273-0979-07-01191-3; Grady D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1847; Hyekyoung L, 2011, BIOM IM NAN MACR 201, P841, DOI [10.1109/ISBI.2011.5872535, DOI 10.1109/ISBI.2011.5872535]; Jun WU, 2010, CHINESE PHYS LETT, V27; Lum P, SCI REPORTS; MacArthur B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026117; Mahadevan P, 2006, ACM SIGCOMM COMP COM, V36, P135, DOI 10.1145/1151659.1159930; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Munkres J. R., 1984, ELEMENTS ALGEBRAIC T; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicolau M, 2011, P NATL ACAD SCI USA, V108, P7265, DOI 10.1073/pnas.1102826108; Opsahl T, 2010, SOC NET; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Pajevic S, 2012, NAT PHYS, V8, P429, DOI [10.1038/nphys2257, 10.1038/NPHYS2257]; Palla G, 2005, EFFECTS SPATIAL CONS; Penrose M., 2003, RANDOM GEOMETRIC GRA; Petri G, 2013, P EUR C COMPL SYST 2; Petri G, 2013, HOLES PYTHON PACKAGE; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Tausz A., 2011, JAVAPLEX RES SOFTWAR; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; van de Weygaert Rien, 2011, Transactions on Computational Science XIV. Special Issue on Voronoi Diagrams and Delaunay Triangulation, P60, DOI 10.1007/978-3-642-25249-5_3; Vazquez A, P NAT ACAD SCI US, V101, P17940; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zomorodian A, 2005, DISCRETE COMPUT GEOM, V33, P249, DOI 10.1007/s00454-004-1146-y; Zomorodian A, 2010, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY (SCG'10), P257, DOI 10.1145/1810959.1811004	54	103	103	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66506	10.1371/journal.pone.0066506	http://dx.doi.org/10.1371/journal.pone.0066506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805226	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500054
J	Pileggi, C; Lotito, F; Bianco, A; Nobile, CGA; Pavia, M				Pileggi, Claudia; Lotito, Francesca; Bianco, Aida; Nobile, Carmelo G. A.; Pavia, Maria			Relationship between Chronic Short Sleep Duration and Childhood Body Mass Index: A School-Based Cross-Sectional Study	PLOS ONE			English	Article							RISK-FACTORS; OBESITY; CHILDREN; OVERWEIGHT; ADOLESCENTS; WEIGHT; ASSOCIATION; PREVALENCE; ACTIGRAPHY; TRENDS	Objective: To assess relationship between obesity and chronic shorter sleep duration in children and to determine if lack of sleep represents an independent determinant of childhood Body Mass Index. Methods: This cross-sectional study was conducted in all children enrolled in the fifth class (approximately 10 years of age) of all public primary schools in Catanzaro (Southern Italy). The overall response rate was 62% resulting in 542 participating children. Parents completed a questionnaire with information on their demographics and socio-economic characteristics, their health status, characteristics of their child birth and health status. The sleeping habits were investigated in the 3 months preceding the consultation and parents were asked to indicate hours of bedtime and wake-up of their children. Multivariate linear regression analysis was performed to examine the association between child BMI and chronic lack of sleep. Results: 36.7% of the children surveyed were overweight or obese. A quarter of children did not routinely play sports and many of them spent more than an hour a day watching TV (60.7%) and using videogames or computer (51.1%). Widespread dietary habits were inadequate, especially concerning vegetables and fruit intake with more than 95% of children who consumed insufficient amounts. The average duration of sleep was equal to 9.4 (SD = +/- 60.6) hours, and the short-sleepers accounted for 38.9% of the total sample. The results of multivariate analysis showed a significant 0.77 Kg/m(2) increase of BMI for children classified as short compared to normal sleepers (95% CI = 0.16-1.38, p = 0.01). Conclusions: Chronic lack of sleep appears to be associated to higher BMI even in middle childhood and strongly suggests that public health strategies, focused on promoting healthy lifestyles should include an innovative approach to ensure an adequate duration of sleep at night especially in children, alongside more traditional approaches.	[Pileggi, Claudia; Lotito, Francesca; Bianco, Aida; Nobile, Carmelo G. A.; Pavia, Maria] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Pavia, M (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.	pavia@unicz.it	Bianco, Aida/R-6612-2016; PILEGGI, Claudia/AGU-6397-2022	PILEGGI, Claudia/0000-0002-6288-5540; BIANCO, Aida/0000-0003-4674-0306; PAVIA, Maria/0000-0003-3879-1322; NOBILE, Carmelo Giuseppe Angelo/0000-0002-0762-513X				Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Bayer O, 2009, SLEEP, V32, P1183, DOI 10.1093/sleep/32.9.1183; Ben Slama Fethi, 2002, Tunis Med, V80, P542; Benedict C, 2012, J CLIN ENDOCR METAB, V97, pE443, DOI 10.1210/jc.2011-2759; Cacciari E, 2002, EUR J CLIN NUTR, V56, P171, DOI 10.1038/sj.ejcn.1601314; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carter PJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2712; Chaput JP, 2006, INT J OBESITY, V30, P1080, DOI 10.1038/sj.ijo.0803291; CREA, 2018, LINEE GUIDA SANA ALI; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Giannotti F, 2005, SLEEP BIOL RHYTHMS, V3, P15, DOI [10.1111/j.1479-8425.2005.00155.x, DOI 10.1111/J.1479-8425.2005.00155.X]; Hense S, 2011, SLEEP, V34, P633, DOI 10.1093/sleep/34.5.633; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Istituto Superiore di Sanita. Cnesps, CNESPS PROM SAL CRES; Kleiser C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-46; LOCARD E, 1992, INT J OBESITY, V16, P721; Martin LE, 2010, OBESITY, V18, P254, DOI 10.1038/oby.2009.220; National Sleep Foundation, 2005, AD SLEEP HAB STYL; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Padez C, 2005, ACTA PAEDIATR, V94, P1550, DOI 10.1080/08035250510042924; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pileggi C, 2005, J PAEDIATR CHILD H, V41, P347, DOI 10.1111/j.1440-1754.2005.00629.x; Regione Calabria, STIL VIT SAL DCI GIO; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Sadeh A, 1996, SLEEP, V19, P757, DOI 10.1093/sleep/19.10.757; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Seicean A, 2007, SLEEP BREATH, V11, P285, DOI 10.1007/s11325-007-0108-z; Sekine M, 2002, CHILD CARE HLTH DEV, V28, P163, DOI 10.1046/j.1365-2214.2002.00260.x; Snell EK, 2007, CHILD DEV, V78, P309, DOI 10.1111/j.1467-8624.2007.00999.x; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Touchette E, 2008, SLEEP, V31, P1507, DOI 10.1093/sleep/31.11.1507; von Kries R, 2002, INT J OBESITY, V26, P710, DOI 10.1038/sj.ijo.0801980; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; WHO Europe, IN YOUNG PEOPL HLTH; Yu YX, 2007, SLEEP, V30, P1688, DOI 10.1093/sleep/30.12.1688	37	14	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66680	10.1371/journal.pone.0066680	http://dx.doi.org/10.1371/journal.pone.0066680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805261	gold, Green Published			2022-12-27	WOS:000320846500089
J	Riesco, MF; Robles, V				Riesco, Marta F.; Robles, Vanesa			Cryopreservation Causes Genetic and Epigenetic Changes in Zebrafish Genital Ridges	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; PRIMORDIAL GERM-CELLS; DNA-DAMAGE; RAINBOW-TROUT; EXPRESSION; MODEL; PCR; DEADENYLATION; ASSOCIATION; PATTERNS	Cryopreservation is an important tool routinely employed in Assisted Reproduction Technologies (ARTs) and germplasm banking. For several years, the assessment of global DNA fragmentation seemed to be enough to ensure the integrity of genetic material. However, cryopreservation can produce molecular alterations in key genes and transcripts undetectable by traditional assays, such modifications could interfere with normal embryo development. We used zebrafish as a model to study the effect of cryopreservation on key transcripts and genes. We employed an optimized cryopreservation protocol for genital ridges (GRs) containing primordial germ cells (PGCs) considered one of the best cell sources for gene banking. Our results indicated that cryopreservation produced a decrease in most of the zebrafish studied transcripts (cxcr4b, pou5f1, vasa and sox2) and upregulation of heat shock proteins (hsp70, hsp90). The observed downregulation could not always be explained by promoter hypermethylation (only the vasa promoter underwent clear hypermethylation). To corroborate this, we used human spermatozoa (transcriptionally inactive cells) obtaining a reduction in some transcripts (eIF2S1, and LHCGR). Our results also demonstrated that this effect was caused by freezing/thawing rather than exposure to cryoprotectants (CPAs). Finally, we employed real-time PCR (qPCR) technology to quantify the number of lesions produced by cryopreservation in the studied zebrafish genes, observing very different vulnerability to damage among them. All these data suggest that molecular alterations caused by cryopreservation should be studied in detail in order to ensure the total safety of the technique.	[Robles, Vanesa] Univ Leon, INDEGSAL, E-24071 Leon, Spain; Univ Leon, E-24071 Leon, Spain	Universidad de Leon; Universidad de Leon	Robles, V (corresponding author), Univ Leon, INDEGSAL, E-24071 Leon, Spain.	v.robles@unileon.es	Riesco, Marta/O-9766-2014; rodriguez, vanesa robles/N-7508-2015	Riesco, Marta/0000-0002-3655-6401; rodriguez, vanesa robles/0000-0002-7917-7700	Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion [MICINN AGL2009-06994]; Ramon y Cajal program [RYC-2008-02339]; Junta de Castilla y Leon [E-24-2009-0036681]; Fondo Social Europeo	Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion; Ramon y Cajal program(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by the Fundacion Ramon Areces and Ministerio de Ciencia e Innovacion (MICINN AGL2009-06994), Ramon y Cajal program (RYC-2008-02339), Junta de Castilla y Leon (E-24-2009-0036681) and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken J, 2007, REPROD BIOMED ONLINE, V14, P727, DOI 10.1016/S1472-6483(10)60676-1; Al-Khtib M, 2011, FERTIL STERIL, V95, P1955, DOI 10.1016/j.fertnstert.2011.02.029; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bermejo R, 2012, TRENDS CELL BIOL, V22, P465, DOI 10.1016/j.tcb.2012.05.007; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Dodd A, 2000, HUM MOL GENET, V9, P2443, DOI 10.1093/hmg/9.16.2443; Flores E, 2011, THERIOGENOLOGY, V76, P1450, DOI 10.1016/j.theriogenology.2011.05.039; Garcia-Herrero S, 2011, REPROD BIOMED ONLINE, V22, P25, DOI 10.1016/j.rbmo.2010.09.013; Goto-Kazeto R, 2010, INT J DEV BIOL, V54, P1487, DOI 10.1387/ijdb.092914rg; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Hu Yu, 2012, Yichuan, V34, P1097, DOI 10.3724/SP.J.1005.2012.01097; Igreja C, 2011, GENE DEV, V25, P1955, DOI 10.1101/gad.17136311; Jeske M, 2011, EMBO J, V30, P90, DOI 10.1038/emboj.2010.283; Kobayashi T, 2004, MOL REPROD DEV, V67, P91, DOI 10.1002/mrd.20003; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Li YJ, 2012, J GENET GENOMICS, V39, P521, DOI 10.1016/j.jgg.2012.07.006; Lim D, 2009, HUM REPROD, V24, P741, DOI 10.1093/humrep/den406; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Liu WY, 2010, FASEB J, V24, P2641, DOI 10.1096/fj.09-148403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzilli F, 1995, Acta Eur Fertil, V26, P145; Mimeault M, 2013, DRUG DISCOV TODAY, V18, P128, DOI 10.1016/j.drudis.2012.08.002; Miyake A, 2006, INT J DEV BIOL, V50, P619, DOI 10.1387/ijdb.062172am; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; OSTERMEIER GC, 2004, NATURE, V13, P429; Patterson Kate, 2011, J Vis Exp, DOI 10.3791/3170; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Riesco MF, 2012, J APPL ICHTHYOL, V28, P925, DOI 10.1111/jai.12089; Riesco MF, 2012, THERIOGENOLOGY, V77, P122, DOI 10.1016/j.theriogenology.2011.07.024; Robles V, 2011, ZEBRAFISH, V8, P57, DOI 10.1089/zeb.2010.0684; Robles V, 2009, ZEBRAFISH, V6, P281, DOI 10.1089/zeb.2009.0592; Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082; Sanchez-Sanchez AV, 2011, INT J BIOL SCI, V7, P410, DOI 10.7150/ijbs.7.410; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Sorensen AL, 2010, STEM CELLS DEV, V19, P1257, DOI 10.1089/scd.2009.0309; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Thomson LK, 2009, HUM REPROD, V24, P2061, DOI 10.1093/humrep/dep214; Trapphoff T, 2010, HUM REPROD, V25, P3025, DOI 10.1093/humrep/deq278; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vassena R, 2011, DEVELOPMENT, V138, P3699, DOI 10.1242/dev.064741; Wang AW, 1997, UROLOGY, V49, P921, DOI 10.1016/S0090-4295(97)00070-8; Watkins SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044018; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiao JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038742; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015; Zilli L, 2003, CRYOBIOLOGY, V47, P227, DOI 10.1016/j.cryobiol.2003.10.002	56	63	66	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67614	10.1371/journal.pone.0067614	http://dx.doi.org/10.1371/journal.pone.0067614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805321	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500149
J	Su, CW; Chiou, YW; Tsai, YH; Teng, RD; Chau, GY; Lei, HJ; Hung, HH; Huo, TI; Wu, JC				Su, Chien-Wei; Chiou, Yu-Wei; Tsai, Yi-Hsuan; Teng, Ruei-Dun; Chau, Gar-Yang; Lei, Hao-Jan; Hung, Hung-Hsu; Huo, Teh-Ia; Wu, Jaw-Ching			The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy	PLOS ONE			English	Article							CORE PROMOTER MUTATIONS; PORTAL-HYPERTENSION; LIVER; RISK; ASSOCIATION; RESECTION; SURVIVAL; PROGNOSIS	Background: Whether or not hepatitis B virus (HBV) genotypes, mutations, and viral loads determine outcomes for patients with HBV-induced hepatocellular carcinoma (HCC) remains controversial. Aims: To study the influence of HBV viral factors on prognoses for patients with HBV-induced HCC after resection surgery and investigate if antiviral therapy could counteract the adverse effects of viral factors. Methods: A total of 333 HBV-related HCC patients who underwent tumor resection were enrolled retrospectively. Serum HBV DNA levels, mutations, anti-viral therapy, and other clinical variables were analyzed for their association with post-operative recurrence. Results: After a median follow-up of 45.9 months, 208 patients had HCC recurrence after resection. The 5-year overall survival and recurrence-free survival rates were 55.4% and 35.3%, respectively. Multivariate analysis showed indocyanine green retention rate at 15 minutes > 10%, gamma-glutamyltransferase (GGT) level >60 U/L, macroscopic and microscopic venous invasion, and the absence of anti-viral therapy were significant risk factors for recurrence. Anti-viral therapy could decrease recurrence in patients with early stage HCC, but the effect was less apparent in those with the Barcelona-Clinic Liver Cancer stage C HCC. For patients without antiviral therapy after resection, serum HBV DNA levels > 10(6) copies/mL, GGT >60 U/L, and macroscopic and microscopic venous invasion were significant risk factors predicting recurrence. Among the 216 patients without anti-viral therapy but with complete HBV surface gene mapping data, 73 were with pre-S deletion mutants. Among patients with higher serum HBV DNA levels, those with pre-S deletion had significantly higher rates of recurrence. Moreover, multivariate analysis showed multi-nodularity, macroscopic venous invasion, cirrhosis, advanced tumor cell differentiation, and pre-S deletion were significant risk factors predictive of recurrence. Conclusions: Ongoing HBV viral replication and pre-S deletion are crucial for determining post-operative tumor recurrence. Anti-viral therapy can help reduce recurrence and improve prognosis, especially for those with early stage HCC.	[Su, Chien-Wei; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Su, Chien-Wei; Chau, Gar-Yang; Lei, Hao-Jan; Hung, Hung-Hsu] Natl Yang Ming Univ, Canc Res Ctr, Fac Med, Taipei 112, Taiwan; [Su, Chien-Wei; Tsai, Yi-Hsuan; Teng, Ruei-Dun; Hung, Hung-Hsu; Wu, Jaw-Ching] Natl Yang Ming Univ, Canc Res Ctr, Inst Clin Med, Taipei 112, Taiwan; [Chiou, Yu-Wei; Wu, Jaw-Ching] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chau, Gar-Yang; Lei, Hao-Jan] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Hung, Hung-Hsu] Cheng Hsin Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University	Wu, JC (corresponding author), Natl Yang Ming Univ, Canc Res Ctr, Inst Clin Med, Taipei 112, Taiwan.	jcwu@vghtpe.gov.tw	Su, Chien-Wei/AHC-8307-2022; Su, Chien-Wei/C-1521-2012	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004	National Science Council of Taiwan, Taipei, Taiwan [NSC 101-2314-B-075-013-MY2]; Taipei Veterans General Hospital, Taipei, Taiwan [V95C1-014, VGHUST100-G7-2-1]; Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taipei, Taiwan [101AC-T501]; Center of Excellence for Cancer Research at TVGH, Taipei, Taiwan [DOH101-TD-C-111-007]	National Science Council of Taiwan, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taipei, Taiwan; Center of Excellence for Cancer Research at TVGH, Taipei, Taiwan	This work was supported by grants from the National Science Council of Taiwan (NSC 101-2314-B-075-013-MY2), Taipei Veterans General Hospital (V95C1-014, VGHUST100-G7-2-1), Yang-Ming University (101AC-T501, Ministry of Education, Aim for the Top University Plan), and the Center of Excellence for Cancer Research at TVGH (DOH101-TD-C-111-007), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; CHISARI FV, 1995, SPRINGER SEMIN IMMUN, V17, P261, DOI 10.1007/BF00196169; Choi GH, 2011, LIVER INT, V31, P485, DOI 10.1111/j.1478-3231.2010.02436.x; Colombo M, 2010, DIGEST LIVER DIS, V42, pS298, DOI 10.1016/S1590-8658(10)60520-8; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fan ST, 2011, ANN SURG, V253, P745, DOI 10.1097/SLA.0b013e3182111195; Fuks D, 2012, HEPATOLOGY, V55, P132, DOI 10.1002/hep.24680; Huang YH, 2011, GASTROENTEROLOGY, V141, P1412, DOI 10.1053/j.gastro.2011.06.048; Hung HH, 2011, CLIN GASTROENTEROL H, V9, P79, DOI 10.1016/j.cgh.2010.08.018; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Kao JH, 2012, LIVER INT, V32, P1373, DOI 10.1111/j.1478-3231.2012.02826.x; Liaw YF, 2010, DIGEST LIVER DIS, V42, pS293, DOI 10.1016/S1590-8658(10)60519-1; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Ryu HJ, 2011, J MED VIROL, V83, P2088, DOI 10.1002/jmv.22238; Su CW, 2012, ARCH SURG-CHICAGO, V147, P137, DOI 10.1001/archsurg.2011.288; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Wang LHC, 2012, CARCINOGENESIS, V33, P466, DOI 10.1093/carcin/bgr296; Wong JSW, 2011, ALIMENT PHARM THER, V33, P1104, DOI 10.1111/j.1365-2036.2011.04634.x; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096	31	66	65	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66457	10.1371/journal.pone.0066457	http://dx.doi.org/10.1371/journal.pone.0066457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805222	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500050
J	Faller, KME; Medway, DJ; Aksentijevic, D; Sebag-Montefiore, L; Schneider, JE; Lygate, CA; Neubauer, S				Faller, Kiterie M. E.; Medway, Debra J.; Aksentijevic, Dunja; Sebag-Montefiore, Liam; Schneider, Juergen E.; Lygate, Craig A.; Neubauer, Stefan			Ribose Supplementation Alone or with Elevated Creatine Does Not Preserve High Energy Nucleotides or Cardiac Function in the Failing Mouse Heart	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ADENINE-NUCLEOTIDES; DIASTOLIC FUNCTION; FAILURE PATIENTS; RAT-LIVER; METABOLISM; ISCHEMIA; RECOVERY; MICE; ATP	Background: Reduced levels of creatine and total adenine nucleotides (sum of ATP, ADP and AMP) are hallmarks of chronic heart failure and restoring these pools is predicted to be beneficial by maintaining the diseased heart in a more favourable energy state. Ribose supplementation is thought to support both salvage and re-synthesis of adenine nucleotides by bypassing the rate-limiting step. We therefore tested whether ribose would be beneficial in chronic heart failure in control mice and in mice with elevated myocardial creatine due to overexpression of the creatine transporter (CrT-OE). Methods and Results: Four groups were studied: sham; myocardial infarction (MI); MI+ribose; MI+CrT-OE+ribose. In a pilot study, ribose given in drinking water was bioavailable, resulting in a two-fold increase in myocardial ribose-5-phosphate levels. However, 8 weeks post-surgery, total adenine nucleotide (TAN) pool was decreased to a similar amount (8-14%) in all infarcted groups irrespective of the treatment received. All infarcted groups also presented with a similar and substantial degree of left ventricular (LV) dysfunction (3-fold reduction in ejection fraction) and LV hypertrophy (32-47% increased mass). Ejection fraction closely correlated with infarct size independently of treatment (r(2) = 0.63, p<0.0001), but did not correlate with myocardial creatine or TAN levels. Conclusion: Elevating myocardial ribose and creatine levels failed to maintain TAN pool or improve post-infarction LV remodeling and function. This suggests that ribose is not rate-limiting for purine nucleotide biosynthesis in the chronically failing mouse heart and that alternative strategies to preserve TAN pool should be investigated.	[Lygate, Craig A.] Univ Oxford, Radcliffe Dept Med, British Heart Fdn Ctr Res Excellence, Div Cardiovasc Med, Oxford, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics	Lygate, CA (corresponding author), Univ Oxford, Radcliffe Dept Med, British Heart Fdn Ctr Res Excellence, Div Cardiovasc Med, Oxford, England.	clygate@well.ox.ac.uk	Lygate, Craig/AAO-4731-2020	Lygate, Craig/0000-0001-6079-0284; Neubauer, Stefan/0000-0001-9017-5645; Aksentijevic, Dunja/0000-0002-8480-6727; Faller, Kiterie ME/0000-0002-4525-7059	British Heart Foundation (BHF) [FS/07/065, RG/10/002/28187, FS11/50/29038]; BHF Centre of Research Excellence, Oxford [RE/08/004]; Wellcome Trust [090532/Z/09/Z]; British Heart Foundation [RG/10/002/28187, FS/11/50/29038] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10005] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF Centre of Research Excellence, Oxford; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the British Heart Foundation (BHF, Grants FS/07/065 and RG/10/002/28187, FS11/50/29038) http://www.bhf.org.uk. Additional funding for the Visualsonics ultrasound system was provided by the BHF Centre of Research Excellence, Oxford (RE/08/004). The research centre where this work was conducted is funded by a Wellcome Trust Core Award (090532/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caretti A, 2010, CELL PHYSIOL BIOCHEM, V26, P831, DOI 10.1159/000323992; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; KIM YA, 1992, AM J PHYSIOL, V262, pE344, DOI 10.1152/ajpendo.1992.262.3.E344; KING MT, 1990, ANAL BIOCHEM, V187, P179, DOI 10.1016/0003-2697(90)90438-F; Lamberts RR, 2007, AM J PHYSIOL-HEART C, V293, pH1869, DOI 10.1152/ajpheart.00294.2007; LORTET S, 1989, CARDIOVASC RES, V23, P702, DOI 10.1093/cvr/23.8.702; Lygate C, 2006, DRUG DISCOV TODAY DI, V3, P283, DOI 10.1016/j.ddmod.2006.10.002; Lygate CA, 2007, J MOL CELL CARDIOL, V42, P1129, DOI 10.1016/j.yjmcc.2007.03.899; Lygate CA, 2012, CARDIOVASC RES, V96, P466, DOI 10.1093/cvr/cvs272; MacCarter D, 2009, INT J CARDIOL, V137, P79, DOI 10.1016/j.ijcard.2008.05.025; MAUSER M, 1985, CIRC RES, V56, P220, DOI 10.1161/01.RES.56.2.220; NEUBAUER S, 1995, J CLIN INVEST, V95, P1092, DOI 10.1172/JCI117756; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Omran H, 2003, EUR J HEART FAIL, V5, P615, DOI 10.1016/S1388-9842(03)00060-6; Perkowski D, 2007, J CARDIAC SURG, V22, P370, DOI 10.1111/j.1540-8191.2007.00427.x; PLIML W, 1992, LANCET, V340, P507, DOI 10.1016/0140-6736(92)91709-H; Sawada SG, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-5; Schneider JE, 2004, MAGNET RESON MED, V52, P1029, DOI 10.1002/mrm.20257; Shen WQ, 1999, CIRCULATION, V100, P2113, DOI 10.1161/01.CIR.100.20.2113; Sonoda T, 1998, BBA-PROTEIN STRUCT M, V1387, P32, DOI 10.1016/S0167-4838(98)00106-X; Starling RC, 1998, MOL CELL BIOCHEM, V180, P171, DOI 10.1023/A:1006876031121; STCYR JA, 1989, J SURG RES, V46, P157, DOI 10.1016/0022-4804(89)90220-5; ten Hove M, 2005, CIRCULATION, V111, P2477, DOI 10.1161/01.CIR.0000165147.99592.01; Wallis J, 2005, CIRCULATION, V112, P3131, DOI 10.1161/CIRCULATIONAHA.105.572990; Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106; ZIMMER HG, 1989, BASIC RES CARDIOL, V84, P332, DOI 10.1007/BF01907981; ZIMMER HG, 1980, SCIENCE, V207, P319, DOI 10.1126/science.7350664; ZIMMER HG, 1983, SCIENCE, V220, P81, DOI 10.1126/science.6402820; ZIMMER HG, 1984, J MOL CELL CARDIOL, V16, P863, DOI 10.1016/S0022-2828(84)80010-3; ZIMMER HG, 1973, CIRC RES, V32, P635, DOI 10.1161/01.RES.32.5.635	32	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66461	10.1371/journal.pone.0066461	http://dx.doi.org/10.1371/journal.pone.0066461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823183	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000320576400111
J	Gaberman, E; Pinzur, L; Levdansky, L; Tsirlin, M; Netzer, N; Aberman, Z; Gorodetsky, R				Gaberman, Elena; Pinzur, Lena; Levdansky, Lilia; Tsirlin, Maria; Netzer, Nir; Aberman, Zami; Gorodetsky, Raphael			Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TOTAL-BODY IRRADIATION; HEMATOPOIETIC STEM; IMMUNE MODULATION; PROGENITOR CELLS; DOSE-RATE; RADIOBIOLOGICAL BASIS; COLLAGEN SCAFFOLDS; REPAIR; PROTECTION	Exposure to high lethal dose of ionizing radiation results in acute radiation syndrome with deleterious systemic effects to different organs. A primary target is the highly sensitive bone marrow and the hematopoietic system. In the current study C3H/HeN mice were total body irradiated by 7.7 Gy. Twenty four hrs and 5 days after irradiation 2610 6 cells from different preparations of human derived 3D expanded adherent placental stromal cells (PLX) were injected intramuscularly. Treatment with batches consisting of pure maternal cell preparations (PLX-Mat) increased the survival of the irradiated mice from similar to 27% to 68% (P < 0.001), while cell preparations with a mixture of maternal and fetal derived cells (PLX-RAD) increased the survival to similar to 98% (P < 0.0001). The dose modifying factor of this treatment for both 50% and 37% survival (DMF50 and DMF37) was similar to 1.23. Initiation of the more effective treatment with PLX-RAD injection could be delayed for up to 48 hrs after irradiation with similar effect. A delayed treatment by 72 hrs had lower, but still significantly effect (p < 0.05). A faster recovery of the BM and improved reconstitution of all blood cell lineages in the PLX-RAD treated mice during the follow-up explains the increased survival of the cells treated irradiated mice. The number of CD45+/SCA1+ hematopoietic progenitor cells within the fast recovering population of nucleated BM cells in the irradiated mice was also elevated in the PLX-RAD treated mice. Our study suggests that IM treatment with PLX-RAD cells may serve as a highly effective "off the shelf" therapy to treat BM failure following total body exposure to high doses of radiation. The results suggest that similar treatments may be beneficial also for clinical conditions associated with severe BM aplasia and pancytopenia.	[Gaberman, Elena; Levdansky, Lilia; Tsirlin, Maria; Gorodetsky, Raphael] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Pinzur, Lena; Netzer, Nir; Aberman, Zami] Pluristem Therapeut Inc, Haifa, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Gorodetsky, R (corresponding author), Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel.	rafi@hadassah.org.il	, Rafi/GPW-8563-2022		Pluristem Therapeutic	Pluristem Therapeutic	The major funding by Pluristem Therapeutic enabled the execution of this scientific project, without compromising its scientific unbiased value. The funding company participated in the study design, but the data collection and analysis as well as preparation of the manuscript for publication was done by the academic researcher according to academic standards. The role of the author from Pluristem Therapeutics (LP and NN) who participated in the study was associated with the supply and examination of the GMP controlled cultivation and careful examination of or relevant cells that they supplied for the study, in disclosing and supplying part of the reagents and media needed for the research project, in advising the Hadassah's team and helping in the setup of experimental protocols based on their specific vast relevant experience. ZA from Pluristem Therapeutics is included as an author as he had a major role in envisioning and in the instigation of the research project. These authors were consulted on technical issues related to the current manuscript. The major funding by Pluristem Therapeutic enabled the execution of this scientific project, without compromising its scientific unbiased value. The funding company contributed to the study design, but the planning of the experiments, the data collection and analysis, as well as preparation of the manuscript for publication was done by the academic researcher guided by unbiased academic standards.	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Andersson KG, 2008, RADIAT PROT DOSIM, V131, P297, DOI 10.1093/rpd/ncn173; Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; Anno GH, 2003, HEALTH PHYS, V84, P565, DOI 10.1097/00004032-200305000-00001; Awwad Hassan K, 2005, J Egypt Natl Canc Inst, V17, P221; Baker JE, 2011, ANTIOXID REDOX SIGN, V15, P1945, DOI 10.1089/ars.2010.3742; Barria E, 2004, STEM CELLS DEV, V13, P548, DOI 10.1089/scd.2004.13.548; Barrilleaux BL, 2009, TISSUE ENG PT A, V15, P2335, DOI 10.1089/ten.tea.2008.0434; Basile LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030434; Bifari F, 2008, TRANSFUS MED HEMOTH, V35, P194, DOI 10.1159/000128968; BISTROVIC M, 1984, PHYS MED BIOL, V29, P895, DOI 10.1088/0031-9155/29/7/014; BLEEHEN NM, 1984, RECENT RES CANCER, V92, P65; Brizel DM, 2007, J CLIN ONCOL, V25, P4084, DOI 10.1200/JCO.2007.11.5816; Bunnell BA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt34; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Chiesa C, 2011, Q J NUCL MED MOL IM, V55, P168; Chung Jin Kwon, 2011, Korean J Ophthalmol, V25, P268, DOI 10.3341/kjo.2011.25.4.268; Clarke D, 1996, CYTOKINE, V8, P717, DOI 10.1006/cyto.1996.0095; Dawson LA, 2010, INT J RADIAT ONCOL, V76, pS108, DOI 10.1016/j.ijrobp.2009.02.089; Donnelly EH, 2010, SOUTH MED J, V103, P541, DOI 10.1097/SMJ.0b013e3181ddd571; ELKIND MM, 1970, BIOPHYS J, V10, P237, DOI 10.1016/S0006-3495(70)86296-8; English K, 2011, J CELL BIOCHEM, V112, P1963, DOI 10.1002/jcb.23119; Feinendegen LE, 2007, EXP HEMATOL, V35, P37, DOI 10.1016/j.exphem.2007.01.011; Fischer-Valuck BW, 2010, BIOTECHNOL LETT, V32, P19, DOI 10.1007/s10529-009-0110-6; Gao ZM, 2012, CYTOTHERAPY, V14, P267, DOI 10.3109/14653249.2011.616194; GORODETSKY R, 1990, INT J RADIAT ONCOL, V18, P1077, DOI 10.1016/0360-3016(90)90443-N; Gratwohl A, 1998, BLOOD, V92, P765; Guinan EC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003126; Hagby Moti, 2009, J Emerg Trauma Shock, V2, P117, DOI 10.4103/0974-2700.50747; Hopewell JW, 2003, INT J RADIAT BIOL, V79, P513, DOI 10.1080/09553000310001600907; Hu KX, 2010, BRIT J RADIOL, V83, P52, DOI 10.1259/bjr/61042310; Isern Joan, 2011, Curr Osteoporos Rep, V9, P210, DOI 10.1007/s11914-011-0075-y; Kim YH, 2011, MOL MED, V17, P697, DOI 10.2119/molmed.2010.00098; KIMURA H, 1990, EUR J IMMUNOL, V20, P1927, DOI 10.1002/eji.1830200909; KINNAMON KE, 1980, RADIAT RES, V82, P215, DOI 10.2307/3575250; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; Kranz A, 2010, BRAIN RES, V1315, P128, DOI 10.1016/j.brainres.2009.12.001; KRUEGER WWO, 1978, OTOLARYNG HEAD NECK, V86, P804, DOI 10.1177/019459987808600527; Kulkarni S, 2010, RADIAT RES, V173, P738, DOI 10.1667/RR1824.1; KUNA P, 1983, NEOPLASMA, V30, P349; Lange C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014486; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; Meineke V., 2005, BR J RADIOL S, P196, DOI DOI 10.1259/BJR/25654769; MENDIONDO OA, 1982, ACTA RADIOL ONCOL, V21, P319, DOI 10.3109/02841868209134022; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Need JT, 2006, MIL MED, V171, P698, DOI 10.7205/MILMED.171.8.698; Neves H, 2012, DEV BIOL, V361, P208, DOI 10.1016/j.ydbio.2011.10.022; Oya N, 2006, INT J HEMATOL, V83, P86, DOI 10.1532/IJH97.05046; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Prather WR, 2008, EXPERT OPIN BIOL TH, V8, P1241, DOI [10.1517/14712598.8.8.1241, 10.1517/14712598.8.8.1241 ]; Prather WR, 2009, CYTOTHERAPY, V11, P427, DOI 10.1080/14653240902849762; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Raaijmakers MHGP, 2012, INT J HEMATOL, V95, P17, DOI 10.1007/s12185-011-1001-x; Rabbani ZN, 2007, FREE RADICAL RES, V41, P1273, DOI 10.1080/10715760701689550; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Saha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024072; Santucci MA, 1997, ACTA HAEMATOL-BASEL, V97, P90; Schaniel C, 2009, ANN NY ACAD SCI, V1176, P26, DOI 10.1111/j.1749-6632.2009.04608.x; Schlosser S, 2012, MICROVASC RES, V83, P267, DOI 10.1016/j.mvr.2012.02.011; Shim S, 2013, EXP HEMATOL, V41, P346, DOI 10.1016/j.exphem.2013.01.002; Singh VK, 2012, RADIAT RES, V177, P781, DOI 10.1667/RR2894.1; Sioud M, 2011, INT J ONCOL, V38, P385, DOI 10.3892/ijo.2010.869; SONG CW, 1981, INT J RADIAT ONCOL, V7, P1695, DOI 10.1016/0360-3016(81)90195-4; TAMAYO E, 1994, STEM CELLS, V12, P304, DOI 10.1002/stem.5530120306; THIERRY D., 2005, BR J RADIOL S, V27, P175, DOI DOI 10.1259/BJR/90209767; TILL JE, 1964, ANN NY ACAD SCI, V114, P115; Tonn T, 2008, TRANSFUS MED HEMOTH, V35, P269, DOI 10.1159/000147276; UTLEY JF, 1976, INT J RADIAT ONCOL, V1, P699, DOI 10.1016/0360-3016(76)90152-8; VANDYK J, 1983, INT J RADIAT ONCOL, V9, P1913, DOI 10.1016/0360-3016(83)90362-0; WEICHSELBAUM RR, 1983, INT J RADIAT ONCOL, V9, P91, DOI 10.1016/0360-3016(83)90215-8; Wheldon TE, 1997, BRIT J RADIOL, V70, P1204, DOI 10.1259/bjr.70.840.9505837; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; Williams JP, 2011, INT J RADIAT BIOL, V87, P851, DOI 10.3109/09553002.2011.560996; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Yang Xiaodong, 2012, Adv Hematol, V2012, P142530, DOI 10.1155/2012/142530; Yuan T, 2011, J BIOMED MATER RES A, V98A, P332, DOI 10.1002/jbm.a.33121; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	82	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66549	10.1371/journal.pone.0066549	http://dx.doi.org/10.1371/journal.pone.0066549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823334	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400125
J	Azevedo, LCP; Toscano, CM; Bierrenbach, AL				Pontes Azevedo, Luciano Cesar; Toscano, Cristiana M.; Bierrenbach, Ana Luiza			Bacterial Meningitis in Brazil: Baseline Epidemiologic Assessment of the Decade Prior to the Introduction of Pneumococcal and Meningococcal Vaccines	PLOS ONE			English	Article							INFLUENZAE TYPE-B; CONJUGATE VACCINE; SURVEILLANCE; MORTALITY; ENGLAND; SALVADOR; CHILDREN; DISEASE; WALES	Background: Bacterial meningitis is associated with significant burden in Brazil. In 2010, both 10-valent pneumococcal conjugate vaccine and meningococcal capsular group C conjugate vaccine were introduced into the routine vaccination schedule. Haemophilus influenzae type b vaccine was previously introduced in 1999. This study presents trends in demographics, microbiological characteristics and seasonality patterns of bacterial meningitis cases in Brazil from 2000 to 2010. Methods and Findings: All meningitis cases confirmed by clinical and/or laboratory criteria notified to the national information system for notifiable diseases between 2000 and 2010 were analyzed. Proportions of bacterial meningitis cases by demographic characteristics, criteria used for confirmation and etiology were calculated. We estimated disease rates per 100,000 population and trends for the study period, with emphasis on H. influenzae, N. meningitidis and S. pneumoniae cases. In the decade, 341,805 cases of meningitis were notified in Brazil. Of the 251,853 cases with defined etiology, 110,264 (43.8%) were due to bacterial meningitis (excluding tuberculosis). Of these, 34,997 (31.7%) were due to meningococcal disease. The incidence of bacterial meningitis significantly decreased from 3.1/100,000 population in 2000-2002 to 2.14/100,000 in 2009-2010 (p<0.01). Among cases of meningococcal disease, the proportion of those associated with group C increased from 41% in 2007 to 61.7% in 2010, while the proportion of group B disease progressively declined. Throughout the study period, an increased number of cases occurred during winter. Conclusions: Despite the reduction in bacterial meningitis incidence during the last decade, it remains a significant healthcare issue in Brazil. Meningococcal disease is responsible for the majority of the cases with group C the most common capsular type. Our study demonstrates the appropriateness of introduction of meningococcal vaccination in Brazil. Furthermore, this study provides a baseline for future evaluation of the impact of the vaccines introduction in Brazil and changes in disease epidemiology.	[Pontes Azevedo, Luciano Cesar; Bierrenbach, Ana Luiza] Hosp Sirio Libanes, Res & Educ Inst IEP, Sao Paulo, Brazil; [Pontes Azevedo, Luciano Cesar] Univ Sao Paulo, Dept Emergency Med, BR-05508 Sao Paulo, Brazil; [Toscano, Cristiana M.; Bierrenbach, Ana Luiza] Univ Fed Goias, Dept Collect Hlth, Goiania, Go, Brazil; [Bierrenbach, Ana Luiza] Sanas Epidemiol & Res, Sao Paulo, Brazil	Hospital Sirio Libanes; Universidade de Sao Paulo; Universidade Federal de Goias	Azevedo, LCP (corresponding author), Hosp Sirio Libanes, Res & Educ Inst IEP, Sao Paulo, Brazil.	luciano.azevedo@hsl.org.br	Azevedo, Luciano CP/H-2652-2012; Bierrenbach, Ana L/F-3185-2014	Azevedo, Luciano CP/0000-0001-6759-3910; Bierrenbach, Ana L/0000-0002-6837-0636; TOSCANO, CRISTIANA/0000-0002-9453-2643	Research and Education Institute, Hospital Sirio-Libanes	Research and Education Institute, Hospital Sirio-Libanes	Supported by Research and Education Institute, Hospital Sirio-Libanes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P72; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; [Anonymous], MAN CTR REF IM ESP; Braikat M, 2012, VACCINE, V30, P2594, DOI 10.1016/j.vaccine.2012.01.041; Brasil. Ministerio da Saude, 2009, GUIA VIG EP; Brasil. Ministerio da Saude, 2010, INTR VAC MEN C CONJ; Brasil. Ministerio da Saude, 2010, PROP INTR VAC PNEUM; Brasil. Ministerio da Saude, 2001, MAN NORM VAC; Brasil Ministerio da Saude, 2012, QUE SIN; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Carmo EH, 2009, MORB MORT DOENC TRAN; Miranzi SDC, 2007, CAD SAUDE PUBLICA, V23, P1689, DOI 10.1590/S0102-311X2007000700021; Cordeiro SM, 2007, T ROY SOC TROP MED H, V101, P1147, DOI 10.1016/j.trstmh.2007.06.012; do Nascimento KA, 2012, REV SOC BRAS MED TRO, V45, P334, DOI 10.1590/S0037-86822012000300011; Domingues C, 2013, EMERGING INFECT DIS; Escosteguy CC, 2004, REV SAUDE PUBL, V38, P657, DOI 10.1590/S0034-89102004000500007; Figueira GCN, 2012, B EPIDEMIOLOGICO PAU, V9, P5; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Ladhani SN, 2012, EMERG INFECT DIS, V18, P63, DOI 10.3201/eid1801.110901; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Nascimento-Carvalho CM, 2004, ARQ NEURO-PSIQUIAT, V62, P250, DOI 10.1590/S0004-282X2004000200011; Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249; Perez AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-130; Ribeiro GS, 2007, VACCINE, V25, P4420, DOI 10.1016/j.vaccine.2007.03.024; Santos Magda Levantezi, 2005, Cad. Saúde Pública, V21, P823, DOI 10.1590/S0102-311X2005000300016; Sinclair D, 2010, TROP MED INT HEALTH, V15, P1421, DOI 10.1111/j.1365-3156.2010.02660.x; Stanton MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025957; Tanno LK, 2012, ALLERGY, V67, P783, DOI 10.1111/j.1398-9995.2012.02829.x; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Trotter CL, 2006, LANCET INFECT DIS, V6, P616, DOI 10.1016/S1473-3099(06)70584-9; Weiss DPL, 2001, REV SAUDE PUBL, V35, P249, DOI 10.1590/S0034-89102001000300006; World Health Organization, 2011, WKLY EPIDEMIOL REC, V86, P521; World Health Organization, 2003, WHO REC STAND SURV S; Zanella RC, 2011, VACCINE, V29, P8937, DOI 10.1016/j.vaccine.2011.09.053	38	34	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e64524	10.1371/journal.pone.0064524	http://dx.doi.org/10.1371/journal.pone.0064524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823579	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400002
J	Ceccato, L; Masiero, S; Roy, DS; Bencivenga, S; Roig-Villanova, I; Ditengou, FA; Palme, K; Simon, R; Colombo, L				Ceccato, Luca; Masiero, Simona; Roy, Dola Sinha; Bencivenga, Stefano; Roig-Villanova, Irma; Ditengou, Franck Anicet; Palme, Klaus; Simon, Ruediger; Colombo, Lucia			Maternal Control of PIN1 Is Required for Female Gametophyte Development in Arabidopsis	PLOS ONE			English	Article							DEPENDENT AUXIN GRADIENTS; OVULE DEVELOPMENT; WILD-TYPE; TRANSPORT; THALIANA; EFFLUX; GENE; PLANTS; TRANSFORMATION; BIOSYNTHESIS	Land plants are characterised by haplo-diploid life cycles, and developing ovules are the organs in which the haploid and diploid generations coexist. Recently it has been shown that hormones such as auxin and cytokinins play important roles in ovule development and patterning. The establishment and regulation of auxin levels in cells is predominantly determined by the activity of the auxin efflux carrier proteins PIN-FORMED (PIN). To study the roles of PIN1 and PIN3 during ovule development we have used mutant alleles of both genes and also perturbed PIN1 and PIN3 expression using micro-RNAs controlled by the ovule specific DEFH9 (DEFIFICENS Homologue 9) promoter. PIN1 down-regulation and pin1-5 mutation severely affect female gametophyte development since embryo sacs arrest at the mono- and/or bi-nuclear stages (FG1 and FG3 stage). PIN3 function is not required for ovule development in wild-type or PIN1-silenced plants. We show that sporophytically expressed PIN1 is required for megagametogenesis, suggesting that sporophytic auxin flux might control the early stages of female gametophyte development, although auxin response is not visible in developing embryo sacs.	[Ceccato, Luca; Masiero, Simona; Roy, Dola Sinha; Bencivenga, Stefano; Roig-Villanova, Irma; Colombo, Lucia] Univ Milan, Dipartimento BioSci, Milan, Italy; [Ditengou, Franck Anicet; Palme, Klaus; Colombo, Lucia] Univ Freiburg, Inst Biol 2, Fac Biol, Freiburg, Germany; [Simon, Ruediger; Colombo, Lucia] Univ Dusseldorf, Inst Entwicklungsgenet, D-40225 Dusseldorf, Germany; [Colombo, Lucia] CNR, Ist Biofis, I-20133 Milan, Italy	University of Milan; University of Freiburg; Heinrich Heine University Dusseldorf; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Colombo, L (corresponding author), Univ Milan, Dipartimento BioSci, Milan, Italy.	lucia.colombo@unimi.it	Ditengou, Franck Anicet/E-6626-2016; Palme, Klaus/A-9524-2013; Masiero, Simona/J-2898-2013; Roig Villanova, Irma/K-3865-2014; Simon, Rudiger/T-6755-2018	Ditengou, Franck Anicet/0000-0001-5355-0282; Palme, Klaus/0000-0002-2728-3835; masiero, simona/0000-0002-7563-7634; Roig Villanova, Irma/0000-0001-9124-0429; Simon, Rudiger/0000-0002-1317-7716; Colombo, Lucia/0000-0001-8415-1399; Bencivenga, Stefano/0000-0002-3862-5159	short term EMBO fellowship [ASTF 388.00-2008]; Universita degli Studi di Milano	short term EMBO fellowship; Universita degli Studi di Milano	The authors thank R. Gatta for their help and J. Friml, E. Benkova, M. Heisler and Y. Zhao for providing material. Luca Ceccato was supported by a short term EMBO fellowship (ASTF 388.00-2008). The authors thank A. Spena for DEH9 promoter sequence. L.C., D.S.-R., and B.C. were funded by a PhD fellowship from the Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2000, DEVELOPMENT, V127, P4227; Bencivenga S, 2012, PLANT CELL, V24, P2886, DOI 10.1105/tpc.112.100164; Bencivenga S, 2011, SEX PLANT REPROD, V24, P113, DOI 10.1007/s00497-011-0162-3; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Braselton JP, 1996, BIOTECH HISTOCHEM, V71, P84, DOI 10.3109/10520299609117139; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dal Bosco C, 2012, PLANT J, V71, P860, DOI 10.1111/j.1365-313X.2012.05037.x; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Mirabella R, 2004, PLANT PHYSIOL, V135, P1879, DOI 10.1104/pp.103.038539; Note-Wilson S, 2010, DEV BIOL, V346, P181, DOI 10.1016/j.ydbio.2010.07.016; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Okada K, 1994, ARABIDOPSIS ATLAS MO, P180; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Rotino GL, 1997, NAT BIOTECHNOL, V15, P1398, DOI 10.1038/nbt1297-1398; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; YADEGARI R, 1994, PLANT CELL, V6, P1713, DOI 10.1105/tpc.6.12.1713; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Zadnikova P, 2010, DEVELOPMENT, V137, P607, DOI 10.1242/dev.041277; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552	35	85	88	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66148	10.1371/journal.pone.0066148	http://dx.doi.org/10.1371/journal.pone.0066148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799075	gold, Green Published, Green Submitted			2022-12-27	WOS:000321397800024
J	Gomes, FM; Subramanian, SV; Escobar, AMDU; Valente, MH; Grisi, SJFE; Brentani, A; Fink, G				Gomes, Filumena Maria; Subramanian, S. V.; de Ulhoa Escobar, Ana Maria; Valente, Maria Helena; Ferraz Ellero Grisi, Sandra Josefina; Brentani, Alexandra; Fink, Guenther			No Association between Low Birth Weight and Cardiovascular Risk Factors in Early Adulthood: Evidence from Sao Paulo, Brazil	PLOS ONE			English	Article							FETAL ORIGINS; GROWTH; OBESITY; CHILDHOOD; INFANCY; COHORT; SIZE	Background: A growing literature suggests that low birth weight increases the risk of poor health outcomes in adulthood. We tested this hypothesis among young adults living in Sao Paulo State, Brazil. Methods and Findings: To identify the effects of low birth weight on young adulthood outcomes, a medical assessment of 297 individuals born between 1977 and 1989 was conducted at a primary care unit in Sao Paulo State, Brazil. We analyzed body mass index (BMI), waist-hip ratio, blood pressure, fasting glucose and total cholesterol levels using linear and logistic regressions. Low birth was negatively associated with BMI (beta = 22.0, 95% CI: 23.69, 20.27, p = 0.02), fasting glucose levels (beta = 21.9, 95% CI: 23.9, 20.07, p = 0.05), waist-hip ratio (beta = 20.03, 95% CI: 20.07, 20.01, p = 0.10), systolic blood pressure (beta = 23.32, 95% CI: 27.60, 0.96, p = 0.12), and total cholesterol levels (beta = 23.19, 95% CI: 216.43, 10.05, p = 0.636). Low birth weight was also associated with lower odds of young adults being overweight and obese, but neither association was statistically significant. Weight gain in the first 12 months of life was associated with higher adult BMI (beta = 0.79, 95% CI: 20.0455, 1.623, p = 0.064) and blood pressure (beta = 2.79, 95% CI: 0.22, 5.35, p = 0.034). No associations were found between low birth weight and early life (catch-up) growth. Conclusions: Low birth weight was not associated with poor health outcomes among young adults in Brazil. These results appear inconsistent with the original Barker hypothesis, but will need to be corroborated in larger samples with longer follow-ups to allow a more general evaluation of the validity of the hypothesis in low and middle income countries.	[Gomes, Filumena Maria; Valente, Maria Helena] Univ Sao Paulo, Fac Med, Ctr Saude Samuel Barnsley Pessoa, Sao Paulo, Brazil; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [de Ulhoa Escobar, Ana Maria; Ferraz Ellero Grisi, Sandra Josefina; Brentani, Alexandra] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Fink, Guenther] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Harvard T.H. Chan School of Public Health	Brentani, A (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil.	abrentani@hu.usp.br	Grisi, Sandra/ABB-9976-2020; Gomes, Filumena/W-5178-2019; Brentani, Alexandra/G-4535-2013	Gomes, Filumena/0000-0002-0889-231X; Brentani, Alexandra/0000-0001-6650-9705; Grisi, Sandra Josefina Ferraz Ellero/0000-0003-1846-3591	Robert Wood Johnson Investigator Award in Health Policy Research	Robert Wood Johnson Investigator Award in Health Policy Research	The present study had no other funding besides the Medicine School's support. SVS is also supported by the Robert Wood Johnson Investigator Award in Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1992, FETAL INFANT ORIGINS; Barker DJP, 1997, NUTR ABSTR REV, P13; Binelliy C, 2009, ED WAGES BRAZIL; Gigante DP, 2008, REV SAUDE PUBL, V42, P60, DOI 10.1590/S0034-89102008000900009; Johnson RC, 2011, BE J ECON ANAL POLI, P11; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Stevens LM, 2002, JAMA-J AM MED ASSOC, P287; Unicef, 2012, UNIC COUNTR STAT; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	21	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66554	10.1371/journal.pone.0066554	http://dx.doi.org/10.1371/journal.pone.0066554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799115	gold, Green Published, Green Submitted			2022-12-27	WOS:000321397800036
J	Seto, SW; Au, ALS; Poon, CCW; Zhang, Q; Li, RWS; Yeung, JHK; Kong, SK; Ngai, SM; Wan, S; Ho, HP; Lee, SMY; Hoi, MPM; Chan, SW; Leung, GPH; Kwan, YW				Seto, Sai Wang; Au, Alice Lai Shan; Poon, Christina Chui Wa; Zhang, Qian; Li, Rachel Wai Sum; Yeung, John Hok Keung; Kong, Siu Kai; Ngai, Sai Ming; Wan, Song; Ho, Ho Pui; Lee, Simon Ming Yuen; Hoi, Maggie Pui Man; Chan, Shun Wan; Leung, George Pak Heng; Kwan, Yiu Wa			Acute Simvastatin Inhibits K-ATP Channels of Porcine Coronary Artery Myocytes	PLOS ONE			English	Article							ACTIVATED-PROTEIN-KINASE; SENSITIVE POTASSIUM CHANNELS; VASCULAR SMOOTH-MUSCLE; HMG-COA REDUCTASE; ENDOTHELIAL-CELLS; NITRIC-OXIDE; GLUCOSE-UPTAKE; INSULIN-SECRETION; PHOSPHATASE 2A; AMPK ACTIVITY	Background: Statins (3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors) consumption provides beneficial effects on cardiovascular systems. However, effects of statins on vascular KATP channel gatings are unknown. Methods: Pig left anterior descending coronary artery and human left internal mammary artery were isolated and endothelium-denuded for tension measurements and Western immunoblots. Enzymatically-dissociated/cultured arterial myocytes were used for patch-clamp electrophysiological studies and for [Ca2+](i), [ATP](i) and [glucose](o) uptake measurements. Results: The cromakalim (10 nM to 10 mu M)- and pinacidil (10 nM to 10 mu M)-induced concentration-dependent relaxation of porcine coronary artery was inhibited by simvastatin (3 and 10 mu M). Simvastatin (1, 3 and 10 mu M) suppressed (in okadaic acid (10 nM)-sensitive manner) cromakalim (10 mM)-and pinacidil (10 mu M)-mediated opening of whole-cell K-ATP channels of arterial myocytes. Simvastatin (10 mu M) and AICAR (1 mM) elicited a time-dependent, compound C (1 mu M)-sensitive [H-3]-2-deoxy- glucose uptake and an increase in [ATP](i) levels. A time (2-30 min)- and concentration (0.1-10 mu M)-dependent increase by simvastatin of p-AMPK alpha-Thr(172) and p-PP2A-Tyr(307) expression was observed. The enhanced p-AMPK alpha-Thr(172) expression was inhibited by compound C, ryanodine (100 mu M) and KN93 (10 mu M). Simvastatin-induced p-PP2A-Tyr(307) expression was suppressed by okadaic acid, compound C, ryanodine, KN93, phloridzin (1 mM), ouabain (10 mu M), and in [glucose](o)-free or [Na+](o)-free conditions. Conclusions: Simvastatin causes ryanodine-sensitive Ca2+ release which is important for AMPK alpha-Thr(172) phosphorylation via Ca2+/CaMK II. AMPK alpha-Thr(172) phosphorylation causes [glucose](o) uptake (and an [ATP](i) increase), closure of K-ATP channels, and phosphorylation of AMPK alpha-Thr(172) and PP2A-Tyr(307) resulted. Phosphorylation of PP2A-Tyr(307) occurs at a site downstream of AMPK alpha-Thr(172) phosphorylation.	[Seto, Sai Wang] James Cook Univ, Vasc Biol Unit, Queensland Res Ctr Peripheral Vasc Dis, Sch Med & Dent, Townsville, Qld 4811, Australia; [Seto, Sai Wang; Au, Alice Lai Shan; Poon, Christina Chui Wa; Zhang, Qian; Yeung, John Hok Keung; Kwan, Yiu Wa] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Li, Rachel Wai Sum; Leung, George Pak Heng] Univ Hong Kong, Dept Pharmacol & Pharm, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Shun Wan] Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Kong, Siu Kai; Ngai, Sai Ming] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Shatin, Hong Kong, Peoples R China; [Wan, Song] Chinese Univ Hong Kong, Dept Surg, Fac Med, Shatin, Hong Kong, Peoples R China; [Ho, Ho Pui] Chinese Univ Hong Kong, Fac Engn, Dept Elect Engn, Shatin, Hong Kong, Peoples R China; [Lee, Simon Ming Yuen; Hoi, Maggie Pui Man] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China	James Cook University; Chinese University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Macau	Chan, SW (corresponding author), Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	sw.chan@polyu.edu.hk; gphleung@hkucc.hku.hk; yiuwakwan@cuhk.edu.hk	Hoi, Maggie Pui Man/AAY-5962-2021; Wan, Song/N-7352-2016; Chan, Shun-Wan/K-9363-2013; HO, Ho-Pui/AAT-9650-2021; Ngai, Sai Ming/S-4898-2018; Kwan, Yiu Wa/R-6468-2018; Wan, Song/AAV-6696-2020; Leung, George Pak Heng/B-4529-2009	Chan, Shun-Wan/0000-0001-8238-798X; Ngai, Sai Ming/0000-0002-4484-2483; Kwan, Yiu Wa/0000-0002-9024-1275; Wan, Song/0000-0002-9394-1672; Seto, Sai Wang/0000-0003-0236-4935; Leung, George Pak Heng/0000-0003-3529-9367; Poon, Chui Wa Christina/0000-0002-4569-876X; Hoi, Maggie Pui Man/0000-0003-2630-3707	University Grant Council (UGC) Earmarked Grants of Hong Kong [4107/01M, 4166/02M, 2140565]; Direct Grants for Research (The Chinese University of Hong Kong) [2401149, 2041231, 2401296]; Australia Government National Health and Medical Research Council (NHMRC) Fellowship [1016349]; National Heart Foundation (NHF) of Australia Fellowship [PF12B6825]	University Grant Council (UGC) Earmarked Grants of Hong Kong; Direct Grants for Research (The Chinese University of Hong Kong)(Chinese University of Hong Kong); Australia Government National Health and Medical Research Council (NHMRC) Fellowship; National Heart Foundation (NHF) of Australia Fellowship(National Heart Foundation of Australia)	This project is financially supported by University Grant Council (UGC) Earmarked Grants of Hong Kong (Ref. #: 4107/01M; 4166/02M, project code: 2140565) and Direct Grants for Research (The Chinese University of Hong Kong) (Reference no.: 2401149; Project code/ID: 2041231; 2401296). Dr SW Seto, Ms CCW Poon, Ms ALS Au and Ms Q Zhang are recipients of postgraduate studentship of the Department of Pharmacology/School of Biomedical Sciences (The Chinese University of Hong Kong, Hong Kong). Dr SW Seto is supported by the Australia Government National Health and Medical Research Council (NHMRC) Fellowship (1016349) and the National Heart Foundation (NHF) of Australia Fellowship (PF12B6825). Provision of the Student Campus Work Scheme by the Chou's Foundation Fund and the Student Campus Work Scheme (Shaw College, The Chinese University of Hong Kong) is appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au ALS, 2004, EUR J PHARMACOL, V502, P123, DOI 10.1016/j.ejphar.2004.08.045; Aziz Q, 2010, EUR J PHARMACOL, V634, P26, DOI 10.1016/j.ejphar.2010.02.023; Bao N, 2007, CIRC J, V71, P1622, DOI 10.1253/circj.71.1622; Bergdahl A, 2003, PHARMACOL TOXICOL, V93, P128, DOI 10.1034/j.1600-0773.2003.930304.x; Calderon-Sanchez E, 2009, CARDIOVASC RES, V82, P115, DOI 10.1093/cvr/cvp006; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; de Sotomayor MA, 2001, EUR J PHARMACOL, V415, P217, DOI 10.1016/S0014-2999(01)00819-6; Finder JD, 1997, J BIOL CHEM, V272, P13484, DOI 10.1074/jbc.272.21.13484; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Ford RJ, 2011, AM J PHYSIOL-HEART C, V300, pH64, DOI 10.1152/ajpheart.00597.2010; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Han J, 2001, J BIOL CHEM, V276, P22140, DOI 10.1074/jbc.M010103200; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; HOPFER U, 1987, ANNU REV PHYSIOL, V49, P51, DOI 10.1146/annurev.ph.49.030187.000411; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Koh HJ, 2008, CURR OPIN CLIN NUTR, V11, P227, DOI 10.1097/MCO.0b013e3282fb7b76; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Lange Y, 2002, BIOCHEM BIOPH RES CO, V290, P488, DOI 10.1006/bbrc.2001.6156; Lee TM, 2007, BASIC RES CARDIOL, V102, P171, DOI 10.1007/s00395-006-0628-x; Li HB, 2008, EUR J PHARMACOL, V588, P165, DOI 10.1016/j.ejphar.2008.04.036; Lin SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049605; Lorkowska B, 2005, PROSTAG LEUKOTR ESS, V72, P133, DOI 10.1016/j.plefa.2004.10.012; Majithiya JB, 2006, LIFE SCI, V78, P2615, DOI 10.1016/j.lfs.2005.10.020; McNeish AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046735; Nishizaki T, 1998, STROKE, V29, P844, DOI 10.1161/01.STR.29.4.844; Nissen SE, 2005, AM J CARDIOL, V96, p61F, DOI 10.1016/j.amjcard.2005.07.013; Pallottini V, 2007, MECH AGEING DEV, V128, P688, DOI 10.1016/j.mad.2007.10.001; Park JE, 2008, XENOBIOTICA, V38, P1240, DOI [10.1080/00498250802334391, 10.1080/00498250802334391 ]; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Perez-Guerrero C, 2000, Z NATURFORSCH C, V55, P121; Robertson TP, 2008, EUR J PHARMACOL, V595, P39, DOI 10.1016/j.ejphar.2008.07.035; Rohra DK, 2005, EUR J PHARMACOL, V514, P175, DOI 10.1016/j.ejphar.2005.02.041; Rossoni LV, 2011, CLIN SCI, V121, P449, DOI 10.1042/CS20110259; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; Sadaba JR, 2000, EUR J CARDIO-THORAC, V17, P319, DOI 10.1016/S1010-7940(00)00325-0; Seto SW, 2007, BRIT J PHARMACOL, V151, P987, DOI 10.1038/sj.bjp.0707327; Seto SW, 2007, EUR J PHARMACOL, V572, P40, DOI 10.1016/j.ejphar.2007.05.070; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Terata Y, 2003, PHARMACOLOGY, V68, P169, DOI 10.1159/000070455; Tesfamariam B, 1999, J CARDIOVASC PHARM, V34, P95, DOI 10.1097/00005344-199907000-00016; Uhiara CO, 2012, EUR J PHARMACOL, V690, P158, DOI 10.1016/j.ejphar.2012.07.006; Urena J, 2007, CELL CALCIUM, V42, P513, DOI 10.1016/j.ceca.2007.04.010; Uydes-Dogan BS, 2005, LIFE SCI, V76, P1771, DOI 10.1016/j.lfs.2004.11.002; Wang CZ, 2005, BIOCHEM BIOPH RES CO, V330, P1073, DOI 10.1016/j.bbrc.2005.03.093; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Wu HM, 2011, MOL PHARMACOL, V80, P859, DOI 10.1124/mol.111.072769; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang YJ, 2007, EUR J HEART FAIL, V9, P30, DOI 10.1016/j.ejheart.2006.04.013	61	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66404	10.1371/journal.pone.0066404	http://dx.doi.org/10.1371/journal.pone.0066404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799098	Green Published, gold, Green Accepted			2022-12-27	WOS:000321397800030
J	Stojanovic, A; Chen, SH; Chen, XJ; Stojanovic, F; Zhang, J; Zhang, T; Utheim, TP				Stojanovic, Aleksandar; Chen, Shihao; Chen, Xiangjun; Stojanovic, Filip; Zhang, Jia; Zhang, Ting; Utheim, Tor Paaske			One-Step Transepithelial Topography-Guided Ablation in the Treatment of Myopic Astigmatism	PLOS ONE			English	Article							ASSISTED SUBEPITHELIAL KERATECTOMY; LASER EPITHELIAL KERATOMILEUSIS; OPTIMIZED SURFACE ABLATION; IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; EXCIMER-LASER; KERATOCYTE APOPTOSIS; EPI-LASIK; REFRACTIVE SURGERY; CLINICAL-OUTCOMES	Purpose: To evaluate one-step topography-guided transepithelial ablation in the treatment of low to moderate myopic astigmatism using a 1KHz excimer laser. Methods: Retrospective study of 117 consecutive eyes available for evaluation 12 months after surgery. Pre- and postoperative visual and refractive data as well as post-operative pain and haze were analyzed. A novel technique integrating custom refractive-and epithelial-ablation in a single uninterrupted procedure was used. Results: The mean pre-operative spherical equivalent (SE) and the mean cylinder were: -3.22 diopters (D) +/- 1.54 (SD) (range -0.63 to -7.25 D) and -0.77 D +/- 0.65 (range 0 to -4.50 D), respectively. At 12 months after surgery: no eyes lost >= 2 lines of corrected distant visual acuity (CDVA). Safety and efficacy indexes were 1.27 and 1.09, respectively. Uncorrected distant visual acuity (UDVA) was >= 20/20 in 96.6% of the eyes. Manifest refraction spherical equivalent was within +/- 0.5 D of the desired refraction in 93.2% of the eyes. Average root mean square (RMS) wavefront error measured at central 6 mm, increased from 0.38 pre-operatively to 0.47 mu m post-operatively. Refractive stability was achieved and sustained 1 month after surgery. No visually significant haze was registered during the observation period. Post-operative pain was reported in 4.5% of patients. Conclusions: One-step transepithelial topography-guided treatment for low to moderate myopia and astigmatism performed with a 1 KHz laser, provided safe, effective, predictable and stable results with low pain and no visually significant haze.	[Stojanovic, Aleksandar; Chen, Xiangjun; Utheim, Tor Paaske] SynsLaser Kirurgi, Oslo, Norway; [Stojanovic, Aleksandar; Chen, Xiangjun; Utheim, Tor Paaske] SynsLaser Kirurgi, Tromso, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Eye Dept, Tromso, Norway; [Chen, Shihao; Zhang, Jia; Zhang, Ting] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou, Zhejiang, Peoples R China; [Chen, Shihao; Zhang, Jia; Zhang, Ting] Wenzhou Med Coll, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Chen, Shihao; Zhang, Jia] Minist Hlth PR China, Key Lab Vis Sci, Wenzhou, Zhejiang, Peoples R China; [Stojanovic, Filip] Univ Tromso, Fac Med, Tromso, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; Wenzhou Medical University; Wenzhou Medical University; UiT The Arctic University of Tromso; University of Oslo	Stojanovic, A (corresponding author), SynsLaser Kirurgi, Oslo, Norway.	aleks@online.no	Stojanovic, Aleksandar/AAG-9933-2019	Chen, Xiangjun/0000-0003-0331-9028	SynsLaser Kirurgi AS, Tromso, Norway; Norges forskningsrad, Oslo, Norway	SynsLaser Kirurgi AS, Tromso, Norway; Norges forskningsrad, Oslo, Norway	This work was supported by SynsLaser Kirurgi AS, Tromso, Norway and Norges forskningsrad, Oslo, Norway. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio G, 2001, OPHTHALMOLOGY, V108, P1695, DOI 10.1016/S0161-6420(01)00706-0; Ambrosio Renato Jr, 2003, Semin Ophthalmol, V18, P2, DOI 10.1080/08820530390897738; Argento C, 2006, J REFRACT SURG, V22, P782, DOI 10.3928/1081-597X-20061001-08; Autrata R, 2003, J CATARACT REFR SURG, V29, P661, DOI 10.1016/S0886-3350(02)01897-7; Bilgihan K, 2002, EYE, V16, P63, DOI 10.1038/sj.eye.6700065; Buzzonetti L, 2009, J REFRACT SURG, V25, P709, DOI [10.3928/1081597X-20090115-08, 10.3928/1081597X-20090707-05]; Caffi M, 1966, Ann Ottalmol Clin Ocul, V92, P429; Carr J D, 1995, J Refract Surg, V11, pS309; Chen X, 2010, 28 C EUR SOC CAT REF; Chen XJ, 2012, J REFRACT SURG, V28, P120, DOI 10.3928/1081597X-20110926-01; Chen XJ, 2010, J REFRACT SURG, V26, P529, DOI 10.3928/1081597X-20100226-01; Clinch TE, 1999, OPHTHALMOLOGY, V106, P483, DOI 10.1016/S0161-6420(99)90135-5; Cummings AB, 2010, J REFRACT SURG, V26, P478, DOI 10.3928/1081597X-20090814-05; Cusumano A, 1998, OPHTHALMOLOGY, V105, P300, DOI 10.1016/S0161-6420(98)93211-0; de Benito-Llopis L, 2007, J REFRACT SURG, V23, P139; El Awady HE, 2011, OPHTHAL SURG LAS IM, V42, P314, DOI 10.3928/15428877-20110421-01; Fadlallah A, 2011, J CATARACT REFR SURG, V37, P1852, DOI 10.1016/j.jcrs.2011.04.029; Faktorovich EG, 2010, J REFRACT SURG, V26, P934, DOI 10.3928/1081597X-20100212-06; Falavarjani KG, 2011, J REFRACT SURG, V27, P13, DOI 10.3928/1081597X-20100310-02; Gambato C, 2011, J REFRACT SURG, V27, P792, DOI 10.3928/1081597X-20110407-01; Ghadhfan F, 2007, J CATARACT REFR SURG, V33, P2041, DOI 10.1016/j.jcrs.2007.07.026; GIMBEL HV, 1995, J REFRACT SURG, V11, P36; Helena MC, 1998, INVEST OPHTH VIS SCI, V39, P276; Kanitkar KD, 2000, J REFRACT SURG, V16, P519; Kapadia MS, 1999, OPHTHALMOLOGY, V106, P29, DOI 10.1016/S0161-6420(99)90002-7; Kapadia MS, 1998, AM J OPHTHALMOL, V126, P827, DOI 10.1016/S0002-9394(98)00222-0; Kermani O, 2006, J REFRACT SURG, V22, P754, DOI 10.3928/1081-597X-20061001-05; Khoramnia R, 2011, ACTA OPHTHALMOL; Kim WJ, 1998, J REFRACT SURG, V14, P526; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165; Krueger RR, 2008, J REFRACT SURG, V24, pS713, DOI 10.3928/1081597X-20080901-13; La Tegola MG, 2007, J REFRACT SURG, V23, P681; Leccisotti A, 2003, EUR J OPHTHALMOL, V13, P676, DOI 10.1177/112067210301300802; Lee HK, 2005, AM J OPHTHALMOL, V139, P56, DOI 10.1016/j.ajo.2004.08.049; Lee JB, 2001, J CATARACT REFR SURG, V27, P565, DOI 10.1016/S0886-3350(00)00880-4; Manche Edward E, 2011, Trans Am Ophthalmol Soc, V109, P201; Mifflin MD, 2012, J REFRACT SURG, V28, P127, DOI 10.3928/1081597X-20120103-01; O'Doherty M, 2007, J REFRACT SURG, V23, P133; Pedrotti E, 2006, J CATARACT REFR SURG, V32, P1288, DOI 10.1016/j.jcrs.2006.03.032; Phillips AF, 1997, AM J OPHTHALMOL, V123, P42, DOI 10.1016/S0002-9394(14)70990-0; Pop M, 2005, J REFRACT SURG, V21, pS636; Porter J, 2006, J CATARACT REFR SURG, V32, P21, DOI 10.1016/j.jcrs.2005.10.027; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Seiler T, 2000, GRAEF ARCH CLIN EXP, V238, P822, DOI 10.1007/s004179900111; Seiler T, 1990, Refract Corneal Surg, V6, P99; Shortt AJ, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005135.PUB2; Sia RK, 2012, J REFRACT SURG, V28, P65, DOI 10.3928/1081597X-20111004-01; Stojanovic A, 2003, J REFRACT SURG, V19, P338; Stojanovic A, 2001, J CATARACT REFR SURG, V27, P404, DOI 10.1016/S0886-3350(00)00742-2; Stulting RD, 2011, CORNEA, V30, P945, DOI 10.1097/ICO.0b013e31820a0e53; Torres LF, 2007, J REFRACT SURG, V23, P126; Vinciguerra P, 1998, J REFRACT SURG, V14, pS204; Vinciguerra P, 2007, J REFRACT SURG, V23, pS1029, DOI 10.3928/1081-597X-20071102-09; von Mohrenfels CW, 2010, J CATARACT REFR SURG, V36, P449, DOI 10.1016/j.jcrs.2009.10.041; Waring George, 2007, Trans Am Ophthalmol Soc, V105, P240	56	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66618	10.1371/journal.pone.0066618	http://dx.doi.org/10.1371/journal.pone.0066618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799124	Green Published, gold			2022-12-27	WOS:000321397800044
J	Catchpole, I; Germaschewski, V; Kam, JH; von Leithner, PL; Ford, S; Gough, G; Adamson, P; Overend, P; Hilpert, J; Lopez, FJ; Ng, YSE; Coffey, P; Jeffery, G				Catchpole, Ian; Germaschewski, Volker; Kam, Jaimie Hoh; von Leithner, Peter Lundh; Ford, Susannah; Gough, Gerald; Adamson, Peter; Overend, Philip; Hilpert, Jan; Lopez, Francisco J.; Ng, Yin Shan Eric; Coffey, Pete; Jeffery, Glen			Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; FACTOR-H; BETA; DRUSEN; POLYMORPHISM; PATHOGENESIS; ASSOCIATION; PATHOLOGY; BRAIN	Age-related macular degeneration (AMD) is a leading cause of legal blindness in the Western world. There are effective treatments for the vascular complications of neo-vascular AMD, but no effective therapies are available for the dry/atrophic form of the disease. A previously described transgenic CFH-gene deficient mouse model, (cfh-/-), shows hallmarks of early AMD. The ocular phenotype has been further analysed to demonstrate amyloid beta (A beta) rich basement membrane deposits associated with activated complement C3. Cfh-/- mice were treated systemically in both prophylactic and therapeutic regimes with an anti-A beta monoclonal antibody (mAb), 6F6, to determine the effect on the cfh-/- retinal phenotype. Prophylactic treatment with 6F6 demonstrated a dose dependent reduction in the accumulation of both A beta and activated C3 deposition. A similar reduction in the retinal endpoints could be seen after therapeutic treatment. Serum A beta levels after systemic administration of 6F6 show accumulation of Ab in the periphery suggestive of a peripheral sink mechanism. In summary, anti-A beta mAb treatment can partially prevent or reverse ocular phenotypes of the cfh-/- mouse. The data support this therapeutic approach in humans potentially modulating two key elements in the pathogenesis of AMD - A beta and activated, complement C3.	[Catchpole, Ian; Germaschewski, Volker; Ford, Susannah; Gough, Gerald] Top BioPharm Discovery Res & Dev Unit, King Of Prussia, PA USA; [Kam, Jaimie Hoh; von Leithner, Peter Lundh; Ng, Yin Shan Eric; Coffey, Pete; Jeffery, Glen] UCL, Inst Ophthalmol, London, England; [Catchpole, Ian; Adamson, Peter; Lopez, Francisco J.] GSK Ophthalmol, King Of Prussia, PA USA; [Overend, Philip; Hilpert, Jan] GlaxoSmithKline, BioPharm Discovery Med, Stevenage, Herts, England	University of London; University College London; GlaxoSmithKline; GlaxoSmithKline	Catchpole, I (corresponding author), Top BioPharm Discovery Res & Dev Unit, King Of Prussia, PA USA.	ian.r.catchpole@gsk.com	Ng, Wing Yin/HHN-1743-2022	Ng, Yin Shan/0000-0002-4982-1999; Coffey, Peter/0000-0002-5427-2939	GSK	GSK(GlaxoSmithKline)	JHK, PLvL, PC & GJ received funding from GSK for this work which was performed collaboratively by Institute of Ophthalmology and GSK researchers. The funders were actively involved in study design, some aspects of experimental end point analysis and in rigorous statistical analysis of the data and jointly decided to publish and prepare the manuscript with their academic colleagues.; IC, VG, SF, GG, PA, PO, JH are or were during some stage of this work employed by GSK who funded this study. GSK owns intellectual property on anti-amyloid beta monoclonal antibodies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Baker ML, 2009, ARCH OPHTHALMOL-CHIC, V127, P667, DOI 10.1001/archophthalmol.2009.30; Baumritter A, 2007, ARVO M AG EYE MAY 6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowes Rickman C, 2007, 11 ANN VIS RES C RET; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dentchev T, 2003, MOL VIS, V9, P184; Ding JD, 2008, VISION RES, V48, P339, DOI 10.1016/j.visres.2007.07.025; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hamilton G, 2007, NEUROMOL MED, V9, P331, DOI 10.1007/s12017-007-8013-y; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hoh Kam J, 2012, PATHOGENS TRIG UNPUB; Howlett DR, 2011, EXP BRAIN RES, V214, P185, DOI 10.1007/s00221-011-2819-4; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kam JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013127; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; Klaver CCW, 1999, AM J EPIDEMIOL, V150, P963; Kliffen M, 2000, BRIT J OPHTHALMOL, V84, P1415, DOI 10.1136/bjo.84.12.1415; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Le Fur I, 2010, NEUROBIOL AGING, V31, P165, DOI 10.1016/j.neurobiolaging.2008.03.003; Ling CY, 2008, International Patent Application, Patent No. [WO 2008/110885, 2008110885]; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; Liu TR, 2013, INVEST OPHTHMOL VIS, V54, P2225; LOFFLER KU, 1995, INVEST OPHTH VIS SCI, V36, P24; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Puzzo D, 2013, J ALZHEIMERS DIS, V33, pS111, DOI 10.3233/JAD-2012-129033; Puzzo D, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.020; Rodrigues EB, 2007, OPHTHALMOLOGICA, V221, P143, DOI 10.1159/000099293; Rosenthal A, 2004, International Patent Application, Patent No. [WO 2004/032868, 2004032868]; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Terai K, 2001, NEUROSCIENCE, V104, P299, DOI 10.1016/S0306-4522(01)00095-1; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Wang J, 2008, J IMMUNOL, V181, P16651; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Yang SP, 2004, NEUROBIOL AGING, V25, P283, DOI 10.1016/S0197-4580(03)00111-8; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zetterberg M, 2008, AM J MED GENET B, V147B, P720, DOI 10.1002/ajmg.b.30668; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	49	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65518	10.1371/journal.pone.0065518	http://dx.doi.org/10.1371/journal.pone.0065518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799019	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300020
J	Hernaus, D; Collip, D; Lataster, J; Ceccarini, J; Kenis, G; Booij, L; Pruessner, J; Van Laere, K; van Winkel, R; van Os, J; Myin-Germeys, I				Hernaus, Dennis; Collip, Dina; Lataster, Johan; Ceccarini, Jenny; Kenis, Gunther; Booij, Linda; Pruessner, Jens; Van Laere, Koen; van Winkel, Ruud; van Os, Jim; Myin-Germeys, Inez			COMT Val(158)Met Genotype Selectively Alters Prefrontal [F-18]Fallypride Displacement and Subjective Feelings of Stress in Response to a Psychosocial Stress Challenge	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; POSITRON-EMISSION-TOMOGRAPHY; DOPAMINE RELEASE; F-18 FALLYPRIDE; WORKING-MEMORY; PET; SCHIZOPHRENIA; BINDING; RECEPTOR; SENSITIVITY	Catechol-O-methyltransferase (COMT) plays an essential role in degradation of extracellular dopamine in prefrontal regions of the brain. Although a polymorphism in this gene, COMT Val(158)Met, affects human behavior in response to stress little is known about its effect on dopaminergic activity associated with the human stress response, which may be of interest for stress-related psychiatric disorders such as psychosis. We aimed to investigate the effect of variations in COMT genotype on in vivo measures of stress-induced prefrontal cortex (PFC) dopaminergic processing and subjective stress responses. A combined sample of healthy controls and healthy first-degree relatives of psychosis patients (n = 26) were subjected to an [F-18] fallypride Positron Emission Tomography scan. Psychosocial stress during the scan was induced using the Montreal Imaging Stress Task and subjective stress was assessed every 12 minutes. Parametric t-maps, generated using the linear extension of the simplified reference region model, revealed an effect of COMT genotype on the spatial extent of [F-18] fallypride displacement. Detected effects of exposure to psychosocial stress were unilateral and remained restricted to the left superior and right inferior frontal gyrus, with Met-hetero- and homozygotes showing less [F-18] fallypride displacement than Val-homozygotes. Additionally, Met-hetero- and homozygotes experienced larger subjective stress responses than Val-homozygotes. The direction of the effects remained the same when the data was analyzed separately for controls and first-degree relatives. The human stress response may be mediated in part by COMT-dependent dopaminergic PFC activity, providing speculation for the neurobiology underlying COMT-dependent differences in human behaviour following stress. Implications of these results for stress-related psychopathology and models of dopaminergic functioning are discussed.	[Hernaus, Dennis; Collip, Dina; Lataster, Johan; Kenis, Gunther; van Winkel, Ruud; van Os, Jim; Myin-Germeys, Inez] MHeNS Maastricht Univ, Dept Psychiat & Neuropsychol, South Limburg Mental Hlth Res & Teaching Network, EURON,Sch Mental Hlth & NeuroSci, Maastricht, Netherlands; [Lataster, Johan] Open Univ Netherlands, Fac Psychol, Heerlen, Netherlands; [Ceccarini, Jenny; Van Laere, Koen] Univ Hosp, Div Nucl Med, Louvain, Belgium; [Ceccarini, Jenny; Van Laere, Koen] Catholic Univ Louvain, B-3000 Louvain, Belgium; [Booij, Linda] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Booij, Linda] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Booij, Linda] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Pruessner, Jens] McGill Univ, Dept Psychiat, Douglas Mental Hlth Inst, Montreal, PQ, Canada; [van Winkel, Ruud] Catholic Univ Louvain, Univ Psychiat Ctr, Kortenberg, Belgium; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England	Maastricht University; Open University Netherlands; Universite Catholique Louvain; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite Catholique Louvain; University of London; King's College London	Myin-Germeys, I (corresponding author), MHeNS Maastricht Univ, Dept Psychiat & Neuropsychol, South Limburg Mental Hlth Res & Teaching Network, EURON,Sch Mental Hlth & NeuroSci, Maastricht, Netherlands.	i.germeys@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; Lataster, Johan/S-9462-2017; Ceccarini, Jenny/AAE-5084-2019; Myin-Germeys, Inez/L-5106-2014; Myin Germeys, Inez/HIR-3364-2022; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Ceccarini, Jenny/AAY-9271-2020	van Os, Jim/0000-0002-7245-1586; Lataster, Johan/0000-0003-3889-8154; Myin Germeys, Inez/0000-0002-3731-4930; Ceccarini, Jenny/0000-0003-2774-9516; Hernaus, Dennis/0000-0002-8370-5756; Pruessner, Jens/0000-0002-8582-2980	Dutch Medical Research Council; Fonds de recherche du Quebec-Sante; King Baudouin Foundation; Maastricht University	Dutch Medical Research Council(Danish Medical Research Council); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); King Baudouin Foundation; Maastricht University	Inez Myin-Germeys was supported by a 2006 NARSAD Young Investigator Award and by a VIDI grant from the Dutch Medical Research Council, which were used to cover all costs (materials, personnel) related to the experiment. Koen Van Laere is Senior Clinical Investigator for the Flemish Fund for Scientific Research (FWO). Linda Booij is supported by a career award from the Fonds de recherche du Quebec-Sante. Ruud van Winkel is supported by the King Baudouin Foundation (Fund Dr. Gustave Delport). Dina Collip is supported by a Maastricht University post-doc Kootstra fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Backman L, 2000, AM J PSYCHIAT, V157, P635; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Badgaiyan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028075; Buckert M, 2012, PSYCHONEUROENDOCRINO; Castner SA, 2004, J NEUROSCI, V24, P1446, DOI 10.1523/JNEUROSCI.3987-03.2004; Ceccarini J, 2012, J NUCL MED, V53, P1565, DOI 10.2967/jnumed.111.099416; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; Collip D, 2011, CNS NEUROSCI THER, V17, P612, DOI 10.1111/j.1755-5949.2010.00213.x; Cropley VL, 2008, SYNAPSE, V62, P399, DOI 10.1002/syn.20506; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DEUTCH AY, 1990, BRAIN RES, V521, P311, DOI 10.1016/0006-8993(90)91557-W; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Hirvonen MM, 2010, MOL IMAGING BIOL, V12, P192, DOI 10.1007/s11307-009-0257-5; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jabbi M, 2007, MOL PSYCHIATR, V12, P483, DOI 10.1038/sj.mp.4001975; Karlsson S, 2009, NEUROIMAGE, V48, P398, DOI 10.1016/j.neuroimage.2009.06.030; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lataster J, 2013, SCHIZOPHRENIA B; Lataster J, 2011, NEUROIMAGE, V58, P1081, DOI 10.1016/j.neuroimage.2011.07.030; Lataster T, 2009, ACTA PSYCHIAT SCAND, V119, P45, DOI 10.1111/j.1600-0447.2008.01263.x; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009; Mukherjee J, 2002, SYNAPSE, V46, P170, DOI 10.1002/syn.10128; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Peerbooms O, 2012, ACTA PSYCHIAT SCAND, V125, P247, DOI 10.1111/j.1600-0447.2011.01806.x; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; Scornaiencki R, 2009, INT J NEUROPSYCHOPH, V12, P1195, DOI 10.1017/S1461145709000121; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Slifstein M, 2010, SYNAPSE, V64, P350, DOI 10.1002/syn.20734; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; StataCorp, 2009, STATA SE STAT SOFTW; Stein DJ, 2006, CNS SPECTRUMS, V11, P745, DOI 10.1017/S1092852900014863; Stokes PRA, 2010, NEUROIMAGE, V52, P1521, DOI 10.1016/j.neuroimage.2010.04.274; Tunbridge E, 2004, SYNAPSE, V51, P112, DOI 10.1002/syn.10286; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; van Winkel R, 2008, AM J MED GENET B, V147B, P10, DOI 10.1002/ajmg.b.30559; Vernaleken I, 2011, J CEREBR BLOOD F MET, V31, P1958, DOI 10.1038/jcbfm.2011.73; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Vrieze E, 2011, HUMAN BRAIN MAPPING; Walder DJ, 2010, PSYCHIAT GENET, V20, P166, DOI 10.1097/YPG.0b013e32833a1ff3; Woodward ND, 2011, AM J PSYCHIAT, V168, P418, DOI 10.1176/appi.ajp.2010.10020165; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104; Yoder KK, 2004, J NUCL MED, V45, P903	57	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65662	10.1371/journal.pone.0065662	http://dx.doi.org/10.1371/journal.pone.0065662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799032	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300032
J	Mizuki, T; Sawai, M; Nagaoka, Y; Morimoto, H; Maekawa, T				Mizuki, Toru; Sawai, Miyuki; Nagaoka, Yutaka; Morimoto, Hisao; Maekawa, Toru			Activity of Lipase and Chitinase Immobilized on Superparamagnetic Particles in a Rotational Magnetic Field	PLOS ONE			English	Article							ENZYME-ACTIVITY; NANOPARTICLES; STABILITY	We immobilize hydrolases such as lipase and chitinase on superparamagnetic particles, which are subjected to a rotational magnetic field, and measure the activities of the enzymes. We find that the activities of lipase and chitinase increase in the rotational magnetic field compared to those in the absence of a magnetic field and reach maximum at certain frequencies. The present methodology may well be utilized for the design and development of efficient micro reactors and micro total analysis systems (mu-TASs).	[Mizuki, Toru; Sawai, Miyuki; Nagaoka, Yutaka; Morimoto, Hisao; Maekawa, Toru] Toyo Univ, Bio Nano Elect Res Ctr, Saitama, Japan	Toyo University	Maekawa, T (corresponding author), Toyo Univ, Bio Nano Elect Res Ctr, Saitama, Japan.	maekawa@toyo.jp		Mizuki, Toru/0000-0003-2744-881X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S1101017]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant for the Program for the Strategic Research Foundation at Private Universities S1101017 organized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 1998, J BIOTECHNOL, V60, P37, DOI 10.1016/S0168-1656(97)00179-X; Arica MY, 2000, J MOL CATAL B-ENZYM, V11, P127, DOI 10.1016/S1381-1177(00)00223-X; Chen DH, 2002, J MOL CATAL B-ENZYM, V16, P283, DOI 10.1016/S1381-1177(01)00074-1; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n; Gao C, 2006, J PHYS CHEM B, V110, P7213, DOI 10.1021/jp0602474; Gijs MAM, 2010, CHEM REV, V110, P1518, DOI 10.1021/cr9001929; Grobert N, 1999, APPL PHYS LETT, V75, P3363, DOI 10.1063/1.125352; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; HABERDIT.W, 1967, NATURE, V213, P72, DOI 10.1038/213072a0; Hasumura T, 2011, J NANOPART RES, V13, P53, DOI 10.1007/s11051-010-0142-9; Hayasaki Yasuhiro, 2012, Advances in Natural Sciences: Nanoscience & Nanotechnology, V3, DOI 10.1088/2043-6262/3/3/035010; Ho KM, 2008, LANGMUIR, V24, P11036, DOI 10.1021/la8016529; Kim J, 2006, BIOTECHNOL ADV, V24, P296, DOI 10.1016/j.biotechadv.2005.11.006; Koutsopoulos S, 2004, LANGMUIR, V20, P6401, DOI 10.1021/la049821y; Liao MH, 2001, BIOTECHNOL LETT, V23, P1723, DOI 10.1023/A:1012485221802; Liu XQ, 2005, J CHROMATOGR B, V822, P91, DOI 10.1016/j.jchromb.2005.06.001; Mandal S, 2005, CURR APPL PHYS, V5, P118, DOI 10.1016/j.cap.2004.06.006; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; Mizuki T, 2010, BIOCHEM BIOPH RES CO, V393, P779, DOI 10.1016/j.bbrc.2010.02.081; Morimoto H, 2000, J PHYS A-MATH GEN, V33, P247, DOI 10.1088/0305-4470/33/2/302; Morimoto H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021403; Nagaoka Y, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.032502; Nagaoka Y, 2011, LANGMUIR, V27, P9160, DOI 10.1021/la201156q; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Schmidt-Dannert C, 1999, BIOORGAN MED CHEM, V7, P2123, DOI 10.1016/S0968-0896(99)00141-8; Ukai T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061406; Yang ZP, 2008, BIOCHEM BIOPH RES CO, V367, P169, DOI 10.1016/j.bbrc.2007.12.113	29	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66528	10.1371/journal.pone.0066528	http://dx.doi.org/10.1371/journal.pone.0066528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799111	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300088
J	Sanz-Sanchez, L; Risco, C				Sanz-Sanchez, Laura; Risco, Cristina			Multilamellar Structures and Filament Bundles Are Found on the Cell Surface during Bunyavirus Egress	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; BUNYAMWERA-VIRUS; FEVER VIRUS; ADHESION; GOLGI; FACTORIES; RELEASE; ARCHITECTURE; REPLICATION; ATTACHMENT	Inside cells, viruses build specialized compartments for replication and morphogenesis. We observed that virus release associates with specific structures found on the surface of mammalian cells. Cultured adherent cells were infected with a bunyavirus and processed for oriented sectioning and transmission electron microscopy. Imaging of cell basal regions showed sophisticated multilamellar structures (MLS) and extracellular filament bundles with attached viruses. Correlative light and electron microscopy confirmed that both MLS and filaments proliferated during the maximum egress of new viruses. MLS dimensions and structure were reminiscent of those reported for the nanostructures on gecko fingertips, which are responsible for the extraordinary attachment capacity of these lizards. As infected cells with MLS were more resistant to detachment than control cells, we propose an adhesive function for these structures, which would compensate for the loss of adherence during release of new virus progeny.	[Sanz-Sanchez, Laura; Risco, Cristina] CSIC, CNB, Cell Struct Lab, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Risco, C (corresponding author), CSIC, CNB, Cell Struct Lab, Madrid, Spain.	crisco@cnb.csic.es	Risco, Cristina/K-4308-2014	Risco, Cristina/0000-0001-7501-5934	Spanish Ministry of Education and Science (FPU Program); Spanish Ministry of Economy and Competitiveness [BIO2009-07255]	Spanish Ministry of Education and Science (FPU Program)(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Our gratitude to Dr. Sylvia Gutierrez Erlandsson for expert support with confocal and live cell video microscopy, to Drs. Ines M. Anton, Isidoro Martinez and Richard M. Elliott for providing reagents, and to Catherine Mark for editorial assistance. LSS received a fellowship from the Spanish Ministry of Education and Science (FPU Program). This research was funded by a grant from the Spanish Ministry of Economy and Competitiveness (BIO2009-07255 to C.R.).	Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486; Boesel LF, 2010, ADV MATER, V22, P2125, DOI 10.1002/adma.200903200; Burckhardt CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000621; Connolly-Andersen AM, 2007, J VIROL, V81, P2158, DOI 10.1128/JVI.02070-06; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; de Castro IF, 2013, CELL MICROBIOL, V15, P24, DOI 10.1111/cmi.12029; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Fontana J, 2007, CELL MICROBIOL, V9, P875, DOI 10.1111/j.1462-5822.2006.00837.x; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131; Hemmings DG, 2002, J VIROL, V76, P6710, DOI 10.1128/JVI.76.13.6710-6717.2002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hill GC, 2011, J R SOC INTERFACE, V8, P926, DOI 10.1098/rsif.2010.0720; Hu SH, 2012, SMALL, V8, P2464, DOI 10.1002/smll.201200413; Huber G, 2005, BIOL LETTERS, V1, P2, DOI 10.1098/rsbl.2004.0254; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jouvenet N, 2006, CELL MICROBIOL, V8, P1803, DOI 10.1111/j.1462-5822.2006.00750.x; Kim TW, 2007, ULTRAMICROSCOPY, V107, P902, DOI 10.1016/j.ultramic.2006.11.008; LAPPIN DF, 1994, J GEN VIROL, V75, P3441, DOI 10.1099/0022-1317-75-12-3441; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Lopez-Montero N, 2011, CELL MICROBIOL, V13, P300, DOI 10.1111/j.1462-5822.2010.01536.x; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Novoa RR, 2005, J VIROL, V79, P10852, DOI 10.1128/JVI.79.17.10852-10863.2005; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Reichelt M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002740; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Risco C, 2013, STRUCTURE P IN PRESS; Risco C, 2012, STRUCTURE, V20, P759, DOI 10.1016/j.str.2012.04.001; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Shi XH, 2006, J VIROL, V80, P8089, DOI 10.1128/JVI.00579-06; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103; Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775; van Weering JRT, 2010, METHOD CELL BIOL, V96, P619, DOI 10.1016/S0091-679X(10)96026-3; Weber F, 2001, VIROLOGY, V281, P67, DOI 10.1006/viro.2000.0774; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Zimmer G, 2002, J VIROL, V76, P4103, DOI 10.1128/JVI.76.8.4103-4107.2002	48	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65526	10.1371/journal.pone.0065526	http://dx.doi.org/10.1371/journal.pone.0065526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799021	gold, Green Submitted, Green Published			2022-12-27	WOS:000320363300021
J	Dacheux, E; Vincent, A; Nazaret, N; Combet, C; Wierinckx, A; Mazoyer, S; Diaz, JJ; Lachuer, J; Venezia, ND				Dacheux, Estelle; Vincent, Anne; Nazaret, Nicolas; Combet, Christophe; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla			BRCA1-Dependent Translational Regulation in Breast Cancer Cells	PLOS ONE			English	Article							IRES-MEDIATED TRANSLATION; ACETYL-COA CARBOXYLASE; TRANS-ACTING FACTORS; MESSENGER-RNAS; POLY(A)-BINDING PROTEIN; BRCA1 INTERACTS; TOPOISOMERASE-I; HIPK2; EXPRESSION; CLEAVAGE	BRCA1 (Breast Cancer 1) has been implicated in a number of cellular processes, including transcription regulation, DNA damage repair and protein ubiquitination. We previously demonstrated that BRCA1 interacts with PABP1 (Poly(A)-Binding Protein 1) and that BRCA1 modulates protein synthesis through this interaction. To identify the mRNAs that are translationally regulated by BRCA1, we used a microarray analysis of polysome-bound mRNAs in BRCA1-depleted and non-depleted MCF7 cells. Our findings show that BRCA1 modifies the translational efficiency of approximately 7% of the mRNAs expressed in these cells. Further analysis revealed that several processes contributing to cell surveillance such as cell cycle arrest, cell death, cellular growth and proliferation, DNA repair and gene expression, are largely enriched for the mRNAs whose translation is impacted by BRCA1. The BRCA1-dependent translation of these species of mRNAs therefore uncovers a novel mechanism through which BRCA1 exerts its onco-suppressive role. In addition, the BRCA1-dependent translation of mRNAs participating in unexpected functions such as cellular movement, nucleic acid metabolism or protein trafficking is indicative of novel functions for BRCA1. Finally, this study contributes to the identification of several markers associated with BRCA1 deficiency and to the discovery of new potential anti-neoplastic therapeutic targets.	[Dacheux, Estelle; Vincent, Anne; Combet, Christophe; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Univ Lyon, Lyon, France; [Dacheux, Estelle; Vincent, Anne; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Univ Lyon 1, ISPB, F-69365 Lyon, France; [Dacheux, Estelle; Vincent, Anne; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Dacheux, Estelle; Vincent, Anne; Wierinckx, Anne; Mazoyer, Sylvie; Diaz, Jean-Jacques; Lachuer, Joel; Venezia, Nicole Dalla] Ctr Rech Cancerol Lyon, CNRS, UMR5286, Lyon, France; [Dacheux, Estelle; Vincent, Anne; Mazoyer, Sylvie; Venezia, Nicole Dalla] Equipe Labellisee LIGUE 2008, Lyon, France; [Nazaret, Nicolas; Wierinckx, Anne; Lachuer, Joel] ProfileXpert, Lyon, France; [Combet, Christophe] CNRS, Unite Bases Mol & Struct Systemes Infect, UMR5086, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Venezia, ND (corresponding author), Univ Lyon, Lyon, France.	nicole.dalla-venezia@lyon.unicancer.fr	DIAZ, Jean-Jacques/AAT-3846-2021; DIAZ, Jean-Jacques/H-3018-2014; VENEZIA, Nicole DALLA/C-6542-2017; VINCENT, Anne/X-6761-2019; Mazoyer, Sylvie/N-7559-2017; Wierinckx, Anne/AAF-5233-2021	DIAZ, Jean-Jacques/0000-0002-7914-4319; DIAZ, Jean-Jacques/0000-0002-7914-4319; VENEZIA, Nicole DALLA/0000-0002-4553-3535; VINCENT, Anne/0000-0003-4616-7685; Wierinckx, Anne/0000-0002-0186-6645; Dacheux, Estelle/0000-0001-8713-2185; lachuer, joel/0000-0002-5209-5094; COMBET, Christophe/0000-0002-7348-3520; Mazoyer, Sylvie/0000-0002-2135-0160	'Institut National contre le Cancer' (INCa) (RIBOCAN); 'Ligue Nationale Contre le Cancer'(LNCC) (Equipe labellisee); 'Association pour la Recherche sur le Cancer' (ARC); 'Electricite de France' (EDF) (Commission de Radioprotection); French Ministry of Research; Universite Lyon 1 (Attache Temporaire d'Enseignement et de Recherche)	'Institut National contre le Cancer' (INCa) (RIBOCAN); 'Ligue Nationale Contre le Cancer'(LNCC) (Equipe labellisee); 'Association pour la Recherche sur le Cancer' (ARC)(Fondation ARC pour la Recherche sur le Cancer); 'Electricite de France' (EDF) (Commission de Radioprotection); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Universite Lyon 1 (Attache Temporaire d'Enseignement et de Recherche)	This work was supported by the 'Institut National contre le Cancer' (INCa) (RIBOCAN), the 'Ligue Nationale Contre le Cancer'(LNCC) (Equipe labellisee 2008), the 'Association pour la Recherche sur le Cancer' (ARC) and the 'Electricite de France' (EDF) (Commission de Radioprotection). ED is supported by a fellowship from the French Ministry of Research and from the Universite Lyon 1 (Attache Temporaire d'Enseignement et de Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Beiti MAM, 2008, AUST NZ J OBSTET GYN, V48, P329, DOI 10.1111/j.1479-828X.2008.00874.x; Anh TNL, 2011, J PROTEOMICS, V74, P167, DOI 10.1016/j.jprot.2010.10.007; Belin S., 2010, CURR PROTOC CELL BIO; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Brunet J, 2008, MOL CARCINOGEN, V47, P157, DOI 10.1002/mc.20364; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Dizin E, 2008, APOPTOSIS, V13, P237, DOI 10.1007/s10495-007-0167-4; Dizin E, 2006, J BIOL CHEM, V281, P24236, DOI 10.1074/jbc.M602176200; Fabbro M, 2004, EXP CELL RES, V298, P661, DOI 10.1016/j.yexcr.2004.05.004; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gorski JJ, 2011, NUCLEIC ACIDS RES, V39, P9536, DOI 10.1093/nar/gkr679; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Hakem R, 1998, J MAMMARY GLAND BIOL, V3, P431, DOI 10.1023/A:1018792200700; Hauge H, 2007, GENOMICS, V90, P14, DOI 10.1016/j.ygeno.2007.03.002; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hofmann TG, 2013, BIOESSAYS, V35, P55, DOI 10.1002/bies.201200060; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Kawai T, 2004, MOL CELL BIOL, V24, P6773, DOI 10.1128/MCB.24.15.6773-6787.2004; King HA, 2010, BIOCHEM SOC T, V38, P1581, DOI 10.1042/BST0381581; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Lamber EP, 2010, CANCER RES, V70, P996, DOI 10.1158/0008-5472.CAN-09-2842; Lamy PJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2824; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Laulier C, 2011, CANCER RES, V71, P3590, DOI 10.1158/0008-5472.CAN-10-3119; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lin NU, 2011, J NEURO-ONCOL, V105, P613, DOI 10.1007/s11060-011-0629-y; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; NAGAI MA, 1994, GENE CHROMOSOME CANC, V11, P58, DOI 10.1002/gcc.2870110109; Nousch M, 2007, RNA, V13, P374, DOI 10.1261/rna.372307; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Ortega FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033233; Pesole G, 2000, NUCLEIC ACIDS RES, V28, P193, DOI 10.1093/nar/28.1.193; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Ramaswamy B, 2012, BREAST CANCER RES TR, V132, P1063, DOI 10.1007/s10549-011-1928-x; Ray H, 2006, J MOL BIOL, V359, P973, DOI 10.1016/j.jmb.2006.04.010; Rio PG, 1999, INT J CANCER, V80, P823, DOI 10.1002/(SICI)1097-0215(19990315)80:6<823::AID-IJC5>3.0.CO;2-3; Rivera CI, 2008, VIROLOGY, V375, P59, DOI 10.1016/j.virol.2008.02.002; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang H, 2010, CANCER RES, V70, P6258, DOI 10.1158/0008-5472.CAN-09-4713; Warmoes M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013334; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Yang ES, 2010, FEBS J, V277, P3079, DOI 10.1111/j.1742-4658.2010.07734.x; Zhu XG, 2010, CURR OPIN ENDOCRINOL, V17, P408, DOI 10.1097/MED.0b013e32833d6d46	63	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67313	10.1371/journal.pone.0067313	http://dx.doi.org/10.1371/journal.pone.0067313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805307	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500135
J	Meli, R; Raso, GM; Irace, C; Simeoli, R; Di Pascale, A; Paciello, O; Pagano, TB; Calignano, A; Colonna, A; Santamaria, R				Meli, Rosaria; Raso, Giuseppina Mattace; Irace, Carlo; Simeoli, Raffaele; Di Pascale, Antonio; Paciello, Orlando; Pagano, Teresa Bruna; Calignano, Antonio; Colonna, Alfredo; Santamaria, Rita			High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats	PLOS ONE			English	Article							REGULATORY PROTEINS; INSULIN-RESISTANCE; MESSENGER-RNA; HEPCIDIN; DISEASE; INFLAMMATION; HOMEOSTASIS; FERRITIN; RECEPTOR; STEATOHEPATITIS	This paper is dedicated to the memory of our wonderful colleague Professor Alfredo Colonna, who passed away the same day of its acceptance. Fatty liver accumulation, inflammatory process and insulin resistance appear to be crucial in non-alcoholic fatty liver disease (NAFLD), nevertheless emerging findings pointed an important role also for iron overload. Here, we investigate the molecular mechanisms of hepatic iron metabolism in the onset of steatosis to understand whether its impairment could be an early event of liver inflammatory injury. Rats were fed with control diet or high fat diet (HFD) for 5 or 8 weeks, after which liver morphology, serum lipid profile, transaminases levels and hepatic iron content (HIC), were evaluated. In liver of HFD fed animals an increased time-dependent activity of iron regulatory protein 1 (IRP1) was evidenced, associated with the increase in transferrin receptor-1 (TfR1) expression and ferritin down-regulation. Moreover, ferroportin (FPN-1), the main protein involved in iron export, was down-regulated accordingly with hepcidin increase. These findings were indicative of an increased iron content into hepatocytes, which leads to an increase of harmful free-iron also related to the reduction of hepatic ferritin content. The progressive inflammatory damage was evidenced by the increase of hepatic TNF-alpha, IL-6 and leptin, in parallel to increased iron content and oxidative stress. The major finding that emerged of this study is the impairment of iron homeostasis in the ongoing and sustaining of liver steatosis, suggesting a strong link between iron metabolism unbalance, inflammatory damage and progression of disease.	[Meli, Rosaria; Raso, Giuseppina Mattace; Irace, Carlo; Simeoli, Raffaele; Di Pascale, Antonio; Calignano, Antonio; Colonna, Alfredo; Santamaria, Rita] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Paciello, Orlando; Pagano, Teresa Bruna] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Meli, R (corresponding author), Univ Naples Federico II, Dept Pharm, Naples, Italy.	meli@unina.it; alfcolon@unina.it	Calignano, Antonio/K-2542-2018; Simeoli, Raffaele/J-1101-2018	Simeoli, Raffaele/0000-0002-3989-7703; CALIGNANO, Antonio/0000-0002-1742-3179; Mattace Raso, Giuseppina/0000-0002-5254-139X; Meli, Rosaria/0000-0002-6246-6813	Ministero dell'Istruzione, dell'Universita e della Rierca, Progetti di ricerca di interesse nazionale, Italy [prot. 2003060394-002]	Ministero dell'Istruzione, dell'Universita e della Rierca, Progetti di ricerca di interesse nazionale, Italy	This study was partially supported by a grant from the Ministero dell'Istruzione, dell'Universita e della Rierca, Progetti di ricerca di interesse nazionale (prot. 2003060394-002), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; Baynes RD, 1996, CLIN BIOCHEM, V29, P209, DOI 10.1016/0009-9120(96)00010-K; Chitturi Shivakumar, 2003, Curr Gastroenterol Rep, V5, P18, DOI 10.1007/s11894-003-0005-y; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Imeryuz N, 2007, J HEPATOL, V47, P851, DOI 10.1016/j.jhep.2007.06.018; Irace C, 2005, J NEUROCHEM, V95, P1321, DOI 10.1111/j.1471-4159.2005.03449.x; ITAYA K, 1965, J LIPID RES, V6, P16; Kirsch R, 2006, LIVER INT, V26, P1258, DOI 10.1111/j.1478-3231.2006.01329.x; Maffettone C, 2008, J CELL BIOCHEM, V104, P213, DOI 10.1002/jcb.21618; Maffettone C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010163; McCord JM, 1998, SEMIN HEMATOL, V35, P5; Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Pietrangelo A, 2009, CURR OPIN GASTROEN, V25, P209, DOI 10.1097/MOG.0b013e328329e13d; Raso GM, 2009, BIOCHEM PHARMACOL, V78, P1001, DOI 10.1016/j.bcp.2009.05.034; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Scheuer PJ, 2006, LIVER BIOPSY INTERPR, P304; Sebastiani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025138; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Trombini P, 2007, J HEPATOL, V46, P549, DOI 10.1016/j.jhep.2007.01.004; Turlin B, 2001, AM J CLIN PATHOL, V116, P263; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825	39	67	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66570	10.1371/journal.pone.0066570	http://dx.doi.org/10.1371/journal.pone.0066570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805238	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500066
J	Ogunjimi, B; Van Damme, P; Beutels, P				Ogunjimi, Benson; Van Damme, Pierre; Beutels, Philippe			Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review	PLOS ONE			English	Article							AUSTRALIAN GENERAL-PRACTICE; VARICELLA VACCINE COVERAGE; HEALTH-CARE WORKERS; IMMUNE-RESPONSES; INCREASING FREQUENCY; VIRUS; IMPACT; EPIDEMIOLOGY; DISEASE; ADULTS	Varicella-zoster virus (VZV) causes chickenpox and may subsequently reactivate to cause herpes zoster later in life. The exogenous boosting hypothesis states that re-exposure to circulating VZV can inhibit VZV reactivation and consequently also herpes zoster in VZV-immune individuals. Using this hypothesis, mathematical models predicted widespread chickenpox vaccination to increase herpes zoster incidence over more than 30 years. Some countries have postponed universal chickenpox vaccination, at least partially based on this prediction. After a systematic search and selection procedure, we analyzed different types of exogenous boosting studies. We graded 13 observational studies on herpes zoster incidence after widespread chickenpox vaccination, 4 longitudinal studies on VZV immunity after re-exposure, 9 epidemiological risk factor studies, 7 mathematical modeling studies as well as 7 other studies. We conclude that exogenous boosting exists, although not for all persons, nor in all situations. Its magnitude is yet to be determined adequately in any study field.	[Ogunjimi, Benson; Beutels, Philippe] Univ Antwerp, Ctr Hlth Econ Res & Modeling Infect Dis, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Ogunjimi, Benson] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Van Damme, Pierre] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium; [Beutels, Philippe] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of Antwerp; Hasselt University; University of Antwerp; University of New South Wales Sydney	Ogunjimi, B (corresponding author), Univ Antwerp, Ctr Hlth Econ Res & Modeling Infect Dis, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium.	benson.ogunjimi@ua.ac.be	Beutels, Philippe/A-1919-2010; van damme, pierre/I-4846-2013; Ogunjimi, Benson/AGK-8323-2022; Ogunjimi, Benson/G-2606-2011	Beutels, Philippe/0000-0001-5034-3595; van damme, pierre/0000-0002-8642-1249; Ogunjimi, Benson/0000-0002-0831-2063	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	BO thanks the Research Foundation Flanders (FWO) for the financial support he has received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVIN AM, 1983, J INFECT DIS, V148, P200, DOI 10.1093/infdis/148.2.200; BERGER R, 1981, INFECT IMMUN, V32, P24, DOI 10.1128/IAI.32.1.24-27.1981; Bilcke J, 2012, EPIDEMIOL INFECT, V140, P2096, DOI 10.1017/S0950268811002640; Bonmarin I, 2008, REV EPIDEMIOL SANTE, V56, P323, DOI 10.1016/j.respe.2008.07.087; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Brisson M, 2010, VACCINE, V28, P3385, DOI 10.1016/j.vaccine.2010.02.079; Carville KS, 2012, EPIDEMIOL INFECT, V140, P599, DOI 10.1017/S095026881100149X; Carville KS, 2010, VACCINE, V28, P2532, DOI 10.1016/j.vaccine.2010.01.036; Chao DY, 2012, EPIDEMIOL INFECT, V140, P1131, DOI 10.1017/S0950268811001786; Chaves SS, 2008, J INFECT DIS, V197, pS127, DOI 10.1086/522150; Chaves SS, 2007, NEW ENGL J MED, V356, P1121, DOI 10.1056/NEJMoa064040; Chaves SS, 2007, PUBLIC HEALTH REP, V122, P155, DOI 10.1177/003335490712200204; Donahue JG, 2010, AM J PUBLIC HEALTH, V100, P1116, DOI 10.2105/AJPH.2009.160002; Gaillat J, 2012, CLIN INFECT DIS, V54, P306, DOI 10.1093/cid/cir843; Gaillat J, 2011, CLIN INFECT DIS, V53, P405, DOI 10.1093/cid/cir436; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; GERSHON AA, 1982, PEDIATR INFECT DIS J, V1, P164, DOI 10.1097/00006454-198205000-00007; GERSHON AA, 1990, J INFECT DIS, V161, P661, DOI 10.1093/infdis/161.4.661; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Grant KA, 2010, MED J AUSTRALIA, V193, P483, DOI 10.5694/j.1326-5377.2010.tb04009.x; Heywood AE, 2011, MED J AUSTRALIA, V194, P268, DOI 10.5694/j.1326-5377.2011.tb02965.x; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Jardine A, 2011, EPIDEMIOL INFECT, V139, P658, DOI 10.1017/S0950268810001949; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Lasserre A, 2012, J CLIN VIROL, V55, P153, DOI 10.1016/j.jcv.2012.06.020; Lenders K, 2010, J IMMUNOL METHODS, V357, P51, DOI 10.1016/j.jim.2010.03.001; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Levin MJ, 2003, J INFECT DIS, V188, P1336, DOI 10.1086/379048; LEVIN MJ, 1994, J INFECT DIS, V170, P522, DOI 10.1093/infdis/170.3.522; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MILLER AE, 1980, NEUROLOGY, V30, P582, DOI 10.1212/WNL.30.6.582; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Nelson MR, 2010, MED J AUSTRALIA, V193, P110, DOI 10.5694/j.1326-5377.2010.tb03818.x; Ogunjimi B, 2014, J MED VIROL, V86, P812, DOI 10.1002/jmv.23749; Ogunjimi B, 2012, CLIN INFECT DIS, V54, P305, DOI 10.1093/cid/cir841; Ogunjimi B, 2011, VIRAL IMMUNOL, V24, P151, DOI 10.1089/vim.2010.0031; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Patel MS, 2008, INFECT CONT HOSP EP, V29, P1157, DOI 10.1086/591975; Porru S, 2007, G Ital Med Lav Ergon, V29, P407; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Saadatian-Elahi M, 2007, EUR J EPIDEMIOL, V22, P405, DOI 10.1007/s10654-007-9136-z; Salleras M, 2011, VACCINE, V29, P7602, DOI 10.1016/j.vaccine.2011.08.023; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; Smith JG, 2001, CLIN DIAGN LAB IMMUN, V8, P871, DOI 10.1128/CDLI.8.5.871-879.2001; Solomon BA, 1998, J AM ACAD DERMATOL, V38, P763, DOI 10.1016/S0190-9622(98)70207-5; Tanuseputro P, 2011, VACCINE, V29, P8580, DOI 10.1016/j.vaccine.2011.09.024; TERADA K, 1993, SCAND J INFECT DIS, V25, P775, DOI 10.3109/00365549309008578; Terada K, 2000, J MED VIROL, V62, P46, DOI 10.1002/1096-9071(200009)62:1&lt;46::AID-JMV8&gt;3.0.CO;2-Y; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Toyama N, 2009, J MED VIROL, V81, P2053, DOI 10.1002/jmv.21599; Valdarchi C, 2008, SCAND J INFECT DIS, V40, P943, DOI 10.1080/00365540802308449; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; Vossen MTM, 2004, J INFECT DIS, V190, P72, DOI 10.1086/421277; Wu CY, 2010, J DERMATOL, V37, P463, DOI 10.1111/j.1346-8138.2010.00804.x; Yavuz T, 2005, JPN J INFECT DIS, V58, P383; Yih WK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-68	61	80	81	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66485	10.1371/journal.pone.0066485	http://dx.doi.org/10.1371/journal.pone.0066485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805224	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500052
J	Wedellova, Z; Kovacova, Z; Tencerova, M; Vedral, T; Rossmeislova, L; Siklova-Vitkova, M; Stich, V; Polak, J				Wedellova, Zuzana; Kovacova, Zuzana; Tencerova, Michaela; Vedral, Tomas; Rossmeislova, Lenka; Siklova-Vitkova, Michaela; Stich, Vladimir; Polak, Jan			The Impact of Full-Length, Trimeric and Globular Adiponectin on Lipolysis in Subcutaneous and Visceral Adipocytes of Obese and Non-Obese Women	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE LIPOLYSIS; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; MULTIMERIC COMPLEXES; MOUSE ADIPOCYTES; WEIGHT-LOSS; TNF-ALPHA; KAPPA-B	Contribution of individual adiponectin isoforms to lipolysis regulation remains unknown. We investigated the impact of full-length, trimeric and globular adiponectin isoforms on spontaneous lipolysis in subcutaneous abdominal (SCAAT) and visceral adipose tissues (VAT) of obese and non-obese subjects. Furthermore, we explored the role of AMPK (5'-AMP-activated protein kinase) in adiponectin-dependent lipolysis regulation and expression of adiponectin receptors type 1 and 2 (AdipoR1 and AdipoR2) in SCAAT and VAT. Primary adipocytes isolated from SCAAT and VAT of obese and non-obese women were incubated with 20 mu g/ml of: A) full-length adiponectin (physiological mixture of all adiponectin isoforms), B) trimeric adiponectin isoform or C) globular adiponectin isoform. Glycerol released into media was used as a marker of lipolysis. While full-length adiponectin inhibited lipolysis by 22% in non-obese SCAAT, globular isoform inhibited lipolysis by 27% in obese SCAAT. No effect of either isoform was detected in non-obese VAT, however trimeric isoform inhibited lipolysis by 21% in obese VAT (all p<0.05). Trimeric isoform induced Thr172 p-AMPK in differentiated preadipocytes from a non-obese donor, while globular isoform induced Ser79 p-ACC by 32% (p<0.05) and Ser565 p-HSL by 52% (p = 0.08) in differentiated preadipocytes from an obese donor. AdipoR2 expression was 17% and 37% higher than AdipoR1 in SCAAT of obese and non-obese groups and by 23% higher in VAT of obese subjects (all p<0.05). In conclusion, the anti-lipolytic effect of adiponectin isoforms is modified with obesity: while full-length adiponectin exerts anti-lipolytic action in non-obese SCAAT, globular and trimeric isoforms show anti-lipolytic activity in obese SCAAT and VAT, respectively.	[Wedellova, Zuzana; Kovacova, Zuzana; Tencerova, Michaela; Siklova-Vitkova, Michaela; Stich, Vladimir; Polak, Jan] Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic; [Wedellova, Zuzana; Polak, Jan] Univ Hosp Kralovske Vinohrady, Dept Internal Med 2, Prague, Czech Republic; [Vedral, Tomas] Univ Hosp Kralovske Vinohrady, Dept Gen Surg, Prague, Czech Republic; [Rossmeislova, Lenka; Stich, Vladimir] Charles Univ Prague, Fac Med 3, Francoczech Lab Clin Res Obes, Prague, Czech Republic; [Rossmeislova, Lenka; Stich, Vladimir] Charles Univ Prague, INSERM Unite 586, Prague, Czech Republic; [Polak, Jan] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA	Charles University Prague; University Hospital Vinohrady; University Hospital Vinohrady; Charles University Prague; Charles University Prague; Johns Hopkins University	Polak, J (corresponding author), Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic.	jan.polak@lf3.cuni.cz	Siklova, Michaela/G-6939-2015; Rossmeislová, Lenka/D-1931-2013; Tencerova, Michaela/G-8089-2017; Polak, Jan/J-3404-2014	Siklova, Michaela/0000-0003-0489-1069; Rossmeislová, Lenka/0000-0002-7611-7585; Tencerova, Michaela/0000-0001-8670-425X; Polak, Jan/0000-0001-9964-652X	Grant Agency of Charles University in Prague [1269/08/C/2008]; Research Project of the Czech Ministry of Education [MSM 0021620814]	Grant Agency of Charles University in Prague; Research Project of the Czech Ministry of Education	The study was supported by the grant of The Grant Agency of Charles University in Prague 1269/08/C/2008 and by the Research Project of the Czech Ministry of Education MSM 0021620814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addabbo F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1143, DOI 10.1152/ajpendo.00208.2011; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; Bluher M, 2007, DIABETES CARE, V30, P3110, DOI 10.2337/dc07-1257; Chedid P, 2012, AM J PATHOL, V180, P682, DOI 10.1016/j.ajpath.2011.10.013; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Dostalova I, 2009, REGUL PEPTIDES, V155, P156, DOI 10.1016/j.regpep.2009.03.008; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; GARTON AJ, 1990, EUR J BIOCHEM, V191, P245, DOI 10.1111/j.1432-1033.1990.tb19116.x; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kim JE, 2010, J ENDOCRINOL, V207, P35, DOI 10.1677/JOE-10-0093; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Kolditz CI, 2010, CURR OPIN CLIN NUTR, V13, P377, DOI 10.1097/MCO.0b013e32833bed6a; Kovacova Z, 2011, INT J OBES LOND, V36, P1360; Kovacova Z, 2009, EUR J ENDOCRINOL, V160, P585, DOI 10.1530/EJE-08-0727; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Nannipieri M, 2007, INT J OBESITY, V31, P1843, DOI 10.1038/sj.ijo.0803676; OPIE LH, 1963, NEW ENGL J MED, V268, P757, DOI 10.1056/NEJM196304042681404; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Polak J, 2007, CLIN SCI, V112, P557, DOI 10.1042/CS20060296; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wedellova Z, 2011, PHYSIOL RES, V60, P139, DOI 10.33549/physiolres.931863; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Xiao XH, 2011, ENDOCRINE, V40, P386, DOI 10.1007/s12020-011-9531-9; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zhang HR, 2010, WORLD J CARDIOL, V2, P370, DOI 10.4330/wjc.v2.i11.370	46	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66783	10.1371/journal.pone.0066783	http://dx.doi.org/10.1371/journal.pone.0066783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805277	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500105
J	Parker, NH; Donninger, H; Birrer, MJ; Leaner, VD				Parker, Nina Holderness; Donninger, Howard; Birrer, Michael J.; Leaner, Virna D.			p21-Activated Kinase 3 (PAK3) Is an AP-1 Regulated Gene Contributing to Actin Organisation and Migration of Transformed Fibroblasts	PLOS ONE			English	Article							C-JUN ACTIVATION; CELL-MIGRATION; PROTEIN-KINASE; STRESS FIBERS; GROWTH-FACTOR; RAT-1A CELLS; EXPRESSION; CANCER; PROLIFERATION; TARGET	Activating Protein 1 (AP-1) plays a vital role in cell proliferation, differentiation and apoptosis. While de-regulation of AP-1 has been linked to many cancers, little is known regarding its downstream transcriptional targets that associate with cellular transformation. Previous studies identified PAK3, a serine/threonine kinase, as a potential AP-1 target gene. PAK3 has been implicated in a variety of pathological disorders and over-expression of other PAK-family members has been linked to cancer. In this study, we investigate AP-1 regulation of PAK3 expression and the role of PAK3 in cJun/AP-1-associated cellular transformation. Our results showed elevated PAK3 expression at both the mRNA and protein level in cJun-over-expressing Rat1a fibroblasts, as well as in transformed human fibroblasts. Elevated PAK3 expression in cJun/AP-1 over-expressing cells associated with a significant increase in PAK3 promoter activation. This increased promoter activity was lost when a single putative Jun binding site, which can bind AP-1 directly both in vitro and in vivo, was mutated. Further, inhibition of PAK3 using siRNA showed a regression in the cell morphology, migratory potential and actin organisation associated with AP-1 transformed cells. Our study is a first to describe a role for AP-1 in regulating PAK3 expression and suggest that PAK3 is an AP-1 target required for actin organization and migration observed in transformed cells.	[Parker, Nina Holderness; Leaner, Virna D.] Univ Cape Town, Div Med Biochem, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Donninger, Howard] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA; [Birrer, Michael J.] Harvard Univ, Massachusetts Gen Hosp, Gillette Ctr Gynecol Oncol, Gynecol Canc Res Program,Med Sch, Boston, MA 02115 USA	University of Cape Town; University of Louisville; Harvard University; Harvard Medical School; Massachusetts General Hospital	Leaner, VD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Gillette Ctr Gynecol Oncol, Gynecol Canc Res Program,Med Sch, Boston, MA 02115 USA.	Virna.Leaner@uct.ac.za	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660	University of Cape Town/Carnegie Corporation of New York Development Grants; Medical Research Council (SA)	University of Cape Town/Carnegie Corporation of New York Development Grants; Medical Research Council (SA)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by grants from the University of Cape Town/Carnegie Corporation of New York Development Grants, the Medical Research Council (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453; Baek SH, 2012, FEBS LETT, V586, P772, DOI 10.1016/j.febslet.2012.01.061; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Bamberger AM, 2001, J CANCER RES CLIN, V127, P545, DOI 10.1007/s004320100255; Berezikov E, 2004, GENOME RES, V14, P170; Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200; Cohen SB, 2001, ONCOGENE, V20, P141, DOI 10.1038/sj.onc.1204077; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Houghton SG, 2006, SURGERY, V139, P1, DOI 10.1016/j.surg.2005.02.010; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Kinoshita I, 2003, ONCOGENE, V22, P2710, DOI 10.1038/sj.onc.1206371; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leaner VD, 2003, ONCOGENE, V22, P5619, DOI 10.1038/sj.onc.1206644; Liu RX, 2010, ENDOCRINE, V38, P38, DOI 10.1007/s12020-010-9324-6; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Maritz MF, 2011, BIOL CHEM, V392, P439, DOI 10.1515/BC.2011.036; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737; Meng JS, 2005, J NEUROSCI, V25, P6641, DOI 10.1523/JNEUROSCI.0028-05.2005; Neyns B, 1996, ONCOGENE, V12, P1247; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oya M, 2005, J UROLOGY, V174, P726, DOI 10.1097/01.ju.0000164656.99251.77; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rinehart-Kim J, 2000, INT J CANCER, V88, P180, DOI 10.1002/1097-0215(20001015)88:2<180::AID-IJC6>3.0.CO;2-H; Risse-Hackl G, 1998, ONCOGENE, V16, P3057, DOI 10.1038/sj.onc.1201845; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; Sells MA, 1998, J BIOL CHEM, V273, P18490, DOI 10.1074/jbc.273.29.18490; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wang HLL, 2002, INT J CANCER, V101, P301, DOI 10.1002/ijc.10630; Wang J, 1999, J BIOL CHEM, V274, P31641, DOI 10.1074/jbc.274.44.31641; WATTS RG, 1995, MOL CARCINOGEN, V13, P27, DOI 10.1002/mc.2940130106; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866	46	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66892	10.1371/journal.pone.0066892	http://dx.doi.org/10.1371/journal.pone.0066892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818969	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800107
J	Zhang, M; Wei, J; Shan, H; Wang, H; Zhu, YH; Xue, JH; Lin, L; Yan, R				Zhang, Ming; Wei, Jin; Shan, Hu; Wang, Hao; Zhu, Yanhe; Xue, Jiahong; Lin, Lin; Yan, Rui			Calreticulin-STAT3 Signaling Pathway Modulates Mitochondrial Function in a Rat Model of Furazolidone-Induced Dilated Cardiomyopathy	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXYGEN SPECIES PRODUCTION; AVIAN MODEL; ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; PROGNOSTIC VALUE; HEART-FAILURE; STAT3; CALCIUM; MICE	Background: Calreticulin is a Ca2+-binding chaperone of the endoplasmic reticulum which regulates the signal transducer and activator of transcription 3 (STAT3). The effects of the calreticulin-STAT3 signaling pathway on cardiac mitochondria and on the progress of dilated cardiomyopathy (DCM) are still unclear. Methods and Results: The DCM model was generated in rats by the daily oral administration of furazolidone. Echocardiographic and hemodynamic studies demonstrated enlarged LV dimensions and reduced systolic and diastolic functions at thirty weeks after the first furazolidone administration. Morphometric analysis showed significant myocardial degeneration, interstitial fibrosis, and mitochondrial swelling with fractured or dissolved cristae in the model group. Compared with the control group, the mitochondrial membrane potential (MMP) level of the freshly isolated cardiac mitochondria and the enzyme activities of cytochrome c oxidase and succinate dehydrogenase in the model group were significantly decreased (P<0.05). Real-time PCR and western-blot revealed the increased expression of calreticulin associated with decreased activity of STAT3 in the model group. When cultured neonatal rat cardiomyocytes were exposed to furazolidone, a dose-dependent decrease in cell viability and MMP, and the increase of apoptosis rate were observed. The mRNA and protein expression of CRT gradually increased with the increase of furazolidone concentration, associated with a gradual decrease of the STAT3 phosphorylation level both in the whole cell and mitochondrial fraction. When calreticulin was knocked down with siRNA in cardiomyocytes, these changes of cardiomyocytes and mitochondria induced by furazolidone were significantly attenuated. Conclusions: A rat model of DCM induced by furazolidone is successfully established. The calreticulin-STAT3 signaling pathway is involved in cardiac mitochondrial injury and the progress of furazolidone induced DCM.	[Zhang, Ming; Wei, Jin; Shan, Hu; Zhu, Yanhe; Xue, Jiahong; Lin, Lin; Yan, Rui] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Xian 710049, Shaanxi, Peoples R China; [Wang, Hao] Wake Forest Univ, Sch Med, Dept Anesthesiol, Winston Salem, NC 27109 USA	Xi'an Jiaotong University; Wake Forest University	Wei, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, Xian 710049, Shaanxi, Peoples R China.	weijindr@163.com		Wang, Hao/0000-0003-1537-661X	Science and Technology Projects of Shaanxi Province [2007K13-03]; National Natural Science Foundation of China [81170209, 81100210]	Science and Technology Projects of Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Science and Technology Projects of Shaanxi Province (No. 2007K13-03 to J.W.), and grants from National Natural Science Foundation of China (No. 81170209 to J.W. and No. 81100210 to J.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Deisher T A, 1995, Am J Cardiovasc Pathol, V5, P79; Du XL, 2009, ONCOGENE, V28, P3714, DOI 10.1038/onc.2009.237; Dujardin KS, 1998, AM J CARDIOL, V82, P1071, DOI 10.1016/S0002-9149(98)00559-1; Goedel-Meinen L, 2001, AM J CARDIOL, V87, P809, DOI 10.1016/S0002-9149(00)01514-9; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; HAJJAR RJ, 1993, CARDIOVASC RES, V27, P2212, DOI 10.1093/cvr/27.12.2212; Hattori K, 2007, MOL GENET METAB, V91, P285, DOI 10.1016/j.ymgme.2007.02.003; Hilfiker-Kleiner D, 2005, PHARMACOL THERAPEUT, V107, P131, DOI 10.1016/j.pharmthera.2005.02.003; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; JENSEN RA, 1984, J CARDIOVASC PHARM, V6, P186; Kim CS, 2000, J COMP PHYSIOL B, V170, P295, DOI 10.1007/s003600000103; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lee KS, 2011, CELL SIGNAL, V23, P1100, DOI 10.1016/j.cellsig.2011.01.006; Lim S, 2008, MOL CELLS, V25, P390; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Nozynski J, 2009, TRANSPL P, V41, P3171, DOI 10.1016/j.transproceed.2009.09.030; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; POWERS MD, 1983, POULTRY SCI, V62, P1850, DOI 10.3382/ps.0621850; Recchia FA, 2007, VET RES COMMUN, V31, P35, DOI 10.1007/s11259-007-0005-8; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu T, 2010, GERIATR GERONTOL INT, V10, pS70, DOI 10.1111/j.1447-0594.2010.00604.x; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; Suzuki O, 2011, P JPN ACAD B-PHYS, V87, P550, DOI 10.2183/pjab.87.550; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Toyoda Y, 1998, J THORAC CARDIOV SUR, V115, P1367, DOI 10.1016/S0022-5223(98)70221-1; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wu YM, 2004, J MOL CELL CARDIOL, V37, P111, DOI 10.1016/j.yjmcc.2004.04.010; Yoo KJ, 2000, CIRCULATION, V102, P204; Yu HC, 2011, HEPATOLOGY, V54, P979, DOI 10.1002/hep.24469	41	19	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66779	10.1371/journal.pone.0066779	http://dx.doi.org/10.1371/journal.pone.0066779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818963	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800100
J	Eichler, TW; Totland, C; Haugen, M; Qvale, TH; Mazengia, K; Storstein, A; Haukanes, BI; Vedeler, CA				Eichler, Tilo W.; Totland, Cecilie; Haugen, Mette; Qvale, Tor H.; Mazengia, Kibret; Storstein, Anette; Haukanes, Bjorn I.; Vedeler, Christian A.			CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration	PLOS ONE			English	Article							YO ANTIBODIES; DISORDERS; AVIDITY	Objective: Yo antibodies are associated with paraneoplastic cerebellar degeneration (PCD). We have characterized Yo sera by measuring CDR2 and CDR2L antibodies and the localization of their antigens. Methods: Forty-two Yo sera from patients with paraneoplastic neurological syndromes (PNS), 179 sera from ovarian and 114 sera from breast cancer patients without PNS and 100 blood donors were screened for CDR2 and CDR2L antibodies by radioactive immune assay (RIA). Fluorescence microscopy was also used to determine the presence of CDR2 or CDR2L antibodies by staining of HeLa cells transfected with CDR2 or CDR2L fused to green fluorescent protein (GFP). Confocal microscopy was further used to localize the CDR2 and CDR2L proteins. Results: RIA showed that 36 of the 42 Yo positive sera contained CDR2 and CDR2L antibodies whereas 6 sera contained only CDR2 antibodies. Five of the ovarian cancer patients had CDR2L antibodies and 4 of the breast cancer patients had either CDR2 or CDR2L antibodies. Only patients with both antibodies had PCD. RIA and staining of transfected cells showed similar results. Yo antibodies were not present in the 100 blood donors. Confocal microscopy showed that CDR2 and CDR2L were localized to the cytoplasm, whereas CDR2L was also present on the cell membrane. Interpretation: Yo sera usually contain CDR2 and CDR2L antibodies and both antibodies are associated with PCD. Since only CDR2L is localized to the cell membrane it is likely that CDR2L antibodies may be of primary pathogenic importance for the development of PCD.	[Eichler, Tilo W.; Totland, Cecilie; Qvale, Tor H.; Mazengia, Kibret; Vedeler, Christian A.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Haugen, Mette; Storstein, Anette; Vedeler, Christian A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Haukanes, Bjorn I.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Eichler, TW (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	tilo.eichler@helse-bergen.no		Haukanes, Bjorn Ivar/0000-0003-1559-3366	Western Norway Regional Health Authority (Helse Vest); University of Bergen	Western Norway Regional Health Authority (Helse Vest); University of Bergen	The Western Norway Regional Health Authority (Helse Vest) and the University of Bergen supported the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Bittins CM, 2010, CELL MOL NEUROBIOL, V30, P369, DOI 10.1007/s10571-009-9459-2; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Greenlee JE, 2010, J NEUROPATH EXP NEUR, V69, P997, DOI 10.1097/NEN.0b013e3181f0c82b; Hida C TTAHYT, 1994, ARCH NEUROL-CHICAGO, V51, P555; Monstad SE, 2006, CLIN EXP IMMUNOL, V144, P53, DOI 10.1111/j.1365-2249.2006.03031.x; Monstad SE, 2009, CANCER IMMUNOL IMMUN, V58, P1797, DOI 10.1007/s00262-009-0690-y; O'Donovan KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010045; Rossi CL, 1998, DIAGN MICR INFEC DIS, V30, P25, DOI 10.1016/S0732-8893(97)00194-6; Storstein A, 2009, ACTA NEUROL SCAND, V120, P64, DOI 10.1111/j.1600-0404.2008.01138.x; Storstein A, 2011, J NEUROIMMUNOL, V232, P166, DOI 10.1016/j.jneuroim.2010.10.009; Totland C, 2007, J NEUROIMMUNOL, V185, P162, DOI 10.1016/j.jneuroim.2007.01.016; Totland C, 2011, CANCER IMMUNOL IMMUN, V60, P283, DOI 10.1007/s00262-010-0943-9; Vincent A, 2008, NEUROL INDIA, V56, P305, DOI 10.4103/0028-3886.43449; Vincent A, 2010, CURR OPIN NEUROL, V23, P144, DOI 10.1097/WCO.0b013e32833735fe	16	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66002	10.1371/journal.pone.0066002	http://dx.doi.org/10.1371/journal.pone.0066002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823982	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400046
J	Ferraguti, M; Martinez-de La Puente, J; Munoz, J; Roiz, D; Ruiz, S; Soriguer, R; Figuerola, J				Ferraguti, Martina; Martinez-de la Puente, Josue; Munoz, Joaquin; Roiz, David; Ruiz, Santiago; Soriguer, Ramon; Figuerola, Jordi			Avian Plasmodium in Culex and Ochlerotatus Mosquitoes from Southern Spain: Effects of Season and Host-Feeding Source on Parasite Dynamics	PLOS ONE			English	Article							CYTOCHROME-B LINEAGES; WEST-NILE-VIRUS; MALARIA PARASITES; DIPTERA-CULICIDAE; BLOOD PARASITES; EVOLUTIONARY RELATIONSHIPS; VECTOR COMPETENCE; TRANSMISSION; HAEMOPROTEUS; ASSOCIATIONS	Haemosporidians, a group of vector-borne parasites that include Plasmodium, infect vertebrates including birds. Although mosquitoes are crucial elements in the transmission of avian malaria parasites, little is known of their ecology as vectors. We examined the presence of Plasmodium and Haemoproteus lineages in five mosquito species belonging to the genera Culex and Ochlerotatus to test for the effect of vector species, season and host-feeding source on the transmission dynamics of these pathogens. We analyzed 166 blood-fed individually and 5,579 unfed mosquitoes (grouped in 197 pools) from a locality in southern Spain. In all, 15 Plasmodium and two Haemoproteus lineages were identified on the basis of a fragment of 478 bp of the mitochondrial cytochrome b gene. Infection prevalence of blood parasites in unfed mosquitoes varied between species (range: 0-3.2%) and seasons. The feeding source was identified in 91 mosquitoes where 78% were identified as bird. We found that i) several Plasmodium lineages are shared among different Culex species and one Plasmodium lineage is shared between Culex and Ochlerotatus genera; ii) mosquitoes harboured Haemoproteus parasites; iii) pools of unfed females of mostly ornithophilic Culex species had a higher Plasmodium prevalence than the only mammophylic Culex species studied. However, the mammophylic Ochlerotatus caspius had in pool samples the greatest Plasmodium prevalence. This relative high prevalence may be determined by inter-specific differences in vector survival, susceptibility to infection but also the possibility that this species feeds on birds more frequently than previously thought. Finally, iv) infection rate of mosquitoes varies between seasons and reaches its maximum prevalence during autumn and minimum prevalence in spring.	[Ferraguti, Martina; Martinez-de la Puente, Josue; Munoz, Joaquin; Roiz, David; Figuerola, Jordi] CSIC, EBD, Dept Ecol Humedales, E-41080 Seville, Spain; [Ruiz, Santiago] Diputac Huelva, Serv Control Mosquitos, Huelva, Spain; [Soriguer, Ramon] CSIC, EBD, Dept Etol & Conservac Biodiversidad, E-41080 Seville, Spain; [Munoz, Joaquin] Univ Oklahoma, Biol Stn, Dept Biol, Kingston, OK USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Oklahoma System; University of Oklahoma - Norman	Ferraguti, M (corresponding author), CSIC, EBD, Dept Ecol Humedales, E-41080 Seville, Spain.	mferraguti@ebd.csic.es	la Puente, Josué Martínez-de/E-8597-2011; Roiz, David/F-2082-2011; Martinez-de la Puente, Josue/B-1648-2008; Ruíz, Santiago/HGU-6016-2022; Ferraguti, Martina/C-6109-2015; Figuerola, Jordi/B-7917-2008; ANGARITA, JOSUE MARTINEZ/AAL-9543-2021; Soriguer, Ramon/J-1494-2014; Munoz, Joaquin/B-9938-2009	la Puente, Josué Martínez-de/0000-0001-8055-4115; Roiz, David/0000-0002-5819-3648; Ferraguti, Martina/0000-0001-7481-4355; Figuerola, Jordi/0000-0002-4664-9011; ANGARITA, JOSUE MARTINEZ/0000-0001-5531-1920; Soriguer, Ramon/0000-0002-9165-7766; Munoz, Joaquin/0000-0003-3623-2439	Spanish Ministry of Science and Innovation [CGL2009-11445, CGL2012-30759]; Junta de Andalucia [P07-RNM-02511]; EU [FP7-261504]; LLP/Erasmus Student Placement Program of the UE; FPU program; Junta para la Ampliacion de Estud ios (CSIC); Fondo Social Europeo	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); EU(European Commission); LLP/Erasmus Student Placement Program of the UE; FPU program(Spanish Government); Junta para la Ampliacion de Estud ios (CSIC); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This study was partially funded by projects CGL2009-11445 and CGL2012-30759 from the Spanish Ministry of Science and Innovation, P07-RNM-02511 from Junta de Andalucia, and funded by EU grant FP7-261504 projects EuroWestnile and EDENext, and is catalogued by the EDENext Steering Committee as EDENext124 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. MF was first supported by a LLP/Erasmus Student Placement Program of the UE and later, by a grant from the FPU program. JMP is supported by the programme Junta para la Ampliacion de Estud ios (CSIC) co-financed by Fondo Social Europeo. Consejeria de Medio Ambiente, Junta de Andalucia gave permission for mosquito sampling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Gager AB, 2008, MOL ECOL, V17, P2552, DOI 10.1111/j.1365-294X.2008.03764.x; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harbach Ralph E., 1999, European Mosquito Bulletin, V4, P7; Hellgren O, 2008, MOL ECOL, V17, P1605, DOI 10.1111/j.1365-294X.2007.03680.x; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hughes T, 2010, J AM MOSQUITO CONTR, V26, P24, DOI 10.2987/09-5893.1; Hurford C, 2010, INTEGRATED MONITORIN, P325; Iezhova TA, 2011, J PARASITOL, V97, P682, DOI 10.1645/GE-2709.1; Inci A, 2012, VET PARASITOL, V188, P179, DOI 10.1016/j.vetpar.2012.02.012; Ishtiaq F, 2008, MOL ECOL, V17, P4545, DOI 10.1111/j.1365-294X.2008.03935.x; Jovani R, 2006, TRENDS PARASITOL, V22, P214, DOI 10.1016/j.pt.2006.02.011; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Kim KS, 2009, PARASITOL RES, V105, P1351, DOI 10.1007/s00436-009-1568-9; Kim KS, 2009, J MED ENTOMOL, V46, P1230, DOI 10.1603/033.046.0535; Kimura M, 2010, J PARASITOL, V96, P144, DOI 10.1645/GE-2060.1; Koella JC, 1999, MICROBES INFECT, V1, P303, DOI 10.1016/S1286-4579(99)80026-4; Komar Nicholas, 2003, Adv Virus Res, V61, P185; LaPointe DA, 2005, J PARASITOL, V91, P843, DOI 10.1645/GE-3431.1; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Martinez J, 2009, PARASITOLOGY, V136, P713, DOI 10.1017/S0031182009006118; Martinez-de la Puente J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-109; Martinez-de la Puente J, 2012, J MED ENTOMOL, V49, P1419, DOI 10.1603/ME12081; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Martinez-de la Puente J, 2010, ACTA OECOL, V36, P543, DOI 10.1016/j.actao.2010.07.008; Martinez-de la Puente J, 2009, J AVIAN BIOL, V40, P653, DOI 10.1111/j.1600-048X.2009.04726.x; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Munoz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039549; Njabo KY, 2011, MOL ECOL, V20, P1049, DOI 10.1111/j.1365-294X.2010.04904.x; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Perez-Tris J, 2005, TRENDS PARASITOL, V21, P209, DOI 10.1016/j.pt.2005.03.001; Perez-Tris J, 2005, PARASITOLOGY, V131, P15, DOI 10.1017/S003118200500733X; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; Schaffner F., 2001, MOSQUITOES EUROPE ID; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson J. N., 2005, INTERSPEC INTERACT; Tripet F, 2008, TRENDS PARASITOL, V24, P219, DOI 10.1016/j.pt.2008.02.008; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2005, TRENDS PARASITOL, V21, P357, DOI 10.1016/j.pt.2005.06.005; Valkiunas G, 2011, MOL ECOL, V20, P3084, DOI 10.1111/j.1365-294X.2011.05187.x; Ventim R, 2012, PARASITOL RES, V111, P637, DOI 10.1007/s00436-012-2880-3; Williams CJ, 2001, J AQUAT ANIM HEALTH, V13, P300, DOI 10.1577/1548-8667(2001)013&lt;0300:ACOMOS&gt;2.0.CO;2	66	55	56	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66237	10.1371/journal.pone.0066237	http://dx.doi.org/10.1371/journal.pone.0066237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823127	Green Published, gold			2022-12-27	WOS:000320576400071
J	Jia, W; Liu, R; Shi, JG; Wu, B; Dang, W; Du, Y; Zhou, Q; Wang, JH; Zhang, R				Jia, Wei; Liu, Rui; Shi, Jianguo; Wu, Bin; Dang, Wei; Du, Ying; Zhou, Qiong; Wang, Jianhua; Zhang, Rui			Differential Regulation of MAPK Phosphorylation in the Dorsal Hippocampus in Response to Prolonged Morphine Withdrawal-Induced Depressive-Like Symptoms in Mice	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-1; OPIATE WITHDRAWAL; MAJOR DEPRESSION; RAT-BRAIN; BEHAVIOR; EXPRESSION; NALOXONE; NEURONS; MKP-3; SANGUINARINE	Depression is one of the most frequent neuropsychiatric comorbidities associated with opiate addiction. Mitogen activated protein kinase (MAPK) and MAPK phosphatase (MKP) are involved in drug addiction and depression. However, the potential role of MAPK and MKP in depression caused by morphine withdrawal remains unclear. We utilized a mouse model of repeated morphine administration to examine the molecular mechanisms that contribute to prolonged withdrawal induced depressive-like behaviors. Depressive-like behaviors were significant at 1 week after withdrawal and worsened over time. Phospho-ERK (extracellular signal-regulated protein kinase) was decreased and MKP-1 was elevated in the hippocampus, and JNK (c-Jun N-terminal protein kinase), p38 (p38 protein kinase) and MKP-3 were unaffected. A pharmacological blockade of MKP-1 by intra-hippocampal sanguinarine (SA) infusion prevented the development of depressive-like behaviors and resulted in relatively normal levels of MKP-1 and phospho-ERK after withdrawal. Our findings support the association between hippocampal MAPK phosphorylation and prolonged morphine withdrawal-induced depression, and emphasize the MKP-1 as an negative regulator of the ERK phosphorylation that contributes to depression.	[Jia, Wei; Shi, Jianguo; Wu, Bin; Dang, Wei; Zhang, Rui] Xian Mental Hlth Ctr, Methadone Maintenance Treatment Clin, Xian, Peoples R China; [Liu, Rui; Wang, Jianhua] Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Peoples R China; [Du, Ying; Zhou, Qiong] Fourth Mil Med Univ, Dept Neurol, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liu, R (corresponding author), Xian Mental Hlth Ctr, Methadone Maintenance Treatment Clin, Xian, Peoples R China.	liurui761@126.com			National Natural Science Foundation of China [81200966]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81200966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHARA A, 1995, BEHAV NEUROSCI, V109, P91, DOI 10.1037/0735-7044.109.1.91; Berke JD, 2001, SCIENCE, V294; Bokemeyer D, 1996, J BIOL CHEM, V271, P639, DOI 10.1074/jbc.271.2.639; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Caille S, 1999, J PHARMACOL EXP THER, V290, P881; Canales JJ, 2007, EUR ARCH PSY CLIN N, V257, P261, DOI 10.1007/s00406-007-0730-6; Carroll BJ, 2004, AM J PSYCHIAT, V161, P1309, DOI 10.1176/appi.ajp.161.7.1309-a; Chen YC, 2012, NEUROSCI LETT, V506, P327, DOI 10.1016/j.neulet.2011.11.038; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dwivedi Y, 2005, BIOL PSYCHIAT, V58, P315, DOI 10.1016/j.biopsych.2005.04.014; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Goeldner C, 2011, BIOL PSYCHIAT, V69, P236, DOI 10.1016/j.biopsych.2010.08.021; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hafen E, 1998, SCIENCE, V280, P1212, DOI 10.1126/science.280.5367.1212; Haghparast A, 2011, BEHAV BRAIN RES, V220, P112, DOI 10.1016/j.bbr.2011.01.045; Heinzen EL, 2004, BRAIN RES, V1023, P175, DOI 10.1016/j.brainres.2004.07.015; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042054; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Le Duigou C, 2005, J PHYSIOL-LONDON, V569, P833, DOI 10.1113/jphysiol.2005.094599; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Li T, 2010, NEUROSCI LETT, V468, P348, DOI 10.1016/j.neulet.2009.11.030; Ligeza A, 2008, FEBS J, V275, P3836, DOI 10.1111/j.1742-4658.2008.06531.x; Liu QF, 2011, NEUROL RES, V33, P56, DOI 10.1179/016164110X12714125204236; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1996, J BIOL CHEM, V271, P4319; Nunes EV, 2006, ADDICTION, V101, P89, DOI 10.1111/j.1360-0443.2006.01585.x; Paxinos K.B.J., 2001, MOUSE BRAIN STEREOTA; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qi XL, 2006, BEHAV BRAIN RES, V175, P233, DOI 10.1016/j.bbr.2006.08.035; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Rehni AK, 2013, NEUROPHARMACOLOGY; Rehni AK, 2011, BEHAV PHARMACOL, V22, P182, DOI 10.1097/FBP.0b013e328343d7a0; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shu SY, 2003, J NEUROSCI RES, V71, P609, DOI 10.1002/jnr.10545; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Sun WL, 2008, BRAIN RES, V1243, P1, DOI 10.1016/j.brainres.2008.09.016; Takaki M, 2001, J NEUROCHEM, V79, P679, DOI 10.1046/j.1471-4159.2001.00615.x; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184; Yu T, 2011, INT J NEUROPSYCHOPH, V14, P303, DOI 10.1017/S1461145710000945; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004; Zimmerman M, 2000, AM J PSYCHIAT, V157, P1337, DOI 10.1176/appi.ajp.157.8.1337	48	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66111	10.1371/journal.pone.0066111	http://dx.doi.org/10.1371/journal.pone.0066111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823128	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400054
J	Mares, J; Hrouzek, P; Kana, R; Ventura, S; Strunecky, O; Komarek, J				Mares, Jan; Hrouzek, Pavel; Kana, Radek; Ventura, Stefano; Strunecky, Otakar; Komarek, Jiri			The Primitive Thylakoid-Less Cyanobacterium Gloeobacter Is a Common Rock-Dwelling Organism	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; VIOLACEUS PCC-7421; PHYLOGENETIC-RELATIONSHIPS; PHOTOSYSTEM-I; ORIGIN; PHYCOBILISOME; BIODIVERSITY; CAROTENOIDS; MEMBRANE; PROTEINS	Cyanobacteria are an ancient group of photosynthetic prokaryotes, which are significant in biogeochemical cycles. The most primitive among living cyanobacteria, Gloeobacter violaceus, shows a unique ancestral cell organization with a complete absence of inner membranes (thylakoids) and an uncommon structure of the photosynthetic apparatus. Numerous phylogenetic papers proved its basal position among all of the organisms and organelles capable of plant-like photosynthesis (i.e., cyanobacteria, chloroplasts of algae and plants). Hence, G. violaceus has become one of the key species in evolutionary study of photosynthetic life. It also numbers among the most widely used organisms in experimental photosynthesis research. Except for a few related culture isolates, there has been little data on the actual biology of Gloeobacter, being relegated to an "evolutionary curiosity'' with an enigmatic identity. Here we show that members of the genus Gloeobacter probably are common rock-dwelling cyanobacteria. On the basis of morphological, ultrastructural, pigment, and phylogenetic comparisons of available Gloeobacter strains, as well as on the basis of three new independent isolates and historical type specimen, we have produced strong evidence as to the close relationship of Gloeobacter to a long known rock-dwelling cyanobacterial morphospecies Aphanothece caldariorum. Our results bring new clues to solving the 40 year old puzzle of the true biological identity of Gloeobacter violaceus, a model organism with a high value in several biological disciplines. A probable broader distribution of Gloeobacter in common wet-rock habitats worldwide is suggested by our data, and its ecological meaning is discussed taking into consideration the background of cyanobacterial evolution. We provide observations of previously unknown genetic variability and phenotypic plasticity, which we expect to be utilized by experimental and evolutionary researchers worldwide.	[Mares, Jan; Strunecky, Otakar; Komarek, Jiri] Ctr Phycol, Inst Bot ASCR, Trebon, Czech Republic; [Mares, Jan; Komarek, Jiri] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Hrouzek, Pavel; Kana, Radek] ALGATECH, Dept Autotroph Microorganisms, Inst Microbiol ASCR, Trebon, Czech Republic; [Ventura, Stefano] CNR, ISE, Sesto Fiorentino, Italy; [Strunecky, Otakar] Univ South Bohemia, Fac Sci, Ctr Polar Ecol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); University of South Bohemia Ceske Budejovice	Mares, J (corresponding author), Ctr Phycol, Inst Bot ASCR, Trebon, Czech Republic.	mares@butbn.cas.cz	strunecky, otakar/M-2643-2019; Kaňa, Radek/A-6434-2009; Strunecky, Otakar/H-1629-2014; Mareš, Jan/B-2395-2009; Ventura, Stefano/A-4014-2009; Komarek, Jiri/H-1597-2014	Kaňa, Radek/0000-0001-5768-6902; Strunecky, Otakar/0000-0001-9735-4662; Mareš, Jan/0000-0002-5745-7023; Ventura, Stefano/0000-0002-8134-3675; Hrouzek, Pavel/0000-0002-2061-0266	long-term research development project [RVO 67985939]; Center for Algal Biotechnology Trebon - ALGATECH [CZ. 1.05/21.00/03.0110];  [GA JU 135/2010/P];  [GACR P506/12/1818]	long-term research development project; Center for Algal Biotechnology Trebon - ALGATECH; ; 	This study was supported as a long-term research development project no. RVO 67985939, by the grant no. GA JU 135/2010/P, GACR P506/12/1818 and by the Center for Algal Biotechnology Trebon - ALGATECH (CZ. 1.05/21.00/03.0110). The authors acknowledge MetaCentrum v.o. for providing supercomputing facilities under the research agreement MSM6383917201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ-COBELAS M, 1988, Acta Botanica Malacitana, V13, P53; Beck C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-56; Bernat G, 2012, PLANT CELL PHYSIOL, V53, P528, DOI 10.1093/pcp/pcs009; Blank CE, 2010, GEOBIOLOGY, V8, P1, DOI 10.1111/j.1472-4669.2009.00220.x; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BRYANT DA, 1981, ARCH MICROBIOL, V129, P190, DOI 10.1007/BF00425249; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P7, DOI 10.1099/00207713-52-1-7; Couradeau E, 2012, SCIENCE, V336, P459, DOI 10.1126/science.1216171; Criscuolo A, 2011, MOL BIOL EVOL, V28, P3019, DOI 10.1093/molbev/msr108; Cuzman OA, 2010, MICROB ECOL, V60, P81, DOI 10.1007/s00248-010-9672-z; Dreher C, 2010, J BIOENERG BIOMEMBR, V42, P517, DOI 10.1007/s10863-010-9279-6; FOSS P, 1986, PHYTOCHEMISTRY, V25, P1127, DOI 10.1016/S0031-9422(00)81568-X; GEITLER L., 1927, ARCH PROTISTENKD, V60, P440; GOLUBIC S, 1979, PRECAMBRIAN RES, V8, P201, DOI 10.1016/0301-9268(79)90029-9; GUGLIELMI G, 1981, ARCH MICROBIOL, V129, P181, DOI 10.1007/BF00425248; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P2510, DOI 10.1099/ijs.0.005678-0; Gutierrez-Cirlos EB, 2006, BBA-BIOENERGETICS, V1757, P130, DOI 10.1016/j.bbabio.2006.01.006; HALDA J., 2011, OPERA CORCONTICA, V48, P45; Hansgirg, 1892, ARCH NATURWISS LANDE, V8, P1; Hauer T, 2008, FOTTEA, V8, P129, DOI 10.5507/fot.2008.011; Herrero A., 2008, CYANOBACTERIA MOL BI; Hoffmann L, 2005, ARCH HYDROBIOL S, V117, P21; Inoue H, 2004, FEBS LETT, V578, P275, DOI 10.1016/j.febslet.2004.11.013; Johansen JR, 2007, SOUTHEAST NAT, V6, P99, DOI 10.1656/1528-7092(2007)6[99:NASRFG]2.0.CO;2; Kana R, 2009, BBA-BIOENERGETICS, V1787, P1170, DOI 10.1016/j.bbabio.2009.04.013; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Koksharova OA, 2010, MICROBIOLOGY+, V79, P721, DOI 10.1134/S0026261710060020; Komarek J., 1998, SUSSWASSER FLORA MIT, P548; Kondo K, 2007, PLANT PHYSIOL, V144, P1200, DOI 10.1104/pp.107.099267; Krogmann DW, 2007, PHOTOSYNTH RES, V93, P27, DOI 10.1007/s11120-007-9133-9; Lamprinou V, 2012, INT J SPELEOL, V41, P267, DOI 10.5038/1827-806X.41.2.12; Matula Jan, 2007, Polish Polar Research, V28, P283; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Mimuro M, 2010, PHOTOCHEM PHOTOBIOL, V86, P62, DOI 10.1111/j.1751-1097.2009.00619.x; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Rexroth S, 2011, PLANT CELL, V23, P2379, DOI 10.1105/tpc.111.085779; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Seo PS, 2003, J GEN APPL MICROBIOL, V49, P191, DOI 10.2323/jgam.49.191; Singh Shiv Mohan, 2008, Acta Botanica Malacitana, V33, P17; Skinner Stephen, 2001, Telopea, V9, P573; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; StatSoft Inc, 2012, STAT DAT AN SOFTW SY; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Takaichi S, 2010, MICROBIOL-SGM, V156, P757, DOI 10.1099/mic.0.034249-0; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; UHER B, 2002, B SLOVENSKEJ BOT SPO, V24, P25; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Williamson A, 2011, PHOTOSYNTH RES, V107, P71, DOI 10.1007/s11120-010-9559-3; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yilmaz M, 2009, J PHYCOL, V45, P517, DOI 10.1111/j.1529-8817.2009.00651.x; Yokono M, 2008, BBA-BIOENERGETICS, V1777, P55, DOI 10.1016/j.bbabio.2007.11.001; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	62	61	62	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66323	10.1371/journal.pone.0066323	http://dx.doi.org/10.1371/journal.pone.0066323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823729	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400084
J	Vilhelmsson, A; Svensson, T; Meeuwisse, A				Vilhelmsson, Andreas; Svensson, Tommy; Meeuwisse, Anna			A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression	PLOS ONE			English	Article							ANTIDEPRESSANT; DISORDERS; SEROTONIN; IMPACT; DRUGS	Background:Starting in the 1960s, a broad-based patients' rights movement began to question doctors' paternalism and health care. According to scholars, these changes contributed to downplay the biomedical approach in favor of a more patient-oriented perspective. The Swedish non-profit organization Consumer Association for Medicines and Health (KILEN) has offered the possibility for consumers to report their perceptions and experiences from their use of medicines in order to strengthen consumer rights within the health care sector. Methodology: In this paper, qualitative content analysis was used to analyze 181 KILEN consumer reports of adverse events from antidepressant medications in order to explore patients' views of mental ill health symptoms and the doctor-patient interaction. Principal Findings: Overall, the KILEN stories contained negative experiences of the patients' medical encounters. Some reports indicated intense emotional outrage and strong feelings of abuse by the health care system. Many reports suggested that doctors and patients had very different accounts of the nature of the problems for which the patient was seeking help. Although patients sought help for problems like tiredness and sleeplessness (often with a personal crisis of some sort as a described cause), the treating doctor in most cases was exceptionally quick in both diagnosing depression and prescribing antidepressant treatment. When patients felt they were not being listened to, trust in the doctor was compromised. This was evident in the cases when the doctor tried to convince them to take part in medical treatment, sometimes by threatening to withdraw their sick-listing. Conclusions: Overall, this study suggests that the dynamics happening in the medical encounter may still be highly affected by a medical dominance, instead of a patient-oriented perspective. This may contribute to a questionable medicalization and/or pharmaceuticalization of depression.	[Vilhelmsson, Andreas] Nord Sch Publ Hlth, Gothenburg, Sweden; [Svensson, Tommy] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Meeuwisse, Anna] Lund Univ, Sch Social Work, Lund, Sweden	Linkoping University; Lund University	Vilhelmsson, A (corresponding author), Nord Sch Publ Hlth, Gothenburg, Sweden.	andreas.vilhelmsson@nhv.se	Vilhelmsson, Andreas/D-3879-2018	Vilhelmsson, Andreas/0000-0002-6635-8182	Stiftelsen Kempe-Carlgrenska Fonden; Lundgrenska Fonden; Stiftelsen Sigurd och Elsa Goljes Minne; Stiftelsen Lars Hiertas Minne; Elsa Lundberg och Greta Flerons; studier av lakemedelsbiverkan	Stiftelsen Kempe-Carlgrenska Fonden; Lundgrenska Fonden; Stiftelsen Sigurd och Elsa Goljes Minne; Stiftelsen Lars Hiertas Minne; Elsa Lundberg och Greta Flerons; studier av lakemedelsbiverkan	This study has received funding from Stiftelsen Kempe-Carlgrenska Fonden, Lundgrenska Fonden, Stiftelsen Sigurd och Elsa Goljes Minne, Stiftelsen Lars Hiertas Minne and Elsa Lundberg och Greta Flerons fond for studier av lakemedelsbiverkan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2010, SOCIOLOGY, V44, P603, DOI 10.1177/0038038510369368; Almasi EA, 2006, PLOS MED, V3, P284, DOI 10.1371/journal.pmed.0030145; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], 2018, QUAL PRIM HLTH CAR; Barry CA, 2001, SOC SCI MED, V53, P487, DOI 10.1016/S0277-9536(00)00351-8; Bayer R, 2007, PUBLIC HLTH ETHICS T, P3; Bowling A., 2014, RES METHODS HLTH INV; Broom DH, 1996, SOCIOL HEALTH ILL, V18, P357, DOI 10.1111/1467-9566.ep10934730; Bunton R, 1997, FOUCAULT HLTH MED, P118; Busfield J, 2006, SOCIOLOGY, V40, P297, DOI 10.1177/0038038506062034; Busfield J, 2011, MENTAL ILLNESS; COHEN CI, 1993, COMMUNITY MENT HLT J, V29, P509, DOI 10.1007/BF00754260; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; CONRAD P, 1992, ANNU REV SOCIOL, V18, P209, DOI 10.1146/annurev.so.18.080192.001233; Conrad P., 2007, MED SOC TRANSFORMATI; COPPEN A, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; Cornford CS, 2007, FAM PRACT, V24, P358, DOI 10.1093/fampra/cmm032; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Fox NJ, 2008, SOCIOL HEALTH ILL, V30, P856, DOI 10.1111/j.1467-9566.2008.01114.x; Frazzetto G, 2008, EMBO REP, V9, P605, DOI 10.1038/embor.2008.116; Freidson E, 2007, PROFESSIONAL DOMINAN; Freidson E., 1988, PROFESSION MED STUDY; Gilmore K A, 2000, Int J Health Care Qual Assur Inc Leadersh Health Serv, V13, P34, DOI 10.1108/09526860010311071; Golafshani N., 2003, QUAL REP, V8, P597, DOI [DOI 10.46743/2160-3715/2003.1870, 10.46743/2160-3715/2003.1870]; Goldacre B., 2012, BAD PHARM DRUG CO MI; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Healy D., 2004, CREATION PSYCHOPHARM; Healy D., 1997, ANTIDEPRESSANT ERA; Healy D, 2006, GLOBAL PHARM ETHICS, P61, DOI DOI 10.1215/9780822387916-003; Healy D., 2012, PHARMAGEDDON; Helman C.G., 2007, CULTURE HLTH ILLNESS; Horwitz A.V., 2002, CREATING MENTAL ILLN; Illich I., 1976, LIMITS MED MED NEMES; Karp DA, 2007, IS IT ME MY MEDS LIV; Kessing LV, 2005, PSYCHOL MED, V35, P1205, DOI 10.1017/S0033291705004605; Kirsch I., 2011, EMPERORS NEW DRUGS E; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Knudsen P, 2003, PHARM WORLD SCI, V25, P162, DOI 10.1023/A:1024897427249; Knudsen P, 2002, QUAL HEALTH RES, V12, P932, DOI 10.1177/104973202129120368; Kramer Peter D., 1993, LISTENING PROZAC PSY; Lacasse JR, 2005, PLOS MED, V2, P1211, DOI 10.1371/journal.pmed.0020392; Law J, 2006, BIG PHARM BIGGEST DR; Leo J, 2008, SOCIETY, V45, P35, DOI 10.1007/s12115-007-9047-3; Lexchin J, 2006, CAN MED ASSOC J, V174, P191, DOI 10.1503/cmaj.050971; Lexchin J, 2001, CAN MED ASSOC J, V164, P1449; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; Lynoe N, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000246; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Metzl JM, 2007, LANCET, V369, P697, DOI 10.1016/S0140-6736(07)60317-1; Middleton H, 2011, BRIT J GEN PRACT, V61, P47, DOI 10.3399/bjgp11X548983; Mintzes B, 2002, BRIT MED J, V324, P908, DOI 10.1136/bmj.324.7342.908; Moncrieff J., 2009, MYTH CHEM CURE CRITI; Moncrieff J, 2008, SOC SCI MED, V66, P2346, DOI 10.1016/j.socscimed.2008.01.047; Mulinari S, 2012, J HIST NEUROSCI, V21, P366, DOI 10.1080/0964704X.2011.623917; Ogden J, 1999, BRIT J GEN PRACT, V49, P123; Ogden J, 2000, HTLH PSYCHOL TXB; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Prior L, 2005, MED WORK MED KNOWLED, P1; Prior L, 2005, MED WORK MED KNOWLED, P208; Rose N, 2007, LANCET, V369, P700, DOI 10.1016/S0140-6736(07)60319-5; Rose Nikolas, 2007, POLITICS LIFE ITSELF; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Shorter E., 2009, PROZAC TROUBLED HIST; Spence D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3135; The National Board of Health and Welfare, 2006, ANTIDEPRESSIVE LAKEM; Thom DH, 1997, J FAM PRACTICE, V44, P169; Thomas RK, 2003, SOC HLTH SOCIOLOGY H; Thomas-MacLean R, 2004, HEALTH-LONDON, V8, P275, DOI 10.1177/1363459304043461; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Valenstein E., 2002, BLAMING BRAIN TRUTH; van Geffen ECG, 2007, EUR J CLIN PHARMACOL, V63, P1193, DOI 10.1007/s00228-007-0375-4; Vilhelmsson A, 2012, BMC PHARMACOL TOXICO, V13, DOI 10.1186/2050-6511-13-19; Vilhelmsson Andreas, 2011, BMC Clin Pharmacol, V11, P16, DOI 10.1186/1472-6904-11-16; Wessel M, 2013, EUR J PUBLIC HEALTH, V23, P230, DOI 10.1093/eurpub/cks030; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2002, SAF MED GUID DET REP; World Health Organization, 2004, PROM MENT HLTH CONC; ZOLA IK, 1972, SOCIOL REV, V20, P487, DOI 10.1111/j.1467-954X.1972.tb00220.x; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	84	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66338	10.1371/journal.pone.0066338	http://dx.doi.org/10.1371/journal.pone.0066338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823902	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400087
J	Chacko, JV; Canale, C; Harke, B; Diaspro, A				Chacko, Jenu Varghese; Canale, Claudio; Harke, Benjamin; Diaspro, Alberto			Sub-Diffraction Nano Manipulation Using STED AFM	PLOS ONE			English	Article							RESOLUTION; MICROSCOPY	In the last two decades, nano manipulation has been recognized as a potential tool of scientific interest especially in nanotechnology and nano-robotics. Contemporary optical microscopy (super resolution) techniques have also reached the nanometer scale resolution to visualize this and hence a combination of super resolution aided nano manipulation ineluctably gives a new perspective to the scenario. Here we demonstrate how specificity and rapid determination of structures provided by stimulated emission depletion (STED) microscope can aid another microscopic tool with capability of mechanical manoeuvring, like an atomic force microscope (AFM) to get topological information or to target nano scaled materials. We also give proof of principle on how high-resolution real time visualization can improve nano manipulation capability within a dense sample, and how STED-AFM is an optimal combination for this job. With these evidences, this article points to future precise nano dissections and maybe even to a nano-snooker game with an AFM tip and fluorospheres.	[Chacko, Jenu Varghese; Canale, Claudio; Harke, Benjamin; Diaspro, Alberto] Ist Italiano Tecnol, Genoa, Italy; [Chacko, Jenu Varghese; Diaspro, Alberto] Univ Genoa, Dept Phys, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa	Harke, B (corresponding author), Ist Italiano Tecnol, Genoa, Italy.	benjamin.harke@iit.it; alberto.diaspro@iit.it	Diaspro, Alberto/E-7833-2010; Chacko, Jenu Varghese/N-1498-2018	Diaspro, Alberto/0000-0002-4916-5928; Chacko, Jenu Varghese/0000-0002-6676-0358; Canale, Claudio/0000-0002-7582-6849				BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Diaspro A, 1997, IEEE ENG MED BIOL, V16, P26, DOI 10.1109/MEMB.1997.582172; Dvorak JA, 2003, METHODS, V29, P86, DOI 10.1016/S1046-2023(02)00284-0; Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9; Hansen LT, 1998, NANOTECHNOLOGY, V9, P337, DOI 10.1088/0957-4484/9/4/006; Harke B., 2012, OPT NANOSCOPY, V1, P3, DOI DOI 10.1186/2192-2853-1-3; Harke B, 2008, OPT EXPRESS, V16, P4154, DOI 10.1364/OE.16.004154; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; JUNNO T, 1995, APPL PHYS LETT, V66, P3627, DOI 10.1063/1.113809; Kassies R, 2005, J MICROSC-OXFORD, V217, P109, DOI 10.1111/j.0022-2720.2005.01428.x; Landolsi F, 2013, J DYN SYST-T ASME, V135, DOI 10.1115/1.4006370; Ludwig T., 2007, MODERN RES ED TOPICS, P11; Messa M, 2009, IEEE T NANOBIOSCI, V8, P161, DOI 10.1109/TNB.2009.2019109; Onal CD, 2011, IEEE T NANOTECHNOL, V10, P472, DOI 10.1109/TNANO.2010.2047510; RADMACHER M, 1994, BIOPHYS J, V66, P2159, DOI 10.1016/S0006-3495(94)81011-2; Requicha A, 2008, NANOMANIPULATION ATO; Rubio-Sierra FJ, 2005, ADV ENG MATER, V7, P193, DOI 10.1002/adem.200400174; Sitti M, 2001, PROCEEDINGS OF THE 2001 1ST IEEE CONFERENCE ON NANOTECHNOLOGY, P75, DOI 10.1109/NANO.2001.966397; Smith C, 2012, NATURE, V492, P293, DOI 10.1038/492293a; Tafazzoli A, 2005, ISATP 2005: IEEE International Symposium on Assembly and Task Planning (ISATP), P230, DOI 10.1109/ISATP.2005.1511478; Westphal V, 2003, APPL PHYS B-LASERS O, V77, P377, DOI 10.1007/s00340-003-1280-x	23	36	36	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66608	10.1371/journal.pone.0066608	http://dx.doi.org/10.1371/journal.pone.0066608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799123	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800043
J	Torchia, MLG; Conze, DB; Ashwell, JD				Giardino Torchia, Maria Letizia; Conze, Dietrich B.; Ashwell, Jonathan D.			c-IAP1 and c-IAP2 Redundancy Differs between T and B Cells	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; MULTIPLE-MYELOMA; ACTIVATION; CIAP2; TRAF2; UBIQUITINATION; RECEPTOR; IAPS; INHIBITOR	Cellular Inhibitors of Apoptosis 1 and 2 (c-IAP1 and c-IAP2) are ubiquitin protein ligases (E3s) that constitutively ubiquitinate and induce proteasomal-mediated degradation of NF-kappa B Inducing Kinase (NIK) and repress non-canonical NF-kappa B activation. Mice expressing an E3-inactive c-IAP2 mutant (c-IAP2(H570A)) have constitutive activation of non-canonical NF-kappa B, resulting in B cell hyperplasia and T cell costimulation-independence. If, and if so to what extent, c-IAP1 and c-IAP2 are redundant in NF-kappa B regulation in these mice is not known. Here we have generated mice expressing a mutant c-IAP1 that lacks E3 activity (c-IAP1(H582A)). These mice were phenotypically normal and did not have constitutive NF-kappa B activation in B cells or MEFs. siRNA-mediated knockdown of c-IAP2 showed that accumulated c-IAP2, resulting from lack of c-IAP1-dependent degradation, compensated for absent c-IAP1 E3 activity. Surprisingly, c-IAP1(H582A) T cells had a lower p100/p52 ratio than wild type T cells, and in the absence of costimulation proliferated to a degree intermediate between wild type and c-IAP2(H570A) T cells. Therefore, although c-IAP1 and c-IAP2 both can repress constitutive NF-kappa B activation, the relative importance of each varies according to cell type.	[Giardino Torchia, Maria Letizia; Conze, Dietrich B.; Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov			National Institutes of Health, Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010779] Funding Source: NIH RePORTER	National Institutes of Health, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Conze DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000518; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Corn RA, 2003, J IMMUNOL, V171, P1816, DOI 10.4049/jimmunol.171.4.1816; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Gardam S, 2011, BLOOD, V117, P4041, DOI 10.1182/blood-2010-10-312793; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Graber TE, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.20; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Li YQ, 2005, J BIOL CHEM, V280, P1217, DOI 10.1074/jbc.M409492200; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Moulin M, 2012, EMBO J; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Prakash H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006519; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Torchia MLG, 2013, J IMMUNOL, V190, P549, DOI 10.4049/jimmunol.1201697; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2012, NAT REV IMMUNOL, V12, P833, DOI 10.1038/nri3325; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012	46	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66161	10.1371/journal.pone.0066161	http://dx.doi.org/10.1371/journal.pone.0066161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799077	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800026
J	Hoffmann, C; Dollive, S; Grunberg, S; Chen, J; Li, HZ; Wu, GD; Lewis, JD; Bushman, FD				Hoffmann, Christian; Dollive, Serena; Grunberg, Stephanie; Chen, Jun; Li, Hongzhe; Wu, Gary D.; Lewis, James D.; Bushman, Frederic D.			Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; METHANOBREVIBACTER-SMITHII; DIVERSITY; FERMENTATION; COMMUNITIES; INFECTION; HEALTH	Diet influences health as a source of nutrients and toxins, and by shaping the composition of resident microbial populations. Previous studies have begun to map out associations between diet and the bacteria and viruses of the human gut microbiome. Here we investigate associations of diet with fungal and archaeal populations, taking advantage of samples from 98 well-characterized individuals. Diet was quantified using inventories scoring both long-term and recent diet, and archaea and fungi were characterized by deep sequencing of marker genes in DNA purified from stool. For fungi, we found 66 genera, with generally mutually exclusive presence of either the phyla Ascomycota or Basiodiomycota. For archaea, Methanobrevibacter was the most prevalent genus, present in 30% of samples. Several other archaeal genera were detected in lower abundance and frequency. Myriad associations were detected for fungi and archaea with diet, with each other, and with bacterial lineages. Methanobrevibacter and Candida were positively associated with diets high in carbohydrates, but negatively with diets high in amino acids, protein, and fatty acids. A previous study emphasized that bacterial population structure was associated primarily with long-term diet, but high Candida abundance was most strongly associated with the recent consumption of carbohydrates. Methobrevibacter abundance was associated with both long term and recent consumption of carbohydrates. These results confirm earlier targeted studies and provide a host of new associations to consider in modeling the effects of diet on the gut microbiome and human health.	[Hoffmann, Christian; Dollive, Serena; Grunberg, Stephanie; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Wu, Gary D.] Univ Penn, Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Li, Hongzhe; Lewis, James D.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Li, Hongzhe; Lewis, James D.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Hoffmann, Christian] Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil; [Chen, Jun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Universidade Federal de Goias; Harvard University; Harvard T.H. Chan School of Public Health	Wu, GD (corresponding author), Univ Penn, Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	gdwu@mail.med.upenn.edu; lewisjd@mail.med.upenn.edu; bushman@mail.med.upenn.edu	Hoffmann, Christian/C-1298-2015	Hoffmann, Christian/0000-0003-1736-8007; Bushman, Frederic/0000-0003-4740-4056	Penn Genome Frontiers Institute; National Institutes of Health (NIH) [DK 089472]; Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine [S10RR024525, UL1RR024134, K24DK078228]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, S10RR024525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089472, K24DK078228, UH2DK083981, P30DK050306] Funding Source: NIH RePORTER	Penn Genome Frontiers Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Project UH2/3 DK083981, the Penn Genome Frontiers Institute; National Institutes of Health (NIH) DK 089472 (GDW); Penn Digestive Disease Center (P30 DK050306); The Joint Penn-CHOP Center for Digestive, Liver, and Pancreatic Medicine; S10RR024525; UL1RR024134, and K24DK078228. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, National Institutes of Health, or Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HW, 1917, J INFECT DIS, V21, P341, DOI 10.1093/infdis/21.4.341; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CDC/NCHS, 2011, NAT HLTH NUTR EX SUR; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Downes J, 2010, INT J SYST EVOL MICR, V60, P2458, DOI 10.1099/ijs.0.014720-0; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dridi B, 2011, ANAEROBE, V17, P56, DOI 10.1016/j.anaerobe.2011.03.001; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gumbo T, 1999, MEDICINE, V78, P220, DOI 10.1097/00005792-199907000-00002; Hamad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040888; Handley SA, 2012, CELL, V151, P253, DOI 10.1016/j.cell.2012.09.024; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; IANNOTTI EL, 1973, J BACTERIOL, V114, P1231, DOI 10.1128/JB.114.3.1231-1240.1973; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Matarazzo F, 2012, CLIN MICROBIOL INFEC, V18, P834, DOI 10.1111/j.1469-0691.2012.03958.x; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; Minot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042342; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot Samuel, 2011, GENOME RES; Murdoch TB, 2012, INFLAMM BOWEL DIS, V18, P1743, DOI 10.1002/ibd.22884; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Seibold F, 2001, SCAND J GASTROENTERO, V36, P196, DOI 10.1080/003655201750065960; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Stewart JA, 2006, LETT APPL MICROBIOL, V43, P58, DOI 10.1111/j.1472-765X.2006.01906.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; WILLETT WC, 1983, AM J CLIN NUTR, V38, P631, DOI 10.1093/ajcn/38.4.631; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	60	454	485	7	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66019	10.1371/journal.pone.0066019	http://dx.doi.org/10.1371/journal.pone.0066019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799070	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800022
J	Kwon, KC; Verma, D; Jin, SX; Singh, ND; Daniell, H				Kwon, Kwang-Chul; Verma, Dheeraj; Jin, Shuangxia; Singh, Nameirakpam D.; Daniell, Henry			Release of Proteins from Intact Chloroplasts Induced by Reactive Oxygen Species during Biotic and Abiotic Stress	PLOS ONE			English	Article							BOUND TRANSCRIPTION FACTORS; MG-PROTOPORPHYRIN IX; ARABIDOPSIS-THALIANA; TOBACCO CHLOROPLASTS; GENE-EXPRESSION; SALICYLIC-ACID; CELL-DEATH; HIGH LIGHT; NUCLEUS; CAROTOVORA	Plastids sustain life on this planet by providing food, feed, essential biomolecules and oxygen. Such diverse metabolic and biosynthetic functions require efficient communication between plastids and the nucleus. However, specific factors, especially large molecules, released from plastids that regulate nuclear genes have not yet been fully elucidated. When tobacco and lettuce transplastomic plants expressing GFP within chloroplasts, were challenged with Erwinia carotovora (biotic stress) or paraquat (abiotic stress), GFP was released into the cytoplasm. During this process GFP moves gradually towards the envelope, creating a central red zone of chlorophyll fluorescence. GFP was then gradually released from intact chloroplasts into the cytoplasm with an intact vacuole and no other visible cellular damage. Different stages of GFP release were observed inside the same cell with a few chloroplasts completely releasing GFP with detection of only red chlorophyll fluorescence or with no reduction in GFP fluorescence or transitional steps between these two phases. Time lapse imaging by confocal microscopy clearly identified sequence of these events. Intactness of chloroplasts during this process was evident from chlorophyll fluorescence emanated from thylakoid membranes and in vivo Chla fluorescence measurements (maximum quantum yield of photosystem II) made before or after infection with pathogens to evaluate their photosynthetic competence. Hydrogen peroxide and superoxide anion serve as signal molecules for generation of reactive oxygen species and Tiron, scavenger of superoxide anion, blocked release of GFP from chloroplasts. Significant increase in ion leakage in the presence of paraquat and light suggests changes in the chloroplast envelope to facilitate protein release. Release of GFP-RC101 (an antimicrobial peptide), which was triggered by Erwinia infection, ceased after conferring protection, further confirming this export phenomenon. These results suggest a novel signaling mechanism, especially for participation of chloroplast proteins (e.g. transcription factors) in retrograde signaling, thereby offering new opportunities to regulate pathways outside chloroplasts.	[Kwon, Kwang-Chul; Verma, Dheeraj; Jin, Shuangxia; Singh, Nameirakpam D.; Daniell, Henry] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Kwon, Kwang-Chul; Daniell, Henry] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Kwon, Kwang-Chul; Daniell, Henry] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	State University System of Florida; University of Central Florida; University of Pennsylvania; University of Pennsylvania	Daniell, H (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	hdaniell@upenn.edu	Daniell, Henry/L-3655-2019; Kwon, Kwang-Chul/T-8694-2019; Kwon, Kwang-Chul/P-6558-2017	Daniell, Henry/0000-0003-4485-1176; Kwon, Kwang-Chul/0000-0002-4037-1776; Jin, Shuangxia/0000-0002-1495-9154	United States Department of Agriculture (USDA) CSREES [2009-39200-19972]; USDA-National Institute of Food and Agriculture [2010-39200-21704]; National Institutes of Health (NIH) [R01 GM 63879, NIH R01 HL 109442, NIH R01 HL 107904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109442, R01HL107904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063879] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA) CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All investigators were supported by funding from the following grants to Henry Daniell: United States Department of Agriculture (USDA) CSREES 2009-39200-19972, USDA-National Institute of Food and Agriculture 2010-39200-21704, National Institutes of Health (NIH) R01 GM 63879, NIH R01 HL 109442 and NIH R01 HL 107904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2007, PLANT PHYSIOL, V143, P1720, DOI 10.1104/pp.106.094771; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BABBS CF, 1989, PLANT PHYSIOL, V90, P1267, DOI 10.1104/pp.90.4.1267; BAKER NR, 1991, PHYSIOL PLANTARUM, V81, P563, DOI 10.1111/j.1399-3054.1991.tb05101.x; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Chen YN, 2008, CURR OPIN PLANT BIOL, V11, P695, DOI 10.1016/j.pbi.2008.10.005; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Dutta S, 2009, PLANT PHYSIOL, V150, P1050, DOI 10.1104/pp.109.137265; Enami K, 2011, PLANT PHYSIOL, V157, P518, DOI 10.1104/pp.111.178897; ENSMINGER MP, 1985, PLANT PHYSIOL, V78, P46, DOI 10.1104/pp.78.1.46; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fernandez AP, 2008, CURR OPIN PLANT BIOL, V11, P509, DOI 10.1016/j.pbi.2008.06.002; Fey V, 2005, J BIOL CHEM, V280, P5318, DOI 10.1074/jbc.M406358200; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Govindjee, 2004, PHOTOSYNTH RES, V80, P447; Hess FD, 2000, WEED SCI, V48, P160, DOI 10.1614/0043-1745(2000)048[0160:LDHAO]2.0.CO;2; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Inaba T, 2010, BIOSCI BIOTECH BIOCH, V74, P471, DOI 10.1271/bbb.90842; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Jung HS, 2010, PLANT PHYSIOL, V152, P453, DOI 10.1104/pp.109.149070; Kariola T, 2003, MOL PLANT MICROBE IN, V16, P179, DOI 10.1094/MPMI.2003.16.3.179; Kiba A, 2006, MOL PLANT MICROBE IN, V19, P112, DOI 10.1094/MPMI-19-0112; Lazar D, 2006, FUNCT PLANT BIOL, V33, P9, DOI 10.1071/FP05095; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Lee SB, 2011, PLANT BIOTECHNOL J, V9, P100, DOI 10.1111/j.1467-7652.2010.00538.x; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Lo SM, 2012, PLANT J, V71, P656, DOI 10.1111/j.1365-313X.2012.05020.x; Lo SM, 2011, METHODS MOL BIOL, V684, P139, DOI [10.1007/978.1.60761.925.3_13, 10.1007/978-1-60761-925-3_13]; Maruta T, 2012, J BIOL CHEM, V287, P11717, DOI 10.1074/jbc.M111.292847; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Montesano M, 2004, MOL PLANT PATHOL, V5, P115, DOI 10.1111/J.1364-3703.2004.00213.X; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; PALVA TK, 1993, MOL PLANT MICROBE IN, V6, P190, DOI 10.1094/MPMI-6-190; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Ramel F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-28; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Sambrook J., 2001, MOL CLONING LAB MANU; Scarpeci TE, 2008, PLANT MOL BIOL, V66, P361, DOI 10.1007/s11103-007-9274-4; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Singh N. Dolendro, 2009, V483, P163, DOI 10.1007/978-1-59745-407-0_10; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Sun XW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1486; Sunil B, 2008, INDIAN J BIOCHEM BIO, V45, P37; Suzuki N, 2012, PLANT CELL ENVIRON, V35, P259, DOI 10.1111/j.1365-3040.2011.02336.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Vandenabeele S, 2004, PLANT J, V39, P45, DOI 10.1111/j.1365-313X.2004.02105.x; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x; Vidal S, 1998, MOL PLANT MICROBE IN, V11, P23, DOI 10.1094/MPMI.1998.11.1.23; Vranova E, 2002, P NATL ACAD SCI USA, V99, P10870, DOI 10.1073/pnas.152337999; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	63	26	26	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67106	10.1371/journal.pone.0067106	http://dx.doi.org/10.1371/journal.pone.0067106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799142	gold, Green Published			2022-12-27	WOS:000320363300104
J	Van der Hauwaert, C; Savary, G; Gnemmi, V; Glowacki, F; Pottier, N; Bouillez, A; Maboudou, P; Zini, L; Leroy, X; Cauffiez, C; Perrais, M; Aubert, S				Van der Hauwaert, Cynthia; Savary, Gregoire; Gnemmi, Viviane; Glowacki, Francois; Pottier, Nicolas; Bouillez, Audrey; Maboudou, Patrice; Zini, Laurent; Leroy, Xavier; Cauffiez, Christelle; Perrais, Michael; Aubert, Sebastien			Isolation and Characterization of a Primary Proximal Tubular Epithelial Cell Model from Human Kidney by CD10/CD13 Double Labeling	PLOS ONE			English	Article							PRIMARY CULTURES; DISTAL TUBULE; IN-VITRO; EXPRESSION; IMMUNODISSECTION; LOCALIZATION; PROTEINURIA; TRANSPORT; SEGMENTS	uRenal proximal tubular epithelial cells play a central role in renal physiology and are among the cell types most sensitive to ischemia and xenobiotic nephrotoxicity. In order to investigate the molecular and cellular mechanisms underlying the pathophysiology of kidney injuries, a stable and well-characterized primary culture model of proximal tubular cells is required. An existing model of proximal tubular cells is hampered by the cellular heterogeneity of kidney; a method based on cell sorting for specific markers must therefore be developed. In this study, we present a primary culture model based on the mechanical and enzymatic dissociation of healthy tissue obtained from nephrectomy specimens. Renal epithelial cells were sorted using co-labeling for CD10 and CD13, two renal proximal tubular epithelial markers, by flow cytometry. Their purity, phenotypic stability and functional properties were evaluated over several passages. Our results demonstrate that CD10/CD13 double-positive cells constitute a pure, functional and stable proximal tubular epithelial cell population that displays proximal tubule markers and epithelial characteristics over the long term, whereas cells positive for either CD10 or CD13 alone appear to be heterogeneous. In conclusion, this study describes a method for establishing a robust renal proximal tubular epithelial cell model suitable for further experimentation.	[Van der Hauwaert, Cynthia; Savary, Gregoire; Glowacki, Francois; Pottier, Nicolas; Cauffiez, Christelle] Fac Med Lille, Dept Biochim & Biol Mol, EA4483, F-59045 Lille, France; [Gnemmi, Viviane; Bouillez, Audrey; Zini, Laurent; Leroy, Xavier; Perrais, Michael; Aubert, Sebastien] INSERM, U837, Ctr Rech Jean Pierre Aubert, Equipe Mucines Differentiat & Cancerogenese Epith, F-59045 Lille, France; [Gnemmi, Viviane; Leroy, Xavier; Aubert, Sebastien] CHRU Lille, Serv Anat Pathol, Ctr Biol & Pathol, F-59037 Lille, France; [Gnemmi, Viviane; Glowacki, Francois; Pottier, Nicolas; Zini, Laurent; Leroy, Xavier; Cauffiez, Christelle; Perrais, Michael; Aubert, Sebastien] Univ Lille 2, Fac Med Lille, Lille, France; [Glowacki, Francois] CHRU Lille, Hop Huriez, Serv Nephrol, F-59037 Lille, France; [Maboudou, Patrice] CHRU Lille, Ctr Biol & Pathol, Serv Biochim, F-59037 Lille, France; [Zini, Laurent] CHRU Lille, Hop Huriez, Serv Urol, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Aubert, S (corresponding author), INSERM, U837, Ctr Rech Jean Pierre Aubert, Equipe Mucines Differentiat & Cancerogenese Epith, F-59045 Lille, France.	sebastien.aubert@inserm.fr	Cauffiez, Christelle/H-5816-2019	Cauffiez, Christelle/0000-0003-0951-7973; Glowacki, Francois/0000-0001-5443-9172; Van der Hauwaert, Cynthia/0000-0001-9549-3722; pottier, nicolas/0000-0001-8913-6286; Savary, Gregoire/0000-0001-8021-2676	University of Lille 2 graduate scholarship; Agence Nationale de la Recherche [ANR-09-JCJC-0002]; Conseil Regional du Nord Pas de Calais	University of Lille 2 graduate scholarship; Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional du Nord Pas de Calais(Region Hauts-de-FranceRegion Ile-de-France)	CVDH is supported by University of Lille 2 graduate scholarship. This study was supported by grants from Agence Nationale de la Recherche (ANR-09-JCJC-0002 (MP)) and the Conseil Regional du Nord Pas de Calais (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CLIN J AM SOC NEPHRO, V4, P1523, DOI 10.2215/CJN.02010309; Baer PC, 2006, CELLS TISSUES ORGANS, V184, P16, DOI 10.1159/000096947; Baer PC, 1999, EXP NEPHROL, V7, P306; Baer PC, 1997, KIDNEY INT, V52, P1321, DOI 10.1038/ki.1997.457; Bai SJ, 2012, INT J BIOL SCI, V8, P859, DOI 10.7150/ijbs.3490; Bakris GL, 2009, KIDNEY INT, V75, P1272, DOI 10.1038/ki.2009.87; Bens M, 2008, PFLUG ARCH EUR J PHY, V457, P1, DOI 10.1007/s00424-008-0507-4; Brown CDA, 2008, TOXICOL APPL PHARM, V233, P428, DOI 10.1016/j.taap.2008.09.018; BROWN D, 1990, P NATL ACAD SCI USA, V87, P7457, DOI 10.1073/pnas.87.19.7457; COURJAULTGAUTIER F, 1995, J AM SOC NEPHROL, V5, P1949; Cummings BS, 2000, J PHARMACOL EXP THER, V293, P677; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Delabarre S, 1997, TISSUE CELL, V29, P99, DOI 10.1016/S0040-8166(97)80076-6; Denker BM, 2011, J AM SOC NEPHROL, V22, P622, DOI 10.1681/ASN.2010090922; Elberg G, 2008, CELL TISSUE RES, V331, P495, DOI 10.1007/s00441-007-0521-4; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Helbert MJF, 2001, KIDNEY INT, V59, P554, DOI 10.1046/j.1523-1755.2001.059002554.x; Helbert MJF, 1997, KIDNEY INT, V52, P414, DOI 10.1038/ki.1997.348; Kamiyama M, 2012, J HYPERTENS, V30, P2365, DOI 10.1097/HJH.0b013e3283598eed; Kamiyama M, 2012, INT J MOL SCI, V13, P5098, DOI 10.3390/ijms13045098; Konigs M, 2009, TOXICOLOGY, V258, P106, DOI 10.1016/j.tox.2009.01.012; Lash LH, 1995, TOXICOLOGY, V103, P85, DOI 10.1016/0300-483X(95)03110-2; Li W, 2003, TOXICOL IN VITRO, V17, P107, DOI 10.1016/S0887-2333(02)00128-5; Li W, 2006, TOXICOL IN VITRO, V20, P669, DOI 10.1016/j.tiv.2005.09.016; Maria OM, 2011, INT J BIOCHEM CELL B, V43, P622, DOI 10.1016/j.biocel.2011.01.001; Molitoris BA, 1996, KIDNEY INT, V49, P1592, DOI 10.1038/ki.1996.231; Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006; Qi W, 2007, NEPHROLOGY, V12, P155, DOI 10.1111/j.1440-1797.2007.00779.x; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Schaaf GJ, 2001, CHEM-BIOL INTERACT, V134, P167, DOI 10.1016/S0009-2797(01)00151-X; Schlatter P, 2006, EUR J PHARM SCI, V28, P141, DOI 10.1016/j.ejps.2006.01.009; Sens DA, 1999, EXP NEPHROL, V7, P344; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Valente MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019337; VANDERBIEST I, 1994, KIDNEY INT, V45, P85, DOI 10.1038/ki.1994.10; Wang Q, 2013, AM J PHYSIOL-RENAL, V304, pF168, DOI 10.1152/ajprenal.00129.2012; Weiland C, 2007, TOXICOL IN VITRO, V21, P466, DOI 10.1016/j.tiv.2006.10.008; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511	38	58	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66750	10.1371/journal.pone.0066750	http://dx.doi.org/10.1371/journal.pone.0066750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799132	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300097
J	Wang, T; Wang, ZQ; Wang, L; Yan, L; Wan, J; Zhang, S; Jiang, HQ; Li, WF; Lin, ZF				Wang, Tao; Wang, Zhi-qin; Wang, Lv; Yan, Li; Wan, Jian; Zhang, Sheng; Jiang, Hong-quan; Li, Wen-fang; Lin, Zhao-fen			CRISPLD2 Is Expressed at Low Levels during Septic Shock and Is Associated with Procalcitonin	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; SEVERE SEPSIS; BRANCHING MORPHOGENESIS; PREDICTS MORTALITY; DR EXPRESSION; ORGAN FAILURE; LGL1; ENDOTOXIN; EPIDEMIOLOGY; DEFINITIONS	Introduction: Previous studies have shown that cysteine-rich secretory protein containing LCCL domain 2 (CRISPLD2) is a novel lipopolysaccharide (LPS)-binding protein, and the upregulation of CRISPLD2 expression protects mice against LPS-induced lethality. The aim of this study was to examine the expression of CRISPLD2 in patients with sepsis and characterize the association of this protein with procalcitonin. Methods: The expression of CRISPLD2 was determined in 100 healthy volunteers and 119 septic patients. According to the definition of sepsis, patients were divided into three groups sepsis, severe sepsis, and septic shock. The relationship between CRISPLD2 levels and procalcitonin was also examined and statistically analyzed. Results: The CRISPLD2 levels in healthy individuals were 219.3 +/- 69.1 mu g/ml. Patients with sepsis exhibited higher CRISPLD2 levels than observed in healthy individuals (p = 0.001), but CRISPLD2 expression was not upregulated in patients with septic shock. No significant differences were observed between the levels of CRISPLD2 in surviving and non-surviving spesis patients. CRISPLD2 levels were negatively correlated with procalcitonin levels(r = -0.334, p<0.001). Conclusions: The present study is the first to demonstrate the decreased expression of CRISPLD2 in septic shock and its association with PCT in sepsis. Further studies are needed to clarify the potential association between CRISPLD2 expression and clinical outcomes to determine if it could be used as a novel sepsis biomarker.	[Wang, Tao] Chinese Peoples Liberat Army Gen Hosp, Dept Emergency, Sanya, Hainan Province, Peoples R China; [Wang, Tao] Chinese Peoples Liberat Army Gen Hosp, Intens Care Unit, Hainan Branch, Sanya, Hainan Province, Peoples R China; [Wang, Tao; Wang, Lv; Yan, Li; Wan, Jian; Zhang, Sheng; Li, Wen-fang; Lin, Zhao-fen] Second Mil Med Univ, Changzheng Hosp, Dept Emergency & Crit Care Med, Shanghai, Peoples R China; [Wang, Zhi-qin; Jiang, Hong-quan] Shanghai South Gene Technol Co Ltd, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Naval Medical University	Li, WF (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Emergency & Crit Care Med, Shanghai, Peoples R China.	jijiuke415@163.com; Linzhaofen@sina.com	tao, wang/N-4875-2016	tao, wang/0000-0001-6427-8800	National Natural Science Foundation of China [81171844/H1511]; Innovation Fund for Small Technology-based Firms [1002H124800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Fund for Small Technology-based Firms	This work was supported by National Natural Science Foundation of China (81171844/H1511), and the Innovation Fund for Small Technology-based Firms (1002H124800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, SHOCK, V20, P197, DOI 10.1097/01.shk.0000079423.72656.2f; Appelmelk BJ, 1992, IMMUNO PATHO, V2, P375; ARDITI M, 1993, INFECT IMMUN, V61, P3149, DOI 10.1128/IAI.61.8.3149-3156.1993; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Caille V, 2004, SHOCK, V22, P521, DOI 10.1097/01.shk.0000143410.63698.57; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; DUNN DL, 1988, ARCH SURG-CHICAGO, V123, P1389; GALLAY P, 1994, J INFECT DIS, V170, P1319, DOI 10.1093/infdis/170.5.1319; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gomis S, 2003, INFECT IMMUN, V71, P857, DOI 10.1128/IAI.71.2.857-863.2003; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lan J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-83; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Nadeau K, 2010, PEDIATR RES, V67, P375, DOI 10.1203/PDR.0b013e3181d23656; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Oyewumi L, 2003, BIOCHEM J, V376, P61, DOI 10.1042/BJ20030591; Oyewumi L, 2003, AM J RESP CELL MOL, V28, P232, DOI 10.1165/rcmb.4877; Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386; Quinlan J, 2007, AM J PHYSIOL-RENAL, V293, pF987, DOI 10.1152/ajprenal.00098.2007; Rice L, 2005, J INFECT DIS, V191, P1368, DOI 10.1086/428452; Ruiz-Alvarez M J, 2009, J Intensive Care Med, V24, P63, DOI 10.1177/0885066608327095; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Schefold JC, 2010, INTENS CARE MED, V36, P1810, DOI 10.1007/s00134-010-1965-7; Schuetz P, 2010, CLIN BIOCHEM, V43, P341, DOI 10.1016/j.clinbiochem.2009.08.029; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Steinbach G, 2004, CLIN CHEM LAB MED, V42, P440, DOI 10.1515/CCLM.2004.077; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vreugdenhil ACE, 1999, J IMMUNOL, V163, P2792; Waag DM, 2006, INFECT IMMUN, V74, P1944, DOI 10.1128/IAI.74.3.1944-1948.2006; Wang ZQ, 2009, J IMMUNOL, V183, P6646, DOI 10.4049/jimmunol.0802348; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001	44	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65743	10.1371/journal.pone.0065743	http://dx.doi.org/10.1371/journal.pone.0065743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799041	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300037
J	Zimmer, JY; Smeets, F; Simonon, G; Fagot, J; Haubruge, E; Francis, F; Losson, B				Zimmer, Jean-Yves; Smeets, Francois; Simonon, Gregory; Fagot, Jean; Haubruge, Eric; Francis, Frederic; Losson, Bertrand			Are Bogs Reservoirs for Emerging Disease Vectors? Evaluation of Culicoides Populations in the Hautes Fagnes Nature Reserve (Belgium)	PLOS ONE			English	Article							SCOTTISH BITING MIDGE; BLUETONGUE VIRUS; IMPUNCTATUS DIPTERA; NORTHERN EUROPE; CERATOPOGONIDAE; IDENTIFICATION; BLOODMEALS; EPIDEMIC; CATTLE; HOST	Several species of Culicoides (Diptera: Ceratopogonidae) biting midges serve as biological vectors for the bluetongue virus (BTV) and the recently described Schmallenberg virus (SBV) in northern Europe. Since their recent emergence in this part of the continent, these diseases have caused considerable economic losses to the sheep and cattle industries. Much data is now available that describe the distribution, population dynamics, and feeding habits of these insects. However, little is known regarding the presence of Culicoides in unusual habitats such as peaty marshes, nor their potential vector capacity. This study evaluated Culicoides biting midges present in the bogs of a Belgian nature reserve compared to those residing at a nearby cattle farm. Culicoides were trapped in 2011 at four different sites (broadleaved and coniferous forested areas, open environments, and at a scientific station) located in the Hautes Fagnes Nature Reserve (Belgium). An additional light trap was operated on a nearby cattle farm. Very high numbers of biting midges were captured in the marshy area and most of them (70 to 95%) were Culicoides impunctatus, a potential vector of BTV and other pathogens. In addition, fewer numbers of C. obsoletus/C. scoticus species, C. chiopterus, and C. dewulfi were observed in the bogs compared to the farm. The wet environment and oligotrophic nature of the soil were probably responsible for these changes in the respective populations. A total of 297,808 Culicoides midges belonging to 27 species were identified during this study and 3 of these species (C. sphagnumensis, C. clintoni and C. comosioculatus) were described in Belgium for the first time.	[Zimmer, Jean-Yves; Simonon, Gregory; Fagot, Jean; Haubruge, Eric; Francis, Frederic] Univ Liege, Gembloux Agrobio Tech, Dept Agron Sci, Unit Funct & Evolutionary Entomol, Gembloux, Belgium; [Smeets, Francois; Losson, Bertrand] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Lab Parasitol & Parasit Dis, Liege, Belgium	University of Liege; University of Liege	Zimmer, JY (corresponding author), Univ Liege, Gembloux Agrobio Tech, Dept Agron Sci, Unit Funct & Evolutionary Entomol, Gembloux, Belgium.	entomologie.gembloux@ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476	Gembloux Agro-Bio Tech (University of Liege, Belgium)	Gembloux Agro-Bio Tech (University of Liege, Belgium)	Funding for this research was provided by Gembloux Agro-Bio Tech (University of Liege, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldet T, 2008, PREV VET MED, V87, P84, DOI 10.1016/j.prevetmed.2008.06.014; Balenghien T., 2008, CULICOIDES CHIOPTERU; BLACKWELL A, 1992, B ENTOMOL RES, V82, P299, DOI 10.1017/S0007485300041055; BLACKWELL A, 1995, MED VET ENTOMOL, V9, P214, DOI 10.1111/j.1365-2915.1995.tb00183.x; BLACKWELL A, 1994, MED VET ENTOMOL, V8, P20, DOI 10.1111/j.1365-2915.1994.tb00378.x; BOORMAN J, 1970, B ENTOMOL RES, V60, P189, DOI 10.1017/S0007485300058624; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Collard R., 1993, GUIDE PLATEAU HAUTES; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; Del?colle J.C., 1985, THESIS U LOUIS PASTE; Delecolle Jean-Claude, 2002, Bulletin de la Societe Entomologique de France, V107, P371; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; DYCE A L, 1969, Journal of the Australian Entomological Society, V8, P11; Dzhafarov SH, 1976, BITING MIDGES DIPTER; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Glushchenko N. P., 2008, Russian Entomological Journal, V17, P63; Goetghebuer M., 1952, Biologisch Jaarboek Antwerpen, V19, P185; Harrup LE, 2013, MED VET ENTOMOL, V27, P441, DOI 10.1111/mve.12006; HENDRY G, 1988, Scottish Forestry, V42, P113; HILL MA, 1947, ANN TROP MED PARASIT, V41, P55, DOI 10.1080/00034983.1947.11685315; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoffmann B, 2009, EMERG INFECT DIS, V15, P1481, DOI 10.3201/eid1509.090562; HOLMES PR, 1987, MED VET ENTOMOL, V1, P349, DOI 10.1111/j.1365-2915.1987.tb00366.x; JENNINGS DM, 1988, VET MICROBIOL, V17, P1, DOI 10.1016/0378-1135(88)90074-0; KETTLE D. S., 1961, BULL ENTOMOL RES, V52, P381, DOI 10.1017/S0007485300055474; KETTLE DS, 1952, B ENTOMOL RES, V43, P421, DOI 10.1017/S000748530002945X; Logan JG, 2009, J MED ENTOMOL, V46, P208, DOI 10.1603/033.046.0205; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MURRAY WILLIAM S., 1957, MOSQUITO NEWS, V17, P77; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Saegerman C, 2008, POINT VET, V39, P41; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Takken W, 2008, PREV VET MED, V87, P41, DOI 10.1016/j.prevetmed.2008.06.015; Thiry E, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327; Uslu U, 2006, MED VET ENTOMOL, V20, P350, DOI 10.1111/j.1365-2915.2006.00626.x; Valkiunas G, 2004, J PARASITOL, V90, P196, DOI 10.1645/GE-3223RN; Weinburgh H. B., 1962, CULICOIDES PUBLIC HL; Zimmer JY, 2008, VET REC, V162, P131, DOI 10.1136/vr.162.4.131; Zimmer JY, 2013, VET PARASITOL, V191, P197, DOI 10.1016/j.vetpar.2012.08.014; Zimmer JY, 2009, ANN SOC ENTOMOL FR, V45, P393, DOI 10.1080/00379271.2009.10697623; Zimmer JY, 2010, EMERG INFECT DIS, V16, P575, DOI 10.3201/eid1603.091311	48	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66893	10.1371/journal.pone.0066893	http://dx.doi.org/10.1371/journal.pone.0066893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799137	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300102
J	Alfonso-Morales, A; Martinez-Perez, O; Dolz, R; Valle, R; Perera, CL; Bertran, K; Frias, MT; Majo, N; Ganges, L; Perez, LJ				Alfonso-Morales, Abdulahi; Martinez-Perez, Orlando; Dolz, Roser; Valle, Rosa; Perera, Carmen L.; Bertran, Kateri; Frias, Maria T.; Majo, Natalia; Ganges, Llilianne; Perez, Lester J.			Spatiotemporal Phylogenetic Analysis and Molecular Characterisation of Infectious Bursal Disease Viruses Based on the VP2 Hyper-Variable Region	PLOS ONE			English	Article							WILD BIRDS; RECOMBINATION; INFERENCE; OUTBREAK; IBDV; EPIDEMIOLOGY; ALGORITHM; SEQUENCES; SELECTION; REVEALS	Background: Infectious bursal disease is a highly contagious and acute viral disease caused by the infectious bursal disease virus (IBDV); it affects all major poultry producing areas of the world. The current study was designed to rigorously measure the global phylogeographic dynamics of IBDV strains to gain insight into viral population expansion as well as the emergence, spread and pattern of the geographical structure of very virulent IBDV (vvIBDV) strains. Methodology/Principal Findings: Sequences of the hyper-variable region of the VP2 (HVR-VP2) gene from IBDV strains isolated from diverse geographic locations were obtained from the GenBank database; Cuban sequences were obtained in the current work. All sequences were analysed by Bayesian phylogeographic analysis, implemented in the Bayesian Evolutionary Analysis Sampling Trees (BEAST), Bayesian Tip-association Significance testing (BaTS) and Spatial Phylogenetic Reconstruction of Evolutionary Dynamics (SPREAD) software packages. Selection pressure on the HVR-VP2 was also assessed. The phylogeographic association-trait analysis showed that viruses sampled from individual countries tend to cluster together, suggesting a geographic pattern for IBDV strains. Spatial analysis from this study revealed that strains carrying sequences that were linked to increased virulence of IBDV appeared in Iran in 1981 and spread to Western Europe (Belgium) in 1987, Africa (Egypt) around 1990, East Asia (China and Japan) in 1993, the Caribbean Region (Cuba) by 1995 and South America (Brazil) around 2000. Selection pressure analysis showed that several codons in the HVR-VP2 region were under purifying selection. Conclusions/Significance: To our knowledge, this work is the first study applying the Bayesian phylogeographic reconstruction approach to analyse the emergence and spread of vvIBDV strains worldwide.	[Alfonso-Morales, Abdulahi; Perera, Carmen L.; Frias, Maria T.; Perez, Lester J.] Ctr Nacl Sanidad Agropecuaria CENSA, Havana, Cuba; [Martinez-Perez, Orlando] UCI, Havana, Cuba; [Dolz, Roser; Valle, Rosa; Bertran, Kateri; Majo, Natalia; Ganges, Llilianne] Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona	Perez, LJ (corresponding author), Ctr Nacl Sanidad Agropecuaria CENSA, Havana, Cuba.	lesterjosue@censa.edu.cu	Masferrer, Natàlia Majó/AAV-3696-2021; Perez, Lester J./A-1339-2016; Ganges, Llilianne/O-7342-2017; Bertran, Kateri/H-3458-2019	Perez, Lester J./0000-0002-5717-5181; Ganges, Llilianne/0000-0002-8644-3560; Bertran, Kateri/0000-0002-6920-4154; Perera, Carmen Laura/0000-0002-8032-0412; Alfonso, Abdulahi/0000-0002-8710-6099; Majo, Natalia/0000-0003-0189-9751	MAEC-AECID program of the Spanish government	MAEC-AECID program of the Spanish government	The work was partially supported by a 2011/12 scholarship from the MAEC-AECID program of the Spanish government. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhan S. M., 1994, Archives de l'Institut Razi, P1; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Babaahmady E, 2005, REDVET, V4; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Banda A, 2004, AVIAN DIS, V48, P540, DOI 10.1637/7157-12304R; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Cortey M, 2012, AVIAN PATHOL, V41, P277, DOI 10.1080/03079457.2012.682562; COSGROVE AS, 1962, AVIAN DIS, V6, P385, DOI 10.2307/1587909; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Dolz R, 2005, AVIAN DIS, V49, P332, DOI 10.1637/7299-110204R1.1; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duret L, 2008, NATURE ED, V1, P1; Elena SF, 1997, EVOLUTION, V51, P984, DOI 10.1111/j.1558-5646.1997.tb03679.x; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; de Carvalho LMF, 2013, INFECT GENET EVOL, V13, P76, DOI 10.1016/j.meegid.2012.08.016; Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003; Fernandez A, 1998, TALL INT GUMB 98 CUB, P17; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gonzalez Insua R, 2005, REDVET, V4; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Hon CC, 2006, J VIROL, V80, P8503, DOI 10.1128/JVI.00585-06; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; ISMAIL NM, 1991, AVIAN DIS, V35, P460, DOI 10.2307/1591208; ISMAIL NM, 1988, AVIAN DIS, V32, P757, DOI 10.2307/1590995; Jackwood DJ, 2007, VIROLOGY, V365, P369, DOI 10.1016/j.virol.2007.03.046; Jeon WJ, 2008, VIRUS RES, V137, P153, DOI 10.1016/j.virusres.2008.06.013; Kasanga CJ, 2008, VIRUS GENES, V36, P521, DOI 10.1007/s11262-008-0219-z; KIBENGE FSB, 1988, J GEN VIROL, V69, P1757, DOI 10.1099/0022-1317-69-8-1757; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Lasher HN, 1997, AVIAN DIS, V41, P11, DOI 10.2307/1592439; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu HJ, 2001, RES VET SCI, V70, P139, DOI 10.1053/rvsc.2001.0450; Lukert PD, 1997, DIS POULTRY, P721; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MCFERRAN JB, 1980, AVIAN PATHOL, V9, P395, DOI 10.1080/03079458008418423; Moscoso H, 2006, AVIAN DIS, V50, P391, DOI 10.1637/7505-011306R.1; NEI M, 1986, MOL BIOL EVOL, V3, P418; Noda J., 2003, Revista Cubana de Ciencia Avicola, V27, P139; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perera CL, 2002, REV CUBANA CIENCIA A, V26, P137; Perera CL, 2005, REDVET, V6; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2012, PARASITOLOGY, V139, P1914, DOI 10.1017/S0031182012000261; Rambaut A., 2008, FIGTREE V112; Rodriguez-Lecompte JC, 2005, COMP IMMUNOL MICROB, V28, P321, DOI 10.1016/j.cimid.2005.08.004; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silva FMF, 2013, INFECT GENET EVOL, V13, P18, DOI 10.1016/j.meegid.2012.09.005; SMITH JM, 1992, J MOL EVOL, V34, P126; VAKHARIA VN, 1994, VIRUS RES, V31, P265, DOI 10.1016/0168-1702(94)90009-4; Van den Berg TP, 2004, AVIAN PATHOL, V1, P1; VANDENBERG TP, 1991, AVIAN PATHOL, V20, P409, DOI 10.1080/03079459108418779; Venereo M., 1982, Revista Cubana de Ciencias Veterinarias, V13, P29; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	70	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65999	10.1371/journal.pone.0065999	http://dx.doi.org/10.1371/journal.pone.0065999			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805195	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500023
J	Bengani, H; Mendiratta, S; Maini, J; Vasanthi, D; Sultana, H; Ghasemi, M; Ahluwalia, J; Ramachandran, S; Mishra, RK; Brahmachari, V				Bengani, Hemant; Mendiratta, Shweta; Maini, Jayant; Vasanthi, Dasari; Sultana, Hina; Ghasemi, Mohsen; Ahluwalia, Jasmine; Ramachandran, Sowmya; Mishra, Rakesh K.; Brahmachari, Vani			Identification and Validation of a Putative Polycomb Responsive Element in the Human Genome	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DROSOPHILA-ENGRAILED GENE; TRITHORAX-GROUP GENE; GROUP PROTEINS; BITHORAX COMPLEX; DNA-BINDING; EPIGENETIC INHERITANCE; REPRESSOR COMPLEX; STEM-CELLS; IN-VIVO	Epigenetic cellular memory mechanisms that involve polycomb and trithorax group of proteins are well conserved across metazoans. The cis-acting elements interacting with these proteins, however, are poorly understood in mammals. In a directed search we identified a potential polycomb responsive element with 25 repeats of YY1 binding motifthatwe designate PRE-PIK3C2B as it occurs in the first intron of human PIK3C2B gene. It down regulates reporter gene expression in HEK cells and the repression is dependent on polycomb group of proteins (PcG). We demonstrate that PRE-PIK3C2B interacts directly with YY1 in vitro and recruits PRC2 complex in vivo. The localization of PcG proteins including YY1 to PRE-PIK3C2B in HEK cells is decreased on knock-down of either YY1 or SUZ12. Endogenous PRE-PIK3C2B shows bivalent marking having H3K27me3 and H3K4me3 for repressed and active state respectively. In transgenic Drosophila, PRE-PIK3C2B down regulates mini-white expression, exhibits variegation and pairing sensitive silencing (PSS), which has not been previously demonstrated for mammalian PRE. Taken together, our results strongly suggest that PRE-PIK3C2B functions as a site of interaction for polycomb proteins.	[Bengani, Hemant; Mendiratta, Shweta; Maini, Jayant; Ghasemi, Mohsen; Ahluwalia, Jasmine; Ramachandran, Sowmya; Brahmachari, Vani] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Vasanthi, Dasari; Sultana, Hina; Mishra, Rakesh K.] Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Brahmachari, V (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	vbrahmachari@acbr.du.ac.in	Ramachandran, Sowmya/AAF-9554-2019; Maini, Jayant/ABH-3245-2021; Mishra, Rakesh K/F-3496-2010	Mishra, Rakesh K/0000-0001-6636-7380	Department of Science and Technology; Council for Scientific and Industrial Research, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	VB and RKM acknowledge the grant from Department of Science and Technology and Council for Scientific and Industrial Research, Government of India. HB, HS, JA, SM, SR and JM acknowledge the financial assistance through research fellowship from Council for Scientific and Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blastyak A, 2006, MOL CELL BIOL, V26, P1434, DOI 10.1128/MCB.26.4.1434-1444.2006; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; CAMPBELL RB, 1995, MOL GEN GENET, V246, P291, DOI 10.1007/BF00288601; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Cuddapah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036365; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Fritsch C, 1999, DEVELOPMENT, V126, P3905; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Gupta R, 2011, NUCLEIC ACIDS RES, V39, pD92, DOI 10.1093/nar/gkq1171; Hagstrom K, 1997, GENETICS, V14, P61365; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kal AJ, 2000, GENE DEV, V14, P1058; Kassis JA, 2002, ADV GENET, V46, P421; KASSIS JA, 1994, GENETICS, V136, P1025; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Mishra RK, 2007, GENESIS, V45, P570, DOI 10.1002/dvg.20326; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Muller M, 1999, GENETICS, V153, P1333; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ono R, 2005, INT J HEMATOL, V81, P288, DOI 10.1532/IJH97.04196; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Ratajewski L, 2009, GENE, V94, P407; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Sipos L, 2007, P NATL ACAD SCI USA, V104, P12416, DOI 10.1073/pnas.0703144104; Soshnikova N, 2009, EPIGENETICS-US, V4, P537, DOI 10.4161/epi.4.8.10132; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Srivastava S, 2009, MOL BIOL CELL, V20, P3783, DOI 10.1091/mbc.E09-05-0390; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Voie A, 1997, CELL BIOL LAB HDB, V3, P510; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	67	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67217	10.1371/journal.pone.0067217	http://dx.doi.org/10.1371/journal.pone.0067217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805300	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500128
J	Brante, A; Fernandez, M; Viard, F				Brante, Antonio; Fernandez, Miriam; Viard, Frederique			Non-Random Sibling Cannibalism in the Marine Gastropod Crepidula coquimbensis	PLOS ONE			English	Article							EGG MASSES; OXYGEN AVAILABILITY; KIN RECOGNITION; SIZE; INVERTEBRATES; CONSTRAINTS; PERFORMANCE; EMBRYOS; AGE; IDENTIFICATION	Sibling cannibalism is commonly observed in marine species. For instance, intrabrood cannibalism has been documented in marine gastropods with direct development, suggesting a relationship between embryo behavior and the evolution of life history strategies. However, there has been little effort to document the factors driving sibling cannibalism in marine species. The kin selection theory suggests that the level of relatedness plays an important role in cannibalism patterns. We examined Crepidula coquimbensis, a marine gastropod that broods and encloses its brooded offspring in capsules. Encapsulated embryos show sibling cannibalism and high levels of intracapsular multiple paternity. Given these features, cannibalistic behavior may be driven by kin-relatedness. To test this hypothesis, we constructed artificial aggregations of embryos to mimic three levels of relatedness: high, medium and low. For each category of aggregation, the cannibalism rate and benefits (i.e. size at hatching of surviving offspring) were estimated. In addition, at the end of embryo development, we performed parentage analyses to determine if cannibalism was associated with the relatedness between cannibal and victim embryos. Our results show that the intensity of sibling cannibalism increased in aggregations characterized by the lowest level of relatedness. There were important benefits of cannibalism in terms of hatching cannibal size. In addition, cannibalism between embryos was not random: the variation in reproductive success between males increased over the course of the experiment and the effective number of fathers decreased. Altogether, these results suggest that polyandry may play an important role in the evolution of sibling cannibalism in C. coquimbensis and that kin selection may operate during early embryonic stages in this species.	[Brante, Antonio] Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile; [Fernandez, Miriam] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Estn Costera Invest Marinas Las Cruces, Ctr Marine Conservat,Dept Ecol, Santiago, Chile; [Brante, Antonio; Fernandez, Miriam; Viard, Frederique] Int Associated Lab Dispersal & Adaptat Marine Spe, Stn Biol Roscoff, Roscoff, France; [Brante, Antonio; Fernandez, Miriam; Viard, Frederique] Int Associated Lab Dispersal & Adaptat Marine Spe, Ctr Adv Studies Ecol & Biodivers CASEB, Roscoff, France; [Viard, Frederique] UPMC Univ Paris 06, Adaptat & Div Marine Environm UMR 7144, Stn Biolog Roscoff, F-29682 Roscoff, France; [Viard, Frederique] CNRS, Stn Biol Roscoff, Team Divers & Connect Coastal Marine Landscapes, UMR 7144, F-29682 Roscoff, France	Universidad Catolica de la Santisima Concepcion; Pontificia Universidad Catolica de Chile; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Brante, A (corresponding author), Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile.	abrante@ucsc.cl	Viard, Frédérique/O-4360-2018	Viard, Frédérique/0000-0001-5603-9527; Brante, Antonio/0000-0002-2699-9700	CONICYT [AT 24050187]; French Ministry for Higher Education and Research; International Relations Department of the National Centre for Scientific (CNRS); ECOS funds; Fondecyt [11090221, 1060489]; FONDAP-FONDECYT grant [1501-0001]; French National Research Agency [ANR-05-BLAN-0001]; CNRS	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); French Ministry for Higher Education and Research; International Relations Department of the National Centre for Scientific (CNRS); ECOS funds; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP-FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); French National Research Agency(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	AB received financial support from a CONICYT PhD scholarship (AT 24050187), French Ministry for Higher Education and Research, and the International Relations Department of the National Centre for Scientific (CNRS). Travel grants were provided by ECOS funds. AB thanks the IDEA Wild foundation and Fondecyt project # 11090221. MF thanks Fondecyt project # 1060489 and FONDAP-FONDECYT grant 1501-0001 to the Center for Advanced Studies in Ecology and Biodiversity. FV and AB were supported by the French National Research Agency (Project MIRAGE, No. ANR-05-BLAN-0001). FV, MF and AB acknowledge the CNRS for its financial support of the International Associated Laboratory DIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; BAUR B, 1990, FUNCT ECOL, V4, P679, DOI 10.2307/2389736; Baur Bruno, 1992, P102; Brante A, 2008, MAR ECOL PROG SER, V368, P197, DOI 10.3354/meps07605; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Brante A, 2009, J EXP BIOL, V212, P2287, DOI 10.1242/jeb.016329; Brown DI, 1996, J NAT HIST, V30, P1443, DOI 10.1080/00222939600770821; CHAFFEE C, 1984, J EXP MAR BIOL ECOL, V84, P73, DOI 10.1016/0022-0981(84)90231-4; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; COLLINS JP, 1983, AM ZOOL, V23, P77; Crump Martha L., 1992, P256; Dugin C, 2007, MOL ECOL NOTES, DOI [10.1111/j.1471-8286.2007.01788.x, DOI 10.1111/J.1471-8286.2007.01788.X]; EICKWORT KR, 1973, AM NAT, V107, P452, DOI 10.1086/282847; Elgar M., 1992, CANNIBALISM ECOLOGY, V1st; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Emlet RB, 1997, EVOLUTION, V51, P141, DOI 10.1111/j.1558-5646.1997.tb02395.x; Fioroni P, 1967, VIE MILLEU, V18, P143; GALLARDO CS, 1979, BIOL BULL, V157, P453, DOI 10.2307/1541030; Gibson G, 1999, MAR BIOL, V134, P743, DOI 10.1007/s002270050591; GODFRAY HCJ, 1992, NATURE, V360, P213, DOI 10.1038/360213a0; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; Ito K, 1997, MAR ECOL PROG SER, V152, P187, DOI 10.3354/meps152187; Kamel SJ, 2010, INTEGR COMP BIOL, V50, P619, DOI 10.1093/icb/icq104; Kamel SJ, 2010, TRENDS ECOL EVOL, V25, P442, DOI 10.1016/j.tree.2010.05.008; KAWAI A, 1978, Kontyu, V46, P14; KLAHN JE, 1983, SCIENCE, V221, P482, DOI 10.1126/science.221.4609.482; Kudo S, 2004, OIKOS, V107, P28, DOI 10.1111/j.0030-1299.2004.13169.x; Lardies MA, 2002, MAR ECOL PROG SER, V239, P139, DOI 10.3354/meps239139; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MEAGHER TR, 1986, AM NAT, V128, P199, DOI 10.1086/284554; Miloslavich P, 2001, NAUTILUS, V115, P39; Mock D. W., 1997, EVOLUTION SIBLING RI; Mock Douglas W., 1998, P146; Moran AL, 2001, ECOLOGY, V82, P1597, DOI 10.2307/2679803; Moran AL, 2007, J EXP BIOL, V210, P722, DOI 10.1242/jeb.02702; Ng SM, 1986, ECOLOGY APHIDOPHAGA, P69; OSAWA N, 1992, RES POPUL ECOL, V34, P45, DOI 10.1007/BF02513521; PECHENIK JA, 1979, AM NAT, V114, P859, DOI 10.1086/283533; PERRON FE, 1982, OECOLOGIA, V55, P319, DOI 10.1007/BF00376919; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Pfennig DW, 1997, BIOSCIENCE, V47, P667, DOI 10.2307/1313207; PFENNIG DW, 1994, BEHAV ECOL, V5, P225, DOI 10.1093/beheco/5.2.225; PIENKOWSKI ROBERT L., 1965, ANN ENTOMOL SOC AMER, V58, P150, DOI 10.1093/aesa/58.2.150; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SPIGHT TM, 1976, BIOL BULL, V150, P491, DOI 10.2307/1540687; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; STRATHMANN RR, 1984, J EXP MAR BIOL ECOL, V84, P85, DOI 10.1016/0022-0981(84)90232-6; TRIVERS RL, 1974, AM ZOOL, V14, P249; Veliz D, 2003, MAR BIOL, V143, P131, DOI 10.1007/s00227-003-1042-7; WADE MJ, 1980, EVOLUTION, V34, P844, DOI 10.1111/j.1558-5646.1980.tb04023.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WOURMS JP, 1977, AM ZOOL, V17, P379; YUND PO, 1994, ECOLOGY, V75, P2151, DOI 10.2307/1940874	60	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67050	10.1371/journal.pone.0067050	http://dx.doi.org/10.1371/journal.pone.0067050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805291	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500119
J	Csolle, C; Baranyi, M; Zsilla, G; Kittel, A; Goloncser, F; Illes, P; Papp, E; Vizi, ES; Sperlagh, B				Csoelle, Cecilia; Baranyi, Maria; Zsilla, Gabriella; Kittel, Agnes; Goeloencser, Flora; Illes, Peter; Papp, Edit; Vizi, E. Sylvester; Sperlagh, Beata			Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; C-FOS EXPRESSION; P2X(7) RECEPTORS; NMDA RECEPTORS; ANIMAL-MODELS; P2RX7 GENE; NEUROTRANSMITTER RELEASE; DIFFERENTIAL REGULATION; GLN460ARG POLYMORPHISM; GLUTAMATE RELEASE	Recent investigations have revealed that the genetic deletion of P2X7 receptors (P2rx7) results in an antidepressant phenotype in mice. However, the link between the deficiency of P2rx7 and changes in behavior has not yet been explored. In the present study, we studied the effect of genetic deletion of P2rx7 on neurochemical changes in the hippocampus that might underlie the antidepressant phenotype. P2X7 receptor deficient mice (P2rx7-/-) displayed decreased immobility in the tail suspension test (TST) and an attenuated anhedonia response in the sucrose preference test (SPT) following bacterial endotoxin (LPS) challenge. The attenuated anhedonia was reproduced through systemic treatments with P2rx7 antagonists. The activation of P2rx7 resulted in the concentration-dependent release of [H-3]glutamate in P2rx7+/+ but not P2rx7-/- mice, and the NR2B subunit mRNA and protein was upregulated in the hippocampus of P2rx7-/- mice. The brain-derived neurotrophic factor (BDNF) expression was higher in saline but not LPS-treated P2rx7-/- mice; the P2rx7 antagonist Brilliant blue G elevated and the P2rx7 agonist benzoylbenzoyl ATP (BzATP) reduced BDNF level. This effect was dependent on the activation of NMDA and non-NMDA receptors but not on Group I metabotropic glutamate receptors (mGluR(1,5)). An increased 5-bromo-2-deoxyuridine (BrdU) incorporation was also observed in the dentate gyrus derived from P2rx7-/- mice. Basal level of 5-HT was increased, whereas the 5HIAA/5-HT ratio was lower in the hippocampus of P2rx7-/- mice, which accompanied the increased uptake of [H-3]5-HT and an elevated number of [H-3]citalopram binding sites. The LPS-induced elevation of 5-HT level was absent in P2rx7-/- mice. In conclusion there are several potential mechanisms for the antidepressant phenotype of P2rx7-/- mice, such as the absence of P2rx7-mediated glutamate release, elevated basal BDNF production, enhanced neurogenesis and increased 5-HT bioavailability in the hippocampus.	[Csoelle, Cecilia; Baranyi, Maria; Zsilla, Gabriella; Kittel, Agnes; Goeloencser, Flora; Vizi, E. Sylvester; Sperlagh, Beata] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary; [Papp, Edit] Hungarian Acad Sci, Inst Expt Med, Dept Cellular & Network Neurobiol, Budapest, Hungary; [Vizi, E. Sylvester] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary; [Illes, Peter] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04109 Leipzig, Germany	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; Leipzig University	Sperlagh, B (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary.	sperlagh@koki.hu			Hungarian Research and Development Fund [NN79957]; Hungarian Medical Research Council [ETT 05-102]; Gedeon Richter plc [4700127848]; NIH grant [U24NS050606]; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	Hungarian Research and Development Fund; Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gedeon Richter plc; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Hungarian Research and Development Fund (Grant NN79957 to B.S.) and the Hungarian Medical Research Council (ETT 05-102 to B.S.) and the Gedeon Richter plc (4700127848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study received funding from the Gedeon Richter plc (4700127848). This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.; The authors are grateful to Zsuzsanna Korossy for the participation in [<SUP>3</SUP>H]glutamate, [<SUP>3</SUP>H]5-HT and [<SUP>3</SUP>H]NA release experiments. They wish to thank Mr. Laszlo Barna, the Nikon Microscopy Center at IEM, Nikon Austria GmbH and Auro-Science Consulting Ltd for kindly providing microscopy support and for Kata Kenesei and Katalin Kerti (IEM HAS) for their valuable help at microscopic work. The monoclonal antibody GluN2B/NR2B was developed by and obtained from the UC Davis/NIH NeuroMab Facility, supported by NIH grant U24NS050606 and maintained by the Department of Neurobiology, Physiology and Behaviour, College of Biological Sciences, University of California, Davis, CA 95616.	Alloisio S, 2008, FEBS LETT, V582, P3948, DOI 10.1016/j.febslet.2008.10.041; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Backlund L, 2011, BIPOLAR DISORD, V13, P500, DOI 10.1111/j.1399-5618.2011.00952.x; Balazsa T, 2008, NEUROCHEM INT, V52, P95, DOI 10.1016/j.neuint.2007.07.008; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; BANERJEE SP, 1977, NATURE, V268, P455, DOI 10.1038/268455a0; Baranyi M, 2006, J CHROMATOGR A, V1120, P13, DOI 10.1016/j.chroma.2006.03.018; BARBACCIA ML, 1983, P NATL ACAD SCI-BIOL, V80, P5134, DOI 10.1073/pnas.80.16.5134; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Barnholtz JS, 1999, GENET EPIDEMIOL, V17, pS49; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bocchio-Chiavetto L, 2006, EUR NEUROPSYCHOPHARM, V16, P620, DOI 10.1016/j.euroneuro.2006.04.010; Boucher AA, 2011, NEUROSCIENCE, V189, P170, DOI 10.1016/j.neuroscience.2011.05.049; Boyce-Rustay JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2405, DOI 10.1038/sj.npp.1301039; Brautigam VM, 2005, J NEUROIMMUNOL, V166, P113, DOI 10.1016/j.jneuroim.2005.05.012; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Csolle C, 2013, INT J NEUROPSYCHOPH, V16, P213, DOI 10.1017/S1461145711001933; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Deltheil T, 2008, PHARMACOL BIOCHEM BE, V90, P174, DOI 10.1016/j.pbb.2007.09.018; Diaz-Hernandez M, 2008, J CELL SCI, V121, P3717, DOI 10.1242/jcs.034082; Drigues N, 2003, J NEURAL TRANSM, V110, P1413, DOI 10.1007/s00702-003-0077-8; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Duman RS, 1998, J ECT, V14, P181; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Fuchs E, 2004, EUR NEUROPSYCHOPHARM, V14, pS481, DOI 10.1016/j.euroneuro.2004.09.002; Gourine AV, 2005, BRIT J PHARMACOL, V146, P139, DOI 10.1038/sj.bjp.0706287; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Grigoroiu-Serbanescu M, 2009, AM J MED GENET B, V150B, P1017, DOI 10.1002/ajmg.b.30952; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Guerra AN, 2003, J ENDOTOXIN RES, V9, P256, DOI 10.1179/096805103225001468; Guiard BP, 2008, INT J NEUROPSYCHOPH, V11, P79, DOI 10.1017/S1461145707007857; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Hogg RC, 2004, EUR J NEUROSCI, V19, P2410, DOI 10.1111/j.0953-816X.2004.03346.x; Hracsko Z, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-28; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Kozisek ME, 2008, NEUROPHARMACOLOGY, V54, P251, DOI 10.1016/j.neuropharm.2007.08.001; Krueger JM, 2010, J APPL PHYSIOL, V109, P1318, DOI 10.1152/japplphysiol.00586.2010; Labrousse VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006006; LAPCHAK PA, 1993, NEUROBIOL AGING, V14, P121, DOI 10.1016/0197-4580(93)90087-R; Lavebratt C, 2010, J AFFECT DISORDERS, V125, P249, DOI 10.1016/j.jad.2010.02.113; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Masin M, 2012, BRIT J PHARMACOL, V165, P978, DOI 10.1111/j.1476-5381.2011.01624.x; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Meador-Woodruff JH, 2001, NEUROPSYCHOPHARMACOL, V24, P545, DOI 10.1016/S0893-133X(00)00189-5; Michel AD, 2008, BRIT J PHARMACOL, V153, P737, DOI 10.1038/sj.bjp.0707625; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Mundo E, 2003, MOL PSYCHIATR, V8, P241, DOI 10.1038/sj.mp.4001218; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nowak G, 1998, EUR J PHARMACOL, V342, P367, DOI 10.1016/S0014-2999(97)01589-6; Papp L, 2004, NEUROREPORT, V15, P2387, DOI 10.1097/00001756-200410250-00017; Papp L, 2004, J PHARMACOL EXP THER, V310, P973, DOI 10.1124/jpet.104.066712; Patti L, 2006, NEUROPHARMACOLOGY, V50, P705, DOI 10.1016/j.neuropharm.2005.11.016; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Sanacora G, 2008, J CLIN PSYCHIAT, V69, P22; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sanacora G, 2010, BIOL PSYCHIAT, V67, P397, DOI 10.1016/j.biopsych.2010.01.003; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schnydrig S, 2007, NEUROSCI LETT, V429, P69, DOI 10.1016/j.neulet.2007.09.067; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Shukla V, 2005, J NEUROSCI RES, V80, P600, DOI 10.1002/jnr.20508; Skolnick P, 1996, PHARMACOPSYCHIATRY, V29, P23, DOI 10.1055/s-2007-979537; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Toro C, 2005, SCHIZOPHR RES, V80, P323, DOI 10.1016/j.schres.2005.07.003; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Verderio C, 2006, BRAIN CELL BIOL, V35, P187, DOI 10.1007/s11068-007-9011-6; Viwatpinyo K, 2009, NEUROSCI LETT, V467, P127, DOI 10.1016/j.neulet.2009.10.020; Wager-Smith K, 2011, NEUROSCI BIOBEHAV R, V35, P742, DOI 10.1016/j.neubiorev.2010.09.010; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Williams SN, 2010, J PHARMACOL EXP THER, V332, P463, DOI 10.1124/jpet.109.158535; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Zhang L, 2011, J PSYCHIATR RES, V45, P435, DOI 10.1016/j.jpsychires.2010.08.012; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	106	80	83	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66547	10.1371/journal.pone.0066547	http://dx.doi.org/10.1371/journal.pone.0066547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805233	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500061
J	Day, TE; Ravi, N; Xian, H; Brugh, A				Day, Theodore Eugene; Ravi, Nathan; Xian, Hong; Brugh, Ann			An Agent-Based Modeling Template for a Cohort of Veterans with Diabetic Retinopathy	PLOS ONE			English	Article							MACULAR DEGENERATION; HEALTH; PREVALENCE	Background: Agent-based models are valuable for examining systems where large numbers of discrete individuals interact with each other, or with some environment. Diabetic Veterans seeking eye care at a Veterans Administration hospital represent one such cohort. Objective: The objective of this study was to develop an agent-based template to be used as a model for a patient with diabetic retinopathy (DR). This template may be replicated arbitrarily many times in order to generate a large cohort which is representative of a real-world population, upon which in-silico experimentation may be conducted. Methods: Agent-based template development was performed in java-based computer simulation suite AnyLogic Professional 6.6. The model was informed by medical data abstracted from 535 patient records representing a retrospective cohort of current patients of the VA St. Louis Healthcare System Eye clinic. Logistic regression was performed to determine the predictors associated with advancing stages of DR. Predicted probabilities obtained from logistic regression were used to generate the stage of DR in the simulated cohort. Results: The simulated cohort of DR patients exhibited no significant deviation from the test population of real-world patients in proportion of stage of DR, duration of diabetes mellitus (DM), or the other abstracted predictors. Simulated patients after 10 years were significantly more likely to exhibit proliferative DR (P<0.001). Conclusions: Agent-based modeling is an emerging platform, capable of simulating large cohorts of individuals based on manageable data abstraction efforts. The modeling method described may be useful in simulating many different conditions where course of disease is described in categorical stages.	[Day, Theodore Eugene; Ravi, Nathan; Xian, Hong; Brugh, Ann] VA St Louis Healthcare Syst, St Louis, MO USA; [Ravi, Nathan] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Ravi, Nathan] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA; [Xian, Hong] St Louis Univ, Dept Biostat, St Louis, MO 63103 USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Day, TE (corresponding author), Childrens Hosp Philadelphia, Off Patient Safety & Qual, Philadelphia, PA 19104 USA.	dayt@chop.edu			Veterans Affairs Office of Research and Development's Health Services Research and Development Merit Review Pilot Program [PPO 11-167]; Veterans Affairs [I01HX000622] Funding Source: NIH RePORTER	Veterans Affairs Office of Research and Development's Health Services Research and Development Merit Review Pilot Program; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Office of Research and Development's Health Services Research and Development Merit Review Pilot Program, PPO 11-167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Elliott E, 2002, P NATL ACAD SCI USA, V99, P7193, DOI 10.1073/pnas.102079099; Forrest S., 1994, COMPLEX SYSTEMS MECH; Gorman DM, 2006, AM J PUBLIC HEALTH, V96, P2055, DOI 10.2105/AJPH.2005.063289; Harper C Alex, 1999, Clin Exp Optom, V82, P98; Jones Spencer S, 2008, AMIA Annu Symp Proc, P338; KLEIN R, 1995, DIABETES AM, P293; Kupersmith J, 2007, HEALTH AFFAIR, V26, pW156, DOI 10.1377/hlthaff.26.2.w156; Landers J, 2012, CLIN EXP OPHTHALMOL, V40, P83, DOI 10.1111/j.1442-9071.2011.02725.x; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; MOSS SE, 1988, OPHTHALMOLOGY, V95, P1340; Rein DB, 2007, OPHTHALMOLOGY, V114, P1319, DOI 10.1016/j.ophtha.2006.10.041; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Sloan FA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1462, DOI 10.1001/archopht.121.10.1462; Tapp RJ, 2008, DIABETES CARE, V31, P1349, DOI 10.2337/dc07-1707; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	20	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66812	10.1371/journal.pone.0066812	http://dx.doi.org/10.1371/journal.pone.0066812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805280	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500108
J	Gordon, J; Sariyer, IK; De La Fuente-Granada, M; Augelli, BJ; Otte, J; Azizi, SA; Amini, S; Khalili, K; Krynska, B				Gordon, Jennifer; Sariyer, Ilker K.; De La Fuente-Granada, Marisol; Augelli, Brian J.; Otte, Jessica; Azizi, S. Ausim; Amini, Shohreh; Khalili, Kamel; Krynska, Barbara			Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HUMAN NEUROTROPIC POLYOMAVIRUS; STEM-CELLS; STROMAL CELLS; PROGENITOR CELLS; BRAIN-TUMORS; VIRUS; DIFFERENTIATION; PATHOGENESIS	JC virus (JCV), a common human polyomavirus, is the etiological agent of the demyelinating disease, progressive multifocal leukoencephalopathy (PML). In addition to its role in PML, studies have demonstrated the transforming ability of the JCV early protein, T-antigen, and its association with some human cancers. JCV infection occurs in childhood and latent virus is thought to be maintained within the bone marrow, which harbors cells of hematopoietic and non-hematopoietic lineages. Here we show that non-hematopoietic mesenchymal stem cells (MSCs) isolated from the bone marrow of JCV T-antigen transgenic mice give rise to JCV T-antigen positive cells when cultured under neural conditions. JCV T-antigen positive cells exhibited neural crest characteristics and demonstrated p75, SOX-10 and nestin positivity. When cultured in conditions typical for mesenchymal cells, a population of T-antigen negative cells, which did not express neural crest markers arose from the MSCs. JCV T-antigen positive cells could be cultured long-term while maintaining their neural crest characteristics. When these cells were induced to differentiate into neural crest derivatives, JCV T-antigen was downregulated in cells differentiating into bone and maintained in glial cells expressing GFAP and S100. We conclude that JCV T-antigen can be stably expressed within a fraction of bone marrow cells differentiating along the neural crest/glial lineage when cultured in vitro. These findings identify a cell population within the bone marrow permissible for JCV early gene expression suggesting the possibility that these cells could support persistent viral infection and thus provide clues toward understanding the role of the bone marrow in JCV latency and reactivation. Further, our data provides an excellent experimental model system for studying the cell-type specificity of JCV T-antigen expression, the role of bone marrow-derived stem cells in the pathogenesis of JCV-related diseases and the opportunities for the use of this model in development of therapeutic strategies.	[Gordon, Jennifer; Sariyer, Ilker K.; Otte, Jessica; Amini, Shohreh; Khalili, Kamel] Temple Univ, Sch Med, Ctr Neurovirol, Dept Neurosci, Philadelphia, PA USA; [De La Fuente-Granada, Marisol; Augelli, Brian J.; Azizi, S. Ausim; Krynska, Barbara] Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19122 USA; [De La Fuente-Granada, Marisol; Krynska, Barbara] Temple Univ, Sch Med, Ctr Neural Repair & Rehabil, Shriners Hosp,Pediat Res Ctr, Philadelphia, PA USA; [Amini, Shohreh] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Krynska, B (corresponding author), Temple Univ, Sch Med, Dept Neurol, Philadelphia, PA 19122 USA.	krynskb@tuhs.temple.edu	De La Fuente-Granada, Marisol/F-3745-2019; Sariyer, Ilker/AAE-7677-2020	De La Fuente-Granada, Marisol/0000-0002-6878-4265; Azizi, Sayed/0000-0002-0888-5013	National Institutes of Health; SHPRC; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine [P30MH092177]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SHPRC; Comprehensive NeuroAIDS Center (CNAC NIMH) at Temple University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was made possible by grants awarded by National Institutes of Health to JG and by SHPRC to BK. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH P30MH092177) at Temple University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTROM KE, 1958, BRAIN, V81, P93, DOI 10.1093/brain/81.1.93; Azizi SA, 2002, CONT NEUROS, P395; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BEGGS AH, 1990, J GEN VIROL, V71, P151, DOI 10.1099/0022-1317-71-1-151; Beltrami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053447; Berger JR, 2003, J NEUROVIROL, V9, P38, DOI 10.1080/13550280390195261; Del Valle L, 2010, CANC BIOL THER, V9; Franks RR, 1996, ONCOGENE, V12, P2573; Glejzer A, 2011, CELL MOL LIFE SCI, V68, P2101, DOI 10.1007/s00018-010-0558-5; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Keene CD, 2003, CELL TRANSPLANT, V12, P201, DOI 10.3727/000000003108746768; Khalili K, 2003, ONCOGENE, V22, P5181, DOI 10.1038/sj.onc.1206559; Krynska B, 1999, ONCOGENE, V18, P39, DOI 10.1038/sj.onc.1202278; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Marshall LJ, 2010, J NEUROIMMUNE PHARM, V5, P404, DOI 10.1007/s11481-010-9203-1; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Paratore C, 2001, DEVELOPMENT, V128, P3949; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; Shollar D, 2004, ONCOGENE, V23, P5459, DOI 10.1038/sj.onc.1207728; SMALL JA, 1986, P NATL ACAD SCI USA, V83, P8288, DOI 10.1073/pnas.83.21.8288; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; Warnke C, 2011, MULT SCLER J, V17, P151, DOI 10.1177/1352458510385834; Weber T, 1997, INTERVIROLOGY, V40, P98, DOI 10.1159/000150537; White MK, 2005, BRAIN RES REV, V50, P69, DOI 10.1016/j.brainresrev.2005.04.007	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65947	10.1371/journal.pone.0065947	http://dx.doi.org/10.1371/journal.pone.0065947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805194	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500022
J	Jha, A; Shankar, R				Jha, Ashwani; Shankar, Ravi			miReader: Discovering Novel miRNAs in Species without Sequenced Genome	PLOS ONE			English	Article							MICRORNA BIOGENESIS; PREDICTION; IDENTIFICATION; TRANSCRIPTION; PRECURSORS; MACHINE; GENES; REAL; TOOL	Along with computational approaches, NGS led technologies have caused a major impact upon the discoveries made in the area of miRNA biology, including novel miRNAs identification. However, to this date all microRNA discovery tools compulsorily depend upon the availability of reference or genomic sequences. Here, for the first time a novel approach, miReader, has been introduced which could discover novel miRNAs without any dependence upon genomic/reference sequences. The approach used NGS read data to build highly accurate miRNA models, molded through a Multi-boosting algorithm with Best-First Tree as its base classifier. It was comprehensively tested over large amount of experimental data from wide range of species including human, plants, nematode, zebrafish and fruit fly, performing consistently with >90% accuracy. Using the same tool over Illumina read data for Miscanthus, a plant whose genome is not sequenced; the study reported 21 novel mature miRNA duplex candidates. Considering the fact that miRNA discovery requires handling of high throughput data, the entire approach has been implemented in a standalone parallel architecture. This work is expected to cause a positive impact over the area of miRNA discovery in majority of species, where genomic sequence availability would not be a compulsion any more.	[Jha, Ashwani; Shankar, Ravi] CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Studio Computat Biol & Bioinformat, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Shankar, R (corresponding author), CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Studio Computat Biol & Bioinformat, Palampur, Himachal Prades, India.	ravish@ihbt.res.in		jha, Ashwani/0000-0001-8752-3477	ICAR [NFBSFARA/RNA-3022/2012-13]; CSIR 12th FYP project [GENESIS BSC0121]; CSIR, Govt of India	ICAR(Indian Council of Agricultural Research (ICAR)); CSIR 12th FYP project; CSIR, Govt of India(Council of Scientific & Industrial Research (CSIR) - India)	The present work was supported by ICAR grant NFBSFARA/RNA-3022/2012-13 and CSIR 12th FYP project GENESIS BSC0121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to CSIR, Govt of India, for support to Ashwani Jha. We are grateful to Dr RD Singh, CSIR-IHBT, for proofreading and editing this MS for language. We are also thankful to the Director, CSIR-IHBT, for his support. Also, we would like to show our gratitude to open source and open access communities and portals.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Baigude H, 2012, ANGEW CHEM INT EDIT, V51, P5880, DOI 10.1002/anie.201201512; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gardner PP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-140; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; He CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051673; Jha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045782; Jha A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-636; Jha A, 2011, J BIOSCIENCES, V36, P621, DOI 10.1007/s12038-011-9109-y; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Piriyapongsa J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-61; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Ronen R, 2010, BIOINFORMATICS, V26, p[261, 5]; Shi H., 2007, BEST 1 DECISION TREE; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Terai G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044314; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Webb Geoffrey I., 2000, MACHINE LEARNING, V40; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491	36	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66857	10.1371/journal.pone.0066857	http://dx.doi.org/10.1371/journal.pone.0066857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805282	Green Published, gold			2022-12-27	WOS:000320846500110
J	O'Neill, V; Asani, FF; Jeffery, TJ; Saccone, DS; Bornman, L				O'Neill, Vanessa; Asani, Furaha Florence; Jeffery, Tamsyn Jacki; Saccone, Donovan Sean; Bornman, Liza			Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; SKIN PIGMENTATION; COLORECTAL-CANCER; D DEFICIENCY; TUBERCULOSIS; POLYMORPHISM; SUPPLEMENTATION; DETERMINANTS; INFECTION; PROMOTER	Polymorphisms of the vitamin D receptor gene (VDR) have been associated inconsistently with various diseases, across populations of diverse origin. The T(f) allele of the functional SNP FokI, in exon 2 of VDR, results in a longer vitamin D receptor protein (VDR) isoform, proposed to be less active. Genetic association of VDR with disease is likely confounded by ethnicity and environmental factors such as plasma 25(OH)D-3 status. We hypothesized that VDR expression, VDR level and transactivation of target genes, CAMP and CYP24A1, depend on vitamin D, ethnicity and FokI genotype. Healthy volunteers participated in the study (African, n = 40 and White, n = 20). Plasma 25(OH)D-3 levels were quantified by LC-MS and monocytes cultured, with or without 1,25(OH)(2)D-3. Gene expression and protein level was quantified using qRT-PCR and flow cytometry, respectively. Mean plasma 25(OH)D-3 status was normal and not significantly different between ethnicities. Neither 25(OH)D-3 status nor 1,25(OH)(2)D-3 supplementation significantly influenced expression or level of VDR. Africans had significantly higher mean VDR protein levels (P<0.050), nonetheless transactivated less CAMP expression than Whites. Genotyping the FokI polymorphism by pyrosequencing together with HapMap data, showed a significantly higher (P<0.050) frequency of the CC genotype in Africans than in Whites. FokI genotype, however, did not influence VDR expression or VDR level, but influenced overall transactivation of CAMP and 1,25(OH)(2)D-3-elicited CYP24A1 induction; the latter, interacting with ethnicity. In conclusion, differential VDR expression relates to ethnicity, rather than 25(OH)D-3 status and FokI genotype. Instead, VDR transactivation of CAMP is influenced by FokI genotype and, together with ethnicity, influence 1,25(OH)(2)D-3-elicited CYP24A1 expression. Thus, the expression and role of VDR to transactivate target genes is determined not only by genetics, but also by ethnicity and environment involving complex interactions which may confound disease association.	[O'Neill, Vanessa; Asani, Furaha Florence; Jeffery, Tamsyn Jacki; Saccone, Donovan Sean; Bornman, Liza] Univ Johannesburg, Dept Biochem, Johannesburg, Gauteng, South Africa	University of Johannesburg	Bornman, L (corresponding author), Univ Johannesburg, Dept Biochem, Johannesburg, Gauteng, South Africa.	lizab@uj.ac.za		Meyer, Vanessa/0000-0002-1171-8195	National Research Foundation (NRF) [81774]; Cancer Association of South Africa (CANSA)	National Research Foundation (NRF); Cancer Association of South Africa (CANSA)	This study was supported by funding from the National Research Foundation (NRF, www.nrf.ac.za, Grant No 81774) and Cancer Association of South Africa (CANSA, www.cansa.org.za, Research Grant L. Bornman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Alimirah F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016024; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Ashktorab H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025314; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Berry D, 2011, CURR OPIN NEPHROL HY, V20, P331, DOI 10.1097/MNH.0b013e328346d6ba; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buttigliero C, 2011, ONCOLOGIST, V16, P1215, DOI 10.1634/theoncologist.2011-0098; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Carter GD, 2011, CURR DRUG TARGETS, V12, P19; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Dawson-Hughes B, 2004, AM J CLIN NUTR, V80, p1763S, DOI 10.1093/ajcn/80.6.1763S; Dendrou Calliope A., 2009, Advances in Bioinformatics, V2009, P476106, DOI 10.1155/2009/476106; Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hendrickson WK, 2011, J CLIN ONCOL, V29, P2378, DOI 10.1200/JCO.2010.30.9880; INTERNATIONAL H, 2013, INT, V15, P2013; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Luong KVQ, 2010, CRIT REV ONCOL HEMAT, V73, P192, DOI 10.1016/j.critrevonc.2009.04.008; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; LUI PT, 2006, SCIENCE, V311, P1770; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; MILNER J, 2008, BIOSOCIAL SURVEYS, P14; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Norman AW, 1998, AM J CLIN NUTR, V67, P1108, DOI 10.1093/ajcn/67.6.1108; OSWALD NC, 1946, THORAX, V1, P100, DOI 10.1136/thx.1.2.100; Parisi E, 2008, J STEROID BIOCHEM, V111, P87, DOI 10.1016/j.jsbmb.2008.05.001; Pettifor JM, 1996, S AFR MED J, V86, P1270; Roff A, 2008, J STEROID BIOCHEM, V112, P47, DOI 10.1016/j.jsbmb.2008.08.009; Selvaraj P, 2009, J CLIN IMMUNOL, V29, P470, DOI 10.1007/s10875-009-9277-9; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; SUMETHKUL K, 2012, RHEUMATOL INT; THEIMMUNE S, EUR J IMMUNOL, V37, P395; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; VALDIVIELSO JM, CLIN CHIMICA ACTA, V371, P1; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; WHOGLOBAL TB, 2012, WHO GLOBAL TB REPORT, V2, P2013; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Wong HL, 2003, CARCINOGENESIS, V24, P1091, DOI 10.1093/carcin/bgg059; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	56	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67663	10.1371/journal.pone.0067663	http://dx.doi.org/10.1371/journal.pone.0067663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805323	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500151
J	Rossi, F; Gribsholt, B; Gazeau, F; Di Santo, V; Middelburg, JJ				Rossi, Francesca; Gribsholt, Britta; Gazeau, Frederic; Di Santo, Valentina; Middelburg, Jack J.			Complex Effects of Ecosystem Engineer Loss on Benthic Ecosystem Response to Detrital Macroalgae	PLOS ONE			English	Article							COMMUNITY STRUCTURE; MARINE-SEDIMENTS; SPECIES RICHNESS; DIVERSITY; BIODIVERSITY; STABILITY; IMPACT; ENRICHMENT; ARENICOLA; BURROW	Ecosystem engineers change abiotic conditions, community assembly and ecosystem functioning. Consequently, their loss may modify thresholds of ecosystem response to disturbance and undermine ecosystem stability. This study investigates how loss of the bioturbating lugworm Arenicola marina modifies the response to macroalgal detrital enrichment of sediment biogeochemical properties, microphytobenthos and macrofauna assemblages. A field manipulative experiment was done on an intertidal sandflat (Oosterschelde estuary, The Netherlands). Lugworms were deliberately excluded from 1x m sediment plots and different amounts of detrital Ulva (0, 200 or 600 g Wet Weight) were added twice. Sediment biogeochemistry changes were evaluated through benthic respiration, sediment organic carbon content and porewater inorganic carbon as well as detrital macroalgae remaining in the sediment one month after enrichment. Microalgal biomass and macrofauna composition were measured at the same time. Macroalgal carbon mineralization and transfer to the benthic consumers were also investigated during decomposition at low enrichment level (200 g WW). The interaction between lugworm exclusion and detrital enrichment did not modify sediment organic carbon or benthic respiration. Weak but significant changes were instead found for porewater inorganic carbon and microalgal biomass. Lugworm exclusion caused an increase of porewater carbon and a decrease of microalgal biomass, while detrital enrichment drove these values back to values typical of lugworm-dominated sediments. Lugworm exclusion also decreased the amount of macroalgae remaining into the sediment and accelerated detrital carbon mineralization and CO2 release to the water column. Eventually, the interaction between lugworm exclusion and detrital enrichment affected macrofauna abundance and diversity, which collapsed at high level of enrichment only when the lugworms were present. This study reveals that in nature the role of this ecosystem engineer may be variable and sometimes have no or even negative effects on stability, conversely to what it should be expected based on current research knowledge.	[Rossi, Francesca] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, Montpellier, France; [Gribsholt, Britta; Middelburg, Jack J.] Royal Netherlands Inst Sea Res, Dept Ecosyst, Yerseke, Netherlands; [Gazeau, Frederic] Ctr Natl Rech Sci, Inst Natl Sci Univers, Lab Oceanograph Villefranche, Villefranche Sur Mer, France; [Gazeau, Frederic] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France; [Di Santo, Valentina] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Middelburg, Jack J.] Univ Utrecht, Dept Earth Sci Geochem, Fac Geosci, Utrecht, Netherlands	Universite de Montpellier; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Boston University; Utrecht University	Rossi, F (corresponding author), Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, Montpellier, France.		Rossi, Francesca/G-2807-2013; Middelburg, Jack/B-4951-2011; Gazeau, Frédéric/G-3050-2011	Rossi, Francesca/0000-0003-1928-9193; Middelburg, Jack/0000-0003-3601-9072; Gazeau, Frédéric/0000-0001-8807-4597; Di Santo, Valentina/0000-0002-5419-3747	PIONIER grant of the Netherlands Organization for Scientific Research	PIONIER grant of the Netherlands Organization for Scientific Research	This work was funded by a PIONIER grant of the Netherlands Organization for Scientific Research to JJM. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Berke SK, 2010, INTEGR COMP BIOL, V50, P147, DOI 10.1093/icb/icq077; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Bolam SG, 2000, J EXP MAR BIOL ECOL, V249, P123, DOI 10.1016/S0022-0981(00)00185-4; Braeckman U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018078; BUCHSBAUM R, 1991, MAR ECOL PROG SER, V72, P131, DOI 10.3354/meps072131; Cebrian J, 2004, ECOL LETT, V7, P232, DOI 10.1111/j.1461-0248.2004.00574.x; D'Andrea AF, 2009, LIMNOL OCEANOGR, V54, P1911, DOI 10.4319/lo.2009.54.6.1911; Downing AL, 2010, FRESHWATER BIOL, V55, P2123, DOI 10.1111/j.1365-2427.2010.02472.x; Eisenhauer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003489; Eklof JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023229; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Ford RB, 1999, MAR ECOL PROG SER, V191, P163, DOI 10.3354/meps191163; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Goodsell PJ, 2008, OECOLOGIA, V157, P509, DOI 10.1007/s00442-008-1087-x; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Hansen K, 1998, J EXP MAR BIOL ECOL, V231, P201, DOI 10.1016/S0022-0981(98)00070-7; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hillebrand H, 2000, MAR ECOL PROG SER, V204, P27, DOI 10.3354/meps204027; Huettel M, 2003, HYDROBIOLOGIA, V494, P231, DOI 10.1023/A:1025426601773; HULL SC, 1987, ESTUAR COAST SHELF S, V25, P519, DOI 10.1016/0272-7714(87)90112-0; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kelaher BP, 2003, MAR ECOL PROG SER, V261, P85, DOI 10.3354/meps261085; Kristensen E, 2001, ABSTR PAP AM CHEM S, V221, pU538; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Lennon JT, 2004, OECOLOGIA, V138, P584, DOI 10.1007/s00442-003-1459-1; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mckie BG, 2009, OECOLOGIA, V160, P757, DOI 10.1007/s00442-009-1336-7; Meysman FJR, 2006, LIMNOL OCEANOGR, V51, P142, DOI 10.4319/lo.2006.51.1.0142; Nedergaard RI, 2002, J EXP MAR BIOL ECOL, V275, P15, DOI 10.1016/S0022-0981(02)00211-3; Needham HR, 2011, ECOSYSTEMS, V14, P1096, DOI 10.1007/s10021-011-9468-0; Norkko A, 1996, MAR ECOL PROG SER, V140, P141, DOI 10.3354/meps140141; Norkko J, 2012, GLOBAL CHANGE BIOL, V18, P422, DOI 10.1111/j.1365-2486.2011.02513.x; O'Brien AL, 2009, J EXP MAR BIOL ECOL, V371, P51, DOI 10.1016/j.jembe.2009.01.004; Papaspyrou S, 2007, ESTUAR COAST SHELF S, V72, P213, DOI 10.1016/j.ecss.2006.10.020; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Raffaelli DG, 1998, OCEANOGR MAR BIOL<D>, V36, P97; Retraubun ASW, 1996, J EXP MAR BIOL ECOL, V202, P107, DOI 10.1016/0022-0981(96)00017-2; Riera P, 2010, J SEA RES, V63, P78, DOI 10.1016/j.seares.2009.10.001; Romanuk TN, 2009, OIKOS, V118, P819, DOI 10.1111/j.1600-0706.2008.17273.x; Rossi F, 2006, J EXP MAR BIOL ECOL, V332, P84, DOI 10.1016/j.jembe.2005.11.003; Rossi F, 2002, MAR ECOL PROG SER, V241, P29, DOI 10.3354/meps241029; Rossi F, 2007, MAR BIOL, V150, P1073, DOI 10.1007/s00227-006-0438-6; Rossi F, 2009, OIKOS, V118, P503, DOI 10.1111/j.1600-0706.2009.17112.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; THRUSH SF, 1986, J EXP MAR BIOL ECOL, V96, P199, DOI 10.1016/0022-0981(86)90203-0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Volkenborn N, 2006, J EXP MAR BIOL ECOL, V330, P169, DOI 10.1016/j.jembe.2005.12.025; Vonk JA, 2008, ESTUAR COAST SHELF S, V79, P79, DOI 10.1016/j.ecss.2008.03.003; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	54	17	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66650	10.1371/journal.pone.0066650	http://dx.doi.org/10.1371/journal.pone.0066650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805256	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500084
J	Staggs, SE; Beckman, EM; Keely, SP; Mackwan, R; Ware, MW; Moyer, AP; Ferretti, JA; Abu Sayed; Xiao, LH; Villegas, EN				Staggs, Sarah E.; Beckman, Erin M.; Keely, Scott P.; Mackwan, Reena; Ware, Michael W.; Moyer, Alan P.; Ferretti, James A.; Abu Sayed; Xiao, Lihua; Villegas, Eric N.			The Applicability of TaqMan-Based Quantitative Real-Time PCR Assays for Detecting and Enumerating Cryptosporidium spp. Oocysts in the Environment	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; N. SP APICOMPLEXA; SOURCE TRACKING; WATER; PARVUM; GENOTYPES; QUANTIFICATION; CUNICULUS; HOMINIS	Quantitative real-time polymerase chain reaction (qPCR) assays to detect Cryptosporidium oocysts in clinical samples are increasingly being used to diagnose human cryptosporidiosis, but a parallel approach for detecting and identifying Cryptosporidium oocyst contamination in surface water sources has yet to be established for current drinking water quality monitoring practices. It has been proposed that Cryptosporidium qPCR-based assays could be used as viable alternatives to current microscopic-based detection methods to quantify levels of oocysts in drinking water sources; however, data on specificity, analytical sensitivity, and the ability to accurately quantify low levels of oocysts are limited. The purpose of this study was to provide a comprehensive evaluation of TaqMan-based qPCR assays, which were developed for either clinical or environmental investigations, for detecting Cryptosporidium oocyst contamination in water. Ten different qPCR assays, six previously published and four developed in this study were analyzed for specificity and analytical sensitivity. Specificity varied between all ten assays, and in one particular assay, which targeted the Cryptosporidium 18S rRNA gene, successfully detected all Cryptosporidium spp. tested, but also cross-amplified T. gondii, fungi, algae, and dinoflagellates. When evaluating the analytical sensitivity of these qPCR assays, results showed that eight of the assays could reliably detect ten flow-sorted oocysts in reagent water or environmental matrix. This study revealed that while a qPCR-based detection assay can be useful for detecting and differentiating different Cryptosporidium species in environmental samples, it cannot accurately measure low levels of oocysts that are typically found in drinking water sources.	[Staggs, Sarah E.; Keely, Scott P.; Ware, Michael W.; Villegas, Eric N.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA; [Beckman, Erin M.; Mackwan, Reena; Abu Sayed] Dynamac Corp, Cincinnati, OH USA; [Moyer, Alan P.; Villegas, Eric N.] Univ Cincinnati, McMicken Sch Arts & Sci, Dept Biol Sci, Cincinnati, OH USA; [Ferretti, James A.] US EPA, Edison, NJ USA; [Xiao, Lihua] Ctr Dis Control & Prevent, Atlanta, GA USA	United States Environmental Protection Agency; University System of Ohio; University of Cincinnati; United States Environmental Protection Agency; Centers for Disease Control & Prevention - USA	Villegas, EN (corresponding author), US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA.	villegas.eric@epa.gov	Keely, Scott/W-5761-2019; Xiao, Lihua/B-1704-2013; Villegas, Eric N/A-7373-2015	Keely, Scott/0000-0002-5343-3649; Xiao, Lihua/0000-0001-8532-2727; Villegas, Eric N/0000-0002-8059-8588	United States Environmental Protection Agency through its Office of Research and Development [EP-D-06-096]	United States Environmental Protection Agency through its Office of Research and Development(United States Environmental Protection Agency)	The United States Environmental Protection Agency through its Office of Research and Development partially funded and collaborated in the research described here under contract number EP-D-06-096. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2003, INFECT IMMUN, V71, P1828, DOI 10.1128/IAI.71.4.1828-1832.2003; Akiyoshi DE, 2002, INFECT IMMUN, V70, P5670, DOI 10.1128/IAI.70.10.5670-5675.2002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrowood MJ, 1996, J EUKARYOT MICROBIOL, V43, pS89, DOI 10.1111/j.1550-7408.1996.tb05015.x; Brescia CC, 2009, APPL ENVIRON MICROB, V75, P6856, DOI 10.1128/AEM.00540-09; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Chalmers RM, 2011, EMERG INFECT DIS, V17, P536, DOI 10.3201/eid1703.100410; Di Giovanni GD, 2005, APPL ENVIRON MICROB, V71, P1495, DOI 10.1128/AEM.71.3.1495-1500.2005; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2010, VET PARASITOL, V172, P23, DOI 10.1016/j.vetpar.2010.04.028; Fayer R, 2009, VET PARASITOL, V164, P192, DOI 10.1016/j.vetpar.2009.05.011; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontaine M, 2003, J MICROBIOL METH, V54, P29, DOI 10.1016/S0167-7012(03)00005-8; Fontaine M, 2002, FEMS MICROBIOL LETT, V214, P13, DOI 10.1111/j.1574-6968.2002.tb11318.x; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haque R, 2007, AM J TROP MED HYG, V76, P713, DOI 10.4269/ajtmh.2007.76.713; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; Hayes SL, 2003, J APPL MICROBIOL, V94, P54, DOI 10.1046/j.1365-2672.2003.01805.x; Hester JD, 2002, MOL CELL PROBE, V16, P435, DOI 10.1006/mcpr.2002.0442; Hill VR, 2007, APPL ENVIRON MICROB, V73, P4218, DOI 10.1128/AEM.02713-06; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P1135, DOI 10.1128/AEM.71.3.1135-1141.2005; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnson AM, 2011, APPL ENV MICROBIOL; Jothikumar N, 2008, J MED MICROBIOL, V57, P1099, DOI 10.1099/jmm.0.2008/001461-0; JUKES T H, 1969, P21; MacKenzie WR, 1995, EPIDEMIOL INFECT, V115, P545, DOI 10.1017/S0950268800058714; Masago Y, 2006, WATER SCI TECHNOL, V54, P119, DOI 10.2166/wst.2006.457; Messner MJ, 2001, WATER RES, V35, P3934, DOI 10.1016/S0043-1354(01)00119-1; Morgan-Ryan UM, 2002, J EUKARYOT MICROBIOL, V49, P433, DOI 10.1111/j.1550-7408.2002.tb00224.x; Nichols Gordon, 2007, P79, DOI 10.1201/9781420052275.ch4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quintero-Betancourt W, 2003, APPL ENVIRON MICROB, V69, P5380, DOI 10.1128/AEM.69.9.5380-5388.2003; Ren XP, 2012, EXP PARASITOL, V130, P274, DOI 10.1016/j.exppara.2011.07.012; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Robinson G, 2010, INT J PARASITOL, V40, P1539, DOI 10.1016/j.ijpara.2010.05.010; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Ryu H, 2011, J MICROBIOL METH, V86, P337, DOI 10.1016/j.mimet.2011.06.001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAEFER FW, 1991, APPL ENVIRON MICROB, V57, P2408, DOI 10.1128/AEM.57.8.2408-2409.1991; Smith HV, 2010, EXP PARASITOL, V124, P61, DOI 10.1016/j.exppara.2009.05.014; Smith HV, 1998, PARASITOL TODAY, V14, P14, DOI 10.1016/S0169-4758(97)01150-2; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Stroup SE, 2006, J MED MICROBIOL, V55, P1217, DOI 10.1099/jmm.0.46678-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; USEPA, 2005, 1622 USEPA; Ware MW, 2010, VET PARASITOL, V168, P329, DOI 10.1016/j.vetpar.2009.11.019; Ware MW, 2003, J MICROBIOL METH, V55, P575, DOI 10.1016/j.mimet.2003.06.001; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Xiao L, 2009, EXP PARASITOL; Xiao Lihua, 2008, P119; Yang RC, 2011, VET PARASITOL, V179, P22, DOI 10.1016/j.vetpar.2011.02.011; Yang WL, 2008, APPL ENVIRON MICROB, V74, P6495, DOI 10.1128/AEM.01345-08; Yoder JS, 2010, EXP PARASITOL, V124, P31, DOI 10.1016/j.exppara.2009.09.020	55	19	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66562	10.1371/journal.pone.0066562	http://dx.doi.org/10.1371/journal.pone.0066562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805235	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500063
J	Yin, J; Wang, C; Mody, A; Bao, L; Hung, SH; Svoronos, SA; Tseng, Y				Yin, Jun; Wang, Chengyuan; Mody, Aaron; Bao, Lin; Hung, Shen-Hsiu; Svoronos, Spyros A.; Tseng, Yiider			The Effect of Z-Ligustilide on the Mobility of Human Glioblastoma T98G Cells	PLOS ONE			English	Article							PC12 CELLS; IN-VITRO; RHO	Z-ligustilide (LIG), an essential oil extract from Radix Angelica sinensis, has broad pharmaceutical applications in treating cardio-vascular diseases and ischemic brain injury. Recently, LIG has been connected to Glioblastoma multiforme (GBM) because of its structural similarity to 3-n-alkyphthalide (NBP), which is specifically cytotoxic to GBM cells. Hence, we investigated LIG's effect on GBM T98G cells. The study shows that LIG can significantly reduce T98G cells' migration in a dose-dependent manner. Furthermore, the attenuation of cellular mobility can be linked to the activity of the Rho GTPases (RhoA, Rac1 and Cdc42), the three critical molecular switches governing cytoskeleton remodeling; thus, regulating cell migration. LIG significantly reduces the expression of RhoA and affects in a milder manner the expression of Cdc42 and Rac1.	[Yin, Jun; Mody, Aaron; Bao, Lin; Hung, Shen-Hsiu; Svoronos, Spyros A.; Tseng, Yiider] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; [Wang, Chengyuan] Chongqing Technol & Business Univ, Res Ctr Med Chem & Chem Biol, Chongqing, Peoples R China; [Yin, Jun; Hung, Shen-Hsiu; Tseng, Yiider] NCI, Phys Sci Oncol Ctr, Gainesville, FL USA; [Tseng, Yiider] Inst Cell Engn & Regenerat Med, Gainesville, FL USA	State University System of Florida; University of Florida; Chongqing Technology & Business University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tseng, Y (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	ytseng@che.ufl.edu		Mody, Aaron/0000-0002-9883-389X	NIH/NCI [U54CA143868]; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from NIH/NCI U54CA143868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Chao WW, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-29; Kuang X, 2006, BRAIN RES, V1102, P145, DOI 10.1016/j.brainres.2006.04.110; Liang MJ, 2005, LIFE SCI, V78, P128, DOI 10.1016/j.lfs.2005.04.038; Lin Q, 2011, CHIN J EXP MED FORMU, V17, P165; Lu Q, 2006, EUR J PHARMACOL, V542, P136, DOI 10.1016/j.ejphar.2006.04.023; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Qi HY, 2012, NEUROTOX RES, V22, P345, DOI 10.1007/s12640-012-9319-6; Qi HY, 2012, NEUROPHARMACOLOGY, V62, P1659, DOI 10.1016/j.neuropharm.2011.11.012; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; [王雁南 Wang Yannan], 2010, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V25, P685; WINKLBAUER R, 1992, DEV DYNAM, V195, P290, DOI 10.1002/dvdy.1001950407; Wu Guangtong, 1998, Yaoxue Xuebao, V33, P457; Yang JY, 2012, CHIN HERB MED, V4, P26, DOI 10.3969/j.issn.1674-6384.2012.01.005; Zhu ZG, 2004, MOD PRAC MED, V16, P51	17	22	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66598	10.1371/journal.pone.0066598	http://dx.doi.org/10.1371/journal.pone.0066598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805245	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500073
J	Zhang, WL; Bielaszewska, M; Kunsmann, L; Mellmann, A; Bauwens, A; Kock, R; Kossow, A; Anders, A; Gatermann, S; Karch, H				Zhang, Wenlan; Bielaszewska, Martina; Kunsmann, Lisa; Mellmann, Alexander; Bauwens, Andreas; Koeck, Robin; Kossow, Annelene; Anders, Agnes; Gatermann, Soeren; Karch, Helge			Lability of the pAA Virulence Plasmid in Escherichia coli O104:H4: Implications for Virulence in Humans	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; O104/H4 STRAINS; IN-VIVO; OUTBREAK; INFECTION; GERMANY; TIME; IDENTIFICATION; FRANCE; PCR	Background: Escherichia coli O104:H4 that caused the large German outbreak in 2011 is a highly virulent hybrid of enterohemorrhagic (EHEC) and enteroaggregative (EAEC) E. coli. The strain displays "stacked-brick'' aggregative adherence to human intestinal epithelial cells mediated by aggregative adherence fimbriae I (AAF/I) encoded on the pAA plasmid. The AAF/I-mediated augmented intestinal adherence might facilitate systemic absorption of Shiga toxin, the major virulence factor of EHEC, presumably enhancing virulence of the outbreak strain. However, the stability of pAA in the outbreak strain is unknown. We therefore tested outbreak isolates for pAA, monitored pAA loss during infection, and determined the impact of pAA loss on adherence and clinical outcome of infection. Methodology/Principal Findings: E. coli O104:H4 outbreak isolates from 170 patients (128 with hemolytic uremic syndrome [HUS] and 42 with diarrhea without HUS) were tested for pAA using polymerase chain reaction and plasmid profiling. pAA-harboring bacteria in stool samples were quantified using colony blot hybridization, and adherence to HCT-8 cells was determined. Isolates from 12 (7.1%) patients lacked pAA. Analyses of sequential stool samples demonstrated that the percentages of pAA-positive populations in the initial stools were significantly higher than those in the follow-up stools collected two to eight days later in disease (P <= 0.01). This indicates a rapid loss of pAA during infections of humans. The pAA loss was associated with loss of the aggregative adherence phenotype and significantly reduced correlation with HUS (P = 0.001). Conclusions/Significance: The pAA plasmid can be lost by E. coli O104:H4 outbreak strain in the human gut in the course of disease. pAA loss might attenuate virulence and diminish the ability to cause HUS. The pAA instability has clinical, diagnostic, epidemiologic, and evolutionary implications.	[Zhang, Wenlan; Bielaszewska, Martina; Kunsmann, Lisa; Mellmann, Alexander; Bauwens, Andreas; Koeck, Robin; Kossow, Annelene; Karch, Helge] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Zhang, Wenlan; Bielaszewska, Martina; Kunsmann, Lisa; Mellmann, Alexander; Bauwens, Andreas; Koeck, Robin; Kossow, Annelene; Karch, Helge] Univ Munster, Natl Consulting Lab Hemolyt Urem Syndrome, D-48149 Munster, Germany; [Mellmann, Alexander; Karch, Helge] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany; [Anders, Agnes; Gatermann, Soeren] Ruhr Univ Bochum, Inst Hyg & Microbiol, Bochum, Germany	University of Munster; University of Munster; University of Munster; Ruhr University Bochum	Karch, H (corresponding author), Univ Munster, Inst Hyg, D-48149 Munster, Germany.	hkarch@uni-muenster.de	Köck, Robin/AAC-1552-2019; Bielaszewska, Martina/AAC-9812-2022	Mellmann, Alexander/0000-0002-0649-5185	Interdisciplinary Center of Clinical Research (IZKF) Munster [Me2/021/12]; EU [278976]; Medical Faculty of the University of Munster [BD9817044]	Interdisciplinary Center of Clinical Research (IZKF) Munster; EU(European Commission); Medical Faculty of the University of Munster	This work was supported by grants from the Interdisciplinary Center of Clinical Research (IZKF) Munster (no. Me2/021/12), the EU FP7 ANTIGONE (278976), and the Medical Faculty of the University of Munster (no. BD9817044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Beutin L, 2012, J VIROL, V86, P10444, DOI 10.1128/JVI.00986-12; Beutin L, 2012, J FOOD PROTECT, V75, P408, DOI 10.4315/0362-028X.JFP-11-452; Bielaszewska M, 2005, THROMB HAEMOSTASIS, V94, P312, DOI 10.1160/TH05-04-0265; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Bielaszewska M, 2012, ANTIMICROB AGENTS CH, V56, P3277, DOI 10.1128/AAC.06315-11; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; EUCAST, 2012, ANT SUSC TEST EUCAT; EUCAST, 2012, EUCAST MIC ZONE DIAM; European Food Safety Association, 2011, TRACING SEEDS PARTIC; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gault G, 2011, EUROSURVEILLANCE, V16, P5; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; King LA, 2012, CLIN INFECT DIS, V54, P1588, DOI 10.1093/cid/cis255; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Mellmann A, 2008, APPL ENVIRON MICROB, V74, P67, DOI 10.1128/AEM.01906-07; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mellmann A, 2009, GASTROENTEROLOGY, V136, P1925, DOI 10.1053/j.gastro.2008.12.072; Mendez-Arancibia E, 2008, AM J TROP MED HYG, V78, P985, DOI 10.4269/ajtmh.2008.78.985; Monecke S, 2011, APPL ENVIRON MICROB, V77, P8784, DOI 10.1128/AEM.06524-11; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Nataro JP, 2005, CURR OPIN GASTROEN, V21, P4; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Pritchard L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034498; Qin JJ, 2011, J CLIN MICROBIOL, V49, P3439, DOI 10.1128/JCM.01312-11; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Restieri C, 2007, APPL ENVIRON MICROB, V73, P1553, DOI 10.1128/AEM.01542-06; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Scavia G, 2011, EMERG INFECT DIS, V17, P1957, DOI 10.3201/eid1710.111072; SCHMIDT H, 1995, J CLIN MICROBIOL, V33, P701, DOI 10.1128/JCM.33.3.701-705.1995; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zangari Tonia, 2013, Infect Immun, V81, P1562, DOI 10.1128/IAI.01310-12; Zhang WL, 2012, J CLIN MICROBIOL, V50, P1752, DOI 10.1128/JCM.06817-11; Zoja C, 2010, PEDIATR NEPHROL, V25, P2231, DOI 10.1007/s00467-010-1522-1	49	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66717	10.1371/journal.pone.0066717	http://dx.doi.org/10.1371/journal.pone.0066717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805269	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500097
J	Atteritano, M; Sorbara, S; Bagnato, G; Miceli, G; Sangari, D; Morgante, S; Visalli, E; Bagnato, G				Atteritano, Marco; Sorbara, Stefania; Bagnato, Gianluca; Miceli, Giovanni; Sangari, Donatella; Morgante, Salvatore; Visalli, Elisa; Bagnato, Gianfilippo			Bone Mineral Density, Bone Turnover Markers and Fractures in Patients with Systemic Sclerosis: A Case Control Study	PLOS ONE			English	Article							VITAMIN-D INTAKE; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASES; INCREASED RISK; OSTEOPOROSIS; 25-HYDROXYVITAMIN-D; SCLERODERMA; HEALTH; WOMEN	Objective: The aim of our study was to elucidate the pathophysiology of systemic sclerosis-related osteoporosis and the prevalence of vertebral fragility fracture in postmenopausal women with systemic sclerosis (SSc). Methodology: Fifty-four postmenopausal women with scleroderma and 54 postmenopausal controls matched for age, BMI, and smoking habits were studied. BMD was measured by dual energy-x-ray absorptiometry at spine and femur, and by ultrasonography at calcaneus The markers of bone turnover included serum osteocalcin and urinary deoxypyridinoline. All subjects had a spine X-ray to ascertain the presence of vertebral fractures. Results: bone mineral density at lumbar spine (BMD 0.78 +/- 0.08 vs 0.88 +/- 0.07; p<0,001), femoral neck (BMD: 0.56 +/- 0.04 vs 0.72 +/- 0.07; p<0,001) and total femur (BMD: 0.57 +/- 0.04 vs 0.71 +/- 0.06; p<0,001) and ultrasound parameter at calcaneus (SI: 80.10 +/- 5.10 vs 94.80 +/- 6.10 p<0,001) were significantly lower in scleroderma compared with controls; bone turnover markers and parathyroid hormone level were significantly higher in scleroderma compared with controls, while serum of 25(OH)D3 was significantly lower. In scleroderma group the serum levels of 25(OH)D3 significantly correlated with PTH levels, BMD, stiffness index and bone turnover markers. One or more moderate or severe vertebral fractures were found in 13 patients with scleroderma, wherease in control group only one patient had a mild vertebral fracture. Conclusion: Our data shows, for the first time, that vertebral fractures are frequent in subjects with scleroderma, and suggest that lower levels of 25(OH)D3 may play a role in the risk of osteoporosis and vertebral fractures.	[Atteritano, Marco; Sorbara, Stefania; Bagnato, Gianluca; Miceli, Giovanni; Sangari, Donatella; Morgante, Salvatore; Visalli, Elisa; Bagnato, Gianfilippo] Univ Messina, Dept Internal Med, Messina, Italy	University of Messina	Atteritano, M (corresponding author), Univ Messina, Dept Internal Med, Messina, Italy.	matteritano@unime.it	Atteritano, Marco/AAL-9565-2020; Bagnato, Gianluca/D-5742-2018	Bagnato, Gianluca/0000-0002-7594-8520; visalli, elisa/0000-0002-8213-5528; Atteritano, Marco/0000-0001-9342-802X				Adorini L, 2008, NAT CLIN PRACT RHEUM, V4, P404, DOI 10.1038/ncprheum0855; Avouac J, 2012, ARTHRIT CARE RES, V64, P1871, DOI 10.1002/acr.21761; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Braun-Moscovici Y, 2008, J RHEUMATOL, V35, P2201, DOI 10.3899/jrheum.071171; Caramaschi P, 2010, CLIN RHEUMATOL, V29, P1419, DOI 10.1007/s10067-010-1478-3; Carbone L, 1999, RHEUMATOLOGY, V37, P1; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; Costenbader KH, 2008, ANN RHEUM DIS, V67, P530, DOI 10.1136/ard.2007.072736; Cutolo M, 2008, LUPUS, V17, P6, DOI 10.1177/0961203307085879; Cutolo M, 2007, AUTOIMMUN REV, V7, P59, DOI 10.1016/j.autrev.2007.07.001; DIMUNNO O, 1995, CLIN RHEUMATOL, V14, P407, DOI 10.1007/BF02207673; Fredlani B, 2004, CLIN EXP RHEUMATOL, V22, P313; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gluer CC, 1997, J BONE MINER RES, V12, P1280, DOI 10.1359/jbmr.1997.12.8.1280; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Kamen D, 2008, CURR OPIN RHEUMATOL, V20, P532, DOI 10.1097/BOR.0b013e32830a991b; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016/j.autrev.2005.05.009; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; LAMONTAGNA G, 1991, CLIN RHEUMATOL, V10, P18, DOI 10.1007/BF02208027; Lee SC, 1997, BONE, V21, P119, DOI 10.1016/S8756-3282(97)00076-8; LEROY EC, 1988, J RHEUMATOL, V15, P202; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Morgan JW, 2000, ENDOCRINOLOGY, V141, P3225, DOI 10.1210/en.141.9.3225; Mouyis M, 2008, RHEUMATOLOGY, V47, P1348, DOI 10.1093/rheumatology/ken203; Neumann K, 2000, J RHEUMATOL, V27, P1822; Sampaio-Barros PD, 2005, CLIN EXP RHEUMATOL, V23, P180; Souza RBC, 2006, SCAND J RHEUMATOL, V35, P384, DOI 10.1080/03009740600704296; Szodoray P, 2008, SCAND J IMMUNOL, V68, P261, DOI 10.1111/j.1365-3083.2008.02127.x; Valentini G, 2003, CLIN EXP RHEUMATOL, V21, pS39; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Yuen SY, 2008, J RHEUMATOL, V35, P1073	32	50	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66991	10.1371/journal.pone.0066991	http://dx.doi.org/10.1371/journal.pone.0066991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818972	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800110
J	Berdot, S; Gillaizeau, F; Caruba, T; Prognon, P; Durieux, P; Sabatier, B				Berdot, Sarah; Gillaizeau, Florence; Caruba, Thibaut; Prognon, Patrice; Durieux, Pierre; Sabatier, Brigitte			Drug Administration Errors in Hospital Inpatients: A Systematic Review	PLOS ONE			English	Review							BAR-CODE TECHNOLOGY; MEDICATION ERRORS; INTENSIVE-CARE; INTRAVENOUS MEDICATION; DISPENSING SYSTEM; PRESCRIPTION; FREQUENCY; SEVERITY; IMPACT; NURSES	Context: Drug administration in the hospital setting is the last barrier before a possible error reaches the patient. Objectives: We aimed to analyze the prevalence and nature of administration error rate detected by the observation method. Data Sources: Embase, MEDLINE, Cochrane Library from 1966 to December 2011 and reference lists of included studies. Study Selection: Observational studies, cross-sectional studies, before-and-after studies, and randomized controlled trials that measured the rate of administration errors in inpatients were included. Data Extraction: Two reviewers (senior pharmacists) independently identified studies for inclusion. One reviewer extracted the data; the second reviewer checked the data. The main outcome was the error rate calculated as being the number of errors without wrong time errors divided by the Total Opportunity for Errors (TOE, sum of the total number of doses ordered plus the unordered doses given), and multiplied by 100. For studies that reported it, clinical impact was reclassified into four categories from fatal to minor or no impact. Due to a large heterogeneity, results were expressed as median values (interquartile range, IQR), according to their study design. Results: Among 2088 studies, a total of 52 reported TOE. Most of the studies were cross-sectional studies (N=46). The median error rate without wrong time errors for the cross-sectional studies using TOE was 10.5% [IQR: 7.3%-21.7%]. No fatal error was observed and most errors were classified as minor in the 18 studies in which clinical impact was analyzed. We did not find any evidence of publication bias. Conclusions: Administration errors are frequent among inpatients. The median error rate without wrong time errors for the cross-sectional studies using TOE was about 10%. A standardization of administration error rate using the same denominator (TOE), numerator and types of errors is essential for further publications.	[Berdot, Sarah; Caruba, Thibaut; Prognon, Patrice; Sabatier, Brigitte] Hop Europeen Georges Pompidou, AP HP, Dept Pharm, Paris, France; [Berdot, Sarah; Durieux, Pierre; Sabatier, Brigitte] INSERM, Ctr Rech Cordeliers, Equipe 22, UMR S 872, Paris, France; [Gillaizeau, Florence; Durieux, Pierre] INSERM, Ctr Invest Epidemiol 4, Paris, France; [Caruba, Thibaut] Univ Paris 05, Lab Interdisciplinaire Rech Econ Sante, Sorbonne Paris Cite, EA4410, Paris, France; [Prognon, Patrice] Univ Paris 11, Chatenay Malabry, France; [Durieux, Pierre] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Durieux, Pierre] Hop Europeen Georges Pompidou, AP HP, Dept Med Informat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Durieux, P (corresponding author), INSERM, Ctr Rech Cordeliers, Equipe 22, UMR S 872, Paris, France.	pierre.durieux@egp.aphp.fr	Berdot, Sarah/I-9913-2019	Berdot, Sarah/0000-0001-6607-4318; Sabatier, Brigitte/0000-0003-1643-2070				ALLAN BL, 1987, AM J HOSP PHARM, V44, P1046, DOI 10.1093/ajhp/44.5.1044; ALLAN EL, 1990, AM J HOSP PHARM, V47, P555, DOI 10.1093/ajhp/47.3.555; Teixeira TCA, 2010, REV ESC ENFERM USP, V44, P139, DOI 10.1590/S0080-62342010000100020; [Anonymous], 2008, MED ERR NAT COORD CO; [Anonymous], 1993, AM J HOSP PHARM, V50, P305, DOI DOI 10.1093/AJHP/50.2.305; Anselmi ML, 2007, J CLIN NURS, V16, P1839, DOI 10.1111/j.1365-2702.2007.01834.x; Aspden P, 2007, PREVENTING MED ERROR; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; BARKER KN, 1984, AM J HOSP PHARM, V41, P1352, DOI 10.1093/ajhp/41.7.1352; BARKER KN, 1984, AM J HOSP PHARM, V41, P2009, DOI 10.1093/ajhp/41.10.2009; BARKER KN, 1982, AM J HOSP PHARM, V39, P987, DOI 10.1093/ajhp/39.6.987; BARKER KN, 1969, AM J HOSP PHARM, V26, P324, DOI 10.1093/ajhp/26.6.324; Barker KN, 1962, AM J HOSP PHARM, V19, P361; BOREL JM, 1995, AM J HEALTH-SYST PH, V52, P1875, DOI 10.1093/ajhp/52.17.1875; Bourlon S., 2006, Journal de Pharmacie Clinique, V25, P23; Bruce J, 2001, DRUG SAFETY, V24, P855, DOI 10.2165/00002018-200124110-00006; Calabrese AD, 2001, INTENS CARE MED, V27, P1592, DOI 10.1007/s001340101065; Chapuis C, 2010, CRIT CARE MED, V38, P2275, DOI 10.1097/CCM.0b013e3181f8569b; Chua SS, 2009, J CLIN PHARM THER, V34, P215, DOI 10.1111/j.1365-2710.2008.00997.x; Chua SS, 2010, EUR J PEDIATR, V169, P603, DOI 10.1007/s00431-009-1084-z; CONROY S, 2007, PAEDIATR PERINAT DRU, V8, P18; Dean B, 2000, INT J PHARM PRACT, V8, P209, DOI [10.1111/j.2042-7174.2000.tb01007.x, DOI 10.1111/J.2042-7174.2000.TB01007.X]; DEAN BS, 1995, AM J HEALTH-SYST PH, V52, P2543, DOI 10.1093/ajhp/52.22.2543; DeYoung JL, 2009, AM J HEALTH-SYST PH, V66, P1110, DOI 10.2146/ajhp080355; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH; Fahimi Fanak, 2008, Aust Crit Care, V21, P110, DOI 10.1016/j.aucc.2007.10.004; Flynn EA, 2002, AM J HEALTH-SYST PH, V59, P436, DOI 10.1093/ajhp/59.5.436; Fontan JE, 2003, PHARM WORLD SCI, V25, P112, DOI 10.1023/A:1024053514359; Ford DG, 2010, INTENS CARE MED, V36, P1526, DOI 10.1007/s00134-010-1860-2; Franklin BD, 2006, QUAL SAF HEALTH CARE, V15, P329, DOI 10.1136/qshc.2005.017608; Franklin BD, 2007, QUAL SAF HEALTH CARE, V16, P279, DOI 10.1136/qshc.2006.019497; Ghaleb MA, 2006, ANN PHARMACOTHER, V40, P1766, DOI 10.1345/aph.1G717; Ghaleb MA, 2010, ARCH DIS CHILD, V95, P113, DOI 10.1136/adc.2009.158485; Gokhman R, 2012, RESUSCITATION, V83, P482, DOI 10.1016/j.resuscitation.2011.10.001; Greengold NL, 2003, ARCH INTERN MED, V163, P2359, DOI 10.1001/archinte.163.19.2359; Rodriguez-Gonzalez CG, 2012, J AM MED INFORM ASSN, V19, P72, DOI 10.1136/amiajnl-2011-000332; Han PY, 2005, QUAL SAF HEALTH CARE, V14, P179, DOI 10.1136/qshc.2004.010728; Hartley GM, 1998, INT J PHARM PRACT, V6, P38, DOI [10.1111/j.2042-7174.1998.tb00914.x, DOI 10.1111/J.2042-7174.1998.TB00914.X]; Haw C, 2007, INT J QUAL HEALTH C, V19, P210, DOI 10.1093/intqhc/mzm019; Helmons PJ, 2009, AM J HEALTH-SYST PH, V66, P1202, DOI 10.2146/ajhp080357; Hicks RW, 2004, AM J HEALTH-SYST PH, V61, P993, DOI 10.1093/ajhp/61.10.993; Ho C., 1997, INT J PHARM PRACT, V5, P91, DOI DOI 10.1111/J.2042-7174.1997.TB00891.X; HYNNIMAN CE, 1970, AM J HOSP PHARM, V27, P802, DOI 10.1093/ajhp/27.10.802; Kelly J, 2011, J ADV NURS, V67, P2615, DOI 10.1111/j.1365-2648.2011.05700.x; Lam Judit, 2011, Orvosi Hetilap, V152, P1391, DOI 10.1556/OH.2011.29198; Le Grognec C, 2005, THERAPIE, V60, P391, DOI 10.2515/therapie:2005057; Font Noguera I, 2008, Farm Hosp, V32, P274; Lisby M, 2005, INT J QUAL HEALTH C, V17, P15, DOI 10.1093/intqhc/mzi015; McKibbon K, 2011, AHRQ PUBLICATION, V11-E008-EF; MEANS BJ, 1975, AM J HOSP PHARM, V32, P186, DOI 10.1093/ajhp/32.2.186; Meyer-Massetti C, 2011, AM J HEALTH-SYST PH, V68, P227, DOI 10.2146/ajhp100019; Miller MR, 2007, QUAL SAF HEALTH CARE, V16, P116, DOI 10.1136/qshc.2006.019950; Montesi G, 2009, BRIT J CLIN PHARMACO, V67, P651, DOI 10.1111/j.1365-2125.2009.03422.x; O'Brodovich M, 1991, Can J Hosp Pharm, V44, P5; Ozkan S, 2011, J NURS CARE QUAL, V26, P136, DOI 10.1097/NCQ.0b013e3182031006; Paoletti RD, 2007, AM J HEALTH-SYST PH, V64, P536, DOI 10.2146/ajhp060140; Pasto-Cardona Lourdes, 2009, Farm Hosp, V33, P257; PEPPER GA, 1995, AM J HEALTH-SYST PH, V52, P390, DOI 10.1093/ajhp/52.4.390; Perras C, 2009, 121 CAN AG DRUGS TEC; Poon EG, 2010, NEW ENGL J MED, V362, P1698, DOI 10.1056/NEJMsa0907115; Pourrat X, 2003, PRESSE MED, V32, P876; Prot S, 2005, INT J QUAL HEALTH C, V17, P381, DOI 10.1093/intqhc/mzi066; Raja LRJ, 2009, SINGAP MED J, V50, P68; Reifsteck Mark, 2006, J Healthc Inf Manag, V20, P35; Ridge K W, 1995, Qual Health Care, V4, P240, DOI 10.1136/qshc.4.4.240; Ros H, 2009, EUR J HOSP PHARM SCI, V15, P86; Rosati JR, 1983, QUAL REV B, V9, P34; Schneider MP, 1998, PHARM WORLD SCI, V20, P178, DOI 10.1023/A:1012087727393; Schneider PJ, 2006, AM J HEALTH-SYST PH, V63, P59, DOI 10.2146/ajhp040609; Schnell B R, 1976, Can J Hosp Pharm, V29, P85; Taxis K, 2004, EUR J CLIN PHARMACOL, V59, P815, DOI 10.1007/s00228-003-0689-9; Taxis K, 2003, BMJ-BRIT MED J, V326, P684, DOI 10.1136/bmj.326.7391.684; Taylor JA, 2008, PEDIATRICS, V121, P123, DOI 10.1542/peds.2007-0919; THUR MP, 1972, AM J HOSP PHARM, V72, P298, DOI 10.1093/ajhp/29.4.298; TISDALE JE, 1986, AM J HOSP PHARM, V43, P368, DOI 10.1093/ajhp/43.2.368; Tissot E, 2003, PHARM WORLD SCI, V25, P264, DOI 10.1023/B:PHAR.0000006519.44483.a0; Tissot E, 1999, INTENS CARE MED, V25, P353, DOI 10.1007/s001340050857; van den Bemt PMLA, 2002, CRIT CARE MED, V30, P846, DOI 10.1097/00003246-200204000-00022; van Gijssel-Wiersma DG, 2005, DRUG SAFETY, V28, P1119, DOI 10.2165/00002018-200528120-00006; Westbrook JI, 2011, BMJ QUAL SAF, V20, P1027, DOI 10.1136/bmjqs-2011-000089; Westbrook JI, 2010, ARCH INTERN MED, V170, P683, DOI 10.1001/archinternmed.2010.65; Wirtz V, 2003, PHARM WORLD SCI, V25, P104, DOI 10.1023/A:1024009000113; Zribi Triki E, 2011, PHARMACIEN HOSPITALI, V46, P226, DOI [10.1016/j.phclin.2011.05.022, DOI 10.1016/J.PHCLIN.2011.05.022]	84	48	49	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68856	10.1371/journal.pone.0068856	http://dx.doi.org/10.1371/journal.pone.0068856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23818992	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800149
J	Li, C; Zhang, BY; Cressman, R; Tao, Y				Li, Cong; Zhang, Boyu; Cressman, Ross; Tao, Yi			Evolution of Cooperation in a Heterogeneous Graph: Fixation Probabilities under Weak Selection	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; SOCIAL DILEMMAS; NETWORKS; DIVERSITY; DYNAMICS	It has been shown that natural selection favors cooperation in a homogenous graph if the benefit-to-cost ratio exceeds the degree of the graph. However, most graphs related to interactions in real populations are heterogeneous, in which some individuals have many more neighbors than others. In this paper, we introduce a new state variable to measure the time evolution of cooperation in a heterogeneous graph. Based on the diffusion approximation, we find that the fixation probability of a single cooperator depends crucially on the number of its neighbors. Under weak selection, a cooperator with more neighbors has a larger probability of fixation in the population. We then investigate the average fixation probability of a randomly chosen cooperator. If a cooperator pays a cost for each of its neighbors (the so called fixed cost per game case), natural selection favors cooperation if the benefit-to-cost ratio is larger than the average degree. In contrast, if a cooperator pays a fixed cost and all its neighbors share the benefit (the fixed cost per individual case), cooperation is favored if the benefit-to-cost ratio is larger than the harmonic mean of the degree distribution. Moreover, increasing the graph heterogeneity will reduce the effect of natural selection.	[Li, Cong; Tao, Yi] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Zhang, Boyu] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Cressman, Ross] Wilfrid Laurier Univ, Dept Math, Waterloo, ON N2L 3C5, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Normal University; Wilfrid Laurier University	Zhang, BY (corresponding author), Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China.	zhangboyu5507@gmail.com; rcressman@wlu.ca		Li, Cong/0000-0002-7201-4140; Tao, Yi/0000-0002-0749-6614	NSFC of China [31270439]; NSERC of Canada	NSFC of China(National Natural Science Foundation of China (NSFC)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research received financial support from the NSFC 31270439 of China and from NSERC of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Axelord Robert, 1984, EVOLUTION COOPERATIO; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Devlin S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016107; Dorogotsev SN, 2003, EVOLUTION NETWORKS B; ERDOS P, 1960, B INT STATIST INST, V38, P343; Ewens W.J., 2004, MATH POPULATION GENE; Fu F, 2007, EUR PHYS J B, V56, P367, DOI 10.1140/epjb/e2007-00124-5; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Grujic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047718; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Konno T, 2011, J THEOR BIOL, V269, P224, DOI 10.1016/j.jtbi.2010.10.033; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Nobari S., 2011, EDBT, P331, DOI DOI 10.1145/1951365.1951406; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Nowak Martin A., 2007, P7; Ohtsuki H, 2008, J THEOR BIOL, V251, P698, DOI 10.1016/j.jtbi.2008.01.005; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pinheiro FL, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073035; Pinheiro FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032114; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2010, INT J BIFURCAT CHAOS, V20, P849, DOI 10.1142/S0218127410026137; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2012, J THEOR BIOL, V299, P88, DOI 10.1016/j.jtbi.2011.09.003; Segbroeck SV, 2011, NEW J PHYS, V13, DOI DOI 10.1088/1367-2630/13/1/013007; Sherratt T. N., 2009, BIG QUESTIONS ECOLOG; Shigaki K, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031141; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2009, PHYS REV E, V80; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Tanimoto J, 2010, PHYSICA A, V389, P2284, DOI 10.1016/j.physa.2010.01.033; Traulsen A, 2010, P NATL ACAD SCI USA, V91, P4877; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; WATTS D, 1999, SMALL WORLDS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026724; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	62	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66560	10.1371/journal.pone.0066560	http://dx.doi.org/10.1371/journal.pone.0066560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818942	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800078
J	Palkovits, M; Sebekova, K; Klenovics, KS; Kebis, A; Fazeli, G; Bahner, U; Heidland, A				Palkovits, Miklos; Sebekova, Katarina; Klenovics, Kristina Simon; Kebis, Anton; Fazeli, Gholamreza; Bahner, Udo; Heidland, August			Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; ATRIAL-NATRIURETIC-PEPTIDE; GLYCATION END-PRODUCTS; CHRONIC-RENAL-FAILURE; QUALITY-OF-LIFE; ASYMMETRIC DIMETHYLARGININE; SYMPATHETIC HYPERACTIVITY; COGNITIVE FUNCTION; ANGIOTENSIN-II; HEMODIALYSIS-PATIENTS	The effect of mild chronic renal failure (CRF) induced by 4/6-nephrectomy (4/6NX) on central neuronal activations was investigated by c-Fos immunohistochemistry staining and compared to sham-operated rats. In the 4/6 NX rats also the effect of the angiotensin receptor blocker, losartan, and the central sympatholyticum moxonidine was studied for two months. In serial brain sections Fos-immunoreactive neurons were localized and classified semiquantitatively. In 37 brain areas/nuclei several neurons with different functional properties were strongly affected in 4/6NX. It elicited a moderate to high Fos-activity in areas responsible for the monoaminergic innervation of the cerebral cortex, the limbic system, the thalamus and hypothalamus (e.g. noradrenergic neurons of the locus coeruleus, serotonergic neurons in dorsal raphe, histaminergic neurons in the tuberomamillary nucleus). Other monoaminergic cell groups (A5 noradrenaline, C1 adrenaline, medullary raphe serotonin neurons) and neurons in the hypothalamic paraventricular nucleus (innervating the sympathetic preganglionic neurons and affecting the peripheral sympathetic outflow) did not show Fos-activity. Stress-and painsensitive cortical/subcortical areas, neurons in the limbic system, the hypothalamus and the circumventricular organs were also affected by 4/6NX. Administration of losartan and more strongly moxonidine modulated most effects and particularly inhibited Fos-activity in locus coeruleus neurons. In conclusion, 4/6NX elicits high activity in central sympathetic, stress-and pain-related brain areas as well as in the limbic system, which can be ameliorated by losartan and particularly by moxonidine. These changes indicate a high sensitivity of CNS in initial stages of CKD which could be causative in clinical disturbances.	[Palkovits, Miklos] Semmelweis Univ, Neuromorphol & Neuroendocrine Res Lab, H-1085 Budapest, Hungary; [Palkovits, Miklos] Hungarian Acad Sci, Budapest, Hungary; [Sebekova, Katarina] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Klenovics, Kristina Simon] Comenius Univ, Fac Med, Inst Physiol, Bratislava, Slovakia; [Kebis, Anton] Slovak Med Univ, Slovak Ctr Organ Transplantat, Lab Organ Perfus, Bratislava, Slovakia; [Fazeli, Gholamreza] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Bahner, Udo; Heidland, August] KfH Kidney Ctr, Wurzburg, Germany; [Heidland, August] Univ Wurzburg, Dept Internal Med, D-97070 Wurzburg, Germany	Semmelweis University; Hungarian Academy of Sciences; Comenius University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences; Slovak Medical University Bratislava; University of Wurzburg; University of Wurzburg	Heidland, A (corresponding author), Univ Wurzburg, Dept Internal Med, D-97070 Wurzburg, Germany.	august.heidland@t-online.de	Palkovits, Miklos/F-2707-2013; Sebekova, Katarina/GSD-7056-2022; Sebekova, Katarina/H-4906-2016	Palkovits, Miklos/0000-0003-0578-0387; Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265; Fazeli, Gholamreza/0000-0002-1367-1941	Slovak Academy of Sciences (CENDO) [II/2/2007]; Stiftung Zukunft Mensch	Slovak Academy of Sciences (CENDO); Stiftung Zukunft Mensch	This study was partially supported by a grant from Slovak Academy of Sciences (CENDO, No. II/2/2007, to KS), and from Stiftung Zukunft Mensch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBADIE C, 1992, NEUROSCIENCE, V48, P985, DOI 10.1016/0306-4522(92)90287-C; Abdelhafiz AH, 2011, NEPHRON EXP NEPHROL, V119, pE6, DOI 10.1159/000328015; Aguilera A, 2000, PERITON DIALYSIS INT, V20, P810; Amann K, 1996, NEPHROL DIAL TRANSPL, V11, P1003, DOI 10.1093/oxfordjournals.ndt.a027447; Amann K, 2000, J AM SOC NEPHROL, V11, P1469, DOI 10.1681/ASN.V1181469; Armstrong JE, 2010, PEDIATR NEPHROL, V25, P1497, DOI 10.1007/s00467-010-1529-7; Asif M, 2012, CURR ALZHEIMER RES; Augustyniak RA, 2006, AM J PHYSIOL-REG I, V290, pR726, DOI 10.1152/ajpregu.00768.2004; AVERILL DB, 1994, BRAIN RES, V665, P245, DOI 10.1016/0006-8993(94)91344-7; Barzilay JI, 2011, ARCH INTERN MED, V171, P142, DOI 10.1001/archinternmed.2010.502; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; BIGAZZI R, 1994, J AM SOC NEPHROL, V4, P1901; Bomback AS, 2011, KIDNEY INT, V80, P803, DOI 10.1038/ki.2011.219; Bossola M, 2006, KIDNEY INT, V70, P417, DOI 10.1038/sj.ki.5001572; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Campese V M, 2000, J Renin Angiotensin Aldosterone Syst, V1, P202, DOI 10.3317/jraas.2000.026; Campese VM, 2004, AM J PHYSIOL-HEART C, V287, pH695, DOI 10.1152/ajpheart.00619.2003; CAMPESE VM, 1995, AM J KIDNEY DIS, V26, P861, DOI 10.1016/0272-6386(95)90456-5; Casper R C, 1998, Depress Anxiety, V8 Suppl 1, P96, DOI 10.1002/(SICI)1520-6394(1998)8:1+<96::AID-DA15>3.0.CO;2-4; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P919, DOI 10.2215/CJN.00820207; CONVERSE RL, 1992, NEW ENGL J MED, V327, P1912, DOI 10.1056/NEJM199212313272704; Davison SN, 2005, ADV CHRONIC KIDNEY D, V12, P326, DOI 10.1016/j.ackd.2005.03.008; De Santo RM, 2010, J RENAL NUTR, V20, pS59, DOI 10.1053/j.jrn.2010.06.003; Elias MF, 2009, NEPHROL DIAL TRANSPL, V24, P2446, DOI 10.1093/ndt/gfp107; Ernsberger P, 2000, J CARDIOVASC PHARM, V35, pS27, DOI 10.1097/00005344-200000004-00005; Fliser D, 2005, J AM SOC NEPHROL, V16, P2456, DOI 10.1681/ASN.2005020179; GEIGER H, 1989, J CARDIOVASC PHARM, V13, pS20, DOI 10.1097/00005344-198905006-00007; GEIGER H, 1993, KIDNEY INT, V44, P24, DOI 10.1038/ki.1993.208; Gianaros PJ, 2012, HUM BRAIN MAPP, V33, P1700, DOI 10.1002/hbm.21315; Grassi G, 2011, CLIN J AM SOC NEPHRO, V6, P2620, DOI 10.2215/CJN.06970711; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Griep MI, 1997, NEPHROL DIAL TRANSPL, V12, P2093, DOI 10.1093/ndt/12.10.2093; Guasti L, 2002, J HYPERTENS, V20, P485, DOI 10.1097/00004872-200203000-00024; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Hebert MA, 2005, J NEUROCHEM, V95, P484, DOI 10.1111/j.1471-4159.2005.03386.x; Hedayati SS, 2006, KIDNEY INT, V69, P1662, DOI 10.1038/sj.ki.5000308; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hirotsu C, 2011, BRAIN BEHAV IMMUN, V25, P416, DOI 10.1016/j.bbi.2010.10.021; Iliescu EA, 2004, NEPHROL DIAL TRANSPL, V19, P95, DOI 10.1093/ndt/gfg423; Imbe H, 2006, FRONT BIOSCI-LANDMRK, V11, P2179, DOI 10.2741/1960; JELLINGER K, 1977, J NEURAL TRANSM, V41, P275, DOI 10.1007/BF01252022; JEPPSSON B, 1982, SURGERY, V92, P30; Joosten H, 2011, CLIN J AM SOC NEPHRO, V6, P1400, DOI 10.2215/CJN.05530610; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Knopman DS, 2010, AM J EPIDEMIOL, V171, P287, DOI 10.1093/aje/kwp429; Konsman JP, 2005, EUR J NEUROSCI, V21, P2752, DOI 10.1111/j.1460-9568.2005.04102.x; Koomans HA, 2004, J AM SOC NEPHROL, V15, P524, DOI 10.1097/01.ASN.0000113320.57127.B9; Kotanko P, 2006, BLOOD PURIFICAT, V24, P95, DOI 10.1159/000089444; Krivosikova Z, 1999, PHYSIOL RES, V48, P429; Landis BN, 2011, KIDNEY INT, V80, P886, DOI 10.1038/ki.2011.189; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; Lux S, 2010, KIDNEY INT, V78, P794, DOI 10.1038/ki.2010.253; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORRISON AB, 1962, LAB INVEST, V11, P321; Muders F, 2001, PHARMACOL RES, V43, P251, DOI 10.1006/phrs.2000.0767; Mukaddam-Daher S, 2000, HYPERTENSION, V35, P1215, DOI 10.1161/01.HYP.35.6.1215; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Neil MJE, 2011, CURR CLIN PHARMACOL, V6, P280, DOI 10.2174/157488411798375886; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Niiya Y, 2006, BRAIN RES, V1108, P179, DOI 10.1016/j.brainres.2006.06.038; Orth SR, 2001, NEPHROL DIAL TRANSPL, V16, P67, DOI 10.1093/ndt/16.suppl_1.67; Palkovits M, 2009, NEUROSCIENCE, V159, P862, DOI 10.1016/j.neuroscience.2008.12.062; Parker KP, 2003, SLEEP MED REV, V7, P131, DOI 10.1053/smrv.2001.0240; Pikula A, 2009, STROKE, V40, P2959, DOI 10.1161/STROKEAHA.109.557116; Prichard BNC, 1999, J HYPERTENS, V17, pS41; Rabbani N, 2007, KIDNEY INT, V72, P1113, DOI 10.1038/sj.ki.5002513; REID IA, 1992, AM J PHYSIOL, V262, pE763, DOI 10.1152/ajpendo.1992.262.6.E763; Riezebos RK, 2010, NEPHROL DIAL TRANSPL, V25, P231, DOI 10.1093/ndt/gfp383; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; SCHMID G, 1978, AM J CLIN NUTR, V31, P1665, DOI 10.1093/ajcn/31.9.1665; Sebekova K, 1999, MINER ELECTROL METAB, V25, P380; Seifter JL, 2011, SEMIN NEUROL, V31, P139, DOI 10.1055/s-0031-1277984; Seliger SL, 2008, AM J NEPHROL, V28, P304, DOI 10.1159/000111386; Selley ML, 2003, NEUROBIOL AGING, V24, P903, DOI 10.1016/S0197-4580(03)00007-1; SIASSI F, 1977, AM J PHYSIOL, V232, pE526, DOI 10.1152/ajpendo.1977.232.5.E526; Sim JJ, 2009, CHEST, V135, P710, DOI 10.1378/chest.08-2248; Sink KM, 2009, ARCH INTERN MED, V169, P1195, DOI 10.1001/archinternmed.2009.175; Spiegel BMR, 2008, CLIN J AM SOC NEPHRO, V3, P1759, DOI 10.2215/CJN.00820208; Stamp JA, 1999, NEUROSCIENCE, V94, P1313, DOI 10.1016/S0306-4522(99)00368-1; Tamura MK, 2011, AM J KIDNEY DIS, V58, P756, DOI 10.1053/j.ajkd.2011.05.027; Timofeeva E, 2001, J COMP NEUROL, V441, P71, DOI 10.1002/cne.1398; Vanholder R, 2008, PEDIATR NEPHROL, V23, P1211, DOI 10.1007/s00467-008-0762-9; Vanholder R, 2008, J AM SOC NEPHROL, V19, P1253, DOI 10.1681/ASN.2008040404; Wada M, 2008, J NEUROL SCI, V272, P36, DOI 10.1016/j.jns.2008.04.029; Weiner DE, 2009, AM J KIDNEY DIS, V53, P438, DOI 10.1053/j.ajkd.2008.08.022; Witko-Sarsat V, 1998, J IMMUNOL, V161, P2524; Ye SH, 1997, KIDNEY INT, V51, P722, DOI 10.1038/ki.1997.103; Ye SH, 2002, HYPERTENSION, V39, P1101, DOI 10.1161/01.HYP.0000018590.26853.C7; Yilmaz MI, 2010, NEPHROL DIAL TRANSPL, V25, P3250, DOI 10.1093/ndt/gfq159	96	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66543	10.1371/journal.pone.0066543	http://dx.doi.org/10.1371/journal.pone.0066543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818940	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800076
J	Pradel, A; Didier, D; Casane, D; Tafforeau, P; Maisey, JG				Pradel, Alan; Didier, Dominique; Casane, Didier; Tafforeau, Paul; Maisey, John Graham			Holocephalan Embryo Provides New Information on the Evolution of the Glossopharyngeal Nerve, Metotic Fissure and Parachordal Plate in Gnathostomes	PLOS ONE			English	Article							CHIMAEROID FISH; BRAINCASE; CHONDRICHTHYAN; PHYLOGENY; SKULL	The phylogenetic relationships between the different groups of Paleozoic gnathostomes are still debated, mainly because of incomplete datasets on Paleozoic jawed vertebrate fossils and ontogeny of some modern taxa. This issue is illustrated by the condition of the glossopharyngeal nerve relative to the parachordal plate, the otic capsules and the metotic fissure in gnathostomes. Two main conditions are observed in elasmobranchs (shark and rays) and osteichthyans (bony fishes and tetrapods). The condition in the other chondrichthyan taxon, the holocephalans, is still poorly known, and without any information on this taxon, it remains difficult to polarize the condition in gnathostomes. Based on the anatomical study of an embryo of the holocephalan Callorhinchus milii by means of propagation X-Ray Synchrotron phase contrast microtomography using both holotomography and single distance phase retrieval process, we show that, contrary to what was previously inferred for holocephalans (i.e. an osteichthyan-like condition), the arrangement of the glossopharyngeal nerve relative to the surrounding structure in holocephalans is more similar to that of elasmobranchs. Furthermore, the holocephalan condition represents a combination of plesiomorphic characters for gnathostomes (e. g., the glossopharyngeal nerve leaves the braincase via the metotic fissure) and homoplastic characters. By contrast, the crown osteichthyans are probably derived in having the glossopharyngeal nerve that enters the saccular chamber and in having the glossopharyngeal foramen separated from the metotic fissure.	[Pradel, Alan; Maisey, John Graham] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Didier, Dominique] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Casane, Didier] UPR 9034 CNRS, Lab Evolut Genome & Speciat, Gif Sur Yvette, France; [Casane, Didier] Univ Paris Diderot, Paris, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	American Museum of Natural History (AMNH); Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; European Synchrotron Radiation Facility (ESRF)	Pradel, A (corresponding author), Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA.	apradel@amnh.org		Tafforeau, Paul/0000-0002-5962-1683	H.R. & E. Axelrod Research Chair in paleoichthyology at the AMNH; ESRF; National Science Foundation Assembling the Tree Of Life (ATOL) [1132229]; National Science Foundation ("Collaborative Research: Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life'') [1036488]; Herbert and Evelyn Research Chair in Vertebrate Paleontology at the AMNH; NSF DEB Assembling the Tree Of Life (ATOL) [1036505]; Direct For Biological Sciences [1036488, 1036505] Funding Source: National Science Foundation	H.R. & E. Axelrod Research Chair in paleoichthyology at the AMNH; ESRF; National Science Foundation Assembling the Tree Of Life (ATOL)(National Science Foundation (NSF)); National Science Foundation ("Collaborative Research: Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life'')(National Science Foundation (NSF)); Herbert and Evelyn Research Chair in Vertebrate Paleontology at the AMNH; NSF DEB Assembling the Tree Of Life (ATOL); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The main work was supported by the H.R. & E. Axelrod Research Chair in paleoichthyology at the AMNH, the ESRF (beamline ID19, proposal ec361) and part by the National Science Foundation Assembling the Tree Of Life (ATOL) 1132229, the National Science Foundation Award No. 1036488 ("Collaborative Research: Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life''). Research for this project was also supported by the Herbert and Evelyn Research Chair in Vertebrate Paleontology at the AMNH. Dominique Didier research is supported by NSF DEB Assembling the Tree Of Life (ATOL) 1036505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Beer G., 1937, DEV VERTEBRATE SKULL; Didier DA, 1998, J MORPHOL, V236, P25; Didier DA, 1995, AM MUS NOVIT, V3119, P1; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gillis JA, 2011, P NATL ACAD SCI USA, V108, P1507, DOI 10.1073/pnas.1012968108; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Holmgren Nils, 1943, ADA ZOOL [STOCKHOLM], V24, P1; Holmgren Nils, 1940, ACTA ZOOL [STOCKHOLM], V21, P51; Inoue JG, 2010, MOL BIOL EVOL, V27, P2576, DOI 10.1093/molbev/msq147; Janvier P., 1996, EARLY VERTEBRATES; JARVIK ERIK, 1954, K SVENSKA VETENSKAPSAKAD HANDL, V5, P1; JOLLIE M, 1971, J MORPHOL, V133, P17, DOI 10.1002/jmor.1051330103; Khonsari RH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-27; MAISEY J G, 1983, American Museum Novitates, P1; Maisey J.G., 1984, Journal of Vertebrate Paleontology, V4, P359; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)429<0001:MOTBIT>2.0.CO;2; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey JG, 2007, B AM MUS NAT HIST, P4; Maisey JG, 2010, CR PALEVOL, V9, P289, DOI 10.1016/j.crpv.2010.07.021; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; PATTERSO.C, 1965, PHILOS T ROY SOC B, V249, P101, DOI 10.1098/rstb.1965.0010; Poplin C, 1974, ETUDE QUELQUES PALEO; Pradel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024938; Pradel A, 2010, GEODIVERSITAS, V32, P595, DOI 10.5252/g2010n4a2; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Schaeffer B., 1981, B AM MUS NAT HIST, V169, P3; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; YOUNG G C, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P10; YOUNG GC, 1979, ZOOL J LINN SOC-LOND, V66, P309, DOI 10.1111/j.1096-3642.1979.tb01912.x	38	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66988	10.1371/journal.pone.0066988	http://dx.doi.org/10.1371/journal.pone.0066988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799138	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800047
J	Wu, MY; Dai, DQ; Zhang, XF; Zhu, Y				Wu, Meng-Yun; Dai, Dao-Qing; Zhang, Xiao-Fei; Zhu, Yuan			Cancer Subtype Discovery and Biomarker Identification via a New Robust Network Clustering Algorithm	PLOS ONE			English	Article							GENE-EXPRESSION; MAXIMUM-LIKELIHOOD; FACTOR ANALYZERS; ADAPTIVE LASSO; LEUKEMIA; MIXTURES; CLASSIFICATION; UNIVARIATE; SELECTION; ONTOLOGY	In cancer biology, it is very important to understand the phenotypic changes of the patients and discover new cancer subtypes. Recently, microarray-based technologies have shed light on this problem based on gene expression profiles which may contain outliers due to either chemical or electrical reasons. These undiscovered subtypes may be heterogeneous with respect to underlying networks or pathways, and are related with only a few of interdependent biomarkers. This motivates a need for the robust gene expression-based methods capable of discovering such subtypes, elucidating the corresponding network structures and identifying cancer related biomarkers. This study proposes a penalized model-based Student's t clustering with unconstrained covariance (PMT-UC) to discover cancer subtypes with cluster-specific networks, taking gene dependencies into account and having robustness against outliers. Meanwhile, biomarker identification and network reconstruction are achieved by imposing an adaptive L-1 penalty on the means and the inverse scale matrices. The model is fitted via the expectation maximization algorithm utilizing the graphical lasso. Here, a network-based gene selection criterion that identifies biomarkers not as individual genes but as subnetworks is applied. This allows us to implicate low discriminative biomarkers which play a central role in the subnetwork by interconnecting many differentially expressed genes, or have cluster-specific underlying network structures. Experiment results on simulated datasets and one available cancer dataset attest to the effectiveness, robustness of PMT-UC in cancer subtype discovering. Moveover, PMT-UC has the ability to select cancer related biomarkers which have been verified in biochemical or biomedical research and learn the biological significant correlation among genes.	[Wu, Meng-Yun; Dai, Dao-Qing; Zhang, Xiao-Fei; Zhu, Yuan] Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Meng-Yun; Dai, Dao-Qing; Zhang, Xiao-Fei; Zhu, Yuan] Sun Yat Sen Univ, Dept Math, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Yuan] Guangdong Univ Business Studies, Dept Math, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong University of Finance & Economics	Dai, DQ (corresponding author), Sun Yat Sen Univ, Ctr Comp Vis, Guangzhou 510275, Guangdong, Peoples R China.	stsddq@mail.sysu.edu.cn			National Science Foundation of China [90920007, 11171354]; Ministry of Education of China [20120171110016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	Funding provided by National Science Foundation of China (90920007, 11171354), and the Ministry of Education of China (20120171110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, MODERN PATHOL, V22, P206, DOI 10.1038/modpathol.2008.148; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek J, 2011, BIOINFORMATICS, V27, P1269, DOI 10.1093/bioinformatics/btr112; Banerjee O, 2008, J MACH LEARN RES, V9, P485; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bentink S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030269; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cozzini A, 2013, J BIOINFORM IN PRESS; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Di Camillo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032200; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Fan JQ, 2009, ANN APPL STAT, V3, P521, DOI 10.1214/08-AOAS215; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Fruhwirth-Schnatter S, 2010, BIOSTATISTICS, V11, P317, DOI 10.1093/biostatistics/kxp062; Glazko GV, 2009, BIOINFORMATICS, V25, P2348, DOI 10.1093/bioinformatics/btp406; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; Kim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052973; Klener P, 2006, J VIROL, V80, P1922, DOI 10.1128/JVI.80.4.1922-1938.2006; Krajinovic M, 2001, INT J CANCER S, V97, P230; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee H, 2011, IEEE T MED IMAGING, V30, P1154, DOI 10.1109/TMI.2011.2140380; Li J., 2012, NAT COMMUN, V3, P655, DOI [10.1038/ncomms1400, DOI 10.1038/NCOMMS1400]; McLachlan G., 2000, WILEY SER PROB STAT; Mukherjee S, 2011, BIOINFORMATICS, V27, P994, DOI 10.1093/bioinformatics/btr070; Nahar R, 2009, CELL CYCLE, V8, P3874, DOI 10.4161/cc.8.23.10035; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Ni IBP, 2010, PATHOL RES PRACT, V206, P223, DOI 10.1016/j.prp.2009.11.006; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; Pan W, 2007, J MACH LEARN RES, V8, P1145; Payne Kimberly J., 2011, Critical Reviews in Oncogenesis, V16, P3; Peel D, 2000, STAT COMPUT, V10, P339, DOI 10.1023/A:1008981510081; Ramezani-Rad P, 2013, BLOOD, V121, P148, DOI 10.1182/blood-2012-05-428938; Roy J, 2012, BRIEF BIOIN IN PRESS; Sakhinia E, 2005, BRIT J HAEMATOL, V130, P233, DOI 10.1111/j.1365-2141.2005.05594.x; Shachar I, 2011, LEUKEMIA LYMPHOMA, V52, P1446, DOI 10.3109/10428194.2011.565437; Shand JC, 2010, CANCER IMMUNOL IMMUN, V59, P1633, DOI 10.1007/s00262-010-0889-y; Shen K, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040900, 10.1371/journal.pone.0049529]; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; Simoes RD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-38; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Tadesse MG, 2005, J AM STAT ASSOC, V100, P602, DOI 10.1198/016214504000001565; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Winter C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002511; Wu MY, 2012, IEEE ACM T COMPUT BI, V9, P1649, DOI 10.1109/TCBB.2012.105; Xie BH, 2010, BIOINFORMATICS, V26, P501, DOI 10.1093/bioinformatics/btp707; Xie BH, 2008, ELECTRON J STAT, V2, P168, DOI 10.1214/08-EJS194; Yang WH, 2011, IEEE T KNOWL DATA EN, V23, P568, DOI 10.1109/TKDE.2010.150; Yu Y, 2012, BIOCHEM BIOPH RES CO, V423, P721, DOI 10.1016/j.bbrc.2012.06.025; Zhang J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002656; Zhang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043092; Zhang XF, 2012, IEEE ACM T COMPUT BI, V9, P857, DOI 10.1109/TCBB.2012.20; Zhou H, 2009, ELECTRON J STAT, V3, P1473, DOI 10.1214/09-EJS487; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	61	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66256	10.1371/journal.pone.0066256	http://dx.doi.org/10.1371/journal.pone.0066256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799085	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800027
J	Farahani, HS; Lagergren, J				Farahani, Hossein Shahrabi; Lagergren, Jens			Learning Oncogenetic Networks by Reducing to Mixed Integer Linear Programming	PLOS ONE			English	Article							CONJUNCTIVE BAYESIAN NETWORKS; HYBRIDIZATION DATA; TREE MODELS; PATHWAYS; CARCINOMA	Cancer can be a result of accumulation of different types of genetic mutations such as copy number aberrations. The data from tumors are cross-sectional and do not contain the temporal order of the genetic events. Finding the order in which the genetic events have occurred and progression pathways are of vital importance in understanding the disease. In order to model cancer progression, we propose Progression Networks, a special case of Bayesian networks, that are tailored to model disease progression. Progression networks have similarities with Conjunctive Bayesian Networks (CBNs) [1], a variation of Bayesian networks also proposed for modeling disease progression. We also describe a learning algorithm for learning Bayesian networks in general and progression networks in particular. We reduce the hard problem of learning the Bayesian and progression networks to Mixed Integer Linear Programming (MILP). MILP is a Non-deterministic Polynomial-time complete (NP-complete) problem for which very good heuristics exists. We tested our algorithm on synthetic and real cytogenetic data from renal cell carcinoma. We also compared our learned progression networks with the networks proposed in earlier publications. The software is available on the website https://bitbucket.org/farahani/diprog.	[Farahani, Hossein Shahrabi; Lagergren, Jens] KTH Royal Inst Technol, Sci Life Lab SciLifeLab, Ctr Ind & Appl Math, Sch Comp Sci & Commun, Stockholm, Sweden	Royal Institute of Technology; SciLifeLab	Lagergren, J (corresponding author), KTH Royal Inst Technol, Sci Life Lab SciLifeLab, Ctr Ind & Appl Math, Sch Comp Sci & Commun, Stockholm, Sweden.	jensl@csc.kth.se		Lagergren, Jens/0000-0002-4552-0240; Farahani, Hossein/0000-0002-9503-1875	Center for Industrial and Applied Mathematics	Center for Industrial and Applied Mathematics	Funding provided by the Center for Industrial and Applied Mathematics, website: http://www.ciam.kth.se/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudis M, 2001, PROGENETIX NET ONLIN; Beerenwinkel N, 2005, J COMPUT BIOL, V12, P584, DOI 10.1089/cmb.2005.12.584; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P2106, DOI 10.1093/bioinformatics/bti274; Beerenwinkel N, 2007, BERNOULLI, V13, P893, DOI 10.3150/07-BEJ6133; Beerenwinkel N, 2006, J THEOR BIOL, V242, P409, DOI 10.1016/j.jtbi.2006.03.013; Cheng YK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002337; Cussens J., 2010, P WORKSH CONSTR BAS; Desper R, 1999, J COMPUT BIOL, V6, P37, DOI 10.1089/cmb.1999.6.37; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gerstung M, 2009, BIOINFORMATICS, V25, P2809, DOI 10.1093/bioinformatics/btp505; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Hjelm M, 2006, J COMPUT BIOL, V13, P853, DOI 10.1089/cmb.2006.13.853; Hoglund M, 2002, CANCER RES, V62, P5939; Hoglund M, 2002, CANCER RES, V62, P2675; Hoglund M, 2004, CANC GENETICS CYTOGE; Jiang F, 2000, CANCER RES, V60, P6503; KOLLER D., 2009, PROBABILISTIC GRAPHI; Mitelman F, 2012, MITELMAN DATABASE CH; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tofigh A., 2011, ADV NEURAL INFORM PR, V24, P163; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	23	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65773	10.1371/journal.pone.0065773	http://dx.doi.org/10.1371/journal.pone.0065773			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799047	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300042
J	Lansade, L; Coutureau, E; Marchand, A; Baranger, G; Valenchon, M; Calandreau, L				Lansade, Lea; Coutureau, Etienne; Marchand, Alain; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic			Dimensions of Temperament Modulate Cue-Controlled Behavior: A Study on Pavlovian to Instrumental Transfer in Horses (Equus Caballus)	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COGNITIVE PERFORMANCE; LEARNING PERFORMANCES; STRESS; TRAIT; TIME; HIPPOCAMPAL; PERSONALITY; REACTIVITY; ANXIETY	Pavlovian to instrumental transfer (PIT) is a central factor in how cues influence animal behavior. PIT refers to the capacity of a Pavlovian cue that predicts a reward to elicit or increase a response intended to obtain the same reward. In the present study, using an equine model, we assessed whether PIT occurs in hoofed domestic animals and whether its efficacy can be modulated by temperamental dimensions. To study PIT, horses were submitted to Pavlovian conditioning whereby an auditory-visual stimulus was repeatedly followed by food delivery. Then, horses were submitted to instrumental conditioning during which they learned to touch with their noses an object signaled by the experimenter in order to obtain the same reward. During the PIT test, the Pavlovian conditioned stimulus was presented to the animal in the absence of reward. At the end of the experiment, a battery of behavioral tests was performed on all animals to assess five temperamental dimensions and investigate their relationships with instrumental performance. The results indicate that PIT can be observed in horses and that its efficacy is greatly modulated by individual temperament. Indeed, individuals with a specific pattern of temperamental dimensions (i.e., higher levels of gregariousness, fearfulness, and sensory sensitivity) exhibited the strongest PIT. The demonstration of the existence of PIT in domesticated animals (i.e., horses) is important for the optimization of its use by humans and the improvement of training methods. Moreover, because PIT may be implicated in psychological phenomena, including addictive behaviors, the observation of relationships between specific temperamental dimensions and PIT efficacy may aid in identifying predisposing temperamental attributes.	[Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] INRA, UMR Physiol Reprod & Comportements 85, F-37380 Nouzilly, France; [Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] CNRS, UMR 7247, Nouzilly, France; [Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] Univ Tours, Tours, France; [Lansade, Lea; Baranger, Gersende; Valenchon, Mathilde; Calandreau, Ludovic] IFCE, Nouzilly, France; [Coutureau, Etienne; Marchand, Alain] Univ Bordeaux, INCIA, Talence, France; [Coutureau, Etienne; Marchand, Alain] CNRS, UMR 5287, INCIA, Talence, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Lansade, L (corresponding author), INRA, UMR Physiol Reprod & Comportements 85, F-37380 Nouzilly, France.	lansade@tours.inra.fr	INCIA, NeurexTeam/D-6197-2014	Coutureau, Etienne/0000-0001-6695-020X; Valenchon, Mathilde/0000-0003-0226-8433; Marchand, Alain/0000-0002-0231-5562	National French Stud (les Haras nationaux)	National French Stud (les Haras nationaux)	The National French Stud (les Haras nationaux) funded this experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates J.E., 1989, TEMPERAMENT CHILDHOO, P3; Brinks V, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.008.2007, 10.3389/neuro.08/008.2007]; Budaev SV, 1998, J COMP PSYCHOL, V112, P92, DOI 10.1037/0735-7036.112.1.92; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Holmes NM, 2010, NEUROSCI BIOBEHAV R, V34, P1277, DOI 10.1016/j.neubiorev.2010.03.007; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kurland A., 2003, CLICK TEACHES STEP B; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P534, DOI 10.1016/j.applanim.2008.02.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lansade L, 2008, APPL ANIM BEHAV SCI, V109, P355, DOI 10.1016/j.applanim.2007.03.003; Lansade L, 2010, APPL ANIM BEHAV SCI, V125, P30, DOI 10.1016/j.applanim.2010.02.010; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lindberg AC, 1999, APPL ANIM BEHAV SCI, V61, P187, DOI 10.1016/S0168-1591(98)00184-1; MADER DR, 1980, J ANIM SCI, V50, P962, DOI 10.2527/jas1980.505962x; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; Ohl F, 2003, EUR J NEUROSCI, V17, P128, DOI 10.1046/j.1460-9568.2003.02436.x; Ohl F, 2002, BEHAV NEUROSCI, V116, P464, DOI 10.1037//0735-7044.116.3.464; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Schwabe L, 2010, NEUROBIOL LEARN MEM, V93, P183, DOI 10.1016/j.nlm.2009.09.009; Schwabe L, 2009, J NEUROSCI, V29, P7191, DOI 10.1523/JNEUROSCI.0979-09.2009; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Talmi D, 2008, J NEUROSCI, V28, P360, DOI 10.1523/JNEUROSCI.4028-07.2008; Teskey GC, 1998, PHYSIOL BEHAV, V65, P555, DOI 10.1016/S0031-9384(98)00196-6; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Visser EK, 2003, APPL ANIM BEHAV SCI, V80, P311, DOI 10.1016/S0168-1591(02)00235-6; Vyas A, 2002, J NEUROSCI, V22, P6810; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	40	17	18	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64853	10.1371/journal.pone.0064853	http://dx.doi.org/10.1371/journal.pone.0064853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798994	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300003
J	Matser, A; Luu, N; Geskus, R; Heijman, T; Heiligenberg, M; van Veen, M; van der Loeff, MS				Matser, Amy; Luu, Nancy; Geskus, Ronald; Heijman, Titia; Heiligenberg, Marlies; van Veen, Maaike; van der Loeff, Maarten Schim			Higher Chlamydia trachomatis Prevalence in Ethnic Minorities Does Not Always Reflect Higher Sexual Risk Behaviour	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; MIGRANT POPULATIONS; MIXING PATTERNS; NETHERLANDS; GONORRHEA; AFRICAN; HEALTH; SERVICES; BARRIERS; BRITAIN	Background: In affluent countries, the prevalence of Chlamydia trachomatis (CT) is often higher in certain ethnic minorities than in the majority population. In the Netherlands, we examined why CT prevalence is higher in Surinamese/Antilleans, the largest minority in the country. Methods: Heterosexuals were recruited for a cross-sectional survey from May through August 2010 at the sexually transmitted infections (STI) clinic in Amsterdam. Participants completed a questionnaire and were tested for STI. A causal directed acyclic graph was assumed to investigate whether the association between ethnicity and CT could be explained by differences in sexual risk behaviour and socio-economic status. Results: Subjects included 1044 with Dutch background and 335 with Surinamese/Antillean background. Median age for the combined population was 25 (IQR 22-30) years, and 55.4% was female. Sexual risk behaviour did not differ significantly between the two groups. CT was diagnosed in 17.9% of Surinamese/Antilleans and in 11.4% of Dutch. Surinamese/Antilleans were significantly more likely to have CT (OR 1.70; 95% CI 1.21-2.38). The association between ethnicity and CT remained statistically significant after adjusting for sexual risk behaviour, age, sex, and ethnic mixing (aOR 1.48; 95% CI 1.00-2.18), but not after adjusting for education and neighbourhood, markers of socioeconomic status (aOR 1.08; 95% CI 0.71-1.64). Conclusion: The difference in CT prevalence between the minority and majority groups was not explained by differences in sexual risk behaviour. The higher CT prevalence found among Surinamese/Antilleans appeared to reflect their lower educational level and neighbourhood, two markers of lower socio-economic status. We hypothesise that the effect results from lower health-seeking behaviour.	[Matser, Amy; Luu, Nancy; Geskus, Ronald; Heijman, Titia; Heiligenberg, Marlies; van Veen, Maaike; van der Loeff, Maarten Schim] Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands; [Matser, Amy] UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Geskus, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Heiligenberg, Marlies; van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	Public Health Service Amsterdam; Unilever; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Matser, A (corresponding author), Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands.	amatser@ggd.amsterdam.nl	Geskus, Ronald B/H-3684-2019	Geskus, Ronald B/0000-0002-2740-3155; Heijman, Titia/0000-0002-1944-2007; Matser, Amy/0000-0003-4291-1905	Netherlands Organisation for Health and Research (ZonMw) [71150001]	Netherlands Organisation for Health and Research (ZonMw)	This work was supported by the Netherlands Organisation for Health and Research (ZonMw) (grant number 71150001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415; Burns FM, 2007, AIDS CARE, V19, P102, DOI 10.1080/09540120600908440; Fakoya I, 2008, HIV MED, V9, P23, DOI 10.1111/j.1468-1293.2008.00587.x; Fenton KA, 2005, LANCET, V365, P1246, DOI 10.1016/S0140-6736(05)74813-3; Fenton KA, 2001, CURR OPIN INFECT DIS, V14, P63, DOI 10.1097/00001432-200102000-00011; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Ford K, 2002, SEX TRANSM DIS, V29, P13, DOI 10.1097/00007435-200201000-00003; Geronimus AT, 1998, AM J EPIDEMIOL, V148, P475; Gotz HM, 2005, SEX TRANSM INFECT, V81, P24, DOI 10.1136/sti.2004.010181; Gras MJ, 1999, AIDS, V13, P1953, DOI 10.1097/00002030-199910010-00019; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; James AB, 2012, J NATL MED ASSOC, V104, P20, DOI 10.1016/S0027-9684(15)30129-2; Knol F, 2012, DEV STATUS NEIGHBOUR; Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094; Kretzschmar M, 2009, SEX TRANSM INFECT, V85, P359, DOI 10.1136/sti.2009.036251; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; Low N, 2001, SEX TRANSM INFECT, V77, P15, DOI 10.1136/sti.77.1.15; Navarro Christine, 2002, Can J Infect Dis, V13, P195; Op de Coul ELM, 2012, SEX TRANSM DIS, V39, P97, DOI 10.1097/OLQ.0b013e3182383097; Prost A, 2007, SEX TRANSM INFECT, V83, P547, DOI 10.1136/sti.2007.027110; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Stuart B, 2010, J BIOSOC SCI, V42, P27, DOI 10.1017/S0021932009990289; van Bergen JEAM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-293; van Bergen JEAM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-42; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; van Veen MG, 2011, INT J STD AIDS, V22, P245, DOI 10.1258/ijsa.2009.008511; van Veen MG, 2009, AIDS CARE, V21, P683, DOI 10.1080/09540120802511984; Vriend HJ, 2011, SEXUALLY TRANSMITTED, P1	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67287	10.1371/journal.pone.0067287	http://dx.doi.org/10.1371/journal.pone.0067287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799146	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300109
J	Gobbini, MI; Gors, JD; Halchenko, YO; Rogers, C; Guntupalli, JS; Hughes, H; Cipolli, C				Gobbini, Maria Ida; Gors, Jason D.; Halchenko, Yaroslav O.; Rogers, Courtney; Guntupalli, J. Swaroop; Hughes, Howard; Cipolli, Carlo			Prioritized Detection of Personally Familiar Faces	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; CONTINUOUS FLASH SUPPRESSION; ATTENTIONAL BLINK; HUMAN AMYGDALA; CONGENITAL PROSOPAGNOSIA; INTEROCULAR SUPPRESSION; BINOCULAR-RIVALRY; NEURAL SYSTEMS; RECOGNITION; AWARENESS	We investigated whether personally familiar faces are preferentially processed in conditions of reduced attentional resources and in the absence of conscious awareness. In the first experiment, we used Rapid Serial Visual Presentation (RSVP) to test the susceptibility of familiar faces and faces of strangers to the attentional blink. In the second experiment, we used continuous flash interocular suppression to render stimuli invisible and measured face detection time for personally familiar faces as compared to faces of strangers. In both experiments we found an advantage for detection of personally familiar faces as compared to faces of strangers. Our data suggest that the identity of faces is processed with reduced attentional resources and even in the absence of awareness. Our results show that this facilitated processing of familiar faces cannot be attributed to detection of low-level visual features and that a learned unique configuration of facial features can influence preconscious perceptual processing.	[Gobbini, Maria Ida; Cipolli, Carlo] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperime, Bologna, Italy; [Gobbini, Maria Ida; Gors, Jason D.; Halchenko, Yaroslav O.; Rogers, Courtney; Guntupalli, J. Swaroop; Hughes, Howard] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	University of Bologna; Dartmouth College	Gobbini, MI (corresponding author), Univ Bologna, Dipartimento Med Specialist Diagnost & Sperime, Bologna, Italy.	mariaida.gobbini@unibo.it		Halchenko, Yaroslav/0000-0003-3456-2493; Guntupalli, J. Swaroop/0000-0002-0677-5590	National Science Foundation, NSF [0446801]	National Science Foundation, NSF(National Science Foundation (NSF))	This research was funded by the National Science Foundation, NSF grant 0446801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers GW, 2009, J NEURAL TRANSM, V116, P747, DOI 10.1007/s00702-008-0106-8; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Avidan G, 2008, J NEUROPSYCHOL, V2, P141, DOI 10.1348/174866407X260180; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; Barragan-Jason G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00100; Barragan-Jason Gladys, 2012, Front Psychol, V3, P454, DOI 10.3389/fpsyg.2012.00454; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DEHAAN EHF, 1992, CORTEX, V28, P77, DOI 10.1016/S0010-9452(13)80167-0; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Gobbini MI, 2011, J COGNITIVE NEUROSCI, V23, P1911, DOI 10.1162/jocn.2010.21574; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Gobbini MI, 2013, CONSCIOUSNE IN PRESS; Gobbini MI, 2010, SOCIAL NEUROSCIENCE, P40, DOI DOI 10.1093/ACPR0F:0S0/9780195316872.001.0001; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2011, HDB FACE PERCEPTION; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Kang MS, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00088; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Maratos FA, 2008, COGNITION EMOTION, V22, P1340, DOI 10.1080/02699930701774218; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Milders M, 2006, EMOTION, V6, P10, DOI 10.1037/1528-3542.6.1.10; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Rajimehra R, 2009, P NATL ACAD SCI USA, V106, P1995, DOI 10.1073/pnas.0807304106; Ramon M, 2011, PERCEPTION, V40, P437, DOI 10.1068/p6794; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rivolta D, 2010, J CLIN EXP NEUROPSYC, V32, P1002, DOI 10.1080/13803391003662710; Rodriguez V, 2012, J COGNITIVE NEUROSCI, V24, P396, DOI 10.1162/jocn_a_00137; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Valdes-Sosa M, 2011, NEUROIMAGE, V57, P1162, DOI 10.1016/j.neuroimage.2011.04.057; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whalen PJ, 1998, J NEUROSCI, V18, P411; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Zhou GM, 2010, CONSCIOUS COGN, V19, P408, DOI 10.1016/j.concog.2009.12.009	54	68	69	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66620	10.1371/journal.pone.0066620	http://dx.doi.org/10.1371/journal.pone.0066620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805248	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500076
J	Weihmann, T				Weihmann, Tom			Crawling at High Speeds: Steady Level Locomotion in the Spider Cupiennius salei-Global Kinematics and Implications for Centre of Mass Dynamics	PLOS ONE			English	Article							SLIT SENSE-ORGANS; INSECT LOCOMOTION; MECHANICAL MODELS; STEPPING PATTERNS; HORIZONTAL PLANE; LEG BEHAVIOR; WALKING; ARANEAE; ENERGY; STABILITY	Spiders are an old yet very successful predatory group of arthropods. Their locomotor system differs from those of most other arthropods by the lack of extensor muscles in two major leg joints. Though specific functional characteristics can be expected regarding the locomotion dynamics of spiders, this aspect of movement physiology has been only scarcely examined so far. This study presents extensive analyses of a large dataset concerning global kinematics and the implications for dynamics of adult female specimens of the large Central American spider Cupiennius salei (Keyserling). The experiments covered the entire speed-range of straight runs at constant speeds. The analyses revealed specific characteristics of velocity dependent changes in the movements of the individual legs, as well as in the translational and rotational degrees of freedom of both the centre of mass and the body. In contrast to many other fast moving arthropods, C. salei avoid vertical fluctuations of their centre of mass during fast locomotion. Accordingly, aerial phases were not observed here. This behaviour is most likely a consequence of optimising energy expenditure with regard to the specific requirements of spiders' leg anatomy. A strong synchronisation of two alternating sets of legs appears to play only a minor role in the locomotion of large spiders. Reduced frequency and low centre of mass amplitudes as well as low angular changes of the body axes, in turn, seems to be the result of relatively low leg coordination.	Univ Jena, Inst Sports Sci, Jena, Germany	Friedrich Schiller University of Jena	Weihmann, T (corresponding author), Univ Jena, Inst Sports Sci, Jena, Germany.	tom@uni-jena.de	Weihmann, Tom/GYJ-8011-2022	Weihmann, Tom/0000-0002-6628-1816	German Science Foundation [BI 236/14-1]	German Science Foundation(German Research Foundation (DFG))	This work was partly supported by the German Science Foundation (www.dfg.de), grant no. BI 236/14-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; ANDERSON JF, 1975, Z MORPHOL TIERE, V81, P257, DOI 10.1007/BF00298488; [Anonymous], 2002, ANGEW STAT ANWENDUNG; Barth FG, 1986, NATURWISSENSCHAFTEN, V73; Bethe A, 1930, PFLUG ARCH GES PHYS, V224, P793, DOI 10.1007/BF01771422; Biancardi CM, 2011, J EXP BIOL, V214, P3433, DOI 10.1242/jeb.057471; BLICKHAN R, 1986, J BIOMECH, V19, P375, DOI 10.1016/0021-9290(86)90014-X; BLICKHAN R, 1987, J EXP BIOL, V130, P155; BLICKHAN R, 1993, J COMP PHYSIOL A, V173, P509; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Blickhan R, 1983, THESIS WOLFGANG GOET; BLICKHAN R, 2005, AUTONOMES LAUFEN, P19; Blickhan R, 2007, PHILOS T R SOC A, V365, P199, DOI 10.1098/rsta.2006.1911; Bohmann L, 1998, Z ANGEW MATH MECH, V78, P87, DOI 10.1002/(SICI)1521-4001(199802)78:2<87::AID-ZAMM87>3.0.CO;2-H; Brussel A, 1987, THESIS JW GOETHE U F; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Cruse H, 2007, PHILOS T R SOC A, V365, P221, DOI 10.1098/rsta.2006.1913; Damen WGM, 1998, DEV GENES EVOL, V208, P586, DOI 10.1007/s004270050218; Dudek DM, 2006, J EXP BIOL, V209, P1502, DOI 10.1242/jeb.02146; ECKWEILER W, 1988, J COMP PHYSIOL A, V162, P611, DOI 10.1007/BF01342636; Ehlers M., 1939, Zoologische Jahrbuecher Jena Systematik, V72, P373; Fenk LM, 2010, J EXP BIOL, V213, P3111, DOI 10.1242/jeb.041939; FERDINAND W, 1981, ZOOL JAHRB ALLG ZOOL, V85, P46; Fisher NI, 1995, STAT ANAL CIRCULAR D; Frischholz RW, 1993, CLASS ALGORITHMS REA; Full Robert J., 1993, P3; Gaiser I, 2010, ENHANCED FLEXIBLE FL, P1423; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Goldman DI, 2006, J EXP BIOL, V209, P2990, DOI 10.1242/jeb.02322; GRAHAM D, 1978, J EXP BIOL, V73, P147; GRAHAM D, 1985, ADV INSECT PHYSIOL, V18, P31; GRAHAM D, 1981, J EXP BIOL, V92, P229; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; Gunther M, 2004, J MATH BIOL, V48, P623, DOI 10.1007/s00285-004-0269-3; Herreid C.F. II, 1981, P491; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; HUGHES GM, 1952, J EXP BIOL, V29, P267; Ijspeert AJ, 2008, NEURAL NETWORKS, V21, P642, DOI 10.1016/j.neunet.2008.03.014; Jacobi-Kleemann M, 1953, J COMP PHYSL, V34, P606; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Koditschek DE, 2004, ARTHROPOD STRUCT DEV, V33, P251, DOI 10.1016/j.asd.2004.06.003; Kram R, 1997, J EXP BIOL, V200, P1919; Kukillaya RP, 2007, BIOL CYBERN, V97, P379, DOI 10.1007/s00422-007-0180-2; Lewis J. G. E., 1981, BIOL CENTIPEDES; LINZEN B, 1975, J COMP PHYSIOL, V96, P101, DOI 10.1007/BF00706589; Manton, 1977, ARTHROPODA HABITS FU; MCMAHON TA, 1987, J APPL PHYSIOL, V62, P2326, DOI 10.1152/jappl.1987.62.6.2326; McMeeking RM, 2012, J THEOR BIOL, V297, P17, DOI 10.1016/j.jtbi.2011.12.003; Menon C, 2006, BIOINSPIR BIOMIM, V1, P52, DOI 10.1088/1748-3182/1/2/003; MOFFETT S, 1980, J EXP ZOOL, V213, P219, DOI 10.1002/jez.1402130209; Moya-Larano J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001841; PARRY DA, 1959, J EXP BIOL, V36, P654; Pelletier Y, 2001, BIOL CYBERN, V84, P269, DOI 10.1007/s004220000214; PRESTWICH KN, 1988, J COMP PHYSIOL B, V158, P449, DOI 10.1007/BF00691142; Ringrose RP, 1997, SELF STABILIZING RUN; RUHLAND M, 1978, ZOOMORPHOLOGIE, V89, P33, DOI 10.1007/BF00993780; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Schmid A, 1998, J EXP BIOL, V201, P221; Schmitt J, 2000, BIOL CYBERN, V83, P501, DOI 10.1007/s004220000181; Schmitt J, 2000, BIOL CYBERN, V83, P517, DOI 10.1007/s004220000180; Schmitz A, 2005, J EXP BIOL, V208, P1401, DOI 10.1242/jeb.01497; Seidl T, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-8; Sens J, 1996, THESIS U SAARLANDES; Sensenig AT, 2006, J ARACHNOL, V34, P627, DOI 10.1636/0161-8202(2006)034[0627:MEODLI]2.0.CO;2; Sensenig AT, 2003, J EXP BIOL, V206, P771, DOI 10.1242/jeb.00182; Seyfarth A, 2001, BIOL CYBERN, V84, P365, DOI 10.1007/PL00007982; SEYFARTH EA, 1972, J COMP PHYSIOL, V78, P176, DOI 10.1007/BF00693611; SEYFARTH EA, 1978, J COMP PHYSIOL, V125, P45, DOI 10.1007/BF00656830; SEYFARTH EA, 1984, J NEUROBIOL, V15, P365, DOI 10.1002/neu.480150506; SHULTZ JW, 1987, J EXP BIOL, V128, P427; Siebert T, 2010, J COMP PHYSIOL B, V180, P199, DOI 10.1007/s00360-009-0401-1; Spagna JC, 2011, J ARACHNOL, V39, P84, DOI 10.1636/B10-45.1; Sponberg S, 2008, J EXP BIOL, V211, P433, DOI 10.1242/jeb.012385; Srinivasan M, 2008, J THEOR BIOL, V255, P1, DOI 10.1016/j.jtbi.2008.06.034; STEWART DM, 1974, J COMP PHYSIOL, V88, P141, DOI 10.1007/BF00695405; TING LH, 1994, J EXP BIOL, V197, P251; WARD TM, 1981, J EXP BIOL, V92, P323; WARD TM, 1981, J EXP BIOL, V92, P305; Weihmann T, 2007, THESIS F SCHILLER U; Weihmann T, 2009, J COMP PHYSL A; Weihmann T, 2006, J BIOMECHANICS S1, V39, P361; Weihmann T, 2012, J EXP BIOL, V215, P578, DOI 10.1242/jeb.054585; Weihmann T, 2010, J COMP PHYSIOL A, V196, P421, DOI 10.1007/s00359-010-0527-3; WILSON DM, 1966, ANNU REV ENTOMOL, V11, P103, DOI 10.1146/annurev.en.11.010166.000535; WILSON DM, 1967, J EXP BIOL, V47, P133; ZOLLIKOFER CPE, 1994, J EXP BIOL, V192, P107	87	23	23	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65788	10.1371/journal.pone.0065788	http://dx.doi.org/10.1371/journal.pone.0065788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805189	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500017
J	Jugel, C; Ehlen, F; Taskin, B; Marzinzik, F; Muller, T; Klostermann, F				Jugel, Constanze; Ehlen, Felicitas; Taskin, Birol; Marzinzik, Frank; Mueller, Thomas; Klostermann, Fabian			Neuropathy in Parkinson's Disease Patients with Intestinal Levodopa Infusion versus Oral Drugs	PLOS ONE			English	Article							PERIPHERAL NEUROPATHY; AXONAL NEUROPATHY; DUODOPA THERAPY; MONOTHERAPY; SURGERY	Background: Severe polyneuropathy has been observed in a number of patients treated for Parkinson's disease with Levodopa/Carbidopa intestinal gel infusion. This may reflect a rare individual complication or a systematic side effect. Objective: To investigate whether peripheral nerve function differed between patients with oral treatment versus Levodopa/Carbidopa intestinal gel infusion. Methods: In an observational design, data from median, tibial, and peroneal neurography were prospectively assessed and compared between patients with conventional drug treatment (n = 15) and with Levodopa/Carbidopa intestinal gel infusion (n = 15). The groups were matched for age and disease duration. In view of the medical risk profile for polyneuropathy, comorbidity and basic serological parameters were assessed. Results: Axonal neuropathy was common in both patient groups. However, although group differences in risk factors for polyneuropathy were not evident, neurographic abnormalities were more severe in the patients treated with Levodopa/Carbidopa intestinal gel infusion than in the orally treated patients. In the group with Levodopa/Carbidopa intestinal gel infusion, the degree of neuropathic change correlated with weight lost since therapy initiation and with the drug dose. In contrast to the axonal abnormalities, conduction velocity was found normal in both groups. Conclusion: The results are compatible with the promotion of axonal neuropathy by Levodopa/Carbidopa intestinal gel infusion. This could be due to the intrinsically high levodopa doses associated with the therapy and/or malnutritional effects from intestinal drug application. The results should be corroborated by a larger longitudinal and controlled trial.	[Jugel, Constanze; Ehlen, Felicitas; Taskin, Birol; Marzinzik, Frank; Klostermann, Fabian] Charite, Dept Neurol, Campus Benjamin Franklin, D-13353 Berlin, Germany; [Mueller, Thomas] St Joseph Hosp, Dept Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klostermann, F (corresponding author), Charite, Dept Neurol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	fabian.klostermann@charite.de		Ehlen, Felicitas/0000-0003-4595-1822	German Research Foundation [KI 1276/4, KI 1276/5]	German Research Foundation(German Research Foundation (DFG))	Thomas Muller received honoraria for advisory activities from Orion, GSK, Merck Serono, Lundbeck, Teva, Meda, Boehringer and Abbott. Fabian Klostermann received honoraria for advisory activities from Archimedes, UCB, and Abbott, and holds grants from the German Research Foundation (KI 1276/4 and KI 1276/5). All funds are unrelated to the present study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aasheim ET, 2008, OBES SURG, V18, P1640, DOI 10.1007/s11695-008-9539-2; Antonini A, 2007, MOVEMENT DISORD, V22, P1145, DOI 10.1002/mds.21500; Bortz J, 1993, STAT SOZIALWISSENSCH; Bril V, 2009, DIABETIC MED, V26, P240, DOI 10.1111/j.1464-5491.2009.02667.x; Devos D, 2009, MOVEMENT DISORD, V24, P993, DOI 10.1002/mds.22450; Juhasz-Pocsine K, 2007, NEUROLOGY, V68, P1843, DOI 10.1212/01.wnl.0000262768.40174.33; Klostermann F, 2012, J NEURAL TRANSM, V119, P369, DOI 10.1007/s00702-011-0689-3; Manca D, 2009, MOVEMENT DISORD, V24, P2293, DOI 10.1002/mds.22807; Meppelink AM, 2011, MOVEMENT DISORD, V26, P331, DOI 10.1002/mds.23408; Muller T, 2004, ARCH NEUROL-CHICAGO, V61, P657, DOI 10.1001/archneur.61.5.657; Nyholm D, 2005, NEUROLOGY, V64, P216, DOI 10.1212/01.WNL.0000149637.70961.4C; Oertel WH, 2006, MOVEMENT DISORD, V21, P343, DOI 10.1002/mds.20724; Rajabally YA, 2011, NEUROLOGY, V77, P1947, DOI 10.1212/WNL.0b013e31823a0ee4; Santos-Garcia D, 2012, J NEUROL, V259, P1668, DOI 10.1007/s00415-011-6396-z; Thaisetthawatkul P, 2004, NEUROLOGY, V63, P1462; Tison F, 2011, NEUROLOGY, V77, P1938, DOI 10.1212/WNL.0b013e31823de107; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Toth C, 2008, MOVEMENT DISORD, V23, P1850, DOI 10.1002/mds.22137; Toth C, 2010, ANN NEUROL, V68, P28, DOI 10.1002/ana.22021; Urban PP, 2010, MOVEMENT DISORD, V25, P1748, DOI 10.1002/mds.23342	20	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66639	10.1371/journal.pone.0066639	http://dx.doi.org/10.1371/journal.pone.0066639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818953	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800089
J	Yeo, SY; Choi, S; Dien, V; Sow-Peh, YK; Qi, GG; Hatton, TA; Doyle, PS; Thio, BJR				Yeo, Siang Yee; Choi, Siwon; Dien, Vivian; Sow-Peh, Yoke Keow; Qi, Genggeng; Hatton, T. Alan; Doyle, Patrick S.; Thio, Beng Joo Reginald			Using Magnetically Responsive Tea Waste to Remove Lead in Waters under Environmentally Relevant Conditions	PLOS ONE			English	Article							FULLERENE C-60 NANOPARTICLES; LOW-COST ADSORBENT; HUMIC-ACID; ACTIVATED CARBON; HEAVY-METALS; THERMAL REGENERATION; SORPTION; AGGREGATION; ADSORPTION; STABILITY	We report the use of a simple yet highly effective magnetite-waste tea composite to remove lead(II) (Pb2+) ions from water. Magnetite-waste tea composites were dispersed in four different types of water-deionized (DI), artificial rainwater, artificial groundwater and artificial freshwater-that mimic actual environmental conditions. The water samples had varying initial concentrations (0.16-5.55 ppm) of Pb2+ ions and were mixed with the magnetite-waste tea composite for at least 24 hours to allow adsorption of the Pb2+ ions to reach equilibrium. The magnetite-waste tea composites were stable in all the water samples for at least 3 months and could be easily removed from the aqueous media via the use of permanent magnets. We detected no significant leaching of iron (Fe) ions into the water from the magnetite-waste tea composites. The percentage of Pb adsorbed onto the magnetite-waste tea composite ranged from similar to 70% to 100%; the composites were as effective as activated carbon (AC) in removing the Pb2+ ions from water, depending on the initial Pb concentration. Our prepared magnetite-waste tea composites show promise as a green, inexpensive and highly effective sorbent for removal of Pb in water under environmentally realistic conditions.	[Yeo, Siang Yee; Thio, Beng Joo Reginald] Singapore Univ Technol & Design, Singapore, Singapore; [Choi, Siwon; Hatton, T. Alan; Doyle, Patrick S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Dien, Vivian] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Sow-Peh, Yoke Keow] Hwa Chong Inst, High Sch, Dept Sci, Singapore, Singapore; [Qi, Genggeng] Cornell Univ, Kaust Cornell Ctr Energy & Sustainabil, Ithaca, NY USA	Singapore University of Technology & Design; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cornell University	Thio, BJR (corresponding author), Singapore Univ Technol & Design, Singapore, Singapore.	reginaldthio@sutd.edu.sg	Qi, Genggeng/D-5250-2009; Doyle, Patrick S/H-7031-2013	Qi, Genggeng/0000-0001-7968-0931; Doyle, Patrick S/0000-0003-2147-9172; Thio, Beng Joo/0000-0002-5157-2477	Singapore University of Technology and Design (SUTD) [SRG EPD 2012 022]; SUTD-MIT International Design Centre Research [IDG11200105/IDD11200109]; Singapore-MIT Alliance (SMA)	Singapore University of Technology and Design (SUTD); SUTD-MIT International Design Centre Research; Singapore-MIT Alliance (SMA)	This work was supported in part by the Singapore University of Technology and Design (SUTD) Start-Up Research Grant SRG EPD 2012 022 and the SUTD-MIT International Design Centre Research Grant IDG11200105/IDD11200109, together with financial support from the Singapore-MIT Alliance (SMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Halim SH, 2003, WATER RES, V37, P1678, DOI 10.1016/S0043-1354(02)00554-7; Adekunle I. M., 2007, ANN ENV SCI, V1, P23; Ahluwalia SS, 2005, ENG LIFE SCI, V5, P158, DOI 10.1002/elsc.200420066; Amarasinghe BMWPK, 2007, CHEM ENG J, V132, P299, DOI 10.1016/j.cej.2007.01.016; Barancikova G, 2003, PLANT SOIL ENVIRON, V49, P565, DOI 10.17221/4195-PSE; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Chen KL, 2008, ENVIRON SCI TECHNOL, V42, P7607, DOI 10.1021/es8012062; Chen KL, 2007, J COLLOID INTERF SCI, V309, P126, DOI 10.1016/j.jcis.2007.01.074; Coles CA, 2006, ENG GEOL, V85, P26, DOI 10.1016/j.enggeo.2005.09.024; CORAPCIOGLU MO, 1987, WATER RES, V21, P1031, DOI 10.1016/0043-1354(87)90024-8; COSPER EM, 1993, DEV MAR BIO, V3, P667; Gobler CJ, 2001, MAR ECOL PROG SER, V209, P19, DOI 10.3354/meps209019; Hu GP, 2003, CHEMOSPHERE, V51, P747, DOI 10.1016/S0045-6535(03)00028-6; Jin CW, 2005, CHEMOSPHERE, V59, P1151, DOI 10.1016/j.chemosphere.2004.11.058; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Li W, 2008, IND CROP PROD, V28, P294, DOI 10.1016/j.indcrop.2008.03.007; Lin DH, 2007, J AGR FOOD CHEM, V55, P5718, DOI 10.1021/jf0707031; Liu N, 2009, J ENVIRON QUAL, V38, P2260, DOI 10.2134/jeq2009.0114; Makokha A.O., 2008, AFRICAN J ENV SCI TE, V2, P349; MORENOCASTILLA C, 1995, CARBON, V33, P1417, DOI 10.1016/0008-6223(95)00090-Z; Pyrzynska K, 2010, COLLOID SURFACE A, V362, P102, DOI 10.1016/j.colsurfa.2010.03.047; ROSEN JF, 1992, SCIENCE, V256, P294, DOI 10.1126/science.256.5055.294; Sabio E, 2004, CARBON, V42, P2285, DOI 10.1016/j.carbon.2004.05.007; Shen LF, 1999, LANGMUIR, V15, P447, DOI 10.1021/la9807661; STEVENSON F. J, 1994, HUMUS CHEM; STEVENSON FJ, 1976, SOIL SCI SOC AM J, V40, P665, DOI 10.2136/sssaj1976.03615995004000050021x; Suh SK, 2012, J AM CHEM SOC, V134, P7337, DOI 10.1021/ja209245v; TEE TW, 1988, ENVIRON TECHNOL LETT, V9, P1223, DOI 10.1080/09593338809384685; Thio BJR, 2012, ENVIRON SCI TECHNOL, V46, P6985, DOI 10.1021/es203596w; Thio BJR, 2011, J HAZARD MATER, V194, P53, DOI 10.1016/j.jhazmat.2011.07.070; von Smoluchowski M., 1903, B INT ACAD SCI CRACO, V3, P184; WHO, 2003, LEAD DRINK WAT BACKG; WHO, 2011, GUID DRINK WAT QUAL; Xuan SH, 2009, CHEM MATER, V21, P5079, DOI 10.1021/cm901618m; Yoon SH, 1998, WATER RES, V32, P2180, DOI 10.1016/S0043-1354(97)00416-8	36	13	13	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66648	10.1371/journal.pone.0066648	http://dx.doi.org/10.1371/journal.pone.0066648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818955	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800091
J	Zhou, YC; Ru, YF; Wang, CM; Wang, SL; Zhou, ZM; Zhang, YL				Zhou, Yuchuan; Ru, Yanfei; Wang, Chunmei; Wang, Shoulin; Zhou, Zuomin; Zhang, Yonglian			Tripeptidyl Peptidase II Regulates Sperm Function by Modulating Intracellular Ca2+ Stores via the Ryanodine Receptor	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERMATOZOA; ACROSOME REACTION; CAPACITATION; PROTEASOME; PROGESTERONE; INHIBITION; FERTILIZATION; PURIFICATION; DEGRADATION	Recent studies have identified Ca2+ stores in sperm cells; however, it is not clear whether these Ca2+ stores are functional and how they are mobilized. Here, in vitro and in vivo, we determined that tripeptidyl peptidase II antagonists strongly activated the cAMP/PKA signaling pathway that drives sperm capacitation-associated protein tyrosine phosphorylation. We demonstrated that in the absence of Ca2+, TPIII antagonists elevated the intracellular Ca2+ levels in sperm, resulting in a marked improvement in sperm movement, capacitation, acrosome reaction, and the in vitro fertilizing ability. This antagonist-induced release of intracellular Ca2+ could be blocked by the inhibitors of ryanodine receptors (RyRs) which are the main intracellular Ca2+ channels responsible for releasing stored Ca2+. Consistent with these results, indirect immunofluorescence assay using anti-RyR antibodies further validated the presence of RyR(3) in the acrosomal region of mature sperm. Thus, TPPII can regulate sperm maturation by modulating intracellular Ca2+ stores via the type 3 RyR.	[Zhou, Yuchuan; Ru, Yanfei; Wang, Chunmei; Zhang, Yonglian] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai, Peoples R China; [Wang, Shoulin] Nanjing Med Univ, Sch Publ Hlth, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhou, Zuomin] Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University; Nanjing Medical University	Zhang, YL (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai, Peoples R China.	ylzhang@sibcb.ac.cn	zhou, yuchuan/AAF-6202-2019		National Key Basic Research Program (973 Program) [2009CB941701]; National Natural Science Foundation of China [30930053, 31171115, 30971089]; Chinese Academy of Sciences Knowledge Creative Program [KSCX2-EW-R-07]	National Key Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Knowledge Creative Program	This work was supported by grants from the National Key Basic Research Program (973 Program) (2009CB941701), the National Natural Science Foundation of China (30930053, 31171115 and 30971089), and the Chinese Academy of Sciences Knowledge Creative Program (No. KSCX2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; BALOW RM, 1983, J BIOL CHEM, V258, P1622; BALOW RM, 1986, J BIOL CHEM, V261, P2409; Bastian Y, 2010, REPRODUCTION, V140, P673, DOI 10.1530/REP-09-0545; Brewis Ian A, 2005, Hum Fertil (Camb), V8, P253, DOI 10.1080/14647270500420178; Chiarella P, 2004, J CELL SCI, V117, P4127, DOI 10.1242/jcs.01283; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Espino J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-11; FRASER LR, 1987, J REPROD FERTIL, V81, P77, DOI 10.1530/jrf.0.0810077; FRASER LR, 1990, J REPROD FERTIL, V88, P611, DOI 10.1530/jrf.0.0880611; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; HANDROW RR, 1989, J EXP ZOOL, V252, P174, DOI 10.1002/jez.1402520209; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; Huai J, 2008, P NATL ACAD SCI USA, V105, P5177, DOI 10.1073/pnas.0801413105; HYNE RV, 1979, BIOL REPROD, V21, P1135, DOI 10.1095/biolreprod21.5.1135; Kawahara M, 2009, J IMMUNOL, V183, P6069, DOI 10.4049/jimmunol.0803564; KRAUSZ C, 1995, HUM REPROD, V10, P120, DOI 10.1093/humrep/10.1.120; MATSUMURA K, 1989, GAMETE RES, V23, P255, DOI 10.1002/mrd.1120230303; Mckay RM, 2007, EMBO REP, V8, P1183, DOI 10.1038/sj.embor.7401086; Morales P, 2003, HUM REPROD, V18, P1010, DOI 10.1093/humrep/deg111; Morales P, 2000, BIOL REPROD, V63, P635, DOI 10.1095/biolreprod63.2.635; Pasten C, 2005, MOL REPROD DEV, V71, P209, DOI 10.1002/mrd.20280; PILLAI MC, 1991, J EXP ZOOL, V258, P384, DOI 10.1002/jez.1402580314; Preta G, 2010, J ONCOL, V2010, DOI 10.1155/2010/128478; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Roberts KP, 2003, BIOL REPROD, V69, P572, DOI 10.1095/biolreprod.102.013771; Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Schonegge AM, 2012, STRUCTURE, V20, P593, DOI 10.1016/j.str.2012.01.025; Sutovsky P, 2011, REPRODUCTION, V142, P1, DOI 10.1530/REP-11-0041; THOMAS P, 1989, J REPROD FERTIL, V85, P241; TOMKINSON B, 1994, BIOCHEM J, V304, P517, DOI 10.1042/bj3040517; Trevino CL, 1998, ZYGOTE, V6, P159, DOI 10.1017/S0967199498000094; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wang EW, 2000, P NATL ACAD SCI USA, V97, P9990, DOI 10.1073/pnas.180328897; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8; WILSON C, 1993, NEUROCHEM RES, V18, P743, DOI 10.1007/BF00966768; Yanagimachi R., 1994, P189; Zeng HT, 2003, J CELL SCI, V116, P1981, DOI 10.1242/jcs.00396; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66634	10.1371/journal.pone.0066634	http://dx.doi.org/10.1371/journal.pone.0066634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818952	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800088
J	Bailey, LC; Milov, DE; Kelleher, K; Kahn, MG; Del Beccaro, M; Yu, F; Richards, T; Forrest, CB				Bailey, L. Charles; Milov, David E.; Kelleher, Kelly; Kahn, Michael G.; Del Beccaro, Mark; Yu, Feliciano; Richards, Thomas; Forrest, Christopher B.			Multi-Institutional Sharing of Electronic Health Record Data to Assess Childhood Obesity	PLOS ONE			English	Article							PEDIATRIC OBESITY; CHILDREN; UNDERDIAGNOSIS; TECHNOLOGY; PREVALENCE; OVERWEIGHT; DISEASE	Objective: To evaluate the validity of multi-institutional electronic health record (EHR) data sharing for surveillance and study of childhood obesity. Methods: We conducted a non-concurrent cohort study of 528,340 children with outpatient visits to six pediatric academic medical centers during 2007-08, with sufficient data in the EHR for body mass index (BMI) assessment. EHR data were compared with data from the 2007-08 National Health and Nutrition Examination Survey (NHANES). Results: Among children 2-17 years, BMI was evaluable for 1,398,655 visits (56%). The EHR dataset contained over 6,000 BMI measurements per month of age up to 16 years, yielding precise estimates of BMI. In the EHR dataset, 18% of children were obese versus 18% in NHANES, while 35% were obese or overweight versus 34% in NHANES. BMI for an individual was highly reliable over time (intraclass correlation coefficient 0.90 for obese children and 0.97 for all children). Only 14% of visits with measured obesity (BMI >= 95%) had a diagnosis of obesity recorded, and only 20% of children with measured obesity had the diagnosis documented during the study period. Obese children had higher primary care (4.8 versus 4.0 visits, p<0.001) and specialty care (3.7 versus 2.7 visits, p<0.001) utilization than non-obese counterparts, and higher prevalence of diverse co-morbidities. The cohort size in the EHR dataset permitted detection of associations with rare diagnoses. Data sharing did not require investment of extensive institutional resources, yet yielded high data quality. Conclusions: Multi-institutional EHR data sharing is a promising, feasible, and valid approach for population health surveillance. It provides a valuable complement to more resource-intensive national surveys, particularly for iterative surveillance and quality improvement. Low rates of obesity diagnosis present a significant obstacle to surveillance and quality improvement for care of children with obesity.	[Bailey, L. Charles; Richards, Thomas; Forrest, Christopher B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Bailey, L. Charles; Forrest, Christopher B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Milov, David E.] Nemours Childrens Hosp, Orlando, FL USA; [Kelleher, Kelly] Nationwide Childrens Hosp, Columbus, OH USA; [Kahn, Michael G.] Childrens Hosp Colorado, Aurora, CO USA; [Del Beccaro, Mark] Seattle Childrens Hosp, Seattle, WA USA; [Yu, Feliciano] St Louis Childrens Hosp, St Louis, MO 63178 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's Hospital Colorado; Seattle Children's Hospital; St. Louis Children's Hospital; Washington University (WUSTL)	Bailey, LC (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	baileyc@email.chop.edu	Forrest, Christopher/CAF-1379-2022; Kelleher, Kelly/E-3361-2011	Forrest, Christopher/0000-0003-1252-068X; 	Agency for Healthcare Research and Quality (AHRQ) [U18 HS020508-01]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Work on this project was supported in part by grant U18 HS020508-01 from the Agency for Healthcare Research and Quality (AHRQ). The AHRQ had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2011, CURR OPIN ENDOCRINOL, V18, P23, DOI 10.1097/MED.0b013e3283424b37; Allscripts Corporation, 2011, ALLSCR; [Anonymous], MYSQL DAT MAN SYST; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; BARTKO JJ, 1976, PSYCHOL BULL, V83, P762, DOI 10.1037/0033-2909.83.5.762; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Borycki EM, 2011, STUD HEALTH TECHNOL, V166, P197, DOI 10.3233/978-1-60750-740-6-197; Centers for Disease Control and Prevention, 2011, SAS PROGR CDC GROWTH; Centers for Disease Prevention and Control, 2011, CUT OFFS DEF OUTL 20; Centers for Medicare and Medicaid Services, 2011, EL PROF MEAN US TABL; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; Cerner Corporation, 2011, CERN MILL; Collins L, 2010, J PEDIAT HEMATOL ONC, V32, pE304, DOI 10.1097/MPH.0b013e3181ece2bb; Cook S, 2011, PEDIATR CLIN N AM, V58, P1363, DOI 10.1016/j.pcl.2011.09.003; Diamond CC, 2009, HEALTH AFFAIR, V28, P454, DOI 10.1377/hlthaff.28.2.454; Dolin RH, 2011, J AM MED INFORM ASSN, V18, P99, DOI 10.1136/jamia.2010.007864; Epic Systems Corporation, 2011, EPICARE EL MED REC; Etheredge LM, 2007, HEALTH AFFAIR, V26, pW107, DOI 10.1377/hlthaff.26.2.w107; Falkner B, 2006, J PEDIATR-US, V148, P195, DOI 10.1016/j.jpeds.2005.10.030; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Franks S, 2008, INT J OBESITY, V32, P1035, DOI 10.1038/ijo.2008.61; Grossman C, 2011, CLIN DATA BASIC STAP; Holve E, 2012, MED CARE, V50, pS11, DOI 10.1097/MLR.0b013e318258530f; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Hripcsak G, 2011, J BIOMED DISCOV COLL, V6, DOI 10.5210/disco.v6i0.3581; Huang RC, 2011, DIABETES CARE, V34, P1019, DOI 10.2337/dc10-1809; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kahn MG, 2012, MED CARE, V50, pS21, DOI 10.1097/MLR.0b013e318257dd67; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Koebnick C, 2012, J PEDIATR GASTR NUTR, V55, P328, DOI 10.1097/MPG.0b013e31824d256f; Lemay CA, 2003, J AM BOARD FAM PRACT, V16, P14, DOI 10.3122/jabfm.16.1.14; Lieu TA, 2011, CLIN MED RES, V9, P137, DOI 10.3121/cmr.2011.1025; Lim Choi Keung Sarah N, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P9; Lin MC, 2012, J BIOMED INFORM, V45, P658, DOI 10.1016/j.jbi.2012.01.008; Maxson ER, 2010, HEALTH AFFAIR, V29, P1671, DOI 10.1377/hlthaff.2010.0577; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; National Center for Health Statistics CfDCaP, 2012, INT CLASS DIS 9 REV; National Research Council, 2004, CHILDR HLTH NAT WEAL; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Patel AI, 2010, ACAD PEDIATR, V10, P405, DOI 10.1016/j.acap.2010.09.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rea S, 2012, J BIOMEDICAL INFORM; Ruser CB, 2005, J GEN INTERN MED, V20, P1139, DOI 10.1111/j.1525-1497.2005.0263.x; SAS Institute Inc, 2008, SAS SYST MICR WIND 9; Slutsky JR, 2007, HEALTH AFFAIR, V26, pW122, DOI 10.1377/hlthaff.26.2.w122; Tauman R, 2011, EXPERT REV RESP MED, V5, P425, DOI [10.1586/ERS.11.7, 10.1586/ers.11.7]; The Perl Foundation, 2010, PERL; Volovelsky O, 2011, INT J PEDIATR OBES, V6, P59, DOI 10.3109/17477166.2011.583661; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191; Weiner JP, 2009, J HOPKINS ACG SYSTEM; Wen XZ, 2012, PEDIATRICS, V129, P823, DOI 10.1542/peds.2011-1833; Williams C, 2012, HEALTH AFFAIR, V31, P527, DOI 10.1377/hlthaff.2011.1314	54	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66192	10.1371/journal.pone.0066192	http://dx.doi.org/10.1371/journal.pone.0066192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823186	Green Published, gold			2022-12-27	WOS:000320576400066
J	Khumalo, T; Reusch, U; Knackmuss, S; Little, M; Veale, RB; Weiss, SFT				Khumalo, Thandokuhle; Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn; Veale, Robin B.; Weiss, Stefan F. T.			Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18	PLOS ONE			English	Article							67-KDA LAMININ RECEPTOR; BINDING PROTEIN; DIFFERENTIAL EXPRESSION; PROSTATE-CANCER; PRION PROTEIN; CARCINOMA; IDENTIFICATION; LOCALIZATION; RELEASE; DISEASE	Adhesion and invasion have been identified as the two key components of metastasis. The 37 kDa/67 kDa laminin receptor (LRP/LR) is thought to enhance these two processes thus endorsing the progression of cancer. Here we report on LRP/LR and the metastatic potential of MDA-MB 231 breast and WHCO1 oesophageal cancer cells. Western blot analysis revealed a significant increase in total laminin receptor precursor (LRP) levels of breast and oesophageal cancer cells in comparison to non-invasive MCF-7 breast cancer cells, whereas LRP/LR cell surface levels in both cell lines were not significantly different to those of MCF-7 cells as analysed by flow cytometry. Incubation of breast and oesophageal cancer cells with the anti-LRP/LR specific antibody, IgG1-iS18, resulted in significant reduction in the adhesive potential of WHCO1 and MDA-MB 231 cells by 92% and 16%, respectively. Moreover, invasion was significantly impeded by 98% and 25% for WHCO1 and MDA-MB 231 cells, respectively. Pearson's correlation coefficients proved a positive correlation between total LRP/LR levels and invasive potential as well as between the adhesive and invasive potential of breast and oesophageal cancer cells. Our findings suggest that through interference of the LRP/LR-laminin-1 interaction, anti-LRP/LR specific antibody IgG1-iS18 may act as a possible alternative therapeutic tool for metastatic breast and oesophageal cancer treatment.	[Khumalo, Thandokuhle; Veale, Robin B.; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa; [Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn] Affimed Therapeut AG, Heidelberg, Baden Wuerttemb, Germany	University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	stefan.weiss@wits.ac.za			National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	National Research Foundation, the Republic of South Africa; Medical Research Council, the Republic of South Africa	This work was supported by the National Research Foundation, the Republic of South Africa and the Medical Research Council, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Ardini E, 2002, CANCER RES, V62, P1321; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; BEY E, 1976, IN VITRO CELL DEV B, V12, P107; de Manzoni G, 1998, ONCOLOGY-BASEL, V55, P456, DOI 10.1159/000011895; Fontanini G, 1997, CLIN CANCER RES, V3, P227; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; LIOTTA LA, 1991, CANCER RES, V51, pS5054; McKenna DJ, 2001, EXP EYE RES, V73, P81, DOI 10.1006/exer.2001.1013; MECHAM RP, 1989, J BIOL CHEM, V264, P16652; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; Moodley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057409; Nadji M, 1999, CANCER-AM CANCER SOC, V85, P432, DOI 10.1002/(SICI)1097-0142(19990115)85:2<432::AID-CNCR22>3.0.CO;2-J; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Nikles D, 2008, BBA-MOL BASIS DIS, V1782, P335, DOI 10.1016/j.bbadis.2008.02.003; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Ozaki I, 1998, GUT, V43, P837, DOI 10.1136/gut.43.6.837; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Siziopikou KP, 2007, BREAST, V16, P104, DOI 10.1016/j.breast.2006.09.003; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; TURPEENNIEMIHUJANEN T, 1986, J BIOL CHEM, V261, P1883; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vana Karen, 2009, Infectious Disorders - Drug Targets, V9, P69; VANDENBRULE FA, 1994, EUR J CANCER, V30A, P1096, DOI 10.1016/0959-8049(94)90464-2; Waltregny D, 1997, JNCI-J NATL CANCER I, V89, P1224, DOI 10.1093/jnci/89.16.1224; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Zhou L, 2006, LARYNGOSCOPE, V116, P28, DOI 10.1097/01.mlg.0000184505.05662.b9; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	40	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66297	10.1371/journal.pone.0066297	http://dx.doi.org/10.1371/journal.pone.0066297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823499	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400079
J	Schack, LM; Noack, S; Winkler, R; Wissmann, G; Behrens, P; Wellmann, M; Jagodzinski, M; Krettek, C; Hoffmann, A				Schaeck, Luisa M.; Noack, Sandra; Winkler, Ramona; Wissmann, Gesa; Behrens, Peter; Wellmann, Mathias; Jagodzinski, Michael; Krettek, Christian; Hoffmann, Andrea			The Phosphate Source Influences Gene Expression and Quality of Mineralization during In Vitro Osteogenic Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; VASCULAR CALCIFICATION; OSTEOBLAST DIFFERENTIATION; INORGANIC-PHOSPHATE; OSTEOCALCIN; HYDROXYAPATITE; DEXAMETHASONE; OSTEOPONTIN; MECHANISM	For in vitro differentiation of bone marrow-derived mesenchymal stem cells/mesenchymal stromal cells into osteoblasts by 2-dimensional cell culture a variety of protocols have been used and evaluated in the past. Especially the external phosphate source used to induce mineralization varies considerably both in respect to chemical composition and concentration. In light of the recent findings that inorganic phosphate directs gene expression of genes crucial for bone development, the need for a standardized phosphate source in in vitro differentiation becomes apparent. We show that chemical composition (inorganic versus organic phosphate origin) and concentration of phosphate supplementation exert a severe impact on the results of gene expression for the genes commonly used as markers for osteoblast formation as well as on the composition of the mineral formed. Specifically, the intensity of gene expression does not necessarily correlate with a high quality mineralized matrix. Our study demonstrates advantages of using inorganic phosphate instead of beta-glycerophosphate and propose colorimetric quantification methods for calcium and phosphate ions as cost-and time-effective alternatives to X-ray diffraction and Fourier-transform infrared spectroscopy for determination of the calcium phosphate ratio and concentration of mineral matrix formed under in vitro-conditions. We critically discuss the different assays used to assess in vitro bone formation in respect to specificity and provide a detailed in vitro protocol that could help to avoid contradictory results due to variances in experimental design.	[Schaeck, Luisa M.; Noack, Sandra; Winkler, Ramona; Jagodzinski, Michael; Krettek, Christian; Hoffmann, Andrea] Hannover Med Sch, Trauma Dept, Hannover, Germany; [Wissmann, Gesa; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, D-30167 Hannover, Germany; [Wellmann, Mathias] Hannover Med Sch, Clin Orthoped Surg, Hannover, Germany	Hannover Medical School; Leibniz University Hannover; Hannover Medical School	Hoffmann, A (corresponding author), Hannover Med Sch, Trauma Dept, Hannover, Germany.	Hoffmann.Andrea@mh-hannover.de	Hoffmann, Andrea/AAG-4488-2020	Hoffmann, Andrea/0000-0003-2318-8985; Krettek, Christian/0000-0001-9807-0020; Gladitz, Luisa Marilena/0000-0002-6460-1644	German Research Foundation [SFB 599, Ho2058/4-1]; Studienstiftung des Deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes	AH acknowledges funding by the German Research Foundation (www.dfg.de) within SFB 599 and Ho2058/4-1. LMS was supported by a PhD fellowship from the Studienstiftung des Deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Ali AT, 2006, ANN CLIN BIOCHEM, V43, P207, DOI 10.1258/000456306776865179; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Benayahu D, 1997, BIOCHEM BIOPH RES CO, V231, P442, DOI 10.1006/bbrc.1997.6116; BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; Boskey AL, 2008, CHEM REV, V108, P4716, DOI 10.1021/cr0782473; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; BOSKEY AL, 1989, J PHYS CHEM-US, V93, P1628, DOI 10.1021/j100341a086; CASSELLA JP, 1995, CALCIFIED TISSUE INT, V56, P118, DOI 10.1007/BF00296342; Chang PL, 2006, CONNECT TISSUE RES, V47, P67, DOI 10.1080/03008200600584074; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492; Farlay D, 2010, J BONE MINER METAB, V28, P433, DOI 10.1007/s00774-009-0146-7; Foresta C, 2010, J CLIN ENDOCR METAB, V95, P3502, DOI 10.1210/jc.2009-2557; FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Ichikawa H, 2002, BRAIN RES, V958, P459, DOI 10.1016/S0006-8993(02)03701-0; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/JBMR.090508, 10.1359/jbmr.090508]; Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002; Lian J B, 1993, J Oral Implantol, V19, P95; Lian J B, 1995, Iowa Orthop J, V15, P118; Lynch MP, 1998, J CELL BIOCHEM, V68, P31; Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Mori K, 1998, FEBS LETT, V433, P19, DOI 10.1016/S0014-5793(98)00870-9; Mori K, 1999, ARTERIOSCL THROM VAS, V19, P2112, DOI 10.1161/01.ATV.19.9.2112; Park KW, 2009, MOL CELL BIOL, V29, P3905, DOI 10.1128/MCB.00002-09; Paschalis EP, 2011, CLIN ORTHOP RELAT R, V469, P2170, DOI 10.1007/s11999-010-1751-4; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; PUCHTLER H, 1978, HISTOCHEMISTRY, V56, P177, DOI 10.1007/BF00495978; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sotiropoulou PA, 2006, STEM CELLS, V24, P1409, DOI 10.1634/stemcells.2005-0654; Stich S, 2009, CELL TISSUE RES, V336, P225, DOI 10.1007/s00441-009-0768-z; Tekkatte C, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/504723; TENENBAUM HC, 1982, CALCIFIED TISSUE INT, V34, P76, DOI 10.1007/BF02411212; THIEDE MA, 1994, ENDOCRINOLOGY, V135, P929, DOI 10.1210/en.135.3.929; Wolf G, 1996, NUTR REV, V54, P332, DOI 10.1111/j.1753-4887.1996.tb03798.x	50	42	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65943	10.1371/journal.pone.0065943	http://dx.doi.org/10.1371/journal.pone.0065943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823126	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400036
J	Zhao, DH; Lv, MT; Jiang, H; Cai, Y; Xu, DL; An, SQ				Zhao, Dehua; Lv, Meiting; Jiang, Hao; Cai, Ying; Xu, Delin; An, Shuqing			Spatio-Temporal Variability of Aquatic Vegetation in Taihu Lake over the Past 30 Years	PLOS ONE			English	Article							CLASSIFICATION TREE; WATER; IMAGERY; CHINA; MACROPHYTES; THRESHOLDS; ECOSYSTEMS; FEATURES; SHIFTS; NORTH	It is often difficult to track the spatio-temporal variability of vegetation distribution in lakes because of the technological limitations associated with mapping using traditional field surveys as well as the lack of a unified field survey protocol. Using a series of Landsat remote sensing images (i.e. MSS, TM and ETM+), we mapped the composition and distribution area of emergent, floating-leaf and submerged macrophytes in Taihu Lake, China, at approximate five-year intervals over the past 30 years in order to quantify the spatio-temporal dynamics of the aquatic vegetation. Our results indicated that the total area of aquatic vegetation increased from 187.5 km(2) in 1981 to 485.0 km(2) in 2005 and then suddenly decreased to 341.3 km(2) in 2010. Similarly, submerged vegetation increased from 127.0 km(2) in 1981 to 366.5 km(2) in 2005, and then decreased to 163.3 km(2). Floating-leaf vegetation increased continuously through the study period in both area occupied (12.9 km(2) in 1981 to 146.2 km(2) in 2010) and percentage of the total vegetation (6.88% in 1981 to 42.8% in 2010). In terms of spatial distribution, the aquatic vegetation in Taihu Lake has spread gradually from the East Bay to the surrounding areas. The proportion of vegetation in the East Bay relative to that in the entire lake has decreased continuously from 62.3% in 1981, to 31.1% in 2005 and then to 21.8% in 2010. Our findings have suggested that drastic changes have taken place over the past 30 years in the spatial pattern of aquatic vegetation as well as both its relative composition and the amount of area it occupies.	[Zhao, Dehua; Lv, Meiting; Jiang, Hao; Cai, Ying; Xu, Delin; An, Shuqing] Nanjing Univ, Dept Biol Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Zhao, DH (corresponding author), Nanjing Univ, Dept Biol Sci & Technol, Nanjing 210008, Jiangsu, Peoples R China.	dhzhao@nju.edu.cn			National Natural Science Foundation of China [31000226]; Environmental Monitoring Research Foundation of Jiangsu Province [1014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental Monitoring Research Foundation of Jiangsu Province	This research was supported by the National Natural Science Foundation of China (31000226) and Environmental Monitoring Research Foundation of Jiangsu Province (1014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S.Q., 2009, LECT CHINAS ENV; Brisson J, 2009, SCI TOTAL ENVIRON, V407, P3923, DOI 10.1016/j.scitotenv.2008.05.047; Chambers PA, 2008, HYDROBIOLOGIA, V595, P9, DOI 10.1007/s10750-007-9154-6; Contamin R, 2009, ECOL APPL, V19, P799, DOI 10.1890/08-0109.1; Deng Jian-cai, 2008, Huanjing Kexue, V29, P3382; [谷孝鸿 Gu Xiaohong], 2005, [生态学报, Acta Ecologica Sinica], V25, P1541; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Harma P, 2001, SCI TOTAL ENVIRON, V268, P107, DOI 10.1016/S0048-9697(00)00688-4; He Jun, 2008, Hupo Kexue, V20, P790; Hu WP, 2008, ECOL ENG, V34, P30, DOI 10.1016/j.ecoleng.2008.05.018; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jiang H, 2012, SENSORS-BASEL, V12, P12437, DOI 10.3390/s120912437; [金相灿 JIN Xiangcan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P21; Jin Xiangcan, 2007, Hupo Kexue, V19, P151; Kloiber SM, 2002, WATER RES, V36, P4330, DOI 10.1016/S0043-1354(02)00146-X; Le CF, 2009, REMOTE SENS ENVIRON, V113, P1175, DOI 10.1016/j.rse.2009.02.005; Li YP, 2011, ECOL ENG, V37, P325, DOI 10.1016/j.ecoleng.2010.11.024; [刘伟龙 Liu Weilong], 2007, [生态学报, Acta Ecologica Sinica], V27, P159; [吕振霖 Lv Zhenlin], 2012, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V40, P123; Ma RH, 2008, SENSORS-BASEL, V8, P3988, DOI 10.3390/s8063988; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Qin B Q, 2004, PROCESS MECH ENV CHA; Qin BQ, 2009, ECOL ENG, V35, P1569, DOI 10.1016/j.ecoleng.2009.04.003; Qing BQ, 2009, J LAKE SCI, V21, P445; Rouse J., 1974, MONITORING VEGETATIO, V1, P309; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; Wang Qian, 2010, Environmental Science & Technology (China), V33, P96; Wu GF, 2007, WATER RES, V41, P3271, DOI 10.1016/j.watres.2007.05.018; Wu Q. L., 2000, ACTA SCI CIRCUMST, V20, P275; Xie P, 2008, HIST DEV CYANOBACTER; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yang Guishan, 2010, Hupo Kexue, V22, P799; Yang M, 2008, SCIENCE, V319, P158, DOI 10.1126/science.319.5860.158a; [俞海桥 YU Hai-qiao], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1903; Zhao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044836; Zhao DH, 2012, J ENVIRON MANAGE, V95, P98, DOI 10.1016/j.jenvman.2011.10.007; Zhao DH, 2011, ADV WATER RESOUR, V34, P165, DOI 10.1016/j.advwatres.2010.08.010; Zimmer KD, 2009, ECOSYSTEMS, V12, P843, DOI 10.1007/s10021-009-9262-4	40	33	42	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66365	10.1371/journal.pone.0066365	http://dx.doi.org/10.1371/journal.pone.0066365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823189	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400093
J	Lambert, O; Piroux, M; Puyo, S; Thorin, C; L'Hostis, M; Wiest, L; Bulete, A; Delbac, F; Pouliquen, H				Lambert, Olivier; Piroux, Melanie; Puyo, Sophie; Thorin, Chantal; L'Hostis, Monique; Wiest, Laure; Bulete, Audrey; Delbac, Frederic; Pouliquen, Herve			Widespread Occurrence of Chemical Residues in Beehive Matrices from Apiaries Located in Different Landscapes of Western France	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BEES APIS-MELLIFERA; LAND-USE CHANGE; SPECIES RICHNESS; HONEY; PESTICIDE; POLLEN; IMPACT; PROCHLORAZ; SENTINELS	Background: The honey bee, Apis mellifera, is frequently used as a sentinel to monitor environmental pollution. In parallel, general weakening and unprecedented colony losses have been reported in Europe and the USA, and many factors are suspected to play a central role in these problems, including infection by pathogens, nutritional stress and pesticide poisoning. Honey bee, honey and pollen samples collected from eighteen apiaries of western France from four different landscape contexts during four different periods in 2008 and in 2009 were analyzed to evaluate the presence of pesticides and veterinary drug residues. Methodology/Findings: A multi-residue analysis of 80 compounds was performed using a modified QuEChERS method, followed by GC-ToF and LC-MS/MS. The analysis revealed that 95.7%, 72.3% and 58.6% of the honey, honey bee and pollen samples, respectively, were contaminated by at least one compound. The frequency of detection was higher in the honey samples (n = 28) than in the pollen (n = 23) or honey bee (n = 20) samples, but the highest concentrations were found in pollen. Although most compounds were rarely found, some of the contaminants reached high concentrations that might lead to adverse effects on bee health. The three most frequent residues were the widely used fungicide carbendazim and two acaricides, amitraz and coumaphos, that are used by beekeepers to control Varroa destructor. Apiaries in rural-cultivated landscapes were more contaminated than those in other landscape contexts, but the differences were not significant. The contamination of the different matrices was shown to be higher in early spring than in all other periods. Conclusions/Significance: Honey bees, honeys and pollens are appropriate sentinels for monitoring pesticide and veterinary drug environmental pollution. This study revealed the widespread occurrence of multiple residues in beehive matrices and suggests a potential issue with the effects of these residues alone or in combination on honey bee health.	[Lambert, Olivier; Piroux, Melanie; Puyo, Sophie; L'Hostis, Monique; Pouliquen, Herve] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Ctr Vet Faune Sauvage & Ecosyst Pays Loire CVFSE, Nantes, France; [Thorin, Chantal] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Unite Physiopathol Anim & Pharmacol Fonct, Nantes, France; [Wiest, Laure; Bulete, Audrey] Univ Lyon 1, Inst Sci Analyt, Dept Serv Cent Anal, ENS Lyon,UMR CNRS 5280, F-69622 Villeurbanne, France; [Lambert, Olivier; Piroux, Melanie; Delbac, Frederic] Univ Blaise Pascal, Clermont Univ, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Lambert, Olivier; Piroux, Melanie; Delbac, Frederic] LMGE, CNRS, UMR 6023, Aubiere, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA)	Lambert, O (corresponding author), LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Ctr Vet Faune Sauvage & Ecosyst Pays Loire CVFSE, Nantes, France.	olivier.lambert@oniris-nantes.fr		Wiest, Laure/0000-0001-7271-9143	European Union through European Agricultural Guidance Guarantee fund projects; Nantes Metropole; le Conseil General de Loire Atlantique; le Conseil Regional des Pays de la Loire; Pullman hotels by Bee My Friend	European Union through European Agricultural Guidance Guarantee fund projects; Nantes Metropole(Region Pays de la Loire); le Conseil General de Loire Atlantique(Region Pays de la Loire); le Conseil Regional des Pays de la Loire(Region Pays de la Loire); Pullman hotels by Bee My Friend	This project was supported by the European Union through European Agricultural Guidance Guarantee fund projects, Nantes Metropole, le Conseil General de Loire Atlantique, le Conseil Regional des Pays de la Loire and Pullman hotels by Bee My Friend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Andresen JA, 2004, SCI TOTAL ENVIRON, V332, P155, DOI 10.1016/j.scitotenv.2004.04.021; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Barmaz S, 2010, ECOTOXICOLOGY, V19, P1347, DOI 10.1007/s10646-010-0521-0; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bilandzic N, 2011, FOOD CHEM, V128, P1160, DOI 10.1016/j.foodchem.2011.04.023; Brittain CA, 2010, BASIC APPL ECOL, V11, P106, DOI 10.1016/j.baae.2009.11.007; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Celli Giorgio, 2003, Bulletin of Insectology, V56, P137; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chaves A, 2008, CHEMOSPHERE, V71, P629, DOI 10.1016/j.chemosphere.2007.11.015; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Core A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029639; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Ghini S, 2004, ARCH ENVIRON CON TOX, V47, P479, DOI 10.1007/s00244-003-3219-y; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2011, AM BEE J, V151, P975; Orantes-Bermejo FJ, 2010, J APICULT RES, V49, P243, DOI 10.3896/IBRA.1.49.3.03; Kalbande DM, 2008, ENVIRON MONIT ASSESS, V138, P233, DOI 10.1007/s10661-007-9793-0; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lambert O, 2012, ENVIRON POLLUT, V170, P254, DOI 10.1016/j.envpol.2012.07.012; Lambert O, 2012, CHEMOSPHERE, V86, P98, DOI 10.1016/j.chemosphere.2011.09.025; Lodesani M., 2003, APIACTA, V38, P31; MACKENZIE KE, 1989, APIDOLOGIE, V20, P29, DOI 10.1051/apido:19890104; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Maver L., 2003, APIACTA, V38, P54; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Morgano MA, 2010, J AGR FOOD CHEM, V58, P6876, DOI 10.1021/jf100433p; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Office of Pesticide Programs USEPA, 2000, ASS VAL NOND NONQ PE; Perugini M, 2011, BIOL TRACE ELEM RES, V140, P170, DOI 10.1007/s12011-010-8688-z; Perugini M, 2009, J AGR FOOD CHEM, V57, P7440, DOI 10.1021/jf9011054; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Porrini C., 2003, APIACTA, V38, P63, DOI DOI 10.1080/10942912.2015.1107578; R Core Team, 2012, R LANG ENV STAT COMP; Reidsma P, 2006, AGR ECOSYST ENVIRON, V114, P86, DOI 10.1016/j.agee.2005.11.026; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sabatini AG, 2003, APIACTA, V38, P46; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Tsigouri A., 2003, APIACTA, V38, P50; Tuzen M, 2007, FOOD CHEM, V103, P325, DOI 10.1016/j.foodchem.2006.07.053; VANBUREN NWM, 1992, ENVIRON ENTOMOL, V21, P860, DOI 10.1093/ee/21.4.860; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wiest L, 2011, J CHROMATOGR A, V1218, P5743, DOI 10.1016/j.chroma.2011.06.079; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	65	116	116	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e67007	10.1371/journal.pone.0067007	http://dx.doi.org/10.1371/journal.pone.0067007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799139	gold, Green Submitted, Green Published			2022-12-27	WOS:000321397800048
J	Gowher, A; Smirnov, A; Tarassov, I; Entelis, N				Gowher, Ali; Smirnov, Alexandre; Tarassov, Ivan; Entelis, Nina			Induced tRNA Import into Human Mitochondria: Implication of a Host Aminoacyl-tRNA-Synthetase	PLOS ONE			English	Article							5S RIBOSOMAL-RNA; YEAST MITOCHONDRIA; BINDING DOMAIN; PROTEIN IMPORT; ENCODED RNAS; TRANSLATION; ENOLASE; DNA; REQUIREMENTS; CONSEQUENCES	In human cell, a subset of small non-coding RNAs is imported into mitochondria from the cytosol. Analysis of the tRNA import pathway allowing targeting of the yeast tRNA(CUU)(Lys) into human mitochondria demonstrates a similarity between the RNA import mechanisms in yeast and human cells. We show that the cytosolic precursor of human mitochondrial lysyl-tRNA synthetase (preKARS2) interacts with the yeast tRNA(CUU)(Lys) and small artificial RNAs which contain the structural elements determining the tRNA mitochondrial import, and facilitates their internalization by isolated human mitochondria. The tRNA import efficiency increased upon addition of the glycolytic enzyme enolase, previously found to be an actor of the yeast RNA import machinery. Finally, the role of preKARS2 in the RNA mitochondrial import has been directly demonstrated in vivo, in cultured human cells transfected with the yeast tRNA and artificial importable RNA molecules, in combination with preKARS2 overexpression or downregulation by RNA interference. These findings suggest that the requirement of protein factors for the RNA mitochondrial targeting might be a conserved feature of the RNA import pathway in different organisms.	[Gowher, Ali; Smirnov, Alexandre; Tarassov, Ivan; Entelis, Nina] Univ Strasbourg, CNRS, UMR Genet Mol 7156, Dept Mol & Cellular Genet,Microbiol GMGM, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Entelis, N (corresponding author), Univ Strasbourg, CNRS, UMR Genet Mol 7156, Dept Mol & Cellular Genet,Microbiol GMGM, Strasbourg, France.	n.entelis@unistra.fr	Smirnov, Alexandre/H-4253-2019	Smirnov, Alexandre/0000-0002-9142-7979; Entelis, Nina/0000-0002-7915-5528; Tarassov, Ivan/0000-0001-8763-6703	CNRS (Centre National de Recherche Scientifique); University of Strasbourg; AFM (Association Francaise contre les Myopathies); ANR (Agence Nationale de la Recherche); FRM (Fondation pour la Recherche Medicale); National Program "Investissment d'Avenir" (Labex MitoCross); Pakistan Government's HEC-SFERE PhD fellowship	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); National Program "Investissment d'Avenir" (Labex MitoCross); Pakistan Government's HEC-SFERE PhD fellowship	This work was supported by CNRS (Centre National de Recherche Scientifique), University of Strasbourg, AFM (Association Francaise contre les Myopathies), ANR (Agence Nationale de la Recherche), FRM (Fondation pour la Recherche Medicale) and National Program "Investissment d'Avenir" (Labex MitoCross). A. G. was supported by Pakistan Government's HEC-SFERE PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Belostotsky R, 2012, RNA BIOL, V9, P33, DOI 10.4161/rna.9.1.18009; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Comte C, 2012, NUCL ACIDS RES; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Dias J, 2012, BIOCHEMISTRY-US, V51, P909, DOI 10.1021/bi201337b; Diaz-Lazcoz Y, 1998, MOL BIOL EVOL, V15, P1548, DOI 10.1093/oxfordjournals.molbev.a025882; Duchene AM, 2008, CURR GENET; Entelis N, 2002, GENET ENG P, V24, P191; Entelis N, 2006, GENE DEV, V20, P1609, DOI 10.1101/gad.385706; Entelis NS, 1996, FEBS LETT, V384, P38, DOI 10.1016/0014-5793(96)00259-1; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Kamenski P, 2007, MOL CELL, V26, P625, DOI 10.1016/j.molcel.2007.04.019; Kamenski P, 2010, MITOCHONDRION, V10, P284, DOI 10.1016/j.mito.2010.01.002; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Kaminska M, 2007, J VIROL, V81, P68, DOI 10.1128/JVI.01267-06; Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546; Kolesnikova OA, 2000, SCIENCE, V289, P1931, DOI 10.1126/science.289.5486.1931; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Sepuri NBV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035321; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Wang G, 2012, P NATL ACAD SCI USA, V109, P4840, DOI 10.1073/pnas.1116792109; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035	50	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66228	10.1371/journal.pone.0066228	http://dx.doi.org/10.1371/journal.pone.0066228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799079	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300064
J	Johnsen, AB; Hoydal, M; Rosbjorgen, R; Stolen, T; Wisloff, U				Johnsen, Anne Berit; Hoydal, Morten; Rosbjorgen, Ragnhild; Stolen, Tomas; Wisloff, Ulrik			Aerobic Interval Training Partly Reverse Contractile Dysfunction and Impaired Ca2+ Handling in Atrial Myocytes from Rats with Post Infarction Heart Failure	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+; MOLECULAR DETERMINANTS; MYOCARDIAL-INFARCTION; CALCIUM-RELEASE; LEAK; FIBRILLATION; PHOSPHORYLATION; HYPERTROPHY; EXPRESSION; EXCHANGER	Background: There is limited knowledge about atrial myocyte Ca2+ handling in the failing hearts. The aim of this study was to examine atrial myocyte contractile function and Ca2+ handling in rats with post-infarction heart failure (HF) and to examine whether aerobic interval training could reverse a potential dysfunction. Methods and results: Post-infarction HF was induced in Sprague Dawley rats by ligation of the left descending coronary artery. Atrial myocyte shortening was depressed (p<0.01) and time to relaxation was prolonged (p<0.01) in sedentary HF-rats compared to healthy controls. This was associated with decreased Ca2+ amplitude, decreased SR Ca2+ content, and slower Ca2+ transient decay. Atrial myocytes from HF-rats had reduced sarcoplasmic reticulum Ca2+ ATPase activity, increased Na+/Ca2+-exchanger activity and increased diastolic Ca2+ leak through ryanodine receptors. High intensity aerobic interval training in HF-rats restored atrial myocyte contractile function and reversed changes in atrial Ca2+ handling in HF. Conclusion: Post infarction HF in rats causes profound impairment in atrial myocyte contractile function and Ca2+ handling. The observed dysfunction in atrial myocytes was partly reversed after aerobic interval training.	[Johnsen, Anne Berit; Hoydal, Morten; Rosbjorgen, Ragnhild; Stolen, Tomas; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, Fac Med, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	ulrik.wisloff@ntnu.no	Høydal, Morten A/K-2806-2012; Wisloff, Ulrik/K-2899-2012	Høydal, Morten A/0000-0003-1804-2578; Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Research Council Funding for Outstanding Young investigators	K.G. Jebsen Foundation; Norwegian Research Council Funding for Outstanding Young investigators	This work was supported by grants from K.G. Jebsen Foundation and the Norwegian Research Council Funding for Outstanding Young investigators (to Ulrik Wisloff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Armoundas AA, 2007, AM J PHYSIOL-HEART C, V292, pH1607, DOI 10.1152/ajpheart.00525.2006; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B; Bers DM, 2001, EXCITATION CONTRACTI; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Bers Donald M., 2002, Basic Research in Cardiology, V97; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Chelu MG, 2007, BIOCHEM SOC T, V35, P952, DOI 10.1042/BST0350952; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; Greiser M, 2009, J MOL CELL CARDIOL, V46, P385, DOI 10.1016/j.yjmcc.2008.11.012; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Hasenfuss G, 1998, CIRC RES, V83, P966; Hobai IA, 2001, CIRCULATION, V103, P1577; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Kemi OJ, 2002, J APPL PHYSIOL, V93, P1301, DOI 10.1152/japplphysiol.00231.2002; Kemi OJ, 2012, J CELL PHYSIOL, V227, P20, DOI 10.1002/jcp.22771; Kemi OJ, 2007, CARDIOVASC RES, V76, P91, DOI 10.1016/j.cardiores.2007.06.008; Loennechen JP, 2001, AM J PHYSIOL-HEART C, V280, pH2902, DOI 10.1152/ajpheart.2001.280.6.H2902; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Neef S, 2009, CIRC RES; Pogwizd SM, 2000, CIRC RES, V87, P641, DOI 10.1161/01.RES.87.8.641; Pogwizd SM, 1999, CIRC RES, V85, P1009; Schotten U, 2002, CARDIOVASC RES, V53, P192, DOI 10.1016/S0008-6363(01)00453-9; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Stolen TO, 2009, CIRC RES, V105, P527, DOI 10.1161/CIRCRESAHA.109.199810; Sun H, 1998, CIRCULATION, V98, P719, DOI 10.1161/01.CIR.98.7.719; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Workman AJ, 2010, N-S ARCH PHARMACOL, V381, P235, DOI 10.1007/s00210-009-0474-0; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788	42	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66288	10.1371/journal.pone.0066288	http://dx.doi.org/10.1371/journal.pone.0066288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799089	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300073
J	von Jonquieres, G; Mersmann, N; Klugmann, CB; Harasta, AE; Lutz, B; Teahan, O; Housley, GD; Frohlich, D; Kramer-Albers, EM; Klugmann, M				von Jonquieres, Georg; Mersmann, Nadine; Klugmann, Claudia Bettina; Harasta, Anne Editha; Lutz, Beat; Teahan, Orla; Housley, Gary David; Frohlich, Dominik; Kramer-Albers, Eva-Maria; Klugmann, Matthias			Glial Promoter Selectivity following AAV-Delivery to the Immature Brain	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; CENTRAL-NERVOUS-SYSTEM; MOUSE-BRAIN; GENE DELIVERY; NONHUMAN-PRIMATES; EXPRESSION; OLIGODENDROCYTES; NEURONS; TRANSDUCTION; ASTROCYTES	Recombinant adeno-associated virus (AAV) vectors are versatile tools for gene transfer to the central nervous system (CNS) and proof-of-concept studies in adult rodents have shown that the use of cell type-specific promoters is sufficient to target AAV-mediated transgene expression to glia. However, neurological disorders caused by glial pathology usually have an early onset. Therefore, modelling and treatment of these conditions require expanding the concept of targeted glial transgene expression by promoter selectivity for gene delivery to the immature CNS. Here, we have investigated the AAV-mediated green fluorescent protein (GFP) expression driven by the myelin basic protein (MBP) or glial fibrillary acidic protein (GFAP) promoters in the developing mouse brain. Generally, the extent of transgene expression after infusion at immature stages was widespread and higher than in adults. The GFAP promoter-driven GFP expression was found to be highly specific for astrocytes following vector infusion to the brain of neonates and adults. In contrast, the selectivity of the MBP promoter for oligodendrocytes was poor following neonatal AAV delivery, but excellent after vector injection at postnatal day 10. To extend these findings obtained in naive mice to a disease model, we performed P10 infusions of AAV-MBP-GFP in aspartoacylase (ASPA)-deficient mouse mutants presenting with early onset oligodendrocyte pathology. Spread of GFP expression and selectivity for oligodendrocytes in ASPA-mutants was comparable with our observations in normal animals. Our data suggest that direct AAV infusion to the developing postnatal brain, utilising cellular promoters, results in targeted and long-term transgene expression in glia. This approach will be relevant for disease modelling and gene therapy for the treatment of glial pathology.	[von Jonquieres, Georg; Klugmann, Claudia Bettina; Harasta, Anne Editha; Teahan, Orla; Housley, Gary David; Klugmann, Matthias] Univ New S Wales, Sch Med Sci, Dept Physiol, Translat Neurosci Facil, Sydney, NSW, Australia; [Mersmann, Nadine; Lutz, Beat; Klugmann, Matthias] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, D-55122 Mainz, Germany; [Frohlich, Dominik; Kramer-Albers, Eva-Maria] Johannes Gutenberg Univ Mainz, Dept Mol Cell Biol, D-55122 Mainz, Germany	University of New South Wales Sydney; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Klugmann, M (corresponding author), Univ New S Wales, Sch Med Sci, Dept Physiol, Translat Neurosci Facil, Sydney, NSW, Australia.	m.klugmann@unsw.edu.au	Eva-Maria, Kraemer-Albers/AAP-8805-2020; Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022; von Jonquieres, Georg/W-1781-2019	Eva-Maria, Kraemer-Albers/0000-0001-7994-1185; von Jonquieres, Georg/0000-0002-7423-3355; Frohlich, Dominik/0000-0002-9551-3620; Housley, Gary/0000-0002-8413-588X	EU; European Leukodystrophy Association (ELA)	EU(European Commission); European Leukodystrophy Association (ELA)	This work was supported by a project grant of the EU FP7 LeukoTreat to MK, a project grant of the European Leukodystrophy Association (ELA) to MK and EMKA. MK is an Australian Research Council (ARC) Future Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen H, 1999, J NEUROSCI RES, V55, P504, DOI 10.1002/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO;2-0; Chen H, 1998, GENE THER, V5, P50, DOI 10.1038/sj.gt.3300547; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Dayton RD, 2012, EXPERT OPIN BIOL TH, V12, P757, DOI 10.1517/14712598.2012.681463; de Leeuw B, 2006, J NEUROSCI RES, V83, P744, DOI 10.1002/jnr.20776; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; During Matthew J, 2003, Methods Mol Med, V76, P221; Feldmann A, 2009, J NEUROSCI RES, V87, P1760, DOI 10.1002/jnr.22020; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Franich NR, 2008, MOL THER, V16, P947, DOI 10.1038/mt.2008.50; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Klein RL, 1998, EXP NEUROL, V150, P183, DOI 10.1006/exnr.1997.6736; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Klugmann M, 2005, MOL THER, V11, P745, DOI 10.1016/j.ymthe.2005.01.006; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Markakis EA, 2010, MOL THER, V18, P588, DOI 10.1038/mt.2009.286; Mattar CN, 2013, GENE THER, V20, P69, DOI 10.1038/gt.2011.216; Mays LE, 2011, MOL THER, V19, P16, DOI 10.1038/mt.2010.250; McClure C, 2011, JOVE-J VIS EXP, DOI 10.3791/3348; Mersmann N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020336; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Piguet F, 2012, HUM GENE THER, V23, P903, DOI 10.1089/hum.2012.015; Pilpel N, 2009, J NEUROSCI METH, V182, P55, DOI 10.1016/j.jneumeth.2009.05.020; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009	32	89	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65646	10.1371/journal.pone.0065646	http://dx.doi.org/10.1371/journal.pone.0065646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799030	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300030
J	Zhou, B; Pearce, MB; Li, Y; Wang, JR; Mason, RJ; Tumpey, TM; Wentworth, DE				Zhou, Bin; Pearce, Melissa B.; Li, Yan; Wang, Jieru; Mason, Robert J.; Tumpey, Terrence M.; Wentworth, David E.			Asparagine Substitution at PB2 Residue 701 Enhances the Replication, Pathogenicity, and Transmission of the 2009 Pandemic H1N1 Influenza A Virus	PLOS ONE			English	Article							ALVEOLAR TYPE-II; MOLECULAR-BASIS; EPITHELIAL-CELLS; HOST-RANGE; POLYMERASE; H5N1; DETERMINANT; VIRULENCE; SUBUNIT; FERRETS	The 2009/2010 pandemic influenza virus (H1N1pdm) contains an avian-lineage PB2 gene that lacks E627K and D701N substitutions important in the pathogenesis and transmission of avian-origin viruses in humans or other mammals. Previous studies have shown that PB2-627K is not necessary because of a compensatory Q591R substitution. The role that PB2-701N plays in the H1N1pdm phenotype is not well understood. Therefore, PB2-D701N was introduced into an H1N1pdm virus (A/New York/1682/2009 (NY1682)) and analyzed in vitro and in vivo. Mini-genome replication assay, in vitro replication characteristics in cell lines, and analysis in the mouse and ferret models demonstrated that PB2-D701N increased virus replication rates and resulted in more severe pathogenicity in mice and more efficient transmission in ferrets. In addition, compared to the NY1682-WT virus, the NY1682-D701N mutant virus induced less IFN-lambda and replicated to a higher titer in primary human alveolar epithelial cells. These findings suggest that the acquisition of the PB2-701N substitution by H1N1pdm viruses may result in more severe disease or increase transmission in humans.	[Zhou, Bin; Wentworth, David E.] J Craig Venter Inst, Rockville, MD USA; [Zhou, Bin; Li, Yan; Wentworth, David E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Zhou, Bin; Wentworth, David E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Pearce, Melissa B.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA; [Wang, Jieru; Mason, Robert J.] Natl Jewish Hlth, Dept Med, Denver, CO USA	J. Craig Venter Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Centers for Disease Control & Prevention - USA; National Jewish Health	Wentworth, DE (corresponding author), J Craig Venter Inst, Rockville, MD USA.	dwentworth@JCVI.org	Zhou, Bin/H-8688-2014	Zhou, Bin/0000-0002-1535-6283; Wentworth, David/0000-0002-5190-980X	NIH/NIAID [U54-AI057158, P01AI059576-05]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, P01AI059576, R03AI101953] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by NIH/NIAID U54-AI057158 (Northeast Biodefense Center-Lipkin). DEW was also supported by NIH/NIAID P01AI059576-05. DEW and BZ are also supported in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Jagger BW, 2010, MBIO, V1, DOI 10.1128/mBio.00067-10; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Le QM, 2010, J GEN VIROL, V91, P2485, DOI 10.1099/vir.0.021659-0; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wang JR, 2006, FREE RADICAL BIO MED, V40, P1914, DOI 10.1016/j.freeradbiomed.2006.01.017; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10; Zhou B, 2012, VACCINE, V30, P3691, DOI 10.1016/j.vaccine.2012.03.025; Zhou B, 2011, J VIROL METHODS, V173, P378, DOI 10.1016/j.jviromet.2011.01.021; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zhou B, 2010, VACCINE, V28, P8015, DOI 10.1016/j.vaccine.2010.08.106; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09; Zhu HC, 2010, VIROLOGY, V401, P1, DOI 10.1016/j.virol.2010.02.024	45	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67616	10.1371/journal.pone.0067616	http://dx.doi.org/10.1371/journal.pone.0067616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799150	gold, Green Submitted, Green Published			2022-12-27	WOS:000320363300113
J	Choudhary, G; Ranjitkumar, N; Surapaneni, M; Deborah, DA; Vipparla, A; Anuradha, G; Siddiq, EA; Vemireddy, LR				Choudhary, Gangaprasad; Ranjitkumar, Nagireddy; Surapaneni, Malathi; Deborah, Dondapati Annekitty; Vipparla, Abhilash; Anuradha, Ghanta; Siddiq, Ebrahimali Abubacker; Vemireddy, Lakshminarayana Reddy			Molecular Genetic Diversity of Major Indian Rice Cultivars over Decadal Periods	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; TEMPORAL TRENDS; WHEAT GERMPLASM; MARKER SYSTEM; PCR; ACCESSIONS; VARIETIES; LENGTH; CHINA; AFLP	Genetic diversity in representative sets of high yielding varieties of rice released in India between 1970 and 2010 was studied at molecular level employing hypervariable microsatellite markers. Of 64 rice SSR primer pairs studied, 52 showed polymorphism, when screened in 100 rice genotypes. A total of 184 alleles was identified averaging 3.63 alleles per locus. Cluster analysis clearly grouped the 100 genotypes into their respective decadal periods i.e., 1970s, 1980s, 1990s and 2000s. The trend of diversity over the decadal periods estimated based on the number of alleles (Na), allelic richness (Rs), Nei's genetic diversity index (He), observed heterozygosity (Ho) and polymorphism information content (PIC) revealed increase of diversity over the periods in year of releasewise and longevitywise classification of rice varieties. Analysis of molecular variance (AMOVA) suggested more variation in within the decadal periods than among the decades. Pairwise comparison of population differentiation (Fst) among decadal periods showed significant difference between all the pairs except a few. Analysis of trends of appearing and disappearing alleles over decadal periods showed an increase in the appearance of alleles and decrease in disappearance in both the categories of varieties. It was obvious from the present findings, that genetic diversity was progressively on the rise in the varieties released during the decadal periods, between 1970s and 2000s.	[Choudhary, Gangaprasad; Ranjitkumar, Nagireddy; Surapaneni, Malathi; Deborah, Dondapati Annekitty; Vipparla, Abhilash; Anuradha, Ghanta; Siddiq, Ebrahimali Abubacker; Vemireddy, Lakshminarayana Reddy] Acharya NG Ranga Agr Univ, Inst Biotechnol, Hyderabad, Andhra Pradesh, India	Acharya N. G. Ranga Agricultural University	Vemireddy, LR (corresponding author), Acharya NG Ranga Agr Univ, Inst Biotechnol, Hyderabad, Andhra Pradesh, India.	vlnreddi@gmail.com	ANNEKITTY DEBORAH, DONDAPATI/GOE-6684-2022; Vemireddy, Lakshmi Narayana Reddy/GSD-9210-2022; Vemireddy, Lakshminarayana R/S-7926-2019	Vemireddy, Lakshmi Narayana Reddy/0000-0002-9452-8492; Vemireddy, Lakshminarayana R/0000-0002-9452-8492	ANGRAU (Acharya NG Ranga Agricultural University) under Rashtriya Krishi Vikas Yojana (RKVY)	ANGRAU (Acharya NG Ranga Agricultural University) under Rashtriya Krishi Vikas Yojana (RKVY)	The authors acknowledge ANGRAU (Acharya NG Ranga Agricultural University) for providing the financial and lab facilities under Rashtriya Krishi Vikas Yojana (RKVY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Christiansen MJ, 2002, MOL BREEDING, V9, P1, DOI 10.1023/A:1019234323372; Chuan-Guang Gui-Quan Z, 2010, ACTA AGRON SIN, V36, P1843; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YB, 2006, THEOR APPL GENET, V112, P1239, DOI 10.1007/s00122-006-0225-2; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Giarrocco LE, 2007, CROP SCI, V47, P853, DOI 10.2135/cropsci2005.07.0198; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hazen SP, 2002, GENET RESOUR CROP EV, V49, P437, DOI 10.1023/A:1020670013249; Heal G, 2004, RESOUR ENERGY ECON, V26, P175, DOI 10.1016/j.reseneeco.2003.11.006; Huang XQ, 2007, CROP SCI, V47, P343, DOI 10.2135/cropsci2006.04.0261; Hysing S-C, 2008, PLANT GENETIC RESOUR, P6; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jayamani P, 2007, CROP SCI, V47, P879, DOI 10.2135/cropsci2006.04.0236; Luce C, 2001, ACTA HORTIC, P221, DOI 10.17660/ActaHortic.2001.546.26; Mantegazza R, 2008, CROP SCI, V48, P1832, DOI 10.2135/cropsci2007.09.0532; Mir RR, 2012, GENET RESOUR CROP EV, V59, P717, DOI 10.1007/s10722-011-9713-6; Morin S. R., 2002, Agriculture and Human Values, V19, P133, DOI 10.1023/A:1016018711315; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaraju J, 2002, P NATL ACAD SCI USA, V99, P5836, DOI 10.1073/pnas.042099099; Narshimulu G, 2011, PLANT BREEDING, V130, P314, DOI 10.1111/j.1439-0523.2010.01834.x; Neeraja CN, 2009, ELECTRON J BIOTECHN, P12; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Priti Upadhyay, 2011, International Journal of Plant Breeding and Genetics, V5, P130, DOI 10.3923/ijpbg.2011.130.140; Qi YW, 2006, CHINESE SCI BULL, V51, P681, DOI 10.1007/s11434-006-0681-8; Ramkumar G, 2010, MOL BREEDING, V26, P735, DOI 10.1007/s11032-010-9492-3; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; Sambrook J., 2001, MOL CLONING LAB MANU; Singh A, 2010, MOL BREEDING, V26, P325, DOI 10.1007/s11032-010-9425-1; Spada A, 2004, PLANT BREEDING, V123, P105, DOI 10.1046/j.1439-0523.2003.00950.x; Steele KA, 2009, FIELD CROP RES, V113, P24, DOI 10.1016/j.fcr.2009.04.002; Sundaram RM, 2010, MOL BREEDING, V26, P719, DOI 10.1007/s11032-010-9482-5; Tian QZ, 2005, GENET RESOUR CROP EV, V52, P325, DOI 10.1007/s10722-005-5716-5; van de Wouw M, 2010, THEOR APPL GENET, V120, P1241, DOI 10.1007/s00122-009-1252-6; Wei XH, 2009, J GENET GENOMICS, V36, P363, DOI 10.1016/S1673-8527(08)60125-3; White J, 2008, THEOR APPL GENET, V116, P439, DOI 10.1007/s00122-007-0681-3; Yonemaru J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032982; Yu SB, 2003, THEOR APPL GENET, V108, P131, DOI 10.1007/s00122-003-1400-3; Yuan XP, 2007, RICE SCI, V14, P78, DOI 10.1016/S1672-6308(07)60012-2; [朱明雨 Zhu Mingyu], 2004, [华中农业大学学报, Journal of Huazhong Agricultural University], V23, P187	42	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66197	10.1371/journal.pone.0066197	http://dx.doi.org/10.1371/journal.pone.0066197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805204	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500032
J	Daru, BH; Yessoufou, K; Mankga, LT; Davies, TJ				Daru, Barnabas H.; Yessoufou, Kowiyou; Mankga, Ledile T.; Davies, T. Jonathan			A Global Trend towards the Loss of Evolutionarily Unique Species in Mangrove Ecosystems	PLOS ONE			English	Article							EXTINCTION RISK; PHYLOGENETIC DIVERSITY; NONRANDOM EXTINCTION; BIODIVERSITY; CONSERVATION; IMPACTS; FORESTS; FUTURE; RATES	The mangrove biome stands out as a distinct forest type at the interface between terrestrial, estuarine, and near-shore marine ecosystems. However, mangrove species are increasingly threatened and experiencing range contraction across the globe that requires urgent conservation action. Here, we assess the spatial distribution of mangrove species richness and evolutionary diversity, and evaluate potential predictors of global declines and risk of extinction. We found that human pressure, measured as the number of different uses associated with mangroves, correlated strongly, but negatively, with extinction probability, whereas species ages were the best predictor of global decline, explaining 15% of variation in extinction risk. Although the majority of mangrove species are categorised by the IUCN as Least Concern, our finding that the more threatened species also tend to be those that are more evolutionarily unique is of concern because their extinction would result in a greater loss of phylogenetic diversity. Finally, we identified biogeographic regions that are relatively species-poor but rich in evolutionary history, and suggest these regions deserve greater conservation priority. Our study provides phylogenetic information that is important for developing a unified management plan for mangrove ecosystems worldwide.	[Daru, Barnabas H.; Yessoufou, Kowiyou; Mankga, Ledile T.] Univ Johannesburg, African Ctr DNA Barcoding, Johannesburg, South Africa; [Davies, T. Jonathan] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Johannesburg; McGill University	Daru, BH (corresponding author), Univ Johannesburg, African Ctr DNA Barcoding, Johannesburg, South Africa.	darunabas@gmail.com	Mankga, Ledile/GPF-8316-2022; Daru, Barnabas/B-4051-2011; Elansary, Hosam O./E-3684-2019	Mankga, Ledile/0000-0002-5326-1197; Daru, Barnabas/0000-0002-2115-0257; Elansary, Hosam O./0000-0002-4476-2408; Yessoufou, Prof. Kowiyou/0000-0002-4789-1723	University of Johannesburg through the African Centre for DNA Barcoding	University of Johannesburg through the African Centre for DNA Barcoding	The University of Johannesburg through the African Centre for DNA Barcoding provide logistics and financial support to the first two authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Butchart SHM, 2010, BIOL CONSERV, V143, P239, DOI 10.1016/j.biocon.2009.10.008; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Chapman VJ, 1977, WET COASTAL ECOSYSTE, V1, P1; Chapman VJ, 1975, P INT S BIOL MANAGEM, P3; Clough BF, 1993, EC ENV VALUES MANGRO, V1, P1; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahdouh-Guebas F, 2000, ECON BOT, V54, P513, DOI 10.1007/BF02866549; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; Davies TJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000620; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Duke N.C., 1992, TROPICAL MANGROVE EC, V41, P63, DOI [10.1029/ce041p0063, DOI 10.1029/CE041P0063]; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Duke NC, 2006, AUSTR MANGROVES AUTH; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; Ellison J, 2005, PALAEOGEOGR PALAEOCL, V220, P291, DOI 10.1016/j.palaeo.2005.01.008; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; Ewel KC, 1998, GLOBAL ECOL BIOGEOGR, V7, P83, DOI 10.2307/2997700; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; FAO, 2007, 153 FAO FOR RES DIV; Field CB, 1998, GLOBAL ECOL BIOGEOGR, V7, P3, DOI 10.2307/2997693; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fordham DA, 2012, GLOBAL CHANGE BIOL, V18, P1357, DOI 10.1111/j.1365-2486.2011.02614.x; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Garcia N, 2010, STATUS DISTRIBUTION, pxiii; Goulder L. H., 1997, Nature's services: societal dependence on natural ecosystems., P23; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hauff Robert D., 2006, Wetlands Ecology and Management, V14, P95, DOI 10.1007/s11273-005-2567-y; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2012, IUCN RED LIST THREAT; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kissling WD, 2012, P NATL ACAD SCI USA, V109, P7379, DOI 10.1073/pnas.1120467109; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Liu X, 2005, ORYX, V39, P335, DOI 10.1017/S0030605305000712; Luther DA, 2009, BIOSCIENCE, V59, P602, DOI 10.1525/bio.2009.59.7.11; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; May Robert M., 1995, P1; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Michie M, 1993, 5 CHANN ISL FIELD ST; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Miththapala S, 2008, COASTAL ECOSYSTEMS S, V2, P28; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; Ndenecho EN, 2007, INT J SUST DEV WORLD, V14, P618, DOI 10.1080/13504500709469759; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; NYLANDER JAA, 2004, MODELTEST V2; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Paphavasit N, 1993, EC ENV VALUE MANGROV; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Queen WH, 1974, ECOLOGY HALOPHYTES, P31; Rasolofo M.V., 1997, MANGROVE SALT MARSHE, V1, P243, DOI DOI 10.1023/A:1009923022474; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schwartz MW, 2001, ECOL LETT, V4, P464, DOI 10.1046/j.1461-0248.2001.00241.x; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Siddiqi NA, 1994, P 7 PAC SCI INT C MA; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Sullivan C, 2005, IMPORTANCE MANGROVES; Tomlinson PB, 2016, BOTANY OF MANGROVES, 2ND EDITION, P315; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; Vamosi JC, 2008, ECOL LETT, V11, P1047, DOI 10.1111/j.1461-0248.2008.01215.x; Vamosi JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003886; Walters BB, 2003, ENVIRON CONSERV, V30, P293, DOI 10.1017/S0376892903000298; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wilkie ML, 2003, 63 FAO FOR RES DIV F; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yessoufou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047082	85	38	38	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66686	10.1371/journal.pone.0066686	http://dx.doi.org/10.1371/journal.pone.0066686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805263	Green Published, gold			2022-12-27	WOS:000320846500091
J	Fernandez, V; Abdala, F; Carlson, KJ; Cook, DC; Rubidge, BS; Yates, A; Tafforeau, P				Fernandez, Vincent; Abdala, Fernando; Carlson, Kristian J.; Cook, Della Collins; Rubidge, Bruce S.; Yates, Adam; Tafforeau, Paul			Synchrotron Reveals Early Triassic Odd Couple: Injured Amphibian and Aestivating Therapsid Share Burrow	PLOS ONE			English	Article							KAROO BASIN; POSTCRANIAL SKELETON; VERTEBRATE TAPHONOMY; EARLIEST EVIDENCE; BEAUFORT GROUP; HIBERNATION; SURVIVAL	Fossorialism is a beneficial adaptation for brooding, predator avoidance and protection from extreme climate. The abundance of fossilised burrow casts from the Early Triassic of southern Africa is viewed as a behavioural response by many tetrapods to the harsh conditions following the Permo-Triassic mass-extinction event. However, scarcity of vertebrate remains associated with these burrows leaves many ecological questions unanswered. Synchrotron scanning of a lithified burrow cast from the Early Triassic of the Karoo unveiled a unique mixed-species association: an injured temnospondyl amphibian (Broomistega) that sheltered in a burrow occupied by an aestivating therapsid (Thrinaxodon). The discovery of this rare rhinesuchid represents the first occurrence in the fossil record of a temnospondyl in a burrow. The amphibian skeleton shows signs of a crushing trauma with partially healed fractures on several consecutive ribs. The presence of a relatively large intruder in what is interpreted to be a Thrinaxodon burrow implies that the therapsid tolerated the amphibian's presence. Among possible explanations for such unlikely cohabitation, Thrinaxodon aestivation is most plausible, an interpretation supported by the numerous Thrinaxodon specimens fossilised in curled-up postures. Recent advances in synchrotron imaging have enabled visualization of the contents of burrow casts, thus providing a novel tool to elucidate not only anatomy but also ecology and biology of ancient tetrapods.	[Fernandez, Vincent; Abdala, Fernando; Carlson, Kristian J.; Rubidge, Bruce S.; Yates, Adam] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa; [Carlson, Kristian J.; Cook, Della Collins] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Yates, Adam] Museum Cent Australia, Alice Springs, NT, Australia; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Witwatersrand; Indiana University System; Indiana University Bloomington; European Synchrotron Radiation Facility (ESRF)	Fernandez, V (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa.	vinfernand@gmail.com	Rubidge, Bruce/AAE-7021-2019; Abdala, Fernando/I-8054-2019	Rubidge, Bruce/0000-0003-2477-1873; Tafforeau, Paul/0000-0002-5962-1683; Fernandez, Vincent/0000-0002-8315-1458	ESRF [EC-847]; University Research Committee (URC) of Wits; Palaeontological Scientific Trust (PAST); National Research Foundation (NRF); Department of Science and Technology (DST); Intel South Africa; Running Computers	ESRF; University Research Committee (URC) of Wits; Palaeontological Scientific Trust (PAST); National Research Foundation (NRF); Department of Science and Technology (DST)(Department of Science & Technology (India)); Intel South Africa; Running Computers	This work was supported by the ESRF (proposal EC-847), the University Research Committee (URC) of Wits, and the Palaeontological Scientific Trust (PAST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Research Foundation (NRF), Department of Science and Technology (DST), Intel South Africa and Running Computers for supporting the Virtual Image Processing Laboratory (VIP Lab) at the University of the Witwatersrand (Wits: Johannesburg, South Africa). We acknowledge the assistance of Michael Day for proofreading various drafts of the manuscript. This article benefited greatly from thoughtful comments and important scientific insights from reviewers Ann Warren and Roger Smith and the editor.	Abdala F, 2006, PALAIOS, V21, P507, DOI 10.2110/palo.2005.P06-001R; Bordy EM, 2011, LETHAIA, V44, P33, DOI 10.1111/j.1502-3931.2010.00223.x; BRINK A. S., 1958, PALAEONTOL AFRICANA, V6, P15; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Chinsamy-Turan A., 2011, FORERUNNERS MAMMALS; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; deBraga M, 2003, CAN J EARTH SCI, V40, P527, DOI 10.1139/E02-082; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; Fiorillo AR, 2000, PALAIOS, V15, P373, DOI 10.2307/3515510; Gastaldo RA, 2008, PALAEONTOLOGY, V51, P215, DOI 10.1111/j.1475-4983.2007.00743.x; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; Geiser F, 2009, NATURWISSENSCHAFTEN, V96, P1235, DOI 10.1007/s00114-009-0583-0; Groenewald G, 1991, BURROW CASTS LYSTROS, P34; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kinlaw A, 1999, J ARID ENVIRON, V41, P127, DOI 10.1006/jare.1998.0476; Klevezal G.A., 1967, AGE DETERMINATION MA; Kowalczyk R, 2008, CAN J ZOOL, V86, P1389, DOI 10.1139/Z08-127; Modesto SP, 2010, PALAIOS, V25, P274, DOI 10.2110/palo.2009.p09-077r; Morrison C, 2004, HERPETOLOGICA, V60, P34, DOI 10.1655/02-68; MYERS TP, 1980, AM ANTIQUITY, V45, P483, DOI 10.2307/279863; Navas CA., 2010, AESTIVATION MOL PHYS, DOI [10.1007/978-3-642-02421-4, DOI 10.1007/978-3-642-02421-4]; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Pawley Kat, 2004, Palaeontologia Africana, V40, P1; Reichman O.J., 1990, Current Mammalogy, V2, P197; Roznik EA, 2009, J HERPETOL, V43, P431, DOI 10.1670/08-159R.1; Shipman P., 1981, LIFE HIST FOSSIL INT; Shishkin MA, 2000, PALAEONTOLOGY, V43, P653, DOI 10.1111/1475-4983.00144; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; Smith RMH, 2002, PALAIOS, V17, P249, DOI 10.1669/0883-1351(2002)017<0249:CFEAVT>2.0.CO;2; SMITH RMH, 1987, PALAEOGEOGR PALAEOCL, V60, P155, DOI 10.1016/0031-0182(87)90030-7; SMITH RMH, 1993, PALAIOS, V8, P45, DOI 10.2307/3515221; Smith R, 2009, J VERTEBR PALEONTOL, V29, p183A; Steyer JS, 2004, PALAEOGEOGR PALAEOCL, V206, P193, DOI 10.1016/j.palaeo.2004.01.003; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; VAUGHAN TERRY A., 1961, JOUR MAMMAL, V42, P171, DOI 10.2307/1376826; Voorhies M.R., 1975, STUDY TRACE FOSSILS, P325; WARREN A, 1991, ALCHERINGA, V15, P43, DOI 10.1080/03115519108619009; Waterman JM, 2007, BEHAV ECOL SOCIOBIOL, V61, P1675, DOI 10.1007/s00265-007-0398-y; Yates AM, 1999, J VERTEBR PALEONTOL, V19, P302, DOI 10.1080/02724634.1999.10011143; Zeigler Kate E., 2005, New Mexico Geological Society Field Conference Guidebook, V56, P297; Zervanos SM, 2009, J COMP PHYSIOL B, V179, P411, DOI 10.1007/s00360-008-0327-z	42	57	58	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64978	10.1371/journal.pone.0064978	http://dx.doi.org/10.1371/journal.pone.0064978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805181	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500009
J	Gui, J; Moore, JH; Williams, SM; Andrews, P; Hillege, HL; van der Harst, P; Navis, G; Van Gilst, WH; Asselbergs, FW; Gilbert-Diamond, D				Gui, Jiang; Moore, Jason H.; Williams, Scott M.; Andrews, Peter; Hillege, Hans L.; van der Harst, Pim; Navis, Gerjan; Van Gilst, Wiek H.; Asselbergs, Folkert W.; Gilbert-Diamond, Diane			A Simple and Computationally Efficient Approach to Multifactor Dimensionality Reduction Analysis of Gene-Gene Interactions for Quantitative Traits	PLOS ONE			English	Article							PENALIZED LOGISTIC-REGRESSION; PLASMA T-PA; RENIN-ANGIOTENSIN; EPISTASIS; SUSCEPTIBILITY; POLYMORPHISMS; POPULATION; BRADYKININ; DISEASE; SYSTEMS	We present an extension of the two-class multifactor dimensionality reduction (MDR) algorithm that enables detection and characterization of epistatic SNP-SNP interactions in the context of a quantitative trait. The proposed Quantitative MDR (QMDR) method handles continuous data by modifying MDR's constructive induction algorithm to use a T-test. QMDR replaces the balanced accuracy metric with a T-test statistic as the score to determine the best interaction model. We used a simulation to identify the empirical distribution of QMDR's testing score. We then applied QMDR to genetic data from the ongoing prospective Prevention of Renal and Vascular End-Stage Disease (PREVEND) study.	[Gui, Jiang; Moore, Jason H.; Williams, Scott M.; Andrews, Peter; Gilbert-Diamond, Diane] Geisel Sch Med, Inst Quantitat Biomed Sci, Lebanon, NH USA; [Gui, Jiang; Moore, Jason H.; Gilbert-Diamond, Diane] Geisel Sch Med, Dept Community Med, Sect Biostat & Epidemiol, Lebanon, NH USA; [Gui, Jiang; Moore, Jason H.; Gilbert-Diamond, Diane] Geisel Sch Med, Dept Family Med, Lebanon, NH USA; [Moore, Jason H.; Williams, Scott M.] Geisel Sch Med, Dept Genet, Lebanon, NH USA; [Hillege, Hans L.; van der Harst, Pim; Van Gilst, Wiek H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center	Moore, JH (corresponding author), Geisel Sch Med, Inst Quantitat Biomed Sci, Lebanon, NH USA.	jason.h.moore@dartmouth.edu	van Gilst, Wiek/R-1806-2019; Williams, Scott/Q-4812-2019; Asselbergs, Folkert W./ABD-6752-2021; Moore, Jason H./AAV-9645-2021	van Gilst, Wiek/0000-0003-2968-8585; Williams, Scott/0000-0002-4835-9544; Asselbergs, Folkert W./0000-0002-1692-8669; Moore, Jason H./0000-0002-5015-1099	National Center for Research Resources of the National Institutes of Health [P20 RR024475]; National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103534, LM010098, AI59694]; National Library of Medicine of the National Institutes of Health [LM010098, R01 LM009012]; National Institute for Allergy and Infectious Diseases of the National Institutes of Health [R01 AI59693]; Netherlands Organization for Health Research and Development [ZonMw 90700342]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012, R01LM010098] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute for Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This project was supported by grants from the National Center for Research Resources (P20 RR024475), the National Institute of General Medical Sciences (P20 GM103534, LM010098 and AI59694), The National Library of Medicine (R01 LM009012 and LM010098) and the National Institute for Allergy and Infectious Diseases (R01 AI59693) of the National Institutes of Health. Folkert W. Asselbergs is supported by a clinical fellowship from the Netherlands Organization for Health Research and Development (ZonMw 90700342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2006, THROMB HAEMOSTASIS, V96, P471, DOI 10.1160/TH06-06-0335; Calle M.L., 2008, MB MDR MODEL BASED M; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Freund Y., 1995, DESICION THEORETIC G, P23, DOI DOI 10.1007/3-540-59119-2_166; Gui JA, 2011, HUM GENET, V129, P101, DOI 10.1007/s00439-010-0905-5; Gui J, 2011, ANN HUM GENET, V75, P20, DOI 10.1111/j.1469-1809.2010.00624.x; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Hahn Lance W, 2004, In Silico Biol, V4, P183; He H, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-127; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Li M, 2011, GENET EPIDEMIOL, V35, P457, DOI 10.1002/gepi.20594; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; Margaglione M, 1998, ARTERIOSCL THROM VAS, V18, P562, DOI 10.1161/01.ATV.18.4.562; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; Moore J. H., 2007, KNOWLEDGE DISCOVERY, P17; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211	28	68	74	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66545	10.1371/journal.pone.0066545	http://dx.doi.org/10.1371/journal.pone.0066545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805232	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500060
J	Johannsen, NM; Sparks, LM; Zhang, ZY; Earnest, CP; Smith, SR; Church, TS; Ravussin, E				Johannsen, Neil M.; Sparks, Lauren M.; Zhang, Zhengyu; Earnest, Conrad P.; Smith, Steven R.; Church, Timothy S.; Ravussin, Eric			Determinants of the Changes in Glycemic Control with Exercise Training in Type 2 Diabetes: A Randomized Trial	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; PGC-1-ALPHA; ADIPONECTIN; ACTIVATION; METABOLISM; OXIDATION; GENE	Aims: To assess the determinants of exercise training-induced improvements in glucose control (HbA(1C)) including changes in serum total adiponectin and FFA concentrations, and skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) protein content. Methods: A sub-cohort (n = 35; 48% men; 74% Caucasian) from the HART-D study undertaking muscle biopsies before and after 9 months of aerobic (AT), resistance (RT), or combination training (ATRT). Results: Changes in HbA(1C) were associated with changes in adiponectin (r = -0.45, P = 0.007). Participants diagnosed with type 2 diabetes for a longer duration had the largest increase in PGC-1 alpha (r = 0.44, P = 0.008). Statistical modeling examining changes in HbA(1C) suggested that male sex (P = 0.05), non-Caucasian ethnicity (P = 0.02), duration of type 2 diabetes (r = 0.40; P<0.002) and changes in FFA (r = 0.36; P<0.004), adiponectin (r = -0.26; P<0.03), and PGC-1 alpha (r = -0.28; P = 0.02) explain, similar to 65% of the variability in the changes in HbA(1C). Conclusions: Decreases in HbA(1C) after 9 months of exercise were associated with shorter duration of diabetes, lowering of serum FFA concentrations, increasing serum adiponectin concentrations and increasing skeletal muscle PGC-1 alpha protein expression.	[Johannsen, Neil M.; Zhang, Zhengyu; Church, Timothy S.; Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Johannsen, Neil M.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Sparks, Lauren M.] Translat Res Inst Metab & Diabet, Orlando, FL USA; [Earnest, Conrad P.] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Smith, Steven R.] Sanford Burnham Med Res Inst, Orlando, FL USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; University of Bath; Sanford Burnham Prebys Medical Discovery Institute	Ravussin, E (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	eric.ravussin@pbrc.edu	Smith, Steven/HDM-9496-2022; Ravussin, Eric/N-1985-2017; Earnest, Conrad P./M-6849-2017	Ravussin, Eric/0000-0003-2129-547X; Earnest, Conrad P./0000-0002-6546-1268; Smith, Steven/0000-0002-5098-8147	NORC Center Grant [2P30DK072476]; Coca-Cola Company; Pennington Biomedical Research Center Clinical and Translational Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	NORC Center Grant; Coca-Cola Company; Pennington Biomedical Research Center Clinical and Translational Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially funded by an institutional grant to ER and by a NORC Center Grant (#2P30DK072476; PI-ER). Cost of analyses was partially supported by an unrestricted research funding grant from The Coca-Cola Company. Further funding was contributed by Dr. Donna Ryan from the Pennington Biomedical Research Center Clinical and Translational Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A commercial funding source is acknowledged in the manuscript: The Coca-Cola Company. The authors have no declarations for this funding source relating to employment, consultancy, patents, products in development or marketed products and the funding source does not alter their adherence to the PLOS ONE policies on sharing data and materials, as detailed in the online guide for authors.	Alexander-Bridges M., 1992, ADV ENZYME REGUL, V32, P149; American College of Sports Medicine, 2006, ACSMS GUID EX TEST P; Benton CR, 2008, APPL PHYSIOL NUTR ME, V33, P843, DOI 10.1139/H08-074; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Layne AS, 2011, J CLIN ENDOCR METAB, V96, P1815, DOI 10.1210/jc.2010-2532; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Services USDoHaH, 2008, 2008 PHYS ACT GUID A	17	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e62973	10.1371/journal.pone.0062973	http://dx.doi.org/10.1371/journal.pone.0062973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805175	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500003
J	Nandi, A; Ashok, A; Laxminarayan, R				Nandi, Arindam; Ashok, Ashvin; Laxminarayan, Ramanan			The Socioeconomic and Institutional Determinants of Participation in India's Health Insurance Scheme for the Poor	PLOS ONE			English	Article							PUBLIC-GOODS; CORRUPTION; POVERTY; POLICY; WOMEN; WATER; ASIA	The Rashtriya Swasthya Bima Yojana (RSBY), which was introduced in 2008 in India, is a social health insurance scheme that aims to improve healthcare access and provide financial risk protection to the poor. In this study, we analyse the determinants of participation and enrolment in the scheme at the level of districts. We used official data on RSBY enrolment, socioeconomic data from the District Level Household Survey 2007-2008, and additional state-level information on fiscal health, political affiliation, and quality of governance. Results from multivariate probit and OLS analyses suggest that political and institutional factors are among the strongest determinants explaining the variation in participation and enrolment in RSBY. In particular, districts in state governments that are politically affiliated with the opposition or neutral parties at the centre are more likely to participate in RSBY, and have higher levels of enrolment. Districts in states with a lower quality of governance, a pre-existing state-level health insurance scheme, or with a lower level of fiscal deficit as compared to GDP, are significantly less likely to participate, or have lower enrolment rates. Among socioeconomic factors, we find some evidence of weak or imprecise targeting. Districts with a higher share of socioeconomically backward castes are less likely to participate, and their enrolment rates are also lower. Finally, districts with more non-poor households may be more likely to participate, although with lower enrolment rates.	[Nandi, Arindam; Ashok, Ashvin; Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC USA.	ramanan@phfi.org	Laxminarayan, Ramanan/ABD-5050-2021	Nandi, Arindam/0000-0002-3967-2424				Acharya A, 2013, WORLD BANK RES OBSER, V28, P236, DOI 10.1093/wbro/lks009; Andersen S, 2008, AM ECON REV, V98, P376, DOI 10.1257/aer.98.2.376; [Anonymous], DISTR LEV HOUS FAC S; [Anonymous], 2010, EC POLITICAL WEEKLY; Arhin-Tenkorang D., 2004, HLTH FINANCING POOR, P157; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Banerjee A, 2005, J EUR ECON ASSOC, V3, P639, DOI 10.1162/jeea.2005.3.2-3.639; Banerjee A, 2007, J DEV ECON, V82, P287, DOI 10.1016/j.jdeveco.2006.04.005; Bang A, 2011, HIGH LEVEL EXPERT GR; Basaza R, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-105; Besley T, 2004, J EUR ECON ASSOC, V2, P416, DOI 10.1162/154247604323068104; Betancourt R, 2000, WORLD DEV, V28, P2169, DOI 10.1016/S0305-750X(00)00074-7; Bhalotra SR, 2011, 6216 IZA; Centre for Policy Research, 2011, MAPP MED PROV RUR IN; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Das J., 2011, Economic and Political Weekly, V46, P87; David P.H., 2007, 102 ERD AS DEV BANK; Davis J, 2004, WORLD DEV, V32, P53, DOI 10.1016/j.worlddev.2003.07.003; Dhoot V, 2011, EC TIMES; Dilip TR, 2012, EC POLITICAL WEEKLY, VXLVII; Dror DM, 2012, INDIAN J MED RES, V135, P56, DOI 10.4103/0971-5916.93425; Fan V, 2012, 298 CTR GLOB DEV; Fan VY, 2011, NATL MED J INDIA, V24, P325; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gamser M, 2011, LOW COST INDIAN HLTH; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Gine X, 2009, J DEV ECON, V89, P1, DOI 10.1016/j.jdeveco.2008.09.007; Jain N, 2010, 56 MILLION STEPS UNI; Jakab M, 2004, HLTH FINANCING POOR, p53e117; Jalan J, 2003, J ECONOMETRICS, V112, P153, DOI 10.1016/S0304-4076(02)00158-6; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Kannan KP, 2013, LONG ROAD SOCIAL SEC, P552; Krishnaswamy K, 2011, RSBY WORKING PAPER S; LaForgia G, 2012, DIR DEV, P1, DOI 10.1596/978-0-8213-9618-6; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Mahal A, 2010, INDIA HLTH REPORT; Platteau JP, 2004, DISCIPLINING LOCAL L; Rajasekhar D, 2011, EC POLITICAL WEEKLY, VXLVI; RBI, 2013, RES BANK IND STAT FI; Selvaraj S., 2012, EC POLITICAL WEEKLY, VXLVII; Selvaraj Sakthivel, 2012, ECON POLIT WEEKLY, V47, P61; Sen Amiti, 2012, EC TIMES; Seshadri T, 2012, BMC P S5, V6, pO9; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Sun C, 2010, 2 RSBY; Swarup A, 2010, RSBY WORKING PAPER S; Swarup A, 2011, SOME INITIAL TRENDS; Transparency International-Centre for Media Studies India, 2008, ITT CMS IND CORR STU; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Vellakkal S, 2013, EC POLITICAL WEEKLY, V48; Veron R, 2006, WORLD DEV, V34, P1922, DOI 10.1016/j.worlddev.2005.11.024; WADE R, 1982, J DEV STUD, V18, P287, DOI 10.1080/00220388208421833; Westat India Social Sciences, 2010, RSBY BEN EXP SURV SU; World Bank, 2009, WORLD DEV IND	54	30	30	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66296	10.1371/journal.pone.0066296	http://dx.doi.org/10.1371/journal.pone.0066296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805211	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500039
J	O'Mahony, AM; Ogier, J; Darcy, R; Cryan, JF; O'Driscoll, CM				O'Mahony, Aoife M.; Ogier, Julien; Darcy, Raphael; Cryan, John F.; O'Driscoll, Caitriona M.			Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery	PLOS ONE			English	Article							SMALL INTERFERING RNA; GENE DELIVERY; INTRACELLULAR TRAFFICKING; TRANSFECTION; COMPLEXES; NANOPARTICLES; DNA; CONJUGATE; BARRIERS; VECTORS	Optimising non-viral vectors for neuronal siRNA delivery presents a significant challenge. Here, we investigate a co-formulation, consisting of two amphiphilic cyclodextrins (CDs), one cationic and the other PEGylated, which were blended together for siRNA delivery to a neuronal cell culture model. Co-formulated CD-siRNA complexes were characterised in terms of size, charge and morphology. Stability in salt and serum was also examined. Uptake was determined by flow cytometry and toxicity was measured by MTT assay. Knockdown of a luciferase reporter gene was used as a measure of gene silencing efficiency. Incorporation of a PEGylated CD in the formulation had significant effects on the physical and biological properties of CD. siRNA complexes. Co-formulated complexes exhibited a lower surface charge and greater stability in a high salt environment. However, the inclusion of the PEGylated CD also dramatically reduced gene silencing efficiency due to its effects on neuronal uptake. The co-formulation strategy for cationic and PEGylated CDs improved the stability of the CD. siRNA delivery systems, although knockdown efficiency was impaired. Future work will focus on the addition of targeting ligands to the co-formulated complexes to restore transfection capabilities.	[O'Mahony, Aoife M.; O'Driscoll, Caitriona M.] Univ Coll Cork, Sch Pharm, Pharmacodelivery Grp, Cork, Ireland; [Ogier, Julien; Darcy, Raphael] Univ Coll Dublin, Sch Chem & Chem Biol, Dublin 2, Ireland; [Cryan, John F.] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland	University College Cork; University College Dublin; University College Cork	O'Driscoll, CM (corresponding author), Univ Coll Cork, Sch Pharm, Pharmacodelivery Grp, Cork, Ireland.	caitriona.odriscoll@ucc.ie	Cryan, John F./A-6950-2013	Cryan, John F./0000-0001-5887-2723; OGIER, Julien/0000-0002-2093-1617; O'Driscoll, Caitriona/0000-0002-6915-6201	Science Foundation Ireland [07/SRC/B1154]; Irish Drug Delivery Network; Irish Research Council of Science, Engineering and Technology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Drug Delivery Network(Science Foundation Ireland); Irish Research Council of Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	This work was supported by Science Foundation Ireland (Grant no. 07/SRC/B1154), the Irish Drug Delivery Network and by a scholarship to AO'M from the Irish Research Council of Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett DW, 2007, BIOCONJUGATE CHEM, V18, P456, DOI 10.1021/bc0603539; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bergen JM, 2008, PHARM RES-DORDR, V25, P983, DOI 10.1007/s11095-007-9439-5; Bergen JM, 2008, J GENE MED, V10, P187, DOI 10.1002/jgm.1137; Beyerle A, 2010, TOXICOL APPL PHARM, V242, P146, DOI 10.1016/j.taap.2009.10.001; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Cardoso ALC, 2010, J CONTROL RELEASE, V142, P392, DOI 10.1016/j.jconrel.2009.11.004; Cheng TL, 1999, BIOCONJUGATE CHEM, V10, P520, DOI 10.1021/bc980143z; Cryan SA, 2004, J DRUG DELIV SCI TEC, V14, P57, DOI 10.1016/S1773-2247(04)50006-0; Cryan SA, 2004, EUR J PHARM SCI, V21, P625, DOI 10.1016/j.ejps.2004.01.001; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y; Desigaux L, 2007, P NATL ACAD SCI USA, V104, P16534, DOI 10.1073/pnas.0707431104; Diaz-Moscoso A, 2011, BIOMATERIALS, V32, P7263, DOI 10.1016/j.biomaterials.2011.06.025; Donohue R, 2002, CHEM COMMUN, P2864, DOI 10.1039/b207238f; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Godinho BMDC, 2013, MOL PHARMACEUT, V10, P640, DOI 10.1021/mp3003946; Guo JF, 2012, BIOMATERIALS, V33, P7775, DOI 10.1016/j.biomaterials.2012.07.012; Guo JF, 2012, EUR J PHARM SCI, V45, P521, DOI 10.1016/j.ejps.2011.11.024; Guo JF, 2010, MOL BIOSYST, V6, P1143, DOI 10.1039/c001050m; Hong KL, 1997, FEBS LETT, V400, P233, DOI 10.1016/S0014-5793(96)01397-X; Jung S, 2010, J CONTROL RELEASE, V144, P306, DOI 10.1016/j.jconrel.2010.03.002; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kong WH, 2009, J CONTROL RELEASE, V138, P141, DOI 10.1016/j.jconrel.2009.04.034; Kostarelos K, 2005, CHEM SOC REV, V34, P970, DOI 10.1039/b307062j; Krichevsky AM, 2002, P NATL ACAD SCI USA, V99, P11926, DOI 10.1073/pnas.182272699; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lee SH, 2007, BIOCHEM BIOPH RES CO, V357, P511, DOI 10.1016/j.bbrc.2007.03.185; Lingor P, 2004, BIOCHEM BIOPH RES CO, V315, P1126, DOI 10.1016/j.bbrc.2004.01.170; McMahon A, 2008, J DRUG DELIV SCI TEC, V18, P303, DOI 10.1016/S1773-2247(08)50060-8; McMahon A, 2012, J PHARM PHARMACOL, V64, P1063, DOI 10.1111/j.2042-7158.2012.01497.x; Mendez-Ardoy A, 2011, NANOMEDICINE-UK, V6, P1697, DOI [10.2217/nnm.11.59, 10.2217/NNM.11.59]; Mendonca LS, 2010, BIOCONJUGATE CHEM, V21, P157, DOI 10.1021/bc9004365; Mishra S, 2004, EUR J CELL BIOL, V83, P97, DOI 10.1078/0171-9335-00363; Morille M, 2011, BIOMATERIALS, V32, P2327, DOI 10.1016/j.biomaterials.2010.11.063; O'Mahony AM, 2012, EUR J PHARM SCI, V47, P896, DOI 10.1016/j.ejps.2012.08.020; O'Mahony AM, 2012, ACS CHEM NEUROSCI, V3, P744, DOI 10.1021/cn3000372; O'Mahony AM, 2013, PHARM NANOTECHNOL, V1, P6, DOI DOI 10.2174/2211738511301010006; O'Mahony AM, 2013, PHARM RES-DORDR, V30, P1086, DOI 10.1007/s11095-012-0945-8; O'Mahony AM, 2012, ORG BIOMOL CHEM, V10, P4954, DOI 10.1039/c2ob25490e; O' Neill MJ, 2011, INT J PHARMACEUT, V413, P174, DOI 10.1016/j.ijpharm.2011.04.021; Ohki EC, 2001, J NEUROSCI METH, V112, P95, DOI 10.1016/S0165-0270(01)00441-1; Mellet CO, 2011, CHEM SOC REV, V40, P1586, DOI 10.1039/c0cs00019a; Perez-Martinez FC, 2011, PHARM RES-DORDR, V28, P1843, DOI 10.1007/s11095-010-0364-7; Ping Y, 2011, BIOMATERIALS, V32, P8328, DOI 10.1016/j.biomaterials.2011.07.038; Pun SH, 2002, BIOCONJUGATE CHEM, V13, P630, DOI 10.1021/bc0155768; Rettig GR, 2012, MOL THER, V20, P483, DOI 10.1038/mt.2011.263; Schafer J, 2010, BIOMATERIALS, V31, P6892, DOI 10.1016/j.biomaterials.2010.05.043; Tsutsumi T, 2008, J PHARM SCI-US, V97, P3022, DOI 10.1002/jps.21206; Vader P, 2012, PHARM RES-DORDR, V29, P352, DOI 10.1007/s11095-011-0545-z	50	30	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66413	10.1371/journal.pone.0066413	http://dx.doi.org/10.1371/journal.pone.0066413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805220	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500048
J	Shinya, R; Morisaka, H; Kikuchi, T; Takeuchi, Y; Ueda, M; Futai, K				Shinya, Ryoji; Morisaka, Hironobu; Kikuchi, Taisei; Takeuchi, Yuko; Ueda, Mitsuyoshi; Futai, Kazuyoshi			Secretome Analysis of the Pine Wood Nematode Bursaphelenchus xylophilus Reveals the Tangled Roots of Parasitism and Its Potential for Molecular Mimicry	PLOS ONE			English	Article							THAUMATIN-LIKE; ESOPHAGEAL-GLAND; ANCYLOSTOMA-CANINUM; CYSTEINE PROTEASES; WILT DISEASE; 1ST REPORT; PROTEINS; IDENTIFICATION; EXPRESSION; EVOLUTION	Since it was first introduced into Asia from North America in the early 20th century, the pine wood nematode Bursaphelenchus xylophilus has caused the devastating forest disease called pine wilt. The emerging pathogen spread to parts of Europe and has since been found as the causal agent of pine wilt disease in Portugal and Spain. In 2011, the entire genome sequence of B. xylophilus was determined, and it allowed us to perform a more detailed analysis of B. xylophilus parasitism. Here, we identified 1,515 proteins secreted by B. xylophilus using a highly sensitive proteomics method combined with the available genomic sequence. The catalogue of secreted proteins contained proteins involved in nutrient uptake, migration, and evasion from host defenses. A comparative functional analysis of the secretome profiles among parasitic nematodes revealed a marked expansion of secreted peptidases and peptidase inhibitors in B. xylophilus via gene duplication and horizontal gene transfer from fungi and bacteria. Furthermore, we showed that B. xylophilus secreted the potential host mimicry proteins that closely resemble the host pine's proteins. These proteins could have been acquired by host-parasite co-evolution and might mimic the host defense systems in susceptible pine trees during infection. This study contributes to an understanding of their unique parasitism and its tangled roots, and provides new perspectives on the evolution of plant parasitism among nematodes.	[Shinya, Ryoji; Morisaka, Hironobu; Takeuchi, Yuko; Ueda, Mitsuyoshi; Futai, Kazuyoshi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Shinya, Ryoji] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 487, Japan; [Kikuchi, Taisei] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan	Kyoto University; Chubu University; Forestry & Forest Products Research Institute - Japan	Shinya, R (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	shinya@caltech.edu		Shinya, Ryoji/0000-0002-2450-3054; Kikuchi, Taisei/0000-0003-2759-9167	JSPS Research Fellowship for Young Scientists;  [KAKENHI 23248024];  [21780147]; Grants-in-Aid for Scientific Research [25660121] Funding Source: KAKEN	JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI 23248024 and 21780147) (http://www.jsps.go.jp/). Ryoji Shinya was supported by JSPS Research Fellowship for Young Scientists (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; [Anonymous], 2004, CURR OPIN PLANT BIOL, V7, P1; [Anonymous], PINE WILT DIS; [Anonymous], 2008, PINE WILT DISEASE; Arai S, 2002, J AGR FOOD CHEM, V50, P6612, DOI 10.1021/jf0201935; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; Batalia MA, 1996, NAT STRUCT BIOL, V3, P19, DOI 10.1038/nsb0196-19; Belenghi B, 2003, EUR J BIOCHEM, V270, P2593, DOI 10.1046/j.1432-1033.2003.03630.x; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; BIRD AF, 1968, J PARASITOL, V54, P879, DOI 10.2307/3277114; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brandazza A, 2004, FEBS LETT, V572, P3, DOI 10.1016/j.febslet.2004.07.003; Brinkworth RI, 2001, J BIOL CHEM, V276, P38844, DOI 10.1074/jbc.M101934200; Curtis Rosane H. C., 2007, Briefings in Functional Genomics & Proteomics, V6, P50, DOI 10.1093/bfgp/elm006; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Gao B, 2001, INT J PARASITOL, V31, P1617, DOI 10.1016/S0020-7519(01)00300-9; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grenier J, 2000, MYCOLOGIA, V92, P841, DOI 10.2307/3761579; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Guo YF, 2011, PLANT PHYSIOL, V157, P476, DOI 10.1104/pp.111.180554; Han H, 2008, PLANT DIS, V92, P1251, DOI 10.1094/PDIS-92-8-1251A; HAWDON JM, 1995, EXP PARASITOL, V80, P205, DOI 10.1006/expr.1995.1025; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hussey Richard S., 2002, Braz. J. Plant Physiol., V14, P183, DOI 10.1590/S1677-04202002000300002; HUSSEY RS, 1989, J NEMATOL, V21, P392; Iwahori H., 1993, JPN J NEMATOL, V23, P79, DOI [10.3725/jjn1993.23.2_79, DOI 10.3725/JJN1993.23.2_79]; Jasmer DP, 2004, MOL BIOCHEM PARASIT, V137, P297, DOI 10.1016/j.molbiopara.2004.06.010; Jaubert S, 2002, MOL BIOCHEM PARASIT, V121, P205, DOI 10.1016/S0166-6851(02)00034-8; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kikuchi T, 2005, BIOCHEM J, V389, P117, DOI 10.1042/BJ20042042; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2009, NEMATOLOGY, V11, P355, DOI 10.1163/156854109X446953; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Komatsu M, 2006, TREE FOR HLTH, V10, P25; Kuroda M, 2001, BIOSCI BIOTECH BIOCH, V65, P22, DOI 10.1271/bbb.65.22; Lambert KN, 1999, MOL PLANT MICROBE IN, V12, P328, DOI 10.1094/MPMI.1999.12.4.328; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lin SF, 2011, EXP PARASITOL, V127, P440, DOI 10.1016/j.exppara.2010.10.013; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Marokhazi J, 2004, APPL ENVIRON MICROB, V70, P7311, DOI 10.1128/AEM.70.12.7311-7320.2004; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; Mitchum MG, 2012, ANNU REV PHYTOPATHOL, V50, P175, DOI 10.1146/annurev-phyto-081211-173008; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Motokawa M, 2002, J CHROMATOGR A, V961, P53, DOI 10.1016/S0021-9673(02)00133-4; MYERS RF, 1988, J NEMATOL, V20, P236; ODANI K, 1985, Journal of the Japanese Forestry Society, V67, P366; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pernas M, 1999, MOL PLANT MICROBE IN, V12, P624, DOI 10.1094/MPMI.1999.12.7.624; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Rawlings ND, 2008, BIOCHIMIE, V90, P243, DOI 10.1016/j.biochi.2007.09.014; Robertson L, 1999, PARASITOLOGY, V119, P167, DOI 10.1017/S0031182099004448; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rosso M.N., 2012, EFFECTORS PLANT MICR, V13, P327; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Santamaria ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-307; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Shinya R, 2010, PHYTOPATHOLOGY, V100, P1289, DOI 10.1094/PHYTO-04-10-0109; Steiner G, 1934, J AGRIC RES, V48, P0949; Toubarro D, 2010, J BIOL CHEM, V285, P30666, DOI 10.1074/jbc.M110.129346; Toubarro D, 2009, INT J PARASITOL, V39, P1319, DOI 10.1016/j.ijpara.2009.04.013; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Wang JY, 2011, MOL PLANT PATHOL, V12, P177, DOI 10.1111/j.1364-3703.2010.00660.x; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Yatsuda AP, 2006, INFECT IMMUN, V74, P1989, DOI 10.1128/IAI.74.3.1989-1993.2006; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141; Zhao Y, 1996, PLANT PHYSIOL, V111, P1299, DOI 10.1104/pp.111.4.1299	83	82	86	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67377	10.1371/journal.pone.0067377	http://dx.doi.org/10.1371/journal.pone.0067377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805310	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500138
J	Tong, HY; Hu, C; Yin, XF; Yu, MX; Yang, J; Jin, J				Tong, Hongyan; Hu, Chao; Yin, Xiufeng; Yu, Mengxia; Yang, Jun; Jin, Jie			A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes	PLOS ONE			English	Article							HAIR DYE USE; RISK-FACTORS; LEUKEMIA; EXPOSURE; BENZENE; SMOKERS; COHORT	Background: In recent years, epidemiologic studies have reported controversial results relating cigarette smoking to myelodysplastic syndromes (MDS) risk. A meta-analysis was performed to assess such potential relationship between cigarette smoking and incidence of MDS. Methods: A search of literature published before October 2012 for observational studies evaluating the association between cigarette smoking and MDS, returned 123 articles and of these, 14 were selected for this study. The outcomes from these studies were calculated and reported as odds ratios (OR). Quality assessments were performed with the Newcastle-Ottawa Scale. Heterogeneity was evaluated by the I 2 index and source of heterogeneity was detected by sensitivity analyses. Finally, publication bias was assessed through visual inspection of funnel plots and Egger's test. Results: The pooled OR of developing MDS in ever-smokers was 1.45 (95% CI, 1.25 to 1.68) versus non-smokers. Current and former smokers had increased risks of MDS, with ORs of 1.81 (95% CI, 1.24 to 2.66) and 1.67 (95% CI, 1.42 to 1.96), respectively. In subset analyses, ever-smokers had increased risks of developing MDS if they were living in the United States, or in Europe, female in gender, had refractory anemia (RA)/RA with ringed sideroblasts (RARS) or RA with excess blasts (RAEB)/RAEB in transformation (RAEBt), respectively. Our results demonstrated that the association was stronger in individuals who smoked >= 20 cigarettes/day (OR, 1.62; 95% CI, 1.03 to 2.55) versus those who smoked,20 cigarettes/day (OR, 1.36; 95% CI, 1.13 to 1.64). Moreover, individuals who smoked more than 20 pack-years had increased MDS risk (OR, 1.94; 95% CI, 1.29 to 2.92). Conclusion: Our outcomes show that smoking increases the risk of developing MDS in ever-smokers who are current or former smokers. We also demonstrate here that positive association between cigarette smoking and risk of MDS exists, and occurs in a dose-dependent manner.	[Tong, Hongyan; Hu, Chao; Yin, Xiufeng; Jin, Jie] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Tong, Hongyan; Hu, Chao; Yin, Xiufeng; Jin, Jie] Zhejiang Univ, Sch Med, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Mengxia] Ningbo Univ, Affiliated Hosp 1, Dept Hematol, Ningbo 315211, Zhejiang, Peoples R China; [Yang, Jun] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Ningbo University; Zhejiang University	Tong, HY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China.	hongyantong@yahoo.com.cn; zjuhematology@163.com			Zhejiang Province Fund for Distinguished Young Scholars [LR12H08001]; National Natural Science Foundation of China [30870914, 81270582]	Zhejiang Province Fund for Distinguished Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from Zhejiang Province Fund for Distinguished Young Scholars (LR12H08001) and grants from the National Natural Science Foundation of China (No. 30870914, No. 81270582)(http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSOY M, 1972, AM J MED, V52, P160, DOI 10.1016/0002-9343(72)90065-4; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Bjork J, 2000, EPIDEMIOLOGY, V11, P285, DOI 10.1097/00001648-200005000-00010; Bjork J, 2009, LEUKEMIA RES, V33, P788, DOI 10.1016/j.leukres.2008.10.009; Brugnone F, 1990, Med Lav, V81, P101; Calderon-Ezquerro C, 2007, HUM EXP TOXICOL, V26, P715, DOI 10.1177/0960327107083451; CRANE MM, 1991, CANCER, V67, P2211, DOI 10.1002/1097-0142(19910415)67:8<2211::AID-CNCR2820670835>3.0.CO;2-4; Dalamaga M, 2002, CANCER CAUSE CONTROL, V13, P603, DOI 10.1023/A:1019573319803; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg Peter L, 2002, Hematology Am Soc Hematol Educ Program, P136; Group IW, 2004, IARC MONOGR EVAL CAR, V83, P1; Ido M, 1996, LEUKEMIA RES, V20, P727, DOI 10.1016/0145-2126(96)00042-2; Lv L, 2011, AM J HEMATOL, V86, P163, DOI 10.1002/ajh.21941; Ma XM, 2009, AM J EPIDEMIOL, V169, P1492, DOI 10.1093/aje/kwp074; Mauritzson N, 2001, BRIT J HAEMATOL, V113, P347, DOI 10.1046/j.1365-2141.2001.02750.x; McMillan SA, 1997, J CLIN PATHOL, V50, P819, DOI 10.1136/jcp.50.10.819; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; MELE A, 1994, AM J EPIDEMIOL, V139, P609, DOI 10.1093/oxfordjournals.aje.a117050; Moszczynski P, 2001, TOXICOL LETT, V118, P121, DOI 10.1016/S0378-4274(00)00270-8; Nagata C, 1999, LEUKEMIA RES, V23, P57, DOI 10.1016/S0145-2126(98)00135-0; Nisse C, 2001, BRIT J HAEMATOL, V112, P927, DOI 10.1046/j.1365-2141.2001.02645.x; Pasqualetti P, 1997, BRIT J HAEMATOL, V97, P659, DOI 10.1046/j.1365-2141.1997.942910.x; Pekmezovic T, 2006, ANN HEMATOL, V85, P514, DOI 10.1007/s00277-006-0128-y; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; Steensma DP, 2006, LEUKEMIA RES, V30, P1227, DOI 10.1016/j.leukres.2005.12.001; Strom SS, 2008, SEMIN HEMATOL, V45, P8, DOI 10.1053/j.seminhematol.2007.10.003; Strom SS, 2005, LEUKEMIA, V19, P1912, DOI 10.1038/sj.leu.2403945; VIGLIANI EC, 1964, NEW ENGL J MED, V271, P872, DOI 10.1056/NEJM196410222711703; Wells G, 2009, OTTAWA HOSP RES I NE; WEST RR, 1995, LEUKEMIA RES, V19, P127, DOI 10.1016/0145-2126(94)00141-V; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	34	24	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67537	10.1371/journal.pone.0067537	http://dx.doi.org/10.1371/journal.pone.0067537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805315	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500143
J	Ji, BH; Wang, X; Pinto-Duarte, A; Kim, M; Caldwell, S; Young, JW; Behrens, MM; Sejnowski, TJ; Geyer, MA; Zhou, XJ				Ji, Baohu; Wang, Xin; Pinto-Duarte, Antonio; Kim, Minjung; Caldwell, Sorana; Young, Jared W.; Behrens, Margarita M.; Sejnowski, Terrence J.; Geyer, Mark A.; Zhou, Xianjin			Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia	PLOS ONE			English	Article							NMDA-RECEPTOR ENCEPHALITIS; TRANSCRIPTION FACTOR SP4; PREFRONTAL CORTEX; FREQUENCY OSCILLATIONS; PREPULSE INHIBITION; BIPOLAR DISORDER; MESSENGER-RNA; EXPRESSION; DEFICITS; NEURONS	It has been well established that schizophrenia patients display impaired NMDA receptor (NMDAR) functions as well as exacerbation of symptoms in response to NMDAR antagonists. Abnormal NMDAR signaling presumably contributes to cognitive deficits which substantially contribute to functional disability in schizophrenia. Establishing a mouse genetic model will help investigate molecular mechanisms of hypoglutmatergic neurotransmission in schizophrenia. Here, we examined the responses of Sp4 hypomorphic mice to NMDAR antagonists in electroencephalography and various behavioral paradigms. Sp4 hypomorphic mice, previously reported to have reduced NMDAR1 expression and LTP deficit in hippocampal CA1, displayed increased sensitivity and prolonged responses to NMDAR antagonists. Molecular studies demonstrated reduced expression of glutamic acid decarboxylase 67 (GAD67) in both cortex and hippocampus, consistent with abnormal gamma oscillations in Sp4 hypomorphic mice. On the other hand, human SP4 gene was reported to be deleted in schizophrenia. Several human genetic studies suggested the association of SP4 gene with schizophrenia and other psychiatric disorders. Therefore, elucidation of the Sp4 molecular pathway in Sp4 hypomorphic mice may provide novel insights to our understanding of abnormal NMDAR signaling in schizophrenia.	[Ji, Baohu; Kim, Minjung; Caldwell, Sorana; Young, Jared W.; Geyer, Mark A.; Zhou, Xianjin] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Wang, Xin; Pinto-Duarte, Antonio; Behrens, Margarita M.; Sejnowski, Terrence J.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Wang, Xin; Pinto-Duarte, Antonio; Behrens, Margarita M.; Sejnowski, Terrence J.] Howard Hughes Med Inst, La Jolla, CA USA; [Caldwell, Sorana; Young, Jared W.; Geyer, Mark A.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Pinto-Duarte, Antonio] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1699 Lisbon, Portugal; [Pinto-Duarte, Antonio] Univ Lisbon, Inst Mol Med, Neurosci Unit, P-1699 Lisbon, Portugal	University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Universidade de Lisboa; Universidade de Lisboa	Zhou, XJ (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	xzhou@ucsd.edu	Behrens, M. Margarita/K-2576-2014; Young, Jared W/G-9601-2012; Sejnowski, Terrence/AAV-5558-2021; Ji, Baohu/D-2281-2014; Pinto-Duarte, Antonio/B-6392-2008	Pinto-Duarte, Antonio/0000-0002-2215-7653	Howard Hughes Medical Institute; Life Sciences Research Foundation Pfizer Fellowship; NARSAD Young Investigator Grant; Calouste Gulbenkian Foundation Fellowship; Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center;  [R01MH073991];  [MH091407]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073991, R01MH091407] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Life Sciences Research Foundation Pfizer Fellowship; NARSAD Young Investigator Grant(NARSAD); Calouste Gulbenkian Foundation Fellowship; Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center(US Department of Veterans Affairs); ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study is supported by R01MH073991 (XZ), MH091407 (MMB), and Howard Hughes Medical Institute (TJS), the Life Sciences Research Foundation Pfizer Fellowship (XW), the NARSAD Young Investigator Grant (XW), the Calouste Gulbenkian Foundation Fellowship (APD), and the Veterans Affairs VISN 22 Mental Illness Research, Education, and Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 1998, J NEUROSCI, V18, P5545, DOI 10.1523/JNEUROSCI.18-14-05545.1998; Bakshi VP, 1999, J PHARMACOL EXP THER, V288, P643; BANBURY, 1997, NEURON, V19, P755; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brody SA, 2003, PSYCHOPHARMACOLOGY, V169, P240, DOI 10.1007/s00213-003-1421-2; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2011, MOL PSYCHIAT; Curley AA, 2011, AM J PSYCHIAT, V168, P921, DOI 10.1176/appi.ajp.2011.11010052; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Greenwood TA, 2011, AM J PSYCHIAT, V168, P930, DOI 10.1176/appi.ajp.2011.10050723; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Heisler LE, 2005, NUCLEIC ACIDS RES, V33, P2952, DOI 10.1093/nar/gki582; Holcomb HH, 2005, NEUROPSYCHOPHARMACOL, V30, P2275, DOI 10.1038/sj.npp.1300824; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hunt MJ, 2006, BIOL PSYCHIAT, V60, P1206, DOI 10.1016/j.biopsych.2006.01.020; Iizuka T, 2008, NEUROLOGY, V70, P504, DOI 10.1212/01.wnl.0000278388.90370.c3; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Nicolas MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021814; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; Kim M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032043; Knowles JA, 2009, MOL PSYCHIAT; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Law AJ, 2001, NEUROREPORT, V12, P2971, DOI 10.1097/00001756-200109170-00043; LUBY ED, 1959, ARCH NEURO PSYCHIATR, V81, P363, DOI 10.1001/archneurpsyc.1959.02340150095011; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Razoux F, 2007, NEUROPSYCHOPHARMACOL, V32, P719, DOI 10.1038/sj.npp.1301057; Risbrough VB, 2006, NEUROPSYCHOPHARMACOL, V31, P2349, DOI 10.1038/sj.npp.1301161; Rotaru DC, 2011, J NEUROSCI, V31, P142, DOI 10.1523/JNEUROSCI.1970-10.2011; Shi J., 2010, MOL PSYCHIAT; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Tanaka S, 2012, BEHAV BRAIN RES, V233, P55, DOI 10.1016/j.bbr.2012.04.045; Uhlhaas PJ, 2011, PROG BIOPHYS MOL BIO, V105, P14, DOI 10.1016/j.pbiomolbio.2010.10.004; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Weickert C.S., 2012, MOL PSYCHIAT; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2010, HUM MOL GENET, V19, P3797, DOI 10.1093/hmg/ddq298; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196	51	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66327	10.1371/journal.pone.0066327	http://dx.doi.org/10.1371/journal.pone.0066327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823008	Green Published, gold			2022-12-27	WOS:000320576400085
J	Motozono, C; Miles, JJ; Hasan, Z; Gatanaga, H; Meribe, SC; Price, DA; Oka, S; Sewell, AK; Ueno, T				Motozono, Chihiro; Miles, John J.; Hasan, Zafrul; Gatanaga, Hiroyuki; Meribe, Stanley C.; Price, David A.; Oka, Shinichi; Sewell, Andrew K.; Ueno, Takamasa			CD8(+) T Cell Cross-Reactivity Profiles and HIV-1 Immune Escape towards an HLA-B35-Restricted Immunodominant Nef Epitope	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CLASS-I MOLECULES; RECEPTOR; RECOGNITION; CLONOTYPES; REPERTOIRE; RESPONSES; ENGAGEMENT; INFECTION; PEPTIDES	Antigen cross-reactivity is an inbuilt feature of the T cell compartment. However, little is known about the flexibility of T cell recognition in the context of genetically variable pathogens such as HIV-1. In this study, we used a combinatorial library containing 24 billion octamer peptides to characterize the cross-reactivity profiles of CD8(+) T cells specific for the immunodominant HIV-1 subtype B Nef epitope VY8 (VPLRPMTY) presented by HLA-B*35:01. In conjunction, we examined naturally occurring antigenic variations within the VY8 epitope. Sequence analysis of plasma viral RNA isolated from 336 HIV-1-infected individuals revealed variability at position (P) 3 and P8 of VY8; Phe at P8, but not Val at P3, was identified as an HLA-B*35:01-associated polymorphism. VY8-specific T cells generated from several different HIV-1-infected patients showed unique and clonotype-dependent cross-reactivity footprints. Nonetheless, all T cells recognized both the index Leuandmutant Val atP3 equally well. In contrast, competitive titration assays revealed that the Tyr to Phe substitution at P8 reduced T cell recognition by 50-130 fold despite intact peptide binding to HLA-B*35:01. These findings explain the preferential selection of Phe at the C-terminus of VY8 in HLA-B*35:01(+) individuals and demonstrate that HIV-1 can exploit the limitations of T cell recognition in vivo.	[Motozono, Chihiro; Miles, John J.; Price, David A.; Sewell, Andrew K.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales; [Motozono, Chihiro; Hasan, Zafrul; Gatanaga, Hiroyuki; Meribe, Stanley C.; Oka, Shinichi; Ueno, Takamasa] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Miles, John J.] Queensland Inst Med Res, Australian Ctr Vaccine Dev, Human Immun Lab, Brisbane, Qld 4006, Australia; [Miles, John J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	Cardiff University; Kumamoto University; QIMR Berghofer Medical Research Institute; University of Queensland; National Center for Global Health & Medicine - Japan	Sewell, AK (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	sewellak@cardiff.ac.uk; uenotaka@kumamoto-u.ac.jp	Ueno, Takamasa/AAW-9491-2020; Hasan, Zafrul/G-2984-2015; Ueno, Takamasa/F-5788-2013; Miles, John J/ABC-1105-2020; Sewell, Andrew/GPT-4220-2022; Price, David A/C-7876-2013	Ueno, Takamasa/0000-0003-4852-4236; Ueno, Takamasa/0000-0003-4852-4236; Miles, John J/0000-0001-5506-6304; Sewell, Andrew/0000-0003-3194-3135; Price, David A/0000-0001-9416-2737; Oka, Shinichi/0000-0002-9283-2167	Ministry of Education, Science, Sports, and Culture (MEXT); Ministry of Health, Labor, and Welfare of Japan; Biotechnology and Biological Sciences Research Council [BB/H001085/1]; BBSRC [BB/H001085/1] Funding Source: UKRI; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	Ministry of Education, Science, Sports, and Culture (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by a grant-in-aid for scientific research and a Global COE Program (Global Education and Research Center Aiming at the Control of AIDS) from the Ministry of Education, Science, Sports, and Culture (MEXT), and by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan (to TU). ZH and SCM are supported by scholarships from The International Priority Graduate Programs, MEXT. JJM is a National Health and Medical Research Council (NHMRC) Career Development Fellow. The authors' studies of TCR binding degeneracy were made possible by generous support from the Biotechnology and Biological Sciences Research Council (grant BB/H001085/1 to AKS and DAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; De Rosa SC, 2004, J IMMUNOL, V173, P5372, DOI 10.4049/jimmunol.173.9.5372; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Ekeruche-Makinde J, 2012, J BIOL CHEM, V287, P37269, DOI 10.1074/jbc.M112.386409; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Ladell K, 2013, IMMUNITY, V38, P425, DOI 10.1016/j.immuni.2012.11.021; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Motozono C, 2009, J IMMUNOL, V182, P5528, DOI 10.4049/jimmunol.0803471; Mwimanzi P, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-50; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Ueno T, 2002, J IMMUNOL, V169, P4961, DOI 10.4049/jimmunol.169.9.4961; Ueno T, 2008, J IMMUNOL, V180, P1107, DOI 10.4049/jimmunol.180.2.1107; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wooldridge L, 2010, J IMMUNOL, V185, P4625, DOI 10.4049/jimmunol.1001480; Yamada T, 2003, J VIROL, V77, P1589, DOI 10.1128/JVI.77.2.1589-1594.2003	28	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66152	10.1371/journal.pone.0066152	http://dx.doi.org/10.1371/journal.pone.0066152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799076	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800025
J	Barboza, R; Camara, NOS; Gomes, E; Sa-Nunes, A; Florsheim, E; Mirotti, L; Labrada, A; Alcantara-Neves, NM; Russo, M				Barboza, Renato; Saraiva Camara, Niels Olsen; Gomes, Eliane; Sa-Nunes, Anderson; Florsheim, Esther; Mirotti, Luciana; Labrada, Alexis; Alcantara-Neves, Neuza Maria; Russo, Momtchilo			Endotoxin Exposure during Sensitization to Blomia tropicalis Allergens Shifts TH2 Immunity Towards a TH17-Mediated Airway Neutrophilic Inflammation: Role of TLR4 and TLR2	PLOS ONE			English	Article							INDUCED EOSINOPHIL RECRUITMENT; ENDOTHELIAL GROWTH-FACTOR; RESPIRATORY ALLERGY; EXPERIMENTAL-MODEL; MOUSE; LIPOPOLYSACCHARIDE; ASTHMA; RECEPTOR; INNATE; CELLS	Experimental evidence and epidemiological studies indicate that exposure to endotoxin lipopolysaccharide (eLPS) or other TLR agonists prevent asthma. We have previously shown in the OVA-model of asthma that eLPS administration during alum-based allergen sensitization blocked the development of lung TH2 immune responses via MyD88 pathway and IL-12/IFN-gamma axis. In the present work we determined the effect of eLPS exposure during sensitization to a natural airborne allergen extract derived from the house dust mite Blomia tropicalis (Bt). Mice were subcutaneously sensitized with Bt allergens co-adsorbed onto alum with or without eLPS and challenged twice intranasally with Bt. Cellular and molecular parameters of allergic lung inflammation were evaluated 24 h after the last Bt challenge. Exposure to eLPS but not to ultrapure LPS (upLPS) preparation during sensitization to Bt allergens decreased the influx of eosinophils and increased the influx of neutrophils to the airways. Inhibition of airway eosinophilia was not observed in IFN-gamma deficient mice while airway neutrophilia was not observed in IL-17RA-deficient mice as well in mice lacking MyD88, CD14, TLR4 and, surprisingly, TLR2 molecules. Notably, exposure to a synthetic TLR2 agonist (PamCSK4) also induced airway neutrophilia that was dependent on TLR2 and TLR4 molecules. In the OVA model, exposure to eLPS or PamCSK4 suppressed OVA-induced airway inflammation. Our results suggest that B. tropicalis allergens engage TLR4 that potentiates TLR2 signaling. This dual TLR activation during sensitization results in airway neutrophilic inflammation associated with increased frequency of lung TH17 cells. Our work highlight the complex interplay between bacterial products, house dust mite allergens and TLR signaling in the induction of different phenotypes of airway inflammation.	[Barboza, Renato; Saraiva Camara, Niels Olsen; Gomes, Eliane; Sa-Nunes, Anderson; Florsheim, Esther; Mirotti, Luciana; Russo, Momtchilo] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Labrada, Alexis] Ctr Nacl Biopreparados, Dept Alergenos, Havana, Cuba; [Alcantara-Neves, Neuza Maria] Univ Fed Bahia, Inst Ciencias Saude, BR-41170290 Salvador, BA, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia	Russo, M (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	momtchilo@usp.br	Barboza, Renato/G-5833-2012; Sa-Nunes, Anderson/D-8667-2012; Florsheim, Esther Borges/G-5260-2015; camara, niels olsen saraiva/AAX-3269-2020; Labrada, Alexis/AAD-9750-2019; Camara, Niels OS/G-8336-2011; Sa-Nunes, Anderson/M-5654-2019	Barboza, Renato/0000-0002-6441-7513; Sa-Nunes, Anderson/0000-0002-1859-4973; Florsheim, Esther Borges/0000-0002-5889-7442; camara, niels olsen saraiva/0000-0001-5436-1248; Labrada, Alexis/0000-0003-0956-7946; Camara, Niels OS/0000-0001-5436-1248; Sa-Nunes, Anderson/0000-0002-1859-4973; Alcantara-Neves, Neuza Maria/0000-0002-2102-260X	State of Sao Paulo Foundation for Research Support (FAPESP) [07/03031-3, 11/17880-8]; CAPES, Brazilian Council of Scientific and Technologic Development	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES, Brazilian Council of Scientific and Technologic Development	This study was supported by grants 07/03031-3 and 11/17880-8 from the State of Sao Paulo Foundation for Research Support (FAPESP), CAPES, Brazilian Council of Scientific and Technologic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda LK, 1997, AM J RESP CRIT CARE, V155, P343, DOI 10.1164/ajrccm.155.1.9001334; Baqueiro T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-51; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Bortolatto J, 2008, CLIN EXP ALLERGY; Carvalho AF, 2004, J CLIN IMMUNOL, V24, P533, DOI 10.1023/B:JOCI.0000040924.37824.29; Cerqueira-Lima AT, 2010, CURR DRUG TARGETS, V11, P1458; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Eisenbarth SC, 2008, CLIN EXP ALLERGY, V38, P1572, DOI 10.1111/j.1365-2222.2008.03069.x; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Epstein MM, 2004, INT ARCH ALLERGY IMM, V133, P84, DOI 10.1159/000076131; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Kuo IC, 2003, J ALLERGY CLIN IMMUN, V111, P603, DOI 10.1067/mai.2003.167; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Mirotti L, 2013, ALLERGY, V68, P74, DOI 10.1111/all.12057; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; NAKAJIMA H, 1993, AM REV RESPIR DIS, V148, P1102, DOI 10.1164/ajrccm/148.4_Pt_1.1102; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Rizzo MC, 1997, PEDIAT ALLERG IMM-UK, V8, P121; Rogerio AP, 2010, PHARMACOL RES, V62, P298, DOI 10.1016/j.phrs.2010.04.005; Sa-Nunes A, 2007, MICROBES INFECT, V9, P1393, DOI 10.1016/j.micinf.2006.10.007; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Schroder NWJ, 2007, ALLERGY, V62, P579, DOI 10.1111/j.1398-9995.2007.01386.x; Schulz O, 1997, EUR J IMMUNOL, V27, P584, DOI 10.1002/eji.1830270303; Schulz O, 1998, J EXP MED, V187, P271, DOI 10.1084/jem.187.2.271; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tsai JJ, 1998, INT ARCH ALLERGY IMM, V115, P144, DOI 10.1159/000023894; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	47	30	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67115	10.1371/journal.pone.0067115	http://dx.doi.org/10.1371/journal.pone.0067115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805294	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500122
J	Fillafer, C; Schneider, MF				Fillafer, Christian; Schneider, Matthias F.			On the Temperature Behavior of Pulse Propagation and Relaxation in Worms, Nerves and Gels	PLOS ONE			English	Article							SPREADING DEPRESSION; CONDUCTION-VELOCITY; ACTION-POTENTIALS; CHEMICAL WAVES; DEPENDENCE; AXON; MEMBRANE; NITELLA; RETINA	The effect of temperature on pulse propagation in biological systems has been an important field of research. Environmental temperature not only affects a host of physiological processes e.g. in poikilotherms but also provides an experimental means to investigate the thermodynamic phenomenology of nerves and muscle. In the present work, the temperature dependence of blood vessel pulsation velocity and frequency was studied in the annelid Lumbriculus variegatus. The pulse velocity was found to vary linearily between 0 degrees C and 30 degrees C. In contrast, the pulse frequency increased non-linearly in the same temperature range. A heat block ultimately resulted in complete cessation of vessel pulsations at 37.2 +/- 2.7 degrees C (lowest: 33 degrees C, highest: 43 degrees C). However, quick cooling of the animal led to restoration of regularly propagating pulses. This experimentally observed phenomenology of pulse propagation and frequency is interpreted without any assumptions about molecules in the excitable membrane (e.g. ion channels) or their temperature-dependent behaviour. By following Einstein's approach to thermodynamics and diffusion, a relation between relaxation time tau and compressibility kappa of the excitable medium is derived that can be tested experimentally (for k(T) similar to k(S)). Without fitting parameters this theory predicts the temperature dependence of the limiting (i.e. highest) pulse frequency in good agreement with experimental data. The thermodynamic approach presented herein is neither limited to temperature nor to worms nor to living systems. It describes the coupling between pulse propagation and relaxation equally well in nerves and gels. The inherent consistency and universality of the concept underline its potential to explain the dependence of pulse propagation and relaxation on any thermodynamic observable.	[Fillafer, Christian; Schneider, Matthias F.] Boston Univ, Dept Mech Engn, Biol Phys Grp, Boston, MA 02215 USA	Boston University	Schneider, MF (corresponding author), Boston Univ, Dept Mech Engn, Biol Phys Grp, Boston, MA 02215 USA.	mfs@bu.edu		/0000-0002-6124-4899	Max Kade Foundation; Austrian Academy of Sciences; BU-ENG-ME; German Science Foundation (DFG); research unit SHENC	Max Kade Foundation; Austrian Academy of Sciences; BU-ENG-ME; German Science Foundation (DFG)(German Research Foundation (DFG)); research unit SHENC	CF is grateful for funding by the Max Kade Foundation (http://maxkadefoundation.org/) and the Austrian Academy of Sciences (www.oeaw.ac.at/). Furthermore, financial support by BU-ENG-ME (www.bu.edu/me/) is acknowledged. MFS would also like to recognize funding through the German Science Foundation (DFG) and the research unit SHENC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SSL, 2009, PROG NEUROBIOL, V88, P104, DOI 10.1016/j.pneurobio.2009.03.002; BEILBY M J, 1976, Australian Journal of Plant Physiology, V3, P275; BLATT FJ, 1974, BIOCHIM BIOPHYS ACTA, V339, P382, DOI 10.1016/0005-2736(74)90165-5; Castro G de O, 1970, J Neurophysiol, V33, P891; CHAPMAN RA, 1967, NATURE, V213, P1143, DOI 10.1038/2131143a0; COHEN LB, 1972, J PHYSIOL-LONDON, V224, P727, DOI 10.1113/jphysiol.1972.sp009920; Engelhardt A, 1951, J COMP PHYSL NEUROET, V128, P125; Fernandes De Lima VM, 1997, PROGR RETINAL EYE RE, V16, P657; FRANZ DN, 1968, J PHYSIOL-LONDON, V199, P319, DOI 10.1113/jphysiol.1968.sp008656; Grabitz P, 2002, BIOPHYS J, V82, P299, DOI 10.1016/S0006-3495(02)75395-2; Griesbauer J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198103; Griesbauer J, 2009, BIOPHYS J, V97, P2710, DOI 10.1016/j.bpj.2009.07.049; Hamilton M.F, 1998, NONLINEAR ACOUSTICS; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; HODGKIN AL, 1949, J PHYSIOL-LONDON, V109, P240, DOI 10.1113/jphysiol.1949.sp004388; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUTCHINSON NA, 1970, J PHYSIOL-LONDON, V208, P279, DOI 10.1113/jphysiol.1970.sp009119; INOUE I, 1973, BIOCHIM BIOPHYS ACTA, V307, P471, DOI 10.1016/0005-2736(73)90294-0; IWASA K, 1980, SCIENCE, V210, P338, DOI 10.1126/science.7423196; Jaffe LF, 2002, CELL CALCIUM, V32, P217, DOI 10.1016/S0143416002001574; Kaufmann K., 1989, ACTION POTENTIALS; Lesiuk NM, 1999, AM BIOL TEACH, V61, P48, DOI 10.2307/4450609; LOWITZSCH K, 1977, J NEUROL, V216, P181, DOI 10.1007/BF00313619; LUDIN HP, 1977, J NEUROL, V216, P173, DOI 10.1007/BF00313618; MARTINSFERREIRA H, 1974, J NEUROPHYSIOL, V37, P773, DOI 10.1152/jn.1974.37.4.773; Miyakawa K, 2000, PHYS REV E, V62, P793, DOI 10.1103/PhysRevE.62.793; RITCHIE JM, 1985, Q REV BIOPHYS, V18, P451, DOI 10.1017/S0033583500005382; ROOTS BI, 1962, J EXP BIOL, V39, P617; SANDLIN R, 1968, NATURE, V217, P575, DOI 10.1038/217575b0; TASAKI I, 1969, SCIENCE, V163, P683, DOI 10.1126/science.163.3868.683; TASAKI I, 1949, BIOCHIM BIOPHYS ACTA, V3, P494, DOI 10.1016/0006-3002(49)90121-3; TASAKI I, 1989, BIOPHYS J, V55, P1033, DOI 10.1016/S0006-3495(89)82902-9; TASAKI I, 1991, BIOCHEM BIOPH RES CO, V174, P293, DOI 10.1016/0006-291X(91)90519-D; TASAKI I, 1948, J NEUROPHYSIOL, V11, P311, DOI 10.1152/jn.1948.11.4.311; UEDA T, 1974, J MEMBRANE BIOL, V18, P177, DOI 10.1007/BF01870110; Weimer M, 2005, EXP BRAIN RES, V161, P201, DOI 10.1007/s00221-004-2060-5; Wilke E, 1912, PFLUGERS ARCH EUROPE, P35; WOOD PM, 1985, J CHEM PHYS, V82, P1924, DOI 10.1063/1.448376	38	12	12	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66773	10.1371/journal.pone.0066773	http://dx.doi.org/10.1371/journal.pone.0066773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805275	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500103
J	Huyet, J; Naylor, CE; Savva, CG; Gibert, M; Popoff, MR; Basak, AK				Huyet, Jessica; Naylor, Claire E.; Savva, Christos G.; Gibert, Maryse; Popoff, Michel R.; Basak, Ajit K.			Structural Insights into Clostridium perfringens Delta Toxin Pore Formation	PLOS ONE			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; CRYSTAL-STRUCTURE; GAMMA-HEMOLYSIN; FORMING TOXINS; BETA-TOXIN; REVEALS; BINDING; LUKF; COMPONENT; MEMBRANE	Clostridium perfringens Delta toxin is one of the three hemolysin-like proteins produced by C. perfringens type C and possibly type B strains. One of the others, NetB, has been shown to be the major cause of Avian Nectrotic Enteritis, which following the reduction in use of antibiotics as growth promoters, has become an emerging disease of industrial poultry. Delta toxin itself is cytotoxic to the wide range of human and animal macrophages and platelets that present G(M2) ganglioside on their membranes. It has sequence similarity with Staphylococcus aureus beta-pore forming toxins and is expected to heptamerize and form pores in the lipid bilayer of host cell membranes. Nevertheless, its exact mode of action remains undetermined. Here we report the 2.4 angstrom crystal structure of monomeric Delta toxin. The superposition of this structure with the structure of the phospholipid-bound F component of S. aureus leucocidin (LukF) revealed that the glycerol molecules bound to Delta toxin and the phospholipids in LukF are accommodated in the same hydrophobic clefts, corresponding to where the toxin is expected to latch onto the membrane, though the binding sites show significant differences. From structure-based sequence alignment with the known structure of staphylococcal alpha-hemolysin, a model of the Delta toxin pore form has been built. Using electron microscopy, we have validated our model and characterized the Delta toxin pore on liposomes. These results highlight both similarities and differences in the mechanism of Delta toxin (and by extension NetB) cytotoxicity from that of the staphylococcal pore-forming toxins.	[Huyet, Jessica; Naylor, Claire E.; Savva, Christos G.; Basak, Ajit K.] Birkbeck Coll, Dept Biol Sci, London, England; [Gibert, Maryse; Popoff, Michel R.] Inst Pasteur, Dept Microbiol, Paris, France	University of London; Birkbeck University London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Basak, AK (corresponding author), Birkbeck Coll, Dept Biol Sci, London, England.	a.basak@mail.cryst.bbk.ac.uk	Popoff, Michel/O-7719-2016	Popoff, Michel/0000-0001-9305-8989	Medical Research Council [G0700051]; Wellcome Trust [WT089618MA]; MRC [G0700051] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank the Medical Research Council for the salaries of CEN and JH (award number G0700051), the Wellcome Trust for the salary of CS (award number WT089618MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALOUF JE, 1981, INFECT IMMUN, V31, P536, DOI 10.1128/IAI.31.2.536-546.1981; [Anonymous], 2001, WHO GLOBAL STRATEGY; Briggs DC, 2011, J MOL BIOL, V413, P138, DOI 10.1016/j.jmb.2011.07.066; CAVAILLON JM, 1986, J LEUKOCYTE BIOL, V40, P65, DOI 10.1002/jlb.40.1.65; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fivaz M, 2001, CURR TOP MICROBIOL, V257, P35; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heuck AP, 2010, SUBCELL BIOCHEM, V51, P551, DOI 10.1007/978-90-481-8622-8_20; Huyet J, 2011, ACTA CRYSTALLOGR F, V67, P369, DOI 10.1107/S1744309110054187; Jayasinghe L, 2006, J BIOL CHEM, V281, P2195, DOI 10.1074/jbc.M510841200; JOLIVETREYNAUD C, 1982, INFECT IMMUN, V38, P860, DOI 10.1128/IAI.38.3.860-864.1982; JOLIVETREYNAUD C, 1988, ARCH BIOCHEM BIOPHYS, V262, P59, DOI 10.1016/0003-9861(88)90168-3; JOLIVETREYNAUD C, 1983, J BIOL CHEM, V258, P1871; JOLIVETREYNAUD C, 1989, TOXICON, V27, P1113, DOI 10.1016/0041-0101(89)90005-6; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Knapp O, 2010, TOXICON, V55, P61, DOI 10.1016/j.toxicon.2009.06.037; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Manich M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003764; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menestrina G, 2001, TOXICON, V39, P1661, DOI 10.1016/S0041-0101(01)00153-2; Meyer F, 2009, INFECT IMMUN, V77, P266, DOI 10.1128/IAI.00402-08; Monma N, 2004, J BIOCHEM, V136, P427, DOI 10.1093/jb/mvh140; Moran Y, 2012, MOL BIOL EVOL, V29, P2223, DOI 10.1093/molbev/mss089; Nguyen AH, 2006, BIOCHEMISTRY-US, V45, P2570, DOI 10.1021/bi0514156; Nguyen VT, 2002, MOL MICROBIOL, V45, P1485, DOI 10.1046/j.1365-2958.2002.03125.x; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Potrich C, 2009, J MEMBRANE BIOL, V227, P13, DOI 10.1007/s00232-008-9140-6; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Schwarz S, 2001, INT J ANTIMICROB AG, V17, P431, DOI 10.1016/S0924-8579(01)00297-7; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Steinthorsdottir V, 1998, FEMS MICROBIOL LETT, V158, P17, DOI 10.1016/S0378-1097(97)00470-9; Tanaka Y, 2011, PROTEIN SCI, V20, P448, DOI 10.1002/pro.579; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Theobald DL, 2012, BIOINFORMATICS, V28, P1972, DOI 10.1093/bioinformatics/bts243; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Yan XX, 2013, MBIO, V4, DOI 10.1128/mBio.00019-13	53	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66673	10.1371/journal.pone.0066673	http://dx.doi.org/10.1371/journal.pone.0066673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805259	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000320846500087
J	Jeoung, M; Abdelmoti, L; Jang, ER; Kooi, CWV; Galperin, E				Jeoung, Myoungkun; Abdelmoti, Lina; Jang, Eun Ryoung; Kooi, Craig W. Vander; Galperin, Emilia			Functional Integration of the Conserved Domains of Shoc2 Scaffold	PLOS ONE			English	Article							LEUCINE-RICH-REPEAT; MAP KINASE ACTIVATION; GROWTH-FACTOR; STRUCTURAL DIVERSITY; SIGNAL-TRANSDUCTION; RAS KSR; PROTEIN; BINDING; MEK; SUPPRESSOR	Shoc2 is a positive regulator of signaling to extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). Shoc2 is also proposed to interact with RAS and Raf-1 in order to accelerate ERK1/2 activity. To understand the mechanisms by which Shoc2 regulates ERK1/2 activation by the epidermal growth factor receptor (EGFR), we dissected the role of Shoc2 structural domains in binding to its signaling partners and its role in regulating ERK1/2 activity. Shoc2 is comprised of two main domains: the 21 leucine rich repeats (LRRs) core and the N-terminal non-LRR domain. We demonstrated that the N-terminal domain mediates Shoc2 binding to both M-Ras and Raf-1, while the C-terminal part of Shoc2 contains a late endosomal targeting motif. We found that M-Ras binding to Shoc2 is independent of its GTPase activity. While overexpression of Shoc2 did not change kinetics of ERK1/2 activity, both the N-terminal and the LRR-core domain were able to rescue ERK1/2 activity in cells depleted of Shoc2, suggesting that these Shoc2 domains are involved in modulating ERK1/2 activity.	[Jeoung, Myoungkun; Abdelmoti, Lina; Jang, Eun Ryoung; Kooi, Craig W. Vander; Galperin, Emilia] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Kooi, Craig W. Vander] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Galperin, E (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	emilia.galperin@uky.edu		Galperin, Emilia/0000-0002-8743-026X	National Cancer Institute [R00CA126161]; National Institutes of Health (NIH) Grant from the National Center for Research Resources [P20GM103486]; NATIONAL CANCER INSTITUTE [R00CA126161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) Grant from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grants from the National Cancer Institute (R00CA126161 to EG) and National Institutes of Health (NIH) Grant P20GM103486 from the National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or the NIGMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Berridge MJ, 2012, CELL SIGNALING BIOL; Brown M. D., 2008, V186, P205, DOI 10.1007/978-3-540-72843-6_9; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Ceulemans H, 1999, FEBS LETT, V456, P349, DOI 10.1016/S0014-5793(99)00965-5; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ehrhardt GRA, 1999, BLOOD, V94, P2433, DOI 10.1182/blood.V94.7.2433.419k31_2433_2444; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galperin E, 2005, METHOD ENZYMOL, V403, P119, DOI 10.1016/S0076-6879(05)03011-9; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Galperin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036469; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; Istomin AY, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-48; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Ko J, 2007, J NEUROSCI RES, V85, P2824, DOI 10.1002/jnr.21306; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Li WQ, 2000, GENE DEV, V14, P895; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Park H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-599; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sharma C, 2005, J CELL BIOCHEM, V94, P708, DOI 10.1002/jcb.20344; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sorkin A, 2010, QUANTITATIVE ANAL EN; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Wezner-Ptasinska M, 2011, BBA-PROTEINS PROTEOM, V1814, P1140, DOI 10.1016/j.bbapap.2011.05.009; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yi J, 2010, DEV DYNAM, V239, P2005, DOI 10.1002/dvdy.22343; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	58	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66067	10.1371/journal.pone.0066067	http://dx.doi.org/10.1371/journal.pone.0066067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805200	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500028
J	Kamada, Y; Akita, M; Takeda, Y; Yamada, S; Fujii, H; Sawai, Y; Doi, Y; Asazawa, H; Nakayama, K; Mizutani, K; Fujii, H; Yakushijin, T; Miyazaki, M; Ezaki, H; Hiramatsu, N; Yoshida, Y; Kiso, S; Imai, Y; Kawada, N; Takehara, T; Miyoshi, E				Kamada, Yoshihiro; Akita, Maaya; Takeda, Yuri; Yamada, Shin; Fujii, Hideki; Sawai, Yoshiyuki; Doi, Yoshinori; Asazawa, Hitomi; Nakayama, Kotarosumitomo; Mizutani, Kayo; Fujii, Hironobu; Yakushijin, Takayuki; Miyazaki, Masanori; Ezaki, Hisao; Hiramatsu, Naoki; Yoshida, Yuichi; Kiso, Shinichi; Imai, Yasuharu; Kawada, Norifumi; Takehara, Tetsuo; Miyoshi, Eiji			Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; PANCREATIC-CANCER; N-GLYCANS; NATURAL-HISTORY; SCORING SYSTEM; CELL-LINES; MARKER; FIBROSIS; IDENTIFICATION; GLYCOSYLATION	Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem around the world. NAFLD patients with nonalcoholic steatohepatitis (NASH) can develop cirrhosis and hepatocellular carcinoma. The ability to distinguish NASH from simple steatosis would be of great clinical significance. Ballooning hepatocytes are characteristic of typical pathological NASH; here, the polarized secretion of proteins is disrupted due to destruction of the cytoskeleton. We previously reported that fucosylated glycoproteins are secreted into bile, but not into sera in normal liver. Therefore, we hypothesized that the fucosylation-based sorting machinery would be disrupted in ballooning hepatocytes, and serum fucosylated glycoproteins would increase in NASH patients. To confirm our hypothesis, we evaluated serum fucosylated haptoglobin (Fuc-Hpt) levels in biopsy-proven NAFLD patients (n = 126) using a lectin-antibody ELISA kit. Fuc-Hpt levels were significantly increased in NASH patients compared with non-NASH (NAFLD patients without NASH) patients. Interestingly, Fuc-Hpt levels showed a significant stepwise increase with increasing hepatocyte ballooning scores. Multiple logistic regression analysis showed that Fuc-Hpt levels were independent and significant determinants of the presence of ballooning hepatocytes. Moreover, Fuc-Hpt levels were useful in monitoring liver fibrosis staging. Next, to investigate the significance of serum Fuc-Hpt in a larger population, we measured Fuc-Hpt levels in ultrasound-diagnosed NAFLD subjects (n = 870) who received a medical health checkup. To evaluate NAFLD disease severity, we used the FIB-4 index (based on age, serum AST and ALT levels, and platelet counts). Fuc-Hpt levels increased stepwise with increasing FIB-4 index. Conclusion: Measurement of serum Fuc-Hpt levels can distinguish NASH from non-NASH patients, and predict the presence of ballooning hepatocytes in NAFLD patients with sufficient accuracy. These results support the potential usefulness of measuring Fuc-Hpt levels in clinical practice.	[Kamada, Yoshihiro; Akita, Maaya; Takeda, Yuri; Asazawa, Hitomi; Nakayama, Kotarosumitomo; Mizutani, Kayo; Fujii, Hironobu; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka, Japan; [Kamada, Yoshihiro; Yakushijin, Takayuki; Miyazaki, Masanori; Ezaki, Hisao; Hiramatsu, Naoki; Yoshida, Yuichi; Kiso, Shinichi; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Yamada, Shin] AMs New Otani Clin, Osaka, Japan; [Fujii, Hideki; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Sawai, Yoshiyuki; Imai, Yasuharu] Ikeda Municipal Hosp, Dept Gastroenterol, Ikeda, Osaka, Japan; [Doi, Yoshinori] Otemae Hosp, Dept Gastroenterol, Osaka, Japan	Osaka University; Osaka University; Osaka Metropolitan University	Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp	kawada, norifumi/AAS-1367-2020; Kamada, Yoshihiro/H-3309-2019; Kamada, Yoshihiro/AHC-1613-2022; Kamada, Yoshihiro/GQA-8854-2022	Kamada, Yoshihiro/0000-0001-5485-902X; Kamada, Yoshihiro/0000-0001-5485-902X; SAWAI, YOSHIYUKI/0000-0001-8504-5117	Japan Society for the Promotion of Science [21249038, 24590972]; Global COE Program of Osaka University; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program of Osaka University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (A), No. 21249038 and ( C), No. 24590972 from the Japan Society for the Promotion of Science, and by the Global COE Program of Osaka University funded by Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; CHAMBERS W, 1993, CLIN CHIM ACTA, V219, P177, DOI 10.1016/0009-8981(93)90209-M; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gawrieh S, 2011, ANN DIAGN PATHOL, V15, P19, DOI 10.1016/j.anndiagpath.2010.08.001; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hashimoto S, 2004, CANCER-AM CANCER SOC, V101, P2825, DOI 10.1002/cncr.20713; Ito K, 2012, HEPATOLOGY, V56, P1448, DOI 10.1002/hep.25815; Juluri R, 2011, J CLIN GASTROENTEROL, V45, P55, DOI 10.1097/MCG.0b013e3181dd1348; KITAGAWA Y, 1994, EXP CELL RES, V213, P449, DOI 10.1006/excr.1994.1222; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kuno A, 2011, CLIN CHEM, V57, P48, DOI 10.1373/clinchem.2010.151340; Lackner C, 2008, J HEPATOL, V48, P821, DOI 10.1016/j.jhep.2008.01.026; Lackner C, 2011, EXPERT REV GASTROENT, V5, P223, DOI [10.1586/EGH.11.8, 10.1586/egh.11.8]; Lefkowitch Jay H, 2005, Clin Liver Dis, V9, P37, DOI 10.1016/j.cld.2004.11.001; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Nakagawa T, 2012, J PROTEOME RES; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Nakano M, 2008, INT J CANCER, V122, P2301, DOI 10.1002/ijc.23364; Narisada M, 2008, BIOCHEM BIOPH RES CO, V377, P792, DOI 10.1016/j.bbrc.2008.10.061; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Nonaka M, 2011, J BIOL CHEM, V286, P22403, DOI 10.1074/jbc.M110.215301; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Przybylo M, 2007, BBA-GEN SUBJECTS, V1770, P1427, DOI 10.1016/j.bbagen.2007.05.006; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Takeda Y, 2011, CANCER; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yoon Y, 1998, AM J PHYSIOL-GASTR L, V274, pG757, DOI 10.1152/ajpgi.1998.274.4.G757; Younossi ZM, 1998, MODERN PATHOL, V11, P560; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	44	47	47	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66328	10.1371/journal.pone.0066328	http://dx.doi.org/10.1371/journal.pone.0066328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805214	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500042
J	Schubert, TW; Murteira, C; Collins, EC; Lopes, D				Schubert, Thomas W.; Murteira, Carla; Collins, Elizabeth C.; Lopes, Diniz			ScriptingRT: A Software Library for Collecting Response Latencies in Online Studies of Cognition	PLOS ONE			English	Article							REACTION-TIME MEASUREMENT; PSYCHOLOGICAL-RESEARCH; ACCURACY; REPLICABILITY; INTERFERENCE; COMPUTERS; INTERNET; WORLD	ScriptingRT is a new open source tool to collect response latencies in online studies of human cognition. ScriptingRT studies run as Flash applets in enabled browsers. ScriptingRT provides the building blocks of response latency studies, which are then combined with generic Apache Flex programming. Six studies evaluate the performance of ScriptingRT empirically. Studies 1-3 use specialized hardware to measure variance of response time measurement and stimulus presentation timing. Studies 4-6 implement a Stroop paradigm and run it both online and in the laboratory, comparing ScriptingRT to other response latency software. Altogether, the studies show that Flash programs developed in ScriptingRT show a small lag and an increased variance in response latencies. However, this did not significantly influence measured effects: The Stroop effect was reliably replicated in all studies, and the found effects did not depend on the software used. We conclude that ScriptingRT can be used to test response latency effects online.	[Schubert, Thomas W.] Univ Oslo, Dept Psychol, Oslo, Norway; [Schubert, Thomas W.; Murteira, Carla; Collins, Elizabeth C.; Lopes, Diniz] Inst Univ Lisboa ISCTE IUL, Ctr Invest & Intervencao Social, Lisbon, Portugal	University of Oslo; Instituto Universitario de Lisboa	Schubert, TW (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	schubert@igroup.org	Lopes, Diniz/I-7691-2012; Collins, Elizabeth/D-5539-2012	Lopes, Diniz/0000-0002-4353-2248; Collins, Elizabeth/0000-0002-2117-6967; Schubert, Thomas/0000-0002-3797-4568	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/PSI-PSO/101366/2008]; Instituto Universitario de Lisboa (ISCTE-IUL)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Instituto Universitario de Lisboa (ISCTE-IUL)	This research and development was supported by Fundacao para a Ciencia e a Tecnologia (FCT) grant PTDC/PSI-PSO/101366/2008 and funding by Instituto Universitario de Lisboa (ISCTE-IUL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; E-Prime, 2012, COMPUTER SOFTWARE; Eichstaedt J, 2001, BEHAV RES METH INS C, V33, P179, DOI 10.3758/BF03195364; Forster J. C, 2012, DMDX HELP INPUT; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fraley R. Chris, 2007, HDB RES METHODS PERS, P130; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Hoffman L, 2007, BEHAV RES METHODS, V39, P101, DOI 10.3758/BF03192848; Inquisit, 2011, COMPUTER SOFTWARE; Jostmann NB, 2007, J EXP PSYCHOL GEN, V136, P593, DOI 10.1037/0096-3445.136.4.593; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Keller F, 2009, BEHAV RES METHODS, V41, P1, DOI 10.3758/BRM.41.1.12; Kraut R, 2004, AM PSYCHOL, V59, P105, DOI 10.1037/0003-066X.59.2.105; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mason W., 2011, OPEN SOURCE WEB BASE; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Neath I, 2011, BEHAV RES METHODS, V43, P353, DOI 10.3758/s13428-011-0069-9; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Plant RR, 2009, BEHAV RES METHODS, V41, P598, DOI 10.3758/BRM.41.3.598; Plant RR, 2003, BEHAV RES METH INS C, V35, P276, DOI 10.3758/BF03202553; Reimers S, 2007, BEHAV RES METHODS, V39, P365, DOI 10.3758/BF03193004; Sargis EG, 2012, INTERNET PSYCHOL LAB, P253; Schubert TW, 2013, BEHAV RES METHODS, V45, P1332, DOI 10.3758/s13428-013-0336-z; Schubert TW, 2012, ELECTROMECHANICAL TU; Schubert TW, 2012, SCRIPTINGRT; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SuperLab, 2011, COMPUTER SOFTWARE; von Bastian CC, 2013, BEHAV RES METHODS, V45, P108, DOI 10.3758/s13428-012-0224-y; Zwaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051382	32	38	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67769	10.1371/journal.pone.0067769	http://dx.doi.org/10.1371/journal.pone.0067769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805326	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500154
J	Jakobsen, MR; Cashin, K; Roche, M; Sterjovski, J; Ellett, A; Borm, K; Flynn, J; Erikstrup, C; Gouillou, M; Gray, LR; Saksena, NK; Wang, B; Purcell, DFJ; Kallestrup, P; Zinyama-Gutsire, R; Gomo, E; Ullum, H; Ostergaard, L; Lee, B; Ramsland, PA; Churchill, MJ; Gorry, PR				Jakobsen, Martin R.; Cashin, Kieran; Roche, Michael; Sterjovski, Jasminka; Ellett, Anne; Borm, Katharina; Flynn, Jacqueline; Erikstrup, Christian; Gouillou, Maelenn; Gray, Lachlan R.; Saksena, Nitin K.; Wang, Bin; Purcell, Damian F. J.; Kallestrup, Per; Zinyama-Gutsire, Rutendo; Gomo, Exnevia; Ullum, Henrik; Ostergaard, Lars; Lee, Benhur; Ramsland, Paul A.; Churchill, Melissa J.; Gorry, Paul R.			Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naive Subjects with Progressive HIV-1 Subtype C Infection	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; CORECEPTOR USAGE; MACROPHAGE TROPISM; FUNCTIONAL-ANALYSIS; LYMPHOID-TISSUES; RURAL ZIMBABWE; VIRUS; GP120; CD4; ENTRY	HIV-1 subtype C (C-HIV) is responsible for most HIV-1 cases worldwide. Although the pathogenesis of C-HIV is thought to predominantly involve CCR5-restricted (R5) strains, we do not have a firm understanding of how frequently CXCR4-using (X4 and R5X4) variants emerge in subjects with progressive C-HIV infection. Nor do we completely understand the molecular determinants of coreceptor switching by C-HIV variants. Here, we characterized a panel of HIV-1 envelope glycoproteins (Envs) (n = 300) cloned sequentially from plasma of 21 antiretroviral therapy (ART)-naive subjects who experienced progression from chronic to advanced stages of C-HIV infection, and show that CXCR4-using C-HIV variants emerged in only one individual. Mutagenesis studies and structural models suggest that the evolution of R5 to X4 variants in this subject principally involved acquisition of an "Ile-Gly'' insertion in the gp120 V3 loop and replacement of the V3 "Gly-Pro-Gly'' crown with a "Gly-Arg-Gly'' motif, but that the accumulation of additional gp120 "scaffold'' mutations was required for these V3 loop changes to confer functional effects. In this context, either of the V3 loop changes could confer possible transitional R5X4 phenotypes, but when present together they completely abolished CCR5 usage and conferred the X4 phenotype. Our results show that the emergence of CXCR4-using strains is rare in this cohort of untreated individuals with advanced C-HIV infection. In the subject where X4 variants did emerge, alterations in the gp120 V3 loop were necessary but not sufficient to confer CXCR4 usage.	[Jakobsen, Martin R.; Cashin, Kieran; Roche, Michael; Sterjovski, Jasminka; Ellett, Anne; Borm, Katharina; Flynn, Jacqueline; Gray, Lachlan R.; Churchill, Melissa J.; Gorry, Paul R.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Ramsland, Paul A.] Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia; [Gouillou, Maelenn] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Jakobsen, Martin R.; Ostergaard, Lars] Aarhus Univ, Dept Infect Dis, Aarhus, Denmark; [Erikstrup, Christian] Aarhus Univ, Dept Clin Immunol, Aarhus, Denmark; [Ramsland, Paul A.] Univ Melbourne, Dept Surg, Austin Hlth, Melbourne, Vic 3010, Australia; [Cashin, Kieran; Purcell, Damian F. J.; Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Gray, Lachlan R.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Churchill, Melissa J.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Churchill, Melissa J.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Gorry, Paul R.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Lee, Benhur] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Saksena, Nitin K.; Wang, Bin] Westmead Millennium Inst, Ctr Virus Res, Westmead, NSW, Australia; [Kallestrup, Per; Ullum, Henrik] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Zinyama-Gutsire, Rutendo; Gomo, Exnevia] Natl Inst Hlth Res, Harare, Zimbabwe	Burnet Institute; Burnet Institute; Burnet Institute; Aarhus University; Aarhus University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University; Monash University; Monash University; Monash University; Monash University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Sydney; Westmead Institute for Medical Research; Rigshospitalet; University of Copenhagen	Gorry, PR (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	gorry@burnet.edu.au	Lee, Benhur/A-8554-2016; Kallestrup, Per/AAA-8313-2022; Ostergaard, Lars/AAA-3020-2020	Lee, Benhur/0000-0003-0760-1709; Kallestrup, Per/0000-0001-6041-4510; Ostergaard, Lars/0000-0003-2459-0511; Gomo, Exnevia/0000-0003-0891-6251; Ostergaard, Lars/0000-0002-7619-605X; Flynn, Jacqueline/0000-0002-3822-294X; , Martin/0000-0001-8847-9201; Ramsland, Paul/0000-0002-2107-2738; Sterjovski, Jasminka/0000-0002-2471-3000; Churchill, Melissa/0000-0001-5510-7954; Erikstrup, Christian/0000-0001-6551-6647; Gray, Lachlan/0000-0002-9894-1049; Ullum, Henrik/0000-0001-7306-9058; Roche, Michael/0000-0001-8819-0096	Australian National Health and Medical Research Council [543133, 1022066]; Alfred Benzon foundation of Denmark; Aase foundation of Denmark; Ejner Danielsens foundation of Denmark; University of Melbourne Postgraduate Research Scholarship; Victorian International Research Scholarship; Australian National Health and Medical Research Council (NHMRC); Australian NHMRC Level 2 Biomedical Career Development Award; Australian Research Council Future Fellowship [FT2]; Sir Zelman Cowen Fellowship Fund, Burnet Institute	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alfred Benzon foundation of Denmark; Aase foundation of Denmark; Ejner Danielsens foundation of Denmark; University of Melbourne Postgraduate Research Scholarship(University of Melbourne); Victorian International Research Scholarship; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC Level 2 Biomedical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); Sir Zelman Cowen Fellowship Fund, Burnet Institute	This study was supported by grants from the Australian National Health and Medical Research Council to PRG and MJC (543133 & 1022066). MRJ was supported by grants from the Alfred Benzon and Aase and Ejner Danielsens foundations of Denmark. KC is supported by a University of Melbourne Postgraduate Research Scholarship. KB is supported by a Victorian International Research Scholarship. LRG is the recipient of an Australian National Health and Medical Research Council (NHMRC) Postdoctoral Training Fellowship. PAR is the Sir Zelman Cowen Senior Research Fellow (Sir Zelman Cowen Fellowship Fund, Burnet Institute). PRG was the recipient of an Australian NHMRC Level 2 Biomedical Career Development Award, and is presently supported by an Australian Research Council Future Fellowship (FT2). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Bjorndal A, 1997, J VIROL, V71, P7478; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Cashin K, 2011, J VIROL, V85, P10699, DOI 10.1128/JVI.05510-11; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Coetzer M, 2011, JAIDS-J ACQ IMM DEF, V56, P9, DOI 10.1097/QAI.0b013e3181f63906; Connell BJ, 2008, AIDS, V22, P896, DOI 10.1097/QAD.0b013e3282f57f7a; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Creery D, 2006, VIRAL IMMUNOL, V19, P409, DOI 10.1089/vim.2006.19.409; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Erikstrup C, 2008, AM J TROP MED HYG, V79, P331; Erikstrup C, 2007, JAIDS-J ACQ IMM DEF, V44, P478, DOI 10.1097/QAI.0b013e318032bbcd; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gray L, 2006, J VIROL, V80, P3684, DOI 10.1128/JVI.80.7.3684-3691.2006; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; Gray L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-42; Gray L, 2009, J VIROL, V83, P5430, DOI 10.1128/JVI.02648-08; Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-52; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Jakobsen MR, 2010, FUTURE VIROL, V5, P219, DOI 10.2217/FVL.09.77; Johnston ER, 2003, J VIROL, V77, P7682, DOI 10.1128/JVI.77.13.7682-7688.2003; Kallestrup P, 2005, J INFECT DIS, V191, P1311, DOI 10.1086/428907; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lin NH, 2012, VIROLOGY, V433, P296, DOI 10.1016/j.virol.2012.08.013; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michler K, 2008, AIDS RES HUM RETROV, V24, P743, DOI 10.1089/aid.2007.0304; Nedellec R, 2009, J VIROL, V83, P8353, DOI 10.1128/JVI.00780-09; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Roche M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-89; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salimi H, 2013, J LEUKOCYTE BIOL, V93, P113, DOI 10.1189/jlb.0612308; Secor WE, 2007, CURR OPIN INFECT DIS, V20, P519, DOI 10.1097/QCO.0b013e3282e9ac03; Shimizu N, 2009, AIDS, V23, P761, DOI 10.1097/QAD.0b013e328326cc0d; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Sterjovski J, 2011, VIROLOGY, V410, P418, DOI 10.1016/j.virol.2010.12.010; Sterjovski J, 2010, VIROLOGY, V404, P269, DOI 10.1016/j.virol.2010.05.006; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; *UNAIDS, 2008, 2008 REP GLOB AIDS E; van Rensburg EJ, 2002, AIDS, V16, P2479, DOI [10.1097/00002030-200212060-00015, 10.1097/01.aids.0000042582.93174.df]; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zhang H, 2010, VIROLOGY, V407, P68, DOI 10.1016/j.virol.2010.07.047	67	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65950	10.1371/journal.pone.0065950	http://dx.doi.org/10.1371/journal.pone.0065950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824043	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400038
J	Xu, JY; Deng, BQ; Fang, YB; Yu, Y; Cheng, JY; Wang, SZ; Wang, KZ; Liu, JM; Huang, QH				Xu, Jinyu; Deng, Benqiang; Fang, Yibin; Yu, Ying; Cheng, Jiyong; Wang, Shengzhang; Wang, Kuizhong; Liu, Jian-Min; Huang, Qinghai			Hemodynamic Changes Caused by Flow Diverters in Rabbit Aneurysm Models: Comparison of Virtual and Realistic FD Deployments Based on Micro-CT Reconstruction	PLOS ONE			English	Article							PIPELINE EMBOLIZATION DEVICE; IN-VITRO EVALUATION; SACCULAR ANEURYSM; STENT POROSITY; METAL COVERAGE; SIMULATION; EFFICACY	Adjusting hemodynamics via flow diverter (FD) implantation is emerging as a novel method of treating cerebral aneurysms. However, most previous FD-related hemodynamic studies were based on virtual FD deployment, which may produce different hemodynamic outcomes than realistic (in vivo) FD deployment. We compared hemodynamics between virtual FD and realistic FD deployments in rabbit aneurysm models using computational fluid dynamics (CFD) simulations. FDs were implanted for aneurysms in 14 rabbits. Vascular models based on rabbit-specific angiograms were reconstructed for CFD studies. Real FD configurations were reconstructed based on micro-CT scans after sacrifice, while virtual FD configurations were constructed with SolidWorks software. Hemodynamic parameters before and after FD deployment were analyzed. According to the metal coverage (MC) of implanted FDs calculated based on micro-CT reconstruction, 14 rabbits were divided into two groups (A, MC >35%; B, MC <35%). Normalized mean wall shear stress (WSS), relative residence time (RRT), inflow velocity, and inflow volume in Group A were significantly different (P<0.05) from virtual FD deployment, but pressure was not (P>0.05). The normalized mean WSS in Group A after realistic FD implantation was significantly lower than that of Group B. All parameters in Group B exhibited no significant difference between realistic and virtual FDs. This study confirmed MC-correlated differences in hemodynamic parameters between realistic and virtual FD deployment.	[Xu, Jinyu; Fang, Yibin; Yu, Ying; Cheng, Jiyong; Wang, Kuizhong; Liu, Jian-Min; Huang, Qinghai] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Deng, Benqiang] Second Mil Med Univ, Changhai Hosp, Dept Neurol, Shanghai, Peoples R China; [Wang, Shengzhang] Fudan Univ, Dept Mech & Engn Sci, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Fudan University	Liu, JM (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	chstroke@163.com; ocinhqh@163.com			National Natural Science Foundation of China [30901556, 81171092]; Rising-Star Program of Shanghai Science and Technology Committee [11QA1408400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Rising-Star Program of Shanghai Science and Technology Committee	This research was supported by National Natural Science Foundation of China (Grant No. 30901556 and Grant No. 81171092) and Rising-Star Program of Shanghai Science and Technology Committee (Grant no. 11QA1408400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appanaboyina S, 2008, INT J NUMER METH FL, V57, P475, DOI 10.1002/fld.1590; Augsburger L, 2011, ANN BIOMED ENG, V39, P850, DOI 10.1007/s10439-010-0200-6; Byrne JV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012492; Cebral JR, 2005, IEEE T MED IMAGING, V24, P468, DOI 10.1109/TMI.2005.844172; Chalouhi N, 2012, NEUROSURGERY, V71, P785, DOI 10.1227/NEU.0b013e318265a416; Cheung SCP, 2010, AUSTRALAS PHYS ENG S, V33, P319, DOI 10.1007/s13246-010-0050-4; Dorn F, 2011, NEURORADIOLOGY, V53, P267, DOI 10.1007/s00234-010-0723-4; Finol Ender A., 2003, Acta Cientifica Venezolana, V54, P43; Fu WY, 2010, J BIOMECH, V43, P1337, DOI 10.1016/j.jbiomech.2010.01.009; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; Hong B, 2012, NEURORADIOLOGY, V54, P849, DOI 10.1007/s00234-011-0984-6; Ionita CN, 2009, STROKE, V40, P959, DOI 10.1161/STROKEAHA.108.524124; Kim JH, 2008, J BIOMECH, V41, P3202, DOI 10.1016/j.jbiomech.2008.08.005; Kim YH, 2010, ANN BIOMED ENG, V38, P2274, DOI 10.1007/s10439-010-9994-5; Kulcsar Z, 2012, ACTA NEUROCHIR, V154, P1827, DOI 10.1007/s00701-012-1482-2; Larrabide I, 2012, MED IMAGE ANAL, V16, P721, DOI 10.1016/j.media.2010.04.009; Lee SW, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127252; Liou TM, 2004, EXP MECH, V44, P253, DOI 10.1177/0014485104039770; Liou TM, 2008, J BIOMECH, V41, P1174, DOI 10.1016/j.jbiomech.2008.01.025; Lylyk P, 2009, NEUROSURGERY, V64, P632, DOI 10.1227/01.NEU.0000339109.98070.65; Ma D, 2012, J BIOMECH, V45, P2256, DOI 10.1016/j.jbiomech.2012.06.013; Nelson PK, 2011, AM J NEURORADIOL, V32, P34, DOI 10.3174/ajnr.A2421; Ohta M, 2008, J INTEL MAT SYST STR, V19, P313, DOI 10.1177/1045389X07083184; ROGERS C, 1995, CIRCULATION, V91, P2995, DOI 10.1161/01.CIR.91.12.2995; Schneiders J J, 2013, AJNR Am J Neuroradiol, V34, pE1, DOI 10.3174/ajnr.A2613; Seong J, 2007, J BIOMECH ENG-T ASME, V129, P863, DOI 10.1115/1.2800787; Sheard GJ, 2009, J ENG MATH, V64, P379, DOI 10.1007/s10665-008-9261-z; TOMINAGA R, 1992, AM HEART J, V123, P21, DOI 10.1016/0002-8703(92)90742-E; Wang K, 2009, AM J NEURORADIOL, V30, P1685, DOI 10.3174/ajnr.A1542; Wang KZ, 2012, NEURORADIOLOGY, V54, P607, DOI 10.1007/s00234-011-0922-7; Wang SZ, 2011, COMPUT METHOD BIOMEC, V14, P927, DOI 10.1080/10255842.2010.502531; Wong KKL, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500012; Wong KKL, 2010, J MECH MED BIOL, V10, P191, DOI 10.1142/S0219519410003319; Wong KKL, 2010, MED ENG PHYS, V32, P174, DOI 10.1016/j.medengphy.2009.11.007; Wong KK, 2007, International (PCT) Patent, Patent No. [PCT/AU/2007/000827, 2007000827]; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu J, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0055413; Zhang Y, 2013, MED ENG PHYS, V35, P608, DOI 10.1016/j.medengphy.2012.07.005; Zhao KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057253	40	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66072	10.1371/journal.pone.0066072	http://dx.doi.org/10.1371/journal.pone.0066072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823503	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400052
J	Chen, J; Tang, HM; Wu, ZH; Zhou, CZ; Jiang, T; Xue, YM; Huang, GY; Yan, DW; Peng, ZH				Chen, Jian; Tang, Huamei; Wu, Zehua; Zhou, Chongzhi; Jiang, Tao; Xue, Yingming; Huang, Guoyu; Yan, Dongwang; Peng, Zhihai			Overexpression of RBBP6, Alone or Combined with Mutant TP53, Is Predictive of Poor Prognosis in Colon Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; P53; MUTATIONS; UBIQUITIN; PROTEIN; GAIN; PROLIFERATION; METASTASIS; RECURRENCE; INTERACTS	Retinoblastoma binding protein 6 (RBBP6) plays an important role in chaperone-mediated ubiquitination and interacts with TP53 in carcinogenesis. However, the clinicopathologic significance of RBBP6 expression in colon cancer is unknown; in particular, the prognostic value of RBBP6 combined with TP53 expression has not been explored. Therefore, quantitative real-time PCR and western blot analyses were performed to detect RBBP6 expression in colon cancer tissues. RBBP6 and TP53 expression were assessed by immunohistochemistry in a tissue microarray format, in which the primary colon cancer tissue was paired with noncancerous tissue. Tissue specimens were obtained from 203 patients. We found that RBBP6 was overexpressed in colon tumorous tissues and was significantly associated with clinical stage, depth of tumor invasion, lymph node metastasis (LNM), distant metastasis, and histologic grade. Further studies revealed that a corresponding correlation between RBBP6 overexpression and mutant TP53 was evident in colon cancer (r = 0.450; P<0.001). RBBP6 expression was an independent prognostic factor for overall survival (OS) and disease free survival (DFS). Interestingly, patients with tumors that had both RBBP6 overexpression and mutant TP53 protein accumulation relapsed and died within a significantly short period after surgery (P<0.001). Multivariate analysis showed that patients with LNM and patients with both RBBP6- and TP53-positive tumors had extremely poor OS (HR 6.75; 95% CI 2.63-17.35; P<0.001) and DFS (HR 8.08; 95% CI 2.80-23.30; P<0.001). These clinical findings indicate that the assessment of both RBBP6 and mutant TP53 expression will be helpful in predicting colon cancer prognosis.	[Chen, Jian; Wu, Zehua; Zhou, Chongzhi; Jiang, Tao; Xue, Yingming; Huang, Guoyu; Yan, Dongwang; Peng, Zhihai] Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China; [Tang, Huamei] Shanghai Jiao Tong Univ, Dept Pathol, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, DW (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China.	yandw70@163.com	Wong, Gregory/AAA-1063-2020		National Natural Science Foundation of China [81072008, 81172328]; Medical Guidance Project of Shanghai Science and Technology Commission [114119a4600, 124119a1700]; Natural Science Foundation of Shanghai Municipality [11ZR1429200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Guidance Project of Shanghai Science and Technology Commission; Natural Science Foundation of Shanghai Municipality(Natural Science Foundation of Shanghai)	This project was supported by the funds: National Natural Science Foundation of China (81072008, 81172328), Medical Guidance Project of Shanghai Science and Technology Commission (114119a4600, 124119a1700), Natural Science Foundation of Shanghai Municipality (11ZR1429200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cao Z, 2009, NEOPLASMA, V56, P114, DOI 10.4149/neo_2009_02_114; Chibi M, 2008, J MOL BIOL, V384, P908, DOI 10.1016/j.jmb.2008.09.060; Compagnin C, 2010, CELL PROLIFERAT, V43, P262, DOI 10.1111/j.1365-2184.2010.00673.x; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; GALANDIUK S, 1992, SURG GYNECOL OBSTET, V174, P27; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Hashimoto Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-488; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Ji F, 2009, WORLD J GASTROENTERO, V15, P2228, DOI 10.3748/wjg.15.2228; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; LEVY A, 1994, CLIN ENDOCRINOL, V41, P809, DOI 10.1111/j.1365-2265.1994.tb02797.x; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Mbita Z, 2012, MOL CELL BIOCHEM, V362, P249, DOI 10.1007/s11010-011-1150-5; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Miladi-Abdennadher I, 2011, APPL IMMUNOHISTO M M, V19, P1562, DOI 10.1097/PAI.0b013e3182143380; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Phimsen S, 2012, APOPTOSIS, V17, P679, DOI 10.1007/s10495-012-0711-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pugh DJR, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-1; Selivanova G, 2009, CELL, V139, P1220, DOI 10.1016/j.cell.2009.12.016; Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Solomon H, 2011, J PATHOL, V225, P475, DOI 10.1002/path.2988; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Won KY, 2012, HUM PATHOL, V43, P221, DOI 10.1016/j.humpath.2011.04.021; Yan DW, 2010, BRIT J CANCER, V103, P961, DOI 10.1038/sj.bjc.6605870; Yan DW, 2012, BBA-MOL BASIS DIS, V1822, P918, DOI 10.1016/j.bbadis.2012.02.021; Yoshitake Y, 2004, CLIN CANCER RES, V10, P6437, DOI 10.1158/1078-0432.CCR-04-0841	33	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66524	10.1371/journal.pone.0066524	http://dx.doi.org/10.1371/journal.pone.0066524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799110	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800034
J	Hoepfner, AR; Goller, F				Hoepfner, Amanda R.; Goller, Franz			Atypical Song Reveals Spontaneously Developing Coordination between Multi-Modal Signals in Brown-Headed Cowbirds (Molothrus ater)	PLOS ONE			English	Article							RESPONSES	The courtship and dominance behavior of brown-headed cowbirds (Molothrus ater) consists of a multi-modal display, including song as well as postural and wing movements. The temporal sequences of the acoustic and the visual display are coordinated. In adult male cowbirds the largest wing movements of the display are synchronized with silent periods of song, but it is unknown how this coordination emerges during song development. Here we investigate how visual display features are coordinated with song by using atypical song sequence structure of isolation-reared male cowbirds. In birds with atypical song, all components of the visual display were highly similar to those of "normal" song displays, but their timing was slightly different. The number of maximal wing movement cycles of isolation-reared males was linked to the number of sound units in the song, and was therefore reduced during the abbreviated song types of isolates. These data indicate that young cowbirds do not need to be exposed to a model of the visual display during ontogeny and that there is synchronization with the temporal structure of song. A physiological link between respiratory and syringeal control of silent periods between sound units and wing movement cycles may be driving this synchronization.	[Hoepfner, Amanda R.; Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Hoepfner, AR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	amanda.hoepfner@utah.edu			National Institutes of Health (NIH) [DC 04390]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004390, R01DC006876] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institutes of Health (NIH) DC 04390. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SE, 1994, J NEUROBIOL, V25, P1154, DOI 10.1002/neu.480250910; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; DUFTY AM, 1985, Z TIERPSYCHOL, V69, P177; KING AP, 1977, SCIENCE, V195, P1002, DOI 10.1126/science.841321; KING AP, 1980, J COMP PHYSIOL PSYCH, V94, P1028, DOI 10.1037/h0077737; NERO ROBERT W., 1963, WILSON BULL, V75, P376; O'Loghlen AL, 2010, CONDOR, V112, P615, DOI 10.1525/cond.2010.090216; O'Loghlen AL, 2010, ANIM BEHAV, V79, P1285, DOI 10.1016/j.anbehav.2010.03.001; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; ROTHSTEIN SI, 1988, ANIM BEHAV, V36, P73, DOI 10.1016/S0003-3472(88)80251-3; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; SUTHERS RA, 2008, NEUROSCIENCE BIRDSON, P78; West MJ, 1998, ETHOLOGY, V104, P250; WEST MJ, 1980, J COMP PHYSIOL PSYCH, V94, P263, DOI 10.1037/h0077657; Wild JM, 1998, J NEUROBIOL, V36, P441, DOI 10.1002/(SICI)1097-4695(19980905)36:3<441::AID-NEU11>3.0.CO;2-E	15	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65525	10.1371/journal.pone.0065525	http://dx.doi.org/10.1371/journal.pone.0065525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799020	Green Submitted, gold, Green Published			2022-12-27	WOS:000321397800010
J	Lim, S; Becker, A; Zimmer, A; Lu, JR; Buettner, R; Kirfel, J				Lim, Soyoung; Becker, Astrid; Zimmer, Andreas; Lu, Jianrong; Buettner, Reinhard; Kirfel, Jutta			SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN BREAST-CANCER; TGF-BETA; SELF-RENEWAL; IN-VITRO; ACTIVATION; SNAIL; INFLAMMATION; METASTASIS; MECHANISMS	Tumor cells at the tumor margin lose epithelial properties and acquire features of mesenchymal cells, a process called epithelial-to-mesenchymal transition (EMT). Recently, features of EMT were shown to be linked to cells with tumor-founding capability, so-called cancer stem cells (CSCs). Inducers of the EMT include several transcription factors, such as Snail (SNAI1) and Slug (SNAI2), as well as the secreted transforming growth factor (TGF beta). In the present study, we found that EMT induction in MCF10A cells by stably expressing SNAI1 contributed to drug resistance and acquisition of stem/progenitor-like character as shown by increased cell population for surface marker CD44(+)/CD24(-) and mammosphere forming capacity. Using a microarray approach, we demonstrate that SNAI1 overexpression results in a dramatic change in signaling pathways involved in the regulation of cell death and stem cell maintenance. We showed that NF-kappa B/MAPK signaling pathways are highly activated in MCF10A-SNAI1 cells by IL1 beta stimulation, leading to the robust induction in IL6 and IL8. Furthermore, MCF10A-SNAI1 cells showed enhanced TCF/beta-catenin activity responding to the exogenous Wnt3a treatment. However, EMT-induced stem/progenitor cell activation process is tightly regulated in non-transformed MCF10A cells, as WNT5A and TGFB2 are strongly upregulated in MCF10A-SNAI1 cells antagonizing canonical Wnt pathway. In summary, our data provide new molecular findings how EMT contributes to the enhanced chemoresistance and the acquisition of stem/progenitor-like character by regulating signaling pathways.	[Lim, Soyoung; Buettner, Reinhard] Univ Cologne, Inst Pathol, D-50931 Cologne, Germany; [Becker, Astrid; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Lu, Jianrong] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Kirfel, Jutta] Univ Bonn, Inst Pathol, Bonn, Germany	University of Cologne; University of Bonn; State University System of Florida; University of Florida; University of Bonn	Kirfel, J (corresponding author), Univ Bonn, Inst Pathol, Bonn, Germany.	Jutta.Kirfel@ukb.uni-bonn.de	Zimmer, Andreas/B-8357-2009; Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040	Deutsche Forschungsgemeinschaft [FOR 926, GRK 804]; German Cancer Aid (KoSAR Research Grant) [109742]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Aid (KoSAR Research Grant)	A.B. was funded by a grant from the Deutsche Forschungsgemeinschaft (FOR 926). R.B. and J.K. were funded by grants from the Deutsche Forschungsgemeinschaft (GRK 804) and the German Cancer Aid (KoSAR Research Grant 109742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bierie B, 2009, CELL CYCLE, V8, P3319, DOI 10.4161/cc.8.20.9727; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Kooreman NG, 2010, J R SOC INTERFACE, V7, pS753, DOI 10.1098/rsif.2010.0353.focus; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maugeri-Sacca M, 2011, CLIN CANCER RES, V17, P4942, DOI 10.1158/1078-0432.CCR-10-2538; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Park SA, 2009, CANCER RES, V69, P2416, DOI 10.1158/0008-5472.CAN-08-2177; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shostak K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2886; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	41	62	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66558	10.1371/journal.pone.0066558	http://dx.doi.org/10.1371/journal.pone.0066558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799116	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800037
J	Liu, W; Chen, Z; Ma, YS; Wu, XC; Jin, YP; Hou, S				Liu, Wei; Chen, Zhi; Ma, Yansen; Wu, Xiaochun; Jin, Yaping; Hou, Steven			Genetic Characterization of the Drosophila Birt-Hogg-Dube Syndrome Gene	PLOS ONE			English	Article							MTOR ACTIVATION; AMINO-ACIDS; GROWTH; TUMORIGENESIS; REQUIREMENTS; MELANOGASTER; MECHANISMS; FOLLICULIN; INTERACTS; RAPAMYCIN	Folliculin (FLCN) is a conserved tumor suppressor gene whose loss is associated with the human Birt-Hogg-Dube (BHD) syndrome. However, its molecular functions remain largely unknown. In this work, we generated a Drosophila BHD model through genomic deletion of the FLCN gene (DBHD-). The DBHD mutant larvae grew slowly and stopped development before pupation, displaying various characteristics of malnutrition. We found the growth delay was sensitive to the nutrient supplies. It became more severe upon restrictions of the dietary yeast; while high levels of yeast significantly restored the normal growth, but not viability. We further demonstrated that leucine was able to substitute for yeast to provide similar rescues. Moreover, the human FLCN could partially rescue the DBHD- phenotypes, indicating the two genes are involved in certain common mechanisms. Our work provides a new animal model of the BHD syndrome and suggests that modulation of the local nutrient condition might be a potential treatment of the BHD lesions.	[Liu, Wei; Chen, Zhi; Ma, Yansen; Wu, Xiaochun; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Liu, Wei; Hou, Steven] NCI, Mouse Canc Genet Program, NIH, Frederick, MD 21701 USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jin, YP (corresponding author), Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	yapingjin@163.com; hous@mail.nih.gov			NSAF Foundation; Doctoral Programs Foundation of Ministry of Education of China; Intramural Research Program of the National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC010738] Funding Source: NIH RePORTER	NSAF Foundation; Doctoral Programs Foundation of Ministry of Education of China(Ministry of Education, China); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NSAF Foundation (W.L.), Doctoral Programs Foundation of Ministry of Education of China (Y.J.) and the Intramural Research Program of the National Institutes of Health, National Cancer Institute (S.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Britton JS, 1998, DEVELOPMENT, V125, P2149; BURNET B, 1968, GENETICS, V59, P211; Cash TP, 2011, ONCOGENE, V30, P2534, DOI 10.1038/onc.2010.628; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hong SB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-160; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Le Rohellec M, 2009, EXP GERONTOL, V44, P695, DOI 10.1016/j.exger.2009.08.001; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SANG JH, 1961, J EXP BIOL, V38, P793; Singh SR, 2006, ONCOGENE, V25, P5933, DOI 10.1038/sj.onc.1209593; Tatum EL, 1941, P NATL ACAD SCI USA, V27, P193, DOI 10.1073/pnas.27.4.193; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zinke I, 1999, DEVELOPMENT, V126, P5275	27	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65869	10.1371/journal.pone.0065869	http://dx.doi.org/10.1371/journal.pone.0065869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799055	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800018
J	Campolo, J; De Maria, R; Mariotti, C; Tomasello, C; Parolini, M; Frontali, M; Inzitari, D; Valenti, R; Federico, A; Taroni, F; Parodi, O				Campolo, Jonica; De Maria, Renata; Mariotti, Caterina; Tomasello, Chiara; Parolini, Marina; Frontali, Marina; Inzitari, Domenico; Valenti, Raffaella; Federico, Antonio; Taroni, Franco; Parodi, Oberdan			Is the Oxidant/Antioxidant Status Altered in CADASIL Patients?	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; OXIDATIVE STRESS; NITRIC-OXIDE; SUBCORTICAL INFARCTS; LIPID-PEROXIDATION; ALZHEIMERS-DISEASE; GLUTATHIONE SYSTEM; BLOOD GLUTATHIONE; PLASMA; VASOREACTIVITY	The altered aggregation of proteins in non-native conformation is associated with endoplasmic reticulum derangements, mitochondrial dysfunction and excessive production of reactive oxygen species. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare hereditary systemic vasculopathy, caused by NOTCH3 mutations within the receptor extracellular domain, that lead to abnormal accumulation of the mutated protein in the vascular wall. NOTCH3 misfolding could cause free radicals increase also in CADASIL. Aim of the study was to verify whether CADASIL patients have increased oxidative stress compared to unrelated healthy controls. We enrolled 15 CADASIL patients and 16 gender- and age-matched healthy controls with comparable cardiovascular risk factor. Blood and plasma reduced and total aminothiols (homocysteine, cysteine, glutathione, cysteinylglycine) were measured by HPLC and plasma 3-nitrotyrosine by ELISA. Only plasma reduced cysteine (Pr-Cys) and blood reduced glutathione (Br-GSH) concentrations differed between groups: in CADASIL patients Br-GSH levels were higher (p = 0.019) and Pr-Cys lower (p = 0.010) than in controls. No correlation was found between Br-GSH and Pr-Cys either in CADASIL patients (rho 0.25, P=0.36) or in controls (rho -0.15, P=0.44). Conversely, 3-nitrotyrosine values were similar in CADASIL and healthy subjects (p = 0.82). The high levels of antioxidant molecules and low levels of oxidant mediators found in our CADASIL population might either be expression of an effective protective action against free radical formation at an early stage of clinical symptoms or they could suggest that oxidative stress is not directly involved in the pathogenesis of CADASIL.	[Campolo, Jonica; De Maria, Renata; Parolini, Marina; Parodi, Oberdan] Osped Niguarda Ca Granda, Cardiothorac & Vasc Dept, Community Networking Resources Inst Clin Physiol, Milan, Italy; [Mariotti, Caterina; Tomasello, Chiara; Taroni, Franco] Fdn IRCCS Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Frontali, Marina] Community Networking Resources Inst Translat Phar, Rome, Italy; [Inzitari, Domenico; Valenti, Raffaella] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; [Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Istituto Neurologico Besta; University of Florence; University of Siena	Campolo, J (corresponding author), Osped Niguarda Ca Granda, Cardiothorac & Vasc Dept, Community Networking Resources Inst Clin Physiol, Milan, Italy.	jonica.campolo@ospedaleniguarda.it	De Maria, Renata/I-9065-2012; Mariotti, Caterina/AAP-9425-2021; Campolo, Jonica/ABC-5841-2020; Inzitari, Domenico/AAH-8722-2020; Valenti, Raffaella/AAB-7974-2019; Taroni, Franco/N-3879-2013	De Maria, Renata/0000-0002-8474-7923; Mariotti, Caterina/0000-0003-2405-3564; Valenti, Raffaella/0000-0002-4975-3754; Taroni, Franco/0000-0002-2420-5233; federico, antonio/0000-0002-5246-1621	Italian Medicine Agency (AIFA) [FARM659PTX]	Italian Medicine Agency (AIFA)	This study was supported by grant FARM659PTX from the Italian Medicine Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinni R, 1998, J CHROMATOGR A, V828, P397, DOI 10.1016/S0021-9673(98)00661-X; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Campolo J, 2007, INT J CARDIOL, V117, P45, DOI 10.1016/j.ijcard.2006.04.065; Campolo J, 2012, J NEUROL NEUROSUR PS, V83, P268, DOI 10.1136/jnnp-2011-300080; Cesar Tobon-Velasco Julio, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P278; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen Yung-Hsiang, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P279; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; El-Khairy L, 2001, CIRCULATION, V103, P2544; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Formichi P, 2009, J CELL PHYSIOL, V219, P494, DOI 10.1002/jcp.21695; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Fujiwara Y, 2012, CEREBROVASC DIS, V33, P128, DOI 10.1159/000334185; Gavin JR, 1999, DIABETES CARE, V22, pS5; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guglielmotto M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.003.2010; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Hogg N, 1999, FREE RADICAL BIO MED, V27, P28, DOI 10.1016/S0891-5849(99)00029-5; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kleinman WA, 2000, BIOCHEM PHARMACOL, V60, P19, DOI 10.1016/S0006-2952(00)00293-8; Kolesnichenko LS, 2008, ZH NEVROL PSIKHIATR, V108, P36; Kolesnichenko L. S., 2007, Biomeditsinskaya Khimiya, V53, P454; LI J, 1993, J PHARMACOL EXP THER, V267, P371; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Nakamura T, 2011, CELL DEATH DIFFER, V18, P1478, DOI 10.1038/cdd.2011.65; Ozkul A, 2007, J CLIN NEUROSCI, V14, P1062, DOI 10.1016/j.jocn.2006.11.008; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Ragno M, 2011, NEUROGENETICS, V12, P337, DOI 10.1007/s10048-011-0298-1; Rufa A, 2005, STROKE, V36, P2554, DOI 10.1161/01.STR.0000190832.17620.25; Stenborg A, 2007, STROKE, V38, P2692, DOI 10.1161/STROKEAHA.107.490029; Tinkel J, 2012, CARDIOL REV, V20, P77, DOI 10.1097/CRD.0b013e31823dbbad; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Zimmerman MC, 2004, PROG BIOPHYS MOL BIO, V84, P125, DOI 10.1016/j.pbiomolbio.2003.11.009	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67077	10.1371/journal.pone.0067077	http://dx.doi.org/10.1371/journal.pone.0067077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799141	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300103
J	D'Amico, LA; Boujard, D; Coumailleau, P				D'Amico, Laure Anne; Boujard, Daniel; Coumailleau, Pascal			The Neurogenic Factor NeuroD1 Is Expressed in Post-Mitotic Cells during Juvenile and Adult Xenopus Neurogenesis and Not in Progenitor or Radial Glial Cells	PLOS ONE			English	Article							ZEBRAFISH BRAIN; NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; DIFFERENTIAL EXPRESSION; PROJECTION PATTERN; DENTATE GYRUS; LAEVIS; PROLIFERATION; PROTEINS; BETA2/NEUROD1	In contrast to mammals that have limited proliferation and neurogenesis capacities, the Xenopus frog exhibit a great potential regarding proliferation and production of new cells in the adult brain. This ability makes Xenopus a useful model for understanding the molecular programs required for adult neurogenesis. Transcriptional factors that control adult neurogenesis in vertebrate species undergoing widespread neurogenesis are unknown. NeuroD1 is a member of the family of proneural genes, which function during embryonic neurogenesis as a potent neuronal differentiation factor. Here, we study in detail the expression of NeuroD1 gene in the juvenile and adult Xenopus brains by in situ hybridization combined with immunodetections for proliferation markers (PCNA, BrdU) or in situ hybridizations for cell type markers (Vimentin, Sox2). We found NeuroD1 gene activity in many brain regions, including olfactory bulbs, pallial regions of cerebral hemispheres, preoptic area, habenula, hypothalamus, cerebellum and medulla oblongata. We also demonstrated by double staining NeuroD1/BrdU experiments, after long post-BrdU administration survival times, that NeuroD1 gene activity was turned on in new born neurons during post-metamorphic neurogenesis. Importantly, we provided evidence that NeuroD1-expressing cells at this brain developmental stage were post-mitotic (PCNA-) cells and not radial glial (Vimentin+) or progenitors (Sox2+) cells.	[D'Amico, Laure Anne; Boujard, Daniel; Coumailleau, Pascal] CNRS, Ctr Ressources Biol Xenope UMS U3387, Rennes, France; [D'Amico, Laure Anne; Boujard, Daniel; Coumailleau, Pascal] Univ Rennes 1, Rennes, France; [Coumailleau, Pascal] INSERM, IRSET U1085, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Coumailleau, P (corresponding author), CNRS, Ctr Ressources Biol Xenope UMS U3387, Rennes, France.	Pascal.coumailleau@univ-rennes1.fr	coumailleau, pascal/K-1697-2015		Bretagne region; Ministry of Nationale Education	Bretagne region(Region Bretagne); Ministry of Nationale Education	This research was supported by funds from the Bretagne region, the Ministry of Nationale Education and by an undergraduate fellowship from Bretagne region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; Chae JH, 2004, MOL CELLS, V18, P271; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Coumailleau P, 2009, INT J DEV BIOL, V53, P149, DOI 10.1387/ijdb.082659pc; D'Amico LA, 2011, BRAIN RES, V1405, P31, DOI 10.1016/j.brainres.2011.06.032; Ganz J, 2012, J COMP NEUROL, V520, P633, DOI 10.1002/cne.22757; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lee JK, 2000, DEV DYNAM, V217, P361, DOI 10.1002/(SICI)1097-0177(200004)217:4<361::AID-DVDY3>3.0.CO;2-8; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; LOPEZGARCIA C, 1988, DEV BRAIN RES, V43, P167, DOI 10.1016/0165-3806(88)90096-X; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marin O, 1998, J COMP NEUROL, V392, P285; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Mueller T, 2002, BRAIN RES BULL, V57, P377, DOI 10.1016/S0361-9230(01)00694-3; Nieber F, 2009, DEV DYNAM, V238, P451, DOI 10.1002/dvdy.21845; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Rogers CD, 2008, DEV BIOL, V313, P307, DOI 10.1016/j.ydbio.2007.10.023; Roth G, 2007, J COMP NEUROL, V501, P443, DOI 10.1002/cne.21255; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Schlosser G, 2000, J COMP NEUROL, V418, P121; Schlosser G, 2003, CELL TISSUE RES, V312, P21, DOI 10.1007/s00441-003-0710-8; Schlosser G, 2002, DEV DYNAM, V225, P485, DOI 10.1002/dvdy.10179; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Tuinhof R, 1998, CELL TISSUE RES, V292, P251, DOI 10.1007/s004410051056; Uittenbogaard M, 2000, NEUROSCI LETT, V280, P95, DOI 10.1016/S0304-3940(00)00761-8; Westhoff G, 2002, J COMP NEUROL, V445, P97, DOI 10.1002/cne.10136; Wullimann MF, 2005, J COMP NEUROL, V489, P387, DOI 10.1002/cne.20634; Yokoyama M, 1996, MOL BRAIN RES, V42, P135, DOI 10.1016/S0169-328X(96)00154-4; Yoshida M, 2001, J NEUROSCI RES, V63, P284, DOI 10.1002/1097-4547(20010201)63:3<284::AID-JNR1022>3.0.CO;2-6; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	56	32	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66487	10.1371/journal.pone.0066487	http://dx.doi.org/10.1371/journal.pone.0066487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799108	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300086
J	Ryu, YH; Kim, YH; Lee, JY; Shim, GB; Uhm, HS; Park, G; Choi, EH				Ryu, Young-Hyo; Kim, Yong-Hee; Lee, Jin-Young; Shim, Gun-Bo; Uhm, Han-Sup; Park, Gyungsoon; Choi, Eun Ha			Effects of Background Fluid on the Efficiency of Inactivating Yeast with Non-Thermal Atmospheric Pressure Plasma	PLOS ONE			English	Article							ESCHERICHIA-COLI; STERILIZATION; DISCHARGE; STRESS; WATER; DEGRADATION; BACTERIA	Non-thermal plasma at atmospheric pressure has been actively applied to sterilization. However, its efficiency for inactivating microorganisms often varies depending on microbial species and environments surrounding the microorganisms. We investigated the influence of environmental factors (surrounding media) on the efficiency of microbial inactivation by plasma using an eukaryotic model microbe, Saccharomyces cerevisiae, to elucidate the mechanisms for differential efficiency of sterilization by plasma. Yeast cells treated with plasma in water showed the most severe damage in viability and cell morphology as well as damage to membrane lipids, and genomic DNA. Cells in saline were less damaged compared to those in water, and those in YPD (Yeast extract, Peptone, Dextrose) were least impaired. HOG1 mitogen activated protein kinase was activated in cells exposed to plasma in water and saline. Inactivation of yeast cells in water and saline was due to the acidification of the solutions by plasma, but higher survival of yeast cells treated in saline may have resulted from the additional effect related to salt strength. Levels of hydroxyl radical (OH.) produced by plasma were the highest in water and the lowest in YPD. This may have resulted in differential inactivation of yeast cells in water, saline, and YPD by plasma. Taken together, our data suggest that the surrounding media (environment) can crucially affect the outcomes of yeast cell plasma treatment because-plasma modulates vital properties of media, and the toxic nature of plasma can also be altered by the surrounding media.	[Ryu, Young-Hyo; Kim, Yong-Hee; Lee, Jin-Young; Shim, Gun-Bo; Uhm, Han-Sup; Park, Gyungsoon; Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea	Kwangwoon University	Park, G (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea.	gyungp@kw.ac.kr; ehchoi@kw.ac.kr	Choi, Eun Ha/AFN-9488-2022	Choi, Eun Ha/0000-0001-5385-1878; Park, Gyungsoon/0000-0003-1592-3847	National Foundation of Korea (NRF); Korean Government (MEST) [2010-20100029418, 20110014825]	National Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Foundation of Korea (NRF) Grant funded by the Korean Government (MEST), No. 2010-20100029418 and No. 20110014825 (G. Park). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2009, CLIN MICROBIOL INFEC, V15, P17, DOI 10.1111/j.1469-0691.2008.02690.x; Avramidis G, 2010, SURF COAT TECH, V205, pS405, DOI 10.1016/j.surfcoat.2010.08.141; Bai MD, 2010, PLASMA CHEM PLASMA P, V30, P831, DOI 10.1007/s11090-010-9252-5; Baik KY, 2013, PLASMA PROCESS POLYM, V10, P235, DOI 10.1002/ppap.201200076; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; David A, 2010, PHYSIOL PLANTARUM, V140, P342, DOI 10.1111/j.1399-3054.2010.01408.x; De Geyter N, 2012, ANNU REV BIOMED ENG, V14, P255, DOI 10.1146/annurev-bioeng-071811-150110; Dobrynin D, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103033; Gweon B, 2009, CURR APPL PHYS, V9, P625, DOI 10.1016/j.cap.2008.06.001; JAHN B, 1995, J CLIN MICROBIOL, V33, P661, DOI 10.1128/JCM.33.3.661-667.1995; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Kamgang-Youbi G, 2009, LETT APPL MICROBIOL, V48, P13, DOI 10.1111/j.1472-765X.2008.02476.x; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; Kang SK, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3574639; Kim KW, 2007, MICRON, V38, P626, DOI 10.1016/j.micron.2006.09.006; Korachi M, 2011, PLASMA SCI TECHNOL, V13, P99, DOI 10.1088/1009-0630/13/1/20; Korachi M, 2010, J ELECTROSTAT, V68, P508, DOI 10.1016/j.elstat.2010.06.014; Lee K, 2006, J MICROBIOL, V44, P269; Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI DOI 10.1023/A:1013196629791; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Muranyi P, 2007, J APPL MICROBIOL, V103, P1535, DOI 10.1111/j.1365-2672.2007.03385.x; Pang H, 2011, IEEE T PLASMA SCI, V39, P1689, DOI 10.1109/TPS.2011.2155104; Park G, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3684632; Park JC, 2004, J MICROBIOL BIOTECHN, V14, P188; Pavlovich MJ, 2013, PLASMA PROCESS POLYM, V10, P69, DOI 10.1002/ppap.201200073; Sambrook J., 2001, MOL CLONING LAB MANU; Shintani H, 2010, EXP THER MED, V1, P731, DOI 10.3892/etm.2010.136; Song HP, 2009, FOOD MICROBIOL, V26, P432, DOI 10.1016/j.fm.2009.02.010; Tang YZ, 2008, PLASMA PROCESS POLYM, V5, P552, DOI 10.1002/ppap.200800014; Tukmechi A, 2013, AQUA RES, P1; Wolf RA, 2013, ATMOSPHERIC PRESSURE, P181; Xiong Z, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3526678; Yang Y, 2013, ENVIRON SCI-PROC IMP, V15, P39, DOI 10.1039/c2em30655g	34	61	63	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66231	10.1371/journal.pone.0066231	http://dx.doi.org/10.1371/journal.pone.0066231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799081	Green Submitted, gold, Green Published			2022-12-27	WOS:000320363300066
J	Diaz, MH; Waller, JL; Napoliello, RA; Islam, MS; Wolff, BJ; Burken, DJ; Holden, RL; Srinivasan, V; Arvay, M; McGee, L; Oberste, MS; Whitney, CG; Schrag, SJ; Winchell, JM; Saha, SK				Diaz, Maureen H.; Waller, Jessica L.; Napoliello, Rebecca A.; Islam, Md. Shahidul; Wolff, Bernard J.; Burken, Daniel J.; Holden, Rhiannon L.; Srinivasan, Velusamy; Arvay, Melissa; McGee, Lesley; Oberste, M. Steven; Whitney, Cynthia G.; Schrag, Stephanie J.; Winchell, Jonas M.; Saha, Samir K.			Optimization of Multiple Pathogen Detection Using the TaqMan Array Card: Application for a Population-Based Study of Neonatal Infection	PLOS ONE			English	Article							REAL-TIME PCR; COMMUNITY-ACQUIRED PNEUMONIA; POLYMERASE-CHAIN-REACTION; CHILD-MORTALITY; BLOOD; DIAGNOSIS; ETIOLOGY; ASSAYS; DNA	Identification of etiology remains a significant challenge in the diagnosis of infectious diseases, particularly in resource-poor settings. Viral, bacterial, and fungal pathogens, as well as parasites, play a role for many syndromes, and optimizing a single diagnostic system to detect a range of pathogens is challenging. The TaqMan Array Card (TAC) is a multiple-pathogen detection method that has previously been identified as a valuable technique for determining etiology of infections and holds promise for expanded use in clinical microbiology laboratories and surveillance studies. We selected TAC for use in the Aetiology of Neonatal Infection in South Asia (ANISA) study for identifying etiologies of severe disease in neonates in Bangladesh, India, and Pakistan. Here we report optimization of TAC to improve pathogen detection and overcome technical challenges associated with use of this technology in a large-scale surveillance study. Specifically, we increased the number of assay replicates, implemented a more robust RT-qPCR enzyme formulation, and adopted a more efficient method for extraction of total nucleic acid from blood specimens. We also report the development and analytical validation of ten new assays for use in the ANISA study. Based on these data, we revised the study-specific TACs for detection of 22 pathogens in NP/OP swabs and 12 pathogens in blood specimens as well as two control reactions (internal positive control and human nucleic acid control) for each specimen type. The cumulative improvements realized through these optimization studies will benefit ANISA and perhaps other studies utilizing multiple-pathogen detection approaches. These lessons may also contribute to the expansion of TAC technology to the clinical setting.	[Diaz, Maureen H.; Waller, Jessica L.; Napoliello, Rebecca A.; Wolff, Bernard J.; Burken, Daniel J.; Holden, Rhiannon L.; Srinivasan, Velusamy; McGee, Lesley; Whitney, Cynthia G.; Schrag, Stephanie J.; Winchell, Jonas M.] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA; [Islam, Md. Shahidul; Saha, Samir K.] Dhaka Shishu Hosp, Child Hlth Res Fdn, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh; [Arvay, Melissa] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Atlanta, GA USA; [Oberste, M. Steven] Ctr Dis Control & Prevent, Polio & Picornavirus Lab Branch, Div Viral Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Winchell, JM (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA 30333 USA.	jwinchell@cdc.gov	Islam, Shahidul/N-5897-2013; Diaz, Maureen/AAM-4587-2020	Islam, Md Shahidul/0000-0003-4712-4046	Bill and Melinda Gates Foundation [OPPGH5307]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/) grant number OPPGH5307 to Child Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat N, 2012, CLIN INFECT DIS, V54, pS153, DOI 10.1093/cid/cir1060; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Cieslak Paul R., 2012, Morbidity and Mortality Weekly Report, V61, P480; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Jain S, 2012, ETIOLOGY COMMUNITY A; Jordan JA, 2005, J MOL DIAGN, V7, P575, DOI 10.1016/S1525-1578(10)60590-9; Kodani M, 2012, J CLIN MICROBIOL, V50, P1057, DOI 10.1128/JCM.05987-11; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; Marrie TJ, 2012, SEMIN RESP CRIT CARE, V33, P244, DOI 10.1055/s-0032-1315636; Rachwal PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035971; Regan JF, 2012, J MOL DIAGN, V14, P120, DOI 10.1016/j.jmoldx.2011.10.001; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Weller SA, 2012, J MED MICROBIOL, V61, P1546, DOI 10.1099/jmm.0.049007-0; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127	21	46	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66183	10.1371/journal.pone.0066183	http://dx.doi.org/10.1371/journal.pone.0066183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805203	gold, Green Published			2022-12-27	WOS:000320846500031
J	Li, YY; Zhang, RN; Xiang, HY; Abouelnasr, H; Li, DW; Yu, JL; McBeath, JH; Han, CG				Li, Yuan-Yuan; Zhang, Ru-Nan; Xiang, Hai-Ying; Abouelnasr, Hesham; Li, Da-Wei; Yu, Jia-Lin; McBeath, Jenifer Huang; Han, Cheng-Gui			Discovery and Characterization of a Novel Carlavirus Infecting Potatoes in China	PLOS ONE			English	Article							NUCLEIC-ACID-BINDING; ROUGH-DWARF-VIRUS; PROTEIN; SUPPRESSORS; INDUCTION; STRAINS	A new carlavirus, tentatively named Potato virus H (PVH), was found on potato plants with mild symptoms in Hohhot, Inner Mongolia Autonomous Region, China. PVH was confirmed by genome sequencing, serological reactions, electron microscopy, and host index assays. The PVH particles were filamentous and slightly curved, with a modal length of 570 nm. Complete RNA genomic sequences of two isolates of PVH were determined using reverse transcription-PCR (RT-PCR) and the 5' rapid amplification of cDNA ends (5' RACE) method. Sequence analysis revealed that PVH had the typical genomic organization of members of the genus Carlavirus, with a positive-sense single-stranded genome of 8410 nt. It shared coat protein (CP) and replicase amino acid sequence identities of 17.9-56.7% with those of reported carlaviruses. Phylogenetic analyses based on the protein-coding sequences of replicase and CP showed that PVH formed a distinct branch, which was related only distantly to other carlaviruses. Western blotting assays showed that PVH was not related serologically to other potato carlaviruses (Potato virus S, Potato virus M, and Potato latent virus). PVH systemically infected Nicotiana glutinosa but not Nicotiana tabacum, Nicotiana benthamiana, or Chenopodium quinoa, which is in contrast with the other potato carlaviruses. These results support the classification of PVH as a novel species in the genus Carlavirus. Preliminary results also indicated that a cysteine-rich protein encoded by the smallest ORF located in the 3' proximal region of the genome suppressed local RNA silencing and enhanced the pathogenicity of the recombinant PVX.	[Li, Yuan-Yuan; Zhang, Ru-Nan; Xiang, Hai-Ying; Abouelnasr, Hesham; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Yuan-Yuan; Zhang, Ru-Nan; Xiang, Hai-Ying; Abouelnasr, Hesham; Li, Da-Wei; Yu, Jia-Lin; Han, Cheng-Gui] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [McBeath, Jenifer Huang] Univ Alaska Fairbanks, Plant Pathol & Biotechnol Lab, Agr & Forestry Expt Stn, Fairbanks, AK USA	China Agricultural University; China Agricultural University; University of Alaska System; University of Alaska Fairbanks	Han, CG (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hanchenggui@cau.edu.cn	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; LI, YUANYUAN/0000-0001-8615-4374; ABOUELNASR, hesham/0000-0003-2386-8809	National Natural Science Foundation of China [31071663]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by the National Natural Science Foundation of China (31071663) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT1042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [白艳菊 BAI Yanju], 2007, [东北农业大学学报, Journal of Northeast Agricultural University], V38, P733; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; BODE O, 1971, Potato Research, V14, P119, DOI 10.1007/BF02361820; Brattey C, 2002, PLANT PATHOL, V51, P495, DOI 10.1046/j.1365-3059.2002.00729.x; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; DEBRUYN MPO, 1951, P C POTATO VIRUS DIS, P83; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Flatken S, 2008, ARCH VIROL, V153, P1385, DOI 10.1007/s00705-008-0127-5; Goth RW, 1999, PLANT DIS, V83, P751, DOI 10.1094/PDIS.1999.83.8.751; GRAMSTAT A, 1990, FEBS LETT, V276, P34, DOI 10.1016/0014-5793(90)80500-I; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPER S, 1999, CURRENT PROTOCOLS PR; Hen CG, 2000, PLANT DIS, V84, P627, DOI 10.1094/PDIS.2000.84.6.627; Huang Ping, 2009, Guizhou Agricultural Sciences, P88; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; KOONIN EV, 1991, VIROLOGY, V181, P395, DOI 10.1016/0042-6822(91)90512-A; KOSTIW M, 1975, Potato Research, V18, P641, DOI 10.1007/BF02365690; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; [刘洪义 LIU Hongyi], 2006, [东北农业大学学报, Journal of Northeast Agricultural University], V37, P307; Loebenstein G., 2001, VIRUS VIRUS LIKE DIS; Lukhovilskaya NI, 2005, MOL BIOL+, V39, P896; Lukhovitskaya NI, 2009, J GEN VIROL, V90, P723, DOI 10.1099/vir.0.005025-0; LUKHOVITSKAYA NI, 2013, PLANT CELL; MACKINNON JP, 1974, CAN J BOT, V52, P461, DOI 10.1139/b74-060; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Massa GA, 2006, ARCH VIROL, V151, P1243, DOI 10.1007/s00705-006-0760-9; Matousek J, 2009, VIRUS RES, V146, P81, DOI 10.1016/j.virusres.2009.09.003; Nie XZ, 2008, J VIROL METHODS, V149, P209, DOI 10.1016/j.jviromet.2008.02.004; Nisbet C, 2006, PLANT PATHOL, V55, P803, DOI 10.1111/j.1365-3059.2006.01448.x; Nyalugwe EP, 2012, PLANT DIS, V96, P43, DOI 10.1094/PDIS-04-11-0305; Pfeffer S, 2002, J VIROL, V76, P6815, DOI 10.1128/JVI.76.13.6815-6824.2002; ROGER ACJ, 2009, VIRUS DIS PLANTS GRA; Salazar LF, 1996, POTATO VIRUSES THEIR; SCHULTZ E, 1923, AGR RES, V25, P393; Senshu H, 2011, J VIROL, V85, P10269, DOI 10.1128/JVI.05273-11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAVANTZIS SM, 1983, PHYTOPATHOLOGY, V73, P190, DOI 10.1094/Phyto-73-190; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Vreugdenhil D., 2007, POTATO BIOL BIOTECHN; Wang BA, 2011, CROP PROT, V30, P1117, DOI 10.1016/j.cropro.2011.04.001; Wang X.M, 2005, CHIN POTATO J, V19, P285; WETTER C, 1960, POTATO RES, V3, P158; Xiang HY, 2011, ARCH VIROL, V156, P2251, DOI 10.1007/s00705-011-1091-z; Zhang W., 2010, HEILONGJIANG AGR SCI, V4, P71; Zhong TingTing, 2008, Southwest China Journal of Agricultural Sciences, V21, P96; [周巧梅 ZHOU Qiaomei], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P39	51	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e69255	10.1371/journal.pone.0069255	http://dx.doi.org/10.1371/journal.pone.0069255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805334	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500163
J	Parra, GI; Azure, J; Fischer, R; Bok, K; Sandoval-Jaime, C; Sosnovtsev, SV; Sander, P; Green, KY				Parra, Gabriel I.; Azure, JoLynn; Fischer, Renate; Bok, Karin; Sandoval-Jaime, Carlos; Sosnovtsev, Stanislav V.; Sander, Peter; Green, Kim Y.			Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; BLOOD GROUP ANTIGENS; MONOCLONAL-ANTIBODIES; GENOGROUP-II; PROTEIN; GASTROENTERITIS; EXPRESSION; INFECTION; VACCINE; DETERMINANTS	Noroviruses are major pathogens associated with acute gastroenteritis. They are diverse viruses, with at least six genogroups (GI-GVI) and multiple genotypes defined by differences in the major capsid protein, VP1. This diversity has challenged the development of broadly cross-reactive vaccines as well as efficient detection methods. Here, we report the characterization of a broadly cross-reactive monoclonal antibody (MAb) raised against the capsid protein of a GII. 3 norovirus strain. The MAb reacted with VLPs and denatured VP1 protein from GI, GII, GIV and GV noroviruses, and mapped to a linear epitope located in the inner shell domain. An alignment of all available VP1 sequences showed that the putative epitope (residues 52-56) is highly conserved across the genus Norovirus. This broadly cross-reactive MAb thus constitutes a valuable reagent for the diagnosis and study of these diverse viruses.	[Parra, Gabriel I.; Azure, JoLynn; Bok, Karin; Sandoval-Jaime, Carlos; Sosnovtsev, Stanislav V.; Green, Kim Y.] NIAID, Caliciviruses Sect, Infect Dis Lab, DHHS,NIH, Bethesda, MD 20892 USA; [Fischer, Renate; Sander, Peter] R Biopharm AG, Clin Diagnost, Darmstadt, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Parra, GI (corresponding author), NIAID, Caliciviruses Sect, Infect Dis Lab, DHHS,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	parrag@niaid.nih.gov; kgreen@niaid.nih.gov	Parra, Gabriel I./H-4339-2019; Sandoval-Jaime, Carlos/AAR-7196-2020	Parra, Gabriel I./0000-0002-1102-4740; Sandoval-Jaime, Carlos/0000-0001-6649-9180	NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000897] Funding Source: NIH RePORTER	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was partially supported by the Intramural Research Program of the NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Almanza H, 2008, J CLIN MICROBIOL, V46, P3971, DOI 10.1128/JCM.01204-08; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Batten CA, 2006, VIROLOGY, V356, P179, DOI 10.1016/j.virol.2006.07.034; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; de Bruin E, 2006, J VIROL METHODS, V137, P259, DOI 10.1016/j.jviromet.2006.06.024; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Donaldson EF, 2010, NAT REV MICROBIOL, V8, P231, DOI 10.1038/nrmicro2296; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Geginat G, 2012, EUR J CLIN MICROBIOL, V31, P733, DOI 10.1007/s10096-011-1366-z; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; GREEN KY, 1993, J CLIN MICROBIOL, V31, P2185, DOI 10.1128/JCM.31.8.2185-2191.1993; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Herbst-Kralovetz M, 2010, EXPERT REV VACCINES, V9, P299, DOI [10.1586/erv.09.163, 10.1586/ERV.09.163]; Holzinger A, 1996, BIOTECHNIQUES, V20, P804; Kirby A, 2010, J CLIN VIROL, V49, P254, DOI 10.1016/j.jcv.2010.08.004; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Leite JPG, 1996, ARCH VIROL, V141, P865, DOI 10.1007/BF01718161; LEW JF, 1994, VIROLOGY, V200, P319, DOI 10.1006/viro.1994.1194; Li XA, 2010, VIRUS RES, V151, P142, DOI 10.1016/j.virusres.2010.04.005; Li X, 2009, VIRUS RES, V140, P188, DOI 10.1016/j.virusres.2008.12.004; Lindesmith LC, 2012, J VIROL, V86, P873, DOI 10.1128/JVI.06200-11; LoBue AD, 2006, VACCINE, V24, P5220, DOI 10.1016/j.vaccine.2006.03.080; Lochridge VP, 2005, J GEN VIROL, V86, P2799, DOI 10.1099/vir.0.81134-0; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Oliver SL, 2006, J CLIN MICROBIOL, V44, P992, DOI 10.1128/JCM.44.3.992-998.2006; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Parra GI, 2012, J VIROL, V86, P7414, DOI 10.1128/JVI.06729-11; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Shiota T, 2007, J VIROL, V81, P12298, DOI 10.1128/JVI.00891-07; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Tan M, 2008, VIROLOGY, V382, P115, DOI 10.1016/j.virol.2008.08.047; Tan M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000983; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Yoda T, 2000, MICROBIOL IMMUNOL, V44, P905, DOI 10.1111/j.1348-0421.2000.tb02582.x	43	39	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67592	10.1371/journal.pone.0067592	http://dx.doi.org/10.1371/journal.pone.0067592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805319	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500147
J	Schneider, E; Zimmermann, H; Oberwahrenbrock, T; Kaufhold, F; Kadas, EM; Petzold, A; Bilger, F; Borisow, N; Jarius, S; Wildemann, B; Ruprecht, K; Brandt, AU; Paul, F				Schneider, Elisa; Zimmermann, Hanna; Oberwahrenbrock, Timm; Kaufhold, Falko; Kadas, Ella Maria; Petzold, Axel; Bilger, Frieder; Borisow, Nadja; Jarius, Sven; Wildemann, Brigitte; Ruprecht, Klemens; Brandt, Alexander U.; Paul, Friedemann			Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis	PLOS ONE			English	Article							NERVE-FIBER LAYER; MICROCYSTIC MACULAR EDEMA; CLINICAL-COURSE; SPINAL MS; DISEASE; AQUAPORIN-4; SPECTRUM; DEGENERATION; NATALIZUMAB; ANTIBODIES	Background: Neuromyelitis optica (NMO) and relapsing-remitting multiple sclerosis (RRMS) are difficult to differentiate solely on clinical grounds. Optical coherence tomography (OCT) studies investigating retinal changes in both diseases focused primarily on the retinal nerve fiber layer (RNFL) while rare data are available on deeper intra-retinal layers. Objective: To detect different patterns of intra-retinal layer alterations in patients with NMO spectrum disorders (NMOSD) and RRMS with focus on the influence of a previous optic neuritis (ON). Methods: We applied spectral-domain OCT in eyes of NMOSD patients and compared them to matched RRMS patients and healthy controls (HC). Semi-automatic intra-retinal layer segmentation was used to quantify intra-retinal layer thicknesses. In a subgroup low contrast visual acuity (LCVA) was assessed. Results: NMOSD-, MS- and HC-groups, each comprising 17 subjects, were included in analysis. RNFL thickness was more severely reduced in NMOSD compared to MS following ON. In MS-ON eyes, RNFL thinning showed a clear temporal preponderance, whereas in NMOSD-ON eyes RNFL was more evenly reduced, resulting in a significantly lower ratio of the nasal versus temporal RNFL thickness. In comparison to HC, ganglion cell layer thickness was stronger reduced in NMOSD-ON than in MS-ON, accompanied by a more severe impairment of LCVA. The inner nuclear layer and the outer retinal layers were thicker in NMOSD-ON patients compared to NMOSD without ON and HC eyes while these differences were primarily driven by microcystic macular edema. Conclusion: Our study supports previous findings that ON in NMOSD leads to more pronounced retinal thinning and visual function impairment than in RRMS. The different retinal damage patterns in NMOSD versus RRMS support the current notion of distinct pathomechanisms of both conditions. However, OCT is still insufficient to help with the clinically relevant differentiation of both conditions in an individual patient.	[Schneider, Elisa; Zimmermann, Hanna; Oberwahrenbrock, Timm; Kaufhold, Falko; Kadas, Ella Maria; Bilger, Frieder; Borisow, Nadja; Brandt, Alexander U.; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Petzold, Axel] Vrije Univ Amsterdam, Med Ctr, MS Ctr Amsterdam, Amsterdam, Netherlands; [Jarius, Sven; Wildemann, Brigitte] Heidelberg Univ, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany; [Ruprecht, Klemens; Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Ruprecht, Klemens; Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany; [Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Paul, F (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	friedemann.paul@charite.de	Paul, Friedemann/ABF-9415-2020; Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749; Zimmermann, Hanna/0000-0002-0276-8051; paul, friedemann/0000-0002-6378-0070	German Research Council [DFG Exc 257]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (DFG Exc 257 to FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2012, BRAIN, V135, DOI 10.1093/brain/aws215; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Balk LJ, 2012, BRAIN, V135, DOI 10.1093/brain/aws216; Barnett MH, 2012, MULT SCLER J, V18, P108, DOI 10.1177/1352458511421185; Bock M, 2012, BRIT J OPHTHALMOL, V96, P62, DOI 10.1136/bjo.2010.193581; Bock M, 2010, CLIN NEUROL NEUROSUR, V112, P647, DOI 10.1016/j.clineuro.2010.04.014; Bock M, 2010, MULT SCLER J, V16, P893, DOI 10.1177/1352458510365156; Bomprezzi R, 2011, NEUROLOGY, V77, P195, DOI 10.1212/WNL.0b013e318219dde5; Bouyon M, 2013, MULT SCLER J, V19, P1320, DOI 10.1177/1352458513476562; Brandt AU, 2011, BRAIN, V134, DOI 10.1093/brain/awr095; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; de Seze J, 2008, ARCH NEUROL-CHICAGO, V65, P920, DOI 10.1001/archneur.65.7.920; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Evangelou N, 2001, BRAIN, V124, P1813, DOI 10.1093/brain/124.9.1813; Fernandes DB, 2012, OPHTHALMOLOGY; FRISEN L, 1974, ARCH OPHTHALMOL-CHIC, V92, P91, DOI 10.1001/archopht.1974.01010010097001; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Green AJ, 2009, J NEUROL NEUROSUR PS, V80, P1002, DOI 10.1136/jnnp.2008.166207; Jacob A, 2012, NEUROLOGY, V79, P1065, DOI 10.1212/WNL.0b013e31826845fe; Jarernsook B, 2012, MULT SCLER; Jarius S, 2010, J NEUROL SCI, V291, P52, DOI 10.1016/j.jns.2010.01.002; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Kim SH, 2012, MULT SCLER J, V18, P1480, DOI 10.1177/1352458512439439; Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mealy MA, 2012, ARCH NEUROL-CHICAGO, V69, P1176, DOI 10.1001/archneurol.2012.314; Merle H, 2008, INVEST OPHTH VIS SCI, V49, P4412, DOI 10.1167/iovs.08-1815; Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Mowry EM, 2009, J NEUROL NEUROSUR PS, V80, P767, DOI 10.1136/jnnp.2008.165449; Naismith RT, 2009, NEUROLOGY, V72, P1077, DOI 10.1212/01.wnl.0000345042.53843.d5; Nakamura M, 2010, GRAEF ARCH CLIN EXP, V248, P1777, DOI 10.1007/s00417-010-1344-7; Noval S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/472790; Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Papeix C, 2007, MULT SCLER, V13, P256, DOI 10.1177/1352458506070732; Paul F, 2007, PLOS MED, V4, P669, DOI 10.1371/journal.pmed.0040133; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Saidha S, 2012, ARCH NEUROL-CHICAGO, P1; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Sellner J, 2010, EUR J NEUROL, V17, P1019, DOI 10.1111/j.1468-1331.2010.03066.x; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Siger M, 2008, J NEUROL, V255, P1555, DOI 10.1007/s00415-008-0985-5; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Toledo J, 2008, MULT SCLER J, V14, P906, DOI 10.1177/1352458508090221; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van Horssen J, 2012, MULT SCLER J, V18, P1058, DOI 10.1177/1352458512452924; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2003, NEUROLOGY, V60, P848, DOI 10.1212/01.WNL.0000049912.02954.2C; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844	73	114	118	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66151	10.1371/journal.pone.0066151	http://dx.doi.org/10.1371/journal.pone.0066151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805202	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000320846500030
J	Stodden, V; Guo, PX; Ma, ZK				Stodden, Victoria; Guo, Peixuan; Ma, Zhaokun			Toward Reproducible Computational Research: An Empirical Analysis of Data and Code Policy Adoption by Journals	PLOS ONE			English	Article								Journal policy on research data and code availability is an important part of the ongoing shift toward publishing reproducible computational science. This article extends the literature by studying journal data sharing policies by year (for both 2011 and 2012) for a referent set of 170 journals. We make a further contribution by evaluating code sharing policies, supplemental materials policies, and open access status for these 170 journals for each of 2011 and 2012. We build a predictive model of open data and code policy adoption as a function of impact factor and publisher and find higher impact journals more likely to have open data and code policies and scientific societies more likely to have open data and code policies than commercial publishers. We also find open data policies tend to lead open code policies, and we find no relationship between open data and code policies and either supplemental material policies or open access journal status. Of the journals in this study, 38% had a data policy, 22% had a code policy, and 66% had a supplemental materials policy as of June 2012. This reflects a striking one year increase of 16% in the number of data policies, a 30% increase in code policies, and a 7% increase in the number of supplemental materials policies. We introduce a new dataset to the community that categorizes data and code sharing, supplemental materials, and open access policies in 2011 and 2012 for these 170 journals.	[Stodden, Victoria; Guo, Peixuan] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Ma, Zhaokun] Columbia Univ, Dept Ind Engn & Operat Res, New York, NY 10027 USA	Columbia University; Columbia University	Stodden, V (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.	victoria@stodden.net	Guo, Peixuan/AAE-2573-2022; Guo, Peixuan/I-7184-2015	Guo, Peixuan/0000-0001-5706-2833; 	NSF [1153384]; Office of Advanced Cyberinfrastructure (OAC) [1153384] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by NSF award number 1153384 "EAGER: Policy Design for Reproducibility and Data Sharing in Computational Science.'' See http://www.nsf.gov/awardsearch/showAward?AWD_ID = 1153384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 2011, ECONOMIST; Barnes N, 2010, NATURE, V467, P753, DOI 10.1038/467753a; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Cech T. R., 2003, PLANT PHYSIOL, V132, P1; Donoho DL, 2009, COMPUT SCI ENG, V11, P8, DOI 10.1109/MCSE.2009.15; *ED, 1998, NATURE STRUCTURAL BI, V5, P164; Ferry G., 2002, COMMON THREAD STORY, V1st edn; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; *INST MED COMM, 2012, EV TRANSL OM LESS LE; KING G, 1995, PS, V28, P444, DOI 10.2307/420301; LeVeque RJ, 2012, COMPUT SCI ENG, V14, P13, DOI 10.1109/MCSE.2012.38; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; *NAT ED, 2011, NATURE, V470, P305; NOSEK B, 2012, PERSPECT PSYCHOL SCI, V7, P6; Nosek BA, 2012, PSYCHOL INQ, V23, P217, DOI 10.1080/1047840X.2012.692215; *OAK RIDG NATL LAB, POL REL HUM GEN SEQ; *REPR RES, COMPUTING SCI ENG; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Vandewalle P, 2012, COMPUT SCI ENG, V14, P42, DOI 10.1109/MCSE.2012.63; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; *YAL ROUNDT PART, 2010, COMPUTING SCI ENG, V12, P5, DOI DOI 10.1109/MCSE.2010.113	23	113	115	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67111	10.1371/journal.pone.0067111	http://dx.doi.org/10.1371/journal.pone.0067111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805293	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500121
J	Zhang, YH; Yan, WS; Jung, YS; Chen, XB				Zhang, Yanhong; Yan, Wensheng; Jung, Yong Sam; Chen, Xinbin			PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition	PLOS ONE			English	Article							CELL POLARITY; DNA-DAMAGE; TRANSCRIPTION FACTORS; P53; EXPRESSION; APOPTOSIS; P73; GENE; DELTA-NP73; SURVIVAL	Lumen formation is essential for mammary morphogenesis and requires proliferative suppression and apoptotic clearance of the inner cells within developing acini. Previously, we showed that knockdown of p53 or p73 leads to aberrant mammary acinus formation accompanied with decreased expression of p53 family targets PUMA and p21, suggesting that PUMA, an inducer of apoptosis, and p21, an inducer of cell cycle arrest, directly regulate mammary morphogenesis. To address this, we generated multiple MCF10A cell lines in which PUMA, p21, or both were stably knocked down. We found that morphogenesis of MCF10A cells was altered modestly by knockdown of either PUMA or p21 alone but markedly by knockdown of both PUMA and p21. Moreover, we found that knockdown of PUMA and p21 leads to loss of E-cadherin expression along with increased expression of epithelial-to-mesenchymal transition (EMT) markers. Interestingly, we found that knockdown of Delta Np73, which antagonizes the ability of wide-type p53 and TA isoform of p73 to regulate PUMA and p21, mitigates the abnormal morphogenesis and EMT induced by knockdown of PUMA or p21. Together, our data suggest that PUMA cooperates with p21 to regulate normal acinus formation and EMT.	[Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Cancer Institute [CA081237]; NATIONAL CANCER INSTITUTE [R01CA081237] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Cancer Institute Grant CA081237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bachman KE, 2004, CANCER BIOL THER, V3, P221, DOI 10.4161/cbt.3.2.666; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gartel AL, 1996, EXP CELL RES, V227, P171, DOI 10.1006/excr.1996.0264; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; HUPPI K, 1994, ONCOGENE, V9, P3017; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Karakas B, 2006, ONCOGENE, V25, P5561, DOI 10.1038/sj.onc.1209540; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Parichy DM, 2003, DEV BIOL, V256, P221, DOI 10.1016/S0012-1606(03)00016-2; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Ravni A, 2010, CELL CYCLE, V9, P1523, DOI 10.4161/cc.9.8.11291; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Schuster A, 2010, CELL CYCLE, V9, P2629, DOI 10.4161/cc.9.13.12110; Shaltouki A, 2007, APOPTOSIS, V12, P2143, DOI 10.1007/s10495-007-0135-z; Simoes-Wust AP, 2005, J NEURO-ONCOL, V72, P29, DOI 10.1007/s11060-004-3118-8; Stadanlick JE, 2011, J IMMUNOL, V187, P664, DOI 10.4049/jimmunol.1100029; Strange R, 2001, MICROSC RES TECHNIQ, V52, P171, DOI 10.1002/1097-0029(20010115)52:2<171::AID-JEMT1003>3.3.CO;2-K; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang KJ, 2011, MED ONCOL, V28, pS301, DOI 10.1007/s12032-010-9759-x; Zhang KJ, 2011, INT J MOL SCI, V12, P385, DOI 10.3390/ijms12010385; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585	42	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66464	10.1371/journal.pone.0066464	http://dx.doi.org/10.1371/journal.pone.0066464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805223	gold, Green Submitted, Green Published			2022-12-27	WOS:000320846500051
J	Lagache, L; Leger, JB; Daudin, JJ; Petit, RJ; Vacher, C				Lagache, Lelia; Leger, Jean-Benoist; Daudin, Jean-Jacques; Petit, Remy J.; Vacher, Corinne			Putting the Biological Species Concept to the Test: Using Mating Networks to Delimit Species	PLOS ONE			English	Article							HYBRIDIZATION; INTROGRESSION; MODEL; INDIVIDUALS; RECOGNITION; DIRECTION	Although interfertility is the key criterion upon which Mayr's biological species concept is based, it has never been applied directly to delimit species under natural conditions. Our study fills this gap. We used the interfertility criterion to delimit two closely related oak species in a forest stand by analyzing the network of natural mating events between individuals. The results reveal two groups of interfertile individuals connected by only few mating events. These two groups were largely congruent with those determined using other criteria (morphological similarity, genotypic similarity and individual relatedness). Our study, therefore, shows that the analysis of mating networks is an effective method to delimit species based on the interfertility criterion, provided that adequate network data can be assembled. Our study also shows that although species boundaries are highly congruent across methods of species delimitation, they are not exactly the same. Most of the differences stem from assignment of individuals to an intermediate category. The discrepancies between methods may reflect a biological reality. Indeed, the interfertility criterion is an environment-dependant criterion as species abundances typically affect rates of hybridization under natural conditions. Thus, the methods of species delimitation based on the interfertility criterion are expected to give results slightly different from those based on environment-independent criteria (such as the genotypic similarity criteria). However, whatever the criterion chosen, the challenge we face when delimiting species is to summarize continuous but non-uniform variations in biological diversity. The grade of membership model that we use in this study appears as an appropriate tool.	[Lagache, Lelia; Petit, Remy J.; Vacher, Corinne] INRA, BIOGECO, UMR1202, Cestas, France; [Lagache, Lelia; Petit, Remy J.; Vacher, Corinne] Univ Bordeaux, BIOGECO, UMR 1202, Talence, France; [Leger, Jean-Benoist; Daudin, Jean-Jacques] INRA, MIA, UMR 518, Paris, France; [Leger, Jean-Benoist; Daudin, Jean-Jacques] AgroParisTech, MIA, UMR 518, Paris, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Vacher, C (corresponding author), INRA, BIOGECO, UMR1202, Cestas, France.	corinne.vacher@pierroton.inra.fr	Vacher, Corinne/Q-3182-2019; Vacher, Corinne/ABG-8163-2020; Petit, Rémy/A-8842-2008; Daudin, Jean-Jacques/A-8582-2008; Vacher, Corinne/J-1777-2012; Petit, Remy/AAD-9078-2019	Vacher, Corinne/0000-0003-3023-6113; Petit, Rémy/0000-0002-4809-1453; Vacher, Corinne/0000-0003-3023-6113; 	LinkTree project (ANR BIODIVERSA); EU Network of Excellence EvolTree; INRA (CJS); Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227];  [ANR-10-EQPX-16 XYLOFOREST]	LinkTree project (ANR BIODIVERSA)(French National Research Agency (ANR)); EU Network of Excellence EvolTree; INRA (CJS); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER; 	Funding was provided by the LinkTree project (ANR BIODIVERSA), by the EU Network of Excellence EvolTree, by ANR-10-EQPX-16 XYLOFOREST and by the INRA (CJS grant). The genotyping was funded by grants from the Conseil Regional d'Aquitaine no20030304002FA, no20040305003FA and from the European Union, FEDER no2003227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacilieri R, 1996, EVOLUTION, V50, P900, DOI 10.1111/j.1558-5646.1996.tb03898.x; Bacilieri R, 1996, ANN SCI FOREST, V53, P79, DOI 10.1051/forest:19960106; Batagelj V., 1998, PAJEK PROGRAM LARGE; Coyne J.A., 2004, SPECIATION; Daudin JJ, 2010, BIOMETRICS, V66, P1043, DOI 10.1111/j.1541-0420.2009.01378.x; de Meeus T, 2003, TRENDS PARASITOL, V19, P425, DOI 10.1016/S1471-4922(03)00195-8; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; de Queiroz K, 1998, GEN LINEAGE CONCEPT; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dettman JR, 2003, EVOLUTION, V57, P2721; DONOGHUE MJ, 1985, BRYOLOGIST, V88, P172, DOI 10.2307/3243026; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Eldredge N., 1980, PHYLOGENETIC PATTERN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Field DL, 2008, J ECOL, V96, P1198, DOI 10.1111/j.1365-2745.2008.01434.x; Focke WO, 1881, PFLANZENMISCHLINGE; Fortuna MA, 2008, ECOL LETT, V11, P490, DOI 10.1111/j.1461-0248.2008.01167.x; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FROST DR, 1990, HERPETOLOGICA, V46, P87; Guichoux E, 2013, MOL ECOL, V22, P450, DOI 10.1111/mec.12125; Guichoux E, 2011, MOL ECOL RESOUR, V11, P578, DOI 10.1111/j.1755-0998.2011.02983.x; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; HIBBETT DS, 1995, MYCOLOGIA, V87, P618, DOI 10.2307/3760806; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Lagache L, 2013, MOL ECOL, V22, P423, DOI 10.1111/mec.12121; Legendre G, 1984, ECOLOGIE NUMERIQUE; Leger J-B, 2013, STAT COMPUT IN PRESS; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Lepais O, 2011, EVOLUTION, V65, P156, DOI 10.1111/j.1558-5646.2010.01101.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Marcussen T, 2011, PLANT SYST EVOL, V291, P183, DOI 10.1007/s00606-010-0377-z; Mariadassou M, 2010, ANN APPL STAT, V4, P715, DOI 10.1214/10-AOAS361; Marin J, 2010, ZOOL SCR, V39, P591, DOI 10.1111/j.1463-6409.2010.00450.x; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; Mayr E, 1942, SYSTEMATICS ORIGIN S; MISHLER BD, 1985, BRYOLOGIST, V88, P207, DOI 10.2307/3243030; Moalic Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-33; Nelson G., 1981, SYSTEMATICS BIOGEORA; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noor MAF, 2002, TRENDS ECOL EVOL, V17, P153, DOI 10.1016/S0169-5347(02)02452-7; Orr HA, 2001, J EVOLUTION BIOL, V14, P870, DOI 10.1046/j.1420-9101.2001.00340.x; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Simpson G.G., 1961, PRINCIPLES ANIMAL TA, DOI DOI 10.7312/SIMP92414; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; SOKAL RR, 1970, AM NAT, V104, P127, DOI 10.1086/282646; Streiff R, 1998, GENET SEL EVOL, V30, pS137, DOI 10.1051/gse:19980708; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809	55	7	7	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68267	10.1371/journal.pone.0068267	http://dx.doi.org/10.1371/journal.pone.0068267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818990	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800147
J	Stenrod, M; Klemsdal, SS; Norli, HR; Eklo, OM				Stenrod, Marianne; Klemsdal, Sonja S.; Norli, Hans Ragnar; Eklo, Ole Martin			Effects of Picoxystrobin and 4-n-Nonylphenol on Soil Microbial Community Structure and Respiration Activity	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; 4-NONYLPHENOL; NONYLPHENOL; DEGRADATION; DIVERSITY; TOXICITY; FUNGI	There is widespread use of chemical amendments to meet the demands for increased productivity in agriculture. Potentially toxic compounds, single or in mixtures, are added to the soil medium on a regular basis, while the ecotoxicological risk assessment procedures mainly follow a chemical by chemical approach. Picoxystrobin is a fungicide that has caused concern due to studies showing potentially detrimental effects to soil fauna (earthworms), while negative effects on soil microbial activities (nitrification, respiration) are shown to be transient. Potential mixture situations with nonylphenol, a chemical frequently occurring as a contaminant in sewage sludge used for land application, infer a need to explore whether these chemicals in mixture could alter the potential effects of picoxystrobin on the soil microflora. The main objective of this study was to assess the effects of picoxystrobin and nonylphenol, as single chemicals and mixtures, on soil microbial community structure and respiration activity in an agricultural sandy loam. Effects of the chemicals were assessed through measurements of soil microbial respiration activity and soil bacterial and fungal community structure fingerprints, together with a degradation study of the chemicals, through a 70 d incubation period. Picoxystrobin caused a decrease in the respiration activity, while 4-n-nonylphenol caused an increase in respiration activity concurring with a rapid degradation of the substance. Community structure fingerprints were also affected, but these results could not be directly interpreted in terms of positive or negative effects, and were indicated to be transient. Treatment with the chemicals in mixture caused less evident changes and indicated antagonistic effects between the chemicals in soil. In conclusion, the results imply that the application of the fungicide picoxystrobin and nonylphenol from sewage sludge application to agricultural soil in environmentally relevant concentrations, as single chemicals or in mixture, will not cause irreversible effects on soil microbial respiration and community structure.	[Stenrod, Marianne; Klemsdal, Sonja S.; Norli, Hans Ragnar; Eklo, Ole Martin] Bioforsk, Norwegian Inst Agr & Environm Res, As, Norway	Bioforsk	Stenrod, M (corresponding author), Bioforsk, Norwegian Inst Agr & Environm Res, As, Norway.	marianne.stenrod@bioforsk.no			Norwegian Research Council [186901/i30]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was performed as part of the strategic institute programme 'Bioavailability and biological effects of chemicals - Novel tools in risk assessment of mixtures in agricultural and contaminated soil' funded by the Norwegian Research Council, project number 186901/i30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken JT, 2011, SOIL SCI SOC AM J, V75, P102, DOI 10.2136/sssaj2008.0088; ALEXANDER M, 1995, ENVIRON SCI TECHNOL, V29, P2713, DOI 10.1021/es00011a003; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; BCPC, 2011, EPESTICIDE MAN V5 2; Bending GD, 2007, CHEMOSPHERE, V69, P82, DOI 10.1016/j.chemosphere.2007.04.042; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Chaussod R., 1986, SCI SOL, V2, P201; Coleman DC, 2008, SOIL BIOL BIOCHEM, V40, P271, DOI 10.1016/j.soilbio.2007.08.005; Corvini PFX, 2006, APPL MICROBIOL BIOT, V72, P223, DOI 10.1007/s00253-006-0476-5; Defra, 2010, DEV GUID IMPL AG SOI; EC, 2003, SANCO101962003FINAL; [EFSA PPR] European Food Safety Authority Plant Protection Products and Their Residues Panel, 2010, EFSA J, V8, P1821, DOI DOI 10.2903/J.EFSA.2010.1821; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen AB, 2008, TEMANORD2008530; Hesselsoe M, 2001, ENVIRON SCI TECHNOL, V35, P3695, DOI 10.1021/es010024l; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; JRC, 2001, ORG CONT SEW SLUDG A; Kollmann A, 2003, J ENVIRON QUAL, V32, P1269, DOI 10.2134/jeq2003.1269; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Loewe S., 1927, J MOL MED, V6, P1077, DOI DOI 10.1007/BF01890305; Macdonald CA, 2011, SOIL BIOL BIOCHEM, V43, P932, DOI 10.1016/j.soilbio.2011.01.004; Norwegian Food Safety Autority, 2005, VURD PLANT AC PRIM P; Norwegian Scientific Committee for Food Safety, 2009, RISK ASS CONT SEW SL; OECD, 2000, TEST 216 SOIL MICROO, DOI [10.1787/9789264070226-en., DOI 10.1787/9789264070226-EN]; OECD, 2000, TEST 217 SOIL MICROO, DOI [10.1787/9789264070240-en, DOI 10.1787/9789264070240-EN]; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ovreas L, 1998, MICROB ECOL, V36, P303, DOI 10.1007/s002489900117; R Core Team, 2012, R LANG ENV STAT COMP; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shan J, 2011, ENVIRON SCI TECHNOL, V45, P8283, DOI 10.1021/es200224c; Singh BK, 2008, ENVIRON MICROBIOL, V10, P534, DOI 10.1111/j.1462-2920.2007.01474.x; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; Topp E, 2000, ENVIRON TOXICOL CHEM, V19, P313, DOI [10.1002/etc.5620190210, 10.1897/1551-5028(2000)019&lt;0313:RMOTED&gt;2.3.CO;2]; Venables WN., 2002, MODERN APPL STAT S, V4; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Winding A, 2005, ECOTOX ENVIRON SAFE, V62, P230, DOI 10.1016/j.ecoenv.2005.03.026; Wu LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020611	40	11	14	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66989	10.1371/journal.pone.0066989	http://dx.doi.org/10.1371/journal.pone.0066989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818971	gold, Green Submitted, Green Published			2022-12-27	WOS:000322342800109
J	Trautmann-Lengsfeld, SA; Dominguez-Borras, J; Escera, C; Herrmann, M; Fehr, T				Trautmann-Lengsfeld, Sina Alexa; Dominguez-Borras, Judith; Escera, Carles; Herrmann, Manfred; Fehr, Thorsten			The Perception of Dynamic and Static Facial Expressions of Happiness and Disgust Investigated by ERPs and fMRI Constrained Source Analysis	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FUSIFORM FACE AREA; SEX-DIFFERENCES; VISUAL-CORTEX; TIME-COURSE; EMOTION; RESPONSES; AMYGDALA; RECOGNITION; INTENSITY	A recent functional magnetic resonance imaging (fMRI) study by our group demonstrated that dynamic emotional faces are more accurately recognized and evoked more widespread patterns of hemodynamic brain responses than static emotional faces. Based on this experimental design, the present study aimed at investigating the spatio-temporal processing of static and dynamic emotional facial expressions in 19 healthy women by means of multi-channel electroencephalography (EEG), event-related potentials (ERP) and fMRI-constrained regional source analyses. ERP analysis showed an increased amplitude of the LPP (late posterior positivity) over centro-parietal regions for static facial expressions of disgust compared to neutral faces. In addition, the LPP was more widespread and temporally prolonged for dynamic compared to static faces of disgust and happiness. fMRI constrained source analysis on static emotional face stimuli indicated the spatio-temporal modulation of predominantly posterior regional brain activation related to the visual processing stream for both emotional valences when compared to the neutral condition in the fusiform gyrus. The spatio-temporal processing of dynamic stimuli yielded enhanced source activity for emotional compared to neutral conditions in temporal (e. g., fusiform gyrus), and frontal regions (e. g., ventromedial prefrontal cortex, medial and inferior frontal cortex) in early and again in later time windows. The present data support the view that dynamic facial displays trigger more information reflected in complex neural networks, in particular because of their changing features potentially triggering sustained activation related to a continuing evaluation of those faces. A combined fMRI and EEG approach thus provides an advanced insight to the spatio-temporal characteristics of emotional face processing, by also revealing additional neural generators, not identifiable by the only use of an fMRI approach.	[Trautmann-Lengsfeld, Sina Alexa; Herrmann, Manfred; Fehr, Thorsten] Univ Bremen, Dept Neuropsychol & Behav Neurobiol, Ctr Cognit Sci ZKW, D-28359 Bremen, Germany; [Trautmann-Lengsfeld, Sina Alexa] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Dominguez-Borras, Judith; Escera, Carles] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Cognit Neurosci Res Grp, Barcelona, Catalonia, Spain; [Dominguez-Borras, Judith] Univ Med Ctr, Dept Neurosci, Lab Behav Neurol & Imaging Cognit, Geneva, Switzerland; [Escera, Carles] Hanse Wissenschaftskolleg, Delmenhorst, Germany; [Escera, Carles] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain; [Herrmann, Manfred; Fehr, Thorsten] Univ Bremen, Ctr Adv Imaging, D-28359 Bremen, Germany; [Fehr, Thorsten] Otto von Guericke Univ, Dept Neurol 2, Magdeburg, Germany	University of Bremen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Barcelona; University of Geneva; University of Barcelona; University of Bremen; Otto von Guericke University	Trautmann-Lengsfeld, SA (corresponding author), Univ Bremen, Dept Neuropsychol & Behav Neurobiol, Ctr Cognit Sci ZKW, D-28359 Bremen, Germany.	s.trautmann-lengsfeld@uke.de	Fehr, Thorsten/P-5058-2018; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; , Judith/ABG-1910-2020; Domínguez-Borràs, Judith/B-1557-2018; Herrmann, Manfred/H-3931-2011; Escera, Carles/A-8658-2010	Fehr, Thorsten/0000-0002-2224-1740; , Judith/0000-0003-3233-5713; Domínguez-Borràs, Judith/0000-0003-3233-5713; Herrmann, Manfred/0000-0003-1872-8406; Escera, Carles/0000-0001-8203-2951	Spanish Ministry of Science and Innovation [CSD2007-00012]; ICREA Academia Program; Generalitat de Catalunya [SGR2009-11]; DAAD/Acciones Integrades Program [HA2005-0024]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA Academia Program(ICREA); Generalitat de Catalunya(Generalitat de Catalunya); DAAD/Acciones Integrades Program	The study was supported by the Spanish Ministry of Science and Innovation (CSD2007-00012), the ICREA Academia 2010 Program (CE), the Generalitat de Catalunya (SGR2009-11) and the DAAD/Acciones Integrades Program HA2005-0024 (MH and CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Blau VC, 2007, BEHAV BRAIN FUNCT, V3; Bledowski C, 2006, J NEUROSCI, V26, P821, DOI 10.1523/JNEUROSCI.3542-05.2006; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Cornwell BR, 2008, BRAIN RES, V1244, P103, DOI 10.1016/j.brainres.2008.09.068; Dominguez-Borras J, 2009, CEREB CORTEX, V19, P1521, DOI 10.1093/cercor/bhn188; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; EKMAN P, 1987, J PERS SOC PSYCHOL, V53, P712, DOI 10.1037/0022-3514.53.4.712; Ekman Paul, 1972, EMOTION HUMAN FACE; Fichtenholtz HM, 2009, SOC NEUROSCI-UK, V4, P317, DOI 10.1080/17470910902809487; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Gepner B, 2001, J AUTISM DEV DISORD, V31, P37, DOI 10.1023/A:1005609629218; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Herrmann M., 2007, TOPICS ADV NEUROIMAG, P27; Hofer A, 2007, PSYCHOL MED, V37, P109, DOI 10.1017/S0033291706008919; Hopfinger JB, 2005, EVENT RELATED POTENT; Hung YW, 2010, NEUROIMAGE, V50, P727, DOI 10.1016/j.neuroimage.2009.12.093; Im CH, 2007, MED BIOL ENG COMPUT, V45, P79, DOI 10.1007/s11517-006-0142-1; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Lange K, 2003, BIOL PSYCHIAT, V53, P226, DOI 10.1016/S0006-3223(02)01455-5; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lewis S, 2003, NEUROREPORT, V14, P1841, DOI 10.1097/00001756-200310060-00017; Luck S.J., 2005, INTRO EVENT RELATED; Mayes AK, 2009, BRAIN TOPOGR, V22, P145, DOI 10.1007/s10548-009-0106-5; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Regenbogen C, 2010, SOC NEUROSCI-UK, V5, P221, DOI 10.1080/17470910903315989; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Sabatinelli D, 2007, CEREB CORTEX, V17, P1085, DOI 10.1093/cercor/bhl017; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; SCHERG M, 1991, ELECTROEN CLIN NEURO, P24; Scherg M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P127; SCHERG M, 1991, Brain Topography, V4, P143, DOI 10.1007/BF01132771; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Simons RF, 1999, PSYCHOPHYSIOLOGY, V36, P619, DOI 10.1017/S0048577299980976; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Vanni S, 2004, NEUROIMAGE, V21, P801, DOI 10.1016/j.neuroimage.2003.10.047; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Werheid K, 2005, INT J PSYCHOPHYSIOL, V55, P209, DOI 10.1016/j.ijpsycho.2004.07.006; Wibral M, 2008, INT J PSYCHOPHYSIOL, V67, P200, DOI 10.1016/j.ijpsycho.2007.06.009; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009	69	29	30	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66997	10.1371/journal.pone.0066997	http://dx.doi.org/10.1371/journal.pone.0066997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818974	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800112
J	Zhang, D; Zhou, B; Li, Y; Wang, MJ; Wang, C; Zhou, ZG; Sun, XF				Zhang, Dan; Zhou, Bin; Li, Yuan; Wang, Mojin; Wang, Cun; Zhou, Zongguang; Sun, Xiaofeng			Polymorphisms of Glucose-Regulated Protein 78 and Risk of Colorectal Cancer: A Case-Control Study in Southwest China	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; ER CHAPERONE; PROMOTER POLYMORPHISM; STRESS INDUCTION; GRP78; EXPRESSION; OVEREXPRESSION; ASSOCIATION; HSPA5; GENE	Glucose-regulated protein 78 (GRP78), an endoplasmic reticulum chaperone, up-regulation serves as an efficient mechanism to promote malignant transformation of colorectal cancer (CRC) and protect CRC cells against apoptosis. Recently, the analysis of GRP78 polymorphisms has already determined that GRP78 rs391957 polymorphism could predict clinical outcome in CRC patients. Thus, we tested whether GRP78 polymorphisms are related to the risk of CRC. In this study, we detected two GRP78 polymorphisms (rs391957 (C>T) and rs430397 (G>A)) in 414 CRC cases and 502 hospital-based cancer-free healthy controls in Southwest China using a polymerase chain reaction-restriction fragment length polymorphism technique. Compared with the CC genotype, carriers of CT and TT genotypes of rs391957 polymorphism had higher risks of CRC (odds ratio (OR) = 1.39, 95% confidence interval (CI) = 1.06-1.83 for CT genotype and OR = 2.10, 95% CI = 1.06-4.14 for TT genotype, respectively). In CRC cases, the variant T allele was significantly associated with tumor invasion stage (P = 0.030), but not with status of lymph nodes metastasis (P = 0.052). Compared with the GG genotype, carriers of GA and AA genotypes of rs430397 polymorphism had higher risks of CRC (OR = 1.63, 95% CI = 1.23-2.15 for GA genotype and OR = 2.92, 95% CI = 1.23-6.94 for AA genotype, respectively). The rs430397 polymorphism was not associated with the clinicopathological characteristics of CRC. These data provide the first evidence that GRP78 rs391957 and rs430397 polymorphisms could serve as markers to predict the risk of CRC.	[Zhang, Dan; Wang, Mojin; Wang, Cun; Zhou, Zongguang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zhang, Dan; Zhou, Bin; Li, Yuan; Wang, Mojin; Wang, Cun; Zhou, Zongguang] Sichuan Univ, West China Hosp, Lab Digest Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Sun, Xiaofeng] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden	Sichuan University; Sichuan University; Linkoping University	Zhou, ZG (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	zhou767@163.com	Wang, Cun/C-5600-2015	, Zongguang/0000-0002-7616-1199	Outstanding Doctoral Dissertation Foundation of Ministry of Education of China [2007B66]	Outstanding Doctoral Dissertation Foundation of Ministry of Education of China	This research was supported by grants from Outstanding Doctoral Dissertation Foundation of Ministry of Education of China (No. 2007B66). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Houlston RS, 2001, GASTROENTEROLOGY, V121, P282, DOI 10.1053/gast.2001.26265; Hsu WC, 2008, J NEURAL TRANSM, V115, P1537, DOI 10.1007/s00702-008-0117-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakiuchi C, 2005, BIOCHEM BIOPH RES CO, V336, P1136, DOI 10.1016/j.bbrc.2005.08.248; Kemp Z, 2004, HUM MOL GENET, V13, pR177, DOI 10.1093/hmg/ddh247; Koomagi R, 1999, ANTICANCER RES, V19, P4333; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee H P, 1987, Ann Acad Med Singap, V16, P397; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Maekelae R, 2008, CLIN BIOCHEM, V41, P532, DOI 10.1016/j.clinbiochem.2008.01.017; Merrick DT, 2012, CHEST, V141, P1377, DOI 10.1378/chest.11-2662; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Uramoto H, 2005, LUNG CANCER, V49, P55, DOI 10.1016/j.lungcan.2004.12.011; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang MJ, 2009, ONCOLOGY-BASEL, V76, P199, DOI 10.1159/000201572; Winder T, 2011, ANN ONCOL, V22, P2431, DOI 10.1093/annonc/mdq771; Xing XM, 2011, ACTA HISTOCHEM, V113, P777, DOI 10.1016/j.acthis.2010.11.006; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Zhang J, 2006, CLIN EXP METASTAS, V23, P401, DOI 10.1007/s10585-006-9051-9; Zhang LH, 2011, BRAIN RES, V1371, P23, DOI 10.1016/j.brainres.2010.11.063; Zhu X, 2013, CARCINOGENESIS; Zhu X, 2012, CHEST, V141, P1466, DOI 10.1378/chest.11-0469; Zhu X, 2009, INT J CANCER, V125, P1352, DOI 10.1002/ijc.24487	37	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66791	10.1371/journal.pone.0066791	http://dx.doi.org/10.1371/journal.pone.0066791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818965	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800102
J	Sims-Lucas, S; Schaefer, C; Bushnell, D; Ho, J; Logar, A; Prochownik, E; Gittes, G; Bates, CM				Sims-Lucas, Sunder; Schaefer, Caitlin; Bushnell, Daniel; Ho, Jacqueline; Logar, Alison; Prochownik, Edward; Gittes, George; Bates, Carlton M.			Endothelial Progenitors Exist within the Kidney and Lung Mesenchyme	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEIN; PHENOTYPIC HETEROGENEITY; VASCULOGENIC MIMICRY; CELLS; MECHANISMS; ORIGIN	The renal endothelium has been debated as arising from resident hemangioblast precursors that transdifferentiate from the nephrogenic mesenchyme (vasculogenesis) and/or from invading vessels (angiogenesis). While the Foxd1-positive renal cortical stroma has been shown to differentiate into cells that support the vasculature in the kidney (including vascular smooth muscle and pericytes) it has not been considered as a source of endothelial cell progenitors. In addition, it is unclear if Foxd1-positive mesenchymal cells in other organs such as the lung have the potential to form endothelium. This study examines the potential for Foxd1-positive cells of the kidney and lung to give rise to endothelial progenitors. We utilized immunofluorescence (IF) and fluorescence-activated cell sorting (FACS) to co-label Foxd1-expressing cells (including permanently lineage-tagged cells) with endothelial markers in embryonic and postnatal mice. We also cultured FACsorted Foxd1-positive cells, performed in vitro endothelial cell tubulogenesis assays and examined for endocytosis of acetylated low-density lipoprotein (Ac-LDL), a functional assay for endothelial cells. Immunofluorescence and FACS revealed that a subset of Foxd1-positive cells from kidney and lung co-expressed endothelial cell markers throughout embryogenesis. In vitro, cultured embryonic Foxd1-positive cells were able to differentiate into tubular networks that expressed endothelial cell markers and were able to endocytose Ac-LDL. IF and FACS in both the kidney and lung revealed that lineage-tagged Foxd1-positive cells gave rise to a significant portion of the endothelium in postnatal mice. In the kidney, the stromal-derived cells gave rise to a portion of the peritubular capillary endothelium, but not of the glomerular or large vessel endothelium. These findings reveal the heterogeneity of endothelial cell lineages; moreover, Foxd1-positive mesenchymal cells of the developing kidney and lung are a source of endothelial progenitors that are likely critical to patterning the vasculature.	[Sims-Lucas, Sunder; Schaefer, Caitlin; Bushnell, Daniel; Ho, Jacqueline; Logar, Alison; Prochownik, Edward; Gittes, George; Bates, Carlton M.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Sims-Lucas, Sunder; Schaefer, Caitlin; Bushnell, Daniel; Ho, Jacqueline; Bates, Carlton M.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Nephrol,Dept Pediat, Pittsburgh, PA USA; [Prochownik, Edward] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Sect Hematol Oncol, Pittsburgh, PA USA; [Prochownik, Edward] Univ Pittsburgh, Med Ctr, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Prochownik, Edward] Univ Pittsburgh, Ctr Comprehens Canc, Pittsburgh, PA USA; [Gittes, George] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Pediat Gen & Thorac Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sims-Lucas, S (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Rangos Res Ctr, Pittsburgh, PA 15213 USA.	simslucass@upmc.edu; batescm@upmc.edu	Ho, Jackie/AAP-1531-2021	Ho, Jackie/0000-0001-7115-1381; Sims-Lucas, Sunder/0000-0003-1908-4809	American Heart Association postdoctoral fellowship [11POST7330002]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096996, R00DK087922] Funding Source: NIH RePORTER	American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SSL was supported by an American Heart Association postdoctoral fellowship (11POST7330002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 1998, KIDNEY INT, V54, pS7, DOI 10.1046/j.1523-1755.1998.06702.x; Aird WC, 2006, CIRC RES, V98, P159, DOI 10.1161/01.RES.0000204553.32549.a7; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; deMello DE, 1997, AM J RESP CELL MOL, V16, P568, DOI 10.1165/ajrcmb.16.5.9160839; ESKILD W, 1987, SCAND J GASTROENTERO, V22, P1263, DOI 10.3109/00365528708996474; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hyink DP, 1996, AM J PHYSIOL-RENAL, V270, pF886, DOI 10.1152/ajprenal.1996.270.5.F886; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Lancrin C, 2010, J MOL MED, V88, P167, DOI 10.1007/s00109-009-0554-0; Lopez MLSS, 2011, J AM SOC NEPHROL, V22, P2156, DOI 10.1681/ASN.2011080818; Lopez MLSS, 2001, AM J PHYSIOL-RENAL, V281, pF345, DOI 10.1152/ajprenal.2001.281.2.F345; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Robert B, 1998, AM J PHYSIOL-RENAL, V275, pF164, DOI 10.1152/ajprenal.1998.275.1.F164; Sajithlal GB, 2010, INT J CANCER, V127, P2268, DOI 10.1002/ijc.25251; Schnapp L, 2012, AC LUNG INJ AJRCCM C; Shah SR, 2011, DEV BIOL, V349, P342, DOI 10.1016/j.ydbio.2010.10.033; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034	20	47	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65993	10.1371/journal.pone.0065993	http://dx.doi.org/10.1371/journal.pone.0065993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823180	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000320576400045
J	Fitzsimmons, KE; Hambach, U; Veres, D; Iovita, R				Fitzsimmons, Kathryn E.; Hambach, Ulrich; Veres, Daniel; Iovita, Radu			The Campanian Ignimbrite Eruption: New Data on Volcanic Ash Dispersal and Its Potential Impact on Human Evolution	PLOS ONE			English	Article							GRANDE-DI-MONTICCHIO; UPPER PALEOLITHIC TRANSITION; LATE PLEISTOCENE; DEPOSITIONAL PROCESSES; VOJVODINA REGION; CLIMATE-CHANGE; LOESS; TEPHRA; NORTHERN; HISTORY	The Campanian Ignimbrite (CI) volcanic eruption was the most explosive in Europe in the last 200,000 years. The event coincided with the onset of an extremely cold climatic phase known as Heinrich Event 4 (HE4) approximately 40,000 years ago. Their combined effect may have exacerbated the severity of the climate through positive feedbacks across Europe and possibly globally. The CI event is of particular interest not only to investigate the role of volcanism on climate forcing and palaeoenvironments, but also because its timing coincides with the arrival into Europe of anatomically modern humans, the demise of Neanderthals, and an associated major shift in lithic technology. At this stage, however, the degree of interaction between these factors is poorly known, based on fragmentary and widely dispersed data points. In this study we provide important new data from Eastern Europe which indicate that the magnitude of the CI eruption and impact of associated distal ash (tephra) deposits may have been substantially greater than existing models suggest. The scale of the eruption is modelled by tephra distribution and thickness, supported by local data points. CI ashfall extends as far as the Russian Plain, Eastern Mediterranean and northern Africa. However, modelling input is limited by very few data points in Eastern Europe. Here we investigate an unexpectedly thick CI tephra deposit in the southeast Romanian loess steppe, positively identified using geochemical and geochronological analyses. We establish the tephra as a widespread primary deposit, which blanketed the topography both thickly and rapidly, with potentially catastrophic impacts on local ecosystems. Our discovery not only highlights the need to reassess models for the magnitude of the eruption and its role in climatic transition, but also suggests that it may have substantially influenced hominin population and subsistence dynamics in a region strategic for human migration into Europe.	[Fitzsimmons, Kathryn E.; Iovita, Radu] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Hambach, Ulrich] Univ Bayreuth, Chair Geomorphol, Lab Palaeo & Enviromagnetism, Bayreuth, Germany; [Veres, Daniel] Romanian Acad, Inst Speleol, Cluj Napoca, Romania; [Veres, Daniel] Univ Babes Bolyai, Fac Environm Sci, R-3400 Cluj Napoca, Romania; [Iovita, Radu] RGZM, MONREPOS Archaeol Res Ctr, Neuwied, Germany; [Iovita, Radu] RGZM, Museum Human Behav Evolut, Neuwied, Germany	Max Planck Society; University of Bayreuth; Emil Racovita Institute of Speleology; Romanian Academy of Sciences; Babes Bolyai University from Cluj; Leibniz-Forschungsinstitut fur Archaologie (RGZM); Leibniz-Forschungsinstitut fur Archaologie (RGZM)	Fitzsimmons, KE (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	kathryn_fitzsimmons@eva.mpg.de	Fitzsimmons, Kathryn/U-3565-2018; Veres, Daniel/AAX-3319-2020; Iovita, Radu/B-9580-2015; Veres, Daniel S/GNH-2578-2022; Fitzsimmons, Kathryn/P-3471-2014; Veres, Daniel/GNH-2718-2022	Fitzsimmons, Kathryn/0000-0002-9337-0793; Veres, Daniel/0000-0003-3932-577X; Iovita, Radu/0000-0001-9531-1159; Fitzsimmons, Kathryn/0000-0002-9337-0793; 	Max Planck Society through the project "Lower Danube Survey for Palaeolithic Sites''; CNCS-UEFISCDI [PN-II-RU-TE-2011-3-0062, 73/05.10.2011]	Max Planck Society through the project "Lower Danube Survey for Palaeolithic Sites''; CNCS-UEFISCDI	This work was funded by the Max Planck Society through the project "Lower Danube Survey for Palaeolithic Sites''. D. Veres acknowledges the support of CNCS-UEFISCDI through grant PN-II-RU-TE-2011-3-0062, contract no. 73/05.10.2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott PM, 2012, EARTH-SCI REV, V115, P173, DOI 10.1016/j.earscirev.2012.09.001; Accorsi C.A., 1979, ATTI SOC TOSCANA S A, V86, P435; Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Andersen KK, 2006, QUATERNARY SCI REV, V25, P3246, DOI 10.1016/j.quascirev.2006.08.002; Anghelinu M, 2013, QUAT INT IN PRESS, DOI [10.1016/j.quaint.2012.03.013, DOI 10.1016/J.QUAINT.2012.03.013.(IN]; Baales M, 2002, QUATERNARY RES, V58, P273, DOI 10.1006/qres.2002.2379; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Barberi F., 1978, B VOLCANOL, V41, P10, DOI DOI 10.1007/BF02597680; Barton L, 2007, DEV QUATER SCI, V9, P105, DOI 10.1016/S1571-0866(07)09009-4; Baumgart P, 2013, QUATERN INT, V296, P82, DOI 10.1016/j.quaint.2012.12.021; Botter-Jensen L, 1999, QUATERNARY SCI REV, V18, P303, DOI 10.1016/S0277-3791(98)00063-8; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; Buggle B, 2013, GEOLOGY IN PRESS, DOI [10.1130/G34198.1, DOI 10.1130/G34198.1.(IN]; Buggle B, 2008, QUATERNARY SCI REV, V27, P1058, DOI 10.1016/j.quascirev.2008.01.018; Buggle B, 2009, QUATERN INT, V196, P86, DOI 10.1016/j.quaint.2008.07.013; Buylaert JP, 2012, BOREAS, V41, P435, DOI 10.1111/j.1502-3885.2012.00248.x; Byerly RM, 2007, J ARCHAEOL SCI, V34, P1847, DOI 10.1016/j.jas.2007.01.001; Civetta L, 1997, J VOLCANOL GEOTH RES, V75, P183, DOI 10.1016/S0377-0273(96)00027-3; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; Constantin D, 2012, QUAT GEOCHRONOL, V10, P81, DOI 10.1016/j.quageo.2012.01.012; Costa A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051605; Cronin SJ, 2003, J VOLCANOL GEOTH RES, V121, P271, DOI 10.1016/S0377-0273(02)00465-1; D'Alessandro W, 2006, WIT TR BIOMED HEALTH, V10, P21, DOI 10.2495/ETOX060031; Davies SM, 2010, EARTH PLANET SC LETT, V294, P69, DOI 10.1016/j.epsl.2010.03.004; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; Dumond DE, 2004, ARCTIC ANTHROPOL, V41, P112, DOI 10.1353/arc.2011.0023; Evans ME, 2001, EARTH-SCI REV, V54, P129, DOI 10.1016/S0012-8252(01)00044-7; Fedele F., 2007, LIVING SHADOW CULTUR, P19; Fedele F. G., 2003, GEOPHYS MONOGR SER, V139, P301, DOI DOI 10.1029/139GM20; Fedele FG, 2008, J HUM EVOL, V55, P834, DOI 10.1016/j.jhevol.2008.08.012; Ferrier C, 2000, TEMNATA CAVE EXCAVAT, P13; Fitzsimmons KE, 2012, QUATERNARY SCI REV, V41, P104, DOI 10.1016/j.quascirev.2012.03.002; Frechen M, 1996, ANCIENT TL, V14, P15; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Gambassini P., 1997, PALEOLITICO CASTELCI; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Giaccio B., 2006, NEANDERTHALS MODERN, P343; Giaccio B, 2008, J VOLCANOL GEOTH RES, V177, P208, DOI 10.1016/j.jvolgeores.2007.10.007; Grattan J, 2006, QUATERN INT, V151, P10, DOI 10.1016/j.quaint.2006.01.019; GRATTAN JP, 1994, J ARCHAEOL SCI, V21, P851, DOI 10.1006/jasc.1994.1082; Haase D, 2007, QUATERNARY SCI REV, V26, P1301, DOI 10.1016/j.quascirev.2007.02.003; Hambach U., 2010, NEW ASPECTS CENTRAL, V72, P295; Hambach U, 2008, EISZEITALTER GEGENWA, V57, P25, DOI DOI 10.3285/EG.57.1-2.2; Haslam M, 2010, J ARCHAEOL SCI, V37, P3370, DOI 10.1016/j.jas.2010.07.034; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; Hoffecker JF, 2008, J HUM EVOL, V55, P858, DOI 10.1016/j.jhevol.2008.08.018; Horwell CJ, 2006, B VOLCANOL, V69, P1, DOI 10.1007/s00445-006-0052-y; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; Iovita R, 2012, ANTIQUITY, V86, P973, DOI 10.1017/S0003598X00048195; Iovita RP, 2013, QUAT INT IN PRESS; Jones SC, 2012, QUATERN INT, V258, P100, DOI 10.1016/j.quaint.2011.09.017; Kadereit A, 2013, QUATERNARY SCI REV, V59, P67, DOI 10.1016/j.quascirev.2012.10.026; Klein R, 1999, HUMAN BIOL CULTURAL; Kockum PCF, 2006, CHEM GEOL, V231, P57, DOI 10.1016/j.chemgeo.2005.12.008; KUKLA GJ, 1975, AUSTRALOPITHECINES, P99; Lane CS, 2012, QUATERNARY SCI REV, V36, P50, DOI 10.1016/j.quascirev.2010.10.015; Lowe J, 2012, P NATL ACAD SCI USA, V109, P13532, DOI 10.1073/pnas.1204579109; Markovic SB, 2012, NETH J GEOSCI, V91, P173; Markovic SB, 2008, J QUATERNARY SCI, V23, P73, DOI 10.1002/jqs.1124; Melekeszev I. V., 1984, VULCANOLOGIA SEISMOL, V3, P35; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mihailovic D, 2008, PALAEOLITHIC BALKANS, V1819, P93; Morley MW, 2011, QUATERNARY RES, V75, P683, DOI 10.1016/j.yqres.2011.02.005; Munteanu Mihai Tudor, 2008, Acta Palaeontologica Romaniae, V6, P229; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Nowaczyk NR, 2012, EARTH PLANET SC LETT, V351, P54, DOI 10.1016/j.epsl.2012.06.050; Ort MH, 2003, B VOLCANOL, V65, P55, DOI 10.1007/s00445-002-0241-2; Panaiotu CG, 2001, PHYS CHEM EARTH PT A, V26, P893, DOI 10.1016/S1464-1895(01)00138-7; Pappalardo L, 2002, J VOLCANOL GEOTH RES, V114, P479, DOI 10.1016/S0377-0273(01)00302-X; Paterne M., 1992, TEMNATA CAVE EXCAVAT, V1, P99; Pawlikowskj M, 1992, TEMNATA CAVE EXCAVAT, P89; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Pyle DM, 2006, QUATERNARY SCI REV, V25, P2713, DOI 10.1016/j.quascirev.2006.06.008; PYLE DM, 1989, B VOLCANOL, V51, P1, DOI 10.1007/BF01086757; Rees-Jones J, 1995, ANCIENT TL, V13, P9; ReesJones J, 1997, ARCHAEOMETRY, V39, P177, DOI 10.1111/j.1475-4754.1997.tb00797.x; Riede F, 2008, J ARCHAEOL SCI, V35, P591, DOI 10.1016/j.jas.2007.05.007; Riede F, 2009, LITHIC TECHNOL, V34, P27, DOI 10.1080/01977261.2009.11721072; Riede F, 2009, J ARCHAEOL SCI, V36, P675, DOI 10.1016/j.jas.2008.10.013; Romanowska I., 2012, UNRAVELLING PALAEOLI, P1; Rosi M, 1999, J VOLCANOL GEOTH RES, V91, P179, DOI 10.1016/S0377-0273(99)00035-9; Rousseau DD, 2006, QUATERNARY SCI REV, V25, P2025, DOI 10.1016/j.quascirev.2006.03.009; Signorelli S, 1999, J VOLCANOL GEOTH RES, V91, P199, DOI 10.1016/S0377-0273(99)00036-0; Sinitsyn AA, 2006, QUATERN INT, V152, P164, DOI 10.1016/j.quaint.2005.12.007; Sinitsyn AA, 2003, ANTIQUITY, V77, P9, DOI 10.1017/S0003598X00061299; Sitlivy V, 2014, QUATERN INT, V351, P193, DOI 10.1016/j.quaint.2012.07.024; SMALLEY IJ, 1978, SEDIMENT GEOL, V21, P1, DOI 10.1016/0037-0738(78)90031-3; SPARKS S, 2005, SUPERERUPTIONS GLOBA; Stevens T, 2011, QUATERNARY SCI REV, V30, P662, DOI 10.1016/j.quascirev.2010.12.011; Storey M, 2012, P NATL ACAD SCI USA, V109, P18684, DOI 10.1073/pnas.1208178109; Stringer CB, 2007, VERTEBR PALEOBIOL PA, P315; Stuut JB, 2009, QUATERN INT, V198, P234, DOI 10.1016/j.quaint.2008.10.007; Timar A, 2010, QUAT GEOCHRONOL, V5, P143, DOI 10.1016/j.quageo.2009.03.003; Timmreck C, 2012, QUATERN INT, V258, P30, DOI 10.1016/j.quaint.2011.10.008; Ton-That T, 2001, EARTH PLANET SC LETT, V184, P645, DOI 10.1016/S0012-821X(00)00358-7; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Tzedakis PC, 2002, SCIENCE, V297, P2044, DOI 10.1126/science.1073083; Ujvari G, 2008, QUATERNARY RES, V69, P421, DOI 10.1016/j.yqres.2008.02.001; Upton J, 2002, QUAT RES ASS 1 POSTG; van der Kaars S, 2012, QUATERN INT, V258, P45, DOI 10.1016/j.quaint.2011.09.006; Veres D, 2013, QUATERN INT, V293, P22, DOI 10.1016/j.quaint.2012.02.042; Watts WA, 2000, PALAEOGEOGR PALAEOCL, V155, P83, DOI 10.1016/S0031-0182(99)00096-6; Watts WA, 1996, QUATERNARY SCI REV, V15, P133, DOI 10.1016/0277-3791(95)00093-3; Williams M, 2012, QUATERN INT, V258, P19, DOI 10.1016/j.quaint.2011.08.025; Wolff EW, 2010, QUATERNARY SCI REV, V29, P2828, DOI 10.1016/j.quascirev.2009.10.013; Wood RE, 2013, P NATL ACAD SCI USA, V110, P2781, DOI 10.1073/pnas.1207656110; Zielinski GA, 1996, QUATERNARY RES, V45, P109, DOI 10.1006/qres.1996.0013; Zilhao Joao, 2007, RETHINKING HUMAN REV, P249; Zolitschka B, 1996, QUATERNARY SCI REV, V15, P101, DOI 10.1016/0277-3791(95)00022-4	111	71	72	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65839	10.1371/journal.pone.0065839	http://dx.doi.org/10.1371/journal.pone.0065839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799050	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800017
J	Hunter, LJR; Westwood, JH; Heath, G; Macaulay, K; Smith, AG; MacFarlane, SA; Palukaitis, P; Carr, JP				Hunter, Lydia J. R.; Westwood, Jack H.; Heath, Geraldine; Macaulay, Keith; Smith, Alison G.; MacFarlane, Stuart A.; Palukaitis, Peter; Carr, John P.			Regulation of RNA-Dependent RNA Polymerase 1 and Isochorismate Synthase Gene Expression in Arabidopsis	PLOS ONE			English	Article							DICER-LIKE PROTEINS; SALICYLIC-ACID; ABSCISIC-ACID; VIRUS; PLANT; RESISTANCE; BIOGENESIS; DEFENSE; INFECTION; THALIANA	Background: RNA-dependent RNA polymerases (RDRs) function in anti-viral silencing in Arabidopsis thaliana and other plants. Salicylic acid (SA), an important defensive signal, increases RDR1 gene expression, suggesting that RDR1 contributes to SA-induced virus resistance. In Nicotiana attenuata RDR1 also regulates plant-insect interactions and is induced by another important signal, jasmonic acid (JA). Despite its importance in defense RDR1 regulation has not been investigated in detail. Methodology/Principal Findings: In Arabidopsis, SA-induced RDR1 expression was dependent on 'NON-EXPRESSER OF PATHOGENESIS-RELATED GENES 1', indicating regulation involves the same mechanism controlling many other SA-defenserelated genes, including pathogenesis-related 1 (PR1). Isochorismate synthase 1 (ICS1) is required for SA biosynthesis. In defensive signal transduction RDR1 lies downstream of ICS1. However, supplying exogenous SA to ics1-mutant plants did not induce RDR1 or PR1 expression to the same extent as seen in wild type plants. Analysing ICS1 gene expression using transgenic plants expressing ICS1 promoter: reporter gene (beta-glucuronidase) constructs and by measuring steady-state ICS1 transcript levels showed that SA positively regulates ICS1. In contrast, ICS2, which is expressed at lower levels than ICS1, is unaffected by SA. The wound-response hormone JA affects expression of Arabidopsis RDR1 but jasmonate-induced expression is independent of CORONATINE-INSENSITIVE 1, which conditions expression of many other JA-responsive genes. Transiently increased RDR1 expression following tobacco mosaic virus inoculation was due to wounding and was not a direct effect of infection. RDR1 gene expression was induced by ethylene and by abscisic acid (an important regulator of drought resistance). However, rdr1-mutant plants showed normal responses to drought. Conclusions/Significance: RDR1 is regulated by a much broader range of phytohormones than previously thought, indicating that it plays roles beyond those already suggested in virus resistance and plant-insect interactions. SA positively regulates ICS1.	[Hunter, Lydia J. R.; Westwood, Jack H.; Heath, Geraldine; Macaulay, Keith; Smith, Alison G.; Carr, John P.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Hunter, Lydia J. R.; MacFarlane, Stuart A.; Palukaitis, Peter] James Hutton Inst, Dundee, Scotland; [Palukaitis, Peter] Seoul Womens Univ, Div Environm & Life Sci, Seoul, South Korea	University of Cambridge; James Hutton Institute; Seoul Women's University	Carr, JP (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	jpc1005@hermes.cam.ac.uk	Carr, John/H-5646-2016; Carr, John Peter/N-7707-2019	Carr, John/0000-0002-5028-2160; Carr, John Peter/0000-0002-5028-2160; Smith, Alison Gail/0000-0001-6511-5704	James Hutton Institute; UK Biotechnological and Biological Sciences Research Council (BBSRC); Leverhulme Trust [RPG-2012-667]; BBSRC [BB/D014376/1, BB/J011762/1]; Cambridge University Newton Trust; Biotechnology and Biological Sciences Research Council [BB/J011762/1] Funding Source: researchfish	James Hutton Institute; UK Biotechnological and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge University Newton Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	First author (LJRH) supported by a studentship co-funded by the James Hutton (formerly Scottish Crop Research) Institute and the UK Biotechnological and Biological Sciences Research Council (BBSRC). Work in the JPC lab is funded by The Leverhulme Trust (RPG-2012-667), BBSRC (BB/D014376/1, BB/J011762/1) and the Cambridge University Newton Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Carr JP, 2010, ADV VIRUS RES, V76, P57, DOI 10.1016/S0065-3527(10)76003-6; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Donaire L, 2008, J VIROL, V82, P5167, DOI 10.1128/JVI.00272-08; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Earley K, 2010, SILENCE, V1, P15, DOI [10.1186/1758-907X-1-15, DOI 10.1186/1758-907X-1-15]; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hase S, 2003, PHYSIOL MOL PLANT P, V62, P219, DOI 10.1016/S0885-5765(03)00059-6; He JG, 2010, MOL BIOL REP, V37, P865, DOI 10.1007/s11033-009-9692-2; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Kachroo P, 2000, PLANT CELL, V12, P677, DOI 10.1105/tpc.12.5.677; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Lee WS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-41; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; MacDiarmid R, 2005, ANNU REV PHYTOPATHOL, V43, P523, DOI 10.1146/annurev.phyto.43.040204.140204; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Molnar A, 2005, J VIROL, V79, P7812, DOI 10.1128/JVI.79.12.7812-7818.2005; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Palukaitis P, 2011, PLANT PATHOLOGY J, V27, P197, DOI 10.5423/PPJ.2011.27.3.197; Pandey SP, 2008, P NATL ACAD SCI USA, V105, P4559, DOI 10.1073/pnas.0711363105; Pandey SP, 2007, PLANT J, V50, P40, DOI 10.1111/j.1365-313X.2007.03030.x; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qi XP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004971; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Rakhshandehroo F, 2009, MOL PLANT MICROBE IN, V22, P1312, DOI 10.1094/MPMI-22-10-1312; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson F, 2009, PLANT MOL BIOL, V69, P419, DOI 10.1007/s11103-008-9407-4; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Thaler JS, 2004, PLANT PHYSIOL, V135, P530, DOI 10.1104/pp.104.041566; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Westwood JH, 2013, MOL PLANT PATHOL, V14, P158, DOI 10.1111/j.1364-3703.2012.00840.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wong CE, 2002, MOL PLANT MICROBE IN, V15, P75, DOI 10.1094/MPMI.2002.15.1.75; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x; Yang HF, 2011, MOL BIOL REP, V38, P929, DOI 10.1007/s11033-010-0186-z; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; ZAITLIN M, 1987, ANNU REV PLANT PHYS, V38, P291, DOI 10.1146/annurev.pp.38.060187.001451; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107	64	60	61	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66530	10.1371/journal.pone.0066530	http://dx.doi.org/10.1371/journal.pone.0066530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799112	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800035
J	Sealy-Jefferson, S; Gillespie, BW; Aiello, AE; Haan, MN; Morgenstern, LB; Lisabeth, LD				Sealy-Jefferson, Shawnita; Gillespie, Brenda W.; Aiello, Allison E.; Haan, Mary N.; Morgenstern, Lewis B.; Lisabeth, Lynda D.			Antibody Levels to Persistent Pathogens and Incident Stroke in Mexican Americans	PLOS ONE			English	Article							HELICOBACTER-PYLORI-INFECTION; C-REACTIVE PROTEIN; BRAIN ATTACK SURVEILLANCE; TYPE-2 DIABETES-MELLITUS; POPULATION-BASED COHORT; CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; ISCHEMIC-STROKE; UNITED-STATES; RISK-FACTORS	Background: Persistent pathogens have been proposed as risk factors for stroke; however, the evidence remains inconclusive. Mexican Americans have an increased risk of stroke especially at younger ages, as well as a higher prevalence of infections caused by several persistent pathogens. Methodology/Principal: Findings Using data from the Sacramento Area Latino Study on Aging (n = 1621), the authors used discrete-time regression to examine associations between stroke risk and (1) immunoglobulin G antibody levels to Helicobacter pylori (H. pylori), Cytomegalovirus, Varicella Zoster Virus, Toxoplasma gondii and Herpes simplex virus 1, and (2) concurrent exposure to several pathogens (pathogen burden), defined as: (a) summed sero-positivity, (b) number of pathogens eliciting high antibody levels, and (c) average antibody level. Models were adjusted for socio-demographics and stroke risk factors. Antibody levels to H. pylori predicted incident stroke in fully adjusted models (Odds Ratio: 1.58; 95% Confidence Interval: 1.09, 2.28). No significant associations were found between stroke risk and antibody levels to the other four pathogens. No associations were found for pathogen burden and incident stroke in fully adjusted models. Conclusions/Significance: Our results suggest that exposure to H. pylori may be a stroke risk factor in Mexican Americans and may contribute to ethnic differences in stroke risk given the increased prevalence of exposure to H. pylori in this population. Future studies are needed to confirm this association.	[Sealy-Jefferson, Shawnita] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48202 USA; [Gillespie, Brenda W.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Gillespie, Brenda W.] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Aiello, Allison E.; Lisabeth, Lynda D.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Haan, Mary N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Morgenstern, Lewis B.; Lisabeth, Lynda D.] Univ Michigan, Sch Med, Stroke Program, Ann Arbor, MI USA; [Morgenstern, Lewis B.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Wayne State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sealy-Jefferson, S (corresponding author), Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48202 USA.	ssealyj@med.wayne.edu	Sealy-Jefferson, Shawnita/AAS-8992-2020; Haan, Mary N/Y-9354-2018	Haan, Mary N/0000-0001-9312-4501	National Research Service Award [NRSA: 1F31NS070430-01A1]; National Institutes of Health [AG12975, DK60753]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012975] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Research Service Award (NRSA: 1F31NS070430-01A1) and the National Institutes of Health Grants AG12975 and DK60753. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J INFECT DIS, V197, P34, DOI 10.1086/524144; Allison PD, 2010, SURV AN US SAS PRACT; American Stroke Association, ATH STROK; BARNES RJ, 1991, BRIT J GEN PRACT, V41, P286; Baudron CR, 2013, J AM GERIATR SOC, V61, P74, DOI 10.1111/jgs.12065; Beck JD, 2005, J PERIODONTOL, V76, P2089, DOI 10.1902/jop.2005.76.11-S.2089; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; Dierkes J, 2003, DIGEST DIS, V21, P237, DOI 10.1159/000073341; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; Elkind MSV, 2006, STROKE, V37, P790, DOI 10.1161/01.STR.0000202624.89869.e9; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Evrengul H, 2007, HELICOBACTER, V12, P298, DOI 10.1111/j.1523-5378.2007.00505.x; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Genco R, 2002, J AM DENT ASSOC, V133, p14S, DOI 10.14219/jada.archive.2002.0375; Gerard HC, 2005, MICROB PATHOGENESIS, V39, P19, DOI 10.1016/j.micpath.2005.05.002; Glymour MM, 2009, STROKE, V40, P873, DOI 10.1161/STROKEAHA.108.529479; Haan MN, 2003, J AM GERIATR SOC, V51, P169, DOI 10.1046/j.1532-5415.2003.51054.x; Haider AW, 2002, J AM COLL CARDIOL, V40, P1408, DOI 10.1016/S0735-1097(02)02272-6; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Itou Simon, 2007, Int J Med Sci, V4, P98; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Kis Z, 2007, NEW MICROBIOL, V30, P213; Liao W, 1996, J LAB CLIN MED, V128, P452, DOI 10.1016/S0022-2143(96)90042-6; Lindsberg PJ, 2003, STROKE, V34, P2518, DOI 10.1161/01.STR.0000089015.51603.CC; Lip GYH, 1996, BRIT MED J, V312, P250; Liu LJ, 2007, CIRC J, V71, P1761, DOI 10.1253/circj.71.1761; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; Miggins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018890; Moon SK, 2004, J CELL PHYSIOL, V198, P417, DOI 10.1002/jcp.10435; Morgenstern LB, 2004, AM J EPIDEMIOL, V160, P376, DOI 10.1093/aje/kwh225; Nazmi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-706; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; OMURA Y, 1988, ACUPUNCTURE ELECTRO, V13, P131, DOI 10.3727/036012988816358633; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Price DA, 2006, GUT, V55, P715, DOI 10.1136/gut.2005.079905; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Redeen S, 2010, DIGEST DIS SCI, V55, P351, DOI 10.1007/s10620-009-0761-0; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rubicz Rohina, 2011, BMC Res Notes, V4, P433, DOI 10.1186/1756-0500-4-433; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Schottker B, 2012, ATHEROSCLEROSIS, V220, P569, DOI 10.1016/j.atherosclerosis.2011.11.029; Simpson CF, 2004, J AM GERIATR SOC, V52, P123, DOI 10.1111/j.1532-5415.2004.52021.x; Smith MA, 2003, STROKE, V34, P2671, DOI 10.1161/01.STR.0000096459.62826.1F; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stettin D, 2008, ADV MED SCI-POLAND, V53, P205, DOI 10.2478/v10039-008-0050-8; Thorand B, 2003, ARCH INTERN MED, V163, P93, DOI 10.1001/archinte.163.1.93; Triantafillidis John K, 2003, Hepatogastroenterology, V50 Suppl 2, pcccxviii; Turchan-Cholewo J, 2006, NEUROBIOL DIS, V23, P109, DOI 10.1016/j.nbd.2006.02.005; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568; Wozniak MA, 2002, HEPATOLOGY, V36, P456, DOI 10.1053/jhep.2002.34745; Wu JH, 2003, DIABETES CARE, V26, P314, DOI 10.2337/diacare.26.2.314; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456	59	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65959	10.1371/journal.pone.0065959	http://dx.doi.org/10.1371/journal.pone.0065959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799066	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300056
J	Thome, R; Moraes, AS; Bombeiro, AL; Farias, AD; Francelin, C; da Costa, TA; Di Gangi, R; dos Santos, LMB; de Oliveira, ALR; Verinaud, L				Thome, Rodolfo; Moraes, Adriel S.; Bombeiro, Andre Luis; Farias, Alessandro dos Santos; Francelin, Carolina; da Costa, Thiago Alves; Di Gangi, Rosaria; Barbosa dos Santos, Leonilda Maria; Rodrigues de Oliveira, Alexandre Leite; Verinaud, Liana			Chloroquine Treatment Enhances Regulatory T Cells and Reduces the Severity of Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IMMUNOLOGICAL SELF-TOLERANCE; VERSUS-HOST-DISEASE; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; TGF-BETA; ORAL TOLERANCE; FACTOR-ALPHA; TH17 CELLS; HYDROXYCHLOROQUINE	Background: The modulation of inflammatory processes is a necessary step, mostly orchestrated by regulatory T (Treg) cells and suppressive Dendritic Cells (DCs), to prevent the development of deleterious responses and autoimmune diseases. Therapies that focused on adoptive transfer of Treg cells or their expansion in vivo achieved great success in controlling inflammation in several experimental models. Chloroquine (CQ), an anti-malarial drug, was shown to reduce inflammation, although the mechanisms are still obscure. In this context, we aimed to access whether chloroquine treatment alters the frequency of Treg cells and DCs in normal mice. In addition, the effects of the prophylactic and therapeutic treatment with CQ on Experimental Autoimmune Encephalomyelitis (EAE), an experimental model for human Multiple Sclerosis, was investigated as well. Methodology/Principal Findings: EAE was induced in C57BL/6 mice by immunization with myelin oligodendrocyte glycoprotein (MOG(35-55)) peptide. C57BL/6 mice were intraperitoneally treated with chloroquine. Results show that the CQ treatment provoked an increase in Treg cells frequency as well as a decrease in DCs. We next evaluated whether prophylactic CQ administration is capable of reducing the clinical and histopathological signs of EAE. Our results demonstrated that CQ-treated mice developed mild EAE compared to controls that was associated with lower infiltration of inflammatory cells in the central nervous system CNS) and increased frequency of Treg cells. Also, proliferation of MOG(35-55)-reactive T cells was significantly inhibited by chloroquine treatment. Similar results were observed when chloroquine was administrated after disease onset. Conclusion: We show for the first time that CQ treatment promotes the expansion of Treg cells, corroborating previous reports indicating that chloroquine has immunomodulatory properties. Our results also show that CQ treatment suppress the inflammation in the CNS of EAE-inflicted mice, both in prophylactic and therapeutic approaches. We hypothesized that the increased number of regulatory T cells induced by the CQ treatment is involved in the reduction of the clinical signs of EAE.	[Thome, Rodolfo; Bombeiro, Andre Luis; Francelin, Carolina; da Costa, Thiago Alves; Di Gangi, Rosaria; Rodrigues de Oliveira, Alexandre Leite; Verinaud, Liana] Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Moraes, Adriel S.; Farias, Alessandro dos Santos; Barbosa dos Santos, Leonilda Maria] Univ Estadual Campinas, Dept Genet Evolut & Bioagents, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Verinaud, L (corresponding author), Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil.	verinaud@unicamp.br	da Costa, Thiago Alves/F-8187-2016; Oliveira, Alexandre L. R./C-4436-2012; Francelin, Carolina/AAZ-9572-2020; Moraes, Adriel S/F-1259-2013; Thome, Rodolfo/C-1564-2012; Oliveira, Alexandre/AAI-6815-2020; Farias, Alessandro/AAH-2228-2020	Oliveira, Alexandre L. R./0000-0003-4224-4575; Francelin, Carolina/0000-0001-7439-3124; Moraes, Adriel S/0000-0002-9365-573X; Thome, Rodolfo/0000-0001-7627-4137; Oliveira, Alexandre/0000-0003-4224-4575; Farias, Alessandro/0000-0001-6759-1819; Alves da Costa, Thiago/0000-0001-9591-331X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/17965-3]; FAPESP [2011-13191-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under grant number 2011/17965-3. R. T. was recipient of a FAPESP scholarship (#2011-13191-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom NF, 2004, ARTHRITIS RES THER, V6, pR151, DOI 10.1186/ar1049; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BERNARD CCA, 1976, J IMMUNOGENET, V3, P263; Bernstein H N, 1967, Surv Ophthalmol, V12, P415; BERNSTEIN HN, 1983, AM J MED, V75, P25, DOI 10.1016/0002-9343(83)91267-6; Bondeson J, 1998, GEN PHARMACOL, V30, P357, DOI 10.1016/S0306-3623(97)00269-3; Buttmann M, 2010, EXPERT REV NEUROTHER, V10, P791, DOI [10.1586/ern.10.38, 10.1586/ERN.10.38]; Capalbo D, 2012, INT REV IMMUNOL, V31, P344, DOI 10.3109/08830185.2012.697230; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Farias AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017849; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; FOX RI, 1993, SEMIN ARTHRITIS RHEU, V23, P82, DOI 10.1016/S0049-0172(10)80012-5; Grierson DJ, 1997, ANN RHEUM DIS, V56, P188, DOI 10.1136/ard.56.3.188; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jee Y, 2007, CLIN IMMUNOL, V125, P34, DOI 10.1016/j.clim.2007.05.020; Jeong JY, 1997, J IMMUNOL, V158, P4901; Kang YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049994; Karres I, 1998, AM J PHYSIOL-REG I, V274, pR1058, DOI 10.1152/ajpregu.1998.274.4.R1058; KOJIMA A, 1976, LAB INVEST, V34, P601; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lapierre P, 2013, HEPATOLOGY, V57, P217, DOI 10.1002/hep.26023; Loehberg CR, 2012, BIOCHEM PHARMACOL, V83, P480, DOI 10.1016/j.bcp.2011.11.022; Mavrikakis I, 2003, OPHTHALMOLOGY, V110, P1321, DOI 10.1016/S0161-6420(03)00409-3; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; MORAND EF, 1992, ANN RHEUM DIS, V51, P1318, DOI 10.1136/ard.51.12.1318; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Peron JPS, 2010, J NEUROIMMUNOL, V227, P10, DOI 10.1016/j.jneuroim.2010.06.002; Petermann F, 2011, FEBS LETT; PICOT S, 1993, IMMUNOLOGY, V80, P127; RAINES MF, 1989, INVEST OPHTH VIS SCI, V30, P1726; Rintelen B, 2006, CLIN RHEUMATOL, V25, P557, DOI 10.1007/s10067-005-0149-2; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; SANTOS LMB, 1994, CELL IMMUNOL, V157, P439, DOI 10.1006/cimm.1994.1240; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; SCHULTZ KR, 1995, BLOOD, V86, P4344, DOI 10.1182/blood.V86.11.4344.bloodjournal86114344; Schultz KR, 2002, BIOL BLOOD MARROW TR, V8, P648, DOI 10.1053/bbmt.2002.v8.abbmt080648; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Sprent J, 1995, Int Rev Immunol, V13, P95, DOI 10.3109/08830189509061740; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sundelin SP, 2002, APMIS, V110, P481, DOI 10.1034/j.1600-0463.2002.100606.x; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 2003, CURR MOL MED, V3, P693, DOI 10.2174/1566524033479429; Takata K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027644; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thome R, 2012, CELL IMMUNOL, V280, P113, DOI 10.1016/j.cellimm.2012.11.017; van Herwijnen MJC, 2012, P NATL ACAD SCI USA, V109, P14134, DOI 10.1073/pnas.1206803109; vandenBorne BEEM, 1997, J RHEUMATOL, V24, P55; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yurchenko E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035572; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	65	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65913	10.1371/journal.pone.0065913	http://dx.doi.org/10.1371/journal.pone.0065913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799062	gold, Green Submitted, Green Published			2022-12-27	WOS:000320363300053
J	Gibson, AR; Ojiambo, R; Konstabel, K; Lieberman, DE; Reilly, JJ; Speakman, JR; Pitsiladis, YP				Gibson, Alexander R.; Ojiambo, Robert; Konstabel, Kenn; Lieberman, Daniel E.; Reilly, John J.; Speakman, John R.; Pitsiladis, Yannis P.			Aerobic Capacity, Activity Levels and Daily Energy Expenditure in Male and Female Adolescents of the Kenyan Nandi Sub-Group	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; PHYSICAL-ACTIVITY; DEMOGRAPHIC CHARACTERISTICS; ANAEROBIC THRESHOLD; EXERCISE CAPACITY; AFRICAN-AMERICAN; CHILDREN; ENDURANCE; BOYS; FITNESS	The relative importance of genetic and socio-cultural influences contributing to the success of east Africans in endurance athletics remains unknown in part because the pre-training phenotype of this population remains incompletely assessed. Here cardiopulmonary fitness, physical activity levels, distance travelled to school and daily energy expenditure in 15 habitually active male (13.9 +/- 1.6 years) and 15 habitually active female (13.9 +/- 1.2) adolescents from a rural Nandi primary school are assessed. Aerobic capacity ((V) over dot O(2)max) was evaluated during two maximal discontinuous incremental exercise tests; physical activity using accelerometry combined with a global positioning system; and energy expenditure using the doubly labelled water method. The (V) over dot O(2)max of the male and female adolescents were 73.9 +/- 5.7 ml.kg(-1).min(-1) and 61.5 +/- 6.3 ml.kg(-1).min(-1), respectively. Total time spent in sedentary, light, moderate and vigorous physical activities per day was 406 +/- 63 min (50% of total monitored time), 244 +/- 56 min (30%), 75 +/- 18 min (9%) and 82 +/- 30 min (10%). Average total daily distance travelled to and from school was 7.5 +/- 3.0 km (0.8-13.4 km). Mean daily energy expenditure, activity-induced energy expenditure and physical activity level was 12.2 +/- 3.4 MJ. day(-1), 5.4 +/- 3.0 MJ. day(-1) and 2.2 +/- 0.6. 70.6% of the variation in (V) over dot O(2)max was explained by sex (partial R-2 = 54.7%) and body mass index (partial R-2 = 15.9%). Energy expenditure and physical activity variables did not predict variation in (V) over dot O(2)max once sex had been accounted for. The highly active and energy-demanding lifestyle of rural Kenyan adolescents may account for their exceptional aerobic fitness and collectively prime them for later training and athletic success.	[Gibson, Alexander R.; Ojiambo, Robert; Konstabel, Kenn; Reilly, John J.; Pitsiladis, Yannis P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ojiambo, Robert; Pitsiladis, Yannis P.] Moi Univ, Dept Med Physiol, Eldoret, Kenya; [Konstabel, Kenn] Univ Tartu, Inst Psychol, EE-50090 Tartu, Estonia; [Konstabel, Kenn] Univ Tartu, Sch Psychol Sci, Phys Act Hlth Grp, EE-50090 Tartu, Estonia; [Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, Key State Lab Mol Dev Biol, Beijing, Peoples R China	University of Glasgow; Moi University; University of Tartu; University of Tartu; Harvard University; University of Aberdeen; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Pitsiladis, YP (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, West Med Bldg, Glasgow, Lanark, Scotland.	Yannis.Pitsiladis@glasgow.ac.uk	Konstabel, Kenn/E-9919-2016; Speakman, John R./A-9494-2008	Konstabel, Kenn/0000-0002-9673-8469; Speakman, John R./0000-0002-2457-1823; Pitsiladis, Yannis/0000-0001-6210-2449; Gibson, Alexander/0000-0002-7314-0325				ANDERSEN KL, 1974, EUR J APPL PHYSIOL, V33, P177; ANDERSEN LB, 1987, EUR J APPL PHYSIOL O, V56, P74, DOI 10.1007/BF00696380; ANDERSEN LB, 1994, J INTERN MED, V236, P323, DOI 10.1111/j.1365-2796.1994.tb00803.x; Armstrong N., 1996, European Physical Education Review, V2, P19, DOI 10.1177/1356336X9600200103; ARMSTRONG N, 1991, EUR J APPL PHYSIOL, V62, P369, DOI 10.1007/BF00634975; Armstrong N, 1994, Exerc Sport Sci Rev, V22, P435; Armstrong N, 1998, SPORTS CHILDREN, P50; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Beunen GP, 1997, ANN HUM BIOL, V24, P33, DOI 10.1080/03014469700004752; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; COOPER DM, 1984, J APPL PHYSIOL, V56, P628, DOI 10.1152/jappl.1984.56.3.628; COOPER DM, 1994, MED SCI SPORT EXER, V26, P733, DOI 10.1249/00005768-199406000-00013; CURETON KJ, 1978, MED SCI SPORT EXER, V10, P194; Dencker M, 2006, EUR J APPL PHYSIOL, V96, P587, DOI 10.1007/s00421-005-0117-1; Eisenmann JC, 2001, J APPL PHYSIOL, V90, P2172, DOI 10.1152/jappl.2001.90.6.2172; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Hamilton B, 2000, BRIT J SPORT MED, V34, P391, DOI 10.1136/bjsm.34.5.391; Howe CCF, 2013, J SPORTS SC IN PRESS; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Klissouras V, 2001, EUR J SPORT SCI, V1, P1; Krahenbuhl G S, 1985, Exerc Sport Sci Rev, V13, P503; KRAHENBUHL GS, 1992, MED SCI SPORT EXER, V24, P462; Larsen HB, 2005, SCAND J MED SCI SPOR, V15, P48, DOI 10.1111/j.1600-0838.2004.00304.x; Larsen HB, 2004, ANN HUM BIOL, V31, P159, DOI 10.1080/03014460410001663416; Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Lucia A, 2006, APPL PHYSIOL NUTR ME, V31, P530, DOI 10.1139/H06-029; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; Morgan DW., 2008, PAEDIAT EXERCISE SCI, V2nd ed, P283; Myburgh KH, 2003, COMP BIOCHEM PHYS A, V136, P171, DOI 10.1016/S1095-6433(03)00220-4; Ojiambo R, 2013, ANN HUM BIO IN PRESS; Onywera VO, 2006, J SPORT SCI, V24, P415, DOI 10.1080/02640410500189033; Pettersen SA, 2001, SCAND J MED SCI SPOR, V11, P223, DOI 10.1034/j.1600-0838.2001.110405.x; Pitsiladis Y. P., 2004, Equine and Comparative Exercise Physiology, V1, P285, DOI 10.1079/ECP200433; Pitsiladis Yannis., 2007, E AFRICAN RUNNING CR; Poehlman ET, 2002, J CLIN ENDOCR METAB, V87, P1004, DOI 10.1210/jc.87.3.1004; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; REYBROUCK T, 1985, EUR J APPL PHYSIOL, V54, P278, DOI 10.1007/BF00426145; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; ROWLAND TW, 1992, CHEST, V101, P485, DOI 10.1378/chest.101.2.485; RUTENFRANZ J, 1981, EUR J PEDIATR, V136, P123, DOI 10.1007/BF00441914; RUTENFRANZ J, 1990, EUR J APPL PHYSIOL, V60, P282, DOI 10.1007/BF00379397; Saltin B, 1995, Scand J Med Sci Sports, V5, P315; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Scott RA, 2003, MED SCI SPORT EXER, V35, P1727, DOI 10.1249/01.MSS.0000089335.85254.89; Sheng LW, 1996, AM J HUM BIOL, V8, P497, DOI 10.1002/(SICI)1520-6300(1996)8:4<497::AID-AJHB10>3.0.CO;2-H; SIMON J, 1986, J APPL PHYSIOL, V60, P777, DOI 10.1152/jappl.1986.60.3.777; Speakman J.R., 1997, DOUBLY LABELLED WATE; SUNDBERG S, 1982, ACTA PAEDIATR SCAND, V71, P603, DOI 10.1111/j.1651-2227.1982.tb09482.x; Treuth MS, 2003, MED SCI SPORT EXER, V35, P532, DOI 10.1249/01.MSS.0000053702.03884.3F; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Trowbridge CA, 1997, AM J PHYSIOL-ENDOC M, V273, pE809, DOI 10.1152/ajpendo.1997.273.4.E809; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Welsman JR, 1996, J ROY SOC MED, V89, pP281, DOI 10.1177/014107689608900522; Westerterp KR, 2001, J EXP BIOL, V204, P3183	58	14	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66552	10.1371/journal.pone.0066552	http://dx.doi.org/10.1371/journal.pone.0066552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805234	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500062
J	Golubeva, YG; Smith, RM; Sternberg, LR				Golubeva, Yelena G.; Smith, Roberta M.; Sternberg, Lawrence R.			Optimizing Frozen Sample Preparation for Laser Microdissection: Assessment of CryoJane Tape-Transfer System (R)	PLOS ONE			English	Article							CAPTURE MICRODISSECTION; TISSUE; EXPRESSION; SECTIONS; CANCER; RNA; DNA	Laser microdissection is an invaluable tool in medical research that facilitates collecting specific cell populations for molecular analysis. Diversity of research targets (e.g., cancerous and precancerous lesions in clinical and animal research, cell pellets, rodent embryos, etc.) and varied scientific objectives, however, present challenges toward establishing standard laser microdissection protocols. Sample preparation is crucial for quality RNA, DNA and protein retrieval, where it often determines the feasibility of a laser microdissection project. The majority of microdissection studies in clinical and animal model research are conducted on frozen tissues containing native nucleic acids, unmodified by fixation. However, the variable morphological quality of frozen sections from tissues containing fat, collagen or delicate cell structures can limit or prevent successful harvest of the desired cell population via laser dissection. The CryoJane Tape-Transfer System (R), a commercial device that improves cryosectioning outcomes on glass slides has been reported superior for slide preparation and isolation of high quality osteocyte RNA (frozen bone) during laser dissection. Considering the reported advantages of CryoJane for laser dissection on glass slides, we asked whether the system could also work with the plastic membrane slides used by UV laser based microdissection instruments, as these are better suited for collection of larger target areas. In an attempt to optimize laser microdissection slide preparation for tissues of different RNA stability and cryosectioning difficulty, we evaluated the CryoJane system for use with both glass (laser capture microdissection) and membrane (laser cutting microdissection) slides. We have established a sample preparation protocol for glass and membrane slides including manual coating of membrane slides with CryoJane solutions, cryosectioning, slide staining and dissection procedure, lysis and RNA extraction that facilitated efficient dissection and high quality RNA retrieval from CryoJane preparations. CryoJane technology therefore has the potential to facilitate standardization of laser microdissection slide preparation from frozen tissues.	[Golubeva, Yelena G.; Smith, Roberta M.; Sternberg, Lawrence R.] Sci Applicat Int Corp, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Golubeva, YG (corresponding author), Sci Applicat Int Corp, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD USA.	golubevay@mail.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Ehrig T, 2001, J MOL DIAGN, V3, P22, DOI 10.1016/S1525-1578(10)60645-9; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Erickson HS, 2009, NAT PROTOC, V4, P902, DOI 10.1038/nprot.2009.61; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Flake GP, 2007, TOXICOL PATHOL, V35, P65, DOI 10.1080/01926230601052659; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gjerdrum LM, 2001, METHOD MOL BIOL, V239, P127; Golubeva Yelena, 2009, V511, P3, DOI 10.1007/978-1-59745-447-6_1; Huang LE, 2002, METHOD ENZYMOL, V356, P49; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kube DM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-25; Matas AJ, 2010, J EXP BOT, V61, P3321, DOI 10.1093/jxb/erq153; Nelson T, 2006, ANNU REV PLANT BIOL, V57, P181, DOI 10.1146/annurev.arplant.56.032604.144138; Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276; Sonne SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005536; Wang Z, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-100; Xu C, 2008, J MOL DIAGN, V10, P129, DOI 10.2353/jmoldx.2008.070131	20	12	13	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66854	10.1371/journal.pone.0066854	http://dx.doi.org/10.1371/journal.pone.0066854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805281	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500109
J	Kumfor, F; Irish, M; Hodges, JR; Piguet, O				Kumfor, Fiona; Irish, Muireann; Hodges, John R.; Piguet, Olivier			Discrete Neural Correlates for the Recognition of Negative Emotions: Insights from Frontotemporal Dementia	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; FACIAL EXPRESSIONS; BEHAVIORAL-VARIANT; BASIC EMOTIONS; HUMAN AMYGDALA; IMPAIRED RECOGNITION; SEMANTIC DEMENTIA; HUNTINGTONS-DISEASE; FUNCTIONAL NEUROANATOMY; PROCESSING IMPAIRMENTS	Patients with frontotemporal dementia have pervasive changes in emotion recognition and social cognition, yet the neural changes underlying these emotion processing deficits remain unclear. The multimodal system model of emotion proposes that basic emotions are dependent on distinct brain regions, which undergo significant pathological changes in frontotemporal dementia. As such, this syndrome may provide important insight into the impact of neural network degeneration upon the innate ability to recognise emotions. This study used voxel-based morphometry to identify discrete neural correlates involved in the recognition of basic emotions (anger, disgust, fear, sadness, surprise and happiness) in frontotemporal dementia. Forty frontotemporal dementia patients (18 behavioural-variant, 11 semantic dementia, 11 progressive nonfluent aphasia) and 27 healthy controls were tested on two facial emotion recognition tasks: The Ekman 60 and Ekman Caricatures. Although each frontotemporal dementia group showed impaired recognition of negative emotions, distinct associations between emotion-specific task performance and changes in grey matter intensity emerged. Fear recognition was associated with the right amygdala; disgust recognition with the left insula; anger recognition with the left middle and superior temporal gyrus; and sadness recognition with the left subcallosal cingulate, indicating that discrete neural substrates are necessary for emotion recognition in frontotemporal dementia. The erosion of emotion-specific neural networks in neurodegenerative disorders may produce distinct profiles of performance that are relevant to understanding the neurobiological basis of emotion processing.	[Kumfor, Fiona; Irish, Muireann; Hodges, John R.; Piguet, Olivier] Neurosci Res Australia, Sydney, NSW, Australia; [Kumfor, Fiona; Hodges, John R.; Piguet, Olivier] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Kumfor, Fiona; Irish, Muireann; Hodges, John R.; Piguet, Olivier] Univ New S Wales, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Irish, Muireann] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Piguet, O (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	o.piguet@neura.edu.au	Kumfor, Fiona/D-8839-2016; Piguet, Olivier/C-9658-2011; Kumfor, Fiona/AAK-9997-2020	Kumfor, Fiona/0000-0002-3208-075X; Piguet, Olivier/0000-0002-6696-1440; Irish, Muireann/0000-0002-4950-8169	National Health and Medical Research Council (NHMRC), of Australia [510106, APP1022684]; Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; Australian Postgraduate Award; ARC Federation Fellowship [FF0776229]	National Health and Medical Research Council (NHMRC), of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders(Australian Research Council); Australian Postgraduate Award(Australian Government); ARC Federation Fellowship(Australian Research Council)	This work was supported by a National Health and Medical Research Council (NHMRC), of Australia project grant [510106]; the Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders [CE110001021]; an Australian Postgraduate Award (to FK); an ARC Federation Fellowship [FF0776229 to JRH]; and an NHMRC of Australia Career Development Fellowship [APP1022684 to OP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Andersson J.L., 2007, TR07JA1 FMRIB U OXF; Andersson J.L.R., 2007, TR07JA2 FMRIB AN GR; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Bertoux M, 2012, J INT NEUROPSYCH SOC, V18, P972, DOI 10.1017/S1355617712001300; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Brambati SM, 2009, NEUROBIOL AGING, V30, P103, DOI 10.1016/j.neurobiolaging.2007.05.014; Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Calder AJ, 1997, P ROY SOC B-BIOL SCI, V264, P919, DOI 10.1098/rspb.1997.0127; Calder AJ, 2000, COGNITION, V76, P105, DOI 10.1016/S0010-0277(00)00074-3; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1976, PICTURES FACIAL AFFE; Fernandez-Duque D, 2005, NEUROPSYCHOLOGIA, V43, P1673, DOI 10.1016/j.neuropsychologia.2005.01.005; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Goodkind MS, 2012, HUM BRAIN MAPP, V33, P753, DOI 10.1002/hbm.21251; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hennenlotter A, 2006, PROG BRAIN RES, V156, P443, DOI 10.1016/S0079-6123(06)56024-8; HITCHCOCK J, 1986, BEHAV NEUROSCI, V100, P11, DOI 10.1037/0735-7044.100.1.11; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hsieh S, 2012, NEUROPSYCHOLOGY, V26, P624, DOI 10.1037/a0029326; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Irish M, 2012, NAT REV NEUROL, V8, P152, DOI 10.1038/nrneurol.2012.11; IZARD CE, 1992, PSYCHOL REV, V99, P561, DOI 10.1037/0033-295X.99.3.561; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kipps CM, 2007, J COGNITIVE NEUROSCI, V19, P1206, DOI 10.1162/jocn.2007.19.7.1206; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kril JJ, 2005, J NEUROL SCI, V232, P83, DOI 10.1016/j.jns.2005.02.003; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kubota M, 2011, NEUROSCI RES, V70, P206, DOI 10.1016/j.neures.2011.01.019; Kumfor F, NEURODEGENE IN PRESS; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Kumfor F, 2011, SOC NEUROSCI-UK, V6, P502, DOI 10.1080/17470919.2011.620779; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Meyers J., 1995, MEYERS SCORING SYSTE; Miller LA, 2012, BEHAV NEUROL, V25, P53, DOI [10.1155/2012/683052, 10.3233/BEN-2012-0349]; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Mutschler I, 2009, NEUROSCI LETT, V457, P66, DOI 10.1016/j.neulet.2009.03.101; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Perry RJ, 2006, DEMENT GERIATR COGN, V22, P278, DOI 10.1159/000095128; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Piguet O, DEMENTIA GE IN PRESS; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rohrer JD, 2012, CORTEX, V48, P308, DOI 10.1016/j.cortex.2010.09.004; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Rosen HJ, 2006, NEUROPSYCHOLOGIA, V44, P365, DOI 10.1016/j.neuropsychologia.2005.06.012; Rosen HJ, 2004, DEMENT GERIATR COGN, V17, P277, DOI 10.1159/000077154; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rosen HJ, 2002, BRAIN, V125, P2286, DOI 10.1093/brain/awf225; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snowden JS, 2008, NEUROPSYCHOLOGIA, V46, P2638, DOI 10.1016/j.neuropsychologia.2008.04.018; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Sprengelmeyer R, 1999, P ROY SOC B-BIOL SCI, V266, P2451, DOI 10.1098/rspb.1999.0945; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wright P, 2004, NEUROREPORT, V15, P2347, DOI 10.1097/00001756-200410250-00009; Wu XL, 2011, EUR NEUROL, V66, P98, DOI 10.1159/000329371; Young AW, 2002, FACIAL EXPRESSIONS E; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	91	119	123	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67457	10.1371/journal.pone.0067457	http://dx.doi.org/10.1371/journal.pone.0067457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805313	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500141
J	Lenchi, N; Inceoglu, O; Kebbouche-Gana, S; Gana, ML; Lliros, M; Servais, P; Garcia-Armisen, T				Lenchi, Nesrine; Inceoglu, Ozgul; Kebbouche-Gana, Salima; Gana, Mohamed Lamine; Lliros, Marc; Servais, Pierre; Garcia-Armisen, Tamara			Diversity of Microbial Communities in Production and Injection Waters of Algerian Oilfields Revealed by 16S rRNA Gene Amplicon 454 Pyrosequencing	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; CONTINENTAL HIGH-TEMPERATURE; IN-SITU HYBRIDIZATION; OIL-FIELD; ARCHAEAL COMMUNITY; NORTH-SEA; SP-NOV; SHEWANELLA-PUTREFACIENS; PHYLOGENETIC DIVERSITY; PETROLEUM RESERVOIRS	The microorganisms inhabiting many petroleum reservoirs are multi-extremophiles capable of surviving in environments with high temperature, pressure and salinity. Their activity influences oil quality and they are an important reservoir of enzymes of industrial interest. To study these microbial assemblages and to assess any modifications that may be caused by industrial practices, the bacterial and archaeal communities in waters from four Algerian oilfields were described and compared. Three different types of samples were analyzed: production waters from flooded wells, production waters from non-flooded wells and injection waters used for flooding (water-bearing formations). Microbial communities of production and injection waters appeared to be significantly different. From a quantitative point of view, injection waters harbored roughly ten times more microbial cells than production waters. Bacteria dominated in injection waters, while Archaea dominated in production waters. Statistical analysis based on the relative abundance and bacterial community composition (BCC) revealed significant differences between production and injection waters at both OTUs(0.03) and phylum level. However, no significant difference was found between production waters from flooded and non-flooded wells, suggesting that most of the microorganisms introduced by the injection waters were unable to survive in the production waters. Furthermore, a Venn diagram generated to compare the BCC of production and injection waters of one flooded well revealed only 4% of shared bacterial OTUs. Phylogenetic analysis of bacterial sequences indicated that Alpha-, Beta-and Gammaproteobacteria were the main classes in most of the water samples. Archaeal sequences were only obtained from production wells and each well had a unique archaeal community composition, mainly belonging to Methanobacteria, Methanomicrobia, Thermoprotei and Halobacteria classes. Many of the bacterial genera retrieved had already been reported as degraders of complex organic molecules and pollutants. Nevertheless, a large number of unclassified bacterial and archaeal sequences were found in the analyzed samples, indicating that subsurface waters in oilfields could harbor new and still-non-described microbial species.	[Lenchi, Nesrine; Kebbouche-Gana, Salima] Univ MHamed Bougara Boumerdes, Dept Biol, Lab Conservat & Valorisat Biol Ressources, Boumerdes, Algeria; [Lenchi, Nesrine; Inceoglu, Ozgul; Servais, Pierre; Garcia-Armisen, Tamara] Univ Libre Bruxelles, Brussels, Belgium; [Gana, Mohamed Lamine] Biocorros Lab Sonatrach, Ctr Res & Dev, Boumerdes, Algeria; [Lliros, Marc] Univ Autonoma Barcelona, Biosci Fac, Dept Genet & Microbiol, Bellaterra, Spain	Universite de M'hammed Bougara Boumerdes; Universite Libre de Bruxelles; Universite de M'hammed Bougara Boumerdes; Autonomous University of Barcelona	Lenchi, N (corresponding author), Univ MHamed Bougara Boumerdes, Dept Biol, Lab Conservat & Valorisat Biol Ressources, Boumerdes, Algeria.	nesrine.lenchi@hotmail.fr; pservais@ulb.ac.be	Llirós, Marc/R-5241-2016; SALIMA, KEBBOUCHE GANA/R-7906-2019; Nesrine, LENCHI/AAO-9442-2021	Llirós, Marc/0000-0001-8456-4230; SALIMA, KEBBOUCHE GANA/0000-0002-6021-7522; KEBBOUCHE-GANA, SALIMA/0000-0001-5263-2999	Wallonie-Bruxelles International	Wallonie-Bruxelles International	Funding provided by Wallonie-Bruxelles International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; Akit RJ, 1989, GEOMICROBIOL J, V7, P115; Al-Awadhi H, 2007, APPL MICROBIOL BIOT, V77, P183, DOI 10.1007/s00253-007-1127-1; Albuquerque L, 2009, SYST APPL MICROBIOL, V32, P306, DOI 10.1016/j.syapm.2009.05.002; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; [Anonymous], 2005, STANDARD METHODS EXA; Antipov VA, 2002, PETRO CHEM, V6, P475; Bagge D, 2001, APPL ENVIRON MICROB, V67, P2319, DOI 10.1128/AEM.67.5.2319-2325.2001; Bastin ES, 1926, AAPG BULL, V10, P1270; Bauer M, 2004, J MOL EVOL, V59, P571, DOI 10.1007/s00239-004-2643-6; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; Burns DG, 2010, INT J SYST EVOL MICR, V60, P1196, DOI 10.1099/ijs.0.010017-0; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Casamayor EO, 2012, AQUAT SCI, V74, P61, DOI 10.1007/s00027-011-0196-5; Chen JF, 2008, MAR POLLUT BULL, V57, P695, DOI 10.1016/j.marpolbul.2008.03.013; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Das Nilanjana, 2011, Biotechnol Res Int, V2011, P941810, DOI 10.4061/2011/941810; DAVYDOVACHARAKH.IA, 1993, MICROBIOLOGY, V61, P306; Eckford RE, 2002, J IND MICROBIOL BIOT, V29, P83, DOI 10.1038/sj.jim.7000274; Folarin Y, 2012, INT BIODETERIOR, Vxxx, P1; Fratesi S.E., 2002, THESIS MISSISSIPPI S; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; Gana ML, 2011, J IND MICROBIOL BIOT, V38, P391, DOI 10.1007/s10295-010-0887-2; Garcia-Armisen T, 2010, APPL MICROBIOL BIOT, V87, P2281, DOI 10.1007/s00253-010-2698-9; Gorley C.K., 2006, GETTING STARTED PRIM; Grabowski A, 2005, FEMS MICROBIOL ECOL, V54, P427, DOI 10.1016/j.femsec.2005.05.007; Grassia GS, 1996, FEMS MICROBIOL ECOL, V21, P47; Greene AC, 1997, INT J SYST BACTERIOL, V47, P505, DOI 10.1099/00207713-47-2-505; Hou Y. F., 2009, ENG OUR FUTURE ARE W, P27; Hubert C, 2007, APPL ENVIRON MICROB, V73, P2644, DOI 10.1128/AEM.02332-06; Jeon CO, 2004, INT J SYST EVOL MICR, V54, P93, DOI 10.1099/ijs.0.02636-0; KISHIMOTO N, 1993, CURR MICROBIOL, V27, P131, DOI 10.1007/BF01576009; Korenblum E, 2012, BMC MICROBIOL, V12, DOI [10.1155/2012/156537, 10.1186/1471-2180-12-252]; Kotelnikova S, 1998, FEMS MICROBIOL ECOL, V26, P121, DOI 10.1016/S0168-6496(98)00028-2; Kryachko Y, 2012, ANTON LEEUW INT J G, V101, P493, DOI 10.1007/s10482-011-9658-y; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LHARIDON S, 1995, NATURE, V377, P223, DOI 10.1038/377223a0; Li H, 2006, FEMS MICROBIOL LETT, V257, P92, DOI 10.1111/j.1574-6968.2006.00149.x; Li H, 2007, CURR MICROBIOL, V55, P382, DOI 10.1007/s00284-007-9002-y; Li H, 2007, FEMS MICROBIOL ECOL, V60, P74, DOI 10.1111/j.1574-6941.2006.00266.x; Liu YJ, 2009, ANAEROBE, V15, P214, DOI 10.1016/j.anaerobe.2009.03.007; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; MAGOT M, 1992, INT J SYST BACTERIOL, V42, P398, DOI 10.1099/00207713-42-3-398; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin-Gil J, 2004, ANTON LEEUW INT J G, V86, P283, DOI 10.1023/B:ANTO.0000047939.49597.eb; Miranda E, 2006, CORROS SCI, V48, P2417, DOI 10.1016/j.corsci.2005.09.005; Mitterer RM, 2010, EARTH PLANET SC LETT, V295, P358, DOI 10.1016/j.epsl.2010.04.009; Mueller RF, 1996, APPL ENVIRON MICROB, V62, P3083, DOI 10.1128/AEM.62.9.3083-3087.1996; Musat F, 2008, ENVIRON MICROBIOL, V10, P10, DOI 10.1111/j.1462-2920.2007.01425.x; Nazina T N, 2006, Mikrobiologiia, V75, P70; Nazina Tamara N., 2000, Resource and Environmental Biotechnology, V3, P161; Nazina TN, 1995, GEOMICROBIOL J, V13, P181, DOI 10.1080/01490459509378016; Nilsen RK, 1996, APPL ENVIRON MICROB, V62, P1793, DOI 10.1128/AEM.62.5.1793-1798.1996; Nilsen RK, 1996, APPL ENVIRON MICROB, V62, P728, DOI 10.1128/AEM.62.2.728-731.1996; Orphan VJ, 2003, GEOMICROBIOL J, V20, P295, DOI 10.1080/01490450303898; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pernthaler A., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P711; Pham VD, 2009, ENVIRON MICROBIOL, V11, P176, DOI 10.1111/j.1462-2920.2008.01751.x; Plotnikova EG, 2011, RUSS J ECOL+, V42, P502, DOI 10.1134/S1067413611060130; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Ren HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023258; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rosario-Passapera, 2012, INT J SYST EVOL MICR; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rozanova EP, 2001, MICROBIOLOGY+, V70, P102, DOI 10.1023/A:1004809308305; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Salinas MB, 2004, INT J SYST EVOL MICR, V54, P645, DOI 10.1099/ijs.0.02732-0; Schafer G, 1996, BBA-BIOENERGETICS, V1275, P16, DOI 10.1016/0005-2728(96)00043-6; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sen R, 2008, PROG ENERG COMBUST, V34, P714, DOI 10.1016/j.pecs.2008.05.001; [佘跃惠 She Yuehui], 2005, [生态学报, Acta Ecologica Sinica], V25, P237; Silva T. R., 2012, INT BIODETERIOR, P1; Slobodkin AI, 1999, CURR MICROBIOL, V39, P99, DOI 10.1007/s002849900426; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033535; Tapilatu YH, 2010, EXTREMOPHILES, V14, P225, DOI 10.1007/s00792-010-0301-z; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; van der Kraan GM, 2010, FEMS MICROBIOL ECOL, V71, P428, DOI 10.1111/j.1574-6941.2009.00813.x; Wang L-Y., 2012, BIOGEOSCIENCES DISCU, V9, P5177; Wang XX, 2011, J ENVIRON SCI-CHINA, V23, P1858, DOI 10.1016/S1001-0742(10)60640-7; Warren Ean, 2003, Bioremediation Journal, V7, P139, DOI 10.1080/713607984; Wei L, 2010, BIORESOURCE TECHNOL, V101, P2643, DOI 10.1016/j.biortech.2009.10.068; Widdel F, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P265, DOI 10.1017/CBO9780511541490.010; Wierzchos J, 2006, ASTROBIOLOGY, V6, P415, DOI 10.1089/ast.2006.6.415; Worden RH, 2006, APPL GEOCHEM, V21, P455, DOI 10.1016/j.apgeochem.2005.12.007; Youssef N, 2007, APPL ENVIRON MICROB, V73, P1239, DOI 10.1128/AEM.02264-06; Yuan San-qing, 2007, Weishengwu Xuebao, V47, P290; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zvyagintseva I. S., 1995, Mikrobiologiya, V64, P83; ZWEIFEL UL, 1995, APPL ENVIRON MICROB, V61, P2180, DOI 10.1128/AEM.61.6.2180-2185.1995	99	69	73	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66588	10.1371/journal.pone.0066588	http://dx.doi.org/10.1371/journal.pone.0066588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805243	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500071
J	Lim, J; Thompson, J; May, RC; Hotchin, NA; Caron, E				Lim, Jenson; Thompson, Jo; May, Robin C.; Hotchin, Neil A.; Caron, Emmanuelle			Regulator of G-Protein Signalling-14 (RGS14) Regulates the Activation of alpha M beta 2 Integrin during Phagocytosis	PLOS ONE			English	Article							NEURITE OUTGROWTH; ADHESION; TALIN; RAP1; RAS; BINDING; GTPASE; DISRUPTION; KINDLIN-3; EFFECTOR	Integrin-mediated phagocytosis, an important physiological activity undertaken by professional phagocytes, requires bidirectional signalling to/from alpha M beta 2 integrin and involves Rap1 and Rho GTPases. The action of Rap1 and the cytoskeletal protein talin in activating alpha M beta 2 integrins, in a RIAM-independent manner, has been previously shown to be critical during phagocytosis in mammalian phagocytes. However, the events downstream of Rap1 are not clearly understood. Our data demonstrate that one potential Rap1 effector, Regulator of G-Protein Signalling-14 (RGS14), is involved in activating alpha M beta 2. Exogenous expression of RGS14 in COS-7 cells expressing alpha M beta 2 results in increased binding of C3bi-opsonised sheep red blood cells. Consistent with this, knock-down of RGS14 in J774.A1 macrophages results in decreased association with C3bi-opsonised sheep red blood cells. Regulation of alpha M beta 2 function occurs through the R333 residue of the RGS14 Ras/Rap binding domain (RBD) and the F754 residue of beta 2, residues previously shown to be involved in binding of H-Ras and talin1 head binding prior to alpha M beta 2 activation, respectively. Surprisingly, overexpression of talin2 or RAPL had no effect on alpha M beta 2 regulation. Our results establish for the first time a role for RGS14 in the mechanism of Rap1/talin1 activation of alpha M beta 2 during phagocytosis.	[Lim, Jenson; May, Robin C.; Hotchin, Neil A.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Lim, Jenson] NanoTher Ltd, Newcastle Under Lyme, Staffs, England; [Thompson, Jo] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Caron, Emmanuelle] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol, London, England; [Caron, Emmanuelle] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England	University of Birmingham; University of Exeter; Imperial College London; Imperial College London	Lim, J (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	Limj@adf.bham.ac.uk	May, Robin Charles/ABA-9266-2021	May, Robin Charles/0000-0001-5364-1838; Hotchin, Neil/0000-0002-1844-7607	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Cancer Research United Kingdom; MRC [MR/J008176/1] Funding Source: UKRI; Medical Research Council [MR/J008176/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research United Kingdom(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Wellcome Trust, Biotechnology and Biological Sciences Research Council and Cancer Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Debrand E, 2009, FEBS J, V276, P1610, DOI 10.1111/j.1742-4658.2009.06893.x; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2011, IMMUNITY, V34, P24, DOI 10.1016/j.immuni.2010.12.010; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Lim J, 2011, BIOCHEM J, V437, P461, DOI 10.1042/BJ20101666; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; Mechai N, 2005, J NEUROSCI RES, V82, P753, DOI 10.1002/jnr.20693; Medrano-Fernandez I, 2013, CELL MOL LIFE SCI, V70, P2395, DOI 10.1007/s00018-013-1268-6; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Self AJ, 2001, J CELL SCI, V114, P1357; Senetar MA, 2007, CELL MOTIL CYTOSKEL, V64, P157, DOI 10.1002/cm.20173; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TOMASELLI KJ, 1990, NEURON, V5, P651, DOI 10.1016/0896-6273(90)90219-6; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Traver S, 2004, BIOCHEM J, V379, P627, DOI 10.1042/BJ20031889; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; Xue ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056911; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhao PS, 2013, J CELL BIOCHEM, V114, P1414, DOI 10.1002/jcb.24483	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e69163	10.1371/journal.pone.0069163	http://dx.doi.org/10.1371/journal.pone.0069163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805333	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500162
J	Nordfeldt, S; Angarne-Lindberg, T; Nordwall, M; Ekberg, J; Bertero, C				Nordfeldt, Sam; Angarne-Lindberg, Teresia; Nordwall, Maria; Ekberg, Joakim; Bertero, Carina			As Facts and Chats Go Online, What Is Important for Adolescents with Type 1 Diabetes?	PLOS ONE			English	Article							DAWN YOUTH; CARE; INTERNET; COMPLICATIONS; MANAGEMENT; ATTITUDES; PERSPECTIVE; USABILITY; EDUCATION; CHILDREN	Background: Continued refinement of resources for patient information, education and support is needed. Considering the rapid development of new communication practices, the perspectives of young people themselves warrant more attention using a wide research focus. The purpose of this study was to understand information-seeking behaviours, Internet use and social networking online in adolescents with type 1 diabetes (T1DM). This applied to their everyday life, including the context of diabetes and their experiences and need of contact with T1DM peers. Methodology/Principal Findings: Twenty-four adolescents aged 10-17 years with T1DM were recruited from a county hospital in the south-east of Sweden. Qualitative data were obtained using eight focus groups, wherein each participant engaged in a 60-90 minute video/audio-recorded session. The focus group data were transcribed and analysed using qualitative content analysis. Some demographic and medical information was also collected. The three main categories that were identified; Aspects of Security, Updating, and Plainness and their sub-categories gave significant information about how to enhance information retrieval and peer contacts related to T1DM. Regarding the persons' information-seeking behaviour, Internet use, and use of social media some differences could be identified depending on gender and age. Conclusions/Significance: Sensitivity and adaptation to users' needs and expectations seem crucial in the development of future online resources for adolescents with T1DM. To start with, this could mean applying a wider range of already existing information and communication technologies. Health practitioners need to focus on the areas of security of information and communication, frequency of updating, and simplicity of design-less is more.	[Nordfeldt, Sam; Angarne-Lindberg, Teresia] Linkoping Univ, Dept Clin & Expt Med, Div Child & Adolescent Psychiat, Linkoping, Sweden; [Nordfeldt, Sam] Linkoping Univ, Dept Med & Hlth Sci, Ctr Med Technol Assessment, Linkoping, Sweden; [Nordwall, Maria] Linkoping Univ, Dept Clin & Expt Med, Div Paediat, Linkoping, Sweden; [Nordwall, Maria] Vrinnevi Hosp, Paediat Clin, Linkoping, Sweden; [Ekberg, Joakim] Univ Skovde, Sch Life Sci, Publ Hlth Unit, Skovde, Sweden; [Bertero, Carina] Linkoping Univ, Dept Med & Hlth Sci, Div Nursing Sci, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; University of Skovde; Linkoping University	Nordfeldt, S (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Child & Adolescent Psychiat, Linkoping, Sweden.	sam.nordfeldt@liu.se	Berterö, Carina/H-8659-2019	Berterö, Carina/0000-0003-1588-135X	Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden; County Council of Ostergotland, Sweden	Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden; County Council of Ostergotland, Sweden	This study was supported by the Linkoping Centre for Life Science Technologies (LIST), Linkoping University, Sweden and the County Council of Ostergotland, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstoot HJ, 2009, PEDIATR DIABETES, V10, P21, DOI 10.1111/j.1399-5448.2009.00611.x; Aanstoot HJ, 2009, PEDIATR DIABETES, V10, P15, DOI 10.1111/j.1399-5448.2009.00610.x; Brink SJ, 2002, J PEDIATR ENDOCR MET, V15, P1113; Carroll AE, 2011, DIABETES EDUCATOR, V37, P59, DOI 10.1177/0145721710387163; Couch Robert, 2008, Evid Rep Technol Assess (Full Rep), P1; Ekberg J, 2010, J MED SYST, V34, P107, DOI 10.1007/s10916-008-9222-0; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Findahl O., 2010, SVENSKARNA INTERNET; Flicker S, 2004, J MED INTERNET RES, V6, P77, DOI 10.2196/jmir.6.3.e32; Gentles Stephen James, 2010, J Med Internet Res, V12, pe22, DOI 10.2196/jmir.1390; Hanberger L, 2006, DIABETES RES CLIN PR, V72, P197, DOI 10.1016/j.diabres.2005.10.009; Hanberger L, 2008, DIABETES CARE, V31, P927, DOI 10.2337/dc07-1863; Hansen DL, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.4.e25; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kerr C, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e13; Kreuger RA, 1998, ANAL REPORTING FOCUS; Krippendorff K., 2018, CONTENT ANAL INTRO I, V4th ed.; Lenhart A, 2010, SOCIAL MEDIA MOBILE; Lowe P, 2005, J TELEMED TELECARE, V11, P59, DOI 10.1258/1357633054461840; Ludvigsson J, 2001, DIABETES NUTR METAB, V14, P292; Martenson EK, 2009, NURS SCI QUART, V22, P281, DOI 10.1177/0894318409338681; Martenson EK, 2009, INT J NURS PRACT, V15, P185, DOI 10.1111/j.1440-172X.2009.01743.x; Mayring P., 2000, QUALITATIVE CONTENT; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Nordfeldt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062096; Nordfeldt S, 2012, J MED INTERNET RES, V14, P279, DOI 10.2196/jmir.1987; Nordfeldt S, 2012, FUTURE INTERNET, V4, P514, DOI 10.3390/fi4020514; Nordfeldt S, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1267; Nordqvist C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1152; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Nordwall M, 2009, PEDIATR DIABETES, V10, P168, DOI 10.1111/j.1399-5448.2008.00472.x; Pak R, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1220; Peyrot M, 2009, PEDIATR DIABETES, V10, P37, DOI 10.1111/j.1399-5448.2009.00612.x; Powell J, 2009, J TELEMED TELECARE, V15, P150, DOI 10.1258/jtt.2009.003014; Ravert RD, 2004, DIABETES EDUCATOR, V30, P827, DOI 10.1177/014572170403000518; Ritterband LM, 2009, ANN BEHAV MED, V38, P18, DOI 10.1007/s12160-009-9133-4; Stinson J, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1349; Swift PGF, 2009, PEDIATR DIABETES, V10, P51, DOI 10.1111/j.1399-5448.2009.00570.x; Valaitis RK, 2005, HEALTH PROMOT PRACT, V6, P464, DOI 10.1177/1524839904263897; Verhoeven Fenne, 2010, J Diabetes Sci Technol, V4, P666; Verhoeven F, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e37; Wysocki T, 2011, DIABETES CARE, V34, P1701, DOI 10.2337/dc11-0577; Zrebiec JF, 2005, DIABETES EDUCATOR, V31, P825, DOI 10.1177/0145721705282162; Zrebiec JF, 2005, DIABETES ED, V31, P36, DOI DOI 10.1177/0145721705282162	44	13	13	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67659	10.1371/journal.pone.0067659	http://dx.doi.org/10.1371/journal.pone.0067659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805322	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500150
J	Otte, DM; de Arellano, MLB; Bilkei-Gorzo, A; Albayram, O; Imbeault, S; Jeung, H; Alferink, J; Zimmer, A				Otte, David-Marian; de Arellano, Maria Luisa Barcena; Bilkei-Gorzo, Andras; Albayram, Oender; Imbeault, Sophie; Jeung, Haang; Alferink, Judith; Zimmer, Andreas			Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; NMDA-RECEPTOR; GLUTAMINE-SYNTHETASE; D-CYCLOSERINE; RAT-BRAIN; GLYCINE SITE; GLUTAMATERGIC NEUROTRANSMISSION; FUNCTIONAL ANTAGONISTS; MEDIATED RESPONSES	NMDA receptors are activated after binding of the agonist glutamate to the NR2 subunit along with a co-agonist, either L-glycine or D-serine, to the NR1 subunit. There is substantial evidence to suggest that D-serine is the most relevant co-agonist in forebrain regions and that alterations in D-serine levels contribute to psychiatric disorders. D-serine is produced through isomerization of L-serine by serine racemase (Srr), either in neurons or in astrocytes. It is released by astrocytes by an activity-dependent mechanism involving secretory vesicles. In the present study we generated transgenic mice (SrrTg) expressing serine racemase under a human GFAP promoter. These mice were biochemically and behaviorally analyzed using paradigms of anxiety, depression and cognition. Furthermore, we investigated the behavioral effects of long-term administration of D-serine added to the drinking water. Elevated brain D-serine levels in SrrTg mice resulted in specific behavioral phenotypes in the forced swim, novelty suppression of feeding and olfactory bulbectomy paradigms that are indicative of a reduced proneness towards depression-related behavior. Chronic dietary D-serine supplement mimics the depression-related behavioral phenotype observed in SrrTg mice. Our results suggest that D-serine supplementation may improve mood disorders.	[Otte, David-Marian; de Arellano, Maria Luisa Barcena; Bilkei-Gorzo, Andras; Albayram, Oender; Imbeault, Sophie; Alferink, Judith; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Jeung, Haang; Alferink, Judith] Univ Bonn, Dept Psychiat, Bonn, Germany	University of Bonn; University of Bonn	Zimmer, A (corresponding author), Univ Bonn, Inst Mol Psychiat, Bonn, Germany.	a.zimmer@uni-bonn.de	Bilkei-Gorzo, Andras/F-8114-2010; Zimmer, Andreas/B-8357-2009; Barcena, Maria Luisa Luisa/AAX-6732-2021; Otte, David-Marian/J-7402-2012	Barcena, Maria Luisa Luisa/0000-0003-1391-9262; Imbeault, Sophie/0000-0003-1454-9267; Albayram, Onder/0000-0002-2028-1458; alferink, judith/0000-0002-3251-6584	Federal Ministry of Education and Research [NGFN2 01G10474, NGFN-MOODS FKZ 01GS08144, 01GW0511]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research (NGFN2 01G10474, NGFN-MOODS FKZ 01GS08144 and 01GW0511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec RE, 1999, PHYSIOL BEHAV, V65, P739; Bado P, 2011, PSYCHOPHARMACOLOGY, V218, P461, DOI 10.1007/s00213-011-2330-4; Baptista V, 2005, J NEUROPHYSIOL, V94, P147, DOI 10.1152/jn.00927.2004; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Benneyworth MA, 2012, CELL MOL NEUROBIOL, V32, P613, DOI 10.1007/s10571-012-9808-4; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; Bilkei-Gorzo A, 2007, NEUROPSYCHOPHARMACOL, V32, P2330, DOI 10.1038/sj.npp.1301370; Breier A, 1997, AM J PSYCHIAT, V154, P805; BRUNELLI SA, 1994, J COMP PSYCHOL, V108, P298, DOI 10.1037/0735-7036.108.3.298; Chen L, 2003, J NEUROPHYSIOL, V89, P691, DOI 10.1152/jn.00680.2002; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; De Miranda J, 2000, GENE, V256, P183, DOI 10.1016/S0378-1119(00)00356-5; de Miranda J, 2002, P NATL ACAD SCI USA, V99, P14542, DOI 10.1073/pnas.222421299; Duncan EJ, 2004, SCHIZOPHR RES, V71, P239, DOI 10.1016/j.schres.2004.03.013; GARDNER CR, 1985, J PHARMACOL METHOD, V14, P181, DOI 10.1016/0160-5402(85)90031-2; Grant SL, 2006, J CHROMATOGR B, V844, P278, DOI 10.1016/j.jchromb.2006.07.022; HALLERMAYER K, 1981, J NEUROCHEM, V37, P43, DOI 10.1111/j.1471-4159.1981.tb05289.x; Hashimoto A, 2004, EUR J PHARMACOL, V495, P153, DOI 10.1016/j.ejphar.2004.05.036; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hashimoto K, 2011, EXPERT REV NEUROTHER, V11, P33, DOI [10.1586/ern.10.176, 10.1586/ERN.10.176]; HEIMER L, 1968, J ANAT, V103, P413; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Heresco-Levy U, 2002, INT J NEUROPSYCHOPH, V5, P301, DOI 10.1017/S1461145702003061; Heresco-Levy U, 2006, J AFFECT DISORDERS, V93, P239, DOI 10.1016/j.jad.2006.03.004; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Kantrowitz JT, 2010, SCHIZOPHR RES, V121, P125, DOI 10.1016/j.schres.2010.05.012; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; Kinney GG, 2003, J NEUROSCI, V23, P7586; LAAKE K, 2002, COCHRANE DB SYST REV; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Lim R, 2004, J NEUROPHYSIOL, V92, P2530, DOI 10.1152/jn.01123.2003; Lopes T, 1997, PHARMACOL BIOCHEM BE, V58, P1059, DOI 10.1016/S0091-3057(97)00302-X; Malkesman O, 2011, INT J NEUROPSYCHOPH, V12, P1; Martina M, 2003, J PHYSIOL-LONDON, V548, P411, DOI 10.1113/jphysiol.2002.037127; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; MATSUI T, 1995, J NEUROCHEM, V65, P454; Merali Z, 2003, BIOL PSYCHIAT, V54, P552, DOI 10.1016/S0006-3223(02)01827-9; MICZEK KA, 1995, PSYCHOPHARMACOLOGY, V121, P38, DOI 10.1007/BF02245590; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Minkeviciene R, 2008, NEUROPHARMACOLOGY, V54, P1079, DOI 10.1016/j.neuropharm.2008.02.014; Moghaddam B, 1997, J NEUROSCI, V17, P2921; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORSE WH, 1958, J EXP ANAL BEHAV, V1, P103, DOI 10.1901/jeab.1958.1-103; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Nolte C, 2001, GLIA, V33, P72; Onur OA, 2010, BIOL PSYCHIAT, V67, P1205, DOI 10.1016/j.biopsych.2010.01.022; Panizzutti R, 2005, NEUROSCI LETT, V380, P111, DOI 10.1016/j.neulet.2005.01.062; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Rex A, 1998, PHARMACOL BIOCHEM BE, V59, P677, DOI 10.1016/S0091-3057(97)00461-9; Rochford J, 1997, PSYCHOPHARMACOLOGY, V132, P145, DOI 10.1007/s002130050330; Rodgers RJ, 2002, PHYSIOL BEHAV, V77, P301, DOI 10.1016/S0031-9384(02)00856-9; Rowland LM, 2005, AM J PSYCHIAT, V162, P394, DOI 10.1176/appi.ajp.162.2.394; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shimazaki T, 2010, PSYCHOPHARMACOLOGY, V209, P263, DOI 10.1007/s00213-010-1794-y; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; THOMSON AM, 1989, NATURE, V338, P422, DOI 10.1038/338422a0; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Wang LZ, 2003, ACTA PHARMACOL SIN, V24, P965; Welberg Leonie, 2010, Nat Rev Neurosci, V11, P666; WINSLOW JT, 1990, EUR J PHARMACOL, V190, P11, DOI 10.1016/0014-2999(90)94107-9; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008	84	40	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67131	10.1371/journal.pone.0067131	http://dx.doi.org/10.1371/journal.pone.0067131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805296	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500124
J	Sipos, L; Pers, BM; Kalmar, M; Toth, I; Krishna, S; Jensen, MH; Semsey, S				Sipos, Lilla; Pers, Benedicte Mengel; Kalmar, Magda; Toth, Ildiko; Krishna, Sandeep; Jensen, Mogens H.; Semsey, Szabolcs			Comparative Network Analysis of Preterm vs. Full-Term Infant-Mother Interactions	PLOS ONE			English	Article							RISK INFANTS; TODDLERS; STYLES; ENVIRONMENT; COMPETENCE; ATTACHMENT; STABILITY; PATTERNS; CHILDREN; LANGUAGE	Several studies have reported that interactions of mothers with preterm infants show differential characteristics compared to that of mothers with full-term infants. Interaction of preterm dyads is often reported as less harmonious. However, observations and explanations concerning the underlying mechanisms are inconsistent. In this work 30 preterm and 42 fullterm mother-infant dyads were observed at one year of age. Free play interactions were videotaped and coded using a micro-analytic coding system. The video records were coded at one second resolution and studied by a novel approach using network analysis tools. The advantage of our approach is that it reveals the patterns of behavioral transitions in the interactions. We found that the most frequent behavioral transitions are the same in the two groups. However, we have identified several high and lower frequency transitions which occur significantly more often in the preterm or full-term group. Our analysis also suggests that the variability of behavioral transitions is significantly higher in the preterm group. This higher variability is mostly resulted from the diversity of transitions involving non-harmonious behaviors. We have identified a maladaptive pattern in the maternal behavior in the preterm group, involving intrusiveness and disengagement. Application of the approach reported in this paper to longitudinal data could elucidate whether these maladaptive maternal behavioral changes place the infant at risk for later emotional, cognitive and behavioral disturbance.	[Sipos, Lilla; Kalmar, Magda] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Pers, Benedicte Mengel; Jensen, Mogens H.; Semsey, Szabolcs] Univ Copenhagen, Niels Bohr Inst, CMOL, DK-2100 Copenhagen, Denmark; [Toth, Ildiko] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Krishna, Sandeep] Natl Ctr Biol Sci, Bangalore, Karnataka, India	Eotvos Lorand University; University of Copenhagen; Niels Bohr Institute; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Semsey, S (corresponding author), Univ Copenhagen, Niels Bohr Inst, CMOL, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	semsey@nbi.dk	Jensen, Mogens H./U-5510-2017; Toth, Ildiko/A-6603-2011; Toth, Ildiko/AAB-1086-2021; Semsey, Szabolcs/L-6329-2013	Jensen, Mogens H./0000-0001-8104-4299; Toth, Ildiko/0000-0002-3759-8726; Semsey, Szabolcs/0000-0002-4522-5495; Mengel Pers, Anne Benedicte/0000-0003-4601-3002; krishna, sandeep/0000-0002-0581-173X	Danish National Research Foundation; Hungarian Scientific Research Fund [T18346, F18380, T29517, T4367]; Psychology Doctoral School of Eotvos Lorand University	Danish National Research Foundation(Danmarks Grundforskningsfond); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Psychology Doctoral School of Eotvos Lorand University	This research was supported by the Danish National Research Foundation, by the Hungarian Scientific Research Fund Grants T18346, F18380, T29517, and T4367), and by the Psychology Doctoral School of Eotvos Lorand University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward GP, 2002, J PEDIATR PSYCHOL, V27, P37, DOI 10.1093/jpepsy/27.1.37; Aylward GP, 1990, INFANTS YOUNG CHILDR, V2, P1; BAKEMAN R, 1980, CHILD DEV, V51, P437, DOI 10.2307/1129277; Bakeman R., 2011, SEQUENTIAL ANAL OBSE; Bakeman R., 2005, HDB RES METHODS DEV, P394, DOI [DOI 10.1002/9780470756676.CH20/SUMMARY, 10.1002/9780470756676.ch20, DOI 10.1002/9780470756676.CH20]; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; BARNARD KE, 1984, INFANT BEHAV DEV, V7, P101, DOI 10.1016/S0163-6383(84)80026-0; Beebe B, 2010, ATTACH HUM DEV, V12, P3, DOI 10.1080/14616730903338985; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Brown J, 1980, MATERNAL INFLUENCES, P353; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; CRNIC KA, 1983, CHILD DEV, V54, P1199, DOI 10.1111/j.1467-8624.1983.tb00540.x; Driscoll JR, 2007, INFANT CHILD DEV, V16, P649, DOI 10.1002/icd.515; FIELD TM, 1977, CHILD DEV, V48, P763, DOI 10.1111/j.1467-8624.1977.tb01232.x; Fiese BH, 2001, INFANT MENT HEALTH J, V22, P463, DOI 10.1002/imhj.1011; Forcada-Guex M, 2006, PEDIATRICS, V118, pE107, DOI 10.1542/peds.2005-1145; Gervai J, 2007, SOC NEUROSCI-UK, V2, P307, DOI 10.1080/17470910701391893; GOLDBERG S, 1995, HDB PARENTING, V1, P209; GOTTMAN JM, 1981, CHILD DEV, V52, P393, DOI 10.2307/1129157; Gunning M, 2004, BRIT J PSYCHIAT, V184, pS38, DOI 10.1192/bjp.184.46.s38; HAYNES SN, 1982, BEHAV ASSESS, V4, P369; HEYMAN RE, 1995, BEHAV RES THER, V33, P737, DOI 10.1016/0005-7967(95)00003-G; Holditch-Davis D, 2007, RES NURS HEALTH, V30, P333, DOI 10.1002/nur.20190; Kerstjens JM, 2011, J PEDIATR-US, V159, P92, DOI 10.1016/j.jpeds.2010.12.041; Klein PS, 2007, EARLY CHILD DEV CARE, V177, P383, DOI 10.1080/03004430600551682; Landry SH, 1998, CHILD DEV, V69, P105, DOI 10.1111/j.1467-8624.1998.tb06137.x; Landry SH, 2000, CHILD DEV, V71, P358, DOI 10.1111/1467-8624.00150; LITTMAN B, 1978, PEDIATRICS, V61, P470, DOI 10.1542/peds.61.3.470; MALATESTA CZ, 1986, CHILD DEV, V57, P316, DOI 10.1111/j.1467-8624.1986.tb00031.x; Mantymaa M, 2004, INFANT BEHAV DEV, V27, P134, DOI 10.1016/j.infbeh.2003.09.006; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masur EF, 2001, MERRILL PALMER QUART, V47, P100, DOI 10.1353/mpq.2001.0003; MINDE K, 1985, J CHILD PSYCHOL PSYC, V26, P231, DOI 10.1111/j.1469-7610.1985.tb02262.x; Murray AD, 1997, DEV PSYCHOPATHOL, V9, P507, DOI 10.1017/S0954579497001272; ROCISSANO L, 1983, CHILD DEV, V54, P1229, DOI 10.2307/1129678; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Skirbekk Helge, 2004, Patient Educ Couns, V54, P245; Stevenson Barratt M, 1996, INT J BEHAV DEV, V19, P581; VANBEEK Y, 1994, EARLY DEV PARENTING, V3, P37; Wijnroks L, 1999, INF MENTAL HLTH J, V20, P393, DOI 10.1002/(SICI)1097-0355(199924)20:4<393::AID-IMHJ3>3.0.CO;2-I; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598	42	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67183	10.1371/journal.pone.0067183	http://dx.doi.org/10.1371/journal.pone.0067183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805298	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500126
J	Wang, X; Mu, ZD; Shangguan, FQ; Liu, R; Pu, YP; Yin, LH				Wang, Xuan; Mu, Zhongde; Shangguan, Fengqi; Liu, Ran; Pu, Yuepu; Yin, Lihong			Simultaneous Detection of Fenitrothion and Chlorpyrifos-Methyl with a Photonic Suspension Array	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SOLID-PHASE MICROEXTRACTION; LINKED-IMMUNOSORBENT-ASSAY; MASS-SPECTROMETRY; ORGANOPHOSPHORUS INSECTICIDES; GAS-CHROMATOGRAPHY; WATER SAMPLES; MULTIPLEXED IMMUNOASSAYS; SORPTIVE EXTRACTION; PESTICIDE-RESIDUES	A technique was developed for simultaneous detection of fenitrothion (FNT) and chlorpyrifos-methyl (CLT) using a photonic suspension array based on silica colloidal crystal beads (SCCBs). The SCCBs were encoded with the characteristic reflection peak originating from the stop-band of colloidal crystal. This approach avoids the bleaching, fading or potential interference seen when encoding by fluorescence. SCCBs with a nanopatterned surface had increased biomolecule binding capacity and improved stability. Under optimal conditions, the proposed suspension array allowed simultaneous detection of the selected pesticides in the ranges of 0.25 to 1024 ng/mL and 0.40 to 735.37 ng/mL, with the limits of detection (LODs) of 0.25 and 0.40 ng/mL, respectively. The suspension array was specific and had no significant cross-reactivity with other chemicals. The mean recoveries in tests in which samples were spiked with target standards were 82.35% to 109.90% with a standard deviation within 9.93% for CLT and 81.64% to 108.10% with a standard deviation within 8.82% for FNT. The proposed method shows a potentially powerful capability for fast quantitative analysis of pesticide residues.	[Wang, Xuan; Liu, Ran; Pu, Yuepu; Yin, Lihong] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Mu, Zhongde; Shangguan, Fengqi] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Yin, LH (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.	lhyin@seu.edu.cn			Science and Technology Project of Suzhou [SYN201207]	Science and Technology Project of Suzhou	The authors gratefully acknowledge the financial support by Science and Technology Project of Suzhou (No. SYN201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2006, ANAL CHEM, V78, P2279, DOI 10.1021/ac051995c; Gonzalez-Curbelo MA, 2011, FOOD CHEM, V125, P1083, DOI 10.1016/j.foodchem.2010.09.083; Blasco C, 2004, J CHROMATOGR A, V1030, P77, DOI 10.1016/j.chroma.2003.11.037; Cajka T, 2008, J CHROMATOGR A, V1186, P281, DOI 10.1016/j.chroma.2007.12.009; Cakir S, 2005, FOOD CHEM TOXICOL, V43, P443, DOI 10.1016/j.fct.2004.11.010; Chen F, 2009, FOOD CHEM, V112, P956, DOI 10.1016/j.foodchem.2008.07.016; Daglish GJ, 2008, J STORED PROD RES, V44, P71, DOI 10.1016/j.jspr.2007.06.003; Dai RH, 2011, B ENVIRON CONTAM TOX, V86, P559, DOI 10.1007/s00128-011-0264-5; de Barros LA, 2010, ANAL BIOANAL CHEM, V397, P1355, DOI 10.1007/s00216-010-3629-4; Eskandari H, 2012, ANAL CHIM ACTA, V743, P137, DOI 10.1016/j.aca.2012.07.012; Gao YL, 2011, SMALL, V7, P137, DOI 10.1002/smll.201000909; Giordano A, 2011, TALANTA, V85, P2425, DOI 10.1016/j.talanta.2011.07.087; Giordano G, 2007, TOXICOL APPL PHARM, V219, P181, DOI 10.1016/j.taap.2006.09.016; GOSLING JP, 1990, CLIN CHEM, V36, P1408; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; He B, 2007, ANAL CHEM, V79, P5257, DOI 10.1021/ac0704964; Hua XD, 2010, BIOSENS BIOELECTRON, V26, P189, DOI 10.1016/j.bios.2010.06.005; Jani IV, 2002, LANCET INFECT DIS, V2, P243, DOI 10.1016/S1473-3099(02)00242-6; Kang HG, 2004, TOXICOLOGY, V199, P219, DOI 10.1016/j.tox.2004.02.025; Kavvalakis MP, 2012, FORENSIC SCI INT, V218, P111, DOI 10.1016/j.forsciint.2011.10.019; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Kim HJ, 2004, ANAL CHIM ACTA, V509, P111, DOI 10.1016/j.aca.2003.12.006; Kim YJ, 2007, ANAL CHIM ACTA, V591, P183, DOI 10.1016/j.aca.2007.03.072; Klostranec JM, 2007, NANO LETT, V7, P2812, DOI 10.1021/nl071415m; Kong Y, 2010, J AGR FOOD CHEM, V58, P8189, DOI 10.1021/jf101483w; Leandro CC, 2006, J CHROMATOGR A, V1103, P94, DOI 10.1016/j.chroma.2005.10.077; LeDoux M, 2011, J CHROMATOGR A, V1218, P1021, DOI 10.1016/j.chroma.2010.12.097; Ling MM, 2007, EXPERT REV MOL DIAGN, V7, P87, DOI 10.1586/14737159.7.1.87; Liu N, 2009, ANAL CHIM ACTA, V632, P128, DOI 10.1016/j.aca.2008.10.061; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Pedersen JA, 2006, ENVIRON SCI TECHNOL, V40, P2120, DOI 10.1021/es051677v; Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048; Qian GL, 2009, FOOD CHEM, V117, P364, DOI 10.1016/j.foodchem.2009.03.097; Rahman MF, 2002, MUTAT RES-GEN TOX EN, V516, P139, DOI 10.1016/S1383-5718(02)00033-5; Ravelo-Perez LM, 2008, J CHROMATOGR A, V1211, P33, DOI 10.1016/j.chroma.2008.09.084; Sanchez-Ortega A, 2005, J CHROMATOGR A, V1094, P70, DOI 10.1016/j.chroma.2005.07.089; Sanghi R, 2001, B ENVIRON CONTAM TOX, V67, P587, DOI 10.1007/s001280164; Sarikaya R, 2004, CHEMOSPHERE, V56, P697, DOI 10.1016/j.chemosphere.2004.04.008; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Su P, 2011, TALANTA, V85, P1160, DOI 10.1016/j.talanta.2011.05.040; Sun JW, 2009, ANAL BIOANAL CHEM, V394, P2223, DOI 10.1007/s00216-009-2911-9; Tankiewicz M, 2010, TRAC-TREND ANAL CHEM, V29, P1050, DOI 10.1016/j.trac.2010.05.008; Tao CJ, 2009, B ENVIRON CONTAM TOX, V82, P111, DOI 10.1007/s00128-008-9528-0; Uygun U, 2005, FOOD CHEM, V92, P643, DOI 10.1016/j.foodchem.2004.08.045; Wang HQ, 2007, J FLUORESC, V17, P133, DOI 10.1007/s10895-007-0157-5; Wilson R, 2006, ANGEW CHEM INT EDIT, V45, P6104, DOI 10.1002/anie.200600288; Yan XM, 2004, INT CONGR SER, V1263, P342, DOI 10.1016/j.ics.2004.02.075; Yang L, 2001, GENOME RES, V11, P1888, DOI 10.1101/gr.190901; Yang ZJ, 2008, ADV FUNCT MATER, V18, P3991, DOI 10.1002/adfm.200801022; Yeh SP, 2005, AQUACULTURE, V243, P383, DOI 10.1016/j.aquaculture.2004.10.017; Zhang BH, 2008, TALANTA, V75, P1055, DOI 10.1016/j.talanta.2008.01.032; Zhao WJ, 2011, FOOD CHEM, V127, P683, DOI 10.1016/j.foodchem.2010.12.122; Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a; Zhao YJ, 2011, J AM CHEM SOC, V133, P8790, DOI 10.1021/ja200729w; Zhao YJ, 2010, ADV FUNCT MATER, V20, P2970, DOI 10.1002/adfm.201000098	55	11	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66703	10.1371/journal.pone.0066703	http://dx.doi.org/10.1371/journal.pone.0066703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805266	gold, Green Submitted, Green Published			2022-12-27	WOS:000320846500094
J	Jutras, BL; Chenail, AM; Rowland, CL; Carroll, D; Miller, MC; Bykowski, T; Stevenson, B				Jutras, Brandon L.; Chenail, Alicia M.; Rowland, Christi L.; Carroll, Dustin; Miller, M. Clarke; Bykowski, Tomasz; Stevenson, Brian			Eubacterial SpoVG Homologs Constitute a New Family of Site-Specific DNA-Binding Proteins	PLOS ONE			English	Article							BORRELIA-BURGDORFERI EBFC; LYME-DISEASE SPIROCHETE; BACILLUS-SUBTILIS; SPORULATION GENE; SIGMA-FACTOR; MOLECULAR CHARACTERIZATION; ANTIGENIC VARIATION; CLONED GENE; EXPRESSION; CAPSULE	A site-specific DNA-binding protein was purified from Borrelia burgdorferi cytoplasmic extracts, and determined to be a member of the highly conserved SpoVG family. This is the first time a function has been attributed to any of these ubiquitous bacterial proteins. Further investigations into SpoVG orthologues indicated that the Staphylococcus aureus protein also binds DNA, but interacts preferentially with a distinct nucleic acid sequence. Site-directed mutagenesis and domain swapping between the S. aureus and B. burgdorferi proteins identified that a 6-residue stretch of the SpoVG alpha-helix contributes to DNA sequence specificity. Two additional, highly conserved amino acid residues on an adjacent beta-sheet are essential for DNA-binding, apparently by contacts with the DNA phosphate backbone. Results of these studies thus identified a novel family of bacterial DNA-binding proteins, developed a model of SpoVG-DNA interactions, and provide direction for future functional studies on these wide-spread proteins.	[Jutras, Brandon L.; Chenail, Alicia M.; Bykowski, Tomasz; Stevenson, Brian] Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA; [Rowland, Christi L.] Univ Kentucky, Coll Med, Dept Agr Sci, Lexington, KY USA; [Carroll, Dustin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY USA; [Miller, M. Clarke] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Louisville	Stevenson, B (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40506 USA.	brian.stevenson@uky.edu	Miller, M. Clarke/C-9483-2011	Miller, M. Clarke/0000-0002-9877-6581; Jutras, Brandon/0000-0002-7989-1031	National Research Fund for Tick-Borne Diseases	National Research Fund for Tick-Borne Diseases	This work was supported by a grant from the National Research Fund for Tick-Borne Diseases to B. Stevenson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babb K, 2004, J BACTERIOL, V186, P2745, DOI 10.1128/JB.186.9.2745-2756.2004; Babb K, 2006, J BACTERIOL, V188, P4331, DOI 10.1128/JB.00005-06; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Burns LH, 2010, NUCLEIC ACIDS RES, V38, P5443, DOI 10.1093/nar/gkq284; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Cocchiaro JL, 2006, MOL MICROBIOL, V59, P948, DOI 10.1111/j.1365-2958.2005.04978.x; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FURBASS R, 1991, MOL GEN GENET, V225, P347; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; HALDENWANG WG, 1979, NATURE, V282, P256, DOI 10.1038/282256a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JOHNSON WC, 1983, NATURE, V302, P800, DOI 10.1038/302800a0; Jutras BL, 2012, CURR PROTOCOLS MICRO; Jutras BL, 2012, J BACTERIOL, V194, P778, DOI 10.1128/JB.06394-11; Kim HH, 2010, ARCH PHARM RES, V33, P1285, DOI 10.1007/s12272-010-0820-2; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Luong T, 2002, INFECT IMMUN, V70, P444, DOI 10.1128/IAI.70.2.444-450.2002; Luong TT, 2006, MICROBIOL-SGM, V152, P3123, DOI 10.1099/mic.0.29177-0; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; MARGOLIS PS, 1993, J BACTERIOL, V175, P528, DOI 10.1128/JB.175.2.528-540.1993; Matsuno K, 1999, J BACTERIOL, V181, P3392, DOI 10.1128/JB.181.11.3392-3401.1999; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; Norris SJ, 2006, MOL MICROBIOL, V60, P1319, DOI 10.1111/j.1365-2958.2006.05204.x; Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172; Perez AR, 2006, J BACTERIOL, V188, P1159, DOI 10.1128/JB.188.3.1159-1164.2006; Perez AR, 2000, J BACTERIOL, V182, P1096, DOI 10.1128/JB.182.4.1096-1108.2000; RESNEKOV O, 1995, J BACTERIOL, V177, P5628, DOI 10.1128/jb.177.19.5628-5635.1995; Riley SP, 2009, NUCLEIC ACIDS RES, V37, P1973, DOI 10.1093/nar/gkp027; ROBERTSON JB, 1989, P NATL ACAD SCI USA, V86, P8457, DOI 10.1073/pnas.86.21.8457; ROSENBLUH A, 1981, J BACTERIOL, V148, P341, DOI 10.1128/JB.148.1.341-351.1981; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Schulthess B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-17; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; SEGALL J, 1977, CELL, V11, P751, DOI 10.1016/0092-8674(77)90289-6; Walia R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057792; WILLEMS A, 1995, INT J SYST BACTERIOL, V45, P832, DOI 10.1099/00207713-45-4-832; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; ZUBER P, 1983, CELL, V35, P275, DOI 10.1016/0092-8674(83)90230-1; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	51	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66683	10.1371/journal.pone.0066683	http://dx.doi.org/10.1371/journal.pone.0066683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818957	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800094
J	Temerozo, JR; Joaquim, R; Regis, EG; Savino, W; Bou-Habib, DC				Temerozo, Jairo R.; Joaquim, Rafael; Regis, Eduardo G.; Savino, Wilson; Bou-Habib, Dumith Chequer			Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYCLASE-ACTIVATING POLYPEPTIDE; IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-COUPLED RECEPTORS; NITRIC-OXIDE PRODUCTION; NECROSIS-FACTOR-ALPHA; ADENYLATE-CYCLASE; CHEMOKINE PRODUCTION; IN-VITRO; T-CELLS	It is well established that host factors can modulate HIV-1 replication in macrophages, critical cells in the pathogenesis of HIV-1 infection due to their ability to continuously produce virus. The neuropeptides VIP and PACAP induce well-characterized effects on macrophages through binding to the G protein-coupled receptors VPAC1, VPAC2 and PAC1, but their influence on HIV-1 production by these cells has not been established. Here, we describe that VIP and PACAP reduce macrophage production of HIV-1, acting in a synergistic or additive manner to decrease viral growth. Using receptor antagonists, we detected that the HIV-1 inhibition promoted by VIP is dependent on its ligation to VPAC1/2, whereas PACAP decreases HIV-1 growth via activation of the VPAC1/2 and PAC1 receptors. Specific agonists of VPAC2 or PAC1 decrease macrophage production of HIV-1, whereas sole activation of VPAC1 enhances viral growth. However, the combination of specific agonists mimicking the receptor preference of the natural neuropeptides reproduces the ability of VIP and PACAP to increase macrophage resistance to HIV-1 replication. VIP and PACAP up-regulated macrophage secretion of the beta-chemokines CCL3 and CCL5 and the cytokine IL-10, whose neutralization reversed the neuropeptide-induced inhibition of HIV-1 replication. Our results suggest that VIP and PACAP and the receptors VPAC2 and PAC1 could be used as targets for developing alternative therapeutic strategies for HIV-1 infection.	[Temerozo, Jairo R.; Regis, Eduardo G.; Savino, Wilson; Bou-Habib, Dumith Chequer] Fiocruz MS, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil; [Joaquim, Rafael] Cent Hosp Maputo, Microbiol Lab, Maputo, Mozambique	Fundacao Oswaldo Cruz	Bou-Habib, DC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Thymus Res, BR-21045900 Rio De Janeiro, Brazil.	dumith@ioc.fiocruz.br	Temerozo, Jairo R/K-4894-2012; Bou-Habib, Dumith/GPP-1624-2022	Temerozo, Jairo R/0000-0002-8092-2149; Bou-Habib, Dumith/0000-0003-0552-9045	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475958/2011-0]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj) [E-26/102755/2008]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant # 475958/2011-0) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj; grant # E-26/102755/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2011, CURR PHARM DESIGN, V17, P1025, DOI 10.2174/138161211795589364; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Andreani G, 2012, CURR OPIN HIV AIDS, V7, P276, DOI 10.1097/COH.0b013e32835211e9; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bokaei PB, 2007, VIROLOGY, V362, P38, DOI 10.1016/j.virol.2006.12.012; Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027; Branch DR, 2002, AIDS, V16, P309, DOI 10.1097/00002030-200202150-00001; Brenneman DE, 2002, NEUROPEPTIDES, V36, P271, DOI 10.1016/S0143-4179(02)00045-8; Brenneman DE, 1999, BRAIN RES, V838, P27, DOI 10.1016/S0006-8993(99)01644-3; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Chorny A, 2006, ANN NY ACAD SCI, V1088, P187, DOI 10.1196/annals.1366.004; Dejda A, 2005, PHARMACOL REP, V57, P307; Delgado M, 1999, ANN NY ACAD SCI, V897, P401, DOI 10.1111/j.1749-6632.1999.tb07909.x; Delgado M, 2004, FASEB J, V18, P1453, DOI 10.1096/fj.04-1548fje; Delgado M, 2001, Arch Physiol Biochem, V109, P377; Delgado M, 1999, J NEUROIMMUNOL, V96, P167, DOI 10.1016/S0165-5728(99)00023-5; Delgado M, 2001, J IMMUNOL, V167, P966, DOI 10.4049/jimmunol.167.2.966; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ganea D, 2002, CRIT REV ORAL BIOL M, V13, P229, DOI 10.1177/154411130201300303; Garzino-Demo A, 2000, IMMUNOL REV, V177, P79, DOI 10.1034/j.1600-065X.2000.17711.x; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gonzalez-Rey E, 2008, BRAIN BEHAV IMMUN, V22, P35, DOI 10.1016/j.bbi.2007.07.004; Gonzalez-Rey E, 2007, CURR PHARM DESIGN, V13, P1113, DOI 10.2174/138161207780618966; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Kim WK, 2000, J NEUROSCI, V20, P3622, DOI 10.1523/JNEUROSCI.20-10-03622.2000; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Langer I, 2007, BIOCHEM SOC T, V35, P724, DOI 10.1042/BST0350724; Larocca L, 2007, INT IMMUNOPHARMACOL, V7, P1343, DOI 10.1016/j.intimp.2007.05.017; Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591, DOI 10.1002/jlb.63.5.591; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MONTANER LJ, 1994, J GEN VIROL, V75, P3393, DOI 10.1099/0022-1317-75-12-3393; Naif HM, 1996, AIDS RES HUM RETROV, V12, P1237, DOI 10.1089/aid.1996.12.1237; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; PISEGNA JR, 1993, P NATL ACAD SCI USA, V90, P6345, DOI 10.1073/pnas.90.13.6345; Pozo D, 2007, PEPTIDES, V28, P1833, DOI 10.1016/j.peptides.2007.04.008; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Sanchez A, 2009, NEUROPEPTIDES, V43, P315, DOI 10.1016/j.npep.2009.05.002; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Souza TML, 2011, BLOOD, V117, P2944, DOI 10.1182/blood-2010-05-287193; WEISSMAN D, 1994, AIDS RES HUM RETROV, V10, P1199, DOI 10.1089/aid.1994.10.1199	47	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67701	10.1371/journal.pone.0067701	http://dx.doi.org/10.1371/journal.pone.0067701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818986	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800143
J	Capozzi, A; Vincentini, O; Gizzi, P; Porzia, A; Longo, A; Felli, C; Mattei, V; Mainiero, F; Silano, M; Sorice, M; Misasi, R				Capozzi, Antonella; Vincentini, Olimpia; Gizzi, Pietro; Porzia, Alessandra; Longo, Agostina; Felli, Cristina; Mattei, Vincenzo; Mainiero, Fabrizio; Silano, Marco; Sorice, Maurizio; Misasi, Roberta			Modulatory Effect of Gliadin Peptide 10-mer on Epithelial Intestinal CACO-2 Cell Inflammatory Response	PLOS ONE			English	Article							CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; DIETARY GLUTEN; ACTIVATION; THERAPY; CHALLENGE; SECRETION; MUCOSA; IL-8	Celiac Disease (CD) is a chronic inflammatory enteropathy, triggered in genetically susceptible individuals by dietary gluten. Gluten is able to elicit proliferation of specific T cells and secretion of inflammatory cytokines in the small intestine. In this study we investigated the possibility that p10-mer, a decapeptide from durum wheat (QQPQDAVQPF), which was previously shown to prevent the activation of celiac peripheral lymphocytes, may exert an inhibitory effect on peptic-tryptic digested gliadin (PT-Gly)-stimulated intestinal carcinoma CACO-2 cells. In these cells, incubated with PT-Gly or p31-43 alpha-gliadin derived peptide in the presence or in the absence of p10-mer, IRAK1 activation and NF-kB, ERK1/2 and p38 MAPK phosphorylation were measured by immunoblotting, Cyclooxigenase 2 (COX-2) activity by PGE-2 release assay, and production of cytokines in the cell supernatants by ELISA. Our results showed that pre-treatment of CACO-2 cells with p10-mer significantly inhibited IRAK1 activation and NF-kB, ERK1/2 and p38 MAPK phosphorylation, as well as COX-2 activity (i.e. PGE-2 release) and production of the IL-6 and IL-8 pro-inflammatory cytokines, induced by gliadin peptides. These findings demonstrate the inhibitory effect of the p10-mer peptide on inflammatory response in CACO-2 cells. The results of the present study show that this p10-mer peptide can modulate "in vitro" the inflammatory response induced by gliadin peptides, allowing to move towards new therapeutic strategies. Turning off the inflammatory response, may in fact represent a key target in the immunotherapy of celiac disease.	[Capozzi, Antonella; Gizzi, Pietro; Porzia, Alessandra; Longo, Agostina; Mainiero, Fabrizio; Sorice, Maurizio; Misasi, Roberta] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Vincentini, Olimpia; Felli, Cristina; Silano, Marco] Ist Super Sanita, Unit Human Nutr & Hlth, I-00161 Rome, Italy; [Mattei, Vincenzo] Univ La Sapienza, Expt Med & Environm Pathol Lab, Rieti, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome	Misasi, R (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	roberta.misasi@uniromal.it	Felli, Cristina/I-9795-2014; porzia, alessandra/AAA-7753-2020; Sousa, Maria/HCI-9642-2022; Sorice, Maurizio/Q-5079-2019; Mattei, Vincenzo/AAQ-3667-2020; Silano, Marco/B-3835-2015; Silano, Marco/AAC-9792-2022; vincentini, olimpia/N-3332-2019; VINCENTINI, OLIMPIA/B-3837-2015	Felli, Cristina/0000-0002-5253-0367; Mattei, Vincenzo/0000-0003-4677-088X; Silano, Marco/0000-0002-7051-3405; vincentini, olimpia/0000-0002-4137-4135; VINCENTINI, OLIMPIA/0000-0002-4137-4135; porzia, alessandra/0000-0002-7545-3018; Sorice, Maurizio/0000-0003-3534-1502; Mainiero, Fabrizio/0000-0002-7136-9839	University La Sapienza School of Medicine	University La Sapienza School of Medicine	This work has been supported by grants from the University La Sapienza School of Medicine (to RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Camarca A, 2009, J IMMUNOL, V182, P4158, DOI 10.4049/jimmunol.0803181; Chow WL, 2008, BRIT J NUTR, V99, P449, DOI 10.1017/S0007114507812062; Cinova J, 2007, J CLIN IMMUNOL, V27, P201, DOI 10.1007/s10875-006-9061-z; De Vita P, 2012, J CEREAL SCI, V55, P234, DOI 10.1016/j.jcs.2011.12.006; DeVincenzi M, 1997, TOXICOLOGY, V120, P207, DOI 10.1016/S0300-483X(97)00060-7; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hall RP, 2007, J INVEST DERMATOL, V127, P2158, DOI 10.1038/sj.jid.5700929; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; Kelly CP, 2013, ALIMENT PHARM THER, V37, P252, DOI 10.1111/apt.12147; Lammers KM, 2011, IMMUNOLOGY, V132, P432, DOI 10.1111/j.1365-2567.2010.03378.x; LAVO B, 1990, GASTROENTEROLOGY, V99, P703, DOI 10.1016/0016-5085(90)90958-4; Lerner A, 2010, AUTOIMMUN REV, V9, P144, DOI 10.1016/j.autrev.2009.05.002; Londei M, 2005, MOL IMMUNOL, V42, P913, DOI 10.1016/j.molimm.2004.12.005; Maiuri L, 2005, GASTROENTEROLOGY, V129, P1400, DOI 10.1053/j.gastro.2005.07.054; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Martin-Venegas R, 2006, J LIPID RES, V47, P1416, DOI 10.1194/jlr.M500564-JLR200; Morisi G, 1979, PEDIATR RES, V131, P255; Pardin C, 2008, J ORG CHEM, V73, P5766, DOI 10.1021/jo8004843; Pinier M, 2009, GASTROENTEROLOGY, V136, P288, DOI 10.1053/j.gastro.2008.09.016; Salvati VM, 2005, GUT, V54, P46, DOI 10.1136/gut.2003.023150; Siegel M, 2007, BIOORGAN MED CHEM, V15, P6253, DOI 10.1016/j.bmc.2007.06.020; Silano M, 2008, AM J CLIN NUTR, V87, P415, DOI 10.1093/ajcn/87.2.415; Silano M, 2007, PEDIATR RES, V61, P67, DOI 10.1203/01.pdr.0000250173.88049.79; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Vincentini O, 2011, CLIN NUTR, V30, P541, DOI 10.1016/j.clnu.2011.02.007	34	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66561	10.1371/journal.pone.0066561	http://dx.doi.org/10.1371/journal.pone.0066561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823806	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400130
J	Zhao, DX; Zhang, XF; Chen, DS; Zhang, YK; Hong, XY				Zhao, Dong-Xiao; Zhang, Xiang-Fei; Chen, Da-Song; Zhang, Yan-Kai; Hong, Xiao-Yue			Wolbachia-Host Interactions: Host Mating Patterns Affect Wolbachia Density Dynamics	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; INDUCED HYBRID BREAKDOWN; CYTOPLASMIC INCOMPATIBILITY; ENDOSYMBIONT WOLBACHIA; TETRANYCHUS-URTICAE; DROSOPHILA; INFECTION; MOSQUITO; FITNESS; MITOCHONDRIAL	Wolbachia are maternally inherited intracellular bacteria that infect a wide range of arthropods and cause an array of effects on host reproduction, fitness and mating behavior. Although our understanding of the Wolbachia-associated effects on hosts is rapidly expanding, our knowledge of the host factors that mediate Wolbachia dynamics is rudimentary. Here, we explore the interactions between Wolbachia and its host, the two-spotted spider mite Tetranychus urticae Koch. Our results indicate that Wolbachia induces strong cytoplasmic incompatibility (CI), increases host fecundity, but has no effects on the longevity of females and the mating competitiveness of males in T. urticae. Most importantly, host mating pattern was found to affect Wolbachia density dynamics during host aging. Mating of an uninfected mite of either sex with an infected mite attenuates the Wolbachia density in the infected mite. According to the results of Wolbachia localization, this finding may be associated with the tropism of Wolbachia for the reproductive tissue in adult spider mites. Our findings describe a new interaction between Wolbachia and their hosts.	[Zhao, Dong-Xiao; Zhang, Xiang-Fei; Chen, Da-Song; Zhang, Yan-Kai; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Hong, XY (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Hong, Xiao-Yue/AAF-4759-2020		Science and Technology Program of the National Public Welfare Professional Fund, Ministry of Agriculture of China [201103020]; National Basic Science Program of China (973 program) [2009CB119202]; National Natural Science Foundation of China [31172131]	Science and Technology Program of the National Public Welfare Professional Fund, Ministry of Agriculture of China; National Basic Science Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Grant-in-Aid from the Science and Technology Program of the National Public Welfare Professional Fund (number 201103020) from the Ministry of Agriculture of China (www.moa.gov.cn), a Grant-in-Aid from the National Basic Science Program of China (973 program, number 2009CB119202)(www.most.gov.cn), and a Grant-in-Aid for Scientific Research (number 31172131) from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Bordenstein SR, 2003, GENETICS, V164, P223; Breeuwer JAJ, 1997, HEREDITY, V79, P41, DOI 10.1038/hdy.1997.121; Calvitti M, 2009, MED VET ENTOMOL, V23, P132, DOI 10.1111/j.1365-2915.2008.00791.x; Carrington LB, 2010, P ROY SOC B-BIOL SCI, V277, P2059, DOI 10.1098/rspb.2010.0166; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Cone W.W., 1985, P243; Corsaro D, 1999, CRIT REV MICROBIOL, V25, P39, DOI 10.1080/10408419991299167; De Crespigny FEC, 2006, J EVOLUTION BIOL, V19, P1964, DOI 10.1111/j.1420-9101.2006.01143.x; de Crespigny FEC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1229, DOI 10.1007/s00265-007-0353-y; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Fleury F, 2000, PARASITOLOGY, V121, P493, DOI 10.1017/S0031182099006599; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koukou K, 2006, EVOLUTION, V60, P87, DOI 10.1111/j.0014-3820.2006.tb01084.x; Lu MH, 2012, EXP APPL ACAROL, V58, P207, DOI 10.1007/s10493-012-9578-1; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Mouton L, 2005, HEREDITY, V94, P187, DOI 10.1038/sj.hdy.6800596; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; Perrot-Minnot MJ, 2002, J EVOLUTION BIOL, V15, P808, DOI 10.1046/j.1420-9101.2002.00446.x; Ros VID, 2009, HEREDITY, V102, P413, DOI 10.1038/hdy.2009.4; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Ruang-areerate T, 2004, CURR MICROBIOL, V49, P10, DOI 10.1007/s00284-003-4245-8; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Snook RR, 2000, GENETICS, V155, P167; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vala F, 2000, P ROY SOC B-BIOL SCI, V267, P1931, DOI 10.1098/rspb.2000.1232; Vala F, 2003, EXP APPL ACAROL, V29, P253, DOI 10.1023/A:1025810414956; Vala F, 2003, EXP APPL ACAROL, V29, P1, DOI 10.1023/A:1024279831966; Vavre F, 2000, EVOLUTION, V54, P191, DOI 10.1111/j.0014-3820.2000.tb00019.x; Veneti Z, 2003, GENETICS, V164, P545; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xie L, 2006, ZOOTAXA, P33, DOI 10.11646/zootaxa.1165.1.2; Xie RR, 2011, APPL ENTOMOL ZOOL, V46, P95, DOI 10.1007/s13355-010-0014-x; Zhao DX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054964; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zhu LY, 2012, CURR MICROBIOL, V65, P516, DOI 10.1007/s00284-012-0190-8; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	54	25	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66373	10.1371/journal.pone.0066373	http://dx.doi.org/10.1371/journal.pone.0066373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823081	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400096
J	Popic, TJ; Davila, YC; Wardle, GM				Popic, Tony J.; Davila, Yvonne C.; Wardle, Glenda M.			Evaluation of Common Methods for Sampling Invertebrate Pollinator Assemblages: Net Sampling Out-Perform Pan Traps	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; COMMUNITIES; ARCHITECTURE; HYMENOPTERA; APIFORMES; BEES	Methods for sampling ecological assemblages strive to be efficient, repeatable, and representative. Unknowingly, common methods may be limited in terms of revealing species function and so of less value for comparative studies. The global decline in pollination services has stimulated surveys of flower-visiting invertebrates, using pan traps and net sampling. We explore the relative merits of these two methods in terms of species discovery, quantifying abundance, function, and composition, and responses of species to changing floral resources. Using a spatially-nested design we sampled across a 5000 km 2 area of arid grasslands, including 432 hours of net sampling and 1296 pan trap-days, between June 2010 and July 2011. Net sampling yielded 22% more species and 30% higher abundance than pan traps, and better reflected the spatio-temporal variation of floral resources. Species composition differed significantly between methods; from 436 total species, 25% were sampled by both methods, 50% only by nets, and the remaining 25% only by pans. Apart from being less comprehensive, if pan traps do not sample flower-visitors, the link to pollination is questionable. By contrast, net sampling functionally linked species to pollination through behavioural observations of flower-visitation interaction frequency. Netted specimens are also necessary for evidence of pollen transport. Benefits of net-based sampling outweighed minor differences in overall sampling effort. As pan traps and net sampling methods are not equivalent for sampling invertebrate-flower interactions, we recommend net sampling of invertebrate pollinator assemblages, especially if datasets are intended to document declines in pollination and guide measures to retain this important ecosystem service.	[Popic, Tony J.; Davila, Yvonne C.; Wardle, Glenda M.] Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia; [Wardle, Glenda M.] LTERN, Sydney, NSW, Australia	University of Sydney	Popic, TJ (corresponding author), Univ Sydney, Sch Biol Sci, Desert Ecol Res Grp, Sydney, NSW 2006, Australia.	tony.popic@sydney.edu.au	Wardle, Glenda/D-6533-2016; Wardle, Glenda/ABD-9228-2021	Wardle, Glenda/0000-0003-0189-1899; Wardle, Glenda/0000-0003-0189-1899; Davila, Yvonne/0000-0002-5144-5742	Australian Research Council Discovery Project Grant; Australian Postgraduate Award	Australian Research Council Discovery Project Grant(Australian Research Council); Australian Postgraduate Award(Australian Government)	Funding for the project was provided by an Australian Research Council Discovery Project Grant (GMW) and an Australian Postgraduate Award (to TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Alexander R, 2005, FIELD GUIDE PLANTS C; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Baum KA, 2011, J KANSAS ENTOMOL SOC, V84, P155, DOI 10.2317/JKES100629.1; Berenbaum M, 2007, STATUS POLLINATORS N; Cane JH, 2000, J KANSAS ENTOMOL SOC, V73, P225; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Clements F.E., 1916, PLANT SUCCESSION ANA; Dafni A, 2005, PRACTICAL POLLINATIO, P503; Droege S., 2009, VERY HANDY MANUAL CA; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Gollan JR, 2011, AUST J ENTOMOL, V50, P174, DOI 10.1111/j.1440-6055.2010.00797.x; Gorley C.K., 2006, GETTING STARTED PRIM; Grundel R, 2011, ENVIRON ENTOMOL, V40, P374, DOI 10.1603/EN09278; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Mayer C., 2011, Journal of Pollination Ecology, V3, P8; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Nielsen A, 2011, ECOL RES, V26, P969, DOI 10.1007/s11284-011-0852-1; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pellmyr Olle, 2002, P157; Popic TJ, 2013, AUSTRAL ECOL, V38, P76, DOI 10.1111/j.1442-9993.2012.02377.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Roubik DW, 2001, UPS DOWNS POLLINATOR; Roulston TH, 2007, J KANSAS ENTOMOL SOC, V80, P179, DOI 10.2317/0022-8567(2007)80[179:ACOPTA]2.0.CO;2; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; THOMSON JD, 2001, CONSERVATION ECOLOGY; Urban A., 2001, WILDFLOWERS PLANTS I; Van Etten EJB, 2009, AUST GEOGR, V40, P109, DOI 10.1080/00049180802657075; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Williams N. M., 2001, CONSERVATION ECOLOGY; Willmer P., 2011, POLLINATION FLORAL E; Wilson JS, 2008, J KANSAS ENTOMOL SOC, V81, P288, DOI 10.2317/JKES-802.06.1; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	38	74	75	2	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66665	10.1371/journal.pone.0066665	http://dx.doi.org/10.1371/journal.pone.0066665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799127	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800046
J	Guerreiro, LTA; Robottom-Ferreira, AB; Ribeiro-Alves, M; Toledo-Pinto, TG; Brito, TR; Rosa, PS; Sandoval, FG; Jardim, MR; Antunes, SG; Shannon, EJ; Sarno, EN; Pessolani, MCV; Williams, DL; Moraes, MO				Albuquerque Guerreiro, Luana Tatiana; Robottom-Ferreira, Anna Beatriz; Ribeiro-Alves, Marcelo; Toledo-Pinto, Thiago Gomes; Brito, Tiana Rosa; Rosa, Patricia Sammarco; Sandoval, Felipe Galvan; Jardim, Marcia Rodrigues; Antunes, Sergio Gomes; Shannon, Edward J.; Sarno, Euzenir Nunes; Vidal Pessolani, Maria Cristina; Williams, Diana Lynn; Moraes, Milton Ozorio			Gene Expression Profiling Specifies Chemokine, Mitochondrial and Lipid Metabolism Signatures in Leprosy	PLOS ONE			English	Article							MYCOBACTERIUM-LEPRAE; REAL-TIME; GENOMEWIDE ASSOCIATION; SUSCEPTIBILITY GENES; LEPROMATOUS LEPROSY; LYMPHOTOXIN-ALPHA; TUBERCULOSIS; MODEL; DIAGNOSIS; CELLS	Herein, we performed microarray experiments in Schwann cells infected with live M. leprae and identified novel differentially expressed genes (DEG) in M. leprae infected cells. Also, we selected candidate genes associated or implicated with leprosy in genetic studies and biological experiments. Forty-seven genes were selected for validation in two independent types of samples by multiplex qPCR. First, an in vitro model using THP-1 cells was infected with live Mycobacterium leprae and M. bovis bacillus Calmette-Guerin (BCG). In a second situation, mRNA obtained from nerve biopsies from patients with leprosy or other peripheral neuropathies was tested. We detected DEGs that discriminate M. bovis BCG from M. leprae infection. Specific signatures of susceptible responses after M. leprae infection when compared to BCG lead to repression of genes, including CCL2, CCL3, IL8 and SOD2. The same 47-gene set was screened in nerve biopsies, which corroborated the down-regulation of CCL2 and CCL3 in leprosy, but also evidenced the down-regulation of genes involved in mitochondrial metabolism, and the up-regulation of genes involved in lipid metabolism and ubiquitination. Finally, a gene expression signature from DEG was identified in patients confirmed of having leprosy. A classification tree was able to ascertain 80% of the cases as leprosy or non-leprous peripheral neuropathy based on the expression of only LDLR and CCL4. A general immune and mitochondrial hypo-responsive state occurs in response to M. leprae infection. Also, the most important genes and pathways have been highlighted providing new tools for early diagnosis and treatment of leprosy.	[Albuquerque Guerreiro, Luana Tatiana; Robottom-Ferreira, Anna Beatriz; Ribeiro-Alves, Marcelo; Toledo-Pinto, Thiago Gomes; Brito, Tiana Rosa; Jardim, Marcia Rodrigues; Antunes, Sergio Gomes; Sarno, Euzenir Nunes; Moraes, Milton Ozorio] FIOCRUZ RJ, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] FIOCRUZ RJ, Inst Pesquisa Clin Evandro Chagas IPEC, Lab Pesquisa Farmacogenet, Rio De Janeiro, Brazil; [Vidal Pessolani, Maria Cristina] FIOCRUZ RJ, Lab Microbiol Celular, Rio De Janeiro, Brazil; [Rosa, Patricia Sammarco] Inst Lauro Souza Lima, Sao Paulo, Brazil; [Sandoval, Felipe Galvan; Shannon, Edward J.; Williams, Diana Lynn] Louisiana State Univ, Sch Vet Med, Hlth Resources & Serv Adm HRSA,Lab Res Branch, Bur Primary Hlth Care BPHC,Div Natl Hansens Dis P, Baton Rouge, LA 70803 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; United States Health Resources & Service Administration (HRSA)	Moraes, MO (corresponding author), FIOCRUZ RJ, Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil.	mmoraes@fiocruz.br	Moraes, Milton Ozório/G-9753-2011; Moraes, Milton/AFF-1842-2022; Rosa, Patrïcia/G-5880-2012	Moraes, Milton Ozório/0000-0003-2653-0037; Robottom Ferreira, Anna Beatriz/0000-0003-3553-1744; Nunes Sarno, Euzenir/0000-0003-0129-2159; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	PAPES (Programa Estrategico de Apoio a Pesquisa em Saude, FIOCRUZ); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	PAPES (Programa Estrategico de Apoio a Pesquisa em Saude, FIOCRUZ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work has been funded by PAPES (Programa Estrategico de Apoio a Pesquisa em Saude, FIOCRUZ); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). LTAG and ABRF were PhD students sponsored by CNPq and CAPES. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001303; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; Alter A, 2010, HUM GENET, V127, P337, DOI 10.1007/s00439-009-0775-x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basso D., 2009, PERMUTATION TESTS ST, V3, DOI DOI 10.1007/978-0-387-85956-9_5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger AK, 2009, HUM MOL GENET, V18, P4317, DOI 10.1093/hmg/ddp384; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cardoso CC, 2010, HUM GENET, V128, P481, DOI 10.1007/s00439-010-0872-x; Cardoso CC, 2011, J INFECT DIS, V204, P1256, DOI 10.1093/infdis/jir521; Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/FMB.11.39, 10.2217/fmb.11.39]; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; Garg N, 2003, BBA-MOL BASIS DIS, V1638, P106, DOI 10.1016/S0925-4439(03)00060-7; Geluk A, 2012, J IMMUNOL, V188, P4782, DOI 10.4049/jimmunol.1103452; Antunes SLG, 2012, MEM I OSWALDO CRUZ, V107, P246, DOI 10.1590/S0074-02762012000200015; Grant AV, 2012, J INFECT DIS, V206, P1763, DOI 10.1093/infdis/jis588; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Hagge DA, 2002, J INFECT DIS, V186, P1283, DOI 10.1086/344313; Hagge DA, 2009, AM J PATHOL, V174, P1379, DOI 10.2353/ajpath.2009.080550; Hasan Z, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-78; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Jardim MR, 2005, LEPROSY REV, V76, P232; JOB CK, 1970, ARCH PATHOL, V89, P195; Lahiri R, 2005, J MED MICROBIOL, V54, P235, DOI 10.1099/jmm.0.45700-0; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Martinez AN, 2006, J CLIN MICROBIOL, V44, P3154, DOI 10.1128/JCM.02250-05; Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09; Martinez AN, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001354; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; Menicucci LA, 2005, J AM ACAD DERMATOL, V52, P648, DOI 10.1016/j.jaad.2004.11.068; Merle CSC, 2010, EXPERT REV VACCINES, V9, P209, DOI 10.1586/ERV.09.161; Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Murray RA, 2007, J IMMUNOL, V178, P338, DOI 10.4049/jimmunol.178.1.338; Oliveira MM, 2001, MEM I OSWALDO CRUZ, V96, P973, DOI 10.1590/S0074-02762001000700015; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Paul S, 1996, J INFECT DIS, V174, P105, DOI 10.1093/infdis/174.1.105; Pereira AC, 2009, GENES IMMUN, V10, P174, DOI 10.1038/gene.2008.97; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; R Core Team, 2020, R LANG ENV STAT COMP; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Sapkota BR, 2010, HUM IMMUNOL, V71, P992, DOI 10.1016/j.humimm.2010.07.001; Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Sinsimer D, 2010, INFECT IMMUN, V78, P293, DOI 10.1128/IAI.00816-09; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sun YH, 2011, EXP DERMATOL, V20, P520, DOI 10.1111/j.1600-0625.2011.01270.x; SUZUKI K, 1993, INT J LEPROSY, V61, P609; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Truman RW, 2001, INT J LEPROSY, V69, P1; Vandesompele J, 2003, GENOME BIOL, DOI [10.1186/gb-2002-3-7-re-search0034, DOI 10.1186/GB-2002-3-7-RE-SEARCH0034]; Virchow R, 1863, KRANKHAFTEN GESCHWU; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Wong SH, 2010, NEW ENGL J MED, V362, P1446, DOI 10.1056/NEJMc1001451; Wu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038367; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	68	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64748	10.1371/journal.pone.0064748	http://dx.doi.org/10.1371/journal.pone.0064748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798993	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300002
J	Caron, MA; Morissette, MC; Theriault, ME; Nikota, JK; Stampfli, MR; Debigare, R				Caron, Marc-Andre; Morissette, Mathieu C.; Theriault, Marie-Eve; Nikota, Jake K.; Staempfli, Martin R.; Debigare, Richard			Alterations in Skeletal Muscle Cell Homeostasis in a Mouse Model of Cigarette Smoke Exposure	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; UBIQUITIN-PROTEASOME PATHWAY; INDUCED OXIDATIVE STRESS; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; IN-VIVO/; ATROPHY; COPD; HYPERTROPHY; DYSFUNCTION	Background: Skeletal muscle dysfunction is common in chronic obstructive pulmonary disease (COPD), a disease mainly caused by chronic cigarette use. An important proportion of patients with COPD have decreased muscle mass, suggesting that chronic cigarette smoke exposure may interfere with skeletal muscle cellular equilibrium. Therefore, the main objective of this study was to investigate the kinetic of the effects that cigarette smoke exposure has on skeletal muscle cell signaling involved in protein homeostasis and to assess the reversibility of these effects. Methods: A mouse model of cigarette smoke exposure was used to assess skeletal muscle changes. BALB/c mice were exposed to cigarette smoke or room air for 8 weeks, 24 weeks or 24 weeks followed by 60 days of cessation. The gastrocnemius and soleus muscles were collected and the activation state of key mediators involved in protein synthesis and degradation was assessed. Results: Gastrocnemius and soleus were smaller in mice exposed to cigarette smoke for 8 and 24 weeks compared to room air exposed animals. Pro-degradation proteins were induced at the mRNA level after 8 and 24 weeks. Twenty-four weeks of cigarette smoke exposure induced pro-degradation proteins and reduced Akt phosphorylation and glycogen synthase kinase-3 beta quantity. A 60-day smoking cessation period reversed the cell signaling alterations induced by cigarette smoke exposure. Conclusions: Repeated cigarette smoke exposure induces reversible muscle signaling alterations that are dependent on the duration of the cigarette smoke exposure. These results highlights a beneficial aspect associated with smoking cessation.	[Caron, Marc-Andre; Theriault, Marie-Eve; Debigare, Richard] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Caron, Marc-Andre; Theriault, Marie-Eve; Debigare, Richard] Univ Laval, Quebec City, PQ, Canada; [Morissette, Mathieu C.; Nikota, Jake K.; Staempfli, Martin R.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Staempfli, Martin R.] McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada	Laval University; Laval University; McMaster University; McMaster University	Debigare, R (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	Richard.Debigare@rea.ulaval.ca		Stampfli, Martin/0000-0003-4918-5889	 [CIHR 93776]		This research was supported by grant CIHR 93776, which funded the cost of reagents and the technician salary of RD research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AR, 2012, AM J PHYSIOL-LUNG C, V303, pL889, DOI 10.1152/ajplung.00219.2012; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Barreiro E, 2012, RESP PHYSIOL NEUROBI, V182, P9, DOI 10.1016/j.resp.2012.02.001; Barreiro E, 2010, AM J RESP CRIT CARE, V182, P477, DOI 10.1164/rccm.200908-1220OC; Basic VT, 2012, AM J PHYSIOL-LUNG C, V303, pL519, DOI 10.1152/ajplung.00007.2012; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Caron MA, 2011, AM J RESP CRIT CARE, V183; Caron MA, 2009, J APPL PHYSIOL, V107, P952, DOI 10.1152/japplphysiol.00194.2009; de Oca MM, 2008, CHEST, V133, P13, DOI 10.1378/chest.07-1592; De Paepe B, 2008, ACTA NEUROPATHOL, V115, P675, DOI 10.1007/s00401-008-0348-4; Debigarte R, 2001, AM J RESP CRIT CARE, V164, P1712, DOI 10.1164/ajrccm.164.9.2104035; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Jobse BN, 2013, J NUCL MED, V54, P616, DOI 10.2967/jnumed.112.111419; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rinaldi M, 2012, DIS MODEL MECH, V5, P333, DOI 10.1242/dmm.008508; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Tang K, 2010, J CELL PHYSIOL, V222, P320, DOI 10.1002/jcp.21955; Tanni SE, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-29; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	37	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66433	10.1371/journal.pone.0066433	http://dx.doi.org/10.1371/journal.pone.0066433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799102	Green Submitted, gold, Green Published			2022-12-27	WOS:000320363300081
J	Schep, AN; Adryan, B				Schep, Alicia N.; Adryan, Boris			A Comparative Analysis of Transcription Factor Expression during Metazoan Embryonic Development	PLOS ONE			English	Article							GENE-EXPRESSION; EVOLUTION; DATABASE; PACKAGE; STAGE	During embryonic development, a complex organism is formed from a single starting cell. These processes of growth and differentiation are driven by large transcriptional changes, which are following the expression and activity of transcription factors (TFs). This study sought to compare TF expression during embryonic development in a diverse group of metazoan animals: representatives of vertebrates (Danio rerio, Xenopus tropicalis), a chordate (Ciona intestinalis) and invertebrate phyla such as insects (Drosophila melanogaster, Anopheles gambiae) and nematodes (Caenorhabditis elegans) were sampled, The different species showed overall very similar TF expression patterns, with TF expression increasing during the initial stages of development. C2H2 zinc finger TFs were over-represented and Homeobox TFs were under-represented in the early stages in all species. We further clustered TFs for each species based on their quantitative temporal expression profiles. This showed very similar TF expression trends in development in vertebrate and insect species. However, analysis of the expression of orthologous pairs between more closely related species showed that expression of most individual TFs is not conserved, following the general model of duplication and diversification. The degree of similarity between TF expression between Xenopus tropicalis and Danio rerio followed the hourglass model, with the greatest similarity occuring during the early tailbud stage in Xenopus tropicalis and the late segmentation stage in Danio rerio. However, for Drosophila melanogaster and Anopheles gambiae there were two periods of high TF transcriptome similarity, one during the Arthropod phylotypic stage at 8-10 hours into Drosophila development and the other later at 16-18 hours into Drosophila development.	[Schep, Alicia N.; Adryan, Boris] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Schep, Alicia N.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of Cambridge; Stanford University	Adryan, B (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	adryan@sysbiol.cam.ac.uk		Schep, Alicia/0000-0002-3915-0618	Churchill Scholarship	Churchill Scholarship	B.A. is a Royal Society University Research Fellow. A. S. was supported by a Churchill Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adryan B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r40; Alexa A, 2012, TOPGO ENRICHMENT ANA; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bozinovic G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-132; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBOULE D, 1994, DEVELOPMENT, P135; Durinck S, 2012, BIOMART INTERFACE BI; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Futschik M, 2009, MUFZZ SOFT CLUSTERIN; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gilbert SF, 2006, DEV BIOL; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hall BK, 1997, TRENDS ECOL EVOL, V12, P461, DOI 10.1016/S0169-5347(97)01222-6; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Haudry Y, 2008, NUCLEIC ACIDS RES, V36, pD847, DOI 10.1093/nar/gkm797; Hooper SD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100112; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Kalinka AT, 2012, TRENDS ECOL EVOL, V27, P385, DOI 10.1016/j.tree.2012.03.007; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mitiku N, 2007, DEV CELL, V13, P897, DOI 10.1016/j.devcel.2007.10.004; Papatsenko D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000584; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Satou Y, 2005, ZOOL SCI, V22, P837, DOI 10.2108/zsj.22.837; Seidel F., 1960, Zoologischer Anzeiger Leipzig, V164, P245; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sobral D, 2009, CURR BIOL, V19, P2014, DOI 10.1016/j.cub.2009.10.036; Stafford P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1133; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Wagner RA, 2005, DEV BIOL, V288, P595, DOI 10.1016/j.ydbio.2005.09.036; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Wolpert L, 2007, PRINCIPLES DEV; Wu J, 2012, GCRMA BACKGROUND ADJ; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109	51	23	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66826	10.1371/journal.pone.0066826	http://dx.doi.org/10.1371/journal.pone.0066826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799133	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300098
J	Clendenning, M; Young, JP; Walsh, MD; Woodall, S; Arnold, J; Jenkins, M; Win, AK; Hopper, JL; Sweet, K; Gallinger, S; Rosty, C; Parry, S; Buchanan, DD				Clendenning, Mark; Young, Joanne P.; Walsh, Michael D.; Woodall, Sonja; Arnold, Julie; Jenkins, Mark; Win, Aung Ko; Hopper, John L.; Sweet, Kevin; Gallinger, Steven; Rosty, Christophe; Parry, Susan; Buchanan, Daniel D.			Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome	PLOS ONE			English	Article							COLORECTAL-CANCER PATIENTS; HYPERPLASTIC POLYPOSIS; MOLECULAR CLASSIFICATION; RISK; PHENOTYPE; VARIANTS; IDENTIFICATION; EXPRESSION; RELATIVES; SERIES	Background: Recent reports have observed that individuals with serrated polyps, some of whom meet the clinical diagnostic criteria for Serrated Polyposis Syndrome (SPS), are among those who carry germline mutations in genes associated with polyposis syndromes including; (1) genes known to underlie hamartomatous polyposes (SMAD4, BMPR1A, and PTEN), (2) MUTYH-associated polyposis and (3) GREM1 in Hereditary Mixed Polyposis Syndrome (HMPS). The aim of this study was to characterise individuals fulfilling the current WHO criteria for SPS for germline mutations in these polyposis-associated genes. Methods: A total of 65 individuals with SPS (fulfilling WHO criteria 1 or 3), were recruited to the Genetics of Serrated Neoplasia study between 2000 and 2012, through multiple Genetics or Family Cancer Clinics within Australia, or from the New Zealand Familial Gastrointestinal Cancer Service. Individuals with SPS were tested for coding mutations and large deletions in the PTEN, SMAD4, and BMPR1A genes, for the MUTYH variants in exons 7 (Y179C) and 13 (G396D), and for the duplication upstream of GREM1. Results: We found no variants that were likely to be deleterious germline mutations in the SPS cases in the PTEN, SMAD4, and BMPR1A genes. A novel variant in intron 2 (c.164+223T.C) of PTEN was identified in one individual and was predicted by in silico analysis to have no functional consequences. One further individual with SPS was found to be mono-allelic for the MUTYH G396D mutation. No individuals carried the recently reported duplication within GREM1. Conclusions: Genes involved in the gastrointestinal hamartomatous polyposis, Hereditary Mixed Polyposis Syndrome and MUTYH-associated polyposis syndromes are not commonly altered in individuals with SPS.	[Clendenning, Mark; Young, Joanne P.; Walsh, Michael D.; Rosty, Christophe; Buchanan, Daniel D.] Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia; [Walsh, Michael D.] Sullivan Nicolaides Pathol, Dept Histopathol, Brisbane, Qld, Australia; [Woodall, Sonja; Arnold, Julie; Parry, Susan] Auckland Hosp, New Zealand Familial Gastrointestinal Canc Serv, Auckland, New Zealand; [Jenkins, Mark; Win, Aung Ko; Hopper, John L.] Univ Melbourne, Ctr MEGA Epidemiol, Melbourne, Vic, Australia; [Sweet, Kevin] Ohio State Univ, Med Ctr, Div Human Genet, Columbus, OH 43210 USA; [Gallinger, Steven] Canc Care Ontario, Toronto, ON, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Toronto, ON M5G 1X5, Canada; [Rosty, Christophe] Univ Queensland, Dept Mol & Cellular Pathol, Brisbane, Qld, Australia; [Rosty, Christophe] Envoi Specialist Pathologists, Brisbane, Qld, Australia; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol & Hepatol, Auckland 6, New Zealand	QIMR Berghofer Medical Research Institute; Auckland City Hospital; University of Melbourne; University System of Ohio; Ohio State University; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Queensland	Buchanan, DD (corresponding author), Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4006, Australia.	Daniel.Buchanan@qimr.edu.au	Young, Joanne P/H-7774-2014; Jenkins, Mark/P-7803-2015; Win, Aung K./J-6204-2015; Rosty, Christophe/F-1796-2010; Gallinger, Steven/E-4575-2013	Jenkins, Mark/0000-0002-8964-6160; Win, Aung K./0000-0002-2794-5261; Young, Joanne/0000-0002-1514-1522; Buchanan, Daniel/0000-0003-2225-6675; Rosty, Christophe/0000-0001-7671-2651; Woodall, Sonja/0000-0002-9910-5560	Cancer Council Queensland [1006290]; National Cancer Institute [RO1 CA123010]; NATIONAL CANCER INSTITUTE [U24CA097735, U01CA097735] Funding Source: NIH RePORTER	Cancer Council Queensland(Cancer Council Queensland); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from Cancer Council Queensland (1006290) and National Cancer Institute (RO1 CA123010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boparai KS, 2010, GUT, V59, P1222, DOI 10.1136/gut.2009.200741; Boparai KS, 2010, GUT, V59, P1094, DOI 10.1136/gut.2009.185884; Boparai KS, 2008, GASTROENTEROLOGY, V135, P2014, DOI 10.1053/j.gastro.2008.09.020; Buchanan D, 2009, GASTROENTEROLOGY, V136, P2407, DOI 10.1053/j.gastro.2008.12.076; Buchanan DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011636; Buchanan DD, 2010, INT J COLORECTAL DIS, V25, P703, DOI 10.1007/s00384-010-0907-8; Carvajal-Carmona LG, 2007, J PATHOL, V212, P378, DOI 10.1002/path.2187; Cheah PY, 2009, AM J GASTROENTEROL, V104, P3027, DOI 10.1038/ajg.2009.542; Clendenning M, 2011, FAM CANCER, V10, P297, DOI 10.1007/s10689-011-9427-0; English DR, 2008, CANCER EPIDEM BIOMAR, V17, P1774, DOI 10.1158/1055-9965.EPI-08-0091; Heald B, 2010, GASTROENTEROLOGY, V139, P1927, DOI 10.1053/j.gastro.2010.06.061; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jaeger E, 2012, NAT GENET, V44, P699, DOI 10.1038/ng.2263; Kalady MF, 2011, DIS COLON RECTUM, V54, P164, DOI 10.1007/DCR.0b013e3181fd4c15; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Mongin C, 2012, CLIN GENET, V81, P38, DOI 10.1111/j.1399-0004.2011.01676.x; Morak M, 2010, CLIN GENET, V78, P353, DOI 10.1111/j.1399-0004.2010.01478.x; Nieminen TT, 2011, GASTROENTEROLOGY, V141, pE23, DOI 10.1053/j.gastro.2011.03.063; Rosty C, 2012, AM J SURG PATHOL; Rosty C, 2011, PATHOLOG RES INT, V2011, DOI DOI 10.4061/2011/157073; Rosty C, 2012, AM J SURG PATHOL, V36, P876, DOI 10.1097/PAS.0b013e31824e133f; Snover D, 2010, WHO CLASSIFICATION T; Spjut H, 1977, Pathol Annu, V12 Pt 1, P147; Stanich PP, 2011, MAYO CLIN PROC, V86, P489, DOI 10.4065/mcp.2010.0816; Sweet K, 2005, JAMA-J AM MED ASSOC, V294, P2465, DOI 10.1001/jama.294.19.2465; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Venkatachalam R, 2011, INT J CANCER, V129, P1635, DOI 10.1002/ijc.25821; Walsh MD, 2009, FAM CANCER, V8, P313, DOI 10.1007/s10689-009-9238-8; Ward RL, 2013, GENET MED, V15, P25, DOI 10.1038/gim.2012.91; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; Win AK, 2012, AM J GASTROENTEROL, V107, P770, DOI 10.1038/ajg.2012.52; Yeoman Andrew, 2007, N Z Med J, V120, pU2827; Zbuk KM, 2007, NAT CLIN PRACT GASTR, V4, P492, DOI 10.1038/ncpgasthep0902	33	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66705	10.1371/journal.pone.0066705	http://dx.doi.org/10.1371/journal.pone.0066705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805267	Green Published, gold			2022-12-27	WOS:000320846500095
J	Meitern, R; Sild, E; Lind, MA; Manniste, M; Sepp, T; Karu, U; Horak, P				Meitern, Richard; Sild, Elin; Lind, Mari-Ann; Maenniste, Marju; Sepp, Tuul; Karu, Ulvi; Hoerak, Peeter			Effects of Endotoxin and Psychological Stress on Redox Physiology, Immunity and Feather Corticosterone in Greenfinches	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; OXIDATIVE STRESS; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; LIFE-HISTORY; IN-VIVO; LIPOPOLYSACCHARIDE; RESPONSES; CONSEQUENCES; COLORATION	Assessment of costs accompanying activation of immune system and related neuroendocrine pathways is essential for understanding the selective forces operating on these systems. Here we attempted to detect such costs in terms of disruption to redox balance and interference between different immune system components in captive wild-caught greenfinches (Carduelis chloris). Study birds were subjected to an endotoxin-induced inflammatory challenge and temporary exposure to a psychological stressor (an image of a predator) in a 2*2 factorial experiment. Injection of bacterial endotoxin resulted in up-regulation of two markers of antioxidant protection - erythrocyte glutathione, and plasma oxygen radical absorbance (OXY). These findings suggest that inflammatory responses alter redox homeostasis. However, no effect on markers of oxidative damage to proteins or DNA in erythrocytes could be detected. We found no evidence that the endotoxin injection interfered with antibody production against Brucella abortus antigen or the intensity of chronic coccidiosis. The hypothesis of within-immune system trade-offs as a cost of immunity was thus not supported in our model system. We showed for the first time that administration of endotoxin can reduce the level of corticosterone deposited into feathers. This finding suggests a down-regulation of the corticosterone secretion cascade due to an endotoxin-induced immune response, a phenomenon that has not been reported previously. Exposure to the predator image did not affect any of the measured physiological parameters.	[Meitern, Richard; Sild, Elin; Lind, Mari-Ann; Maenniste, Marju; Sepp, Tuul; Karu, Ulvi; Hoerak, Peeter] Univ Tartu, Dept Zool, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Sild, Elin] Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, Lund, Sweden	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Lund University	Horak, P (corresponding author), Univ Tartu, Dept Zool, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	horak@ut.ee	Horak, Peeter/A-2351-2009	Horak, Peeter/0000-0002-1442-9903; Meitern, Richard/0000-0002-2600-3002; Sepp, Tuul/0000-0002-8677-7069	Estonian Science Foundation [7737]; Estonian Ministry of Education and Science [0180004s09]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR)	Estonian Science Foundation; Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission)	The study was financed by Estonian Science Foundation grants #7737, the Estonian Ministry of Education and Science (target-financing project #0180004s09) and by the European Union through the European Regional Development Fund (Centre of Excellence FIBIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-El-Saad AASA, 2007, IMMUNOBIOLOGY, V212, P179, DOI 10.1016/j.imbio.2007.01.006; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; Baze MM, 2011, J EXP BIOL, V214, P3255, DOI 10.1242/jeb.054544; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bradley JE, 2008, PARASITOLOGY, V135, P807, DOI 10.1017/S0031182008000322; Casagrande S, 2012, COMP BIOCHEM PHYS A, V163, P296, DOI 10.1016/j.cbpa.2012.07.018; Cohen A, 2007, COMP BIOCHEM PHYS B, V147, P110, DOI 10.1016/j.cbpb.2006.12.015; Collins AR, 2009, MUTAT RES-REV MUTAT, V681, P24, DOI 10.1016/j.mrrev.2007.10.002; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Costantini D, 2011, METHODS ECOL EVOL, V2, P321, DOI 10.1111/j.2041-210X.2010.00080.x; Costantini D, 2010, ECOL LETT, V13, P1435, DOI 10.1111/j.1461-0248.2010.01531.x; Cote J, 2010, J EXP BIOL, V213, P271, DOI 10.1242/jeb.035188; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; Cyr NE, 2009, GEN COMP ENDOCR, V161, P295, DOI 10.1016/j.ygcen.2009.02.001; Degen WGJ, 2005, VET MICROBIOL, V105, P163, DOI 10.1016/j.vetmic.2004.12.001; DEMAS GE, 2011, ECOIMMUNOLOGY; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dickens MJ, 2009, P R SOC B, V276, P2051, DOI 10.1098/rspb.2008.1778; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Fair JM, 1999, P ROY SOC B-BIOL SCI, V266, P1735, DOI 10.1098/rspb.1999.0840; Freeman-Gallant CR, 2011, BIOL LETTERS, V7, P429, DOI 10.1098/rsbl.2010.1186; French SS, 2009, INTEGR COMP BIOL, V49, P246, DOI 10.1093/icb/icp032; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Gasparini J, 2009, J EVOLUTION BIOL, V22, P2348, DOI 10.1111/j.1420-9101.2009.01831.x; Goutte A, 2010, GEN COMP ENDOCR, V167, P246, DOI 10.1016/j.ygcen.2010.03.018; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Graham AL, 2002, Q REV BIOL, V77, P409, DOI 10.1086/344414; Graham AL, 2011, FUNCT ECOL, V25, P5, DOI 10.1111/j.1365-2435.2010.01777.x; Halliwell B., 2007, FREE RADICALS BIOL M; HAMPTON RR, 1994, BEHAVIOUR, V130, P41, DOI 10.1163/156853994X00136; Horak P, 2006, J EVOLUTION BIOL, V19, P277, DOI 10.1111/j.1420-9101.2005.00988.x; Horak P, 2004, J ANIM ECOL, V73, P935, DOI 10.1111/j.0021-8790.2004.00870.x; Horak P, 2006, J EXP BIOL, V209, P4329, DOI 10.1242/jeb.02502; Horak P, 2010, J EXP BIOL, V213, P2225, DOI 10.1242/jeb.042085; Isaksson C, 2011, BIOSCIENCE, V61, P194, DOI 10.1525/bio.2011.61.3.5; JAESCHKE H, 1992, AM J PHYSIOL, V263, pG60, DOI 10.1152/ajpgi.1992.263.1.G60; Khatun MM, 2009, J INFECT DEV COUNTR, V3, P392; Klasing K.C., 2004, ACTA ZOOL SINICA, V50, P961; Krams I, 2012, COMP BIOCHEM PHYS A, V161, P422, DOI 10.1016/j.cbpa.2011.12.018; Larcombe SD, 2008, J EXP BIOL, V211, P2859, DOI 10.1242/jeb.017970; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; Laugero KD, 2000, AM J PHYSIOL-ENDOC M, V279, pE44, DOI 10.1152/ajpendo.2000.279.1.E44; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lohmus M, 2011, COMP BIOCHEM PHYS A, V158, P560, DOI 10.1016/j.cbpa.2011.01.002; Lynn SE, 2010, GEN COMP ENDOCR, V165, P337, DOI 10.1016/j.ygcen.2009.07.018; Manniste M, 2013, ETHOLOGY, V119, P581, DOI 10.1111/eth.12099; Martin LB, 2006, FUNCT ECOL, V20, P630, DOI 10.1111/j.1365-2435.2006.01138.x; Martin LB, 2011, J EXP BIOL, V214, P2579, DOI 10.1242/jeb.057216; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Meitern R, 2013, J EXP BIOL, V216, P2713, DOI 10.1242/jeb.087528; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Mireles AJ, 2005, POULTRY SCI, V84, P553, DOI 10.1093/ps/84.4.553; Muller C, 2009, GEN COMP ENDOCR, V160, P59, DOI 10.1016/j.ygcen.2008.10.018; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Owen-Ashley NT, 2006, HORM BEHAV, V49, P15, DOI 10.1016/j.yhbeh.2005.04.009; Parmentier HK, 2004, POULTRY SCI, V83, P1133, DOI 10.1093/ps/83.7.1133; Patterson SH, 2011, ANIM BEHAV, V81, P1239, DOI 10.1016/j.anbehav.2011.03.012; Portoles MT, 1996, MOL CELL BIOCHEM, V159, P115, DOI 10.1007/BF00420913; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Pursall E. R., 2012, ECOIMMUNOLOGY, P530; Qujeq D, 2005, INT J DIABETES METAB, V13, P96; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Saks L, 2006, FUNCT ECOL, V20, P75, DOI 10.1111/j.1365-2435.2006.01068.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sarv T, 2009, J AVIAN BIOL, V40, P569, DOI 10.1111/j.1600-048X.2009.04713.x; Segerstrom SC, 2007, CURR DIR PSYCHOL SCI, V16, P326, DOI 10.1111/j.1467-8721.2007.00522.x; Sepp T, 2012, PHYSIOL BIOCHEM ZOOL, V85, P299, DOI 10.1086/664827; Sepp T, 2011, EXP PARASITOL, V127, P651, DOI 10.1016/j.exppara.2010.12.004; Sepp T, 2010, PHYSIOL BIOCHEM ZOOL, V83, P276, DOI 10.1086/648580; Serra L, 2012, BEHAV ECOL SOCIOBIOL, V66, P697, DOI 10.1007/s00265-012-1318-3; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sies H., 2007, ENCY STRESS, V2nd ed., P45, DOI DOI 10.1016/B978-012373947-6.00285-3; Sild E, 2011, BRAIN BEHAV IMMUN, V25, P1349, DOI 10.1016/j.bbi.2011.03.020; Sohn SH, 2012, POULTRY SCI, V91, P829, DOI 10.3382/ps.2011-01904; Sompamit K, 2009, EUR J PHARMACOL, V616, P192, DOI 10.1016/j.ejphar.2009.06.014; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Star L, 2008, POULTRY SCI, V87, P1031, DOI 10.3382/ps.2007-00143; Travers M, 2010, ECOL LETT, V13, P980, DOI 10.1111/j.1461-0248.2010.01488.x; van de Crommenacker J, 2010, J EXP BIOL, V213, P3527, DOI 10.1242/jeb.045591; van Oers K, 2007, J ORNITHOL, V148, pS185, DOI 10.1007/s10336-007-0200-y; WINGFIELD JC, 1992, J EXP ZOOL, V264, P419, DOI 10.1002/jez.1402640407; Xie H, 2000, POULTRY SCI, V79, P33, DOI 10.1093/ps/79.1.33; Zhang HJ, 2008, BRIT POULTRY SCI, V49, P213, DOI 10.1080/00071660801989836; Zhang WH, 2011, POULTRY SCI, V90, P2592, DOI 10.3382/ps.2011-01446	87	17	17	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67545	10.1371/journal.pone.0067545	http://dx.doi.org/10.1371/journal.pone.0067545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805316	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500144
J	Monnerat, S; Costa, CIA; Forkert, AC; Benz, C; Hamilton, A; Tetley, L; Burchmore, R; Novo, C; Mottram, JC; Hammarton, TC				Monnerat, Severine; Costa, Cristina I. Almeida; Forkert, Andrea C.; Benz, Corinna; Hamilton, Alana; Tetley, Laurence; Burchmore, Richard; Novo, Carlos; Mottram, Jeremy C.; Hammarton, Tansy C.			Identification and Functional Characterisation of CRK12:CYC9, a Novel Cyclin-Dependent Kinase (CDK)-Cyclin Complex in Trypanosoma brucei	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; BLOOD-STREAM FORMS; POLO-LIKE KINASE; CELL-CYCLE; PROTEIN-KINASES; INDUCIBLE EXPRESSION; TRANSCRIPTION FACTOR; RNA INTERFERENCE; PROCYCLIC FORM; TARGETS	The protozoan parasite, Trypanosoma brucei, is spread by the tsetse fly and causes trypanosomiasis in humans and animals. Both the life cycle and cell cycle of the parasite are complex. Trypanosomes have eleven cdc2-related kinases (CRKs) and ten cyclins, an unusually large number for a single celled organism. To date, relatively little is known about the function of many of the CRKs and cyclins, and only CRK3 has previously been shown to be cyclin-dependent in vivo. Here we report the identification of a previously uncharacterised CRK:cyclin complex between CRK12 and the putative transcriptional cyclin, CYC9. CRK12:CYC9 interact to form an active protein kinase complex in procyclic and bloodstream T. brucei. Both CRK12 and CYC9 are essential for the proliferation of bloodstream trypanosomes in vitro, and we show that CRK12 is also essential for survival of T. brucei in a mouse model, providing genetic validation of CRK12:CYC9 as a novel drug target for trypanosomiasis. Further, functional characterisation of CRK12 and CYC9 using RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively.	[Monnerat, Severine; Forkert, Andrea C.; Hamilton, Alana; Mottram, Jeremy C.] Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Costa, Cristina I. Almeida; Novo, Carlos] Univ Nova Lisboa, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Tetley, Laurence] Univ Glasgow, Sch Life Sci, Glasgow, Lanark, Scotland; [Costa, Cristina I. Almeida; Benz, Corinna; Burchmore, Richard; Hammarton, Tansy C.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Glasgow; University of Glasgow	Mottram, JC (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland.	Jeremy.Mottram@glasgow.ac.uk; Tansy.Hammarton@glasgow.ac.uk	Hammarton, Tansy/A-5632-2011; Benz, Corinna/AAD-8702-2021; Novo, Carlos/I-5537-2012	Hammarton, Tansy/0000-0002-0799-6600; Benz, Corinna/0000-0003-4367-2758; Novo, Carlos/0000-0003-3572-5426; Correia de Almeida Costa, Cristina Isabel/0000-0003-1733-2530; Hamilton, Alana/0000-0001-5704-2293; Burchmore, Richard/0000-0003-1663-9004; Mottram, Jeremy/0000-0001-5574-3766	Wellcome Trust [070231, 085349/Z/08/Z]; Swiss National Foundation [PBLA33-103364]; MRC [G120/1001, GO900239]; RCUK (Academic fellowship) [GR/T28003/01]; Fundacao para a Cieancia e Tecnologia, Portugal [SFRH/BD/40223/2007, PTDC/CVT/098183/2008]; MRC [G0900239] Funding Source: UKRI; Medical Research Council [G0900239, G120/1001] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RCUK (Academic fellowship); Fundacao para a Cieancia e Tecnologia, Portugal; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the Wellcome Trust (to JCM and TCH; reference number 070231), the Swiss National Foundation (to SM and JCM; reference number PBLA33-103364), the MRC (Career Development fellowship reference number G120/1001 and New Investigator Research Grant, reference number GO900239, both to TCH), RCUK (Academic fellowship reference number GR/T28003/01 to TCH) and Fundacao para a Cieancia e Tecnologia, Portugal (to CC: PhD Grant reference number SFRH/BD/40223/2007; and CN:Project Development Grant reference number PTDC/CVT/098183/2008). The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust [085349/Z/08/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Badjatia N, 2013, MOL CELL BIOL, V33, P1965, DOI 10.1128/MCB.00156-13; Barette C, 2001, ONCOGENE, V20, P551, DOI 10.1038/sj.onc.1204129; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Gourguechon S, 2007, J MOL BIOL, V368, P939, DOI 10.1016/j.jmb.2007.02.050; Gourguechon S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-68; Gregory SL, 2007, FLY, V1, P13, DOI 10.4161/fly.3806; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2000, MOL BIOCHEM PARASIT, V111, P229, DOI 10.1016/S0166-6851(00)00308-X; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Helms MJ, 2006, J CELL SCI, V119, P1105, DOI 10.1242/jcs.02809; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lahti J M, 1995, Prog Cell Cycle Res, V1, P329; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Ma JT, 2010, J BIOL CHEM, V285, P15356, DOI 10.1074/jbc.M109.074591; Mackey ZB, 2011, CHEM BIOL DRUG DES, V78, P454, DOI 10.1111/j.1747-0285.2011.01156.x; May SF, 2012, MOL MICROBIOL, V84, P77, DOI 10.1111/j.1365-2958.2012.08008.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan GW, 2001, J CELL SCI, V114, P2605; Mottram JC, 1996, BIOCHEM J, V316, P833, DOI 10.1042/bj3160833; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nishizawa M, 2010, EUKARYOT CELL, V9, P943, DOI 10.1128/EC.00247-09; Nolan DP, 2000, J BIOL CHEM, V275, P4072, DOI 10.1074/jbc.275.6.4072; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Silverman JS, 2011, MOL MICROBIOL, V82, P664, DOI 10.1111/j.1365-2958.2011.07842.x; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tang DM, 1997, J BIOL CHEM, V272, P12318, DOI 10.1074/jbc.272.19.12318; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tu XM, 2005, MOL BIOL CELL, V16, P97, DOI 10.1091/mbc.E04-05-0368; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Van Hellemond JJ, 2000, J BIOL CHEM, V275, P8315, DOI 10.1074/jbc.275.12.8315; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; XIANG JL, 1994, BIOCHEM BIOPH RES CO, V199, P1167, DOI 10.1006/bbrc.1994.1353; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Zong HL, 2005, FEBS LETT, V579, P3579, DOI 10.1016/j.febslet.2005.05.039; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	71	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67327	10.1371/journal.pone.0067327	http://dx.doi.org/10.1371/journal.pone.0067327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805309	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000320846500137
J	Rajaram, M; Zhang, JP; Wang, T; Li, JY; Kuscu, C; Qi, H; Kato, M; Grubor, V; Weil, RJ; Helland, A; Borrenson-Dale, AL; Cho, KR; Levine, DA; Houghton, AN; Wolchok, JD; Myeroff, L; Markowitz, SD; Lowe, SW; Zhang, M; Krasnitz, A; Lucito, R; Mu, D; Powers, RS				Rajaram, Megha; Zhang, Jianping; Wang, Tim; Li, Jinyu; Kuscu, Cem; Qi, Huan; Kato, Mamoru; Grubor, Vladimir; Weil, Robert J.; Helland, Aslaug; Borrenson-Dale, Anne-Lise; Cho, Kathleen R.; Levine, Douglas A.; Houghton, Alan N.; Wolchok, Jedd D.; Myeroff, Lois; Markowitz, Sanford D.; Lowe, Scott W.; Zhang, Michael; Krasnitz, Alex; Lucito, Robert; Mu, David; Powers, R. Scott			Two Distinct Categories of Focal Deletions in Cancer Genomes	PLOS ONE			English	Article							COMMON FRAGILE SITES; SOMATIC MUTATIONS; ONCOGENIC PROPERTIES; LIVER-CANCER; AMPLIFICATION; GENE; IDENTIFICATION; INACTIVATION; FRA3B	One of the key questions about genomic alterations in cancer is whether they are functional in the sense of contributing to the selective advantage of tumor cells. The frequency with which an alteration occurs might reflect its ability to increase cancer cell growth, or alternatively, enhanced instability of a locus may increase the frequency with which it is found to be aberrant in tumors, regardless of oncogenic impact. Here we've addressed this on a genome-wide scale for cancer-associated focal deletions, which are known to pinpoint both tumor suppressor genes (tumor suppressors) and unstable loci. Based on DNA copy number analysis of over one-thousand human cancers representing ten different tumor types, we observed five loci with focal deletion frequencies above 5%, including the A2BP1 gene at 16p13.3 and the MACROD2 gene at 20p12.1. However, neither RNA expression nor functional studies support a tumor suppressor role for either gene. Further analyses suggest instead that these are sites of increased genomic instability and that they resemble common fragile sites (CFS). Genome-wide analysis revealed properties of CFS-like recurrent deletions that distinguish them from deletions affecting tumor suppressor genes, including their isolation at specific loci away from other genomic deletion sites, a considerably smaller deletion size, and dispersal throughout the affected locus rather than assembly at a common site of overlap. Additionally, CFS-like deletions have less impact on gene expression and are enriched in cell lines compared to primary tumors. We show that loci affected by CFS-like deletions are often distinct from known common fragile sites. Indeed, we find that each tumor tissue type has its own spectrum of CFS-like deletions, and that colon cancers have many more CFS-like deletions than other tumor types. We present simple rules that can pinpoint focal deletions that are not CFS-like and more likely to affect functional tumor suppressors.	[Rajaram, Megha; Zhang, Jianping; Wang, Tim; Li, Jinyu; Kuscu, Cem; Qi, Huan; Kato, Mamoru; Grubor, Vladimir; Lowe, Scott W.; Zhang, Michael; Krasnitz, Alex; Lucito, Robert; Mu, David; Powers, R. Scott] Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY USA; [Weil, Robert J.] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Helland, Aslaug; Borrenson-Dale, Anne-Lise] Norwegian Radium Hosp, Dept Genet, Oslo, Norway; [Cho, Kathleen R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cho, Kathleen R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Levine, Douglas A.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Levine, Douglas A.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Myeroff, Lois; Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Myeroff, Lois; Markowitz, Sanford D.] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Myeroff, Lois; Markowitz, Sanford D.] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Cold Spring Harbor Laboratory; Cleveland Clinic Foundation; University of Oslo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Powers, RS (corresponding author), Cold Spring Harbor Lab, Canc Genome Ctr, Woodbury, NY USA.	powers@cshl.edu	Helland, Åslaug/H-3910-2015; Mu, David/E-8933-2011; Lucito, Robert/AID-7159-2022	Helland, Åslaug/0000-0002-5520-0275; Mu, David/0000-0002-7762-0182; Levine, Douglas/0000-0003-1038-8232; Wang, Timothy/0000-0001-5730-3019; Powers, Scott/0000-0003-2769-1932; Cho, Kathleen/0000-0003-0500-9998	NIH [CA124648, RC2CA148532]; NATIONAL CANCER INSTITUTE [RC2CA148532, U01CA168409, P30CA008748] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA124648 and RC2CA148532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; CHEN S, 2008, CANC BIOL THER, V7; Chi YH, 2009, INT J CANCER, V124, P1483, DOI 10.1002/ijc.24094; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Farrell CL, 2008, CANCER BIOL THER, V7, P609, DOI 10.4161/cbt.7.4.5623; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fungtammasan A, 2012, GENOME RES, V22, P993, DOI 10.1101/gr.134395.111; Hasan MK, 2009, J BIOL CHEM, V284, P1664, DOI 10.1074/jbc.M805778200; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Komuro Hiroaki, 1999, Neoplasia (New York), V1, P253, DOI 10.1038/sj.neo.7900033; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lee SH, 2012, PATHOL ONCOL RES; Letessier A, 2011, NATURE, V470, P120, DOI 10.1038/nature09745; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; MURANO I, 1989, HUM GENET, V83, P45, DOI 10.1007/BF00274145; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nancarrow DJ, 2008, CANCER RES, V68, P4163, DOI 10.1158/0008-5472.CAN-07-6710; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Raschke S, 2005, GENE CHROMOSOME CANC, V42, P58, DOI 10.1002/gcc.20119; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Suzuki M, 2005, ONCOGENE, V24, P1302, DOI 10.1038/sj.onc.1208263; Teng DHF, 1997, CANCER RES, V57, P4177; Thiagalingam S, 1996, CANCER RES, V56, P2936; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Watanabe A, 2003, CANCER RES, V63, P8629; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	38	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66264	10.1371/journal.pone.0066264	http://dx.doi.org/10.1371/journal.pone.0066264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805207	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000320846500035
J	Weinhold, M; Eisenblatter, M; Jasny, E; Fehlings, M; Finke, A; Gayum, H; Ruschendorf, U; Viveros, PR; Moos, V; Allers, K; Schneider, T; Schaible, UE; Schumann, RR; Mielke, ME; Ignatius, R				Weinhold, Mario; Eisenblaetter, Martin; Jasny, Edith; Fehlings, Michael; Finke, Antje; Gayum, Hermine; Rueschendorf, Ursula; Viveros, Pablo Renner; Moos, Verena; Allers, Kristina; Schneider, Thomas; Schaible, Ulrich E.; Schumann, Ralf R.; Mielke, Martin E.; Ignatius, Ralf			The Attenuated Brucella abortus Strain 19 Invades, Persists in, and Activates Human Dendritic Cells, and Induces the Secretion of IL-12p70 but Not IL-23	PLOS ONE			English	Article							DELAYED-TYPE HYPERSENSITIVITY; TOLL-LIKE RECEPTOR-4; PROINFLAMMATORY RESPONSE; MUCOSAL IMMUNITY; HIV-1 PEPTIDE; B-ABORTUS; T-CELLS; IN-VIVO; V3 LOOP; INDUCTION	Background: Bacterial vectors have been proposed as novel vaccine strategies to induce strong cellular immunity. Attenuated strains of Brucella abortus comprise promising vector candidates since they have the potential to induce strong CD4(+) and CD8(+) T-cell mediated immune responses in the absence of excessive inflammation as observed with other Gram-negative bacteria. However, some Brucella strains interfere with the maturation of dendritic cells (DCs), which is essential for antigen-specific T-cell priming. In the present study, we investigated the interaction of human monocyte-derived DCs with the smooth attenuated B. abortus strain (S) 19, which has previously been employed successfully to vaccinate cattle. Methodology/Principal findings: We first looked into the potential of S19 to hamper the cytokine-induced maturation of DCs; however, infected cells expressed CD25, CD40, CD80, and CD86 to a comparable extent as uninfected, cytokine-matured DCs. Furthermore, S19 activated DCs in the absence of exogeneous stimuli, enhanced the expression of HLA-ABC and HLA-DR, and was able to persist intracellularly without causing cytotoxicity. Thus, DCs provide a cellular niche for persisting brucellae in vivo as a permanent source of antigen. S19-infected DCs produced IL-12/23p40, IL-12p70, and IL-10, but not IL-23. While heat-killed bacteria also activated DCs, soluble mediators were not involved in S19-induced activation of human DCs. HEK 293 transfectants revealed cellular activation by S19 primarily through engagement of Toll-like receptor (TLR)2. Conclusions/Significance: Thus, as an immunological prerequisite for vaccine efficacy, B. abortus S19 potently infects and potently activates (most likely via TLR2) human DCs to produce Th1-promoting cytokines.	[Weinhold, Mario; Eisenblaetter, Martin; Jasny, Edith; Fehlings, Michael; Gayum, Hermine; Rueschendorf, Ursula; Viveros, Pablo Renner; Schumann, Ralf R.; Ignatius, Ralf] Charite, Dept Infect Immunol, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Finke, Antje] Robert Koch Inst, Berlin, Germany; [Viveros, Pablo Renner; Ignatius, Ralf] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Moos, Verena; Allers, Kristina; Schneider, Thomas] Charite, Med Clin 1, D-13353 Berlin, Germany; [Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Res, Borstel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Forschungszentrum Borstel	Ignatius, R (corresponding author), Charite, Dept Infect Immunol, Inst Microbiol & Hyg, D-13353 Berlin, Germany.	ralf.ignatius@charite.de		Fehlings, Michael/0000-0002-5722-6364; Schneider, Thomas/0000-0003-1125-0518; Moos, Verena/0000-0002-9558-7291	H.W.&J. Hector Foundation; Charite-Universitatsmedizin Berlin; MRC [G0700163] Funding Source: UKRI; Medical Research Council [G0700163] Funding Source: researchfish	H.W.&J. Hector Foundation; Charite-Universitatsmedizin Berlin; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the H.W.&J. Hector Foundation and by the Charite-Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrionuevo P, 2008, INFECT IMMUN, V76, P250, DOI 10.1128/IAI.00949-07; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Billard E, 2007, INFECT IMMUN, V75, P5916, DOI 10.1128/IAI.00931-07; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chandran SS, 2009, J IMMUNOL, V183, P7832, DOI 10.4049/jimmunol.0901683; Corbel MJ, 1997, J MED MICROBIOL, V46, P267, DOI 10.1099/00222615-46-4-267; Crasta OR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002193; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Eller N, 2004, J MED PRIMATOL, V33, P167, DOI 10.1111/j.1600-0684.2004.00068.x; Fernandes DM, 1996, FEMS IMMUNOL MED MIC, V16, P193, DOI 10.1016/S0928-8244(96)00083-1; Ferrero MC, 2011, MICROBES INFECT, V13, P852, DOI 10.1016/j.micinf.2011.04.010; Galen JE, 2009, IMMUNOL CELL BIOL, V87, P400, DOI 10.1038/icb.2009.31; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Golding B, 2002, VACCINE, V20, P1445, DOI 10.1016/S0264-410X(01)00477-7; GOLDING B, 1995, J VIROL, V69, P3299, DOI 10.1128/JVI.69.6.3299-3307.1995; GOLDSTEIN J, 1992, INFECT IMMUN, V60, P1385, DOI 10.1128/IAI.60.4.1385-1389.1992; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hort GM, 2003, MICROBES INFECT, V5, P95, DOI 10.1016/S1286-4579(02)00076-X; Huang LY, 1999, INFECT IMMUN, V67, P6257; Huang LY, 2005, J IMMUNOL, V175, P3964, DOI 10.4049/jimmunol.175.6.3964; Huang LY, 2003, J IMMUNOL, V171, P1441, DOI 10.4049/jimmunol.171.3.1441; Huang LY, 2001, J IMMUNOL, V167, P1423, DOI 10.4049/jimmunol.167.3.1423; Ignatius R, 2000, J VIROL, V74, P11329, DOI 10.1128/JVI.74.23.11329-11338.2000; Jasny E, 2008, J IMMUNOL, V180, P6629, DOI 10.4049/jimmunol.180.10.6629; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Lapham C, 1996, J VIROL, V70, P3084, DOI 10.1128/JVI.70.5.3084-3092.1996; Macedo GC, 2013, INFECT IMMUN; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Oliveira F. S., 2012, CLIN DEV IMMUNOL, V2012, DOI DOI 10.1155/2012/861426; Oliveira SC, 1996, CELL IMMUNOL, V172, P262, DOI 10.1006/cimm.1996.0241; OLIVEIRA SC, 1995, EUR J IMMUNOL, V25, P2551, DOI 10.1002/eji.1830250922; Oliveira SC, 2012, VET IMMUNOL IMMUNOP, V148, P129, DOI 10.1016/j.vetimm.2011.05.036; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Ramamoorthy S, 2007, INT J PARASITOL, V37, P1521, DOI 10.1016/j.ijpara.2007.04.020; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Garcia JVSY, 2008, MICROBES INFECT, V10, P635, DOI 10.1016/j.micinf.2008.02.010; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Steinman RM, 2002, J CLIN INVEST, V109, P1519, DOI 10.1172/JCI200215962; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vemullpalli R, 2000, INFECT IMMUN, V68, P3290, DOI 10.1128/IAI.68.6.3290-3296.2000; Wallach JC, 2008, CLIN MICROBIOL INFEC, V14, P805, DOI 10.1111/j.1469-0691.2008.02029.x; Weiss DS, 2005, INFECT IMMUN, V73, P5137, DOI 10.1128/IAI.73.8.5137-5143.2005; Zaitseva M, 2001, INFECT IMMUN, V69, P3817, DOI 10.1128/IAI.69.6.3817-3826.2001; Zaitseva M, 1996, INFECT IMMUN, V64, P3109, DOI 10.1128/IAI.64.8.3109-3117.1996; Zwerdling A, 2009, MICROBES INFECT, V11, P689, DOI 10.1016/j.micinf.2009.04.010; Zwerdling A, 2008, MICROBES INFECT, V10, P1346, DOI 10.1016/j.micinf.2008.07.035	59	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65934	10.1371/journal.pone.0065934	http://dx.doi.org/10.1371/journal.pone.0065934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805193	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500021
J	Cheng, J; Guggino, W				Cheng, Jie; Guggino, William			Ubiquitination and Degradation of CFTR by the E3 Ubiquitin Ligase MARCH2 through Its Association with Adaptor Proteins CAL and STX6	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS GENE; PDZ DOMAIN; DOWN-REGULATION; QUALITY-CONTROL; PROTEASOMAL DEGRADATION; PLASMA-MEMBRANE; CLASS-I	Golgi-localized cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand (CAL) and syntaxin 6 (STX6) regulate the abundance of mature, post-ER CFTR by forming a CAL/STX6/CFTR complex (CAL complex) that promotes CFTR degradation in lysosomes. However, the molecular mechanism underlying this degradation is unknown. Here we investigated the interaction of a Golgi-localized, membrane-associated RING-CH E3 ubiquitin ligase, MARCH2, with the CAL complex and the consequent binding, ubiquitination, and degradation of mature CFTR. We found that MARCH2 not only co-immunoprecipitated and co-localized with CAL and STX6, but its binding to CAL was also enhanced by STX6, suggesting a synergistic interaction. In vivo ubiquitination assays demonstrated the ubiquitination of CFTR by MARCH2, and overexpression of MARCH2, like that of CAL and STX6, led to a dose-dependent degradation of mature CFTR that was blocked by bafilomycin A1 treatment. A catalytically dead MARCH2 RING mutant was unable to promote CFTR degradation. In addition, MARCH2 had no effect on a CFTR mutant lacking the PDZ motif, suggesting that binding to the PDZ domain of CAL is required for MARCH2-mediated degradation of CFTR. Indeed, silencing of endogenous CAL ablated the effect of MARCH2 on CFTR. Consistent with its Golgi localization, MARCH2 had no effect on ER-localized Delta F508-CFTR. Finally, siRNA-mediated silencing of endogenous MARCH2 in the CF epithelial cell line CFBE-CFTR increased the abundance of mature CFTR. Taken together, these data suggest that the recruitment of the E3 ubiquitin ligase MARCH2 to the CAL complex and subsequent ubiquitination of CFTR are responsible for the CAL-mediated lysosomal degradation of mature CFTR.	[Cheng, Jie; Guggino, William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Guggino, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu			NIDDK [PO1 DK072084]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIDDK (PO1 DK072084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher JF, 2011, ACTA CRYSTALLOGR F, V67, P600, DOI 10.1107/S1744309111009985; Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; CUTTING GR, 1993, J BIOENERG BIOMEMBR, V25, P7, DOI 10.1007/BF00768062; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Fukuda H, 2006, J BIOCHEM, V139, P137, DOI 10.1093/jb/mvj012; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Han SO, 2012, J CELL BIOL, V199, P817, DOI 10.1083/jcb.201208192; Ito H, 2006, BIOCHEM J, V397, P389, DOI 10.1042/BJ20052015; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nakamura N, 2005, MOL BIOL CELL, V16, P1696, DOI 10.1091/mbc.E04-03-0216; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	50	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68001	10.1371/journal.pone.0068001	http://dx.doi.org/10.1371/journal.pone.0068001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818989	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800146
J	Kao, WF; Huang, JH; Kuo, TBJ; Chang, PL; Chang, WC; Chan, KH; Liu, WH; Wang, SH; Su, TY; Chiang, HC; Chen, JJ				Kao, Wei-Fong; Huang, Jyh-How; Kuo, Terry B. J.; Chang, Po-Lun; Chang, Wen-Chen; Chan, Kuo-Hung; Liu, Wen-Hsiung; Wang, Shih-Hao; Su, Tzu-Yao; Chiang, Hsiu-chen; Chen, Jin-Jong			Real-Time Electrocardiogram Transmission from Mount Everest during Continued Ascent	PLOS ONE			English	Article							EXTREME ALTITUDE; GENDER; TELEMEDICINE	The feasibility of a real-time electrocardiogram (ECG) transmission via satellite phone from Mount Everest to determine a climber's suitability for continued ascent was examined. Four Taiwanese climbers were enrolled in the 2009 Mount Everest summit program. Physiological measurements were taken at base camp (5300 m), camp 2 (6400 m), camp 3 (7100 m), and camp 4 (7950 m) 1 hour after arrival and following a 10 minute rest period. A total of 3 out of 4 climbers were able to summit Mount Everest successfully. Overall, ECG and global positioning system (GPS) coordinates of climbers were transmitted in real-time via satellite phone successfully from base camp, camp 2, camp 3, and camp 4. At each camp, Resting Heart Rate (RHR) was transmitted and recorded: base camp (54-113 bpm), camp 2 (94-130 bpm), camp 3 (98-115 bpm), and camp 4 (93-111 bpm). Real-time ECG and GPS coordinate transmission via satellite phone is feasible for climbers on Mount Everest. Real-time RHR data can be used to evaluate a climber's physiological capacity to continue an ascent and to summit.	[Kao, Wei-Fong; Wang, Shih-Hao] Taipei Med Univ Hosp, Dept Emergency & Crit Care Med, Taipei, Taiwan; [Kao, Wei-Fong; Chang, Po-Lun] Natl Yang Ming Univ, Inst BioMed Informat, Taipei 112, Taiwan; [Kuo, Terry B. J.] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Chen, Jin-Jong] Natl Yang Ming Univ, Inst Phys Therapy, Taipei 112, Taiwan; [Huang, Jyh-How] Natl Taiwan Coll Phys Educ, Dept Sports Informat & Commun, Chiaryi, Taiwan; [Chang, Wen-Chen; Chan, Kuo-Hung] Ind Technol Res Inst, Ctr Measurement Stand, Hsinchu, Taiwan; [Liu, Wen-Hsiung; Su, Tzu-Yao] Taiwan Telemed Device Co, Kaohsiung, Taiwan; [Chiang, Hsiu-chen] Yu Shan Natl Pk, Nan Tou, Taiwan	Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Industrial Technology Research Institute - Taiwan	Kao, WF (corresponding author), Taipei Med Univ Hosp, Dept Emergency & Crit Care Med, Taipei, Taiwan.	wfkao100a@hotmail.com.tw						Agostoni P, 2010, EUR HEART J, V31, P457, DOI 10.1093/eurheartj/ehp472; Angood PB, 2000, TELEMED J E-HEALTH, V6, P315, DOI 10.1089/153056200750040174; [Anonymous], 2011, WINDOWS CE 2011; [Anonymous], 2011, THUR SAT PHON; Di Rienzo M, 2010, IEEE T INF TECHNOL B, V14, P711, DOI 10.1109/TITB.2010.2048921; Dunin-Bell O, 2009, HIGH ALT MED BIOL, V10, P293, DOI 10.1089/ham.2008.1094; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Huey RB, 2007, BIOL LETTERS, V3, P498, DOI 10.1098/rsbl.2007.0317; KARLINER JS, 1985, AM HEART J, V109, P505, DOI 10.1016/0002-8703(85)90555-1; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Kuo Terry B. J., 1992, Biological Signals, V1, P282; Litch J, 2001, HIGH ALT MED BIOL, V2, P53, DOI 10.1089/152702901750067927; Liu CC, 2003, AM J PHYSIOL-HEART C, V285, pH2188, DOI 10.1152/ajpheart.00256.2003; National Center for Chronic Disease Prevention and Health Promotion, 2011, TARG HEART RAT EST M; Satava R, 2000, TELEMED J E-HEALTH, V6, P203; West J B, 1982, Physiologist, V25, P36; West J B, 1983, Prog Clin Biol Res, V136, P431; WEST JB, 1984, SCIENCE, V223, P784, DOI 10.1126/science.6364351; Wiseman C, 2006, WILD ENVIRON MED, V17, P103, DOI 10.1580/PR45-04.1; Wu TY, 2005, WILD ENVIRON MED, V16, P47, DOI 10.1580/PR04-04.1	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66579	10.1371/journal.pone.0066579	http://dx.doi.org/10.1371/journal.pone.0066579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818945	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800081
J	Lai, LJ; Hsu, WH; Wu, AM; Wu, JH				Lai, Li-Ju; Hsu, Wei-Hsiu; Wu, Albert M.; Wu, June H.			Ocular Injury by Transient Formaldehyde Exposure in a Rabbit Eye Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CORNEAL EPITHELIAL-CELLS; MESENCHYMAL TRANSITION; OCCUPATIONAL-EXPOSURE; FIBROBLASTS DERIVE; SIGNALING PATHWAYS; UV-IRRADIATION; APOPTOSIS; IRRITATION; FIBROSIS	Formaldehyde (FA) is frequently used in sterilizing surgical instruments and materials. Exposure to FA is highly concerned for eye tissues. Rabbit corneal epithelial cells were examined for changes after FA exposure. Our results showed that cell survival decreased 7 days after transient 3 min exposure to more than 100 ppm FA by trypan blue staining while MTT assay detected significant decrease at 20 ppm at 24 hours observation. The decrease of cell survival rate was concentration (up to 600 ppm)- and observation time (1-7 day)- dependent. The cell number decreased after 100 ppm FA exposure for more than 10 min at 7-day observation. The FA treated cells showed increased apoptosis/necrosis and cell cycle accumulation at sub G1 phase as well as mitochondria clustering around nucleus. The in vivo rabbit eye exposure for tear production by Schirmer's test revealed that the FA-induced overproduction of tear also exhibited observation time (1-10 day)- and FA concentration (20-300 ppm for 5 min exposure)- dependent. Activated extracellular signal-regulated kinase (pERK2) in cornea explants by western blotting was reduced and increased c-Jun amino - terminal kinase (JNK) activation (pJNK) in cornea and conjunctiva was evident at 2 month after exposure to 50-200 ppm FA for 5 min. In conclusion, injury to the eye with transient exposure of up to 100 ppm FA for 3 min decreased corneal cell survival while a more sensitive MTT test detected the cell decrease at 20 ppm FA exposure. Morphology changes can be observed even at 5 ppm FA exposure for 3 min at 7 days after. The FA exposure also increased apoptotic/necrotic cells and sub-G1 phase in cell cycle. Long term effect (2 months after exposure) on the eye tissues even after the removal of FA can be observed with persistent JNK activation in cornea and conjunctiva.	[Lai, Li-Ju] Chang Gang Mem Hosp, Dept Ophthalmol, Chiayi, Taiwan; [Lai, Li-Ju; Hsu, Wei-Hsiu] Chang Gang Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Wu, Albert M.] Chang Gang Univ, Coll Med, Dept Biochem & Mol Biol, Tao Yuan, Taiwan; [Wu, June H.] Chang Gang Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Wu, JH (corresponding author), Chang Gang Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan.	jhwu@mail.cgu.edu.tw		Hsu, Wei-Hsiu/0000-0003-4831-8467	Chang Gung Memorial Hospital, Taiwan [CMRPG670401]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The work is suported by grant CMRPG670401 of Chang Gung Memorial Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Costa S, 2011, J TOXICOL ENV HEAL A, V74, P1040, DOI 10.1080/15287394.2011.582293; Duong A, 2011, MUTAT RES-REV MUTAT, V728, P118, DOI 10.1016/j.mrrev.2011.07.003; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; Horwath-Winter J, 2003, ARCH OPHTHALMOL-CHIC, V121, P1364, DOI 10.1001/archopht.121.10.1364; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jester JV, 2001, TOXICOL IN VITRO, V15, P115, DOI 10.1016/S0887-2333(00)00065-5; Kawakita T, 2005, AM J PATHOL, V167, P381, DOI 10.1016/S0002-9440(10)62983-5; Kawashima M, 2007, ARCH OPHTHALMOL-CHIC, V125, P1337, DOI 10.1001/archopht.125.10.1337; Kim KH, 2011, J ENVIRON SCI HEAL C, V29, P277, DOI 10.1080/10590501.2011.629972; Lanigan RS, 2001, INT J TOXICOL, V20, P53; Lazenby V, 2012, CHEMOSPHERE, V88, P966, DOI 10.1016/j.chemosphere.2012.03.029; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R; Matsuoka T, 2010, J TOXICOL SCI, V35, P721, DOI 10.2131/jts.35.721; Maurer JK, 2001, TOXICOL PATHOL, V29, P187, DOI 10.1080/019262301317052468; Mirabelli MC, 2011, OCCUP ENVIRON MED, V68, P375, DOI 10.1136/oem.2010.059352; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Pratt GC, 2012, RISK ANAL, V32, P96, DOI 10.1111/j.1539-6924.2011.01640.x; Saika S, 2008, PROG RETIN EYE RES, V27, P177, DOI 10.1016/j.preteyeres.2007.12.002; Shimmura Shigeto, 2002, Curr Opin Ophthalmol, V13, P213, DOI 10.1097/00055735-200208000-00004; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Tang XQ, 2011, CLIN EXP PHARMACOL P, V38, P208, DOI 10.1111/j.1440-1681.2011.05485.x; Ushio H, 1999, TOXICOL LETT, V105, P17, DOI 10.1016/S0378-4274(98)00379-8; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Wang L, 2007, INVEST OPHTH VIS SCI, V48, P652, DOI 10.1167/iovs.06-1007; YAN MH, 1994, NATURE, V372, P798; YAN MH, 1994, J BIOL CHEM, V269, P19067; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang LP, 2010, ENVIRON MOL MUTAGEN, V51, P181, DOI 10.1002/em.20534	33	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66649	10.1371/journal.pone.0066649	http://dx.doi.org/10.1371/journal.pone.0066649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818956	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800092
J	DeSouza, DD; Moayedi, M; Chen, DQ; Davis, KD; Hodaie, M				DeSouza, Danielle D.; Moayedi, Massieh; Chen, David Q.; Davis, Karen D.; Hodaie, Mojgan			Sensorimotor and Pain Modulation Brain Abnormalities in Trigeminal Neuralgia: A Paroxysmal, Sensory-Triggered Neuropathic Pain	PLOS ONE			English	Article							GRAY-MATTER; HEMISPHERIC LATERALIZATION; CORTEX; MECHANISMS; PLASTICITY; THICKNESS; ROBUST; MODEL	Objective: Idiopathic trigeminal neuralgia (TN) is characterized by paroxysms of severe facial pain but without the major sensory loss that commonly accompanies neuropathic pain. Since neurovascular compression of the trigeminal nerve root entry zone does not fully explain the pathogenesis of TN, we determined whether there were brain gray matter abnormalities in a cohort of idiopathic TN patients. We used structural MRI to test the hypothesis that TN is associated with altered gray matter (GM) in brain areas involved in the sensory and affective aspects of pain, pain modulation, and motor function. We further determined the contribution of long-term TN on GM plasticity. Methods: Cortical thickness and subcortical GM volume were measured from high-resolution 3T T1-weighted MRI scans in 24 patients with right-sided TN and 24 healthy control participants. Results: TN patients had increased GM volume in the sensory thalamus, amygdala, periaqueductal gray, and basal ganglia (putamen, caudate, nucleus accumbens) compared to healthy controls. The patients also had greater cortical thickness in the contralateral primary somatosensory cortex and frontal pole compared to controls. In contrast, patients had thinner cortex in the pregenual anterior cingulate cortex, the insula and the orbitofrontal cortex. No relationship was observed between GM abnormalities and TN pain duration. Conclusions: TN is associated with GM abnormalities in areas involved in pain perception, pain modulation and motor function. These findings may reflect increased nociceptive input to the brain, an impaired descending modulation system that does not adequately inhibit pain, and increased motor output to control facial movements to limit pain attacks.	[DeSouza, Danielle D.; Moayedi, Massieh; Chen, David Q.; Davis, Karen D.] Univ Hlth Network, Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [DeSouza, Danielle D.; Moayedi, Massieh; Chen, David Q.; Davis, Karen D.; Hodaie, Mojgan] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Davis, Karen D.; Hodaie, Mojgan] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Davis, Karen D.; Hodaie, Mojgan] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Hodaie, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	mojgan.hodaie@uhn.on.ca	DeSouza, Danielle/J-9821-2019	DeSouza, Danielle/0000-0001-6861-5691; Moayedi, Massieh/0000-0002-7324-2540; Chen, David Qixiang/0000-0001-6407-8024	PSI Foundation; Canadian Institutes of Health Research Strategic Training Fellowship [TGF-53877]; University of Toronto/Purdue Pharma OGSST award	PSI Foundation; Canadian Institutes of Health Research Strategic Training Fellowship(Canadian Institutes of Health Research (CIHR)); University of Toronto/Purdue Pharma OGSST award	This work was supported by the PSI Foundation, the Canadian Institutes of Health Research Strategic Training Fellowship, TGF-53877, and the University of Toronto/Purdue Pharma OGSST award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Borsook D, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-34; CALVIN WH, 1977, PAIN, V3, P147, DOI 10.1016/0304-3959(77)90078-1; Coghill RC, 2001, J NEUROPHYSIOL, V85, P2602, DOI 10.1152/jn.2001.85.6.2602; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Daskalakis ZJ, 2012, J NEUROIMMUNE PHARM; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FROMM GH, 1981, NEUROLOGY, V31, P683, DOI 10.1212/WNL.31.6.683; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Ji GC, 2009, J NEUROPHYSIOL, V102, P2253, DOI 10.1152/jn.00166.2009; Knight YE, 2001, NEUROSCIENCE, V106, P793, DOI 10.1016/S0306-4522(01)00303-7; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Miller JP, 2009, J NEUROSURG, V110, P627, DOI 10.3171/2008.6.17620; Moayedi M, 2012, J NEUROIMMUNE PHARM; Moayedi M, 2012, BRAIN RES, V1456, P82, DOI 10.1016/j.brainres.2012.03.040; Moayedi M, 2011, J NEUROSCI, V31, P12396, DOI 10.1523/JNEUROSCI.3103-11.2011; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Nurmikko TJ, 2001, BRIT J ANAESTH, V87, P117, DOI 10.1093/bja/87.1.117; Peck CC, 2008, AUST DENT J, V53, P201, DOI 10.1111/j.1834-7819.2008.00050.x; RAPPAPORT ZH, 1994, PAIN, V56, P127, DOI 10.1016/0304-3959(94)90086-8; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Schweinhardt P, 2010, J CLIN INVEST, V120, P3788, DOI 10.1172/JCI43498; Siccoli MM, 2006, LANCET NEUROL, V5, P257, DOI 10.1016/S1474-4422(06)70375-1; Siddiqui MN, 2003, HOSP PHYS, V39, P64; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sinay VJ, 2003, CEPHALALGIA, V23, P541, DOI 10.1046/j.1468-2982.2003.00581.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Starr CJ, 2011, BRAIN, V134, P1987, DOI 10.1093/brain/awr117; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taylor KS, 2009, BRAIN, V132, P3122, DOI 10.1093/brain/awp231; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tsujimoto S, 2010, NAT NEUROSCI, V13, P120, DOI 10.1038/nn.2453; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006; Zald D. H., 2006, ORBITOFRONTAL CORTEX; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	54	85	95	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66340	10.1371/journal.pone.0066340	http://dx.doi.org/10.1371/journal.pone.0066340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823184	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400089
J	Jin, H; Xiong, YY; Sun, J; Zhang, Y; Huang, F; Zhou, HS; Fan, ZP; Xu, D; Wei, YQ; Dai, M; Feng, R; Liu, QF				Jin, Hua; Xiong, Yiying; Sun, Jing; Zhang, Yu; Huang, Fen; Zhou, Hongsheng; Fan, Zhiping; Xu, Dan; Wei, Yongqiang; Dai, Min; Feng, Ru; Liu, Qifa			Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; CHRONIC MYELOGENOUS LEUKEMIA; DONOR LYMPHOCYTE INFUSIONS; VERSUS-HOST-DISEASE; COMPLETE MOLECULAR REMISSION; PATIENTS RECEIVING IMATINIB; FOLLOW-UP; MESYLATE DISCONTINUATION; KINASE INHIBITORS; INTERFERON-ALPHA	Imatinib can induce complete molecular remission (CMR) in relapse chronic myelogenous leukemia (CML) after allogeneic hematopoietic stem cell transplantation, but it is indefinite whether imatinib is required to maintain CMR. We retrospectively reviewed 37 relapse CML post-transplants treated with imatinib (n = 20) or donor lymphocyte infusion (DLI) (n = 17). The rate of CMR was 85% and 76.47% (P = 0.509) and treatment-related mortality was 0% and 29.4% (P = 0.019), respectively, in imatinib and DLI groups. Fifteen patients obtaining CMR voluntarily ceased imatinib, and did not experience relapse. The 8-year overall survival (OS) after relapse was 85% 68% and 40.3 +/- 12.1% (P = 0.017), and disease-free survival (DFS) after relapse was 85%+/- 68% and 40.3 +/- 12.1% (P = 0.011), respectively, in imatinib and DLI groups. Imatinib resulted in higher OS and DFS than that of DLI in relapse CML. Imatinib maintenance might not be required for patients with relapse CML post-transplants after they achieved full donor chimerism and CMR.	[Jin, Hua; Xiong, Yiying; Sun, Jing; Zhang, Yu; Huang, Fen; Zhou, Hongsheng; Fan, Zhiping; Xu, Dan; Wei, Yongqiang; Dai, Min; Feng, Ru; Liu, Qifa] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Feng, R (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	ruth1626@hotmail.com; liuqifa628@163.com	DAI, M/GPS-8291-2022		National Natural Science Foundation of China [81000231, 81270647, 30971300]; National Public Health Grand Research Foundation of China [201202017]; Technology Plan of Guangdong Province of China [2009A030200007]; Science and Technology Project of Guangdong Province of China [2011J4300104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation of China; Technology Plan of Guangdong Province of China; Science and Technology Project of Guangdong Province of China	The study was supported by grants from the National Natural Science Foundation of China (No. 81000231, No. 81270647, and No. 30971300), the National Public Health Grand Research Foundation of China (No. 201202017) the Technology Plan of Guangdong Province of China (No. 2009A030200007) and the Science and Technology Project of Guangdong Province of China (No. 2011J4300104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Breccia M, 2012, LEUKEMIA RES, V36, P1498, DOI 10.1016/j.leukres.2012.09.006; Collins RH, 1997, J CLIN ONCOL, V15, P433, DOI 10.1200/JCO.1997.15.2.433; Dazzi F, 2000, BLOOD, V96, P2712; Dazzi F, 2007, BEST PRACT RES CL HA, V20, P311, DOI 10.1016/j.beha.2006.10.002; Deangelo DJ, 2004, CLIN CANCER RES, V10, P5065, DOI 10.1158/1078-0432.CCR-03-0580; Deenik W, 2010, HAEMATOL-HEMATOL J, V95, P914, DOI 10.3324/haematol.2009.016766; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Fernandez HF, 2009, CANCER CONTROL, V16, P153, DOI 10.1177/107327480901600207; Forrest DL, 2009, LEUKEMIA RES, V33, P271, DOI 10.1016/j.leukres.2008.07.015; Goh HG, 2009, LEUKEMIA LYMPHOMA, V50, P944, DOI 10.1080/10428190902926973; Goldman JM, 2008, BONE MARROW TRANSPL, V42, pS11, DOI 10.1038/bmt.2008.105; Guglielmi C, 2002, BLOOD, V100, P397, DOI 10.1182/blood.V100.2.397; HERTENSTEIN B, 1993, TRANSPLANTATION, V56, P1114, DOI 10.1097/00007890-199311000-00013; Hess G, 2005, J CLIN ONCOL, V23, P7583, DOI 10.1200/JCO.2005.01.3110; Higano CS, 1997, BLOOD, V90, P2549, DOI 10.1182/blood.V90.7.2549.2549_2549_2554; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Igarashi Tetsuyuki, 2012, Rinsho Ketsueki, V53, P215; Jabbour E, 2007, CANCER-AM CANCER SOC, V109, P2171, DOI 10.1002/cncr.22661; Kantarjian HM, 2002, BLOOD, V100, P1590, DOI 10.1182/blood.V100.5.1590.h81702001590_1590_1595; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Lipka DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040853; Liu QF, 2011, ANN HEMATOL, V90, P331, DOI 10.1007/s00277-010-1081-3; Liu QF, 2009, BIOL BLOOD MARROW TR, V15, P1376, DOI 10.1016/j.bbmt.2009.06.017; Luo Y, 2011, LEUKEMIA RES, V35, P1307, DOI 10.1016/j.leukres.2011.01.001; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Martinez C, 2005, BONE MARROW TRANSPL, V36, P301, DOI 10.1038/sj.bmt.1705063; Merante S, 2005, HAEMATOLOGICA, V90, P979; Olavarria E, 2003, LEUKEMIA, V17, P1707, DOI 10.1038/sj.leu.2403068; Olavarria E, 2007, BLOOD, V110, P4614, DOI 10.1182/blood-2007-04-082990; Olivieri J, 2011, THESCIENTIFICWORLDJO, V11, P1908, DOI 10.1100/2011/924954; Palandri F, 2007, BONE MARROW TRANSPL, V39, P189, DOI 10.1038/sj.bmt.1705554; PORTER DL, 1994, NEW ENGL J MED, V330, P100, DOI 10.1056/NEJM199401133300204; Raiola AM, 2003, BONE MARROW TRANSPL, V31, P687, DOI 10.1038/sj.bmt.1703883; Ringden O, 2009, BLOOD, V113, P3110, DOI 10.1182/blood-2008-07-163212; Robin M, 2005, LEUKEMIA, V19, P1613, DOI 10.1038/sj.leu.2403821; Roman J, 2000, HAEMATOLOGICA, V85, P1072; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Savani BN, 2005, BONE MARROW TRANSPL, V36, P1009, DOI 10.1038/sj.bmt.1705167; Sekhri A, 2009, LEUKEMIA RES, V33, P1291, DOI 10.1016/j.leukres.2009.03.010; Shah Neil P, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS31; Steegmann JL, 1999, BONE MARROW TRANSPL, V23, P483, DOI 10.1038/sj.bmt.1701607; Takahashi N, 2012, HAEMATOL-HEMATOL J, V97, P903, DOI 10.3324/haematol.2011.056853; Ullmann Andrew J., 2003, Keio Journal of Medicine, V52, P182; Wang HW, 2005, BLOOD, V105, P1135, DOI 10.1182/blood-2004-01-0027; Weisdorf DJ, 2002, BLOOD, V99, P1971, DOI 10.1182/blood.V99.6.1971; Weisser M, 2006, HAEMATOLOGICA, V91, P663; Wright MP, 2010, BIOL BLOOD MARROW TR, V16, P639, DOI 10.1016/j.bbmt.2009.11.026; Xuan L, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-46; Yhim HY, 2012, LEUKEMIA RES, V36, P689, DOI 10.1016/j.leukres.2012.02.011	52	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65981	10.1371/journal.pone.0065981	http://dx.doi.org/10.1371/journal.pone.0065981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823695	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400042
J	Furuhashi, K; Saga, K; Okada, S; Imou, K				Furuhashi, Kenichi; Saga, Kiyotaka; Okada, Shigeru; Imou, Kenji			Seawater-Cultured Botryococcus braunii for Efficient Hydrocarbon Extraction	PLOS ONE			English	Article							MICROALGAE; GROWTH; CULTIVATION; RECOVERY; WATER	As a potential source of biofuel, the green colonial microalga Botryococcus braunii produces large amounts of hydrocarbons that are accumulated in the extracellular matrix. Generally, pretreatment such as drying or heating of wet algae is needed for sufficient recoveries of hydrocarbons from B. braunii using organic solvents. In this study, the Showa strain of B. braunii was cultured in media derived from the modified Chu13 medium by supplying artificial seawater, natural seawater, or NaCl. After a certain period of culture in the media with an osmotic pressure corresponding to 1/4-seawater, hydrocarbon recovery rates exceeding 90% were obtained by simply mixing intact wet algae with n-hexane without any pretreatments and the results using the present culture conditions indicate the potential for hydrocarbon milking. Highlights: Seawater was used for efficient hydrocarbon extraction from Botryococcus braunii. The alga was cultured in media prepared with seawater or NaCl. Hydrocarbon recovery rate exceeding 90% was obtained without any pretreatment.	[Furuhashi, Kenichi; Saga, Kiyotaka; Imou, Kenji] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biol & Mech Engn, Bunkyo Ku, Yayoi, Japan; [Okada, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat & Nat Prod Chem, Bunkyo Ku, Yayoi, Japan	University of Tokyo; University of Tokyo	Imou, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biol & Mech Engn, Bunkyo Ku, Yayoi, Japan.	aimou@mail.ecc.u-tokyo.ac.jp	Okada, Shigeru/U-8305-2017	Okada, Shigeru/0000-0003-3663-7778	Tokyo Gas Co. Ltd.; Grants-in-Aid for Scientific Research [13J07091] Funding Source: KAKEN	Tokyo Gas Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Tokyo Gas Co. Ltd. for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Dayananda C, 2007, BIOMASS BIOENERG, V31, P87, DOI 10.1016/j.biombioe.2006.05.001; DOTE Y, 1994, FUEL, V73, P1855, DOI 10.1016/0016-2361(94)90211-9; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; FRENZ J, 1989, BIOTECHNOL BIOENG, V34, P755, DOI 10.1002/bit.260340605; Hejazi MA, 2004, TRENDS BIOTECHNOL, V22, P189, DOI 10.1016/j.tibtech.2004.02.009; Kita K, 2010, APPL ENERG, V87, P2420, DOI 10.1016/j.apenergy.2009.11.036; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Li Y, 2005, J APPL PHYCOL, V17, P551, DOI 10.1007/s10811-005-9005-7; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Rao AR, 2007, BIORESOURCE TECHNOL, V98, P560, DOI 10.1016/j.biortech.2006.02.007; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; VAZQUEZDUHALT R, 1991, PHYTOCHEMISTRY, V30, P2919, DOI 10.1016/S0031-9422(00)98225-6; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; Yeesang C, 2011, BIORESOURCE TECHNOL, V102, P3034, DOI 10.1016/j.biortech.2010.10.013; Yonezawa N, 2012, BIORESOURCE TECHNOL, V109, P304, DOI 10.1016/j.biortech.2011.07.090; Yoo G, 2012, BIORESOURCE TECHNOL, V123, P717, DOI 10.1016/j.biortech.2012.07.102; Zhang HF, 2011, BIOMASS BIOENERG, V35, P1710, DOI 10.1016/j.biombioe.2011.01.002	23	22	22	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66483	10.1371/journal.pone.0066483	http://dx.doi.org/10.1371/journal.pone.0066483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799107	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300085
J	Gao, SJ; Damaj, MB; Park, JW; Beyene, G; Buenrostro-Nava, MT; Molina, J; Wang, XF; Ciomperlik, JJ; Manabayeva, SA; Alvarado, VY; Rathore, KS; Scholthof, HB; Mirkov, TE				Gao, San-Ji; Damaj, Mona B.; Park, Jong-Won; Beyene, Getu; Buenrostro-Nava, Marco T.; Molina, Joe; Wang, Xiaofeng; Ciomperlik, Jessica J.; Manabayeva, Shuga A.; Alvarado, Veria Y.; Rathore, Keerti S.; Scholthof, Herman B.; Mirkov, T. Erik			Enhanced Transgene Expression in Sugarcane by Co-Expression of Virus-Encoded RNA Silencing Suppressors	PLOS ONE			English	Article							TRANSIENT GENE-EXPRESSION; DOUBLE-STRANDED-RNA; VIRAL SUPPRESSORS; MICROPROJECTILE BOMBARDMENT; GFP EXPRESSION; NICOTIANA-BENTHAMIANA; PARTICLE BOMBARDMENT; SUSPENSION-CULTURES; BETA-GLUCURONIDASE; PROTOPLAST SYSTEM	Post-transcriptional gene silencing is commonly observed in polyploid species and often poses a major limitation to plant improvement via biotechnology. Five plant viral suppressors of RNA silencing were evaluated for their ability to counteract gene silencing and enhance the expression of the Enhanced Yellow Fluorescent Protein (EYFP) or the beta-glucuronidase (GUS) reporter gene in sugarcane, a major sugar and biomass producing polyploid. Functionality of these suppressors was first verified in Nicotiana benthamiana and onion epidermal cells, and later tested by transient expression in sugarcane young leaf segments and protoplasts. In young leaf segments co-expressing a suppressor, EYFP reached its maximum expression at 48-96 h post-DNA introduction and maintained its peak expression for a longer time compared with that in the absence of a suppressor. Among the five suppressors, Tomato bushy stunt virus-encoded P19 and Barley stripe mosaic virus-encoded gamma b were the most efficient. Co-expression with P19 and gamma b enhanced EYFP expression 4.6-fold and 3.6-fold in young leaf segments, and GUS activity 2.3-fold and 2.4-fold in protoplasts compared with those in the absence of a suppressor, respectively. In transgenic sugarcane, co-expression of GUS and P19 suppressor showed the highest accumulation of GUS levels with an average of 2.7-fold more than when GUS was expressed alone, with no detrimental phenotypic effects. The two established transient expression assays, based on young leaf segments and protoplasts, and confirmed by stable transgene expression, offer a rapid versatile system to verify the efficiency of RNA silencing suppressors that proved to be valuable in enhancing and stabilizing transgene expression in sugarcane.	[Gao, San-Ji] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China; [Damaj, Mona B.; Park, Jong-Won; Molina, Joe; Mirkov, T. Erik] Texas A&M AgriLife Res, Dept Plant Pathol & Microbiol, Weslaco, TX USA; [Beyene, Getu] Donald Danforth Plant Sci Ctr, Inst Int Crop Improvement, St Louis, MO USA; [Buenrostro-Nava, Marco T.] Univ Colima, FCBA Lab Biotecnol, Tecoman, Colima, Mexico; [Wang, Xiaofeng] VirginiaTech Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA; [Ciomperlik, Jessica J.; Scholthof, Herman B.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Manabayeva, Shuga A.] Natl Ctr Biotechnol Republ Kazakhstan, Astana, Kazakhstan; [Alvarado, Veria Y.] Texas A&M Univ, Stoller Enterprises Inc, Norman E Borlaug Ctr Southern Crop Improvement, College Stn, TX USA; [Rathore, Keerti S.] Texas A&M Univ, Inst Plant Genom & Biotechnol, Norman E Borlaug Ctr Southern Crop Improvement, Lab Crop Transformat, College Stn, TX USA	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Donald Danforth Plant Science Center; Universidad de Colima; Texas A&M University System; Texas A&M University College Station; National Center for Biotechnology (NCB); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mirkov, TE (corresponding author), Texas A&M AgriLife Res, Dept Plant Pathol & Microbiol, Weslaco, TX USA.	e-mirkov@tamu.edu	Manabayeva, Shuga A./A-2529-2015; Wang, Xiaofeng/E-9940-2016; Park, Jong-Won/O-5097-2014; Gao, San-Ji/AAZ-3967-2021	Manabayeva, Shuga A./0000-0001-7884-1713; Wang, Xiaofeng/0000-0002-3850-3274; Park, Jong-Won/0000-0002-1936-8230; Duguma, Getu/0000-0002-4194-1267	Texas AgriLife Bioenergy grant [0809]	Texas AgriLife Bioenergy grant	This work was supported by a Texas AgriLife Bioenergy grant 0809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab F, 1999, PLANT CELL TISS ORG, V56, P155, DOI 10.1023/A:1006296320725; Alvarez ML, 2008, PLANT MOL BIOL, V68, P61, DOI 10.1007/s11103-008-9352-2; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; ARAGAO FJL, 1993, PLANT CELL REP, V12, P483, DOI 10.1007/BF00236092; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Beyene G, 2011, PLANT CELL REP, V30, P13, DOI 10.1007/s00299-010-0936-3; Birch R. G., 2010, Tropical Plant Biology, V3, P88, DOI 10.1007/s12042-010-9047-0; BOWER R, 1992, PLANT J, V2, P409, DOI 10.1111/j.1365-313X.1992.00409.x; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Carrington JC, 2000, NATURE, V408, P150, DOI 10.1038/35041662; CHAREST PJ, 1993, PLANT CELL REP, V12, P189, DOI 10.1007/BF00237051; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; CHEN WH, 1987, PLANT CELL REP, V6, P297, DOI 10.1007/BF00272003; Chiba M, 2006, VIROLOGY, V346, P7, DOI 10.1016/j.virol.2005.09.068; Chiera JM, 2008, TRANSGENIC RES, V17, P1143, DOI 10.1007/s11248-008-9192-5; Chiera JM, 2007, PLANT CELL REP, V26, P1501, DOI 10.1007/s00299-007-0359-y; CHOWDHURY MKU, 1992, PLANT CELL REP, V11, P494, DOI 10.1007/BF00236264; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Circelli Patrizia, 2010, Bioeng Bugs, V1, P221, DOI 10.4161/bbug.1.3.11722; Damavandi MY, 2009, EL C EL POW EN CONV, P1; Dhillon T, 2009, PLANT CELL REP, V28, P639, DOI 10.1007/s00299-009-0675-5; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; GALLOMEAGHER M, 1993, PLANT CELL REP, V12, P666, DOI 10.1007/BF00233416; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; Hsieh YC, 2009, J VIROL, V83, P2188, DOI 10.1128/JVI.02186-08; HUNOLD R, 1994, PLANT J, V5, P593, DOI 10.1046/j.1365-313X.1994.5040593.x; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ingelbrecht IL, 1999, PLANT PHYSIOL, V119, P1187, DOI 10.1104/pp.119.4.1187; JEFFERSON RA, 1987, EMBO J, V6, P3901; Joyce P, 2010, PLANT CELL REP, V29, P173, DOI 10.1007/s00299-009-0810-3; KRISHNAMURTHI M, 1976, EUPHYTICA, V25, P145, DOI 10.1007/BF00041539; Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lozsa R, 2008, NUCLEIC ACIDS RES, V36, P4099, DOI 10.1093/nar/gkn365; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Mangwende T, 2009, VIROLOGY, V384, P38, DOI 10.1016/j.virol.2008.10.034; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Menossi M, 2008, Int J Plant Genomics, V2008, P458732, DOI 10.1155/2008/458732; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Mudge SR, 2009, PLANTA, V229, P549, DOI 10.1007/s00425-008-0852-8; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Omarov R, 2006, J VIROL, V80, P3000, DOI 10.1128/JVI.80.6.3000-3008.2006; Omarov Rustem T, 2012, Methods Mol Biol, V894, P39, DOI 10.1007/978-1-61779-882-5_3; Pantaleo V, 2011, ADV EXP MED BIOL, V722, P39, DOI 10.1007/978-1-4614-0332-6_3; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; PROLS F, 1992, PLANT J, V2, P465; Qi YJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh180; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; RATHUS C, 1992, PLANT SCI, V82, P81, DOI 10.1016/0168-9452(92)90010-J; Reddy MSS, 2003, PLANT CELL REP, V21, P676, DOI 10.1007/s00299-002-0567-4; Roth BM, 2004, VIRUS RES, V102, P97, DOI 10.1016/j.virusres.2004.01.020; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU; Saxena P, 2011, PLANT BIOTECHNOL J, V9, P703, DOI 10.1111/j.1467-7652.2010.00574.x; Senshu H, 2011, J VIROL, V85, P10269, DOI 10.1128/JVI.05273-11; Shimura H, 2008, J GEN PLANT PATHOL, V74, P326, DOI 10.1007/s10327-008-0099-z; Siddiqui SA, 2008, MOL PLANT MICROBE IN, V21, P178, DOI 10.1094/MPMI-21-2-0178; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Snyman SJ, 2006, PLANT CELL REP, V25, P1016, DOI 10.1007/s00299-006-0148-z; Tai T., 1990, PLANT MOL BIOL REP, V8, P297, DOI [10.1007/BF02668766, DOI 10.1007/BF02668766]; TAYLOR PWJ, 1992, PLANT CELL TISS ORG, V28, P69, DOI 10.1007/BF00039917; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vanithatani R, 2003, P NATL ACAD SCI USA, V100, P9632, DOI 10.1073/pnas.1733874100; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang MB, 2005, CURR OPIN PLANT BIOL, V8, P216, DOI 10.1016/j.pbi.2005.01.006; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Weld R, 2001, PLANT MOL BIOL, V45, P377, DOI 10.1023/A:1010798625203; Yelina NE, 2002, J VIROL, V76, P12981, DOI 10.1128/JVI.76.24.12981-12991.2002; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu B, 2006, FEBS LETT, V580, P3117, DOI 10.1016/j.febslet.2006.04.063; Zhai ZY, 2009, PLANT PHYSIOL, V149, P642, DOI 10.1104/pp.108.130260; Zheng ZM, 2010, PLANT J, V62, P92, DOI 10.1111/j.1365-313X.2010.04130.x	90	22	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66046	10.1371/journal.pone.0066046	http://dx.doi.org/10.1371/journal.pone.0066046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799071	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300060
J	Guo, L; Zhang, LL; Zheng, B; Liu, Y; Cao, XJ; Pi, Y; Li, BH; Li, JC				Guo, Lu; Zhang, Li-Li; Zheng, Bo; Liu, Yun; Cao, Xiao-Jie; Pi, Yan; Li, Bing-Hu; Li, Jing-Cheng			The C825T Polymorphism of the G-Protein beta 3 Subunit Gene and Its Association with Hypertension and Stroke: An Updated Meta-Analysis	PLOS ONE			English	Article							ARTERIAL-BLOOD PRESSURE; ACE I/D POLYMORPHISMS; GNB3 C825T; CARDIOVASCULAR-DISEASE; CANDIDATE GENES; 825C/T POLYMORPHISM; ALPHA-ADDUCIN; 825T ALLELE; RISK-FACTOR; VARIANT	Objective: Several epidemiological studies have evaluated the association between the GNB3 C825T polymorphism and hypertension or stroke. The results of these studies were inconsistent; therefore, we performed a meta-analysis to clarify these discrepancies. Methods: We systematically searched the PubMed, Embase, Web of Science, CNKI, and CBM databases, and manually searched reference lists of relevant papers, meeting abstracts, and relevant journals. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for dominant, recessive, and allelic models. A fixed or random effects model was separately adopted depending on study heterogeneity. Subgroup and sensitivity analyses were performed to detect study heterogeneity and examine result stability, respectively. Publication bias was tested using funnel plots, the Egger's regression test, and Begg's test. Results: We screened 66 studies regarding hypertension and eight concerning stroke. A combined analysis showed that only the allelic model found a marginal association with hypertension (OR = 1.07, 95% CI = 1.01-1.13) and female gender (OR = 1.11, 95% CI = 0.99-1.24). However, no comparison models found an association with stroke (allelic model: OR = 1.11, 95% CI = 0.94-1.32; dominant model: OR = 1.16, 95% CI = 0.92-1.48; and recessive model: OR = 1.05, 95% CI = 0.97-1.14). Sensitivity analysis suggested that all models did not yield a relationship to hypertension or stroke among Asians. Besides, there was a lack of statistical association with hypertension in Caucasians, which maybe due to a small sample size. When we restricted the included studies to normal populations according to the Hardy-Weinberg equilibrium, no association was found. Conclusions: There was no evidence indicating that the 825T allele or TT genotype was associated with hypertension or stroke in Asians or hypertension in Caucasians. However, further studies regarding Africans and other ethnicities are needed to identify further correlations.	[Guo, Lu; Zhang, Li-Li; Liu, Yun; Cao, Xiao-Jie; Pi, Yan; Li, Bing-Hu; Li, Jing-Cheng] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China; [Zheng, Bo] Third Mil Med Univ, Southwest Hosp, Dept Neurol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, JC (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China.	lijingcheng11@yahoo.com.cn			National Natural Science Foundation of China [81271282, 30970998]; Chongqing Natural Science Foundation [CSTC2011BB5031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This work was financially supported by the National Natural Science Foundation of China (81271282, 30970998) and by the Chongqing Natural Science Foundation (CSTC2011BB5031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioglu E, 2008, ANATOL J CARDIOL, V8, P331; Bae Y, 2007, J HUM HYPERTENS, V21, P159, DOI 10.1038/sj.jhh.1002110; Bagos PG, 2007, J HYPERTENS, V25, P487, DOI 10.1097/HJH.0b013e328011db24; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beige J, 1999, HYPERTENSION, V33, P1049, DOI 10.1161/01.HYP.33.4.1049; Benjafield AV, 1998, HYPERTENSION, V32, P1094, DOI 10.1161/01.HYP.32.6.1094; Brand E, 2003, J HYPERTENS, V21, P729, DOI 10.1097/00004872-200304000-00016; Brand E, 1999, HYPERTENSION, V33, P1175, DOI 10.1161/01.HYP.33.5.1175; Buchmayer H, 2000, CRIT CARE MED, V28, P3203, DOI 10.1097/00003246-200009000-00015; Chen XJ, 2007, J CLIN INTERN MED, V24, P333; Chen YY, 2003, NAT MED J CHINA; Chistiakov DA, 2009, DIS MARKERS, V26, P111, DOI [10.1155/2009/426074, 10.3233/DMA-2009-0620]; Dai Shu-Ping, 2002, Acta Genetica Sinica, V29, P294; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Dong H.Y., 2006, S CHINA J CARDIOVASC, V12, P258; Dong YB, 1999, HYPERTENSION, V34, P1193, DOI 10.1161/01.HYP.34.6.1193; [窦贵旺 DOU Gui-wang], 2009, [生物学杂志, Journal of Biology], V26, P18; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; [盖小群 GAI Xiaoqun], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P413; GALBRAITH RF, 1988, TECHNOMETRICS, V30, P271, DOI 10.2307/1270081; Hager A, 2011, INT J CARDIOL, V151, P63, DOI 10.1016/j.ijcard.2010.04.090; Hayakawa T, 2007, METABOLISM, V56, P44, DOI 10.1016/j.metabol.2006.08.020; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holmen OL, 2010, AM J HYPERTENS, V23, P1121, DOI 10.1038/ajh.2010.121; Hu RL, 2006, CHIN J BIRTH HLTH HE, V14, P15; Huang WT, 2007, PROG BIOCHEM BIOPHYS, V34, P471; Huang XH, 2003, J MOL MED, V81, P729, DOI 10.1007/s00109-003-0482-3; Huang XM, 2005, CHIN J BIRTH HLTH HE, V13, P21; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Ishikawa K, 2000, AM J HYPERTENS, V13, P140, DOI 10.1016/S0895-7061(99)00118-1; Izawa H, 2003, HYPERTENSION, V41, P1035, DOI 10.1161/01.HYP.0000065618.56368.24; Jing Jian-ying, 2006, Fudan Xuebao (Yixueban), V33, P433; Kato N, 1998, HYPERTENSION, V32, P935, DOI 10.1161/01.HYP.32.5.935; Kedzierska K, 2006, ARCH MED RES, V37, P150, DOI 10.1016/j.arcmed.2005.05.012; Khamidullaeva GA, 2011, TURK KARDIYOL DERN A, V39, P198, DOI 10.5543/tkda.2011.01103; Klenke S, 2011, PHARMACOGENET GENOM, V21, P594, DOI 10.1097/FPC.0b013e3283491153; Kuo TY, 2012, AM J HYPERTENS, V25, P804, DOI 10.1038/ajh.2012.44; Larson N, 2000, HYPERTENSION, V35, P1297, DOI 10.1161/01.HYP.35.6.1297; Lee JY, 2009, INT J SPORTS MED, V30, P892, DOI 10.1055/s-0029-1233465; Li B, 2005, ANN HUM GENET, V69, P468, DOI 10.1111/j.1529-8817.2005.00172.x; Li D.B., 2005, J CAPITAL U MED SCI, V26, P725; Li DB, 2005, J CAPITAL U MED SCI, V27, P480; Li QX, 2006, J CHIN MICROCIRC, V10, P205; Li QX, 2003, THESIS; Li QX, 2006, CHIN J PUBLIC HLTH, V22, P1334; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; LIU L. P., 2003, THESIS; liu WJ, 2009, CHINESE CIRCULATION, V24; Lu FH, 2009, CHIN J PUBLIC HLTH, V25, P20; Lu JP, 2012, MOL BIOL REP, V39, P8937, DOI 10.1007/s11033-012-1762-1; MANTEL N, 1959, J NATL CANCER I, V22, P719; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Montasser ME, 2011, AM J HYPERTENS, V24, P1035, DOI 10.1038/ajh.2011.97; Morrison AC, 2001, STROKE, V32, P822, DOI 10.1161/01.STR.32.4.822; Nejatizadeh A, 2011, GENET MOL BIOL, V34, P553, DOI 10.1590/S1415-47572011005000052; Niu WQ, 2011, PLOS ONE, V6; Ozkececi E, 2008, TRAK UNIV TIP FAK DE, V25, P100; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Panoulas VF, 2009, CLIN EXP HYPERTENS, V31, P428, DOI 10.1080/10641960802668748; Hui P, 2007, HYPERTENS RES, V30, P585, DOI 10.1291/hypres.30.585; Petiti DB, 1999, METAANALYSIS DECISIO; Pitsavos C, 2006, J HUM HYPERTENS, V20, P303, DOI 10.1038/sj.jhh.1001985; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sarzynski MA, 2011, J HUM HYPERTENS, V25, P509, DOI 10.1038/jhh.2010.94; Shioji K, 2004, HYPERTENS RES, V27, P31, DOI 10.1291/hypres.27.31; Siffert W, 2005, ANNU REV MED, V56, P17, DOI 10.1146/annurev.med.56.082103.104625; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; [宋洁 Song Jie], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P9491; Sun AJ, 2005, EUR J HUM GENET, V13, P361, DOI 10.1038/sj.ejhg.5201334; Sun LL, 2003, CHIN J DIABETE, V11, P110; [孙宁玲 Sun Ninglingf], 2003, [中国糖尿病杂志, Chinese Journal of Diabetes], V11, P110; Suwazono Y, 2006, ANN HUM GENET, V70, P767, DOI 10.1111/j.1469-1809.2006.00284.x; Suwazono Y, 2004, J HYPERTENS, V22, P493, DOI 10.1097/00004872-200403000-00011; Tan JC, 2003, CHONGQING MED, V32, P13; Tan JC, 2003, CHIN J GERIATR CARDI, V5, P177; [谭建聪 Tan Jiancong], 2003, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V25, P1381; Tozawa Y, 2001, BLOOD PRESSURE, V10, P131, DOI 10.1080/080370501753182334; Tsai CH, 2000, INT J CARDIOL, V73, P191, DOI 10.1016/S0167-5273(00)00209-6; Turner ST, 2001, HYPERTENSION, V37, P739, DOI 10.1161/01.HYP.37.2.739; Varda NM, 2006, ACTA PAEDIATR, V95, P353, DOI 10.1080/08035250500434777; Vasudevan R, 2009, AFR J BIOTECHNOL, V8, P2069; Wang HL, 2011, INT J CEREBROVASC DI, V19, P580; Wang Hongyi, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P423; Wang HuiLing, 2011, Clinical Focus, V26, P766; Wang X, 2004, J HUM HYPERTENS, V18, P663, DOI 10.1038/sj.jhh.1001700; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Yamagishi K, 2006, ANN HUM GENET, V70, P759, DOI 10.1111/j.1469-1809.2006.00276.x; Yamamoto M, 2004, BIOCHEM BIOPH RES CO, V316, P744, DOI 10.1016/j.bbrc.2004.02.113; Yang JM, 2007, THESIS; Yin RX, 2009, J HYPERTENS, V27, P251, DOI 10.1097/HJH.0b013e32831bc74d; You T, 2000, MED J LIAONING, V14, P179; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zeltner R, 2001, HYPERTENSION, V37, P882, DOI 10.1161/01.HYP.37.3.882; Zhang CY, 2007, NEURAL REGENERATION, V2, P146; Zhang J, 2005, CHINESE MED INFORM, V18, P358; Zhang L, 2005, J HUM HYPERTENS, V19, P709, DOI 10.1038/sj.jhh.1001883; Zhang L., 2006, THESIS; Zhang MH, 2001, CHIN J HYPERTENS, V9, P288; [赵红晔 ZHAO Hong-ye], 2009, [基础医学与临床, Basic & Clinical Medicine], V29, P393; Zhao Y, 2001, STROKE NERVOUS DIS, V8, P14; Zhao Y, 2004, J APOPLEXY NERVOUS D, P21; Zhao Y, 2000, THESIS; Zychma MJ, 2000, AM J NEPHROL, V20, P305, DOI 10.1159/000013605	107	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65863	10.1371/journal.pone.0065863	http://dx.doi.org/10.1371/journal.pone.0065863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799054	Green Submitted, gold, Green Published			2022-12-27	WOS:000320363300048
J	Liu, J; Luo, Y; Ge, HT; Han, CQ; Zhang, H; Wang, YS; Su, JM; Quan, FS; Gao, MQ; Zhang, Y				Liu, Jun; Luo, Yan; Ge, Hengtao; Han, Chengquan; Zhang, Hui; Wang, Yongsheng; Su, Jianmin; Quan, Fusheng; Gao, Mingqing; Zhang, Yong			Anti-Bacterial Activity of Recombinant Human beta-Defensin-3 Secreted in the Milk of Transgenic Goats Produced by Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							LARGE-SCALE PRODUCTION; MAMMARY-GLAND; HUMAN LACTOFERRIN; ANTIMICROBIAL PEPTIDE; FETAL FIBROBLASTS; EPITHELIAL-CELLS; BETA-DEFENSINS; DONOR CELLS; MASTITIS; EXPRESSION	The present study was conducted to determine whether recombinant human beta-defensin-3 (rHBD3) in the milk of transgenic goats has an anti-bacterial activity against Escherichia coli (E. coli), Staphylococcus aureus (S. aureus) and Streptococcus agalactiae (S. agalactiae) that could cause mastitis. A HBD3 mammary-specific expression vector was transfected by electroporation into goat fetal fibroblasts which were used to produce fourteen healthy transgenic goats by somatic cell nuclear transfer. The expression level of rHBD3 in the milk of the six transgenic goats ranged from 98 to 121 mu g/ml at 15 days of lactation, and was maintained at 90-111 mu g/ml during the following 2 months. Milk samples from transgenic goats showed an obvious inhibitory activity against E. coli, S. aureus and S. agalactiae in vitro. The minimal inhibitory concentrations of rHBD3 in milk against E. coli, S. aureus and S. agalactiae were 9.5-10.5, 21.8-23.0 and 17.3-18.5 mu g/mL, respectively, which was similar to those of the HBD3 standard (P>0.05). The in vivo anti-bacterial activities of rHBD3 in milk were examined by intramammary infusion of viable bacterial inoculums. We observed that 9/10 and 8/10 glands of non-transgenic goats infused with S. aureus and E. coli became infected. The mean numbers of viable bacteria went up to 2.9x10(3) and 95.4x10(3) CFU/ml at 48 h after infusion, respectively; the mean somatic cell counts (SCC) in infected glands reached up to 260.4x10(5) and 622.2x10(5) cells/ml, which were significantly higher than the SCC in uninfected goat glands. In contrast, no bacteria was presented in glands of transgenic goats and PBS-infused controls, and the SSC did not significantly change throughout the period. Moreover, the compositions and protein profiles of milk from transgenic and non-transgenic goats were identical. The present study demonstrated that HBD3 were an effective anti-bacterial protein to enhance the mastitis resistance of dairy animals.	[Liu, Jun; Luo, Yan; Ge, Hengtao; Han, Chengquan; Zhang, Hui; Wang, Yongsheng; Su, Jianmin; Quan, Fusheng; Gao, Mingqing; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	zhangylab@yahoo.com.cn	Zhang, Yong/K-7945-2016	Zhang, Yong/0000-0001-8642-4071	National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303) (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LY, 2012, THERIOGENOLOGY, V78, P1303, DOI 10.1016/j.theriogenology.2012.05.027; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Dunsche A, 2002, EUR J ORAL SCI, V110, P121, DOI 10.1034/j.1600-0722.2002.11186.x; Giraldo AM, 2006, MOL REPROD DEV, V73, P1230, DOI 10.1002/mrd.20558; Goni P, 2004, INT J ANTIMICROB AG, V23, P268, DOI 10.1016/j.ijantimicag.2003.07.016; Gray C, 2005, AUST J EXP AGR, V45, P757, DOI 10.1071/EA05046; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Hyvonen P, 2006, INFECT IMMUN, V74, P6206, DOI 10.1128/IAI.00238-06; Keefer CL, 2001, BIOL REPROD, V64, P849, DOI 10.1095/biolreprod64.3.849; Kerr DE, 2003, J ANIM SCI, V81, P38; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kuhholzer B, 2001, BIOL REPROD, V64, P1695, DOI 10.1095/biolreprod64.6.1695; Liu J, 2011, THERIOGENOLOGY, V76, P1076, DOI 10.1016/j.theriogenology.2011.05.013; Liu J, 2012, THERIOGENOLOGY, DOI [10.1016/j.theriogenology.2012.11.021, DOI 10.1016/J.THERI0GEN0L0GY.2012.11.021]; Maga EA, 1998, J FOOD PROTECT, V61, P52, DOI 10.4315/0362-028X-61.1.52; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; McDougall S, 2009, VET MICROBIOL, V134, P177, DOI 10.1016/j.vetmic.2008.09.026; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Rainard P, 2006, VET RES, V37, P369, DOI 10.1051/vetres:2006007; Roosen S, 2004, MAMM GENOME, V15, P834, DOI 10.1007/s00335-004-2387-z; Ross JW, 2010, TRANSGENIC RES, V19, P611, DOI 10.1007/s11248-009-9345-1; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; Swanson K, 2004, INFECT IMMUN, V72, P7311, DOI 10.1128/IAI.72.12.7311-7314.2004; van Berkel PHC, 2002, NAT BIOTECHNOL, V20, P484, DOI 10.1038/nbt0502-484; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yarus S, 1996, P NATL ACAD SCI USA, V93, P14118, DOI 10.1073/pnas.93.24.14118; Yekta AA, 2013, TRANSGENIC RES, V22, P131, DOI 10.1007/s11248-012-9634-y; Zhang JX, 2007, J DAIRY SCI, V90, P5218, DOI 10.3168/jds.2007-0301; Zhang YL, 2008, THERIOGENOLOGY, V69, P1165, DOI 10.1016/j.theriogenology.2007.10.028	35	12	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65379	10.1371/journal.pone.0065379	http://dx.doi.org/10.1371/journal.pone.0065379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799010	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300017
J	Shi, SJ; Wang, R; Chen, YT; Song, HZ; Chen, LB; Huang, GC				Shi, Shujing; Wang, Rui; Chen, Yitian; Song, Haizhu; Chen, Longbang; Huang, Guichun			Combining Antiangiogenic Therapy with Adoptive Cell Immunotherapy Exerts Better Antitumor Effects in Non-Small Cell Lung Cancer Models	PLOS ONE			English	Article							INDUCED KILLER-CELLS; TUMOR-ASSOCIATED MACROPHAGES; ANTI-ANGIOGENESIS; VASCULAR NORMALIZATION; GROWTH-FACTOR; IN-VITRO; MICROENVIRONMENT; INHIBITION; EXPRESSION; INFILTRATION	Introduction: Cytokine-induced killer cells (CIK cells) are a heterogeneous subset of ex-vivo expanded T lymphocytes which are characterized with a MHC-unrestricted tumor-killing activity and a mixed T-NK phenotype. Adoptive CIK cells transfer, one of the adoptive immunotherapy represents a promising nontoxic anticancer therapy. However, in clinical studies, the therapeutic activity of adoptive CIK cells transfer is not as efficient as anticipated. Possible explanations are that abnormal tumor vasculature and hypoxic tumor microenvironment could impede the infiltration and efficacy of lymphocytes. We hypothesized that antiangiogenesis therapy could improve the antitumor activity of CIK cells by normalizing tumor vasculature and modulating hypoxic tumor microenvironment. Methods: We combined recombinant human endostatin (rh-endostatin) and CIK cells in the treatment of lung carcinoma murine models. Intravital microscopy, dynamic contrast enhanced magnetic resonance imaging, immunohistochemistry, and flow cytometry were used to investigate the tumor vasculature and hypoxic microenvironment as well as the infiltration of immune cells. Results: Our results indicated that rh-endostatin synergized with adoptive CIK cells transfer to inhibit the growth of lung carcinoma. We found that rh-endostatin normalized tumor vasculature and reduced hypoxic area in the tumor microenvironment. Hypoxia significantly inhibited the proliferation, cytotoxicity and migration of CIK cells in vitro and impeded the homing of CIK cells into tumor parenchyma ex vivo. Furthermore, we found that treatment with rh-endostatin significantly increased the homing of CIK cells and decreased the accumulation of suppressive immune cells in the tumor tissue. In addition, combination therapy produced higher level of tumor-infiltration lymphocytes compared with other treatments. Conclusions: Our results demonstrate that rh-endostatin improves the therapeutic effect of adoptive CIK cells therapy against lung carcinomas and unmask the mechanisms of the synergistic antitumor efficacy, providing a new rationale for combining antiangiogenesis therapy with immunotherapy in the treatment of lung cancer.	[Shi, Shujing; Wang, Rui; Chen, Yitian; Song, Haizhu; Chen, Longbang; Huang, Guichun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Chen, LB (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China.	dr.chenlb@nju.edu.cn; huangguichun@nju.edu.cn			National Natural Science Foundation of China [81101739]; China International Medical Foundation [CIMF-F-H001-023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Medical Foundation	The work was supported by National Natural Science Foundation of China (Grant number: 81101739) and China International Medical Foundation (Grant number: CIMF-F-H001-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum IB, 2011, CANCER RES, V71, P7433, DOI 10.1158/0008-5472.CAN-11-2104; Cerniglia GJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006539; Chen J, 2012, CANCER BIOTHER RADIO, V27, P210, DOI 10.1089/cbr.2011.1116; Chinnasamy D, 2010, J CLIN INVEST, V120, P3953, DOI 10.1172/JCI43490; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dirkx AEM, 2003, CANCER RES, V63, P2322; Dirkx AEM, 2006, FASEB J, V20, P621, DOI 10.1096/fj.05-4493com; Doublier S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-4; Draghiciu O, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/439053; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; George AL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-80; Griffioen AW, 2008, CANCER IMMUNOL IMMUN, V57, P1553, DOI 10.1007/s00262-008-0524-3; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hasmim M, 2011, J IMMUNOL, V187, P4031, DOI 10.4049/jimmunol.1101011; Hompland T, 2012, ACTA ONCOL, DOI DOI 10.3109/0284186X.2012.737931.ACCEPTED; Hongeng S, 2003, INT J HEMATOL, V77, P175, DOI 10.1007/BF02983217; Huang GC, 2010, J CANCER RES CLIN, V136, P1201, DOI 10.1007/s00432-010-0770-6; Huang KW, 2010, P NATL ACAD SCI USA, V107, P14769, DOI 10.1073/pnas.1009534107; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Javaherian K, 2011, DOSE-RESPONSE, V9, P369, DOI 10.2203/dose-response.10-020.Javaherian; Jemal A, 2010, CA-CANCER J CLIN, V55, P10, DOI DOI 10.3322/CANJCLIN.55.1.10; Jiang XD, 2011, LUNG CANCER, V72, P165, DOI 10.1016/j.lungcan.2010.09.003; Jin ZJ, 1980, ACTA PHARMACOL SIN, V1, P3; Lee CT, 2010, INT J HYPERTHER, V26, P232, DOI 10.3109/02656731003601745; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Myers AL, 2012, J PEDIATR SURG, V45, P1080; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Naruse T, 2011, ANTICANCER RES, V31, P4429; Noman MZ, 2011, CRIT REV IMMUNOL, V31, P357, DOI 10.1615/CritRevImmunol.v31.i5.10; Ogino T, 2012, CANCER IMMUNOL IMMUN, V61, P409, DOI 10.1007/s00262-011-1112-5; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ovrebo KM, 2012, ACTA ONCOL, DOI DOI 10.3109/0284186X.2012.689851.ACCESSED; Relf M, 1997, CANCER RES, V57, P963; Rettinger E, 2012, CYTOTHERAPY, V14, P91, DOI 10.3109/14653249.2011.613931; Rosenberg SA, 2008, P NATL ACAD SCI USA, V105, P12643, DOI 10.1073/pnas.0806877105; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; Sangiolo D, 2011, J CANCER, V2, P363, DOI 10.7150/jca.2.363; Sharma R, 2011, CURR RADIOPHARM, V4, P379, DOI 10.2174/1874471011104040379; Shi H, 2011, CHINESE MED J-PEKING, V124, P751, DOI 10.3760/cma.j.issn.0366-6999.2011.05.022; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Wei J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016195, 10.1371/journal.pone.0017868]; Wen QL, 2009, CANCER SCI, V100, P1510, DOI 10.1111/j.1349-7006.2009.01193.x; Yu JP, 2011, CANCER BIOTHER RADIO, V26, P485, DOI 10.1089/cbr.2010.0927; Zhang HY, 2005, CANCER BIOL THER, V4, P207; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544	51	38	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65757	10.1371/journal.pone.0065757	http://dx.doi.org/10.1371/journal.pone.0065757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799045	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300040
J	Berestovsky, N; Nakhleh, L				Berestovsky, Natalie; Nakhleh, Luay			An Evaluation of Methods for Inferring Boolean Networks from Time-Series Data	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS	Regulatory networks play a central role in cellular behavior and decision making. Learning these regulatory networks is a major task in biology, and devising computational methods and mathematical models for this task is a major endeavor in bioinformatics. Boolean networks have been used extensively for modeling regulatory networks. In this model, the state of each gene can be either 'on' or 'off' and that next-state of a gene is updated, synchronously or asynchronously, according to a Boolean rule that is applied to the current-state of the entire system. Inferring a Boolean network from a set of experimental data entails two main steps: first, the experimental time-series data are discretized into Boolean trajectories, and then, a Boolean network is learned from these Boolean trajectories. In this paper, we consider three methods for data discretization, including a new one we propose, and three methods for learning Boolean networks, and study the performance of all possible nine combinations on four regulatory systems of varying dynamics complexities. We find that employing the right combination of methods for data discretization and network learning results in Boolean networks that capture the dynamics well and provide predictive power. Our findings are in contrast to a recent survey that placed Boolean networks on the low end of the "faithfulness to biological reality'' and "ability to model dynamics'' spectra. Further, contrary to the common argument in favor of Boolean networks, we find that a relatively large number of time points in the time-series data is required to learn good Boolean networks for certain data sets. Last but not least, while methods have been proposed for inferring Boolean networks, as discussed above, missing still are publicly available implementations thereof. Here, we make our implementation of the methods available publicly in open source at http://bioinfo.cs.rice.edu/.	[Berestovsky, Natalie; Nakhleh, Luay] Rice Univ, Dept Comp Sci, Houston, TX 77251 USA	Rice University	Nakhleh, L (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77251 USA.	nakhleh@rice.edu			Gulf Coast Center for Computational Cancer Research; John and Ann Doerr Fund for Computational Biomedicine; Alfred P. Sloan Research Fellowship	Gulf Coast Center for Computational Cancer Research; John and Ann Doerr Fund for Computational Biomedicine; Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation)	This work was supported by a Seed Grant from the Gulf Coast Center for Computational Cancer Research, funded by John and Ann Doerr Fund for Computational Biomedicine and and an Alfred P. Sloan Research Fellowship to L.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, BOOLEAN NETWORK SIMU, V3; Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50; Bartlett MS., 1953, J ROYAL STAT SOC SER, V2, P44, DOI [10.2307/2985327, DOI 10.2307/2985327]; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Erkkild T, 2007, IEEE INT WORKSH GEN, P1; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hopfensitz M, 2012, IEEE ACM T COMPUT BI, V9, P487, DOI 10.1109/TCBB.2011.62; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klipp Edda, 2009, SYSTEMS BIOL TXB; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Li C, 2010, BMC SYSTEMS BIOL, V4; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liang JH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-113; Liang S, 1998, Pac Symp Biocomput, P18; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308	26	38	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66031	10.1371/journal.pone.0066031	http://dx.doi.org/10.1371/journal.pone.0066031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805196	Green Published, gold			2022-12-27	WOS:000320846500024
J	Chu, HL; Tang, YP; Dong, Q				Chu, Heling; Tang, Yuping; Dong, Qiang			Protection of Vascular Endothelial Growth Factor to Brain Edema Following Intracerebral Hemorrhage and Its Involved Mechanisms: Effect of Aquaporin-4	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; BARRIER PERMEABILITY; VEGF; ANGIOGENESIS; RAT; ASTROCYTES; EXPRESSION; INJURY; CELLS; NEURONS	Vascular endothelial growth factor (VEGF) has protective effects on many neurological diseases. However, whether VEGF acts on brain edema following intracerebral hemorrhage (ICH) is largely unknown. Our previous study has shown aquaporin-4 (AQP4) plays an important role in brain edema elimination following ICH. Meanwhile, there is close relationship between VEGF and AQP4. In this study, we aimed to test effects of VEGF on brain edema following ICH and examine whether they were AQP4 dependent. Recombinant human VEGF165 (rhVEGF165) was injected intracerebroventricularly 1 d after ICH induced by microinjecting autologous whole blood into striatum. We detected perihemotomal AQP4 protein expression, then examined the effects of rhVEGF165 on perihemotomal brain edema at 1 d, 3 d, and 7 d after injection in wild type (AQP4(+/+)) and AQP4 knock-out (AQP4(-/-)) mice. Furthermore, we assessed the possible signal transduction pathways activated by VEGF to regulate AQP4 expression via astrocyte cultures. We found perihemotomal AQP4 protein expression was highly increased by rhVEGF165. RhVEGF165 alleviated perihemotomal brain edema in AQP4(+/+) mice at each time point, but had no effect on AQP4(-/-) mice. Perihemotomal EB extravasation was increased by rhVEGF165 in AQP4(-/-) mice, but not AQP4(+/+) mice. RhVEGF165 reduced neurological deficits and increased Nissl's staining cells surrounding hemotoma in both types of mice and these effects were related to AQP4. RhVEGF165 up-regulated phospharylation of C-Jun amino-terminal kinase (p-JNK) and extracellular signal-regulated kinase (p-ERK) and AQP4 protein in cultured astrocytes. The latter was inhibited by JNK and ERK inhibitors. In conclusion, VEGF reduces neurological deficits, brain edema, and neuronal death surrounding hemotoma but has no influence on BBB permeability. These effects are closely related to AQP4 up-regulation, possibly through activating JNK and ERK pathways. The current study may present new insights to treatment of brain edema following ICH.	[Chu, Heling; Tang, Yuping] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Dong, Qiang] Fudan Univ, State Key Lab Med Neurobiol, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Dong, Q (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	qiang_dong163@163.com	Chu, Heling/AAG-8255-2019	Chu, Heling/0000-0001-8418-5775				Abumiya T, 2005, BRAIN RES, V1049, P95, DOI 10.1016/j.brainres.2005.05.011; AGRAWAL HC, 1968, J NEUROCHEM, V15, P917, DOI 10.1111/j.1471-4159.1968.tb11633.x; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Belayev L, 2003, STROKE, V34, P2221, DOI 10.1161/01.STR.0000088061.06656.1E; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Dobrogowska DH, 1998, J NEUROCYTOL, V27, P163, DOI 10.1023/A:1006907608230; Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278; Feng YZ, 2010, BRAIN RES, V1325, P1, DOI 10.1016/j.brainres.2010.02.029; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Habas A, 2006, J NEUROCHEM, V96, P335, DOI 10.1111/j.1471-4159.2005.03543.x; Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kawasaki T, 2007, GLIA, V55, P1325, DOI 10.1002/glia.20541; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Lee HT, 2010, J NEUROCHEM, V113, P79, DOI 10.1111/j.1471-4159.2010.06584.x; Lee Hyoshin, 2007, Plant Biology (Rockville), V2007, P156; Li Z, 2006, NEUROSCI LETT, V403, P294, DOI 10.1016/j.neulet.2006.05.004; Loreto C, 2010, CURR NEUROPHARMACOL, V8, P105, DOI 10.2174/157015910791233196; Miki Y, 2007, NEUROSURGERY, V61, P586, DOI 10.1227/01.NEU.0000290907.30814.42; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nakagawa T, 2010, J PHARMACOL SCI, V114, P347, DOI 10.1254/jphs.10R04CP; Nico B, 2001, J CELL SCI, V114, P1297; PETTERSSON CAV, 1990, ACTA NEUROPATHOL, V81, P148, DOI 10.1007/BF00334503; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Rao KVR, 2010, GLIA, V58, P1490, DOI 10.1002/glia.21023; Rite I, 2008, NEUROCHEM INT, V52, P897, DOI 10.1016/j.neuint.2007.10.004; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Sanchez A, 2010, NEUROPEPTIDES, V44, P323, DOI 10.1016/j.npep.2010.04.002; Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x; Sobrino T, 2009, J CEREBR BLOOD F MET, V29, P1968, DOI 10.1038/jcbfm.2009.182; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sutherland BA, 2009, NEUROSCI RES, V65, P326, DOI 10.1016/j.neures.2009.08.007; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Tang YP, 2010, EXP NEUROL, V223, P485, DOI 10.1016/j.expneurol.2010.01.015; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang P, 2011, GENET MOL RES, V10, P2165, DOI 10.4238/vol10-3gmr1212; Wang YF, 2011, BRAIN RES, V1370, P220, DOI 10.1016/j.brainres.2010.11.016; Wang YM, 2006, BRAIN RES, V1115, P186, DOI 10.1016/j.brainres.2006.07.060; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yang CS, 2008, J CELL BIOCHEM, V183, P213; Yang JP, 2010, J INVEST SURG, V23, P149, DOI 10.3109/08941930903469482; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zeng XN, 2007, MOL CELL NEUROSCI, V34, P34, DOI 10.1016/j.mcn.2006.09.008; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhou JP, 2008, NEUROREPORT, V19, P1, DOI 10.1097/WNR.0b013e3282f2b4eb	53	38	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66051	10.1371/journal.pone.0066051	http://dx.doi.org/10.1371/journal.pone.0066051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805198	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500026
J	Miyake, K; Yang, C; Minakuchi, Y; Ohori, K; Soutome, M; Hirasawa, T; Kazuki, Y; Adachi, N; Suzuki, S; Itoh, M; Goto, Y; Andoh, T; Kurosawa, H; Oshimura, M; Sasaki, M; Toyoda, A; Kubota, T				Miyake, Kunio; Yang, Chunshu; Minakuchi, Yohei; Ohori, Kenta; Soutome, Masaki; Hirasawa, Takae; Kazuki, Yasuhiro; Adachi, Noboru; Suzuki, Seiko; Itoh, Masayuki; Goto, Yu-ichi; Andoh, Tomoko; Kurosawa, Hiroshi; Oshimura, Mitsuo; Sasaki, Masayuki; Toyoda, Atsushi; Kubota, Takeo			Comparison of Genomic and Epigenomic Expression in Monozygotic Twins Discordant for Rett Syndrome	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; NOVO MECP2 MUTATIONS; CREATINE-KINASE-BB; DNA METHYLATION; DE-NOVO; PARENTAL ORIGIN; BRAIN; GENE; PAIR; PHENOTYPE	Monozygotic (identical) twins have been widely used in genetic studies to determine the relative contributions of heredity and the environment in human diseases. Discordance in disease manifestation between affected monozygotic twins has been attributed to either environmental factors or different patterns of X chromosome inactivation (XCI). However, recent studies have identified genetic and epigenetic differences between monozygotic twins, thereby challenging the accepted experimental model for distinguishing the effects of nature and nurture. Here, we report the genomic and epigenomic sequences in skin fibroblasts of a discordant monozygotic twin pair with Rett syndrome, an X-linked neurodevelopmental disorder characterized by autistic features, epileptic seizures, gait ataxia and stereotypical hand movements. The twins shared the same de novo mutation in exon 4 of the MECP2 gene (G269AfsX288), which was paternal in origin and occurred during spermatogenesis. The XCI patterns in the twins did not differ in lymphocytes, skin fibroblasts, and hair cells (which originate from ectoderm as does neuronal tissue). No reproducible differences were detected between the twins in single nucleotide polymorphisms (SNPs), insertion-deletion polymorphisms (indels), or copy number variations. Differences in DNA methylation between the twins were detected in fibroblasts in the upstream regions of genes involved in brain function and skeletal tissues such as Mohawk Homeobox (MKX), Brain-type Creatine Kinase (CKB), and FYN Tyrosine Kinase Protooncogene (FYN). The level of methylation in these upstream regions was inversely correlated with the level of gene expression. Thus, differences in DNA methylation patterns likely underlie the discordance in Rett phenotypes between the twins.	[Miyake, Kunio; Yang, Chunshu; Ohori, Kenta; Soutome, Masaki; Hirasawa, Takae; Kubota, Takeo] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Fac Med, Dept Epigenet Med, Chuo, Japan; [Minakuchi, Yohei; Toyoda, Atsushi] Natl Inst Genet, Ctr Informat Biol, Comparat Genom Lab, Mishima, Shizuoka 411, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Adachi, Noboru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Chuo, Japan; [Suzuki, Seiko; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp Mental Nervous & Muscular Disorders, Dept Child Neurol, Tokyo, Japan; [Itoh, Masayuki; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan; [Andoh, Tomoko; Kurosawa, Hiroshi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biotechnol, Fac Life & Environm Sci, Kofu, Yamanashi, Japan	University of Yamanashi; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tottori University; University of Yamanashi; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; University of Yamanashi	Kubota, T (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Fac Med, Dept Epigenet Med, Chuo, Japan.	takeot@yamanashi.ac.jp			Ministry of Education, Culture Sports, Science and Technology, Japan; Kawano foundation for medical research, Japan; Grants-in-Aid for Scientific Research [25670473] Funding Source: KAKEN	Ministry of Education, Culture Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kawano foundation for medical research, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research (K.M. and T.K.), the Grant-in-Aid for Exploratory Research (A.T. and T.K.), and the Grant-in-Aid for Scientific Research on Innovative Areas "Genome Science'' (A.T. and T.K.) from the Ministry of Education, Culture Sports, Science and Technology, Japan, and the Grant from the Kawano foundation for medical research, Japan (T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Auranen M, 2001, NEUROLOGY, V56, P611, DOI 10.1212/WNL.56.5.611; Azofeifa J, 1996, HUM GENET, V97, P330, DOI 10.1007/s004390050044; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Bell JT, 2012, INT J EPIDEMIOL, V41, P140, DOI 10.1093/ije/dyr179; Bienvenu T, 2006, PEDIATR NEUROL, V34, P372, DOI 10.1016/j.pediatrneurol.2005.10.013; Breckpot J, 2011, MOL SYNDROMOL, V2, P81, DOI 10.1159/000335284; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; BRUCK I, 1991, AM J MED GENET, V39, P415, DOI 10.1002/ajmg.1320390411; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Burbaeva GS, 2003, WORLD J BIOL PSYCHIA, V4, P177, DOI 10.1080/15622970310029916; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Coolen MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025590; Ehli EA, 2012, EUR J HUM GENET, V20, P1037, DOI 10.1038/ejhg.2012.49; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Furukawa H, 2012, HUM IMMUNOL     1128, DOI [10.1016/j.humimm.2012.11.007, DOI 10.1016/J.HUMIMM.2012.11.007.]; Girard M, 2001, EUR J HUM GENET, V9, P231, DOI 10.1038/sj.ejhg.5200618; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; Goebel-Goody SM, 2012, PHARMACOL REV, V64, P65, DOI 10.1124/pr.110.003053; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Ishii T, 2001, BRAIN DEV-JPN, V23, pS161, DOI 10.1016/S0387-7604(01)00344-8; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Kerr AM, 2001, BRAIN DEV-JPN, V23, P208, DOI 10.1016/S0387-7604(01)00193-0; Knudsen GPS, 2006, EUR J HUM GENET, V14, P1189, DOI 10.1038/sj.ejhg.5201682; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Kubota T, 1996, AM J MED GENET, V66, P77, DOI 10.1002/(SICI)1096-8628(19961202)66:1<77::AID-AJMG18>3.0.CO;2-N; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Kugoh H, 1999, DNA Res, V6, P165, DOI 10.1093/dnares/6.3.165; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Laborie LB, 2010, EUR J PEDIATR, V169, P207, DOI 10.1007/s00431-009-1008-y; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YS, 2011, AGING-US, V3, P657, DOI 10.18632/aging.100338; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Loke YJ, 2012, TWIN RES HUM GENET, V22, P1; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mittal K, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-113; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Niederhoffer KY, 2012, AM J MED GENET A, V158A, P1662, DOI 10.1002/ajmg.a.35377; Ogawa A, 1997, BRAIN DEV-JPN, V19, P568, DOI 10.1016/S0387-7604(97)00084-3; Ollikainen M, 2011, EPIGENOMICS-UK, V3, P295, DOI [10.2217/EPI.11.18, 10.2217/epi.11.18]; Ono S, 2010, TWIN RES HUM GENET, V13, P455, DOI 10.1375/twin.13.5.455; PARTINGTON MW, 1988, AM J MED GENET, V29, P633, DOI 10.1002/ajmg.1320290322; Sakai J, 2006, RES PRACT FORENS MED, V49, P213; Sakazume S, 2012, HUM GENET, V131, P121, DOI 10.1007/s00439-011-1051-4; Sasaki H, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-24; Shumay E, 2012, EPIGENETICS-US, V7, P1151, DOI 10.4161/epi.21976; Sugawara H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.26; TARIVERDIAN G, 1987, HUM GENET, V75, P88; Tierling S, 2011, CLIN GENET, V79, P546, DOI 10.1111/j.1399-0004.2010.01482.x; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; Trepanier CH, 2012, FEBS J, V279, P12, DOI 10.1111/j.1742-4658.2011.08391.x; Veenma D, 2012, EUR J HUM GENET, V20, P298, DOI 10.1038/ejhg.2011.194; Yu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047081; Zhu XW, 2010, J CHILD NEUROL, V25, P842, DOI 10.1177/0883073809350722; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701	62	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66729	10.1371/journal.pone.0066729	http://dx.doi.org/10.1371/journal.pone.0066729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805272	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500100
J	Bottermann, K; Reinartz, M; Barsoum, M; Kotter, S; Godecke, A				Bottermann, Katharina; Reinartz, Michael; Barsoum, Marian; Koetter, Sebastian; Goedecke, Axel			Systematic Analysis Reveals Elongation Factor 2 and alpha-Enolase as Novel Interaction Partners of AKT2	PLOS ONE			English	Article							PROTEIN-KINASE-B; GLUCOSE-HOMEOSTASIS; MASS-SPECTROMETRY; CELL-CULTURE; CANCER-CELLS; AMINO-ACIDS; PHOSPHORYLATION; INSULIN; COMPLEXES; MICE	AKT2 is one of the three isoforms of the protein kinase AKT being involved in the modulation of cellular metabolism. Since protein-protein interactions are one possibility to convey specificity in signal transduction, we performed AKT2-protein interaction analysis to elucidate their relevance for AKT2-dependent cellular functions. We identified heat shock protein 90 kDa (HSP90), Cdc37, heat shock protein 70 kDa (HSP70), 78 kDa glucose regulated protein (GRP78), tubulin, GAPDH, alpha-enolase and elongation factor 2 (EF2) as AKT2-interacting proteins by a combination of tandem affinity purification and mass spectrometry in HEK293T cells. Quantitative MS-analysis using stable isotope labeling by amino acids in cell culture (SILAC) revealed that only HSP90 and Cdc37 interact stably with AKT2, whereas the other proteins interact with low affinity with AKT2. The interactions of AKT2 with a-enolase and EF2 were further analyzed in order to uncover the functional relevance of these newly discovered binding partners. Despite the interaction of AKT2 and alpha-enolase, which was additionally validated by proximity ligation assay (PLA), no significant impact of AKT on alpha-enolase activity was detected in activity measurements. AKT stimulation via insulin and/or inhibition with the ATP-competitive inhibitor CCT128930 did not alter enzymatic activity of alpha-enolase. Interestingly, the direct interaction of AKT2 and EF2 was found to be dynamically regulated in embryonic rat cardiomyocytes. Treatment with the PI3-kinase inhibitor LY294002 before stimulation with several hormones stabilized the complex, whereas stimulation alone led to complex dissociation which was analyzed in situ with PLA. Taken together, these findings point to new aspects of AKT2-mediated signal transduction in protein synthesis and glucose metabolism.	[Bottermann, Katharina; Reinartz, Michael; Barsoum, Marian; Koetter, Sebastian; Goedecke, Axel] Univ Dusseldorf, Dept Cardiovasc Physiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Godecke, A (corresponding author), Univ Dusseldorf, Dept Cardiovasc Physiol, D-40225 Dusseldorf, Germany.	axel.goedecke@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft (DFG) [SFB612, TPA5, GRK1089]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG) SFB612, TPA5 to AG. KB and MB were supported by stipends for medical doctoral students and PhD students via the DFG funded GRK1089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Baba T, 2010, FEBS LETT, V584, P2796, DOI 10.1016/j.febslet.2010.05.015; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Drummond A., 2011, GENEIOUS V5 5; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Everett AD, 2001, AM J PHYSIOL-HEART C, V281, pH161, DOI 10.1152/ajpheart.2001.281.1.H161; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horman S, 2003, J BIOL CHEM, V278, P41970, DOI 10.1074/jbc.M302403200; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Li YF, 2011, BIOTECHNOL LETT, V33, P1487, DOI 10.1007/s10529-011-0592-x; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oeljeklaus S, 2012, J PROTEOME RES, V11, P2567, DOI 10.1021/pr3000333; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pfaffenbach KT, 2012, J CELL PHYSIOL, V227, P3803, DOI 10.1002/jcp.24090; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tuana BS, 2004, J BIOL; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weser S, 2006, J BIOCHEM BIOPH METH, V68, P189, DOI 10.1016/j.jbbm.2006.06.002; Yamagishi N, 2012, BIOCHEM BIOPH RES CO, V417, P364, DOI 10.1016/j.bbrc.2011.11.118; Yap TA, 2011, MOL CANCER THER, V10, P360, DOI 10.1158/1535-7163.MCT-10-0760; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	58	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66045	10.1371/journal.pone.0066045	http://dx.doi.org/10.1371/journal.pone.0066045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823123	Green Published, gold			2022-12-27	WOS:000320576400049
J	Chang, SH; Pollack, LM; Colditz, GA				Chang, Su-Hsin; Pollack, Lisa M.; Colditz, Graham A.			Life Years Lost Associated with Obesity-Related Diseases for US Non-Smoking Adults	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST-HIP RATIO; PROSPECTIVE COHORT; MORTALITY; OVERWEIGHT; WEIGHT; UNDERWEIGHT; HETEROGENEITY; CONSEQUENCES; EXPECTANCY	The objectives of this paper are to predict life years lost associated with obesity-related diseases (ORDs) for U.S. non-smoking adults, and to examine the relationship between those ORDs and mortality. Data from the National Health Interview Survey, 1997-2000, were used. We employed mixed proportional hazard models to estimate the association between those ORDs and mortality and used simulations to project life years lost associated with the ORDs. We found that obesity-attributable comorbidities are associated with large decreases in life years and increases in mortality rates. The life years lost associated with ORDs is more marked for younger adults than older adults, for blacks than whites, for males than females, and for the more obese than the less obese. Using U. S. non-smoking adults aged 40 to 49 years as an example to illustrate percentage of the life years lost associated with ORDs, we found that the mean life years lost associated with ORDs for U. S. non-smoking black males aged 40 to 49 years with a body mass index above 40 kg/m(2) was 5.43 years, which translates to a 7.5% reduction in total life years. White males of the same age range and same degree of obesity lost 5.23 life years on average - a 6.8% reduction in total life years, followed by black females (5.04 years, a 6.5% reduction in life years), and white females (4.7 years, a 5.8% reduction in life years). Overall, ORDs increased chances of dying and lessened life years by 0.2 to 11.7 years depending on gender, race, BMI classification, and age.	[Chang, Su-Hsin; Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA; [Pollack, Lisa M.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Chang, SH (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA.	changsh@wudosis.wustl.edu	Chang, Su-Hsin/Q-8556-2019; Colditz, Graham/A-3963-2009	Chang, Su-Hsin/0000-0001-5872-9556; Colditz, Graham/0000-0002-7307-0291	Foundation for Barnes-Jewish Hospital; American Cancer Society Clinical Research Professorship;  [U54 CA 155496]; NATIONAL CANCER INSTITUTE [U54CA155496, KM1CA156708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER	Foundation for Barnes-Jewish Hospital; American Cancer Society Clinical Research Professorship(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding from the Foundation for Barnes-Jewish Hospital and U54 CA 155496 supported this research. G. Colditz is supported by an American Cancer Society Clinical Research Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbring JH, 2007, BIOMETRIKA, V94, P87, DOI 10.1093/biomet/asm013; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Anderson R N, 1999, Natl Vital Stat Rep, V47, P1; Anderson RH, 2001, CARDIOL YOUNG, V11, P1, DOI 10.1017/S1047951100012348; [Anonymous], 2000, Vital Health Stat 2, P1; Arias E, 2002, NATL VITAL STAT REP, V51, P1; Arias Elizabeth, 2008, Natl Vital Stat Rep, V57, P1; Baio G., 2011, STAT METHODS MED RES, DOI 0962280211419832; Beasley JW, 2003, JAMA-J AM MED ASSOC, V289, P1777, DOI 10.1001/jama.289.14.1777-a; Beason T, 2012, ENERG BALANCE CANCER, V5, P71, DOI 10.1007/978-1-4614-2403-1_4; BOTMAN SL, 1995, STAT MED, V14, P669, DOI 10.1002/sim.4780140523; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cai LM, 2010, MED CARE, V48, P510, DOI 10.1097/MLR.0b013e3181dbdb20; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cawley J., 2011, J HLTH EC; Centers for Disease Control and Prevention, 2010, NAT HLTH INT SUR NHI; Centers for Disease Control and Prevention National Health Interview Survey, NAT HLTH INT SURV PR; Chang SH, 2011, MATURITAS, V69, P230, DOI 10.1016/j.maturitas.2011.04.007; COX DR, 1972, J R STAT SOC B, V34, P187; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Durazo-Arvizu R, 1997, J AM STAT ASSOC, V92, P1312, DOI 10.2307/2965401; Dvorak RV, 1999, DIABETES, V48, P2210, DOI 10.2337/diabetes.48.11.2210; Efron B, 1993, INTRO BOOTSTRAP, pxvi; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Finkelstein EA, 2010, OBESITY, V18, P333, DOI 10.1038/oby.2009.253; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; HECKMAN JJ, 1984, J ECONOMETRICS, V24, P63, DOI 10.1016/0304-4076(84)90075-7; Hens N, 2006, STAT MED, V25, P2502, DOI 10.1002/sim.2559; Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Lancaster T, 1997, ECONOMETRIC ANAL TRA, VXII; Leyland AH, 2010, INT J OBES LOND; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Padwal R, 2011, APPL PHYSL NUTR META; Paolini JBM, 2010, CRIT CARE MED, V38, P1308, DOI 10.1097/CCM.0b013e3181d8cd8b; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Price GM, 2006, AM J CLIN NUTR, V84, P449; Rao J. N. K., 1992, SURV METHODOL, V18, P209; RAO JNK, 1988, J AM STAT ASSOC, V83, P231, DOI 10.2307/2288945; Roberts M, 2012, VALUE HEALTH, V15, P804, DOI 10.1016/j.jval.2012.06.016; Rosner F, 2010, ISR MED ASSOC J, V12, P47; Sakata S, 2002, QUASIMAXIMUM LIKELIH; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Stevens J, 1999, AM J EPIDEMIOL, V150, P399, DOI 10.1093/oxfordjournals.aje.a010019; Strickler HD, 2005, JAMA-J AM MED ASSOC, V294, P551, DOI 10.1001/jama.294.5.551-b; Van den Berg G. J., 2001, HDB ECONOMETRICS, V5, P3381, DOI DOI 10.1016/S1573-4412(01)05008-5; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787	61	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66550	10.1371/journal.pone.0066550	http://dx.doi.org/10.1371/journal.pone.0066550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823705	Green Published, gold			2022-12-27	WOS:000320576400126
J	Sahu, U; Sidhar, H; Ghate, PS; Advirao, GM; Raghavan, SC; Giri, RK				Sahu, Upasana; Sidhar, Himakshi; Ghate, Pankaj S.; Advirao, Gopal M.; Raghavan, Sathees C.; Giri, Ranjit K.			A Novel Anticancer Agent, 8-Methoxypyrimido[4 ',5 ': 4,5]thieno(2,3-b) Quinoline-4(3H)-One Induces Neuro 2a Neuroblastoma Cell Death through p53-Dependent, Caspase-Dependent and Independent Apoptotic Pathways	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; DNA-DAMAGE; CANCER-CELLS; IONIZING-RADIATION; SIGNALING PATHWAYS; DRUG ELLIPTICINE; THP-1 MONOCYTES; STRAND BREAKS; CYTOCHROME-C; CYCLE ARREST	Neuroblastoma is the most common cancer in infants and fourth most common cancer in children. Despite recent advances in cancer treatments, the prognosis of stage-IV neuroblastoma patients continues to be dismal which warrant new pharmacotherapy. A novel tetracyclic condensed quinoline compound, 8-methoxypyrimido [4 ',5 ': 4,5] thieno(2,3-b) quinoline-4(3H)-one (MPTQ) is a structural analogue of an anticancer drug ellipticine and has been reported to posses anticancer property. Study on MPTQ on neuroblastoma cells is very limited and mechanisms related to its cytotoxicity on neuroblastoma cells are completely unknown. Here, we evaluated the anticancer property of MPTQ on mouse neuro 2a and human SH-SY5Y neuroblastoma cells and investigated the mechanisms underlying MPTQ-mediated neuro 2a cell death. MPTQ-mediated neuro 2a and SH-SY5Y cell deaths were found to be dose and time dependent. Moreover, MPTQ induced cell death reached approximately 99.8% and 90% in neuro 2a and SH-SY5Y cells respectively. Nuclear oligonucleosomal DNA fragmentation and Terminal dUTP Nick End Labelling assays indicated MPTQ-mediated neuro 2a cell death involved apoptosis. MPTQ-mediated apoptosis is associated with increased phosphorylation of p53 at Ser15 and Ser20 which correlates with the hyperphosphorylation of Ataxia-Telangiectasia mutated protein (ATM). Immunocytochemical analysis demonstrated the increased level of Bax protein in MPTQ treated neuro 2a cells. MPTQ-mediated apoptosis is also associated with increased activation of caspase-9, -3 and -7 but not caspase-2 and -8. Furthermore, increased level of caspase-3 and cleaved Poly ( ADP Ribose) polymerase were observed in the nucleus of MPTQ treated neuro 2a cells, suggesting the involvement of caspase-dependent intrinsic but not extrinsic apoptotic pathway. Increased nuclear translocation of apoptosis inducing factor suggests additional involvement of caspase-independent apoptosis pathway in MPTQ treated neuro 2a cells. Collectively, MPTQ-induced neuro 2a cell death is mediated by ATM and p53 activation, and Bax-mediated activation of caspase-dependent and caspase-independent mitochondrial apoptosis pathways.	[Sahu, Upasana; Sidhar, Himakshi; Ghate, Pankaj S.; Giri, Ranjit K.] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India; [Advirao, Gopal M.] Kuvempu Univ, Dept Biochem, Davanagere, Karnataka, India; [Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Kuvempu University; Indian Institute of Science (IISC) - Bangalore	Giri, RK (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India.	ranjit@nbrc.ac.in	Advirao, Gopal M/ABD-1766-2020	Sahu, Upasana/0000-0003-2473-9312	National Brain Research Centre, Manesar, Haryana, India [BT/PR10721/Med/30/105/2008, 102/IFD/SAN/758/2007-08]; Department of Biotechnology, New Delhi, India; UGC; CSIR Fellowship, New Delhi, India	National Brain Research Centre, Manesar, Haryana, India; Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); UGC(University Grants Commission, India); CSIR Fellowship, New Delhi, India	This study was supported by core funding of National Brain Research Centre, Manesar, Haryana, India and partly by grants (No. BT/PR10721/Med/30/105/2008 and 102/IFD/SAN/758/2007-08) from Department of Biotechnology, New Delhi, India to RKG. HS and PSG are supported by UGC and CSIR Fellowship, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; AUCLAIR C, 1987, ARCH BIOCHEM BIOPHYS, V259, P1, DOI 10.1016/0003-9861(87)90463-2; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bansal D, 2008, INDIAN PEDIATR, V45, P135; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brossard J, 1996, BRIT MED BULL, V52, P787; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Chong MJ, 2000, P NATL ACAD SCI USA, V97, P889, DOI 10.1073/pnas.97.2.889; Chu CM, 2011, BRIT J RADIOL, V84, P81, DOI 10.1259/bjr/31861984; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; David R, 1989, Radiographics, V9, P859; Didenko VV, 2003, AM J PATHOL, V162, P1571, DOI 10.1016/S0002-9440(10)64291-5; Dong Z, 1997, AM J PATHOL, V151, P1205; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P14998, DOI 10.1074/jbc.270.25.14998; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Giri RK, 2006, P NATL ACAD SCI USA, V103, P3875, DOI 10.1073/pnas.0510902103; Giri RK, 2004, J NEUROCHEM, V91, P1199, DOI 10.1111/j.1471-4159.2004.02800.x; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; GOODWIN S, 1959, J AM CHEM SOC, V81, P1903, DOI 10.1021/ja01517a031; Gopal M, 2004, INDIAN J MED RES, V119, P198; Gopal M, 2002, P INDIAN AS-CHEM SCI, V114, P687; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jana NR, 2004, J BIOL CHEM, V279, P11680, DOI 10.1074/jbc.M310369200; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kuo PL, 2005, ANTI-CANCER DRUG, V16, P789, DOI 10.1097/01.cad.0000171768.36317.93; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Maity R, 2010, J CELL BIOCHEM, V109, P933, DOI 10.1002/jcb.22469; Malik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018116; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Nichols NM, 2008, CURR PROTOC MOL BIOL, V84; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Poljakova J, 2009, BIOCHEM PHARMACOL, V77, P1466, DOI 10.1016/j.bcp.2009.01.021; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Prochazka P, 2012, CANCER SCI, V103, P334, DOI 10.1111/j.1349-7006.2011.02137.x; RAJ TT, 1988, J CHEM RES, V50, P537; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schor NF, 2009, PHARMACOL THERAPEUT, V122, P44, DOI 10.1016/j.pharmthera.2009.01.001; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P873, DOI 10.1007/s10637-010-9436-0; Sharma S, 2013, MOL CARCINOGEN, V52, P413, DOI 10.1002/mc.21867; SHAW PJ, 1992, MED PEDIATR ONCOL, V20, P149, DOI 10.1002/mpo.2950200211; Shiloh Y, 2003, CELL CYCLE, V2, P116, DOI 10.4161/cc.2.2.342; Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004; Sottile F, 2012, ONCOTARGET, V3, P535; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; Stiborova M, 2012, BIOMED PAP, V156, P115, DOI 10.5507/bp.2012.043; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thornborrow EC, 2002, ONCOGENE, V21, P990, DOI 10.1038/sj.onc.1205069; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wu Y, 2012, INT J NANOMED, V7, P3221, DOI 10.2147/IJN.S31858; WYLLIE AH, 1993, BRIT J CANCER, V67, P205, DOI 10.1038/bjc.1993.40; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zhang JH, 2002, TRENDS CELL BIOL, V12, P84, DOI 10.1016/S0962-8924(01)02206-1; Zhivotovsky B, 1999, CELL DEATH DIFFER, V6, P644, DOI 10.1038/sj.cdd.4400536; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	82	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66430	10.1371/journal.pone.0066430	http://dx.doi.org/10.1371/journal.pone.0066430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824039	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000320576400109
J	Zheng, Y; Xu, ZY; Zhu, QY; Liu, JF; Qian, J; You, HZ; Gu, Y; Hao, CM; Jiao, Z; Ding, F				Zheng, Yin; Xu, Zhongye; Zhu, Qiuyu; Liu, Junfeng; Qian, Jing; You, Huaizhou; Gu, Yong; Hao, Chuanming; Jiao, Zheng; Ding, Feng			Citrate Pharmacokinetics in Critically IllPatients with Acute Kidney Injury	PLOS ONE			English	Article							CONTINUOUS RENAL REPLACEMENT; CONTINUOUS VENOVENOUS HEMODIAFILTRATION; SYSTEMIC HEPARIN ANTICOAGULATION; REGIONAL CITRATE; HEMODIALYSIS; THERAPY; BLOOD; METABOLISM	Introduction: Regional citrate anticoagulation (RCA) is gaining popularity in continous renal replacement therapy (CRRT) for critically ill patients. The risk of citrate toxicity is a primary concern during the prolonged process. The aim of this study was to assess the pharmacokinetics of citrate in critically ill patients with AKI, and used the kinetic parameters to predict the risk of citrate accumulation in this population group undergoing continuous veno-venous hemofiltration (CVVH) with RCA. Methods: Critically ill patients with AKI (n = 12) and healthy volunteers (n = 12) were investigated during infusing comparative dosage of citrate. Serial blood samples were taken before, during 120 min and up to 120 min after infusion. Citrate pharmacokinetics were calculated and compared between groups. Then the estimated kinetic parameters were applied to the citrate kinetic equation for validation in other ten patients' CVVH sessions with citrate anticoagulation. Results: Total body clearance of citrate was similar in critically ill patients with AKI and healthy volunteers (648.04 +/- 347.00 L/min versus 686.64 +/- 353.60 L/min; P = 0.624). Basal and peak citrate concentrations were similar in both groups (p = 0.423 and 0.247, respectively). The predicted citrate curve showed excellent fit to the measurements. Conclusions: Citrate clearance is not impaired in critically ill patients with AKI in the absence of severe liver dysfunction. Citrate pharmacokinetic data can provide a basis for the clinical use of predicting the risk of citrate accumulation.	[Zheng, Yin; Xu, Zhongye; Zhu, Qiuyu; Liu, Junfeng; Qian, Jing; You, Huaizhou; Gu, Yong; Hao, Chuanming; Ding, Feng] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai 200433, Peoples R China; [Jiao, Zheng] Fudan Univ, Clin Pharm Lab, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Jiao, Z (corresponding author), Fudan Univ, Clin Pharm Lab, Huashan Hosp, Shanghai 200433, Peoples R China.	zjiao@fudan.edu.cn; dingfeng@fudan.edu.cn	Jiao, Zheng/H-7596-2014	Jiao, Zheng/0000-0001-7999-7162	National Natural Science Foundation of China [81270850, 81070609]; Science and Technology Commission of Shanghai Municipality [09411961500, 11441901401]; Board of Health of Shanghai Municipality [20124Y126]; Scientific Research foundation of Huashan Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Board of Health of Shanghai Municipality; Scientific Research foundation of Huashan Hospital	This study was supported, in part, by grants from the National Natural Science Foundation of China (No: 81270850, 81070609), the Science and Technology Commission of Shanghai Municipality (No: 09411961500,11441901401) (to FD), the Board of Health of Shanghai Municipality (20124Y126) (to JL), and the Scientific Research foundation of Huashan Hospital (to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsner R, 1997, WIEN KLIN WOCHENSCHR, V109, P123; Bagshaw SM, 2005, J CRIT CARE, V20, P155, DOI 10.1016/j.jcrc.2005.01.001; Bauer E, 2005, AM J KIDNEY DIS, V46, P903, DOI 10.1053/j.ajkd.2005.07.041; Bohler J, 1999, KIDNEY INT, V56, pS24; Chow S. C., 2003, SAMPLE SIZE CALCULAT; Dhondt A, 2000, NEPHRON, V85, P334, DOI 10.1159/000045683; Durao MS, 2008, CRIT CARE MED, V36, P3024, DOI 10.1097/CCM.0b013e31818b9100; Hofbauer R, 1999, KIDNEY INT, V56, P1578, DOI 10.1046/j.1523-1755.1999.00671.x; Kozik-Jaromin J, 2009, NEPHROL DIAL TRANSPL, V24, P2244, DOI 10.1093/ndt/gfp017; Kramer L, 2003, CRIT CARE MED, V31, P2450, DOI 10.1097/01.CCM.0000084871.76568.E6; Kutsogiannis DJ, 2005, KIDNEY INT, V67, P2361, DOI 10.1111/j.1523-1755.2005.00342.x; Mariano F, 2011, NEPHROL DIAL TRANSPL, V26, P3882, DOI 10.1093/ndt/gfr106; Meier-Kriesche HU, 2001, CRIT CARE MED, V29, P748, DOI 10.1097/00003246-200104000-00010; Monchi M, 2004, INTENS CARE MED, V30, P260, DOI 10.1007/s00134-003-2047-x; Morgera S, 2009, CRIT CARE MED, V37, P2018, DOI 10.1097/CCM.0b013e3181a00a92; Oudemans-van Straaten HM, 2009, CRIT CARE MED, V37, P545, DOI 10.1097/CCM.0b013e3181953c5e; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WEXLER IB, 1949, J CLIN INVEST, V28, P474, DOI 10.1172/JCI102093; WHITFIELD LR, 1981, THROMB RES, V21, P681, DOI 10.1016/0049-3848(81)90270-X; Wu MY, 2012, AM J KIDNEY DIS, V59, P810, DOI 10.1053/j.ajkd.2011.11.030; Yee J, 2007, J AM SOC NEPHROL, V18, p455A	21	18	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65992	10.1371/journal.pone.0065992	http://dx.doi.org/10.1371/journal.pone.0065992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824037	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400044
J	Deng, Y; Coen, P; Sun, MZ; Shaevitz, JW				Deng, Yi; Coen, Philip; Sun, Mingzhai; Shaevitz, Joshua W.			Efficient Multiple Object Tracking Using Mutually Repulsive Active Membranes	PLOS ONE			English	Article							EXTRACTION	Studies of social and group behavior in interacting organisms require high-throughput analysis of the motion of a large number of individual subjects. Computer vision techniques offer solutions to specific tracking problems, and allow automated and efficient tracking with minimal human intervention. In this work, we adopt the open active contour model to track the trajectories of moving objects at high density. We add repulsive interactions between open contours to the original model, treat the trajectories as an extrusion in the temporal dimension, and show applications to two tracking problems. The walking behavior of Drosophila is studied at different population density and gender composition. We demonstrate that individual male flies have distinct walking signatures, and that the social interaction between flies in a mixed gender arena is gender specific. We also apply our model to studies of trajectories of gliding Myxococcus xanthus bacteria at high density. We examine the individual gliding behavioral statistics in terms of the gliding speed distribution. Using these two examples at very distinctive spatial scales, we illustrate the use of our algorithm on tracking both short rigid bodies (Drosophila) and long flexible objects (Myxococcus xanthus). Our repulsive active membrane model reaches error rates better than 5 x 10(-6) per fly per second for Drosophila tracking and comparable results for Myxococcus xanthus.	[Deng, Yi; Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Coen, Philip] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Sun, Mingzhai; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Shaevitz, JW (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	shaevitz@princeton.edu	Deng, Yi/F-9358-2015; Sun, Mingzhai/B-4945-2012	Deng, Yi/0000-0002-6822-6343; COEN, PHILIP/0000-0003-1495-1061	Pew Charitable Trusts and National Science Foundation [0844466]	Pew Charitable Trusts and National Science Foundation	This work was funded by a fellowship to JWS from the Pew Charitable Trusts and National Science Foundation award 0844466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Can A, 1999, IEEE Trans Inf Technol Biomed, V3, P125, DOI 10.1109/4233.767088; Chan YB, 2007, P NATL ACAD SCI USA, V104, P19577, DOI 10.1073/pnas.0709803104; Cormen Thomas H., 2009, INTRO ALGORITHMS; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Emre M, 2011, IEEE T IMAGE PROCESS, V20, P1023, DOI 10.1109/TIP.2010.2081680; Frye MA, 2004, CURR OPIN NEUROBIOL, V14, P729, DOI 10.1016/j.conb.2004.10.004; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; Iyengar A, 2012, J NEUROGENET; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kirbas C, 2004, ACM COMPUT SURV, V36, P81, DOI 10.1145/1031120.1031121; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; Li HS, 2010, LECT NOTES COMPUT SC, V6361, P86; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Tsai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034784; Vallotton P, 2009, 2009 24TH INTERNATIONAL CONFERENCE IMAGE AND VISION COMPUTING NEW ZEALAND (IVCNZ 2009), P221, DOI 10.1109/IVCNZ.2009.5378409; Vasilkoski Z, 2009, J NEUROSCI METH, V178, P197, DOI 10.1016/j.jneumeth.2008.11.008; Wang Y, 2011, NEUROINFORMATICS, V9, P193, DOI 10.1007/s12021-011-9110-5; Xie CY, 2011, P NATL ACAD SCI USA, V108, P5915, DOI 10.1073/pnas.1018383108; Xu T, 2011, I S BIOMED IMAGING, P1334, DOI 10.1109/ISBI.2011.5872647; Zhang Y, 2012, FEMS MICROBIOL REV, V36, P149, DOI 10.1111/j.1574-6976.2011.00307.x	28	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65769	10.1371/journal.pone.0065769	http://dx.doi.org/10.1371/journal.pone.0065769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799046	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300041
J	Ding, YH; Du, YG; Luo, SK; Li, YX; Li, TM; Yoshina, S; Wang, X; Klage, K; Mitani, S; Ye, KQ; Dong, MQ				Ding, Yue-He; Du, Yun-Guang; Luo, Shukun; Li, Yu-Xin; Li, Tie-Mei; Yoshina, Sawako; Wang, Xing; Klage, Karsten; Mitani, Shohei; Ye, Keqiong; Dong, Meng-Qiu			Characterization of PUD-1 and PUD-2, Two Proteins Up-Regulated in a Long-Lived daf-2 Mutant	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; C-ELEGANS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; GENES; LONGEVITY; EXPRESSION; RESISTANCE; MUTATIONS	C. elegans PUD-1 and PUD-2, two proteins up-regulated in daf-2(loss-of-function) (PUD), are homologous 17-kD proteins with a large abundance increase in long-lived daf-2 mutant animals of reduced insulin signaling. In this study, we show that both PUD-1 and PUD-2 are abundantly expressed in the intestine and hypodermis, and form a heterodimer. We have solved their crystal structure to 1.9-angstrom resolution and found that both proteins adopt similar beta-sandwich folds in the V-shaped dimer. In contrast, their homologs PUD-3, PUD-4, PUDL-1 and PUDL-2 are all monomeric proteins with distinct expression patterns in C. elegans. Thus, the PUD-1/PUD-2 heterodimer probably has a function distinct from their family members. Neither overexpression nor deletion of pud-1 and pud-2 affected the lifespan of WT or daf-2 mutant animals, suggesting that their induction in daf-2 worms does not contribute to longevity. Curiously, deletion of pud-1 and pud-2 was associated with a protective effect against paralysis induced by the amyloid beta-peptide (1-42), which further enhanced the protection conferred by daf-2(RNAi) against A beta.	[Ding, Yue-He; Du, Yun-Guang; Luo, Shukun; Li, Yu-Xin; Li, Tie-Mei; Wang, Xing; Ye, Keqiong; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing, Peoples R China; [Ding, Yue-He; Dong, Meng-Qiu] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Ding, Yue-He; Dong, Meng-Qiu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yoshina, Sawako; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Tokyo, Japan; [Klage, Karsten] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tokyo Women's Medical University; Max Planck Society	Ye, KQ (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	yekeqiong@nibs.ac.cn; dongmengqiu@nibs.ac.cn	Luo, Shukun/AAT-8195-2021; Li, yu/HHZ-5236-2022; Luo, Shukun/A-8371-2017; li, Yu/HCI-9086-2022; ding, yuehe/AAZ-6994-2021; li, yu/HGL-9518-2022; Li, yuxin/GSD-1668-2022	Luo, Shukun/0000-0002-2766-3125; Luo, Shukun/0000-0002-2766-3125; 	Ministry of Science and Technology of China (863 grant) [2007AA02Z1A7, 2008AA022310]; Ministry of Science and Technology of China (973 grant) [2010CB835203, 2010CB835402]; municipal government of Beijing	Ministry of Science and Technology of China (863 grant); Ministry of Science and Technology of China (973 grant); municipal government of Beijing	The Ministry of Science and Technology of China (863 grant 2007AA02Z1A7 and 973 grant 2010CB835203 to M-QD; 863 grant 2008AA022310 and 973 grant 2010CB835402 to KY) and the municipal government of Beijing funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2004, PROTEOMICS, V4, P2283, DOI 10.1002/pmic.200400807; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; DeLano WL, 2002, PYMOL USERS MANUAL; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Honda Y, 2008, EXP GERONTOL, V43, P520, DOI 10.1016/j.exger.2008.02.009; Johnson TE, 2000, EXP GERONTOL, V35, P687, DOI 10.1016/S0531-5565(00)00138-8; Johnstone I. L, 2007, WORMBOOK; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paik YK, 2006, EXPERT REV PROTEOMIC, V3, P439, DOI 10.1586/14789450.3.4.439; PARK EC, 1986, GENETICS, V113, P821; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Sharabi K, 2009, P NATL ACAD SCI USA, V106, P4024, DOI 10.1073/pnas.0900309106; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weber F, 2000, METH MOL B, V140, P117; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107	45	10	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67158	10.1371/journal.pone.0067158	http://dx.doi.org/10.1371/journal.pone.0067158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799143	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300105
J	Frank, S; Heni, M; Moss, A; von Schnurbein, J; Farooqi, S; Haring, HU; Fritsche, A; Preissl, H; Wabitsch, M				Frank, Sabine; Heni, Martin; Moss, Anja; von Schnurbein, Julia; Farooqi, Sadaf; Haering, Hans-Ulrich; Fritsche, Andreas; Preissl, Hubert; Wabitsch, Martin			Long-Term Stabilization Effects of Leptin on Brain Functions in a Leptin-Deficient Patient	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; NEURAL RESPONSIVITY; FOOD CUES; REPLACEMENT; HYPOGONADISM; OBESITY; BEHAVIOR; THERAPY; ADULTS	Context: Congenital leptin deficiency, caused by a very rare mutation in the gene encoding leptin, leads to severe obesity, hyperphagia and impaired satiety. The only systemic treatment is the substitution with metreleptin leading to weight reduction based on hormonal changes. Several studies have also shown alterations in brain function after metreleptin therapy. In a previous study, we were able to show changes in homeostatic (hypothalamus) and reward-related brain areas (striatum, orbitofrontal cortex (OFC), substantia nigra/ventral tegmental area, amygdala) 3 days and 6 months after therapy start in a leptin-deficient adolescent girl. To further access the time course of functional brain activation changes, we followed the patient for 2 years after initiation of the therapy. Design, Patient: Functional magnetic resonance imaging during visual stimulation with food (high-and low-caloric) and non-food pictures was performed 1 and 2 years after therapy start in the previously described patient. Results: The comparison of 'food vs. non-food' pictures showed a stabilization of the long-term effects in the amygdala and in the OFC. Therefore, no significant differences were observed between 6 months compared to 12 and 24 months in these regions. Additionally, a reduction of the frontopolar cortex activity over the whole time span was observed. For the comparison of high-and low-caloric pictures, long-term effects in the hypothalamus showed an assimilating pattern for the response to the food categories whereas only acute effects after 3 months were observed in hedonic brain regions. Conclusion: This follow-up study shows that the long lasting benefit of metreleptin therapy is also associated with activation changes in homeostatic, hedonic and frontal control regions in congenital leptin deficiency.	[Frank, Sabine; Preissl, Hubert] Univ Tubingen, fMEG Ctr, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Heni, Martin; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Hosp, Dept Internal Med 4, Tubingen, Germany; [Preissl, Hubert] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Heni, Martin; Haering, Hans-Ulrich; Fritsche, Andreas; Preissl, Hubert] German Ctr Diabet Res, Neuherberg, Germany; [Moss, Anja; von Schnurbein, Julia; Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany; [Farooqi, Sadaf] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ulm University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Frank, S (corresponding author), Univ Tubingen, fMEG Ctr, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.	sabine.frank@med.uni-tuebingen.de	Farooqi, Ismaa Sadaf/AAZ-3046-2020; Preißl, Hubert/E-9070-2012; O'Rahilly, Stephen/ABF-6509-2020; Frank-Podlech, Sabine/I-8986-2012	Preißl, Hubert/0000-0002-8859-4661; O'Rahilly, Stephen/0000-0003-2199-4449; Frank-Podlech, Sabine/0000-0002-9646-3987; Farooqi, Sadaf/0000-0001-7609-3504; Heni, Martin/0000-0002-8462-3832	"Kompetenznetz Adipositas (Competence Network for Adiposity)''; German Federal Ministry of Education and Research [FKZ: 01GI1122F, FKZ: 01GI1120A]; German Federal Ministry of Education and Research (BMBF) [FKZ: 01GI0925]; Deutsche Forschungsgemeinschaft (DFG); University Tubingen	"Kompetenznetz Adipositas (Competence Network for Adiposity)''; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University Tubingen	This work was supported by the "Kompetenznetz Adipositas (Competence Network for Adiposity)'' funded by the German Federal Ministry of Education and Research (FKZ: 01GI1122F) and (FKZ: 01GI1120A) and by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e. V., FKZ: 01GI0925). Additionally, the authors acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of the University Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berman SM, 2013, CEREBELLUM, V12, P59, DOI 10.1007/s12311-012-0360-z; Berthoud HR, 2007, PHYSIOL BEHAV, V91, P486, DOI 10.1016/j.physbeh.2006.12.016; Berthoud HR, 2011, CURR OPIN NEUROBIOL, V21, P888, DOI 10.1016/j.conb.2011.09.004; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Finlayson G, 2007, PHYSIOL BEHAV, V90, P36, DOI 10.1016/j.physbeh.2006.08.020; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Fossati P, 2012, EUR NEUROPSYCHOPHARM, V22, pS487, DOI 10.1016/j.euroneuro.2012.07.008; Frank S, 2011, J CLIN ENDOCR METAB, V96, pE1283, DOI 10.1210/jc.2010-2713; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Galgani JE, 2010, J CLIN ENDOCR METAB, V95, P851, DOI 10.1210/jc.2009-1739; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; McCaffery JM, 2009, AM J CLIN NUTR, V90, P928, DOI 10.3945/ajcn.2009.27924; Ochner CN, 2012, NEUROSCIENCE, V209, P128, DOI 10.1016/j.neuroscience.2012.02.030; Ochner CN, 2012, NEUROSCI RES, V74, P138, DOI 10.1016/j.neures.2012.08.002; Paz G, 2011, OBES REV, V12, pe315, DOI 10.1111/j.1467-789X.2010.00840.x; Pudel D, 1989, FRAGEBOGEN ZUM ESSVE; Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055; von Schnurbein J, 2012, HORM RES PAEDIAT, V77, P127, DOI 10.1159/000336003; Williams KW, 2009, AM J CLIN NUTR, V89, p985S, DOI 10.3945/ajcn.2008.26788D	24	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65893	10.1371/journal.pone.0065893	http://dx.doi.org/10.1371/journal.pone.0065893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799059	Green Submitted, gold, Green Published			2022-12-27	WOS:000320363300051
J	Tirumalai, MR; Rastogi, R; Zamani, N; Williams, EO; Allen, S; Diouf, F; Kwende, S; Weinstock, GM; Venkateswaran, KJ; Fox, GE				Tirumalai, Madhan R.; Rastogi, Rajat; Zamani, Nader; Williams, Elisha O'Bryant; Allen, Shamail; Diouf, Fatma; Kwende, Sharon; Weinstock, George M.; Venkateswaran, Kasthuri J.; Fox, George E.			Candidate Genes That May Be Responsible for the Unusual Resistances Exhibited by Bacillus pumilus SAFR-032 Spores	PLOS ONE			English	Article							DNA-REPAIR; SUBTILIS SPORES; SP-NOV.; STRUCTURAL COMPONENTS; PHOTOPRODUCT LYASE; ESCHERICHIA-COLI; UV RESISTANCE; SPACECRAFT; PROTECTION; SURVIVAL	The spores of several Bacillus species, including Bacillus pumilus SAFR-032 and B. safensis FO-36b, which were isolated from the spacecraft assembly facility at NASA's Jet Propulsion Laboratory, are unusually resistant to UV radiation and hydrogen peroxide. In order to identify candidate genes that might be associated with these resistances, the whole genome of B. pumilus SAFR-032, and the draft genome of B. safensis FO-36b were compared in detail with the very closely related type strain B. pumilus ATCC7061(T). 170 genes are considered characteristic of SAFR-032, because they are absent from both FO-36b and ATCC7061(T). Forty of these SAFR-032 characteristic genes are entirely unique open reading frames. In addition, four genes are unique to the genomes of the resistant SAFR-032 and FO-36b. Fifty three genes involved in spore coat formation, regulation and germination, DNA repair, and peroxide resistance, are missing from all three genomes. The vast majority of these are cleanly deleted from their usual genomic context without any obvious replacement. Several DNA repair and peroxide resistance genes earlier reported to be unique to SAFR-032 are in fact shared with ATCC7061 (T) and no longer considered to be promising candidates for association with the elevated resistances. Instead, several SAFR-032 characteristic genes were identified, which along with one or more of the unique SAFR-032 genes may be responsible for the elevated resistances. These new candidates include five genes associated with DNA repair, namely, BPUM_0608 a helicase, BPUM_0652 an ATP binding protein, BPUM_0653 an endonuclease, BPUM_0656 a DNA cytosine-5-methyltransferase, and BPUM_3674 a DNA helicase. Three of these candidate genes are in immediate proximity of two conserved hypothetical proteins, BPUM_0654 and BPUM_0655 that are also absent from both FO-36b and ATCC7061(T). This cluster of five genes is considered to be an especially promising target for future experimental work.	[Tirumalai, Madhan R.; Rastogi, Rajat; Zamani, Nader; Williams, Elisha O'Bryant; Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Allen, Shamail; Diouf, Fatma; Kwende, Sharon] Texas So Univ, Dept Biol, Houston, TX 77004 USA; [Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Venkateswaran, Kasthuri J.] CALTECH, NASA, Jet Prop Labs, Biotechnol & Planetary Protect Grp, Pasadena, CA 91125 USA	University of Houston System; University of Houston; Texas Southern University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Fox, GE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	gefox@central.uh.edu	Willson, richard/AAD-4832-2019; Weinstock, George M/C-6314-2013; Tirumalai, Madhan R/J-4988-2017	Weinstock, George M/0000-0002-2997-4592; Tirumalai, Madhan R/0000-0002-5999-333X	Institute of Space Systems Operations at the University of Houston; Center for Bio-nanotechnology and Environmental Research at Texas Southern University (NASA) [NNX08B4A47A]; Center for Ribosomal Evolution and Adaptation at the Georgia Institute of Technology (NASA) [NNA09DA78A]; National Science Foundation [414410]	Institute of Space Systems Operations at the University of Houston; Center for Bio-nanotechnology and Environmental Research at Texas Southern University (NASA)(National Aeronautics & Space Administration (NASA)); Center for Ribosomal Evolution and Adaptation at the Georgia Institute of Technology (NASA); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Institute of Space Systems Operations at the University of Houston, the Center for Bio-nanotechnology and Environmental Research at Texas Southern University (NASA Cooperative agreement NNX08B4A47A) and the Center for Ribosomal Evolution and Adaptation at the Georgia Institute of Technology (NASA Cooperative Agreement NNA09DA78A) to George E. Fox and National Science Foundation grant -414410 to George M. Weinstock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860; Cahoon LA, 2011, MOL MICROBIOL, V79, P729, DOI 10.1111/j.1365-2958.2010.07481.x; Chang XS, 2010, CURR MICROBIOL, V61, P458, DOI 10.1007/s00284-010-9638-x; Checinska A, 2012, APPL ENVIRON MICROB, V78, P6413, DOI 10.1128/AEM.01211-12; Davidsen T, 2009, NUCL ACIDS RES; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Ghosh S, 2010, ASTROBIOLOGY, V10, P325, DOI 10.1089/ast.2009.0396; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Henaut A, 1998, ELECTROPHORESIS, V19, P515, DOI 10.1002/elps.1150190411; Horneck G, 2012, ASTROBIOLOGY, V12, P445, DOI 10.1089/ast.2011.0737; Ibarra JR, 2008, J BACTERIOL, V190, P2031, DOI 10.1128/JB.01625-07; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DT, 2002, TRENDS BIOCHEM SCI, V27, P161, DOI 10.1016/S0968-0004(01)02039-4; Kempf MJ, 2005, ASTROBIOLOGY, V5, P391, DOI 10.1089/ast.2005.5.391; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; La Duc MT, 2004, INT J SYST EVOL MICR, V54, P195, DOI [10.1099/ijs.0.02747-0, 10.1099/ijs.0.02747]; Lee KS, 2008, P NATL ACAD SCI USA, V105, P2806, DOI 10.1073/pnas.0708244105; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Link L, 2004, MICROB ECOL, V47, P159, DOI 10.1007/s00248-003-1029-4; Marri PR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S8; Moeller R, 2007, J BACTERIOL, V189, P3306, DOI 10.1128/JB.00018-07; Moeller R, 2012, APPL ENVIRON MICROB, V78, P8849, DOI 10.1128/AEM.02527-12; Moeller R, 2012, ASTROBIOLOGY, V12, P1069, DOI 10.1089/ast.2012.0890; Mulder Nicola, 2007, V396, P59; Newcombe DA, 2005, APPL ENVIRON MICROB, V71, P8147, DOI 10.1128/AEM.71.12.8147-8156.2005; Ng WO, 2001, MOL GEN GENET, V264, P924, DOI 10.1007/s004380000383; Nicholson WL, 2002, ASTROBIOLOGY, V2, P417, DOI 10.1089/153110702762470518; Norais C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056558; Onodera T, 2013, EXTREMOPHILES, V17, P171, DOI 10.1007/s00792-012-0506-4; PEDRAZAREYES M, 1994, J BACTERIOL, V176, P3983, DOI 10.1128/JB.176.13.3983-3991.1994; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; ROGERS EJ, 1991, J BACTERIOL, V173, P7881, DOI 10.1128/jb.173.24.7881-7886.1991; Rummel J D, 1992, Adv Space Res, V12, P129; Rummel J D, 1989, Adv Space Res, V9, P181, DOI 10.1016/0273-1177(89)90227-5; RUMMEL JD, 1996, ADV SPACE RES-SERIES, V18, P317, DOI 10.1016/0273-1177(95)00822-V; Rummel JD, 2001, ADV SPACE RES-SERIES, V26, P1893; Rummel JD, 2001, P NATL ACAD SCI USA, V98, P2128, DOI 10.1073/pnas.061021398; Satomi M, 2006, INT J SYST EVOL MICR, V56, P1735, DOI 10.1099/ijs.0.64189-0; Schuerger AC, 2003, ICARUS, V165, P253, DOI 10.1016/S0019-1035(03)00200-8; Serizawa M, 2004, GENE, V329, P125, DOI 10.1016/j.gene.2003.12.024; Sghaier H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-297; Vaishampayan P, 2010, INT J SYST EVOL MICR, V60, P1031, DOI 10.1099/ijs.0.008979-0; Vaishampayan PA, 2012, ASTROBIOLOGY, V12, P487, DOI 10.1089/ast.2011.0738; van Hijum SAFT, 2005, NUCLEIC ACIDS RES, V33, pW560, DOI 10.1093/nar/gki356; Venkateswaran K, 2004, ASTROBIOLOGY, V4, P377, DOI 10.1089/ast.2004.4.377; Viswanath L, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-1; Votava M, 2009, EPIDEMIOL MIKROBI IM, V58, P36; WEINFELD M, 1988, NUCLEIC ACIDS RES, V16, P5693, DOI 10.1093/nar/16.12.5693; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Williams LE, 2012, GENOME BIOL EVOL, V4, P44, DOI 10.1093/gbe/evr128; Xue YM, 1996, APPL ENVIRON MICROB, V62, P2221, DOI 10.1128/AEM.62.7.2221-2227.1996; Yang YJ, 2010, INT J SYST EVOL MICR, V60, P776, DOI 10.1099/ijs.0.010876-0; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	59	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66012	10.1371/journal.pone.0066012	http://dx.doi.org/10.1371/journal.pone.0066012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799069	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300059
J	Zhou, JL; Wu, M; Xu, SY; Cheng, M; Ding, CZ; Liu, Y; Yan, HB; Biyashev, D; Kishore, R; Qin, GJ				Zhou, Junlan; Wu, Min; Xu, Shiyue; Cheng, Min; Ding, Caizhi; Liu, Ye; Yan, Hongbin; Biyashev, Dauren; Kishore, Raj; Qin, Gangjian			Contrasting Roles of E2F2 and E2F3 in Cardiac Neovascularization	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CELL-PROLIFERATION; ANGIOGENESIS; APOPTOSIS; FAMILY; EXPRESSION; SPECIFICITY; PREVENTION; PROTEINS; NECROSIS	Insufficient neovascularization, characterized by poor endothelial cell (EC) growth, contributes to the pathogenesis of ischemic heart disease and limits cardiac tissue preservation and regeneration. The E2F family of transcription factors are critical regulators of the genes responsible for cell-cycle progression and growth; however, the specific roles of individual E2Fs in ECs are not well understood. Here we investigated the roles of E2F2 and E2F3 in EC growth, angiogenesis, and their functional impact on myocardial infarction (MI). An endothelial-specific E2F3-deficient mouse strain VE-Cre; E2F3(fl/fl) was generated, and MI was surgically induced in VE-Cre; E2F3(fl/fl) and E2F2-null (E2F2 KO) mice and their wild-type (WT) littermates, VE-Cre; E2F3(+/+) and E2F2 WT, respectively. The cardiac function, infarct size, and vascular density were significantly better in E2F2 KO mice and significantly worse in VE-Cre; E2F3(fl/fl) mice than in their WT littermates. The loss of E2F2 expression was associated with an increase in the proliferation of ECs both in vivo and in vitro, while the loss of E2F3 expression led to declines in EC proliferation. Thus, E2F3 promotes while E2F2 suppresses ischemic cardiac repair through corresponding changes in EC proliferation; and differential targeting of specific E2F members may provide a novel strategy for therapeutic angiogenesis of ischemic heart disease.	[Zhou, Junlan; Xu, Shiyue; Biyashev, Dauren; Kishore, Raj; Qin, Gangjian] Northwestern Univ, Feinberg Cardiovasc Res Inst, Dept Med Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wu, Min] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Plast Surg, Wuhan 430074, Hubei, Peoples R China; [Cheng, Min] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiol, Union Hosp, Wuhan 430074, Hubei, Peoples R China; [Ding, Caizhi] Renmin Hosp, Dept Cardiol, Songzi, Hubei, Peoples R China; [Liu, Ye] Renmin Hosp, Songzi, Hubei, Peoples R China; [Yan, Hongbin] Chinese Acad Med Sci, Dept Cardiol, Cardiovasc Inst, Beijing 100730, Peoples R China; [Yan, Hongbin] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Yan, Hongbin] Peking Union Med Coll, Beijing 100021, Peoples R China	Northwestern University; Feinberg School of Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qin, GJ (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, Dept Med Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA.	g-qin@northwestern.edu			National Institute of Health [HL093439, HL113541]; American Heart Association [0430135N, 10POST4360009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093439, R01HL113541] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health Grants (HL093439 and HL113541 to G.Q.) and American Heart Association Grants (0430135N to G.Q. and 10POST4360009 to J.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; DeGregori J, 2006, CURR MOL MED, V6, P739; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Giangrande PH, 2007, P NATL ACAD SCI USA, V104, P12988, DOI 10.1073/pnas.0704754104; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Lahteenvuo J, 2012, CIRC RES, V110, P1252, DOI 10.1161/CIRCRESAHA.111.246116; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Qin G, 2008, CONTROL CELLULAR PHY, P341; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Qin GJ, 2006, J EXP MED, V203, P153, DOI 10.1084/jem.20050459; Robich MP, 2011, EXPERT REV CARDIOVAS, V9, P1469, DOI [10.1586/erc.11.148, 10.1586/ERC.11.148]; Saavedra HI, 2002, CELL GROWTH DIFFER, V13, P215; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Spyridopoulos I, 1998, CIRCULATION, V98, P2883, DOI 10.1161/01.CIR.98.25.2883; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Toutain CE, 2009, CIRC RES, V104, P245, DOI 10.1161/CIRCRESAHA.108.182410; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wenzel PL, 2011, DEV BIOL, V351, P35, DOI 10.1016/j.ydbio.2010.12.025; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zhou JL, 2009, CIRCULATION, V120, P1213, DOI 10.1161/CIRCULATIONAHA.109.859207	35	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65755	10.1371/journal.pone.0065755	http://dx.doi.org/10.1371/journal.pone.0065755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799044	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300039
J	Guha, M; Castellanos-Rizaldos, E; Makrigiorgos, GM				Guha, Minakshi; Castellanos-Rizaldos, Elena; Makrigiorgos, G. Mike			DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation	PLOS ONE			English	Article							CELL LUNG-CANCER; GROWTH-FACTOR-RECEPTOR; REAL-TIME PCR; COLD-PCR; ACQUIRED-RESISTANCE; GENE-MUTATIONS; GEFITINIB; ERLOTINIB; IDENTIFICATION; ENRICHMENT	Non-small cell lung cancer (NSCLC) patients treated with small molecule EGFR inhibitors, such as gefitinib, frequently develop drug resistance due to the presence of secondary mutations like the T790M mutation on EGFR exon 20. These mutations may originate from small subclonal populations in the primary tumor that become dominant later on during treatment. In order to detect these low-level DNA variations in the primary tumor or to monitor their progress in plasma, it is important to apply reliable and sensitive mutation detection methods. Here, we combine two recently developed methodologies, Differential Strand Separation at Critical Temperature (DISSECT), with peptide nucleic acid-locked nucleic acid (PNA-LNA) polymerase chain reaction (PCR) for the detection of T790M EGFR mutation. DISSECT pre-enriches low-abundance T790M EGFR mutations from target DNA prior to implementing PNA-LNA PCR, a method that can detect 1 mutant allele in a background of 100-1000 wild type alleles. The combination of DISSECT and PNA-LNA PCR enables the detection of 1 mutant allele in a background of 10,000 wild type alleles. The combined DISSECT-PNA-LNA PCR methodology is amenable to adaptation for the sensitive detection of additional emerging resistance mutations in cancer.	[Guha, Minakshi; Castellanos-Rizaldos, Elena; Makrigiorgos, G. Mike] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div DNA Repair & Genome Stabil,Dept Radiat Oncol, Boston, MA 02115 USA; [Makrigiorgos, G. Mike] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Div Med Phys & Biophys,Dept Radiat Oncol,Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Makrigiorgos, GM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div DNA Repair & Genome Stabil,Dept Radiat Oncol, 44 Binney St, Boston, MA 02115 USA.	mmakrigiorgos@lroc.harvard.edu	Makrigiorgos, Mike/AFC-4575-2022		Innovative Molecular Analysis Technologies Program of National Cancer Institute [CA-111994]	Innovative Molecular Analysis Technologies Program of National Cancer Institute	This work was supported in part by grant CA-111994 of the Innovative Molecular Analysis Technologies Program of National Cancer Institute. The contents of this manuscript do not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amicarelli G, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm809; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Li J, 2011, CLIN CHEM, V57, P770, DOI 10.1373/clinchem.2010.157784; Li J, 2009, HUM MUTAT, V30, P1583, DOI 10.1002/humu.21112; Li J, 2009, CLIN CHEM, V55, P748, DOI 10.1373/clinchem.2008.113381; Li J, 2009, BIOCHEM SOC T, V37, P427, DOI 10.1042/BST0370427; Makrigiorgos GM, 2012, NUCL ACIDS RES; Milbury CA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq899; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; Miyazawa H, 2008, CANCER SCI, V99, P595, DOI 10.1111/j.1349-7006.2007.00706.x; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nielsen P E, 1999, Curr Issues Mol Biol, V1, P89; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; TADA M, 1993, CANCER RES, V53, P2472	22	29	36	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67782	10.1371/journal.pone.0067782	http://dx.doi.org/10.1371/journal.pone.0067782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805327	gold, Green Submitted, Green Published			2022-12-27	WOS:000320846500155
J	Horton, M; Modi, J; Patel, SK; Demchuk, AM; Goyal, M; Hill, MD; Coutts, SB				Horton, Myles; Modi, Jayesh; Patel, Shiel K.; Demchuk, Andrew M.; Goyal, Mayank; Hill, Michael D.; Coutts, Shelagh B.			Refinement of Imaging Predictors of Recurrent Events following Transient Ischemic Attack and Minor Stroke	PLOS ONE			English	Article							CAROTID-ENDARTERECTOMY; CT ANGIOGRAPHY; FATAL STROKES; RISK; MICROBLEEDS; VALIDATION	Background: TIA and minor stroke have a high risk of recurrent stroke. Abnormalities on CT/CTA and MRI predict recurrent events in TIA and minor stroke. However there are many other imaging abnormalities that could potentially predict outcome that have not been assessed in this population. Also the definition of recurrent events used includes deterioration due to stroke progression or recurrent stroke and whether imaging is either of these is not known. Aims: To improve upon the clinical, CT/CTA and MRI parameters that predict recurrent events after TIA and minor stroke by assessing further imaging parameters. Secondary aim was to explore predictors of stroke progression versus recurrent stroke. Methods: 510 consecutive TIA and minor stroke patients had CT/CTA and most had MRI. Primary outcome was recurrent events (stroke progression or recurrent stroke) within 90 days. Further imaging parameters were assessed for prediction of recurrent events (combined outcome of stroke progression and recurrent stroke). We also explored predictors of symptom progression versus recurrence individually. Results: 36 recurrent events (36/510, 7.1% (95% CI: 5.0-9.6)) including 19 progression and 17 recurrent strokes. On CT/CTA: white matter disease, prior stroke, aortic arch focal plaque >= 4 mm, or intraluminal thrombus did not predict recurrent events (progression or recurrent stroke). On MRI: white matter disease, prior stroke, and microbleeds did not predict recurrent events. Parameters predicting the individual outcome of symptom progression included: ongoing symptoms at initial assessment, symptom fluctuation, intracranial occlusion, intracranial occlusion or stenosis, and the CT/CTA metric. No parameter was strongly predictive of a distinct recurrent stroke. Conclusions: There was no imaging parameter that could improve upon our original CT/CTA or MRI metrics to predict the combined outcome of stroke progression or a recurrent stroke after TIA and minor stroke. We are better at using imaging to predict stroke progression rather than recurrent stroke.	[Horton, Myles; Patel, Shiel K.; Demchuk, Andrew M.; Goyal, Mayank; Hill, Michael D.; Coutts, Shelagh B.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Modi, Jayesh; Demchuk, Andrew M.; Goyal, Mayank; Hill, Michael D.; Coutts, Shelagh B.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Hill, Michael D.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Hill, Michael D.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Demchuk, Andrew M.; Goyal, Mayank; Hill, Michael D.; Coutts, Shelagh B.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Coutts, SB (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.	scoutts@ucalgary.ca	Goyal, Mayank/AAE-7323-2019; Hill, Michael D/C-9073-2012; Demchuk, Andrew M/E-1103-2012	Hill, Michael D/0000-0002-6269-1543; Demchuk, Andrew M/0000-0002-4930-7789	Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Canada's Distinguished Clinician Scientist award; Canadian Institute of Health Research (CIHR); Institute of Circulatory and Respiratory Health; AstraZeneca Canada Inc.; Heart & Stroke Foundation of Alberta/Northwest Territories/Nunavut; Pfizer Cardiovascular research award	Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Canada's Distinguished Clinician Scientist award; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Institute of Circulatory and Respiratory Health; AstraZeneca Canada Inc.(AstraZeneca); Heart & Stroke Foundation of Alberta/Northwest Territories/Nunavut; Pfizer Cardiovascular research award	S.B.C. received salary support from the Alberta Innovates-Health Solutions and the Heart and Stroke Foundation of Canada's Distinguished Clinician Scientist award, supported in partnership with the Canadian Institute of Health Research (CIHR), Institute of Circulatory and Respiratory Health and AstraZeneca Canada Inc. M.D.H. receives salary support from Alberta Innovates-Health Solutions and by the Heart & Stroke Foundation of Alberta/Northwest Territories/Nunavut. A.M.D. receives salary support from Alberta Innovates-Health Solutions. Funding sources consisted of a Canadian Institute of Health Research (CIHR) and a Pfizer Cardiovascular research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.B.C. received salary support from the Heart and Stroke Foundation of Canada's Distinguished Clinician Scientist award, supported in partnership with the Canadian Institute of Health Research (CIHR), Institute of Circulatory and Respiratory Health and AstraZeneca Canada Inc. Funding sources consisted of a Pfizer Cardiovascular research award. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202; Asdaghi N, 2011, STROKE, V42, P2191, DOI 10.1161/STROKEAHA.110.611376; Ay H, 2009, STROKE, V40, P181, DOI 10.1161/STROKEAHA.108.521476; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Boulanger JM, 2006, STROKE, V37, P911, DOI 10.1161/01.STR.0000204237.66466.5f; Chatzikonstantinou A, 2009, CEREBROVASC DIS, V27, P594, DOI 10.1159/000214224; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; Coutts SB, 2008, STROKE, V39, P2461, DOI 10.1161/STROKEAHA.107.513234; Coutts SB, 2012, STROKE, V43, P1013, DOI 10.1161/STROKEAHA.111.637421; Coutts SB, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-18; DONNAN GA, 1993, NEUROLOGY, V43, P957, DOI 10.1212/WNL.43.5.957; Halliday A, 2004, LANCET, V363, P1491; Hill MD, 2000, TNK TPA EV MIN ISCH; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513; Menon BK, 2010, NEURORADIOLOGY, V52, P1055, DOI 10.1007/s00234-010-0738-x; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; Nakajima M, 2010, CEREBROVASC DIS, V29, P221, DOI 10.1159/000267844; Sciolla R, 2008, STROKE, V39, P297, DOI 10.1161/STROKEAHA.107.496612; Thijs V, 2010, STROKE, V41, P2005, DOI 10.1161/STROKEAHA.110.588020; Thorvaldsen P, 1997, STROKE, V28, P500, DOI 10.1161/01.STR.28.3.500; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Wardlaw JM, 2006, STROKE, V37, P2633, DOI 10.1161/01.STR.0000240513.00579.bf; Wasserman JK, 2011, P 2 ANN CAN STROK C; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	27	13	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65752	10.1371/journal.pone.0065752	http://dx.doi.org/10.1371/journal.pone.0065752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805187	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500015
J	Huang, WC; Yang, CC; Chen, IH; Liu, YML; Chang, SJ; Chuang, YJ				Huang, Wei-Chang; Yang, Chung-Chi; Chen, I-Hui; Liu, Yu-Min Lawrence; Chang, Shing-Jyh; Chuang, Yung-Jen			Treatment of Glucocorticoids Inhibited Early Immune Responses and Impaired Cardiac Repair in Adult Zebrafish	PLOS ONE			English	Article							HEART REGENERATION; STEM-CELLS; EXPRESSION; DISEASE; CARDIOMYOCYTES; ANGIOGENESIS; INFLAMMATION; PATHWAYS; THERAPY; SYSTEM	Myocardial injury, such as myocardial infarction (MI), can lead to drastic heart damage. Zebrafish have the extraordinary ability to regenerate their heart after a severe injury. Upon ventricle resection, fibrin clots seal the wound and serve as a matrix for recruiting myeloid-derived phagocytes. Accumulated neutrophils and macrophages not only reduce the risk of infection but also secrete cytokines and growth factors to promote tissue repair. However, the underlying cellular and molecular mechanisms for how immune responses are regulated during the early stages of cardiac repair are still unclear. We investigated the role and programming of early immune responses during zebrafish heart regeneration. We found that zebrafish treated with an anti-inflammatory glucocorticoid had significantly reduced heart regenerative capacities, consistent with findings in other higher vertebrates. Moreover, inhibiting the inflammatory response led to excessive collagen deposition. A microarray approach was used to assess the differential expression profiles between zebrafish hearts with normal or impaired healing. Combining cytokine profiling and immune-staining, our data revealed that impaired heart regeneration could be due to reduced phagocyte recruitment, leading to diminished angiogenesis and cell proliferation post-cardiac injury. Despite their robust regenerative ability, our study revealed that glucocorticoid treatment could effectively hinder cardiac repair in adult zebrafish by interfering with the inflammatory response. Our findings may help to clarify the initiation of cardiac repair, which could be used to develop a therapeutic intervention that may enhance cardiac repair in humans to compensate for the loss of cardiomyocytes after an MI.	[Huang, Wei-Chang; Yang, Chung-Chi; Chen, I-Hui; Liu, Yu-Min Lawrence; Chuang, Yung-Jen] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Huang, Wei-Chang; Yang, Chung-Chi; Chen, I-Hui; Liu, Yu-Min Lawrence; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yang, Chung-Chi] Taoyuan Armed Forces Gen Hosp, Div Cardiol, Tao Yuan, Taiwan; [Liu, Yu-Min Lawrence] Mackay Mem Hosp, Hsinchu Branch, Dept Internal Med, Div Cardiol, Hsinchu, Taiwan; [Chang, Shing-Jyh] Mackay Mem Hosp, Hsinchu Branch, Dept Obstet & Gynecol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; Mackay Memorial Hospital; Mackay Memorial Hospital	Chuang, YJ (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.	yjchuang@life.nthu.edu.tw	Chuang, Yung-Jen/D-2362-2013	Chuang, Yung-Jen/0000-0002-6022-0107	Taiwan National Science Council [101-2325-B-007-004]; Taoyuan Armed Forces General Hospital [9909]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Taoyuan Armed Forces General Hospital	This work was supported by Taiwan National Science Council [http://web1.nsc.gov.tw/mp.aspx grant number: 101-2325-B-007-004] & Taoyuan Armed Forces General Hospital [http://804.mnd.gov.tw/ grant number: 9909]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adcock IM, 2001, PULM PHARMACOL THER, V14, P211, DOI 10.1006/pupt.2001.0283; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chen JN, 1996, DEVELOPMENT, V122, P3809; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; CONNOLLY DT, 1991, J CELL BIOCHEM, V47, P219, DOI 10.1002/jcb.240470306; Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KNIGHTON DR, 1990, J TRAUMA, V30, pS134; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kyritsis N, 2012, SCIENCE; Lafontant PJ, 2012, ANAT REC, V295, P234, DOI 10.1002/ar.21492; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; MATHEWS MB, 1984, NATURE, V309, P374, DOI 10.1038/309374a0; Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Rasmussen TL, 2011, CIRCULATION, V123, P1771, DOI 10.1161/CIRCULATIONAHA.109.858019; Schweitzer J, 2003, GLIA, V41, P301, DOI 10.1002/glia.10192; SEIBERT K, 1995, AGENT ACTION SUPPL, V46, P41; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	42	59	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66613	10.1371/journal.pone.0066613	http://dx.doi.org/10.1371/journal.pone.0066613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805247	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500075
J	Ingersoll, TE; Sewall, BJ; Amelon, SK				Ingersoll, Thomas E.; Sewall, Brent J.; Amelon, Sybill K.			Improved Analysis of Long-Term Monitoring Data Demonstrates Marked Regional Declines of Bat Populations in the Eastern United States	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; BIG-EARED BAT; MYOTIS-SODALIS; HIBERNATING BATS; FLYING FOXES; BROWN BATS; DISEASE; CONSERVATION; WINTER; PATTERNS	Bats are diverse and ecologically important, but are also subject to a suite of severe threats. Evidence for localized bat mortality from these threats is well-documented in some cases, but long-term changes in regional populations of bats remain poorly understood. Bat hibernation surveys provide an opportunity to improve understanding, but analysis is complicated by bats' cryptic nature, non-conformity of count data to assumptions of traditional statistical methods, and observation heterogeneities such as variation in survey timing. We used generalized additive mixed models (GAMMs) to account for these complicating factors and to evaluate long-term, regional population trajectories of bats. We focused on four hibernating bat species - little brown myotis (Myotis lucifugus), tri-colored bat (Perimyotis subflavus), Indiana myotis (M. sodalis), and northern myotis (M. septentrionalis) - in a four-state region of the eastern United States during 1999-2011. Our results, from counts of nearly 1.2 million bats, suggest that cumulative declines in regional relative abundance by 2011 from peak levels were 71% (with 95% confidence interval of +/- 11%) in M. lucifugus, 34% (+/- 38%) in P. subflavus, 30% (+/- 26%) in M. sodalis, and 31% (+/- 18%) in M. septentrionalis. The M. lucifugus population fluctuated until 2004 before persistently declining, and the populations of the other three species declined persistently throughout the study period. Population trajectories suggest declines likely resulted from the combined effect of multiple threats, and indicate a need for enhanced conservation efforts. They provide strong support for a change in the IUCN Red List conservation status in M. lucifugus from Least Concern to Endangered within the study area, and are suggestive of a need to change the conservation status of the other species. Our modeling approach provided estimates of uncertainty, accommodated non-linearities, and controlled for observation heterogeneities, and thus has wide applicability for evaluating population trajectories in other wildlife species.	[Ingersoll, Thomas E.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Sewall, Brent J.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Amelon, Sybill K.] Univ Missouri, No Res Stn, US Forest Serv, Columbia, MO USA	University of Tennessee System; University of Tennessee Knoxville; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	Ingersoll, TE (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	tomingersoll@yahoo.com; bjsewall@temple.edu	amelon, s/GYQ-7127-2022	Amelon, Sybill/0000-0003-3940-8153	National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF Award [EF-0832858]; University of Tennessee, Knoxville; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF Award; University of Tennessee, Knoxville; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was conducted while TEI was a Postdoctoral Fellow at the National Institute for Mathematical and Biological Synthesis (http://www.nimbios.org), an Institute sponsored by the National Science Foundation (http://www.nsf.gov), the U.S. Department of Homeland Security (http://www.dhs.gov), and the U.S. Department of Agriculture (http://www.usda.gov) through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville (http://www.utk.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Barbour R.W., 1969, BATS AM; Barclay RMR, 2003, BAT ECOLOGY, P209; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2006, MAMMAL REV, V36, P267, DOI 10.1111/j.1365-2907.2006.00095.x; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Brack V, 2007, ENVIRON MANAGE, V40, P739, DOI 10.1007/s00267-006-0274-y; BRADY J. T., 1982, GRAY BAT RECOVERY PL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butchkoski CM, 2013, WHITE NOSE SYNDROME; Caceres M.C., 2000, MAMMAL SPECIES, V634, P1; Chambers JM., 1992, STAT MODELS S; Clark BS, 2002, J MAMMAL, V83, P590, DOI 10.1644/1545-1542(2002)083<0590:SVIAPO>2.0.CO;2; CLARK DR, 1988, WILDLIFE SOC B, V16, P399; CLAWSON RL, 1980, J MAMMAL, V61, P245, DOI 10.2307/1380045; Clawson RL, 2004, P IND BAT COAL MIN T, P1; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Duchamp JE, 2006, WILDLIFE SOC B, V34, P408, DOI 10.2193/0091-7648(2006)34[408:EPODFB]2.0.CO;2; Ellison L.E., 2003, MONITORING BAT POPUL, P127; Fenolio DB, 2006, P ROY SOC B-BIOL SCI, V273, P439, DOI 10.1098/rspb.2005.3341; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Fenton M.B., 1992, BATS; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; FUJITA M S, 1984, Mammalian Species, P1, DOI 10.2307/3504021; FUJITA MS, 1991, CONSERV BIOL, V5, P455, DOI 10.1111/j.1523-1739.1991.tb00352.x; Gotelli N.J., 1998, PRIMER ECOLOGY; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HARDIN JW, 1970, J MAMMAL, V51, P829, DOI 10.2307/1378324; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hein CD, 2012, POTENTIAL IMPACTS SH; Hutson A, 2001, MICROCHIROPTERAN BAT; Ingersoll TE, 2010, J MAMMAL, V91, P1242, DOI 10.1644/09-MAMM-A-288.1; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN, 2012, IUCN RED LIST THREAT; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kannan K, 2010, CHEMOSPHERE, V80, P613, DOI 10.1016/j.chemosphere.2010.04.060; Kunz T.H., 2003, MONITORING TRENDS BA, P9; Kunz TH, 2011, STATUS REV LITTLE BR; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Link WA, 1997, BIOMETRICS, V53, P488, DOI 10.2307/2533952; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Matteson M, 2010, PETITION LIST E SMAL; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McCullagh P, 1989, GEN LINEAR MODELS; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Meretsky VJ, 2010, J WILDLIFE MANAGE, V74, P166, DOI 10.2193/2008-306; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Mumma TL, 2011, WIND ENERGY VOLUNTAR; NEILSON AL, 1994, WILDLIFE SOC B, V22, P8; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; O'Shea TJ, 2003, WILDLIFE SOC B, V31, P16; O'Shea TJ, 2003, USGSBRDITR20030003; Pennsylvania Game Commission, 2012, PENNS B, V42, P5310; Pierson Elizabeth D., 1998, P309; Poulson TL, 2000, ECOSY WORLD, V30, P231; Pruitt L, 2007, INDIANA BAT IN PRESS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Rodenhouse NL, 2009, CAN J FOREST RES, V39, P249, DOI 10.1139/X08-160; Rodhouse TJ, 2012, ECOL APPL, V22, P1098, DOI 10.1890/11-1662.1; Royle J. A., 2008, HIERARCHICAL MODELIN; Russell Amy L., 2009, Endangered Species Research, V8, P49, DOI 10.3354/esr00121; Shore R. F., 2001, ECOTOXICOLOGY WILD M; Thomas DW, 1997, FUNCT ECOL, V11, P585, DOI 10.1046/j.1365-2435.1997.00129.x; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; THOMAS DW, 1995, J MAMMAL, V76, P940, DOI 10.2307/1382764; Thomas L, 1996, ECOLOGY, V77, P49, DOI 10.2307/2265653; THOMSON C E, 1982, Mammalian Species, P1, DOI 10.2307/3504013; Turner Gregory G., 2011, Bat Research News, V52, P13; TUTTLE M. D, 2003, MONITORING TRENDS BA, P31; TUTTLE MD, 1979, J WILDLIFE MANAGE, V43, P1, DOI 10.2307/3800631; U.S. Department of the Interior, 1967, END SPEC 32 FR 4001; U.S. Fish Wildlife Service [USFWS], 2012, N AM BAT DEATH TOLL; US Department of Energy, 2012, WIND POW AM; USFWS, 2007, IND BAT MYOT SOD DRA, P258; WHITAKER JO, 1992, AM MIDL NAT, V127, P52, DOI 10.2307/2426321; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	99	53	58	2	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65907	10.1371/journal.pone.0065907	http://dx.doi.org/10.1371/journal.pone.0065907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805192	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500020
J	Kumari, K; Muthamilarasan, M; Misra, G; Gupta, S; Subramanian, A; Parida, SK; Chattopadhyay, D; Prasad, M				Kumari, Kajal; Muthamilarasan, Mehanathan; Misra, Gopal; Gupta, Sarika; Subramanian, Alagesan; Parida, Swarup Kumar; Chattopadhyay, Debasis; Prasad, Manoj			Development of eSSR-Markers in Setaria italica and Their Applicability in Studying Genetic Diversity, Cross-Transferability and Comparative Mapping in Millet and Non-Millet Species	PLOS ONE			English	Article							EST-SSR MARKERS; PERIWINKLE CATHARANTHUS-ROSEUS; GENOMIC MICROSATELLITE MARKERS; FOXTAIL MILLET; GENOTYPING APPLICATIONS; PHYLOGENETIC ANALYSIS; MEDICAGO-TRUNCATULA; LOLIUM-PERENNE; GRASS MODEL; SEQUENCE	Foxtail millet (Setaria italica L.) is a tractable experimental model crop for studying functional genomics of millets and bioenergy grasses. But the limited availability of genomic resources, particularly expressed sequence-based genic markers is significantly impeding its genetic improvement. Considering this, we attempted to develop EST-derived-SSR (eSSR) markers and utilize them in germplasm characterization, cross-genera transferability and in silico comparative mapping. From 66,027 foxtail millet EST sequences 24,828 non-redundant ESTs were deduced, representing similar to 16 Mb, which revealed 534 (similar to 2%) eSSRs in 495 SSR containing ESTs at a frequency of 1/30 kb. A total of 447 pp were successfully designed, of which 327 were mapped physically onto nine chromosomes. About 106 selected primer pairs representing the foxtail millet genome showed high-level of cross-genera amplification at an average of similar to 88% in eight millets and four non-millet species. Broad range of genetic diversity (0.02-0.65) obtained in constructed phylogenetic tree using 40 eSSR markers demonstrated its utility in germplasm characterizations and phylogenetics. Comparative mapping of physically mapped eSSR markers showed considerable proportion of sequence-based orthology and syntenic relationship between foxtail millet chromosomes and sorghum (similar to 68%), maize (similar to 61%) and rice (similar to 42%) chromosomes. Synteny analysis of eSSRs of foxtail millet, rice, maize and sorghum suggested the nested chromosome fusion frequently observed in grass genomes. Thus, for the first time we had generated large-scale eSSR markers in foxtail millet and demonstrated their utility in germplasm characterization, transferability, phylogenetics and comparative mapping studies in millets and bioenergy grass species.	[Kumari, Kajal; Muthamilarasan, Mehanathan; Misra, Gopal; Gupta, Sarika; Parida, Swarup Kumar; Chattopadhyay, Debasis; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India; [Subramanian, Alagesan] Tamil Nadu Agr Univ, Coimbatore 641003, Tamil Nadu, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Tamil Nadu Agricultural University	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	Alagesan, Subramanian/AAO-2343-2020; Prasad, Manoj/AAE-8540-2019; Muthamilarasan, Mehanathan/H-9340-2017	Alagesan, Subramanian/0000-0002-7992-1384; Prasad, Manoj/0000-0003-0691-0163; Muthamilarasan, Mehanathan/0000-0001-7589-6372; Chattopadhyay, Debasis/0000-0002-5754-4987	National Institute of Plant Genome Research (NIPGR), New Delhi, India; University Grants Commission, New Delhi	National Institute of Plant Genome Research (NIPGR), New Delhi, India; University Grants Commission, New Delhi(University Grants Commission, India)	This work was financially supported by the core grant of National Institute of Plant Genome Research (NIPGR), New Delhi, India. MM acknowledges the award of Junior Research Fellowship from University Grants Commission, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Devos KM, 2005, CURR OPIN PLANT BIOL, V8, P155, DOI 10.1016/j.pbi.2005.01.005; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 1998, THEOR APPL GENET, V96, P63, DOI 10.1007/s001220050709; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gupta PK, 2002, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, P9; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Gupta S, 2009, GENOME, V52, P761, DOI [10.1139/g09-051, 10.1139/G09-051]; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Jung Sook, 2005, Functional & Integrative Genomics, V5, P136, DOI 10.1007/s10142-005-0139-0; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2013, J PLANT BIOCHEM BIOT, V22, P257, DOI 10.1007/s13562-013-0216-8; Lata C, 2013, PLANT BREEDING, V132, P496, DOI 10.1111/j.1439-0523.2012.01983.x; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; MAROOF MAS, 1994, P NATL ACAD SCI USA, V91, P5466, DOI 10.1073/pnas.91.12.5466; Mishra RK, 2011, PLANT OMICS, V4, P154; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Roldan-Ruiz I, 2001, THEOR APPL GENET, V103, P1138, DOI 10.1007/s001220100571; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Shokeen B, 2007, PLANT SCI, V172, P441, DOI 10.1016/j.plantsci.2006.10.010; Siles MM, 2001, CROP SCI, V41, P1408, DOI 10.2135/cropsci2001.4151408x; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Soto-Cerda BJ, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue2-fulltext-6; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WANG CB, 2006, CHINESE SCI BULL, V51, P316; Xie WG, 2010, BIOCHEM SYST ECOL, V38, P740, DOI 10.1016/j.bse.2010.06.009; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316	56	80	82	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67742	10.1371/journal.pone.0067742	http://dx.doi.org/10.1371/journal.pone.0067742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805325	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500153
J	Li, HT; Min, DL; Zhao, H; Wang, ZY; Qi, WX; Zheng, SE; Tang, LN; He, AN; Sun, YJ; Yao, Y; Shen, Z				Li, Hongtao; Min, Daliu; Zhao, Hui; Wang, Zhiyu; Qi, Weixiang; Zheng, Shuier; Tang, Lina; He, Aina; Sun, Yuanjue; Yao, Yang; Shen, Zan			The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data	PLOS ONE			English	Article							GRADE OSTEOSARCOMA; LINKER EZRIN; SURVIVAL; EXPRESSION; IMMUNOREACTIVITY; CHEMOTHERAPY; METASTASIS; EXTREMITY; PROTEINS; SARCOMA	Background: The significance of ezrin immunoexpression and prognosis for osteosarcoma is still controversial. The aim was to provide a meta-analysis for ezrin immunoexpression and prognostic features of osteosarcoma patients. Methods: A detailed search was made in MEDLINE, EMBASE and the Web of Knowledge for relevant original articles published in English; methodological quality of the included studies was also assessed. Two reviewers extracted data independently. Studies were pooled and summary hazard ratios (HRs) and odds ratio (ORs) with corresponding confidence intervals (CIs) were calculated. Results: Final analysis of 318 patients from 5 eligible studies was performed. Combined HR of ezrin immunohistochemical staining suggested that positive immunoexpression had an unfavorable impact on osteosarcoma patients' overall survival (n = 223 in 4 studies; HR = 4.79; 95% CI: 1.50-15.30; P = 0.008) but not on event-free survival (n = 202 in 3 studies; HR = 1.59; 95% CI: 0.61-4.15; P = 0. 0.342). Combined OR of ezrin immunohistochemical staining indicated that positive immunoexpression was associated with recurrence (n = 134 in 2 studies; OR = 3.79; 95% CI: 1.49-9.64; P = 0.005) but not with serum ALP level (n = 160 in 2 studies; OR = 2.16; 95% CI: 0.09-52.50; P = 0.637) and histological response to neoadjuvant chemotherapy(n = 260 in 4 studies; OR = 0.87; 95% CI: 0.37-2.03; P = 0.740). Conclusions: The results of this meta-analysis suggest that ezrin positive immunoexpression confers a higher risk of recurrence and a worse survival in osteosarcoma patients. Large prospective studies are needed to provide solid data to investigate the precise prognostic significance of ezrin.	[Li, Hongtao; Min, Daliu; Zhao, Hui; Wang, Zhiyu; Qi, Weixiang; Zheng, Shuier; Tang, Lina; He, Aina; Sun, Yuanjue; Yao, Yang; Shen, Zan] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Shen, Z (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Oncol, Shanghai 200030, Peoples R China.	shenzanok@yahoo.com		Li, Hongtao/0000-0001-6532-2092	National Natural Scientific Foundation of China (NSFC) [81102038, 81172105, 81172548]	National Natural Scientific Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Scientific Foundation of China (NSFC) (No: 81102038, 81172105, and 81172548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bakhshi S, 2010, EXPERT REV ANTICANC, V10, P271, DOI [10.1586/era.09.186, 10.1586/ERA.09.186]; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; BOLDRINI E, 2010, ONCOLOGY, V32, pE213; Brambilla D, 2012, INT J CANCER, V130, P2824, DOI 10.1002/ijc.26285; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; DerSimonian R, 1996, STAT MED, V15, P1237, DOI 10.1002/(SICI)1097-0258(19960630)15:12<1237::AID-SIM301>3.0.CO;2-N; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Ferrari S, 2008, PEDIATR BLOOD CANCER, V50, P752, DOI 10.1002/pbc.21360; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kim C, 2009, CANCER RES TREAT, V41, P138, DOI 10.4143/crt.2009.41.3.138; Kim MS, 2007, CLIN ORTHOP RELAT R, P229, DOI 10.1097/BLO.0b013e3180413dbf; Krishnan K, 2006, CLIN EXP METASTAS, V23, P227, DOI 10.1007/s10585-006-9033-y; LINK MP, 1986, NEW ENGL J MED, V314, P1600, DOI 10.1056/NEJM198606193142502; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; Meyers PA, 1997, PEDIATR CLIN N AM, V44, P973, DOI 10.1016/S0031-3955(05)70540-X; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Moilanen J, 2003, GYNECOL ONCOL, V90, P273, DOI 10.1016/S0090-8258(03)00262-2; Park HR, 2006, PATHOL RES PRACT, V202, P509, DOI 10.1016/j.prp.2006.01.015; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Salas S, 2007, VIRCHOWS ARCH, V451, P999, DOI 10.1007/s00428-007-0474-8; Shen XD, 2009, CLIN INVEST MED, V32, pE180; Wells G.A., NEWCASTLE OTTAWA SCA; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548	31	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64513	10.1371/journal.pone.0064513	http://dx.doi.org/10.1371/journal.pone.0064513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805177	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500005
J	Skjot-Arkil, H; Clausen, RE; Rasmussen, LM; Wang, WC; Wang, YG; Zheng, QL; Mickley, H; Saaby, L; Diederichsen, ACP; Lambrechtsen, J; Martinez, FJ; Hogaboam, CM; Han, ML; Larsen, MR; Nawrocki, A; Vainer, B; Krustrup, D; Bjorling-Poulsen, M; Karsdal, MA; Leeming, DJ				Skjot-Arkil, Helene; Clausen, Rikke E.; Rasmussen, Lars M.; Wang, Wanchun; Wang, Yaguo; Zheng, Qinlong; Mickley, Hans; Saaby, Lotte; Diederichsen, Axel C. P.; Lambrechtsen, Jess; Martinez, Fernando J.; Hogaboam, Cory M.; Han, MeiLan; Larsen, Martin R.; Nawrocki, Arkadiusz; Vainer, Ben; Krustrup, Dorrit; Bjorling-Poulsen, Marina; Karsdal, Morten A.; Leeming, Diana J.			Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; OSTEOPONTIN-DEFICIENT MICE; MATRIX-METALLOPROTEINASE; BIOCHEMICAL MARKERS; ARTICULAR-CARTILAGE; EX-VIVO; COLLAGEN; CLEAVAGE; PEPTIDE; ATHEROSCLEROSIS	Background: Elastin is a signature protein of the arteries and lungs, thus it was hypothesized that elastin is subject to enzymatic degradation during cardiovascular and pulmonary diseases. The aim was to investigate if different fragments of the same protein entail different information associated to two different diseases and if these fragments have the potential of being diagnostic biomarkers. Methods: Monoclonal antibodies were raised against an identified fragment (the ELM-2 neoepitope) generated at the amino acid position '552 in elastin by matrix metalloproteinase (MMP) -9/-12. A newly identified ELM neoepitope was generated by the same proteases but at amino acid position '441. The distribution of ELM-2 and ELM, in human arterial plaques and fibrotic lung tissues were investigated by immunohistochemistry. A competitive ELISA for ELM-2 was developed. The clinical relevance of the ELM and ELM-2 ELISAs was evaluated in patients with acute myocardial infarction (AMI), no AMI, high coronary calcium, or low coronary calcium. The serological release of ELM-2 in patients with chronic obstructive pulmonary disease (COPD) or idiopathic pulmonary fibrosis (IPF) was compared to controls. Results: ELM and ELM-2 neoepitopes were both localized in diseased carotid arteries and fibrotic lungs. In the cardiovascular cohort, ELM-2 levels were 66% higher in serum from AMI patients compared to patients with no AMI (p<0.01). Levels of ELM were not significantly increased in these patients and no correlation was observed between ELM-2 and ELM. ELM-2 was not elevated in the COPD and IPF patients and was not correlated to ELM. ELM was shown to be correlated with smoking habits (p<0.01). Conclusions: The ELM-2 neoepitope was related to AMI whereas the ELM neoepitope was related to pulmonary diseases. These results indicate that elastin neoepitopes generated by the same proteases but at different amino acid sites provide different tissue-related information depending on the disease in question.	[Skjot-Arkil, Helene; Clausen, Rikke E.; Karsdal, Morten A.; Leeming, Diana J.] Nordic Biosci AS, Herlev, Denmark; [Skjot-Arkil, Helene] Univ Southern Denmark, Sch Endocrinol, Odense, Denmark; [Rasmussen, Lars M.; Bjorling-Poulsen, Marina] Odense Univ Hosp, Inst Clin Res, DK-5000 Odense, Denmark; [Wang, Wanchun; Wang, Yaguo; Zheng, Qinlong] Nordic Biosci Beijing, Beijing, Peoples R China; [Mickley, Hans; Saaby, Lotte; Diederichsen, Axel C. P.] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Lambrechtsen, Jess] Svenborg Hosp, Dept Cardiol, Svenborg, Denmark; [Martinez, Fernando J.; Hogaboam, Cory M.; Han, MeiLan] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Martinez, Fernando J.; Hogaboam, Cory M.; Han, MeiLan] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Larsen, Martin R.; Nawrocki, Arkadiusz] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Vainer, Ben; Krustrup, Dorrit] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Leeming, DJ (corresponding author), Nordic Biosci AS, Herlev, Denmark.	DJL@nordicbioscience.com	Lambrechtsen, Jess/M-3822-2014; Hogaboam, Cory M./AAI-1433-2021; Diederichsen, Axel Cosmus Pyndt/C-3355-2013; ZHENG, Qin/T-2925-2019; hogaboam, cory/M-3578-2014; Skjøt-Arkil, Helene/X-2899-2019; Larsen, Martin Rossel/F-1411-2015	Hogaboam, Cory M./0000-0003-3366-4850; Diederichsen, Axel Cosmus Pyndt/0000-0002-1285-4826; Skjøt-Arkil, Helene/0000-0002-2236-6375; Rasmussen, Lars Melholt/0000-0001-5795-4794; Karsdal, Morten/0000-0001-5026-8740; Larsen, Martin Rossel/0000-0001-6203-0123; Lambrechtsen, Jess/0000-0002-9976-9981	Danish Research Foundation (Den Danske Forskningsfond)	Danish Research Foundation (Den Danske Forskningsfond)	The authors gratefully acknowledge funding from the Danish Research Foundation (Den Danske Forskningsfond) to support this work. The funders had no role in the study design, data collection and analysis, decision to publish, or prepaparation of the manuscript.	Anborgh PH, 2011, J CELL COMMUN SIGNAL, V5, P111, DOI 10.1007/s12079-011-0130-6; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Barroso B, 2006, ANAL BIOCHEM, V358, P216, DOI 10.1016/j.ab.2006.07.011; Bay-Jensen AC, 2011, CLIN BIOCH; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; Billinghurst RC, 2010, METHODS MOL BIOL, V622, P349, DOI 10.1007/978-1-60327-299-5_21; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Diederichsen ACP, 2012, EUR J PREV CARDIOL, V19, P558, DOI 10.1177/1741826711409172; DILLON TJ, 1992, AM REV RESPIR DIS, V146, P1143, DOI 10.1164/ajrccm/146.5_Pt_1.1143; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Fritze O, 2012, J VASC RES, V49, P77, DOI 10.1159/000331278; Fuernau G, 2012, INT J CARDIOL; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; Georgiadou P, 2010, EUR J CLIN INVEST, V40, P288, DOI 10.1111/j.1365-2362.2010.02257.x; Gioia M, 2010, J BIOL INORG CHEM, V15, P1219, DOI 10.1007/s00775-010-0680-8; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; Hoffmann U, 2003, CIRCULATION, V108, pE50, DOI 10.1161/01.CIR.0000085363.88377.F2; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; JACOB MP, 1992, CR SOC BIOL, V186, P342; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Karsdal MA, 2011, CLIN BIOCHEM, V44, P1278, DOI 10.1016/j.clinbiochem.2011.08.1135; Karsdal MA, 2009, BIOMARKERS, V14, P181, DOI 10.1080/13547500902777608; Karsdal MA, 2010, CLIN BIOCHEM, V43, P793, DOI 10.1016/j.clinbiochem.2010.03.015; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; KIELTY CM, 1994, FEBS LETT, V351, P85, DOI 10.1016/0014-5793(94)00818-3; Kielty CM, 2002, J CELL SCI, V115, P2817; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; Lagente V, 2009, EXPERT OPIN THER TAR, V13, P287, DOI [10.1517/14728220902751632, 10.1517/14728220902751632 ]; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Leeming DJ, 2010, CLIN BIOCHEM, V43, P1249, DOI 10.1016/j.clinbiochem.2010.07.025; Leeming DJ, 2006, EUR J CLIN PHARM; Lemjabbar H, 1999, AM J RESP CELL MOL, V20, P903, DOI 10.1165/ajrcmb.20.5.3260; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Ma SR, 2003, P NATL ACAD SCI USA, V100, P12941, DOI 10.1073/pnas.2235344100; Madsen SH, 2010, BIOMARKERS, V15, P266, DOI 10.3109/13547500903521810; Marciniak SJ, 2009, THORAX, V64, P359, DOI 10.1136/thx.2008.099408; Mouritzen U, 2003, ANN RHEUM DIS, V62, P332, DOI 10.1136/ard.62.4.332; Muehlschlegel JD, 2009, EUR HEART J, V30, P1574, DOI 10.1093/eurheartj/ehp134; O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946; Orn S, 2007, J CARD FAIL, V13, P843, DOI 10.1016/j.cardfail.2007.07.006; PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011; Petersen E, 2001, EUR J VASC ENDOVASC, V22, P48, DOI 10.1053/ejvs.2001.1404; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Sato Y, 2012, J CARDIOL; Schaller S, 2005, ASSAY DRUG DEV TECHN, V3, P553, DOI 10.1089/adt.2005.3.553; SCHRIVER EE, 1992, AM REV RESPIR DIS, V145, P762, DOI 10.1164/ajrccm/145.4_Pt_1.762; SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654; Skjot-Arkil H, 2012, CLIN EXP RHEUMATOL, V30, P371; Skjot-Arkil H, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-34; Skjot-Arkil H, 2010, ASSAY DRUG DEV TECHN, V8, P542, DOI 10.1089/adt.2009.0258; Stamatelopoulos KS, 2008, EUR J CARDIOV PREV R, V15, P619, DOI 10.1097/HJR.0b013e32830f95a4; STARCHER BC, 1976, ANAL BIOCHEM, V74, P441, DOI 10.1016/0003-2697(76)90224-4; Sukhova GK, 1999, CIRCULATION, V99, P2503, DOI 10.1161/01.CIR.99.19.2503; Taddese S, 2009, MATRIX BIOL, V28, P84, DOI 10.1016/j.matbio.2008.12.002; Tanner RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023609; Thingholm Tine E., 2009, V527, P57, DOI 10.1007/978-1-60327-834-8_5; Thygesen K, 2007, EUR HEART J, V28, P2525; Turino GM, 2012, COPD, V9, P435, DOI 10.3109/15412555.2012.697753; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Umeda H, 2011, BIOCHEM BIOPH RES CO, V411, P281, DOI 10.1016/j.bbrc.2011.06.124; Vassiliadis E, 2012, BIOMARK INSIGHTS, V7, P45, DOI 10.4137/BMI.S9536; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Warming L, 2002, OSTEOPOROSIS INT, V13, P105, DOI 10.1007/s001980200001; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Wohlschlaeger J, 2005, PATHOL RES PRACT, V201, P809, DOI 10.1016/j.prp.2005.08.009; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Zeng B, 2005, INTERN MED J, V35, P331, DOI 10.1111/j.1445-5994.2005.00822.x; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	78	15	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e60936	10.1371/journal.pone.0060936	http://dx.doi.org/10.1371/journal.pone.0060936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805173	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500001
J	Tassano, E; Buttgereit, J; Bader, M; Lerone, M; Divizia, MT; Bocciardi, R; Napoli, F; Pala, G; Sloan-Bena, F; Gimelli, S; Gimelli, G				Tassano, Elisa; Buttgereit, Jens; Bader, Michael; Lerone, Margherita; Divizia, Maria Teresa; Bocciardi, Renata; Napoli, Flavia; Pala, Giovanna; Sloan-Bena, Frederique; Gimelli, Stefania; Gimelli, Giorgio			Genotype-Phenotype Correlation of 2q37 Deletions Including NPPC Gene Associated with Skeletal Malformations	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; OVEREXPRESSION; OVERGROWTH; MUTATIONS; DWARFISM; GROWTH; NPR2; CNP	Coordinated bone growth is controlled by numerous mechanisms which are only partially understood because of the involvement of many hormones and local regulators. The C-type Natriuretic Peptide (CNP), encoded by NPPC gene located on chromosome 2q37.1, is a molecule that regulates endochondral ossification of the cartilaginous growth plate and influences longitudinal bone growth. Two independent studies have described three patients with a Marfan-like phenotype presenting a de novo balanced translocation involving the same chromosomal region 2q37.1 and overexpression of NPPC. We report on two partially overlapping interstitial 2q37 deletions identified by array CGH. The two patients showed opposite phenotypes characterized by short stature and skeletal overgrowth, respectively. The patient with short stature presented a 2q37 deletion causing the loss of one copy of the NPPC gene and the truncation of the DIS3L2 gene with normal CNP plasma concentration. The deletion identified in the patient with a Marfan-like phenotype interrupted the DIS3L2 gene without involving the NPPC gene. In addition, a strongly elevated CNP plasma concentration was found in this patient. A possible role of NPPC as causative of the two opposite phenotypes is discussed in this study.	[Tassano, Elisa; Gimelli, Giorgio] Ist Giannina Gaslini, Lab Citogenet, Genoa, Italy; [Buttgereit, Jens] Joint Inst Max Delbruck Ctr Mol Med MDC, ECRC, Berlin, Germany; [Buttgereit, Jens] Fac Med Charite, Berlin, Germany; [Buttgereit, Jens; Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Lerone, Margherita; Divizia, Maria Teresa] Ist Giannina Gaslini, Lab Genet Mol, Genoa, Italy; [Bocciardi, Renata] Ist Giannina Gaslini, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, DiNOGMI, Genoa, Italy; [Bocciardi, Renata] Ist Giannina Gaslini, Lab Genet Mol, Genoa, Italy; [Sloan-Bena, Frederique; Gimelli, Stefania] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland; [Napoli, Flavia; Pala, Giovanna] Univ Genoa, Ist G Gaslini, Dipartimento Pediat, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Geneva; University of Genoa; IRCCS Istituto Giannina Gaslini	Tassano, E (corresponding author), Ist Giannina Gaslini, Lab Citogenet, Genoa, Italy.	eli.tassano@gmail.com	lerone, margherita/AAC-1583-2021; Napoli, Flavia/AAA-7624-2020; Tassano, Elisa/AAB-1108-2020; Bader, Michael/K-2124-2013; Bocciardi, Renata/J-8577-2016; Divizia, Maria Teresa/AAC-1622-2021; Divizia, Maria Teresa/AAB-1120-2020	lerone, margherita/0000-0003-0666-4740; Tassano, Elisa/0000-0003-2037-0554; Bocciardi, Renata/0000-0001-8415-3802; Divizia, Maria Teresa/0000-0002-8776-0015; Bader, Michael/0000-0003-4780-4164	Cinque per mille dell'IRPEF-Finanziamento della ricerca sanitaria; Finanziamento Ricerca Corrente, Ministero Salute (contributo per la ricerca intramurale)	Cinque per mille dell'IRPEF-Finanziamento della ricerca sanitaria; Finanziamento Ricerca Corrente, Ministero Salute (contributo per la ricerca intramurale)	This work was supported by "Cinque per mille dell'IRPEF-Finanziamento della ricerca sanitaria'' and "Finanziamento Ricerca Corrente, Ministero Salute (contributo per la ricerca intramurale)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Bocciardi R, 2007, HUM MUTAT, V28, P724, DOI 10.1002/humu.20511; Bocciardi R, 2009, ENDOCRIN DEV, V14, P61, DOI 10.1159/000207477; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Drake KM, 2009, CLIN CANCER RES, V15, P5985, DOI 10.1158/1078-0432.CCR-09-1065; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Higashimoto K, 2013, EUR J HUM GENET, V21, P1316, DOI 10.1038/ejhg.2013.45; Kondo E, 2012, CALCIFIED TISSUE INT, V90, P307, DOI 10.1007/s00223-011-9567-0; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Moncla A, 2007, HUM MUTAT, V28, P1183, DOI 10.1002/humu.20611; Olney RC, 2006, J CLIN ENDOCR METAB, V91, P1229, DOI 10.1210/jc.2005-1949; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695	18	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66048	10.1371/journal.pone.0066048	http://dx.doi.org/10.1371/journal.pone.0066048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805197	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000320846500025
J	Vanhomwegen, J; Berthet, N; Mazuet, C; Guigon, G; Vallaeys, T; Stamboliyska, R; Dubois, P; Kennedy, GC; Cole, ST; Caro, V; Manuguerra, JC; Popoff, MR				Vanhomwegen, Jessica; Berthet, Nicolas; Mazuet, Christelle; Guigon, Ghislaine; Vallaeys, Tatiana; Stamboliyska, Rayna; Dubois, Philippe; Kennedy, Giulia C.; Cole, Stewart T.; Caro, Valerie; Manuguerra, Jean-Claude; Popoff, Michel-Robert			Application of High-Density DNA Resequencing Microarray for Detection and Characterization of Botulinum Neurotoxin-Producing Clostridia	PLOS ONE			English	Article							FOOD-BORNE BOTULISM; FOODBORNE BOTULISM; A STRAINS; GENETIC-CHARACTERIZATION; TOXIN; IDENTIFICATION; OUTBREAKS; SEQUENCE; DIFFERENTIATION; DIAGNOSTICS	Background: Clostridium botulinum and related clostridia express extremely potent toxins known as botulinum neurotoxins (BoNTs) that cause severe, potentially lethal intoxications in humans. These BoNT-producing bacteria are categorized in seven major toxinotypes (A through G) and several subtypes. The high diversity in nucleotide sequence and genetic organization of the gene cluster encoding the BoNT components poses a great challenge for the screening and characterization of BoNT-producing strains. Methodology/Principal Findings: In the present study, we designed and evaluated the performances of a resequencing microarray (RMA), the PathogenId v2.0, combined with an automated data approach for the simultaneous detection and characterization of BoNT-producing clostridia. The unique design of the PathogenID v2.0 array allows the simultaneous detection and characterization of 48 sequences targeting the BoNT gene cluster components. This approach allowed successful identification and typing of representative strains of the different toxinotypes and subtypes, as well as the neurotoxin-producing C. botulinum strain in a naturally contaminated food sample. Moreover, the method allowed fine characterization of the different neurotoxin gene cluster components of all studied strains, including genomic regions exhibiting up to 24.65% divergence with the sequences tiled on the arrays. Conclusions/Significance: The severity of the disease demands rapid and accurate means for performing risk assessments of BoNT-producing clostridia and for tracing potentials sources of contamination in outbreak situations. The RMA approach constitutes an essential higher echelon component in a diagnostics and surveillance pipeline. In addition, it is an important asset to characterise potential outbreak related strains, but also environment isolates, in order to obtain a better picture of the molecular epidemiology of BoNT-producing clostridia.	[Vanhomwegen, Jessica; Dubois, Philippe; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Berthet, Nicolas; Guigon, Ghislaine; Caro, Valerie] Inst Pasteur, Paris, France; [Berthet, Nicolas] CNRS, UMR3569, Paris, France; [Mazuet, Christelle; Popoff, Michel-Robert] Inst Pasteur, Anaerob Bacteria & Toxins Unit, Paris, France; [Vallaeys, Tatiana] Univ Montpellier 2, CNRS, CC093, Ecosyst Lagunaires UMR5119, Montpellier, France; [Stamboliyska, Rayna] Univ Munich LMU, Dept Biol 2, Planegg Martinsried, Germany; [Kennedy, Giulia C.] Veracyte Inc, Dept Res & Dev, San Francisco, CA USA; [Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Munich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Vanhomwegen, J (corresponding author), Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France.	jvhomweg@pasteur.fr	Vallaeys, Tatiana/AAE-5508-2019; Berthet, Nicolas/J-9373-2012; Popoff, Michel/O-7719-2016; Mazuet, Christelle/O-7731-2016	Popoff, Michel/0000-0001-9305-8989; Mazuet, Christelle/0000-0001-7619-9050; Dubois, Philippe/0000-0003-1534-1564	U.S. National Institute of Allergy and Infectious Diseases, National Institute of Health [UC1 AI062613]; "Programme Transversal de Recherche'' (DEVA) [246]; Institut Pasteur (Paris, France); Fondation Total-Institut Pasteur; Elisabeth Taub award from the Academie Nationale de Medecine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062613] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases, National Institute of Health; "Programme Transversal de Recherche'' (DEVA); Institut Pasteur (Paris, France); Fondation Total-Institut Pasteur; Elisabeth Taub award from the Academie Nationale de Medecine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This program was supported by grant UC1 AI062613 (to GC Kennedy) from the U.S. National Institute of Allergy and Infectious Diseases, National Institute of Health; by the "Programme Transversal de Recherche'' (DEVA No. 246), financed by the Institut Pasteur (Paris, France), sponsorship by the Fondation Total-Institut Pasteur and the Elisabeth Taub award from the Academie Nationale de Medecine. The funders had no role in study design, data analysis or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Bouzid M, 2010, PARASITOLOGY, V137, P27, DOI 10.1017/S0031182009991132; Browning LM, 2011, EUROSURVEILLANCE, V16, P11; Bruggemann H, 2005, CURR OPIN MICROBIOL, V8, P601, DOI 10.1016/j.mib.2005.08.006; BRUGGEMANN H, 2011, CLOSTRIDIUM BOTULINU, P185; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Corless CE, 2008, J MOL DIAGN, V10, P265, DOI 10.2353/jmoldx.2008.070152; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; Daminelli P, 2011, NEW MICROBIOL, V34, P287; Date K, 2011, J FOOD PROTECT, V74, P2090, DOI 10.4315/0362-028X.JFP-11-128; Davignon L, 2005, J CLIN MICROBIOL, V43, P5690, DOI 10.1128/JCM.43.11.5690-5695.2005; Dineen SS, 2003, CURR MICROBIOL, V46, P345, DOI 10.1007/s00284-002-3851-1; Erlandsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022631; Fach P, 2011, INT J FOOD MICROBIOL, V145, pS145, DOI 10.1016/j.ijfoodmicro.2010.04.006; Fach P, 2009, J APPL MICROBIOL, V107, P465, DOI 10.1111/j.1365-2672.2009.04215.x; Fillo S, 2011, J CLIN MICROBIOL, V49, P4252, DOI 10.1128/JCM.05396-11; Franciosa G, 2004, APPL ENVIRON MICROB, V70, P7192, DOI 10.1128/AEM.70.12.7192-7199.2004; Franciosa G, 2006, FEMS MICROBIOL LETT, V261, P88, DOI 10.1111/j.1574-6968.2006.00331.x; Gadkar V, 2005, J MICROBIOL METH, V63, P157, DOI 10.1016/j.mimet.2005.03.009; Han T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-217; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; HUTSON RA, 1993, ANTON LEEUW INT J G, V64, P273, DOI 10.1007/BF00873087; Hutson RA, 1996, J BIOL CHEM, V271, P10786, DOI 10.1074/jbc.271.18.10786; Jalava K, 2011, EUROSURVEILLANCE, V16, P8; Kirma N, 2004, FEMS MICROBIOL LETT, V231, P159, DOI 10.1016/S0378-1097(03)00911-X; Lai Lung-Shiang, 2011, Acta Neurol Taiwan, V20, P138; Leclair D, 2006, J CLIN MICROBIOL, V44, P1635, DOI 10.1128/JCM.44.5.1635-1644.2006; Leski TA, 2011, APPL ENVIRON MICROB, V77, P4285, DOI 10.1128/AEM.00021-11; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Lin Baochuan, 2009, V529, P231, DOI 10.1007/978-1-59745-538-1_15; Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006; Lindstrom M, 2009, APPL ENVIRON MICROB, V75, P2643, DOI 10.1128/AEM.02557-08; Luquez C, 2009, APPL ENVIRON MICROB, V75, P6094, DOI 10.1128/AEM.01009-09; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; Moriishi K, 1996, BBA-GENE STRUCT EXPR, V1307, P123, DOI 10.1016/0167-4781(96)00006-1; Oriot C, 2011, CLIN TOXICOL, V49, P752, DOI 10.3109/15563650.2011.606222; Pandya GA, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015950., DOI 10.1371/J0URNAL.P0NE.0015950]; Peck MW, 2009, ADV MICROB PHYSIOL, V55, P183, DOI 10.1016/S0065-2911(09)05503-9; Pingeon JM, 2011, EUROSURVEILLANCE, V16, P5; Pourshaban M, 2002, FEMS MICROBIOL LETT, V214, P119, DOI 10.1016/S0378-1097(02)00849-2; Raphael BH, 2008, APPL ENVIRON MICROB, V74, P4390, DOI 10.1128/AEM.00260-08; Raphael BH, 2010, MOL CELL PROBE, V24, P146, DOI 10.1016/j.mcp.2009.12.003; Santos-Buelga JA, 1998, CURR MICROBIOL, V37, P312, DOI 10.1007/s002849900384; Sasaki Y, 2001, INT J SYST EVOL MICR, V51, P901, DOI 10.1099/00207713-51-3-901; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Takeda M, 2005, AVIAN DIS, V49, P376, DOI 10.1637/7347-022305R1.1; Therre H., 1999, EURO SURVEILL, V4, P2; Umeda K, 2010, MICROBIOL IMMUNOL, V54, P308, DOI 10.1111/j.1348-0421.2010.00213.x; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Villar RG, 2006, INFECT DIS CLIN N AM, V20, P313, DOI 10.1016/j.idc.2006.02.003; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Zwick ME, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r10	59	12	13	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67510	10.1371/journal.pone.0067510	http://dx.doi.org/10.1371/journal.pone.0067510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818983	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800140
J	Zhu, Y; Hsu, WH; Hollis, JH				Zhu, Yong; Hsu, Walter H.; Hollis, James H.			The Impact of Food Viscosity on Eating Rate, Subjective Appetite, Glycemic Response and Gastric Emptying Rate	PLOS ONE			English	Article							AFFECT POSTPRANDIAL APPETITE; GLUCAGON-LIKE PEPTIDE-1; NASAL AROMA RELEASE; ENERGY-INTAKE; HORMONAL RESPONSES; MEAL VISCOSITY; PORTION SIZE; YOUNG-ADULTS; OLDER-ADULTS; BITE SIZE	Understanding the impact of rheological properties of food on postprandial appetite and glycemic response helps to design novel functional products. It has been shown that solid foods have a stronger satiating effect than their liquid equivalent. However, whether a subtle change in viscosity of a semi-solid food would have a similar effect on appetite is unknown. Fifteen healthy males participated in the randomized cross-over study. Each participant consumed a 1690 kJ portion of a standard viscosity (SV) and a high viscosity (HV) semi-solid meal with 1000 mg acetaminophen in two separate sessions. At regular intervals during the three hours following the meal, subjective appetite ratings were measured and blood samples collected. The plasma samples were assayed for insulin, glucose-dependent insulinotropic peptide (GIP), glucose and acetaminophen. After three hours, the participants were provided with an ad libitum pasta meal. Compared with the SV meal, HV was consumed at a slower eating rate (P = 0.020), with postprandial hunger and desire to eat being lower (P = 0.019 and P < 0.001 respectively) while fullness was higher (P < 0.001). In addition, consuming the HV resulted in lower plasma concentration of GIP (P < 0.001), higher plasma concentration of glucose (P < 0.001) and delayed gastric emptying as revealed by the acetaminophen absorption test (P < 0.001). However, there was no effect of food viscosity on insulin or food intake at the subsequent meal. In conclusion, increasing the viscosity of a semi-solid food modulates glycemic response and suppresses postprandial satiety, although the effect may be short-lived. A slower eating rate and a delayed gastric emptying rate can partly explain for the stronger satiating properties of high viscous semi-solid foods.	[Zhu, Yong; Hollis, James H.] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; [Hsu, Walter H.] Iowa State Univ, Dept Biomed Sci, Ames, IA USA	Iowa State University; Iowa State University	Hollis, JH (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.	jhollis@iastate.edu			Iowa State University	Iowa State University	The study was funded by Iowa State University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AM, 2008, J AM DIET ASSOC, V108, P1186, DOI 10.1016/j.jada.2008.04.026; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Beck EJ, 2009, MOL NUTR FOOD RES, V53, P1343, DOI 10.1002/mnfr.200800343; BOBROFF EM, 1986, APPETITE, V7, P85, DOI 10.1016/S0195-6663(86)80044-7; Bolhuis DP, 2011, J NUTR, V141, P2242, DOI 10.3945/jn.111.143867; Brynes AE, 1998, NUTRITION, V14, P433, DOI 10.1016/S0899-9007(98)00014-8; Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437; de Wijk RA, 2008, PHYSIOL BEHAV, V95, P527, DOI 10.1016/j.physbeh.2008.07.026; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Flammang AM, 2006, J AM COLL NUTR, V25, P409, DOI 10.1080/07315724.2006.10719553; HABER GB, 1977, LANCET, V2, P679; HEADING RC, 1973, BRIT J PHARMACOL, V47, P415, DOI 10.1111/j.1476-5381.1973.tb08339.x; Jensen LS, 2004, J PHARMACEUT BIOMED, V34, P585, DOI 10.1016/S0731-7085(03)00573-9; Jones KL, 1997, AM J CLIN NUTR, V66, P127, DOI 10.1093/ajcn/66.1.127; Juvonen KR, 2009, J NUTR, V139, P461, DOI 10.3945/jn.108.099945; KISSILEFF HR, 1980, AM J PHYSIOL, V238, pR14, DOI 10.1152/ajpregu.1980.238.1.R14; Kokkinos A, 2010, J CLIN ENDOCR METAB, V95, P333, DOI 10.1210/jc.2009-1018; Leidy HJ, 2010, OBESITY, V18, P293, DOI 10.1038/oby.2009.217; Lundin L, 2009, AUST J DAIRY TECHNOL, V64, P68; Lundin L, 2008, NUTR DIET, V65, pS79, DOI 10.1111/j.1747-0080.2008.00266.x; Marciani L, 2000, J NUTR, V130, P122; Marciani L, 2001, AM J PHYSIOL-GASTR L, V280, pG1227, DOI 10.1152/ajpgi.2001.280.6.G1227; Mattes RD, 2001, PHYSIOL BEHAV, V74, P551, DOI 10.1016/S0031-9384(01)00597-2; Mattes RD, 2009, J AM DIET ASSOC, V109, P430, DOI 10.1016/j.jada.2008.11.031; McCrory MA, 2011, J NUTR, V141, P114; McKiernan F, 2009, J AM DIET ASSOC, V109, P486, DOI 10.1016/j.jada.2008.11.027; MEYER JH, 1986, AM J PHYSIOL, V250, pG161, DOI 10.1152/ajpgi.1986.250.2.G161; Mills JP, 2011, OBESITY, V19, P552, DOI 10.1038/oby.2010.265; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; PERYAM DR, 1957, FOOD TECHNOL-CHICAGO, V11, P32; PROVE J, 1982, GUT, V23, P150, DOI 10.1136/gut.23.2.150; ROLLS BJ, 1991, AM J PHYSIOL, V260, pR756, DOI 10.1152/ajpregu.1991.260.4.R756; Ruijschop RMAJ, 2011, BRIT J NUTR, V105, P307, DOI 10.1017/S000711451000320X; Ruijschop RMAJ, 2009, CHEM SENSES, V34, P395, DOI 10.1093/chemse/bjp011; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Shimoyama Y, 2007, NEUROGASTROENT MOTIL, V19, P879, DOI 10.1111/j.1365-2982.2007.00972.x; Stull AJ, 2008, J AM DIET ASSOC, V108, P1226, DOI 10.1016/j.jada.2008.04.014; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; TORSDOTTIR I, 1989, J NUTR, V119, P1925, DOI 10.1093/jn/119.12.1925; Vuksan V, 2009, NUTR METAB CARDIOVAS, V19, P498, DOI 10.1016/j.numecd.2008.09.006; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Williams JA, 2004, J NUTR, V134, P886, DOI 10.1093/jn/134.4.886; Zhu Y, 2013, BRIT J NUTR, V110, P384, DOI 10.1017/S0007114512005053; Zhu Y, 2013, INT J FOOD SCI NUTR, V64, P385, DOI 10.3109/09637486.2012.759183; Zijlstra N, 2008, INT J OBESITY, V32, P676, DOI 10.1038/sj.ijo.0803776; Zijlstra N, 2009, PHYSIOL BEHAV, V97, P68, DOI 10.1016/j.physbeh.2009.02.001	47	92	93	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67482	10.1371/journal.pone.0067482	http://dx.doi.org/10.1371/journal.pone.0067482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818981	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800138
J	Lau, NM; Green, PHR; Taylor, AK; Hellberg, D; Ajamian, M; Tan, CZ; Kosofsky, BE; Higgins, JJ; Rajadhyaksha, AM; Alaedini, A				Lau, Nga M.; Green, Peter H. R.; Taylor, Annette K.; Hellberg, Dan; Ajamian, Mary; Tan, Caroline Z.; Kosofsky, Barry E.; Higgins, Joseph J.; Rajadhyaksha, Anjali M.; Alaedini, Armin			Markers of Celiac Disease and Gluten Sensitivity in Children with Autism	PLOS ONE			English	Article							IMMUNE-RESPONSE; SPECTRUM DISORDERS; GLIADIN; SCHIZOPHRENIA; PATHOGENESIS; AUTOIMMUNE; ANTIBODIES; SERUM; LINK	Objective: Gastrointestinal symptoms are a common feature in children with autism, drawing attention to a potential association with celiac disease or gluten sensitivity. However, studies to date regarding the immune response to gluten in autism and its association with celiac disease have been inconsistent. The aim of this study was to assess immune reactivity to gluten in pediatric patients diagnosed with autism according to strict criteria and to evaluate the potential link between autism and celiac disease. Methods: Study participants included children (with or without gastrointestinal symptoms) diagnosed with autism according to both the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview, Revised (ADIR) (n = 37), their unaffected siblings (n = 27), and age-matched healthy controls (n = 76). Serum specimens were tested for antibodies to native gliadin, deamidated gliadin, and transglutaminase 2 (TG2). Affected children were genotyped for celiac disease associated HLA-DQ2 and -DQ8 alleles. Results: Children with autism had significantly higher levels of IgG antibody to gliadin compared with unrelated healthy controls (p<0.01). The IgG levels were also higher compared to the unaffected siblings, but did not reach statistical significance. The IgG anti-gliadin antibody response was significantly greater in the autistic children with gastrointestinal symptoms in comparison to those without them (p<0.01). There was no difference in IgA response to gliadin across groups. The levels of celiac disease-specific serologic markers, i.e., antibodies to deamidated gliadin and TG2, did not differ between patients and controls. An association between increased anti-gliadin antibody and presence of HLA-DQ2 and/or -DQ8 was not observed. Conclusions: A subset of children with autism displays increased immune reactivity to gluten, the mechanism of which appears to be distinct from that in celiac disease. The increased anti-gliadin antibody response and its association with GI symptoms points to a potential mechanism involving immunologic and/or intestinal permeability abnormalities in affected children.	[Lau, Nga M.; Green, Peter H. R.; Ajamian, Mary; Tan, Caroline Z.; Alaedini, Armin] Columbia Univ, Dept Med, New York, NY 10027 USA; [Lau, Nga M.; Green, Peter H. R.; Ajamian, Mary; Tan, Caroline Z.; Alaedini, Armin] Columbia Univ, Celiac Dis Ctr, New York, NY USA; [Taylor, Annette K.] LabCorp, Kimball Genet, Denver, CO USA; [Hellberg, Dan] Uppsala Univ, Clin Res Ctr, Falun, Sweden; [Kosofsky, Barry E.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Kosofsky, Barry E.; Higgins, Joseph J.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Alaedini, Armin] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University; Uppsala University; Cornell University; Cornell University; Columbia University	Alaedini, A (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	aa819@columbia.edu		Ajamian, Mary/0000-0001-5819-7078	Department of Defense [W81XWH 10-1-0887]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a grant from the Department of Defense, award number W81XWH 10-1-0887, to Armin Alaedini (PI). The sponsor of the study had no role in the study design, collection, analysis, interpretation of data, writing of the report, or the decision to submit the paper for publication.	Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Alaedini A, 2008, AUTOIMMUNITY, V41, P19, DOI 10.1080/08916930701619219; Alaedini A, 2007, J IMMUNOL, V178, P6590, DOI 10.4049/jimmunol.178.10.6590; Aldrimer M, 2012, SCAND J CLIN LAB INV, V72, P326, DOI 10.3109/00365513.2012.667571; Barcia G, 2008, J AUTISM DEV DISORD, V38, P407, DOI 10.1007/s10803-007-0480-3; Batista IC, 2012, ARQ NEURO-PSIQUIAT, V70, P28, DOI 10.1590/S0004-282X2012000100007; Briani C, 2008, AUTOIMMUN REV, V7, P644, DOI 10.1016/j.autrev.2008.05.006; Brown AC, 2011, EXPERT REV GASTROENT, V5, P465, DOI [10.1586/egh.11.46, 10.1586/EGH.11.46]; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; DEufemia P, 1996, ACTA PAEDIATR, V85, P1076, DOI 10.1111/j.1651-2227.1996.tb14220.x; DOHAN FC, 1969, MENT HYG, V53, P525; Dupont FM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-10; Elder JH, 2008, NUTR CLIN PRACT, V23, P583, DOI 10.1177/0884533608326061; Frye RE, 2012, MOL PSYCHIAT; Goines P, 2011, BRAIN BEHAV IMMUN, V25, P514, DOI 10.1016/j.bbi.2010.11.017; GOODWIN MS, 1969, MENT HYG, V53, P550; Jabri B, 2005, IMMUNOL REV, V206, P219, DOI 10.1111/j.0105-2896.2005.00294.x; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Lundin Knut E A, 2012, Gastrointest Endosc Clin N Am, V22, P723, DOI 10.1016/j.giec.2012.07.006; MCCARTHY DM, 1979, LANCET, V2, P877; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Pavone L, 1997, BIOL PSYCHIAT, V42, P72, DOI 10.1016/S0006-3223(97)00267-9; Qiao SW, 2012, SEMIN IMMUNOPATHOL, V34, P523, DOI 10.1007/s00281-012-0314-z; Samaroo D, 2010, SCHIZOPHR RES, V118, P248, DOI 10.1016/j.schres.2009.08.009; Schwertz E, 2004, CLIN CHEM, V50, P2370, DOI 10.1373/clinchem.2004.036111; Valicenti-McDermott MD, 2008, PEDIATR NEUROL, V39, P392, DOI 10.1016/j.pediatrneurol.2008.07.019; van Eckert R, 2006, J CEREAL SCI, V43, P331, DOI 10.1016/j.jcs.2005.12.009; Vojdani A, 2004, NUTR NEUROSCI, V7, P151, DOI 10.1080/10284150400004155; Wang LW, 2011, J DEV BEHAV PEDIATR, V32, P351, DOI 10.1097/DBP.0b013e31821bd06a; Zhang BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-80	32	73	76	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66155	10.1371/journal.pone.0066155	http://dx.doi.org/10.1371/journal.pone.0066155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823064	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400059
J	Nicastro, A; Bishop, MJ				Nicastro, Andrea; Bishop, Melanie J.			Weak and Habitat-Dependent Effects of Nutrient Pollution on Macrofaunal Communities of Southeast Australian Estuaries	PLOS ONE			English	Article							BENTHIC MACROFAUNA; LAND-USE; ORGANIC ENRICHMENT; WATER-QUALITY; EUTROPHICATION; ASSEMBLAGES; RESPONSES; PATTERNS; NITROGEN; BIOTURBATION	Among the impacts of coastal settlements to estuaries, nutrient pollution is often singled out as a leading cause of modification to the ecological communities of soft sediments. Through sampling of 48 sites, distributed among 16 estuaries of New South Wales, Australia, we tested the hypotheses that (1) anthropogenic nutrient loads would be a better predictor of macrofaunal communities than estuarine geomorphology or local sediment characteristics; and (2) local environmental context, as determined largely by sediment characteristics, would modify the relationship between nutrient loading and community composition. Contrary to the hypothesis, multivariate multiple regression analyses revealed that sediment grain size was the best predictor of macrofaunal assemblage composition. When samples were stratified according to median grain size, relationships between faunal communities and nitrogen loading and latitude emerged, but only among estuaries with sandier sediments. In these estuaries, capitellid and nereid polychaetes and chironomid larvae were the taxa that showed the strongest correlations with nutrient loading. Overall, this study failed to provide evidence of a differential relationship between diffuse nutrient enrichment and benthic macrofauna across a gradient of 7 degrees of latitude and 4 degrees C temperature. Nevertheless, as human population growth continues to place increasing pressure on southeast Australian estuaries, manipulative field studies examining when and where nutrient loading will lead to significant changes in estuarine community structure are needed.	[Nicastro, Andrea; Bishop, Melanie J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia	Macquarie University	Nicastro, A (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	andrea.nicastro@students.mq.edu.au	Bishop, Melanie/AGA-7862-2022	Bishop, Melanie/0000-0001-8210-6500	Macquarie University Higher Degree Research Fund; Australian Research Council Discovery Grant [DP1093444]	Macquarie University Higher Degree Research Fund; Australian Research Council Discovery Grant(Australian Research Council)	The research was funded by the Macquarie University Higher Degree Research Fund (to A. Nicastro) and an Australian Research Council Discovery Grant DP1093444 (to Melanie Bishop). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio K, 1996, J SEA RES, V36, P311, DOI 10.1016/S1385-1101(96)90798-4; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Biles CL, 2002, HYDROL EARTH SYST SC, V6, P999, DOI 10.5194/hess-6-999-2002; Bilkovic DM, 2006, ESTUAR COAST, V29, P1185, DOI 10.1007/BF02781819; Bishop MJ, 2008, OIKOS, V117, P531, DOI 10.1111/j.0030-1299.2008.16418.x; Bishop MJ, 2007, MAR ECOL PROG SER, V341, P25, DOI 10.3354/meps341025; Bishop MJ, 2006, OECOLOGIA, V149, P701, DOI 10.1007/s00442-006-0481-5; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chapman MG, 2007, J EXP MAR BIOL ECOL, V343, P96, DOI 10.1016/j.jembe.2006.12.001; Christensen B, 2000, MAR ECOL PROG SER, V192, P203, DOI 10.3354/meps192203; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Conley DJ, 2007, ECOL APPL, V17, pS165, DOI 10.1890/05-0766.1; Currie DR, 2005, ESTUAR COAST SHELF S, V63, P315, DOI 10.1016/j.ecss.2004.11.023; Davis JR, 2006, HYDROBIOLOGIA, V559, P23, DOI 10.1007/s10750-005-4429-2; Dethier MN, 2006, MAR ECOL PROG SER, V306, P41, DOI 10.3354/meps306041; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Duarte AALS, 2009, ENERGY ENVIRON ENG S, P240; Dugan JE, 2011, ESTUAR COAST, V34, P839, DOI 10.1007/s12237-011-9375-9; Ellis J. I., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P57, DOI 10.1023/A:1009923530894; Fitch JE, 2012, MAR ECOL PROG SER, V461, P59, DOI 10.3354/meps09819; Fukunaga A, 2011, J EXP MAR BIOL ECOL, V396, P244, DOI 10.1016/j.jembe.2010.10.029; GABRIC AJ, 1993, AUST J MAR FRESH RES, V44, P261; Glassom D, 1997, MAR ECOL PROG SER, V149, P1, DOI 10.3354/meps149001; Grant J, 2007, CAN J FISH AQUAT SCI, V64, P387, DOI 10.1139/F07-021; Gray J.S., 1974, Oceanography mar Biol, V12, P223; Griffen BD, 2004, MAR ECOL PROG SER, V269, P223, DOI 10.3354/meps269223; Harris GP, 2001, MAR FRESHWATER RES, V52, P139, DOI 10.1071/MF00031; Hastie BF, 2006, J EXP MAR BIOL ECOL, V330, P356, DOI 10.1016/j.jembe.2005.12.039; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Lindegarth M, 2001, ESTUAR COAST SHELF S, V52, P237, DOI 10.1006/ecss.2000.0741; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Morris L, 2003, MAR FRESHWATER RES, V54, P859, DOI 10.1071/MF02157; MORRISEY DJ, 1992, MAR ECOL PROG SER, V81, P197, DOI 10.3354/meps081197; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; O'Brien AL, 2010, MAR FRESHWATER RES, V61, P1388, DOI 10.1071/MF10085; O'Brien AL, 2009, J EXP MAR BIOL ECOL, V371, P51, DOI 10.1016/j.jembe.2009.01.004; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Pelletier MC, 2011, ENVIRON TOXICOL CHEM, V30, P538, DOI 10.1002/etc.414; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; RHOADS DC, 1970, J MAR RES, V28, P150; Roper T., 2011, ASSESSING CONDITION; Rothenberger MB, 2009, ENVIRON MANAGE, V44, P505, DOI 10.1007/s00267-009-9330-8; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Savage C, 2002, MAR ECOL PROG SER, V243, P67, DOI 10.3354/meps243067; Scanes P, 2007, ESTUAR COAST SHELF S, V74, P306, DOI 10.1016/j.ecss.2007.04.021; Schuckel U, 2013, HELGOLAND MAR RES, V67, P121, DOI 10.1007/s10152-012-0309-0; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Thrush SF, 2003, ECOL APPL, V13, P1433, DOI 10.1890/02-5198; WARWICK RM, 1993, MAR ECOL PROG SER, V92, P221, DOI 10.3354/meps092221; Webb AP, 2004, MAR ECOL PROG SER, V268, P205, DOI 10.3354/meps268205; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; WESTON DP, 1990, MAR ECOL PROG SER, V61, P233, DOI 10.3354/meps061233; Wildsmith MD, 2011, MAR POLLUT BULL, V62, P525, DOI 10.1016/j.marpolbul.2010.11.031; Wildsmith MD, 2009, MAR POLLUT BULL, V58, P1250, DOI 10.1016/j.marpolbul.2009.06.008; York PH, 2012, MAR ECOL PROG SER, V449, P291, DOI 10.3354/meps09541; Ysebaert T, 2002, MAR ECOL PROG SER, V244, P105, DOI 10.3354/meps244105	58	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65706	10.1371/journal.pone.0065706	http://dx.doi.org/10.1371/journal.pone.0065706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799037	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800015
J	Teese, MG; Farnsworth, CA; Li, YQ; Coppin, CW; Devonshire, AL; Scott, C; East, P; Russell, RJ; Oakeshott, JG				Teese, Mark G.; Farnsworth, Claire A.; Li, Yongqiang; Coppin, Chris W.; Devonshire, Alan L.; Scott, Colin; East, Peter; Russell, Robyn J.; Oakeshott, John G.			Heterologous Expression and Biochemical Characterisation of Fourteen Esterases from Helicoverpa armigera	PLOS ONE			English	Article							HUBNER LEPIDOPTERA; MUTANT CARBOXYLESTERASES; METABOLIC RESISTANCE; ACETYLCHOLINESTERASE; INSECTICIDES; PYRETHROIDS; HYDROLYSIS; DNA; AMPLIFICATION; FENVALERATE	Esterases have recurrently been implicated in insecticide resistance in Helicoverpa armigera but little is known about the underlying molecular mechanisms. We used a baculovirus system to express 14 of 30 full-length esterase genes so far identified from midgut cDNA libraries of this species. All 14 produced esterase isozymes after native PAGE and the isozymes for seven of them migrated to two regions of the gel previously associated with both organophosphate and pyrethroid resistance in various strains. Thirteen of the enzymes obtained in sufficient yield for further analysis all showed tight binding to organophosphates and low but measurable organophosphate hydrolase activity. However there was no clear difference in activity between the isozymes from regions associated with resistance and those from elsewhere in the zymogram, or between eight of the isozymes from a phylogenetic clade previously associated with resistance in proteomic and quantitative rtPCR experiments and five others not so associated. By contrast, the enzymes differed markedly in their activities against nine pyrethroid isomers and the enzymes with highest activity for the most insecticidal isomers were from regions of the gel and, in some cases, the phylogeny that had previously been associated with pyrethroid resistance. Phospholipase treatment confirmed predictions from sequence analysis that three of the isozymes were GPI anchored. This unusual feature among carboxylesterases has previously been suggested to underpin an association that some authors have noted between esterases and resistance to the Cry1Ac toxin from Bacillus thuringiensis. However these three isozymes did not migrate to the zymogram region previously associated with Cry1Ac resistance.	[Teese, Mark G.; Farnsworth, Claire A.; Li, Yongqiang; Coppin, Chris W.; Devonshire, Alan L.; Scott, Colin; East, Peter; Russell, Robyn J.; Oakeshott, John G.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Teese, Mark G.] Australian Natl Univ, Sch Chem, Canberra, ACT, Australia; [Farnsworth, Claire A.] Australian Natl Univ, Sch Biol Sci, Canberra, ACT, Australia; [Li, Yongqiang] Northwest A&F Univ, Coll Plant Protect, Res & Dev Ctr Biorat Pesticides, Yangling, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Australian National University; Northwest A&F University - China	Oakeshott, JG (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	john.oakeshott@csiro.au	Oakeshott, John G/B-5365-2009; Coppin, Christopher/C-1269-2009; Scott, Colin/A-4682-2009; Russell, Robyn/C-5449-2008; Teese, Mark G/B-4307-2008	Oakeshott, John G/0000-0001-8324-7874; Scott, Colin/0000-0001-6110-6982; Russell, Robyn/0000-0001-5600-3305; Teese, Mark G/0000-0002-8003-4918	Cotton Catchment Cummunities CRC; China Scholarship Council	Cotton Catchment Cummunities CRC; China Scholarship Council(China Scholarship Council)	This study was supported by an Australian Postgraduate Award and Top-up Scholarship from the Cotton Catchment Cummunities CRC to Claire Farnsworth and the China Scholarship Council to Yongqiang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaleke J, 2009, PEST MANAG SCI, V65, P1147, DOI 10.1002/ps.1807; Alvi AHK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047309; Angelucci C, 2008, INSECT BIOCHEM MOLEC, V38, P685, DOI 10.1016/j.ibmb.2008.03.010; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Campbell BE, 2001, ROLE ESTERASES AUSTR; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P139, DOI 10.1016/S0965-1748(97)00109-4; Coppin CW, 2012, INSECT BIOCHEM MOLEC, V42, P343, DOI 10.1016/j.ibmb.2012.01.004; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; Devonshire AL, 2007, INSECT BIOCHEM MOLEC, V37, P891, DOI 10.1016/j.ibmb.2007.04.011; Devonshire AL, 2003, PESTIC BIOCHEM PHYS, V76, P1, DOI 10.1016/S0048-3575(03)00054-3; ELLIOTT M, 1974, ADV CHEM SER, P80; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farnsworth CA, 2010, J PESTIC SCI, V35, P275, DOI 10.1584/jpestics.R10-13; Gunning R. V., 2006, Biopesticides International, V2, P129; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Gunning RV, 1999, PESTIC BIOCHEM PHYS, V63, P50, DOI 10.1006/pest.1998.2388; Gunning RV, 1996, PESTIC BIOCHEM PHYS, V54, P12, DOI 10.1006/pest.1996.0004; Gunning RV, 1998, PIPERONYL BUTOXIDE I, P215; Han YC, 2012, PESTIC BIOCHEM PHYS, V104, P243, DOI 10.1016/j.pestbp.2012.09.005; Hartley CJ, 2006, P NATL ACAD SCI USA, V103, P8757, DOI 10.1073/pnas.0509590103; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Heidari R, 2004, INSECT BIOCHEM MOLEC, V34, P353, DOI 10.1016/j.ibmb.2004.01.001; Heidari R, 2002, KINETIC PROPERTIES E; Horejsi T, 1999, J AM SOC HORTIC SCI, V124, P128, DOI 10.21273/JASHS.124.2.128; Incardona JP, 1996, MOL BIOL CELL, V7, P595, DOI 10.1091/mbc.7.4.595; Jackson CJ, 2010, ANTICHOLINESTERASE PESTICIDES: METABOLISM, NEUROTOXICITY, AND EPIDEMIOLOGY, P57; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Kranthi KR, 2001, B ENTOMOL RES, V91, P37; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Massoulie J, 1999, CHEM-BIOL INTERACT, V119, P29, DOI 10.1016/S0009-2797(99)00011-3; MASTROPAOLO W, 1981, ANAL BIOCHEM, V115, P188, DOI 10.1016/0003-2697(81)90544-3; McCaffery AR, 1998, PHILOS T R SOC B, V353, P1735, DOI 10.1098/rstb.1998.0326; MOORES GD, 1994, PESTIC BIOCHEM PHYS, V49, P114, DOI 10.1006/pest.1994.1038; Myers MA, 1996, BIOCHEM GENET, V34, P201, DOI 10.1007/BF02407020; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; OAKESHOTT JG, 1993, GENETICA, V90, P239, DOI 10.1007/BF01435043; Pap L, 1996, J ENVIRON SCI HEAL B, V31, P527, DOI 10.1080/03601239609373015; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; Washington MT, 2003, P NATL ACAD SCI USA, V100, P12093, DOI 10.1073/pnas.2134223100; Wu SW, 2011, INSECT BIOCHEM MOLEC, V41, P14, DOI 10.1016/j.ibmb.2010.09.007; Yang YiHua, 2008, Cotton Science, V20, P249; Young SJ, 2005, PEST MANAG SCI, V61, P397, DOI 10.1002/ps.996	44	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65951	10.1371/journal.pone.0065951	http://dx.doi.org/10.1371/journal.pone.0065951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799064	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800021
J	Blanch, A; Robinson, F; Watson, IR; Cheng, LS; Irwin, MS				Blanch, Alvaro; Robinson, Fiona; Watson, Ian R.; Cheng, Lynn S.; Irwin, Meredith S.			Eukaryotic Translation Elongation Factor 1-Alpha 1 Inhibits p53 and p73 Dependent Apoptosis and Chemotherapy Sensitivity	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; FACTOR-I-ALPHA; MOLECULE MDM2 ANTAGONISTS; UBIQUITIN-PROTEIN LIGASE; STRESS-INDUCED APOPTOSIS; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER CELLS; UP-REGULATION; FACTOR EF-1-ALPHA; HOMOLOG P73	The p53 family of transcription factors is a key regulator of cell proliferation and death. In this report we identify the eukaryotic translation elongation factor 1-alpha 1 (eEF1A1) to be a novel p53 and p73 interacting protein. Previous studies have demonstrated that eEF1A1 has translation-independent roles in cancer. We report that overexpression of eEF1A1 specifically inhibits p53-, p73- and chemotherapy-induced apoptosis resulting in chemoresistance. Short-interfering RNA-mediated silencing of eEF1A1 increases chemosensitivity in cell lines bearing wild type p53, but not in p53 null cells. Furthermore, silencing of eEF1A1 partially rescues the chemoresistance observed in response to p53 or p73 knockdown, suggesting that eEF1A1 is a negative regulator of the pro-apoptotic function of p53 and p73. Thus, in the context of p53-family signaling, eEF1A1 has anti-apoptotic properties. These findings identify a novel mechanism of regulation of the p53 family of proteins by eEF1A1 providing additional insight into potential targets to sensitize tumors to chemotherapy.	[Blanch, Alvaro; Robinson, Fiona; Watson, Ian R.; Cheng, Lynn S.; Irwin, Meredith S.] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Blanch, Alvaro; Robinson, Fiona; Watson, Ian R.; Cheng, Lynn S.; Irwin, Meredith S.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Irwin, Meredith S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Irwin, Meredith S.] Univ Toronto, Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Irwin, MS (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada.	meredith.irwin@sickkids.ca		Watson, Ian/0000-0002-6025-3080	Canadian Cancer Society Research Institute (CCSRI) [2010-700580]; Canada Research Chair in Cancer Biology; Hospital for Sick Children; Ministry of Education and Science (MEC) of Spain	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canada Research Chair in Cancer Biology; Hospital for Sick Children; Ministry of Education and Science (MEC) of Spain(Spanish Government)	This work was supported by Canadian Cancer Society Research Institute (CCSRI #2010-700580) and a Canada Research Chair in Cancer Biology to MSI. AB is a recipient of the Hospital for Sick Children and Ministry of Education and Science (MEC) of Spain Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrebir M, 2005, ANTICANCER RES, V25, P2573; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; de Wit NJW, 2002, MELANOMA RES, V12, P57, DOI 10.1097/00008390-200202000-00009; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Edmonds BT, 1996, J CELL SCI, V109, P2705; Frum R, 2007, J PROTEOME RES, V6, P1410, DOI 10.1021/pr060584p; Gopalkrishnan RV, 1999, INT J BIOCHEM CELL B, V31, P151, DOI 10.1016/S1357-2725(98)00138-1; GRANT AG, 1992, INT J CANCER, V50, P740, DOI 10.1002/ijc.2910500513; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Irwin MS, 2004, CELL CYCLE, V3, P319; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Johnsson A, 2000, BRIT J CANCER, V83, P1047, DOI 10.1054/bjoc.2000.1420; Kato MV, 1997, BLOOD, V90, P1373, DOI 10.1182/blood.V90.4.1373.1373_1373_1378; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kim J, 2009, LAB INVEST, V89, P867, DOI 10.1038/labinvest.2009.53; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li BDL, 2002, ANN SURG, V235, P732, DOI 10.1097/00000658-200205000-00016; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nathan CAO, 2000, CANCER RES, V60, P3599; Ohtsuka T, 2003, ONCOGENE, V22, P1678, DOI 10.1038/sj.onc.1206306; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Qian YJ, 2012, CELL CYCLE, V11, P3525, DOI 10.4161/cc.21962; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rosenwald IB, 2001, CANCER-AM CANCER SOC, V92, P2164, DOI 10.1002/1097-0142(20011015)92:8<2164::AID-CNCR1559>3.0.CO;2-A; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Selga E, 2009, GENOME MED, V1, DOI 10.1186/gm83; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Watson IR, 2006, J BIOL CHEM, V281, P34096, DOI 10.1074/jbc.M603654200; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Xie D, 2002, INT J ONCOL, V21, P499; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	58	48	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66436	10.1371/journal.pone.0066436	http://dx.doi.org/10.1371/journal.pone.0066436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799104	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300083
J	Kumar, B; Tripathi, C; Kanchan, RK; Tripathi, JK; Ghosh, JK; Ramachandran, R; Bhadauria, S; Tripathi, RK				Kumar, Balawant; Tripathi, Chakrapani; Kanchan, Ranjana K.; Tripathi, Jitendra Kumar; Ghosh, Jimut K.; Ramachandran, Ravishankar; Bhadauria, Smrati; Tripathi, Raj Kamal			Dynamics of Physical Interaction between HIV-1 Nef and ASK1: Identifying the Interacting Motif(S)	PLOS ONE			English	Article							BLOOD-BANK COHORT; SIGNAL-REGULATING KINASE-1; T-CELL DEPLETION; PROTEIN-KINASE; FAS-LIGAND; PROXIMITY LIGATION; INDUCED APOPTOSIS; INFECTED-CELLS; ACTIVATION; DEATH	FasL mediated preferential apoptosis of bystander CTLs while protection of infected CD4(+)T cells remains one of the hallmarks of immune evasion during HIV infection. The property of infected host cells to evade cell-autonomous apoptosis emanates from ability of HIV-1Nef -protein to physically interact with ASK-1 and thereby inhibit its enzymatic activity. The specific domains of HIV-1Nef through which it may interact with ASK1 and thereby impair the ASK1 activity remain unidentified so far and represent a major challenge towards developing clear understanding about the dynamics of this interaction. Using mammalian two hybrid screen in association with site directed mutagenesis and competitive inhibitor peptides, we identified constituent minimal essential domain (152 DEVGEANN 159) through which HIV-1Nef interacts with ASK1 and inhibits its function. Furthermore our study also unravels a novel alternate mechanism underlying HIV-1 Nef mediated ASK1 functional modulation, wherein by potentiating the inhibitory ser(967) phosphorylation of ASK1, HIV-1Nef negatively modulated ASK1function.	[Kumar, Balawant; Tripathi, Chakrapani; Kanchan, Ranjana K.; Bhadauria, Smrati; Tripathi, Raj Kamal] CSIR, Cent Drug Res Inst, Div Toxicol, Jankipuram, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bhadauria, S (corresponding author), CSIR, Cent Drug Res Inst, Div Toxicol, BS 10-1,Sect 10 Jankipuram Extens, Jankipuram, Uttar Pradesh, India.	smrati_bhadauria@cdri.res.in; rk_tripathi@cdri.res.in	Kumar, Balawant/AAW-9616-2021; Kanchan, Ranjana Kumari/AAD-6218-2022; Tripathi, Jitendra Kumar/N-2631-2013; tripathi, chakrapani/K-5220-2019	Kanchan, Ranjana Kumari/0000-0002-9649-9488; Tripathi, Jitendra Kumar/0000-0001-9246-8388; tripathi, chakrapani/0000-0002-0370-5829; kumar, Balawant/0000-0002-8187-3078; Ramachandran, Ravishankar/0000-0002-0723-9861	CSIR India	CSIR India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Birch MR, 2001, J CLIN VIROL, V22, P263, DOI 10.1016/S1386-6532(01)00198-6; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Dyer WB, 1997, AIDS, V11, P1565, DOI 10.1097/00002030-199713000-00004; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gao YH, 2010, APOPTOSIS, V15, P822, DOI 10.1007/s10495-010-0495-7; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Gullberg M, 2004, P NATL ACAD SCI USA, V101, P8420, DOI 10.1073/pnas.0400552101; Hyun AS, 2010, J BIOL CHEM, V285, P2397, DOI [10.1074/jbc.M109.064295, DOI 10.1074/JBC.M109.064295.PUBMED:19920149]; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jean PH, 2005, BLOOD, V105, P2458, DOI [10.1182/blood-2004-08-3058, DOI 10.1182/BL00D-2004-08-3058.PUBMED:15585654]; Karuppiah M, 2005, BLOOD, V106, P6, DOI [10.1182/blood-2005-04-1582, DOI 10.1182/BL00D-2005-04-1582]; Katsikis PD, 1997, J EXP MED, V186, P1365, DOI 10.1084/jem.186.8.1365; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Lixin Z, 1999, P NATL ACAD SCI USA, V96, P8511, DOI [10.1073/pnas.96.15.8511, DOI 10.1073/PNAS.96.15.8511.PUBMED:10411906]; Masao S, 1998, EMBO J, V17, P2596, DOI [DOI 10.1093/EMB0J/17.9.2596.PUBMED:9564042, 10.1093/emboj/17.9.2596]; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Philippe J, 2009, MOL BIOL CELL, V20, P3628, DOI [10.1091/mbc.E09-03-0211, DOI 10.1091/MBC.E09-03-0211.PUBMED:19570911]; Robichaud GA, 2000, AIDS RES HUM RETROV, V16, P1959, DOI 10.1089/088922200750054684; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SCHULZEOSTHOFF K, 1994, EMBO J, V13, P4587, DOI 10.1002/j.1460-2075.1994.tb06780.x; Silvestris F, 1996, AIDS, V10, P131, DOI 10.1097/00002030-199602000-00002; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Sloand EM, 1997, BLOOD, V89, P1357, DOI 10.1182/blood.V89.4.1357; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Takizawa T, 2002, EUR J BIOCHEM, V269, P6126, DOI 10.1046/j.1432-1033.2002.03325.x; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Young S, 2004, J GEN VIROL, V85, P1451, DOI [10.1099/vir.0.79803-0, DOI 10.1099/VIR.0.79803-0.PUBMED:15166428]; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	41	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67586	10.1371/journal.pone.0067586	http://dx.doi.org/10.1371/journal.pone.0067586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799149	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300112
J	Lai, CH; Huang, SF; Liao, CT; Chen, IH; Wang, HM; Hsieh, LL				Lai, Chih-Hsiung; Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How; Wang, Hung-Ming; Hsieh, Ling-Ling			Clinical Significance in Oral Cavity Squamous Cell Carcinoma of Pathogenic Somatic Mitochondrial Mutations	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA MUTATIONS; PROMOTES TUMORIGENESIS; TRANSCRIPTION FACTOR; NECK-CANCER; P53; PROTEIN; BINDING; HEAD; POLYMORPHISMS	Somatic mutations affecting the mitochondrial DNA (mtDNA) have been frequently observed in human cancers and proposed as important oncological biomarkers. However, the clinical significance of mtDNA mutations in cancer remains unclear. This study was therefore performed to explore the possible clinical use in assessing oral squamous cell carcinoma (OSCC) of pathogenic mtDNA mutations. The entire mitochondrial genome of 300 OSCC with their matched control DNAs was screened by direct sequencing and criteria were set to define a pathogenic somatic mutation. The patients' TP53 R72P genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism. The relationships between pathogenic somatic mutations, clinicopathogical features, TP53 R72P genotype and clinical prognosis were analyzed. Overall, 645 somatic mtDNA mutations were identified and 91 of these mutations were defined as pathogenic. About one quarter (74/300) of the OSCC tumor samples contained pathogenic mutations. Individuals with the TP53 R allele had a higher frequency of pathogenic somatic mutation than those with the PP genotype. Kaplan-Meier analysis indicated that TP53 R allele patients with pathogenic somatic mutations demonstrated a significant association with a poorer disease-free survival than other individuals (HR = 1.71; 95% CI, 1.15-2.57; p = 0.009) and this phenomenon still existed after adjusting for mtDNA haplogroup, tumor stage with treatment regimens, differentiation and age at diagnosis (HR = 1.59; 95% CI, 1.06-2.40; p = 0.03). Subgroup analyses showed that this phenomenon was limited to patients who received adjuvant radiotherapy/chemo-radiotherapy after surgery. The results strongly indicated that pathogenic mtDNA mutations are a potential prognostic marker for OSCCs. Furthermore, functional mitochondria may play an active role in cancer development and the patient's response to radiotherapy/chemo-radiotherapy.	[Lai, Chih-Hsiung] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Huang, Shiang-Fu; Liao, Chun-Ta; Chen, I-How] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan, Taiwan; [Hsieh, Ling-Ling] Chang Gung Univ, Coll Med, Dept Publ Hlth, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsieh, LL (corresponding author), Chang Gung Univ, Coll Med, Dept Publ Hlth, Tao Yuan, Taiwan.	llhsieh@mail.cgu.edu.tw			National Science Council, Executive Yuan, Taiwan [NSC95-2314-B-182-049-MY3, NSC98-2314-B-182-046-MY3]	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Grant NSC95-2314-B-182-049-MY3 and NSC98-2314-B-182-046-MY3 from the National Science Council, Executive Yuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bureau of Health Promotion, 2012, CANC REG ANN REP 200; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Compton S, 2011, J BIOL CHEM, V286, P20297, DOI 10.1074/jbc.M110.163063; de Souza-Pinto NC, 2004, ONCOGENE, V23, P6559, DOI 10.1038/sj.onc.1207874; Galluzzi L, 2010, MOL ASPECTS MED, V31, P1, DOI 10.1016/j.mam.2009.08.002; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Grochola LF, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001032; Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh LL, 2005, BRIT J CANCER, V92, P30, DOI 10.1038/sj.bjc.6602271; Hsieh LL, 2003, CANCER EPIDEM BIOMAR, V12, P439; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; Koczor CA, 2012, AM J PATHOL, V180, P2276, DOI 10.1016/j.ajpath.2012.01.045; Kulawiec M, 2010, ENVIRON MOL MUTAGEN, V51, P427, DOI 10.1002/em.20582; Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893; Lai CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049684; Larman TC, 2012, P NATL ACAD SCI USA, V109, P14087, DOI 10.1073/pnas.1211502109; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069; Pereira L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-53; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Sanchez-Cespedes M, 2001, CANCER RES, V61, P7015; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yoshida Y, 2003, CANCER RES, V63, P3729; Zhou SY, 2007, P NATL ACAD SCI USA, V104, P7540, DOI 10.1073/pnas.0610818104; Zhu F, 2010, CANCER RES, V70, P5851, DOI 10.1158/0008-5472.CAN-09-4646	47	15	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65578	10.1371/journal.pone.0065578	http://dx.doi.org/10.1371/journal.pone.0065578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799027	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300027
J	Arafat, K; Iratni, R; Takahashi, T; Parekh, K; Al Dhaheri, Y; Adrian, TE; Attoub, S				Arafat, Kholoud; Iratni, Rabah; Takahashi, Takashi; Parekh, Khatija; Al Dhaheri, Yusra; Adrian, Thomas E.; Attoub, Samir			Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; APOPTOSIS; CYTOKINE-1; INDUCTION; P21	A major challenge for oncologists and pharmacologists is to develop more potent and less toxic drugs that will decrease the tumor growth and improve the survival of lung cancer patients. Salinomycin is a polyether antibiotic used to kill gram-positive bacteria including mycobacteria, protozoans such as plasmodium falciparum, and the parasites responsible for the poultry disease coccidiosis. This old agent is now a serious anti-cancer drug candidate that selectively inhibits the growth of cancer stem cells. We investigated the impact of salinomycin on survival, colony growth, migration and invasion of the differentiated human non-small cell lung cancer lines LNM35 and A549. Salinomycin caused concentration-and time-dependent reduction in viability of LNM35 and A549 cells through a caspase 3/7-associated cell death pathway. Similarly, salinomycin (2.5-5 mu M for 7 days) significantly decreased the growth of LNM35 and A549 colonies in soft agar. Metastasis is the main cause of death related to lung cancer. In this context, salinomycin induced a time-and concentration-dependent inhibition of cell migration and invasion. We also demonstrated for the first time that salinomycin induced a marked increase in the expression of the pro-apoptotic protein NAG-1 leading to the inhibition of lung cancer cell invasion but not cell survival. These findings identify salinomycin as a promising novel therapeutic agent for lung cancer.	[Arafat, Kholoud; Attoub, Samir] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates; [Iratni, Rabah; Al Dhaheri, Yusra] United Arab Emirates Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates; [Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi 4648601, Japan; [Parekh, Khatija; Adrian, Thomas E.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; Nagoya University; United Arab Emirates University	Attoub, S (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pharmacol & Therapeut, Al Ain, U Arab Emirates.	samir.attoub@uaeu.ac.ae	Takahashi, Takashi/I-7262-2014; Attoub, Samir/N-6852-2018	Takahashi, Takashi/0000-0003-0615-7001; Adrian, Thomas/0000-0002-5051-1111	Terry Fox fund for Cancer Research; UAEU-National Research Foundation fund	Terry Fox fund for Cancer Research; UAEU-National Research Foundation fund	This study was supported by Terry Fox fund for Cancer Research (SA and TA) and partly by the UAEU-National Research Foundation fund to SA. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dhaheri Y, 2013, BBA-GEN SUBJECTS, V1830, P3121, DOI 10.1016/j.bbagen.2013.01.010; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Golkar L, 2007, J SURG RES, V138, P163, DOI 10.1016/j.jss.2006.05.037; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; Huczynski A, 2012, CHEM BIOL DRUG DES, V79, P235, DOI 10.1111/j.1747-0285.2011.01287.x; Kadara H, 2006, CANCER BIOL THER, V5, P518, DOI 10.4161/cbt.5.5.2602; Ketola K, 2012, BRIT J CANCER, V106, P99, DOI 10.1038/bjc.2011.530; Kim CH, 2008, BIOCHEM PHARMACOL, V75, P1751, DOI 10.1016/j.bcp.2008.02.002; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Kim KY, 2011, BIOCHEM BIOPH RES CO, V413, P80, DOI 10.1016/j.bbrc.2011.08.054; Korpanty Grzegorz, 2011, J Thorac Dis, V3, P19, DOI 10.3978/j.issn.2072-1439.2010.11.11; Kozaki K, 2000, CANCER RES, V60, P2535; Lee DH, 2003, CANCER RES, V63, P4648; Liu T, 2003, CANCER RES, V63, P5034; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; Mahmoudi N, 2006, J ANTIMICROB CHEMOTH, V57, P489, DOI 10.1093/jac/dki470; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; Oak PS, 2012, INT J CANCER, V131, P2808, DOI 10.1002/ijc.27595; Parajuli B, 2013, CANC EPIDEMIOL; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Verdoodt B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044132; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050638; Wang Y, 2011, MED CHEM, V7, P106, DOI 10.2174/157340611794859307; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Zhang GN, 2011, CANCER LETT, V313, P137, DOI 10.1016/j.canlet.2011.05.030; Zhang Y, 2012, BIOMATERIALS, V33, P679, DOI 10.1016/j.biomaterials.2011.09.072	35	41	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66931	10.1371/journal.pone.0066931	http://dx.doi.org/10.1371/journal.pone.0066931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805285	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500113
J	Ekdale, EG				Ekdale, Eric G.			Comparative Anatomy of the Bony Labyrinth (Inner Ear) of Placental Mammals	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; RIBOSOMAL-RNA SEQUENCES; WILLEBRAND-FACTOR GENE; LOW-FREQUENCY HEARING; SEMICIRCULAR CANALS; EUTHERIAN MAMMALS; GUINEA-PIG; MITOCHONDRIAL GENOMES; PHYLOGENETIC ANALYSIS; PLANAR RELATIONSHIPS	Background: Variation is a naturally occurring phenomenon that is observable at all levels of morphology, from anatomical variations of DNA molecules to gross variations between whole organisms. The structure of the otic region is no exception. The present paper documents the broad morphological diversity exhibited by the inner ear region of placental mammals using digital endocasts constructed from high-resolution X-ray computed tomography (CT). Descriptions cover the major placental clades, and linear, angular, and volumetric dimensions are reported. Principal Findings: The size of the labyrinth is correlated to the overall body mass of individuals, such that large bodied mammals have absolutely larger labyrinths. The ratio between the average arc radius of curvature of the three semicircular canals and body mass of aquatic species is substantially lower than the ratios of related terrestrial taxa, and the volume percentage of the vestibular apparatus of aquatic mammals tends to be less than that calculated for terrestrial species. Aspects of the bony labyrinth are phylogenetically informative, including vestibular reduction in Cetacea, a tall cochlear spiral in caviomorph rodents, a low position of the plane of the lateral semicircular canal compared to the posterior canal in Cetacea and Carnivora, and a low cochlear aspect ratio in Primatomorpha. Significance: The morphological descriptions that are presented add a broad baseline of anatomy of the inner ear across many placental mammal clades, for many of which the structure of the bony labyrinth is largely unknown. The data included here complement the growing body of literature on the physiological and phylogenetic significance of bony labyrinth structures in mammals, and they serve as a source of data for future studies on the evolution and function of the vertebrate ear.	[Ekdale, Eric G.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Ekdale, Eric G.] San Diego Nat Hist Museum, Dept Paleontol, San Diego, CA USA	California State University System; San Diego State University	Ekdale, EG (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	eekdale@projects.sdsu.edu			Jackson Schools of Geosciences at The University of Texas at Austin; Texas Academy of Science; Paleontological Society; NSF [EAR-034710]	Jackson Schools of Geosciences at The University of Texas at Austin; Texas Academy of Science; Paleontological Society; NSF(National Science Foundation (NSF))	Research was supported by funding from the Jackson Schools of Geosciences at The University of Texas at Austin, the Texas Academy of Science, and the Paleontological Society. The University of Texas High-Resolution X-ray CT facility, at which CT data were collected, is funded by NSF EAR-034710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS RM, 1991, P NATL ACAD SCI USA, V88, P10317, DOI 10.1073/pnas.88.22.10317; Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P225, DOI 10.1016/S1055-7903(03)00118-0; Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; ARCHIBALD JD, 1979, NATURE, V281, P669, DOI 10.1038/281669a0; Armstrong SD, 2011, ANAT REC, V294, P263, DOI 10.1002/ar.21298; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Asher RJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-108; Asher Robert J., 2005, P50; Asher Robert J., 2001, American Museum Novitates, V3352, P1, DOI 10.1206/0003-0082(2001)352<0001:CAITIC>2.0.CO;2; BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; Beck RMD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001858; Billet G, 2012, P ROY SOC B-BIOL SCI, V279, P3932, DOI 10.1098/rspb.2012.1212; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; BLANKS RHI, 1975, ACTA OTO-LARYNGOL, V80, P185, DOI 10.3109/00016487509121318; BLANKS RHI, 1985, BRAIN RES, V340, P315, DOI 10.1016/0006-8993(85)90928-X; BOYDEN ALAN, 1950, ZOOL [NEW YORK], V35, P145; Boyer Doug M., 2007, Journal of Mammalian Evolution, V14, P239, DOI 10.1007/s10914-007-9055-5; Butler P.M., 1972, P253; CAIX M, 1979, ANAT CLIN, V1, P259, DOI 10.1007/BF01654582; Calabrese DR, 2006, JARO-J ASSOC RES OTO, V7, P151, DOI 10.1007/s10162-006-0031-1; CAMPBELL CB, 1966, EVOLUTION, V20, P276, DOI 10.1111/j.1558-5646.1966.tb03365.x; CAO Y, 1994, MOL BIOL EVOL, V11, P593; Cao Y, 1997, MOL BIOL EVOL, V14, P461, DOI 10.1093/oxfordjournals.molbev.a025782; Cao Y, 1999, GENES GENET SYST, V74, P211, DOI 10.1266/ggs.74.211; CARLSSON A., 1922, ACTA ZOOLOGICA, V3, P227; Christiansen P, 2004, ZOOL J LINN SOC-LOND, V140, P523, DOI 10.1111/j.1096-3642.2004.00113.x; Clarke AH, 2005, J VESTIBUL RES-EQUIL, V15, P65; CLEMENS WA, 1968, EVOLUTION, V22, P1, DOI 10.1111/j.1558-5646.1968.tb03444.x; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; Coleman MN, 2012, ANAT REC, V295, P615, DOI 10.1002/ar.22422; Comeaux RS, 2010, ZOOL J LINN SOC-LOND, V160, P118, DOI 10.1111/j.1096-3642.2009.00595.x; Court N., 1990, Journal of Vertebrate Paleontology, V10, P170; Court Nicholas, 1992, Palaeovertebrata (Montpellier), V22, P1; Cox PG, 2008, J ANAT, V213, P583, DOI 10.1111/j.1469-7580.2008.00983.x; Cox PG, 2007, J MORPHOL, V268, P878, DOI 10.1002/jmor.10559; Cox PG, 2010, J ANAT, V216, P37, DOI 10.1111/j.1469-7580.2009.01172.x; CURTHOYS IS, 1977, J MORPHOL, V151, P17, DOI 10.1002/jmor.1051510103; CURTHOYS IS, 1977, J MORPHOL, V151, P1, DOI 10.1002/jmor.1051510102; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; de Beer G. R., 1947, Proceedings of the Linnean Society of London, V159, P125; de Jong WW, 2003, MOL PHYLOGENET EVOL, V28, P328, DOI 10.1016/S1055-7903(03)00116-7; DEJONG WW, 1981, NATURE, V292, P538, DOI 10.1038/292538a0; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; DIMOPOULOS P, 1990, ACTA RADIOL, V31, P439; Douzery EJP, 2004, MOL PHYLOGENET EVOL, V33, P922, DOI 10.1016/j.ympev.2004.07.014; Drake AG, 2011, EVOL DEV, V13, P204, DOI 10.1111/j.1525-142X.2011.00470.x; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; EASTEAL S, 1990, GENETICS, V124, P165; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Ekdale EG, 2004, ACTA PALAEONTOL POL, V49, P161; Ekdale EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021311; Ekdale EG, 2011, J VERTEBR PALEONTOL, V31, P658, DOI 10.1080/02724634.2011.557284; Ekdale EG, 2011, J MORPHOL, V272, P452, DOI 10.1002/jmor.10924; Ekdale EG, 2010, ANAT REC, V293, P1896, DOI 10.1002/ar.21234; Emerson GL, 1999, CLADISTICS, V15, P221, DOI 10.1111/j.1096-0031.1999.tb00265.x; Evans H.E., 1993, MILLERS ANATOMY DOG; Fischer MS, 1993, MAMMAL PHYLOGENY, P217; FLEISCHER G, 1976, J PALEONTOL, V50, P133; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Flower W. H., 1883, Proceedings of the Zoological Society, P178; Flynn John J., 2005, P175; FRYE MS, 1995, MOL BIOL EVOL, V12, P168, DOI 10.1093/oxfordjournals.molbev.a040186; GALVAO PE, 1947, AM J PHYSIOL, V148, P478, DOI 10.1152/ajplegacy.1947.148.2.478; Gatesy J, 1996, MOL BIOL EVOL, V13, P954, DOI 10.1093/oxfordjournals.molbev.a025663; Gatesy J, 1999, SYST BIOL, V48, P6, DOI 10.1080/106351599260409; GAUDIN TJ, 1992, J MORPHOL, V214, P63, DOI 10.1002/jmor.1052140105; Geisler JH, 2003, J VERTEBR PALEONTOL, V23, P991, DOI 10.1671/32; Geisler JH, 1998, ADV VERT PALEOBIOL, P163; Geisler JH, 1996, J PALEONTOL, V70, P1045, DOI 10.1017/S0022336000038749; Geisler Jonathan H., 2001, American Museum Novitates, V3344, P1, DOI 10.1206/0003-0082(2001)344<0001:NMEFTP>2.0.CO;2; Geisler JH, 2009, NATURE, V458, pE1, DOI 10.1038/nature07776; Georgi JA, 2008, THESIS STONY BROOK U; Georgi JA, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P233; Gheerbrant Emmanuel, 2005, P84; Gidley J. W., 1912, Science New York Ser 2, V36, DOI 10.1126/science.36.922.285; Gingerich P. D., 2005, PLACENTAL MAMMALS OR, P234; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; GOULD EDWIN, 1965, PROC AMER PHIL SOC, V109, P352; GRAUR D, 1992, COMP BIOCHEM PHYS B, V101, P495, DOI 10.1016/0305-0491(92)90327-N; GRAUR D, 1994, MOL BIOL EVOL, V11, P357; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; Gray A.A., 1908, LABYRINTH ANIMALS IN, VII; Gray AA, 1906, P R SOC LOND B-CONTA, V78, P284, DOI 10.1098/rspb.1906.0063; Gray AA, 1907, LABYRINTH ANIMALS IN, V1; Gregory W. K., 1910, B AM MUS NAT HIST, V27, P1, DOI DOI 10.1007/S13364-013-0165-6; Grenyer R, 2003, J ZOOL, V260, P245, DOI 10.1017/S0952836903003716; Gunz P, 2012, J ANAT, V220, P529, DOI 10.1111/j.1469-7580.2012.01493.x; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; HEUSNER AA, 1991, J NUTR, V121, pS8, DOI 10.1093/jn/121.suppl_11.S8; Holroyd Patricia A., 2005, P71; HONEYCUTT RL, 1993, ANNU REV ECOL SYST, V24, P279, DOI 10.1146/annurev.es.24.110193.001431; Hooker Jeremy J., 2005, P199; HOYTE DA, 1961, AM J ANAT, V108, P1, DOI 10.1002/aja.1001080102; Huchon D, 1999, MOL BIOL EVOL, V16, P577, DOI 10.1093/oxfordjournals.molbev.a026140; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2001, MOL PHYLOGENET EVOL, V20, P238, DOI 10.1006/mpev.2001.0961; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Hullar TE, 2006, ANAT REC PART A, V288A, P466, DOI 10.1002/ar.a.20304; Hullar TE, 2006, HEARING RES, V213, P17, DOI 10.1016/j.heares.2005.11.009; Hyrtl J., 1845, VERLEICHENDE ANATOMI; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jeffery N, 2004, J ANAT, V204, P71, DOI 10.1111/j.1469-7580.2004.00250.x; Jeffery N, 2010, J ANAT, V216, P496, DOI 10.1111/j.1469-7580.2010.01211.x; JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019; Kaiser HE., 1974, MORPHOLOGY SIRENIA M; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Ketten Darlene R., 1997, Bioacoustics, V8, P103; Kirk EC, 2009, ANAT REC, V292, P765, DOI 10.1002/ar.20907; Kleineidam RG, 1999, J MOL EVOL, V48, P360, DOI 10.1007/PL00006480; Ladeveze S, 2007, ZOOL J LINN SOC-LOND, V150, P85, DOI 10.1111/j.1096-3642.2007.00282.x; Ladeveze S, 2008, J ANAT, V213, P686, DOI 10.1111/j.1469-7580.2008.00985.x; Lavergne A, 1996, MOL PHYLOGENET EVOL, V6, P245, DOI 10.1006/mpev.1996.0074; Lebrun Renaud, 2012, Palaeobiodiversity Palaeoenvironments, V92, P527, DOI 10.1007/s12549-012-0099-z; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; LI WH, 1992, NATURE, V359, P277, DOI 10.1038/359277b0; Lin YH, 2002, GENE, V294, P119, DOI 10.1016/S0378-1119(02)00695-9; Linnaeus C., 1758, SYSTEMA NATURAE REGN, DOI [10.5962/bhl.title.542, DOI 10.5962/BHL.TITLE.542]; Linnaeus C, 1748, SYSTEMA NATURAE SIST; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; LOUGHLIN T R, 1987, Mammalian Species, P1, DOI 10.2307/3503908; Luckett W. P., 1993, Journal of Mammalian Evolution, V1, P127, DOI 10.1007/BF01041591; Luo ZX, 2012, ZOOL J LINN SOC-LOND, V166, P433, DOI 10.1111/j.1096-3642.2012.00852.x; Luo ZX, 2011, P ROY SOC B-BIOL SCI, V278, P28, DOI 10.1098/rspb.2010.1148; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P431, DOI 10.1080/02724634.1995.10011239; Luo ZX, 1996, J VERTEBR PALEONTOL, V16, P328, DOI 10.1080/02724634.1996.10011320; MA DP, 1993, J MOL EVOL, V36, P327; MacFadden BJ, 2003, B AM MUS NAT HIST, P368; Macrini TE, 2010, J ANAT, V216, P600, DOI 10.1111/j.1469-7580.2010.01224.x; Maddison W.P., 2008, MESQUITE MODULAR SYS; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Maisano JA, 2007, J MORPHOL, V268, P371, DOI 10.1002/jmor.10519; Malia MJ, 2002, MOL PHYLOGENET EVOL, V24, P91, DOI 10.1016/S1055-7903(02)00219-1; Malinzack MD, 2011, THESIS DUKE U; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; MANOUSSAKI D, 2006, PHYS REV LETT, V96, P1; Manoussaki D, 2008, P NATL ACAD SCI USA, V105, P6162, DOI 10.1073/pnas.0710037105; Martins EP, 1999, SYST BIOL, V48, P642, DOI 10.1080/106351599260210; MCBEE K, 1982, Mammalian Species, P1, DOI 10.2307/3503864; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; MCKENNA MC, 1991, ANN ZOOL FENN, V28, P349; McKenna MC, 2000, ACTA PALAEONTOL POL, V45, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; MCLAREN IA, 1960, SYST ZOOL, V9, P18, DOI 10.2307/2411537; MENG J, 1995, NATURE, V377, P141, DOI 10.1038/377141a0; Meng J, 2004, B AM MUS NAT HIST, P93, DOI 10.1206/0003-0090(2004)285<0093:C>2.0.CO;2; Meng J, 2003, B AM MUS NAT HIST, P1; MENG J, 1995, ZOOL J LINN SOC-LOND, V115, P47, DOI 10.1006/zjls.1995.0033; Meng Jin, 2005, P145; Meng Jin, 2001, Journal of Mammalian Evolution, V8, P1, DOI 10.1023/A:1011328616715; *MERC COMP SYST, 2003, AM 3 1; Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079; Miller M. R., 1966, Occasional Papers California Academy of Sciences, VNo. 60, P1; MILLER M R, 1968, Proceedings of the California Academy of Sciences, V35, P425; Miller M. R., 1966, Proceedings of the California Academy of Science (4th Series), V23, P255; Misawa K, 2003, MOL PHYLOGENET EVOL, V28, P320, DOI 10.1016/S1055-7903(03)00079-4; MOODY PA, 1949, EVOLUTION, V3, P25, DOI 10.2307/2405449; Mouchaty SK, 2000, ZOOL SCR, V29, P307, DOI 10.1046/j.1463-6409.2000.00045.x; Murata Y, 2003, MOL PHYLOGENET EVOL, V28, P253, DOI 10.1016/S1055-7903(03)00035-6; MUREN C, 1986, ACTA RADIOL, V27, P157, DOI 10.1177/028418518602700205; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Naylor GJP, 2001, SYST BIOL, V50, P444, DOI 10.1080/106351501300318030; Nikaido M, 2003, MOL PHYLOGENET EVOL, V28, P276, DOI 10.1016/S1055-7903(03)00120-9; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Norman JE, 2000, J MOL EVOL, V50, P11, DOI 10.1007/s002399910002; NOVACEK M J, 1986, Cladistics, V2, P257, DOI 10.1111/j.1096-0031.1986.tb00463.x; Novacek M.J., 1988, Systematics Association Special Volume Series, P31; Novacek Michael J., 1993, Journal of Mammalian Evolution, V1, P3, DOI 10.1007/BF01027597; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; NOVACEK MJ, 1992, SYST BIOL, V41, P58, DOI 10.2307/2992506; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Leary MA, 1999, SYST BIOL, V48, P455, DOI 10.1080/106351599260102; O'Leary MA, 1999, CLADISTICS, V15, P315, DOI 10.1111/j.1096-0031.1999.tb00269.x; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; Ogden CL, 2004, ADV DATA VITAL HLTH, V347; Olori JC, 2010, COPEIA, P14, DOI 10.1643/CH-09-082; Orliac MJ, 2012, J ANAT, V221, P417, DOI 10.1111/j.1469-7580.2012.01562.x; Owen R., 1848, Q J GEOL SOC LOND, V4, P103, DOI DOI 10.1144/GSL.JGS.1848.004.01-02.21; PAYNE KB, 1986, BEHAV ECOL SOCIOBIOL, V18, P297, DOI 10.1007/BF00300007; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Porter CA, 1996, MOL PHYLOGENET EVOL, V5, P89, DOI 10.1006/mpev.1996.0008; Poux C, 2004, AM J PHYS ANTHROPOL, V124, P1, DOI 10.1002/ajpa.10322; Prothero Donald R., 2004, P156; RADINSKY LEONARD B., 1964, AMER MUS NOVITATES, V2179, P1; RAMPRASHAD F, 1979, J MORPHOL, V160, P345, DOI 10.1002/jmor.1051600306; RASMUSSEN DT, 1990, P NATL ACAD SCI USA, V87, P4688, DOI 10.1073/pnas.87.12.4688; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; RETZIUS G, 1884, GEHORORGAN WIRBELTHI, V2; Rodgers J.C., 2011, THESIS U TEXAS AUSTI; Rose Kenneth D., 2005, P106; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Ruf I, 2009, J ANAT, V214, P679, DOI 10.1111/j.1469-7580.2009.01059.x; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sánchez-Villagra Marcelo R., 2007, Mastozool. neotrop., V14, P53; Sanchez-Villagra MR, 2007, SYST BIODIVERS, V5, P1, DOI 10.1017/S1477200006002258; Schmelzle Thomas, 2007, Mammal Study, V32, P83, DOI 10.3106/1348-6160(2007)32[83:VLDIDM]2.0.CO;2; Schmidt R. S., 1964, Copeia, V1964, P542, DOI 10.2307/1441521; Schmitz J, 2002, MOL BIOL EVOL, V19, P2308, DOI 10.1093/oxfordjournals.molbev.a004054; Schmitz J, 2003, MOL PHYLOGENET EVOL, V28, P341, DOI 10.1016/S1055-7903(03)00060-5; Schoenebeck JJ, 2013, GENETICS, V193, P317, DOI 10.1534/genetics.112.145284; SEGALL W, 1970, Fieldiana Zoology, V51, P169; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; SHOSHANI J, 1986, MOL BIOL EVOL, V3, P222; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; Shoshani J, 1996, MOL PHYLOGENET EVOL, V5, P102, DOI 10.1006/mpev.1996.0009; SHUTE CCD, 1953, P ZOOL SOC LOND, V123, P695; Silcox Mary T., 2005, P127; Silcox MT, 2009, J HUM EVOL, V56, P315, DOI 10.1016/j.jhevol.2008.10.007; SILVA M, 1995, CRC HDB MAMMALIAN BO; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Sisson S, 1938, ANATOMY DOMESTIC ANI; Solntseva GN, 2007, RUSS ACAD MONOGR, P1; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; SPOOR F, 1995, J ANAT, V186, P271; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Springer MS, 1998, P ROY SOC B-BIOL SCI, V265, P2381, DOI 10.1098/rspb.1998.0587; Stanek VJ, 1933, K TOPOGRAFICKE SROVN; Stanhope MJ, 1992, MOL PHYLOGENET EVOL, V1, P148, DOI 10.1016/1055-7903(92)90026-D; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; TEDFORD RH, 1976, SYST ZOOL, V25, P363, DOI 10.2307/2412511; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Theodor Jessica M., 2005, P215; Theodor Jessica M., 2005, Journal of Mammalian Evolution, V12, P161, DOI 10.1007/s10914-005-5706-6; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418; TOMASI TE, 1979, J MAMMAL, V60, P751, DOI 10.2307/1380190; Ursing BM, 1998, P ROY SOC B-BIOL SCI, V265, P2251, DOI 10.1098/rspb.1998.0567; van Dijk MAM, 2001, P NATL ACAD SCI USA, V98, P188, DOI 10.1073/pnas.250216797; VANVALEN L, 1965, EVOLUTION, V19, P137, DOI 10.1111/j.1558-5646.1965.tb01701.x; VANVALEN L, 1971, EVOLUTION, V25, P420, DOI 10.1111/j.1558-5646.1971.tb01898.x; VAUGHN TA, 2000, MAMMALOGY; *VOL GRAPH, 2004, VGSTUDIO MAX 1 2; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Welker KL, 2009, J ANAT, V215, P444, DOI 10.1111/j.1469-7580.2009.01124.x; WEST CD, 1985, J ACOUST SOC AM, V77, P1091, DOI 10.1121/1.392227; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Wible J.R., 1990, Journal of Vertebrate Paleontology, V10, P183; Wible JR, 2003, ANN CARNEGIE MUS, V72, P137; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Forsten A.-M., 1971, Pearce-Sellards Series Texas Memorial Museum, VNo. 18, P1; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; WOOD AE, 1957, EVOLUTION, V11, P417, DOI 10.1111/j.1558-5646.1957.tb02913.x; WOOD AE, 1962, T AM PHILOS SOC, V52, P3; WYSS A R, 1987, American Museum Novitates, P1; Yamada M., 1953, Scientific Reports of the Whales Research Institute Tokyo, V8, P1; Yang AZ, 2007, J NEUROPHYSIOL, V98, P3197, DOI 10.1152/jn.00798.2007	264	136	143	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66624	10.1371/journal.pone.0066624	http://dx.doi.org/10.1371/journal.pone.0066624			100	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805251	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500079
J	Fong, GT; Craig, LV; Guignard, R; Nagelhout, GE; Tait, MK; Driezen, P; Kennedy, RD; Boudreau, C; Wilquin, JL; Deutsch, A; Beck, F				Fong, Geoffrey T.; Craig, Lorraine V.; Guignard, Romain; Nagelhout, Gera E.; Tait, Megan K.; Driezen, Pete; Kennedy, Ryan David; Boudreau, Christian; Wilquin, Jean-Louis; Deutsch, Antoine; Beck, Francois			Evaluating the Effectiveness of France's Indoor Smoke-Free Law 1 Year and 5 Years after Implementation: Findings from the ITC France Survey	PLOS ONE			English	Article							SECONDHAND SMOKE; ATTITUDES; BARS; ACCEPTABILITY; LEGISLATION; PREVALENCE; POLLUTION; HEALTH; IMPACT	France implemented a comprehensive smoke-free law in two phases: Phase 1 (February 2007) banned smoking in workplaces, shopping centres, airports, train stations, hospitals, and schools; Phase 2 (January 2008) banned smoking in hospitality venues (bars, restaurants, hotels, casinos, nightclubs). This paper evaluates France's smoke-free law based on the International Tobacco Control Policy Evaluation Project in France (the ITC France Project), which conducted a cohort survey of approximately 1,500 smokers and 500 non-smokers before the implementation of the laws (Wave 1) and two waves after the implementation (Waves 2 and 3). Results show that the smoke-free law led to a very significant and near-total elimination of observed smoking in key venues such as bars (from 94-97% to 4%) and restaurants (from 60-71% to 2-3%) at Wave 2, which was sustained four years later (6-8% in bars; 1-2% in restaurants). The reduction in self-reported smoking by smoking respondents was nearly identical to the effects shown in observed smoking. Observed smoking in workplaces declined significantly after the law (from 41-48% to 18-20%), which continued to decline at Wave 3 (to 14-15%). Support for the smoke-free laws increased significantly after their implementation and continued to increase at Wave 3 (p<.001 among smokers for bars and restaurants; p<.001 among smokers and p=.003 for non-smokers for workplaces). The findings demonstrate that smoke-free policies that are implemented in ways consistent with the Guidelines for Article 8 of the WHO Framework Convention on Tobacco Control (WHO FCTC) lead to substantial and sustained reductions in indoor smoking while also leading to high levels of support by the public. Moreover, contrary to arguments by opponents of smoke-free laws, smoking in the home did not increase after the law was implemented and prevalence of smoke-free homes among smokers increased from 23.2% before the law to 37.2% 5 years after the law.	[Fong, Geoffrey T.; Craig, Lorraine V.; Tait, Megan K.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Fong, Geoffrey T.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Fong, Geoffrey T.] Ontario Inst Canc Res, Toronto, ON, Canada; [Guignard, Romain; Wilquin, Jean-Louis; Beck, Francois] French Inst Hlth Promot & Hlth Educ INPES, St Denis, France; [Nagelhout, Gera E.] Maastricht Univ CAPHRI, Maastricht, Netherlands; [Nagelhout, Gera E.] STIVORO Dutch Expert Ctr Tobacco Control, The Hague, Netherlands; [Driezen, Pete; Kennedy, Ryan David] Univ Waterloo, Propel Ctr Populat Hlth Impact, Waterloo, ON N2L 3G1, Canada; [Kennedy, Ryan David] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Boudreau, Christian] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada; [Deutsch, Antoine] French Natl Canc Inst INCa, Paris, France; [Beck, Francois] Univ Paris 05, EHESS, Med Res Ctr, Cesames Team Cermes3, Paris, France	University of Waterloo; University of Waterloo; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Maastricht University; University of Waterloo; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Waterloo; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Paris Cite	Fong, GT (corresponding author), Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada.	geoffrey.fong@uwaterloo.ca	Driezen, Pete/AAX-2804-2020; Nagelhout, Gera/J-3162-2019; Kennedy, Ryan David/U-3794-2017; Fong, Geoffrey T/H-2810-2014	Driezen, Pete/0000-0003-2320-0999; Nagelhout, Gera/0000-0001-7748-5059; Kennedy, Ryan David/0000-0002-9448-5234; Fong, Geoffrey T/0000-0001-9098-6472; Beck, Francois/0000-0002-4880-1638	l'Institut national de prevention et d'education pour la sante (Inpes); U.S. National Cancer Institute [P01 CA138389]; Canadian Institutes of Health Research [79551, 115216]; Ontario Institute for Cancer Research; Canadian Cancer Society Research Institute; l'Institut national du cancer (INCa); NATIONAL CANCER INSTITUTE [P01CA138389] Funding Source: NIH RePORTER	l'Institut national de prevention et d'education pour la sante (Inpes); U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); l'Institut national du cancer (INCa)(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was provided by l'Institut national de prevention et d'education pour la sante (Inpes), l'Institut national du cancer (INCa), the U.S. National Cancer Institute (P01 CA138389); Canadian Institutes of Health Research (79551 and 115216); and the Ontario Institute for Cancer Research. G.T.F. was supported by a Senior Investigator Award from the Ontario Institute for Cancer Research and a Prevention Scientist Award from the Canadian Cancer Society Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AB, 2004, TOB CONTROL, V13, P347, DOI 10.1136/tc.2003.007336; Alesci NL, 2003, PREV MED, V36, P272, DOI 10.1016/S0091-7435(02)00029-4; Apsley A, 2012, TOB CONTROL, V21, P511, DOI 10.1136/tobaccocontrol-2011-050107; BAILAR BA, 1975, J AM STAT ASSOC, V70, P23, DOI 10.2307/2285370; Beck F., 2011, Bulletin Epidemiologique Hebdomadaire, P230; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boudreau C, JAM STAT ASS; Brunner E, 2011, BEH, V20- 21, P241; Connolly GN, 2009, NICOTINE TOB RES, V11, P600, DOI 10.1093/ntr/ntp038; Cook T.C., 1979, QUASIEXPERIMENTATION; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Eisner MD, 1998, JAMA-J AM MED ASSOC, V280, P1909, DOI 10.1001/jama.280.22.1909; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; Fong G. T., 2008, Bulletin Epidemiologique Hebdomadaire, P183; Gallus S, 2012, TOB CONTROL, V21, P59, DOI 10.1136/tc.2010.040774; Ghangurde P.D., 1982, SURV METHODOL, V8, P86; Goodman PG, 2009, INT J PUBLIC HEALTH, V54, P367, DOI 10.1007/s00038-009-0089-8; Hitchman SC, 2012, EUR J PUBLIC HLTH S1, VPredictors of car smoking rules among smokers in France, Germany and the Netherlands, p[Eur, Suppl, 17]; Hyland A, 2009, NICOTINE TOB RES, V11, P642, DOI 10.1093/ntr/ntp063; *IARC, 2001, IARC MON EV CARC RIS; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; International Agency for Research on Cancer, 2008, IARC HDB CANC PREV T, V12; ITC Project, 2011, ITC FRANC NAT REP RE; Longo DR, 2001, TOB CONTROL, V10, P267, DOI 10.1136/tc.10.3.267; Lopez MJ, 2012, TOB CONTROL, V21, P407, DOI 10.1136/tc.2010.042275; Martinez-Sanchez JM, 2014, TOB CONTROL, V23, P238, DOI 10.1136/tobaccocontrol-2012-050700; Mons U, 2012, EUR J PUBLIC HLTH S1, VEur J Public Health, P10; Mons U, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050131; Nagelhout GE, 2012, EUR J PUBLIC HLTH S1, P4; Nagelhout GE, 2011, SOC SCI MED, V72, P1643, DOI 10.1016/j.socscimed.2011.03.018; Office on Smoking and Health (US), 2006, HLTH CONS INV EXP TO; SANDLER DP, 1989, AM J PUBLIC HEALTH, V79, P163, DOI 10.2105/AJPH.79.2.163; Sendzik T, 2009, NICOTINE TOB RES, V11, P627, DOI 10.1093/ntr/ntp019; Thompson ME, 2006, TOB CONTROL, V15, P12, DOI 10.1136/tc.2005.013870; Thompson ME, 2005, STAT CANADA INT S SE; Tramacere I, 2009, J EPIDEMIOL COMMUN H, V63, P559, DOI 10.1136/jech.2008.084426; Trotter L, 2002, TOB CONTROL, V11, P300, DOI 10.1136/tc.11.4.300; WHO Framework Convention on Tobacco Control, 2011, GUID IMPL ART 5 3 AR; Wilson SE, 2005, SOC SCI MED, V60, P2623, DOI 10.1016/j.socscimed.2004.10.027; World Health Organization, 1999, INT CONS ENV TOB SMO	41	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66692	10.1371/journal.pone.0066692	http://dx.doi.org/10.1371/journal.pone.0066692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805265	Green Published, gold			2022-12-27	WOS:000320846500093
J	Garofalo, M; Jeon, YJ; Nuovo, GJ; Middleton, J; Secchiero, P; Joshi, P; Alder, H; Nazaryan, N; Di Leva, G; Romano, G; Crawford, M; Nana-Sinkam, P; Croce, CM				Garofalo, Michela; Jeon, Young-Jun; Nuovo, Gerard J.; Middleton, Justin; Secchiero, Paola; Joshi, Pooja; Alder, Hansjuerg; Nazaryan, Natalya; Di Leva, Gianpiero; Romano, Giulia; Crawford, Melissa; Nana-Sinkam, Patrick; Croce, Carlo M.			MiR-34a/c-Dependent PDGFR-alpha/beta Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer	PLOS ONE			English	Article							RECEPTOR-TYROSINE-KINASES; GROWTH-FACTOR; COLORECTAL-CANCER; POOR-PROGNOSIS; EXPRESSION; TUMOR; BETA; MUTATIONS; INVASION; TARGETS	Lung cancer is the leading cause of cancer mortality in the world today. Although some advances in lung cancer therapy have been made, patient survival is still poor. MicroRNAs (miRNAs) can act as oncogenes or tumor-suppressor genes in human malignancy. The miR-34 family consists of tumor-suppressive miRNAs, and its reduced expression has been reported in various cancers, including non-small cell lung cancer (NSCLC). In this study, we found that miR-34a and miR-34c target platelet-derived growth factor receptor alpha and beta (PDGFR-alpha and PDGFR-beta), cell surface tyrosine kinase receptors that induce proliferation, migration and invasion in cancer. MiR-34a and miR-34c were downregulated in lung tumors compared to normal tissues. Moreover, we identified an inverse correlation between PDGFR-alpha/beta and miR-34a/c expression in lung tumor samples. Finally, miR-34a/c overexpression or downregulation of PDGFR-alpha/beta by siRNAs, strongly augmented the response to TNF-related apoptosis inducing ligand (TRAIL) while reducing migratory and invasive capacity of NSCLC cells.	[Garofalo, Michela; Jeon, Young-Jun; Nuovo, Gerard J.; Middleton, Justin; Joshi, Pooja; Alder, Hansjuerg; Nazaryan, Natalya; Di Leva, Gianpiero; Romano, Giulia; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nuovo, Gerard J.] Phylogeny Inc, Columbus, OH USA; [Secchiero, Paola] Univ Ferrara, Human Anat Sect, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Crawford, Melissa; Nana-Sinkam, Patrick] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Garofalo, M (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	michela.garofalo@osumc.edu; carlo.croce@osumc.edu	secchiero, paola/G-9689-2015; Young, Richard A/F-6495-2012	secchiero, paola/0000-0003-4101-7987; Young, Richard A/0000-0001-8855-8647; , Pooja/0000-0002-1415-1251; Jeon, Young-Jun/0000-0002-5998-9605	National Institutes of Health [CA152758]; Ohio State University Targeted Investment in Excellence Award; Kimmel Scholar Award; NATIONAL CANCER INSTITUTE [U01CA166905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Targeted Investment in Excellence Award(Ohio State University); Kimmel Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health CA152758. The authors are grateful for research support from The Ohio State University Targeted Investment in Excellence Award. MG is a recipient of the Kimmel Scholar Award 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibali D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040269; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chim CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-197; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dierov J, 2002, BLOOD, V99, P1758, DOI 10.1182/blood.V99.5.1758; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Feng H, 2012, ONCOGENE, V31, P2691, DOI 10.1038/onc.2011.436; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; GAZIT A, 1984, CELL, V39, P89, DOI 10.1016/0092-8674(84)90194-6; Gompelmann D, 2011, RESPIRATION, V82, P111, DOI 10.1159/000329703; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Kim Y, 2012, GENE DEV, V26, P1247, DOI 10.1101/gad.193565.112; Lehman HL, 2012, MOL CANCER RES, V10, P1306, DOI 10.1158/1541-7786.MCR-12-0173; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Mahalingam D, 2011, CURR DRUG TARGETS, V12, P2079, DOI 10.2174/138945011798829357; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Nishimura J, 2012, ONCOL REP, V28, P2221, DOI 10.3892/or.2012.2059; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; Rossi G, 2005, J CLIN ONCOL, V23, P8774, DOI 10.1200/JCO.2005.02.8233; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Thomas GV, 2006, CURR OPIN GENET DEV, V16, P78, DOI 10.1016/j.gde.2005.12.003; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034210; Wang Z, 2011, CANCER BIOL THER, V11, P490, DOI 10.4161/cbt.11.5.14550; Wu KJ, 2012, CELL SIGNAL, V24, P2273, DOI 10.1016/j.cellsig.2012.08.004; Wu NN, 2011, FEBS J, V278, P2044, DOI 10.1111/j.1742-4658.2011.08120.x; Yamashita S, 2012, ONCOLOGY-BASEL, V82, P205, DOI 10.1159/000336809; Yu JH, 2000, J BIOL CHEM, V275, P19076, DOI 10.1074/jbc.M910329199	44	83	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67581	10.1371/journal.pone.0067581	http://dx.doi.org/10.1371/journal.pone.0067581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805317	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500145
J	Morelli, JN; Michaely, HJ; Meyer, MM; Rustemeyer, T; Schoenberg, SO; Attenberger, UI				Morelli, John N.; Michaely, Henrik J.; Meyer, Mathias M.; Rustemeyer, Thassilo; Schoenberg, Stefan O.; Attenberger, Ulrike I.			Comparison of Dynamic and Liver-Specific Gadoxetic Acid Contrast-Enhanced MRI versus Apparent Diffusion Coefficients	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATIC HEMANGIOMA; LESION DETECTION; DISODIUM	Background: Hepatic lesions often present diagnostic connundrums with conventional MR techniques. Hepatobiliary phase contrast-enhanced imaging with gadoxetic acid can aid in the characterization of such lesions. However, quantitative measures describing late-phase enhancement must be assessed relative to their accuracy of hepatic lesion classification. Purpose: To compare quantitative parameters in gadoxetic acid contrast-enhanced dynamic and hepatobiliary phase imaging versus apparent diffusion coefficients in hepatic lesion characterization. Material and Methods: 57 patients with focal hepatic lesions on gadoxetic acid MR were included. Lesion enhancement at standard post-contrast time points and in the hepatobiliary phase (HB; 15 and 25 minutes post-contrast) was assessed via calculation of contrast (CR) and enhancement ratios (ER). Apparent diffusion coefficient (ADC) values were also obtained. Values for these parameters were compared among lesions and ROC analyses performed. Results: HB enhancement was greatest with FNH and adenomas. HB ER parameters but not HB CR could distinguish HCC from benign entities (0.9 ER ROC AUC versus 0.5 CR ROC AUC). There was no statistically significant difference found between the 15 and 25 minutes HB time points in detection of any lesion (p>0.4). ADC values were statistically significantly higher with hemangiomas (p<0.05) without greater accuracy in lesion detection relative to HB phase parameters. Conclusion: Hepatobiliary phase gadoxetic acid contrast-enhanced MR characterizes focal hepatic lesions more accurately than ADC and conventional dynamic post-contrast time point enhancement parameters. ER values are generally superior to CR. No discernible benefit of 25 minute versus 15 minute delayed imaging is demonstrated.	[Morelli, John N.] Texas A&M Hlth Sci Ctr, Scott & White Hosp, Dept Radiol, Temple, TX USA; [Morelli, John N.; Michaely, Henrik J.; Meyer, Mathias M.; Rustemeyer, Thassilo; Schoenberg, Stefan O.] Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Dept Clin Radiol & Nucl Med, Mannheim, Baden Wurttembe, Germany	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Ruprecht Karls University Heidelberg	Morelli, JN (corresponding author), Texas A&M Hlth Sci Ctr, Scott & White Hosp, Dept Radiol, Temple, TX USA.	dr.john.morelli@gmail.com	Attenberger, Ulrike/ABD-8541-2020; Attenberger, Ulrike/HDN-2286-2022	Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447				Battal B, 2011, J COMPUT ASSIST TOMO, V35, P326, DOI 10.1097/RCT.0b013e318216efeb; Choi JS, 2010, EUR RADIOL, V20, P1052, DOI 10.1007/s00330-009-1651-8; Chung J, 2011, MAGN RESON IMAGING; Cruite I, 2010, AM J ROENTGENOL, V195, P29, DOI 10.2214/AJR.10.4538; Doo KW, 2009, AM J ROENTGENOL, V193, pW490, DOI 10.2214/AJR.08.1732; Elsayes Khaled M, 2007, HPB (Oxford), V9, P208, DOI 10.1080/13651820701216950; Grazioli L, 2012, RADIOLOGY, V262, P520, DOI 10.1148/radiol.11101742; Holzapfel K, 2011, ABDOM IMAGING; Huppertz A, 2005, RADIOLOGY, V234, P468, DOI 10.1148/radiol.2342040278; Kim HY, 2012, LIVER TRANSPLANT, V18, P850, DOI 10.1002/lt.23426; Kim TK, 2011, RADIOLOGY, V259, P730, DOI 10.1148/radiol.11101549; Kuwatsuru R, 1997, RADIOLOGY, V202, P131, DOI 10.1148/radiology.202.1.8988202; Miller FH, 2010, J MAGN RESON IMAGING, V32, P138, DOI 10.1002/jmri.22235; Morana G, 2011, INVEST RADIOL, V46, P225, DOI 10.1097/RLI.0b013e3181feee3a; Motosugi U, 2011, INVEST RADIOL, V46, P359, DOI 10.1097/RLI.0b013e3182104b77; Narita M, 2009, J GASTROENTEROL, V44, P793, DOI 10.1007/s00535-009-0056-4; Ni YC, 2010, J GASTROENTEROL, V45, P349, DOI 10.1007/s00535-009-0174-z; Nishie A, 2010, J MAGN RESON IMAGING, V31, P373, DOI 10.1002/jmri.22059; Parikh T, 2008, RADIOLOGY, V246, P812, DOI 10.1148/radiol.2463070432; Purysko AS, 2011, CLIN RADIOL, V66, P673, DOI 10.1016/j.crad.2011.01.014; Runge VM, 2000, J MAGN RESON IMAGING, V11, P655, DOI 10.1002/1522-2586(200006)11:6<655::AID-JMRI12>3.3.CO;2-8; Soyer P, 2010, EUR J RADIOL; Vossen JA, 2008, J COMPUT ASSIST TOMO, V32, P750, DOI 10.1097/RCT.0b013e31816a6823	23	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e61898	10.1371/journal.pone.0061898	http://dx.doi.org/10.1371/journal.pone.0061898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805174	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500002
J	Napoleon, C; Raimbault, V; Claquin, P				Napoleon, Camille; Raimbault, Virginie; Claquin, Pascal			Influence of Nutrient Stress on the Relationships between PAM Measurements and Carbon Incorporation in Four Phytoplankton Species	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; REPETITION-RATE FLUOROMETRY; MARINE-PHYTOPLANKTON; DUNALIELLA-TERTIOLECTA; PHOTOSYSTEM-II; FLUORESCENCE MEASUREMENTS; CHLOROPHYLL FLUORESCENCE; INORGANIC PHOSPHORUS; PRIMARY PRODUCTIVITY; OXYGEN EVOLUTION	Two methods of measuring primary production, modulated fluorimetry (PAM) and the traditional carbon incorporation method (C-13), were compared in four phytoplankton species, two diatoms (Pseudo-nitzschia pungens and Asterionellopsis glacialis), and two dinoflagellates (Heterocapsa sp and Karenia mikimotoi), under N (nitrogen), P (phosphorus) and Si (silicon) limited semi-continuous culture. N and Si-limited cultures showed relatively high quantum efficiency of the PSII (F-v/F-m) values, confirming that F-v/F-m is not a good proxy for nutrient stress in balanced systems, whereas P limitation had a drastic effect on many physiological parameters. In all species, the physiological capacity of phytoplankton cells to acclimate to nutrient limitations led to changes in the cellular biochemical composition and the structure of the photosynthetic apparatus. The observed physiological responses were species and nutrient specific. The values of the chlorophyll-specific absorption cross section (a*) increased with nutrient limitation due to package effect, while the carbon/Chl a ratio was higher under N and P limitations. In diatoms, Si limitation did not affect photosynthesis confirming the uncoupling between Si and carbon metabolisms. In all four species and under all treatments, significant relationships were found between photosynthetic activities, ETRChl (electron transport rate) and P-Chl (carbon fixation rate) estimated using PAM measurements and C-13 incorporation, showing that the fluorescence technique can reliably be used to estimate carbon fixation by phytoplankton. The relationship between ETRChl and P-Chl can be described by the shape and the slope of the curve (Phi(C.e)). Linear relationships were found for dinoflagellates and P. pungens under all treatments. A decrease in Phi(C.e). was observed under N and P limitation probably due to structural damage to the photosynthetic apparatus. A. glacialis showed a logarithmic relationship in N and P limited conditions, due to the alternative electron flow which takes place to optimise photosynthetic performances under high light and/or nutrient stress.	[Napoleon, Camille; Raimbault, Virginie; Claquin, Pascal] Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France; [Napoleon, Camille; Raimbault, Virginie; Claquin, Pascal] CNRS INEE, BIOMEA FRE3484, Caen, France; [Napoleon, Camille] IFREMER, Lab Environm Ressources Normandie, Port En Bessin, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer	Claquin, P (corresponding author), Univ Caen Basse Normandie, BIOMEA CNRS FRE3484, Caen, France.	pascal.claquin@unicaen.fr		Claquin, Pascal/0000-0002-5183-203X	European project Interreg 4a CHannel Integrated Approach for Marine Resource Management 3 (CHARM3)	European project Interreg 4a CHannel Integrated Approach for Marine Resource Management 3 (CHARM3)	This study was supported by the European project Interreg 4a CHannel Integrated Approach for Marine Resource Management 3 (CHARM3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; [Anonymous], 1975, CULTURE MARINE INVER; BABIN M, 1994, LIMNOL OCEANOGR, V39, P694, DOI 10.4319/lo.1994.39.3.0694; Barranguet C, 2000, MAR ECOL PROG SER, V204, P39, DOI 10.3354/meps204039; Beardall J, 1996, PHOTOSYNTHESIS LIGHT, P435; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; Claquin P, 2005, MAR BIOL, V146, P877, DOI 10.1007/s00227-004-1493-5; Claquin P, 2002, J PHYCOL, V38, P922, DOI 10.1046/j.1529-8817.2002.t01-1-01220.x; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Geider RJ, 1997, MAR ECOL PROG SER, V148, P187, DOI 10.3354/meps148187; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilbert M, 2000, PHOTOSYNTHETICA, V38, P111, DOI 10.1023/A:1026708327185; Guerrini F, 2000, J PHYCOL, V36, P882, DOI 10.1046/j.1529-8817.2000.99070.x; HAMA T, 1983, MAR BIOL, V73, P31, DOI 10.1007/BF00396282; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; HEINEKE D, 1989, PLANT PHYSIOL, V91, P221, DOI 10.1104/pp.91.1.221; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Juneau P, 2005, PHOTOCHEM PHOTOBIOL, V81, P649, DOI 10.1562/2005-01-13-RA-414.1; Kaiblinger C, 2006, PHOTOSYNTH RES, V88, P19, DOI 10.1007/s11120-005-9018-8; KOLBER Z, 1988, PLANT PHYSIOL, V88, P923, DOI 10.1104/pp.88.3.923; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Kruskopf M, 2006, NEW PHYTOL, V169, P525, DOI 10.1111/j.1469-8137.2005.01601.x; LAROCHE J, 1993, J PHYCOL, V29, P767; Lefebvre S, 2007, J PHOTOCH PHOTOBIO B, V86, P131, DOI 10.1016/j.jphotobiol.2006.08.012; Lippemeier S, 1999, J PLANKTON RES, V21, P269, DOI 10.1093/plankt/21.2.269; Lippemeier S, 2001, EUR J PHYCOL, V36, P89, DOI 10.1017/S0967026201003031; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Marchetti A, 2006, DEEP-SEA RES PT II, V53, P2131, DOI 10.1016/j.dsr2.2006.05.032; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; Morris EP, 2003, EUR J PHYCOL, V38, P133, DOI 10.1080/0967026031000085832; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; Napoleon C, 2012, J SEA RES, V69, P43, DOI 10.1016/j.seares.2012.01.005; Nielsen E.S., 1952, ICES J MAR SCI, V18, P117; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Pannard A, 2008, ESTUAR COAST SHELF S, V80, P212, DOI 10.1016/j.ecss.2008.08.008; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Petrou K, 2008, J PHYCOL, V44, P1204, DOI 10.1111/j.1529-8817.2008.00585.x; PREZELIN BB, 1980, MAR BIOL, V58, P85, DOI 10.1007/BF00396119; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P878, DOI 10.1016/j.bbabio.2011.05.009; Rychter A., 2005, HDB PHOTOSYNTHESIS, V2nd ed., DOI [10.1201/9781420027877.ch7, DOI 10.1201/9781420027877.CH7]; SAVIDGE G, 1995, DEEP-SEA RES PT I, V42, P599, DOI 10.1016/0967-0637(95)00016-Y; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Spijkerman E, 2010, J PHYCOL, V46, P658, DOI 10.1111/j.1529-8817.2010.00859.x; Wang ZC, 2010, HARMFUL ALGAE, V9, P613, DOI 10.1016/j.hal.2010.04.012; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Young EB, 2003, J PHYCOL, V39, P897, DOI 10.1046/j.1529-8817.2003.03042.x	59	40	42	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66423	10.1371/journal.pone.0066423	http://dx.doi.org/10.1371/journal.pone.0066423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805221	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500049
J	Shin, SW; Park, JS; Park, CS				Shin, Seung-Woo; Park, Jong Sook; Park, Choon-Sik			Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; GENE POLYMORPHISMS; GRANULE PROTEINS; ASTHMA; INTOLERANCE; HYPERSENSITIVITY; SENSITIVITY; SEVERITY; DRUGS	Aspirin-exacerbated respiratory disease (AERD) remains widely underdiagnosed in asthmatics, primarily due to insufficient awareness of the relationship between aspirin ingestion and asthma exacerbation. The identification of aspirin hypersensitivity is therefore essential to avoid serious aspirin complications. The goal of the study was to develop plasma biomarkers to predict AERD. We identified differentially expressed genes in peripheral blood mononuclear cells (PBMC) between subjects with AERD and those with aspirin-tolerant asthma (ATA). The genes were matched with the secreted protein database (http://spd.cbi.pku.edu.cn/) to select candidate proteins in the plasma. Plasma levels of the candidate proteins were then measured in AERD (n = 40) and ATA (n = 40) subjects using an enzyme-linked immunosorbent assay (ELISA). Target genes were validated as AERD biomarkers using an ROC curve analysis. From 175 differentially expressed genes (p-value < 0.0001) that were queried to the secreted protein database, 11 secreted proteins were retrieved. The gene expression patterns were predicted as elevated for 7 genes and decreased for 4 genes in AERD as compared with ATA subjects. Among these genes, significantly higher levels of plasma eosinophil-derived neurotoxin (RNASE2) were observed in AERD as compared with ATA subjects (70(14.62 similar to 311.92) mu g/ml vs. 12(2.55 similar to 272.84) mu g/ml, p-value <0.0003). Based on the ROC curve analysis, the AUC was 0.74 (p-value = 0.0001, asymptotic 95% confidence interval [ lower bound: 0.62, upper bound: 0.83]) with 95% sensitivity, 60% specificity, and a cut-off value of 27.15 mu g/ml. Eosinophil-derived neurotoxin represents a novel biomarker to distinguish AERD from ATA.	[Shin, Seung-Woo; Park, Jong Sook; Park, Choon-Sik] Soonchunhyang Univ, Bucheon Hosp, Div Allergy & Resp Med, Genome Res Ctr Allergy & Resp Dis, Puchon, Gyunggi Do, South Korea	Soonchunhyang University	Park, CS (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Div Allergy & Resp Med, Genome Res Ctr Allergy & Resp Dis, Puchon, Gyunggi Do, South Korea.	mdcspark@unitel.co.kr		Park, Choon-Sik/0000-0003-2977-0255	Soonchunhynahg University	Soonchunhynahg University	This work was supported by a grant from Soonchunhynahg University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUGHAZALEH RI, 1992, J LEUKOCYTE BIOL, V52, P611, DOI 10.1002/jlb.52.6.611; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Chang HS, 2011, ALLERGY ASTHMA IMMUN, V3, P256, DOI 10.4168/aair.2011.3.4.256; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; De Weck AL, 2010, J INVEST ALLERG CLIN, V20, P39; Devouassoux G, 2008, ALLERGY, V63, P125, DOI 10.1111/j.1398-9995.2007.01558.x; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; DURACK DT, 1979, P NATL ACAD SCI USA, V76, P1443, DOI 10.1073/pnas.76.3.1443; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FUKUDA T, 1985, AM REV RESPIR DIS, V132, P981; Gollapudi RR, 2004, JAMA-J AM MED ASSOC, V292, P3017, DOI 10.1001/jama.292.24.3017; HAMANN KJ, 1987, J PARASITOL, V73, P523, DOI 10.2307/3282130; HAMANN KJ, 1990, J IMMUNOL, V144, P3166; Kim BS, 2010, PHARMACOGENET GENOM, V20, P748, DOI 10.1097/FPC.0b013e3283402155; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kim TH, 2008, CLIN EXP ALLERGY, V38, P1727, DOI 10.1111/j.1365-2222.2008.03082.x; Lee RU, 2011, ALLERGY ASTHMA IMMUN, V3, P3, DOI 10.4168/aair.2011.3.1.3; Lee SH, 2006, AM J RESP CRIT CARE, V173, P370, DOI 10.1164/rccm.200505-740OC; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P236, DOI 10.4168/aair.2011.3.4.236; MARQUETTE CH, 1992, AM REV RESPIR DIS, V146, P76, DOI 10.1164/ajrccm/146.1.76; Mascia K, 2005, ANN ALLERG ASTHMA IM, V94, P652, DOI 10.1016/S1081-1206(10)61323-3; Mascia K, 2005, J ALLERGY CLIN IMMUN, V116, P970, DOI 10.1016/j.jaci.2005.08.035; Min JW, 2005, CHEST, V128, P3127, DOI 10.1378/chest.128.5.3127; Motojima S, 1995, Arerugi, V44, P1272; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Oh SH, 2009, ALLERGY ASTHMA IMMUN, V1, P30, DOI 10.4168/aair.2009.1.1.30; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; PICADO C, 1989, EUR RESPIR J, V2, P127; Sanak M, 2004, CLIN EXP ALLERGY, V34, P1899, DOI 10.1111/j.1365-2222.2004.02123.x; Shin S, 2012, MOL GENET GENOMICS, V287, P361, DOI 10.1007/s00438-012-0685-9; SLIFMAN NR, 1986, J IMMUNOL, V137, P2913; Stevenson DD, 2001, ANN ALLERG ASTHMA IM, V87, P177, DOI 10.1016/S1081-1206(10)62221-1; Szczeklik A, 2000, EUR RESPIR J, V16, P432, DOI 10.1034/j.1399-3003.2000.016003432.x; Williams AN, 2007, J ALLERGY CLIN IMMUN, V120, P273, DOI 10.1016/j.jaci.2007.03.020	36	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66644	10.1371/journal.pone.0066644	http://dx.doi.org/10.1371/journal.pone.0066644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805255	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500083
J	Zhang, YM; Gao, B; Wang, JJ; Sun, XD; Liu, XW				Zhang, Yu-ming; Gao, Bo; Wang, Juan-juan; Sun, Xu-de; Liu, Xi-wen			Effect of Hypotensive Resuscitation with a Novel Combination of Fluids in a Rabbit Model of Uncontrolled Hemorrhagic Shock	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HYPERTONIC SALINE; LUNG INJURY; INFLAMMATORY RESPONSE; HYPOVOLEMIC SHOCK; OXIDATIVE STRESS; TRAUMA; RATS; STRATEGIES; PREVENTS	Objective: The aim of this study was to compare the effects of hypotensive and normotensive resuscitation with a novel combination of fluids via lactate Ringer's solution (LRS), 6% hydroxyethyl starch 130/0.4 solution (HES), and 7.5% hypertonic saline solution (HSS) at early stage of uncontrolled hemorrhagic shock (UHS) before hemostasis. Methods: New Zealand white rabbits (n = 32) underwent UHS by transecting the splenic parenchyma, followed by blood withdrawal via the femoral artery to target mean arterial pressure (MAP) of 40-45 mmHg. Animals were distributed randomly into 4 groups (n = 8): in group Sham, sham operation was performed; in group HS, UHS was untreated; in group HS-HR, UHS was treated by hypotensive resuscitation with HSS and LRS+HES (ratio of 2:1) to MAP of 50-55 mmHg; in group HS-NR, UHS was treated by normotensive resuscitation with HSS and LRS+HES (ratio of 2:1) to MAP of 75-80 mmHg. Outcomes of hemodynamics, inflammatory and oxidative response, and other metabolic variables were measured and the histopathological studies of heart, lung and kidney were performed at the end of resusucitation. Results: Hypotensive resuscitation with the novel combination of fluids for UHS rabbits decreased blood loss, maintained better stabilization of hemodynamics, and resulted in relatively higher hematocrit and platelet count, superior outcomes of blood gas, and lower plasma lactate concentration. Besides, hypotensive resuscitation attenuated the inflammatory and oxidative response significantly in UHS rabbits. Conclusion: Hypotensive resuscitation with the novel combination of fluids via HSS and LRS+HES (ratio of 2:1) has an effective treatment at early stage of UHS before hemostasis.	[Zhang, Yu-ming; Sun, Xu-de] Fourth Mil Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian 710032, Peoples R China; [Wang, Juan-juan] Yanan Univ, Affiliated Hosp, Dept Surg, Yanan, Peoples R China; [Gao, Bo] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped Surg, Xian 710032, Peoples R China; [Liu, Xi-wen] Fourth Mil Med Univ, Dept Nursing, Xian 710032, Peoples R China	Air Force Military Medical University; Yanan University; Air Force Military Medical University; Air Force Military Medical University	Sun, XD (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian 710032, Peoples R China.	sunxude@fmmu.edu.cn; liuwen@fmmu.edu.cn	wang, juanjuan/GYV-5540-2022; liu, xiwen/GSJ-3861-2022		Army Medical Health Research Fund of China [08G109]	Army Medical Health Research Fund of China	This study was supported by the Army Medical Health Research Fund of China 08G109. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Beer KAS, 2013, JAVMA-J AM VET MED A, V242, P54, DOI 10.2460/javma.242.1.54; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Catrambone JE, 2008, EUR J TRAUMA EMERG S, V34, P397, DOI 10.1007/s00068-007-7068-7; Cherkas David, 2011, Emerg Med Pract, V13, P1; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Crimi E, 2006, AM J RESP CRIT CARE, V174, P178, DOI 10.1164/rccm.200507-1178OC; DEFELIPPE J, 1980, LANCET, V2, P1002; Frithiof R, 2011, AM J PHYSIOL-HEART C, V300, pH685, DOI 10.1152/ajpheart.00930.2010; Gecit I, 2011, BIOL TRACE ELEM RES, V144, P1069, DOI 10.1007/s12011-011-9124-8; Hashiguchi N, 2007, J TRAUMA, V62, P299, DOI 10.1097/01.ta.0000222956.88760.33; Hatanaka E, 2007, SHOCK, V27, P32, DOI 10.1097/01.shk.0000238061.69579.a5; Hauser CJ, 2005, SHOCK, V24, P24, DOI 10.1097/01.shk.0000191387.18818.43; Hussmann B, 2011, UNFALLCHIRURG, V114, P705, DOI 10.1007/s00113-010-1842-4; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Klein CL, 2008, KIDNEY INT, V74, P901, DOI 10.1038/ki.2008.314; Li T, 2011, J SURG RES, V169, P76, DOI 10.1016/j.jss.2010.02.001; Li T, 2011, ANESTHESIOLOGY, V114, P111, DOI 10.1097/ALN.0b013e3181fe3fe7; Matsuoka T, 1996, J TRAUMA, V40, P915, DOI 10.1097/00005373-199606000-00009; Montassier E, 2012, AM J EMERG MED, V30, P184, DOI 10.1016/j.ajem.2010.09.033; Moran A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021449; MORITA H, 1987, J AUTONOM NERV SYST, V20, P57, DOI 10.1016/0165-1838(87)90081-6; Morrison CA, 2011, J TRAUMA, V70, P652, DOI 10.1097/TA.0b013e31820e77ea; Park Marcelo, 2006, Clinics, V61, P47, DOI 10.1590/S1807-59322006000100009; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shah SK, 2011, J SURG RES, V166, P120, DOI 10.1016/j.jss.2009.09.010; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; Wang PF, 2009, INT IMMUNOPHARMACOL, V9, P347, DOI 10.1016/j.intimp.2008.12.014; Watters JM, 2006, J TRAUMA, V61, P75, DOI 10.1097/01.ta.0000222723.54559.47; White NJ, 2010, RESUSCITATION, V81, P111, DOI 10.1016/j.resuscitation.2009.09.017; White SA, 1997, ANAESTHESIA, V52, P422, DOI 10.1111/j.1365-2044.1997.090-az0082.x; Wohlauer M, 2012, CRIT CARE MED, V40, P2647, DOI 10.1097/CCM.0b013e3182592006; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026; Yu GF, 2012, PULM PHARMACOL THER, V25, P27, DOI 10.1016/j.pupt.2011.10.003; Yu YH, 2009, RESUSCITATION, V80, P1424, DOI 10.1016/j.resuscitation.2009.08.024	40	5	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66916	10.1371/journal.pone.0066916	http://dx.doi.org/10.1371/journal.pone.0066916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805284	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500112
J	Zuo, ZT; Wang, R; Zhuo, Y; Xue, R; St Lawrence, KS; Wang, DJJ				Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong; St Lawrence, Keith S.; Wang, Danny J. J.			Turbo-FLASH Based Arterial Spin Labeled Perfusion MRI at 7 T	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; NOISE RATIO; HIGH-FIELD; MODEL; QUANTIFICATION; RELAXATION; EFFICIENCY; COIL	Motivations of arterial spin labeling (ASL) at ultrahigh magnetic fields include prolonged blood T-1 and greater signal-to-noise ratio (SNR). However, increased B-0 and B-1 inhomogeneities and increased specific absorption ratio (SAR) challenge practical ASL implementations. In this study, Turbo-FLASH (Fast Low Angle Shot) based pulsed and pseudo-continuous ASL sequences were performed at 7T, by taking advantage of the relatively low SAR and short TE of Turbo-FLASH that minimizes susceptibility artifacts. Consistent with theoretical predictions, the experimental data showed that Turbo-FLASH based ASL yielded approximately 4 times SNR gain at 7T compared to 3T. High quality perfusion images were obtained with an in-plane spatial resolution of 0.85x1.7 mm(2). A further functional MRI study of motor cortex activation precisely located the primary motor cortex to the precentral gyrus, with the same high spatial resolution. Finally, functional connectivity between left and right motor cortices as well as supplemental motor area were demonstrated using resting state perfusion images. Turbo-FLASH based ASL is a promising approach for perfusion imaging at 7T, which could provide novel approaches to high spatiotemporal resolution fMRI and to investigate the functional connectivity of brain networks at ultrahigh field.	[Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong; Wang, Danny J. J.] Univ Calif Los Angeles, Beijing Joint Ctr Adv Brain Imaging, Beijing, Peoples R China; [Zuo, Zhentao; Wang, Rui; Zhuo, Yan; Xue, Rong; Wang, Danny J. J.] Univ Calif Los Angeles, Beijing Joint Ctr Adv Brain Imaging, Los Angeles, CA USA; [St Lawrence, Keith S.] Lawson Hlth Res Inst, London, ON, Canada; [Wang, Danny J. J.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of California System; University of California Los Angeles; Western University (University of Western Ontario); University of California System; University of California Los Angeles	Zuo, ZT (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	ztzuo@bcslab.ibp.ac.cn	Wang, Danny JJ/O-2482-2018; St. Lawrence, Keith/B-5726-2015	Wang, Danny JJ/0000-0002-0840-7062; St Lawrence, Keith/0000-0001-8022-8205	Ministry of Science and Technology of China [2012CB825500, 2010IM030800]; National Nature Science Foundation of China [91132302, 90820307]; United States National Institutes of Health [R01-MH080892, R01-NS081077, R01-EB014922]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Ministry of Science and Technology of China grants (2012CB825500, 2010IM030800), National Nature Science Foundation of China grants (91132302, 90820307), and United States National Institutes of Health grants R01-MH080892, R01-NS081077 and R01-EB014922. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balu N, 2011, MAGN RESON MED, V65, P627, DOI 10.1002/mrm.22642; Bauer WR, 1996, MAGNET RESON MED, V35, P43, DOI 10.1002/mrm.1910350107; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Cho ZH, 2010, NEUROIMAGE, V49, P2134, DOI 10.1016/j.neuroimage.2009.11.002; Chuang KH, 2008, NEUROIMAGE, V40, P1595, DOI 10.1016/j.neuroimage.2008.01.006; Detre JA, 2000, MED RAD DIA IMG, P47; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; Dixon JE, 2013, EUR J RADIOL, V82, P719, DOI 10.1016/j.ejrad.2011.09.023; Duhamel G, 2011, P ISMRM 19 ANN M MON, P371; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gardener AG, 2009, MAGN RESON MED, V61, P874, DOI 10.1002/mrm.21796; Golay X, 2005, MAGNET RESON MED, V53, P15, DOI 10.1002/mrm.20338; Gunther M, 2001, MAGNET RESON MED, V46, P974, DOI 10.1002/mrm.1284; Jahng GH, 2007, MED PHYS, V34, P4519, DOI 10.1118/1.2795675; Jung Y, 2010, MAGN RESON MED, V64, P799, DOI 10.1002/mrm.22465; KIM SG, 1995, MAGNET RESON MED, V34, P293, DOI 10.1002/mrm.1910340303; Kjolby BF, 2006, MAGN RESON MED, V56, P187, DOI 10.1002/mrm.20920; Lawrence KSS, 2005, MAGN RESON MED, V53, P425, DOI 10.1002/mrm.20364; Lee J, 2010, P NATL ACAD SCI USA, V107, P5130, DOI 10.1073/pnas.0910222107; Luh WM, 2013, MAGN RESON MED, V69, P402, DOI 10.1002/mrm.24266; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Pfeuffer J, 2002, MAGNET RESON MED, V47, P903, DOI 10.1002/mrm.10154; Rane SD, 2013, MAGN RESON IMAGING, V31, P477, DOI 10.1016/j.mri.2012.08.008; Raoult H, 2011, NEUROIMAGE, V58, P157, DOI 10.1016/j.neuroimage.2011.06.011; Sodickson DK, 1999, MAGN RESON MED, V41, P1009, DOI 10.1002/(SICI)1522-2594(199905)41:5<1009::AID-MRM21>3.0.CO;2-4; Lawrence KS, 2012, MAGN RESON MED, V67, P1275, DOI 10.1002/mrm.23104; Talagala SL, 2004, MAGNET RESON MED, V52, P131, DOI 10.1002/mrm.20124; Teeuwisse WM, 2010, P ISMRM 18 ANN M STO; Teeuwisse WM, 2010, INT J IMAG SYST TECH, V20, P62, DOI 10.1002/ima.20218; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wong EC, 2000, MED RAD DIA IMG, P63; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Wong EC, 2006, MAGN RESON MED, V55, P1334, DOI 10.1002/mrm.20906; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Wu WC, 2009, IEEE T MED IMAGING, V28, P703, DOI 10.1109/TMI.2008.2012020; Ziener CH, 2007, J MAGN RESON, V184, P169, DOI 10.1016/j.jmr.2006.09.018; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	43	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66612	10.1371/journal.pone.0066612	http://dx.doi.org/10.1371/journal.pone.0066612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818950	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800086
J	Pafilis, E; Frankild, SP; Fanini, L; Faulwetter, S; Pavloudi, C; Vasileiadou, A; Arvanitidis, C; Jensen, LJ				Pafilis, Evangelos; Frankild, Sune P.; Fanini, Lucia; Faulwetter, Sarah; Pavloudi, Christina; Vasileiadou, Aikaterini; Arvanitidis, Christos; Jensen, Lars Juhl			The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text	PLOS ONE			English	Article								The exponential growth of the biomedical literature is making the need for efficient, accurate text-mining tools increasingly clear. The identification of named biological entities in text is a central and difficult task. We have developed an efficient algorithm and implementation of a dictionary-based approach to named entity recognition, which we here use to identify names of species and other taxa in text. The tool, SPECIES, is more than an order of magnitude faster and as accurate as existing tools. The precision and recall was assessed both on an existing gold-standard corpus and on a new corpus of 800 abstracts, which were manually annotated after the development of the tool. The corpus comprises abstracts from journals selected to represent many taxonomic groups, which gives insights into which types of organism names are hard to detect and which are easy. Finally, we have tagged organism names in the entire Medline database and developed a web resource, ORGANISMS, that makes the results accessible to the broad community of biologists. The SPECIES software is open source and can be downloaded from http://species.jensenlab.org along with dictionary files and the manually annotated gold-standard corpus. The ORGANISMS web resource can be found at http://organisms.jensenlab.org.	[Pafilis, Evangelos; Fanini, Lucia; Faulwetter, Sarah; Pavloudi, Christina; Vasileiadou, Aikaterini; Arvanitidis, Christos] Hellen Ctr Marine Res HCMR, Inst Marine Biol Biotechnol & Aquaculture IMBBC, Iraklion, Greece; [Frankild, Sune P.; Jensen, Lars Juhl] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Syst Biol, Copenhagen, Denmark	Hellenic Centre for Marine Research; University of Copenhagen	Jensen, LJ (corresponding author), Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Syst Biol, Copenhagen, Denmark.	lars.juhl.jensen@cpr.ku.dk	Vasileiadou, Katerina/F-4680-2018; Jensen, Lars Juhl/C-6492-2008; Arvanitidis, Christos/J-1540-2016; Pavloudi, Christina/H-6608-2019	Vasileiadou, Katerina/0000-0002-5057-6417; Jensen, Lars Juhl/0000-0001-7885-715X; Arvanitidis, Christos/0000-0002-6924-5255; Pavloudi, Christina/0000-0001-5106-6067; Pletscher-Frankild, Sune/0000-0002-7745-193X; Faulwetter, Sarah/0000-0003-4892-4440; Fanini, Lucia/0000-0003-2301-2576	European Commission [264089]; Novo Nordisk Foundation Center for Protein Research; European Molecular Biology Organization [356-2011]; Novo Nordisk Foundation Center for Protein Research [PI Lars Juhl Jensen] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation Center for Protein Research; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Novo Nordisk Foundation Center for Protein Research	This work was supported in part by the European Commission FP7-REGPOT project MARBIGEN (grant agreement no 264089), the Novo Nordisk Foundation Center for Protein Research, and European Molecular Biology Organization (Short Term Fellowship 356-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Koning Drew, 2005, Biodiversity Informatics, V2, P79; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Linnaeus C, 1767, SYSTEMA NATURAE; Lok C, 2010, NATURE, V463, P416, DOI 10.1038/463416a; Lu ZY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S2; Plake C, 2006, BIOINFORMATICS, V22, P2444, DOI 10.1093/bioinformatics/btl408; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Rinaldi A, 2010, EMBO REP, V11, P345, DOI 10.1038/embor.2010.57; Sautter G, 2006, BIODIVERSITY INFORM, V3, P46, DOI [10.2307/1216144, DOI 10.17161/BI.V3I0.34]	11	71	71	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65390	10.1371/journal.pone.0065390	http://dx.doi.org/10.1371/journal.pone.0065390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823062	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400006
J	Yakunina, N; Tae, WS; Lee, KU; Kim, SS; Nam, EC				Yakunina, Natalia; Tae, Woo Suk; Lee, Kang Uk; Kim, Sam Soo; Nam, Eui-Cheol			Spatiotemporal Segregation of Neural Response to Auditory Stimulation: An fMRI Study Using Independent Component Analysis and Frequency-Domain Analysis	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; EVENT-RELATED FMRI; TIME-SERIES; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; MAGNETIC-RESONANCE; NEGATIVE BOLD; WORKING-MEMORY; VISUAL-CORTEX	Although auditory processing has been widely studied with conventional parametric methods, there have been a limited number of independent component analysis (ICA) applications in this area. The purpose of this study was to examine spatiotemporal behavior of brain networks in response to passive auditory stimulation using ICA. Continuous broadband noise was presented binaurally to 19 subjects with normal hearing. ICA was performed to segregate spatial networks, which were subsequently classified according to their temporal relation to the stimulus using power spectrum analysis. Classification of separated networks resulted in 3 stimulus-activated, 9 stimulus-deactivated, 2 stimulus-neutral (stimulus-dependent but not correlated with the stimulation timing), and 2 stimulus-unrelated (fluctuations that did not follow the stimulus cycles) components. As a result of such classification, spatiotemporal subdivisions were observed in a number of cortical structures, namely auditory, cingulate, and sensorimotor cortices, where parts of the same cortical network responded to the stimulus with different temporal patterns. The majority of the classified networks seemed to comprise subparts of the known resting-state networks (RSNs); however, they displayed different temporal behavior in response to the auditory stimulus, indicating stimulus-dependent temporal segregation of RSNs. Only one of nine deactivated networks coincided with the "classic'' default-mode network, suggesting the existence of a stimulus-dependent default-mode network, different from that commonly accepted.	[Yakunina, Natalia; Nam, Eui-Cheol] Kangwon Natl Univ, Sch Med, Dept Otolaryngol, Chunchon, South Korea; [Yakunina, Natalia; Tae, Woo Suk; Lee, Kang Uk; Kim, Sam Soo; Nam, Eui-Cheol] Kangwon Natl Univ, Sch Med, Neurosci Res Inst, Chunchon, South Korea; [Lee, Kang Uk] Kangwon Natl Univ, Sch Med, Dept Psychiat, Chunchon, South Korea; [Kim, Sam Soo] Kangwon Natl Univ, Sch Med, Dept Radiol, Chunchon, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Nam, EC (corresponding author), Kangwon Natl Univ, Sch Med, Dept Otolaryngol, Chunchon, South Korea.	birdynec@kangwon.ac.kr			National Research Foundation (NRF) of Korea; Ministry of Education, Science, and Technology [2011-0006602]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science, and Technology (2011-0006602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CC, 2010, AM J GERIAT PSYCHIAT, V18, P897, DOI 10.1097/JGP.0b013e3181e9b9d9; Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Ardekani BA, 1999, IEEE T MED IMAGING, V18, P101, DOI 10.1109/42.759109; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Bassim MK, 2003, HEARING RES, V182, P140, DOI 10.1016/S0378-5955(03)00190-4; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bergomi Margherita, 1991, Public Health Reviews, V19, P263; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Calhoun VD, 2006, IEEE ENG MED BIOL, V25, P79, DOI 10.1109/MEMB.2006.1607672; Calhoun VD, 2001, NEUROIMAGE, V14, P1080, DOI 10.1006/nimg.2001.0921; Calhoun VD, 2005, NEUROIMAGE, V25, P527, DOI 10.1016/j.neuroimage.2004.12.012; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD., 2004, GROUP ICA FMRI TOOLB; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Formisano E, 2002, NEUROCOMPUTING, V49, P241, DOI 10.1016/S0925-2312(02)00517-9; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fraser LM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-91; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; FUJII K, 1990, AM J PHYSIOL, V258, pH1829, DOI 10.1152/ajpheart.1990.258.6.H1829; Gaab N, 2008, HUM BRAIN MAPP, V29, P858, DOI 10.1002/hbm.20578; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gawryluk JR, 2011, NEUROIMAGE, V54, P10, DOI 10.1016/j.neuroimage.2010.07.028; Goldstein, 1996, Int Tinnitus J, V2, P83; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Harms MP, 2003, HUM BRAIN MAPP, V20, P168, DOI 10.1002/hbm.10136; Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Huang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044062; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Langers DRM, 2011, BRAIN CONNECT, V1, P233, DOI 10.1089/brain.2011.0023; Langers DRM, 2011, NEUROIMAGE, V55, P1617, DOI 10.1016/j.neuroimage.2011.01.019; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; McKeown MJ, 2000, NEUROIMAGE, V11, P24, DOI 10.1006/nimg.1999.0518; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Moritz CH, 2003, HUM BRAIN MAPP, V18, P111, DOI 10.1002/hbm.10081; Mosier K, 2001, EXP BRAIN RES, V140, P280, DOI 10.1007/s002210100813; Munoz-Lopez MM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00129; Nam EC, 2008, MAGN RESON IMAGING, V26, P715, DOI 10.1016/j.mri.2008.01.020; Nir Y, 2008, NAT NEUROSCI, V11, P523, DOI 10.1038/nn0508-523; Ortuno F, 2002, NEUROIMAGE, V17, P411, DOI 10.1006/nimg.2002.1168; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajapakse JC, 1998, HUM BRAIN MAPP, V6, P283, DOI 10.1002/(SICI)1097-0193(1998)6:4<283::AID-HBM7>3.0.CO;2-#; Rimol LM, 2006, NEUROIMAGE, V30, P554, DOI 10.1016/j.neuroimage.2005.10.021; Rimol LM, 2005, NEUROIMAGE, V26, P1059, DOI 10.1016/j.neuroimage.2005.03.028; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; SAWADA Y, 1993, EUR J APPL PHYSIOL O, V67, P367, DOI 10.1007/BF00357637; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; Shechter B, 2006, HEARING RES, V221, P91, DOI 10.1016/j.heares.2006.08.002; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Sigalovsky IS, 2006, HEARING RES, V215, P67, DOI 10.1016/j.heares.2006.03.002; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; Talavage TM, 1999, HUM BRAIN MAPP, V7, P79, DOI 10.1002/(SICI)1097-0193(1999)7:2<79::AID-HBM1>3.0.CO;2-R; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Vercammen A, 2012, J PSYCHIATR NEUROSCI, V37, P379, DOI 10.1503/jpn.110088; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Weber B, 2002, NEUROIMAGE, V16, P993, DOI 10.1006/nimg.2002.1104; Willich SN, 2006, EUR HEART J, V27, P276, DOI 10.1093/eurheartj/ehi658; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Windischberger C, 2002, MAGN RESON IMAGING, V20, P575, DOI 10.1016/S0730-725X(02)00563-5; Xie G, 2012, NEUROIMAGE, V63, P245, DOI 10.1016/j.neuroimage.2012.06.057; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018; YUKIE M, 1995, NEUROSCI RES, V22, P179, DOI 10.1016/0168-0102(95)00888-1; Zeng WM, 2009, NEUROIMAGE, V46, P1041, DOI 10.1016/j.neuroimage.2009.02.048	98	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66424	10.1371/journal.pone.0066424	http://dx.doi.org/10.1371/journal.pone.0066424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823501	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400107
J	Zhang, X; Jia, HY; Liu, F; Pan, LP; Xing, AY; Gu, SX; Du, BP; Sun, Q; Wei, RR; Zhang, ZD				Zhang, Xia; Jia, Hongyan; Liu, Fei; Pan, Liping; Xing, Aiying; Gu, Shuxiang; Du, Boping; Sun, Qi; Wei, Rongrong; Zhang, Zongde			Prevalence and Risk Factors for Latent Tuberculosis Infection among Health Care Workers in China: A Cross-Sectional Study	PLOS ONE			English	Article							WHOLE-BLOOD; TB; DIAGNOSIS; DISEASE	Background: Health care workers (HCWs) are at risk of latent tuberculosis infection (LTBI). In China, tuberculosis (TB) is a major public health problem, but the prevalence of LTBI in HCWs especially in the hospital for pulmonary diseases has not been assessed enough. The aim of this study was to determine the prevalence and putative risk factors of LTBI among HCWs in a chest hospital and a TB research institute in China. Methodology/Principal Findings: A cross-sectional study was conducted among HCWs in China in 2012. LTBI was assessed by T-SPOT. TB, and information on HCWs was collected using a standardised questionnaire. Risk factors for LTBI were analyzed by univariate and multivariate regression. The overall prevalence of LTBI among HCWs was 33.6%. Analyzed by job category, the highest prevalence was found among laboratory staff (43.4%). In the different workplaces, the proportion of LTBI was significantly higher among the high risk workplaces (37.4%) compared to the low risk workplaces. The duration of employment had a significant impact on the prevalence of LTBI. Positive T-SPOT. TB test results accounted for 17.6%, 16.8%, 23.5%, 41.8% and 41.6% in groups of <= 2, 3-5, 6-10, 11-20, and > 20 working years respectively. In multivariate analysis, job categories (Laboratory staff [2.76 (95% CI: 1.36; 5.60)], technician staff [2.02 (95% CI: 1.12; 3.64)]); working duration as a HCW for 11 to 20 years [3.57 (95% CI: 1.46; 8.71)], and 20 years above [3.41 (95% CI: 1.28; 9.11)]; and the history of household TB contact [2.47 (95% CI: 1.15; 5.33)] were associated with increased risk of LTBI. Conclusions/Significance: Prevalence of LTBI estimated by T-SPOT. TB is high among Chinese HCWs and working duration, job category and the history of household TB contact were associated with increased risk. These data highlight adequate infection control measures should be undertaken.	[Zhang, Xia; Jia, Hongyan; Liu, Fei; Pan, Liping; Xing, Aiying; Gu, Shuxiang; Du, Boping; Sun, Qi; Wei, Rongrong; Zhang, Zongde] Capital Med Univ, Beijing Chest Hosp, Beijing Key Lab Drug Resistance TB Res, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing Key Lab Drug Resistance TB Res, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China.	zzd417@163.com			National Science and Technology Major Project of China [2012ZX10003002]	National Science and Technology Major Project of China	This work was supported by the National Science and Technology Major Project of China (2012ZX10003002) http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Borroto S, 2011, INT J TUBERC LUNG D, V15, P1510, DOI 10.5588/ijtld.10.0333; de Vries G, 2006, EUR RESPIR J, V28, P1216, DOI 10.1183/09031936.06.00039906; Demkow U, 2008, J PHYSIOL PHARMACOL, V59, P209; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Girardi E, 2009, EURO SURVEIL, V14; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Hirama T, 2011, J HOSP INFECT, V77, P257, DOI 10.1016/j.jhin.2010.11.012; Hosoglu S, 2005, AM J INFECT CONTROL, V33, P23, DOI 10.1016/j.ajic.2004.07.013; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Qi YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032103; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Sawanyawisuth Kittisak, 2009, J Occup Med Toxicol, V4, P20, DOI 10.1186/1745-6673-4-20; Schablon A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-107; Schablon Anja, 2009, J Occup Med Toxicol, V4, P1, DOI 10.1186/1745-6673-4-1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Vinton P, 2009, INFECT CONT HOSP EP, V30, P215, DOI 10.1086/595695; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	32	38	46	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66412	10.1371/journal.pone.0066412	http://dx.doi.org/10.1371/journal.pone.0066412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823871	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400105
J	Lapins, M; Worachartcheewan, A; Spjuth, O; Georgiev, V; Prachayasittikul, V; Nantasenamat, C; Wikberg, JES				Lapins, Maris; Worachartcheewan, Apilak; Spjuth, Ola; Georgiev, Valentin; Prachayasittikul, Virapong; Nantasenamat, Chanin; Wikberg, Jarl E. S.			A Unified Proteochemometric Model for Prediction of Inhibition of Cytochrome P450 Isoforms	PLOS ONE			English	Article							BIOCLIPSE; ENZYMES; QSAR	A unified proteochemometric (PCM) model for the prediction of the ability of drug-like chemicals to inhibit five major drug metabolizing CYP isoforms (i.e. CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) was created and made publicly available under the Bioclipse Decision Support open source system at www.cyp450model.org. In regards to the proteochemometric modeling we represented the chemical compounds by molecular signature descriptors and the CYP-isoforms by alignment-independent description of composition and transition of amino acid properties of their protein primary sequences. The entire training dataset contained 63 391 interactions and the best PCM model was obtained using signature descriptors of height 1, 2 and 3 and inducing the model with a support vector machine. The model showed excellent predictive ability with internal AUC = 0.923 and an external AUC = 0.940, as evaluated on a large external dataset. The advantage of PCM models is their extensibility making it possible to extend our model for new CYP isoforms and polymorphic CYP forms. A key benefit of PCM is that all proteins are confined in one single model, which makes it generally more stable and predictive as compared with single target models. The inclusion of the model in Bioclipse Decision Support makes it possible to make virtual instantaneous predictions (similar to 100 ms per prediction) while interactively drawing or modifying chemical structures in the Bioclipse chemical structure editor.	[Lapins, Maris; Spjuth, Ola; Georgiev, Valentin; Wikberg, Jarl E. S.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Worachartcheewan, Apilak; Nantasenamat, Chanin] Mahidol Univ, Ctr Data Min & Biomed Informat, Fac Med Technol, Bangkok 10700, Thailand; [Worachartcheewan, Apilak; Prachayasittikul, Virapong; Nantasenamat, Chanin] Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Bangkok 10700, Thailand	Uppsala University; Mahidol University; Mahidol University	Wikberg, JES (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	jarl.wikberg@farmbio.uu.se	Nantasenamat, Chanin/AAD-1032-2019; Spjuth, Ola/Q-2638-2019	Nantasenamat, Chanin/0000-0003-1040-663X; Spjuth, Ola/0000-0002-8083-2864; Lapins, Maris/0000-0002-0122-6680; Prachayasittikul, Virapong/0000-0001-7942-1083; Georgiev, Valentin/0000-0002-6064-2684	Swedish Research Links programme [C0610701]; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; SNIC-UPPMAX	Swedish Research Links programme; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; SNIC-UPPMAX	JESW and CN were supported by a joint grant from the Swedish Research Links programme (no. C0610701). The research was also supported in part by the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative. Computations were carried out at Uppsala Multidisciplinary Center for Advanced Computational Science (SNIC-UPPMAX) by support of a grant from SNIC-UPPMAX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng FX, 2011, J CHEM INF MODEL, V51, P996, DOI 10.1021/ci200028n; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Faulon JL, 2003, J CHEM INF COMP SCI, V43, P707, DOI 10.1021/ci020345w; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Kontijevskis A, 2008, J CHEM INF MODEL, V48, P1840, DOI 10.1021/ci8000953; Kumar V, 2006, DRUG METAB DISPOS, V34, P1966, DOI 10.1124/dmd.106.010926; Lapins M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-339; Lapins M, 2009, J CHEM INF MODEL, V49, P1202, DOI 10.1021/ci800453k; Lapinsh M, 2001, BBA-GEN SUBJECTS, V1525, P180, DOI 10.1016/S0304-4165(00)00187-2; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2003, J MED CHEM, V46, P2572, DOI 10.1021/jm020945m; Lewis DFV, 2010, EXPERT OPIN DRUG MET, V6, P661, DOI 10.1517/17425251003674380; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Novotarskyi S, 2011, J CHEM INF MODEL, V51, P1271, DOI 10.1021/ci200091h; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Pelkonen O, 2008, ARCH TOXICOL, V82, P667, DOI 10.1007/s00204-008-0332-8; Pinto N, 2011, CURR DRUG METAB, V12, P487, DOI 10.2174/138920011795495321; Singh D, 2011, DRUG DISCOV TODAY, V16, P793, DOI 10.1016/j.drudis.2011.08.003; Spjuth O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-59; Spjuth O, 2013, BIOINFORMATICS, V29, P286, DOI 10.1093/bioinformatics/bts681; Spjuth O, 2011, J CHEM INF MODEL, V51, P1840, DOI 10.1021/ci200242c; Spjuth O, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-397; Vapnik V., 1998, STAT LEARNING THEORY; Vasanthanathan P, 2009, DRUG METAB DISPOS, V37, P658, DOI 10.1124/dmd.108.023507; Veith H, 2009, NAT BIOTECHNOL, V27, P1050, DOI 10.1038/nbt.1581; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wikberg JE., 2012, COMPUTATIONAL APPROA, P57; Wikberg JES, 2011, INTRO PHARM BIOINFOR	29	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66566	10.1371/journal.pone.0066566	http://dx.doi.org/10.1371/journal.pone.0066566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799117	gold, Green Published			2022-12-27	WOS:000321397800038
J	Morroni, M; Marzioni, D; Ragno, M; Di Bella, P; Cartechini, E; Pianese, L; Lorenzi, T; Castellucci, M; Scarpelli, M				Morroni, Manrico; Marzioni, Daniela; Ragno, Michele; Di Bella, Paolo; Cartechini, Elisabetta; Pianese, Luigi; Lorenzi, Teresa; Castellucci, Mario; Scarpelli, Marina			Role of Electron Microscopy in the Diagnosis of Cadasil Syndrome: A Study of 32 Patients	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; NOTCH3 MUTATIONS; SKIN BIOPSY; LEUKOENCEPHALOPATHY CADASIL; RENAL INVOLVEMENT; VASCULAR CHANGES; ITALIAN PATIENTS; MUSCLE; LESIONS	Background and Purpose: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is caused by NOTCH3 gene mutations that result in vascular smooth muscle cell (VSMC) degeneration. Its distinctive feature by electron microscopy (EM) is granular osmiophilic material (GOM) detected in VSMC indentations and/or the extracellular space close to VSMCs. Reports of the sensitivity of EM in detecting GOM in biopsies from CADASIL patients are contradictory. We present data from 32 patients clinically suspected to have CADASIL and discuss the role of EM in its diagnosis in this retrospective study. Methods: Skin, skeletal muscle, kidney and pericardial biopsies were examined by EM; the NOTCH3 gene was screened for mutations. Skin and muscle biopsies from 12 patients without neurological symptoms served as controls. Results and Discussion: All GOM-positive patients exhibited NOTCH3 mutations and vice versa. This study i) confirms that EM is highly specific and sensitive for CADASIL diagnosis; ii) extends our knowledge of GOM distribution in tissues where it has never been described, e.g. pericardium; iii) documents a novel NOTCH3 mutation in exon 3; and iv) shows that EM analysis is critical to highlight the need for comprehensive NOTCH3 analysis. Our findings also confirm the genetic heterogeneity of CADASIL in a small Italian subpopulation and emphasize the difficulties in designing algorithms for molecular diagnosis.	[Morroni, Manrico; Marzioni, Daniela; Lorenzi, Teresa; Castellucci, Mario] Univ Politecn Marche, Sch Med, Sect Anat, Dept Expt & Clin Med, Ancona, Italy; [Morroni, Manrico] United Hosp, Electron Microscopy Unit, Ancona, Italy; [Ragno, Michele] Azienda Sanit Unica Reg, Mazzoni Hosp, Div Neurol, Ascoli Piceno, Italy; [Di Bella, Paolo] Univ Politecn Marche, United Hosp, Sch Med, Dept Neurosci, Ancona, Italy; [Cartechini, Elisabetta] Azienda Sanit Unica Reg, Macerata Hosp, Div Neurol, Macerata, Italy; [Pianese, Luigi] Azienda Sanit Unica Reg, Mazzoni Hosp, Mol Med Lab, Ascoli Piceno, Italy; [Scarpelli, Marina] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Sect Pathol Anat, Sch Med,United Hosp, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Morroni, M (corresponding author), Univ Politecn Marche, Sch Med, Sect Anat, Dept Expt & Clin Med, Ancona, Italy.	m.morroni@univpm.it; d.marzioni@univpm.it		Lorenzi, Teresa/0000-0002-3723-5378	Universita Politecnica delle Marche	Universita Politecnica delle Marche	The study was supported by a grant from Universita Politecnica delle Marche (2011 FAR, formerly 60%) to M.M. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; Bergmann M, 1996, ACTA NEUROPATHOL, V92, P341, DOI 10.1007/s004010050528; Brulin P, 2002, ACTA NEUROPATHOL, V104, P241, DOI 10.1007/s00401-002-0530-z; Cappelli A, 2009, NEUROSCI LETT, V462, P176, DOI 10.1016/j.neulet.2009.06.087; Chabriat H, 1998, NEUROLOGY, V51, P452, DOI 10.1212/WNL.51.2.452; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; Dichgans M, 2002, STROKE, V33, P67, DOI 10.1161/hs0102.100885; Dotti MT, 2005, J NEUROL NEUROSUR PS, V76, P736, DOI 10.1136/jnnp.2004.048207; Ebke M, 1997, ACTA NEUROL SCAND, V95, P351, DOI 10.1111/j.1600-0404.1997.tb00224.x; Goebel HH, 1997, MUSCLE NERVE, V20, P625, DOI 10.1002/(SICI)1097-4598(199705)20:5<625::AID-MUS17>3.0.CO;2-V; Guerrot D, 2008, AM J KIDNEY DIS, V52, P340, DOI 10.1053/j.ajkd.2008.04.017; Gustavsen WR, 2006, EUR J NEUROL, V13, P359, DOI 10.1111/j.1468-1331.2006.01243.x; Haritoglou C, 2004, AM J OPHTHALMOL, V138, P302, DOI 10.1016/j.ajo.2004.02.073; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2001, LANCET, V358, P2049, DOI 10.1016/S0140-6736(01)07142-2; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Joutel A, 2011, BIOESSAYS, V33, P73, DOI 10.1002/bies.201000093; Kalimo H, 2002, BRAIN PATHOL, V12, P371; Kusaba T, 2007, CLIN NEPHROL, V67, P182; Malandrini A, 2007, NEUROLOGY, V68, P1430, DOI 10.1212/01.wnl.0000264018.46335.c8; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Mayer M, 1999, J NEUROL, V246, P526, DOI 10.1007/s004150050398; Miao Q, 2004, BRAIN PATHOL, V14, P358; Oberstein SAJL, 2003, MEDICINE, V82, P251; Oberstein SAJL, 2003, ACTA NEUROPATHOL, V106, P107, DOI 10.1007/s00401-003-0701-6; Ragno M, 2012, HISTOL HISTOPATHOL, V27, P1307, DOI 10.14670/HH-27.1307; Rubio A, 1997, ACTA NEUROPATHOL, V94, P247, DOI 10.1007/s004010050700; Ruchoux MM, 1998, NEUROPATH APPL NEURO, V24, P60; RUCHOUX MM, 1994, STROKE, V25, P2291, DOI 10.1161/01.STR.25.11.2291; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500; SCHRODER JM, 1995, ACTA NEUROPATHOL, V89, P116, DOI 10.1007/BF00296354; Testi S, 2012, J NEUROL SCI, V319, P37, DOI 10.1016/j.jns.2012.05.025; Tikka S, 2009, BRAIN, V132, P933, DOI 10.1093/brain/awn364; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; van den Boom R, 2002, RADIOLOGY, V224, P791, DOI 10.1148/radiol.2243011123; Wang ZX, 2011, J NEUROL NEUROSUR PS, V82, P534, DOI 10.1136/jnnp.2010.209247	37	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65482	10.1371/journal.pone.0065482	http://dx.doi.org/10.1371/journal.pone.0065482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799017	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800009
J	Qi, N; Liu, PP; Zhang, Y; Wu, H; Chen, YM; Han, DS				Qi, Nan; Liu, Peipei; Zhang, Yue; Wu, Hui; Chen, Yongmei; Han, Daishu			Development of a Spontaneous Liver Disease Resembling Autoimmune Hepatitis in Mice Lacking Tyro3, Axl and Mer Receptor Tyrosine Kinases	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; INNATE IMMUNE-RESPONSES; TAM RECEPTORS; FAMILY RECEPTORS; ANIMAL-MODELS; CELLS; GAS6; LIPOPOLYSACCHARIDE; IMMUNOBIOLOGY; INFLAMMATION	Autoimmune hepatitis (AIH) is a severe type of chronic liver disease. The lack of appropriate animal models has resulted in a limited understanding regarding the etiology of AIH. Here, we demonstrated that mice deficient in Tyro3, Axl and Mer (TAM) receptor tyrosine kinases (RTKs) developed persistent inflammatory liver damage resembling AIH. Tyro3(-/-) Axl(-/-) Mer(-/-) triple mutant (TAM(-/-)) mice exhibited chronic hepatitis, manifested by progressive appearance of interface hepatitis, immune cell infiltrations and elevated inflammatory cytokine levels in the liver. Accordingly, increased levels of transaminases were observed. Moreover, characteristic autoantibodies and high levels of plasma immunoglobulin G for AIH were detected as TAM(-/-) mice aged. Finally, we provided evidence that the liver damage in TAM(-/-) mice mainly result from bone marrow-derived cells and could be rescued by transplantation of WT bone marrow cells. Results suggest that TAM RTKs play an important role in maintaining immune tolerance of the liver.	[Qi, Nan; Liu, Peipei; Zhang, Yue; Chen, Yongmei; Han, Daishu] Chinese Acad Med Sci, Dept Cell Biol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Qi, Nan] Anhui Med Univ, Dept Biochem & Mol Biol, Sch Basic Med, Hefei, Peoples R China; [Wu, Hui] Navy Gen Hosp, Dept Pathol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Anhui Medical University; Sixth Medical Center of Chinese PLA General Hospital	Han, DS (corresponding author), Chinese Acad Med Sci, Dept Cell Biol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	dshan@ibms.pumc.edu.cn			Special Funds for Major State Basic Research Project of China [2007CB947504]; National Supporting Plans of China [2008BAI54B04]; National Natural Science Foundation of China [30971459]	Special Funds for Major State Basic Research Project of China(National Basic Research Program of China); National Supporting Plans of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special Funds for Major State Basic Research Project of China (Grant No. 2007CB947504), the National Supporting Plans of China (Grant No. 2008BAI54B04) and the National Natural Science Foundation of China (Grant No. 30971459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amoh Y, 1997, IMMUNOBIOLOGY, V197, P31, DOI 10.1016/S0171-2985(97)80055-1; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Christen U, 2007, AUTOIMMUN REV, V6, P306, DOI 10.1016/j.autrev.2006.04.001; Christen U, 2009, SEMIN LIVER DIS, V29, P262, DOI 10.1055/s-0029-1233536; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Czaja AJ, 2009, CURR OPIN GASTROEN, V25, P215, DOI 10.1097/MOG.0b013e328324ed06; Czaja MJ, 1989, GROWTH FACTORS, V1, P219, DOI 10.3109/08977198908997998; Deng TT, 2012, IMMUNOLOGY, V135, P40, DOI 10.1111/j.1365-2567.2011.03511.x; Dong ZJ, 2004, WORLD J GASTROENTERO, V10, P1928; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Holdener M, 2008, J EXP MED, V205, P1409, DOI 10.1084/jem.20071859; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; Kunz M, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/979258; KURIKI J, 1983, GASTROENTEROLOGY, V84, P596; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lapierre P, 2004, HEPATOLOGY, V39, P1066, DOI 10.1002/hep.20109; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mieli-Vergani G, 2009, J PEDIATR GASTR NUTR, V49, P158, DOI 10.1097/MPG.0b013e3181a1c265; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pandey S, 2006, IMMUNOL CELL BIOL, V84, P333, DOI 10.1111/j.1440-1711.2006.01444.x; Qingxian Lu, 2010, Front Biol (Beijing), V5, P227; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sacher T, 2002, EUR J IMMUNOL, V32, P3628, DOI 10.1002/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E; Sawaki J, 2007, INT IMMUNOL, V19, P311, DOI 10.1093/intimm/dxl148; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2001, J IMMUNOL, V166, P2651, DOI 10.4049/jimmunol.166.4.2651; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Shang T, 2011, ENDOCRINOLOGY, V152, P2827, DOI 10.1210/en.2011-0031; SHEN W, 1991, TOXICOL APPL PHARM, V111, P242, DOI 10.1016/0041-008X(91)90028-D; Shu SA, 2007, CLIN EXP IMMUNOL, V149, P335, DOI 10.1111/j.1365-2249.2007.03419.x; Sun B, 2010, ENDOCRINOLOGY, V151, P2886, DOI 10.1210/en.2009-1498; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Tang HM, 2009, HAEMATOL-HEMATOL J, V94, P326, DOI 10.3324/haematol.13635; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; Uchida Y, 2010, GASTROENTEROLOGY, V139, P2195, DOI 10.1053/j.gastro.2010.07.003; Vergani D, 2009, SEMIN IMMUNOPATHOL, V31, P421, DOI 10.1007/s00281-009-0170-7; Wang HZ, 2005, J HISTOCHEM CYTOCHEM, V53, P1355, DOI 10.1369/jhc.5A6637.2005; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Zachou Kalliopi, 2004, J Autoimmune Dis, V1, P2, DOI 10.1186/1740-2557-1-2; Zheng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039035	53	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66604	10.1371/journal.pone.0066604	http://dx.doi.org/10.1371/journal.pone.0066604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799121	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800041
J	Rajan, D; Gaston, KA; McCracken, CE; Erdman, DD; Anderson, LJ				Rajan, Devi; Gaston, Kelsey A.; McCracken, Courtney E.; Erdman, Dean D.; Anderson, Larry J.			Response to Rhinovirus Infection by Human Airway Epithelial Cells and Peripheral Blood Mononuclear Cells in an In Vitro Two-Chamber Tissue Culture System	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; MONOCYTIC CELLS; RECEPTOR; CHILDREN; RELEASE; REPLICATION; EXPRESSION; SEROTYPES; CYTOKINES; ALPHA	Human rhinovirus (HRV) infections are associated with the common cold, occasionally with more serious lower respiratory tract illnesses, and frequently with asthma exacerbations. The clinical features of HRV infection and its association with asthma exacerbation suggest that some HRV disease results from virus-induced host immune responses to infection. To study the HRV-infection-induced host responses and the contribution of these responses to disease, we have developed an in vitro model of HRV infection of human airway epithelial cells (Calu-3 cells) and subsequent exposure of human peripheral blood mononuclear cells (PBMCs) to these infected cells in a two-chamber trans-well tissue culture system. Using this model, we studied HRV 14 (species B) and HRV 16 (species A) induced cytokine and chemokine responses with PBMCs from four healthy adults. Infection of Calu-3 cells with either virus induced HRV-associated increases in FGF-Basic, IL-15, IL-6, IL-28A, ENA-78 and IP-10. The addition of PBMCs to HRV 14-infected cells gave significant increases in MIP-1 beta, IL-28A, MCP-2, and IFN-alpha as compared with mock-infected cells. Interestingly, ENA-78 levels were reduced in HRV 14 infected cells that were exposed to PBMCs. Addition of PBMCs to HRV 16-infected cells did not induce MIP-1 beta, IL-28A and IFN-alpha efficiently nor did it decrease ENA-78 levels. Our results demonstrate a clear difference between HRV 14 and HRV 16 and the source of PBMCs, in up or down regulation of several cytokines including those that are linked to airway inflammation. Such differences might be one of the reasons for variation in disease associated with different HRV species including variation in their link to asthma exacerbations as suggested by other studies. Further study of immune responses associated with different HRVs and PBMCs from different patient groups, and the mechanisms leading to these differences, should help characterize pathogenesis of HRV disease and generate novel approaches to its treatment.	[Rajan, Devi; Gaston, Kelsey A.; McCracken, Courtney E.; Anderson, Larry J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Rajan, Devi; Gaston, Kelsey A.; McCracken, Courtney E.; Anderson, Larry J.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Erdman, Dean D.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA); Centers for Disease Control & Prevention - USA	Anderson, LJ (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	larry.anderson@emory.edu			Children's Healthcare of Atlanta; immunology core of Children's Healthcare of Atlanta	Children's Healthcare of Atlanta; immunology core of Children's Healthcare of Atlanta	This work was supported in part by funding provided by Children's Healthcare of Atlanta and the work partly supported by the immunology core of Children's Healthcare of Atlanta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Donninger H, 2003, J INFECT DIS, V187, P1809, DOI 10.1086/375246; Forbes RL, 2012, THORAX, V67, P209, DOI 10.1136/thoraxjnl-2011-200708; Garcia C, 2012, PEDIATR INFECT DIS J, V31, P86, DOI 10.1097/INF.0b013e31822dc8c1; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Iikura K, 2011, INT ARCH ALLERGY IMM, V155, P27, DOI 10.1159/000327262; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Johnston SL, 1998, J IMMUNOL, V160, P6172; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Lenarczyk A, 2000, CLIN EXP IMMUNOL, V122, P41, DOI 10.1046/j.1365-2249.2000.01328.x; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Olsson S, 2003, CLIN EXP IMMUNOL, V132, P254, DOI 10.1046/j.1365-2249.2003.02148.x; Papadopoulos N G, 2000, Can Respir J, V7, P409; Papadopoulos NG, 2001, CLIN EXP ALLERGY, V31, P1060, DOI 10.1046/j.1365-2222.2001.01112.x; Persson T, 2003, CLIN EXP ALLERGY, V33, P531, DOI 10.1046/j.1365-2222.2003.01609.x; Saedisomeolia A, 2009, J NUTR BIOCHEM, V20, P577, DOI 10.1016/j.jnutbio.2008.06.001; Saedisomeolia A, 2009, BRIT J NUTR, V101, P533, DOI 10.1017/S0007114508025798; SCHNYDERCANDRIAN S, 1995, J LEUKOCYTE BIOL, V57, P929, DOI 10.1002/jlb.57.6.929; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Stokes CA, 2011, J VIROL, V85, P7912, DOI 10.1128/JVI.02649-10; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Vlasak M, 2003, J VIROL, V77, P6923, DOI 10.1128/JVI.77.12.6923-6930.2003; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Watters K, 2011, J VIROL, V85, P10874, DOI 10.1128/JVI.00718-11; Xatzipsalti M, 2008, CLIN EXP ALLERGY, V38, P466, DOI 10.1111/j.1365-2222.2007.02906.x	32	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66600	10.1371/journal.pone.0066600	http://dx.doi.org/10.1371/journal.pone.0066600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799120	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800040
J	Hilbe, C; Abou Chakra, M; Altrock, PM; Traulsen, A				Hilbe, Christian; Abou Chakra, Maria; Altrock, Philipp M.; Traulsen, Arne			The Evolution of Strategic Timing in Collective-Risk Dilemmas	PLOS ONE			English	Article							PUBLIC-GOODS; SOCIAL DILEMMA; CLIMATE; GAME; PREVENTION; PROVISION; DYNAMICS; CRISES	In collective-risk dilemmas, a group needs to collaborate over time to avoid a catastrophic event. This gives rise to a coordination game with many equilibria, including equilibria where no one contributes, and thus no measures against the catastrophe are taken. In this game, the timing of contributions becomes a strategic variable that allows individuals to interact and influence one another. Herein, we use evolutionary game theory to study the impact of strategic timing on equilibrium selection. Depending on the risk of catastrophe, we identify three characteristic regimes. For low risks, defection is the only equilibrium, whereas high risks promote equilibria with sufficient contributions. Intermediate risks pose the biggest challenge for cooperation. In this risk regime, the option to interact over time is critical; if individuals can contribute over several rounds, then the group has a higher chance to succeed, and the expected welfare increases. This positive effect of timing is of particular importance in larger groups, where successful coordination becomes increasingly difficult.	[Hilbe, Christian; Abou Chakra, Maria; Altrock, Philipp M.; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany	Max Planck Society	Hilbe, C (corresponding author), Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany.	hilbe@evolbio.mpg.de	Chakra, Maria Abou/K-4735-2013; Traulsen, Arne/A-4955-2009; Hilbe, Christian/K-9412-2013; Altrock, Philipp/X-9063-2018	Chakra, Maria Abou/0000-0002-4895-954X; Traulsen, Arne/0000-0002-0669-5267; Hilbe, Christian/0000-0001-5116-955X; Altrock, Philipp/0000-0001-7731-3345				Abou Chakra M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002652; [Anonymous], 1995, EVOLUTIONARY GAME TH; Archetti M, 2009, J EVOLUTION BIOL, V22, P2192, DOI 10.1111/j.1420-9101.2009.01835.x; Barrett S, 2012, P NATL ACAD SCI USA, V109, P17372, DOI 10.1073/pnas.1208417109; Chen XJ, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/68003; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Ciccarelli JN, 2009, PSYCHOLOGY; Cookson R., 2000, Experimental Economics, V3, P55, DOI 10.1023/A:1009994008166; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; DRAZEN A, 1993, AM ECON REV, V83, P598; GRADSTEIN M, 1992, J POLIT ECON, V100, P581, DOI 10.1086/261830; Greenwood G, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/40006; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Imhof LA, 2006, J MATH BIOL, V52, P667, DOI 10.1007/s00285-005-0369-8; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Marx LM, 2000, REV ECON STUD, V67, P327; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Milinski M, 2011, CLIMATIC CHANGE, V109, P807, DOI 10.1007/s10584-011-0319-y; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Palacios-Huerta I, 2009, AM ECON REV, V99, P1619, DOI 10.1257/aer.99.4.1619; Raihani N, 2011, CLIMATIC CHANGE, V108, P47, DOI 10.1007/s10584-010-0014-4; RAPOPORT A, 1989, ORGAN BEHAV HUM DEC, V44, P325, DOI 10.1016/0749-5978(89)90012-5; Romano R, 2001, J PUBLIC ECON, V81, P423, DOI 10.1016/S0047-2727(00)00078-5; Santos FC, 2012, MATH MOD METH APPL S, V22, DOI 10.1142/S0218202511400045; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Schelling TC, 1960, STRATEGY CONICT; Sigmund K, 2010, PRINC SER THEOR COMP, P1; Summers LH, 2000, AM ECON REV, V90, P1, DOI 10.1257/aer.90.2.1; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Wang J, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016102; Wang J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016101; WEESIE J, 1993, J CONFLICT RESOLUT, V37, P569, DOI 10.1177/0022002793037003008	35	24	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66490	10.1371/journal.pone.0066490	http://dx.doi.org/10.1371/journal.pone.0066490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799109	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300087
J	Petsas, N; Tinelli, E; Lenzi, D; Tomassini, V; Sbardella, E; Tona, F; Raz, E; Nucciarelli, V; Pozzilli, C; Pantano, P				Petsas, Nikolaos; Tinelli, Emanuele; Lenzi, Delia; Tomassini, Valentina; Sbardella, Emilia; Tona, Francesca; Raz, Eytan; Nucciarelli, Valter; Pozzilli, Carlo; Pantano, Patrizia			Evidence of Impaired Brain Activity Balance after Passive Sensorimotor Stimulation in Multiple Sclerosis	PLOS ONE			English	Article							FUNCTIONAL MRI; DEFAULT-MODE; HAND MOVEMENT; DEACTIVATION; FMRI; REORGANIZATION; CORTEX; MS; ACTIVATION; DAMAGE	Objectives: Examination of sensorimotor activation alone in multiple sclerosis (MS) patients may not yield a comprehensive view of cerebral response to task stimulation. Additional information may be obtained by examining the negative BOLD response (deactivation). Aim of this work was to characterize activation and deactivation patterns during passive hand movements in MS patients. Methods: 13 relapsing remitting-MS patients (RRMS), 18 secondary progressive-MS patients (SPMS) and 15 healthy controls (HC) underwent an fMRI study during passive right-hand movements. Activation and deactivation contrasts in the three groups were entered into ANOVA, age and gender corrected. Post-hoc analysis was performed with one-sample and two-sample t-tests. For each patient we obtained lesion volume (LV) from both T1- and T2-weighted images. Results: Activations showed a progressive extension to the ipsilateral brain hemisphere according to the group and the clinical form (HC, RRMS, SPMS). Significant deactivation of the ipsilateral cortical sensorimotor areas was reduced in both patient groups with respect to HC. Deactivation of posterior cortical areas belonging to the default mode network (DMN), was increased in RRMS, but not in SPMS, with respect to HC. The amount of activation in the contralateral sensorimotor cortex was significantly correlated with that of deactivation in the DMN in HC and RRMS, but not in SPMS. Both increased activation and decreased deactivation patterns correlated with LV. Conclusion: In RRMS patients, increased cortical activation was associated with increased deactivation of the posterior cortex suggesting a greater resting-state activity in the DMN, probably aimed at facilitating sensorimotor circuit engagement during task performance. In SPMS the coupling between increased sensorimotor activation/increased DMN deactivation was not observed suggesting disorganization between anticorrelated functional networks as a consequence of a higher level of disconnection.	[Petsas, Nikolaos; Tinelli, Emanuele; Lenzi, Delia; Sbardella, Emilia; Tona, Francesca; Raz, Eytan; Nucciarelli, Valter; Pozzilli, Carlo; Pantano, Patrizia] Univ Roma La Sapienza, Dept Neurol & Psychiat, I-00185 Rome, Italy; [Petsas, Nikolaos; Sbardella, Emilia] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Tomassini, Valentina] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Petsas, Nikolaos; Tomassini, Valentina] Santa Lucia Fdn, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Cardiff University; IRCCS Santa Lucia	Petsas, N (corresponding author), Univ Roma La Sapienza, Dept Neurol & Psychiat, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	petsas@gmail.com	Tomassini, Valentina/HGE-0655-2022; Tinelli, Emanuele/AAH-9176-2021; tona, francesca/J-4792-2016; tinelli, emanuele/GSO-0025-2022; Pozzilli, Carlo/AAC-3270-2022; Raz, Eytan/I-5738-2012; Sbardella, Emilia/K-2167-2016; Patrizia, Pantano/C-8214-2009	Tomassini, Valentina/0000-0002-7368-6280; Tinelli, Emanuele/0000-0002-3007-4022; tona, francesca/0000-0001-9802-2248; tinelli, emanuele/0000-0002-3007-4022; Pozzilli, Carlo/0000-0002-6360-4798; Raz, Eytan/0000-0003-2998-8481; Sbardella, Emilia/0000-0002-9129-9065; Patrizia, Pantano/0000-0001-9659-8294	Italian Federation on Multiple Sclerosis (FISM) [2007/R/11]; Sanofi-Aventis; Merck Serono; Bayer Schering; Medical Research Council [G0801418B] Funding Source: researchfish	Italian Federation on Multiple Sclerosis (FISM); Sanofi-Aventis(Sanofi-Aventis); Merck Serono(Merck & Company); Bayer Schering(Bayer AG); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Italian Federation on Multiple Sclerosis (FISM), grant number 2007/R/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C Pozzilli has received honoraria for consultancy or speaking from Sanofi-Aventis, Biogen Idec, Bayer Schering, Merck Serono, and Novartis and has received research grants from Sanofi-Aventis, Merck Serono, and Bayer Schering. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The following authors have declared that no competing interests exist: N Petsas, E Tinelli, D Lenzi, E Sbardella, F Tona, V Tomassini, E Raz, V Nucciarelli, P Pantano.	Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Brett M., Region of Interest Analysis Using an SPM Toolbox; Ciccarelli O, 2006, J NEUROL, V253, P882, DOI 10.1007/s00415-006-0125-z; Conte A, 2009, J NEUROL, V256, P933, DOI 10.1007/s00415-009-5047-0; Filippi M, 1995, BRAIN, V118, P1601, DOI 10.1093/brain/118.6.1601; Filippi M, 2004, NEUROIMAGE, V21, P1147, DOI 10.1016/j.neuroimage.2003.10.023; Filippi M, 2002, NEUROIMAGE, V15, P537, DOI 10.1006/nimg.2001.1023; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Giorgio A, 2010, NEUROL SCI, V31, P245, DOI 10.1007/s10072-010-0370-x; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Iannetti GD, 2007, MAGN RESON IMAGING, V25, P978, DOI 10.1016/j.mri.2007.03.018; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lee M, 2000, ANN NEUROL, V47, P606, DOI 10.1002/1531-8249(200005)47:5<606::AID-ANA8>3.3.CO;2-C; Lenzi D, 2007, HUM BRAIN MAPP, V28, P636, DOI 10.1002/hbm.20305; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Manson SC, 2008, EXP BRAIN RES, V187, P25, DOI 10.1007/s00221-008-1276-1; Manson SC, 2006, EXP BRAIN RES, V174, P728, DOI 10.1007/s00221-006-0517-4; Marchand WR, 2007, NEUROIMAGE, V38, P538, DOI 10.1016/j.neuroimage.2007.07.036; Matthews PM, 2004, RESTOR NEUROL NEUROS, V22, P245; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mezzapesa DM, 2008, HUM BRAIN MAPP, V29, P562, DOI 10.1002/hbm.20418; Morgen K, 2004, BRAIN, V127, P2506, DOI 10.1093/brain/awh266; Pantano P, 2006, J NEUROIMAGING, V16, P104, DOI 10.1111/j.1552-6569.2006.00029.x; Pantano P, 2005, BRAIN, V128, P2146, DOI 10.1093/brain/awh549; Pantano P, 2002, BRAIN, V125, P1607, DOI 10.1093/brain/awf164; Pantano P, 2011, MULTIPLE SCLEROSIS; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reddy H, 2002, BRAIN, V125, P2646, DOI 10.1093/brain/awf283; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Rocca MA, 2004, NEUROIMAGE, V23, P141, DOI 10.1016/j.neuroimage.2004.05.005; Rocca MA, 2007, J NEUROIMAGING, V17, p36S, DOI 10.1111/j.1552-6569.2007.00135.x; Sakamoto K, 2009, NEUROSCI LETT, V466, P120, DOI 10.1016/j.neulet.2009.09.038; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Tomassini V, 2012, NEUROREHAB NEURAL RE, V26, P581, DOI 10.1177/1545968311433208; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wegner C, 2008, EUR J NEUROL, V15, P113, DOI 10.1111/j.1468-1331.2007.02027.x; Weiller C, 1996, NEUROIMAGE, V4, P105, DOI 10.1006/nimg.1996.0034	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65315	10.1371/journal.pone.0065315	http://dx.doi.org/10.1371/journal.pone.0065315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799005	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000320363300012
J	Allerson, MW; Cardona, CJ; Torremorell, M				Allerson, Matt W.; Cardona, Carol J.; Torremorell, Montserrat			Indirect Transmission of Influenza A Virus between Pig Populations under Two Different Biosecurity Settings	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; MYCOPLASMA-HYOPNEUMONIAE; FOMITES BOOTS; SWINE; SURVIVAL	Respiratory disease due to influenza virus is common in both human and swine populations around the world with multiple transmission routes capable of transmitting influenza virus, including indirect routes. The objective of this study was to evaluate the role of fomites in influenza A virus (IAV) transmission between pig populations separated by two different biosecurity settings. Thirty-five pigs were divided into four experimental groups: 10 pigs (1 replicate) were assigned to the infected group (I), 10 pigs (2 replicates of 5 pigs) were assigned to the low biosecurity sentinel group (LB), 10 pigs (2 replicates of 5 pigs) were assigned to the medium biosecurity sentinel group (MB), and 5 pigs (1 replicate) were assigned to the negative control group (NC). Eight of 10 pigs in the infected group were inoculated with IAV and 36 hours following inoculation, personnel movement events took place in order to move potentially infectious clothing and personal protective equipment (PPE) to sentinel pig rooms. Following contact with the infected group, personnel moved to the MB group after designated hygiene measures while personnel moved directly to the LB group. Nasal swabs and blood samples were collected from pigs to assess IAV infection status and fomites were sampled and tested via RRT-PCR. All experimentally inoculated pigs were infected with IAV and 11 of the 144 fomite samples collected following contact with infected pigs were low level positive for IAV genome. One replicate of each sentinel groups LB and MB became infected with IAV and all five pigs were infected over time. This study provides evidence that fomites can serve as an IAV transmission route from infected to sentinel pigs and highlights the need to focus on indirect routes as well as direct routes of transmission for IAV.	[Allerson, Matt W.; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Cardona, Carol J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	torr0033@umn.edu			NIH, National Institute of Allergy and Infectious Diseases; Department of Health and Human Services [HHSN266200700007C]	NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Health and Human Services	This study was supported in whole or in part with federal funds from the NIH, National Institute of Allergy and Infectious Diseases and Department of Health and Human Services under the contract No. HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amass SF, 2003, J SWINE HEALTH PROD, V11, P61; Batista L, 2004, J SWINE HEALTH PROD, V12, P75; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Boone SA, 2005, J INFECTION, V51, P103, DOI 10.1016/j.jinf.2004.09.011; Bowman AS, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.33; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; Forgie SE, 2011, CLIN INFECT DIS, V52, P10, DOI 10.1093/cid/ciq030; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greatorex JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027932; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Koen J.S., 1919, AM J VET MED ASSOC, V14, P468; MEGURO H, 1979, J CLIN MICROBIOL, V9, P175; Mukherjee DV, 2012, AM J INFECT CONTROL, V40, P590, DOI 10.1016/j.ajic.2011.09.006; Otake S, 2002, J SWINE HEALTH PROD, V10, P59; Pitkin A, 2011, J SWINE HEALTH PROD, V19, P345; Richards Shawn, 2012, Morbidity and Mortality Weekly Report, V61, P619; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Thomas Y, 2008, APPL ENVIRON MICROB, V74, P3002, DOI 10.1128/AEM.00076-08; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Vincent AL, 2009, VIRUS GENES, V39, P176, DOI 10.1007/s11262-009-0386-6; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	23	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67293	10.1371/journal.pone.0067293	http://dx.doi.org/10.1371/journal.pone.0067293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805306	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500134
J	Fan, Q; Chen, M; Zuo, L; Shang, XY; Huang, MZ; Ciccarelli, M; Raake, P; Brinks, H; Chuprun, KJ; Dorn, GW; Koch, WJ; Gao, EH				Fan, Qian; Chen, Mai; Zuo, Lin; Shang, Xiying; Huang, Maggie Z.; Ciccarelli, Michele; Raake, Philip; Brinks, Henriette; Chuprun, Kurt J.; Dorn, Gerald W., II; Koch, Walter J.; Gao, Erhe			Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway	PLOS ONE			English	Article							IMPROVES CARDIAC-FUNCTION; HEART-FAILURE; CYTOCHROME-C; CELL-DEATH; DARBEPOETIN-ALPHA; INFARCTION; ISCHEMIA; MYOCYTES; RELEASE; PHOSPHORYLATION	Studies from our lab have shown that decreasing myocardial G protein-coupled receptor kinase 2 (GRK2) activity and expression can prevent heart failure progression after myocardial infarction. Since GRK2 appears to also act as a pro-death kinase in myocytes, we investigated the effect of cardiomyocyte-specific GRK2 ablation on the acute response to cardiac ischemia/reperfusion (I/R) injury. To do this we utilized two independent lines of GRK2 knockout (KO) mice where the GRK2 gene was deleted in only cardiomyocytes either constitutively at birth or in an inducible manner that occurred in adult mice prior to I/R. These GRK2 KO mice and appropriate control mice were subjected to a sham procedure or 30 min of myocardial ischemia via coronary artery ligation followed by 24 hrs reperfusion. Echocardiography and hemodynamic measurements showed significantly improved post-I/R cardiac function in both GRK2 KO lines, which correlated with smaller infarct sizes in GRK2 KO mice compared to controls. Moreover, there was significantly less TUNEL positive myocytes, less caspase-3, and -9 but not caspase-8 activities in GRK2 KO mice compared to control mice after I/R injury. Of note, we found that lowering cardiac GRK2 expression was associated with significantly lower cytosolic cytochrome C levels in both lines of GRK2 KO mice after I/R compared to corresponding control animals. Mechanistically, the anti-apoptotic effects of lowering GRK2 expression were accompanied by increased levels of Bcl-2, Bcl-xl, and increased activation of Akt after I/R injury. These findings were reproduced in vitro in cultured cardiomyocytes and GRK2 mRNA silencing. Therefore, lowering GRK2 expression in cardiomyocytes limits I/R-induced injury and improves post-ischemia recovery by decreasing myocyte apoptosis at least partially via Akt/Bcl-2 mediated mitochondrial protection and implicates mitochondrial-dependent actions, solidifying GRK2 as a pro-death kinase in the heart.	[Fan, Qian; Chen, Mai; Zuo, Lin; Shang, Xiying; Huang, Maggie Z.; Ciccarelli, Michele; Raake, Philip; Brinks, Henriette; Chuprun, Kurt J.; Koch, Walter J.; Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Fan, Qian] Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China; [Chen, Mai] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Washington University (WUSTL); Capital Medical University; Air Force Military Medical University	Gao, EH (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA.	erhe.gao@temple.edu	Ciccarelli, Michele/ABC-2826-2021; Ciccarelli, Michele/K-2824-2016	Ciccarelli, Michele/0000-0003-2379-1960; Ciccarelli, Michele/0000-0003-2379-1960; Fan, Qian/0000-0002-8269-3060	National Institutes of Health (NIH) [R37 HL061690, P01 HL075443]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061690, P01HL075443, R01HL087871] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (NIH) grants R37 HL061690, P01 HL075443 (Project 2) and P01 HL075443 (Project 1 and Core B) (to WJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Boucher M, 2008, CTS-CLIN TRANSL SCI, V1, P13, DOI 10.1111/j.1752-8062.2008.00008.x; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Chen M, 2013, CIRC RES, V112, P1121, DOI 10.1161/CIRCRESAHA.112.300754; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hata JA, 2006, J CARD FAIL, V12, P360, DOI 10.1016/j.cardfail.2006.02.011; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu HR, 2005, CIRCULATION, V111, P90, DOI 10.1161/01.CIR.0000151613.90994.17; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Petrofski JA, 2003, J MOL CELL CARDIOL, V35, P1167, DOI 10.1016/S0022-2828(03)00243-8; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; Rengo G, 2009, CIRCULATION, V119, P89, DOI 10.1161/CIRCULATIONAHA.108.803999; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Theilade J, 2003, BASIC RES CARDIOL, V98, P97, DOI 10.1007/s00395-003-0395-x; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Ungerer M, 1996, CIRC RES, V79, P455, DOI 10.1161/01.RES.79.3.455; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	38	45	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66234	10.1371/journal.pone.0066234	http://dx.doi.org/10.1371/journal.pone.0066234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805205	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500033
J	Lindsay, S; Scheepers, C; Kamide, Y				Lindsay, Shane; Scheepers, Christoph; Kamide, Yuki			To Dash or to Dawdle: Verb-Associated Speed of Motion Influences Eye Movements during Spoken Sentence Comprehension	PLOS ONE			English	Article							LANGUAGE; INFORMATION; INTEGRATION; TIME	In describing motion events verbs of manner provide information about the speed of agents or objects in those events. We used eye tracking to investigate how inferences about this verb-associated speed of motion would influence the time course of attention to a visual scene that matched an event described in language. Eye movements were recorded as participants heard spoken sentences with verbs that implied a fast ("dash'') or slow ("dawdle'') movement of an agent towards a goal. These sentences were heard whilst participants concurrently looked at scenes depicting the agent and a path which led to the goal object. Our results indicate a mapping of events onto the visual scene consistent with participants mentally simulating the movement of the agent along the path towards the goal: when the verb implies a slow manner of motion, participants look more often and longer along the path to the goal; when the verb implies a fast manner of motion, participants tend to look earlier at the goal and less on the path. These results reveal that event comprehension in the presence of a visual world involves establishing and dynamically updating the locations of entities in response to linguistic descriptions of events.	[Lindsay, Shane; Kamide, Yuki] Univ Dundee, Sch Psychol, Dundee, Scotland; [Scheepers, Christoph] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of Dundee; University of Glasgow	Lindsay, S (corresponding author), Univ Dundee, Sch Psychol, Dundee, Scotland.	shane.lindsay@gmail.com			ESRC [RES-062-23-2842, RES-062-23-2749]; ESRC [ES/I006591/1] Funding Source: UKRI; Economic and Social Research Council [ES/I006591/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The present research was supported by ESRC (RES-062-23-2842 awarded to YK and CS; RES-062-23-2749 awarded to YK). (http://www.esrc.ac.uk/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 2007, J MEM LANG, V57, P502, DOI 10.1016/j.jml.2006.12.004; Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Baayen R. H., 1993, CELEX LEXICAL DATABA; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bergen BK, 2007, COGNITIVE SCI, V31, P733, DOI 10.1080/03640210701530748; Coll-Florit M, 2011, COGNITIVE PSYCHOL, V62, P41, DOI 10.1016/j.cogpsych.2010.09.002; Fecica AM, 2010, COGNITION, V116, P368, DOI 10.1016/j.cognition.2010.05.014; Garnham A., 1987, MENTAL MODELS REPRES; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin JW, 2012, GEN ESTIMATING EQUAT; KOSSLYN SM, 1978, J EXP PSYCHOL HUMAN, V4, P47, DOI 10.1037/0096-1523.4.1.47; Langacker Ronald, 1991, DESCRIPTIVE APPL; Matlock T, 2004, MEM COGNITION, V32, P1389, DOI 10.3758/BF03206329; Matlock T, 2004, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P909; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Richardson D, 2007, COGNITION, V102, P129, DOI 10.1016/j.cognition.2005.12.004; Rinck M, 2000, MEM COGNITION, V28, P1310, DOI 10.3758/BF03211832; Speed L, COGNITIVE S IN PRESS; Spivey MJ, 2000, PROCEEDINGS OF THE TWENTY-SECOND ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P487; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Stanfield RA, 2001, PSYCHOL SCI, V12, P153, DOI 10.1111/1467-9280.00326; Stites MC, 2012, MEM COGNITION, V41, P1; Talmy Leonard, 2000, COGNITIVE SEMANTICS, VI; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Taylor HA, 1996, J MEMORY LANGUAGE; Yao B, 2011, COGNITION, V121, P447, DOI 10.1016/j.cognition.2011.08.007; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1; Zwaan RA, 2004, COGNITIVE SCI, V28, P611, DOI 10.1016/j.cogsci.2004.03.004; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162	35	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67187	10.1371/journal.pone.0067187	http://dx.doi.org/10.1371/journal.pone.0067187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805299	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500127
J	Liu, QL; Wang, JZ; Quan, L; Zhao, H; Wu, YD; Huang, XL; Lu, DJ				Liu, Qiu-Ling; Wang, Jing-Zhou; Quan, Li; Zhao, Hu; Wu, Ye-Da; Huang, Xiao-Ling; Lu, De-Jian			Allele and Haplotype Diversity of 26 X-STR Loci in Four Nationality Populations from China	PLOS ONE			English	Article							GENETIC-ANALYSIS; MARKERS; FREQUENCIES	Background: Haplotype analysis of closely associated markers has proven to be a powerful tool in kinship analysis, especially when short tandem repeats (STR) fail to resolve uncertainty in relationship analysis. STR located on the X chromosome show stronger linkage disequilibrium compared with autosomal STR. So, it is necessary to estimate the haplotype frequencies directly from population studies as linkage disequilibrium is population-specific. Methodology and Findings: Twenty-six X-STR loci including six clusters of linked markers DXS6807-DXS8378-DXS9902(Xp22), DXS7132-DXS10079-DXS10074-DXS10075-DXS981 (Xq12), DXS6801-DXS6809-DXS6789-DXS6799(Xq21), DXS7424-DXS101-DXS7133(Xq22), DXS6804-GATA172D05(Xq23), DXS8377-DXS7423 (Xq28) and the loci DXS6800, DXS6803, DXS9898, GATA165B12, DXS6854, HPRTB and GATA31E08 were typed in four nationality (Han, Uigur, Kazakh and Mongol) samples from China (n = 1522, 876 males and 646 females). Allele and haplotype frequency as well as linkage disequilibrium data for kinship calculation were observed. The allele frequency distribution among different populations was compared. A total of 5-20 alleles for each locus were observed and altogether 289 alleles for all the selected loci were found. Allele frequency distribution for most X-STR loci is different in different populations. A total of 876 male samples were investigated by haplotype analysis and for linkage disequilibrium. A total of 89, 703, 335, 147, 39 and 63 haplotypes were observed. Haplotype diversity was 0.9584, 0.9994, 0.9935, 0.9736, 0.9427 and 0.9571 for cluster I, II, III, IV, V and VI, respectively. Eighty-two percent of the haplotype of cluster IIwas found only once. And 94% of the haplotype of cluster III show a frequency of <1%. Conclusions: These results indicate that allele frequency distribution for most X-STR loci is population-specific and haplotypes of six clusters provide a powerful tool for kinship testing and relationship investigation. So it is necessary to obtain allele frequency and haplotypes data of the linked loci for forensic application.	[Liu, Qiu-Ling; Quan, Li; Zhao, Hu; Wu, Ye-Da; Huang, Xiao-Ling; Lu, De-Jian] Sun Yat Sen Univ, Fac Forens Med, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Jing-Zhou] Criminal Invest Div, Inner Mongolia Publ Secur Dept, Inner Mongolia, Peoples R China; [Lu, De-Jian] Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai, Peoples R China	Sun Yat Sen University; Institute of Forensic Science Ministry of Justice PRC	Lu, DJ (corresponding author), Sun Yat Sen Univ, Fac Forens Med, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	dejianlu@tom.com	Wu, Yeda/K-7621-2019		National Natural Science Foundation of China [81102303]; Open Research Fund Program of Shanghai Key Laboratory of Forensic Medicine [KF1201]; National Innovative Experiment Program for University Students, China [201210558098]; Guangdong Provincial Innovative Experiment Program for University Students, China [1055812361]; Open Research Fund Program of Zhongshan University Laboratory [KF201243]; Guangdong Provincial Laboratory Research Fund Program [GDJ2012098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund Program of Shanghai Key Laboratory of Forensic Medicine; National Innovative Experiment Program for University Students, China; Guangdong Provincial Innovative Experiment Program for University Students, China; Open Research Fund Program of Zhongshan University Laboratory; Guangdong Provincial Laboratory Research Fund Program	This work was supported by the National Natural Science Foundation of China (81102303), Open Research Fund Program of Shanghai Key Laboratory of Forensic Medicine (KF1201), National Innovative Experiment Program for University Students, China (201210558098), Guangdong Provincial Innovative Experiment Program for University Students, China (1055812361), Open Research Fund Program of Zhongshan University Laboratory (KF201243), and Guangdong Provincial Laboratory Research Fund Program (GDJ2012098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asamura H, 2006, INT J LEGAL MED, V120, P303, DOI 10.1007/s00414-006-0103-0; Bekada A, 2010, INT J LEGAL MED, V124, P287, DOI 10.1007/s00414-009-0397-9; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Desmarais D, 1998, J FORENSIC SCI, V43, P1046; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fracasso T, 2008, INT J LEGAL MED, V122, P353, DOI 10.1007/s00414-008-0231-9; Hwa HL, 2009, INT J LEGAL MED, V123, P263, DOI 10.1007/s00414-008-0310-y; Inturri S, 2011, FORENSIC SCI INT-GEN, V5, P152, DOI 10.1016/j.fsigen.2010.10.012; Liu QL, 2012, INT J LEGAL MED, V126, P665, DOI 10.1007/s00414-012-0676-8; Liu QL, 2012, ELECTROPHORESIS, V33, P1299, DOI 10.1002/elps.201100558; Liu QL, 2011, INT J LEGAL MED, V125, P51, DOI 10.1007/s00414-010-0520-y; Liu QL, 2011, MOL BIOL REP, V38, P4879, DOI 10.1007/s11033-010-0629-6; Lu DJ, 2012, INT J LEGAL MED, V126, P331, DOI 10.1007/s00414-011-0630-1; Luo HB, 2011, INT J LEGAL MED, V125, P127, DOI 10.1007/s00414-009-0386-z; Pasino S, 2011, INT J LEGAL MED, V125, P749, DOI 10.1007/s00414-011-0591-4; Penna LS, 2012, INT J LEGAL MED, V126, P327, DOI 10.1007/s00414-011-0629-7; Poetsch M, 2009, INT J LEGAL MED, V123, P81, DOI 10.1007/s00414-008-0251-5; Ribeiro-Rodrigues EM, 2011, INT J LEGAL MED, V125, P445, DOI 10.1007/s00414-011-0561-x; Shin SH, 2005, FORENSIC SCI INT, V147, P35, DOI 10.1016/j.forsciint.2004.04.012; Szibor R, 2003, INT J LEGAL MED, V117, P67, DOI 10.1007/s00414-002-0352-5; Szibor R, 2007, FORENSIC SCI INT-GEN, V1, P93, DOI 10.1016/j.fsigen.2007.03.003; Tariq M, 2009, INT J LEGAL MED, V123, P85, DOI 10.1007/s00414-008-0294-7; Turrina S, 2007, FORENSIC SCI INT-GEN, V1, P201, DOI 10.1016/j.fsigen.2007.01.011; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wu WW, 2009, FORENSIC SCI INT-GEN, V4, pE41, DOI 10.1016/j.fsigen.2009.04.005	25	15	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65570	10.1371/journal.pone.0065570	http://dx.doi.org/10.1371/journal.pone.0065570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805185	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500013
J	Mallavia, B; Oguiza, A; Lopez-Franco, O; Recio, C; Ortiz-Munoz, G; Lazaro, I; Lopez-Parra, V; Egido, J; Gomez-Guerrero, C				Mallavia, Benat; Oguiza, Ainhoa; Lopez-Franco, Oscar; Recio, Carlota; Ortiz-Munoz, Guadalupe; Lazaro, Iolanda; Lopez-Parra, Virginia; Egido, Jesus; Gomez-Guerrero, Carmen			Gene Deficiency in Activating Fc gamma Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; E KNOCKOUT MICE; CORONARY-ARTERY-DISEASE; SMOOTH-MUSCLE-CELLS; REGULATORY T-CELLS; IMMUNE-COMPLEXES; STEM-CELLS; OXIDIZED LDL; KAPPA-B; INHIBITION	Immunity contributes to arterial inflammation during atherosclerosis. Oxidized low-density lipoproteins induce an autoimmune response characterized by specific antibodies and immune complexes in atherosclerotic patients. We hypothesize that specific Fc gamma receptors for IgG constant region participate in atherogenesis by regulating the inflammatory state of lesional macrophages. In vivo we examined the role of activating Fc gamma receptors in atherosclerosis progression using bone marrow transplantation from mice deficient in gamma-chain (the common signaling subunit of activating Fc gamma receptors) to hyperlipidemic mice. Hematopoietic deficiency of Fc gamma receptors significantly reduced atherosclerotic lesion size, which was associated with decreased number of macrophages and T lymphocytes, and increased T regulatory cell function. Lesions of Fc gamma receptor deficient mice exhibited increased plaque stability, as evidenced by higher collagen and smooth muscle cell content and decreased apoptosis. These effects were independent of changes in serum lipids and antibody response to oxidized low-density lipoproteins. Activating Fc gamma receptor deficiency reduced pro-inflammatory gene expression, nuclear factor-kappa B activity, and M1 macrophages at the lesion site, while increasing anti-inflammatory genes and M2 macrophages. The decreased inflammation in the lesions was mirrored by a reduced number of classical inflammatory monocytes in blood. In vitro, lack of activating Fc gamma receptors attenuated foam cell formation, oxidative stress and pro-inflammatory gene expression, and increased M2-associated genes in murine macrophages. Our study demonstrates that activating Fc gamma receptors influence the macrophage phenotypic balance in the artery wall of atherosclerotic mice and suggests that modulation of Fc gamma receptor-mediated inflammatory responses could effectively suppress atherosclerosis.	[Mallavia, Benat; Oguiza, Ainhoa; Lopez-Franco, Oscar; Recio, Carlota; Ortiz-Munoz, Guadalupe; Lazaro, Iolanda; Lopez-Parra, Virginia; Gomez-Guerrero, Carmen] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Renal & Vasc Inflammat Lab, Madrid, Spain; [Mallavia, Benat; Oguiza, Ainhoa; Recio, Carlota; Lazaro, Iolanda; Lopez-Parra, Virginia; Egido, Jesus; Gomez-Guerrero, Carmen] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Dept Nephrol, Madrid, Spain; [Lopez-Franco, Oscar] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Ortiz-Munoz, Guadalupe] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; University of Glasgow; University of California System; University of California San Francisco	Gomez-Guerrero, C (corresponding author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Renal & Vasc Inflammat Lab, Madrid, Spain.	cgomez@fjd.es	Recio, Carlota/ABF-5850-2021; munoz, guadalupe ortiz/B-4969-2019; Lopez-Franco, Oscar/AAS-5979-2021; LOPEZ, IOLANDA LAZARO/L-5393-2014; Recio, Carlota/D-2984-2019	munoz, guadalupe ortiz/0000-0002-8928-0576; LOPEZ, IOLANDA LAZARO/0000-0002-6172-9845; Recio, Carlota/0000-0002-8832-2826; Lopez-Franco, Oscar/0000-0001-5069-3763	Spanish Ministry of Science [SAF2009-11794, SAF2012-38830]; Ministry of Health [FIS PI10/00072, RECAVA RD12/0042/0038]; Spanish Society of Nephrology; Fundacion Renal Inigo Alvarez de Toledo; Lilly Foundation	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Health; Spanish Society of Nephrology; Fundacion Renal Inigo Alvarez de Toledo; Lilly Foundation	This work was supported by grants from Spanish Ministry of Science (SAF2009-11794, SAF2012-38830), Ministry of Health (FIS PI10/00072, RECAVA RD12/0042/0038), Spanish Society of Nephrology, Fundacion Renal Inigo Alvarez de Toledo and Lilly Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1397, DOI 10.1161/ATVBAHA.111.225508; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Gavasso S, 2005, ATHEROSCLEROSIS, V180, P277, DOI 10.1016/j.atherosclerosis.2004.12.011; Gomez-Guerrero C, 2002, KIDNEY INT, V62, P2022, DOI 10.1046/j.1523-1755.2002.00653.x; Gomez-Guerrero C, 2012, CARDIOVASC THER, V30, pe189, DOI 10.1111/j.1755-5922.2011.00274.x; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; Hernandez-Presa MA, 1999, KIDNEY INT, V55, P209, DOI 10.1046/j.1523-1755.1999.00226.x; Hernandez-Vargas P, 2006, CIRC RES, V99, P1188, DOI 10.1161/01.RES.0000250556.07796.6c; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Huang Y, 1999, ARTERIOSCL THROM VAS, V19, P1600, DOI 10.1161/01.ATV.19.7.1600; Kelly JA, 2010, CARDIOVASC RES, V85, P224, DOI 10.1093/cvr/cvp300; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Lopes-Virella MF, 2011, DIABETES, V60, P582, DOI 10.2337/db10-0915; Lopez-Franco O, 2006, ARTERIOSCL THROM VAS, V26, P1864, DOI 10.1161/01.ATV.0000229659.94020.53; Lopez-Parra V, 2012, J AM SOC NEPHROL, V23, P1518, DOI 10.1681/ASN.2011080822; MAGGI E, 1994, ARTERIOSCLER THROMB, V14, P1892, DOI 10.1161/01.ATV.14.12.1892; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mineo C, 2005, CIRC RES, V97, P1124, DOI 10.1161/01.RES.0000194323.77203.fe; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Munder M, 1998, J IMMUNOL, V160, P5347; Ng HP, 2011, J IMMUNOL, V187, P6082, DOI 10.4049/jimmunol.1004133; Nicoletti A, 1998, J CLIN INVEST, V102, P910, DOI 10.1172/JCI119892; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Ortiz-Munoz G, 2009, ARTERIOSCL THROM VAS, V29, P525, DOI 10.1161/ATVBAHA.108.173781; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Pfeiffer JR, 2001, ATHEROSCLEROSIS, V155, P211, DOI 10.1016/S0021-9150(00)00541-4; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Plutzky J, 2001, AM J CARDIOL, V88, p10K; Raaz D, 2009, ATHEROSCLEROSIS, V205, P512, DOI 10.1016/j.atherosclerosis.2009.01.013; Ratcliffe NR, 2001, IMMUNOL LETT, V77, P169, DOI 10.1016/S0165-2478(01)00217-6; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Shoenfeld Y, 2004, CIRCULATION, V110, P2552, DOI 10.1161/01.CIR.0000143225.07377.EA; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; Smook MLF, 2008, CLIN EXP IMMUNOL, V154, P264, DOI 10.1111/j.1365-2249.2008.03746.x; Suzuki Y, 2003, J IMMUNOL, V170, P3243, DOI 10.4049/jimmunol.170.6.3243; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Virella G, 2008, ATHEROSCLEROSIS, V200, P239, DOI 10.1016/j.atherosclerosis.2008.03.025; Xu Y, 2007, BIOCHEM BIOPH RES CO, V363, P782, DOI 10.1016/j.bbrc.2007.09.029; Yan PK, 2011, INT J BIOL SCI, V7, P937, DOI 10.7150/ijbs.7.937; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Zhao M, 2010, J IMMUNOL, V184, P2253, DOI 10.4049/jimmunol.0902654; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff	53	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66754	10.1371/journal.pone.0066754	http://dx.doi.org/10.1371/journal.pone.0066754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805273	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000320846500101
J	Perraudin, C; Le Vaillant, M; Pelletier-Fleury, N				Perraudin, Clemence; Le Vaillant, Marc; Pelletier-Fleury, Nathalie			Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program - A Markov Model	PLOS ONE			English	Article							RISK-FACTORS; FOLLOW-UP; CARE; POLYSOMNOGRAPHY; PREVALENCE; DISORDERS; DIAGNOSIS; SYMPTOMS; HOME; MEN	Background: Despite the high prevalence and major public health ramifications, obstructive sleep apnea syndrome (OSAS) remains underdiagnosed. In many developed countries, because community pharmacists (CP) are easily accessible, they have been developing additional clinical services that integrate the services of and collaborate with other healthcare providers (general practitioners (GPs), nurses, etc.). Alternative strategies for primary care screening programs for OSAS involving the CP are discussed. Objective: To estimate the quality of life, costs, and cost-effectiveness of three screening strategies among patients who are at risk of having moderate to severe OSAS in primary care. Design: Markov decision model. Data Sources: Published data. Target Population: Hypothetical cohort of 50-year-old male patients with symptoms highly evocative of OSAS. Time Horizon: The 5 years after initial evaluation for OSAS. Perspective: Societal. Interventions: Screening strategy with CP (CP-GP collaboration), screening strategy without CP (GP alone) and no screening. Outcomes measures: Quality of life, survival and costs for each screening strategy. Results of base-case analysis: Under almost all modeled conditions, the involvement of CPs in OSAS screening was cost effective. The maximal incremental cost for "screening strategy with CP" was about 455(sic) per QALY gained. Results of sensitivity analysis: Our results were robust but primarily sensitive to the treatment costs by continuous positive airway pressure, and the costs of untreated OSAS. The probabilistic sensitivity analysis showed that the "screening strategy with CP" was dominant in 80% of cases. It was more effective and less costly in 47% of cases, and within the cost-effective range (maximum incremental cost effectiveness ratio at (sic)6186.67/QALY) in 33% of cases. Conclusions: CP involvement in OSAS screening is a cost-effective strategy. This proposal is consistent with the trend in Europe and the United States to extend the practices and responsibilities of the pharmacist in primary care.	[Perraudin, Clemence] Fac Med Paris Sud Paris 6, Le Kremlin Bicetre, France; [Perraudin, Clemence; Le Vaillant, Marc; Pelletier-Fleury, Nathalie] INSERM, Ctr Rech Med Sci Sante Sante Mentale Soc CERMES3, UMR 8211, U988, Villejuif, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Perraudin, C (corresponding author), Fac Med Paris Sud Paris 6, Le Kremlin Bicetre, France.	clemence.perraudin@gmail.com	Pelletier-Fleury, Nathalie/R-4220-2018	Pelletier-Fleury, Nathalie/0000-0002-4821-4863	Ministry of Higher Education and Research; Ordre National des Pharmaciens	Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Ordre National des Pharmaciens	This study is part of a thesis that is funded by a research allowance from the Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the Ordre National des Pharmaciens for their support in this paper.	Albarrak M, 2005, SLEEP, V28, P1306, DOI 10.1093/sleep/28.10.1306; Anderson C, 2000, PATIENT EDUC COUNS, V39, P285, DOI 10.1016/S0738-3991(99)00025-7; Bahammam A, 1999, SLEEP, V22, P740, DOI 10.1093/sleep/22.6.740; Blenkinsopp A, 2003, J PUBLIC HEALTH MED, V25, P144, DOI 10.1093/pubmed/fdg030; Chakravorty I, 2002, EUR RESPIR J, V20, P1233, DOI 10.1183/09031936.00.00014401; Chapman JL, 2004, BRIT J GEN PRACT, V54, P374; Chervin RD, 1999, ANN INTERN MED, V130, P496, DOI 10.7326/0003-4819-130-6-199903160-00006; Christensen DB, 2006, ANN PHARMACOTHER, V40, P1400, DOI 10.1345/aph.1G545; Deutsch PA, 2006, J CLIN SLEEP MED, V2, P145; Dingli K, 2003, EUR RESPIR J, V21, P253, DOI 10.1183/09031936.03.00298103; Engleman HM, 2003, SLEEP MED REV, V7, P81, DOI 10.1053/smrv.2001.0197; Fuhrman C, 2012, SLEEP MED, V13, P852, DOI 10.1016/j.sleep.2012.04.005; Fuller JM, 2011, PATIENT EDUC COUNS, V83, P325, DOI 10.1016/j.pec.2011.05.004; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; Gold MR, 1996, COST EFFECTIVENESS H; Hersberger KE, 2006, J CLIN PHARM THER, V31, P35, DOI 10.1111/j.1365-2710.2006.00698.x; Jenkinson C, 1998, QUAL LIFE RES, V7, P95; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Koshman SL, 2008, ARCH INTERN MED, V168, P687, DOI 10.1001/archinte.168.7.687; Lindberg E, 2001, AM J RESP CRIT CARE, V164, P2031, DOI 10.1164/ajrccm.164.11.2102028; Manolakis Patti Gasdek, 2010, Am J Pharm Educ, V74, pS7; Mar J, 2003, EUR RESPIR J, V21, P515, DOI 10.1183/09031936.03.00040903; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Meslier N, 2007, REV MAL RESPIR, V24, P305, DOI 10.1016/S0761-8425(07)91062-1; *MIN SANT SPORTS, 2006, RAPP THEM SOMM, V2; Mold JW, 2011, J AM BOARD FAM MED, V24, P138, DOI 10.3122/jabfm.2011.02.100095; *NAT INST DEM, 2011, FRENCH LIF TABL 2007; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Noyce PR, 2007, ANN PHARMACOTHER, V41, P861, DOI 10.1345/aph.1K015; Pietzsch JB, 2011, SLEEP, V34, P695, DOI 10.5665/SLEEP.1030; Santschi V, 2011, ARCH INTERN MED, V171, P1441, DOI 10.1001/archinternmed.2011.399; Smith R, 2002, CHEST, V121, P164, DOI 10.1378/chest.121.1.164; TOUSIGNANT P, 1994, SLEEP, V17, P52; Tran A, 2009, PHARM WORLD SCI, V31, P473, DOI 10.1007/s11096-009-9301-4; Tregear S, 2010, SLEEP, V33, P1373, DOI 10.1093/sleep/33.10.1373; WIRRMANN V, 2004, SLEEP MED REV, V8, P269; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Yuksel N, 2010, OSTEOPOROSIS INT, V21, P391, DOI 10.1007/s00198-009-0977-z	39	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e63894	10.1371/journal.pone.0063894	http://dx.doi.org/10.1371/journal.pone.0063894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805176	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500004
J	Priemer, G; Balkema-Buschmann, A; Hills, B; Groschup, MH				Priemer, Grit; Balkema-Buschmann, Anne; Hills, Bob; Groschup, Martin H.			Biochemical Characteristics and PrPSc Distribution Pattern in the Brains of Cattle Experimentally Challenged with H-type and L-type Atypical BSE	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; INTRACEREBRAL INOCULATION; MOLECULAR ANALYSIS; INFECTIVITY; STRAIN; SHEEP; TRANSMISSION; ACCUMULATION	Besides the classical form of bovine spongiform encephalopathy (BSE) that has been known for almost three decades, two atypical forms designated H-type and L-type BSE have recently been described. While the main diagnostic feature of these forms is the altered biochemical profile of the accumulated PrPSc, it was also observed in the initial analysis that L-type BSE displays a distribution pattern of the pathological prion protein (PrPSc), which clearly differs from that observed in classical BSE (C-type). Most importantly, the obex region in the brainstem is not the region with the highest PrPSc concentrations, but PrPSc is spread more evenly throughout the entire brain. A similar distribution pattern has been revealed for H-type BSE by rapid test analysis. Based on these findings, we performed a more detailed Western blot study of the anatomical PrPSc distribution pattern and the biochemical characteristics (molecular mass, glycoprofile as well as PK sensitivity) in ten different anatomical locations of the brain from cattle experimentally challenged with H-or L-type BSE, as compared to cattle challenged with C-type BSE. Results of this study revealed distinct differences in the PrPSc deposition patterns between all three BSE forms, while the biochemical characteristics remained stable for each BSE type among all analysed brain areas.	[Priemer, Grit; Balkema-Buschmann, Anne; Groschup, Martin H.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Hills, Bob] Hlth Canada, Transmissible Spongiform Encephalopathy Secretari, Ottawa, ON K1A 0L2, Canada	Friedrich Loeffler Institute; Health Canada	Groschup, MH (corresponding author), Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Greifswald, Germany.	martin.groschup@fli.bund.de			Health Canada	Health Canada	Bob Hills, representing Health Canada (which majorly funded this project), played an active role as a scientist in the development and design of the study. No additional external funding was received for this study.	[Anonymous], 2012, REPORT MONITORING RU; Balkema-Buschmann A, 2011, PREV VET MED, V102, P112, DOI 10.1016/j.prevetmed.2011.04.006; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Balkema-Buschmann A, 2011, J GEN VIROL, V92, P467, DOI 10.1099/vir.0.025387-0; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Fukuda S, 2012, JPN J INFECT DIS, V65, P37; Gonzalez L, 2005, J GEN VIROL, V86, P827, DOI 10.1099/vir.0.80299-0; Hoffmann C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-21; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kaatz M, 2012, AM J PATHOL, V181, P515, DOI 10.1016/j.ajpath.2012.05.001; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Kuczius T, 1998, J INFECT DIS, V178, P693, DOI 10.1086/515337; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Levavasseur E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002786; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; McGowan J.P., 1922, SCOTT J AGR, V5, P365; Meloni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043133; Nickel R, 1992, PAREY, VIV, P68; Okada H, 2012, VET PATHOL, V49, P819, DOI 10.1177/0300985811427150; Okada H, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-79; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Polak MP, 2012, VET J, V191, P128, DOI 10.1016/j.tvjl.2010.12.019; Siso S, 2009, NEUROPATH APPL NEURO, V35, P247, DOI 10.1111/j.1365-2990.2009.01013.x; Sweeney T, 2000, J GEN VIROL, V81, P1621, DOI 10.1099/0022-1317-81-6-1621; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2005, VET REC, V156, P401, DOI 10.1136/vr.156.13.401	31	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67599	10.1371/journal.pone.0067599	http://dx.doi.org/10.1371/journal.pone.0067599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805320	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500148
J	Yu, XM; Liu, Y; Jin, T; Liu, J; Wang, J; Ma, C; Pan, XL				Yu, Xue-Min; Liu, Ying; Jin, Tong; Liu, Jun; Wang, Juan; Ma, Chao; Pan, Xin-Liang			The Expression of SIRT1 and DBC1 in Laryngeal and Hypopharyngeal Carcinomas	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HISTONE DEACETYLASES; POOR-PROGNOSIS; PROTEIN	Rationale and Objective: Sirtuin 1 (SIRT1) plays an important role in tumorigenesis and is increased in many human tumors. DBC1 is a negative regulator of SIRT1 via promotion of p53-mediated apoptosis. It is necessary to investigate the expression of SIRT1 and DBC1 in laryngeal and hypopharyngeal squamous cell carcinomas (LSCC and HSCC) and its correlation with available clinical parameters. Methods: The mRNA levels of SIRT1 and DBC1 were measured in 54 paired LSCC or HSCC tumors and corresponding adjacent noncancerous mucosae using quantitative RT-PCR (qRT-PCR). The protein levels of SIRT1 and DBC1 were also evaluated in 120 cases of patients with LSCC or HSCC using immunohistochemical staining. The correlation between SIRT1 and DBC1 expression and clinical parameters was analyzed with Pearson chi-square test. Results: qRT-PCR assay showed that, compared with the paired adjacent noncancerous mucosae, SIRT1 mRNA was significantly decreased in tumors. The immunohistochemical results indicated that the SIRT1 protein was also downregulated in tumors compared with noncancerous mucosae. Moreover, decreased SIRT1 was significantly correlated with the tumor clinical stage and lymph node metastasis. Additionally, DBC1 mRNA was significantly increased in tumors compared with noncancerous mucosae. The immunohistochemical results indicated that the DBC1 protein was downregulated in tumors, which is inconsistent with the results obtained by qRT-PCR. Finally, decreased DBC1 protein was significantly correlated with tumor differentiation, lymph node metastasis, and p53 expression. Conclusions: SIRT1 and DBC1 might be involved in the pathophysiology of laryngeal and hypopharyngeal squamous cell carcinomas and are associated with lymph node metastasis and p53 positive staining in LSCCs and HSCCs.	[Yu, Xue-Min; Liu, Ying; Jin, Tong; Liu, Jun; Wang, Juan; Ma, Chao; Pan, Xin-Liang] Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Peoples R China; [Liu, Jun] Sichuan Univ, West China Hosp, Dept Otolaryngol Head & Neck Surg, Chengdu 610064, Peoples R China	Shandong University; Sichuan University	Pan, XL (corresponding author), Shandong Univ, Qilu Hosp, Dept Otolaryngol, Jinan 250100, Peoples R China.	panxinl915@126.com	, 刀客/ABG-3664-2020	Liu, Jun/0000-0003-4800-7749	National Natural Science Foundation of China [30772411, C170702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (no. 30772411 and no. C170702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Byles V, 2010, INT J BIOL SCI, V6, P599; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Hall SF, 2008, LARYNGOSCOPE, V118, P1362, DOI 10.1097/MLG.0b013e318173dc4a; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Hiraike H, 2011, EXP THER MED, V2, P1105, DOI 10.3892/etm.2011.333; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jain KK, 2007, CURR OPIN MOL THER, V9, P563; Jang KY, 2008, AM J SURG PATHOL, V32, P1523, DOI 10.1097/PAS.0b013e31816b6478; Jang KY, 2009, PATHOLOGY, V41, P366, DOI 10.1080/00313020902884451; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-101; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Noguchi A, 2013, OR SURG OR MED OR PA, V115, P385, DOI 10.1016/j.oooo.2012.12.013; Srinivas PR, 2001, LANCET ONCOL, V2, P698, DOI 10.1016/S1470-2045(01)00560-5; Sung JY, 2010, CANCER SCI, V101, P1738, DOI 10.1111/j.1349-7006.2010.01573.x; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Voelter-Mahlknecht S, 2006, INT J MOL MED, V17, P59; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wittekindt C., 2012, GMS CURR TOP OTORHIN; Zhang Y, 2013, INT J CLIN ONCOL; Zhao W, 2008, NATURE, V451	36	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66975	10.1371/journal.pone.0066975	http://dx.doi.org/10.1371/journal.pone.0066975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805287	gold, Green Submitted, Green Published			2022-12-27	WOS:000320846500115
J	Zhao, H; Chan, SJ; Ng, YK; Wong, PTH				Zhao, Heng; Chan, Su-Jing; Ng, Yee-Kong; Wong, Peter T. -H.			Brain 3-Mercaptopyruvate Sulfurtransferase (3MST): Cellular Localization and Downregulation after Acute Stroke	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; NEUROMODULATOR; HOMOCYSTEINE; CYSTEINE; SYSTEM; RISK; RAT	3-Mercaptopyruvate sulfurtransferase (3MST) is an important enzyme for the synthesis of hydrogen sulfide (H2S) in the brain. We present here data that indicate an exclusively localization of 3MST in astrocytes. Regional distribution of 3MST activities is even and unremarkable. Following permanent middle cerebral artery occlusion (pMCAO), 3MST was down-regulated in both the cortex and striatum, but not in the corpus collosum. It appears that the down-regulation of astrocytic 3MST persisted in the presence of astrocytic proliferation due to gliosis. Our observations indicate that 3MST is probably not responsible for the increased production of H2S following pMCAO. Therefore, cystathionine beta-synthase (CBS), the alternative H2S producing enzyme in the CNS, remains as a more likely potential therapeutic target than 3MST in the treatment of acute stroke through inhibition of H2S production.	[Zhao, Heng; Chan, Su-Jing; Wong, Peter T. -H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Natl Univ Hlth Syst, Singapore 117595, Singapore; [Ng, Yee-Kong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Natl Univ Hlth Syst, Singapore 117595, Singapore	National University of Singapore; National University of Singapore	Wong, PTH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Natl Univ Hlth Syst, Singapore 117595, Singapore.	peter_wong@nuhs.edu.sg			Biomedical Research Council of Singapore	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a Biomedical Research Council of Singapore grant awarded to PTHW (http://www.a-star.edu.sg/bmrc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Boysen G, 2003, STROKE, V34, P1258, DOI 10.1161/01.STR.0000069017.78624.37; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Del Ser T, 2001, CEREBROVASC DIS, V12, P91, DOI 10.1159/000047687; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Mikami Y, 2011, J BIOL CHEM, V286, P39379, DOI 10.1074/jbc.M111.298208; Nagai Y, 2004, FASEB J, V18, P557, DOI 10.1096/fj.03-1052fje; Perna AF, 2013, J CELL BIOCHEM, V114, P1536, DOI 10.1002/jcb.24495; Porter D W, 1995, J Biochem Toxicol, V10, P287, DOI 10.1002/jbt.2570100602; Porter DW, 1995, J BIOCHEM TOXICOL, V10, P45; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Wong PTH, 2006, J NEUROPATH EXP NEUR, V65, P109, DOI 10.1097/01.jnen.0000199571.96472.c7; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200	21	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67322	10.1371/journal.pone.0067322	http://dx.doi.org/10.1371/journal.pone.0067322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805308	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500136
J	Kashima, S; Inoue, K; Matsumoto, M; Akimoto, K				Kashima, Saori; Inoue, Kazuo; Matsumoto, Masatoshi; Akimoto, Kimihiko			Do Non-Glycaemic Markers Add Value to Plasma Glucose and Hemoglobin A1c in Predicting Diabetes? Yuport Health Checkup Center Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IMPAIRED FASTING GLUCOSE; MIDDLE-AGED JAPANESE; BLOOD-CELL COUNT; SERUM URIC-ACID; LIVER-ENZYMES; METABOLIC SYNDROME; RISK-FACTORS; DIAGNOSTIC-CRITERIA; ALCOHOL-CONSUMPTION	Background: Many markers have been indicated as predictors of type 2 diabetes. However, the question of whether or not non-glycaemic (blood) biomarkers and non-blood biomarkers have a predictive additive utility when combined with glycaemic (blood) biomarkers is unknown. The study aim is to assess this additive utility in a large Japanese population. Methods: We used data from a retrospective cohort study conducted from 1998 to 2002 for the baseline and 2002 to 2006 for follow-up, inclusive of 5,142 men (mean age of 51.9 years) and 4,847 women (54.1 years) at baseline. The cumulative incidence of diabetes [defined either as a fasting plasma glucose (FPG) >= 7.00 mmol/l or as clinically diagnosed diabetes] was measured. In addition to glycaemic biomarkers [FPG and hemoglobin A1c (HbA1c)], we examined the clinical usefulness of adding non-glycaemic biomarkers and non-blood biomarkers, using sensitivity and specificity, and the area under the curve (AUC) of the receiver operating characteristics. Results: The AUCs to predict diabetes were 0.874 and 0.924 for FPG, 0.793 and 0.822 for HbA1c, in men and women, respectively. Glycaemic biomarkers were the best and second-best for diabetes prediction among the markers. All non-glycaemic markers (except uric acid in men and creatinine in both sexes) predicted diabetes. Among these biomarkers, the highest AUC in the single-marker analysis was 0.656 for alanine aminotransferase (ALT) in men and 0.740 for body mass index in women. The AUC of the combined markers of FPG and HbA1c was 0.895 in men and 0.938 in women, which were marginally increased to 0.904 and 0.940 when adding ALT, respectively. Conclusions: AUC increments were marginal when adding non-glycaemic biomarkers and non-blood biomarkers to the classic model based on FPG and HbA1c. For the prediction of diabetes, FPG and HbA1c are sufficient and the other markers may not be needed in clinical practice.	[Kashima, Saori] Hiroshima Univ, Dept Publ Hlth & Hlth Policy, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Akimoto, Kimihiko] Akimoto Occupat Hlth Consultant Off, Tokyo, Japan	Hiroshima University; Teikyo University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Dept Publ Hlth & Hlth Policy, Inst Biomed & Hlth Sci, Hiroshima, Japan.	saori_ksm@ybb.ne.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303				Chou PS, 1998, DIABETES CARE, V21, P1183, DOI 10.2337/diacare.21.7.1183; Dallmeier D, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000869; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dinneen SF, 1998, DIABETES CARE, V21, P1408, DOI 10.2337/diacare.21.9.1408; Doi Y, 2007, OBESITY, V15, P1841, DOI 10.1038/oby.2007.218; Dotevall A, 2004, DIABETIC MED, V21, P615, DOI 10.1111/j.1464-5491.2004.01189.x; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; Ford ES, 2008, DIABETES CARE, V31, P1138, DOI [10.2337/dc07-2159, 10.2337/dc08-1138]; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garrido-Sanchez L, 2008, EUR J CLIN INVEST, V38, P615, DOI 10.1111/j.1365-2362.2008.01988.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Harita N, 2009, DIABETES CARE, V32, P424, DOI 10.2337/dc08-1265; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Inoue K, 2009, DIABETIC MED, V26, P1175, DOI 10.1111/j.1464-5491.2009.02850.x; Inoue K, 2012, DIABETIC MED, V29, P1327; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kuzuya T, 1999, J JPN DIAB SOC, V42, P385; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Monami M, 2008, METABOLISM, V57, P387, DOI 10.1016/j.metabol.2007.10.015; NAGI DK, 1995, DIABETOLOGIA, V38, P187, DOI 10.1007/s001250050269; Nakanishi N, 2002, DIABETOLOGIA, V45, P42, DOI 10.1007/s125-002-8243-1; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Onat A, 2007, CIRC J, V71, P1463, DOI 10.1253/circj.71.1463; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; Sato KK, 2008, DIABETES CARE, V31, P1230, DOI 10.2337/dc07-2184; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Sattar N, 2012, DIABETIC MED, V29, P5, DOI 10.1111/j.1464-5491.2011.03480.x; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Tan KCB, 2003, DIABETES CARE, V26, P2323, DOI 10.2337/diacare.26.8.2323; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wang WY, 2011, DIABETES CARE, V34, P363, DOI 10.2337/dc10-1680; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; Wilson PWF, 2011, DIABETES RES CLIN PR, V92, P124, DOI 10.1016/j.diabres.2010.12.024; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	46	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66899	10.1371/journal.pone.0066899	http://dx.doi.org/10.1371/journal.pone.0066899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818970	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800108
J	Liu, Y; Zhang, YB; Liu, TK; Gui, JF				Liu, Ying; Zhang, Yi-Bing; Liu, Ting-Kai; Gui, Jian-Fang			Lineage-Specific Expansion of IFIT Gene Family: An Insight into Coevolution with IFN Gene Family	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; INNATE IMMUNE-RESPONSE; CARP CARASSIUS-AURATUS; ANTIVIRAL RESPONSE; INDUCIBLE PROTEIN; MESSENGER-RNA; I IFNS; FISH	In mammals, IFIT (Interferon [IFN]-induced proteins with Tetratricopeptide Repeat [TPR] motifs) family genes are involved in many cellular and viral processes, which are tightly related to mammalian IFN response. However, little is known about non-mammalian IFIT genes. In the present study, IFIT genes are identified in the genome databases from the jawed vertebrates including the cartilaginous elephant shark but not from non-vertebrates such as lancelet, sea squirt and acorn worm, suggesting that IFIT gene family originates from a vertebrate ancestor about 450 million years ago. IFIT family genes show conserved gene structure and gene arrangements. Phylogenetic analyses reveal that this gene family has expanded through lineage-specific and species-specific gene duplication. Interestingly, IFN gene family seem to share a common ancestor and a similar evolutionary mechanism; the function link of IFIT genes to IFN response is present early since the origin of both gene families, as evidenced by the finding that zebrafish IFIT genes are upregulated by fish IFNs, poly(I:C) and two transcription factors IRF3/IRF7, likely via the IFN-stimulated response elements (ISRE) within the promoters of vertebrate IFIT family genes. These coevolution features creates functional association of both family genes to fulfill a common biological process, which is likely selected by viral infection during evolution of vertebrates. Our results are helpful for understanding of evolution of vertebrate IFN system.	[Liu, Ying; Zhang, Yi-Bing; Liu, Ting-Kai; Gui, Jian-Fang] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhang, YB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	ybzhang@ihb.ac.cn; jfgui@ihb.ac.cn	Liu, Ying/A-7127-2019; Liu, Ting-Kai/B-1880-2013	Liu, Ying/0000-0002-6419-1980; Liu, Ting-Kai/0000-0003-2708-0779	973 National Basic Research Program of China [2010CB126303]; National Natural Science Foundation of China [31272690, 31172435]	973 National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from 973 National Basic Research Program of China (2010CB126303), and National Natural Science Foundation of China (31272690, 31172435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; BANDYOPADHYAY SK, 1995, J BIOL CHEM, V270, P19624, DOI 10.1074/jbc.270.33.19624; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLUYSSEN HAR, 1994, GENOMICS, V24, P137, DOI 10.1006/geno.1994.1591; Chang MX, 2009, IMMUNOGENETICS, V61, P315, DOI 10.1007/s00251-009-0366-y; CHEBATH J, 1983, NUCLEIC ACIDS RES, V11, P1213, DOI 10.1093/nar/11.5.1213; Chen M.R., 1985, J FISHERIES CHINA, V9, P121; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Veer MJ, 1998, GENOMICS, V54, P267, DOI 10.1006/geno.1998.5555; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Lai KC, 2008, MOL CANCER RES, V6, P1431, DOI 10.1158/1541-7786.MCR-08-0141; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Liu TK, 2011, J VIROL, V85, P12769, DOI 10.1128/JVI.05849-11; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Lou YJ, 2009, CANCER RES, V69, P3673, DOI 10.1158/0008-5472.CAN-08-4922; Nehyba J, 2009, MOL BIOL EVOL, V26, P2539, DOI 10.1093/molbev/msp167; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Qi ZT, 2010, J IMMUNOL, V184, P5038, DOI 10.4049/jimmunol.0903374; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Shi J, 2012, FISH SHELLFISH IMMUN, V33, P258, DOI 10.1016/j.fsi.2012.05.014; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Sun BJ, 2009, DEV COMP IMMUNOL, V33, P547, DOI 10.1016/j.dci.2008.10.001; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WATHELET MG, 1987, EUR J BIOCHEM, V169, P313, DOI 10.1111/j.1432-1033.1987.tb13614.x; Woelk CH, 2007, GENE, V397, P38, DOI 10.1016/j.gene.2007.03.018; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yu FF, 2010, MOL IMMUNOL, V47, P2330, DOI 10.1016/j.molimm.2010.05.282; Zhang YB, 2004, GENE, V325, P43, DOI 10.1016/j.gene.2003.09.039; Zhang YB, 2007, DEV COMP IMMUNOL, V31, P232, DOI 10.1016/j.dci.2006.05.015; Zhang YB, 2012, DEV COMP IMMUNOL, V38, P193, DOI 10.1016/j.dci.2012.06.003; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859	54	32	36	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66859	10.1371/journal.pone.0066859	http://dx.doi.org/10.1371/journal.pone.0066859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818968	gold, Green Submitted, Green Published			2022-12-27	WOS:000322342800106
J	Odegaard, AO; Choh, AC; Nahhas, RW; Towne, B; Czerwinski, SA; Demerath, EW				Odegaard, Andrew O.; Choh, Audrey C.; Nahhas, Ramzi W.; Towne, Bradford; Czerwinski, Stefan A.; Demerath, Ellen W.			Systematic Examination of Infant Size and Growth Metrics as Risk Factors for Overweight in Young Adulthood	PLOS ONE			English	Article							WEIGHT-GAIN; RAPID GROWTH; OBESITY; CHILDHOOD; COHORT; LIFE	Objective: To systematically examine infant size and growth, according to the 2006 WHO infant growth standards, as risk factors for overweight status in young adulthood in a historical cohort. Specifically, to assess: Whether accounting for length (weight-for-length) provides a different picture of risk than weight-for-age, intervals of rapid growth in both weight-for-age and weight-for-length metrics, and what particular target ages for infant size and intervals of rapid growth associate most strongly with overweight as a young adult. Patients/Methods: Data analysis of 422 appropriate for gestational age white singleton infants enrolled in the Fels Longitudinal Study. Odds ratios (OR) for overweight and obesity in young adulthood (age 20-29) were calculated using logistic regression models for the metrics at each target age (0, 1, 3, 6, 9, 12, 18, 24 months) comparing >= 85th v. <85th percentile, as well as rapid growth (Delta >= 0.67 Z-score) through target age intervals. Models accounted for both maternal and paternal BMI. Results: Infants >= 85th percentile of weight-for-age at each target age (except 3 months) had a greater odds of being overweight as a young adult. After accounting for length (weight-for-length) this association was limited to 12, and 18 months. Rapid weight-for-age growth was infrequently associated with overweight as a young adult. Rapid weight-for-length growth from 0 to 24 months, 1 to 6, 9, 12, 18, and 24 months and from 3 to 9, 12, 18, and 24 months was strongly associated with overweight status as a young adult. Conclusions: The WHO weight-for-length metric associates differently with risk of being overweight as a young adult compared to weight-for-age. Intervals of rapid weight-for-length growth ranging from months (0-24), (1-12, 18, and 24) and (3-9, and 12) displayed the largest OR for being overweight as a young adult.	[Odegaard, Andrew O.; Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Choh, Audrey C.; Nahhas, Ramzi W.; Towne, Bradford; Czerwinski, Stefan A.] Wright State Univ, Boonshoft Sch Med, Lifespan Hlth Res Ctr, Dayton, OH 45435 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Wright State University Dayton	Odegaard, AO (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	Odeg0025@umn.edu	Nahhas, Ramzi W./AAT-4729-2021	Demerath, Ellen/0000-0002-4585-4064	NIH/NICHD [R01 HD053685, R01 HD012252]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD012252] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053685] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NIH/NICHD grants R01 HD053685 and R01 HD012252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronne LJ, 2009, AM J MED, V122, pS24, DOI 10.1016/j.amjmed.2009.01.005; Baird J, 2005, BMJ, V331; Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Eriksson J, 2003, INT J OBESITY, V27, P722, DOI 10.1038/sj.ijo.0802278; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Mei Z, 2011, CLIN PEDIAT PHILA; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; ROCHE AF, 1992, MATURATION BODY COMP; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; van Buuren S, 2008, ARCH DIS CHILD, V93, P549, DOI 10.1136/adc.2007.136010; van Dommelen P, 2004, TWIN RES, V7, P607, DOI 10.1375/1369052042663805; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854	22	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66994	10.1371/journal.pone.0066994	http://dx.doi.org/10.1371/journal.pone.0066994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818973	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800111
J	Zuo, X; Dong, DY; Sun, M; Xie, HQ; Kang, YJ				Zuo, Xiao; Dong, Daoyin; Sun, Miao; Xie, Huiqi; Kang, Y. James			Homocysteine Restricts Copper Availability Leading to Suppression of Cytochrome C Oxidase Activity in Phenylephrine-Treated Cardiomyocytes	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; HYPERTROPHIC CARDIOMYOPATHY; PRESSURE-OVERLOAD; 2.8 ANGSTROM; DEFICIENCY; MUTATIONS; SCO1; SUBUNITS; COX17; GENE	Cardiomyocyte hypertrophy induced by phenylephrine (PE) is accompanied by suppression of cytochrome c oxidase (CCO) activity, and copper (Cu) supplementation restores CCO activity and reverses the hypertrophy. The present study was aimed to understand the mechanism of PE-induced decrease in CCO activity. Primary cultures of neonatal rat cardiomyocytes were treated with PE at a final concentration of l00 mu M in cultures for 72 h to induce cell hypertrophy. The CCO activity was determined by enzymatic assay and changes in CCO subunit COX-IV as well as copper chaperones for CCO (COX17, SCO2, and COX11) were determined by Western blotting. PE treatment increased both intracellular and extracellular homocysteine concentrations and decreased intracellular Cu concentrations. Studies in vitro found that homocysteine and Cu form complexes. Inhibition of the intracellular homocysteine synthesis in the PE-treated cardiomyocytes prevented the increase in the extracellular homocysteine concentration, retained the intracellular Cu concentration, and preserved the CCO activity. PE treatment decreased protein concentrations of the COX-IV, and the Cu chaperones COX17, COX11, and SCO2. These PE effects were prevented by either inhibition of the intracellular homocysteine synthesis or Cu supplementation. Therefore, PE-induced elevation of homocysteine restricts Cu availability through its interaction with Cu and suppression of Cu chaperones, leading to the decrease in CCO enzyme activity.	[Zuo, Xiao; Dong, Daoyin; Sun, Miao; Xie, Huiqi; Kang, Y. James] Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Kang, Y. James] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	Sichuan University; University of Louisville	Kang, YJ (corresponding author), Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	yjkang01@louisville.edu	Dong, Daoyin/D-6014-2016	Dong, Daoyin/0000-0003-0544-8341	National Science Foundation of China (NSFC) [81230004]; US National Institutes of Health [HL-63760]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by the National Science Foundation of China grant (NSFC grant 81230004 to YJK) and US National Institutes of Health grant (HL-63760 to YJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova MD, 2003, J INORG BIOCHEM, V95, P321, DOI 10.1016/S0162-0134(03)00133-8; Carrasco-Pozo C, 2006, EXP BIOL MED, V231, P1569, DOI 10.1177/153537020623100918; Celano L, 2009, ARCH BIOCHEM BIOPHYS, V491, P96, DOI 10.1016/j.abb.2009.08.022; DALLMAN PR, 1967, J CLIN INVEST, V46, P1819, DOI 10.1172/JCI105672; Das J, 2004, MOL BIOL EVOL, V21, P1572, DOI 10.1093/molbev/msh161; Emsley AM, 1999, BRIT J PHARMACOL, V126, P1034, DOI 10.1038/sj.bjp.0702374; Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340; Garcia AJ, 2002, J CHROMATOGR B, V779, P359, DOI 10.1016/S1570-0232(02)00401-4; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Hoffmann P, 1995, CARDIOVASC RES, V30, P889, DOI 10.1016/S0008-6363(95)00133-6; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Huttemann M, 2012, MITOCHONDRION, V12, P294, DOI 10.1016/j.mito.2011.11.002; Hughes WM, 2008, CARDIOVASC TOXICOL, V8, P137, DOI 10.1007/s12012-008-9021-3; Jeremy JY, 2002, ANN THORAC SURG, V74, P1553, DOI 10.1016/S0003-4975(02)03807-9; Jiang YC, 2007, J EXP MED, V204, P657, DOI 10.1084/jem.20061943; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; LIAO ZM, 1995, COMP BIOCHEM PHYS B, V111, P61, DOI 10.1016/0305-0491(94)00226-K; Lu YM, 2009, MOL PHARMACOL, V75, P101, DOI 10.1124/mol.108.050716; Lucas DT, 2003, AM J PHYSIOL-HEART C, V284, pH575, DOI 10.1152/ajpheart.00619.2002; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Mansoor MA, 2000, CLIN CHEM, V46, P385; Medeiros DM, 1997, COMP BIOCHEM PHYS A, V117, P77, DOI 10.1016/S0300-9629(96)00365-9; OBAYASHI T, 1992, AM HEART J, V124, P1263, DOI 10.1016/0002-8703(92)90410-W; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Radford NB, 2002, AM J PHYSIOL-HEART C, V282, pH726, DOI 10.1152/ajpheart.00308.2001; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; Shukla N, 2007, ANN THORAC SURG, V84, P43, DOI 10.1016/j.athoracsur.2007.03.087; Siddiqui RA, 2004, J CELL BIOCHEM, V92, P1141, DOI 10.1002/jcb.20135; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Streck EL, 2003, BBA-MOL BASIS DIS, V1637, P187, DOI 10.1016/S0925-4439(03)00019-X; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; Valnot I, 2000, AM J HUM GENET, V67, P1104; ZEVIANI M, 1986, ARCH NEUROL-CHICAGO, V43, P1198, DOI 10.1001/archneur.1986.00520110084025; Zuo XA, 2010, CARDIOVASC TOXICOL, V10, P208, DOI 10.1007/s12012-010-9080-0	38	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67549	10.1371/journal.pone.0067549	http://dx.doi.org/10.1371/journal.pone.0067549			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818984	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800141
J	Armstrong, CL; Marquardt, D; Dies, H; Kucerka, N; Yamani, Z; Harroun, TA; Katsaras, J; Shi, AC; Rheinstadter, MC				Armstrong, Clare L.; Marquardt, Drew; Dies, Hannah; Kucerka, Norbert; Yamani, Zahra; Harroun, Thad A.; Katsaras, John; Shi, An-Chang; Rheinstaedter, Maikel C.			The Observation of Highly Ordered Domains in Membranes with Cholesterol	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PHASE DPPC BILAYERS; X-RAY-SCATTERING; LIPID-BILAYERS; MOLECULAR SIMULATION; COLLECTIVE DYNAMICS; MAXIMUM SOLUBILITY; MODEL MEMBRANES; CELL BIOLOGY; RAFTS	Rafts, or functional domains, are transient nano- or mesoscopic structures in the exoplasmic leaflet of the plasma membrane, and are thought to be essential for many cellular processes. Using neutron diffraction and computer modelling, we present evidence for the existence of highly ordered lipid domains in the cholesterol-rich (32.5 mol%) liquid-ordered (l(o)) phase of dipalmitoylphosphatidylcholine membranes. The liquid ordered phase in one-component lipid membranes has previously been thought to be a homogeneous phase. The presence of highly ordered lipid domains embedded in a disordered lipid matrix implies non-uniform distribution of cholesterol between the two phases. The experimental results are in excellent agreement with recent computer simulations of DPPC/cholesterol complexes [Meinhardt, Vink and Schmid (2013). Proc Natl Acad Sci USA 110(12): 4476-4481], which reported the existence of nanometer size l(o) domains in a liquid disordered lipid environment.	[Armstrong, Clare L.; Dies, Hannah; Shi, An-Chang; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Marquardt, Drew; Harroun, Thad A.] Brock Univ, Dept Phys, St Catharines, ON L2S 3A1, Canada; [Marquardt, Drew; Kucerka, Norbert; Yamani, Zahra; Katsaras, John; Rheinstaedter, Maikel C.] Natl Res Council Canada, Canadian Neutron Beam Ctr, Chalk River, ON, Canada; [Katsaras, John] Oak Ridge Natl Lab, Neutron Sci Directorate, Oak Ridge, TN USA; [Katsaras, John] Oak Ridge Natl Lab, Joint Inst Neutron Sci, Oak Ridge, TN USA	McMaster University; Brock University; Atomic Energy of Canada Limited; National Research Council Canada; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Armstrong, CL (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	armstc5@mcmaster.ca; rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Harroun, Thad/AAG-3322-2020; yamani, zahra/AAU-4048-2021; Katsaras, John/K-4525-2018; yamani, zahra/B-7892-2012; Kucerka, Norbert/Q-7476-2016; Bacon, Hannah/AAQ-9604-2021; Harroun, Thad/C-6491-2009; Shi, An-Chang/A-2910-2008	Rheinstadter, Maikel C/0000-0002-0558-7475; Harroun, Thad/0000-0001-9816-2590; Kucerka, Norbert/0000-0002-1075-6640; Harroun, Thad/0000-0001-9816-2590; Shi, An-Chang/0000-0003-1379-7162; Marquardt, Drew/0000-0001-6848-2497; yamani, zahra/0000-0001-8445-4656; Bacon, Hannah/0000-0002-2772-141X; Katsaras, John/0000-0002-8937-4177	Natural Sciences and Engineering Research Council of Canada; National Research Council; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Oak Ridge National Laboratory's Laboratory Directed Research and Development program; Early Researcher Award from the Province of Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Oak Ridge National Laboratory's Laboratory Directed Research and Development program; Early Researcher Award from the Province of Ontario	This research was funded by the Natural Sciences and Engineering Research Council of Canada, the National Research Council, the Canada Foundation for Innovation, and the Ontario Ministry of Economic Development and Innovation. JK is partially supported by Oak Ridge National Laboratory's Laboratory Directed Research and Development program. MCR is the recipient of an Early Researcher Award from the Province of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA PFF, 1992, BIOCHEMISTRY-US, V31, P6739, DOI 10.1021/bi00144a013; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Andoh Y, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4704740; Apajalahti T, 2010, FARADAY DISCUSS, V144, P411, DOI 10.1039/b901487j; Armstrong CL, 2012, SOFT MATTER, V8, P4687, DOI 10.1039/c2sm07158d; Armstrong CL, 2012, EUR BIOPHYS J BIOPHY, V41, P901, DOI 10.1007/s00249-012-0826-4; Armstrong CL, 2011, PROTEIN PEPTIDE LETT, V18, P344; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bruning B, 2010, EUR PHYS J E, V31, P419, DOI 10.1140/epje/i2010-10574-6; Bruning B, 2009, SOFT MATTER, V5, P3340, DOI 10.1039/b901389j; Canadian Neutron Beam Centre, SPECTR INF; Casuso I, 2010, BIOPHYS J, V99, pL47, DOI 10.1016/j.bpj.2010.07.028; Dai J, 2010, J PHYS CHEM B, V114, P840, DOI 10.1021/jp909061h; de Meyer F, 2009, P NATL ACAD SCI USA, V106, P3654, DOI 10.1073/pnas.0809959106; de Meyer FJM, 2010, BIOPHYS J, V99, P3629, DOI 10.1016/j.bpj.2010.09.030; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; de Meyer FJM, 2008, BIOPHYS J, V95, P1851, DOI 10.1529/biophysj.107.124164; Edholm O, 2005, BIOPHYS J, V89, P1827, DOI 10.1529/biophysj.105.064329; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ehrig J, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045019; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Hall A, 2010, J PHYS CHEM B, V114, P7797, DOI 10.1021/jp912175d; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Holzwarth U, 2011, NAT NANOTECHNOL, V6, P534, DOI 10.1038/nnano.2011.145; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; KAISER H, 1983, PHYS REV LETT, V50, P560, DOI 10.1103/PhysRevLett.50.560; Katsaras J, 1997, PHYS REV E, V55, P3751, DOI 10.1103/PhysRevE.55.3751; Katsaras J, 2000, PHYS REV E, V61, P5668, DOI 10.1103/PhysRevE.61.5668; KATSARAS J, 1995, BIOCHEMISTRY-US, V34, P4684, DOI 10.1021/bi00014a023; Kaye MD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.050907; Kraus W, 1996, J APPL CRYSTALLOGR, V29, P301, DOI 10.1107/S0021889895014920; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Kucerka N, 2006, BIOPHYS J, V90, pL83, DOI 10.1529/biophysj.106.086017; Lenne PF, 2009, SOFT MATTER, V5, P2841, DOI 10.1039/b822956b; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; M'Baye G, 2008, BIOPHYS J, V95, P1217, DOI 10.1529/biophysj.107.127480; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P688, DOI 10.1016/j.bbamem.2009.12.027; McIntosh TJ, 2003, BIOPHYS J, V85, P1656, DOI 10.1016/S0006-3495(03)74595-0; Meinhardt S, 2013, P NATL ACAD SCI USA, V110, P4476, DOI 10.1073/pnas.1221075110; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Mills TT, 2008, BIOPHYS J, V95, P682, DOI 10.1529/biophysj.107.127910; Mills TT, 2009, GEN PHYSIOL BIOPHYS, V28, P126, DOI 10.4149/gpb_2009_02_126; Murtola T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238102; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Pan JJ, 2012, BBA-BIOMEMBRANES, V1818, P2135, DOI 10.1016/j.bbamem.2012.05.007; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Papanikolaou A, 2005, J BIOL CHEM, V280, P26406, DOI 10.1074/jbc.M413927200; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; RAGHUNATHAN VA, 1995, PHYS REV LETT, V74, P4456, DOI 10.1103/PhysRevLett.74.4456; RAUCH H, 1993, FOUND PHYS, V23, P7, DOI 10.1007/BF01883988; Rheinstadter MC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011907; Rheinstadter MC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108107; Rheinstadter MC, 2004, PHYSICA B, V350, P136, DOI 10.1016/j.physb.2004.04.060; Rheinstadter MC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128104; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Scherrer P., 1918, S AFR J SCI, V2, P98; Shirane G, 2002, NEUTRON SCATTERING T; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SZABO G, 1974, NATURE, V252, P47, DOI 10.1038/252047a0; THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Watkins EB, 2011, P NATL ACAD SCI USA, V108, P6975, DOI 10.1073/pnas.1014579108; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zheludev A, 2009, RESLIB	79	92	92	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66162	10.1371/journal.pone.0066162	http://dx.doi.org/10.1371/journal.pone.0066162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823623	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400060
J	Cheung, V; Bouralexis, S; Gillespie, MT				Cheung, Vanessa; Bouralexis, Steve; Gillespie, Matthew T.			PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L/TRAIL	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; AGONISTIC MONOCLONAL-ANTIBODY; RECEPTOR-SELECTIVE MUTANTS; PARATHYROID-HORMONE; INDUCED APOPTOSIS; BONE DESTRUCTION; APO-2 LIGAND; IN-VITRO; GROWTH; LOCALIZATION	Parathyroid hormone-related protein (PTHrP) is a key component in breast development and breast tumour biology. PTHrP has been discovered as a causative agent of hypercalcaemia of malignancy and is also one of the main factors implicated in breast cancer mediated osteolysis. Clinical studies have determined that PTHrP expression by primary breast cancers was an independent predictor of improved prognosis. Furthermore, PTHrP has been demonstrated to cause tumour cell death both in vitro and in vivo. Apo2L/TRAIL is a promising new anti-cancer agent, due to its ability to selectively induce apoptosis in cancer cells whilst sparing most normal cells. However, some cancer cells are resistant to Apo2L/TRAIL-induced apoptosis thus limiting its therapeutic efficacy. The effects of PTHrP on cell death signalling pathways initiated by Apo2L/TRAIL were investigated in breast cancer cells. Expression of PTHrP in Apo2L/TRAIL resistant cell line MCF-7 sensitised these cells to Apo2L/TRAIL-induced apoptosis. The actions of PTHrP resulted from intracellular effects, since exogenous treatment of PTHrP had no effect on Apo2L/TRAIL-induced apoptosis. Apo2L/TRAIL-induced apoptosis in PTHrP expressing cells occurred through the activation of caspase-10 resulting in caspase-9 activation and induction of apoptosis through the effector caspases, caspase-6 and -7. PTHrP increased cell surface expression of Apo2L/TRAIL death receptors, TRAIL-R1 and TRAIL-R2. Antagonistic antibodies against the death receptors demonstrated that Apo2L/TRAIL mediated its apoptotic signals through activation of the TRAIL-R2 in PTHrP expressing breast cancer cells. These studies reveal a novel role for PTHrP with Apo2L/TRAIL that maybe important for future diagnosis and treatment of breast cancer.	[Cheung, Vanessa; Bouralexis, Steve; Gillespie, Matthew T.] Prince Henrys Inst, Bone Joint & Canc Unit, Melbourne, Vic, Australia; [Gillespie, Matthew T.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Prince Henry's Institute of Medical Research; Monash University	Gillespie, MT (corresponding author), Prince Henrys Inst, Bone Joint & Canc Unit, Melbourne, Vic, Australia.	matthew.gillespie@princehenrys.org		Gillespie, Matthew/0000-0001-6543-8909	National Health and Medical Research Council, Australia [345401, GNT448338]; Cancer Council Victoria and National Breast Cancer Research Foundation; Victorian Government Operational Infrastructure Support Program	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria and National Breast Cancer Research Foundation(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government Operational Infrastructure Support Program	This work was supported by a Program Grant (345401, M.T.G.) and Scholarship GNT448338 (V.C.) of the National Health and Medical Research Council, Australia, Project Grants from the Cancer Council Victoria and National Breast Cancer Research Foundation, and the Victorian Government Operational Infrastructure Support Program. PHI data audit # 13-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyanskaya LL, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-66; BOUIZAR Z, 1993, CANCER RES, V53, P5076; BUNDRED NJ, 1992, EUR J CANCER, V28A, P690, DOI 10.1016/S0959-8049(05)80127-3; Butler LM, 2006, INT J CANCER, V119, P944, DOI 10.1002/ijc.21939; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; Falzon M, 2000, ENDOCRINOLOGY, V141, P1882, DOI 10.1210/en.141.5.1882; Foley J, 2001, DEVELOPMENT, V128, P513; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Henderson MA, 2001, JNCI-J NATL CANCER I, V93, P234, DOI 10.1093/jnci/93.3.234; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Labrinidis A, 2009, CLIN CANCER RES, V15, P1998, DOI 10.1158/1078-0432.CCR-08-2444; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, BIOCHEM BIOPH RES CO, V282, P629, DOI 10.1006/bbrc.2001.4607; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Lam MHC, 1999, J BIOL CHEM, V274, P18559, DOI 10.1074/jbc.274.26.18559; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Luparello C, 2001, J BONE MINER RES, V16, P2173, DOI 10.1359/jbmr.2001.16.12.2173; Luparello C, 2007, BREAST CANC RES TREA; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Marini P, 2006, ONCOGENE, V25, P5145, DOI 10.1038/sj.onc.1209516; Marsters SA, 1996, CURR BIOL, V6, P750, DOI 10.1016/S0960-9822(09)00456-4; Martin TJ, 2000, ENDOCR-RELAT CANCER, V7, P271, DOI 10.1677/erc.0.0070271; MOSELEY JM, 1995, CRIT REV CL LAB SCI, V32, P299, DOI 10.3109/10408369509084687; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Okoumassoun LE, 2007, J CELL PHYSIOL, V212, P591, DOI 10.1002/jcp.21055; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; POWELL GJ, 1991, CANCER RES, V51, P3059; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Saulle E, 2007, APOPTOSIS, V12, P635, DOI 10.1007/s10495-006-0025-9; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Singh TR, 2003, CANCER RES, V63, P5390; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Thai L, 2006, CANCER RES, V66, P5363, DOI 10.1158/0008-5472.CAN-05-4386; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Winter MC, 2009, CURR OPIN ONCOL, V21, P499, DOI 10.1097/CCO.0b013e328331c794; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; WYSOLMERSKI JJ, 1995, DEVELOPMENT, V121, P3539; Ye YM, 2001, REGUL PEPTIDES, V99, P169, DOI 10.1016/S0167-0115(01)00248-8	49	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66343	10.1371/journal.pone.0066343	http://dx.doi.org/10.1371/journal.pone.0066343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822995	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400091
J	Dottorini, T; Palladino, P; Senin, N; Persampieri, T; Spaccapelo, R; Crisanti, A				Dottorini, Tania; Palladino, Pietro; Senin, Nicola; Persampieri, Tania; Spaccapelo, Roberta; Crisanti, Andrea			CluGene: A Bioinformatics Framework for the Identification of Co-Localized, Co-Expressed and Co-Regulated Genes Aimed at the Investigation of Transcriptional Regulatory Networks from High-Throughput Expression Data	PLOS ONE			English	Article							REED-STERNBERG CELLS; ACCESSORY-GLAND GENES; B-CELL; IMMUNOGLOBULIN TRANSCRIPTION; NEIGHBORING GENES; BINDING SITES; MICE LACKING; GENOME; CLUSTERS; HODGKIN	The full understanding of the mechanisms underlying transcriptional regulatory networks requires unravelling of complex causal relationships. Genome high-throughput technologies produce a huge amount of information pertaining gene expression and regulation; however, the complexity of the available data is often overwhelming and tools are needed to extract and organize the relevant information. This work starts from the assumption that the observation of co-occurrent events (in particular co-localization, co-expression and co-regulation) may provide a powerful starting point to begin unravelling transcriptional regulatory networks. Co-expressed genes often imply shared functional pathways; co-expressed and functionally related genes are often co-localized, too; moreover, co-expressed and co-localized genes are also potential targets for co-regulation; finally, co-regulation seems more frequent for genes mapped to proximal chromosome regions. Despite the recognized importance of analysing co-occurrent events, no bioinformatics solution allowing the simultaneous analysis of co-expression, co-localization and co-regulation is currently available. Our work resulted in developing and valuating CluGene, a software providing tools to analyze multiple types of co-occurrences within a single interactive environment allowing the interactive investigation of combined co-expression, co-localization and co-regulation of genes. The use of CluGene will enhance the power of testing hypothesis and experimental approaches aimed at unravelling transcriptional regulatory networks. The software is freely available at http://bioinfolab.unipg.it/.	[Dottorini, Tania; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London, England; [Palladino, Pietro; Persampieri, Tania; Spaccapelo, Roberta; Crisanti, Andrea] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Senin, Nicola] Univ Perugia, Dept Ind Engn, I-06100 Perugia, Italy	Imperial College London; University of Perugia; University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London, England.	acrs@imperial.ac.uk	senin, nicola/B-5292-2016	senin, nicola/0000-0002-9556-0363; Spaccapelo, Roberta/0000-0003-2100-6172; Dottorini, Tania/0000-0001-7733-906X; Crisanti, Andrea/0000-0002-2406-4426	European Union [PIEF-GA-2010-273268]; acronym Vectrap [218164]; acronym FIGHTMAL	European Union(European Commission); acronym Vectrap; acronym FIGHTMAL	This work was supported by the European Union, [PIEF-GA-2010-273268], acronym Vectrap and [218164], acronym FIGHTMAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bavi P, 2011, J PATHOL, V224, P355, DOI 10.1002/path.2864; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Browne P, 2003, AM J CLIN PATHOL, V120, P767, DOI 10.1309/YCH8DWUFFQBKGPVB; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dai Z, 2011, NUCL ACIDS RES; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Dottorini T, 2013, FASEB J, V27, P86, DOI 10.1096/fj.12-219444; Dottorini T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-34; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Flenghi L, 1996, AM J PATHOL, V148, P1543; Foss HD, 1999, BLOOD, V94, P3108, DOI 10.1182/blood.V94.9.3108.421a21_3108_3113; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Garbati MR, 2010, CANCER LETT, V291, P237, DOI 10.1016/j.canlet.2009.10.018; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Hamada T, 1998, BRIT J HAEMATOL, V102, P691; Hamerly G, 2002, ALTERNATIVES K MEANS; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; He X, 2005, J COMPUT BIOL, V12, P638, DOI 10.1089/cmb.2005.12.638; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Janga SC, 2008, P NATL ACAD SCI USA, V105, P15761, DOI 10.1073/pnas.0806317105; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Koonin EV, 2009, INT J BIOCHEM CELL B, V41, P298, DOI 10.1016/j.biocel.2008.09.015; KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence JG, 2002, CELL, V110, P407, DOI 10.1016/S0092-8674(02)00900-5; Li Q, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-7; Ling X, 2009, BIOINFORMATICS, V25, P571, DOI 10.1093/bioinformatics/btp027; Luc N, 2003, COMPUT BIOL CHEM, V27, P59, DOI 10.1016/S1476-9271(02)00097-X; Magnusson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021572; Maher B, 2012, NATURE, V489, P46, DOI 10.1038/489046a; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; McCune RC, 2006, MODERN PATHOL, V19, P1010, DOI 10.1038/modpathol.3800622; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Re D, 2001, CANCER RES, V61, P2080; Saez AI, 2002, MODERN PATHOL, V15, P211, DOI 10.1038/modpathol.3880518; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Starczynowski DT, 2007, ONCOGENE, V26, P2685, DOI 10.1038/sj.onc.1210089; Stein H, 2001, BLOOD, V97, P496, DOI 10.1182/blood.V97.2.496; STORMO GD, 1990, METHOD ENZYMOL, V183, P211; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Theil J, 2001, BLOOD, V97, P3191, DOI 10.1182/blood.V97.10.3191; Thieblemont C, 2004, BLOOD, V103, P2727, DOI 10.1182/blood-2003-06-2160; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Torlakovic E, 2001, AM J PATHOL, V159, P1807, DOI 10.1016/S0002-9440(10)63027-1; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Wasserman WW, 2003, NATURWISSENSCHAFTEN, V90, P156, DOI 10.1007/s00114-003-0409-4; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104	74	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66196	10.1371/journal.pone.0066196	http://dx.doi.org/10.1371/journal.pone.0066196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823315	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400068
J	Foltz, JL; Makumbi, I; Sejvar, JJ; Malimbo, M; Ndyomugyenyi, R; Atai-Omoruto, AD; Alexander, LN; Abang, B; Melstrom, P; Kakooza, AM; Olara, D; Downing, RG; Nutman, TB; Dowell, SF; Lwamafa, DKW				Foltz, Jennifer L.; Makumbi, Issa; Sejvar, James J.; Malimbo, Mugagga; Ndyomugyenyi, Richard; Atai-Omoruto, Anne Deborah; Alexander, Lorraine N.; Abang, Betty; Melstrom, Paul; Kakooza, Angelina M.; Olara, Dennis; Downing, Robert G.; Nutman, Thomas B.; Dowell, Scott F.; Lwamafa, D. K. W.			An Epidemiologic Investigation of Potential Risk Factors for Nodding Syndrome in Kitgum District, Uganda	PLOS ONE			English	Article							CLINICAL CLASSIFICATION; ONCHOCERCA-VOLVULUS; EPILEPSY	Introduction: Nodding Syndrome (NS), an unexplained illness characterized by spells of head bobbing, has been reported in Sudan and Tanzania, perhaps as early as 1962. Hypothesized causes include sorghum consumption, measles, and onchocerciasis infection. In 2009, a couple thousand cases were reportedly in Northern Uganda. Methods: In December 2009, we identified cases in Kitgum District. The case definition included persons who were previously developmentally normal who had nodding. Cases, further defined as 5- to 15-years-old with an additional neurological deficit, were matched to village controls to assess risk factors and test biological specimens. Logistic regression models were used to evaluate associations. Results: Surveillance identified 224 cases; most (95%) were 5-15-years-old (range = 2-27). Cases were reported in Uganda since 1997. The overall prevalence was 12 cases per 1,000 (range by parish = 0.6-46). The case-control investigation (n = 49 case/village control pairs) showed no association between NS and previously reported measles; sorghum was consumed by most subjects. Positive onchocerciasis serology [age-adjusted odds ratio (AOR(1)) = 14.4 (2.7, 78.3)], exposure to munitions [AOR(1)= 13.9 (1.4, 135.3)], and consumption of crushed roots [AOR(1)= 5.4 (1.3, 22.1)] were more likely in cases. Vitamin B6 deficiency was present in the majority of cases (84%) and controls (75%). Conclusion: NS appears to be increasing in Uganda since 2000 with 2009 parish prevalence as high as 46 cases per 1,000 5 to 15-year old children. Our results found no supporting evidence for many proposed NS risk factors, revealed association with onchocerciasis, which for the first time was examined with serologic testing, and raised nutritional deficiencies and toxic exposures as possible etiologies.	[Foltz, Jennifer L.] Ctr Dis Control & Prevent, Div Nutr Phys Activ & Obes, Atlanta, GA 30333 USA; [Makumbi, Issa; Malimbo, Mugagga; Ndyomugyenyi, Richard; Atai-Omoruto, Anne Deborah; Lwamafa, D. K. W.] Uganda Minist Hlth, Kampala, Uganda; [Sejvar, James J.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Alexander, Lorraine N.; Abang, Betty; Olara, Dennis; Downing, Robert G.] Centers Dis Control & Prevent Uganda, Div Global HIV AIDS, Entebbe, Uganda; [Melstrom, Paul] Ctr Dis Control & Prevent, Div Environm Hazards & Hlth Effects, Atlanta, GA USA; [Kakooza, Angelina M.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Nutman, Thomas B.] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA; [Dowell, Scott F.] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Makerere University; National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA	Foltz, JL (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Activ & Obes, Atlanta, GA 30333 USA.	jfoltz@cdc.gov			CDC; WHO; MoH Uganda for public health investigations; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000439, ZIAAI000512] Funding Source: NIH RePORTER	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); WHO(World Health Organization); MoH Uganda for public health investigations; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The investigation was supported with resources available from CDC, WHO, and MoH Uganda for public health investigations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALLJILEK LM, 1965, ACTA PSYCHIAT SCAND, V41, P57, DOI 10.1111/j.1600-0447.1965.tb04970.x; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; [Anonymous], 2010, 2008 UGANDA FOOD CON; Bauernfeind J, 1978, HUMAN VITAMIN B6 REQ; Baxter P, 2001, DEV MED CHILD NEUROL, V43, P416, DOI 10.1017/S0012162201000779; BEG MA, 1995, PARASITOLOGY, V111, P111, DOI 10.1017/S0031182000064660; Burbelo PD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000438; COURSIN DB, 1954, JAMA-J AM MED ASSOC, V154, P406, DOI 10.1001/jama.1954.02940390030009; Food and Nutrition Board, 1998, DIET REF INT THIAM R, P150; GERRITS C, 1983, LANCET, V1, P358; GRABOW JD, 1969, AM J CLIN NUTR, V22, P1429; Kaiser C, 2000, B SOC PATHOL EXOT, V93, P255; Kaiser C, 2009, EPILEPSIA, V50, P2325, DOI 10.1111/j.1528-1167.2009.02280.x; Konig R, 2010, PARASITOLOGY, V137, P1559, DOI 10.1017/S0031182010000338; KRETSCH MJ, 1991, AM J CLIN NUTR, V53, P1266, DOI 10.1093/ajcn/53.5.1266; Lacey M, 2003, LANCET NEUROL, V2, P714, DOI 10.1016/S1474-4422(03)00599-4; Nyungura JL, 2010, SO SUDAN MED J, V4, P3; Pearlman Eric, 2007, Chem Immunol Allergy, V92, P254, DOI 10.1159/000099276; Pion SDS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000461; Prost A., 1978, Medecine Tropicale, V38, P519; Reik Lul, 2012, Morbidity and Mortality Weekly Report, V61, P52; Rybak ME, 2004, ANAL BIOCHEM, V333, P336, DOI 10.1016/j.ab.2004.06.036; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Tumwine JK, 2012, AFR HEALTH SCI, V12, P242, DOI 10.4314/ahs.v12i3.1; van der Waals FW, 1983, NEUROEPIDEMIOLOGY, V2, P35, DOI DOI 10.1159/000110508; Winkler AS, 2010, TROP DOCT, V40, P173, DOI 10.1258/td.2010.090373; Winkler AS, 2008, EPILEPSIA, V49, P2008, DOI 10.1111/j.1528-1167.2008.01671.x	27	73	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66419	10.1371/journal.pone.0066419	http://dx.doi.org/10.1371/journal.pone.0066419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823012	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400106
J	Larsen, MH; Albrechtsen, A; Thorner, LW; Werge, T; Hansen, T; Gether, U; Haastrup, E; Ullum, H				Larsen, Margit Horup; Albrechtsen, Anders; Thorner, Lise Wegner; Werge, Thomas; Hansen, Thomas; Gether, Ulrik; Haastrup, Eva; Ullum, Henrik			Genome-Wide Association Study of Genetic Variants in LPS-Stimulated IL-6, IL-8, IL-10, IL-1ra and TNF-alpha Cytokine Response in a Danish Cohort	PLOS ONE			English	Article								Background: Cytokine response plays a vital role in various human lipopolysaccharide (LPS) infectious and inflammatory diseases. This study aimed to find genetic variants that might affect the levels of LPS-induced interleukin (IL)-6, IL-8, IL-10, IL-1ra and tumor necrosis factor (TNF)-alpha cytokine production. Methods: We performed an initial genome-wide association study using Affymetrix Human Mapping 500 K GeneChip (R) to screen 130 healthy individuals of Danish descent. The levels of IL-6, IL-8, IL-10, IL-1r alpha and TNF-alpha in 24-hour LPS-stimulated whole blood samples were compared within different genotypes. The 152 most significant SNPs were replicated using Illumina Golden Gate (R) GeneChip in an independent cohort of 186 Danish individuals. Next, 9 of the most statistical significant SNPs were replicated using PCR-based genotyping in an independent cohort of 400 Danish individuals. All results were analyzed in a combined study among the 716 Danish individuals. Results: Only one marker of the 500 K Gene Chip in the discovery study showed a significant association with LPS-induced IL-1ra cytokine levels after Bonferroni correction (P, 10 27). However, this SNP was not associated with the IL-1ra cytokine levels in the replication dataset. No SNPs reached genome-wide significance for the five cytokine levels in the combined analysis of all three stages. Conclusions: The associations between the genetic variants and the LPS-induced IL-6, IL-8, IL-10, IL-1ra and TNF-alpha cytokine levels were not significant in the meta-analysis. This present study does not support a strong genetic effect of LPS-stimulated cytokine production; however, the potential for type II errors should be considered.	[Larsen, Margit Horup; Thorner, Lise Wegner; Haastrup, Eva; Ullum, Henrik] Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark; [Albrechtsen, Anders] Univ Copenhagen, Ctr Bioinformat, Copenhagen, Denmark; [Werge, Thomas; Hansen, Thomas] Copenhagen Univ Hosp, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, Roskilde, Denmark; [Gether, Ulrik] Univ Copenhagen, Mol Neuropharmacol & Genet Lab, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Larsen, MH (corresponding author), Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark.	margit.anita.hoerup.larsen@regionh.dk	Hansen, Thomas Folkmann/O-5965-2014; Albrechtsen, Anders/K-4281-2013; Hansen, Thomas/GWZ-2858-2022	Hansen, Thomas Folkmann/0000-0001-6703-7762; Albrechtsen, Anders/0000-0001-7306-031X; Thorner, Lise Wegner/0000-0003-4391-4956; Ullum, Henrik/0000-0001-7306-9058; Gether, Ulrik/0000-0002-0020-3807	Copenhagen University Hospital, Rigshospitalet; Center for Pharmacogenomics Copenhagen University; Villum Fonden [00007171] Funding Source: researchfish	Copenhagen University Hospital, Rigshospitalet; Center for Pharmacogenomics Copenhagen University; Villum Fonden(Villum Fonden)	This study was supported by grants from the Copenhagen University Hospital, Rigshospitalet; Center for Pharmacogenomics Copenhagen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Craen AJM, 2005, GENES IMMUN, V6, P167, DOI 10.1038/sj.gene.6364162; Huang H, 2012, IMMUNOGENETICS, V64, P351; Martin TR, 1997, AM J RESP CRIT CARE, V155, P937, DOI 10.1164/ajrccm.155.3.9117029; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006	5	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66262	10.1371/journal.pone.0066262	http://dx.doi.org/10.1371/journal.pone.0066262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823136	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400074
J	Sheehy, SH; Spencer, AJ; Douglas, AD; Sim, BKL; Longley, RJ; Edwards, NJ; Poulton, ID; Kimani, D; Williams, AR; Anagnostou, NA; Roberts, R; Kerridge, S; Voysey, M; James, ER; Billingsley, PF; Gunasekera, A; Lawrie, AM; Hoffman, SL; Hill, AVS				Sheehy, Susanne H.; Spencer, Alexandra J.; Douglas, Alexander D.; Sim, B. Kim Lee; Longley, Rhea J.; Edwards, Nick J.; Poulton, Ian D.; Kimani, Domtila; Williams, Andrew R.; Anagnostou, Nicholas A.; Roberts, Rachel; Kerridge, Simon; Voysey, Merryn; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Lawrie, Alison M.; Hoffman, Stephen L.; Hill, Adrian V. S.			Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe	PLOS ONE			English	Article							BLOOD-STAGE ANTIGEN; T-CELLS RECOGNIZE; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; SPOROZOITE VACCINE; CHALLENGE; PROTECTION; EPITOPES; SURFACE; CANDIDATE	Background: Controlled human malaria infection (CHMI) studies have become a routine tool to evaluate efficacy of candidate anti-malarial drugs and vaccines. To date, CHMI trials have mostly been conducted using the bite of infected mosquitoes, restricting the number of trial sites that can perform CHMI studies. Aseptic, cryopreserved P. falciparum sporozoites (PfSPZ Challenge) provide a potentially more accurate, reproducible and practical alternative, allowing a known number of sporozoites to be administered simply by injection. Methodology: We sought to assess the infectivity of PfSPZ Challenge administered in different dosing regimens to malaria-naive healthy adults (n = 18). Six participants received 2,500 sporozoites intradermally (ID), six received 2,500 sporozoites intramuscularly (IM) and six received 25,000 sporozoites IM. Findings: Five out of six participants receiving 2,500 sporozoites ID, 3/6 participants receiving 2,500 sporozoites IM and 6/6 participants receiving 25,000 sporozoites IM were successfully infected. The median time to diagnosis was 13.2, 17.8 and 12.7 days for 2,500 sporozoites ID, 2,500 sporozoites IM and 25,000 sporozoites IM respectively (Kaplan Meier method; p = 0.024 log rank test). Conclusions: 2,500 sporozoites ID and 25,000 sporozoites IM have similar infectivities. Given the dose response in infectivity seen with IM administration, further work should evaluate increasing doses of PfSPZ Challenge IM to identify a dosing regimen that reliably infects 100% of participants.	[Sheehy, Susanne H.; Poulton, Ian D.; Anagnostou, Nicholas A.; Roberts, Rachel; Kerridge, Simon; Lawrie, Alison M.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Sheehy, Susanne H.; Spencer, Alexandra J.; Douglas, Alexander D.; Longley, Rhea J.; Edwards, Nick J.; Williams, Andrew R.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst Labs, Oxford, England; [Sim, B. Kim Lee; James, Eric R.; Billingsley, Peter F.; Gunasekera, Anusha; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Kimani, Domtila] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Voysey, Merryn] Univ Oxford, Ctr Stat Med, Oxford, England	University of Oxford; University of Oxford; Sanaria Inc.; Kenya Medical Research Institute; University of Oxford	Sheehy, SH (corresponding author), Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England.	susanne.sheehy@ndm.ox.ac.uk	Williams, Andrew R/A-3057-2013; Longley, Rhea J/C-9573-2018; Spencer, Alexandra/AAE-6494-2019; Douglas, Alexander/E-7040-2012	Williams, Andrew R/0000-0002-8231-282X; Longley, Rhea J/0000-0002-4510-5602; Spencer, Alexandra/0000-0001-7958-6961; Douglas, Alexander/0000-0002-5410-7562; Hodgson, Susanne/0000-0002-0895-3442; Edwards, Nick/0000-0002-7030-7839; Voysey, Merryn/0000-0001-6324-6559	United Kingdom National Institute of Health Research through the Oxford Biomedical Research Centre [A91301]; Wellcome Trust [084113/Z/07/Z, 089455/2/09/Z, 45488/Z/05, 097940/Z/11/Z]; National Institute of Allergy and Infectious Disease [R44AI058375]; National Institute for Health Research Academic Clinical Fellow; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI058375] Funding Source: NIH RePORTER	United Kingdom National Institute of Health Research through the Oxford Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Health Research Academic Clinical Fellow; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United Kingdom National Institute of Health Research through the Oxford Biomedical Research Centre (http://www.oxfordbrc.org/) [A91301 Adult Vaccine], and the Wellcome Trust (http://www.wellcome.ac.uk/) [084113/Z/07/Z]. Funding for manufacture, quality control release and stability studies of Sanaria's PfSPZ Challenge was provided by the National Institute of Allergy and Infectious Disease (http://www.niaid.nih.gov) [R44AI058375] 'Universal Attenuated Malaria Sporozoite Vaccine and Challenge System.' SHS holds a Wellcome Trust research training fellowship (097940/Z/11/Z). ADD recently held a Wellcome Trust research training fellowship (089455/2/09/Z) and is currently an National Institute for Health Research Academic Clinical Fellow. AVSH holds a Wellcome Trust Principal Research Fellowship (45488/Z/05) and is a Jenner Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2000, INFECT IMMUN, V68, P227, DOI 10.1128/IAI.68.1.227-232.2000; BEIER JC, 1991, MED VET ENTOMOL, V5, P71, DOI 10.1111/j.1365-2915.1991.tb00523.x; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; CASPERS P, 1991, MOL BIOCHEM PARASIT, V47, P143, DOI 10.1016/0166-6851(91)90173-4; Chelimo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024852; Dodoo D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-168; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Douglas AD, 2013, J INFECT DIS; Elias SC, 2012, MOL THER; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; FIDOCK DA, 1994, MOL BIOCHEM PARASIT, V64, P219, DOI 10.1016/0166-6851(94)00012-3; Flanagan KL, 2003, AM J TROP MED HYG, V68, P421, DOI 10.4269/ajtmh.2003.68.421; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOPE IA, 1984, NATURE, V308, P191, DOI 10.1038/308191a0; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; MOELANS IIMD, 1991, MOL BIOCHEM PARASIT, V45, P193, DOI 10.1016/0166-6851(91)90086-L; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; Moxon R, 2005, MICROBIAL CHALLENGE; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Perlaza BL, 2008, EUR J IMMUNOL, V38, P2610, DOI 10.1002/eji.200738055; Ploemen I. H., 2012, VACCINE; PONNUDURAI T, 1981, TROP GEOGR MED, V33, P50; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; Porter DW, 2011, VACCINE, V29, P7514, DOI 10.1016/j.vaccine.2011.03.083; Rennenberg A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000825; Roestenberg M, 2012, AM J TROP MED HYG; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Sauzet JP, 2001, INFECT IMMUN, V69, P1202, DOI 10.1128/IAI.69.2.1202-1206.2001; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwenk RJ, 2011, TRENDS PARASITOL, V27, P306, DOI 10.1016/j.pt.2011.02.002; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; Vignali M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-211; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; WIZEL B, 1995, J IMMUNOL, V155, P766	52	67	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65960	10.1371/journal.pone.0065960	http://dx.doi.org/10.1371/journal.pone.0065960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823332	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400040
J	Hu, QD; Yuan, YW; Wang, CY				Hu, Qiande; Yuan, Yewen; Wang, Chiayeng			Structural and Functional Studies of FKHR-PAX3, a Reciprocal Fusion Gene of the t(2;13) Chromosomal Translocation in Alveolar Rhabdomyosarcoma	PLOS ONE			English	Article							GROWTH SUPPRESSIVE ACTIVITIES; TRANSCRIPTION FACTOR; PHYSICAL MAP; PAX3; EXPRESSION; ISOFORMS; PROTEIN; TRANSACTIVATION; IDENTIFICATION; LOCALIZATION	Alveolar rhabdomyosarcoma (ARMS) is an aggressive pediatric cancer of skeletal muscle. More than 70% of ARMS tumors carry balanced t(2;13) chromosomal translocation that leads to the production of two novel fusion genes, PAX3-FKHR and FKHR-PAX3. While the PAX3-FKHR gene has been intensely studied, the reciprocal FKHR-PAX3 gene has rarely been described. We report here the cloning and functional characterization of the FKHR-PAX3 gene as the first step towards a better understanding of its potential impact on ARMS biology. From RH30 ARMS cells, we detected and isolated three versions of FKHR-PAX3 cDNAs whose C-terminal sequences corresponded to PAX3c, PAX3d, and PAX3e isoforms. Unlike the nuclear-specific localization of PAX3-FKHR, the reciprocal FKHR-PAX3 proteins stayed predominantly in the cytoplasm. FKHR-PAX3 potently inhibited myogenesis in both non-transformed myoblast cells and ARMS cells. We showed that FKHR-PAX3 was not a classic oncogene but could act as a facilitator in oncogenic pathways by stabilizing PAX3-FKHR expression, enhancing cell proliferation, clonogenicity, anchorage-independent growth, and matrix adhesion in vitro, and accelerating the onset of tumor formation in xenograft mouse model in vivo. In addition to these pro-oncogenic behaviors, FKHR-PAX3 also negatively affected cell migration and invasion in vitro and lung metastasis in vivo. Taken together, these functional characteristics suggested that FKHR-PAX3 might have a critical role in the early stage of ARMS development.	[Hu, Qiande; Yuan, Yewen; Wang, Chiayeng] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60680 USA; [Yuan, Yewen; Wang, Chiayeng] Univ Illinois, Dept Oral Biol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, CY (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60680 USA.	chiayeng@uic.edu			NCI/NIH [CA074907]; NATIONAL CANCER INSTITUTE [R01CA074907, R29CA074907] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI/NIH (http://m.cancer.gov/) CA074907 to Chiayeng Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber TD, 1999, GENE, V237, P311, DOI 10.1016/S0378-1119(99)00339-X; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Barr FG, 1998, CANCER GENET CYTOGEN, V102, P32, DOI 10.1016/S0165-4608(97)00287-2; BARR FG, 1992, GENOMICS, V13, P1150, DOI 10.1016/0888-7543(92)90030-V; BARR FG, 1991, GENOMICS, V11, P941, DOI 10.1016/0888-7543(91)90018-A; Begum S, 2005, ONCOGENE, V24, P1860, DOI 10.1038/sj.onc.1208315; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cao Y, 2000, J BIOL CHEM, V275, P9854, DOI 10.1074/jbc.275.13.9854; Charytonowicz E, 2011, CLIN TRANSL ONCOL, V13, P194, DOI 10.1007/s12094-011-0640-y; De Giovanni C, 2009, FUTURE ONCOL, V5, P1449, DOI 10.2217/fon.09.97; De Pitta C, 2006, INT J CANCER, V118, P2772, DOI 10.1002/ijc.21698; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; Finckenstein FG, 2008, ONCOGENE, V27, P2004, DOI 10.1038/sj.onc.1210835; Frascella E, 1998, CANCER GENET CYTOGEN, V102, P104, DOI 10.1016/S0165-4608(97)00352-X; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Khan J, 1999, P NATL ACAD SCI USA, V96, P13264, DOI 10.1073/pnas.96.23.13264; Kumar AR, 2011, LEUKEMIA RES, V35, P305, DOI 10.1016/j.leukres.2010.08.011; Lam PYP, 1999, MOL CELL BIOL, V19, P594; Marshall AD, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-25; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parker CJ, 2004, INT J CANCER, V108, P314, DOI 10.1002/ijc.11527; Picchione F, 2011, CARCINOGENESIS, V32, P452, DOI 10.1093/carcin/bgq273; Pollock JL, 1999, P NATL ACAD SCI USA, V96, P15103, DOI 10.1073/pnas.96.26.15103; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Rego EM, 2002, TRENDS MOL MED, V8, P396, DOI 10.1016/S1471-4914(02)02384-5; Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Sumegi J, 2010, GENE CHROMOSOME CANC, V49, P224, DOI 10.1002/gcc.20731; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang C, 2012, J DENT RES, V91, P341, DOI 10.1177/0022034511421490; Wang QY, 2006, CANCER RES, V66, P8574, DOI 10.1158/0008-5472.CAN-06-0947; Wang-Wuu S, 1988, Cancer Res, V48, P983; Xia SJ, 2007, LAB INVEST, V87, P318, DOI 10.1038/labinvest.3700521; Xia SJ, 2009, AM J PATHOL, V175, P2600, DOI 10.2353/ajpath.2009.090192; Xia SJJ, 2004, ONCOGENE, V23, P6864, DOI 10.1038/sj.onc.1207850; Zanola A, 2012, J CELL MOL MED, V16, P1377, DOI 10.1111/j.1582-4934.2011.01518.x; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang Y, 2011, ONCOGENE, V30, P3549, DOI 10.1038/onc.2011.69; Zhang YB, 2009, INT J CLIN EXP PATHO, V2, P370; Zheng XM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007661	49	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e68065	10.1371/journal.pone.0068065	http://dx.doi.org/10.1371/journal.pone.0068065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799156	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300118
J	Johnson, FA; Padmadas, SS; Matthews, Z				Johnson, Fiifi Amoako; Padmadas, Sabu S.; Matthews, Zoe			Are Women Deciding against Home Births in Low and Middle Income Countries?	PLOS ONE			English	Article							HEALTH FACILITIES; RURAL BANGLADESH; CARE; CHILDBIRTH	Background: Although there is evidence to tracking progress towards facility births within the UN Millennium Development Goals framework, we do not know whether women are deciding against home birth over their reproductive lives. Using Demographic and Health Surveys (DHS) data from 44 countries, this study aims to investigate the patterns and shifts in childbirth locations and to determine whether these shifts are in favour of home or health settings. Methods and Findings: The analyses considered 108,777 women who had at least two births in the five years preceding the most recent DHS over the period 2000-2010. The vast majority of women opted for the same place of childbirth for their successive births. However, about 14% did switch their place and not all these decisions favoured health facility over home setting. In 24 of the 44 countries analysed, a higher proportion of women switched from a health facility to home. Multilevel regression analyses show significantly higher odds of switching from home to a facility for high parity women, those with frequent antenatal visits and more wealth. However, in countries with high infant mortality rates, low parity women had an increased probability of switching from home to a health facility. Conclusions: There is clear evidence that women do change their childbirth locations over successive births in low and middle income countries. After two decades of efforts to improve maternal health, it might be expected that a higher proportion of women will be deciding against home births in favour of facility births. The results from this analysis show that is not the case.	[Johnson, Fiifi Amoako] Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England; Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England	University of Southampton; University of Southampton	Johnson, FA (corresponding author), Univ Southampton, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England.	faj100@soton.ac.uk	Amoako Johnson, Fiifi/GWC-1466-2022; Matthews, Zoe/HGD-0506-2022	Padmadas, Sabu/0000-0002-6538-9374; Matthews, Zoe/0000-0003-1533-6618				Achadi E, 2007, TROP MED INT HEALTH, V12, P1490, DOI 10.1111/j.1365-3156.2007.01957.x; Addai I, 2000, J BIOSOC SCI, V32, P1; Chowdhury ME, 2006, LANCET, V367, P327, DOI 10.1016/S0140-6736(06)68070-7; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; Falkingham J, 2003, STUD FAMILY PLANN, V34, P32, DOI 10.1111/j.1728-4465.2003.00032.x; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Freedman LP, 2005, WHOS GOT POWER TRANS; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Guseh JS, 2001, AFRICAN STUDIES Q, V5, P1; IBM Corp, 2011, IBM SPSS COMPL SAMPL; Johnson FA, 2009, J COMMUN HEALTH, V34, P64, DOI 10.1007/s10900-008-9120-x; Kesterton AJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-30; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Labonte R, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-6; Lawn JE, 2008, LANCET, V372, P297; Magadi M, 2000, SOC BIOL, V47, P164; Measure DHS, DEM HLTH SURV DAT; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Paul BK, 2002, SOC SCI MED, V54, P1755, DOI 10.1016/S0277-9536(01)00148-4; Ress P, 2005, BMJ-BRIT MED J, V331, P4742; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Sharan M, 2010, HLTH SYSTEM READINES; Simwaka BN, 2005, BMJ-BRIT MED J, V331, P708, DOI 10.1136/bmj.331.7519.708; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; Titaley CR, 2010, PREGNANCY CHILD BIRT, V10, P1; UN (United Nations), 2008, UN MILL DEV GOALS; *UNICEF, 2008, COUNTD 2015 TRACK PR; Wall LL, 1998, STUD FAMILY PLANN, V29, P341, DOI 10.2307/172248; WHO, 2010, TRENDS MAT MORT 1990	32	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65527	10.1371/journal.pone.0065527	http://dx.doi.org/10.1371/journal.pone.0065527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799022	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000320363300022
J	Smelov, V; Eklund, C; Bzhalava, D; Novikov, A; Dillner, J				Smelov, Vitaly; Eklund, Carina; Bzhalava, Davit; Novikov, Andrey; Dillner, Joakim			Expressed Prostate Secretions in the Study of Human Papillomavirus Epidemiology in the Male	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; PELVIC PAIN SYNDROME; HETEROSEXUAL MEN; RISK-FACTORS; GLOBAL PROFICIENCY; INFECTION; CANCER; PREVALENCE; PATHOGENESIS; INFLAMMATION	Introduction: Exploring different sampling sites and methods is of interest for studies of the epidemiology of HPV infections in the male. Expressed prostate secretions (EPS) are obtained during digital rectal examination (DRE), a daily routine urological diagnostic procedure, following massage of the prostate. Materials and Methods: Urethral swabs and EPS samples were obtained from a consecutive sample of 752 men (mean age 32.4 years; median life-time sex partners 34) visiting urology outpatient clinics in St. Petersburg, Russia and tested for HPV DNA by general primer PCR, followed by genotyping using Luminex. Results: Overall, 47.9% (360/752) of men were HPV-positive, with 42.0% (316/752) being positive for high-risk (HR-) HPV and 12.6% (95/752) for multiple HPV types. HPV-positivity in the EPS samples was 32.6% (27.7% HR-HPV) and in the urethral samples 25.9% (24.5% HR-HPV). 10.6% were HPV positive in both EPS and urethral samples. 6.4% had the same HPV-type in both EPS and urethral samples. 10.6% were HPV positive in both EPS and urethral samples. 6.4% had the same HPV-type in both EPS and urethral samples. The concordance between the urethral samples and EPS was 62.5% (470/752), with 80 cases double positive and 390 cases double negative in both sites. The sensitivity of urethral samples for overall HPV detection was 54.2% (195/360). Compared to analysis of urethral samples only, the analysis of EPS increased the HPV prevalence in this population with 26.2%. Conclusion: EPS represent informative sampling material for the study of HPV epidemiology in the male.	[Smelov, Vitaly; Eklund, Carina; Bzhalava, Davit; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Smelov, Vitaly; Novikov, Andrey] North Western State Med Univ, Dept Urol & Androl, St Petersburg, Russia; [Smelov, Vitaly] St Petersburg State Univ, Outpatient Clin, St Petersburg 199034, Russia; [Smelov, Vitaly] DO Ott Res Inst Obstet & Gynaecol, Med Ctr Mikrobiomed, St Petersburg, Russia; [Smelov, Vitaly] DO Ott Res Inst Obstet & Gynaecol, Microbiol Lab, St Petersburg, Russia	Karolinska Institutet; North-Western State Medical University named after I.I. Mechnikov; Saint Petersburg State University; Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology; Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology	Smelov, V (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	vitaly.smelov@ki.se		Bzhalava, Davit/0000-0002-7646-7892; Smelov, Vitaly/0000-0002-7353-1561	Swedish Cancer Society; European Association of Urology (EUSP)	Swedish Cancer Society(Swedish Cancer Society); European Association of Urology (EUSP)	This work was supported in part by the Swedish Cancer Society (Scholarship 2011 to Vitaly Smelov) and European Association of Urology (EUSP Fellowship 2007 to Vitaly Smelov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami HO, 2003, CANCER EPIDEM BIOMAR, V12, P872; Baldwin SB, 2003, J INFECT DIS, V187, P1064, DOI 10.1086/368220; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bleeker MCG, 2005, CLIN INFECT DIS, V41, P612, DOI 10.1086/431978; Carozzi F, 2004, INT J BIOL MARKER, V19, P257, DOI 10.1177/172460080401900401; Cheng I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008736; Dillner J, 1998, INT J CANCER, V75, P564, DOI 10.1002/(SICI)1097-0215(19980209)75:4<564::AID-IJC12>3.0.CO;2-9; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Eklund C, 2012, J CLIN MICROBIOL, V50, P2289, DOI 10.1128/JCM.00840-12; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Forslund O, 2002, J MED VIROL, V66, P535, DOI 10.1002/jmv.2178; Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194; Giovannelli L, 2007, J MED VIROL, V79, P1882, DOI 10.1002/jmv.21015; Giuliano AR, 2007, J INFECT DIS, V196, P1146, DOI 10.1086/521629; Goldstraw MA, 2007, BJU INT, V99, P966, DOI 10.1111/j.1464-410X.2006.06731.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Leiros Gustavo J, 2005, BMC Urol, V5, P15, DOI 10.1186/1471-2490-5-15; Leskinen MJ, 2003, UROLOGY, V61, P397, DOI 10.1016/S0090-4295(02)02166-0; MEARES EM, 1968, INVEST UROL, V5, P492; Nelson William G, 2004, J Urol, V172, pS6, DOI 10.1097/01.ju.0000142058.99614.ff; Nickel JC, 2006, J UROLOGY, V176, P119, DOI 10.1016/S0022-5347(06)00498-8; Nickel JC, 1998, UROL CLIN N AM, V25, P677, DOI 10.1016/S0094-0143(05)70056-2; Nielson CM, 2007, J INFECT DIS, V196, P1137, DOI 10.1086/521632; Nyitray A, 2008, J INFECT DIS, V197, P1676, DOI 10.1086/588145; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Smelov V, 2011, SCAND J INFECT DIS, V43, P399, DOI 10.3109/00365548.2011.552071; Soderlund-Strand A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.056; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Strickler HD, 1998, CANCER-AM CANCER SOC, V82, P1118; Sutcliffe S, 2006, J UROLOGY, V175, P1937, DOI 10.1016/S0022-5347(05)00892-X; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P2160, DOI 10.1158/1055-9965.EPI-05-0913; Svare EI, 2002, SEX TRANSM INFECT, V78, P215, DOI 10.1136/sti.78.3.215; Taylor ML, 2005, FAM MED, V37, P506; Vardas E, 2011, J INFECT DIS, V203, P58, DOI 10.1093/infdis/jiq015; Wagenlehner FME, 2007, BJU INT, V100, P733, DOI 10.1111/j.1464-410X.2007.07091.x; Zambrano A, 2002, PROSTATE, V53, P263, DOI 10.1002/pros.10157	37	10	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66630	10.1371/journal.pone.0066630	http://dx.doi.org/10.1371/journal.pone.0066630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799125	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300092
J	Yang, JS; Lin, CW; Hsin, CH; Hsieh, MJ; Chang, YC				Yang, Jia-Sin; Lin, Chiao-Wen; Hsin, Chung-Han; Hsieh, Ming-Ju; Chang, Yu-Chao			Selaginella tamariscina Attenuates Metastasis via Akt Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; AMENTOFLAVONE INDUCES APOPTOSIS; MATRIX METALLOPROTEINASE-2; INHIBITS MIGRATION; CYCLE ARREST; TUMOR-CELL; IN-VITRO; INVASION; EXPRESSION; CARCINOMA	Background: Crude extracts of Selaginella tamariscina, an oriental medicinal herb, have been evidenced to treat several human diseases. This study investigated the mechanisms by which Selaginella tamariscina inhibits the invasiveness of human oral squamous-cell carcinoma (OSCC) HSC-3 cells. Methodology/Principal Findings: Herein, we demonstrate that Selaginella tamariscina attenuated HSC-3 cell migration and invasion in a dose-dependent manner. The anti-metastatic activities of Selaginella tamariscina occurred at least partially because of the down-regulation of matrix metalloproteinases (MMP)-2 and MMP-9 gelatinase activity and the down-regulation of protein expression. The expression and function of both MMP-2 and MMP-9 were regulated by Selaginella tamariscina at a transcriptional level, as shown by quantitative real-time PCR and reporter assays. Chromatin immunoprecipitation (ChIP) data further indicated that binding of the cAMP response element-binding (CREB) protein and activating protein-1 (AP-1) to the MMP-2 promoter diminished at the highest dosage level of Selaginella tamariscina. The DNA-binding activity of specificity protein 1 (SP-1) to the MMP-9 promoter was also suppressed at the same concentration. Selaginella tamariscina did not affect the mitogen-activated protein kinase signaling pathway, but did inhibit the effects of gelatinase by reducing the activation of serine-threonine kinase Akt. Conclusions: These results demonstrate that Selaginella tamariscina may be a potent adjuvant therapeutic agent in the prevention of oral cancer.	[Yang, Jia-Sin; Hsieh, Ming-Ju] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen; Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Chang, YC (corresponding author), Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.	cyc@csmu.edu.tw	Hsieh, Ming-Ju/GQB-3025-2022	Hsieh, Ming-Ju/0000-0001-9726-3234	National Science Council, Taiwan [NSC100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from National Science Council, Taiwan (NSC100-2632-B-040-001-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chiang YY, 2008, HISTOL HISTOPATHOL, V23, P1213, DOI 10.14670/HH-23.1213; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Fullar A, 2012, EXP CELL RES, V318, P1517, DOI 10.1016/j.yexcr.2012.03.023; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Hwang IS, 2012, MYCOPATHOLOGIA, V173, P207, DOI 10.1007/s11046-011-9503-x; JUAREZ J, 1993, INT J CANCER, V55, P10, DOI 10.1002/ijc.2910550104; Jung HJ, 2007, BIOL PHARM BULL, V30, P1969, DOI 10.1248/bpb.30.1969; Jung HJ, 2006, ARCH PHARM RES, V29, P746, DOI 10.1007/BF02974074; Kim HS, 2004, ANTICANCER RES, V24, P747; Kuo HP, 2012, J AGR FOOD CHEM, V60, P9649, DOI 10.1021/jf302832n; Kuo YC, 1998, J LAB CLIN MED, V132, P76, DOI 10.1016/S0022-2143(98)90029-4; Lee IS, 1999, CANCER LETT, V144, P93, DOI 10.1016/S0304-3835(99)00202-5; Lee JS, 2009, BIOL PHARM BULL, V32, P1427, DOI 10.1248/bpb.32.1427; Lee J, 2009, J MICROBIOL BIOTECHN, V19, P204, DOI 10.4014/jmb.0810.566; Lee S, 2011, J MED FOOD, V14, P808, DOI 10.1089/jmf.2010.1428; Lu KW, 2011, HUM EXP TOXICOL, V30, P406, DOI 10.1177/0960327110372405; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Miao N, 1996, Zhongguo Zhong Yao Za Zhi, V21, P493; Mirzoeva S, 2013, MOL CARCINOG; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Park SY, 2012, INT J ONCOL, V41, P933, DOI 10.3892/ijo.2012.1518; Pei JS, 2012, IN VIVO, V26, P963; Ribatti D, 2008, GENES NUTR, V3, P29, DOI 10.1007/s12263-008-0076-3; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; SOPATA I, 1979, BIOCHIM BIOPHYS ACTA, V571, P305, DOI 10.1016/0005-2744(79)90100-1; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sze KMF, 2011, HEPATOLOGY, V53, P1558, DOI 10.1002/hep.24232; Tang SW, 2011, CARCINOGENESIS, V32, P138, DOI 10.1093/carcin/bgq225; VARTIO T, 1981, J BIOL CHEM, V256, P3085; Wang KL, 2013, EXPERT OPIN THER TAR, V17, P337, DOI 10.1517/14728222.2013.756869; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Yang JW, 2006, J ETHNOPHARMACOL, V105, P107, DOI 10.1016/j.jep.2005.10.001; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yeh CB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/595292; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zheng XK, 2011, J ETHNOPHARMACOL, V137, P662, DOI 10.1016/j.jep.2011.06.018	41	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e68035	10.1371/journal.pone.0068035	http://dx.doi.org/10.1371/journal.pone.0068035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799155	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300117
J	Chen, YJ; Zhu, JM; Wu, H; Fan, J; Zhou, J; Hu, J; Yu, Q; Liu, TT; Yang, L; Wu, CL; Guo, XL; Huang, XW; Shen, XZ				Chen, Yan-Jie; Zhu, Ji-Min; Wu, Hao; Fan, Jia; Zhou, Jian; Hu, Jie; Yu, Qian; Liu, Tao-Tao; Yang, Lei; Wu, Chun-Lei; Guo, Xiao-Ling; Huang, Xiao-Wu; Shen, Xi-Zhong			Circulating microRNAs as a Fingerprint for Liver Cirrhosis	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; CHRONIC HEPATITIS; FIBROSIS; EXPRESSION; CANCER; TIME; REVERSIBILITY; BIOMARKERS; FAMILY	Background: Sensitive and specific detection of liver cirrhosis is an urgent need for optimal individualized management of disease activity. Substantial studies have identified circulation miRNAs as biomarkers for diverse diseases including chronic liver diseases. In this study, we investigated the plasma miRNA signature to serve as a potential diagnostic biomarker for silent liver cirrhosis. Methods: A genome-wide miRNA microarray was first performed in 80 plasma specimens. Six candidate miRNAs were selected and then trained in CHB-related cirrhosis and controls by qPCR. A classifier, miR-106b and miR-181b, was validated finally in two independent cohorts including CHB-related silent cirrhosis and controls, as well as non-CHB-related cirrhosis and controls as validation sets, respectively. Results: A profile of 2 miRNAs (miR-106b and miR-181b) was identified as liver cirrhosis biomarkers irrespective of etiology. The classifier constructed by the two miRNAs provided a high diagnostic accuracy for cirrhosis (AUC = 0.882 for CHB-related cirrhosis in the training set, 0.774 for CHB-related silent cirrhosis in one validation set, and 0.915 for non-CHB-related cirrhosis in another validation set). Conclusion: Our study demonstrated that the combined detection of miR-106b and miR-181b has a considerable clinical value to diagnose patients with liver cirrhosis, especially those at early stage.	[Chen, Yan-Jie; Zhu, Ji-Min; Wu, Hao; Yu, Qian; Liu, Tao-Tao; Guo, Xiao-Ling; Shen, Xi-Zhong] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Fan, Jia; Zhou, Jian; Hu, Jie; Huang, Xiao-Wu] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Yang, Lei] Fudan Univ, Sch Publ Hlth, Dept Stat, Shanghai 200433, Peoples R China; [Wu, Chun-Lei] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Fudan University; Fudan University; Fudan University; Scripps Research Institute	Huang, XW (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China.	huang.xiaowu@zs-hospital.sh.cn; shen.xizhong@zs-hospital.sh.cn	Fan, Jia/C-6689-2017; liu, taotao/GSI-7460-2022; Chen, Yan-Jie/GXM-9980-2022; Wu, Chunlei/ABF-4720-2020; zhu, jimin/HDN-1451-2022	Wu, Chunlei/0000-0002-2629-6124; Zhu, Ji-Min/0000-0002-2150-473X	Shanghai Science and Technology Commission [10410709400, 10411950100]; National Nature Science Foundation of China [81000968, 81101540, 81101637, 81172273]; National Clinical Key Special Subject of China	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Clinical Key Special Subject of China	This study was supported by the Shanghai Science and Technology Commission (10410709400, 10411950100), National Nature Science Foundation of China (81000968, 81101540, 81101637 and 81172273) and the National Clinical Key Special Subject of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizos I, 2010, NAT REV RHEUMATOL, V6, P391, DOI 10.1038/nrrheum.2010.81; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baker SG, 2009, JNCI-J NATL CANCER I, V101, P1116, DOI 10.1093/jnci/djp186; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Fleming KM, 2008, J HEPATOL, V49, P732, DOI 10.1016/j.jhep.2008.05.023; Gieling RG, 2008, CLIN LIVER DIS, V12, P915, DOI 10.1016/j.cld.2008.07.001; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ichikawa D, 2012, GASTROENTEROLOGY, V142, P1074, DOI 10.1053/j.gastro.2012.03.008; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Pinzani M, 2008, CLIN LIVER DIS, V12, P901, DOI 10.1016/j.cld.2008.07.006; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; SCHEUER PJ, 1995, J HEPATOL, V22, P112, DOI 10.1016/0168-8278(95)80269-X; Schmeltzer PA, 2011, GASTROENTEROL CLIN N, V40, P507, DOI 10.1016/j.gtc.2011.06.010; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Waidmann O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045652; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wang HL, 2010, BRAIN RES, V1357, P166, DOI 10.1016/j.brainres.2010.08.023; Wu H, 2012, CELL SIGNAL, V24, P2179, DOI 10.1016/j.cellsig.2012.07.001; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhao Z, 2012, CLIN CHEM, V58, P896, DOI 10.1373/clinchem.2011.179283; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	34	47	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66577	10.1371/journal.pone.0066577	http://dx.doi.org/10.1371/journal.pone.0066577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805240	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500068
J	Gine-Garriga, M; Martin-Borras, C; Puig-Ribera, A; Martin-Cantera, C; Sola, M; Cuesta-Vargas, A				Gine-Garriga, Maria; Martin-Borras, Carme; Puig-Ribera, Anna; Martin-Cantera, Carlos; Sola, Merce; Cuesta-Vargas, Antonio		PPAF Grp	The Effect of a Physical Activity Program on the Total Number of Primary Care Visits in Inactive Patients: A 15-Month Randomized Controlled Trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; HEALTH SURVEY; EXERCISE; WOMEN; INTERVENTIONS; RELIABILITY	Background: Effective promotion of exercise could result in substantial savings in healthcare cost expenses in terms of direct medical costs, such as the number of medical appointments. However, this is hampered by our limited knowledge of how to achieve sustained increases in physical activity. Objectives: To assess the effectiveness of a Primary Health Care (PHC) based physical activity program in reducing the total number of visits to the healthcare center among inactive patients, over a 15-month period. Research Design: Randomized controlled trial. Subjects: Three hundred and sixty-two (n = 362) inactive patients suffering from at least one chronic condition were included. One hundred and eighty-three patients (n = 183; mean (SD); 68.3 (8.8) years; 118 women) were randomly allocated to the physical activity program (IG). One hundred and seventy-nine patients (n = 179; 67.2 (9.1) years; 106 women) were allocated to the control group (CG). The IG went through a three-month standardized physical activity program led by physical activity specialists and linked to community resources. Measures: The total number of medical appointments to the PHC, during twelve months before and after the program, was registered. Self-reported health status (SF-12 version 2) was assessed at baseline (month 0), at the end of the intervention (month 3), and at 12 months follow-up after the end of the intervention (month 15). Results: The IG had a significantly reduced number of visits during the 12 months after the intervention: 14.8 (8.5). The CG remained about the same: 18.2 (11.1) (P = .002). Conclusions: Our findings indicate that a 3-month physical activity program linked to community resources is a short-duration, effective and sustainable intervention in inactive patients to decrease rates of PHC visits.	[Gine-Garriga, Maria; Martin-Borras, Carme] Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain; [Gine-Garriga, Maria] Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Therapy, Barcelona, Spain; [Puig-Ribera, Anna] Univ Vic, Dept Phys Act & Sport Sci, Vic, Spain; [Martin-Cantera, Carlos; Sola, Merce] Primary Healthcare Res Inst IDIAP Jordi Gol, Res Unit Barcelona, Barcelona, Spain; [Martin-Cantera, Carlos] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Cuesta-Vargas, Antonio] Univ Malaga, Dept Phys Therapy, E-29071 Malaga, Spain	Universitat Ramon Llull; Universitat Ramon Llull; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Autonomous University of Barcelona; Universidad de Malaga	Gine-Garriga, M (corresponding author), Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain.	mariagg@blanquerna.url.edu	Giné-Garriga, Maria/AAF-9828-2019; Giné-Garriga, Maria/F-4089-2016; Martin Cantera, Carlos/D-2693-2011; del Val Garcia, Jose Luis/G-6195-2016	Giné-Garriga, Maria/0000-0003-4449-3524; Giné-Garriga, Maria/0000-0003-4449-3524; Martin Cantera, Carlos/0000-0003-0656-8126; del Val Garcia, Jose Luis/0000-0002-0391-9368; Cuesta-Vargas, Antonio I/0000-0002-8880-4315	Catalan Society of General Practice (CAMFIC)	Catalan Society of General Practice (CAMFIC)	This work was supported by a research award from the Catalan Society of General Practice (CAMFIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Anderson RT, 2005, ANN BEHAV MED, V30, P146, DOI 10.1207/s15324796abm3002_7; Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Department of Health, 2010, 2009 ANN REP CHIEF M; Diari Oficial de la Generalitat de Catalunya, 2009, DIARI OFICIAL GEN CA; Enquesta de Salut de Catalunya, 2012, INF DELS PRINC RES; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Gine-Garriga M, 2008, ATEN PRIM, V40, P374, DOI 10.1157/13124135; Gine-Garriga M, 2010, J AGING PHYS ACTIV, V18, P401, DOI 10.1123/japa.18.4.401; Gine-Garriga M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-31; Guyton AC, 2007, TRATADO FISIOLOGIA M; Hillsdon M, 2005, Cochrane Database Syst Rev, pCD003180; Hubbard RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006174; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; McCusker J, 2006, J GERONTOL A-BIOL, V61, P53, DOI 10.1093/gerona/61.1.53; Ministerio de Sanidad y Consumo, 2001, ENC NAC SAL; Murphy SL, 2002, J AM GERIATR SOC, V50, P516, DOI 10.1046/j.1532-5415.2002.50119.x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Palomo Luis, 2006, Gac Sanit, V20 Suppl 1, P182, DOI 10.1157/13086042; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Ribera AP, 2006, HEALTH EDUC RES, V21, P538, DOI 10.1093/her/cyl008; Ribera AP, 2005, EUR J PUBLIC HEALTH, V15, P569, DOI 10.1093/eurpub/cki045; Robertson R., 2012, MENT HEALTH PHYS ACT, V5, P66, DOI DOI 10.1016/J.MHPA.2012.03.002; Rose Sally B, 2008, N Z Med J, V121, pU2897; Schuch FB, 2011, MENT HEALTH PHYS ACT, V4, p43e48; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shumaker S. A., 1990, QUALITY LIFE ASSESSM, P95; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x; Smith K, 2003, CAN J APPL PHYSIOL, V28, P462, DOI 10.1139/h03-034; Spirduso WW, 2001, MED SCI SPORT EXER, V33, pS598, DOI 10.1097/00005768-200106001-00028; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; van der Bij AK, 2002, AM J PREV MED, V22, P120, DOI 10.1016/S0749-3797(01)00413-5; Vedsted P, 2005, PUBLIC HEALTH, V119, P118, DOI 10.1016/j.puhe.2004.03.007; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WHO, 2010, WOR HEALT REP, P1; Williams NH, 2007, BRIT J GEN PRACT, V57, P979, DOI 10.3399/096016407782604866; Wilson T, 2005, BMJ-BRIT MED J, V330, P657, DOI 10.1136/bmj.330.7492.657; Wolfenstetter SB, 2012, ADV PREV MED, V2012, P601, DOI DOI 10.1155/2012/601631	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66392	10.1371/journal.pone.0066392	http://dx.doi.org/10.1371/journal.pone.0066392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805219	Green Published, gold			2022-12-27	WOS:000320846500047
J	Hwang, HS; Shin, JG; Lee, BH; Eom, TJ; Joo, CK				Hwang, Ho Sik; Shin, Jun Geun; Lee, Byeong Ha; Eom, Tae Joong; Joo, Choun-Ki			In Vivo 3D Meibography of the Human Eyelid Using Real Time Imaging Fourier-Domain OCT	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; OPTICAL COHERENCE TOMOGRAPHY; INTERNATIONAL WORKSHOP; SUBCOMMITTEE; DIAGNOSIS	Recently, we reported obtaining tomograms of meibomian glands from healthy volunteers using commercial anterior segment optical coherence tomography (AS-OCT), which is widely employed in clinics for examination of the anterior segment. However, we could not create 3D images of the meibomian glands, because the commercial OCT does not have a 3D reconstruction function. In this study we report the creation of 3D images of the meibomian glands by reconstructing the tomograms of these glands using high speed Fourier-Domain OCT (FD-OCT) developed in our laboratory. This research was jointly undertaken at the Department of Ophthalmology, Seoul St. Mary's Hospital (Seoul, Korea) and the Advanced Photonics Research Institute of Gwangju Institute of Science and Technology (Gwangju, Korea) with two healthy volunteers and seven patients with meibomian gland dysfunction. A real time imaging FD-OCT system based on a high-speed wavelength swept laser was developed that had a spectral bandwidth of 100 nm at the 1310 nm center wavelength. The axial resolution was 5 mu m and the lateral resolution was 13 mu m in air. Using this device, the meibomian glands of nine subjects were examined. A series of tomograms from the upper eyelid measuring 5 mm (from left to right, B-scan) x 2 mm (from upper part to lower part, C-scan) were collected. Three-D images of the meibomian glands were then reconstructed using 3D "data visualization, analysis, and modeling software''. Established infrared meibography was also performed for comparison. The 3D images of healthy subjects clearly showed the meibomian glands, which looked similar to bunches of grapes. These results were consistent with previous infrared meibography results. The meibomian glands were parallel to each other, and the saccular acini were clearly visible. Here we report the successful production of 3D images of human meibomian glands by reconstructing tomograms of these glands with high speed FD-OCT.	[Hwang, Ho Sik; Joo, Choun-Ki] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea; [Shin, Jun Geun; Lee, Byeong Ha; Eom, Tae Joong] Gwangju Inst Sci & Technol, Adv Photon Res Inst, Kwangju, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Gwangju Institute of Science & Technology (GIST)	Eom, TJ (corresponding author), Gwangju Inst Sci & Technol, Adv Photon Res Inst, Kwangju, South Korea.	eomtj@gist.ac.kr; ckjoo@catholic.ac.kr	Lee, Byeong Ha/T-3397-2019	Lee, Byeong Ha/0000-0003-4544-1232	Technology Innovation Program; Ministry of Trade, Industry & Energy, Republic of Korea [10040121]; National Research Foundation of Korea [2010-0024058]	Technology Innovation Program; Ministry of Trade, Industry & Energy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was partially supported by the Technology Innovation Program funded by the Ministry of Trade, Industry & Energy, Republic of Korea (10040121) and the Basic Science Research Program through the National Research Foundation of Korea (2010-0024058). Role of the funding source: development of high speed OCT for meibomian gland imaging.	Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2010, CORNEA, V29, P980, DOI 10.1097/ICO.0b013e3181cc7b1b; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Bizheva K, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3475957; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Ding HF, 2005, J OPT SOC AM A, V22, P1151, DOI 10.1364/JOSAA.22.001151; Huber R, 2006, OPT EXPRESS, V14, P3225, DOI 10.1364/OE.14.003225; Hwang HS, 2013, CORNEA, V32, P40, DOI 10.1097/ICO.0b013e318247b2fd; Jester BE, 2011, ANAT REC, V294, P185, DOI 10.1002/ar.21305; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; LeDoux MS, 2001, INVEST OPHTH VIS SCI, V42, P2434; Lemp Michael A., 1995, CLAO Journal, V21, P221; MATHERS WD, 1994, ARCH OPHTHALMOL-CHIC, V112, P448, DOI 10.1001/archopht.1994.01090160022008; Matsumoto Y, 2008, MOL VIS, V14, P1263; Nichols JJ, 2005, CORNEA, V24, P382, DOI 10.1097/01.ico.0000148291.38076.59; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE760, DOI 10.1097/OPX.0b013e3182512ac1; ROBIN JB, 1985, OPHTHALMOLOGY, V92, P1423; Schaumberg DA, 2002, ADV EXP MED BIOL, V506, P989; Seifert P, 1996, GRAEF ARCH CLIN EXP, V234, P648, DOI 10.1007/BF00185300; TIFFANY JM, 1986, CURR EYE RES, V5, P887, DOI 10.3109/02713688609029242; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Yokoi N, 2007, JPN J OPHTHALMOL, V51, P53, DOI 10.1007/s10384-006-0397-y	24	42	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67143	10.1371/journal.pone.0067143	http://dx.doi.org/10.1371/journal.pone.0067143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805297	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500125
J	Jun, JJ; Longtin, A; Maler, L				Jun, James Jaeyoon; Longtin, Andre; Maler, Leonard			Real-Time Localization of Moving Dipole Sources for Tracking Multiple Free-Swimming Weakly Electric Fish	PLOS ONE			English	Article							ORGAN DISCHARGE; SOUND LOCALIZATION; APTERONOTUS-LEPTORHYNCHUS; PASSIVE ELECTROLOCATION; IMAGING TECHNIQUE; SOCIAL-BEHAVIOR; ANIMALS; SIGNALS; SYSTEM; COMMUNICATION	In order to survive, animals must quickly and accurately locate prey, predators, and conspecifics using the signals they generate. The signal source location can be estimated using multiple detectors and the inverse relationship between the received signal intensity (RSI) and the distance, but difficulty of the source localization increases if there is an additional dependence on the orientation of a signal source. In such cases, the signal source could be approximated as an ideal dipole for simplification. Based on a theoretical model, the RSI can be directly predicted from a known dipole location; but estimating a dipole location from RSIs has no direct analytical solution. Here, we propose an efficient solution to the dipole localization problem by using a lookup table (LUT) to store RSIs predicted by our theoretically derived dipole model at many possible dipole positions and orientations. For a given set of RSIs measured at multiple detectors, our algorithm found a dipole location having the closest matching normalized RSIs from the LUT, and further refined the location at higher resolution. Studying the natural behavior of weakly electric fish (WEF) requires efficiently computing their location and the temporal pattern of their electric signals over extended periods. Our dipole localization method was successfully applied to track single or multiple freely swimming WEF in shallow water in real-time, as each fish could be closely approximated by an ideal current dipole in two dimensions. Our optimized search algorithm found the animal's positions, orientations, and tail-bending angles quickly and accurately under various conditions, without the need for calibrating individual-specific parameters. Our dipole localization method is directly applicable to studying the role of active sensing during spatial navigation, or social interactions between multiple WEF. Furthermore, our method could be extended to other application areas involving dipole source localization.	[Jun, James Jaeyoon; Longtin, Andre] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Jun, James Jaeyoon; Longtin, Andre; Maler, Leonard] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Jun, James Jaeyoon; Longtin, Andre; Maler, Leonard] Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Jun, JJ (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.	jamesjun@gmail.com			Natural Sciences and Engineering Research Council (Canada); Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge funding from Natural Sciences and Engineering Research Council (Canada) (JJJ and AL) as well as from Canadian Institutes of Health Research (AL, LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Babineau D, 2007, PLOS COMPUT BIOL, V3, P402, DOI 10.1371/journal.pcbi.0030038; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Caputi AA, 1999, J EXP BIOL, V202, P1229; Castello ME, 2009, J EXP BIOL, V212, P1351, DOI 10.1242/jeb.022566; Chen L, 2005, J COMP PHYSIOL A, V191, P331, DOI 10.1007/s00359-004-0587-3; Coombs S, 1996, J COMP PHYSIOL A, V178, P359; DAVIS EA, 1988, ANIM BEHAV, V36, P1658, DOI 10.1016/S0003-3472(88)80106-4; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; FUZESSERY ZM, 1993, J COMP PHYSIOL A, V171, P767, DOI 10.1007/BF00213073; Goulet J, 2008, J COMP PHYSIOL A, V194, P1, DOI 10.1007/s00359-007-0275-1; HAGEDORN M, 1985, ANIM BEHAV, V33, P254, DOI 10.1016/S0003-3472(85)80139-1; HOPKINS CD, 1974, BEHAVIOUR, V50, P270, DOI 10.1163/156853974X00499; Hopkins CD, 1997, BRAIN BEHAV EVOLUT, V50, P32, DOI 10.1159/000113353; Hupe GJ, 2008, J EXP BIOL, V211, P1657, DOI 10.1242/jeb.013516; Sanguinetti-Scheck JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027470; KNUDSEN EI, 1975, J COMP PHYSIOL, V99, P103, DOI 10.1007/BF00618178; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KRAMER B, 1974, J COMP PHYSIOL, V93, P203, DOI 10.1007/BF00607000; Lewejohann L, 2009, BEHAV RES METHODS, V41, P850, DOI 10.3758/BRM.41.3.850; LISSMANN HW, 1958, J EXP BIOL, V35, P156; LISSMANN HW, 1958, J EXP BIOL, V35, P451; MASCANZONI D, 1986, ECOL ENTOMOL, V11, P387, DOI 10.1111/j.1365-2311.1986.tb00317.x; MOHRES FP, 1957, NATURWISSENSCHAFTEN, V44, P431; Nelson ME, 1999, J EXP BIOL, V202, P1195; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; O'Neal M. E., 2004, American Entomologist, V50, P212; Rivera-Vicente AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016008; RODRIGUEZCATTAN.A, 2008, PLOS ONE, V0003; Shieh KT, 1996, J EXP BIOL, V199, P2383; SPRUIJT BM, 1992, PHYSIOL BEHAV, V51, P747, DOI 10.1016/0031-9384(92)90111-E; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Turner CR, 2007, J EXP BIOL, V210, P4104, DOI 10.1242/jeb.007930; Vasserman G, 2012, FRONT BEH NEUR C 10, DOI [10.3389/conf.fnbeh.2012.27. 00026, DOI 10.3389/C0NF.FNBEH.2012.27.00026]; Vatine JJ, 1998, J NEUROSCI METH, V85, P1, DOI 10.1016/S0165-0270(98)00076-4; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; WINBERG S, 1993, J EXP BIOL, V179, P213; Windsor SP, 2008, J EXP BIOL, V211, P2950, DOI 10.1242/jeb.020453; Yu N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002564; Zakon H, 2002, J PHYSIOL-PARIS, V96, P451, DOI 10.1016/S0928-4257(03)00012-3; Zupanc GKH, 2002, J PHYSIOLOGY-PARIS, V96, P459, DOI 10.1016/S0928-4257(03)00002-0	41	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66596	10.1371/journal.pone.0066596	http://dx.doi.org/10.1371/journal.pone.0066596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805244	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500072
J	Sharman, MJ; Nik, SHM; Chen, MQM; Ong, D; Wijaya, L; Laws, SM; Taddei, K; Newman, M; Lardelli, M; Martins, RN; Verdile, G				Sharman, Mathew J.; Nik, Seyyed H. Moussavi; Chen, Mengqi M.; Ong, Daniel; Wijaya, Linda; Laws, Simon M.; Taddei, Kevin; Newman, Morgan; Lardelli, Michael; Martins, Ralph N.; Verdile, Giuseppe			The Guinea Pig as a Model for Sporadic Alzheimer's Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; PRESENILIN-2 SPLICE VARIANT; TRANSGENIC MOUSE MODEL; GAMMA-SECRETASE; MESSENGER-RNA; CATALYTIC PORE; TG2576 MICE; TAU-PROTEIN; IN-VITRO; BETA	We investigated the guinea pig, Cavia porcellus, as a model for Alzheimer's disease (AD), both in terms of the conservation of genes involved in AD and the regulatory responses of these to a known AD risk factor - high cholesterol intake. Unlike rats and mice, guinea pigs possess an A beta peptide sequence identical to human A beta. Consistent with the commonality between cardiovascular and AD risk factors in humans, we saw that a high cholesterol diet leads to up-regulation of BACE1 (beta-secretase) transcription and down-regulation of ADAM10 (alpha-secretase) transcription which should increase release of A beta from APP. Significantly, guinea pigs possess isoforms of AD-related genes found in humans but not present in mice or rats. For example, we discovered that the truncated PS2V isoform of human PSEN2, that is found at raised levels in AD brains and that increases gamma-secretase activity and A beta synthesis, is not uniquely human or aberrant as previously believed. We show that PS2V formation is up-regulated by hypoxia and a high-cholesterol diet while, consistent with observations in humans, A beta concentrations are raised in some brain regions but not others. Also like humans, but unlike mice, the guinea pig gene encoding tau, MAPT, encodes isoforms with both three and four microtubule binding domains, and cholesterol alters the ratio of these isoforms. We conclude that AD-related genes are highly conserved and more similar to human than the rat or mouse. Guinea pigs represent a superior rodent model for analysis of the impact of dietary factors such as cholesterol on the regulation of AD-related genes.	[Sharman, Mathew J.; Chen, Mengqi M.; Ong, Daniel; Wijaya, Linda; Laws, Simon M.; Taddei, Kevin; Martins, Ralph N.; Verdile, Giuseppe] Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Perth, WA, Australia; [Sharman, Mathew J.] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia; [Nik, Seyyed H. Moussavi; Newman, Morgan; Lardelli, Michael] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Genet, Adelaide, SA, Australia; [Taddei, Kevin; Martins, Ralph N.; Verdile, Giuseppe] Hollywood Private Hosp, Sir James McCusker Alzheimers Dis Res Unit, Nedlands, WA, Australia; [Taddei, Kevin; Martins, Ralph N.; Verdile, Giuseppe] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia	Edith Cowan University; University of Tasmania; University of Adelaide; University of Western Australia; University of Western Australia	Verdile, G (corresponding author), Edith Cowan Univ, Sch Med Sci, Ctr Excellence Alzheimers Dis Res & Care, Perth, WA, Australia.	g.verdile@ecu.edu.au	Sharman, Matt/U-4181-2019; Sharman, Matthew J/I-3788-2014; Wijaya, Linda/CAF-1162-2022; , Morgan/Y-5204-2019; Laws, Simon/C-2858-2014	Sharman, Matt/0000-0003-1005-4793; Sharman, Matthew J/0000-0003-1005-4793; Wijaya, Linda/0000-0003-2603-7074; Laws, Simon/0000-0002-4355-7082; Verdile, Giuseppe/0000-0003-2475-0124; Moussavi Nik, Seyyed Hani/0000-0002-5727-6863; Martins, Ralph/0000-0002-4828-9363; Newman, Morgan/0000-0002-4930-4529; Lardelli, Michael/0000-0002-4289-444X	National Health and Medical Research Council (NHMRC) of Australia [453622]; Edith Cowan University Early Career Research Grant; Edith Cowan University's Strategic Research Grant; McCusker Alzheimer's Disease Research Foundation; NHMRC; West Perth Rotary Club	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Edith Cowan University Early Career Research Grant; Edith Cowan University's Strategic Research Grant; McCusker Alzheimer's Disease Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); West Perth Rotary Club	This work was supported by a grant obtained from the National Health and Medical Research Council (NHMRC) of Australia, [ID: 453622 to ML, RM and GV], a Edith Cowan University Early Career Research Grant [to MS] and Edith Cowan University's Strategic Research Grant [to GV]. RM and GV are supported by grants from the McCusker Alzheimer's Disease Research Foundation and NHMRC. MC is supported by a scholarship from the West Perth Rotary Club and the McCusker Alzheimer's Disease Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiles AO, 2012, P NATL ACAD SCI USA, V109, P13835, DOI 10.1073/pnas.1201209109; Beck M, 1997, BBA-GENE STRUCT EXPR, V1351, P17, DOI 10.1016/S0167-4781(96)00232-1; Beck M, 2003, NEUROCHEM RES, V28, P637, DOI 10.1023/A:1022850113083; Bigl M, 2000, NEUROSCI LETT, V292, P107, DOI 10.1016/S0304-3940(00)01452-X; Connell JW, 2005, MOL BRAIN RES, V137, P104, DOI 10.1016/j.molbrainres.2005.02.014; Conrad C, 2007, J NEUROCHEM, V103, P1228, DOI 10.1111/j.1471-4159.2007.04857.x; Cos E, 2001, LIPIDS, V36, P1209, DOI 10.1007/s11745-001-0834-1; Crestini A, 2006, J MOL NEUROSCI, V30, P311, DOI 10.1385/JMN:30:3:311; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Epis R, 2010, EUR J PHARMACOL, V626, P57, DOI 10.1016/j.ejphar.2009.10.020; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fernandez ML, 2001, J NUTR, V131, P10, DOI 10.1093/jn/131.1.10; George AJ, 2004, NEUROBIOL DIS, V16, P124, DOI 10.1016/j.nbd.2004.01.009; Ginsberg SD, 2006, J NEUROCHEM, V96, P1401, DOI 10.1111/j.1471-4159.2005.03641.x; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Higashide S, 2004, J NEUROCHEM, V91, P1191, DOI 10.1111/j.1471-4159.2004.02798.x; Howlett DR, 2009, HISTOL HISTOPATHOL, V24, P83, DOI 10.14670/HH-24.83; Irizarry MC, 2001, AM J PATHOL, V158, P173, DOI 10.1016/S0002-9440(10)63955-7; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jung HJ, 2011, EXP NEUROL, V228, P232, DOI 10.1016/j.expneurol.2011.01.012; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lanz TA, 2005, J PHARMACOL EXP THER, V312, P399, DOI 10.1124/jpet.104.073965; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Lehman EJH, 2003, HUM MOL GENET, V12, P2949, DOI 10.1093/hmg/ddg322; LIN ECK, 1992, J NUTR, V122, P2019, DOI 10.1093/jn/122.10.2019; Liu H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.027; Manabe T, 2003, CELL DEATH DIFFER, V10, P698, DOI 10.1038/sj.cdd.4401221; Matsuzaki S, 2004, J NEUROCHEM, V88, P1345, DOI 10.1111/j.1471-4159.2004.02290.x; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Murphy MP, 2010, J ALZHEIMERS DIS, V22, P135, DOI 10.3233/JAD-2010-100639; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Nik SHM, 2011, EXP CELL RES, V317, P1503, DOI 10.1016/j.yexcr.2011.04.004; Petanceska SS, 2000, EXP GERONTOL, V35, P1317, DOI 10.1016/S0531-5565(00)00157-1; Prasanthi RPJ, 2008, MECH AGEING DEV, V129, P649, DOI 10.1016/j.mad.2008.09.002; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Ringman JM, 2011, NEUROSCI LETT, V487, P287, DOI 10.1016/j.neulet.2010.10.039; Rogaev EI, 1997, GENOMICS, V40, P415, DOI 10.1006/geno.1996.4523; Rossner S, 2001, J NEUROSCI RES, V64, P437; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Sato N, 2001, J BIOL CHEM, V276, P2108, DOI 10.1074/jbc.M006886200; Scheper W, 2004, NEUROGENETICS, V5, P223, DOI 10.1007/s10048-004-0195-y; Schmidt Stephen D., 2004, V299, P279; Sharman MJ, 2008, J NUTR BIOCHEM, V19, P732, DOI 10.1016/j.jnutbio.2007.09.008; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Smith MJ, 2004, MOL BRAIN RES, V127, P128, DOI 10.1016/j.molbrainres.2004.05.019; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Verdile G, 2004, NEUROLOGY, V63, P1385; Wahjoepramono EJ, 2011, NEUROENDOCRINOLOGY; Wahjoepramono EJ, 2008, J ALZHEIMERS DIS, V15, P129; Wanngren J, 2010, J BIOL CHEM, V285, P8527, DOI 10.1074/jbc.M109.055590; Wu CW, 2003, J NEURAL TRANSM, V110, P641, DOI 10.1007/s00702-002-0809-1; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Zern TL, 2003, J NUTR, V133, P2268, DOI 10.1093/jn/133.7.2268; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zhang WJ, 1998, J NEUROSCI, V18, P914	70	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66235	10.1371/journal.pone.0066235	http://dx.doi.org/10.1371/journal.pone.0066235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805206	Green Published, gold			2022-12-27	WOS:000320846500034
J	Boys, CA; Robinson, W; Baumgartner, LJ; Rampano, B; Lowry, M				Boys, Craig A.; Robinson, Wayne; Baumgartner, Lee J.; Rampano, Ben; Lowry, Michael			Influence of Approach Velocity and Mesh Size on the Entrainment and Contact of a Lowland River Fish Assemblage at a Screened Irrigation Pump	PLOS ONE			English	Article							PHYSIOLOGICAL STRESS RESPONSES; SWIMMING PERFORMANCE; CLOSE ENCOUNTERS; 2-VECTOR FLOWS; CHINOOK SALMON; DELTA SMELT; BEHAVIOR; DIVERSIONS; MANAGEMENT; LARVAE	Fish screens can help prevent the entrainment or injury of fish at irrigation diversions, but only when designed appropriately. Design criteria cannot simply be transferred between sites or pump systems and need to be developed using an evidence-based approach with the needs of local species in mind. Laboratory testing is typically used to quantify fish responses at intake screens, but often limits the number of species that can studied and creates artificial conditions not directly applicable to screens in the wild. In this study a field-based approach was used to assess the appropriateness of different screen design attributes for the protection of a lowland river fish assemblage at an experimental irrigation pump. Direct netting of entrained fish was used along with sonar technology to quantify the probability of screen contact for a Murray-Darling Basin (Australia) fish species. Two approach velocities (0.1 and 0.5 m. sec(-1)) and different sizes of woven mesh (5, 10 and 20 mm) were evaluated. Smaller fish (< 150 mm) in the assemblage were significantly more susceptible to entrainment and screen contact, especially at higher approach velocities. Mesh size appeared to have little impact on screen contact and entrainment, suggesting that approach velocity rather than mesh size is likely to be the primary consideration when developing screens. Until the effects of screen contacts on injury and survival of these species are better understood, it is recommended that approach velocities not exceed 0.1 m. sec(-1) when the desire is to protect the largest range of species and size classes for lowland river fish assemblages in the Murray-Darling Basin. The field method tested proved to be a useful approach that could compliment laboratory studies to refine fish screen design and facilitate field validation.	[Boys, Craig A.; Rampano, Ben; Lowry, Michael] Fisheries NSW, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia; [Robinson, Wayne; Baumgartner, Lee J.] Fisheries NSW, Narrandera Fisheries Ctr, Narrandera, NSW, Australia; [Robinson, Wayne] Charles Sturt Univ, Thurgoona, NSW, Australia	NSW Department of Primary Industries; Charles Sturt University	Boys, CA (corresponding author), Fisheries NSW, Port Stephens Fisheries Inst, Nelson Bay, NSW, Australia.	craig.boys@dpi.nsw.gov.au	Baumgartner, Lee/P-2035-2015; Boys, Craig/AAW-8829-2021	Baumgartner, Lee/0000-0002-1237-5163; ROBINSON, WAYNE/0000-0002-8793-7466	Murray-Darling Basin Authority (through the Native Fish Strategy Initiative); Cooperative Research Centre for Cotton Communities and Catchments; Namoi Catchment Management Authority; New South Wales Department of Primary Industries	Murray-Darling Basin Authority (through the Native Fish Strategy Initiative); Cooperative Research Centre for Cotton Communities and Catchments(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Namoi Catchment Management Authority; New South Wales Department of Primary Industries	The Murray-Darling Basin Authority (through the Native Fish Strategy Initiative), Cooperative Research Centre for Cotton Communities and Catchments, Namoi Catchment Management Authority and New South Wales Department of Primary Industries jointly funded this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran E, 2001, FLOODS FLOODPLAINS F, P920; BARROS J. J. C., 2008, SEA HUME DAM RESTORI, P1; Baumgartner L, 2007, FISHERIES FINAL REPO; Baumgartner LJ, 2009, FISHERIES MANAG ECOL, V16, P429, DOI 10.1111/j.1365-2400.2009.00693.x; Baumgartner L.J., 2006, FISHERIES FINAL REPO, V84N5W; Baumgartner Lee J., 2012, Ecological Management & Restoration, V13, P135, DOI 10.1111/j.1442-8903.2012.00655.x; Belcher EO, 1999, OCEANS '99 MTS/IEEE : RIDING THE CREST INTO THE 21ST CENTURY, VOLS 1-3, P1495, DOI 10.1109/OCEANS.1999.800215; Boswell KM, 2008, N AM J FISH MANAGE, V28, P799, DOI 10.1577/M07-116.1; Boys CA, 2013, FISHERIES MANAG ECOL, V20, P362, DOI 10.1111/fme.12026; CDFG, 2000, FISH SCREEN CRIT; Cech JJM, 2006, CEC5002006117; Danley ML, 2002, N AM J FISH MANAGE, V22, P1241, DOI 10.1577/1548-8675(2002)022<1241:SPAPSR>2.0.CO;2; Downes B.J., 2002, MONITORING ECOLOGICA; Galbraith H, 2005, 1 CA COMPR ASS SECR; Gilligan DM, 2003, NSW FISHERIES FINAL, V50; Godinho AL, 2009, RIVER RES APPL, V25, P702, DOI 10.1002/rra.1180; Higginbottom I., 2008, HYDROACOUSTIC DATA P, P40; Humphries P, 2000, REGUL RIVER, V16, P421, DOI 10.1002/1099-1646(200009/10)16:5<421::AID-RRR594>3.0.CO;2-4; Humphries P, 2002, FRESHWATER BIOL, V47, P1307, DOI 10.1046/j.1365-2427.2002.00871.x; Jamieson D, 2005, FISH SCREENING GOOD; JONES DR, 1974, J FISH RES BOARD CAN, V31, P1641, DOI 10.1139/f74-206; King Alison J., 2007, Ecological Management & Restoration, V8, P32, DOI 10.1111/j.1442-8903.2007.00329.x; Kingsford RT, 2000, AUSTRAL ECOL, V25, P109, DOI 10.1111/j.1442-9993.2000.tb00012.x; Koehn John D., 2012, Endangered Species Research, V16, P165, DOI 10.3354/esr00398; Larinier M, 2008, HYDROBIOLOGIA, V609, P97, DOI 10.1007/s10750-008-9398-9; Lintermans M., 2007, FISHES MURRAY DARLIN; Lintermans M., 2004, DOWNSTR MOV FISH MUR; McMichael GA, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:CFSPTP]2.0.CO;2; Moursund RA, 2003, ICES J MAR SCI, V60, P678, DOI 10.1016/S1054-3139(03)00036-5; Moyle PB, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:UA]2.0.CO;2; MOYLE PB, 1990, CONSERV BIOL, V4, P275, DOI 10.1111/j.1523-1739.1990.tb00289.x; Musick JA, 2000, FISHERIES, V25, P6, DOI 10.1577/1548-8446(2000)025<0006:POMFSA>2.0.CO;2; Neter J., 1996, APPL LINEAR STAT MOD; NMFS, 1997, JUV FISH SCREEN CRIT; NSW DPI, 2007, END EC COMM LOWL DAR; Peake S, 2004, N AM J FISH MANAGE, V24, P390, DOI 10.1577/M02-010.1; Prince E. E., 1923, T AM FISH SOC, V52, P157; Puckridge JT, 1998, MAR FRESHWATER RES, V49, P55, DOI 10.1071/MF94161; Rose BP, 2008, N AM J FISH MANAGE, V28, P1702, DOI 10.1577/M07-073.1; Rosegrant M. W., 2002, 14 IFPRI; Sound Metrics, 2009, DUAL FREQ ID SON DID; Swanson C, 2005, T AM FISH SOC, V134, P1111, DOI 10.1577/T04-121.1; Swanson C, 1998, J EXP BIOL, V201, P333; Swanson C, 2004, T AM FISH SOC, V133, P265, DOI 10.1577/03-068; Thoms M., 2004, The Darling, P350; Tiffan KF, 2004, N AM J FISH MANAGE, V24, P1421, DOI 10.1577/1548-8675(2004)24<1421:IFCSRI>2.0.CO;2; Turnpenny WH, 1998, UK GUIDE INTAKE FISH; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; WALKER KF, 1985, HYDROBIOLOGIA, V125, P111, DOI 10.1007/BF00045929; Wood S., 2000, PILOT ANAL GLOBAL EC; Young PS, 2010, T AM FISH SOC, V139, P713, DOI 10.1577/T09-029.1; Zar JH., 2010, BIOSTAT ANAL, V5th; Zydlewski GB, 2002, N AM J FISH MANAGE, V22, P1276, DOI 10.1577/1548-8675(2002)022<1276:ROBTFT>2.0.CO;2	53	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67026	10.1371/journal.pone.0067026	http://dx.doi.org/10.1371/journal.pone.0067026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818975	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800114
J	Ding, R; Chen, XM; Wu, D; Wei, RB; Hong, Q; Shi, SZ; Yin, Z; Ma, LL; Xie, YS				Ding, Rui; Chen, Xiangmei; Wu, Di; Wei, Ribao; Hong, Quan; Shi, Suozhu; Yin, Zhong; Ma, Linlin; Xie, Yuansheng			Effects of Aging on Kidney Graft Function, Oxidative Stress and Gene Expression after Kidney Transplantation	PLOS ONE			English	Article							RECIPIENT AGE DIFFERENCE; SENESCENCE; APOPTOSIS; BIOMARKER; PROTEINS; SIRTUINS; SURVIVAL; OUTCOMES; IMPACT; VIRUS	Conflicting results have been reported regarding the effects of donor age, recipient age and donor-recipient age difference on short-and long-term outcomes after kidney transplantation. The aim of this study was to evaluate the effects of recipient age on graft function, oxidative stress, and gene expression after renal transplantation. Fifty male Fischer 344 rats [25 young (Y, 4 months), 25 senior (S, 16 months)] were randomized to 6 groups: 2 sham groups (Y and S, n = 5 in each group) and 4 renal transplant groups[young-to-young (Y-Y), young-to-senior (Y-S), senior-to-young (S-Y), senior-to-senior (S-S), (n = 10 in each group)]. The left kidneys were transplanted from donor to recipient. After 12 weeks, systematic blood pressure, graft weight, graft function, histology and oxidative stress were measured. Microarray analysis and quantitative real-time PCR confirmation were performed to study gene expression in the grafts. There were no differences in renal graft function between young and senior kidney cross-transplantation. Transplanted kidneys showed no significant differences in glomerulosclerosis index compared to non-transplanted kidneys but had significantly different tubulointerstitium scores compared to age-matched controls. Senior rats had lower SOD activity and higher MDA content than young rats. SOD activity was significantly lower and MDA content significantly higher in the Y-S group than in the Y-Y group. There were 548 transcript differences between senior and young kidneys with 36 upregulated and 512 downregulated transcripts. There were 492 transcript differences between Y-S and Y-Y groups with 127 upregulated and 365 downregulated transcripts. There were 1244 transcript differences between the S-Y and S-S groups with 680 upregulated and 574 downregulated transcripts. Oxidative stress and gene expression profile was significantly different in the Y-S compared to the S-Y group. The identified differences were mainly in the MAPK and insulin signal pathways, making these potential targets for therapeutic intervention.	[Ding, Rui; Chen, Xiangmei; Wu, Di; Wei, Ribao; Hong, Quan; Shi, Suozhu; Yin, Zhong; Ma, Linlin; Xie, Yuansheng] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Nephrol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chen, XM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Dept Nephrol, Beijing, Peoples R China.	xmchen301@126.com			National Natural Sciences Foundation of China [30901573, 81102673]; National Basic Research Program of China [2011CB944000]; Major State Basic Research Development Program of China [2013CB530800]; Nursery Foundation of PLA General Hospital [0712]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Major State Basic Research Development Program of China(National Basic Research Program of China); Nursery Foundation of PLA General Hospital	This work was supported by grants from the National Natural Sciences Foundation of China (30901573), National Basic Research Program of China (No. 2011CB944000), the Major State Basic Research Development Program of China (No. 2013CB530800), National Natural Sciences Foundation of China (No. 81102673), and the Nursery Foundation of PLA General Hospital (No. 0712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak MI, 1998, J MOL CELL CARDIOL, V30, P661, DOI 10.1006/jmcc.1997.0633; Barouki R, 2006, M S-MED SCI, V22, P266, DOI 10.1051/medsci/2006223266; Basar H, 1999, TRANSPLANTATION, V67, P1191, DOI 10.1097/00007890-199904270-00019; Bowie AG, 2008, BIOCHEM SOC T, V36, P449, DOI 10.1042/BST0360449; Brouard S, 2011, TRANSPLANTATION, V91, P691, DOI 10.1097/TP.0b013e31820c4559; D'Souza T, 2009, J GERONTOL A-BIOL, V64, P1146, DOI 10.1093/gerona/glp118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONNELLY P, 1991, TRANSPLANT INT, V4, P88, DOI 10.1007/BF00336403; Esseghir S, 2006, J PATHOL, V210, P420, DOI 10.1002/path.2071; Fan PY, 2010, AM J TRANSPLANT, V10, P1090, DOI 10.1111/j.1600-6143.2009.03009.x; Ferrari P, 2011, NEPHROL DIAL TRANSPL, V26, P702, DOI 10.1093/ndt/gfq383; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Giera M, 2012, CHROMATOGRAPHIA, V75, P433, DOI 10.1007/s10337-012-2237-1; Gong ZW, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/320482; Guo Y, 2005, J VIROL, V79, P14392, DOI 10.1128/JVI.79.22.14392-14403.2005; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jassal S V, 1997, Geriatr Nephrol Urol, V7, P157, DOI 10.1023/A:1008246129084; Kainz A, 2007, TRANSPLANTATION, V83, P1048, DOI 10.1097/01.tp.0000259960.56786.ec; Keith DS, 2004, J AM SOC NEPHROL, V15, P1086, DOI 10.1097/01.ASN.0000119572.02053.F2; Kolodziej S, 2004, AM J TRANSPLANT, V4, P428; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; La Manna G, 2011, AM J NEPHROL, V34, P496, DOI 10.1159/000329320; Lane N, 2003, J THEOR BIOL, V225, P531, DOI 10.1016/S0022-5193(03)00304-7; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lim WH, 2013, TRANSPLANTATION, V95, P106, DOI 10.1097/TP.0b013e318277b2be; Lim WH, 2010, NEPHROL DIAL TRANSPL, V25, P3082, DOI 10.1093/ndt/gfq127; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994; MCLIGEYO SO, 1993, E AFR MED J, V70, P3; Nikolich-Zugich J, 2005, J EXP MED, V201, P837, DOI 10.1084/jem.20050341; Pascher Andreas, 2004, Ann Transplant, V9, P72; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao X, 2005, J GERONTOL A-BIOL, V60, P830, DOI 10.1093/gerona/60.7.830; Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001; REAVEN GM, 1988, DIABETES METAB REV, V4, P639, DOI 10.1002/dmr.5610040703; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583; Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009; Tullius SG, 1998, KIDNEY INT, V53, P465, DOI 10.1046/j.1523-1755.1998.00757.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Waiser J, 2000, NEPHROL DIAL TRANSPL, V15, P696, DOI 10.1093/ndt/15.5.696; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang XJ, 2006, J AM SOC NEPHROL, V17, P1532, DOI 10.1681/ASN.2005070776; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	51	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65613	10.1371/journal.pone.0065613	http://dx.doi.org/10.1371/journal.pone.0065613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23824036	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400013
J	Ganem, MB; De Marzi, MC; Fernandez-Lynch, MJ; Jancic, C; Vermeulen, M; Geffner, J; Mariuzza, RA; Fernandez, MM; Malchiodi, EL				Ganem, Maria B.; De Marzi, Mauricio C.; Fernandez-Lynch, Maria J.; Jancic, Carolina; Vermeulen, Monica; Geffner, Jorge; Mariuzza, Roy A.; Fernandez, Marisa M.; Malchiodi, Emilio L.			Uptake and Intracellular Trafficking of Superantigens in Dendritic Cells	PLOS ONE			English	Article							RECEPTOR-BETA-CHAIN; MHC CLASS-II; INNATE IMMUNE-SYSTEM; TOXIC-SHOCK-SYNDROME; CRYSTAL-STRUCTURE; BACTERIAL SUPERANTIGEN; STAPHYLOCOCCAL ENTEROTOXINS; STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURE; LATE ENDOSOMES	Bacterial superantigens (SAgs) are exotoxins produced mainly by Staphylococcus aureus and Streptococcus pyogenes that can cause toxic shock syndrome (TSS). According to current paradigm, SAgs interact directly and simultaneously with T cell receptor (TCR) on the T cell and MHC class II (MHC-II) on the antigen-presenting cell (APC), thereby circumventing intracellular processing to trigger T cell activation. Dendritic cells (DCs) are professional APCs that coat nearly all body surfaces and are the most probable candidate to interact with SAgs. We demonstrate that SAgs are taken up by mouse DCs without triggering DC maturation. SAgs were found in intracellular acidic compartment of DCs as biologically active molecules. Moreover, SAgs co-localized with EEA1, RAB-7 and LAMP-2, at different times, and were then recycled to the cell membrane. DCs loaded with SAgs are capable of triggering in vitro lymphocyte proliferation and, injected into mice, stimulate T cells bearing the proper TCR in draining lymph nodes. Transportation and trafficking of SAgs in DCs might increase the local concentration of these exotoxins where they will produce the highest effect by promoting their encounter with both MHC-II and TCR in lymph nodes, and may explain how just a few SAg molecules can induce the severe pathology associated with TSS.	[Ganem, Maria B.; De Marzi, Mauricio C.; Fernandez-Lynch, Maria J.; Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Ganem, Maria B.; De Marzi, Mauricio C.; Fernandez-Lynch, Maria J.; Fernandez, Marisa M.; Malchiodi, Emilio L.] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Estudios Inmunidad Humoral IDEHU, RA-1113 Buenos Aires, DF, Argentina; [De Marzi, Mauricio C.] Univ Nacl Lujan, Dept Ciencias Basicas, Buenos Aires, DF, Argentina; [Jancic, Carolina; Vermeulen, Monica; Geffner, Jorge] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Dept Inmunol, Buenos Aires, DF, Argentina; [Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional de Lujan; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas	Malchiodi, EL (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina.	emalchio@ffyb.uba.ar		Fernandez, Marisa/0000-0002-7480-5907; Malchiodi, Emilio/0000-0001-7501-3330	University of Buenos Aires; National Research Council of Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnica [PICT-06 450, PICT-10 1139, PICT-08 608]; Fogarty International Center [TW007972]; International Centre for Genetic Engineering and Biotechnology [CRP/ARG09-02]; FOGARTY INTERNATIONAL CENTER [R03TW007972] Funding Source: NIH RePORTER	University of Buenos Aires(University of Buenos Aires); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Centre for Genetic Engineering and Biotechnology; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the University of Buenos Aires, the National Research Council of Argentina (CONICET), and Agencia Nacional de Promocion Cientifica y Tecnica, grants PICT-06 450 (to M. M. F.), and PICT-10 1139 and PICT-08 608 (to E. L. M.). E. L. M. is also supported by the Fogarty International Center (TW007972) and International Centre for Genetic Engineering and Biotechnology (CRP/ARG09-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PS, 2002, BIOCHEMISTRY-US, V41, P5177, DOI 10.1021/bi0200209; Arad G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001149; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CHAKRABORTY P, 1994, METHOD CELL BIOL, V45, P261; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Coutant KD, 1999, TOXICOL SCI, V52, P189, DOI 10.1093/toxsci/52.2.189; De Marzi MC, 2004, EUR J BIOCHEM, V271, P4075, DOI 10.1111/j.1432-1033.2004.04345.x; Dickgreber N, 2009, J IMMUNOL, V182, P1260, DOI 10.4049/jimmunol.182.3.1260; Earhart CA, 1997, SUPERANTIGENS MOL BI, P127; Fernandez MM, 2007, PROTEINS, V68, P389, DOI 10.1002/prot.21388; Fernandez MM, 2006, J BIOL CHEM, V281, P25356, DOI 10.1074/jbc.M603969200; Fernandez MM, 2011, J BIOL CHEM, V286, P1189, DOI 10.1074/jbc.M110.142471; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Fraser JD, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001145, DOI 10.1371/J0URNAL.PBI0.1001145]; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Kato M, 2011, CANCER IMMUNOL IMMUN, V60, P1029, DOI 10.1007/s00262-011-1015-5; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khandekar SS, 1997, MOL IMMUNOL, V34, P493, DOI 10.1016/S0161-5890(97)00044-8; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Le Roux D, 2012, BLOOD, V119, P95, DOI 10.1182/blood-2011-02-336123; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz MB, 1996, IMMUNOBIOLOGY, V195, P431, DOI 10.1016/S0171-2985(96)80014-3; Lutz MB, 1997, J IMMUNOL, V159, P3707; MALCHIODI EL, 1995, J EXP MED, V182, P1833, DOI 10.1084/jem.182.6.1833; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Martinez D, 2007, J IMMUNOL, V179, P1950, DOI 10.4049/jimmunol.179.3.1950; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Moza B, 2007, EMBO J, V26, P1187, DOI 10.1038/sj.emboj.7601531; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; Muraille E, 2002, J IMMUNOL, V168, P4352, DOI 10.4049/jimmunol.168.9.4352; Muralimohan G, 2006, CELL IMMUNOL, V242, P9, DOI 10.1016/j.cellimm.2006.08.007; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Nobile C, 2008, BLOOD, V111, P3579, DOI 10.1182/blood-2007-08-107755; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Pumphrey N, 2007, J IMMUNOL, V179, P2700, DOI 10.4049/jimmunol.179.5.2700; Qin ZH, 1997, J IMMUNOL, V159, P770; Rahman AKMNU, 2006, J IMMUNOL, V177, P8595, DOI 10.4049/jimmunol.177.12.8595; Redpath S, 1999, J IMMUNOL, V163, P6; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Rossi RJ, 2004, INT IMMUNOL, V16, P1751, DOI 10.1093/intimm/dxh176; SAHLIN S, 1983, J IMMUNOL METHODS, V60, P115, DOI 10.1016/0022-1759(83)90340-X; Saline M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1117; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; SOLDATI T, 1995, J BIOL CHEM, V270, P25541, DOI 10.1074/jbc.270.43.25541; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; VANSTRIJP JAG, 1989, J CLIN INVEST, V84, P107, DOI 10.1172/JCI114129; Volz T, 2010, FASEB J, V24, P4089, DOI 10.1096/fj.09-151001; Wang LM, 2007, NAT STRUCT MOL BIOL, V14, P169, DOI 10.1038/nsmb1193; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Wykes M, 1998, J IMMUNOL, V161, P1313	67	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66244	10.1371/journal.pone.0066244	http://dx.doi.org/10.1371/journal.pone.0066244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799083	Green Published, gold			2022-12-27	WOS:000320363300068
J	Gao, L; Guo, H; Ye, N; Bai, YD; Liu, X; Yu, P; Xue, Y; Ma, SF; Wei, KW; Jin, Y; Wen, LY; Xuan, K				Gao, Li; Guo, Hao; Ye, Nan; Bai, Yudi; Liu, Xin; Yu, Ping; Xue, Yang; Ma, Shufang; Wei, Kewen; Jin, Yan; Wen, Lingying; Xuan, Kun			Oral and Craniofacial Manifestations and Two Novel Missense Mutations of the NTRK1 Gene Identified in the Patient with Congenital Insensitivity to Pain with Anhidrosis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; HIGH-AFFINITY RECEPTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; TRKA; NEUROTROPHINS; DIFFERENTIATION; PROLIFERATION; FRAMESHIFT; PI3K/AKT	Congenital insensitivity to pain with anhidrosis (CIPA) is a rare inherited disorder of the peripheral nervous system resulting from mutations in neurotrophic tyrosine kinase receptor 1 gene (NTRK1), which encodes the high-affinity nerve growth factor receptor TRKA. Here, we investigated the oral and craniofacial manifestations of a Chinese patient affected by autosomal-recessive CIPA and identified compound heterozygosity in the NTRK1 gene. The affected boy has multisystemic disorder with lack of reaction to pain stimuli accompanied by self-mutilation behavior, the inability to sweat leading to defective thermoregulation, and mental retardation. Oral and craniofacial manifestations included a large number of missing teeth, nasal malformation, submucous cleft palate, severe soft tissue injuries, dental caries and malocclusion. Histopathological evaluation of the skin sample revealed severe peripheral nerve fiber loss as well as mild loss and absent innervation of sweat glands. Ultrastructural and morphometric studies of a shed tooth revealed dental abnormalities, including hypomineralization, dentin hypoplasia, cementogenesis defects and a dysplastic periodontal ligament. Genetic analysis revealed a compound heterozygosity-c.1561T>C and c.2057G>A in the NTRK1 gene. This report extends the spectrum of NTRK1 mutations observed in patients diagnosed with CIPA and provides additional insight for clinical and molecular diagnosis.	[Gao, Li; Guo, Hao; Bai, Yudi; Ma, Shufang; Wen, Lingying; Xuan, Kun] Fourth Mil Med Univ, Dept Pediat Dent, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China; [Ye, Nan] Hosp PLA 309, Dept Dent, Beijing, Peoples R China; [Liu, Xin] Fourth Mil Med Univ, Dept Orthodont, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China; [Yu, Ping] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Zhejiang, Peoples R China; [Xue, Yang] Fourth Mil Med Univ, Dept Oral Biol, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China; [Wei, Kewen] Fourth Mil Med Univ, Dept Endodont, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China; [Jin, Yan] Fourth Mil Med Univ, Dept Oral Histol & Pathol, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Wenzhou Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jin, Y (corresponding author), Fourth Mil Med Univ, Dept Oral Histol & Pathol, Sch Stomatol, Xian 710032, Shaanxi Provinc, Peoples R China.	yanjin@fmmu.edu.cn; wxywly@fmmu.edu.cn; xuankun@fmmu.edu.cn	Jin, Yan/I-4204-2013		National Natural Science Foundation of China [81271117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is supported by National Natural Science Foundation of China (No. 81271117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano O, 1999, DEV DYNAM, V216, P299; Arany S, 2009, J CELL BIOCHEM, V106, P539, DOI 10.1002/jcb.22006; Bar-On E, 2002, J BONE JOINT SURG BR, V84B, P252, DOI 10.1302/0301-620X.84B2.11939; Bertrand T, 2012, J MOL BIOL, V423, P439, DOI 10.1016/j.jmb.2012.08.002; BJORKLUND H, 1986, CELL TISSUE RES, V243, P51; Bonkowsky JL, 2003, PEDIATRICS, V112, pE237, DOI 10.1542/peds.112.3.e237; Butler J, 2006, ORAL SURG ORAL MED O, V101, P58, DOI 10.1016/j.tripleo.2005.08.002; Dyck PJ., 1993, PERIPHERAL NEUROPATH, P1065; Fujiyama K, 2004, J DENT RES, V83, P625, DOI 10.1177/154405910408300808; Hong JX, 2012, MOL VIS, V18, P758; Indo Y, 1997, JPN J HUM GENET, V42, P343, DOI 10.1007/BF02766957; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Korkmaz Y, 2010, CELL TISSUE RES, V342, P391, DOI 10.1007/s00441-010-1076-3; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; Li M, 2012, GENET MOL RES, V11, P2156, DOI 10.4238/2012.May.18.8; Louryan S, 1995, EUR J MORPHOL, V33, P415; Mardy S, 1999, AM J HUM GENET, V64, P1570, DOI 10.1086/302422; Miranda C, 2002, J BIOL CHEM, V277, P6455, DOI 10.1074/jbc.M110016200; MITSIADIS TA, 1995, INT J DEV BIOL, V39, P195; Mizuno N, 2007, CELL BIOL INT, V31, P1462, DOI 10.1016/j.cellbi.2007.06.012; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Schalka MMS, 2006, ORAL SURG ORAL MED O, V101, P769, DOI 10.1016/j.tripleo.2005.07.030; SWANSON AG, 1963, ARCH NEUROL-CHICAGO, V8, P299, DOI 10.1001/archneur.1963.00460030083008; Verpoorten N, 2006, NEUROMUSCULAR DISORD, V16, P19, DOI 10.1016/j.nmd.2005.10.007; Wang WX, 2011, ACTA PHARMACOL SIN, V32, P1483, DOI 10.1038/aps.2011.141; Woodnutt DA, 2001, ARCH ORAL BIOL, V46, P163, DOI 10.1016/S0003-9969(00)00097-2	30	14	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66863	10.1371/journal.pone.0066863	http://dx.doi.org/10.1371/journal.pone.0066863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799134	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300099
J	Gero, D; Szoleczky, P; Modis, K; Pribis, JP; Al-Abed, Y; Yang, H; Chevan, S; Billiar, TR; Tracey, KJ; Szabo, C				Geroe, Domokos; Szoleczky, Petra; Modis, Katalin; Pribis, John P.; Al-Abed, Yousef; Yang, Huan; Chevan, Sangeeta; Billiar, Timothy R.; Tracey, Kevin J.; Szabo, Csaba			Identification of Pharmacological Modulators of HMGB1-Induced Inflammatory Response by Cell-Based Screening	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CYTOKINE RELEASE; SYSTEMIC INFLAMMATION; KAPPA-B; HMGB1; RECEPTOR; ACTIVATION; BINDING; TRANSCRIPTION; SURVIVAL	High mobility group box 1 (HMGB1), a highly conserved, ubiquitous protein, is released into the circulation during sterile inflammation (e. g. arthritis, trauma) and circulatory shock. It participates in the pathogenesis of delayed inflammatory responses andorgandysfunction. While several molecules have been identified that modulate the release of HMGB1, less attention has been paid to identify pharmacological inhibitors of the downstream inflammatory processes elicited by HMGB1 (C23-C45 disulfide C106thiol form). In the current study, a cell-based medium-throughput screening of a 5000+ compound focused library of clinical drugs and drug-like compounds was performed in murine RAW264.7 macrophages, in order to identify modulators of HMGB1-induced tumor-necrosis factor alpha(TNF alpha) production. Clinically used drugs that suppressed HMGB1-induced TNF alpha production included glucocorticoids, beta agonists, and the anti-HIV compound indinavir. A re-screen of the NIH clinical compound library identified beta-agonists and various intracellular cAMP enhancers as compounds that potentiate the inhibitory effect of glucocorticoids on HMGB1-induced TNF alpha production. The molecular pathways involved in this synergistic anti-inflammatory effect are related, at least in part, to inhibition of TNF alpha mRNA synthesis via a synergistic suppression of ERK/IkB activation. Inhibition of TNF alpha production by prednisolone+salbutamol pretreatment was also confirmed in vivo in mice subjected to HMGB1 injection; this effect was more pronounced than the effect of either of the agents administered separately. The current study unveils several drug-like modulators of HMGB1-mediated inflammatory responses and offers pharmacological directions for the therapeutic suppression of inflammatory responses in HMGB1-dependent diseases.	[Geroe, Domokos; Szoleczky, Petra; Modis, Katalin; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Pribis, John P.; Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Al-Abed, Yousef; Yang, Huan; Chevan, Sangeeta; Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA	University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwell Health	Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	szabocsaba@aol.com	Gero, Domokos/F-7853-2017; Szabo, Csaba/ABG-2644-2021; Szoleczky, Petra/O-4649-2014	Gero, Domokos/0000-0002-3132-3465; Szoleczky, Petra/0000-0003-4921-6673; Tracey, Kevin J/0000-0003-1884-6314; Chavan, Sangeeta S./0000-0002-4822-3356	National Institutes of Health [P50GM060338, GM062508]; University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM060338, R01GM062508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by grants from the National Institutes of Health (P50GM060338 to C. S., and GM062508 to K. J. T.). M. K. was supported by the James W. McLaughlin Fellowship Fund of the University of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Barnes PJ, 2002, EUR RESPIR J, V19, P182, DOI 10.1183/09031936.02.00283202; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Cai BL, 2009, J CELL MOL MED, V13, P3774, DOI 10.1111/j.1582-4934.2008.00550.x; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Colangelo AM, 2004, MOL BRAIN RES, V124, P97, DOI 10.1016/j.molbrainres.2004.01.011; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Gero D, 2007, INT J MOL MED, V20, P749; Gero D, 2013, DIABETES, V62, P953, DOI 10.2337/db12-0789; Ghio AJ, 1996, AM J RESP CRIT CARE, V154, P783, DOI 10.1164/ajrccm.154.3.8810619; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Kim S, 2013, MOL MED IN PRESS; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Lagathu C, 2004, ANTIVIR THER, V9, P911; Lahat A, 2008, CLIN EXP IMMUNOL, V152, P320, DOI 10.1111/j.1365-2249.2008.03636.x; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; PARK EA, 1993, J BIOL CHEM, V268, P613; Schierbeck H, 2010, MOL MED, V16, P343, DOI 10.2119/molmed.2010.00031; SELYE H, 1971, J PHARM SCI, V60, P1, DOI 10.1002/jps.2600600102; Szabo C, 1997, IMMUNOLOGY, V90, P95, DOI 10.1046/j.1365-2567.1997.00137.x; Szelenyi J, 2007, ANN NY ACAD SCI, V1113, P311, DOI 10.1196/annals.1391.026; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019	31	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65994	10.1371/journal.pone.0065994	http://dx.doi.org/10.1371/journal.pone.0065994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799067	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000320363300057
J	Maciejewska-Karlowska, A; Sawczuk, M; Cieszczyk, P; Zarebska, A; Sawczyn, S				Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek; Cieszczyk, Pawel; Zarebska, Aleksandra; Sawczyn, Stanislaw			Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BODY-MASS INDEX; PPAR-GAMMA; INSULIN SENSITIVITY; PPAR-GAMMA-2 GENE; ALANINE SUBSTITUTION; BONE-FORMATION; PROMOTER; EXPRESSION; VARIANT	Background: The 12Ala allele of the Peroxisome Proliferator-Activated Receptor gamma gene ( PPARG) Pro12Ala polymorphism produces a decreased binding affinity of the PPAR gamma 2 protein, resulting in low activation of the target genes. The 12Ala allele carriers display a significantly improved insulin sensitivity that may result in better glucose utilisation in working skeletal muscles. We hypothesise that the PPARG 12Ala allele could be associated with strength athlete status in Polish athletes. Methodology: The genotype distribution of PPARG Pro12Ala was examined in 660 Polish athletes. The athletes were stratified into four subgroups: endurance, strength-endurance, sprint-strength and strength. Control samples were prepared from 684 unrelated sedentary volunteers. A chi(2) test was used to compare the PPARG Pro12Ala allele and genotype frequencies between the different groups of athletes and control subjects. Bonferroni's correction for multiple testing was applied. Results: A statistically significant higher frequency of PPARG 12Ala alleles was observed in the subgroup of strength athletes performing short-term and very intense exertion characterised by predominant anaerobic energy production (13.2% vs. 7.5% in controls; P = 0.0007). Conclusion: The PPARG 12Ala allele may be a relevant genetic factor favouring strength abilities in professional athletes, especially in terms of insulin-dependent metabolism, a shift of the energy balance towards glucose utilisation and the development of a favourable weight-to-strength ratio.	[Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Tech Univ Szczecin, Fac Phys Educ & Hlth Promot, Dept Biol Bases Phys Culture, Szczecin, Poland; [Maciejewska-Karlowska, Agnieszka; Sawczuk, Marek] Tech Univ Szczecin, Dept Genet, Fac Biol, Szczecin, Poland; [Cieszczyk, Pawel; Zarebska, Aleksandra; Sawczyn, Stanislaw] Acad Phys Educ & Sport, Dept Sport, Fac Tourism & Recreat, Gdansk, Poland	West Pomeranian University of Technology; West Pomeranian University of Technology; Gdansk University of Physical Education & Sport	Maciejewska-Karlowska, A (corresponding author), Tech Univ Szczecin, Fac Phys Educ & Hlth Promot, Dept Biol Bases Phys Culture, Szczecin, Poland.	maciejewska.us@wp.pl	Cieszczyk, Pawel/AFK-4645-2022; Sawczuk, Marek/S-3609-2017; Cieszczyk, Pawel/AAG-3328-2022	Cieszczyk, Pawel/0000-0002-7735-7580; Cieszczyk, Pawel/0000-0002-7735-7580; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; sawczyn, stanislaw/0000-0002-1974-3248; Jazdzewska, Aleksandra/0000-0002-7518-855X; Sawczuk, Marek/0000-0002-5730-5249	Polish Ministry of Science and Higher Education [N 404166334]; Faculty of Biology, University of Szczecin [504-1000-240-849]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Faculty of Biology, University of Szczecin	This work was partly supported by grant N 404166334 founded by Polish Ministry of Science and Higher Education (www.nauka.gov.pl) and by grant 504-1000-240-849 for young researchers founded by Faculty of Biology, University of Szczecin (wb.univ.szczecin.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Ahmetov II, 2008, B EXP BIOL MED+, V146, P630, DOI 10.1007/s10517-009-0364-y; Akhmetov I I, 2007, Ross Fiziol Zh Im I M Sechenova, V93, P837; Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Beamer BA, 1998, DIABETES, V47, P1806, DOI 10.2337/diabetes.47.11.1806; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Cieszczyk P, 2011, EUR J SPORT SCI, V11, P119, DOI 10.1080/17461391.2010.487120; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Doney A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-21; Douglas JA, 2001, DIABETES, V50, P886, DOI 10.2337/diabetes.50.4.886; Druzhevskaya AM, 2008, EUR J APPL PHYSIOL, V103, P631, DOI 10.1007/s00421-008-0763-1; Ek J, 2001, DIABETOLOGIA, V44, P1170, DOI 10.1007/s001250100629; Evangelisti L, 2009, ATHEROSCLEROSIS, V205, P186, DOI 10.1016/j.atherosclerosis.2008.11.009; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Franks PW, 2004, METABOLISM, V53, P11, DOI 10.1016/j.metabol.2003.08.005; Frederiksen L, 2002, J CLIN ENDOCR METAB, V87, P3989, DOI 10.1210/jc.87.8.3989; Gabbasov RT, 2013, J STRENGTH COND RES, V27, P2055, DOI 10.1519/JSC.0b013e31827f06ae; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Honka MJ, 2009, METABOLISM, V58, P541, DOI 10.1016/j.metabol.2008.11.015; Hsueh WC, 2001, DIABETES CARE, V24, P672, DOI 10.2337/diacare.24.4.672; Kawaguchi H, 2005, J BONE MINER METAB, V23, P275, DOI 10.1007/s00774-005-0599-2; Koch M, 1999, DIABETOLOGIA, V42, P758, DOI 10.1007/s001250051225; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Luan J, 2001, DIABETES, V50, P686, DOI 10.2337/diabetes.50.3.686; Maciejewska A, 2012, J SPORT SCI, V30, P101, DOI 10.1080/02640414.2011.623709; Maciejewska A, 2011, J SCI MED SPORT, V14, P58, DOI 10.1016/j.jsams.2010.05.006; Masud S, 2003, J MED GENET, V40, P773, DOI 10.1136/jmg.40.10.773; Masugi J, 2000, BIOCHEM BIOPH RES CO, V268, P178, DOI 10.1006/bbrc.2000.2096; Meirhaeghe A, 2003, ARTERIOSCL THROM VAS, V23, P289, DOI 10.1161/01.ATV.0000051382.28752.FE; Meirhaeghe A, 2004, MOL GENET METAB, V83, P93, DOI 10.1016/j.ymgme.2004.08.014; Ogawa S, 1999, BIOCHEM BIOPH RES CO, V260, P122, DOI 10.1006/bbrc.1999.0896; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Sawczuk M, 2013, J SPORT SCI, V31, P1535, DOI 10.1080/02640414.2013.786184; Schneider J, 2002, DIABETES, V51, P867, DOI 10.2337/diabetes.51.3.867; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Simon I, 2002, HORM RES, V58, P143, DOI 10.1159/000064490; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; Stumvoll M, 2001, DIABETES, V50, P876, DOI 10.2337/diabetes.50.4.876; Sundvold H, 2001, BIOCHEM BIOPH RES CO, V287, P383, DOI 10.1006/bbrc.2001.5602; Thamer C, 2002, HORM METAB RES, V34, P132, DOI 10.1055/s-2002-23196; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vanttinen M, 2005, J CLIN ENDOCR METAB, V90, P4249, DOI 10.1210/jc.2005-0101; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798	50	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67172	10.1371/journal.pone.0067172	http://dx.doi.org/10.1371/journal.pone.0067172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799144	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300106
J	Murakami, K; Kurihara, C; Oka, T; Shimoike, T; Fujii, Y; Takai-Todaka, R; Park, Y; Wakita, T; Matsuda, T; Hokari, R; Miura, S; Katayama, K				Murakami, Kosuke; Kurihara, Chie; Oka, Tomoichiro; Shimoike, Takashi; Fujii, Yoshiki; Takai-Todaka, Reiko; Park, YoungBin; Wakita, Takaji; Matsuda, Tsukasa; Hokari, Ryota; Miura, Soichiro; Katayama, Kazuhiko			Norovirus Binding to Intestinal Epithelial Cells Is Independent of Histo-Blood Group Antigens	PLOS ONE			English	Article							GENOGROUP-II NOROVIRUSES; NORWALK VIRUS-INFECTION; LINE CACO-2; DIFFERENTIATION; PARTICLES; STRAIN; CLASSIFICATION; ATTACHMENT; EXPRESSION; DIVERSITY	Human noroviruses (NoVs) are a major cause of non-bacterial gastroenteritis. Although histo-blood group antigens (HBGAs) have been implicated in the initial binding of NoV, the mechanism of that binding before internalization is not clear. To determine the involvement of NoVs and HBGAs in cell binding, we examined the localization of NoV virus-like particles (VLPs) and HBGAs in a human intestinal cell line and the human ileum biopsy specimens by immunofluorescence microscopy. The localizations of Ueno 7k VLPs (genogroup II.6) and each HBGA (type H1-, H2- and Le(b)-HBGAs) on the human intestinal cell line, Caco-2, were examined by confocal laser-scanning microscopy. To explore any interactions of NoVs and HBGAs in vivo, fresh biopsy specimens from human ileum were directly incubated with NoV VLPs and examined by immunofluorescence microscopy. We found that VLP binding depended on the state of cell differentiation, but not on the presence of HBGAs. In differentiated Caco-2 cells, we detected no type H1 HBGAs, but VLPs bound to the cells anyway. We incubated fresh biopsies of human ileum directly with VLPs, a model that better replicates the in vivo environment. VLPs mainly bound epithelial cells and goblet cells. Although the incubations were performed at 4 degrees C to hinder internalization, VLPs were still detected inside cells. Our results suggest that VLPs utilize molecule(s) other than HBGAs during binding and internalization into cells.	[Murakami, Kosuke; Oka, Tomoichiro; Shimoike, Takashi; Fujii, Yoshiki; Takai-Todaka, Reiko; Park, YoungBin; Wakita, Takaji; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan; [Kurihara, Chie; Hokari, Ryota; Miura, Soichiro] Natl Def Med Coll, Dept Internal Med, Tokorozawa, Saitama 359, Japan; [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	National Institute of Infectious Diseases (NIID); National Defense Medical College - Japan; Nagoya University	Katayama, K (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo, Japan.	katayama@nih.go.jp	Fujii, Yoshiki/GOE-3566-2022	Katayama, Kazuhiko/0000-0002-7692-1151	Japan Society for the Promotion of Science (JSPS KAKENHI) [20380184, 24380069, 23590556]; Ministry of Health, Labor and Welfare of Japan [11103251, 12103310]	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS KAKENHI Grand numbers 20380184, 24380069 and 23590556, http://www.jsps.go.jp/english/e-grants/index.html), by Grants-in-Aid from the Ministry of Health, Labor and Welfare of Japan (Research on Emerging and Re-emerging Infectious Diseases Grand numbers 11103251 and 12103310, http://www.mhlw.go.jp/english/policy/other/research-projects/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano J, 1999, J BIOL CHEM, V274, P21209, DOI 10.1074/jbc.274.30.21209; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Buhrke T, 2011, DEV GROWTH DIFFER, V53, P411, DOI 10.1111/j.1440-169X.2011.01258.x; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; Cheetham S, 2007, J VIROL, V81, P3535, DOI 10.1128/JVI.01306-06; Choi JM, 2008, P NATL ACAD SCI USA, V105, P9175, DOI 10.1073/pnas.0803275105; Farkas T, 2010, J VIROL, V84, P8617, DOI 10.1128/JVI.00630-10; Gerondopoulos A, 2010, J GEN VIROL, V91, P1428, DOI 10.1099/vir.0.016717-0; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Hansman GS, 2006, J GEN VIROL, V87, P909, DOI 10.1099/vir.0.81532-0; Harrington PR, 2004, J VIROL, V78, P3035, DOI 10.1128/JVI.78.6.3035-3045.2004; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Murakami K, 2010, BIOSCI BIOTECH BIOCH, V74, P541, DOI 10.1271/bbb.90729; ORIOL R, 1990, J IMMUNOGENET, V17, P235; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; PINTO M, 1983, BIOL CELL, V47, P323; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Sestak K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037973; Shirato H, 2008, J VIROL, V82, P10756, DOI 10.1128/JVI.00802-08; Stuart AD, 2006, J VIROL, V80, P7500, DOI 10.1128/JVI.02452-05; Tamura M, 2004, J VIROL, V78, P3817, DOI 10.1128/JVI.78.8.3817-3826.2004; Tamura M, 2000, J VIROL, V74, P11589, DOI 10.1128/JVI.74.24.11589-11597.2000; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tian P, 2007, RES VET SCI, V83, P410, DOI 10.1016/j.rvsc.2007.01.017; WALTER E, 1995, EUR J PHARM SCI, V3, P215, DOI 10.1016/0928-0987(95)00010-B; White LJ, 1996, J VIROL, V70, P6589, DOI 10.1128/JVI.70.10.6589-6597.1996; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	37	33	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66534	10.1371/journal.pone.0066534	http://dx.doi.org/10.1371/journal.pone.0066534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799113	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300089
J	Smirnova, E; Shanbhag, R; Kurabi, A; Mobli, M; Kwan, JJ; Donaldson, LW				Smirnova, Ekaterina; Shanbhag, Riya; Kurabi, Arwa; Mobli, Mehdi; Kwan, Jamie J.; Donaldson, Logan W.			Solution Structure and Peptide Binding of the PTB Domain from the AIDA1 Postsynaptic Signaling Scaffolding Protein	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INTRACELLULAR DOMAIN; SUGGESTS; COMPLEX; MODEL	AIDA1 links persistent chemical signaling events occurring at the neuronal synapse with global changes in gene expression. Consistent with its role as a scaffolding protein, AIDA1 is composed of several protein-protein interaction domains. Here we report the NMR structure of the carboxy terminally located phosphotyrosine binding domain (PTB) that is common to all AIDA1 splice variants. A comprehensive survey of peptides identified a consensus sequence around an NxxY motif that is shared by a number of related neuronal signaling proteins. Using peptide arrays and fluorescence based assays, we determined that the AIDA1 PTB domain binds amyloid protein precursor (APP) in a similar manner to the X11/Mint PTB domain, albeit at reduced affinity (similar to 10 mu M) that may allow AIDA1 to effectively sample APP, as well as other protein partners in a variety of cellular contexts.	[Smirnova, Ekaterina; Shanbhag, Riya; Kurabi, Arwa; Kwan, Jamie J.; Donaldson, Logan W.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Mobli, Mehdi] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	York University - Canada; University of Queensland	Donaldson, LW (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	logand@yorku.ca	Mobli, Mehdi/O-7244-2014	Mobli, Mehdi/0000-0003-2420-4262; Donaldson, Logan/0000-0001-5034-2699	Canadian Institutes of Health Research [MOP-81250]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research MOP-81250 to L.W.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya A, 2008, PROTEINS, V70, P105, DOI 10.1002/prot.21466; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emaduddin Muhammad, 2008, Cell Commun Signal, V6, P7, DOI 10.1186/1478-811X-6-7; Fogh RH, 2006, J BIOMOL NMR, V36, P147, DOI 10.1007/s10858-006-9076-z; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Ghersi E, 2004, J BIOL CHEM, V279, P49105, DOI 10.1074/jbc.M405329200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hoch JC, 1996, NMR DATA PROCESSING; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurabi A, 2009, J MOL BIOL, V392, P1168, DOI 10.1016/j.jmb.2009.08.004; Li L, 2006, NEUROSCIENCE, V142, P391, DOI 10.1016/j.neuroscience.2006.06.018; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Margolis B, 1999, KIDNEY INT, V56, P1230, DOI 10.1046/j.1523-1755.1999.00700.x; Matos MF, 2012, P NATL ACAD SCI USA, V109, P3802, DOI 10.1073/pnas.1119075109; Mulvihill MM, 2011, BIOCHEMISTRY-US, V50, P6208, DOI 10.1021/bi200508f; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	25	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65605	10.1371/journal.pone.0065605	http://dx.doi.org/10.1371/journal.pone.0065605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799029	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300029
J	Bosch, T; Verkade, E; van Luit, M; Pot, B; Vauterin, P; Burggrave, R; Savelkoul, P; Kluytmans, J; Schouls, L				Bosch, Thijs; Verkade, Erwin; van Luit, Martijn; Pot, Bruno; Vauterin, Paul; Burggrave, Ronald; Savelkoul, Paul; Kluytmans, Jan; Schouls, Leo			High Resolution Typing by Whole Genome Mapping Enables Discrimination of LA-MRSA (CC398) Strains and Identification of Transmission Events	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; ST398	After its emergence in 2003, a livestock-associated (LA-)MRSA clade (CC398) has caused an impressive increase in the number of isolates submitted for the Dutch national MRSA surveillance and now comprises 40% of all isolates. The currently used molecular typing techniques have limited discriminatory power for this MRSA clade, which hampers studies on the origin and transmission routes. Recently, a new molecular analysis technique named whole genome mapping was introduced. This method creates high-resolution, ordered whole genome restriction maps that may have potential for strain typing. In this study, we assessed and validated the capability of whole genome mapping to differentiate LA- MRSA isolates. Multiple validation experiments showed that whole genome mapping produced highly reproducible results. Assessment of the technique on two well-documented MRSA outbreaks showed that whole genome mapping was able to confirm one outbreak, but revealed major differences between the maps of a second, indicating that not all isolates belonged to this outbreak. Whole genome mapping of LA-MRSA isolates that were epidemiologically unlinked provided a much higher discriminatory power than spa-typing or MLVA. In contrast, maps created from LA-MRSA isolates obtained during a proven LA-MRSA outbreak were nearly indistinguishable showing that transmission of LA-MRSA can be detected by whole genome mapping. Finally, whole genome maps of LA-MRSA isolates originating from two unrelated veterinarians and their household members showed that veterinarians may carry and transmit different LA-MRSA strains at the same time. No such conclusions could be drawn based spa-typing and MLVA. Although PFGE seems to be suitable for molecular typing of LA-MRSA, WGM provides a much higher discriminatory power. Furthermore, whole genome mapping can provide a comparison with other maps within 2 days after the bacterial culture is received, making it suitable to investigate transmission events and outbreaks caused by LA-MRSA.	[Bosch, Thijs; van Luit, Martijn; Schouls, Leo] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening, Bilthoven, Netherlands; [Verkade, Erwin; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [van Luit, Martijn; Kluytmans, Jan] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Pot, Bruno; Vauterin, Paul] Appl Maths, Sint Martens Latem, Belgium; [Burggrave, Ronald] Piext BV, Rosmalen, Netherlands; [Savelkoul, Paul] Univ Limburg, Acad Hosp Maastricht, Dept Med Microbiol, Maastricht, Netherlands; [Savelkoul, Paul; Kluytmans, Jan] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam	Bosch, T (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening, Bilthoven, Netherlands.	thijs.bosch@rivm.nl	Pot, Bruno DF/I-6645-2012	Vauterin, Paul/0000-0003-3665-4519	Food & Nutrition Delta program of the Dutch Ministry of Economic Affairs; Dutch Ministry of Health, Welfare and Sport	Food & Nutrition Delta program of the Dutch Ministry of Economic Affairs; Dutch Ministry of Health, Welfare and Sport	This work was partially funded by a grant in the Food & Nutrition Delta program of the Dutch Ministry of Economic Affairs and partially by the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2010, LETT APPL MICROBIOL, V50, P127, DOI 10.1111/j.1472-765X.2009.02742.x; Bens CCPM, 2006, J CLIN MICROBIOL, V44, P1875, DOI 10.1128/JCM.44.5.1875-1876.2006; Bosch T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-40; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Diep BA, 2013, LANCET INFECT DIS, V13, P99, DOI 10.1016/S1473-3099(12)70276-1; EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428, DOI 10.1128/CMR.6.4.428-442.1993; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Haenen APJ, 2011, INFECTIEZIEKTEN B, V22, P250; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Huijsdens XW, 2008, EMERG INFECT DIS, V14, P1797, DOI 10.3201/eid1411.071297; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Melles D C, 2004, Ned Tijdschr Geneeskd, V148, P1038; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Reuter S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002175; Riley MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-252; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Shukla SK, 2012, J CLIN MICROBIOL, V50, P3526, DOI 10.1128/JCM.01168-12; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3	31	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66493	10.1371/journal.pone.0066493	http://dx.doi.org/10.1371/journal.pone.0066493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805225	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500053
J	Jonsson, JE; Gardarsson, A; Gill, JA; Petursdottir, UK; Petersen, A; Gunnarsson, TG				Jonsson, Jon Einar; Gardarsson, Arnthor; Gill, Jennifer A.; Petursdottir, Una Kristin; Petersen, Aevar; Gunnarsson, Tomas Gretar			Relationships between Long-Term Demography and Weather in a Sub-Arctic Population of Common Eider	PLOS ONE			English	Article							SOMATERIA-MOLLISSIMA; CLIMATE-CHANGE; CLUTCH SIZE; BREEDING SUCCESS; NESTING SUCCESS; ICE CONDITIONS; SEA-ICE; SURVIVAL; DYNAMICS; SITE	Effects of local weather on individuals and populations are key drivers of wildlife responses to climatic changes. However, studies often do not last long enough to identify weather conditions that influence demographic processes, or to capture rare but extreme weather events at appropriate scales. In Iceland, farmers collect nest down of wild common eider Somateria mollissima and many farmers count nests within colonies annually, which reflects annual variation in the number of breeding females. We collated these data for 17 colonies. Synchrony in breeding numbers was generally low between colonies. We evaluated 1) demographic relationships with weather in nesting colonies of common eider across Iceland during 1900-2007; and 2) impacts of episodic weather events (aberrantly cold seasons or years) on subsequent breeding numbers. Except for episodic events, breeding numbers within a colony generally had no relationship to local weather conditions in the preceding year. However, common eider are sexually mature at 2-3 years of age and we found a 3-year time lag between summer weather and breeding numbers for three colonies, indicating a positive effect of higher pressure, drier summers for one colony, and a negative effect of warmer, calmer summers for two colonies. These findings may represent weather effects on duckling production and subsequent recruitment. Weather effects were mostly limited to a few aberrant years causing reductions in breeding numbers, i.e. declines in several colonies followed severe winters (1918) and some years with high NAO (1992, 1995). In terms of life history, adult survival generally is high and stable and probably only markedly affected by inclement weather or aberrantly bad years. Conversely, breeding propensity of adults and duckling production probably do respond more to annual weather variations; i.e. unfavorable winter conditions for adults increase probability of death or skipped breeding, whereas favorable summers can promote boom years for recruitment.	[Jonsson, Jon Einar; Petursdottir, Una Kristin; Gunnarsson, Tomas Gretar] Univ Iceland, Res Ctr Snaefellsnes, Stykkisholmur, Iceland; [Gardarsson, Arnthor] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Gill, Jennifer A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Petersen, Aevar] Iceland Inst Nat Hist, Garoabaer, Iceland; [Gunnarsson, Tomas Gretar] Univ Iceland, South Iceland Res Ctr, Selfoss, Iceland; [Gunnarsson, Tomas Gretar] Univ Iceland, South Iceland Res Ctr, Gunnarsholt Hella, Iceland	University of Iceland; University of Iceland; University of East Anglia; University of Iceland; University of Iceland	Jonsson, JE (corresponding author), Univ Iceland, Res Ctr Snaefellsnes, Stykkisholmur, Iceland.	joneinar@hi.is	Jónsson, Jón Einar/K-7482-2015; Gunnarsson, Tomas G/L-9783-2015; Gill, Jennifer A/A-7759-2008	Jónsson, Jón Einar/0000-0003-1198-786X; Gunnarsson, Tomas Gretar/0000-0001-7692-0637	Icelandic Research Council (RANNIS); Icelandic Agricultural Productivity fund (Framleionisjoour landbunaoarins); Icelandic eider-down farmers association (AEoarraektarfelag Islands); University of Iceland	Icelandic Research Council (RANNIS); Icelandic Agricultural Productivity fund (Framleionisjoour landbunaoarins); Icelandic eider-down farmers association (AEoarraektarfelag Islands); University of Iceland	This study was supported financially by the Icelandic Research Council (RANNIS), the Icelandic Agricultural Productivity fund (Framleionisjoour landbunaoarins), the Icelandic eider-down farmers association (AEoarraektarfelag Islands) and the University of Iceland. The funders had no involvement in study design, data collation or analysis, decision to publish, or manuscript preparation.	ACIA, 2005, IMP WARM CLIM ARCT C; Anders AD, 2006, J ANIM ECOL, V75, P221, DOI 10.1111/j.1365-2656.2006.01034.x; BAILLIE SR, 1989, IBIS, V131, P321, DOI 10.1111/j.1474-919X.1989.tb02782.x; BEUKEMA JJ, 1993, NETH J SEA RES, V31, P395, DOI 10.1016/0077-7579(93)90056-X; Bjornsson H., 2008, HNATTRAENAR LOFTSLAG; Bolduc F, 2005, WILDLIFE BIOL, V11, P273, DOI 10.2981/0909-6396(2005)11[273:NSOCES]2.0.CO;2; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; BUSTNES JO, 1993, ORNIS FENNICA, V70, P11; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Coulson JC, 2010, BIRD STUDY, V57, P1; D'Alba L, 2010, IBIS, V152, P19, DOI 10.1111/j.1474-919X.2009.00978.x; Descamps S, 2010, OIKOS, V119, P1526, DOI 10.1111/j.1600-0706.2010.18508.x; Descamps S, 2009, BIOL LETTERS, V5, P278, DOI 10.1098/rsbl.2008.0704; Einarsson M.A., 1984, WORLD SURV CLIMATOL, V15, P673; Ekroos J, 2012, ORNIS FENNICA, V89, P81; ERIKSTAD KE, 1995, OECOLOGIA, V103, P270, DOI 10.1007/BF00328614; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Gardarsson A, 1997, J ANIM ECOL, V66, P439, DOI 10.2307/5939; GARDARSSON A, 1994, HYDROBIOLOGIA, V279, P15, DOI 10.1007/BF00027837; Gardarsson Arnthor, 2009, Bliki (Reykjavik), V30, P49; Gjerdrum C, 2003, P NATL ACAD SCI USA, V100, P9377, DOI 10.1073/pnas.1133383100; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Grosbois V, 2005, OIKOS, V109, P273, DOI 10.1111/j.0030-1299.2005.13774.x; Gunnarsson TG, 2006, J ANIM ECOL, V75, P1119, DOI 10.1111/j.1365-2656.2006.01131.x; Hanna E, 2004, INT J CLIMATOL, V24, P1193, DOI 10.1002/joc.1051; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hario M, 2009, ORNIS FENNICA, V86, P81; Hario M, 2009, OECOLOGIA, V159, P747, DOI 10.1007/s00442-008-1265-x; Hurrell JW, 2001, SCIENCE, V291, P603, DOI 10.1126/science.1058761; Iles D. T., 2012, THESIS UTAH STATE U; Iles DT, 2013, J ANIM ECOL, V82, P683, DOI 10.1111/1365-2656.12038; Institute of Natural History, 2000, VAL 2 BIRDS; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Jonsson J, 2001, POLAR BIOL; Jonsson J. E., 2001, Wildfowl, V52, P55; Jonsson JE, 2012, ORNIS FENNICA, V89; Jonsson JE, 2009, CLIM RES, V38, P237, DOI 10.3354/cr00790; Jonsson T, 2010, ISLAND NAO FYRIRBRIG; Jonsson T., 2006, HITAFAR ISLANDI EFTI; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Klaassen M, 2006, ARDEA, V94, P371; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Lehikoinen A, 2006, GLOBAL CHANGE BIOL, V12, P1355, DOI 10.1111/j.1365-2486.2006.01162.x; Lepage D, 2000, J ANIM ECOL, V69, P414, DOI 10.1046/j.1365-2656.2000.00404.x; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Love OP, 2010, OECOLOGIA, V164, P277, DOI 10.1007/s00442-010-1678-1; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Mehlum F, 2012, POLAR SCI, V6, P143, DOI 10.1016/j.polar.2012.03.004; MENDENHALL VM, 1985, IBIS, V127, P148, DOI 10.1111/j.1474-919X.1985.tb05051.x; Moe B, 2009, MAR ECOL PROG SER, V393, P235, DOI 10.3354/meps08222; Newton I., 1998, POPULATION LIMITATIO; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Ranta E, 1997, OIKOS, V78, P136, DOI 10.2307/3545809; Robert A, 2012, ECOLOGY, V93, P1944, DOI 10.1890/11-1840.1; ROBERTSON GJ, 1995, IBIS, V137, P109, DOI 10.1111/j.1474-919X.1995.tb03226.x; Robinson SA, 2009, GLOBAL CHANGE BIOL, V15, P1615, DOI 10.1111/j.1365-2486.2009.01977.x; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; *SAS I INC, 2001, SAS SYSTAT US GUID V; Senechal E, 2011, BEHAV ECOL, V22, P162, DOI 10.1093/beheco/arq189; SWENNEN C, 1990, ORNIS SCAND, V21, P17, DOI 10.2307/3676374; SWENNEN C, 1991, J ORNITHOL, V132, P427, DOI 10.1007/BF01640382; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Tiedemann R, 1999, BEHAVIOUR, V136, P1145; Tranquilla LM, 2010, ESTUAR COAST SHELF S, V89, P97, DOI 10.1016/j.ecss.2010.06.003; Traylor JJ, 2006, AUK, V123, P67, DOI 10.1642/0004-8038(2006)123[0067:EOIAEF]2.0.CO;2; van de Pol M, 2010, J APPL ECOL, V47, P720, DOI 10.1111/j.1365-2664.2010.01842.x; WAKELEY JS, 1976, J WILDLIFE MANAGE, V40, P15, DOI 10.2307/3800151; Watanuki Y, 2009, MAR ECOL PROG SER, V393, P259, DOI 10.3354/meps08264; Wilson HM, 2007, J WILDLIFE MANAGE, V71, P403, DOI 10.2193/2005-776; Yaffee R.A., 2000, INTRO TIME SERIES AN	75	17	19	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67093	10.1371/journal.pone.0067093	http://dx.doi.org/10.1371/journal.pone.0067093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805292	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500120
J	Raikkonen, J; Vucetich, JA; Vucetich, LM; Peterson, RO; Nelson, MP				Raikkonen, Jannikke; Vucetich, John A.; Vucetich, Leah M.; Peterson, Rolf O.; Nelson, Michael P.			What the Inbred Scandinavian Wolf Population Tells Us about the Nature of Conservation	PLOS ONE			English	Article							LUMBOSACRAL TRANSITIONAL VERTEBRAE; FOX VULPES-VULPES; INBREEDING DEPRESSION; DENTAL ANOMALIES; CANIS-LUPUS; LARGE CARNIVORE; WOLVES; DOG; WILD; CRYPTORCHIDISM	The genetic aspects of population health are critical, but frequently difficult to assess. Of concern has been the genetic constitution of Scandinavian wolves (Canis lupus), which represent an important case in conservation. We examined the incidence of different congenital anomalies for 171 Scandinavian wolves, including the immigrant founder female, born during a 32-year period between 1978 and 2010. The incidence of anomalies rose from 13% to 40% throughout the 32-year study period. Our ability to detect this increase was likely facilitated by having considered multiple kinds of anomaly. Many of the found anomalies are likely associated with inbreeding or some form of genetic deterioration. These observations have implications for understanding the conservation needs of Scandinavian wolves. Moreover, these observations and the history of managing Scandinavian wolves focus attention on a broader question, whether conservation is merely about avoiding extinction of remnant populations, or whether conservation also entails maintaining genetic aspects of population health.	[Raikkonen, Jannikke] Swedish Museum Nat Hist, Dept Contaminant Res, S-10405 Stockholm, Sweden; [Vucetich, John A.; Vucetich, Leah M.; Peterson, Rolf O.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Nelson, Michael P.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA	Swedish Museum of Natural History; Michigan Technological University; Oregon State University	Raikkonen, J (corresponding author), Swedish Museum Nat Hist, Dept Contaminant Res, S-10405 Stockholm, Sweden.	jannikke.raikkonen@gmail.com	Nelson, Michael Shawn/GXF-4934-2022		United States National Science Foundation [DEB-0424562]; Swedish Environmental Protection Agency	United States National Science Foundation(National Science Foundation (NSF)); Swedish Environmental Protection Agency	Funding was provided by the United States National Science Foundation (DEB-0424562) and by a grant from the Swedish Environmental Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2011, P ROY SOC B-BIOL SCI, V278, P3336, DOI 10.1098/rspb.2011.0261; Akesson M, 2010, 235369710 DNR NAT; Amann RP, 2007, REPRODUCTION, V133, P541, DOI 10.1530/REP-06-0272; Andersone Z, 2000, ACTA THERIOL, V45, P549; Bergstrom BJ, 2009, BIOSCIENCE, V59, P991, DOI 10.1525/bio.2009.59.11.11; Birchard SJ, 2008, COMPENDIUM, V30, P325; BOUWMEESTER J, 1989, J ZOOL, V219, P123, DOI 10.1111/j.1469-7998.1989.tb02571.x; Breit S, 2002, ANAT EMBRYOL, V205, P125, DOI 10.1007/s00429-002-0234-0; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Carpenter Len H., 2000, Human Dimensions of Wildlife, V5, P5; DECKER DJ, 1988, WILDLIFE SOC B, V16, P53; Dunbar MR, 1996, J WILDLIFE DIS, V32, P661, DOI 10.7589/0090-3558-32.4.661; Echegaray J, 2010, ANIM CONSERV, V13, P157, DOI 10.1111/j.1469-1795.2009.00315.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fluckiger MA, 2006, VET RADIOL ULTRASOUN, V47, P39, DOI 10.1111/j.1740-8261.2005.00103.x; Forslund P, 2009, 429858508 DNR EPA; Frankham R, 2010, HEREDITY, V104, P124, DOI 10.1038/hdy.2009.155; Hale FA, 2005, VET CLIN N AM-SMALL, V35, P789, DOI 10.1016/j.cvsm.2005.02.003; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; HELL P, 1990, Z JAGDWISS, V36, P266, DOI 10.1007/BF02242401; Kojola I, 2009, J WILDLIFE MANAGE, V73, P309, DOI 10.2193/2007-539; Lacy RC, 1996, EVOLUTION, V50, P2187, DOI 10.1111/j.1558-5646.1996.tb03609.x; Laikre L, 2013, CONSERV BIOL, V27, P248, DOI 10.1111/j.1523-1739.2012.01965.x; Landon DB, 1998, J WILDLIFE MANAGE, V62, P674, DOI 10.2307/3802343; Lauck T, 1998, ECOL APPL, V8, pS72, DOI 10.1890/1051-0761(1998)8[S72:ITPPIF]2.0.CO;2; Legendre L, 2008, J VET DENT, V25, P216; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Liberg O, 2009, REGULATING HARVEST S; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Lihotop RI, 1994, VESTNIK ZOOLOGII, V3, P45; LYNCH M, 1988, GENETICS, V120, P791; Mech D, 2010, BIOL CONSERV, V143, P535, DOI 10.1016/j.biocon.2009.10.019; Mills L. S., 2007, CONSERVATION WILDLIF; MORGAN JP, 1993, J AM VET MED ASSOC, V202, P1877; MORGAN JP, 1968, J AM VET RADIOL SOC, V9, P21; Naturvardsverket, 2012, NAT FORV VARG 2012 2; Naturvardsverket Statens Jordbruksverk & Statens veterinarmedicinska anstalt, 2010, GEN FORST SVENSK VAR; Nelson M.P., 2011, WILDLIFE PROFESSIONA, V5, P58; Nentvichova M, 2008, ACTA THERIOL, V53, P217, DOI 10.1007/BF03193118; Raikkonen J, 2006, MAMM BIOL, V71, P65, DOI 10.1016/j.mambio.2005.12.002; Raikkonen J, 2009, BIOL CONSERV, V142, P1025, DOI 10.1016/j.biocon.2009.01.014; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Shaffer Mark L., 2000, P301; Steffen F, 2004, J AM ANIM HOSP ASSOC, V40, P338, DOI 10.5326/0400338; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; Tidholm A, 1997, J SMALL ANIM PRACT, V38, P94, DOI 10.1111/j.1748-5827.1997.tb03326.x; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; VILA C, 1993, CAN J ZOOL, V71, P968, DOI 10.1139/z93-127; Vucetich JA, 2012, IGNORING NA IN PRESS; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P, 2011, 1 HOGSK HEDM; Wabakken P, 2010, 4 HOGSK HEDM; Wigger A, 2009, TIERAERZTL PRAX K H, V37, P7; WOBESER G, 1992, J WILDLIFE DIS, V28, P268, DOI 10.7589/0090-3558-28.2.268	58	27	27	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67218	10.1371/journal.pone.0067218	http://dx.doi.org/10.1371/journal.pone.0067218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805301	gold, Green Published			2022-12-27	WOS:000320846500129
J	Raju, I; Kannan, K; Abraham, EC				Raju, Ilangovan; Kannan, Krishnaswamy; Abraham, Edathara C.			FoxO3a Serves as a Biomarker of Oxidative Stress in Human Lens Epithelial Cells under Conditions of Hyperglycemia	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DIABETIC-RAT; DOWNSTREAM; MODULATION; MECHANISMS; CATARACT; PROTEINS; AKT	Background: Forkhead box 'O' transcription factors (FoxOs) are implicated in the pathogenesis of type2 diabetes and other metabolic diseases. Abnormal activity of FoxOs was reported in the glucose and insulin metabolism. Expression of FoxO proteins was reported in ocular tissues; however their function under hyperglycemic conditions was not examined. Methods: Human lens epithelial cell line was used to study the function of FoxO proteins. Immunofluorescence, flow cytometry and Western blotting were employed to detect the FoxO proteins under the conditions of hyperglycemia. Results: In this study we examined the role of FoxO3a in hyperglycemia-induced oxidative stress in human lens epithelial cells. FoxO3a protein expression was elevated in a dose- and time-dependent fashion after high glucose treatment. Antioxidant defense mechanisms of the lens epithelial cells were diminished as evidenced from loss of mitochondrial membrane integrity and lowered MnSOD after 72 h treatment with high glucose. Taken together, FoxO3a acts as a sensitive indicator of oxidative stress and cell homeostasis in human lens epithelial cells during diabetic conditions. Conclusion: FoxO3a is an early stress response protein to glucose toxicity in diabetic conditions.	[Raju, Ilangovan; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Kannan, Krishnaswamy] Univ Arkansas Med Sci, Div Rheumatol, Dept Internal Med, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Abraham, EC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	AbrahamEdatharaC@uams.edu			National Institutes of Health [EY11352]; Sturgis Diabetes Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sturgis Diabetes Foundation	This study was supported by National Institutes of Health grant #EY11352. Research grant money provided by Sturgis Diabetes Foundation to Dr. Kannan is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argirova M, 2002, J BIOCHEM MOL TOXIC, V16, P140, DOI 10.1002/jbt.10031; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CHERIAN M, 1995, BIOCHEM BIOPH RES CO, V212, P184, DOI 10.1006/bbrc.1995.1954; Choi SW, 2008, FREE RADICAL BIO MED, V44, P1217, DOI 10.1016/j.freeradbiomed.2007.12.005; Dansen TB, 2011, ANTIOXID REDOX SIGN, V14, P559, DOI 10.1089/ars.2010.3778; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Kim DH, 2013, J DIABETES; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kowluru A, 2012, BIOCHEM PHARMACOL, V84, P591, DOI 10.1016/j.bcp.2012.05.003; Kumar PA, 2005, MOL VIS, V11, P561; Kumar PA, 2009, J NUTR BIOCHEM, V20, P553, DOI 10.1016/j.jnutbio.2008.05.015; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P4395, DOI 10.1167/iovs.10-6652; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Obrosova IG, 2010, DIABETES-METAB RES, V26, P172, DOI 10.1002/dmrr.1075; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pollreisz A, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/608751; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Srivastava S K, 1990, Lens Eye Toxic Res, V7, P161; Thampi P, 2002, MOL CELL BIOCHEM, V229, P113, DOI 10.1023/A:1017980713089; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Ughade Suresh N., 1998, Indian Journal of Ophthalmology, V46, P221; Zheng TY, 2011, CURR EYE RES, V36, P449, DOI 10.3109/02713683.2011.559301	34	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67126	10.1371/journal.pone.0067126	http://dx.doi.org/10.1371/journal.pone.0067126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805295	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500123
J	Fiers, M; Lognay, G; Fauconnier, ML; Jijakli, MH				Fiers, Marie; Lognay, Georges; Fauconnier, Marie-Laure; Jijakli, M. Haiassam			Volatile Compound-Mediated Interactions between Barley and Pathogenic Fungi in the Soil	PLOS ONE			English	Article							GAS CHROMATOGRAPHY-OLFACTOMETRY; ORGANIC-COMPOUNDS VOCS; AROMA COMPOUNDS; RETENTION INDEXES; ACTIVE COMPOUNDS; PLANT VOLATILES; CROWN ROT; IDENTIFICATION; FLAVOR; BIOSYNTHESIS	Plants are able to interact with their environment by emitting volatile organic compounds. We investigated the volatile interactions that take place below ground between barley roots and two pathogenic fungi, Cochliobolus sativus and Fusarium culmorum. The volatile molecules emitted by each fungus, by non-infected barley roots and by barley roots infected with one of the fungi or the two of them were extracted by head-space solid phase micro extraction and analyzed by gas chromatography mass spectrometry. The effect of fungal volatiles on barley growth and the effect of barley root volatiles on fungal growth were assessed by cultivating both organisms in a shared atmosphere without any physical contact. The results show that volatile organic compounds, especially terpenes, are newly emitted during the interaction between fungi and barley roots. The volatile molecules released by non-infected barley roots did not significantly affect fungal growth, whereas the volatile molecules released by pathogenic fungi decreased the length of barley roots by 19 to 21.5% and the surface of aerial parts by 15%. The spectrum of the volatiles released by infected barley roots had no significant effect on F. culmorum growth, but decreased C. sativus growth by 13 to 17%. This paper identifies the volatile organic compounds emitted by two pathogenic fungi and shows that pathogenic fungi can modify volatile emission by infected plants. Our results open promising perspectives concerning the biological control of edaphic diseases.	[Fiers, Marie; Jijakli, M. Haiassam] Univ Liege, Gembloux Agrobio Tech GxABT, Phytopathol Unit, Gembloux, Belgium; [Lognay, Georges] Univ Liege, Gembloux Agrobio Tech GxABT, Analyt Chem Lab, Gembloux, Belgium; [Fauconnier, Marie-Laure] Univ Liege, Gembloux Agrobio Tech GxABT, Gen & Organ Chem Unit, Gembloux, Belgium	University of Liege; University of Liege; University of Liege	Fauconnier, ML (corresponding author), Univ Liege, Gembloux Agrobio Tech GxABT, Gen & Organ Chem Unit, Gembloux, Belgium.	Marie-Laure.Fauconnier@ulg.ac.be	Fauconnier, Marie-Laure/AAB-9807-2020	Fauconnier, Marie-Laure/0000-0002-2027-3896	University of Liege - Gembloux Agro-Bio Tech	University of Liege - Gembloux Agro-Bio Tech	This study was financially supported by the University of Liege - Gembloux Agro-Bio Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa LCA, 2009, MOLECULES, V14, P160, DOI 10.3390/molecules14010160; BERGER RG, 1989, Z LEBENSM UNTERS FOR, V188, P122, DOI 10.1007/BF01042735; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; Bianchi F, 2007, J SEP SCI, V30, P563, DOI 10.1002/jssc.200600393; BINDER RG, 1990, J AGR FOOD CHEM, V38, P1053, DOI 10.1021/jf00094a030; Blom D, 2011, ENVIRON MICROBIOL, V13, P3047, DOI 10.1111/j.1462-2920.2011.02582.x; Carrapiso AI, 2002, J AGR FOOD CHEM, V50, P6453, DOI 10.1021/jf025526c; Cavalli JF, 2003, FLAVOUR FRAG J, V18, P532, DOI 10.1002/ffj.1263; Choi HS, 2003, J AGR FOOD CHEM, V51, P2687, DOI 10.1021/jf021069o; CHUNG TY, 1993, J AGR FOOD CHEM, V41, P1693, DOI 10.1021/jf00034a033; Claeson AS, 2007, J ENVIRON MONITOR, V9, P240, DOI 10.1039/b614766f; Cullere L, 2004, J AGR FOOD CHEM, V52, P1653, DOI 10.1021/jf0350820; DASTUR J. F., 1942, Indian Journal of Agricultural Science, V12, P731; DAVIES NW, 1990, J CHROMATOGR, V503, P1, DOI 10.1016/S0021-9673(01)81487-4; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Ferreira V, 2001, J AGR FOOD CHEM, V49, P4818, DOI 10.1021/jf010283u; FISCHER KH, 1987, LEBENSM WISS TECHNOL, V20, P233; Fukami K, 2002, J AGR FOOD CHEM, V50, P5412, DOI 10.1021/jf020405y; Garbeva P, 2011, SOIL BIOL BIOCHEM, V43, P469, DOI 10.1016/j.soilbio.2010.11.020; Hamm S, 2004, J SEP SCI, V27, P235, DOI 10.1002/jssc.200301611; Hayata Y, 2003, J AGR FOOD CHEM, V51, P3415, DOI 10.1021/jf0209950; Hiltpold I, 2011, PLANT CELL ENVIRON, V34, P1; Hognadottir A, 2003, J CHROMATOGR A, V998, P201, DOI 10.1016/S0021-9673(03)00524-7; Jelen H, 1997, J MICROBIOL METH, V31, P45, DOI 10.1016/S0167-7012(97)00088-2; Jennings W., 1980, QUALITATIVE ANAL FLA; Jerkovic I, 2003, PHYTOCHEMISTRY, V63, P109, DOI 10.1016/S0031-9422(02)00706-9; Jurjevic Z, 2008, PHYTOPATHOL MEDITERR, V47, P266; Karimi S, 2001, J NAT PROD, V64, P406, DOI 10.1021/np000550a; Kumar J, 2002, MOL PLANT PATHOL, V3, P185, DOI 10.1046/j.1364-3703.2002.00120.x; Lanoue A, 2010, NEW PHYTOL, V185, P577, DOI 10.1111/j.1469-8137.2009.03066.x; Lodewyk MW, 2008, J ORG CHEM, V73, P6570, DOI 10.1021/jo800868r; Macias-Rubalcava ML, 2010, J CHEM ECOL, V36, P1122, DOI 10.1007/s10886-010-9848-5; Maeztu L, 2001, J AGR FOOD CHEM, V49, P5437, DOI 10.1021/jf0107959; Mahmood U, 2004, PHYTOCHEMISTRY, V65, P2163, DOI 10.1016/j.phytochem.2004.04.003; Mancini E, 2009, MOLECULES, V14, P4725, DOI 10.3390/molecules14114725; Mathre DE, 2003, PLANT HLTH PROGR, DOI [10.1094/PHP-2003-0819-01-DG, DOI 10.1094/PHP-2003-0819-01-DG]; Matysik S, 2009, CHEMOSPHERE, V76, P114, DOI 10.1016/j.chemosphere.2009.02.010; MELLON JE, 1979, PLANT PHYSIOL, V64, P406, DOI 10.1104/pp.64.3.406; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Murray GM, 2010, AUSTRALAS PLANT PATH, V39, P85, DOI 10.1071/AP09064; OKUDA M, 1967, PLANTA, V72, P289; Pennarun AL, 2002, J SCI FOOD AGR, V82, P1652, DOI 10.1002/jsfa.1236; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; PIENING LJ, 1976, CAN J PLANT SCI, V56, P419, DOI 10.4141/cjps76-070; PIERS E, 1977, CAN J CHEM, V55, P1039, DOI 10.1139/v77-145; Piesik D, 2013, J APPL ENTOMOL, V137, P296, DOI 10.1111/j.1439-0418.2012.01742.x; Piesik D, 2011, J PLANT PHYSIOL, V168, P878, DOI 10.1016/j.jplph.2010.11.010; PIRY J, 1995, FOOD CHEM, V54, P73, DOI 10.1016/0308-8146(95)92665-7; Priestap HA, 2003, PHYTOCHEMISTRY, V63, P221, DOI 10.1016/S0031-9422(02)00751-3; Rasmann S, 2008, OIKOS, V117, P362, DOI 10.1111/j.2007.0030-1299.16204.x; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Rose LJ, 2000, CURR MICROBIOL, V41, P206, DOI 10.1007/s002840010120; Ruther J, 2000, J CHROMATOGR A, V890, P313, DOI 10.1016/S0021-9673(00)00618-X; RYCHLIK M, 1998, COMPILATION ODOR THR, P63; Sanz C, 2001, J AGR FOOD CHEM, V49, P1364, DOI 10.1021/jf001100r; Schmelz EA, 2011, P NATL ACAD SCI USA, V108, P5455, DOI 10.1073/pnas.1014714108; Schnurer J, 1999, FUNGAL GENET BIOL, V27, P209, DOI 10.1006/fgbi.1999.1139; Semighini CP, 2008, FEMS MICROBIOL LETT, V279, P259, DOI 10.1111/j.1574-6968.2007.01042.x; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Ulrich D, 1997, Z LEBENSM UNTERS F A, V205, P218, DOI 10.1007/s002170050154; Umano K, 2000, J AGR FOOD CHEM, V48, P3463, DOI 10.1021/jf0001738; Umano K, 2002, J AGR FOOD CHEM, V50, P5355, DOI 10.1021/jf0203951; Valim MF, 2003, J AGR FOOD CHEM, V51, P1010, DOI 10.1021/jf025738+; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Varming C, 2004, J AGR FOOD CHEM, V52, P1647, DOI 10.1021/jf035133t; Wagacha JM, 2007, CROP PROT, V26, P877, DOI 10.1016/j.cropro.2006.09.003; Weckerle B, 2001, FLAVOUR FRAG J, V16, P360, DOI 10.1002/ffj.1012; Wenda-Piesik A, 2010, INT J PEST MANAGE, V56, P377, DOI 10.1080/09670874.2010.505668; Wheatley RE, 2002, ANTON LEEUW INT J G, V81, P357, DOI 10.1023/A:1020592802234; Wiese MV, 1977, COMPENDIUM WHEAT DIS, p[xii, 106]; WONG JM, 1988, J AGR FOOD CHEM, V36, P123, DOI 10.1021/jf00079a032; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	78	41	44	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66805	10.1371/journal.pone.0066805	http://dx.doi.org/10.1371/journal.pone.0066805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818966	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800103
J	Adams, AC; Halstead, CA; Hansen, BC; Irizarry, AR; Martin, JA; Myers, SR; Reynolds, VL; Smith, HW; Wroblewski, VJ; Kharitonenkov, A				Adams, Andrew C.; Halstead, Carolyn A.; Hansen, Barbara C.; Irizarry, Armando R.; Martin, Jennifer A.; Myers, Sharon R.; Reynolds, Vincent L.; Smith, Holly W.; Wroblewski, Victor J.; Kharitonenkov, Alexei			LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys	PLOS ONE			English	Article							INSULIN SENSITIVITY; ENERGY-EXPENDITURE; GROWTH; FGF-21	Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that represents a promising target for the treatment of several metabolic diseases. Administration of recombinant wild type FGF21 to diabetic animals leads to a dramatic improvement in glycaemia and ameliorates other systemic measures of metabolic health. Here we report the pharmacologic outcomes observed in non-human primates upon administration of a recently described FGF21 analogue, LY2405319 (LY). Diabetic rhesus monkeys were treated subcutaneously with LY once daily for a period of seven weeks. The doses of LY used were 3, 9 and 50 mg/kg each delivered in an escalating fashion with washout measurements taken at 2, 4, 6 and 8 weeks following the final LY dose. LY therapy led to a dramatic and rapid lowering of several important metabolic parameters including glucose, body weight, insulin, cholesterol and triglyceride levels at all doses tested. In addition, we observed favorable changes in circulating profiles of adipokines, with increased adiponectin and reduced leptin indicative of direct FGF21 action on adipose tissue. Importantly, and for the first time we show that FGF21 based therapy has metabolic efficacy in an animal with late stage diabetes. While the glycemic efficacy of LY in this animal was partially attenuated its lipid lowering effect was fully preserved suggesting that FGF21 may be a viable treatment option even in patients with advanced disease progression. These findings support continued exploration of the FGF21 pathway for the treatment of metabolic disease.	[Adams, Andrew C.; Halstead, Carolyn A.; Irizarry, Armando R.; Martin, Jennifer A.; Myers, Sharon R.; Reynolds, Vincent L.; Smith, Holly W.; Wroblewski, Victor J.; Kharitonenkov, Alexei] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Hansen, Barbara C.] Univ S Florida, Ctr Preclin Res, Tampa, FL USA	Eli Lilly; State University System of Florida; University of South Florida	Kharitonenkov, A (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	a.kharch@lilly.com	Hansen, Barbara C/J-8723-2012	Hansen, Barbara C/0000-0001-9646-3525	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	The study was funded by Eli Lilly and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Gimeno RE, 2012, MOL METABOLISM, P1; Hansen Barbara C, 2012, Methods Mol Biol, V933, P177, DOI 10.1007/978-1-62703-068-7_11; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2012, PLOS ONE; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Moller DE, 2012, CELL METAB, V15, P19, DOI 10.1016/j.cmet.2011.10.012; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Tharakan G, 2011, TRENDS PHARMACOL SCI, V32, P8, DOI 10.1016/j.tips.2010.10.003; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Warner A, 2012, J NEUROENDOCRINOL; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	23	128	138	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65763	10.1371/journal.pone.0065763	http://dx.doi.org/10.1371/journal.pone.0065763			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823755	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400021
J	Ho, EL; Ronquillo, R; Altmeppen, H; Spudich, SS; Price, RW; Sinclair, E				Ho, Emily L.; Ronquillo, Rollie; Altmeppen, Hermann; Spudich, Serena S.; Price, Richard W.; Sinclair, Elizabeth			Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIPLE-SCLEROSIS PATIENTS; CENTRAL-NERVOUS-SYSTEM; CD8(+) T-CELLS; ANTIRETROVIRAL THERAPY; HIV-1 INFECTION; PERIPHERAL-BLOOD; VIRAL LOAD; NEUROCOGNITIVE DISORDERS; TREATMENT INTERRUPTION	In order to characterize the cellular composition of cerebrospinal fluid (CSF) in a healthy state and in the setting of chronic pleocytosis associated with HIV-1 (HIV) infection, multi-parameter flow cytometry was used to identify and quantitate cellular phenotypes in CSF derived from HIV-uninfected healthy controls and HIV-infected subjects across a spectrum of disease and treatment. CD4+ T cells were the most frequent CSF population and the CD4:CD8 ratio was significantly increased in the CSF compared to blood (p = 0.0232), suggesting preferential trafficking of CD4+ over CD8+ T cells to this compartment. In contrast, in HIV-infection, CD8+ T cells were the major cellular component of the CSF and were markedly increased compared to HIV-uninfected subjects (p<0.001). As with peripheral blood, the CSF CD4:CD8 ratio was reversed in HIV-infected subjects compared to HIV-uninfected subjects. Monocytes, B cells and NK cells were rare in the CSF in both groups, although absolute counts of CSF NK cells and B cells were significantly increased in HIV-infected subjects (p<0.05). Our studies show that T cells are the major cellular component of the CSF in HIV-infected and uninfected subjects. The CSF pleocytosis characteristic of HIV infection involves all lymphocyte subsets we measured, except for CD4+ T cells, but is comprised primarily of CD8+ T cells. The reduced proportion of CD4+ T cells in the CSF may reflect both HIV-related peripheral loss and changes in trafficking patterns in response to HIV infection in the central nervous system.	[Ho, Emily L.] Univ Washington, Harborview Med Ctr, Dept Neurol, Seattle, WA 98104 USA; [Ronquillo, Rollie] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Altmeppen, Hermann] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Spudich, Serena S.] Yale Univ, Dept Neurol, New Haven, CT USA; [Price, Richard W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Sinclair, Elizabeth] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Rush University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sinclair, E (corresponding author), Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.	esinclair@sfgh.ucsf.edu	Ho, Emily Lin/AAR-4815-2021	Altmeppen, Hermann/0000-0001-9439-6533	American Academy of Neurology Clinical Research Training Fellowship; National Institutes of Health (UCSF-GIVI Center for AIDS Research) [R01 MH62701, R01 NS37660, R01 NS43103, K23 MH074466, P30AI027763]; NCRR UCSF-CTSI [UL1RR024131]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	American Academy of Neurology Clinical Research Training Fellowship; National Institutes of Health (UCSF-GIVI Center for AIDS Research); NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the subjects who volunteered for these studies, the staff of the San Francisco General Hospital (SFGH)/University of California-San Francisco (UCSF) General Clinical Research Center, the GIVI/UCSF CFAR Immunology Core and the AIDS Research Institute-UCSF Laboratory of Clinical Virology for their invaluable help. E.L.H. was a recipient of the American Academy of Neurology Clinical Research Training Fellowship.; This study was funded by grants from the National Institutes of Health: R01 MH62701; R01 NS37660; R01 NS43103; K23 MH074466; P30AI027763 (UCSF-GIVI Center for AIDS Research); UL1RR024131 (NCRR UCSF-CTSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Cepok S, 2003, ARCH NEUROL-CHICAGO, V60, P849, DOI 10.1001/archneur.60.6.849; Cepok S, 2007, ANN NEUROL, V62, P458, DOI 10.1002/ana.21195; Cepok S, 2006, J NEUROIMMUNOL, V180, P33, DOI 10.1016/j.jneuroim.2006.06.031; Cross AH, 2006, J NEUROIMMUNOL, V180, P63, DOI 10.1016/j.jneuroim.2006.06.029; de Graaf MT, 2011, CYTOM PART B-CLIN CY, V80B, P271, DOI 10.1002/cyto.b.20603; de Graaf MT, 2011, CYTOM PART B-CLIN CY, V80B, P43, DOI 10.1002/cyto.b.20542; Ellis RJ, 1997, ANN NEUROL, V42, P679, DOI 10.1002/ana.410420503; Ellis RJ, 2011, AIDS, V25, P1747, DOI 10.1097/QAD.0b013e32834a40cd; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Garcia F, 1999, AIDS, V13, P1491, DOI 10.1097/00002030-199908200-00008; Gisslen M, 1999, J ACQ IMMUN DEF SYND, V21, P271, DOI 10.1097/00126334-199908010-00003; Gregoire C, 2008, EUR J IMMUNOL, V38, P2076, DOI 10.1002/eji.200838550; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; HOLLANDER H, 1987, AM J MED, V83, P813, DOI 10.1016/0002-9343(87)90635-8; KATZ RL, 1989, ACTA CYTOL, V33, P233; Lescure FX, 2011, CLIN INFECT DIS, V52, P235, DOI 10.1093/cid/ciq041; MARGOLICK JB, 1988, J NEUROIMMUNOL, V20, P73, DOI 10.1016/0165-5728(88)90116-6; Marra CM, 2004, NEUROLOGY, V63, P85, DOI 10.1212/01.WNL.0000131902.69113.34; MARSHALL DW, 1988, ARCH NEUROL-CHICAGO, V45, P954, DOI 10.1001/archneur.1988.00520330032007; Maxeiner HG, 2009, BRAIN BEHAV IMMUN, V23, P134, DOI 10.1016/j.bbi.2008.08.003; MCARTHUR JC, 1988, ANN NEUROL, V23, pS34, DOI 10.1002/ana.410230712; MCARTHUR JH, 1988, NURS CLIN N AM, V23, P823; Morris L, 1998, J INFECT DIS, V177, P473, DOI 10.1086/517379; Neuenburg JK, 2005, JAIDS-J ACQ IMM DEF, V39, P16, DOI 10.1097/01.qai.0000155036.03004.a0; Neuenburg JK, 2005, AIDS, V19, P1351, DOI 10.1097/01.aids.0000181008.39514.ee; Neuenburg JK, 2004, JAIDS-J ACQ IMM DEF, V37, P1237, DOI 10.1097/01.qai.0000136733.09275.fa; NORONHA A, 1985, ANN NEUROL, V18, P722, DOI 10.1002/ana.410180617; Okuda Y, 2005, J NEUROL SCI, V235, P11, DOI 10.1016/j.jns.2005.02.013; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Price RW, 2004, J NEUROVIROL, V10, P44, DOI 10.1080/jnv.10.s1.44.51; Price RW, 2001, AIDS, V15, P1251, DOI 10.1097/00002030-200107060-00006; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; SCOLOZZI R, 1992, J NEUROL SCI, V108, P93, DOI 10.1016/0022-510X(92)90193-O; Shacklett BL, 2004, J INFECT DIS, V189, P2202, DOI 10.1086/421244; Sinclair E, 2008, JAIDS-J ACQ IMM DEF, V47, P544, DOI 10.1097/QAI.0b013e318162754f; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Spudich S, 2006, J INFECT DIS, V194, P1686, DOI 10.1086/508750; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Svenningsson A, 1995, J NEUROIMMUNOL, V63, P39, DOI 10.1016/0165-5728(95)00126-3; TRAUGOTT U, 1978, J NEUROL, V219, P185, DOI 10.1007/BF00314534; VANWIELINK G, 1990, NEUROLOGY, V40, P816, DOI 10.1212/WNL.40.5.816	46	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66188	10.1371/journal.pone.0066188	http://dx.doi.org/10.1371/journal.pone.0066188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822975	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400064
J	Liu, FJ; Lim, KY; Kaur, P; Sepramaniam, S; Armugam, A; Wong, PTH; Jeyaseelan, K				Liu, Fu Jia; Lim, Kai Ying; Kaur, Prameet; Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Wong, Peter Tsun Hon; Jeyaseelan, Kandiah			microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; TRANSIENT FOCAL ISCHEMIA; GENE-EXPRESSION; DOWN-REGULATION; MICROARRAY ANALYSIS; IDENTIFIES MIR-34A; CEREBRAL-ISCHEMIA; SIGNALING PATHWAY; FEEDBACK LOOP; INFARCT SIZE	To date, miRNA expression studies on cerebral ischemia in both human and animal models have focused mainly on acute phase of ischemic stroke. In this study, we present the roles played by microRNAs in the spontaneous recovery phases in cerebral ischemia using rodent stroke models. Brain tissues were harvested at different reperfusion time points ranging from 0-168 hrs after middle cerebral artery occlusion using homologous emboli. MiRNA and mRNA expression profiles were investigated by microarray followed by multiple statistical analysis. Candidate transcripts were also validated by quantitative RT-PCR. Three specific groups of miRNAs were observed among a total of 346 differentially expressed miRNAs. miRNAs, miR-21, -142-3p, -142-5p, and -146a displayed significant upregulation during stroke recovery (48 hrs to 168 hrs) compared with those during acute phases (0 hrs to 24 hrs). On the other hand, an opposite trend was observed in the expression of miR196a/b/c, -224 and -324-3p. Interestingly, miR-206, -290, -291a-5p and -30c-1*, positively correlated with the infarct sizes, with an initial increase up to 24hrs followed by a gradual decrease from 48 hrs to 168 hrs (R = 0.95). Taken together with the expression levels of corresponding mRNA targets, we have also found that Hedgehog, Notch, Wnt and TGF-beta signaling pathways could play significant roles in stroke recovery and especially in neuronal repair.	[Liu, Fu Jia; Lim, Kai Ying; Kaur, Prameet; Sepramaniam, Sugunavathi; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Natl Univ Hlth Syst, Ctr Translat Med, Yong Loo Lin Sch Med,Dept Biochem, Singapore 117595, Singapore; [Liu, Fu Jia; Wong, Peter Tsun Hon] Natl Univ Singapore, Dept Pharmacol, Ctr Translat Med, Yong Loo Lin Sch Med,Natl Univ Hlth Syst, Singapore 117595, Singapore; [Jeyaseelan, Kandiah] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia	National University of Singapore; National University of Singapore; Monash University	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Ctr Translat Med, Yong Loo Lin Sch Med,Dept Biochem, Singapore 117595, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	National Medical Research Council, Singapore [NMRC-IRG/1279/2010: R-183-000-290-213]; National Research Foundation-Competitive Research Program on Stroke, Singapore [NRF - CRP3 -2008-01: R-184-002-165-281]	National Medical Research Council, Singapore(National Medical Research Council, Singapore); National Research Foundation-Competitive Research Program on Stroke, Singapore(National Research Foundation, Singapore)	This work was supported by research grants from National Medical Research Council, Singapore (NMRC-IRG/1279/2010: R-183-000-290-213) and National Research Foundation-Competitive Research Program on Stroke (NRF - CRP3 -2008-01: R-184-002-165-281), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Armugam A, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-120; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285; Blanc EM, 1998, J NEUROCHEM, V70, P958; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Cramer SC, 2008, CURR OPIN NEUROL, V21, P76, DOI 10.1097/WCO.0b013e3282f36cb6; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Franklin TJ, 1997, INT J BIOCHEM CELL B, V29, P79, DOI 10.1016/S1357-2725(96)00121-5; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Gibson CL, 2006, J CEREBR BLOOD F MET, V26, P1103, DOI 10.1038/sj.jcbfm.9600270; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; GROSS CE, 1993, STROKE, V24, P558, DOI 10.1161/01.STR.24.4.558; Guo Y, 2012, PHYSIOL RES, V61, P337, DOI 10.33549/physiolres.932289; Han L, 2012, CNS NEUROSCI THER, V18, P573, DOI 10.1111/j.1755-5949.2012.00344.x; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Hughes DPM, 2009, CANCER TREAT RES, V152, P479, DOI 10.1007/978-1-4419-0284-9_28; Ibad RT, 2011, J NEUROSCI, V31, P5495, DOI 10.1523/JNEUROSCI.0187-11.2011; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Li HY, 2012, J NEUROCHEM, V123, P1010, DOI 10.1111/jnc.12045; Li JYH, 2001, DEVELOPMENT, V128, P4979; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Li PY, 2011, ANTIOXID REDOX SIGN, V14, P1905, DOI 10.1089/ars.2010.3451; Lim KY, 2010, TRANSL STROKE RES, V1, P287, DOI 10.1007/s12975-010-0035-3; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu W, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-64; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lo CW, 1997, DEV GENET, V20, P119, DOI 10.1002/(SICI)1520-6408(1997)20:2<119::AID-DVG5>3.0.CO;2-A; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Macconi D, 2012, J AM SOC NEPHROL, V23, P1496, DOI 10.1681/ASN.2011121144; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Pang L, 2001, STROKE, V32, P544, DOI 10.1161/01.STR.32.2.544; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Rhinn M, 1998, DEVELOPMENT, V125, P845; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang R, 2012, CELL PHYSIOL BIOCHEM, V29, P381, DOI 10.1159/000338493; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; Wei L, 2001, STROKE, V32, P2179, DOI 10.1161/hs0901.094282; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Zhang L, 2012, ARTERIOSCL THROM VAS, V32, P1856, DOI 10.1161/ATVBAHA.112.252619; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang TH, 2011, ANTICANCER RES, V31, P3859; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	86	92	98	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66393	10.1371/journal.pone.0066393	http://dx.doi.org/10.1371/journal.pone.0066393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823624	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400101
J	Jemon, K; Young, V; Wilson, M; McKee, S; Ward, V; Baird, M; Young, S; Hibma, M				Jemon, Khairunadwa; Young, Vivienne; Wilson, Michelle; McKee, Sara; Ward, Vernon; Baird, Margaret; Young, Sarah; Hibma, Merilyn			An Enhanced Heterologous Virus-Like Particle for Human Papillomavirus Type 16 Tumour Immunotherapy	PLOS ONE			English	Article							REGULATORY T-CELLS; HEMORRHAGIC-DISEASE VIRUS; CERVICAL-CANCER; DNA VACCINE; ANTIGEN-4 BLOCKADE; IMMUNE-RESPONSES; CAPSID PROTEIN; COMBINATION IMMUNOTHERAPY; ANTI-CD25 ANTIBODY; ANTITUMOR IMMUNITY	Cervical cancer is caused by high-risk, cancer-causing human papillomaviruses (HPV) and is the second highest cause of cancer deaths in women globally. The majority of cervical cancers express well-characterized HPV oncogenes, which are potential targets for immunotherapeutic vaccination. Here we develop a rabbit haemorrhagic disease virus (RHDV) virus-like particle (VLP)-based vaccine designed for immunotherapy against HPV16 positive tumours. An RHDV-VLP, modified to contain the universal helper T cell epitope PADRE and decorated with an MHC I-restricted peptide (aa 48-57) from the HPV16 E6, was tested for its immunotherapeutic efficacy against the TC-1 HPV16 E6 and E7-expressing tumour in mice. The E6-RHDV-VLP-PADRE was administered therapeutically for the treatment of a pre-existing TC-1 tumour and was delivered with antibodies either to deplete regulatory T cells (anti-CD25) or to block T cell suppression mediated through CTLA-4. As a result, the tumour burden was reduced by around 50% and the median survival time of mice to the humane endpoint was almost doubled the compared to controls. The incorporation of PADRE into the RHDV-VLP was necessary for an E6-specific enhancement of the anti-tumour response and the co-administration of the immune modifying antibodies contributed to the overall efficacy of the immunotherapy. The E6-RHDV-VLP-PADRE shows immunotherapeutic efficacy, prolonging survival for HPV tumour-bearing mice. This was enhanced by the systemic administration of immune-modifying antibodies that are commercially available for use in humans. There is potential to further modify these particles for even greater efficacy in the path to development of an immunotherapeutic treatment for HPV precancerous and cancer stages.	[Jemon, Khairunadwa; Young, Vivienne; Wilson, Michelle; McKee, Sara; Ward, Vernon; Baird, Margaret; Hibma, Merilyn] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [McKee, Sara; Young, Sarah] Univ Otago, Dept Pathol, Dunedin, New Zealand	University of Otago; University of Otago	Hibma, M (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	merilyn.hibma@otago.ac.nz	McKee, Sara/R-7810-2016; Jemon, Khairunadwa/N-2401-2013	McKee, Sara/0000-0002-3513-2906; Jemon, Khairunadwa/0000-0002-6966-3406; Ward, Vernon/0000-0001-8692-5116; Young, Vivienne/0000-0002-9216-5552; Young, Sarah/0000-0003-0374-2221	Health Research Council of New Zealand; Genesis Oncology Trust (New Zealand)	Health Research Council of New Zealand(Health Research Council of New Zealand); Genesis Oncology Trust (New Zealand)	Funding for this study was provided by the Health Research Council of New Zealand and the Genesis Oncology Trust (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Chen YL, 2008, WORLD J GASTROENTERO, V14, P5797, DOI 10.3748/wjg.14.5797; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dawar M, 2007, CAN MED ASSOC J, V177, P456, DOI 10.1503/cmaj.070771; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Gromadzka B, 2006, ACTA BIOCHIM POL, V53, P371; Hamilton DH, 2008, CANCER IMMUNOL IMMUN, V57, P1125, DOI 10.1007/s00262-007-0442-9; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hsu FJ, 2002, J IMMUNOTHER, V25, P455, DOI 10.1097/00002371-200211000-00002; Huang CH, 2005, GENE THER, V12, P1180, DOI 10.1038/sj.gt.3302519; Hung CF, 2007, MOL THER, V15, P1211, DOI 10.1038/sj.mt.6300121; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Hurwitz AA, 2000, CANCER RES, V60, P2444; HUSMANN LA, 1988, ANN NY ACAD SCI, V532, P158, DOI 10.1111/j.1749-6632.1988.tb36335.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katpally U, 2010, J VIROL, V84, P5836, DOI 10.1128/JVI.00314-10; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Laurent S, 2002, ARCH VIROL, V147, P1559, DOI 10.1007/s00705-002-0825-3; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lenz P, 2003, CLIN IMMUNOL, V106, P231, DOI 10.1016/S1521-6616(02)00039-6; Leong CM, 2010, J INVEST DERMATOL, V130, P472, DOI 10.1038/jid.2009.266; Li KY, 2013, J IMMUNOTHER, V36, P11, DOI 10.1097/CJI.0b013e3182787f5e; Li YL, 2010, ONCOL REP, V24, P1323, DOI 10.3892/or_00000989; Lin KY, 1996, CANCER RES, V56, P21; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Loddenkemper C, 2009, CANCER SCI, V100, P1112, DOI 10.1111/j.1349-7006.2009.01153.x; May KF, 2005, BLOOD, V105, P1114, DOI 10.1182/blood-2004-07-2561; McKee SJ, 2012, J CONTROL RELEASE; Molling JW, 2007, INT J CANCER, V121, P1749, DOI 10.1002/ijc.22894; MOUSSA A, 1992, VET MICROBIOL, V33, P375, DOI 10.1016/0378-1135(92)90065-2; NAGESHA HS, 1995, ARCH VIROL, V140, P1095, DOI 10.1007/BF01315418; Ohlinger V F, 1991, Rev Sci Tech, V10, P311; Okita R, 2009, INT J ONCOL, V34, P563, DOI 10.3892/ijo_00000182; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Oosterhuis K, 2011, INT J CANCER, V129, P397, DOI 10.1002/ijc.25894; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peacey M, 2008, VACCINE, V26, P5334, DOI 10.1016/j.vaccine.2008.07.074; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Pedersen AE, 2006, CANCER LETT, V235, P229, DOI 10.1016/j.canlet.2005.04.012; Peng S, 2008, GENE THER, V15, P1156, DOI 10.1038/gt.2008.53; Peng SW, 2004, J VIROL, V78, P8468, DOI 10.1128/JVI.78.16.8468-8476.2004; Persson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022303; Raghunandan R, 2011, EXPERT REV VACCINES, V10, P409, DOI [10.1586/erv.11.37, 10.1586/ERV.11.37]; Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; Saha A, 2010, SCAND J IMMUNOL, V71, P70, DOI 10.1111/j.1365-3083.2009.02355.x; Schwarz K, 2003, EUR J IMMUNOL, V33, P1465, DOI 10.1002/eji.200323919; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; Stanley Margaret, 2003, Expert Rev Vaccines, V2, P615, DOI 10.1586/14760584.2.5.615; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Visser J, 2007, CLIN EXP IMMUNOL, V150, P199, DOI 10.1111/j.1365-2249.2007.03468.x; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Welters MJP, 2008, CLIN CANCER RES, V14, P178, DOI 10.1158/1078-0432.CCR-07-1880; Wick DA, 2011, VACCINE, V29, P7857, DOI 10.1016/j.vaccine.2011.07.090; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; Woo EY, 2002, J IMMUNOL, V168, P4272, DOI 10.4049/jimmunol.168.9.4272; Wu A, 2011, GENE THER, V18, P304, DOI 10.1038/gt.2010.151; Zhang Y, 2007, INT IMMUNOL, V19, P151, DOI 10.1093/intimm/dxl132; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	68	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66866	10.1371/journal.pone.0066866	http://dx.doi.org/10.1371/journal.pone.0066866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799135	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300100
J	Lin, SC; Jan, JT; Dionne, B; Butler, M; Huang, MH; Wu, CY; Wong, CH; Wu, SC				Lin, Shih-Chang; Jan, Jia-Tsrong; Dionne, Ben; Butler, Michael; Huang, Ming-Hsi; Wu, Chung-Yi; Wong, Chi-Huey; Wu, Suh-Chin			Different Immunity Elicited by Recombinant H5N1 Hemagglutinin Proteins Containing Pauci-Mannose, High-Mannose, or Complex Type N-Glycans	PLOS ONE			English	Article							INFLUENZA-VIRUS H5N1; AVIAN INFLUENZA; VIRAL HEMAGGLUTININ; CHALLENGE INFECTION; RECEPTOR-BINDING; INSECT CELLS; CHO-CELLS; GLYCOSYLATION; CULTURE; TRANSMISSION	Highly pathogenic avian influenza H5N1 viruses can result in poultry and occasionally in human mortality. A safe and effective H5N1 vaccine is urgently needed to reduce the pandemic potential. Hemagglutinin (HA), a major envelope protein accounting for approximately 80% of spikes in influenza virus, is often used as a major antigen for subunit vaccine development. In this study, we conducted a systematic study of the immune response against influenza virus infection following immunization with recombinant HA proteins expressed in insect (Sf9) cells, insect cells that contain exogenous genes for elaborating N-linked glycans (Mimic) and mammalian cells (CHO). While the antibody titers are higher with the insect cell derived HA proteins, the neutralization and HA inhibition titers are much higher with the mammalian cell produced HA proteins. Recombinant HA proteins containing tri- or tetra-antennary complex, terminally sialylated and asialyated-galactose type N-glycans induced better protective immunity in mice to lethal challenge. The results are highly relevant to issues that should be considered in the production of fragment vaccines.	[Lin, Shih-Chang; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Jan, Jia-Tsrong; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Dionne, Ben; Butler, Michael] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Huang, Ming-Hsi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; University of Manitoba; National Health Research Institutes - Taiwan	Wu, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	scwu@mx.nthu.edu.tw	Butler, Michael/AAP-7439-2021; Wu, Chung-Yi/K-8334-2018; Wu, Suh-Chin/AAV-6233-2021; Huang, Ming-Hsi/E-3872-2010; Butler, Michael/I-8167-2012	Huang, Ming-Hsi/0000-0002-9670-3821; Butler, Michael/0000-0002-4907-3652	National Science Council of Taiwan [NSC101-2321-B-007-002, NSC99-2311-B-007-005-MY3]; National Health Research Institutes; Academia Sinica Short-term Visitor Program	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Academia Sinica Short-term Visitor Program	This project was supported by the National Science Council of Taiwan (NSC101-2321-B-007-002 and NSC99-2311-B-007-005-MY3), the National Health Research Institutes, and the Academia Sinica Short-term Visitor Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EW, 2008, CHEMBIOCHEM, V9, P294, DOI 10.1002/cbic.200700310; Berns KI, 2012, SCIENCE, V335, P660, DOI 10.1126/science.1217994; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bjorkman C, 1999, J VET DIAGN INVEST, V11, P41; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Buszewski B, 2012, ANAL BIOANAL CHEM, V402, P231, DOI 10.1007/s00216-011-5308-5; Chen WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049224; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; de Vries RP, 2012, J VIROL, V86, P11735, DOI 10.1128/JVI.01084-12; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Hutter J, 2013, J IMMUNOL, V190, P220, DOI 10.4049/jimmunol.1201060; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jarvis DL, 1998, CURR OPIN BIOTECH, V9, P528, DOI 10.1016/S0958-1669(98)80041-4; Kalthoff D, 2010, J VIROL, V84, P12002, DOI 10.1128/JVI.00940-10; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Lin SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039075; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Lin SC, 2010, BIOTECHNOL PROGR, V26, P1733, DOI 10.1002/btpr.480; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Restelli V, 2006, BIOTECHNOL BIOENG, V94, P481, DOI 10.1002/bit.20875; Rodriguez J, 2005, BIOTECHNOL PROGR, V21, P22, DOI 10.1021/bp049807b; Rodriguez J, 2010, J BIOTECHNOL, V150, P509, DOI 10.1016/j.jbiotec.2010.09.959; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Webster RG, 2012, MBIO, V3, DOI 10.1128/mBio.00005-12; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wei HJ, 2011, VACCINE, V29, P7163, DOI 10.1016/j.vaccine.2011.05.077; World Health Organization, CUMULATIVE NUMBER CO; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932	44	25	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66719	10.1371/journal.pone.0066719	http://dx.doi.org/10.1371/journal.pone.0066719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799128	Green Published, gold			2022-12-27	WOS:000320363300093
J	Florencio, DF; Marins, A; Rosa, CS; Cristaldo, PF; Araujo, PA; Silva, IR; DeSouza, O				Florencio, Daniela Faria; Marins, Alessandra; Rosa, Cassiano Sousa; Cristaldo, Paulo Fellipe; Araujo, Paula Albano; Silva, Ivo Ribeiro; DeSouza, Og			Diet Segregation between Cohabiting Builder and Inquiline Termite Species	PLOS ONE			English	Article							CORNITERMES-CUMULANS ISOPTERA; NATIONAL-PARK; ECOLOGY; COMMUNITIES; COEXISTENCE; COMPETITION; EVOLUTION; ISOTOPES; POSITION; SAVANNA	How do termite inquilines manage to cohabit termitaria along with the termite builder species? With this in mind, we analysed one of the several strategies that inquilines could use to circumvent conflicts with their hosts, namely, the use of distinct diets. We inspected overlapping patterns for the diets of several cohabiting Neotropical termite species, as inferred from carbon and nitrogen isotopic signatures for termite individuals. Cohabitant communities from distinct termitaria presented overlapping diet spaces, indicating that they exploited similar diets at the regional scale. When such communities were split into their components, full diet segregation could be observed between builders and inquilines, at regional (environment-wide) and local (termitarium) scales. Additionally, diet segregation among inquilines themselves was also observed in the vast majority of inspected termitaria. Inquiline species distribution among termitaria was not random. Environmental-wide diet similarity, coupled with local diet segregation and deterministic inquiline distribution, could denounce interactions for feeding resources. However, inquilines and builders not sharing the same termitarium, and thus not subject to potential conflicts, still exhibited distinct diets. Moreover, the areas of the builder's diet space and that of its inquilines did not correlate negatively. Accordingly, the diet areas of builders which hosted inquilines were in average as large as the areas of builders hosting no inquilines. Such results indicate the possibility that dietary partitioning by these cohabiting termites was not majorly driven by current interactive constraints. Rather, it seems to be a result of traits previously fixed in the evolutionary past of cohabitants.	[Florencio, Daniela Faria; Marins, Alessandra; Rosa, Cassiano Sousa; Cristaldo, Paulo Fellipe; DeSouza, Og] Univ Fed Vicosa, Dept Entomol, Lab Termitol, Vicosa, MG, Brazil; [Florencio, Daniela Faria] Univ Fed Santa Catarina, Dept Bioquim, Curitibanos, Santa Catarina, Brazil; [Marins, Alessandra] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Rosa, Cassiano Sousa] Univ Estado Minas Gerais, Fac Engn, Joao Monlevade, MG, Brazil; [Araujo, Paula Albano] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Infochem Res Team, Prague, Czech Republic; [Araujo, Paula Albano] Univ Fed Sergipe, Sao Cristovao, Sergipe, Brazil; [Silva, Ivo Ribeiro] Univ Fed Vicosa, Dept Solos, Lab Isotopos Estaveis, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Santa Catarina (UFSC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade do Estado de Minas Gerais; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universidade Federal de Sergipe; Universidade Federal de Vicosa	DeSouza, O (corresponding author), Univ Fed Vicosa, Dept Entomol, Lab Termitol, Vicosa, MG, Brazil.	og.souza@ufv.br	DeSouza, Og/A-7140-2008; Rosa, Cassiano S/A-1780-2011; Cristaldo, Paulo/A-1247-2013; Marins, Alessandra/G-1334-2014	DeSouza, Og/0000-0002-7108-0242; Rosa, Cassiano S/0000-0003-3294-5677; Cristaldo, Paulo/0000-0003-4939-0487; Marins, Alessandra/0000-0002-6233-110X; Albano Araujo, Ana P./0000-0001-7853-8001	Brazilian National Council for Research (CNPq) [140085/2010-6, 142551/2008-2, 150362/2012-9, 302486/2010-0, PQ-2, 200271/2010, PQ-1D]; Coordination for the Improvement of Higher Education Personnel (CAPES) [PDSE 9669/11-6]; Minas Gerais State Foundation for Research Support (FAPEMIG) [CRA-APQ-02124-09, BPD-00135-10, CRA-APQ-01519-11, BPV-00055-11]	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Minas Gerais State Foundation for Research Support (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The Brazilian National Council for Research (CNPq) provided financial support to the following coauthors: AM (SwB posdoctoral grant), PFC (doctoral grant 140085/2010-6), CSR (doctoral grant 142551/2008-2 and posdoctoral grant 150362/2012-9), ODS (fellowship 302486/2010-0, PQ-2 and grant 200271/2010), IRS (fellowship PQ-1D). The Coordination for the Improvement of Higher Education Personnel (CAPES) supported PFC (PDSE 9669/11-6) and DFF (CAPES/REUNI). The Minas Gerais State Foundation for Research Support (FAPEMIG) supported AM (doctoral grand) and funded significant parts of field and lab work through grants CRA-APQ-02124-09, BPD-00135-10, CRA-APQ-01519-11, and BPV-00055-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agritempo, 2009, SIST MON AGR; Araujo R. L., 1970, P527; Bouillon A., 1970, P153; Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Bourguignon T, 2009, SOIL BIOL BIOCHEM, V41, P2038, DOI 10.1016/j.soilbio.2009.07.005; Brightsmith DJ, 2000, CONDOR, V102, P529, DOI 10.1650/0010-5422(2000)102[0529:UOATBN]2.0.CO;2; Chase J.M., 2009, ECOLOGICAL NICHES LI; COLES HR, 1980, THESIS U SOUTHAMPTON; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; CONSTANTINO R., 2002, ZOOTAXA, V67, P1, DOI [10.11646/zootaxa.67.1.1, DOI 10.11646/zootaxa.67.1.1, DOI 10.11646/ZOOTAXA.67.1.1]; Costa Cleide, 2010, Psyche (Cambridge), V2010, P1; Costa DA, 2009, SOCIOBIOLOGY, V53, P443; COUTINHO LM, 1990, ECOL STU AN, V84, P82; Crawley M.J., 2007, R BOOK; Cristaldo PF, 2012, INSECT SOC, V59, P541, DOI 10.1007/s00040-012-0249-3; Darlington JPEC, 2012, INSECT SOC, V59, P159, DOI 10.1007/s00040-011-0199-1; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; De Visser SN, 2008, ECOL ENTOMOL, V33, P758, DOI 10.1111/j.1365-2311.2008.01029.x; Dechmann DKN, 2004, EVOL ECOL RES, V6, P1037; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DeSouza O, 2003, SOCIOBIOLOGY, V42, P639; DeSouza O, 2009, B ENTOMOL RES, V99, P603, DOI 10.1017/S000748530900666X; Eggers T, 2000, TRENDS ECOL EVOL, V15, P265, DOI 10.1016/S0169-5347(00)01877-2; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fry B., 2006, STABLE ISOTOPE ECOLO; Grasse P, 1986, TERMITOLOGIA, VIII, P235; HARRIS RN, 1995, ANIM BEHAV, V50, P1309, DOI 10.1016/0003-3472(95)80046-8; Hines HM, 2010, INSECT SOC, V57, P379, DOI 10.1007/s00040-010-0094-1; Hubbell Stephen P., 2001, V32, pi; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jouquet P, 2002, INSECT SOC, V49, P1, DOI 10.1007/s00040-002-8269-z; Junqueira Domingos Denize, 1996, Revista Brasileira de Biologia, V56, P717; Kalshoven LGE, 1954, INSECT SOC, V1, P319; KISTNER DH, 1990, SOCIOBIOLOGY, V17, P191; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Korb J, 2002, INSECT SOC, V49, P264, DOI 10.1007/s00040-002-8312-0; Korb J, 2001, OECOLOGIA, V127, P324, DOI 10.1007/s004420000597; Korb J, 2001, AFR J ECOL, V39, P257, DOI 10.1046/j.1365-2028.2001.00312.x; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kronland WJ, 2007, WILSON J ORNITHOL, V119, P486, DOI 10.1676/05-139.1; LEE K. E., 1971, TERMITES AND SOIL; Lo N, 2007, BIOL LETTERS, V3, P562, DOI 10.1098/rsbl.2007.0264; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mathews A. G. A., 1977, STUDIES TERMITES MAT; Noirot C., 1970, P73; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perdereau E, 2011, BIOL INVASIONS, V13, P1457, DOI 10.1007/s10530-010-9906-5; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; R Development Core Team, 2012, R LANG ENV STAT COMP; REDFORD KH, 1984, BIOTROPICA, V16, P112, DOI 10.2307/2387842; Sarty M, 2007, INSECT SOC, V54, P166, DOI 10.1007/s00040-007-0927-8; Schonrogge K, 2006, ECOL LETT, V9, P1032, DOI 10.1111/j.1461-0248.2006.00957.x; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; Vander Zanden MJ, 2000, CAN J FISH AQUAT SCI, V57, P725, DOI 10.1139/cjfas-57-4-725; Vasconcellos A, 2007, NEOTROP ENTOMOL, V36, P693, DOI 10.1590/S1519-566X2007000500009	57	26	26	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66535	10.1371/journal.pone.0066535	http://dx.doi.org/10.1371/journal.pone.0066535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805229	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500057
J	Kavanaugh, DW; O'Callaghan, J; Butto, LF; Slattery, H; Lane, J; Clyne, M; Kane, M; Joshi, L; Hickey, RM				Kavanaugh, Devon W.; O'Callaghan, John; Butto, Ludovica F.; Slattery, Helen; Lane, Jonathan; Clyne, Marguerite; Kane, Marian; Joshi, Lokesh; Hickey, Rita M.			Exposure of Bifidobacterium longum subsp infantis to Milk Oligosaccharides Increases Adhesion to Epithelial Cells and Induces a Substantial Transcriptional Response	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; BOTTLE-FED INFANTS; IN-VITRO; HELICOBACTER-PYLORI; CACO-2 CELLS; INTESTINAL MICROFLORA; HAEMOPHILUS-DUCREYI; BACTERIAL ADHESION; HUMAN ENTEROCYTE; STRAINS	In this study, we tested the hypothesis that milk oligosaccharides may contribute not only to selective growth of bifidobacteria, but also to their specific adhesive ability. Human milk oligosaccharides (3'sialyllactose and 6'sialyllactose) and a commercial prebiotic (Beneo Orafti P95; oligofructose) were assayed for their ability to promote adhesion of Bifidobacterium longum subsp. infantis ATCC 15697 to HT-29 and Caco-2 human intestinal cells. Treatment with the commercial prebiotic or 3'sialyllactose did not enhance adhesion. However, treatment with 6'sialyllactose resulted in increased adhesion (4.7 fold), while treatment with a mixture of 3'- and 6'-sialyllactose substantially increased adhesion (9.8 fold) to HT-29 intestinal cells. Microarray analyses were subsequently employed to investigate the transcriptional response of B. longum subsp. infantis to the different oligosaccharide treatments. This data correlated strongly with the observed changes in adhesion to HT-29 cells. The combination of 3'- and 6'-sialyllactose resulted in the greatest response at the genetic level (both in diversity and magnitude) followed by 6'sialyllactose, and 3'sialyllactose alone. The microarray data was further validated by means of real-time PCR. The current findings suggest that the increased adherence phenotype of Bifidobacterium longum subsp. infantis resulting from exposure to milk oligosaccharides is multi-faceted, involving transcription factors, chaperone proteins, adhesion-related proteins, and a glycoside hydrolase. This study gives additional insight into the role of milk oligosaccharides within the human intestine and the molecular mechanisms underpinning host-microbe interactions.	[Kavanaugh, Devon W.; O'Callaghan, John; Slattery, Helen; Lane, Jonathan; Hickey, Rita M.] Teagasc Food Res Ctr, Dept Biosci, Cork, Ireland; [Kavanaugh, Devon W.; Clyne, Marguerite; Kane, Marian; Joshi, Lokesh; Hickey, Rita M.] Natl Univ Ireland, Glycosci Grp, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Butto, Ludovica F.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Butto, Ludovica F.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Clyne, Marguerite] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland	Teagasc; Ollscoil na Gaillimhe-University of Galway; University College Cork; University College Cork; University College Dublin	Hickey, RM (corresponding author), Teagasc Food Res Ctr, Dept Biosci, Moorepk, Cork, Ireland.	rita.hickey@teagasc.ie	O'Callaghan, John/G-6242-2014; Hickey, Rita/AAY-7875-2021; Clyne, Marguerite M/H-4179-2012; Butto, Ludovica/P-1882-2019	O'Callaghan, John/0000-0002-1522-4512; Clyne, Marguerite M/0000-0003-2547-9129; Kavanaugh, Devon/0000-0001-8831-8248; Joshi, Lokesh/0000-0002-3612-0747	Teagasc Walsh Fellowship; Science Foundation Ireland [08/SRC/B1393]; Alimentary Glycoscience Research Cluster (AGRC)	Teagasc Walsh Fellowship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Alimentary Glycoscience Research Cluster (AGRC)(Science Foundation Ireland)	Devon Kavanaugh is in receipt of a Teagasc Walsh Fellowship. The authors would also like to acknowledge the support of Science Foundation Ireland under Grant No. 08/SRC/B1393 and the Alimentary Glycoscience Research Cluster (AGRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali QS, 2009, P WORLD ACAD SCI ENG, V9, P149; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; BENNO Y, 1984, MICROBIOL IMMUNOL, V28, P975, DOI 10.1111/j.1348-0421.1984.tb00754.x; Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006; BERNET MF, 1993, APPL ENVIRON MICROB, V59, P4121, DOI 10.1128/AEM.59.12.4121-4128.1993; Bezirtzoglou E, 1997, ANAEROBE, V3, P173, DOI 10.1006/anae.1997.0102; Boehm G, 2007, J NUTR, V137, p847S, DOI 10.1093/jn/137.3.847S; Brentjens RJ, 1996, J BACTERIOL, V178, P808, DOI 10.1128/jb.178.3.808-816.1996; Candela M, 2005, RES MICROBIOL, V156, P887, DOI 10.1016/j.resmic.2005.04.006; Candela M, 2010, MICROBIOL-SGM, V156, P1609, DOI 10.1099/mic.0.038307-0; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Chichlowski M, 2012, J PEDIATR GASTR NUTR, V55, P321, DOI 10.1097/MPG.0b013e31824fb899; Chopra DP, 2010, STEM CELLS DEV, V19, P131, DOI 10.1089/scd.2009.0109; COCONNIER MH, 1992, APPL ENVIRON MICROB, V58, P2034, DOI 10.1128/AEM.58.6.2034-2039.1992; Cooksley C, 2003, J MED MICROBIOL, V52, P461, DOI 10.1099/jmm.0.05070-0; CROCIANI J, 1995, LETT APPL MICROBIOL, V21, P146, DOI 10.1111/j.1472-765X.1995.tb01027.x; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Dunn BE, 1997, INFECT IMMUN, V65, P1181, DOI 10.1128/IAI.65.4.1181-1188.1997; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Foroni E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S16; Frisk A, 1998, INFECT IMMUN, V66, P1252, DOI 10.1128/IAI.66.3.1252-1257.1998; Garrido D, 2012, ANAEROBE, V18, P430, DOI 10.1016/j.anaerobe.2012.04.012; Garrido D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017315; GILLIS TP, 1985, INFECT IMMUN, V49, P371, DOI 10.1128/IAI.49.2.371-377.1985; Gleinser M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-80; Gnoth MJ, 2000, J NUTR, V130, P3014, DOI 10.1093/jn/130.12.3014; Gonzalez R, 2008, APPL ENVIRON MICROB, V74, P4686, DOI 10.1128/AEM.00122-08; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hennequin C, 2001, MICROBIOL-UK, V147, P87, DOI 10.1099/00221287-147-1-87; Kiyohara M, 2009, BIOSCI BIOTECH BIOCH, V73, P1175, DOI 10.1271/bbb.80697; Lane JI, 2010, TEMPORAL BONE, P1, DOI 10.1007/978-3-642-02210-4_1; Langerholc T, 2011, TRENDS FOOD SCI TECH, V22, pS11, DOI 10.1016/j.tifs.2011.03.010; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Leahy SC, 2005, J APPL MICROBIOL, V98, P1303, DOI 10.1111/j.1365-2672.2005.02600.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; MEVISSENVERHAGE EAE, 1987, J CLIN MICROBIOL, V25, P285, DOI 10.1128/JCM.25.2.285-289.1987; Moss AC, 2007, GUT, V56, P1210, DOI 10.1136/gut.2006.110668; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Mukai T, 1997, CURR MICROBIOL, V34, P326, DOI 10.1007/s002849900190; Preising J, 2010, APPL ENVIRON MICROB, V76, P3048, DOI 10.1128/AEM.03127-09; Remus DM, 2013, J BACTERIOL, V195, P502, DOI 10.1128/JB.01321-12; Riedel CU, 2006, INT J FOOD MICROBIOL, V110, P62, DOI 10.1016/j.ijfoodmicro.2006.01.040; Savage DC, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P19, DOI 10.1016/B978-012491543-5/50006-1; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Sela DA, 2011, INT J FOOD MICROBIOL, V149, P58, DOI 10.1016/j.ijfoodmicro.2011.01.025; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; Ventura M, 2004, APPL ENVIRON MICROB, V70, P6197, DOI 10.1128/AEM.70.10.6197-6209.2004; Ward RE, 2007, MOL NUTR FOOD RES, V51, P1398, DOI 10.1002/mnfr.200700150; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107; Zocco MA, 2007, DIGEST LIVER DIS, V39, P707, DOI 10.1016/j.dld.2007.04.003	58	69	71	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67224	10.1371/journal.pone.0067224	http://dx.doi.org/10.1371/journal.pone.0067224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805302	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500130
J	Reme, T; Hugnot, JP; Bieche, I; Rigau, V; Burel-Vandenbos, F; Prevot, V; Baroncini, M; Fontaine, D; Chevassus, H; Vacher, S; Lidereau, R; Duffau, H; Bauchet, L; Joubert, D				Reme, Thierry; Hugnot, Jean-Philippe; Bieche, Ivan; Rigau, Valerie; Burel-Vandenbos, Fanny; Prevot, Vincent; Baroncini, Marc; Fontaine, Denys; Chevassus, Hugues; Vacher, Sophie; Lidereau, Rosette; Duffau, Hugues; Bauchet, Luc; Joubert, Dominique			A Molecular Predictor Reassesses Classification of Human Grade II/III Gliomas	PLOS ONE			English	Article							PRIMARY BRAIN-TUMORS; ANAPLASTIC OLIGODENDROGLIOMAS; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMAS; PROGNOSTIC VALUE; EXPRESSION; GENE; GROWTH; CANCER; DIAGNOSIS	Diffuse gliomas are incurable brain tumors divided in 3 WHO grades (II; III; IV) based on histological criteria. Grade II/III gliomas are clinically very heterogeneous and their prognosis somewhat unpredictable, preventing definition of appropriate treatment. On a cohort of 65 grade II/III glioma patients, a QPCR-based approach allowed selection of a biologically relevant gene list from which a gene signature significantly correlated to overall survival was extracted. This signature clustered the training cohort into two classes of low and high risk of progression and death, and similarly clustered two external independent test cohorts of 104 and 73 grade II/III patients. A 22-gene class predictor of the training clusters optimally distinguished poor from good prognosis patients (median survival of 13-20 months versus over 6 years) in the validation cohorts. This classification was stronger at predicting outcome than the WHO grade II/III classification (P <= 2.8E-10 versus 0.018). When compared to other prognosis factors (histological subtype and genetic abnormalities) in a multivariate analysis, the 22-gene predictor remained significantly associated with overall survival. Early prediction of high risk patients (3% of WHO grade II), and low risk patients (29% of WHO grade III) in clinical routine will allow the development of more appropriate follow-up and treatments.	[Reme, Thierry] CHRU Montpellier, Inst Res Biotherapy, INSERM UM1 U1040, Montpellier, France; [Hugnot, Jean-Philippe] Univ Montpellier 2, CHRU Montpellier, Inst Neurosci Montpellier, INSERM UM1 U1051, Montpellier, France; [Bieche, Ivan; Vacher, Sophie; Lidereau, Rosette] Hop Rene Huguenin, Inst Curie, St Cloud, France; [Rigau, Valerie] CHRU Montpellier, Dept Pathol, Montpellier, France; [Rigau, Valerie] CHRU Montpellier, Biobank, Montpellier, France; [Burel-Vandenbos, Fanny] CHRU Nice, Dept Pathol, Nice, France; [Prevot, Vincent; Baroncini, Marc] Univ Lille, JPARC, INSERM U837, Lille, France; [Baroncini, Marc] CHRU Lille, Dept Neurosurg, F-59037 Lille, France; [Fontaine, Denys] CHRU Nice, Dept Neurosurg, Nice, France; [Chevassus, Hugues] CHRU Montpellier, INSERM CIC 1001, Montpellier, France; [Chevassus, Hugues] CHRU Montpellier, CIC, Montpellier, France; [Duffau, Hugues; Bauchet, Luc] CHRU Montpellier, Dept Neurosurg, Inst Neurosci Montpellier, INSERM UM1 U1051, Montpellier, France; [Joubert, Dominique] CNRS, UMR5203, INSERM U661, Inst Funct Gen, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; CHU Nice; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Reme, T (corresponding author), CHRU Montpellier, Inst Res Biotherapy, INSERM UM1 U1040, Montpellier, France.	thierry.reme@inserm.fr	Wegglin, Reto/AAV-4341-2021; Bièche, Ivan/O-7399-2017; Prevot, Vincent/E-5720-2016	Bièche, Ivan/0000-0002-2430-5429; Prevot, Vincent/0000-0001-7185-3615; Fontaine, Denys/0000-0001-5012-6769; VACHER, Sophie/0000-0002-0042-6023	INCA [PL06-073]; CHU Montpellier [UF7745]; ARTC Sud "Tumor Inventory"	INCA(Institut National du Cancer (INCA) France); CHU Montpellier; ARTC Sud "Tumor Inventory"	This work was supported by: INCA (www.e-cancer.fr) #PL06-073; CHU Montpellier (www.chu-montpellier.fr) #UF7745; and ARTC Sud (www.artc.asso.fr) "2008 Tumor Inventory." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauchet L, 2010, NEURO-ONCOLOGY, V12, P725, DOI 10.1093/neuonc/noq030; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bie L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025631; Bieche I, 2001, CANCER RES, V61, P1652; CBTRUS, 2012, CBTRUS STAT REP PRIM; Chakravarti A, 2002, J CLIN ONCOL, V20, P1063, DOI 10.1200/JCO.20.4.1063; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; DaumasDuport C, 1997, J NEURO-ONCOL, V34, P37, DOI 10.1023/A:1005707203596; DaumasDuport C, 1997, J NEURO-ONCOL, V34, P61, DOI 10.1023/A:1005759220434; de Tayrac M, 2011, CLIN CANCER RES, V17, P317, DOI 10.1158/1078-0432.CCR-10-1126; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Duhem-Tonnelle V, 2010, J NEUROPATH EXP NEUR, V69, P606, DOI 10.1097/NEN.0b013e3181e00579; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fuller GN, 1999, CANCER RES, V59, P4228; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; HEEGAARD S, 1995, CANCER, V76, P1809, DOI 10.1002/1097-0142(19951115)76:10<1809::AID-CNCR2820761020>3.0.CO;2-I; Jiang LG, 2011, J CLIN NEUROSCI, V18, P387, DOI 10.1016/j.jocn.2010.07.131; Jubb AM, 2012, HISTOPATHOLOGY, V60, P740, DOI 10.1111/j.1365-2559.2011.04138.x; Jukich PJ, 2001, NEURO-ONCOLOGY, V3, P141, DOI 10.1093/neuonc/3.3.141; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kannan K, 2012, ONCOTARGET, V3, P1194; Kostka D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040022; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li J, 2011, J SURG ONCOL, V103, P813, DOI 10.1002/jso.21851; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mamaeva D, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-99; Mandonnet E, 2003, ANN NEUROL, V53, P524, DOI 10.1002/ana.10528; Meissner T, 2011, CLIN CANCER RES, V17, P7240, DOI 10.1158/1078-0432.CCR-11-1628; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Nutt CL, 2003, CANCER RES, V63, P1602; Nutt CL, 2005, CLIN CANCER RES, V11, P2258, DOI 10.1158/1078-0432.CCR-04-1601; Pallud J, 2006, ANN NEUROL, V60, P380, DOI 10.1002/ana.20946; Perry A, 2001, ADV ANAT PATHOL, V8, P183, DOI 10.1097/00125480-200107000-00001; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Prayson RA, 2000, J NEUROL SCI, V175, P33, DOI 10.1016/S0022-510X(00)00274-4; Price SJ, 2010, ADV TECH STAND NEURO, V35, P1; Reme T, 2013, BIOINFORMATICS, V29, P1149, DOI 10.1093/bioinformatics/btt124; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Rigau V, 2011, BRAIN PATHOL, V21, P633, DOI 10.1111/j.1750-3639.2011.00491.x; Shinohara C, 2008, JPN J CLIN ONCOL, V38, P730, DOI 10.1093/jjco/hyn099; Shirahata M, 2007, CLIN CANCER RES, V13, P7341, DOI 10.1158/1078-0432.CCR-06-2789; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Stemmer-Rachamimov Anat O., 1997, Current Opinion in Oncology, V9, P230, DOI 10.1097/00001622-199709030-00003; Tanwar MK, 2002, CANCER RES, V62, P4364; Therneau T.M., 2000, MODELING SURVIVAL DA; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zagzag D, 1996, CANCER RES, V56, P182; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451	63	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66574	10.1371/journal.pone.0066574	http://dx.doi.org/10.1371/journal.pone.0066574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805239	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500067
J	Li, H; Jiang, WH; Zhang, Z; Xing, YR; Li, F				Li, Hang; Jiang, Weihua; Zhang, Zan; Xing, Yanru; Li, Fei			Transcriptome Analysis and Screening for Potential Target Genes for RNAi-Mediated Pest Control of the Beet Armyworm, Spodoptera exigua	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERENCE; LEPIDOPTERA; EXPRESSION; MANAGEMENT; NOCTUIDAE; MOTH	The beet armyworm, Spodoptera exigua (Hubner), is a serious pest worldwide that causes significant losses in crops. Unfortunately, genetic resources for the beet armyworm is extremely scarce. To improve these resources we sequenced the transcriptome of S. exigua representing all stages including eggs, 1st to 5th instar larvae, pupae, male and female adults using the Illumina Solexa platform. We assembled the transcriptome with Trinity that yielded 31,414 contigs. Of these contigs, 18,592 were annotated as protein coding genes by Blast searches against the NCBI nr database. It has been shown that knockdown of important insect genes by dsRNAs or siRNAs is a feasible mechanism to control insect pests. The first key step towards developing an efficient RNAi-mediated pest control technique is to find suitable target genes. To screen for effective target genes in the beet armyworm, we selected nine candidate genes. The sequences of these genes were amplified using the RACE strategy. Then, siRNAs were designed and chemically synthesized. We injected 2 mu l siRNA (2 mu g/mu l) into the 4th instar larvae to knock down the respective target genes. The mRNA abundance of target genes decreased to different levels (similar to 20-94.3%) after injection of siRNAs. Knockdown of eight genes including chitinase7, PGCP, chitinase1, ATPase, tubulin1, arf2, tubulin2 and arf1 caused a significantly high level of mortality compared to the negative control (P<0.05). About 80% of the surviving insects in the siRNA-treated group of five genes (PGCP, chitinase1, tubulin1, tubulin2 and helicase) showed retarded development. In chitinase1-siRNA and chitinase7-siRNA administered groups, 12.5% survivors exhibited "half-ecdysis''. In arf1-siRNA and arf2-siRNA groups, the body color of 15% became black 48 h after injections. In summary, the transcriptome could be a valuable genetic resource for identification of genes in S. exigua and this study provided putative targets for RNAi pest control.	[Li, Hang; Jiang, Weihua; Zhang, Zan; Xing, Yanru; Li, Fei] Nanjing Agr Univ, Coll Plant Protect, Dept Entomol, Nanjing, Jiangsu, Peoples R China; [Li, Hang; Jiang, Weihua; Zhang, Zan; Xing, Yanru; Li, Fei] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Li, F (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	lifei@njau.edu.cn			National High Technology Research and Development Program ("863'' Program) of China [2012AA101505]; Basic Research Development Program of China (973 Program) [2012CB114100]; National Science Foundation of China [31171843]; Jiangsu Science Foundation for Distinguished Young Scholars [BK2012028]	National High Technology Research and Development Program ("863'' Program) of China(National High Technology Research and Development Program of China); Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Science Foundation for Distinguished Young Scholars	This work was in partial supported by the National High Technology Research and Development Program ("863'' Program, http://www.863.gov.cn) of China (2012AA101505), the Basic Research Development Program of China (973 Program, 2012CB114100, http://www.973.gov.cn/), the National Science Foundation of China (31171843, http://www.nsfc.gov.cn/) and the Jiangsu Science Foundation for Distinguished Young Scholars (BK2012028, http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS EL, 1960, J ECON ENTOMOL, V53, P616, DOI 10.1093/jee/53.4.616; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Dzitoyeva S, 2001, MOL PSYCHIATR, V6, P665, DOI 10.1038/sj.mp.4000955; EAST DA, 1989, J ECON ENTOMOL, V82, P1367, DOI 10.1093/jee/82.5.1367; Gay H, 2012, AMBIX, V59, P88, DOI 10.1179/174582312X13345259995930; Gingras R, 1999, J BIOL CHEM, V274, P11742, DOI 10.1074/jbc.274.17.11742; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Taylor JE, 2008, CROP PROT, V27, P268, DOI 10.1016/j.cropro.2007.05.014; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Xiu WM, 2007, J CHEM ECOL, V33, P947, DOI 10.1007/s10886-007-9277-2; Xue XY, 2012, ADV INSECT PHYSIOL, V42, P73, DOI 10.1016/B978-0-12-387680-5.00003-3; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhao YY, 2011, INSECT MOL BIOL, V20, P97, DOI 10.1111/j.1365-2583.2010.01049.x; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048	40	49	52	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65931	10.1371/journal.pone.0065931	http://dx.doi.org/10.1371/journal.pone.0065931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823756	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400034
J	Lin, XW; Xu, WC; Luo, JG; Guo, XJ; Sun, T; Zhao, XL; Fu, ZJ				Lin, Xiao-Wen; Xu, Wei-Cheng; Luo, Jian-Gang; Guo, Xue-Jiao; Sun, Tao; Zhao, Xu-Li; Fu, Zhi-Jian			WW Domain Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Negatively Regulates TLR4-Mediated TNF-alpha and IL-6 Production by Proteasomal Degradation of TNF Receptor Associated Factor 6 (TRAF6)	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; ADAPTER PROTEIN; BREAST-CANCER; FAMILY; IMMUNITY; ACTIVATION; EXPRESSION; TARGETS; TLR4	Background: Toll-like receptors (TLRs) play a pivotal role in the defense against invading pathogens by detecting pathogen-associated molecular patterns (PAMPs). TLR4 recognizes lipopolysaccharides (LPS) in the cell walls of Gram-negative bacteria, resulting in the induction and secretion of proinflammatory cytokines such as TNF-alpha and IL-6. The WW domain containing E3 ubiquitin protein ligase 1 (WWP1) regulates a variety of cellular biological processes. Here, we investigated whether WWP1 acts as an E3 ubiquitin ligase in TLR-mediated inflammation. Methodology/Results: Knocking down WWP1 enhanced the TNF-alpha and IL-6 production induced by LPS, and overexpression of WWP1 inhibited the TNF-alpha and IL-6 production induced by LPS, but not by TNF-alpha. WWP1 also inhibited the I kappa B-alpha, NF-kappa B, and MAPK activation stimulated by LPS. Additionally, WWP1 could degrade TRAF6, but not IRAK1, in the proteasome pathway, and knocking down WWP1 reduced the LPS-induced K48-linked, but not K63-linked, polyubiquitination of endogenous TRAF6. Conclusions/Significance: We identified WWP1 as an important negative regulator of TLR4-mediated TNF-alpha and IL-6 production. We also showed that WWP1 functions as an E3 ligase when cells are stimulated with LPS by binding to TRAF6 and promoting K48-linked polyubiquitination. This results in the proteasomal degradation of TRAF6.	[Lin, Xiao-Wen; Luo, Jian-Gang; Guo, Xue-Jiao; Sun, Tao; Zhao, Xu-Li; Fu, Zhi-Jian] Shandong Univ, Dept Pain Management, Prov Hosp, Jinan 250100, Peoples R China; [Xu, Wei-Cheng] Shandong Univ, Dept Orthoped, Prov Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University	Fu, ZJ (corresponding author), Shandong Univ, Dept Pain Management, Prov Hosp, Jinan 250100, Peoples R China.	zhijian_fu@163.com			National Natural Science Foundation of China [81271346, 30972844]; Independent Innovation Foundation of Shandong University [21300072613161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81271346, 30972844) and the Independent Innovation Foundation of Shandong University (21300072613161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2007, INT J CANCER, V121, P2834; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fukuchi M, 2002, CANCER RES, V62, P7162; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee JO, 2013, J BIOL CHEM, V288, P4673, DOI 10.1074/jbc.M112.406009; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Roach JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054156; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Subik K, 2012, BONE, V50, P813, DOI 10.1016/j.bone.2011.12.022; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7	33	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e67633	10.1371/journal.pone.0067633	http://dx.doi.org/10.1371/journal.pone.0067633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799152	Green Submitted, gold, Green Published			2022-12-27	WOS:000321397800050
J	Liu, Y; Wang, L; Long, ZY; Wu, YM; Wan, Q; Jiang, JX; Wang, ZG				Liu, Yuan; Wang, Li; Long, Zai-yun; Wu, Ya-min; Wan, Qi; Jiang, Jian-xin; Wang, Zheng-guo			Inhibiting PTEN Protects Hippocampal Neurons against Stretch Injury by Decreasing Membrane Translocation of AMPA Receptor GluR2 Subunit	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; IN-VITRO; SYNAPTIC-TRANSMISSION; GLUTAMATE; PLASTICITY; MECHANISMS; ISCHEMIA; SUSCEPTIBILITY; PERMEABILITY; INCREASES	The AMPA type of glutamate receptors (AMPARs)-mediated excitotoxicity is involved in the secondary neuronal death following traumatic brain injury (TBI). But the underlying cellular and molecular mechanisms remain unclear. In this study, the role of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in GluR2-lacking AMPARs mediated neuronal death was investigated through an in vitro stretch injury model of neurons. It was indicated that both the mRNA and protein levels of PTEN were increased in cultured hippocampal neurons after stretch injury, which was associated with the decreasing expression of GluR2 subunits on the surface of neuronal membrane. Inhibition of PTEN activity by its inhibitor can promote the survival of neurons through preventing reduction of GluR2 on membrane. Moreover, the effect of inhibiting GluR2-lacking AMPARs was similar to PTEN suppression-mediated neuroprotective effect in stretch injury-induced neuronal death. Further evidence identified that the total GluR2 protein of neurons was not changed in all groups. So inhibition of PTEN or blockage of GluR2-lacking AMPARs may attenuate the death of hippocampal neurons post injury through decreasing the translocation of GluR2 subunit on the membrane effectively.	[Liu, Yuan; Wang, Li; Long, Zai-yun; Wu, Ya-min; Jiang, Jian-xin; Wang, Zheng-guo] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Res Inst Surg, Chongqing, Peoples R China; [Wan, Qi] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Army Medical University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Wang, ZG (corresponding author), Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Dept Res Inst Surg, Chongqing, Peoples R China.	zhengguowang1212@sina.com			National Natural Science Foundation of China [30728026]; Science funds of Chongqing [csct2012jjA10131]; funds of State Key Laboratory [SKLKF201109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science funds of Chongqing; funds of State Key Laboratory	This work was supported by a grant from the National Natural Science Foundation of China (#30728026), Science funds of Chongqing (csct2012jjA10131) and funds of State Key Laboratory (SKLKF201109). The National Natural Science Foundation of China (#30728026) had role in study design, data collection; Science funds of Chongqing (csct2012jjA10131) had role in data analysis; Funds of State Key Laboratory (SKLKF201109) had role in preparation of the manuscript.	Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Alessandri B, 1998, PROG BRAIN RES, V116, P303, DOI 10.1016/S0079-6123(08)60445-8; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gary DS, 2002, NEUROMOL MED, V2, P261, DOI 10.1385/NMM:2:3:261; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Krassioukov AV, 2002, BRAIN RES PROTOC, V10, P60, DOI 10.1016/S1385-299X(02)00180-0; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65431	10.1371/journal.pone.0065431	http://dx.doi.org/10.1371/journal.pone.0065431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799014	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800006
J	Meynard, CN; Migeon, A; Navajas, M				Meynard, Christine N.; Migeon, Alain; Navajas, Maria			Uncertainties in Predicting Species Distributions under Climate Change: A Case Study Using Tetranychus evansi (Acari: Tetranychidae), a Widespread Agricultural Pest	PLOS ONE			English	Article							GLOBAL FOOD SECURITY; PRESENCE-ONLY DATA; DISTRIBUTION MODELS; EVOLUTIONARY; PERFORMANCE; CHALLENGES; IMPACTS; THREATS; PLANT; BIODIVERSITY	Many species are shifting their distributions due to climate change and to increasing international trade that allows dispersal of individuals across the globe. In the case of agricultural pests, such range shifts may heavily impact agriculture. Species distribution modelling may help to predict potential changes in pest distributions. However, these modelling strategies are subject to large uncertainties coming from different sources. Here we used the case of the tomato red spider mite (Tetranychus evansi), an invasive pest that affects some of the most important agricultural crops worldwide, to show how uncertainty may affect forecasts of the potential range of the species. We explored three aspects of uncertainty: (1) species prevalence; (2) modelling method; and (3) variability in environmental responses between mites belonging to two invasive clades of T. evansi. Consensus techniques were used to forecast the potential range of the species under current and two different climate change scenarios for 2080, and variance between model projections were mapped to identify regions of high uncertainty. We revealed large predictive variations linked to all factors, although prevalence had a greater influence than the statistical model once the best modelling strategies were selected. The major areas threatened under current conditions include tropical countries in South America and Africa, and temperate regions in North America, the Mediterranean basin and Australia. Under future scenarios, the threat shifts towards northern Europe and some other temperate regions in the Americas, whereas tropical regions in Africa present a reduced risk. Analysis of niche overlap suggests that the current differential distribution of mites of the two clades of T. evansi can be partially attributed to environmental niche differentiation. Overall this study shows how consensus strategies and analysis of niche overlap can be used jointly to draw conclusions on invasive threat considering different sources of uncertainty in species distribution modelling.	[Meynard, Christine N.; Migeon, Alain; Navajas, Maria] UMR CBGP INRA IRD Cirad Montpellier SupAgro, INRA, Montferrier Sur Lez, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Meynard, CN (corresponding author), UMR CBGP INRA IRD Cirad Montpellier SupAgro, INRA, Campus Int Baillarguet, Montferrier Sur Lez, France.	cnmeynard@gmail.com	NAVAJAS, Maria/AAM-2294-2020; Meynard, Christine N/B-2082-2010	NAVAJAS, Maria/0000-0002-0702-4238; Meynard, Christine N/0000-0002-5983-6289	INRA AAP-SPE project [470338]; Agence National de la Recherche [2010 BLAN 1715 02]; Programme BLANC-SVE7	INRA AAP-SPE project; Agence National de la Recherche(French National Research Agency (ANR)); Programme BLANC-SVE7	This work was partially funded by an INRA AAP-SPE project no470338 to CNM and by a grant from the Agence National de la Recherche (ID 2010 BLAN 1715 02) to MN, Programme BLANC-SVE7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; BAKER EDWARD W., 1960, HILGARDIA, V29, P455; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Boubou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035601; Boubou A, 2011, BIOL INVASIONS, V13, P81, DOI 10.1007/s10530-010-9791-y; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; Duverney C, 2005, ESSAIS PRELIMINAIRES; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Knapp M, 2003, AFR ENTOMOL, V11, P300; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Li WK, 2011, ECOGRAPHY, V34, P1096, DOI 10.1111/j.1600-0587.2011.06888.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobell D., 2007, ENV RES LETT; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; Meynard CN, 2007, J BIOGEOGR, V34, P1455, DOI 10.1111/j.1365-2699.2007.01720.x; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Meynard CN, 2012, ECOL EVOL, V2, P1008, DOI 10.1002/ece3.219; Meynard CN, 2012, ECOGRAPHY, V35, P499, DOI 10.1111/j.1600-0587.2011.07157.x; Migeon A., 2006, SPIDER MITES WEB COM; Migeon A, 2009, EXP APPL ACAROL, V48, P199, DOI 10.1007/s10493-008-9229-8; Navajas M, 2012, EXPT APPL ACAROLOGY, P1; Navarro M, 2010, BIOTECH AGR IND MED, P149; Palevsky E, 2003, PHYTOPARASITICA, V31, P144, DOI 10.1007/BF02980784; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips S, 2012, ECOGRAPHY, V35, P385, DOI 10.1111/j.1600-0587.2011.07285.x; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roques A, 2012, INTEGR ZOOL, V7, P227, DOI 10.1111/j.1749-4877.2012.00311.x; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Sibanda T, 2000, CROP PROT, V19, P807, DOI 10.1016/S0261-2194(00)00108-3; Silva P., 1954, Boletim do Instituto Biologico da Bahia, V1, P1; Simelton E, 2012, FOOD SECUR, V4, P163, DOI 10.1007/s12571-012-0173-4; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2004, ECOLOGY, V85, P1688, DOI 10.1890/03-0148; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Ward G, 2009, BIOMETRICS, V65, P554, DOI 10.1111/j.1541-0420.2008.01116.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x	67	29	29	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66445	10.1371/journal.pone.0066445	http://dx.doi.org/10.1371/journal.pone.0066445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799105	gold, Green Published, Green Submitted			2022-12-27	WOS:000321397800033
J	Ota, H; Katanosaka, K; Murase, S; Kashio, M; Tominaga, M; Mizumura, K				Ota, Hiroki; Katanosaka, Kimiaki; Murase, Shiori; Kashio, Makiko; Tominaga, Makoto; Mizumura, Kazue			TRPV1 and TRPV4 Play Pivotal Roles in Delayed Onset Muscle Soreness	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CATION CHANNEL TRPV4; MUSCULAR MECHANICAL HYPERALGESIA; N-ARACHIDONOYL-DOPAMINE; POTENTIAL VANILLOID 1; CAPSAICIN-RECEPTOR; ION-CHANNEL; NEUROPATHIC PAIN; SKELETAL-MUSCLE; SPINAL-CORD	Unaccustomed strenuous exercise that includes lengthening contraction (LC) often causes tenderness and movement related pain after some delay (delayed-onset muscle soreness, DOMS). We previously demonstrated that nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) are up-regulated in exercised muscle through upregulation of cyclooxygenase (COX)-2, and they sensitized nociceptors resulting in mechanical hyperalgesia. There is also a study showing that transient receptor potential (TRP) ion channels are involved in DOMS. Here we examined whether and how TRPV1 and/or TRPV4 are involved in DOMS. We firstly evaluated a method to measure the mechanical withdrawal threshold of the deep tissues in wild-type (WT) mice with a modified Randall-Selitto apparatus. WT, TRPV1-/- and TRPV4-/- mice were then subjected to LC. Another group of mice received injection of murine NGF-2.5S or GDNF to the lateral gastrocnemius (LGC) muscle. Before and after these treatments the mechanical withdrawal threshold of LGC was evaluated. The change in expression of NGF, GDNF and COX-2 mRNA in the muscle was examined using real-time RT-PCR. In WT mice, mechanical hyperalgesia was observed 6-24 h after LC and 1-24 h after NGF and GDNF injection. LC induced mechanical hyperalgesia neither in TRPV1-/- nor in TRPV4-/- mice. NGF injection induced mechanical hyperalgesia in WT and TRPV4-/- mice but not in TRPV1-/- mice. GDNF injection induced mechanical hyperalgesia in WT but neither in TRPV1-/- nor in TRPV4-/- mice. Expression of NGF and COX-2 mRNA was significantly increased 3 h after LC in all genotypes. However, GDNF mRNA did not increase in TRPV4-/- mice. These results suggest that TRPV1 contributes to DOMS downstream (possibly at nociceptors) of NGF and GDNF, while TRPV4 is located downstream of GDNF and possibly also in the process of GDNF up-regulation.	[Ota, Hiroki] Nagoya Univ, Grad Sch Med, Dept Neural Regulat, Nagoya, Aichi 4648601, Japan; [Ota, Hiroki; Murase, Shiori; Mizumura, Kazue] Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi 487, Japan; [Katanosaka, Kimiaki] Nagoya Univ, Environm Med Res Inst, Dept Neurosci 2, Nagoya, Aichi 464, Japan; [Kashio, Makiko; Tominaga, Makoto] Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi 444, Japan	Nagoya University; Chubu University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB)	Mizumura, K (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi 487, Japan.	mizu@isc.chubu.ac.jp	Ota, Hiroki/O-6777-2019	Ota, Hiroki/0000-0002-4746-8845; Kashio, Makiko/0000-0001-6404-2339	Japan Society for the Promotion of Sciences [23390154]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21026015]	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Financial support for this study was provided by a Grant-in Aid for Scientific Research (B) (number 23390154) from Japan Society for the Promotion of Sciences and a Grant-in Aid for Scientific Research on Priority areas (number 21026015) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; AMANO T, 1991, NEUROSCI LETT, V132, P5, DOI 10.1016/0304-3940(91)90418-S; Andersen H, 2006, SOMATOSENS MOT RES, V23, P97, DOI 10.1080/08990220600856255; ARMSTRONG RB, 1984, MED SCI SPORT EXER, V16, P529; Asai H, 2005, PAIN, V117, P19, DOI 10.1016/j.pain.2005.05.010; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; BJERRING P, 1990, BRIT J ANAESTH, V64, P173, DOI 10.1093/bja/64.2.173; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Fang M, 2003, NEUROSCIENCE, V117, P503, DOI 10.1016/S0306-4522(02)00958-2; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Fujii Y, 2008, PAIN, V140, P292, DOI 10.1016/j.pain.2008.08.013; Guler AD, 2002, J NEUROSCI, V22, P6408; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kim YH, 2012, NEURON, V74, P640, DOI 10.1016/j.neuron.2012.02.039; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Kubo A, 2012, J PHYSIOL-LONDON, V590, P2995, DOI 10.1113/jphysiol.2012.229153; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Lechner SG, 2011, NEURON, V69, P332, DOI 10.1016/j.neuron.2010.12.028; Lee RHK, 2006, J NEUROSCI RES, V83, P80, DOI 10.1002/jnr.20701; LEVIMONTALCINI R, 1985, P NATL ACAD SCI USA, V82, P7111, DOI 10.1073/pnas.82.20.7111; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Malin S, 2011, J NEUROSCI, V31, P10516, DOI 10.1523/JNEUROSCI.2992-10.2011; Mann MK, 2006, J OROFAC PAIN, V20, P325; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mihara H, 2011, J PHYSIOL-LONDON, V589, P3471, DOI 10.1113/jphysiol.2011.207829; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Murase S., 2012, 35 ANN M JAP NEUR SO; Murase S, 2013, J PHYSL IN PRESS; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Nasu T, 2010, EUR J PAIN, V14, P236, DOI 10.1016/j.ejpain.2009.05.009; Ota HMK, 2012, PAIN RES, V27, P97; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Pritschow BW, 2011, PFLUG ARCH EUR J PHY, V461, P115, DOI 10.1007/s00424-010-0883-4; Radhakrishnan R, 2003, PAIN, V104, P567, DOI 10.1016/S0304-3959(03)00114-3; Ravnefjord A, 2009, EUR J PHARMACOL, V611, P85, DOI 10.1016/j.ejphar.2009.03.058; Rong WF, 2004, J PHYSIOL-LONDON, V560, P867, DOI 10.1113/jphysiol.2004.071746; Sagar DR, 2004, EUR J NEUROSCI, V20, P175, DOI 10.1111/j.1460-9568.2004.03481.x; Sharkey KA, 2007, EUR J NEUROSCI, V25, P2773, DOI 10.1111/j.1460-9568.2007.05521.x; Shinoda M, 2011, J NEUROSCI, V31, P7145, DOI 10.1523/JNEUROSCI.0481-11.2011; Shu X, 2001, J NEUROPHYSIOL, V86, P2931, DOI 10.1152/jn.2001.86.6.2931; Spicarova D, 2009, J NEUROPHYSIOL, V102, P234, DOI 10.1152/jn.00024.2009; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Svensson P, 2003, PAIN, V104, P241, DOI 10.1016/S0304-3959(03)00012-5; Szolcsanyi J, 2004, NEUROSCI LETT, V361, P155, DOI 10.1016/j.neulet.2003.12.025; Taguchi T, 2005, J PHYSIOL-LONDON, V564, P259, DOI 10.1113/jphysiol.2004.079483; Takahashi K, 2004, JPN J PHYSL, V54, pS175; Takasu K, 2011, J PAIN, V12, P1130, DOI 10.1016/j.jpain.2011.04.003; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Troidl C, 2010, J MOL CELL CARDIOL, V49, P142, DOI 10.1016/j.yjmcc.2010.03.021; Turrini P, 2002, NEUROSCI LETT, V323, P109, DOI 10.1016/S0304-3940(02)00090-3; Urban L, 2011, CURR PHARM BIOTECHNO, V12, P115, DOI 10.2174/138920111793937934; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Walder RY, 2012, PAIN, V153, P1664, DOI 10.1016/j.pain.2012.04.034; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhou Y, 2011, RESP PHYSIOL NEUROBI, V177, P327, DOI 10.1016/j.resp.2011.05.011	70	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65751	10.1371/journal.pone.0065751	http://dx.doi.org/10.1371/journal.pone.0065751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799042	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800016
J	Sriwiriyanont, P; Lynch, KA; McFarland, KL; Supp, DM; Boyce, ST				Sriwiriyanont, Penkanok; Lynch, Kaari A.; McFarland, Kevin L.; Supp, Dorothy M.; Boyce, Steven T.			Characterization of Hair Follicle Development in Engineered Skin Substitutes	PLOS ONE			English	Article							BETA-CATENIN; SEBACEOUS GLAND; TERMINAL DIFFERENTIATION; MOUSE EPIDERMIS; CANAL FORMATION; GROWTH-FACTOR; HUMAN EMBRYOS; ATHYMIC MICE; IN-VIVO; CELLS	Generation of skin appendages in engineered skin substitutes has been limited by lack of trichogenic potency in cultured postnatal cells. To investigate the feasibility and the limitation of hair regeneration, engineered skin substitutes were prepared with chimeric populations of cultured human keratinocytes from neonatal foreskins and cultured murine dermal papilla cells from adult GFP transgenic mice and grafted orthotopically to full-thickness wounds on athymic mice. Non-cultured dissociated neonatal murine-only skin cells, or cultured human-only skin keratinocytes and fibroblasts without dermal papilla cells served as positive and negative controls respectively. In this study, neonatal murine-only skin substitutes formed external hairs and sebaceous glands, chimeric skin substitutes formed pigmented hairs without sebaceous glands, and human-only skin substitutes formed no follicles or glands. Although chimeric hair cannot erupt readily, removal of upper skin layer exposed keratinized hair shafts at the skin surface. Development of incomplete pilosebaceous units in chimeric hair corresponded with upregulation of hair-related genes, LEF1 and WNT10B, and downregulation of a marker of sebaceous glands, Steroyl-CoA desaturase. Transepidermal water loss was normal in all conditions. This study demonstrated that while sebaceous glands may be involved in hair eruption, they are not required for hair development in engineered skin substitutes.	[Sriwiriyanont, Penkanok; Boyce, Steven T.] Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA; [Lynch, Kaari A.; Supp, Dorothy M.; Boyce, Steven T.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [McFarland, Kevin L.; Supp, Dorothy M.; Boyce, Steven T.] Shriners Hosp Children, Res Dept, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Boyce, ST (corresponding author), Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA.	steven.boyce@uc.edu	Supp, Dorothy/ABQ-7999-2022	Supp, Dorothy/0000-0002-2429-6630	NIH [GM079542]; Shriners Hospitals for Children grant [84050]; Aderans Research Institute (ARI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079542] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children grant; Aderans Research Institute (ARI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by NIH grant GM079542, and Shriners Hospitals for Children grant #84050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Boyce is the named inventor on patents and patent applications assigned to the University of Cincinnati and Shriners Hospitals for Children according to their intellectual property policies. Patents, patent applications and other intellectual property pertaining to engineered skin substitutes are licensed to Cutanogen Corporation which was founded by Dr. Boyce, and in which he has past and present financial interests. Dr. Boyce resigned as an officer of Cutanogen in 2006, and he has no authority or responsibility for Cutanogen's current activities. Dr. Boyce also is a paid consultant for Aderans Research Institute (ARI). No funding for the reported studies was provided by ARI, and ARI has no rights to any technologies invented by Dr. Boyce. Other authors declare no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BOYCE ST, 1991, SURGERY, V110, P866; Boyce ST, 2001, METHODS TISSUE ENG, P365; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Cawthorn WP, 2011, BONE; Choi EH, 2002, BRIT J DERMATOL, V147, P244, DOI 10.1046/j.1365-2133.2002.04918.x; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fehrenschild D, 2011, J INVESTIGATIVE DERM; Gagnon V, 2011, J INVEST DERMATOL, V131, P1375, DOI 10.1038/jid.2011.34; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; HASHIMOT.K, 1970, DERMATOLOGICA, V141, P49, DOI 10.1159/000252435; HASHIMOTO K, 1970, ARCH KLIN EXP DERM, V238, P333, DOI 10.1007/BF00525727; HOLBROOK KA, 1978, J INVEST DERMATOL, V71, P385, DOI 10.1111/1523-1747.ep12556818; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Ideta R, 2002, J DERMATOL SCI, V28, P48, DOI 10.1016/S0923-1811(01)00145-1; Jordan SA, 2000, DEV BIOL, V225, P424, DOI 10.1006/dbio.2000.9856; Klingenberg JM, 2010, J INVEST DERMATOL, V130, P587, DOI 10.1038/jid.2009.295; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Lee LF, 2011, TISSUE ENG PART C-ME, V17, P391, DOI [10.1089/ten.tec.2010.0477, 10.1089/ten.TEC.2010.0477]; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; LYNE A. G., 1957, AUSTRALIAN JOUR BIOL SCI, V10, P390; Magnusdottir E, 2007, P NATL ACAD SCI USA, V104, P14988, DOI 10.1073/pnas.0707323104; Niemann C, 2012, SEMIN CELL DEV BIOL, V23, P928, DOI 10.1016/j.semcdb.2012.08.010; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sellheyer K, 2010, J CUTAN PATHOL, V37, P362, DOI 10.1111/j.1600-0560.2009.01434.x; Sharov AA, 2011, J INVEST DERMATOL, V131, P257, DOI 10.1038/jid.2010.279; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Supp DM, 2000, J INVEST DERMATOL, V114, P5, DOI 10.1046/j.1523-1747.2000.00824.x; Supp Dorothy M., 2002, Journal of Burn Care & Rehabilitation, V23, P10, DOI 10.1097/00004630-200201000-00004; Takakura N, 1996, J INVEST DERMATOL, V107, P770, DOI 10.1111/1523-1747.ep12371802; Tanabe A, 2006, J DERMATOL SCI, V43, P210, DOI 10.1016/j.jdermsci.2006.04.004; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	39	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65664	10.1371/journal.pone.0065664	http://dx.doi.org/10.1371/journal.pone.0065664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799033	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800012
J	Hatashita, S; Yamasaki, H				Hatashita, Shizuo; Yamasaki, Hidetomo			Diagnosed Mild Cognitive Impairment Due to Alzheimer's Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction	PLOS ONE			English	Article							PITTSBURGH COMPOUND-B; CONVERSION; PREDICTION; DEPOSITION; MCI	The aim of this study is to identify mild cognitive impairment (MCI) due to Alzheimer's disease (AD) using amyloid imaging of beta amyloid (A beta) deposition and FDG imaging of reflecting neuronal dysfunction as PET biomarkers. Sixty-eight MCI patients underwent cognitive testing, [11C]-PIB PET and [18F]-FDG PET at baseline and follow-up. Regions of interest were defined on co-registered MRI. PIB distribution volume ratio (DVR) was calculated using Logan graphical analysis, and the standardized uptake value ratio (SUVR) on the same regions was used as quantitative analysis for [18F]-FDG. Thirty (44.1%) of all 68 MCI patients converted to AD over 19.2 +/- 7.1 months. The annual rate of MCI conversion was 23.4%. A positive A beta PET biomarker significantly identified MCI due to AD in individual MCI subjects with a sensitivity (SS) of 96.6% and specificity (SP) of 42.1%. The positive predictive value (PPV) was 56.8%. A positive A beta biomarker in APOE epsilon 4/4 carriers distinguished with a SS of 100%. In individual MCI subjects who had a prominent impairment in episodic memory and aged older than 75 years, an A beta biomarker identified MCI due to AD with a greater SS of 100%, SP of 66.6% and PPV of 80%, compared to FDG biomarker alone or both PET biomarkers combined. In contrast, when assessed in precuneus, both A beta and FDG biomarkers had the greatest level of certainty for MCI due to AD with a PPV of 87.8%. The A beta PET biomarker primarily defines MCI due to AD in individual MCI subjects. Furthermore, combined FDG biomarker in a cortical region of precuneus provides an added diagnostic value in predicting AD over a short period.	[Hatashita, Shizuo; Yamasaki, Hidetomo] Shonan Atsugi Hosp, Atsugi, Kanagawa, Japan		Hatashita, S (corresponding author), Shonan Atsugi Hosp, Atsugi, Kanagawa, Japan.	hatashita@shonan-atsugi.jp						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Drzezga A, 2005, J NUCL MED, V46, P1625; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ewers M, 2012, NEUROBIOL AGING, V33, P1203, DOI 10.1016/j.neurobiolaging.2010.10.019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Hatashita S, 2010, J ALZHEIMERS DIS, V21, P995, DOI 10.3233/JAD-2010-100222; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Wechsler D, 1987, WMS R WECHSLER MEMOR; Zhang S, 2012, INT J CLIN PRACT, V66, P185, DOI 10.1111/j.1742-1241.2011.02845.x	20	41	46	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66877	10.1371/journal.pone.0066877	http://dx.doi.org/10.1371/journal.pone.0066877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799136	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300101
J	Liu, P; Wang, YY; Qi, X; Gu, QQ; Geng, MY; Li, J				Liu, Ping; Wang, Yuan-yuan; Qi, Xin; Gu, QianQun; Geng, Meiyu; Li, Jing			Undecylprodigiosin Induced Apoptosis in P388 Cancer Cells Is Associated with Its Binding to Ribosome	PLOS ONE			English	Article							CYCLOPRODIGIOSIN HYDROCHLORIDE; H+/CL-SYMPORTER; PRODIGIOSIN; PROLIFERATION; INHIBITION; GROWTH; PHASE	Prodigiosins (PGs) are a family of natural red pigments with anticancer activity, and one member of the family has entered clinical phase II trials. However, the anticancer mechanisms of PGs remain largely unclear. This study was designed to investigate the molecular basis of anticancer activity of UP, a derivative of PGs, in P388 cells. By introducing pharmacological inhibitors and utilizing a variety of analytical approaches including western blotting, flow cytometry and confocal laser microscopy, we found that UP inhibited proliferation of P388 via arresting cells at G2/M phase and inducing cells apoptosis, which was related to the activation of P38, JNK rather than ERK1/2 signaling. ROS regeneration and acidification in cells appear not involved in UP induced apoptosis. Furthermore, utilizing mass spectrometry, sucrose density gradient fractionation and immunofluorescence staining, we discovered that UP was apparently located at ribosome. These results together indicate that ribosome may be the potential target of UP in cancer cells, which opened a new avenue in delineating the anticancer mechanism of PGs.	[Liu, Ping; Wang, Yuan-yuan; Qi, Xin; Gu, QianQun; Li, Jing] Ocean Univ China, Sch Med & Pharm, Minist Educ, Key Lab Marine Drugs, Qingdao, Peoples R China; [Liu, Ping] Chinese Acad Sci, Anal & Testing Ctr, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Drug Res, Shanghai 200031, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Geng, MY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Drug Res, Shanghai 200031, Peoples R China.	mygeng@mail.shcnc.ac.cn; lijing_ouc@ouc.edu.cn	Lv, Yuanjie/AER-0767-2022		National High-tech R&D Program of China [2011AA09070104]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0944]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the grants from National High-tech R&D Program (2011AA09070104) of China and Program for Changjiang Scholars and Innovative Research Team in University (IRT0944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HK, 2009, TOXICOL APPL PHARM, V237, P137, DOI 10.1016/j.taap.2009.03.006; Baldino CM, 2006, BIOORG MED CHEM LETT, V16, P701, DOI 10.1016/j.bmcl.2005.10.027; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Davis W, 2001, J PHARMACOL EXP THER, V296, P1; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Diaz-Ruiz C, 2001, HISTOL HISTOPATHOL, V16, P415, DOI 10.14670/HH-16.415; Esper RJ, 2008, ADV CARDIOL, V45, P17, DOI 10.1159/000115120; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Francisco R, 2007, EUR J PHARMACOL, V572, P111, DOI 10.1016/j.ejphar.2007.06.054; Hsu PC, 2008, LEUKEMIA RES, V32, P1530, DOI 10.1016/j.leukres.2008.01.017; Johnson CR, 2003, LEUKEMIA, V17, P2140, DOI 10.1038/sj.leu.2403132; Lee SR, 2005, J CELL PHYSIOL, V205, P270, DOI 10.1002/jcp.20395; Liu R, 2005, ARCH PHARM RES, V28, P1341, DOI 10.1007/BF02977899; MELLMAN I, 1989, SCIENCE, V244, P853, DOI 10.1126/science.244.4906.853; Miao BC, 2005, MOL PHARMACOL, V68, P1716, DOI 10.1124/mol.105.015412; Montaner B, 2005, TOXICOL SCI, V85, P870, DOI 10.1093/toxsci/kfi149; Montaner B, 2002, TOXICOL LETT, V129, P93, DOI 10.1016/S0378-4274(01)00477-5; OHKUMA S, 1993, IN VITRO CELL DEV-AN, V29A, P862; Pandey R, 2003, INT IMMUNOPHARMACOL, V3, P159, DOI 10.1016/S1567-5769(02)00114-5; Parikh SA, 2010, CL LYMPH MYELOM LEUK, V10, P285, DOI 10.3816/CLML.2010.n.059; Ruiz-Ramos R, 2005, TOXICOLOGY, V209, P279, DOI 10.1016/j.tox.2004.12.035; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Shenoy N, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-32; Shieh WY, 2003, INT J SYST EVOL MICR, V53, P479, DOI 10.1099/ijs.0.02307-0; Shrode LD, 1997, J BIOENERG BIOMEMBR, V29, P393, DOI 10.1023/A:1022407116339; Soto-Cerrato V, 2007, MOL CANCER THER, V6, P362, DOI 10.1158/1535-7163.MCT-06-0266; Yamamoto C, 2001, ONCOL REP, V8, P821; Yamamoto D, 2000, J CANCER RES CLIN, V126, P191, DOI 10.1007/s004320050032; Yamamoto D, 2000, INT J CANCER, V88, P121, DOI 10.1002/1097-0215(20001001)88:1<121::AID-IJC19>3.0.CO;2-C; Yamamoto Y, 1999, HUM REPROD, V14, P3041, DOI 10.1093/humrep/14.12.3041; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang J, 2005, MED CHEM RES, V14, P181, DOI 10.1007/s00044-005-0133-z	33	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65381	10.1371/journal.pone.0065381	http://dx.doi.org/10.1371/journal.pone.0065381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799011	gold, Green Submitted, Green Published			2022-12-27	WOS:000320363300018
J	Ness, D; Ren, Z; Gardai, S; Sharpnack, D; Johnson, VJ; Brennan, RJ; Brigham, EF; Olaharski, AJ				Ness, Daniel; Ren, Zhao; Gardai, Shyra; Sharpnack, Douglas; Johnson, Victor J.; Brennan, Richard J.; Brigham, Elizabeth F.; Olaharski, Andrew J.			Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis	PLOS ONE			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; PEROXIREDOXIN 3; LRRK2; PROTEIN; MUTATIONS; AUTOPHAGY; PATHWAY; GENE	Genetic evidence links mutations in the LRRK2 gene with an increased risk of Parkinson's disease, for which no neuroprotective or neurorestorative therapies currently exist. While the role of LRRK2 in normal cellular function has yet to be fully described, evidence suggests involvement with immune and kidney functions. A comparative study of LRRK2-deficient and wild type rats investigated the influence that this gene has on the phenotype of these rats. Significant weight gain in the LRRK2 null rats was observed and was accompanied by significant increases in insulin and insulin-like growth factors. Additionally, LRRK2-deficient rats displayed kidney morphological and histopathological alterations in the renal tubule epithelial cells of all animals assessed. These perturbations in renal morphology were accompanied by significant decreases of lipocalin-2, in both the urine and plasma of knockout animals. Significant alterations in the cellular composition of the spleen between LRRK2 knockout and wild type animals were identified by immunophenotyping and were associated with subtle differences in response to dual infection with rat-adapted influenza virus (RAIV) and Streptococcus pneumoniae. Ontological pathway analysis of LRRK2 across metabolic and kidney processes and pathological categories suggested that the thioredoxin network may play a role in perturbing these organ systems. The phenotype of the LRRK2 null rat is suggestive of a complex biology influencing metabolism, immune function and kidney homeostasis. These data need to be extended to better understand the role of the kinase domain or other biological functions of the gene to better inform the development of pharmacological inhibitors.	[Ness, Daniel; Olaharski, Andrew J.] Elan Pharmaceut Inc, Nonclin Safety Evaluat, San Francisco, CA USA; [Ren, Zhao] Elan Pharmaceut Inc, Assay Dev, San Francisco, CA USA; [Gardai, Shyra] Elan Pharmaceut Inc, Exploratory Biol, San Francisco, CA USA; [Brigham, Elizabeth F.] Elan Pharmaceut Inc, Pharmacol, San Francisco, CA USA; [Brennan, Richard J.] Thomson Reuters Inc, Carlsbad, CA USA; [Sharpnack, Douglas] Vet Path Serv Inc, Mason, OH USA; [Johnson, Victor J.] Burleson Res Technol Inc BRT, Morrisville, NC USA		Olaharski, AJ (corresponding author), Elan Pharmaceut Inc, Nonclin Safety Evaluat, San Francisco, CA USA.	andrew.olaharski@gmail.com		Johnson, Victor J./0000-0002-3471-6483	Elan Pharmaceuticals	Elan Pharmaceuticals	Daniel Ness, Zhao Ren, Shyra Gardai, Elizabeth F. Brigham, and Andrew J. Olaharski were employees of Elan Pharmaceutical where the work was conducted. Elan Pharmaceuticals funded this study. Richard J. Brennan is employed by Thomson Reuters Inc., Douglas Sharpnack by Vet Path Services Inc., and Victor J. Johnson by Burleson Research Technologies, Inc. Some work was outsourced to contract research organizations, such as Vet Path Services (Douglas Sharpnack for histopathology), Burleson Research Technologies (Victor J. Johnson for the host resistance study), and Thomson Reuters (Richard J. Brennan for pathway analysis). There are no patents, products in development or marketed products to declare. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Angeles DC, 2011, HUM MUTAT, V32, P1390, DOI 10.1002/humu.21582; Blouet C, 2012, J NEUROSCI, V32, P9870, DOI 10.1523/JNEUROSCI.0353-12.2012; Blouet C, 2011, J NEUROSCI, V31, P6019, DOI 10.1523/JNEUROSCI.6498-10.2011; Boverhof DR, 2011, TOXICOL SCI, V121, P207, DOI 10.1093/toxsci/kfr075; Bravo-San Pedro JM, 2012, CELL MOL LIFE SCI; Chen CY, 2012, CELL DEATH DIFFER, V19, P1623, DOI 10.1038/cdd.2012.42; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Das SK, 2011, J CLIN ENDOCR METAB, V96, pE1308, DOI 10.1210/jc.2011-0101; Dawson TM, 2009, BBA-MOL BASIS DIS, V1792, P585, DOI 10.1016/j.bbadis.2009.06.001; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dezso Z, 2009, GENOMICS FUNDAMENTAL, P269; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Ekins S, 2010, SYSTEMS BIOL APPL DR; Gaig C, 2006, ARCH NEUROL-CHICAGO, V63, P377, DOI 10.1001/archneur.63.3.377; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Greggio E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-94; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Huh JY, 2012, ANTIOXID REDOX SIGN, V16, P229, DOI [10.1089/ars.2010.3766, 10.1089/ars.2011.3952]; Ikegami H, 2008, ANN NY ACAD SCI, V1150, P103, DOI 10.1196/annals.1447.060; Inzelberg R, 2012, NEUROLOGY, V78, P781, DOI 10.1212/WNL.0b013e318249f673; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lichtenberg M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.81; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Mellor HR, 2011, TOXICOL SCI, V120, P14, DOI 10.1093/toxsci/kfq378; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Myshkin E, 2012, CHEM BIOL DRUG DES, V80, P406, DOI 10.1111/j.1747-0285.2012.01411.x; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; Nikonova EV, 2012, HUM MOL GENET, V21, P163, DOI 10.1093/hmg/ddr451; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Tong YR, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-2; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tsigou E, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/361078; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Waxman EA, 2009, J NEUROPATH EXP NEUR, V68, P785, DOI 10.1097/NEN.0b013e3181aaf4fd; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	46	73	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66164	10.1371/journal.pone.0066164	http://dx.doi.org/10.1371/journal.pone.0066164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799078	gold, Green Published			2022-12-27	WOS:000320363300063
J	Nishi, H; Tyagi, M; Teng, SL; Shoemaker, BA; Hashimoto, K; Alexov, E; Wuchty, S; Panchenko, AR				Nishi, Hafumi; Tyagi, Manoj; Teng, Shaolei; Shoemaker, Benjamin A.; Hashimoto, Kosuke; Alexov, Emil; Wuchty, Stefan; Panchenko, Anna R.			Cancer Missense Mutations Alter Binding Properties of Proteins and Their Interaction Networks	PLOS ONE			English	Article							HOT-SPOTS; PHOSPHORYLATION SITES; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; DRIVER MUTATIONS; PREDICTION; STABILITY; DISEASE; SERVER; IDENTIFICATION	Many studies have shown that missense mutations might play an important role in carcinogenesis. However, the extent to which cancer mutations might affect biomolecular interactions remains unclear. Here, we map glioblastoma missense mutations on the human protein interactome, model the structures of affected protein complexes and decipher the effect of mutations on protein-protein, protein-nucleic acid and protein-ion binding interfaces. Although some missense mutations over-stabilize protein complexes, we found that the overall effect of mutations is destabilizing, mostly affecting the electrostatic component of binding energy. We also showed that mutations on interfaces resulted in more drastic changes of amino acid physico-chemical properties than mutations occurring outside the interfaces. Analysis of glioblastoma mutations on interfaces allowed us to stratify cancer-related interactions, identify potential driver genes, and propose two dozen additional cancer biomarkers, including those specific to functions of the nervous system. Such an analysis also offered insight into the molecular mechanism of the phenotypic outcomes of mutations, including effects on complex stability, activity, binding and turnover rate. As a result of mutated protein and gene network analysis, we observed that interactions of proteins with mutations mapped on interfaces had higher bottleneck properties compared to interactions with mutations elsewhere on the protein or unaffected interactions. Such observations suggest that genes with mutations directly affecting protein binding properties are preferably located in central network positions and may influence critical nodes and edges in signal transduction networks.	[Nishi, Hafumi; Shoemaker, Benjamin A.; Wuchty, Stefan; Panchenko, Anna R.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Tyagi, Manoj] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Teng, Shaolei; Alexov, Emil] Clemson Univ, Dept Phys, Clemson, SC USA; [Hashimoto, Kosuke] RIKEN, Omics Sci Ctr, Yokohama, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Washington University (WUSTL); Clemson University; RIKEN	Panchenko, AR (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	panch@ncbi.nlm.nih.gov	Hashimoto, Kosuke/C-3675-2017; Tyagi, Manoj/K-8438-2014	Hashimoto, Kosuke/0000-0003-3031-0635; Nishi, Hafumi/0000-0002-0846-0330; Teng, Shaolei/0000-0001-8326-9889	National Library of Medicine at the U.S. National Institutes of Health; JSPS Research Fellowship from the Japan Society for the Promotion of Science; National Institutes of Health, National Institute of General Medical Sciences [R01GM093937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM090313] Funding Source: NIH RePORTER	National Library of Medicine at the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); JSPS Research Fellowship from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at the U.S. National Institutes of Health. K. H. in part was supported by a JSPS Research Fellowship from the Japan Society for the Promotion of Science. EA was supported in part by National Institutes of Health, National Institute of General Medical Sciences, grant number R01GM093937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Asleson EN, 2003, GENETICS, V163, P91; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brock K, 2007, BIOPHYS J, V93, P3340, DOI 10.1529/biophysj.107.112367; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dong WJ, 2011, CANCER SCI, V102, P361, DOI 10.1111/j.1349-7006.2010.01804.x; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hosur R, 2011, J MOL BIOL, V405, P1295, DOI 10.1016/j.jmb.2010.11.025; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim YA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001095; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2009, GENOME RES, V19, P1562, DOI 10.1101/gr.091991.109; Kuzu G, 2012, CURR OPIN STRUC BIOL, V22, P367, DOI 10.1016/j.sbi.2012.04.004; LOEB LA, 1991, CANCER RES, V51, P3075; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PONDER JW, 1999, TINKER SOFTWARE TOOL; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Radivojac P, 2008, BIOINFORMATICS, V24, pI241, DOI 10.1093/bioinformatics/btn267; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Shoemaker BA, 2012, NUCLEIC ACIDS RES, V40, pD834, DOI 10.1093/nar/gkr997; Shoemaker BA, 2010, NUCLEIC ACIDS RES, V38, pD518, DOI 10.1093/nar/gkp842; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Teng Shaolei, 2010, International Journal of Computational Biology and Drug Design, V3, P334, DOI 10.1504/IJCBDD.2010.038396; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Torkamani A, 2009, CANCER LETT, V281, P117, DOI 10.1016/j.canlet.2008.11.008; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Tyagi M, 2012, EMBO REP, V13, P266, DOI 10.1038/embor.2011.261; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	75	66	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66273	10.1371/journal.pone.0066273	http://dx.doi.org/10.1371/journal.pone.0066273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799087	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300071
J	Benhaim, D; Begout, ML; Lucas, G; Chatain, B				Benhaim, David; Begout, Marie-Laure; Lucas, Gael; Chatain, Beatrice			First Insight into Exploration and Cognition in Wild Caught and Domesticated Sea Bass (Dicentrarchus labrax) in a Maze	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; ATLANTIC SALMON; ANTIPREDATOR BEHAVIOR; PIMEPHALES-PROMELAS; FATHEAD MINNOWS; FISH; GROWTH; HATCHERY; TROUT; SIZE	European sea bass aquaculture is so recent that very little is known on the effects of the early steps of its domestication. Behavioural parameters are sensitive indicators of the domestication process since they are generally impacted as soon as the first generation. The present work compared wild-caught and domesticated sea bass juvenile swimming activity, exploration and ability to learn to discriminate between two 2-D objects associated to a simple spatial task that enabled the tested individual to visually interact with an unfamiliar congener (the reward) located behind a transparent wall at the end of one of the two arms of a maze. Ten fish from each origin were individually tested 3 times in a row during 3 days (9 trials in total). Fish were placed in a start box closed by a transparent wall located in front of two 2-D objects. Fish were filmed during 10 min after the removal of the start box wall. Different swimming variables including angular velocity, total distance travelled and velocity mean, were analyzed from videos as well as the time spent in each of 6 virtual zones including the reward zone near the congener (Cong) and the zone opposite to the reward zone (OpCong). Two learning criteria were chosen: the number of successful turns and time to reach Cong. Behavioural differences were found between domesticated and wild fish. Angular velocity was higher in wild fish while the distance travelled and the velocity mean were higher in domesticated ones. Wild and domesticated fish spent most of the time in Cong and in OpCong. No differences were seen in learning ability between wild and domesticated fish. However, our findings for learning require confirmation by further studies with larger numbers of learning sessions and experiments designed to minimise stress. This study therefore demonstrated an impact of domestication on swimming behaviour but not on spatial learning.	[Benhaim, David; Lucas, Gael] INTECHMER CNAM, LERMA, Cherbourg, France; [Begout, Marie-Laure] IFREMER, Lab Ressources Halieut, Lhoumeau, France; [Chatain, Beatrice] Stn Expt Aquaculture Ifremer, Lab Rech Piscicole Mediterrane, Palavas Les Flots, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); Ifremer	Benhaim, D (corresponding author), INTECHMER CNAM, LERMA, BP 324, Cherbourg, France.	david.benhaim@cnam.fr	Begout, Marie-Laure/L-7730-2019; Benhaim, David/A-9991-2019	Begout, Marie-Laure/0000-0003-1416-3479; 				ABBOTT JC, 1985, BEHAVIOUR, V92, P241; Allen PJ, 2009, J FISH BIOL, V74, P90, DOI 10.1111/j.1095-8649.2008.02112.x; Alves C, 2007, ANIM COGN, V10, P29, DOI 10.1007/s10071-006-0027-6; Anthouard M., 1993, ICHTYOPHYSIOL ACTA, V16, P59; Balon EK, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00563.x; Barnabe G., 1989, AQUACULTURE, P675; Beamish F.W.H., 1978, FISH PHYSIOL, V7, P101; Begout-Anras ML, 2004, INRA PROD ANIM, V7, P211; Benhaim D., 2013, Journal of Aquaculture Research and Development, V4, P169; Benhaim D, 2012, APPL ANIM BEHAV SCI, V141, P79, DOI 10.1016/j.applanim.2012.07.002; Benhaim D, 2012, APPL ANIM BEHAV SCI, V136, P63, DOI 10.1016/j.applanim.2011.11.010; Benhaim D, 2011, AQUAT LIVING RESOUR, V24, P391, DOI 10.1051/alr/2011140; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; Brown C, 2005, BEHAV ECOL, V16, P482, DOI 10.1093/beheco/ari016; Brown C, 2001, J FISH BIOL, V59, P471, DOI [10.1006/jfbi.2001.1689, 10.1111/j.1095-8649.2001.tb02354.x]; Brown C, 2007, FISH COGNITION BEHAV; Brown GE, 2007, LEARNING DANGER CHEM; Burns JG, 2009, ETHOLOGY, V115, P122, DOI 10.1111/j.1439-0310.2008.01585.x; CHIVERS DP, 1994, ANIM BEHAV, V48, P597, DOI 10.1006/anbe.1994.1279; Coves D, 2006, AQUACULTURE, V253, P385, DOI 10.1016/j.aquaculture.2005.08.015; Coves D, 1998, AQUAT LIVING RESOUR, V11, P395, DOI 10.1016/S0990-7440(99)80005-9; Dellefors Claes, 1995, Nordic Journal of Freshwater Research, V70, P31; Di-Poi C, 2007, PHYSIOL BEHAV, V90, P559, DOI 10.1016/j.physbeh.2006.11.005; Di-Poi C., 2008, THESIS SAINT ETIENNE; Duarte CM, 2007, SCIENCE, V316, P382, DOI 10.1126/science.1138042; Dudchenko PA, 2001, BEHAV NEUROSCI, V115, P850, DOI 10.1037//0735-7044.115.4.850; Dupont-Nivet M, 2008, AQUACULTURE, V275, P81, DOI 10.1016/j.aquaculture.2007.12.032; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; Ferno A, 2007, ROLE FISH LEARNING S; Ferno Anders, 1998, Nordic Journal of Freshwater Research, V0, P95; Fontaine P, 2003, CAHIERS AGR, V19, P119; Gibson BM, 2005, BEHAV NEUROSCI, V119, P567, DOI 10.1037/0735-7044.119.2.567; Gross MR, 1998, CAN J FISH AQUAT SCI, V55, P131, DOI 10.1139/cjfas-55-S1-131; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; JOHNSSON JI, 1991, CAN J FISH AQUAT SCI, V48, P243, DOI 10.1139/f91-033; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Johnsson JI, 2001, CAN J FISH AQUAT SCI, V58, P788, DOI 10.1139/cjfas-58-4-788; Kieffer J.D., 1992, Reviews in Fish Biology and Fisheries, V2, P125, DOI 10.1007/BF00042881; KLEEREKOPER H, 1974, ANIM BEHAV, V22, P124, DOI 10.1016/S0003-3472(74)80061-8; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; L?pez JC., 1999, ANIM COGN, V2, P109, DOI 10.1007/s100710050031; MAGURRAN AE, 1989, ETHOLOGY, V82, P216, DOI 10.1111/j.1439-0310.1989.tb00501.x; Malavasi S, 2004, J FISH BIOL, V65, P143, DOI 10.1111/j.0022-1112.2004.00545.x; Malavasi S, 2008, AQUAC RES, V39, P276, DOI 10.1111/j.1365-2109.2007.01894.x; Marchetti MP, 2003, ENVIRON BIOL FISH, V66, P9, DOI 10.1023/A:1023269221678; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Matthews KR, 1990, ENVIRON BIOL FISH, V29, P141; Millot S, 2008, AQUACULTURE, V274, P87, DOI 10.1016/j.aquaculture.2007.11.004; Millot S, 2009, APPL ANIM BEHAV SCI, V119, P108, DOI 10.1016/j.applanim.2009.03.009; Odling-Smee L, 2003, FISH FISH, V4, P235, DOI 10.1046/j.1467-2979.2003.00127.x; Odling-Smee L, 2007, ROLE LEARNING FISH O; PEUHKURI N, 1995, J FISH BIOL, V46, P221, DOI 10.1111/j.1095-8649.1995.tb05963.x; POYSA H, 1994, ANIM BEHAV, V48, P921, DOI 10.1006/anbe.1994.1317; RANTA E, 1993, AM NAT, V142, P42, DOI 10.1086/285528; REESE ES, 1989, ENVIRON BIOL FISH, V25, P79, DOI 10.1007/BF00002202; RESTLE F, 1957, PSYCHOL REV, V64, P217, DOI 10.1037/h0040678; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; RUSSELL EM, 1967, ANIM BEHAV, V15, P586, DOI 10.1016/0003-3472(67)90062-0; Siebeck UE, 2009, J EXP BIOL, V212, P2112, DOI 10.1242/jeb.028936; Sovrano VA, 2008, ANIM COGN, V11, P161, DOI 10.1007/s10071-007-0100-9; STIRLING HP, 1977, MAR BIOL, V40, P173, DOI 10.1007/BF00396264; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; Waples RS, 1999, FISHERIES, V24, P12, DOI 10.1577/1548-8446(1999)024<0012:DSMAH>2.0.CO;2; Warburton K, 2007, LEARNING FORAGING SK; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108	66	16	16	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65872	10.1371/journal.pone.0065872	http://dx.doi.org/10.1371/journal.pone.0065872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805190	Green Published, gold			2022-12-27	WOS:000320846500018
J	Gilat, M; Shine, JM; Bolitho, SJ; Matar, E; Kamsma, YPT; Naismith, SL; Lewis, SJG				Gilat, Moran; Shine, James M.; Bolitho, Samuel J.; Matar, Elie; Kamsma, Yvo P. T.; Naismith, Sharon L.; Lewis, Simon J. G.			Variability of Stepping during a Virtual Reality Paradigm in Parkinson's Disease Patients with and without Freezing of Gait	PLOS ONE			English	Article								Background: Freezing of gait is a common and debilitating symptom affecting many patients with advanced Parkinson's disease. Although the pathophysiology of freezing of gait is not fully understood, a number of observations regarding the pattern of gait in patients with this symptom have been made. Increased 'Stride Time Variability' has been one of the most robust of these features. In this study we sought to identify whether patients with freezing of gait demonstrated similar fluctuations in their stepping rhythm whilst performing a seated virtual reality gait task that has recently been used to demonstrate the neural correlate of the freezing phenomenon. Methods: Seventeen patients with freezing and eleven non-freezers performed the virtual reality task twice, once whilst 'On' their regular Parkinsonian medication and once in their practically defined 'Off' state. Results: All patients displayed greater step time variability during their 'Off' state assessment compared to when medicated. Additionally, in the 'Off' state, patients with freezing of gait had greater step time variability compared to non-freezers. The five steps leading up to a freezing episode in the virtual reality environment showed a significant increase in step time variability although the final three steps preceding the freeze were not characterized by a progressive shortening of latency. Conclusions: The results of this study suggest that characteristic features of gait disturbance observed in patients with freezing of gait can also be demonstrated with a virtual reality paradigm. These findings suggest that virtual reality may offer the potential to further explore the freezing phenomenon in Parkinson's disease.	[Gilat, Moran; Shine, James M.; Bolitho, Samuel J.; Matar, Elie; Naismith, Sharon L.; Lewis, Simon J. G.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Gilat, Moran; Kamsma, Yvo P. T.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Sydney; University of Groningen	Lewis, SJG (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	simonl@med.usyd.edu.au	Lewis, Simon/R-9469-2016	Lewis, Simon/0000-0002-4093-7071; Gilat, Moran/0000-0002-0072-4637; Shine, James/0000-0003-1762-5499; Naismith, Sharon/0000-0001-9076-2778; Matar, Elie/0000-0002-4994-0488	Michael J. Fox Foundation; National Health and Medical Research Council Practitioner Fellowship [1003007]; National Health and Medical Research Council [1008117]; 'het Prinses Beatrix Fonds', The Netherlands	Michael J. Fox Foundation; National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); 'het Prinses Beatrix Fonds', The Netherlands(Netherlands Government)	This work is supported by the Michael J. Fox Foundation (www.michaeljfox.org). A/Prof Lewis is supported by the National Health and Medical Research Council Practitioner Fellowship No. 1003007; A/Prof Naismith is supported by the National Health and Medical Research Council Career Development Award No. 1008117; and Moran Gilat MSc. is supported by a scholarship from 'het Prinses Beatrix Fonds', The Netherlands (www.prinsesbeatrixspierfonds.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Espay AJ, 2012, NEUROLOGY, V78, P454, DOI 10.1212/WNL.0b013e3182477ec0; FAHN S, 1995, ADV NEUROL, V67, P53; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Gray P, 2000, J Neurosci Nurs, V32, P222; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Morris TR, 2012, GAIT POSTUR IN PRESS; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327	21	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66718	10.1371/journal.pone.0066718	http://dx.doi.org/10.1371/journal.pone.0066718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805270	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500098
J	Ikeda, T; Kumagai, E; Iwata, S; Yamakawa, A				Ikeda, Tetsurou; Kumagai, Emi; Iwata, Satoshi; Yamakawa, Akio			Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-alpha in THP-1 Cells and Monocytes	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; IMMUNE-RESPONSE; CD26; ACTIVATION; PHOSPHORYLATION; EXPRESSION; CAVEOLIN-1; ANTIBODY; CLONING; RANTES	CD26 is a 110-kDa multifunctional molecule having dipeptidyl peptidase IV (DPPIV) enzyme activity and is present on the surface of human T cells. Soluble CD26 (sCD26) exists in human blood and enhances the proliferation of peripheral T lymphocytes induced by tetanus toxoid (TT). The mechanisms by which CD26 enhances the activation of T cells and monocytes remain to be fully elucidated. In this study, we compared the stimulation of THP-1 cells and isolated human monocytes with a combination of recombinant sCD26 and lipopolysaccharide (LPS) and the stimulation of these cells with LPS alone. We found that addition of sCD26 increased TNF-alpha and IL-6 mRNA and protein expression and enhanced ERK1/2 levels in the cytosol as well as c-Fos, NF-kappa B p50, NF-kappa B p65, and CUX1 levels in the nuclei of these cells. On the other hand, the selective DPPIV inhibitor sitagliptin inhibited the increase in TNF-alpha mRNA and protein expression as well as the increase in ERK, c-Fos, NF-kappa B p50, NF-kappa B p65, and CUX1 levels. However, it did not inhibit the increase in IL-6 mRNA and protein expression. We then demonstrated that sCD26 enhanced binding of transcription factors to the TNF- and IL-6 promoters and used reporter assays to demonstrate that transcription factor binding enhanced promoter activity. Once again, we observed differential activities at the TNF- and IL-6 promoters. Finally, we demonstrated that CUX-1 overexpression enhanced TNF- production on sCD26/LPS stimulation, while CUX-1 depletion had no effect. Neither CUX-1 overexpression nor CUX-1 depletion had an effect on IL-6 stimulation. These results are discussed in the context of a model that describes the mechanisms by which stimulation of monocytic cells by sCD26 and LPS leads to elevation of TNF- and IL-6 expression. CUX-1 is identified as a new transcription factor that differently regulates the activities of the TNF- and IL-6 promoters.	[Ikeda, Tetsurou; Kumagai, Emi; Iwata, Satoshi; Yamakawa, Akio] Univ Tokyo, Inst Med Sci, Tokyo, Japan	University of Tokyo	Ikeda, T (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.	ikedate4@ims.u-tokyo.ac.jp			Global COE Program "Center of Education and Research for Advanced Genome-Based Medicine for personalized medicine and the control of worldwide infectious disease", MEXT Japan	Global COE Program "Center of Education and Research for Advanced Genome-Based Medicine for personalized medicine and the control of worldwide infectious disease", MEXT Japan	The Global COE Program "Center of Education and Research for Advanced Genome-Based Medicine for personalized medicine and the control of worldwide infectious disease", MEXT Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; FLEISCHER B, 1994, IMMUNOL TODAY, V15, P180, DOI 10.1016/0167-5699(94)90316-6; FOX DA, 1984, J IMMUNOL, V133, P1250; Hegen M, 1997, IMMUNOLOGY, V90, P257, DOI 10.1046/j.1365-2567.1997.00053.x; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Kahne T, 1998, CELL IMMUNOL, V189, P60, DOI 10.1006/cimm.1998.1355; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Korom S, 1997, TRANSPLANTATION, V63, P1495, DOI 10.1097/00007890-199705270-00021; KUBOTA T, 1992, CLIN EXP IMMUNOL, V89, P192; Manickasingham SP, 1998, J IMMUNOL, V161, P3827; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; Ohnuma K, 2005, MOL CELL BIOL, V25, P7743, DOI 10.1128/MCB.25.17.7743-7757.2005; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; Ponticos M, 2009, NUCLEIC ACIDS RES, V37, P5378, DOI 10.1093/nar/gkp544; Proost P, 1998, J BIOL CHEM, V273, P7222, DOI 10.1074/jbc.273.13.7222; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; TANAKA T, 1994, P NATL ACAD SCI USA, V91, P3082, DOI 10.1073/pnas.91.8.3082; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; TANAKA T, 1992, J IMMUNOL, V149, P481	23	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66520	10.1371/journal.pone.0066520	http://dx.doi.org/10.1371/journal.pone.0066520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805228	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500056
J	Seltmann, A; Majolo, B; Schulke, O; Ostner, J				Seltmann, Anne; Majolo, Bonaventura; Schuelke, Oliver; Ostner, Julia			The Organization of Collective Group Movements in Wild Barbary Macaques (Macaca sylvanus): Social Structure Drives Processes of Group Coordination in Macaques	PLOS ONE			English	Article							DECISION-MAKING; CONSENSUS DECISION; JAPANESE MACAQUES; DOMINANCE; PROPITHECUS; LEADERSHIP; STEEPNESS; DEPARTURE; BEHAVIOR; SIGNALS	Social animals have to coordinate activities and collective movements to benefit from the advantages of group living. Animals in large groups maintain cohesion by self-organization processes whereas in smaller groups consensus decisions can be reached. Where consensus decisions are relevant leadership may emerge. Variation in the organization of collective movements has been linked to variation in female social tolerance among macaque species ranging from despotic to egalitarian. Here we investigated the processes underlying group movements in a wild macaque species characterized by a degree of social tolerance intermediate to previously studied congeneric species. We focused on processes before, during and after the departure of the first individual. To this end, we observed one group of wild Barbary macaques (Macaca sylvanus) in the Middle Atlas, Morocco using all-occurrence behaviour sampling of 199 collective movements. We found that initiators of a collective movement usually chose the direction in which more individuals displayed pre-departure behavior. Dominant individuals contributed to group movements more than subordinates, especially juveniles, measured as frequencies of successful initiations and pre-departure behaviour. Joining was determined by affiliative relationships and the number of individuals that already joined the movement (mimetism). Thus, in our study group partially shared consensus decisions mediated by selective mimetism seemed to be prevalent, overall supporting the suggestion that a species' social style affects the organization of group movements. As only the most tolerant species show equally shared consensus decisions whereas in others the decision is partially shared with a bias to dominant individuals the type of consensus decisions seems to follow a stepwise relation. Joining order may also follow a stepwise, however opposite, relationship, because dominance only determined joining in highly despotic, but not in intermediate and tolerant species.	[Seltmann, Anne; Ostner, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Kellnerweg, Germany; [Majolo, Bonaventura] Lincoln Univ, Sch Psychol, Lincoln, England; [Schuelke, Oliver] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Kellnerweg, Germany	University of Gottingen; University of Lincoln; University of Gottingen	Seltmann, A (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Kellnerweg, Germany.	anne.seltmann@stud.uni-goettingen.de		Majolo, Bonaventura/0000-0002-0235-3040	German Initiative of Excellence	German Initiative of Excellence	The study was supported by funds from the German Initiative of Excellence to Georg August University Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Balasubramaniam KN, 2012, ANIM BEHAV, V83, P1207, DOI 10.1016/j.anbehav.2012.02.012; Berghanel A, 2011, ANIM BEHAV, V81, P1109, DOI 10.1016/j.anbehav.2011.02.009; Berghanel A, 2010, ANIM BEHAV, V80, P675, DOI 10.1016/j.anbehav.2010.07.002; BLACK JM, 1988, ETHOLOGY, V79, P143, DOI 10.1111/j.1439-0310.1988.tb00707.x; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; Bourjade M, 2009, ETHOLOGY, V115, P321, DOI 10.1111/j.1439-0310.2009.01614.x; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Fichtel C, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P37, DOI 10.1007/978-3-642-15355-6_3; Fischer J, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P229, DOI 10.1007/978-3-642-15355-6_13; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Furrer RD, 2012, ANIM BEHAV, V84, P205, DOI 10.1016/j.anbehav.2012.04.034; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Jacobs A, 2011, INT J PRIMATOL, V32, P1311, DOI 10.1007/s10764-011-9554-3; Kaplan BS, 2011, INT J PRIMATOL, V32, P1397, DOI 10.1007/s10764-011-9541-8; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Krause J, 2002, LIVING GROUPS; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Menard N., 2004, MACAQUE SOC MODEL ST, P117; Pannozzo PL, 2007, ETHOLOGY, V113, P881, DOI 10.1111/j.1439-0310.2007.01392.x; Petit O, 2008, DEV PSYCHOBIOL, V50, P399, DOI 10.1002/dev.20305; Petit O, 2011, INT J PRIMATOL, V32, P1433, DOI 10.1007/s10764-011-9545-4; Prins H.H.T., 1996, ECOLOGY BEHAV AFRICA, P218; Pyritz L, 2010, BEHAV PROCESS, V84, P681, DOI 10.1016/j.beproc.2010.02.025; Pyritz LW, 2011, INT J PRIMATOL, V32, P1325, DOI 10.1007/s10764-011-9549-0; Pyritz LW, 2011, INT J PRIMATOL, V32, P1268, DOI 10.1007/s10764-011-9524-9; Reinhart C.J., 2010, INT J COMP PSYCHOL, V23, P166; Sapolsky RM, 1997, ARCH GEN PSYCHIAT, V54, P1137; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; STEWART KJ, 1994, BEHAVIOUR, V130, P29, DOI 10.1163/156853994X00127; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C., 2010, P R SOC B, V278, P1697; Sueur C, 2012, COMPL SYST IN PRESS; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Sueur C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1875, DOI 10.1007/s00265-010-0999-8; Thierry B, 2008, ANIM BEHAV, V75, P847, DOI 10.1016/j.anbehav.2007.07.006; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P3; Trillmich J, 2004, BEHAVIOUR, V141, P1103, DOI 10.1163/1568539042664579; WASER PM, 1985, INT J PRIMATOL, V6, P569, DOI 10.1007/BF02692289; Young C, 2013, HORM BEHAV, V63, P32, DOI 10.1016/j.yhbeh.2012.11.004	58	17	17	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67285	10.1371/journal.pone.0067285	http://dx.doi.org/10.1371/journal.pone.0067285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805305	Green Published, Green Accepted, gold			2022-12-27	WOS:000320846500133
J	Brandt, F; Thvilum, M; Almind, D; Christensen, K; Green, A; Hegedus, L; Brix, TH				Brandt, Frans; Thvilum, Marianne; Almind, Dorthe; Christensen, Kaare; Green, Anders; Hegedus, Laszlo; Brix, Thomas Heiberg			Morbidity before and after the Diagnosis of Hyperthyroidism: A Nationwide Register-Based Study	PLOS ONE			English	Article							THYROID-HORMONE; GRAVES-DISEASE; INCREASED MORTALITY; CIGARETTE-SMOKING; EXCESS MORTALITY; CANCER-PATIENTS; POPULATION; TWIN; DYSFUNCTION; RISK	Background: Hyperthyroidism has been linked with different morbidities, like atrial fibrillation, stroke and diabetes mellitus. However, our knowledge regarding the extent and temporal relation between hyperthyroidism and other diseases is fragmented. Here, we aimed at evaluating various morbidities before and after the diagnosis of hyperthyroidism. Methods: Observational cohort study. From nationwide Danish health registers 2631 hyperthyroid singletons and 375 twin pairs discordant for hyperthyroidism were identified and followed for an average of 6 years (range 0-13). Data on the occurrence of cardiovascular diseases, lung diseases, diabetes mellitus, rheumatic diseases and malignant diseases was obtained by person-to-person record linkage with the National Danish Patient Register and/or the Danish National Prescription Registry (lung diseases and diabetes mellitus). Logistic and Cox regression models were used to assess the risk of morbidity before and after the diagnosis of hyperthyroidism, respectively. All Cox regression analyses were adjusted for the degree of co-morbidity preceding the diagnosis of hyperthyroidism, using the Charlson score. Results: Hyperthyroid individuals had a significantly higher risk of being diagnosed with cardiovascular diseases (odds ratio (OR) 1.65; 95% confidence interval (CI): 1.45-1.87), lung diseases (OR 1.53; 95% CI: 1.29-1.60), and diabetes mellitus (OR 1.43, 95% CI: 1.20-1.72), but not with malignant diseases (OR 1.16, 95% CI: 0.99-1.36) prior to the diagnosis of hyperthyroidism. After the diagnosis of hyperthyroidism, subjects had a significantly higher risk of being diagnosed with cardiovascular diseases (hazard ratio (HR) 1.34; 95% CI: 1.15-1.56), lung diseases (HR 1.28; 95% CI: 1.10-1.49), and diabetes mellitus (HR 1.46; 95% CI: 1.16-1.84), but not with rheumatic diseases (HR 1.39, 95% CI: 0.92-2.09) or malignant diseases (HR 1.18, 95% CI 0.97-1.42). Conclusions: We demonstrate a significantly increased burden of morbidity, both before and after the diagnosis of hyperthyroidism.	[Brandt, Frans; Thvilum, Marianne; Hegedus, Laszlo; Brix, Thomas Heiberg] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Almind, Dorthe; Christensen, Kaare] Univ Southern Denmark, Danish Aging Res Ctr, Odense, Denmark; [Almind, Dorthe; Christensen, Kaare] Univ Southern Denmark, Danish Twin Registry, Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Christensen, Kaare] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Green, Anders] Univ Southern Denmark, Inst Clin Res, Odense Patient Data Exploratory Network, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Brandt, F (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark.	frans.hjelm.brandt.kristensen@ouh.regionsyddanmark.dk	Green, Anders/T-8788-2019; Christensen, Kaare/C-2360-2009	Green, Anders/0000-0002-5059-3655; Christensen, Kaare/0000-0002-5429-5292; Pedersen, Dorthe Almind/0000-0001-7758-3791	School of Endocrinology, University of Southern Denmark in Odense; Danish Thyroid Patient Organization; Novo Nordisk Foundation	School of Endocrinology, University of Southern Denmark in Odense; Danish Thyroid Patient Organization; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	D.A., K.C., A.G. and T.H.B. have nothing to declare. F.B. and M.T. are enrolled as P.h.D. students financed by the School of Endocrinology, University of Southern Denmark in Odense. F.B. has also received funding from the Danish Thyroid Patient Organization. L.H. is the recipient of an unrestricted research grant from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton RT, 2004, ETHNIC DIS, V14, pS8; Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; Bak S, 2002, STROKE, V33, P769, DOI 10.1161/hs0302.103619; Berkson J, 1946, BIOMETRIC B, V2, P126, DOI DOI 10.2307/3002000; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Biondi B, 2010, NAT REV ENDOCRINOL, V6, P431, DOI 10.1038/nrendo.2010.105; Boelaert K, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.030; Bogazzi F, 2012, J ENDOCRINOL INVEST, V35, P340, DOI 10.3275/8298; Brandt F, 2013, THYROID, V23, P408, DOI 10.1089/thy.2012.0500; Brandt F, 2012, J CLIN ENDOCR METAB, V97, P4123, DOI 10.1210/jc.2012-2268; Brandt F, 2011, EUR J ENDOCRINOL, V165, P491, DOI 10.1530/EJE-11-0299; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Brix TH, 2012, CLIN ENDOCRINOL, V76, P457, DOI 10.1111/j.1365-2265.2011.04318.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; D'Alessandro A, 2012, EUR J PREV CARDIOL, V19, P297, DOI 10.1177/1741826711411738; Danzi S, 2012, MED CLIN N AM, V96, P257, DOI 10.1016/j.mcna.2012.01.006; Diez JJ, 2011, EXP CLIN ENDOCR DIAB, V119, P201, DOI 10.1055/s-0031-1271691; Disel U, 2012, MED ONCOL, V29, P3608, DOI 10.1007/s12032-012-0254-4; Erem C, 2009, ENDOCRINE, V36, P473, DOI 10.1007/s12020-009-9271-2; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Hemminki K, 2009, DIABETOLOGIA, V52, P1820, DOI 10.1007/s00125-009-1427-3; Ingebrigtsen T, 2010, RESP MED, V104, P1890, DOI 10.1016/j.rmed.2010.05.004; Jenkins RC, 2002, THYROID, V12, P977, DOI 10.1089/105072502320908312; Jorgensen TL, 2012, BRIT J CANCER, V106, P1353, DOI 10.1038/bjc.2012.46; Kwakkel J, 2011, NETH J MED, V69, P224; LAURBERG P, 1991, J INTERN MED, V229, P415, DOI 10.1111/j.1365-2796.1991.tb00368.x; Milla CE, 2012, PAEDIATR RESPIR REV, V13, P23, DOI 10.1016/j.prrv.2011.01.004; Owen PJD, 2007, THYROID, V17, P519, DOI 10.1089/thy.2007.0051; Pino-Garcia JM, 1998, EUR RESPIR J, V12, P400, DOI 10.1183/09031936.98.12020400; Rothman XJ, 2008, MODERN EPIDEMIOLOGY; Selmer C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7895; Siu CW, 2007, J CLIN ENDOCR METAB, V92, P1736, DOI 10.1210/jc.2006-1877; Skytthe A, 2011, SCAND J PUBLIC HEALT, V39, P75, DOI 10.1177/1403494810387966; Thomsen AF, 2005, EUR J ENDOCRINOL, V152, P535, DOI 10.1530/eje.1.01894; Thvilum M, 2013, J CLIN ENDOCR METAB, V98, P1069, DOI 10.1210/jc.2012-3375; Thvilum M, 2012, NAT REV ENDOCRINOL, V8, P417, DOI 10.1038/nrendo.2012.29; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Yue WS, 2011, CLIN ENDOCRINOL, V74, P636, DOI 10.1111/j.1365-2265.2011.03981.x	40	67	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66711	10.1371/journal.pone.0066711	http://dx.doi.org/10.1371/journal.pone.0066711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818961	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800098
J	Fonseca, CR; Coutinho, RM; Azevedo, F; Berbert, JM; Corso, G; Kraenkel, RA				Fonseca, Carlos Roberto; Coutinho, Renato M.; Azevedo, Franciane; Berbert, Juliana M.; Corso, Gilberto; Kraenkel, Roberto A.			Modeling Habitat Split: Landscape and Life History Traits Determine Amphibian Extinction Thresholds	PLOS ONE			English	Article							METAPOPULATION DYNAMICS; GLOBAL DECLINE; FRAGMENTATION; CONSERVATION; BIODIVERSITY; DISEASE; BRAZIL; POPULATIONS; FOREST; SIZE	Habitat split is a major force behind the worldwide decline of amphibian populations, causing community change in richness and species composition. In fragmented landscapes, natural remnants, the terrestrial habitat of the adults, are frequently separated from streams, the aquatic habitat of the larvae. An important question is how this landscape configuration affects population levels and if it can drive species to extinction locally. Here, we put forward the first theoretical model on habitat split which is particularly concerned on how split distance - the distance between the two required habitats - affects population size and persistence in isolated fragments. Our diffusive model shows that habitat split alone is able to generate extinction thresholds. Fragments occurring between the aquatic habitat and a given critical split distance are expected to hold viable populations, while fragments located farther away are expected to be unoccupied. Species with higher reproductive success and higher diffusion rate of post-metamorphic youngs are expected to have farther critical split distances. Furthermore, the model indicates that negative effects of habitat split are poorly compensated by positive effects of fragment size. The habitat split model improves our understanding about spatially structured populations and has relevant implications for landscape design for conservation. It puts on a firm theoretical basis the relation between habitat split and the decline of amphibian populations.	[Fonseca, Carlos Roberto] Univ Fed Rio Grande do Norte, Dept Bot Ecol & Zool, BR-59072970 Natal, RN, Brazil; [Coutinho, Renato M.; Azevedo, Franciane; Berbert, Juliana M.; Kraenkel, Roberto A.] Univ Estadual Paulista, Inst Fis Teor, BR-01405 Sao Paulo, Brazil; [Corso, Gilberto] Univ Fed Rio Grande do Norte, Dept Biofis & Farmacol, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Estadual Paulista; Universidade Federal do Rio Grande do Norte	Fonseca, CR (corresponding author), Univ Fed Rio Grande do Norte, Dept Bot Ecol & Zool, BR-59072970 Natal, RN, Brazil.	cfonseca@cb.ufrn.br	Fonseca, Carlos MMS/D-9744-2011; Corso, Gilberto/G-6160-2012; Kraenkel, Roberto A/B-5479-2010; Berbert, Juliana/AAG-1616-2021; Corso, Gilberto/AAE-9056-2021; Fonseca, Carlos Roberto/V-5869-2017; Coutinho, Renato M/H-9133-2017; Fonseca, Carlos Roberto/A-9273-2013	Fonseca, Carlos MMS/0000-0001-6559-7133; Corso, Gilberto/0000-0003-1748-4040; Kraenkel, Roberto A/0000-0001-5602-5184; Corso, Gilberto/0000-0003-1748-4040; Fonseca, Carlos Roberto/0000-0003-0292-0399; Coutinho, Renato M/0000-0002-2828-8558; Berbert, Juliana/0000-0003-2389-7837	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP; Internacional Center for Theoretical Physics - ICTP-SAIFR	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Internacional Center for Theoretical Physics - ICTP-SAIFR	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (CRF, GC, RAK), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (FA), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (RMC,JMB), and Internacional Center for Theoretical Physics - ICTP-SAIFR (RAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Ananthasubramaniam B, 2011, ECOLOGY, V92, P362, DOI 10.1890/09-2346.1; [Anonymous], 2004, HOTSPOTS REVISITED E; Artiles W, 2008, J MATH BIOL, V57, P521, DOI 10.1007/s00285-008-0174-2; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Becker CG, 2010, CONSERV BIOL, V24, P287, DOI 10.1111/j.1523-1739.2009.01324.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Cantrell RS, 1998, J MATH BIOL, V37, P491, DOI 10.1007/s002850050139; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Fonseca CR, 2009, BIOL CONSERV, V142, P1209, DOI 10.1016/j.biocon.2009.02.017; Fonseca CR, 2008, SCIENCE, V320, DOI 10.1126/science.1155686; Gardner TA, 2007, BIOL CONSERV, V138, P166, DOI 10.1016/j.biocon.2007.04.017; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Glista DJ, 2008, HERPETOL CONSERV BIO, V3, P77; HADDAD CFB, 1997, BIODIVERSIDADE ESTAD, P15; Hale JM, 2013, CONSERV GENET, V14, P313, DOI 10.1007/s10592-012-0428-9; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; HANSKI I, 1994, BIOL CONSERV, V68, P167, DOI 10.1016/0006-3207(94)90348-4; Hanski I., 1999, METAPOPULATION ECOLO; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; HARRISON S, 1988, AM NAT, V132, P360, DOI 10.1086/284858; Harrison S, 2008, BIOL J LINN SOC, V42, P73; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; LAAN R, 1990, BIOL CONSERV, V54, P251, DOI 10.1016/0006-3207(90)90055-T; Lehtinen RM, 1999, WETLANDS, V19, P1, DOI 10.1007/BF03161728; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; LOMAN J, 1988, Memoranda Societatis pro Fauna et Flora Fennica, V64, P113; Lomolino MV, 2008, BIOL J LINN SOC, V28, P1; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; MAC ARTHUR ROBERT H., 1967; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; ORBACH R, 1986, SCIENCE, V231, P814, DOI 10.1126/science.231.4740.814; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Relyea RA, 2005, ECOL APPL, V15, P1118, DOI 10.1890/04-1291; Remsburg AJ, 2009, J N AM BENTHOL SOC, V28, P44, DOI 10.1899/08-004.1; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Smith MA, 2005, ECOGRAPHY, V28, P110; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Tockner K, 2010, FRESHWATER BIOL, V55, P135, DOI 10.1111/j.1365-2427.2009.02371.x; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WEDERKINCH E, 1988, Memoranda Societatis pro Fauna et Flora Fennica, V64, P101; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WEYGOLDT P, 1989, STUD NEOTROP FAUNA E, V24, P249, DOI 10.1080/01650528909360795; Wuethrich B, 2007, SCIENCE, V315, P1070, DOI 10.1126/science.315.5815.1070	53	17	17	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66806	10.1371/journal.pone.0066806	http://dx.doi.org/10.1371/journal.pone.0066806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818967	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800104
J	Looyenga, BD; Resau, J; MacKeigan, JP				Looyenga, Brendan D.; Resau, James; MacKeigan, Jeffrey P.			Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway	PLOS ONE			English	Article							INDUCED SWEATING SYNDROME; ACID-INDUCED DIFFERENTIATION; NEURO-BLASTOMA CELLS; PARKINSONS-DISEASE; HUMAN NEUROBLASTOMA; OXIDATIVE STRESS; CNTF RECEPTOR; SH-SY5Y CELLS; MICE LACKING; IN-VIVO	Oxidative stress is an important cause of cellular toxicity in the central nervous system and contributes to the pathology associated with neurodegenerative disorders including Parkinson's disease. As such, elucidation of cellular mechanisms that enhance neuronal resistance to oxidative stress may provide new avenues for therapy. In this study we employed a simple two-state cellular model to identify genes that are associated with resistance to oxidative stress induced by 6-hydroxydopamine (6-OHDA). In this model, undifferentiated neuroblastoma cells display higher sensitivity to 6-OHDA than differentiated cells. By comparing the gene expression between these two states, we identified several genes whose expression is altered concomitant with changes in 6-OHDA sensitivity. This gene set includes cytokine receptor-like factor 1 (CRLF1), which is up-regulated during the differentiation process and has been previously implicated in neuroprotection. We show that the product of this gene is both necessary and sufficient for increased resistance to 6-OHDA in differentiated neuroblastoma cells, and that CRLF1 serves its protective role by a cell autonomous mechanism that is independent from its known role as a co-ligand for the ciliary neurotrophic factor receptor. These data provide an additional role for CRLF1 that could potentially explain its broad expression pattern and effects on cells lacking expression of this receptor.	[Looyenga, Brendan D.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA; [Resau, James] Van Andel Res Inst, Program Biospecimen Sci, Grand Rapids, MI USA	Van Andel Institute; Van Andel Institute	Looyenga, BD (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA.	brendan.looyenga@vai.org		MacKeigan, Jeffrey/0000-0002-0198-5679; Looyenga, Brendan/0000-0002-0661-0956	Van Andel Research Institute	Van Andel Research Institute	This work was funded internally by the Van Andel Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CURR BIOL, V9, P605, DOI 10.1016/S0960-9822(99)80266-8; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BIEDLER JL, 1978, CANCER RES, V38, P3751; Burbulla LF, 2011, J NEUROL SCI, V306, P1, DOI 10.1016/j.jns.2011.04.005; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Choi HJ, 2005, NEUROCHEM INT, V46, P329, DOI 10.1016/j.neuint.2004.10.009; Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039; Collier TJ, 2003, ANN NY ACAD SCI, V991, P140; Crisponi L, 2007, AM J HUM GENET, V80, P971, DOI 10.1086/516843; Dagoneau N, 2007, AM J HUM GENET, V80, P966, DOI 10.1086/513608; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Deumens R, 2002, EXP NEUROL, V175, P303, DOI 10.1006/exnr.2002.7891; Dick FD, 2006, BRIT MED BULL, V79-80, P219, DOI 10.1093/bmb/ldl018; Elson GCA, 1998, J IMMUNOL, V161, P1371; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Gregg C, 2005, DEVELOPMENT, V132, P565, DOI 10.1242/dev.01592; HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315; Herholz J, 2011, EUR J HUM GENET, V19, P525, DOI 10.1038/ejhg.2010.253; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Kestler DP, 2008, MOL MED, V14, P318, DOI 10.2119/2008-00010.Kestler; Knappskog PM, 2003, AM J HUM GENET, V72, P375, DOI 10.1086/346120; Kort EJ, 2009, VET PATHOL, V46, P598, DOI 10.1354/vp.08-VP-0276-R-REV; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Miyazaki I, 2009, NEUROCHEM RES, V34, P698, DOI 10.1007/s11064-008-9843-1; Opacka-Juffry J, 1998, BRAIN RES, V810, P27, DOI 10.1016/S0006-8993(98)00866-X; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; PERUMAL AS, 1992, BRAIN RES BULL, V29, P699, DOI 10.1016/0361-9230(92)90142-K; ROSS RA, 1983, J NATL CANCER I, V71, P741; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirmenstein MA, 2005, TOXICOL IN VITRO, V19, P471, DOI 10.1016/j.tiv.2005.01.006; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; ZIGMOND MJ, 1989, MOL CHEM NEUROPATHOL, V10, P185, DOI 10.1007/BF03159728	45	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66548	10.1371/journal.pone.0066548	http://dx.doi.org/10.1371/journal.pone.0066548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818941	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800077
J	Blicher, A; Heimburg, T				Blicher, Andreas; Heimburg, Thomas			Voltage-Gated Lipid Ion Channels	PLOS ONE			English	Article							PHASE-TRANSITION TEMPERATURE; BILAYER-MEMBRANES; ELECTRICAL BREAKDOWN; MELTING TRANSITION; PHOSPHATIDIC-ACID; CERAMIDE CHANNELS; POTASSIUM CHANNEL; THERMODYNAMICS; CAPACITANCE; FLUCTUATIONS	Synthetic lipid membranes can display channel-like ion conduction events even in the absence of proteins. We show here that these events are voltage-gated with a quadratic voltage dependence as expected from electrostatic theory of capacitors. To this end, we recorded channel traces and current histograms in patch-experiments on lipid membranes. We derived a theoretical current-voltage relationship for pores in lipid membranes that describes the experimental data very well when assuming an asymmetric membrane. We determined the equilibrium constant between closed and open state and the open probability as a function of voltage. The voltage-dependence of the lipid pores is found comparable to that of protein channels. Lifetime distributions of open and closed events indicate that the channel open distribution does not follow exponential statistics but rather power law behavior for long open times.	[Blicher, Andreas; Heimburg, Thomas] Univ Copenhagen, Niels Bohr Inst, Membrane Biophys Grp, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Heimburg, T (corresponding author), Univ Copenhagen, Niels Bohr Inst, Membrane Biophys Grp, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	theimbu@nbi.dk	Heimburg, Thomas/AAA-7726-2022; Heimburg, Thomas R/I-5064-2014	Heimburg, Thomas R/0000-0003-4599-4582	University of Copenhagen; Villum foundation [VKR 022130]	University of Copenhagen; Villum foundation(Villum Fonden)	A.B. was supported by a grant from the University of Copenhagen. T.H. was supported by the Villum foundation (VKR 022130) - URL:http://veluxfoundations.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; ALVAREZ O, 1978, BIOPHYS J, V21, P1, DOI 10.1016/S0006-3495(78)85505-2; ANTONOV VF, 1990, CHEM PHYS LIPIDS, V52, P251, DOI 10.1016/0009-3084(90)90121-7; Antonov VF, 2005, EUR BIOPHYS J BIOPHY, V34, P155, DOI 10.1007/s00249-004-0438-8; ANTONOV VF, 1980, NATURE, V283, P585, DOI 10.1038/283585a0; ANTONOV VF, 1985, BIOCHEM BIOPH RES CO, V133, P1098, DOI 10.1016/0006-291X(85)91249-5; Blicher A, 2011, THESIS U COPENHAGEN; Blicher A, 2009, BIOPHYS J, V96, P4581, DOI 10.1016/j.bpj.2009.01.062; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; CROWLEY JM, 1973, BIOPHYS J, V13, P711, DOI 10.1016/S0006-3495(73)86017-5; Ebel H, 2001, J PHYS CHEM B, V105, P7353, DOI 10.1021/jp010515s; Gallaher J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061925; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Grabitz P, 2002, BIOPHYS J, V82, P299, DOI 10.1016/S0006-3495(02)75395-2; HANKE W, 1984, BIOELECTROCH BIOENER, V12, P329, DOI 10.1016/0302-4598(84)87013-0; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Heimburg T, 2010, BIOPHYS CHEM, V150, P2, DOI 10.1016/j.bpc.2010.02.018; Heimburg T, 1998, BBA-BIOMEMBRANES, V1415, P147, DOI 10.1016/S0005-2736(98)00189-8; Heimburg T., 2007, THERMAL BIOPHYSICS M; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Heimburg T, 2012, BIOPHYS J, V103, P918, DOI 10.1016/j.bpj.2012.07.010; KAUFMANN K, 1983, BIOPHYS CHEM, V18, P89, DOI 10.1016/0301-4622(83)85002-9; KAUFMANN K, 1983, NATURWISSENSCHAFTEN, V70, P147, DOI 10.1007/BF00401606; Kaufmann K., 1989, LIPID MEMBRANE; Laub KR, 2012, BIOCHIM BIOPHYS ACTA, V1818, P1; LIEBOVITCH LS, 1987, BIOPHYS J, V52, P979, DOI 10.1016/S0006-3495(87)83290-3; Liebovitch LS, 2001, METHODS, V24, P359, DOI 10.1006/meth.2001.1206; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Neumann E, 1999, BIOELECTROCH BIOENER, V48, P3, DOI 10.1016/S0302-4598(99)00008-2; Nielsen LK, 2000, NATURE, V404, P352, DOI 10.1038/35006162; Petrov A. G., 2002, BIOCHIM BIOPHYS ACTA, V1561, P1, DOI DOI 10.1016/S0304-4157(01)00007-7; Seeger HM, 2007, J PHYS CHEM B, V111, P13858, DOI 10.1021/jp075346b; Shao CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043513; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Stark JA, 2000, BIOPHYS J, V78, P662, DOI 10.1016/S0006-3495(00)76624-0; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; WHITE SH, 1973, BIOCHIM BIOPHYS ACTA, V323, P7, DOI 10.1016/0005-2736(73)90428-8; WINTERHALTER M, 1987, PHYS REV A, V36, P5874, DOI 10.1103/PhysRevA.36.5874; Wodzinska K, 2009, SOFT MATTER, V5, P3319, DOI 10.1039/b909877a; Wu D, 1995, CELLULAR NEUROPHYSIO; Wunderlich B, 2009, BIOPHYS J, V96, P4592, DOI 10.1016/j.bpj.2009.02.053; YAFUSO M, 1974, J MEMBRANE BIOL, V17, P201, DOI 10.1007/BF01870182; Yang J, 2000, J PHYS CHEM B, V104, P8097, DOI 10.1021/jp001403o	50	21	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65707	10.1371/journal.pone.0065707	http://dx.doi.org/10.1371/journal.pone.0065707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823188	Green Submitted, Green Published, gold			2022-12-27	WOS:000320576400019
J	Solari, A; Giordano, A; Kasper, J; Drulovic, J; van Nunen, A; Vahter, L; Viala, F; Pietrolongo, E; Pugliatti, M; Antozzi, C; Radice, D; Kopke, S; Heesen, C				Solari, Alessandra; Giordano, Andrea; Kasper, Jurgen; Drulovic, Jelena; van Nunen, An; Vahter, Liina; Viala, Frederique; Pietrolongo, Erika; Pugliatti, Maura; Antozzi, Carlo; Radice, Davide; Koepke, Sascha; Heesen, Christoph		AutoMS Project	Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale	PLOS ONE			English	Article							TREATMENT DECISION-MAKING; PARTICIPATION; IMMUNOTHERAPY; WANT	Background: The Control Preference Scale (CPS) is the most frequently used measure of patients' preferred roles in treatment decisions. We revised the original CPS and developed a new computerized patient self-administered version (eCPS). We used the eCPS to assess role preferences, and their determinants, in Italian and German people with multiple sclerosis (MS). Methods: New cartoons were produced, based on MS health professional and patient input/feedback and previous findings, and pilot tested on 26 Italian and German MS patients. eCPS acceptability and reliability (weighted kappa statistic, wK) in comparison to the original tool, was determined in 92 MS patients who received both CPS versions in random order. Results: The new cartoons were well accepted and easily interpreted by patients, who reported they based their choices mainly on the text and considered the images of secondary importance. eCPS reliability was moderate (wK 0.53, 95% confidence interval [CI] 0.40-0.65) and similar to the test-retest reliability of face-to-face administration assessed in a previous publication (wK 0.65, 95% CI 0.45-0.81). Higher education (odds ratio [OR] 3.74, 95% CI 1.00-14.05) and German nationality (OR 10.30, 95% CI 3.10-34.15) were associated with preference for an active role in the logistic model. Conclusions: The newly devised eCPS was well received and considered easy to use by MS patients. Reliability was in line with that of the original version. Role preference appears affected by cultural characteristics and (borderline statistical significance) education.	[Solari, Alessandra; Giordano, Andrea] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Unit Neuroepidemiol, Milan, Italy; [Kasper, Jurgen] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Drulovic, Jelena] Univ Belgrade, Sch Med, Inst Neurol, Belgrade, Serbia; [van Nunen, An] Natl MS Ctr, Melsbroek, Belgium; [Vahter, Liina] West Tallinn Cent Hosp, Dept Neurol, Tallinn, Estonia; [Viala, Frederique] Purpan Univ Hosp, Dept Neurol, Toulouse, France; [Pietrolongo, Erika] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Pugliatti, Maura] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Antozzi, Carlo] Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Dept Neuromuscular Dis, Milan, Italy; [Radice, Davide] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Koepke, Sascha] Med Univ Lubeck, Nursing Res Grp, Inst Social Med, D-23538 Lubeck, Germany; [Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res Inims, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Belgrade; CHU de Toulouse; G d'Annunzio University of Chieti-Pescara; University of Sassari; IRCCS European Institute of Oncology (IEO); University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Solari, A (corresponding author), Fdn Ist Ricovero & Cura Carattere Sci Neurol Inst, Unit Neuroepidemiol, Milan, Italy.	solari@istituto-besta.it	Antozzi, Carlo/AAB-8787-2019; Pugliatti, Maura/K-4071-2016; Giordano, Andrea/AAN-3738-2021; Radice, Davide/B-7462-2016; pietrolongo, erika/AAC-5694-2020; Solari, Alessandra/AAO-1741-2021	Antozzi, Carlo/0000-0001-9270-5224; Pugliatti, Maura/0000-0001-9396-8683; Giordano, Andrea/0000-0003-4466-9788; Radice, Davide/0000-0002-5075-1895; pietrolongo, erika/0000-0002-6311-5994; Solari, Alessandra/0000-0001-9930-7579	Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/37]; German Hertie Foundation, AutoMS project; Novartis; Ritchter Gedeon; Bayer Schering; Biogen Idec; Merck Serono; Sanofi Aventis; Teva	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); German Hertie Foundation, AutoMS project; Novartis(Novartis); Ritchter Gedeon; Bayer Schering(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi Aventis(Sanofi-Aventis); Teva(Teva Pharmaceutical Industries)	This study was supported by grants from the Fondazione Italiana Sclerosi Multipla (FISM) (grant No. 2010/R/37) and by the German Hertie Foundation as part of the AutoMS project. The FISM also supported AG with a research fellowship. The funding sources had no role in study design, data collection, data analysis, data interpretation, or report writing.; AS was a board member for Biogen Idec and Novartis, and has received speaker honoraria from Genzyme and Merck Serono. JD has received honoraria for consultancy from Bayer Healthcare Pharmaceuticals, and speker's fees from Novartis and Ritchter Gedeon. AL was a board member for Bayer Schering, Biogen Idec, and Merck Serono; she has received travel grants and honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva. MP has received speaker honoraria from Sanofi Aventis, and travel support from Biogen Idec, Merck-Serono, Novartis, Sanofi Aventis and Teva. CH has received financial support from Bayer Schering, Biogen Idec, Merck Serono and Teva. All other authors declare that they have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Berry DL, 2010, J MED INTERNET RES, V12, P109, DOI 10.2196/jmir.1576; Bruce JM, 2011, NAT REV NEUROL, V7, P421, DOI 10.1038/nrneurol.2011.106; Charles C, 2006, PATIENT EDUC COUNS, V63, P262, DOI 10.1016/j.pec.2006.06.018; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; Davison B Joyce, 2007, Cancer Nurs, V30, pE7; Davison B Joyce, 2003, Oncol Nurs Forum, V30, P107, DOI 10.1188/03.ONF.107-114; Deber RB, 2007, HEALTH EXPECT, V10, P248, DOI 10.1111/j.1369-7625.2007.00441.x; Degner L F, 1997, Can J Nurs Res, V29, P21; European Commission, 2007, TOG HLTH STRAT APPR; Frosch DL, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-73; Giordano A, 2008, J NEUROL SCI, V275, P86, DOI 10.1016/j.jns.2008.07.026; Hamann J, 2012, EUR J PUBLIC HEALTH, V22, P469, DOI 10.1093/eurpub/ckr112; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Heesen C, 2011, J NEUROL SCI, V306, P192, DOI 10.1016/j.jns.2010.09.012; Hong F, 2011, UROL ONCOL, DOI [10.1016/j.uro-lonc.2011.10.004, DOI 10.1016/J.UR0-L0NC.2011.10.004]; HOSMER DW, 1989, APPL LOGISTIC REGRES; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kagawa-Singer M, 2006, J CANCER EDUC, V21, pS22, DOI 10.1207/s15430154jce2101s_6; Kasper J, 2008, EUR J NEUROL, V15, P1345, DOI 10.1111/j.1468-1331.2008.02313.x; Kasper J, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-60; Kremer H, 2008, MED DECIS MAKING, V28, P899, DOI 10.1177/0272989X08317014; Kryworuchko J, 2008, PATIENT EDUC COUNS, V73, P497, DOI 10.1016/j.pec.2008.07.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; LEVINSON W, 1994, JAMA-J AM MED ASSOC, V272, P1619, DOI 10.1001/jama.272.20.1619; Mansell D, 2000, ARCH INTERN MED, V160, P2991, DOI 10.1001/archinte.160.19.2991; Melbourne E, 2011, PATIENT EDUC COUNS, V83, P55, DOI 10.1016/j.pec.2010.04.019; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Pietrolongo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060721; Solari A, 2007, MULT SCLER J, V13, P763, DOI 10.1177/1352458506074689; Terry K, 1994, Med Econ, V71, ppassim; UK Department of Health, 2012, INV PAT PUBL HEALTHC; Wallberg B, 2000, ACTA ONCOL, V39, P467; Yadav V, 2012, CURR NEUROL NEUROSCI, V12, P489, DOI 10.1007/s11910-012-0295-2; Yennurajalingam S, 2013, J PAIN SYMPTOM MANAG, V46, P376, DOI 10.1016/j.jpainsymman.2012.08.015	36	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66127	10.1371/journal.pone.0066127	http://dx.doi.org/10.1371/journal.pone.0066127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823627	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400055
J	D'Haene, N; Sauvage, S; Maris, C; Adanja, I; Le Mercier, M; Decaestecker, C; Baum, L; Salmon, I				D'Haene, Nicky; Sauvage, Sebastien; Maris, Calliope; Adanja, Ivan; Le Mercier, Marie; Decaestecker, Christine; Baum, Linda; Salmon, Isabelle			VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1-and Galectin-3-Induced Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; CELL-GROWTH; EXPRESSION; RECEPTORS; BINDING; PROTEIN; PLGF	Aim: Accumulating evidence suggests that extracellular galectin-1 and galectin-3 promote angiogenesis. Increased expression of galectin-1 and/or galectin-3 has been reported to be associated with tumour progression. Thus, it is critical to identify their influence on angiogenesis. Methods: We examined the individual and combined effects of galectin-1 and galectin-3 on endothelial cell (EC) growth and tube formation using two EC lines, EA.hy926 and HUVEC. The activation of vascular endothelial growth factor receptors (VEGFR1 and VEGFR2) was determined by ELISA and Western blots. We evaluated the VEGFR1 and VEGFR2 levels in endosomes by proximity ligation assay. Results: We observed different responses to exogenous galectins depending on the EC line. An enhanced effect on EA. hy926 cell growth and tube formation was observed when both galectins were added together. Focusing on this enhanced effect, we observed that together galectins induced the phosphorylation of both VEGFR1 and VEGFR2, whereas galectin-1 and -3 alone induced VEGFR2 phosphorylation only. In the same way, the addition of a blocking VEGFR1 antibody completely abolished the increase in tube formation induced by the combined addition of both galectins. In contrast, the addition of a blocking VEGFR2 antibody only partially inhibited this effect. Finally, the addition of both galectins induced a decrease in the VEGFR1 and VEGFR2 endocytic pools, with a significantly enhanced effect on the VEGFR1 endocytic pool. These results suggest that the combined action of galectin-1 and galectin-3 has an enhanced effect on angiogenesis via VEGFR1 activation, which could be related to a decrease in receptor endocytosis.	[D'Haene, Nicky; Sauvage, Sebastien; Maris, Calliope; Le Mercier, Marie; Salmon, Isabelle] Free Univ Brussels, Erasme Hosp, Dept Pathol, B-1050 Brussels, Belgium; [Adanja, Ivan; Decaestecker, Christine] Univ Libre Bruxelles, Lab Image Synth & Anal, Brussels Sch Engn, Ecole polytech Bruxelles, Brussels, Belgium; [Decaestecker, Christine; Salmon, Isabelle] ULB, DIAPATH Ctr Microscopy & Mol Imaging CMMI, Gosselies, Belgium; [Baum, Linda] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Salmon, I (corresponding author), Free Univ Brussels, Erasme Hosp, Dept Pathol, B-1050 Brussels, Belgium.	isabelle.salmon@erasme.ulb.ac.be		Decaestecker, Christine/0000-0002-5495-1931	Fonds Erasme; Fonds Yvonne Boel (Brussels, Belgium); FNRS	Fonds Erasme; Fonds Yvonne Boel (Brussels, Belgium); FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was performed with the support of grants awarded by the Fonds Erasme and the Fonds Yvonne Boel (Brussels, Belgium). C.D. is a Senior Research Associate with the "Fonds National de la Recherche Scientifique'' (FNRS), Brussels, Belgium. I.A. benefits from a Televie grant from the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, GLYCOBIOLOGY, V14, P817, DOI 10.1093/glycob/cwh095; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Clausse N, 1999, Angiogenesis, V3, P317, DOI 10.1023/A:1026584523789; D'Haene N, 2005, INT J IMMUNOPATH PH, V18, P431, DOI 10.1177/039463200501800304; D'Haene N, 2008, BRIT J HAEMATOL, V140, P402, DOI 10.1111/j.1365-2141.2007.06929.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Jia JH, 2010, PROTEOMICS, V10, P224, DOI 10.1002/pmic.200900607; Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200; Leys C, 2010, J EXP SOC PSYCHOL, V46, P684, DOI 10.1016/j.jesp.2010.02.007; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Luttun A, 2004, BBA-REV CANCER, V1654, P79, DOI 10.1016/j.bbcan.2003.09.002; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rorive S, 2008, GLIA, V56, P1679, DOI 10.1002/glia.20719; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Shtivelband MI, 2003, J THROMB HAEMOST, V1, P2225, DOI 10.1046/j.1538-7836.2003.00446.x; St Croix B, 2000, SCIENCE, V289, P1197; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Thijssen VL, CANC RES, V70, P6216; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; Zar J., 2010, BIOSTATISCTICAL ANAL; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	36	83	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e67029	10.1371/journal.pone.0067029	http://dx.doi.org/10.1371/journal.pone.0067029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799140	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800049
J	Tsai, CP; Lee, CTC				Tsai, Ching-Piao; Lee, Charles Tzu-Chi			Multiple Sclerosis Incidence Associated with the Soil Lead and Arsenic Concentrations in Taiwan	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; RISK; PREVALENCE; POPULATION; ACIDS	Background: Few studies in the world have assessed the incidence of multiple sclerosis (MS) with soil heavy metal concentrations. We explored the association of soil heavy metal factors and the MS incidence in Taiwan. Methods: There were 1240 new MS cases from the National Health Insurance Research Database and were verified with serious disabling disease certificates, 1997-2008. Soil heavy metal factors records included arsenic, mercury, cadmium, chromium, copper, nickel, lead and zinc in Taiwan from 1986 to 2002. Spatial regression was used to reveal the association of soil heavy metals and age- and gender-standardized incidence ratios for townships by controlling sunlight exposure hours, smoking prevalence and spatial autocorrelation. Results: The lead (Pb) concentration in the soil positively correlated with the township incidence; on the other hand, the arsenic (As) concentration in soil negatively correlated with the township incidence and when found together controlled each other. The positive correlation of lead (Pb) predominated in males, whereas the negative correlation of arsenic (As) in soil predominated in females. Conclusions: We conclude that exposure to lead (Pb) in soil positive associated with incidence of MS in Taiwan, especially in males. Exposure to arsenic (As) in soil negative associated with MS in Taiwan, especially in females.	[Tsai, Ching-Piao] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Tsai, Ching-Piao] Natl Yang Ming Univ, Taipei 112, Taiwan; [Lee, Charles Tzu-Chi] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Lee, CTC (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan.	charles@kmu.edu.tw			Ching-Ling Foundation of Taipei Veterans General Hospital	Ching-Ling Foundation of Taipei Veterans General Hospital	This research was supported by Ching-Ling Foundation of Taipei Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelion CM, 2009, SCI TOTAL ENVIRON, V407, P2216, DOI 10.1016/j.scitotenv.2008.11.033; Ammatuna E, 2009, LEUKEMIA LYMPHOMA, V50, P1217, DOI 10.1080/10428190902912486; Benito-Leon J, 2011, NEUROEPIDEMIOLOGY, V36, P148, DOI 10.1159/000325368; Boffetta P, 2003, BRIT MED BULL, V68, P71, DOI 10.1093/bmp/ldg023; Chiang CT, 2010, INT J ENV RES PUB HE, V7, P3916, DOI 10.3390/ijerph7113916; Conradi S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-123; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Elhami SR, 2011, NEUROEPIDEMIOLOGY, V36, P141, DOI 10.1159/000324708; Fisher AA, 2000, J NEUROL NEUROSUR PS, V69, P687, DOI 10.1136/jnnp.69.5.687; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Hirst C, 2009, J NEUROL NEUROSUR PS, V80, P386, DOI 10.1136/jnnp.2008.144667; Hwang BF, 2008, ENVIRON HEALTH PERSP, V116, P1411, DOI 10.1289/ehp.11311; Johnson S, 2000, MED HYPOTHESES, V55, P239, DOI 10.1054/mehy.2000.1051; KLEIN D, 1994, BIOL REPROD, V50, P802, DOI 10.1095/biolreprod50.4.802; Koutsouraki E, 2010, INT REV PSYCHIATR, V22, P2, DOI 10.3109/09540261003589216; Lauer K, 2010, EXPERT REV NEUROTHER, V10, P421, DOI 10.1586/ERN.10.7; Lindberg AL, 2007, ENVIRON HEALTH PERSP, V115, P1081, DOI 10.1289/ehp.10026; Medade MS, 2000, MED GEOGRAPHY; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSKANZER DC, 1981, NEUROLOGY, V31, P708, DOI 10.1212/WNL.31.6.708; ROBERTSON DAF, 1983, BRIT MED J, V286, P605, DOI 10.1136/bmj.286.6365.605-a; Turabelidze G, 2008, J NEUROL SCI, V269, P158, DOI 10.1016/j.jns.2008.01.008; Wingerchuk DM, 2011, MT SINAI J MED, V78, P221, DOI 10.1002/msj.20240; Zhao HR, 2012, SCI TOTAL ENVIRON, V417, P45, DOI 10.1016/j.scitotenv.2011.12.047	24	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65911	10.1371/journal.pone.0065911	http://dx.doi.org/10.1371/journal.pone.0065911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799061	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800020
J	Colle, D; Santos, DB; Moreira, ELG; Hartwig, JM; dos Santos, AA; Zimmermann, LT; Hort, MA; Farina, M				Colle, Dirleise; Santos, Danubia Bonfanti; Gasnhar Moreira, Eduardo Luiz; Hartwig, Juliana Montagna; dos Santos, Alessandra Antunes; Zimmermann, Luciana Teixeira; Hort, Mariana Appel; Farina, Marcelo			Probucol Increases Striatal Glutathione Peroxidase Activity and Protects against 3-Nitropropionic Acid-Induced Pro-Oxidative Damage in Rats	PLOS ONE			English	Article							INDUCED HUNTINGTONS-DISEASE; TRANSGENIC MOUSE MODEL; INDUCED NEUROTOXICITY; IN-VITRO; MITOCHONDRIAL DYSFUNCTION; SUPEROXIDE-DISMUTASE; COENZYME Q(10); ENERGY-METABOLISM; ANIMAL-MODEL; VITAMIN-E	Huntington's disease (HD) is an autosomal dominantly inherited neurodegenerative disease characterized by symptoms attributable to the death of striatal and cortical neurons. The molecular mechanisms mediating neuronal death in HD involve oxidative stress and mitochondrial dysfunction. Administration of 3-nitropropionic acid (3-NP), an irreversible inhibitor of the mitochondrial enzyme succinate dehydrogenase, in rodents has been proposed as a useful experimental model of HD. This study evaluated the effects of probucol, a lipid-lowering agent with anti-inflammatory and antioxidant properties, on the biochemical parameters related to oxidative stress, as well as on the behavioral parameters related to motor function in an in vivo HD model based on 3-NP intoxication in rats. Animals were treated with 3.5 mg/kg of probucol in drinking water daily for 2 months and, subsequently, received 3-NP (25 mg/kg i.p.) once a day for 6 days. At the end of the treatments, 3- NP-treated animals showed a significant decrease in body weight, which corresponded with impairment on motor ability, inhibition of mitochondrial complex II activity and oxidative stress in the striatum. Probucol, which did not rescue complex II inhibition, protected against behavioral and striatal biochemical changes induced by 3-NP, attenuating 3-NP-induced motor impairments and striatal oxidative stress. Importantly, probucol was able to increase activity of glutathione peroxidase (GPx), an enzyme important in mediating the detoxification of peroxides in the central nervous system. The major finding of this study was that probucol protected against 3-NP-induced behavioral and striatal biochemical changes without affecting 3-NP-induced mitochondrial complex II inhibition, indicating that long-term probucol treatment resulted in an increased resistance against neurotoxic events (i.e., increased oxidative damage) secondary to mitochondrial dysfunction. These data appeared to be of great relevance when extrapolated to human neurodegenerative processes involving mitochondrial dysfunction and indicates that GPx is an important molecular target involved in the beneficial effects of probucol.	[Colle, Dirleise; Santos, Danubia Bonfanti; Gasnhar Moreira, Eduardo Luiz; Hartwig, Juliana Montagna; dos Santos, Alessandra Antunes; Zimmermann, Luciana Teixeira; Hort, Mariana Appel; Farina, Marcelo] Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Colle, D (corresponding author), Univ Fed Santa Catarina, Dept Bioquim, Ctr Ciencias Biol, Florianopolis, SC, Brazil.	dirleise@yahoo.com.br; marcelo.farina@.ufsc.br	dos Santos, Alessandra Antunes/F-3484-2019; Hort, Mariana/T-7377-2019; Moreira, Eduardo/S-6205-2016; Farina, Marcelo/HFZ-8788-2022; Farina, Marcelo/AAH-2005-2019; Teixeira Zimmermann, Luciana/F-5284-2013	Hort, Mariana/0000-0001-5877-3506; Moreira, Eduardo/0000-0003-2306-2207; Farina, Marcelo/0000-0001-8255-8515; Teixeira Zimmermann, Luciana/0000-0002-6992-2148; Colle, Dirleise/0000-0003-2345-5297	FINEP Research Grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net) [01.06.0842-00]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC) [TO 1346/2010-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT-CNPq-Excitotoxicity and Neuroprotection; CNPq	FINEP Research Grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT-CNPq-Excitotoxicity and Neuroprotection; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The financial supports by (i) FINEP Research Grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)" #01.06.0842-00, (ii) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), (iii) Fundacao de Apoio a Pesquisa do Estado de Santa Catarina (FAPESC - TO 1346/2010-3), (iv) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and (v) INCT-CNPq-Excitotoxicity and Neuroprotection are gratefully acknowledged. MF is the recipient of a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1974, EUR J BIOCHEM, V48, P137, DOI 10.1111/j.1432-1033.1974.tb03751.x; Al Mutairy A, 2010, NEUROTOXICOL TERATOL, V32, P226, DOI 10.1016/j.ntt.2009.09.003; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Asiri YA, 2010, OXID MED CELL LONGEV, V3, P308, DOI 10.4161/oxim.3.5.13107; Avila DS, 2010, TOXICOL SCI, V115, P194, DOI 10.1093/toxsci/kfq036; Bhateja DK, 2012, EUR J PHARMACOL, V674, P33, DOI 10.1016/j.ejphar.2011.10.029; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Borlongan CV, 1997, BRAIN RES PROTOC, V1, P253, DOI 10.1016/S1385-299X(96)00037-2; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093; Chen Chiung-Mei, 2011, Chang Gung Med J, V34, P135; Cirillo G, 2010, NEUROCHEM INT, V56, P152, DOI 10.1016/j.neuint.2009.09.013; Colle D, 2013, MITOCHONDRION, V13, P125, DOI 10.1016/j.mito.2013.01.005; Colle D, 2012, BRAIN RES BULL, V87, P397, DOI 10.1016/j.brainresbull.2012.01.003; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Du YY, 2012, NEUROSCI LETT, V509, P110, DOI 10.1016/j.neulet.2011.12.054; Farina M, 2009, TOXICOL SCI, V112, P416, DOI 10.1093/toxsci/kfp219; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; Franco JL, 2007, CHEM RES TOXICOL, V20, P1919, DOI 10.1021/tx7002323; Franco JL, 2009, FREE RADICAL BIO MED, V47, P449, DOI 10.1016/j.freeradbiomed.2009.05.013; Gopinath K, 2012, NEUROSCIENCE, V227, P134, DOI 10.1016/j.neuroscience.2012.07.060; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hands S, 2011, J BIOL CHEM, V286, P44512, DOI 10.1074/jbc.M111.307587; HASSEL B, 1995, J NEUROCHEM, V65, P1184; HEINSEN H, 1994, ACTA NEUROPATHOL, V88, P320, DOI 10.1007/BF00310376; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hyson HC, 2010, MOVEMENT DISORD, V25, P1924, DOI 10.1002/mds.22408; Johri A, 2012, J PHARMACOL EXP THER, V342, P619, DOI 10.1124/jpet.112.192138; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kasparova S, 2006, NEUROCHEM INT, V48, P93, DOI 10.1016/j.neuint.2005.09.002; Klivenyi P, 2000, J NEUROSCI, V20, P1; Kumar P, 2007, FUND CLIN PHARMACOL, V21, P297, DOI 10.1111/j.1472-8206.2007.00485.x; Kumar P, 2011, BRIT J PHARMACOL, V164, P644, DOI 10.1111/j.1476-5381.2011.01418.x; Kumar P, 2010, PHARMACOL REP, V62, P1; Kumar P, 2009, EUR J PHARMACOL, V615, P91, DOI 10.1016/j.ejphar.2009.04.058; Kumar P, 2009, PROG NEURO-PSYCHOPH, V33, P100, DOI 10.1016/j.pnpbp.2008.10.013; Latini A, 2005, MOL GENET METAB, V86, P188, DOI 10.1016/j.ymgme.2005.05.002; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; MCDOWELL IFW, 1994, EUR J CLIN INVEST, V24, P759, DOI 10.1111/j.1365-2362.1994.tb01073.x; Menze ET, 2012, NEUROTOXICOLOGY, V33, P1265, DOI 10.1016/j.neuro.2012.07.007; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Montilla P, 2004, J PHYSIOL BIOCHEM, V60, P259, DOI 10.1007/BF03167071; Moreira ELG, 2010, J PHARM PHARMACOL, V62, P1061, DOI 10.1111/j.2042-7158.2010.01124.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Perez-Severiano F, 2004, NEUROCHEM INT, V45, P1175, DOI 10.1016/j.neuint.2004.06.008; Perez-Severiano F, 2000, BRAIN RES, V862, P234, DOI 10.1016/S0006-8993(00)02082-5; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Sandhir R, 2012, NEURODEGENER DIS, V9, P145, DOI 10.1159/000334273; Santamaria A, 2003, J NEUROCHEM, V86, P479, DOI 10.1046/j.1471-4159.2003.01857.x; Santamaria A, 2001, NEUROCHEM RES, V26, P419, DOI 10.1023/A:1010911417383; Santos DB, 2012, EXP NEUROL, V233, P767, DOI 10.1016/j.expneurol.2011.11.036; Schilling G, 2001, NEUROSCI LETT, V315, P149, DOI 10.1016/S0304-3940(01)02326-6; Shimano Y, 1995, OBES RES, V3, pS779, DOI 10.1002/j.1550-8528.1995.tb00499.x; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x; Sudati JH, 2013, NEUROTOXICOLOGY, V37, P118, DOI 10.1016/j.neuro.2013.04.006; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tardif JC, 2003, CIRCULATION, V107, P552, DOI 10.1161/01.CIR.0000047525.58618.3C; Tardif Jean-Claude, 2002, Am J Cardiovasc Drugs, V2, P323, DOI 10.2165/00129784-200202050-00005; Tariq M, 2005, BRAIN RES BULL, V67, P161, DOI 10.1016/j.brainresbull.2005.06.024; Tunez I, 2010, MOLECULES, V15, P878, DOI 10.3390/molecules15020878; Villaran RE, 2008, NEUROTOXICOLOGY, V29, P244, DOI 10.1016/j.neuro.2007.11.001; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wendel A, 1981, Methods Enzymol, V77, P325; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yamashita S, 2009, ATHEROSCLEROSIS, V207, P16, DOI 10.1016/j.atherosclerosis.2009.04.002; Yamashita S, 2008, J ATHEROSCLER THROMB, V15, P292, DOI 10.5551/jat.E610; Yang LC, 2009, J NEUROCHEM, V109, P1427, DOI 10.1111/j.1471-4159.2009.06074.x; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	78	49	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67658	10.1371/journal.pone.0067658	http://dx.doi.org/10.1371/journal.pone.0067658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799154	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300116
J	Dorfman, A; Bereby-Meyer, Y; Moran, S				Dorfman, Anna; Bereby-Meyer, Yoella; Moran, Simone			When Feeling Skillful Impairs Coordination in a Lottery Selection Task	PLOS ONE			English	Article							MARKET-ENTRY DECISIONS; MANUFACTURING-INDUSTRIES; OVERCONFIDENCE; PERFORMANCE; CONFIDENCE; GAMES; FIRMS	Choosing a major field of study to secure a good job after graduation is a tacit coordination problem that requires considering others' choices. We examine how feeling skillful, either induced (Experiment 1) or measured (Experiment 2), affects coordination in this type of task. In both experiments participants chose between two lotteries, one offering a larger prize than the other. Participants' entry into the chosen lottery was either related or unrelated to their skill, with the final prize allocated randomly to one of the entrants in each lottery. Importantly, across conditions skill was irrelevant to choosing between lotteries. Notwithstanding, when skill was related to determining lottery entrants, participants who felt highly skillful chose the high prize lottery excessively. Results further suggest that this stems from high confidence in self skill, rather than incorrect expectations regarding others.	[Dorfman, Anna; Bereby-Meyer, Yoella] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Moran, Simone] Ben Gurion Univ Negev, Gilford Glazer Fac Business & Management, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Bereby-Meyer, Y (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.	yoella@bgu.ac.il	Moran, Simone/F-3272-2012; Bereby-Meyer, Yoella/D-9744-2012; Dorfman, Anna/GYR-1312-2022	Moran, Simone/0000-0002-2261-050X; Bereby-Meyer, Yoella/0000-0001-6569-0186				Andersson P, 2005, INT J FORECASTING, V21, P565, DOI 10.1016/j.ijforecast.2005.03.004; Bereby-Meyer Y, 2013, J BEHAV DECIS MAKING, V26, P338, DOI 10.1002/bdm.1769; Bolger F, 2008, EXP PSYCHOL, V55, P113, DOI 10.1027/1618-3169.55.2.113; Cain DM, STRATEG MAN IN PRESS; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; COOPER AC, 1988, J BUS VENTURING, V3, P97, DOI 10.1016/0883-9026(88)90020-1; DUNNE T, 1988, RAND J ECON, V19, P495, DOI 10.2307/2555454; Erev I., 2010, GAMES, V1, P117, DOI [10.3390/g1020117, DOI 10.3390/G1020117]; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Kahneman D., 1988, BOUNDED RATIONAL BEH, P11, DOI DOI 10.1007/978-3-642-48356-1_2; Koellinger P, 2007, J ECON PSYCHOL, V28, P502, DOI 10.1016/j.joep.2006.11.002; MATA J, 1994, J IND ECON, V42, P227, DOI 10.2307/2950567; Moore DA, 2007, ORGAN SCI, V18, P440, DOI 10.1287/orsc.1060.0243; RAPOPORT A, 1995, GROUP DECIS NEGOT, V4, P117, DOI 10.1007/BF01410098; Rapoport A, 2002, ORGAN BEHAV HUM DEC, V87, P180, DOI 10.1006/obhd.2001.2963; Rapoport A, 1998, MANAGE SCI, V44, P119, DOI 10.1287/mnsc.44.1.119; SUNDALI JA, 1995, ORGAN BEHAV HUM DEC, V64, P203, DOI 10.1006/obhd.1995.1100; WAGNER J, 1994, J IND ECON, V42, P141, DOI 10.2307/2950486; Wu B, 2006, MANAGE SCI, V52, P1315, DOI 10.1287/mnsc.1050.0543	19	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65092	10.1371/journal.pone.0065092	http://dx.doi.org/10.1371/journal.pone.0065092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799001	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300009
J	Eldridge-Thomas, B; Rubin, GJ				Eldridge-Thomas, Buffy; Rubin, G. James			Idiopathic Environmental Intolerance Attributed to Electromagnetic Fields: A Content Analysis of British Newspaper Reports	PLOS ONE			English	Article							MEDIA WARNINGS; HYPERSENSITIVITY; PROVOCATION; SYMPTOMS; EXPOSURE; SENSITIVITY; MEDICINE	Idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF) is a controversial condition in which people describe symptoms following exposure to electromagnetic fields from everyday electrical devices. However, double-blind experiments have found no convincing evidence that electromagnetic fields cause these symptoms. In this study, we assessed whether recent newspaper reporting in the UK reflected this scientific evidence. We searched a database of newspaper articles to identify all those that contained IEI-EMF related keywords and selected a random sample of 60 for content analysis. For our primary outcomes, we assessed how many articles mainly or wholly presented an electromagnetic cause for IEI-EMF and how many discussed unproven treatments for the condition such as strategies intended to reduce exposure to electromagnetic fields or the use of complementary and alternative therapies. We also assessed whether the type of information source used by a newspaper article (e. g. scientist, person with IEI-EMF, politician) or the type of newspaper (broadsheet, tabloid, local or regional) was associated with either outcome. Of the 60 articles, 43 (71.7%) presented a mainly electromagnetic cause, compared to 13 (21.7%) which presented mainly non-electromagnetic causes and 4 (6.7%) which did not discuss a cause. 29 (48.3%) did not mention any potential treatment, while 24 (40.0%) mentioned eletromagnetic field related strategies and 12 (20.0%) mentioned complementary or alternative therapies. Articles which quoted someone with IEI-EMF were significantly more likely to report an electromagnetic cause and to present unproven treatments. Those which used a scientist as a source were more likely to present a non-electromagnetic cause for the condition. The widespread poor reporting we identified is disappointing and has the potential for to encourage more people to misattribute their symptoms to electromagnetic fields. Scientists should remain engaged with the media to counteract this effect.	[Eldridge-Thomas, Buffy; Rubin, G. James] Kings Coll London, Dept Psychol Med, London WC2R 2LS, England	University of London; King's College London	Rubin, GJ (corresponding author), Kings Coll London, Dept Psychol Med, London WC2R 2LS, England.	Gideon.rubin@kcl.ac.uk		Eldridge-Thomas, Buffy/0000-0003-4070-2827	Church of England; UK's Mobile Telecommunications and Health Research programme	Church of England; UK's Mobile Telecommunications and Health Research programme	The authors have read the journal's policy and have the following conflicts to disclose: Dr Rubin has received payment from the Church of England for expert testimony relating to the installation of wifi equipment on Church premises and has previously received funding from the UK's Mobile Telecommunications and Health Research programme. He sits on the UK's Advisory Group for Non Ionising Radiation, and is an external expert for the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks. He was interviewed in some of the articles analysed in this study. These potential conflicts do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Advisory Group on Non-Ionising Radiation (AGNIR), 2012, HLTH EFF RAD EL FIEL; BEGG N, 1998, BRIT MED J, V316, P561, DOI DOI 10.1136/BMJ.316.7130.561; Bergqvist U, 1997, ARBETE HALSA, V19, P1; Boyd I, 2012, J ROY SOC MED, V105, P523, DOI 10.1258/jrsm.2012.120060; Dougall AL, 2005, PSYCHIATRY, V68, P28, DOI 10.1521/psyc.68.1.28.64188; Eltiti S, 2007, ENVIRON HEALTH PERSP, V115, P1603, DOI 10.1289/ehp.10286; Eltiti S, 2007, BIOELECTROMAGNETICS, V28, P137, DOI 10.1002/bem.20279; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Hansson Mild K, 2004, P INT WORKSH EMF HYP; Knudsen AK, 2011, J ROYAL SOC MED SHOR, V2, DOI [10.1258/shorts.2011.011016, DOI 10.1258/SH0RTS.2011.011016]; Lemal M, 2009, PREV MED, V48, P189, DOI 10.1016/j.ypmed.2008.11.011; Manjunatha N, 2011, NATL MED J INDIA, V24, P314; Mortazavi SMJ, 2007, BIOELECTROMAGNETICS, V28, P326, DOI 10.1002/bem.20305; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Rubin GJ, 2008, J PSYCHOSOM RES, V64, P1, DOI 10.1016/j.jpsychores.2007.05.006; Rubin GJ, 2011, BIOELECTROMAGNETICS, V32, P593, DOI 10.1002/bem.20690; Rubin GJ, 2010, BIOELECTROMAGNETICS, V31, P1, DOI 10.1002/bem.20536; Rubin GJ, 2005, PSYCHOSOM MED, V67, P224, DOI 10.1097/01.psy.0000155664.13300.64; Rubin GJ, 2006, PSYCHOTHER PSYCHOSOM, V75, P12, DOI 10.1159/000089222; Seitz H, 2005, SCI TOTAL ENVIRON, V349, P45, DOI 10.1016/j.scitotenv.2005.05.009; STEWART DE, 1990, PSYCHOSOMATICS, V31, P153, DOI 10.1016/S0033-3182(90)72188-3; WHO, 2005, EL FIELDS PUBL HLTH; Winters W, 2003, PSYCHOSOM MED, V65, P332, DOI 10.1097/01.PSY.0000041468.75064.BE; Witthoft M, 2013, J PSYCHOSOM RES, V74, P206, DOI 10.1016/j.jpsychores.2012.12.002; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552	25	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65713	10.1371/journal.pone.0065713	http://dx.doi.org/10.1371/journal.pone.0065713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799038	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300034
J	Perez-Aguilar, JM; Xi, J; Matsunaga, F; Cui, X; Selling, B; Saven, JG; Liu, RY				Perez-Aguilar, Jose Manuel; Xi, Jin; Matsunaga, Felipe; Cui, Xu; Selling, Bernard; Saven, Jeffery G.; Liu, Renyu			A Computationally Designed Water-Soluble Variant of a G-Protein-Coupled Receptor: The Human Mu Opioid Receptor	PLOS ONE			English	Article							ANGSTROM CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; BINDING-SITE; COMBINATORIAL LIBRARIES; CIRCULAR-DICHROISM; STATISTICAL-THEORY; LIGAND-BINDING; NUCLEIC-ACIDS; CHANNEL; CHOLESTEROL	G-protein-coupled receptors (GPCRs) play essential roles in various physiological processes, and are widely targeted by pharmaceutical drugs. Despite their importance, studying GPCRs has been problematic due to difficulties in isolating large quantities of these membrane proteins in forms that retain their ligand binding capabilities. Creating water-soluble variants of GPCRs by mutating the exterior, transmembrane residues provides a potential method to overcome these difficulties. Here we present the first study involving the computational design, expression and characterization of water-soluble variant of a human GPCR, the human mu opioid receptor (MUR), which is involved in pain and addiction. An atomistic structure of the transmembrane domain was built using comparative (homology) modeling and known GPCR structures. This structure was highly similar to the subsequently determined structure of the murine receptor and was used to computationally design 53 mutations of exterior residues in the transmembrane region, yielding a variant intended to be soluble in aqueous media. The designed variant expressed in high yield in Escherichia coli and was water soluble. The variant shared structural and functionally related features with the native human MUR, including helical secondary structure and comparable affinity for the antagonist naltrexone (K-d = 65 nM). The roles of cholesterol and disulfide bonds on the stability of the receptor variant were also investigated. This study exemplifies the potential of the computational approach to produce water-soluble variants of GPCRs amenable for structural and functionally related characterization in aqueous solution.	[Perez-Aguilar, Jose Manuel; Saven, Jeffery G.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Xi, Jin; Matsunaga, Felipe; Cui, Xu; Liu, Renyu] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Cui, Xu] Capital Med Univ, Beijing Tongren Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Selling, Bernard] Impact Biol Inc, Swarthmore, PA USA	University of Pennsylvania; University of Pennsylvania; Capital Medical University	Saven, JG (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	saven@sas.upenn.edu; liur@uphs.upenn.edu		Matsunaga, Felipe/0000-0002-0798-7632; Perez-Aguilar, Jose Manuel/0000-0002-9893-5992	Foundation for Anesthesia Education and Research (FAER); National Institutes of Health (NIH) [K08-GM-093115-01]; GROFF; Department of Anesthesiology and Critical Care at the University of Pennsylvania; Penn Nano/Bio Interface Center through the National Science Foundation (NSF) [NSEC DMR-0425780]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM093115] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research (FAER); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GROFF; Department of Anesthesiology and Critical Care at the University of Pennsylvania; Penn Nano/Bio Interface Center through the National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Foundation for Anesthesia Education and Research (FAER) (PI, RL), National Institutes of Health (NIH) K08 (K08-GM-093115-01) (PI, RL), GROFF (PI, RL), the Department of Anesthesiology and Critical Care at the University of Pennsylvania (PI, RL), and the Penn Nano/Bio Interface Center through the National Science Foundation (NSF) NSEC DMR-0425780 (PI, JGS). NSF MRSEC DMR-1120901 (JGS) provided infrastructural support related to protein computational work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beuming T, 2004, BIOINFORMATICS, V20, P1822, DOI 10.1093/bioinformatics/bth143; Bronson J, 2006, BIOPHYS J, V90, P1156, DOI 10.1529/biophysj.105.068965; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2010, METHODS MOL BIOL, V654, P141, DOI 10.1007/978-1-60761-762-4_8; Cui TX, 2012, BBA-BIOMEMBRANES, V1818, P617, DOI 10.1016/j.bbamem.2011.11.021; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; Inturrisi CE, 2002, CLIN J PAIN, V18, pS3, DOI 10.1097/00002508-200207001-00002; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kono H, 2001, J MOL BIOL, V306, P607, DOI 10.1006/jmbi.2000.4422; Krepkiy D, 2006, PROTEIN EXPRES PURIF, V49, P60, DOI 10.1016/j.pep.2006.03.002; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P249, DOI 10.1001/jama.297.3.249; Liu RY, 2012, ACTA CRYSTALLOGR D, V68, P497, DOI 10.1107/S0907444912002740; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Ma DJ, 2008, P NATL ACAD SCI USA, V105, P16537, DOI 10.1073/pnas.0805501105; Manchikanti L, 2008, PAIN PHYSICIAN, V11, pS63; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muller I, 2008, J MEMBRANE BIOL, V223, P49, DOI 10.1007/s00232-008-9112-x; Muller I, 2010, APPL BIOCHEM BIOTECH, V160, P2175, DOI 10.1007/s12010-009-8715-8; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Oates J, 2012, BBA-BIOMEMBRANES, V1818, P2228, DOI 10.1016/j.bbamem.2012.04.010; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Perez-Aguilar Jose Manuel, 2012, J Anesth Clin Res, V3, P218; Perez-Aguilar JM, 2012, STRUCTURE, V20, P5, DOI 10.1016/j.str.2011.12.003; Poschner BC, 2007, ANAL BIOCHEM, V363, P306, DOI 10.1016/j.ab.2007.01.021; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; Rousseau B, 2007, HEPATOLOGY, V46, P1108, DOI 10.1002/hep.21770; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Slovic AM, 2004, P NATL ACAD SCI USA, V101, P1828, DOI 10.1073/pnas.0306417101; Stanasila L, 1999, EUR J BIOCHEM, V260, P430, DOI 10.1046/j.1432-1327.1999.00187.x; Subramanian G, 2000, J MED CHEM, V43, P381, DOI 10.1021/jm9903702; Surratt CK, 2005, CURR TOP MED CHEM, V5, P315, DOI 10.2174/1568026053544533; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Wallin E, 1997, PROTEIN SCI, V6, P808; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Zhang PS, 1999, MOL BRAIN RES, V72, P195, DOI 10.1016/S0169-328X(99)00241-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zou JM, 2000, J MOL BIOL, V296, P281, DOI 10.1006/jmbi.1999.3426; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	56	33	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66009	10.1371/journal.pone.0066009	http://dx.doi.org/10.1371/journal.pone.0066009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799068	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300058
J	Zhang, HP; Wang, F; Kranzler, HR; Zhao, HY; Gelernter, J				Zhang, Huiping; Wang, Fan; Kranzler, Henry R.; Zhao, Hongyu; Gelernter, Joel			Profiling of Childhood Adversity-Associated DNA Methylation Changes in Alcoholic Patients and Healthy Controls	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MESSENGER-RNA EXPRESSION; NICOTINE DEPENDENCE; GENE-EXPRESSION; ANXIETY DISORDERS; HUMAN BRAIN; RISK; HYPERMETHYLATION; SCHIZOPHRENIA; GENOTYPE	The increased vulnerability to alcohol dependence (AD) seen in individuals with childhood adversity (CA) may result in part from CA-induced epigenetic changes. To examine CA-associated DNA methylation changes in AD patients, we examined peripheral blood DNA methylation levels of 384 CpGs in promoter regions of 82 candidate genes in 279 African Americans [AAs; 88 with CA (70.5% with AD) and 191 without CA (38.2% with AD)] and 239 European Americans [EAs; 61 with CA (86.9% with AD) and 178 without CA (46.6% with AD)] using Illumina GoldenGate Methylation Array assays. The effect of CA on methylation of individual CpGs and overall methylation in promoter regions of genes was evaluated using a linear regression analysis (with consideration of sex, age, and ancestry proportion of subjects) and a principal components-based analysis, respectively. In EAs, hypermethylation of 10 CpGs in seven genes (ALDH1A1, CART, CHRNA5, HTR1B, OPRL1, PENK, and RGS19) were cross validated in AD patients and healthy controls who were exposed to CA. P values of two CpGs survived Bonferroni correction when all EA samples were analyzed together to increase statistical power [CHRNA5_cg17108064: P-adjust = 2.54 x 10(-5); HTR1B_cg06031989: P-adjust = 8.98 x 10(-5)]. Moreover, overall methylation levels in the promoter regions of three genes (ALDH1A1, OPRL1 and RGS19) were elevated in both EA case and control subjects who were exposed to CA. However, in AAs, CA-associated DNA methylation changes in AD patients were not validated in healthy controls. Our findings suggest that CA could induce population-specific methylation alterations in the promoter regions of specific genes, thus leading to changes in gene transcription and an increased risk for AD and other disorders.	[Zhang, Huiping; Wang, Fan; Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Div Biostat, New Haven, CT USA; [Zhang, Huiping; Wang, Fan; Gelernter, Joel] VA Connecticut Healthcare Syst, West Haven, CT USA; [Kranzler, Henry R.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Philadelphia VAMC, MIRECC VISN4, Philadelphia, PA USA	Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Pennsylvania; Pennsylvania Medicine	Zhang, HP (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	huiping.zhang@yale.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450; WANG, FAN/0000-0001-9806-5037; Gelernter, Joel/0000-0002-4067-1859; Zhang, Huiping/0000-0002-4902-0104	National Institutes of Health (NIH) [K99/R00 DA022891, R01 DA12690, R01 AA11330, R01 DA12849, R01 DA018432]; Veteran's Affairs Connecticut Mental Illness Research, Education and Clinical Center (MIRECC); Alcoholic Beverage Medical Research Foundation (ABMRF); Alkermes; Lilly; Lundbeck; Pfizer; Roche; Abbott; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018432, K99DA022891, R01DA012690, R01DA012849] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs Connecticut Mental Illness Research, Education and Clinical Center (MIRECC); Alcoholic Beverage Medical Research Foundation (ABMRF); Alkermes; Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Roche(Roche Holding); Abbott(Abbott Laboratories); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health (NIH) Grants K99/R00 DA022891 (to H. Zhang), R01 DA12690 (to JG), R01 AA11330 (to JG), R01 DA12849 (to JG), R01 DA018432 (to HRK), and grants from the Veteran's Affairs Connecticut Mental Illness Research, Education and Clinical Center (MIRECC) to JG and the Alcoholic Beverage Medical Research Foundation (ABMRF) to H. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The co-author Dr. Kranzler has been a paid consultant or advisory board member for the following pharmaceutical companies: Alkermes, Lilly, Lundbeck, Pfizer, and Roche. Dr. Kranzler has also received honoraria from the Alcohol Clinical Trials Initiative (ACTIVE), which is supported by Abbott, Lilly, Lundbeck, and Pfizer. However, this does not alter his adherence to all the PLOS ONE policies on sharing data and materials. The corresponding author Dr. Zhang is currently the academic editor for PLOS ONE. However, this does not alter his adherence to all the PLOS ONE policies on sharing data and materials.	Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Afifi TO, 2008, AM J PUBLIC HEALTH, V98, P946, DOI 10.2105/AJPH.2007.120253; Afifi TO, 2011, J PSYCHIATR RES, V45, P814, DOI 10.1016/j.jpsychires.2010.11.008; American Psychiatric Association, 1994, DSM 4 DIAGNOSTIC STA; Angst J, 2011, EUR ARCH PSY CLIN N, V261, P21, DOI 10.1007/s00406-010-0120-3; Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bleich S, 2006, ALCOHOL CLIN EXP RES, V30, P587, DOI 10.1111/j.1530-0277.2006.00068.x; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Borghol N, 2012, INT J EPIDEMIOL, V41, P62, DOI 10.1093/ije/dyr147; Douglas KR, 2010, ADDICT BEHAV, V35, P7, DOI 10.1016/j.addbeh.2009.07.004; Franklin TB, 2010, NEUROBIOL DIS, V39, P61, DOI 10.1016/j.nbd.2009.11.012; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Hodson C, 2006, CHILD ABUSE NEGLECT, V30, P1017, DOI 10.1016/j.chiabu.2005.10.017; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kramer DA, 2005, J AM ACAD CHILD PSY, V44, P19, DOI 10.1097/01.chi.0000145804.30112.6b; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee R, 2005, AM J PSYCHIAT, V162, P995, DOI 10.1176/appi.ajp.162.5.995; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Philibert Robert A., 2012, Frontiers in Genetics, V3, P54, DOI 10.3389/fgene.2012.00054; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Piyathilake CJ, 2003, CANCER CAUSE CONTROL, V14, P37, DOI 10.1023/A:1022573630082; Pritchard JK, 2000, GENETICS, V155, P945; Read J, 2010, AM J PSYCHIAT, V167, P717, DOI 10.1176/appi.ajp.2010.10010105; Rosenberg SD, 2007, PSYCHIAT SERV, V58, P245, DOI 10.1176/appi.ps.58.2.245; Shannon C, 2011, SCHIZOPHRENIA BULL, V37, P531, DOI 10.1093/schbul/sbp096; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Sherva R, 2010, NEUROPSYCHOPHARMACOL, V35, P1921, DOI 10.1038/npp.2010.64; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tyrka AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030148; van der Vegt EJM, 2010, BIOL PSYCHIAT, V68, P1048, DOI 10.1016/j.biopsych.2010.07.027; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Venables WN., 2002, MODERN APPL STAT S 4; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; WANG RYH, 1980, NUCLEIC ACIDS RES, V8, P4777, DOI 10.1093/nar/8.20.4777; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilkinson PO, 2011, DEV PSYCHOPATHOL, V23, P1017, DOI 10.1017/S0954579411000472; Xie PX, 2012, NEUROPSYCHOPHARMACOL, V37, P669, DOI 10.1038/npp.2011.240; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005; Zhang H, 2012, ALCOHOL CLIN EXP RES; Zhang HP, 2013, ALCOHOL CLIN EXP RES, V37, pE108, DOI 10.1111/j.1530-0277.2012.01928.x	53	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65648	10.1371/journal.pone.0065648	http://dx.doi.org/10.1371/journal.pone.0065648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799031	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300031
J	Del Fabbro, S; Nazzi, F				Del Fabbro, Simone; Nazzi, Francesco			From Chemistry to Behavior. Molecular Structure and Bioactivity of Repellents against Ixodes ricinus Ticks	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; OLFACTORY RECEPTORS; ANOPHELES-GAMBIAE; ESSENTIAL OILS; INSECT REPELLENTS; CRYSTAL-STRUCTURE; HALLERS ORGAN; DEET	Tick-borne zoonoses are considered as emerging diseases. Tick repellents represent an effective tool for reducing the risk of tick bite and pathogens transmission. Previous work demonstrated the repellent activity of the phenylpropanoid eugenol against Ixodes ricinus; here we investigate the relationship between molecular structure and repellency in a group of substances related to that compound. We report the biological activity of 18 compounds varying for the presence/number of several moieties, including hydroxyl and methoxy groups and carbon side-chain. Each compound was tested at different doses with a bioassay designed to measure repellency against individual tick nymphs. Both vapor pressure and chemical features of the tested compounds appeared to be related to repellency. In particular, the hydroxyl and methoxy groups as well as the side-chain on the benzene ring seem to play a role. These results are discussed in light of available data on chemical perception in ticks. In the course of the study new repellent compounds were identified; the biological activity of some of them (at least as effective as the "gold standard'' repellent DEET) appears to be very promising from a practical point of view.	[Del Fabbro, Simone; Nazzi, Francesco] Univ Udine, Dipartimento Sci Agrarie & Ambientali, I-33100 Udine, Italy	University of Udine	Del Fabbro, S (corresponding author), Univ Udine, Dipartimento Sci Agrarie & Ambientali, I-33100 Udine, Italy.	simone.delfabbro@uniud.it		NAZZI, Francesco/0000-0002-2085-7621; Del Fabbro, Simone/0000-0001-5347-1322	Universita degli Studi di Udine	Universita degli Studi di Udine	The work was financed by the Universita degli Studi di Udine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman A, 2001, EXP NEUROL, V172, P153, DOI 10.1006/exnr.2001.7807; Allan SA, 2010, ECOL CONT VECTOR-BOR, V2, P327; Benton R, 2009, ANN NY ACAD SCI, V1170, P478, DOI 10.1111/j.1749-6632.2009.03880.x; Bissinger BW, 2010, PESTIC BIOCHEM PHYS, V96, P63, DOI 10.1016/j.pestbp.2009.09.010; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00029; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Brown Heather A., 1998, Insect Science and its Application, V18, P9; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Carroll JF, 2005, MED VET ENTOMOL, V19, P101, DOI 10.1111/j.0269-283X.2005.00559.x; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; DAVIS EE, 1985, J MED ENTOMOL, V22, P237, DOI 10.1093/jmedent/22.3.237; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Del Fabbro S, 2008, EXP APPL ACAROL, V45, P219, DOI 10.1007/s10493-008-9182-6; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; DOBROTVORSKII A K, 1989, Izvestiya Sibirskogo Otdeleniya Akademii Nauk SSSR Seriya Biologicheskikh Nauk, P62; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Donze G, 2004, J EXP BIOL, V207, P4283, DOI 10.1242/jeb.01241; Erler F, 2006, FITOTERAPIA, V77, P491, DOI 10.1016/j.fitote.2006.05.028; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Garcia-Domenech R, 2010, MOL DIVERS, V14, P321, DOI 10.1007/s11030-009-9179-z; Gbolade A. A., 2000, Journal of Tropical Medicinal Plants, V1, P146; Grenacher S, 2001, EXP APPL ACAROL, V25, P641, DOI 10.1023/A:1016145805759; Herrington JE, 2004, AM J PREV MED, V26, P135, DOI 10.1016/j.amepre.2003.10.010; Iason GR, 2012, ECOL REV, P1, DOI 10.1017/CBO9780511675751; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kim EH, 2003, J AGR FOOD CHEM, V51, P885, DOI 10.1021/jf0208278; Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418; Koren G, 2003, CAN MED ASSOC J, V169, P209; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Leonovich SA, 2004, EXP APPL ACAROL, V32, P89, DOI 10.1023/B:APPA.0000018200.24760.78; MOORE WARREN, 1934, JOUR NEW YORK ENT SOC, V42, P185; Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009; MWANGI EN, 1995, EXP APPL ACAROL, V19, P11, DOI 10.1007/BF00051933; Nazzi F, 2010, TRENDS IN ACAROLOGY, P517, DOI 10.1007/978-90-481-9837-5_88; Paluch G, 2010, PEST MANAG SCI, V66, P925, DOI 10.1002/ps.1974; Paluch G, 2009, J AGR FOOD CHEM, V57, P7618, DOI 10.1021/jf900964e; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Peterson C., 2001, Pesticide Outlook, V12, P154, DOI 10.1039/b106296b; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Randolph S, 2006, INT J MED MICROBIOL, V296, P84, DOI 10.1016/j.ijmm.2005.12.008; Schoenig GP, 1999, TOXICOL SCI, V47, P99, DOI 10.1093/toxsci/47.1.99; Seyoum A, 2002, T ROY SOC TROP MED H, V96, P225, DOI 10.1016/S0035-9203(02)90084-2; Sfara V, 2011, J INSECT PHYSIOL, V57, P1431, DOI 10.1016/j.jinsphys.2011.07.009; Snyder JC, 2011, EXP APPL ACAROL, V55, P215, DOI 10.1007/s10493-011-9472-2; Soares SF, 2012, ACTA TROP, V124, P192, DOI 10.1016/j.actatropica.2012.08.007; Spinelli S, 2012, INSECT BIOCHEM MOLEC, V42, P41, DOI 10.1016/j.ibmb.2011.10.005; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; STEULLET P, 1994, J COMP PHYSIOL A, V174, P27, DOI 10.1007/BF00192003; Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Szabadics J, 2000, ACTA BIOL HUNG, V51, P265; Thorsell W, 2006, PHYTOMEDICINE, V13, P132, DOI 10.1016/j.phymed.2004.04.008; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Tunon H, 2006, FITOTERAPIA, V77, P257, DOI 10.1016/j.fitote.2006.02.009; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vorou RM, 2007, EPIDEMIOL INFECT, V135, P1231, DOI 10.1017/S0950268807008527; Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; Yang YC, 2003, J AGR FOOD CHEM, V51, P4884, DOI 10.1021/jf034225f; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011	67	11	11	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67832	10.1371/journal.pone.0067832	http://dx.doi.org/10.1371/journal.pone.0067832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805329	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500157
J	Greer, AL; Schanzer, D				Greer, Amy L.; Schanzer, Dena			Using a Dynamic Model to Consider Optimal Antiviral Stockpile Size in the Face of Pandemic Influenza Uncertainty	PLOS ONE			English	Article							CLINICAL PREDICTORS; EPIDEMIC; CHILDREN; IMPACT; CANADA; TRANSMISSIBILITY; SEASONALITY; MORTALITY; ILLNESS; VACCINE	Background: The Canadian National Antiviral Stockpile (NAS) contains treatment for 17.5% of Canadians. This assumes no concurrent intervention strategies and no wastage due to non-influenza respiratory infections. A dynamic model can provide a mechanism to consider complex scenarios to support decisions regarding the optimal NAS size under uncertainty. Methods: We developed a dynamic model for pandemic influenza in Canada that is structured by age and risk to calculate the demand for antivirals to treat persons with pandemic influenza under a wide-range of scenarios that incorporated transmission dynamics, disease severity, and intervention strategies. The anticipated per capita number of acute respiratory infections due to viruses other than influenza was estimated for the full pandemic period from surveys based on criteria to identify potential respiratory infections. Results: Our results demonstrate that up to two thirds of the population could develop respiratory symptoms as a result of infection with a pandemic strain. In the case of perfect antiviral allocation, up to 39.8% of the population could request antiviral treatment. As transmission dynamics, severity and timing of the emergence of a novel influenza strain are unknown, the sensitivity analysis produced considerable variation in potential demand (median: 11%, IQR: 2-21%). If the next pandemic strain emerges in late spring or summer and a vaccine is available before the anticipated fall wave, the median prediction was reduced to 6% and IQR to 0.7-14%. Under the strategy of offering empirical treatment to all patients with influenza like symptoms who present for care, demand could increase to between 65 and 144%. Conclusions: The demand for antivirals during a pandemic is uncertain. Unless an accurate, timely and cost-effective test is available to identify influenza cases, demand for antivirals from persons infected with other respiratory viruses will be substantial and have a significant impact on the NAS.	[Greer, Amy L.; Schanzer, Dena] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Profess Guidelines & Publ Hlth Practice Div, Modelling & Project Sect, Ottawa, ON, Canada; [Greer, Amy L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	Public Health Agency of Canada; University of Toronto	Greer, AL (corresponding author), Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Profess Guidelines & Publ Hlth Practice Div, Modelling & Project Sect, Ottawa, ON, Canada.	amy.greer@phac-aspc.gc.ca	Schanzer, Dena/G-1593-2011	Schanzer, Dena/0000-0001-7093-4309	Public Health Agency of Canada	Public Health Agency of Canada	This work was funded internally by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki FY, 2010, USE ANTIVIRAL DRUGS, P1; Azziz-Baumgartner E, 2009, INFLUENZA OTHER RESP, V3, P189, DOI 10.1111/j.1750-2659.2009.00091.x; Becker NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017764; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Carrasco LR, 2011, J ROYAL SOC INTERFAC, P1; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; D'Aoust MA, 2008, PLANT BIOTECHNOL J, V6, P930, DOI 10.1111/j.1467-7652.2008.00384.x; Dimitrov NB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016094; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Friedman MJ, 2004, ARCH PEDIAT ADOL MED, V158, P391, DOI 10.1001/archpedi.158.4.391; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Glass K, 2009, J R SOC INTERFACE, V6, P695, DOI 10.1098/rsif.2008.0404; Glezen WP, 2011, LANCET; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P496, DOI 10.1093/ije/13.4.496; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; McVernon J, 2010, AUST NZ J PUBL HEAL, V34, P113, DOI 10.1111/j.1753-6405.2010.00493.x; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Moghadas SM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-73; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Monto AS, 2002, AM J MED, V112, p4S; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Moran K, 2009, VACCINE, V27, P2350, DOI 10.1016/j.vaccine.2009.02.017; Moss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014505; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Public Health Agency of Canada, 2008, FLUWATCH REP; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-90; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; Schanzer DL, 2012, INFLUENZA OTHER RESP; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Siddiqui MR, 2008, EMERG INFECT DIS, V14, P267, DOI 10.3201/eid1402.070478; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Socan M, 2010, CENT EUR J MED, V5, P41, DOI 10.2478/s11536-009-0089-3; Statistics Canada, 2009, PREGN OUTC AG GROUP; Statistics Canada, 2007, AG SEX HIGHL TABL 20; Statistics Canada, 2007, CAN COMM HLTH SURV C; Tam T, 2005, CAN J PUBLIC HEALTH, V96, P406, DOI 10.1007/BF03405177; The Public Health Agency of Canada, 2006, CAN PAND INFL PLAN H; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Tsalik EL, 2010, J CLIN VIROL, V47, P286, DOI 10.1016/j.jcv.2009.12.012; Tuite A, 2009, PLOS CURRENTS INFLUE; Tuite A. R., 2010, PLOS ONE, V5, P1; TUITE AR, 2009, CMAJ, V182, P131, DOI DOI 10.1503/CMAJ.091807; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Webster P, 2004, LANCET, V363, P628, DOI 10.1016/S0140-6736(04)15635-3; Zhang XZ, 2006, MED DECIS MAKING, V26, P617, DOI 10.1177/0272989X06295359	60	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67253	10.1371/journal.pone.0067253	http://dx.doi.org/10.1371/journal.pone.0067253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805303	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500131
J	Kato, M; Kumasaka, MY; Ohnuma, S; Furuta, A; Kato, Y; Shekhar, HU; Kojima, M; Koike, Y; Thang, ND; Ohgami, N; Ly, TB; Jia, XF; Yetti, H; Naito, H; Ichihara, G; Yajima, I				Kato, Masashi; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Furuta, Akio; Kato, Yoko; Shekhar, Hossain U.; Kojima, Michiyo; Koike, Yasuko; Dinh Thang, Nguyen; Ohgami, Nobutaka; Ly, Thuy Bich; Jia, Xiaofang; Yetti, Husna; Naito, Hisao; Ichihara, Gaku; Yajima, Ichiro			Comparison of Barium and Arsenic Concentrations in Well Drinking Water and in Human Body Samples and a Novel Remediation System for These Elements in Well Drinking Water	PLOS ONE			English	Article							SKIN-LESIONS; GROUNDWATER; EXPOSURE; CONTAMINATION; BANGLADESH; POPULATION; SAMTA	Health risk for well drinking water is a worldwide problem. Our recent studies showed increased toxicity by exposure to barium alone (<= 700 mu g/L) and coexposure to barium (137 mu g/L) and arsenic (225 mu g/L). The present edition of WHO healthbased guidelines for drinking water revised in 2011 has maintained the values of arsenic (10 mu g/L) and barium (700 mu g/L), but not elements such as manganese, iron and zinc. Nevertheless, there have been very few studies on barium in drinking water and human samples. This study showed significant correlations between levels of arsenic and barium, but not its homologous elements (magnesium, calcium and strontium), in urine, toenail and hair samples obtained from residents of Jessore, Bangladesh. Significant correlation between levels of arsenic and barium in well drinking water and levels in human urine, toenail and hair samples were also observed. Based on these results, a high-performance and low-cost adsorbent composed of a hydrotalcite-like compound for barium and arsenic was developed. The adsorbent reduced levels of barium and arsenic from well water in Bangladesh and Vietnam to <7 mu g/L within 1 min. Thus, we have showed levels of arsenic and barium in humans and propose a novel remediation system.	[Kato, Masashi; Kumasaka, Mayuko Y.; Furuta, Akio; Kato, Yoko; Ohgami, Nobutaka; Yajima, Ichiro] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Kato, Masashi; Kumasaka, Mayuko Y.; Ohnuma, Shoko; Kato, Yoko; Ohgami, Nobutaka; Yajima, Ichiro] Chubu Univ, Kasugai, Aichi 487, Japan; [Kato, Masashi; Kumasaka, Mayuko Y.; Jia, Xiaofang; Yetti, Husna; Naito, Hisao; Ichihara, Gaku; Yajima, Ichiro] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Showa Ku, Nagoya, Aichi 4648601, Japan; [Shekhar, Hossain U.] Univ Dhaka, Dept Biochem, Dhaka 1000, Bangladesh; [Shekhar, Hossain U.] Univ Dhaka, Dept Mol Biol, Dhaka 1000, Bangladesh; [Kojima, Michiyo; Koike, Yasuko] Aichi Prefectural Inst Publ Hlth, Nagoya, Aichi 462, Japan; [Dinh Thang, Nguyen] Vietnam Natl Univ Sci, Dept Biochem & Plant Physiol, Fac Biol, Hanoi, Vietnam; [Ly, Thuy Bich] Hanoi Univ Sci & Technol, Inst Environm Sci & Technol, Hanoi, Vietnam	Chubu University; Chubu University; Nagoya University; University of Dhaka; University of Dhaka; Vietnam National University Hanoi; Hanoi University of Science & Technology	Kato, M (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Unit Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@med.nagoya-u.ac.jp	KATO, Masashi/I-7250-2014; Ohgami, Nobutaka/I-4572-2014; YAJIMA, Ichiro/I-7467-2014	Ichihara, Gaku/0000-0001-5707-5300; Ly, Bich Thuy/0000-0002-1961-9175; Naito, Hisao/0000-0003-4228-637X; Shekhar, Hossain/0000-0002-8960-0840	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24108001]; COE Project (Health Science Hills) for Private Universities form MEXT; Chubu University [S0801055]; Tokyo Biochemical Research Foundation (TBRF); Naito Foundation Natural Science Scholarship; Uehara Memorial Foundation; AEON Environmental Foundation; Cosmetology Research Foundation;  [20406003];  [24390157];  [24406002];  [23650241]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); COE Project (Health Science Hills) for Private Universities form MEXT; Chubu University; Tokyo Biochemical Research Foundation (TBRF); Naito Foundation Natural Science Scholarship; Uehara Memorial Foundation(Uehara Memorial Foundation); AEON Environmental Foundation; Cosmetology Research Foundation; ; ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (B) (No. 20406003, 24390157 and 24406002), Grant-in-Aid for Challenging Exploratory Research (No. 23650241), Grant-in-Aid for Scientific Research on Innovative Areas (No. 24108001) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); COE Project (Health Science Hills) for Private Universities form MEXT and Chubu University (No. S0801055); AA Science Platform Program from the Japan Society for the Promotion of Science (JSPS); Research Grant from the Tokyo Biochemical Research Foundation (TBRF); the Naito Foundation Natural Science Scholarship; the Uehara Memorial Foundation; AEON Environmental Foundation and the Cosmetology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argos M, 2011, AM J EPIDEMIOL, V174, P185, DOI 10.1093/aje/kwr062; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Chakraborti D, 2003, ENVIRON HEALTH PERSP, V111, P1194, DOI 10.1289/ehp.5966; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Frisbie SH, 2009, ENVIRON HEALTH PERSP, V117, P410, DOI 10.1289/ehp.11886; Frisbie SH, 2002, ENVIRON HEALTH PERSP, V110, P1147, DOI 10.1289/ehp.021101147; Gillman GP, 2006, SCI TOTAL ENVIRON, V366, P926, DOI 10.1016/j.scitotenv.2006.01.036; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V84, P1; Kato M, 2011, CANCER EPIDEM BIOMAR, V20, P1622, DOI 10.1158/1055-9965.EPI-11-0228; Kato M, 2010, J CELL BIOCHEM, V110, P399, DOI 10.1002/jcb.22550; Kumasaka MY, 2013, ARCH TOXICOL, V87, P439, DOI 10.1007/s00204-012-0964-6; Kurokawa M, 2001, ARCH DERMATOL, V137, P102; Maddison D, 2004, EFFECTS ARSENIC CONT; Mahata J, 2004, MUTAGENESIS, V19, P223, DOI 10.1093/mutage/geh022; Marchiset-Ferlay N, 2012, ENVIRON INT, V39, P150, DOI 10.1016/j.envint.2011.07.015; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; Thang ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025636; Nguyen VA, 2009, ENVIRON INT, V35, P466, DOI 10.1016/j.envint.2008.07.014; Ohgami N, 2012, NEUROTOXICOLOGY, V33, P1276, DOI 10.1016/j.neuro.2012.07.008; Ohno K, 2005, WATER SCI TECHNOL, V52, P87, DOI 10.2166/wst.2005.0233; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; Seow WJ, 2012, ENVIRON HEALTH PERSP, V120, P1733, DOI 10.1289/ehp.1205381; Singh Amrit Pal, 2011, Toxicol Int, V18, P87, DOI 10.4103/0971-6580.84258; Sun GF, 2006, J HEALTH POPUL NUTR, V24, P176; Tokar EJ, 2010, CRIT REV TOXICOL, V40, P912, DOI 10.3109/10408444.2010.506641; Turk T, 2009, J HAZARD MATER, V171, P665, DOI 10.1016/j.jhazmat.2009.06.052; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yajima I, 2012, ARCH TOXICOL, V86, P961, DOI 10.1007/s00204-012-0848-9; Yokota H, 2002, WATER SCI TECHNOL, V46, P375, DOI 10.2166/wst.2002.0765	29	30	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66681	10.1371/journal.pone.0066681	http://dx.doi.org/10.1371/journal.pone.0066681			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805262	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000320846500090
J	Kuijf, HJ; Brundel, M; de Bresser, J; van Veluw, SJ; Heringa, SM; Viergever, MA; Biessels, GJ; Vincken, KL				Kuijf, Hugo J.; Brundel, Manon; de Bresser, Jeroen; van Veluw, Susanne J.; Heringa, Sophie M.; Viergever, Max A.; Biessels, Geert Jan; Vincken, Koen L.			Semi-Automated Detection of Cerebral Microbleeds on 3.0 T MR Images	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; RADIAL SYMMETRY; DEMENTIA; SCALE	Cerebral microbleeds are associated with vascular disease and dementia. They can be detected on MRI and receive increasing attention. Visual rating is the current standard for microbleed detection, but is rater dependent, has limited reproducibility, modest sensitivity, and can be time-consuming. The goal of the current study is to present a tool for semi-automated detection of microbleeds that can assist human raters in the rating procedure. The radial symmetry transform is originally a technique to highlight circular-shaped objects in two-dimensional images. In the current study, the three-dimensional radial symmetry transform was adapted to detect spherical microbleeds in a series of 72 patients from our hospital, for whom a ground truth visual rating was made by four raters. Potential microbleeds were automatically identified on T2*-weighted 3.0 T MRI scans and the results were visually checked to identify microbleeds. Final ratings of the radial symmetry transform were compared to human ratings. After implementing and optimizing the radial symmetry transform, the method achieved a high sensitivity, while maintaining a modest number of false positives. Depending on the settings, sensitivities ranged from 65%-84% compared to the ground truth rating. Rating of the processed images required 1-2 minutes per participant, in which 20-96 false positive locations per participant were censored. Sensitivities of individual raters ranged from 39%-86% compared to the ground truth and required 5-10 minutes per participant per rater. The sensitivities that were achieved by the radial symmetry transform are similar to those of individual experienced human raters, demonstrating its feasibility and usefulness for semi-automated microbleed detection.	[Kuijf, Hugo J.; Viergever, Max A.; Vincken, Koen L.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Brundel, Manon; van Veluw, Susanne J.; Heringa, Sophie M.; Biessels, Geert Jan] Univ Med Ctr Utrecht, Dept Neurol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [de Bresser, Jeroen] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Kuijf, HJ (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	hugok@isi.uu.nl	Vincken, Koen/AAP-3558-2021; de Bresser, Jeroen/AAL-4056-2021; Viergever, Max A/J-1215-2014; Kuijf, Hugo J/G-2711-2013	de Bresser, Jeroen/0000-0003-0759-8407; Kuijf, Hugo J/0000-0001-6997-9059	VIDI grant from ZonMw, The Netherlands Organisation for Health Research and Development [91711384]	VIDI grant from ZonMw, The Netherlands Organisation for Health Research and Development	The Vascular Cognitive Impairment research group is supported by VIDI grant 91711384 from ZonMw, The Netherlands Organisation for Health Research and Development to G.J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Barnes SRS, 2011, MAGN RESON IMAGING, V29, P844, DOI 10.1016/j.mri.2011.02.028; Bian W, 2013, NEUROIMAGE-CLIN, V2, P282, DOI 10.1016/j.nicl.2013.01.012; Charidimou A, 2011, FUTUR NEUROL, V6, P587, DOI 10.2217/FNL.11.42; Cocosco CA, 2003, MED IMAGE ANAL, V7, P513, DOI 10.1016/S1361-8415(03)00037-9; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; de Bresser J., 2012, AM J NEUROR IN PRESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kuijf HJ, 2012, NEUROIMAGE, V59, P2266, DOI 10.1016/j.neuroimage.2011.09.061; Kuijf HJ, 2011, I S BIOMED IMAGING, P758, DOI 10.1109/ISBI.2011.5872516; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Loy G, 2003, IEEE T PATTERN ANAL, V25, P959, DOI 10.1109/TPAMI.2003.1217601; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Seghier ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017547; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Veta M, 2011, I S BIOMED IMAGING, P618, DOI 10.1109/ISBI.2011.5872483	23	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66610	10.1371/journal.pone.0066610	http://dx.doi.org/10.1371/journal.pone.0066610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805246	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500074
J	Milton, MB; Borsbo, B; Rovner, G; Lundgren-Nilsson, A; Stibrant-Sunnerhagen, K; Gerdle, B				Milton, Maria Bromley; Borsbo, Bjorn; Rovner, Graciela; Lundgren-Nilsson, Asa; Stibrant-Sunnerhagen, Katharina; Gerdle, Bjorn			Is Pain Intensity Really That Important to Assess in Chronic Pain Patients? A Study Based on the Swedish Quality Registry for Pain Rehabilitation (SQRP)	PLOS ONE			English	Article							MULTIDIMENSIONAL SUCCESS CRITERIA; COGNITIVE-BEHAVIORAL THERAPY; MUSCULOSKELETAL PAIN; MENTAL-DISORDERS; CLINICAL-TRIALS; FEAR-AVOIDANCE; RISK-FACTORS; BACK-PAIN; CENTRAL SENSITIZATION; FIBROMYALGIA PATIENTS	Background: Incorporating the patient's view on care and treatment has become increasingly important for health care. Patients describe the variety of consequences of their chronic pain conditions as significant pain intensity, depression, and anxiety. We hypothesised that intensities of common symptoms in chronic pain conditions carry important information that can be used to identify clinically relevant subgroups. This study has three aims: 1) to determine the importance of different symptoms with respect to participation and ill-health; 2) to identify subgroups based on data concerning important symptoms; and 3) to determine the secondary consequences for the identified subgroups with respect to participation and health factors. Methods and Subjects: This study is based on a cohort of patients referred to a multidisciplinary pain centre at a university hospital (n = 4645, participation rate 88%) in Sweden. The patients answered a number of questionnaires concerning symptoms, participation, and health aspects as a part of the Swedish Quality Registry for Pain Rehabilitation (SQRP). Results: Common symptoms (such as pain intensity, depression, and anxiety) in patients with chronic pain showed great variability across subjects and 60% of the cohort had normal values with respect to depressive and anxiety symptoms. Pain intensity more than psychological symptoms showed stronger relationships with participation and health. It was possible to identify subgroups based on pain intensity, depression, and anxiety. With respect to participation and health, high depressive symptomatology had greater negative consequences than high anxiety. Conclusions: Common symptoms (such as pain intensity and depressive and anxiety symptoms) in chronic pain conditions carry important information that can be used to identify clinically relevant subgroups.	[Milton, Maria Bromley; Borsbo, Bjorn; Gerdle, Bjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Linkoping, Sweden; [Gerdle, Bjorn] Linkoping Univ Hosp, Pain & Rehabil Ctr, Cty Council, S-58185 Linkoping, Sweden; [Rovner, Graciela; Lundgren-Nilsson, Asa; Stibrant-Sunnerhagen, Katharina] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Borsbo, Bjorn] Cty Hosp Ryhov, Clin Dept Rehabil Med, Jonkoping, Sweden	Linkoping University; Linkoping University; University of Gothenburg	Gerdle, B (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Linkoping, Sweden.	bjorn.gerdle@liu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020; Rovner, Graciela/ABF-4482-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Rovner, Graciela/0000-0002-6738-1624; Gerdle, Bjorn/0000-0002-4316-1264	Swedish Association of Local Authorities and Regions (SALAR); Vardal Foundation	Swedish Association of Local Authorities and Regions (SALAR); Vardal Foundation	The present study was supported by grants from the Swedish Association of Local Authorities and Regions (SALAR) and the Vardal Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo LF, 2012, J PAIN, V13, P773, DOI 10.1016/j.jpain.2012.05.012; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bennett M, 2010, PAIN, V18, P1; Bergstrom G, 1998, PAIN, V75, P101, DOI 10.1016/S0304-3959(97)00210-8; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Borsbo B, 2008, RELATIONSHIPS PSYCHO; Borsbo B, 2010, DISABIL REHABIL, V32, P1387, DOI 10.3109/09638280903419269; BRESLAU N, 1993, J PSYCHIAT RES, V27, P211, DOI 10.1016/0022-3956(93)90009-Q; Brown JL, 2008, PAIN MED, V9, P851, DOI 10.1111/j.1526-4637.2007.00357.x; Buitenhuis J, 2011, SPINE, V36, pS238, DOI 10.1097/BRS.0b013e3182388400; Casarett D, 2001, PAIN MED, V2, P309, DOI 10.1046/j.1526-4637.2001.01041.x; Cherkin DC, 1996, SPINE, V21, P2900, DOI 10.1097/00007632-199612150-00023; Crombez G, 2009, PAIN, V145, P31, DOI 10.1016/j.pain.2009.04.006; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022; Denison E, 2007, J PAIN, V8, P67, DOI 10.1016/j.jpain.2006.06.007; Dersh J, 2002, PSYCHOSOM MED, V64, P773, DOI 10.1097/01.PSY.0000024232.11538.54; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Egloff N, 2012, Praxis (Bern 1994), V101, P87, DOI 10.1024/1661-8157/a000816; Engel CC, 1996, PAIN, V65, P197, DOI 10.1016/0304-3959(95)00164-6; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; FUGELMEYER AR, 1988, SCAND J REHABIL MED, P51; Gambassi G, 2009, ARCH GERONTOL GERIAT, V49, P103, DOI 10.1016/j.archger.2009.09.018; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Gatchel Robert J, 2008, Pain Pract, V8, P452, DOI 10.1111/j.1533-2500.2008.00239.x; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; Goossens D., 2009, Annals of Physical and Rehabilitation Medicine, V52, P173, DOI 10.1016/j.rehab.2008.12.008; Grodman I, 2011, ISR MED ASSOC J, V13, P769; Gureje O, 2008, PAIN, V135, P82, DOI 10.1016/j.pain.2007.05.005; Harker J, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/371248; Hazard RG, 2012, SPINE J; Hurtig IM, 2001, CLIN J PAIN, V17, P316, DOI 10.1097/00002508-200112000-00005; IASP, 2011, PAIN CLIN UPDATES, V19, P1, DOI DOI 10.1016/J.MPSUR.2016.11.005; Jansen JJ, 2012, METABOLOMICS, V8, P422, DOI 10.1007/s11306-011-0316-1; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Kurita GP, 2012, ACTA ANAESTH SCAND, V56, P1257, DOI 10.1111/j.1399-6576.2012.02760.x; Linton SJ, 2011, SCAND J PAIN, V2, P47, DOI 10.1016/j.sjpain.2011.01.005; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Linton SJ, 2011, EUR J PAIN, V15, P416, DOI 10.1016/j.ejpain.2010.08.009; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P40; Marin C, 2002, PSYCHOSOMATICS, V43, P249, DOI 10.1176/appi.psy.43.3.249; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; McCracken LM, 2010, PAIN, V149, P420, DOI 10.1016/j.pain.2010.02.036; McCracken LM, 2010, EUR J PAIN, V14, P170, DOI 10.1016/j.ejpain.2009.03.004; McWilliams LA, 2004, PAIN, V111, P77, DOI 10.1016/j.pain.2004.06.002; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Menefee LA, 2000, PAIN MED, V1, P156, DOI 10.1046/j.1526-4637.2000.00022.x; Miller LR, 2009, J PAIN, V10, P619, DOI 10.1016/j.jpain.2008.12.007; Nicholas MK, 2007, PAIN, V129, P231, DOI 10.1016/j.pain.2007.03.011; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; O'Brien EM, 2010, PAIN MED, V11, P6, DOI 10.1111/j.1526-4637.2009.00685.x; Ocanez KLS, 2010, DEPRESS ANXIETY, V27, P760, DOI 10.1002/da.20681; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Pohjanen E, 2007, J PROTEOME RES, V6, P2113, DOI 10.1021/pr070007g; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Robinson ME, 2005, PAIN MED, V6, P336, DOI 10.1111/j.1526-4637.2005.00059.x; ROMANO JM, 1985, PSYCHOL BULL, V97, P18, DOI 10.1037/0033-2909.97.1.18; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; SALEN BA, 1994, J CLIN EPIDEMIOL, V47, P1423, DOI 10.1016/0895-4356(94)90086-8; SBU, 2006, METH TREATM CHRON PA; SBU, 2010, REH CHRON PAIN; Simons LE, 2012, PAIN RES MANAG, V17, P93, DOI 10.1155/2012/420676; Sullivan MJL, 2008, PAIN, V135, P151, DOI 10.1016/j.pain.2007.05.021; Thompson M, 2011, CURR PAIN HEADACHE R, V15, P144, DOI 10.1007/s11916-010-0170-2; Trygg T, 2002, J MUSCULOSKELET PAIN, V10, P33, DOI 10.1300/J094v10n03_03; Tunks ER, 2008, CAN J PSYCHIAT, V53, P224, DOI 10.1177/070674370805300403; TURK DC, 1987, BEHAV RES THER, V25, P237, DOI 10.1016/0005-7967(87)90002-7; TURK DC, 1988, J CONSULT CLIN PSYCH, V56, P233, DOI 10.1037/0022-006X.56.2.233; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; van Koulil S, 2008, PATIENT EDUC COUNS, V71, P308, DOI 10.1016/j.pec.2007.11.025; van Koulil S, 2011, ARTHRIT CARE RES, V63, P800, DOI 10.1002/acr.20445; van Koulil S, 2010, ARTHRIT CARE RES, V62, P1377, DOI 10.1002/acr.20268; van Koulil S, 2009, ARTHRIT RHEUM-ARTHR, V61, P1626, DOI 10.1002/art.24792; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; WHO, 2001, WHO INT CLASS FUNCT; Widerstrom-Noga EG, 2001, ARCH PHYS MED REHAB, V82, P1571, DOI 10.1053/apmr.2001.26068; Williams LS, 2004, NEUROLOGY, V63, P674, DOI 10.1212/01.WNL.0000134669.05005.95; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	88	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65483	10.1371/journal.pone.0065483	http://dx.doi.org/10.1371/journal.pone.0065483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805183	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500011
J	Mohr, W; Vagner, T; Kuypers, MMM; Ackermann, M; LaRoche, J				Mohr, Wiebke; Vagner, Tomas; Kuypers, Marcel M. M.; Ackermann, Martin; LaRoche, Julie			Resolution of Conflicting Signals at the Single-Cell Level in the Regulation of Cyanobacterial Photosynthesis and Nitrogen Fixation	PLOS ONE			English	Article							LIGHT-GROWN CULTURES; SP PCC 6909; GENE-EXPRESSION; DIAZOTROPHIC CYANOBACTERIUM; TRANSLATIONAL REGULATION; STRAIN; DARK; METABOLISM; CARBON; IRON	Unicellular, diazotrophic cyanobacteria temporally separate dinitrogen (N-2) fixation and photosynthesis to prevent inactivation of the nitrogenase by oxygen. This temporal segregation is regulated by a circadian clock with oscillating activities of N-2 fixation in the dark and photosynthesis in the light. On the population level, this separation is not always complete, since the two processes can overlap during transitions from dark to light. How do single cells avoid inactivation of nitrogenase during these periods? One possibility is that phenotypic heterogeneity in populations leads to segregation of the two processes. Here, we measured N-2 fixation and photosynthesis of individual cells using nanometer-scale secondary ion mass spectrometry (nanoSIMS) to assess both processes in a culture of the unicellular, diazotrophic cyanobacterium Crocosphaera watsonii during a dark-light and a continuous light phase. We compared single-cell rates with bulk rates and gene expression profiles. During the regular dark and light phases, C. watsonii exhibited the temporal segregation of N-2 fixation and photosynthesis commonly observed. However, N-2 fixation and photosynthesis were concurrently measurable at the population level during the subjective dark phase in which cells were kept in the light rather than returned to the expected dark phase. At the single-cell level, though, cells discriminated against either one of the two processes. Cells that showed high levels of photosynthesis had low nitrogen fixing activities, and vice versa. These results suggest that, under ambiguous environmental signals, single cells discriminate against either photosynthesis or nitrogen fixation, and thereby might reduce costs associated with running incompatible processes in the same cell.	[Mohr, Wiebke; LaRoche, Julie] Helmholtz Ctr Ocean Res GEOMAR, Dept Biogeochem, Kiel, Germany; [Vagner, Tomas; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Ackermann, Martin] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Ackermann, Martin] Eawag, Dept Environm Microbiol, Dubendorf, Switzerland	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Mohr, W (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	wmohr@fas.harvard.edu	LaRoche, Julie/A-1109-2010; Ackermann, Martin/V-4554-2017	Ackermann, Martin/0000-0003-0087-4819; LaRoche, Julie/0000-0003-4809-6411; Mohr, Wiebke/0000-0002-1126-1455	SOPRAN project; German Federal Ministry of Education and Research (BMBF); Max-Planck-Society; Swiss National Science Foundation; NSERC discovery grant	SOPRAN project; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported through the SOPRAN project (http://sopran.pangaea.de) funded by the German Federal Ministry of Education and Research (BMBF). The authors thank the Max-Planck-Society for financial support (http://www.mpg.de). MA was supported by a grant from the Swiss National Science Foundation (http://www.snf.ch). Julie LaRoche was supported by a NSERC discovery grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Cerveny J, 2009, J BIOL RHYTHM, V24, P295, DOI 10.1177/0748730409338367; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; CHOU HM, 1989, BOT BULL ACAD SINICA, V30, P291; CHOW TJ, 1994, J BACTERIOL, V176, P6281, DOI 10.1128/jb.176.20.6281-6285.1994; Colon-Lopez MS, 1998, J BACTERIOL, V180, P519; ColonLopez M, 1997, J BACTERIOL, V179, P4319, DOI 10.1128/jb.179.13.4319-4327.1997; Compaore J, 2010, ENVIRON MICROBIOL, V12, P54, DOI 10.1111/j.1462-2920.2009.02034.x; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Dron A, 2012, ENVIRON MICROBIOL, V14, P967, DOI 10.1111/j.1462-2920.2011.02675.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; GALLON JR, 1992, NEW PHYTOL, V122, P571; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kelly CD, 1932, J BACTERIOL, V23, P147, DOI 10.1128/JB.23.2.147-153.1932; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis Matthieu, 2002, Sci STKE, V2002, ppe33, DOI 10.1126/stke.2002.143.pe33; Mackey SR, 2011, ADV GENET, V74, P13, DOI 10.1016/B978-0-12-387690-4.00002-7; MARYAN PS, 1986, J GEN MICROBIOL, V132, P789; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Mohr W, 2010, ENVIRON MICROBIOL, V12, P412, DOI 10.1111/j.1462-2920.2009.02078.x; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; ORTEGA-CALVO JJ, 1991, J GEN MICROBIOL, V137, P1789; Pennebaker K, 2010, ENVIRON MICROBIOL, DOI [10.1111/j.1462-2920.2009.02144.x., DOI 10.1111/J.1462-2920.2009.02144.X]; Ploug H, 2011, ISME J, V5, P1549, DOI 10.1038/ismej.2011.20; Popa R, 2007, ISME J, V1, P354, DOI 10.1038/ismej.2007.44; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHNEEGURT MA, 1994, J BACTERIOL, V176, P1586, DOI 10.1128/jb.176.6.1586-1597.1994; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Strovas TJ, 2007, J BACTERIOL, V189, P7127, DOI 10.1128/JB.00746-07; Taniuchi Y, 2008, MICROBIOL-SGM, V154, P1859, DOI 10.1099/mic.0.2008/018689-0; Taniuchi Y, 2007, PHYCOL RES, V55, P249, DOI 10.1111/j.1440-1835.2007.00470.x; Toepel J, 2008, J BACTERIOL, V190, P3904, DOI 10.1128/JB.00206-08; Tuit C, 2004, LIMNOL OCEANOGR, V49, P978, DOI 10.4319/lo.2004.49.4.0978	40	20	20	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66060	10.1371/journal.pone.0066060	http://dx.doi.org/10.1371/journal.pone.0066060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805199	gold, Green Published, Green Accepted			2022-12-27	WOS:000320846500027
J	Morgan, AJ; Jorm, AF; Mackinnon, AJ				Morgan, Amy J.; Jorm, Anthony F.; Mackinnon, Andrew J.			Self-Help for Depression via E-mail: A Randomised Controlled Trial of Effects on Depression and Self-Help Behaviour	PLOS ONE			English	Article							SUBTHRESHOLD DEPRESSION; MENTAL-DISORDERS; PSYCHOLOGICAL TREATMENTS; PSYCHOTHERAPY-RESEARCH; CONFIDENCE-INTERVALS; PHYSICAL-ACTIVITY; PUBLIC BELIEFS; SYMPTOMS; INTERVENTIONS; STRATEGIES	Background: Self-help or self-management strategies are commonly used to deal with depression, but not all are thought to be helpful. A previous study found that sub-threshold depression symptoms were improved by an e-mail intervention that encouraged the use of evidence-based self-help strategies. Aim: To investigate whether these e-mails were effective for adults with a range of depression symptomatology including major depression. Method: The study was a parallel-group randomised controlled trial. Adult participants with any level of depressive symptoms were recruited over the internet from the United Kingdom, Australia, Canada, Ireland, New Zealand and the United States. Participants were randomised to receive a series of e-mails either promoting the use of evidence-based self-help strategies or containing depression information as a control. E-mails were sent automatically twice a week for six weeks. Depression symptoms were assessed with the self-rated Patient Health Questionnaire depression scale (PHQ-9). Results: 1736 participants with a wide range of symptom severity were recruited and assigned to active (n = 862) and control (n = 874) groups. However, there was a significant attrition rate, with 66.9% lost to follow-up at post-intervention. Both groups showed large improvements in depression symptoms overall, with no significant difference in improvement at the end of the study (mean difference in improvement 0.35 points, 95% CI: -0.57 to 1.28, d = 0.11, 95% CI: -0.06 to 0.27), although there was a small effect at the study mid-point. Results were similar for the sub-group of participants with major depression. The active group showed small to moderate improvements in self-help behaviour (d = 0.40, 95% CI: 0.23 to 0.56). Conclusions: These results suggest that the e-mails were able to increase participants' use of evidence-based self-help, but that this did not improve depression more than an attention control.	[Morgan, Amy J.; Jorm, Anthony F.; Mackinnon, Andrew J.] Univ Melbourne, Ctr Youth Mental Hlth, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia; [Morgan, Amy J.; Jorm, Anthony F.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3052, Australia	Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Melbourne	Morgan, AJ (corresponding author), Univ Melbourne, Ctr Youth Mental Hlth, Orygen Youth Hlth Res Ctr, Parkville, Vic 3052, Australia.	ajmorgan@unimelb.edu.au	Jorm, Anthony F/B-5555-2009; Morgan, Amy/U-1315-2017	Jorm, Anthony F/0000-0002-1424-4116; Morgan, Amy/0000-0003-3784-0540; Mackinnon, Andrew/0000-0003-0831-9801	National Health and Medical Research Council Postgraduate Scholarship [567056]; Sidney Myer Health Scholarship; NHMRC Australia Fellowship [566652]; Colonial Foundation	National Health and Medical Research Council Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Sidney Myer Health Scholarship; NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Colonial Foundation	This research was supported by a National Health and Medical Research Council Postgraduate Scholarship (567056), a Sidney Myer Health Scholarship, and an NHMRC Australia Fellowship (566652). Orygen Youth Health Research Centre receives funding from the Colonial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Australian Bureau of Statistics, 2009, 4363 0 55 001 NAT HL, V2007-08; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Christensen H, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e20; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cuijpers P, 2010, CLIN PSYCHOL REV, V30, P768, DOI 10.1016/j.cpr.2010.06.001; Donkin L, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1772; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Fry JP, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1138; Garcia-Toro M, 2012, REV PSIQUIATR SALUD, V5, P236, DOI 10.1016/j.rpsm.2012.04.003; Garcia-Toro M, 2012, J AFFECT DISORDERS, V140, P200, DOI 10.1016/j.jad.2012.03.031; Geisner IM, 2006, J CONSULT CLIN PSYCH, V74, P393, DOI 10.1037/0022-006X.74.2.393; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jorm AF, 2000, AUST NZ J PSYCHIAT, V34, P619, DOI 10.1046/j.1440-1614.2000.00761.x; Jorm AF, 2006, PSYCHOL MED, V36, P3, DOI 10.1017/S0033291705005659; Jorm AF, 2004, PSYCHOL MED, V34, P293, DOI 10.1017/S003329170300895X; Jorm AF, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-12; Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levesque DA, 2011, AM J HEALTH PROMOT, V26, P77, DOI 10.4278/ajhp.090123-QUAN-27; McMillan D, 2010, J AFFECT DISORDERS, V127, P122, DOI 10.1016/j.jad.2010.04.030; Morgan AJ, 2013, BEHAV RES THER, V51, P57, DOI 10.1016/j.brat.2012.11.002; Morgan AJ, 2012, BRIT J PSYCHIAT, V200, P412, DOI 10.1192/bjp.bp.111.101394; Morgan AJ, 2012, J AFFECT DISORDERS, V136, P393, DOI 10.1016/j.jad.2011.11.015; Morgan AJ, 2009, J AFFECT DISORDERS, V115, P196, DOI 10.1016/j.jad.2008.08.004; Morgan AJ, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2262; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Parker G, 2007, AUST NZ J PSYCHIAT, V41, P32, DOI 10.1080/00048670601057726; Pincus HA, 1999, BRIT J PSYCHIAT, V174, P288, DOI 10.1192/bjp.174.4.288; Prakash A, 2008, INT J CLIN PRACT, V62, P1147, DOI 10.1111/j.1742-1241.2008.01808.x; Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Sternfeld B, 2009, AM J PREV MED, V36, P475, DOI 10.1016/j.amepre.2009.01.036; Uher R, 2012, DEPRESS ANXIETY, V29, P1043, DOI 10.1002/da.21993; van Beljouw I, 2010, PSYCHIAT SERV, V61, P250, DOI 10.1176/ps.2010.61.3.250; Watkins DC, 2011, J TELEMED TELECARE, V17, P378, DOI 10.1258/jtt.2011.110105	43	5	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66537	10.1371/journal.pone.0066537	http://dx.doi.org/10.1371/journal.pone.0066537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170JP	23805231	Green Published, gold			2022-12-27	WOS:000320846500059
J	Pinter-Kubler, B; Ferenczi, S; Nunez, C; Zelei, E; Polyak, A; Milanes, MV; Kovacs, KJ				Pinter-Kuebler, Bernadett; Ferenczi, Szilamer; Nunez, Cristina; Zelei, Edina; Polyak, Agnes; Victoria Milanes, M.; Kovacs, Krisztina J.			Differential Changes in Expression of Stress- and Metabolic-Related Neuropeptides in the Rat Hypothalamus during Morphine Dependence and Withdrawal	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; MESSENGER-RNA EXPRESSION; C-FOS EXPRESSION; GENE-EXPRESSION; UROCORTIN-II; BRAIN; ACTIVATION; RESPONSES; SYSTEM; VASOPRESSIN	Chronic morphine treatment and naloxone precipitated morphine withdrawal activates stress-related brain circuit and results in significant changes in food intake, body weight gain and energy metabolism. The present study aimed to reveal hypothalamic mechanisms underlying these effects. Adult male rats were made dependent on morphine by subcutaneous implantation of constant release drug pellets. Pair feeding revealed significantly smaller weight loss of morphine treated rats compared to placebo implanted animals whose food consumption was limited to that eaten by morphine implanted pairs. These results suggest reduced energy expenditure of morphine-treated animals. Chronic morphine exposure or pair feeding did not significantly affect hypothalamic expression of selected stress-and metabolic related neuropeptides - corticotropin-releasing hormone (CRH), urocortin 2 (UCN2) and proopiomelanocortin (POMC) compared to placebo implanted and pair fed animals. Naloxone precipitated morphine withdrawal resulted in a dramatic weight loss starting as early as 15-30 min after naloxone injection and increased adrenocorticotrophic hormone, prolactin and corticosterone plasma levels in morphine dependent rats. Using real-time quantitative PCR to monitor the time course of relative expression of neuropeptide mRNAs in the hypothalamus we found elevated CRH and UCN2 mRNA and dramatically reduced POMC expression. Neuropeptide Y (NPY) and arginine vasopressin (AVP) mRNA levels were transiently increased during opiate withdrawal. These data highlight that morphine withdrawal differentially affects expression of stress-and metabolic-related neuropeptides in the rat hypothalamus, while relative mRNA levels of these neuropeptides remain unchanged either in rats chronically treated with morphine or in their pair-fed controls.	[Pinter-Kuebler, Bernadett; Ferenczi, Szilamer; Zelei, Edina; Polyak, Agnes; Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary; [Nunez, Cristina; Victoria Milanes, M.] Univ Murcia, Fac Med, Grp Cellular & Mol Pharmacol, Murcia, Spain	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Murcia	Kovacs, KJ (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary.	kovacs.krisztina@koki.mta.hu	Milanés, M. Victoria/AGB-4075-2022; Milanés, M Victoria/K-6591-2017; Núñez, Cristina/O-8288-2015	Milanés, M. Victoria/0000-0002-0984-2218; Milanés, M Victoria/0000-0002-0984-2218; Núñez, Cristina/0000-0002-0773-4950	Hungarian Research Fund, OTKA grant (International Research Collaboration grant) [68574, 76697]; Ministerio de Ciencia e Innovacion, Spain [2009-07178]; Red de Trastornos Adictivos, Spain [RD06/0001/1006, RD06/0001/1001]	Hungarian Research Fund, OTKA grant (International Research Collaboration grant)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red de Trastornos Adictivos, Spain	This work was supported by the following grants: Hungarian Research Fund, OTKA grants, 68574 and 76697 (International Research Collaboration grant) to KJK and Ministerio de Ciencia e Innovacion (Grant 2009-07178 to MVM), Spain and Red de Trastornos Adictivos (RD06/0001/1006 and RD06/0001/1001), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Anghel A, 2010, NEUROSCIENCE, V167, P554, DOI 10.1016/j.neuroscience.2010.01.043; ARASE K, 1988, AM J PHYSIOL, V255, pE255, DOI 10.1152/ajpendo.1988.255.3.E255; Befort K, 2008, ANN NY ACAD SCI, V1129, P175, DOI 10.1196/annals.1417.028; BRONSTEIN DM, 1990, BRAIN RES, V519, P102, DOI 10.1016/0006-8993(90)90066-K; CICERO TJ, 1973, J PHARMACOL EXP THER, V184, P404; Clausen TR, 2001, J NEUROSCI RES, V64, P410, DOI 10.1002/jnr.1092; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; De Fanti BA, 2002, BRAIN RES, V930, P37, DOI 10.1016/S0006-8993(01)03401-1; DELLE M, 1990, J PHARMACOL EXP THER, V253, P646; DEYEBENES EG, 1993, NEUROPEPTIDES, V25, P91, DOI 10.1016/0143-4179(93)90087-Q; DHATT RK, 1988, PHYSIOL BEHAV, V43, P553, DOI 10.1016/0031-9384(88)90208-9; Ferenczi S, 2010, NEUROCHEM INT, V57, P323, DOI 10.1016/j.neuint.2010.06.011; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; George O, 2007, P NATL ACAD SCI USA, V104, P17198, DOI 10.1073/pnas.0707585104; Hamlin AS, 2004, NEUROSCI LETT, V362, P39, DOI 10.1016/j.neulet.2004.02.033; Houshyar H, 2004, J NEUROSCI, V24, P9414, DOI 10.1523/JNEUROSCI.1641-04.2004; Houshyar H, 2003, NEUROPSYCHOPHARMACOL, V28, P1960, DOI 10.1038/sj.npp.1300271; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; IKONOMOV OC, 1984, ACTA PHYSIOL HUNG, V63, P137; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Kas MJH, 2005, J MOL ENDOCRINOL, V35, P159, DOI 10.1677/jme.1.01819; KAUPPILA T, 1992, PHARMACOL TOXICOL, V71, P173, DOI 10.1111/j.1600-0773.1992.tb00540.x; Kiefer F, 2004, ADDICT BIOL, V9, P205, DOI 10.1111/j.1369-1600.2004.tb00534.x; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Kovacs KJ, 1996, J NEUROSCI, V16, P262; KOVACS KJ, 1988, BRAIN RES, V474, P205, DOI 10.1016/0006-8993(88)90435-0; Kuperman Y, 2008, TRENDS ENDOCRIN MET, V19, P122, DOI 10.1016/j.tem.2007.12.002; la Fleur SE, 2005, P NATL ACAD SCI USA, V102, P7647, DOI 10.1073/pnas.0408531102; LIGHTMAN SL, 1988, J PHYSIOL-LONDON, V403, P511, DOI 10.1113/jphysiol.1988.sp017261; MALDONADO R, 1992, N-S ARCH PHARMACOL, V345, P466; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Martin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031119; Martinez V, 2004, J PHYSIOL-LONDON, V556, P221, DOI 10.1113/jphysiol.2003.059659; Milanes MV, 1998, J PHARMACOL EXP THER, V285, P700; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; Navarro-Zaragoza J, 2010, MOL PHARMACOL, V77, P864, DOI 10.1124/mol.109.062463; Nijsen MJMA, 2000, NEUROPSYCHOPHARMACOL, V22, P388, DOI 10.1016/S0893-133X(99)00126-8; Nunez C, 2007, J NEUROCHEM, V101, P1060, DOI 10.1111/j.1471-4159.2006.04421.x; Nunez C, 2010, J NEUROCHEM, V114, P475, DOI 10.1111/j.1471-4159.2010.06765.x; Papaleo F, 2008, NEUROPSYCHOPHARMACOL, V33, P2878, DOI 10.1038/npp.2008.8; Pennock RL, 2011, J NEUROSCI, V31, P281, DOI 10.1523/JNEUROSCI.4654-10.2011; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Schank JR, 2012, NEURON, V76, P192, DOI 10.1016/j.neuron.2012.09.026; STORNETTA RL, 1993, BRAIN RES, V624, P19, DOI 10.1016/0006-8993(93)90055-R; Szilamer F, 2010, MOL CELL ENDOCRINOL, V321, P138, DOI 10.1016/j.mce.2010.02.036; Tanaka Y, 2003, NEUROENDOCRINOLOGY, V78, P1, DOI 10.1159/000071700; Uehara Y, 1998, DIABETES, V47, P890, DOI 10.2337/diabetes.47.6.890; Williams CL, 1997, J PHARMACOL EXP THER, V280, P656; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Woldbye DPD, 1998, J PHARMACOL EXP THER, V284, P633; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003; Zhang R, 2009, P NATL ACAD SCI USA, V106, P5913, DOI 10.1073/pnas.0808716106	54	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67027	10.1371/journal.pone.0067027	http://dx.doi.org/10.1371/journal.pone.0067027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805290	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000320846500118
J	Zhang, J; Chen, YH; Xu, Y; Li, MA; Wang, TG; Xu, BH; Sun, JC; Xu, M; Lu, JL; Bi, YF				Zhang, Jie; Chen, Yuhong; Xu, Yu; Li, Mian; Wang, Tiange; Xu, Baihui; Sun, Jichao; Xu, Min; Lu, Jieli; Bi, Yufang			Low-Grade Albuminuria Is Associated with Metabolic Syndrome and Its Components in Middle-Aged and Elderly Chinese Population	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; FATTY LIVER-DISEASE; NONDIABETIC SUBJECTS; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; RENAL-FUNCTION; HEART-FAILURE; MICROALBUMINURIA; EXCRETION; HYPERTENSION	Background: Micro-albuminuria has been well established as one of the risk factors of metabolic syndrome (MetS). However, the association of MetS and its components with low-grade albuminuria among those with normal urinary albumin excretion has not been clearly elucidated in Chinese population. Methodology and Findings: A cross-sectional study was conducted among 9,579 participants with normal urinary albumin excretion, who were recruited from Jia Ding District, Shanghai, China. The single-void first morning urine sample was collected for urinary albumin and creatinine measurements, and urinary albumin-to-creatinine ratio (UACR) was calculated as urinary albumin divided by creatinine. Low-grade albuminuria was classified as sex-specific upper UACR quartile in this population. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria. The prevalence of MetS and its components increased across the UACR quartiles (all P (trend) <0.01). A multivariable adjusted logistic regression analysis revealed that the prevalence of MetS was gradually elevated according to the UACR quartiles (adjusted odds ratios [ORs] were 1.14, 1.24 and 1.59 for UACR quartiles 2, 3 and 4, compared with the lowest quartile; P (trend)<0.0001). In the further stratified logistic regression analyses, the associations between low-grade albuminuria and MetS were significant in both sex strata (male and female), both age strata (<60 and >= 60 years), both body mass index strata (<24 and >= 24 kg/m(2)), and both diabetes strata (yes and no). Compared to the lowest UACR quartile, the participants in the highest quartile of UACR had the highest prevalence of central obesity (OR = 1.43; 95% CI = 1.25-1.63), high blood pressure (OR = 1.64; 95% CI = 1.43-1.87), hyperglycemia (OR = 1.52; 95% CI = 1.30-1.78) and high triglycerides (OR = 1.19; 95% CI = 1.04-1.37). Conclusions and Significance: Low-grade albuminuria was significantly associated with the increasing prevalence of MetS and its components in the middle-aged and elderly Chinese population with normal urinary albumin excretion.	[Zhang, Jie; Chen, Yuhong; Xu, Yu; Li, Mian; Wang, Tiange; Xu, Baihui; Sun, Jichao; Xu, Min; Lu, Jieli; Bi, Yufang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui jin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Chen, Yuhong; Xu, Yu; Xu, Min; Lu, Jieli; Bi, Yufang] Shanghai Jiao Tong Univ, Shanghai Univ E Inst, Key Lab Endocrine & Metab Dis, Minist Hlth,Rui Jin Hosp,Sch Med, Shanghai, Peoples R China; [Sun, Jichao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Sun, Jichao] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Bi, YF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui jin Hosp,Sch Med, Shanghai 200030, Peoples R China.	byf10784@rjh.com.cn	Li, Mian/HGE-6038-2022		key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Sector Funds of Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; National Natural Science Foundation of China [81222008, 81170739, 30911120493, 81130016]; Shanghai Natural Science Foundation [10ZR1426400]; New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine	key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Sector Funds of Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine	This study was supported by the grants from the key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the Sector Funds of Ministry of Health (201002002), the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2012ZX09303006-001), the National Natural Science Foundation of China (No. 81222008; No.81170739; No.30911120493; No.81130016), the Shanghai Natural Science Foundation (No.10ZR1426400), New One Hundred Person Project of the Shanghai Jiao-Tong University School of Medicine 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bakker AJ, 1999, DIABETES CARE, V22, P307, DOI 10.2337/diacare.22.2.307; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Brantsma AH, 2005, DIABETES CARE, V28, P2525, DOI 10.2337/diacare.28.10.2525; Campese VM, 1999, KIDNEY INT, V56, pS10, DOI 10.1038/sj.ki.4495390; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; De Leeuw PW, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027871.86296.92; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Esteghamati A, 2010, ACTA DIABETOL, V47, P125, DOI 10.1007/s00592-009-0131-6; Gerstein HC, 2000, DIABETES CARE, V23, pB35; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ), 2005, GUID DAT PROC AN INT; Halimi JM, 2008, J HYPERTENS, V26, P2198, DOI 10.1097/HJH.0b013e328310ddff; Hao Z, 2007, INTERNAL MED, V46, P341, DOI 10.2169/internalmedicine.46.6056; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Huang Y, 2012, ARTERIOSCL THROM VAS, V32, P2321, DOI 10.1161/ATVBAHA.112.252957; Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lee JE, 2007, NEPHRON CLIN PRACT, V106, P98, DOI 10.1159/000102996; Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010; Lieb W, 2006, NEPHROL DIAL TRANSPL, V21, P2780, DOI 10.1093/ndt/gfl364; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mykkanen L, 1998, DIABETES, V47, P793, DOI 10.2337/diabetes.47.5.793; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Patel Arti A, 2008, Endocr Pract, V14, P193; Pedrinelli R, 2004, ARTERIOSCL THROM VAS, V24, P2414, DOI 10.1161/01.ATV.0000147415.40692.7f; Pedrinelli R, 2002, J HUM HYPERTENS, V16, P79, DOI 10.1038/sj.jhh.1001316; PONTREMOLI R, 1995, NEPHROL DIAL TRANSPL, V10, P6, DOI 10.1093/ndt/10.supp6.6; Ritz E, 2010, DIABETOLOGIA, V53, P49, DOI 10.1007/s00125-009-1577-3; Romundstad S, 2003, CIRCULATION, V108, P2783, DOI 10.1161/01.CIR.0000103667.27493.32; Ruggenenti P, 2006, KIDNEY INT, V70, P1214, DOI 10.1038/sj.ki.5001729; Schmieder RE, 2007, CLIN RES CARDIOL, V96, P247, DOI 10.1007/s00392-007-0510-3; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043449; Sung KC, 2008, ATHEROSCLEROSIS, V196, P320, DOI 10.1016/j.atherosclerosis.2006.11.004; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; Vyssoulis G, 2010, J CLIN HYPERTENS, V12, P597, DOI 10.1111/j.1751-7176.2010.00306.x; Wang TJ, 2005, CIRCULATION, V111, P1370, DOI 10.1161/01.CIR.0000158434.69180.2D; WINOCOUR PH, 1992, ATHEROSCLEROSIS, V93, P71, DOI 10.1016/0021-9150(92)90201-Q; YUDKIN JS, 1988, LANCET, V2, P530; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	47	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65597	10.1371/journal.pone.0065597	http://dx.doi.org/10.1371/journal.pone.0065597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805186	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500014
J	Banko, EM; Kortvelyes, J; Weiss, B; Vidnyanszky, Z				Banko, Eva M.; Koertvelyes, Judit; Weiss, Bela; Vidnyanszky, Zoltan			How the Visual Cortex Handles Stimulus Noise: Insights from Amblyopia	PLOS ONE			English	Article							PERCEPTUAL DECISION-MAKING; NEURAL REPRESENTATIONS; RECOGNITION PROCESSES; STRABISMIC AMBLYOPIA; HUMAN BRAIN; FACE; SENSITIVITY; MODULATION; CATEGORIZATION; UNCERTAINTY	Adding noise to a visual image makes object recognition more effortful and has a widespread effect on human electrophysiological responses. However, visual cortical processes directly involved in handling the stimulus noise have yet to be identified and dissociated from the modulation of the neural responses due to the deteriorated structural information and increased stimulus uncertainty in the case of noisy images. Here we show that the impairment of face gender categorization performance in the case of noisy images in amblyopic patients correlates with amblyopic deficits measured in the noise-induced modulation of the P1/P2 components of single-trial event-related potentials (ERP). On the other hand, the N170 ERP component is similarly affected by the presence of noise in the two eyes and its modulation does not predict the behavioral deficit. These results have revealed that the efficient processing of noisy images depends on the engagement of additional processing resources both at the early, feature-specific as well as later, object-level stages of visual cortical processing reflected in the P1 and P2 ERP components, respectively. Our findings also suggest that noise-induced modulation of the N170 component might reflect diminished face-selective neuronal responses to face images with deteriorated structural information.	[Banko, Eva M.; Koertvelyes, Judit; Vidnyanszky, Zoltan] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Koertvelyes, Judit] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [Weiss, Bela; Vidnyanszky, Zoltan] Semmelweis Univ, Szentagothai J Knowledge Ctr, MR Res Ctr, H-1085 Budapest, Hungary; [Vidnyanszky, Zoltan] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary	Semmelweis University; Semmelweis University; Budapest University of Technology & Economics	Banko, EM (corresponding author), Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary.	banko@digitus.itk.ppke.hu; vidnyanszky@digitus.itk.ppke.hu	Weiss, Béla/GVS-4074-2022	Weiss, Béla/0000-0003-1031-0283; Kortvelyes, Judit/0000-0002-3723-9037	Hungarian Scientific Research Fund [OTKA CNK 80369]; National Development Agency [TAMOP-4.2.1/B-09/1/KMR-2010-0001]; Szemunk Vilaga Foundation	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; Szemunk Vilaga Foundation	This work was supported by a grant from the Hungarian Scientific Research Fund (OTKA CNK 80369 to Z.V.), the National Development Agency (TAMOP-4.2.1/B-09/1/KMR-2010-0001), and by the Szemunk Vilaga Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SJ, 1999, VISION RES, V39, P1723, DOI 10.1016/S0042-6989(98)00259-4; Babiloni F, 1996, ELECTROEN CLIN NEURO, V98, P363, DOI 10.1016/0013-4694(96)00284-2; Bach DR, 2012, NAT REV NEUROSCI, V13, P572, DOI 10.1038/nrn3289; Banko EM, 2013, CORTEX, V49, P1013, DOI 10.1016/j.cortex.2012.03.021; Banko EM, 2011, J NEUROSCI, V31, P2663, DOI 10.1523/JNEUROSCI.2725-10.2011; BEDELL HE, 1990, INVEST OPHTH VIS SCI, V31, P968; BENNETT PJ, 1987, NATURE, V326, P873, DOI 10.1038/326873a0; CAVE CB, 1993, PERCEPTION, V22, P229, DOI 10.1068/p220229; Dakin SC, 2002, CURR BIOL, V12, pR476, DOI 10.1016/S0960-9822(02)00960-0; Davis AP, 2003, INVEST OPHTH VIS SCI, V44, P610, DOI 10.1167/iovs.02-0240; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; ESCHWEILER GW, 1993, EUR J NEUROSCI, V5, P1501, DOI 10.1111/j.1460-9568.1993.tb00218.x; Gaspar CM, 2009, VISION RES, V49, P3001, DOI 10.1016/j.visres.2009.09.021; Halit H, 2000, NEUROREPORT, V11, P1871, DOI 10.1097/00001756-200006260-00014; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hess RF, 1997, VISION RES, V37, P3145, DOI 10.1016/S0042-6989(96)00281-7; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Kayser AS, 2010, J NEUROSCI, V30, P15778, DOI 10.1523/JNEUROSCI.3163-10.2010; Kotsoni E, 2007, NEUROPSYCHOLOGIA, V45, P2285, DOI 10.1016/j.neuropsychologia.2007.02.023; Latinus M, 2005, J COGNITIVE NEUROSCI, V17, P1316, DOI 10.1162/0898929055002490; Lerner Y, 2006, NEUROIMAGE, V33, P169, DOI 10.1016/j.neuroimage.2006.06.026; Lerner Y, 2003, NEURON, V40, P1023, DOI 10.1016/S0896-6273(03)00720-7; Levi DM, 2007, VISION RES, V47, P512, DOI 10.1016/j.visres.2006.10.014; LEVI DM, 1987, VISION RES, V27, P581, DOI 10.1016/0042-6989(87)90044-7; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MANNY RE, 1982, EXP BRAIN RES, V47, P15; Melloni L, 2009, TRENDS COGN SCI, V13, P239, DOI 10.1016/j.tics.2009.03.007; Mercure E, 2008, BRAIN RES, V1239, P162, DOI 10.1016/j.brainres.2008.07.098; Milne E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00051; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Parisi V, 2010, INVEST OPHTH VIS SCI, V51, P5041, DOI 10.1167/iovs.10-5412; PERRIN F, 1987, IEEE T BIO-MED ENG, V34, P283, DOI 10.1109/TBME.1987.326089; Philiastides MG, 2006, J NEUROSCI, V26, P8965, DOI 10.1523/JNEUROSCI.1655-06.2006; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Ploran EJ, 2007, J NEUROSCI, V27, P11912, DOI 10.1523/JNEUROSCI.3522-07.2007; Regan D., 1989, HUMAN BRAIN ELECTROP; Rislove EM, 2010, J VISION, V10, DOI 10.1167/10.12.25; ROELFSEMA PR, 1994, EUR J NEUROSCI, V6, P1645, DOI 10.1111/j.1460-9568.1994.tb00556.x; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Rousselet GA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00137; Rousselet GA, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00019; Rousselet GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-98; Schendan HE, 2007, PSYCHON B REV, V14, P612, DOI 10.3758/BF03196810; Schendan HE, 2010, BRAIN RES, V1329, P124, DOI 10.1016/j.brainres.2010.01.062; SCHOR CM, 1984, INVEST OPHTH VIS SCI, V25, P729; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; SINGER W, 1980, EXP BRAIN RES, V40, P294, DOI 10.1007/BF00237794; Sugase-Miyamoto Y, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00141; Tanskanen T, 2005, CEREB CORTEX, V15, P526, DOI 10.1093/cercor/bhh152; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Tosoni A, 2008, NAT NEUROSCI, V11, P1446, DOI 10.1038/nn.2221; ULLMAN S, 2009, OBJECT CATEGORIZATIO; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Zhang B, 2008, J VISION, V8, DOI 10.1167/8.3.16	57	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66583	10.1371/journal.pone.0066583	http://dx.doi.org/10.1371/journal.pone.0066583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818947	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800083
J	Convertino, M; Valverde, LJ				Convertino, Matteo; Valverde, L. James, Jr.			Portfolio Decision Analysis Framework for Value-Focused Ecosystem Management	PLOS ONE			English	Article							EVOLUTIONARY MULTIOBJECTIVE OPTIMIZATION; ENVIRONMENTAL-MANAGEMENT; EXTINCTION RISK; PARETO FRONT; LAND-USE; CONSERVATION; BIODIVERSITY; UNCERTAINTY; DESIGN; INVESTMENT	Management of natural resources in coastal ecosystems is a complex process that is made more challenging by the need for stakeholders to confront the prospect of sea level rise and a host of other environmental stressors. This situation is especially true for coastal military installations, where resource managers need to balance conflicting objectives of environmental conservation against military mission. The development of restoration plans will necessitate incorporating stakeholder preferences, and will, moreover, require compliance with applicable federal/state laws and regulations. To promote the efficient allocation of scarce resources in space and time, we develop a portfolio decision analytic (PDA) framework that integrates models yielding policy-dependent predictions for changes in land cover and species metapopulations in response to restoration plans, under different climate change scenarios. In a manner that is somewhat analogous to financial portfolios, infrastructure and natural resources are classified as human and natural assets requiring management. The predictions serve as inputs to a Multi Criteria Decision Analysis model (MCDA) that is used to measure the benefits of restoration plans, as well as to construct Pareto frontiers that represent optimal portfolio allocations of restoration actions and resources. Optimal plans allow managers to maintain or increase asset values by contrasting the overall degradation of the habitat and possible increased risk of species decline against the benefits of mission success. The optimal combination of restoration actions that emerge from the PDA framework allows decision-makers to achieve higher environmental benefits, with equal or lower costs, than those achievable by adopting the myopic prescriptions of the MCDA model. The analytic framework presented here is generalizable for the selection of optimal management plans in any ecosystem where human use of the environment conflicts with the needs of threatened and endangered species. The PDA approach demonstrates the advantages of integrated, top-down management, versus bottom-up management approaches.	[Convertino, Matteo] Univ Florida, Inst Food & Agr Sci, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Convertino, Matteo] Univ Florida, Florida Climate Inst, Gainesville, FL 32611 USA; [Valverde, L. James, Jr.] USA, Corps Engineers, Engineer Res & Dev Ctr, HQ, Washington, DC 20310 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Geospatial Research Laboratory (GRL)	Convertino, M (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	mconvertino@ufl.edu	Convertino, Matteo/ABD-5828-2021; Convertino, Matteo/J-1365-2016	Convertino, Matteo/0000-0001-7003-7587	Center Directed Research (ERDC/USACE CDR) Program; Strategic Environmental Research and Development Program (SERDP) [1699]	Center Directed Research (ERDC/USACE CDR) Program; Strategic Environmental Research and Development Program (SERDP)	Funding from the Center Directed Research (ERDC/USACE CDR) Program and Strategic Environmental Research and Development Program (SERDP) 1699 Program supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JCJH, 2008, ECOL SOC, V13; Aiello-Lammens ME, 2011, GLOBAL CHANGE BIOL, V17, P3644, DOI 10.1111/j.1365-2486.2011.02497.x; Akcakaya HR, 2011, FRONT ECOL ENVIRON, V9, P485, DOI 10.1890/11.WB.025; Akcakaya R, 2012, ECOLOGICAL MODELLING; Andersen MC, 2004, RISK ANAL, V24, P1231, DOI 10.1111/j.0272-4332.2004.00521.x; Ando AW, 2012, P NATL ACAD SCI USA, V109, P6484, DOI 10.1073/pnas.1114653109; Beale N., 2011, INDIVIDUAL VERSUS SY; Chu-Agor ML, 2011, ENVIRON MODELL SOFTW, V26, P593, DOI 10.1016/j.envsoft.2010.12.003; Chu-Agor ML, 2011, ECOLOGICAL ENG; Convertino M, 2011, ECOL COMPLEX, V8, P364, DOI 10.1016/j.ecocom.2011.07.007; Crowe KA, 2008, CLIMATIC CHANGE, V89, P355, DOI 10.1007/s10584-007-9373-x; Demers SA, 2012, J FISH WILDL MANAG, V3, P123, DOI 10.3996/062011-JFWM-036; Devireddy VK, 2007, ENVIRON MODELL SOFTW, V22, P5, DOI [10.1016/j.envsoft.2005.12.021, DOI 10.1016/J.ENVS0FT.2005.12.021]; Diwekar U, 2005, RESOUR CONSERV RECY, V44, P215, DOI 10.1016/j.resconrec.2005.01.007; Drechsler M, 2003, ECOL APPL, V13, P990, DOI 10.1890/1051-0761(2003)13[990:RMERFP]2.0.CO;2; Dunkel J, 2012, P NATL ACAD SCI USA, V109, pE2304, DOI 10.1073/pnas.1207485109; EAFB, 2012, EGL AIR FORC BAS FLO; EAFB Plan, 2005, EGL AFB SANT ROS ISL; Eberhart-Phillips L. J., 2012, THESIS HUMBOLDT STAT; Edwards SF, 2004, ECOL ECON, V49, P317, DOI 10.1016/j.ecolecon.2004.04.002; Enriquez-Andrade RR, 2004, ECOL ECON, V48, P303, DOI 10.1016/j.ecolecon.2003.09.009; FGDL Florida Geographic Data Library Documentation, 2009, FFWCC POTENTIAL HABI; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Greene R, 2011, GEOGR COMPASS, V5, P412, DOI 10.1111/j.1749-8198.2011.00431.x; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hildebrandt P, 2011, FOREST POLICY ECON, V13, P1, DOI 10.1016/j.forpol.2010.09.001; Hills J, 2009, MAR POLICY, V33, P887, DOI 10.1016/j.marpol.2009.04.017; Hoekstra J, 2012, P NATL ACAD SCI USA, V109, P6360, DOI 10.1073/pnas.1205114109; Huang B, 2008, INT J GEOGR INF SCI, V22, P507, DOI 10.1080/13658810701492365; IUCN, 2010, GUIDELINES USING IUC; Karvetski CW, 2011, IEEE T SYST MAN CY A, V41, P63, DOI 10.1109/TSMCA.2010.2055154; Kasprzyk JR, 2012, ENVIRON MODELL SOFTW, V34, P87, DOI 10.1016/j.envsoft.2011.04.003; Keisler JM, 2011, WILEY ENCY OPERATION, P2960; Kennedy MC, 2008, J APPL ECOL, V45, P181, DOI 10.1111/j.1365-2664.2007.01367.x; Kennedy MC, 2011, BIOSCIENCE, V61, P994, DOI 10.1525/bio.2011.61.12.9; Kim IY, 2005, STRUCT MULTIDISCIP O, V29, P149, DOI 10.1007/s00158-004-0465-1; Knoke T, 2011, ECOL ECON, V70, P1139, DOI 10.1016/j.ecolecon.2011.01.007; Koenen MT, 1996, J FIELD ORNITHOL, V67, P281; Kollat JB, 2007, ENVIRON MODELL SOFTW, V22, P1691, DOI 10.1016/j.envsoft.2007.02.001; Kotaich AA, 2011, DISTRIBUTION REPROD; Labiosa W. B., 2009, 20095181 US GEOL SUR; Leatherman S, 1989, NATL ASSESSMENT BEAC; Linkov I, 2012, SERDP FINAL REPORT I; Linkov I, 2012, MULTICRITERIA DECISI; Linkov I, 2011, SERDP VULN REP INT C; Linkov I, 2013, ENV MODELLING SOFTWA; Linkov I, 2006, INTEGR ENVIRON ASSES, V2, P92, DOI 10.1002/ieam.5630020116; Linkov I, 2012, RISK ANAL, V32, P374, DOI 10.1111/j.1539-6924.2011.01683.x; Lott CA, 2011, TNDOERE28 ERDC; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Macmillan WD, 1992, GEOGRAPHICAL ANAL, V24; Malczewski J, 2006, INT J GEOGR INF SYST, V20, P249; Marinoni O, 2011, ENVIRON MODELL SOFTW, V26, P18, DOI 10.1016/j.envsoft.2010.03.001; Martinez CJ, 2011, PLOS ONE, DOI [10.1371/journal.pone.0015683, DOI 10.1371/J0URNAL.P0NE.0015683]; MILLS WL, 1982, LAND ECON, V58, P33, DOI 10.2307/3146075; Moloney PD, 2011, NAT RESOUR MODEL, V24, P102, DOI 10.1111/j.1939-7445.2010.00084.x; Munoz-Carpena R, 2011, ECOLOGICAL MODELLING; Munoz-Carpena R, 2012, COASTLINE FRACTALITY; Munoz-Carpena R, 2011, INTEGRATED MODELING; Murley JF, 2002, EC FLORIDAS BEACHES; National Academy of Science, 2012, EC SERV CHART PATH S; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PIlkey OH, 1998, J COASTAL RES, P127; Pruner R. A, 2010, THESIS U FLORIDA GAI; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Roberts SA, 2011, J GEOGR SYST, V13, P299, DOI 10.1007/s10109-010-0136-2; Salo A, 2011, INT SER OPER RES MAN, V162, P1, DOI 10.1007/978-1-4419-9943-6; Saltelli A., 2004, GLOBAL SENSITIVITY A, V1st; Schmitz OJ, 2006, BIODIVERSITY ECOSYST, V56, P12; Sethi SA, 2010, FISH FISH, V11, P341, DOI 10.1111/j.1467-2979.2010.00363.x; Smith K. V., 1996, ESTIMATING EC VALUES; Smith WD, 2010, J ENV MANAGEMENT, V91; Sundell RC, 1997, APPL PARK PLANNING J, V1, P100; Warne B, 2007, RECOVERY PLAN PACIFI, V1; Xiao NC, 2007, COMPUT ENVIRON URBAN, V31, P232, DOI 10.1016/j.compenvurbsys.2006.08.001; Yanmei Q, 2001, MAN SCI IND ENG MSIE; Zhou Q, 2012, RISK ANAL, V32, P1873, DOI 10.1111/j.1539-6924.2012.01870.x; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	80	44	44	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65056	10.1371/journal.pone.0065056	http://dx.doi.org/10.1371/journal.pone.0065056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166SA	23823331	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400004
J	Matsumura, CY; de Oliveira, BM; Durbeej, M; Marques, MJ				Matsumura, Cintia Yuri; de Oliveira, Bruno Menezes; Durbeej, Madeleine; Marques, Maria Julia			Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; ENDOPLASMIC-RETICULUM; MUSCULAR-DYSTROPHY; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; DRASTIC INCREASE; ANNEXIN A1; DEFICIENT; EXPRESSION	Duchenne muscular dystrophy (DMD) is the most common childhood myopathy, characterized by muscle loss and cardiorespiratory failure. While the genetic basis of DMD is well established, secondary mechanisms associated with dystrophic pathophysiology are not fully clarified yet. In order to obtain new insights into the molecular mechanisms of muscle dystrophy during earlier stages of the disease, we performed a comparative proteomic profile of the spared extraocular muscles (EOM) vs. affected diaphragm from the mdx mice, using a label based shotgun proteomic approach. Out of the 857 identified proteins, 42 to 62 proteins had differential abundance of peptide ions. The calcium-handling proteins sarcalumenin and calsequestrin-1 were increased in control EOM compared with control DIA, reinforcing the view that constitutional properties of EOM are important for their protection against myonecrosis. The finding that galectin-1 (muscle regeneration), annexin A1 (anti-inflammatory) and HSP 47 (fibrosis) were increased in dystrophic diaphragm provides novel insights into the mechanisms through which mdx affected muscles are able to counteract dystrophy, during the early stage of the disease. Overall, the shotgun technique proved to be suitable to perform quantitative comparisons between distinct dystrophic muscles and allowed the suggestion of new potential biomarkers and drug targets for dystrophinopaties.	[Matsumura, Cintia Yuri; Marques, Maria Julia] Univ Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Sao Paulo, Brazil; [de Oliveira, Bruno Menezes; Durbeej, Madeleine] Lund Univ, Dept Expt Med Sci, Muscle Biol Unit, Lund, Sweden	Universidade de Sao Paulo; Universidade Estadual de Campinas; Lund University	Marques, MJ (corresponding author), Univ Campinas UNICAMP, Inst Biol, Dept Biol Estrutural & Func, Sao Paulo, Brazil.	marques@unicamp.br	Matsumura, Cintia Yuri/K-6622-2012; Matsumura, Cintia Yuri/AFQ-5618-2022	Matsumura, Cintia Yuri/0000-0002-7237-7021; Durbeej Hjalt, Madeleine/0000-0002-5491-2457	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/51697-6, 08/58491-1, 08/54775-5]; Swedish Research Council; Conselho Nacional de Pesquisas [301306/2010-9]; CAPES [2014-10-6]; Knut and Alice Wallenberg (KAW) [2007.0118]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Conselho Nacional de Pesquisas; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Knut and Alice Wallenberg (KAW)(Knut & Alice Wallenberg Foundation)	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants 11/51697-6; 08/58491-1) and the Swedish Research Council. MJM is recipient of fellowships from Conselho Nacional de Pesquisas (301306/2010-9). CYM was recipient of a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant 08/54775-5) and from CAPES (grant 2014-10-6). MS data were obtained from the Proteomics Core Facility, Gothenburg University, on equipment obtained by a grant from Knut and Alice Wallenberg (KAW grant 2007.0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr S, 2004, HUM MOL GENET, V13, P213, DOI 10.1093/hmg/ddh018; Aggarwal K, 2005, PROTEOMICS, V5, P2297, DOI 10.1002/pmic.200401231; Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Andrade FH, 2004, MICROS RES TEC, V48, P192; Banfi G, 2004, CLIN CHEM LAB MED, V42, P1445, DOI 10.1515/CCLM.2004.268; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BARONDES SH, 1981, J CELL BIOL, V91, P568, DOI 10.1083/jcb.91.2.568; Biggar WD, 2006, PEDIATR REV, V27, P83, DOI 10.1542/pir.27-3-83; Buckland AG, 1998, BIOCHEM J, V329, P369; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carberry S, 2012, INT J MOL MED, V30, P229, DOI 10.3892/ijmm.2012.1006; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; De Paepe B, 2012, NEUROMUSCULAR DISORD, V22, P26, DOI 10.1016/j.nmd.2011.07.007; de Souza Daniel Martins, 2008, Briefings in Functional Genomics & Proteomics, V7, P312, DOI 10.1093/bfgp/eln023; Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095; Doran P, 2004, EUR J BIOCHEM, V271, P3943, DOI 10.1111/j.1432-1033.2004.04332.x; Doran P, 2004, ELECTROPHORESIS, V271, P3943; Doran P, 2007, PROTEOM CLIN APPL, V1, P1169, DOI 10.1002/prca.200700042; Doran P, 2006, PROTEOMICS, V6, P4610, DOI 10.1002/pmic.200600082; Doran P, 2006, BBA-PROTEINS PROTEOM, V1764, P773, DOI 10.1016/j.bbapap.2006.01.007; Doran P, 2009, PROTEOMICS, V9, P989, DOI 10.1002/pmic.200800365; Dowling P, 2004, BIOCHEM J, V379, P479, DOI 10.1042/BJ20031311; Dowling P, 2003, EUR J CELL BIOL, V82, P222, DOI 10.1078/0171-9335-00315; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Engel AG, 1994, MYOLOGY BASIC CLIN, V2, P1133; Ferretti R, 2009, MUSCLE NERVE, V39, P609, DOI 10.1002/mus.21154; FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x; Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0; Gardan-Salmon D, 2011, EUR J APPL PHYSIOL, V111, P2763, DOI 10.1007/s00421-011-1906-3; Ge Y, 2003, PROTEOMICS, V3, P1895, DOI 10.1002/pmic.200300561; Geiser L, 2011, METHODS MOL BIOL, V681, P449, DOI 10.1007/978-1-60761-913-0_26; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Goldring K, 2002, J CELL SCI, V115, P355; GOULDING NJ, 1993, CURR OPIN IMMUNOL, V5, P108, DOI 10.1016/0952-7915(93)90089-B; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HARRISON FL, 1992, J CELL SCI, V101, P635; Kubota K, 2005, J CHROMATOGR B, V815, P3, DOI 10.1016/j.jchromb.2004.10.030; Lewis C, 2012, METHODS MOL BIOL, V798, P357, DOI 10.1007/978-1-61779-343-1_20; Lewis C, 2010, BIOCHEM BIOPH RES CO, V396, P1024, DOI 10.1016/j.bbrc.2010.05.052; Lewis C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/648501; Li Q, 2001, ONCOGENE, V20, P3929, DOI 10.1038/sj.onc.1204536; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Pereira JA, 2012, MUSCLE NERVE, V46, P400, DOI 10.1002/mus.23331; Pertille A, 2010, INT J EXP PATHOL, V91, P63, DOI 10.1111/j.1365-2613.2009.00688.x; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; POIRIER F, 1992, DEVELOPMENT, V115, P143; Porter JD, 2003, FASEB J, V17, P893, DOI 10.1096/fj.02-0810fje; Probst-Cousin S, 2004, MUSCLE NERVE, V30, P102, DOI 10.1002/mus.20077; Rabinovich GA, 2000, EUR J IMMUNOL, V30, P1331, DOI 10.1002/(SICI)1521-4141(200005)30:5<1331::AID-IMMU1331>3.3.CO;2-8; Razzaque MS, 1999, HISTOL HISTOPATHOL, V14, P1199, DOI 10.14670/HH-14.1199; Reutelingsperger CPM, 1997, CELL MOL LIFE SCI, V53, P527, DOI 10.1007/s000180050067; Reutenauer-Patte J, 2012, AM J PATHOL, V180, P749, DOI 10.1016/j.ajpath.2011.10.038; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Tagami S, 2000, ONCOGENE, V19, P5736, DOI 10.1038/sj.onc.1203948; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Tews DS, 1997, NEUROPATH APPL NEURO, V23, P331, DOI 10.1046/j.1365-2990.1997.5998059.x; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; TIDBALL JG, 1995, J CELL SCI, V108, P2197; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Waddell LB, 2011, J NEUROPATH EXP NEUR, V70, P302, DOI 10.1097/NEN.0b013e31821350b0; Watt Diana J., 2004, Glycoconjugate Journal, V19, P615; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yoon JH, 2012, J PROTEOME RES, V11, P4413, DOI 10.1021/pr300328r; YOUNG MR, 1993, MOL CELL BIOL, V13, P5637, DOI 10.1128/MCB.13.9.5637	77	31	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65831	10.1371/journal.pone.0065831	http://dx.doi.org/10.1371/journal.pone.0065831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823696	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400023
J	Monceau, K; Arca, M; Lepretre, L; Mougel, F; Bonnard, O; Silvain, JF; Maher, N; Arnold, G; Thiery, D				Monceau, Karine; Arca, Mariangela; Lepretre, Lisa; Mougel, Florence; Bonnard, Olivier; Silvain, Jean-Francois; Maher, Nevile; Arnold, Gerard; Thiery, Denis			Native Prey and Invasive Predator Patterns of Foraging Activity: The Case of the Yellow-Legged Hornet Predation at European Honeybee Hives	PLOS ONE			English	Article							VESPA-VELUTINA; LEPUS-CALIFORNICUS; CHEMICAL DEFENSE; CANIS-LATRANS; APIS-CERANA; WING DAMAGE; BEHAVIOR; WASP; CIRCUMVENTION; HYMENOPTERA	Contrary to native predators, which have co-evolved with their prey, alien predators often benefit from native prey naivete. Vespa velutina, a honeybee predator originating from Eastern China, was introduced into France just before 2004. The present study, based on video recordings of two beehives at an early stage of the invasion process, intends to analyse the alien hornet hunting behaviour on the native prey, Apis mellifera, and to understand the interaction between the activity of the predator and the prey during the day and the season. Chasing hornets spent most of their time hovering facing the hive, to catch flying honeybees returning to the hive. The predation pressure increased during the season confirming previous study based on predator trapping. The number of honeybee captures showed a maximum peak for an intermediate number of V. velutina, unrelated to honeybee activity, suggesting the occurrence of competition between hornets. The number of honeybees caught increased during midday hours while the number of hornets did not vary, suggesting an increase in their efficacy. These results suggest that the impact of V. velutina on honeybees is limited by its own biology and behaviour and did not match the pattern of activity of its prey. Also, it could have been advantageous during the invasion, limiting resource depletion and thus favouring colonisation. This lack of synchronization may also be beneficial for honeybee colonies by giving them an opportunity to increase their activity when the hornets are less effective.	[Monceau, Karine; Lepretre, Lisa; Bonnard, Olivier; Maher, Nevile; Thiery, Denis] INRA, UMR Sante & Agroecol Vignoble 1065, F-33883 Villenave Dornon, France; [Monceau, Karine; Lepretre, Lisa; Bonnard, Olivier; Maher, Nevile; Thiery, Denis] Univ Bordeaux, Bordeaux Sci Agro, ISVV, UMR Sante & Agroecol Vignoble 1065, Villenave Dornon, France; [Arca, Mariangela; Mougel, Florence; Silvain, Jean-Francois; Arnold, Gerard] CNRS, Lab Evolut Genomes & Speciat, UPR 9034, F-91198 Gif Sur Yvette, France; [Arca, Mariangela; Mougel, Florence; Silvain, Jean-Francois; Arnold, Gerard] Univ Paris 11, Orsay, France; [Arca, Mariangela; Mougel, Florence; Silvain, Jean-Francois; Arnold, Gerard] CNRS, Lab Evolut Genomes & Speciat, UPR 9034, Unite Rech IRD 072, F-91198 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay	Thiery, D (corresponding author), INRA, UMR Sante & Agroecol Vignoble 1065, F-33883 Villenave Dornon, France.	denis.thiery@bordeaux.inra.fr		Monceau, Karine/0000-0003-3786-1835	FranceAgriMer grant [797/2007-2010]; Fondation pour la Recherche sur la Biodiversite (Wasprey project); CNRS; IRD; INRA SPE department core budgets	FranceAgriMer grant; Fondation pour la Recherche sur la Biodiversite (Wasprey project); CNRS(Centre National de la Recherche Scientifique (CNRS)); IRD; INRA SPE department core budgets	This research project was funded by a FranceAgriMer grant # 797/2007-2010 and is a part of Labex COTE Continental To coastal Ecosystems. MA was also supported by a grant from the Fondation pour la Recherche sur la Biodiversite (Wasprey project). Financial support was also provided by CNRS, IRD and INRA SPE department core budgets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; Abbott KR, 2009, ANIM BEHAV, V78, P633, DOI 10.1016/j.anbehav.2009.05.029; Arca M, 2012, THESIS U P M CURIE P; Arias-Del Razo I, 2011, J ARID ENVIRON, V75, P112, DOI 10.1016/j.jaridenv.2010.09.008; Arias-Del Razo I, 2012, CAN J ZOOL, V90, P683, DOI 10.1139/Z2012-036; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Baracchi D, 2010, ETHOL ECOL EVOL, V22, P281, DOI 10.1080/03949370.2010.502323; Beaton MJ, 1997, LIMNOL OCEANOGR, V42, P346, DOI 10.4319/lo.1997.42.2.0346; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Benjamini Y, 2001, ANN STAT, V29, P1165; BERENBAUM MR, 1992, J INSECT BEHAV, V5, P547, DOI 10.1007/BF01048003; Bourdeau PE, 2011, BIOL INVASIONS, V13, P2533, DOI 10.1007/s10530-011-0073-0; Bura VL, 2009, NATURWISSENSCHAFTEN, V96, P713, DOI 10.1007/s00114-009-0527-8; Calderone NW, 1998, APIDOLOGIE, V29, P127, DOI 10.1051/apido:19980108; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; D'Adamo P, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.10301; da Rocha AA, 2007, SOCIOBIOLOGY, V50, P813; de Castro MM, 2011, SOCIOBIOLOGY, V58, P133; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; Domenici P, 2008, CURR BIOL, V18, P1792, DOI 10.1016/j.cub.2008.09.062; Dukas R, 2011, ANIM BEHAV, V81, P635, DOI 10.1016/j.anbehav.2010.12.011; Edwards R, 1980, SOCIAL WASPS THEIR B; Eisner T, 2005, CHEMOECOLOGY, V15, P227, DOI 10.1007/s00049-005-0316-6; Eisner T, 1993, P NATL ACAD SCI USA, V90, P6716, DOI 10.1073/pnas.90.14.6716; Eisner T, 1998, P NATL ACAD SCI USA, V95, P1108, DOI 10.1073/pnas.95.3.1108; Eisner T, 2008, CHEMOECOLOGY, V18, P197, DOI 10.1007/s00049-008-0406-3; Feuerbacher E, 2003, J EXP BIOL, V206, P1855, DOI 10.1242/jeb.00347; Fox J., 2019, R COMPANION APPL REG, V.; GILLER PS, 1993, OIKOS, V67, P351, DOI 10.2307/3545482; Glaiim Murtadha K., 2009, Bulletin of the Iraq Natural History Museum, V10, P17; Goodale E, 2012, ANIM BEHAV, V84, P919, DOI 10.1016/j.anbehav.2012.07.016; Grant JB, 2007, J ANIM ECOL, V76, P439, DOI 10.1111/j.1365-2656.2007.01216.x; Haddaway NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032229; Hieber CS, 2002, BEHAV ECOL SOCIOBIOL, V53, P51, DOI 10.1007/s00265-002-0547-2; Higginson AD, 2004, ECOL ENTOMOL, V29, P52, DOI 10.1111/j.0307-6946.2004.00573.x; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Ishay JS, 2004, J ELECTRON MICROSC, V53, P623, DOI 10.1093/jmicro/dfh077; Kasper ML, 2008, INSECT SOC, V55, P288, DOI 10.1007/s00040-008-1004-7; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; Koeniger N, 1996, APIDOLOGIE, V27, P341, DOI 10.1051/apido:19960502; KOTLER BP, 1994, OECOLOGIA, V100, P391, DOI 10.1007/BF00317860; Kotler BP, 2002, EVOL ECOL RES, V4, P495; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044350; Machado G, 2005, J CHEM ECOL, V31, P2519, DOI 10.1007/s10886-005-7611-0; Matsuura M., 1991, P232; Matsuura M., 1990, BIOL VESPINE WASPS; Miyatake T, 2004, P ROY SOC B-BIOL SCI, V271, P2293, DOI 10.1098/rspb.2004.2858; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Monceau K, 2013, APIDOLOGIE, V44, P209, DOI 10.1007/s13592-012-0172-7; PASTEELS JM, 1983, ANNU REV ENTOMOL, V28, P263, DOI 10.1146/annurev.en.28.010183.001403; Perdereau E, 2011, BIOL INVASIONS, V13, P1457, DOI 10.1007/s10530-010-9906-5; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Plotkin M, 2010, NATURWISSENSCHAFTEN, V97, P1067, DOI 10.1007/s00114-010-0728-1; R Development Core Team, 2008, R LANG ENV STAT COMP; Rehage JS, 2009, ETHOLOGY, V115, P1046, DOI 10.1111/j.1439-0310.2009.01694.x; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rome Q, 2010, ATLAS BIODIVERSITY R, P11; Roy HE, 2011, BIOCONTROL, V56, P477, DOI 10.1007/s10526-011-9355-9; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Schaber M, 2011, BIOL INVASIONS, V13, P2647, DOI 10.1007/s10530-011-9936-7; Short J, 2002, BIOL CONSERV, V103, P283, DOI 10.1016/S0006-3207(01)00139-2; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Sileshi G, 2006, B ENTOMOL RES, V96, P479, DOI 10.1079/BER2006449; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; Spradbery JP, 1973, WASPS ACCOUNT BIOL N; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, NATURWISSENSCHAFTEN, V100, P245, DOI 10.1007/s00114-013-1019-4; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; ter Hofstede HM, 2008, BEHAV ECOL SOCIOBIOL, V63, P217, DOI 10.1007/s00265-008-0652-y; Turner AM, 2006, ANIM BEHAV, V72, P1443, DOI 10.1016/j.anbehav.2006.05.010; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volynchik S, 2008, PHOTOCHEM PHOTOBIOL, V84, P81, DOI 10.1111/j.1751-1097.2007.00198.x; Wilson EE, 2009, P NATL ACAD SCI USA, V106, P12809, DOI 10.1073/pnas.0902979106; ZARET TM, 1973, SCIENCE, V182, P449, DOI 10.1126/science.182.4111.449	79	52	55	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66492	10.1371/journal.pone.0066492	http://dx.doi.org/10.1371/journal.pone.0066492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823754	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400118
J	Xiong, YN; Zhang, M; Hong, Y; Wei, MM; Ai, DZ; Meng, PP; Han, YH; Fu, ZQ; Shi, YJ; Yang, JM; Lin, JJ				Xiong, Yanian; Zhang, Ming; Hong, Yang; Wei, Meimei; Ai, Dezhou; Meng, Peipei; Han, Yanhui; Fu, Zhiqiang; Shi, Yaojun; Yang, Jianmei; Lin, Jiaojiao			Characterization Analysis of Schistosoma japonicum Plasma Membrane Repair Relative Gene Myoferlin	PLOS ONE			English	Article							IMMUNE-RESPONSE; INFECTION; MANSONI; PROTEIN; EXPRESSION; FUSION; MICE	Myoferlin is a member of the ferlin family of proteins, which are involved in plasma membrane repair, and has been identified as one of the tegument proteins of Schistosoma japonicum. The tegument proteins are potential candidates for vaccines and new drug targets. In this study, myoferlin of S. japonicum (SjMF) was cloned, expressed and characterized, the potential of SjMF recombinant protein (rSjMF) as a vaccine candidate was evaluated, and the effect of praziquantel on SjMF was detected by Real-time PCR. Immunofluorescence showed that this protein was mainly distributed on the surface of worms at different stages. Sequence analysis revealed that the SjMF open reading frame was conserved at all stages of the S. japonicum life cycle. And SjMF transcription was upregulated in 42-day-old worms, and was significantly higher in female worms. Western blotting revealed that rSjMF showed strong immunogenicity. The cytokine profile and IgG isotype analysis demonstrated that rSjMF plus ISA206 immunization induced a mixed T helper (Th)1/Th2 response. Purified rSjMF emulsified with ISA206 adjuvant significantly reduced worm burden from 21.8% to 23.21% and liver egg number from42.58% to 28.35%. Besides, SjMF transcription was downregulated when worms were exposed to low-dose praziquantel (PZQ) and upregulated when PZQ was degraded, accompanied by recovery of damaged tegument. When worms were exposed to high-dose PZQ, SjMF transcription was downregulated all the time and the damaged tegument did not recover. These findings indicated that SjMF is a potential vaccine against S. japonicum and provides the basis for further investigations into the biological function of SjMF.	[Xiong, Yanian; Zhang, Ming; Hong, Yang; Wei, Meimei; Ai, Dezhou; Meng, Peipei; Han, Yanhui; Fu, Zhiqiang; Shi, Yaojun; Yang, Jianmei; Lin, Jiaojiao] Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Shanghai Vet Res Inst,Minist Agr, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Lin, JJ (corresponding author), Chinese Acad Agr Sci, Natl Lab Anim Schistosomiasis Control, Key Lab Anim Parasitol, Shanghai Vet Res Inst,Minist Agr, Shanghai, Peoples R China.	JJlin@shvri.ac.cn			National Natural Science Foundation of China [31172315]; Agro-scientific Research in the Public Interest [200903036]; China Postdoctoral Science Foundation [2012M510630]; Science Technology and Development Foundation of Shanghai [12140902700]; State-level public welfare scientific research courtyard basic scientific research operation cost [2013JB18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agro-scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science Technology and Development Foundation of Shanghai; State-level public welfare scientific research courtyard basic scientific research operation cost	This work was supported by the National Natural Science Foundation of China (no. 31172315), Agro-scientific Research in the Public Interest (200903036), China Postdoctoral Science Foundation (No. 2012M510630), Science Technology and Development Foundation of Shanghai (no. 12140902700) and State-level public welfare scientific research courtyard basic scientific research operation cost (2013JB18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caffrey CR, 2011, CURR OPIN INFECT DIS, V24, P410, DOI 10.1097/QCO.0b013e328349156f; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Carod AF, 2012, CURR NEUROL NEUROSCI, V5, P1420; COFFMAN RL, 1986, J IMMUNOL, V136, P949; Da'dara AA, 2001, VACCINE, V20, P359, DOI 10.1016/S0264-410X(01)00374-7; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; Demonbreun AR, 2010, J CELL SCI, V123, P2413, DOI 10.1242/jcs.065375; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; HE YX, 1980, ACTA ZOOL SINICA, V26, P32; Hong Y, 2010, EXP PARASITOL, V126, P517, DOI 10.1016/j.exppara.2010.06.029; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Robinson JM, 2010, 4D ELECT MICROSCOPYI; Robinson JM, 2009, BIOL REPROD, V81, P33, DOI 10.1095/biolreprod.108.074591; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Xiao SH, 1996, ACTA PHARMACOL SIN, V17, P535	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66396	10.1371/journal.pone.0066396	http://dx.doi.org/10.1371/journal.pone.0066396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823740	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400102
J	Zhuo, DX; Zhang, XW; Jin, B; Zhang, Z; Xie, BS; Wu, CL; Gong, K; Mao, ZB				Zhuo, De-Xiang; Zhang, Xiao-Wei; Jin, Bo; Zhang, Zheng; Xie, Bu-Shan; Wu, Cheng-Lin; Gong, Kan; Mao, Ze-Bin			CSTP1, a Novel Protein Phosphatase, Blocks Cell Cycle, Promotes Cell Apoptosis, and Suppresses Tumor Growth of Bladder Cancer by Directly Dephosphorylating Akt at Ser473 Site	PLOS ONE			English	Article							KINASE-B; FGFR3 MUTATIONS; GENE-MUTATIONS; ACTIVATION; PHOSPHORYLATION; PTEN/MMAC1; PATHWAYS; PHLPP; PTEN	Akt/protein kinase B is a pivotal component downstream of phosphatidylinositol 3-kinase (PI3K) pathway, whose activity regulates the balance between cell survival and apoptosis. Phosphorylation of Akt occurs at two key sites either at Thr308 site in the activation loop or at Ser473 site in the hydrophobic motif. The phosphorylated form of Akt (pAkt) is activated to promote cell survival. The mechanisms of pAkt dephosphorylation and how the signal transduction of Akt pathway is terminated are still largely unknown. In this study, we identified a novel protein phosphatase CSTP1(complete s transactivated protein 1), which interacts and dephosphorylates Akt specifically at Ser473 site in vivo and in vitro, blocks cell cycle progression and promotes cell apoptosis. The effects of CSTP1 on cell survival and cell cycle were abrogated by depletion of phosphatase domain of CSTP1 or by expression of a constitutively active form of Akt (S473D), suggesting Ser473 site of Akt as a primary cellular target of CSTP1. Expression profile analysis showed that CSTP1 expression is selectively down-regulated in non-invasive bladder cancer tissues and over-expression of CSTP1 suppressed the size of tumors in nude mice. Kaplan-Meier curves revealed that decreased expression of CSTP1 implicated significantly reduced recurrence-free survival in patients suffered from non-invasive bladder cancers.	[Zhuo, De-Xiang; Zhang, Xiao-Wei; Jin, Bo; Xie, Bu-Shan; Wu, Cheng-Lin; Mao, Ze-Bin] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Zhang, Zheng; Gong, Kan] Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China; [Zhang, Zheng; Gong, Kan] Peking Univ, Inst Urol, Beijing 100871, Peoples R China; [Zhuo, De-Xiang] Fujian Med Univ, Hosp Sanming 1, Dept Lab Med, Sanming, Fujian, Peoples R China	Peking University; Peking University; Peking University; Fujian Medical University	Gong, K (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China.	gongkan2004@yahoo.com.cn; zbmao@bjmu.edu.cn	Gong, Kan/AAA-5915-2020	Gong, Kan/0000-0001-7195-677X	National Science Foundation of China [81272827, 30971627]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China grants 81272827 and 30971627. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Aveyard JS, 1999, BRIT J CANCER, V80, P904, DOI 10.1038/sj.bjc.6690439; Bai GQ, 2005, WORLD J GASTROENTERO, V11, P3893; Bakkar AA, 2003, CANCER RES, V63, P8108; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Broach JR, 1997, CURR OPIN GENET DEV, V7, P1, DOI 10.1016/S0959-437X(97)80102-5; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cappellen D, 1997, ONCOGENE, V14, P3059, DOI 10.1038/sj.onc.1201154; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Knowles MA, 2008, SCAND J UROL NEPHROL, V42, P116, DOI 10.1080/03008880802284605; Knowles MA, 2009, CANCER METAST REV, V28, P305, DOI 10.1007/s10555-009-9198-3; Kramer MW, 2007, SCAND J UROL NEPHROL, V41, P478, DOI 10.1080/00365590701430737; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mitra AP, 2006, J CLIN ONCOL, V24, P5552, DOI 10.1200/JCO.2006.08.2073; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shu LL, 2009, MOL CELL BIOL, V29, P4691, DOI 10.1128/MCB.00764-09; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Wang DS, 2000, INT J CANCER, V88, P620, DOI 10.1002/1097-0215(20001115)88:4<620::AID-IJC16>3.0.CO;2-Z; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamada T, 2001, J BIOL CHEM, V276, P5339, DOI 10.1074/jbc.M005685200; Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315	37	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65679	10.1371/journal.pone.0065679	http://dx.doi.org/10.1371/journal.pone.0065679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799035	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800014
J	Oliveira, AC; Garzon, I; Ionescu, AM; Carriel, V; Cardona, JD; Gonzalez-Andrades, M; Perez, MD; Alaminos, M; Campos, A				Celeste Oliveira, Ana; Garzon, Ingrid; Maria Ionescu, Ana; Carriel, Victor; de la Cruz Cardona, Juan; Gonzalez-Andrades, Miguel; del Mar Perez, Maria; Alaminos, Miguel; Campos, Antonio			Evaluation of Small Intestine Grafts Decellularization Methods for Corneal Tissue Engineering	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; STROMA SUBSTITUTE; SCAFFOLD MATERIAL; COLLAGEN-FIBERS; CROSS-LINKING; SUBMUCOSA; FIBRIN; ORGAN; RECONSTRUCTION; REGENERATION	Advances in the development of cornea substitutes by tissue engineering techniques have focused on the use of decellularized tissue scaffolds. In this work, we evaluated different chemical and physical decellularization methods on small intestine tissues to determine the most appropriate decellularization protocols for corneal applications. Our results revealed that the most efficient decellularization agents were the SDS and triton X-100 detergents, which were able to efficiently remove most cell nuclei and residual DNA. Histological and histochemical analyses revealed that collagen fibers were preserved upon decellularization with triton X-100, NaCl and sonication, whereas reticular fibers were properly preserved by decellularization with UV exposure. Extracellular matrix glycoproteins were preserved after decellularization with SDS, triton X-100 and sonication, whereas proteoglycans were not affected by any of the decellularization protocols. Tissue transparency was significantly higher than control non-decellularized tissues for all protocols, although the best light transmittance results were found in tissues decellularized with SDS and triton X-100. In conclusion, our results suggest that decellularized intestinal grafts could be used as biological scaffolds for cornea tissue engineering. Decellularization with triton X-100 was able to efficiently remove all cells from the tissues while preserving tissue structure and most fibrillar and non-fibrillar extracellular matrix components, suggesting that this specific decellularization agent could be safely used for efficient decellularization of SI tissues for cornea TE applications.	[Celeste Oliveira, Ana; Garzon, Ingrid; Carriel, Victor; Gonzalez-Andrades, Miguel; Alaminos, Miguel; Campos, Antonio] Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain; [Maria Ionescu, Ana; de la Cruz Cardona, Juan; del Mar Perez, Maria] Univ Granada, Dept Opt, Granada, Spain; [Gonzalez-Andrades, Miguel] Univ Granada, Div Ophthalmol, Granada, Spain	University of Granada; University of Granada; University of Granada	Alaminos, M (corresponding author), Univ Granada, Dept Histol, Tissue Engn Grp, Granada, Spain.	malaminos@ugr.es	Gonzalez-Andrades, Miguel/AAI-4293-2020; ARAYA, VICTOR CARRIEL/H-9425-2018; Andrades, Miguel González/N-3670-2018; DE LA CRUZ CARDONA PEREZ, JUAN/I-9351-2018; Oliveira, Ana Carolina/GRF-1435-2022; Ionescu, Adrian M./A-9014-2010; ALAMINOS, MIGUEL/N-9960-2016	ARAYA, VICTOR CARRIEL/0000-0002-8114-5644; Andrades, Miguel González/0000-0003-4632-1267; DE LA CRUZ CARDONA PEREZ, JUAN/0000-0003-2867-9708; ALAMINOS, MIGUEL/0000-0003-4876-2672; Ionescu, Ana-Maria-Andreea/0000-0003-4114-9613; Perez Gomez, Maria Del Mar/0000-0003-1528-3659; Campos, A/0000-0003-4061-8182	Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), Instituto de Salud Carlos III (ISCIII) [FIS PI11/2680]; Regional Ministry of Health, Junta de Andalucia Spain [SAS PI-0462-2010]	Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), Instituto de Salud Carlos III (ISCIII); Regional Ministry of Health, Junta de Andalucia Spain	This study was supported by the Spanish Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (I+D+I), Instituto de Salud Carlos III (ISCIII), grant FIS PI11/2680, and by the Regional Ministry of Health, grant SAS PI-0462-2010, Junta de Andalucia Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647; Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Barakat O, 2012, J SURG RES, V173, pE11, DOI 10.1016/j.jss.2011.09.033; Bussieres M, 2004, VET OPHTHALMOL, V7, P352, DOI 10.1111/j.1463-5224.2004.04055.x; Carriel VS, 2011, J HISTOCHEM CYTOCHEM, V59, P270, DOI 10.1369/0022155410398001; Cigliano A., 2012, BIOCH RES INT, V2012, P1, DOI DOI 10.1155/2012/979351; Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Lemos NLDM, 2009, J MINIM INVAS GYN, V16, P765, DOI 10.1016/j.jmig.2009.07.007; Cardona JD, 2011, CORNEA, V30, P1428, DOI 10.1097/ICO.0b013e31821bdfd4; Deeken CR, 2011, J BIOMED MATER RES B, V96B, P199, DOI 10.1002/jbm.b.31753; Featherstone HJ, 2001, VET OPHTHALMOL, V4, P147, DOI 10.1046/j.1463-5224.2001.00192.x; Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099; Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gonzalez-Andrades M, 2011, INVEST OPHTH VIS SCI, V52, P215, DOI 10.1167/iovs.09-4773; Goulle F, 2012, J SMALL ANIM PRACT, V53, P34, DOI 10.1111/j.1748-5827.2011.01149.x; Ionescu AM, 2011, J MECH BEHAV BIOMED, V4, P1963, DOI 10.1016/j.jmbbm.2011.06.013; Ionescu AM, 2010, CORNEA, V29, P895, DOI 10.1097/ICO.0b013e3181ca3650; Keckler SJ, 2007, ANN THORAC SURG, V84, P1383, DOI 10.1016/j.athoracsur.2007.05.009; Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171; Kim Seong-Taeck, 2011, Korean J Ophthalmol, V25, P196, DOI 10.3341/kjo.2011.25.3.196; Kreis T, 1999, GUIDEBOOK EXTRACELLU; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Liang Y, 2011, J MATER SCI-MATER M, V22, P175, DOI 10.1007/s10856-010-4190-6; Lin CC, 2010, EUR CELLS MATER, V19, P50, DOI 10.22203/eCM.v019a06; Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017; Mi SL, 2011, J BIOMED MATER RES A, V99A, P1, DOI 10.1002/jbm.a.33152; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Richter K, 2007, J CELL SCI, V120, P1673, DOI 10.1242/jcs.03440; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Saghizadeh M, 2001, EXP EYE RES, V73, P179, DOI 10.1006/exer.2001.1028; Sharma S, 2011, MOL VIS, V17, P2898; Suh H, 1999, YONSEI MED J, V40, P159, DOI 10.3349/ymj.1999.40.2.159; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; Walter RJ, 1998, BURNS, V24, P104, DOI 10.1016/S0305-4179(97)00110-1; Wu J, 2013, TISSUE EN A IN PRESS; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055; Zhang AY, 2009, J REHABIL RES DEV, V46, P489, DOI 10.1682/JRRD.2008.07.0086; Zou Y, 2012, J SURG RES, V175, P359, DOI 10.1016/j.jss.2011.03.070	44	71	72	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66538	10.1371/journal.pone.0066538	http://dx.doi.org/10.1371/journal.pone.0066538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799114	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300090
J	Gomes, C; Osorio, H; Pinto, MT; Campos, D; Oliveira, MJ; Reis, CA				Gomes, Catarina; Osorio, Hugo; Pinto, Marta Teixeira; Campos, Diana; Oliveira, Maria Jose; Reis, Celso A.			Expression of ST3GAL4 Leads to SLe(x) Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; SIALYL LEWIS(X) ANTIGEN; COLORECTAL-CARCINOMA; ACTIN CYTOSKELETON; THERAPEUTIC TARGET; PROGNOSTIC MARKER; G(D3) SYNTHASE; CDC42 GTPASES; RHO GTPASES; P-SELECTIN	Sialyl-Lewis X (SLe(x)) is a sialylated glycan antigen expressed on the cell surface during malignant cell transformation and is associated with cancer progression and poor prognosis. The increased expression of sialylated glycans is associated with alterations in the expression of sialyltransferases (STs). In this study we determined the capacity of ST3GAL3 and ST3GAL4 sialyltransferases to synthesize the SLe(x) antigen in MKN45 gastric carcinoma cells and evaluated the effect of SLe(x) overexpression in cancer cell behavior both in vitro and in vivo using the chicken chorioallantoic membrane (CAM) model. The activation of tyrosine kinase receptors and their downstream molecular targets was also addressed. Our results showed that the expression of ST3GAL4 in MKN45 gastric cancer cells leads to the synthesis of SLe(x) antigens and to an increased invasive phenotype both in vitro and in the in vivo CAM model. Analysis of phosphorylation of tyrosine kinase receptors showed a specific increase in c-Met activation. The characterization of downstream molecular targets of c-Met activation, involved in the invasive phenotype, revealed increased phosphorylation of FAK and Src proteins and activation of Cdc42, Rac1 and RhoA GTPases. Inhibition of c-Met and Src activation abolished the observed increased cell invasive phenotype. In conclusion, the expression of ST3GAL4 leads to SLe(x) antigen expression in gastric cancer cells which in turn induces an increased invasive phenotype through the activation of c-Met, in association with Src, FAK and Cdc42, Rac1 and RhoA GTPases activation.	[Gomes, Catarina; Osorio, Hugo; Pinto, Marta Teixeira; Campos, Diana; Reis, Celso A.] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Oliveira, Maria Jose] Univ Porto, INEB, Inst Engn Biomed, P-4100 Oporto, Portugal; [Osorio, Hugo; Oliveira, Maria Jose; Reis, Celso A.] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Reis, Celso A.] ICBAS, Inst Biomed Sci Abel Salazar, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Reis, CA (corresponding author), Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	celsor@ipatimup.pt	Gomes, Catarina/AAU-4636-2020; REIS, Celso A/B-9969-2008; Pinto, Marta T/J-2519-2013; Osorio, Hugo/A-7847-2012; Gomes, Catarina/AAC-3325-2021; Oliveira, Maria Jose/K-3275-2013	REIS, Celso A/0000-0002-0286-6639; Pinto, Marta T/0000-0002-8521-2904; Osorio, Hugo/0000-0002-6362-8255; Gomes, Catarina/0000-0002-0352-6783; Campos, Diana/0000-0003-0762-7124; Oliveira, Maria Jose/0000-0002-0724-0272	Portuguese Foundation for Science and Technology FCT [PTDC/BBB-EBI/0786/2012]; Portuguese Foundation for Science and Technology;  [SFRH/BD/44236/2008]	Portuguese Foundation for Science and Technology FCT(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); 	This work was partially supported by Portuguese Foundation for Science and Technology FCT (PTDC/BBB-EBI/0786/2012) financiado no ambito do Programa Operacional Tematico de Fatores de Competitividade (COMPETE) e do Quadro de Referencia Estrategia Nacional QREN. FCT supports CG (PhD grant SFRH/BD/44236/2008), and HO and MTP (Ciencia 2007 program). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Aubert M, 2000, CANCER RES, V60, P1449; Baldus SE, 1998, TUMOR BIOL, V19, P445, DOI 10.1159/000030036; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Cazet A, 2010, CARBOHYD RES, V345, P1377, DOI 10.1016/j.carres.2010.01.024; Cazet A, 2009, BIOL CHEM, V390, P601, DOI 10.1515/BC.2009.054; Colomb F, 2012, BIOCHIMIE, V94, P2045, DOI 10.1016/j.biochi.2012.05.030; de Curtis I, 2012, J CELL SCI; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Dua R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015932; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fukuoka K, 1998, LUNG CANCER, V20, P109, DOI 10.1016/S0169-5002(98)00016-6; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Grabowski P, 2000, INT J CANCER, V88, P281, DOI 10.1002/1097-0215(20001015)88:2<281::AID-IJC21>3.0.CO;2-2; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hall A, 1999, BRIT J CANCER, V80, P25; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hill CAS, 2011, CANCER-AM CANCER SOC, V117, P4493, DOI 10.1002/cncr.26059; Ichikawa D, 2000, J SURG ONCOL, V75, P98, DOI 10.1002/1096-9098(200010)75:2<98::AID-JSO5>3.0.CO;2-R; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kannagi R, 1997, GLYCOCONJUGATE J, V14, P577, DOI 10.1023/A:1018532409041; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Li J, 2012, MED ONCOL, V29, P84, DOI 10.1007/s12032-010-9771-1; Lim SK, 2012, CLIN EXP METASTASIS; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Nakamori S, 1997, DIS COLON RECTUM, V40, P420, DOI 10.1007/BF02258386; Nakamori S, 1999, J EXP CLIN CANC RES, V18, P425; NAKAMORI S, 1993, CANCER RES, V53, P3632; Okajima T, 1999, J BIOL CHEM, V274, P11479, DOI 10.1074/jbc.274.17.11479; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Petretti T, 1999, BBA-GEN SUBJECTS, V1428, P209, DOI 10.1016/S0304-4165(99)00080-X; Sanchez-Bailon MP, 2012, CELL SIGNAL, V24, P1276, DOI 10.1016/j.cellsig.2012.02.011; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shen J, 2012, CANCER LETT, V318, P106, DOI 10.1016/j.canlet.2011.12.008; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Singh R, 2006, GLYCOBIOLOGY, V16, P594, DOI 10.1093/glycob/cwj108; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; SOMAN NR, 1991, P NATL ACAD SCI USA, V88, P4892, DOI 10.1073/pnas.88.11.4892; Sperandio M, 2006, EUR J IMMUNOL, V36, P3207, DOI 10.1002/eji.200636157; TAKADA A, 1993, CANCER RES, V53, P354; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Tatsumi M, 1998, CLIN EXP METASTAS, V16, P743, DOI 10.1023/A:1006584829246; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wessler S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-27; Yu J, 2000, CANCER-AM CANCER SOC, V88, P1801, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1801::AID-CNCR7>3.0.CO;2-U	66	74	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66737	10.1371/journal.pone.0066737	http://dx.doi.org/10.1371/journal.pone.0066737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799130	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300095
J	Hill, J; Dellicour, S; Bruce, J; Ouma, P; Smedley, J; Otieno, P; Ombock, M; Kariuki, S; Desai, M; Hamel, MJ; ter Kuile, FO; Webster, J				Hill, Jenny; Dellicour, Stephanie; Bruce, Jane; Ouma, Peter; Smedley, James; Otieno, Peter; Ombock, Maurice; Kariuki, Simon; Desai, Meghna; Hamel, Mary J.; ter Kuile, Feiko O.; Webster, Jayne			Effectiveness of Antenatal Clinics to Deliver Intermittent Preventive Treatment and Insecticide Treated Nets for the Control of Malaria in Pregnancy in Kenya	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PRESUMPTIVE TREATMENT; BIRTH-WEIGHT; WOMEN; POLICY; ANTIMALARIAL; KNOWLEDGE; COVERAGE; TANZANIA; THERAPY	Background: Malaria in pregnancy can have devastating consequences for mother and baby. Coverage with the WHO prevention strategy for sub-Saharan Africa of intermittent-preventive-treatment (IPTp) with two doses of sulphadoxine-pyrimethamine (SP) and insecticide-treated-nets (ITNs) in pregnancy is low. We analysed household survey data to evaluate the effectiveness of antenatal clinics (ANC) to deliver IPTp and ITNs to pregnant women in Nyando district, Kenya. Methods: We assessed the systems effectiveness of ANC to deliver IPTp and ITNs to pregnant women and the impact on low birthweight (LBW). Logistic regression was used to identify predictors of receipt of IPTp and ITN use during pregnancy. Results: Among 89% of recently pregnant women who attended ANC at least once between 4-9 months gestation, 59% reported receiving one dose of SP and 90% attended ANC again, of whom 57% received a second dose, resulting in a cumulative effectiveness for IPTp of 27%, most of whom used an ITN (96%). Overall ITN use was 89%, and ANC the main source (76%). Women were less likely to receive IPTp if they had low malaria knowledge (0.26, 95% CI 0.08-0.83), had a child who had died (OR 0.36, 95% CI 0.14-0.95), or if they first attended ANC late (OR 0.20, 95% CI 0.06-0.67). Women who experienced side effects to SP (OR 0.18, CI 0.03-0.90) or had low malaria knowledge (OR 0.78, 95% CI 0.11-5.43) were less likely to receive IPTp by directly observed therapy. Ineffective delivery of IPTp reduced its potential impact by 231 LBW cases averted (95% CI 64-359) per 10,000 pregnant women. Conclusion: IPTp presents greater challenges to deliver through ANC than ITNs in this setting. The reduction in public health impact on LBW resulting from ineffective delivery of IPTp is estimated to be substantial. Urgent efforts are required to improve service delivery of this important intervention.	[Hill, Jenny; Dellicour, Stephanie; Smedley, James; ter Kuile, Feiko O.] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Dellicour, Stephanie; Ouma, Peter; Otieno, Peter; Ombock, Maurice; Kariuki, Simon; Desai, Meghna] Ctr Dis Control Res & Publ Hlth Collaborat, Kenya Med Res Inst, Kisumu, Kenya; [Bruce, Jane; Webster, Jayne] London Sch Trop Med & Hyg, Dis Control Dept, London, England; [Desai, Meghna; Hamel, Mary J.] Ctr Dis Control & Prevent, Atlanta, GA USA	Liverpool School of Tropical Medicine; University of Liverpool; Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA	Hill, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	j.hill@liv.ac.uk	Kariuki, Simon/AFT-6596-2022; Hill, Jenny/C-3839-2017; Kuile, Feiko ter/ABD-6681-2020	Hill, Jenny/0000-0003-1588-485X; Kuile, Feiko ter/0000-0003-3663-5617; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; ALTMAN DG, 1991, NEPHRON, V59, P522, DOI 10.1159/000186630; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Anders K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-79; [Anonymous], 2008, GLOB MAL ACT PLAN; Ashwood-Smith Hannah, 2002, Malawi Med J, V14, P8; Baiden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028944; Beer N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-173; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; CHANDRAMOHAN D, 2007, TROP MED INT HEALTH, V12, P1; Chico RM, 2011, TROP MED INT HLTH; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Division of Malaria Control MoH Republic of Kenya, 2001, NAT MAL STRAT 2001 2; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eisele TP, 2012, LANCET INFECT DIS; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Gross K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-140; Guyatt HL, 2004, TROP MED INT HEALTH, V9, P255, DOI 10.1046/j.1365-3156.2003.01193.x; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hill J, 2013, FACTORS AFFECT UNPUB; Kayentao K, 2013, JAMA-J AM MED ASSOC, V309, P594, DOI 10.1001/jama.2012.216231; Kenya Ministry of Health and Sanitation Health MoP, 2010, NAT GUID DIAGN TREAT; [Kenya National Bureau of Statistics ICF Macro], 2003, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics and ICF Macro, 2010, KEN DEM HLTH SURV 20; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Marchant T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-260; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Mubyazi G, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-31; Ndyomugyenyi R, 2010, T ROY SOC TROP MED H, V104, P536, DOI 10.1016/j.trstmh.2010.02.003; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Ouma PO, 2007, TROP MED INT HEALTH, V12, P953, DOI 10.1111/j.1365-3156.2007.01876.x; Paintain LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024035; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; [Roll Back Malaria MEASURE Evaluation USAID UNICEF World Health Organization], 2009, RBMWG2009TP1 USAID U; Roll Back Malaria Partnership, 2011, RBM REF UPD GLOB MAL; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-333; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; van Eijk AM, 2013, COVERAGE INTER UNPUB; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; VLASSOFF C, 1992, HEALTH POLICY PLANN, V7, P1, DOI 10.1093/heapol/7.1.1; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webster J, 2011, THESIS LONDON SCH HY; Webster J, 2010, AM J TROP MED HYG, V82, P672, DOI 10.4269/ajtmh.2010.09-0473; WHO, 2004, STRAT FRAM MAL PREV; World Health Organisation, 2006, MAL PREGN GUID MEAS; World Health Organisation Global Malaria Programme, 2007, POS STAT ITNS; World Health Organization, 2012, UPD WHO POL REC OCT; Worrall E, 2007, LANCET INFECT DIS, V7, P156, DOI 10.1016/S1473-3099(07)70027-0	56	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64913	10.1371/journal.pone.0064913	http://dx.doi.org/10.1371/journal.pone.0064913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798997	Green Published, gold, Green Accepted			2022-12-27	WOS:000320363300006
J	Shermock, KM; Lau, BD; Haut, ER; Hobson, DB; Ganetsky, VS; Kraus, PS; Efird, LE; Lehmann, CU; Pinto, BL; Ross, PA; Streiff, MB				Shermock, Kenneth M.; Lau, Brandyn D.; Haut, Elliott R.; Hobson, Deborah B.; Ganetsky, Valerie S.; Kraus, Peggy S.; Efird, Leigh E.; Lehmann, Christoph U.; Pinto, Brian L.; Ross, Patricia A.; Streiff, Michael B.			Patterns of Non-Administration of Ordered Doses of Venous Thromboembolism Prophylaxis: Implications for Novel Intervention Strategies	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; HOSPITALIZED-PATIENTS; PULMONARY-EMBOLISM; PREVENTION; RISK; COMPRESSION; REGISTRY; TRAUMA	Background: Recent studies have documented high rates of non-administration of ordered venous thromboembolism (VTE) prophylaxis doses. Intervention strategies that target all patients have been effective, but prohibitively resource-intensive. We aimed to identify efficient intervention strategies based on patterns of non-administration of ordered VTE prophylaxis. Methods and Findings: In this retrospective review of electronic medication administration records, we included adult hospitalized patients who were ordered pharmacologic VTE prophylaxis with unfractionated heparin or enoxaparin over a seven-month period. The primary measure was the proportion of ordered doses of VTE prophylaxis not administered, assessed at the patient, floor, and floor type levels. Differences in non-administration rates between groups were assessed using generalized estimating equations. A total of 103,160 ordered VTE prophylaxis doses during 10,516 patient visits on twenty-nine patient floors were analyzed. Overall, 11.9% of ordered doses were not administered. Approximately 19% of patients missed at least one quarter and 8% of patients missed over one half of ordered doses. There was marked heterogeneity in non-administration rate at the floor level (range: 5-27%). Patients on medicine floors missed a significantly larger proportion (18%) of ordered doses compared to patients on other floor types (8%, Odds Ratio: 2.4, p < 0.0001). However, more than half of patients received at least 86% of their ordered doses, even on the lowest performing floor. The 20% of patients who missed at least two ordered doses accounted for 80% of all missed doses. Conclusions: A substantial proportion of ordered doses of VTE prophylaxis were not administered. The heterogeneity in non-administration rate between patients, floors, and floor types can be used to target interventions. The small proportion of patients that missed multiple ordered doses accounted for a large majority of non-administered doses. This recognition of the Pareto principle provides opportunity to efficiently target a relatively small group of patients for intervention.	[Shermock, Kenneth M.; Ganetsky, Valerie S.; Kraus, Peggy S.; Efird, Leigh E.; Pinto, Brian L.; Ross, Patricia A.] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Shermock, Kenneth M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Lau, Brandyn D.; Haut, Elliott R.; Hobson, Deborah B.] Johns Hopkins Univ, Sch Med, Dept Surg, Div Acute Care Surg, Baltimore, MD 21205 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Shermock, Kenneth M.; Lau, Brandyn D.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Shermock, Kenneth M.; Haut, Elliott R.; Hobson, Deborah B.; Streiff, Michael B.] Johns Hopkins Med, Armstrong Inst Patient Safety, Baltimore, MD USA; [Streiff, Michael B.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Lehmann, Christoph U.] Univ Maryland, Sch Med, Dept Pediat, Div Hlth Sci Informat, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Shermock, KM (corresponding author), Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA.	kenneth@jhmi.edu	Lau, Brandyn/H-4825-2018; Lehmann, Christoph U/M-1845-2016; Haut, Elliott R./J-3948-2019	Lau, Brandyn/0000-0003-3575-2440; Lehmann, Christoph U/0000-0001-9559-4646; Haut, Elliott/0000-0001-7075-771X	Agency for Healthcare Research and Quality [K08 1K08HS017952-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017952] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. ERH is the Primary Investigator of a Mentored Clinician Scientist Development Award K08 1K08HS017952-01 from the Agency for Healthcare Research and Quality entitled "Does Screening Variability Make DVT an Unreliable Quality Measure of Trauma Care?" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AN, 2011, ANN PHARMACOTHER, V45, P1045, DOI 10.1345/aph.1Q049; Anderson AF, 1991, ARCH INTERN MED, V151, P933; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; COMEROTA AJ, 1992, AM J SURG, V164, P265, DOI 10.1016/S0002-9610(05)81083-9; Cornwell EE, 2002, AM SURGEON, V68, P470; Fanikos J, 2010, AM J MED, V123, P536, DOI 10.1016/j.amjmed.2009.11.017; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Haut ER, 2012, ARCH SURG-CHICAGO, V147, P901, DOI 10.1001/archsurg.2012.2024; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Maynard G, 2008, AHRQ PUBLICATION; Michota FA, 2007, J GEN INTERN MED, V22, P1762, DOI 10.1007/s11606-007-0369-z; Piazza G, 2012, AM J MED, V125, P258, DOI 10.1016/j.amjmed.2011.09.012; SANDLER DA, 1989, J ROY SOC MED, V82, P203, DOI 10.1177/014107688908200407; Shojania K.G., 2001, MAKING HLTH CARE SAF; Spencer FA, 2007, ARCH INTERN MED, V167, P1471, DOI 10.1001/archinte.167.14.1471; Streiff MB, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3935; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; US Department of Health and Human Services, SURG GEN CALL ACTION; Yu HT, 2007, AM J HEALTH-SYST PH, V64, P69, DOI 10.2146/ajhp060115	20	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66311	10.1371/journal.pone.0066311	http://dx.doi.org/10.1371/journal.pone.0066311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799091	Green Published, gold			2022-12-27	WOS:000320363300075
J	Bakre, A; Andersen, LE; Meliopoulos, V; Coleman, K; Yan, XZ; Brooks, P; Crabtree, J; Tompkins, SM; Tripp, RA				Bakre, Abhijeet; Andersen, Lauren E.; Meliopoulos, Victoria; Coleman, Keegan; Yan, Xiuzhen; Brooks, Paula; Crabtree, Jackelyn; Tompkins, S. Mark; Tripp, Ralph A.			Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs	PLOS ONE			English	Article							NF-KAPPA-B; RESPIRATORY SYNCYTIAL VIRUS; CELL-CYCLE ARREST; A VIRUS; AVIAN INFLUENZA; PROTEIN-KINASE; IN-VIVO; SIGNAL-TRANSDUCTION; RESISTANT INFLUENZA; ANTIVIRAL THERAPY	Human protein kinases (HPKs) have profound effects on cellular responses. To better understand the role of HPKs and the signaling networks that influence influenza virus replication, a small interfering RNA (siRNA) screen of 720 HPKs was performed. From the screen, 17 HPKs (NPR2, MAP3K1, DYRK3, EPHA6, TPK1, PDK2, EXOSC10, NEK8, PLK4, SGK3, NEK3, PANK4, ITPKB, CDC2L5 (CDK13), CALM2, PKN3, and HK2) were validated as essential for A/WSN/33 influenza virus replication, and 6 HPKs (CDK13, HK2, NEK8, PANK4, PLK4 and SGK3) were identified as vital for both A/WSN/33 and A/New Caledonia/20/99 influenza virus replication. These HPKs were found to affect multiple host pathways and regulated by miRNAs induced during infection. Using a panel of miRNA agonists and antagonists, miR-149* was found to regulate NEK8 expression, miR-548d-3p was found to regulate MAPK1 transcript expression, and miRs -1228 and -138 to regulate CDK13 expression. Up-regulation of miR-34c induced PLK4 transcript and protein expression and enhanced influenza virus replication, while miR-34c inhibition reduced viral replication. These findings identify HPKs important for influenza viral replication and show the miRNAs that govern their expression.	[Bakre, Abhijeet; Andersen, Lauren E.; Meliopoulos, Victoria; Coleman, Keegan; Yan, Xiuzhen; Brooks, Paula; Crabtree, Jackelyn; Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Tripp, RA (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008; Bakre, Abhijeet A./A-4632-2013	Tompkins, Stephen/0000-0002-1523-5588; Bakre, Abhijeet A./0000-0002-6755-5233; Tripp, Ralph/0000-0002-2924-9956	National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance [HHSN266200700006C]	National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance	The authors acknowledge National Institute of Allergy and Infectious Diseases Center of Excellence for Influenza Research and Surveillance, contract # HHSN266200700006C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamares-Sapuay JG, 2013, J VIROL, V87, P6020, DOI 10.1128/JVI.01258-12; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Berro R, 2008, J VIROL, V82, P7155, DOI 10.1128/JVI.02543-07; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chang WLW, 2007, J IMMUNOL, V178, P1457, DOI 10.4049/jimmunol.178.3.1457; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Conly Jm, 2006, Can J Infect Dis Med Microbiol, V17, P11; Cottey R, 2001, CURR PROTOC IMMUNOL, V19; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Dove BK, 2012, PROTEOMICS, V12, P1431, DOI 10.1002/pmic.201100470; Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Guan ZH, 2012, BIOCHEM BIOPH RES CO, V425, P662, DOI 10.1016/j.bbrc.2012.07.114; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haney SA, 2007, PHARMACOGENOMICS, V8, P1037, DOI 10.2217/14622416.8.8.1037; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Heynisch B, 2010, VACCINE, V28, P8210, DOI 10.1016/j.vaccine.2010.07.076; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Holland AJ, 2012, MOL BIOL CELL, V23, P1838, DOI 10.1091/mbc.E11-12-1043; Holland PM, 2002, J BIOL CHEM, V277, P16229, DOI 10.1074/jbc.M108662200; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang W, 2013, J VIROL, V87, P3039, DOI 10.1128/JVI.03176-12; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Karlas A, 2010, NATURE; Karlas A, NATURE; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kroeker AL, 2012, J PROTEOME RES, V11, P4132, DOI 10.1021/pr300239r; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Labuda T, 2006, EUR J IMMUNOL, V36, P2076, DOI 10.1002/eji.200535163; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2011, VIROLOGY; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Liang TM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/679563; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu He, 2010, Weishengwu Xuebao, V50, P1399; Liu L, 2012, J PROTEOME RES, V11, P4091, DOI 10.1021/pr3001332; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 2004, FEBS LETT, V561, P37, DOI 10.1016/S0014-5793(04)00108-5; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Majde JA, 2000, J INTERF CYTOK RES, V20, P259, DOI 10.1089/107999000312397; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/NCHEMBIO.645, 10.1038/nchembio.645]; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169; Min JY, 2010, NAT BIOTECHNOL, V28, P239, DOI 10.1038/nbt0310-239; MMWR, 2010, EST DEATHS ASS SEAS; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Munoz-Fontela C, 2011, J IMMUNOL, V187, P6428, DOI 10.4049/jimmunol.1101459; Murray James L., 2012, Antiviral Chemistry & Chemotherapy, V22, P205, DOI 10.3851/IMP2080; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Osterhaus A, 2011, PHILOS T R SOC B, V366, P2766, DOI 10.1098/rstb.2011.0102; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Palese P., 2007, FIELDS VIROLOGY; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Perwitasari O, 2013, ANTIMICROB AGENTS CH, V57, P475, DOI 10.1128/AAC.01532-12; Pinto R, 2011, ANTIVIR RES, V92, P45, DOI 10.1016/j.antiviral.2011.05.009; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Pleschka S, 2008, BIOL CHEM, V389, P1273, DOI 10.1515/BC.2008.145; REED L. J., 1938, AMER JOUR HYG, V27, P493; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schultz-Cherry S, 2010, ADV VIRUS RES, V77, P63, DOI 10.1016/S0065-3527(10)77003-2; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Sillibourne JE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-25; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Straka M, 2010, CURRENT TOPICS RNAI; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062; Xu Y, 2010, SCHIZOPHR RES, V119, P219, DOI 10.1016/j.schres.2010.02.1070; Yamauchi Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002316; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544; Zhang Lijun, 2010, Genomics Proteomics & Bioinformatics, V8, P139, DOI 10.1016/S1672-0229(10)60016-2; Zhe JP, 2012, J PROTEOMICS, V75, P1732, DOI 10.1016/j.jprot.2011.12.012; Zheng SQ, 2005, ANTIVIR RES, V89, P219	119	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66796	10.1371/journal.pone.0066796	http://dx.doi.org/10.1371/journal.pone.0066796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805279	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500107
J	Chen, MW; Lohkamp, B; Schnell, R; Lescar, J; Schneider, G				Chen, Ming Wei; Lohkamp, Bernhard; Schnell, Robert; Lescar, Julien; Schneider, Gunter			Substrate Channel Flexibility in Pseudomonas aeruginosa MurB Accommodates Two Distinct Substrates	PLOS ONE			English	Article							N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; METHYLENETETRAHYDROFOLATE REDUCTASE; PROTEIN-STRUCTURE; NADP(+) BINDING; DOMAIN MOTIONS; S229A MUTANT; WILD-TYPE; ENZYME	Biosynthesis of UDP-N-acetylmuramic acid in bacteria is a committed step towards peptidoglycan production. In an NADPH- and FAD-dependent reaction, the UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) reduces UDP-N-acetylglucosamine-enolpyruvate to UDP-N-acetylmuramic acid. We determined the three-dimensional structures of the ternary complex of Pseudomonas aeruginosa MurB with FAD and NADP(+) in two crystal forms to resolutions of 2.2 and 2.1 angstrom, respectively, to investigate the structural basis of the first half-reaction, hydride transfer from NADPH to FAD. The nicotinamide ring of NADP(+) stacks against the si face of the isoalloxazine ring of FAD, suggesting an unusual mode of hydride transfer to flavin. Comparison with the structure of the Escherichia coli MurB complex with UDP-Nacetylglucosamine-enolpyruvate shows that both substrates share the binding site located between two lobes of the substrate-binding domain III, consistent with a ping pong mechanism with sequential substrate binding. The nicotinamide and the enolpyruvyl moieties are strikingly well-aligned upon superimposition, both positioned for hydride transfer to and from FAD. However, flexibility of the substrate channel allows the non-reactive parts of the two substrates to bind in different conformations. A potassium ion in the active site may assist in substrate orientation and binding. These structural models should help in structure-aided drug design against MurB, which is essential for cell wall biogenesis and hence bacterial survival.	[Chen, Ming Wei; Lohkamp, Bernhard; Schnell, Robert; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Chen, Ming Wei; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Schneider, G (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	Gunter.Schneider@ki.se		Chen, Ming Wei/0000-0003-0718-866X; Lohkamp, Bernhard/0000-0002-5646-2090; Schneider, Gunter/0000-0003-0622-5713; SCHNELL, ROBERT/0000-0001-7530-3629	European Commission [HEALTH-F3-2008-223461]; Swedish Science Council; Clas Groschinskys Foundation	European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Science Council; Clas Groschinskys Foundation	This work was supported by the European Commission through the 7th Framework program, grant agreement HEALTH-F3-2008-223461, the Swedish Science Council (www.vr.se) and by the Clas Groschinskys Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axley MJ, 1997, BIOCHEMISTRY-US, V36, P812, DOI 10.1021/bi962260s; Bae E, 2008, PROTEINS, V70, P303, DOI 10.1002/prot.21678; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENSON TE, 1995, NAT STRUCT BIOL, V2, P644, DOI 10.1038/nsb0895-644; Benson TE, 1997, BIOCHEMISTRY-US, V36, P806, DOI 10.1021/bi962221g; Benson TE, 1996, STRUCTURE, V4, P47, DOI 10.1016/S0969-2126(96)00008-1; BENSON TE, 1993, BIOCHEMISTRY-US, V32, P2024, DOI 10.1021/bi00059a019; Benson TE, 2001, BIOCHEMISTRY-US, V40, P2340, DOI 10.1021/bi002162d; Benson TE, 1997, BIOCHEMISTRY-US, V36, P796, DOI 10.1021/bi962220o; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Constantine KL, 1997, J MOL BIOL, V267, P1223, DOI 10.1006/jmbi.1997.0915; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DHALLA AM, 1995, BIOCHEMISTRY-US, V34, P5390, DOI 10.1021/bi00016a010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gautam A, 2011, CRIT REV BIOTECHNOL, V31, P295, DOI 10.3109/07388551.2010.525498; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harris MS, 2001, ACTA CRYSTALLOGR D, V57, P1032, DOI 10.1107/S0907444901006552; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim MK, 2007, PROTEINS, V66, P751, DOI 10.1002/prot.21174; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Mansour TS, 2007, CHEMMEDCHEM, V2, P1414, DOI 10.1002/cmdc.200700094; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; Moynie L, 2013, ACTA CRYSTALLOGR F, V69, P25, DOI 10.1107/S1744309112044739; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pejchal R, 2005, BIOCHEMISTRY-US, V44, P11447, DOI 10.1021/bi050533q; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; SUMNER JS, 1992, J AM CHEM SOC, V114, P6949, DOI 10.1021/ja00044a001; TAKU A, 1973, J BIOL CHEM, V248, P4971; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Heijenoort J, 1998, CELL MOL LIFE SCI, V54, P300, DOI 10.1007/s000180050155; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	46	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66936	10.1371/journal.pone.0066936	http://dx.doi.org/10.1371/journal.pone.0066936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805286	Green Published, gold			2022-12-27	WOS:000320846500114
J	Lemme, F; Doyle, AM; Changalucha, J; Andreasen, A; Baisley, K; Maganja, K; Watson-Jones, D; Kapiga, S; Hayes, RJ; Ross, DA				Lemme, Francesca; Doyle, Aoife M.; Changalucha, John; Andreasen, Aura; Baisley, Kathy; Maganja, Kaballa; Watson-Jones, Deborah; Kapiga, Saidi; Hayes, Richard J.; Ross, David A.			HIV Infection among Young People in Northwest Tanzania: The Role of Biological, Behavioural and Socio-Demographic Risk Factors	PLOS ONE			English	Article							SEXUAL HEALTH INTERVENTION; SIMPLEX-VIRUS TYPE-2; COMMUNITY-RANDOMIZED-TRIAL; MALE CIRCUMCISION; RURAL TANZANIA; MWANZA REGION; PREVENTION; WOMEN; TRANSMISSION; IMPACT	Background: Young people are at high risk of HIV and developing appropriate prevention programmes requires an understanding of the risk factors for HIV in this age group. We investigated factors associated with HIV among participants aged 15-30 years in a 2007-8 cross-sectional survey nested within a community-randomised trial of the MEMA kwa Vijana intervention in 20 rural communities in northwest Tanzania. Methods: We analysed data for 7259(53%) males and 6476(47%) females. Using a proximate-determinant conceptual framework and conditional logistic regression, we obtained sex-specific Odds Ratios (ORs) for the association of HIV infection with socio-demographic, knowledge, behavioural and biological factors. Results: HSV-2 infection was strongly associated with HIV infection (females: adjOR 4.4, 95%CI 3.2-6.1; males: adjOR 4.2, 95%CI 2.8-6.2). Several socio-demographic factors (such as age, marital status and mobility), behavioural factors (condom use, number and type of sexual partnerships) and biological factors (blood transfusion, lifetime pregnancies, genital ulcers, Neisseria gonorrhoeae) were also associated with HIV infection. Among females, lifetime sexual partners (linear trend, p<0.001), >= 2 partners in the past year (adjOR 2.0, 95%CI 1.4-2.8), >= 2 new partners in the past year (adjOR 1.9 95%CI 1.2, 3.3) and concurrent partners in the past year (adjOR 1.6 95%CI 1.1, 2.4) were all associated with HIV infection. Conclusions: Efforts must be intensified to find effective interventions to reduce HSV-2. Effective behavioural interventions focusing on reducing the number of sexual partnerships and risk behaviour within partnerships are also needed. An increase in risky sexual behaviour may occur following marriage dissolution or when a young woman travels outside of her community and interventions addressing the needs of these subgroups of vulnerable women may be important.	[Lemme, Francesca; Doyle, Aoife M.; Andreasen, Aura; Baisley, Kathy; Watson-Jones, Deborah; Kapiga, Saidi; Hayes, Richard J.; Ross, David A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Lemme, Francesca; Doyle, Aoife M.; Andreasen, Aura; Maganja, Kaballa; Watson-Jones, Deborah; Kapiga, Saidi] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; National Institute of Medical Research	Ross, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ross@lshtm.ac.uk	Doyle, Aoife/AAX-3525-2020	Doyle, Aoife/0000-0002-3305-7738; Andreasen, Aura/0000-0003-0664-7342; Kapiga, Saidi/0000-0003-1753-4060; Hayes, Richard/0000-0002-1729-9892	European Commission; United Kingdom Department for International Development; Medical Research Council of Great Britain; United Nations Joint Programme on HIV/AIDS (UNAIDS); Irish Aid; MRC [G0902121, G0700837, G0901756] Funding Source: UKRI; Medical Research Council [G0902121, G0700837, G0901756] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); United Kingdom Department for International Development; Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Nations Joint Programme on HIV/AIDS (UNAIDS); Irish Aid(CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded through grants from the European Commission, and the United Kingdom Department for International Development and Irish Aid. Additional funding was received from the Medical Research Council of Great Britain and The United Nations Joint Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Blum, 2004, RISK PROTECTIVE FACT; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Doyle AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024866; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Forbes HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040507; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; Hayes R, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000390704.35642.47; Hayes RJ, 2005, CONTEMP CLIN TRIALS, V26, P430, DOI 10.1016/j.cct.2005.04.006; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Msisha WM, 2008, INT J EPIDEMIOL, V37, P1297, DOI 10.1093/ije/dyn186; Obasi AI, 2006, AIDS CARE, V18, P311, DOI 10.1080/09540120500161983; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, P17; Plummer M.L., 2012, PROMOTING ABSTINENCE; Plummer ML, 2011, YOUNG PEOPLES LIVES; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Remes P, 2009, CULT HEALTH SEX, V1; Rodriguez MDM, 2002, AIDS, V16, P451; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Senkoro KP, 2000, J ACQ IMMUN DEF SYND, V23, P194; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; Todd J, 2006, J INFECT DIS, V193, P458, DOI 10.1086/499313; UNAIDS, 2012, WORLD AIDS DAY REP 2; UNAIDS, 2010, OUTL BREAK NEWS YOUN; United Nations, 2001, UNGASS GOALS; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Watson-Jones D, 2009, AIDS, V23, P415, DOI 10.1097/QAD.0b013e32831ef523; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Wight D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-788	42	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66287	10.1371/journal.pone.0066287	http://dx.doi.org/10.1371/journal.pone.0066287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805209	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000320846500037
J	Xing, XB; Cai, WB; Luo, L; Liu, LS; Shi, HJ; Chen, MH				Xing, Xiang-Bin; Cai, Wei-Bin; Luo, Liang; Liu, Long-Shan; Shi, Hui-Juan; Chen, Min-Hu			The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis	PLOS ONE			English	Article							NONSMALL CELL LUNG; RASSF1A PROMOTER HYPERMETHYLATION; COLORECTAL-CANCER; DNA METHYLATION; P16(INK4A) HYPERMETHYLATION; ABERRANT METHYLATION; POOR-PROGNOSIS; GENE; SURVIVAL; INACTIVATION	Background: The prognostic value of p16 promoter hypermethylation in cancers has been evaluated for several years while the results remain controversial. We thus performed a systematic review and meta-analysis of studies assessing the impact of p16 methylation on overall survival (OS) and disease-free survival (DFS) to clarify this issue. Methods: We searched Pubmed, Embase and ISI web of knowledge to identify studies on the prognostic impact of p16 hypermethylation in cancers. A total of 6589 patients from 45 eligible studies were included in the analysis. Pooled hazard ratios (HRs) with 95% confidence interval (95% CI) were calculated to estimate the effect using random-effects model. Results: The analysis indicated that p16 hypermethylation had significant association with poor OS of non-small cell lung cancer (NSCLC) (HR 1.74, 95% CI: 1.36-2.22) and colorectal cancer (CRC) (HR 1.80; 95% CI 1.27-2.55). Moreover, the significant correlation was present between p16 hypermethylation and DFS of NSCLC (HR 2.04, 95% CI: 1.19-3.50) and head and neck cancer (HR 2.24, 95% CI: 1.35-3.73). Additionally, in the analysis of the studies following REMARK guidelines more rigorously, p16 hypermethylation had unfavorable impact on OS of NSCLC (HR 1.79, 95% CI: 1.35-2.39) and CRC (HR 1.96, 1.16-3.34), and on DFS of NSCLC (HR 2.12, 95% CI: 1.21-3.72) and head and neck cancer (HR 2.24, 95% CI: 1.35-3.73). Conclusions: p16 hypermethylation might be a predictive factor of poor prognosis in some surgically treated cancers, particularly in NSCLC.	[Xing, Xiang-Bin; Luo, Liang; Shi, Hui-Juan; Chen, Min-Hu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Wei-Bin] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Long-Shan] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Gen Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, MH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	chenminhu@vip.163.com			National Natural Science Foundation of China [81000887]; Research Fund for the Doctoral Program of Higher Education of China [20090171120064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (81000887) and Research Fund for the Doctoral Program of Higher Education of China (20090171120064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaa M, 2009, INT J ONCOL, V34, P805, DOI 10.3892/ijo_00000206; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Ben Ayed-Guerfali D, 2011, J SURG ONCOL, V103, P687, DOI 10.1002/jso.21875; Buckingham L, 2010, INT J CANCER, V126, P1630, DOI 10.1002/ijc.24896; Chen JT, 2002, INT J CANCER, V98, P724, DOI 10.1002/ijc.10262; Curtis CD, 2005, METH MOLEC MED, V103, P123; Dikshit RP, 2007, CANCER-AM CANCER SOC, V110, P1745, DOI 10.1002/cncr.22975; Dong YY, 2012, J ORAL PATHOL MED, V41, P463, DOI 10.1111/j.1600-0714.2012.01132.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2001, J CLIN ONCOL, V19, P299, DOI 10.1200/JCO.2001.19.2.299; Feng JJ, 2012, CANCER-AM CANCER SOC, V118, P232, DOI 10.1002/cncr.26250; Gonzalez-Quevedo R, 2004, INT J ONCOL, V24, P349; Gu J, 2006, CLIN CANCER RES, V12, P7329, DOI 10.1158/1078-0432.CCR-06-0894; Guerrero D, 2008, BJU INT, V102, P747, DOI 10.1111/j.1464-410X.2008.07603.x; Ishiguro A, 2006, J GASTROEN HEPATOL, V21, P1334, DOI 10.1111/j.1440-1746.2006.04137.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Katsaros D, 2004, GYNECOL ONCOL, V94, P685, DOI 10.1016/j.ygyno.2004.06.018; Kawaguchi K, 2003, J PATHOL, V201, P487, DOI 10.1002/path.1419; Kawamoto K, 2006, BIOCHEM BIOPH RES CO, V339, P790, DOI 10.1016/j.bbrc.2005.11.072; Kim JC, 2010, ANN SURG ONCOL, V17, P1767, DOI 10.1245/s10434-009-0901-y; Kuo LT, 2009, INT J CANCER, V124, P2872, DOI 10.1002/ijc.24303; Kurakawa E, 2001, INT J ONCOL, V19, P277; Li BK, 2010, ANN SURG ONCOL, V17, P1917, DOI 10.1245/s10434-010-0921-7; Li X, 2004, CLIN CANCER RES, V10, P7484, DOI 10.1158/1078-0432.CCR-04-1715; Liang JT, 1999, ONCOLOGY-BASEL, V57, P149, DOI 10.1159/000012023; Lu C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-91; Maeda K, 2003, ONCOL REP, V10, P935; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mitomi H, 2010, J CANCER RES CLIN, V136, P323, DOI 10.1007/s00432-009-0688-z; Mitsuno M, 2007, J GASTROENTEROL, V42, P866, DOI 10.1007/s00535-007-2113-1; Mocellin S, 2006, CLIN CANCER RES, V12, P4605, DOI 10.1158/1078-0432.CCR-06-0823; Nakata S, 2006, CANCER-AM CANCER SOC, V106, P2190, DOI 10.1002/cncr.21870; Ota N, 2006, ANTICANCER RES, V26, P3729; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Sailasree R, 2008, CANCER EPIDEM BIOMAR, V17, P414, DOI 10.1158/1055-9965.EPI-07-0284; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharma G, 2009, CELL ONCOL, V31, P487, DOI 10.3233/CLO-2009-0507; Shi J, 2012, AM J CANCER RES, V2, P116; Shima K, 2011, INT J CANCER, V128, P1080, DOI 10.1002/ijc.25432; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Straume O, 2002, AM J PATHOL, V161, P229, DOI 10.1016/S0002-9440(10)64174-0; Su PF, 2010, ORAL ONCOL, V46, P734, DOI 10.1016/j.oraloncology.2010.07.002; Suzuki M, 2010, ANN SURG ONCOL, V17, P878, DOI 10.1245/s10434-009-0739-3; Taioli E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-354; Tanaka R, 2005, CANCER-AM CANCER SOC, V103, P608, DOI 10.1002/cncr.20827; Toyooka S, 2004, BRIT J CANCER, V91, P771, DOI 10.1038/sj.bjc.6602013; de Castro SV, 2012, REV ESP ENFERM DIG, V104, P111, DOI 10.4321/s1130-01082012000300002; Vidaurreta M, 2008, UROL ONCOL-SEMIN ORI, V26, P239, DOI 10.1016/j.urolonc.2007.01.018; Wang J, 2004, CLIN CANCER RES, V10, P6119, DOI 10.1158/1078-0432.CCR-04-0652; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; Ward RL, 2003, J CLIN ONCOL, V21, P3729, DOI 10.1200/JCO.2003.03.123; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Yanagawa N, 2007, LUNG CANCER, V58, P131, DOI 10.1016/j.lungcan.2007.05.011; Yoshino M, 2009, INT J ONCOL, V35, P1201, DOI 10.3892/ijo_00000437; Yurakh AO, 2006, EUR UROL, V50, P506, DOI 10.1016/j.eururo.2006.03.027; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zhao S, 2011, BREAST CANCER RES TR, V130, P809, DOI 10.1007/s10549-011-1379-4	59	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66587	10.1371/journal.pone.0066587	http://dx.doi.org/10.1371/journal.pone.0066587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805242	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500070
J	Rivas-Pardo, JA; Herrera-Morande, A; Castro-Fernandez, V; Fernandez, FJ; Vega, MC; Guixe, V				Andres Rivas-Pardo, Jaime; Herrera-Morande, Alejandra; Castro-Fernandez, Victor; Fernandez, Francisco J.; Cristina Vega, M.; Guixe, Victoria			Crystal Structure, SAXS and Kinetic Mechanism of Hyperthermophilic ADP-Dependent Glucokinase from Thermococcus litoralis Reveal a Conserved Mechanism for Catalysis	PLOS ONE			English	Article							RAY SOLUTION SCATTERING; CATION-PI INTERACTIONS; INDUCED-FIT; CONFORMATIONAL SELECTION; ADENOSINE KINASE; BINDING; PROTEINS; ENZYME; SPECIFICITY; ARCHAEA	ADP-dependent glucokinases represent a unique family of kinases that belong to the ribokinase superfamily, being present mainly in hyperthermophilic archaea. For these enzymes there is no agreement about the magnitude of the structural transitions associated with ligand binding and whether they are meaningful to the function of the enzyme. We used the ADP-dependent glucokinase from Termococcus litoralis as a model to investigate the conformational changes observed in Xray crystallographic structures upon substrate binding and to compare them with those determined in solution in order to understand their interplay with the glucokinase function. Initial velocity studies indicate that catalysis follows a sequential ordered mechanism that correlates with the structural transitions experienced by the enzyme in solution and in the crystal state. The combined data allowed us to resolve the open-closed conformational transition that accounts for the complete reaction cycle and to identify the corresponding clusters of aminoacids residues responsible for it. These results provide molecular bases for a general mechanism conserved across the ADP-dependent kinase family.	[Andres Rivas-Pardo, Jaime; Herrera-Morande, Alejandra; Castro-Fernandez, Victor; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Herrera-Morande, Alejandra; Fernandez, Francisco J.; Cristina Vega, M.] CSIC, Ctr Invest Biol, Madrid, Spain	Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Vega, MC (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	cvega@cib.csic.es; vguixe@uchile.cl	Guixe, Victoria/I-1126-2013; Castro-Fernandez, Victor/K-9621-2018; Fernandez, Francisco J./C-3647-2011; Vega, M. Cristina/C-3640-2011	Guixe, Victoria/0000-0001-9643-1339; Castro-Fernandez, Victor/0000-0002-4309-6415; Herrera-Morande, Alejandra/0000-0002-4140-0743; Fernandez, Francisco J./0000-0002-5015-1849; Rivas Pardo, Andres/0000-0002-8304-3238; Vega, M. Cristina/0000-0003-0628-8378	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1110137]; Spanish Ministry of Science and Innovation [PET2008_0101, BIO2009-11184, BFU2010-22260-C02-02]; EC [279039]; LNLS (Laboratorio Nacional de Luz Sincrotron), Sao Paulo, Brazil; Departamento de Postgrado y Postitulo, Universidad de Chile; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; Universitat de Barcelona	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EC(European CommissionEuropean Commission Joint Research Centre); LNLS (Laboratorio Nacional de Luz Sincrotron), Sao Paulo, Brazil; Departamento de Postgrado y Postitulo, Universidad de Chile; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile; Universitat de Barcelona	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT grant 1110137 to V.G, Spanish Ministry of Science and Innovation grants PET2008_0101, BIO2009-11184 and BFU2010-22260-C02-02 and the EC project ComplexINC (Framework Programme 7 (FP7) under grant agreement no. 279039) to M.C.V. The SAXS measurements (SAXS1 and SAXS2 beamlines) were supported by LNLS (Laboratorio Nacional de Luz Sincrotron), Sao Paulo, Brazil, to V.G. and J.A.R-P. We also thank the Departamento de Postgrado y Postitulo, Universidad de Chile by the support given to J.A.R-P to accomplish the SAXS studies in Sao Paulo. J.A.R-P and V.C-F are PhD fellowship from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile. A.H-M. acknowledges the support of the PhD program in Molecular Biotechnology of the Universitat de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Cleland W. W, 1970, ENZYMES, V2, P1; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cornish-Bowden A, 2011, FUNDAMENTALS ENZYME; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dougherty DA, 2012, ACCOUNTS CHEM RES; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gromiha MM, 2002, PREP BIOCHEM BIOTECH, V32, P355, DOI 10.1081/PB-120015459; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kumar S, 2000, PROTEIN SCI, V9, P10; Mahadevi AS, 2013, CHEM REV, V113, P2100, DOI 10.1021/cr300222d; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merino F, 2012, BIOCHIMIE, V94, P516, DOI 10.1016/j.biochi.2011.08.021; Minoux H, 1999, J AM CHEM SOC, V121, P10366, DOI 10.1021/ja990914p; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Pecsi I, 2010, NUCLEIC ACIDS RES, V38, P7179, DOI 10.1093/nar/gkq584; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Reddy MCM, 2007, J BIOL CHEM, V282, P27334, DOI 10.1074/jbc.M703290200; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakuraba H, 2004, CHEM REC, V3, P281, DOI 10.1002/tcr.10066; Sakuraba H, 2002, J BIOSCI BIOENG, V93, P441, DOI 10.1263/jbb.93.441; Schumacher MA, 2000, J MOL BIOL, V296, P549, DOI 10.1006/jmbi.1999.3474; Sigrell JA, 1999, J MOL BIOL, V290, P1009, DOI 10.1006/jmbi.1999.2938; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; Varga A, 2006, FEBS LETT, V580, P2698, DOI 10.1016/j.febslet.2006.04.024; Vertessy BG, 2011, BIOESSAYS, V33, P30, DOI 10.1002/bies.201000068; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Vondrasek J, 2009, J PHYS CHEM B, V113, P9041, DOI 10.1021/jp902377q; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zerrad L, 2011, J BIOL CHEM, V286, P14040, DOI 10.1074/jbc.M110.206813; Zhang Y, 2004, STRUCTURE, V12, P1809, DOI 10.1016/j.str.2004.07.020	48	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66687	10.1371/journal.pone.0066687	http://dx.doi.org/10.1371/journal.pone.0066687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818958	Green Submitted, gold, Green Published			2022-12-27	WOS:000322342800095
J	Lovati, AB; Drago, L; Monti, L; De Vecchi, E; Previdi, S; Banfi, G; Romano, CL				Lovati, Arianna B.; Drago, Lorenzo; Monti, Lorenzo; De Vecchi, Elena; Previdi, Sara; Banfi, Giuseppe; Romano, Carlo L.			Diabetic Mouse Model of Orthopaedic Implant-Related Staphylococcus Aureus Infection	PLOS ONE			English	Article							OSTEOMYELITIS; ARTHROPLASTY; MICE; VANCOMYCIN; BONE; HIP; HYDROXYAPATITE; EPIDEMIOLOGY; PATHOGENESIS; DEBRIDEMENT	Background: Periprosthetic bacterial infections represent one of the most challenging orthopaedic complications that often require implant removal and surgical debridement and carry high social and economical costs. Diabetes is one of the most relevant risk factors of implant-related infection and its clinical occurrence is growing worldwide. The aim of the present study was to test a model of implant-related infection in the diabetic mouse, with a view to allow further investigation on the relative efficacy of prevention and treatment options in diabetic and non-diabetic individuals. Methodology: A cohort of diabetic NOD/ShiLtJ mice was compared with non-diabetic CD1 mice as an in vivo model of S. aureus orthopaedic infection of bone and soft tissues after femur intramedullary pin implantation. We tested control and infected groups with 1 x 10(3) colony-forming units of S. aureus ATCC 25923 strain injected in the implant site. At 4 weeks post-inoculation, host response to infection, microbial biofilm formation, and bone damage were assessed by traditional diagnostic parameters (bacterial culture, C-reactive protein and white blood cell count), histological analysis and imaging techniques (micro computed tomography and scanning electron microscopy). Results: Unlike the controls and the CD1 mice, all the diabetic mice challenged with a single inoculum of S. aureus displayed severe osteomyelitic changes around the implant. Conclusions: Our findings demonstrate for the first time that the diabetic mouse can be successfully used in a model of orthopaedic implant-related infection. Furthermore, the same bacteria inoculum induced periprosthetic infection in all the diabetic mice but not in the controls. This animal model of implant-related infection in diabetes may be a useful tool to test in vivo treatments in diabetic and non-diabetic individuals.	[Lovati, Arianna B.] Grp Osped San Donato Fdn, Cell & Tissue Engn Lab, Milan, Italy; [Drago, Lorenzo; De Vecchi, Elena] IRCCS Galeazzi Orthopaed Inst, Lab Clin Chem & Microbiol, Milan, Italy; [Drago, Lorenzo; Banfi, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Monti, Lorenzo; Romano, Carlo L.] IRCCS Galeazzi Orthopaed Inst, Dipartimento Chirurg Ricostrutt & Infez Osteoarti, Milan, Italy; [Previdi, Sara] Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Canc Cachexia AIRC Start Up, Milan, Italy; [Banfi, Giuseppe] IRCCS Galeazzi Orthopaed Inst, Lab Expt Biochem & Mol Biol, Milan, Italy	IRCCS Policlinico San Donato; IRCCS Istituto Ortopedico Galeazzi; University of Milan; IRCCS Istituto Ortopedico Galeazzi; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Ortopedico Galeazzi	Lovati, AB (corresponding author), Grp Osped San Donato Fdn, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposandonato.it	Monti, Lorenzo/AAB-2967-2020; De Vecchi, Elena/B-8209-2017; Lovati, Arianna Barbara/J-8213-2016; ROMANO, CARLO LUCA/C-4310-2017; Banfi, Giuseppe/K-6585-2015	De Vecchi, Elena/0000-0001-9781-8607; Lovati, Arianna Barbara/0000-0002-5230-9718; ROMANO, CARLO LUCA/0000-0001-6726-0593; Lorenzo, Drago/0000-0002-5206-540X; Banfi, Giuseppe/0000-0001-9578-5338	Italian Ministry of Health; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was funded by the Italian Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035; Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Boulton AJM, 2004, NEW ENGL J MED, V351, P48, DOI 10.1056/NEJMcp032966; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; BUTT WP, 1973, CLIN ORTHOP RELAT R, P20; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; Cierny G, 2003, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000088564.81746.62; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Deirmengian C, 2003, J ARTHROPLASTY, V18, P22, DOI 10.1016/S0883-5403(03)00288-2; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Facchiano F, 2002, AM J PATHOL, V161, P531, DOI 10.1016/S0002-9440(10)64209-5; Follak N, 2005, DIABETES-METAB RES, V21, P288, DOI 10.1002/dmrr.537; Fujimura S, 2009, J ORTHOP SCI, V14, P658, DOI 10.1007/s00776-009-1366-3; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; Giavaresi G, 2008, J ORTHOP RES, V26, P785, DOI 10.1002/jor.20543; Guglielmo BJ, 2000, CLIN INFECT DIS, V30, P205, DOI 10.1086/313620; Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506; Jamsen Esa, 2012, J Bone Joint Surg Am, V94, pe101, DOI 10.2106/JBJS.J.01935; Kaya M, 2012, OR SURG OR MED OR PA, V113, P340, DOI 10.1016/j.tripleo.2011.03.032; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Lankinen P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-41; Le Nga N, 2011, J Diabetes Sci Technol, V5, P605; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452; Liu Y, 2012, BIOMATERIALS, V33, P8745, DOI 10.1016/j.biomaterials.2012.08.010; Liu ZD, 2007, ACTA ORTHOP, V78, P46, DOI 10.1080/17453670610013411; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; MARUYAMA T, 1988, DIABETES RES CLIN EX, V7, P93; Mazza A, 2000, J Chemother, V12 Suppl 3, P29; Parvizi Javad, 2010, Orthopedics, V33, P659, DOI 10.3928/01477447-20100722-42; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Pettersson US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022480; PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Romano CL, 2012, HIP INT, V22, pS46, DOI 10.5301/HIP.2012.9570; Romano Carlo Luca, 2011, Eur Orthop Traumatol, V1, P207; Romano CL, 2010, J ORTHOP TRAUMATOL, V11, P167, DOI 10.1007/s10195-010-0106-y; Rubinstein R, 2008, CLIN EXP IMMUNOL, V154, P235, DOI 10.1111/j.1365-2249.2008.03742.x; Sheagren JN, 1997, STAPHYLOCOCCI HUMAN, P565; Spatz M, 2003, CELL IMMUNOL, V221, P15, DOI 10.1016/S0008-8749(03)00043-1; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stewart S, 2012, J BONE JOINT SURG AM, V94A, P1406, DOI 10.2106/JBJS.K.00886; Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf; TATER D, 1987, HORM METAB RES, V19, P642, DOI 10.1055/s-2007-1011899; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Urquhart DM, 2010, J ARTHROPLASTY, V25, P1216, DOI 10.1016/j.arth.2009.08.011; Veronelli A, 2004, DIABETES CARE, V27, P2501, DOI 10.2337/diacare.27.10.2501; Viens Nicholas A, 2012, J Surg Orthop Adv, V21, P253; Wu HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-172	59	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67628	10.1371/journal.pone.0067628	http://dx.doi.org/10.1371/journal.pone.0067628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818985	Green Submitted, gold, Green Published			2022-12-27	WOS:000322342800142
J	Trotta, N; Goldman, S; Legros, B; Baete, K; Van Laere, K; Van Bogaert, P; De Tiege, X				Trotta, Nicola; Goldman, Serge; Legros, Benjamin; Baete, Kristof; Van Laere, Koen; Van Bogaert, Patrick; De Tiege, Xavier			Changes in Functional Integration with the Non-Epileptic Temporal Lobe of Patients with Unilateral Mesiotemporal Epilepsy	PLOS ONE			English	Article							INTERICTAL GLUCOSE HYPOMETABOLISM; HIPPOCAMPAL SCLEROSIS; EMOTION RECOGNITION; DECISION-MAKING; FDG-PET; CONNECTIVITY; METABOLISM; MEMORY; BRAIN; LOBECTOMY	Purpose: To investigate epilepsy-induced changes in effective connectivity between the non-epileptic amygdalo-hippocampal complex (AHC) and the rest of the brain in patients with unilateral mesiotemporal lobe epilepsy (MTLE) associated with hippocampal sclerosis (HS). Methods: Thirty-three patients with unilateral MTLE associated with HS (20 females, mean age: 36 years, 19 left HS) and 33 adult controls matched for age and gender underwent F-18-Fluorodeoxyglucose positron emission tomography (FDG-PET). Right-HS patients' FDG-PET data were flipped to obtain a left-epileptic-focus-lateralized group of patients. Voxels of interest (VOI) were selected within the cytoarchitectonic probabilistic maps of the non-epileptic AHC (probability level = 100%, SPM8 Anatomy toolbox v1.7). Patients and controls were compared using VOI metabolic activity as covariate of interest to search for epilepsy-induced changes in the contribution of the non-epileptic AHC to the level of metabolic activity in other brain areas. Age, gender, duration of epilepsy, seizure type and frequency were used as covariates of no-interest for connectivity analyses. Key findings: Significant decrease in effective connectivity was found between the non-epileptic AHC and ventral prefrontal cortical areas bilaterally, as well as with the temporal pole and the posterior cingulate cortex contralateral to HS. Significant increase in connectivity was found between the non-epileptic AHC and midline structures, such as the anterior cingulate and dorsal medial prefrontal cortices, as well as the temporo-parietal junction bilaterally. Connectivity analyses also revealed a preserved positive connectivity between the non-epileptic and the epileptic AHC in the patients' group. Significance: This study evidences epilepsy-induced changes in connectivity between the non-epileptic AHC and some limbic and default mode network areas. These changes in connectivity probably account for emotional, cognitive and decision-making impairments frequently observed in MTLE patients. The preserved neurometabolic connectivity between the non-epileptic and the epileptic AHC in MTLE patients is pivotal to explain the epilepsy-induced changes found in this study.	[Trotta, Nicola; Goldman, Serge; Van Bogaert, Patrick; De Tiege, Xavier] Univ Libre Brussels, Hop Erasme, Lab Cartog Fonct Cerveau, Brussels, Belgium; [Trotta, Nicola; Goldman, Serge] Univ Libre Brussels, Hop Erasme, Dept Nucl Med, Brussels, Belgium; [Legros, Benjamin; Van Bogaert, Patrick] Univ Libre Brussels, Hop Erasme, Reference Ctr Refractory Epilepsy, Brussels, Belgium; [Baete, Kristof; Van Laere, Koen] UZ Leuven, Dept Nucl Med, Louvain, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven	Trotta, N (corresponding author), Univ Libre Brussels, Hop Erasme, Lab Cartog Fonct Cerveau, Brussels, Belgium.	ntrotta@ulb.ac.be	Baete, Kristof/AAI-6051-2021	Baete, Kristof/0000-0003-0113-1590; De Tiege, Xavier/0000-0003-0127-089X; Goldman, Serge/0000-0002-9917-8735	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium)	Fonds de la Recherche Scientifique (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS)	XDT is "clinicien-chercheur specialiste" at the Fonds de la Recherche Scientifique (FRS-FNRS, Belgium, http://www.fnrs.be/). KVL is senior clinical researcher at the FWO (Fonds voor Wetenschappelijk Onderzoek, Belgium, http://www.fwo.be/). This study was supported by a research grant of the Fonds de la Recherche Scientifique (FRS-FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Arnold S, 1996, NEUROLOGY, V46, P1422, DOI 10.1212/WNL.46.5.1422; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bonatti E, 2009, EPILEPSY BEHAV, V14, P665, DOI 10.1016/j.yebeh.2009.02.015; Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x; Boucsein K, 2001, NEUROPSYCHOLOGIA, V39, P231, DOI 10.1016/S0028-3932(00)00117-2; Brix G, 1997, J NUCL MED, V38, P1614; Broicher SD, 2012, NEUROPSYCHOLOGIA, V50, P118, DOI 10.1016/j.neuropsychologia.2011.11.005; BRUEHL C, 1995, ANN NEUROL, V38, P414, DOI 10.1002/ana.410380311; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Campo P, 2012, CEREB CORTEX, V22, P1225, DOI 10.1093/cercor/bhr201; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; De Tiege X, 2004, NEUROLOGY, V63, P853, DOI 10.1212/01.WNL.0000137015.04054.2C; Delazer M, 2010, NEUROPSYCHOLOGIA, V48, P194, DOI 10.1016/j.neuropsychologia.2009.08.025; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Getz K, 2002, AM J PSYCHIAT, V159, P644, DOI 10.1176/appi.ajp.159.4.644; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; HENRY TR, 1990, J CEREBR BLOOD F MET, V10, P748, DOI 10.1038/jcbfm.1990.128; Hermann B, 1995, J CLIN EXP NEUROPSYC, V17, P809, DOI 10.1080/01688639508402430; Iversen S., 2000, PRINCIPLES NEURAL SC, V4, P982; Jokeit H, 1997, BRAIN, V120, P2283, DOI 10.1093/brain/120.12.2283; Joo EY, 2005, BRAIN, V128, P1802, DOI 10.1093/brain/awh534; Juhasz H, 2011, NEUROIMAGING EPILEPS, P146; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Labudda K, 2009, NEUROPSYCHOLOGIA, V47, P50, DOI 10.1016/j.neuropsychologia.2008.08.014; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Ligot N, 2011, J CEREBR BLOOD F MET, V31, P41, DOI 10.1038/jcbfm.2010.186; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; McClelland S, 2006, EPILEPSIA, V47, P1337, DOI 10.1111/j.1528-1167.2006.00557.x; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Morgan VL, 2011, EPILEPSIA, V52, P1741, DOI 10.1111/j.1528-1167.2011.03196.x; Nelissen N, 2006, NEUROIMAGE, V32, P684, DOI 10.1016/j.neuroimage.2006.04.185; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU, P361; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Powell HWR, 2007, EPILEPSIA, V48, P1512, DOI 10.1111/j.1528-1167.2007.01053.x; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; Rubin E, 1995, NEUROLOGY, V45, P2212, DOI 10.1212/WNL.45.12.2212; Salzberg M, 2006, EPILEPSIA, V47, P2125, DOI 10.1111/j.1528-1167.2006.00860.x; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Schwartz TH, 2001, NAT MED, V7, P1063, DOI 10.1038/nm0901-1063; Shaw P, 2007, NEUROPSYCHOLOGIA, V45, P2783, DOI 10.1016/j.neuropsychologia.2007.04.020; SPERLING MR, 1990, EPILEPSIA, V31, P145, DOI 10.1111/j.1528-1167.1990.tb06299.x; Stephan KE, 2007, NEUROPSYCHOLOGIA, V45, P209, DOI 10.1016/j.neuropsychologia.2006.07.002; Takaya S, 2009, BRAIN, V132, P185, DOI 10.1093/brain/awn218; THEODORE WH, 1992, ANN NEUROL, V32, P789, DOI 10.1002/ana.410320613; Thivard L, 2005, NEUROIMAGE, V24, P841, DOI 10.1016/j.neuroimage.2004.10.001; Trotta N, 2011, EPILEPSIA, V52, P2003, DOI 10.1111/j.1528-1167.2011.03271.x; Van Bogaert P, 2000, NEUROIMAGE, V12, P129, DOI 10.1006/nimg.2000.0606; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Zhang ZQ, 2010, BRAIN RES, V1323, P152, DOI 10.1016/j.brainres.2010.01.042	62	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67053	10.1371/journal.pone.0067053	http://dx.doi.org/10.1371/journal.pone.0067053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818976	Green Published, gold			2022-12-27	WOS:000322342800115
J	Wang, Q; Wang, CY; Mu, CK; Wu, HF; Zhang, LB; Zhao, JM				Wang, Qing; Wang, Chunyan; Mu, Changkao; Wu, Huifeng; Zhang, Linbao; Zhao, Jianmin			A Novel C-Type Lysozyme from Mytilus galloprovincialis: Insight into Innate Immunity and Molecular Evolution of Invertebrate C-Type Lysozymes	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; EXPRESSION ANALYSIS; DROSOPHILA-MELANOGASTER; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; SHRIMP LYSOZYME; GENE-EXPRESSION; SALIVARY-GLANDS; LYTIC ACTIVITY; BOMBYX-MORI	A c-type lysozyme (named as MgCLYZ) gene was cloned from the mussel Mytilus galloprovincialis. Blast analysis indicated that MgCLYZ was a salivary c-type lysozyme which was mainly found in insects. The nucleotide sequence of MgCLYZ was predicted to encode a polypeptide of 154 amino acid residues with the signal peptide comprising the first 24 residues. The deduced mature peptide of MgCLYZ was of a calculated molecular weight of 14.4 kD and a theoretical isoelectric point (pI) of 8.08. Evolution analysis suggested that bivalve branch of the invertebrate c-type lysozymes phylogeny tree underwent positive selection during evolution. By quantitative real-time RT-PCR (qRT-PCR) analysis, MgCLYZ transcript was widely detected in all examined tissues and responded sensitively to bacterial challenge in hemocytes and hepatopancreas. The optimal temperature and pH of recombinant MgCLYZ (rMgCLYZ) were 20 degrees C and 4, respectively. The rMgCLYZ displayed lytic activities against Gram-positive bacteria including Micrococcus luteus and Staphyloccocus aureus, and Gram-negative bacteria including Vibrio anguillarum, Enterobacter cloacae, Pseudomonas putida, Proteus mirabilis and Bacillus aquimaris. These results suggest that MgCLYZ perhaps play an important role in innate immunity of M. galloprovincialis, and invertebrate c-type lysozymes might be under positive selection in a species-specific manner during evolution for undergoing adaptation to different environment and diverse pathogens.	[Wang, Qing; Wu, Huifeng; Zhang, Linbao; Zhao, Jianmin] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc & Ecol Remedia, Yantai, Peoples R China; [Wang, Chunyan; Mu, Changkao] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Ningbo University	Wu, HF (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc & Ecol Remedia, Yantai, Peoples R China.	hfwu@yic.ac.cn; jmzhao@yic.ac.cn	Wang, Qing/O-1991-2013; Wu, Huifeng/E-4886-2016	Wang, Qing/0000-0002-5180-5154; Wu, Huifeng/0000-0002-4042-8103	NSFC [31172388]; 100 Talents Program of the Chinese Academy of Sciences; Department of Science and Technology of Yantai City [2011067]	NSFC(National Natural Science Foundation of China (NSFC)); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Science and Technology of Yantai City(Department of Science & Technology (India))	This work was supported by grant from NSFC (31172388), the 100 Talents Program of the Chinese Academy of Sciences and the Department of Science and Technology of Yantai City (2011067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ABRAHAM EG, 1995, J INVERTEBR PATHOL, V65, P17, DOI 10.1006/jipa.1995.1003; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Canesi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019803; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; de-la-Re-Vega E, 2006, FISH SHELLFISH IMMUN, V20, P405, DOI 10.1016/j.fsi.2005.06.005; Ding JF, 2011, FISH SHELLFISH IMMUN, V30, P163, DOI 10.1016/j.fsi.2010.10.008; Fujimoto S, 2001, COMP BIOCHEM PHYS B, V128, P709, DOI 10.1016/S1096-4959(00)00368-7; Fujita A, 2002, INSECT BIOCHEM MOLEC, V32, P1615, DOI 10.1016/S0965-1748(02)00100-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herreweghe J.M., 2012, J BIOSCIENCE, V37, P327; Hikima S, 2003, GENE, V316, P187, DOI 10.1016/S0378-1119(03)00761-3; Hultmark D, 1996, LYSOZYMES MODEL ENZY, V75, P87; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kaizu A, 2011, J BIOL CHEM, V286, P44344, DOI 10.1074/jbc.M111.292672; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; KYLSTEN P, 1992, MOL GEN GENET, V232, P335, DOI 10.1007/BF00266235; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lynn DJ, 2004, MOL BIOL EVOL, V21, P819, DOI 10.1093/molbev/msh084; MAENAKA K, 1994, J BIOL CHEM, V269, P7070; Mai WJ, 2010, FISH SHELLFISH IMMUN, V28, P727, DOI 10.1016/j.fsi.2010.01.002; Mai WJ, 2009, MOL BIOL REP, V36, P1587, DOI 10.1007/s11033-008-9355-8; Mai WJ, 2009, PROG NAT SCI-MATER, V19, P837, DOI 10.1016/j.pnsc.2008.10.008; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Moreira-Ferro CK, 1998, INSECT MOL BIOL, V7, P257, DOI 10.1111/j.1365-2583.1998.00067.x; MURAKI M, 1992, BIOCHEMISTRY-US, V31, P9212, DOI 10.1021/bi00153a014; NITTA K, 1987, FEBS LETT, V223, P405, DOI 10.1016/0014-5793(87)80328-9; Pan Bao-Ping, 2010, Oceanologia et Limnologia Sinica, V41, P901; PRAGER EM, 1996, LYSOZYMES MODEL ENZY, P323; Ren Q, 2009, J GENET GENOMICS, V36, P7, DOI 10.1016/S1673-8527(09)60002-3; Shen T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-39; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soderhall K, 1999, DEV COMP IMMUNOL, V23, P263; Song LS, 2010, ADV EXP MED BIOL, V708, P44; Supungul P, 2010, FISH SHELLFISH IMMUN, V28, P490, DOI 10.1016/j.fsi.2010.01.003; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045148; Wang Q, 2010, AQUAT TOXICOL, V100, P321, DOI 10.1016/j.aquatox.2010.08.012; Wang WX, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1701; Wei SN, 2012, FISH SHELLFISH IMMUN, V33, P186, DOI 10.1016/j.fsi.2012.03.027; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388; Xue QG, 2004, COMP BIOCHEM PHYS B, V139, P11, DOI 10.1016/j.cbpc.2004.05.011; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye X, 2010, DEV COMP IMMUNOL, V34, P501, DOI 10.1016/j.dci.2009.12.009; Ye X, 2009, MOL BIOL REP, V36, P1239, DOI 10.1007/s11033-008-9303-7; Yu KH, 2002, DEV COMP IMMUNOL, V26, P707, DOI 10.1016/S0145-305X(02)00027-7; Yu LP, 2013, FISH SHELLFISH IMMUN, V34, P46, DOI 10.1016/j.fsi.2012.10.007; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zhu S, 2008, CELL MOL LIFE SCI, V65, P1285, DOI 10.1007/s00018-008-8070-x	55	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67469	10.1371/journal.pone.0067469	http://dx.doi.org/10.1371/journal.pone.0067469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818979	Green Published, gold			2022-12-27	WOS:000322342800136
J	Koepfli, C; Timinao, L; Antao, T; Barry, AE; Siba, P; Mueller, I; Felger, I				Koepfli, Cristian; Timinao, Lincoln; Antao, Tiago; Barry, Alyssa E.; Siba, Peter; Mueller, Ivo; Felger, Ingrid			A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; SULFADOXINE-PYRIMETHAMINE; GENETIC DIVERSITY; DRUG-RESISTANCE; SOLOMON-ISLANDS; MALARIA; FALCIPARUM; INFECTIONS; TRANSMISSION; CHLOROQUINE	Introduction: The importance of Plasmodium vivax in malaria elimination is increasingly being recognized, yet little is known about its population size and population genetic structure in the South Pacific, an area that is the focus of intensified malaria control. Methods: We have genotyped 13 microsatellite markers in 295 P. vivax isolates from four geographically distinct sites in Papua New Guinea (PNG) and one site from Solomon Islands, representing different transmission intensities. Results: Diversity was very high with expected heterozygosity values ranging from 0.62 to 0.98 for the different markers. Effective population size was high (12'872 to 19'533 per site). In PNG population structuring was limited with moderate levels of genetic differentiation. F-ST values (adjusted for high diversity of markers) were 0.14-0.15. Slightly higher levels were observed between PNG populations and Solomon Islands (F-ST = 0.16). Conclusions: Low levels of population structure despite geographical barriers to transmission are in sharp contrast to results from regions of low P. vivax endemicity. Prior to intensification of malaria control programs in the study area, parasite diversity and effective population size remained high.	[Koepfli, Cristian; Timinao, Lincoln; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Koepfli, Cristian; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Timinao, Lincoln; Siba, Peter] PNG Inst Med Res, Goroka, Papua N Guinea; [Antao, Tiago] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England; [Koepfli, Cristian; Barry, Alyssa E.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic, Australia; [Barry, Alyssa E.; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; PNG Institute Of Medical Research; University of Cambridge; Walter & Eliza Hall Institute; University of Melbourne; ISGlobal; CRESIB	Felger, I (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	ingrid.felger@unibas.ch	Koepfli, Cristian/H-8772-2019; Antao, Tiago/C-3615-2009	Koepfli, Cristian/0000-0002-9354-0414; Antao, Tiago/0000-0002-7269-5513; Barry, Alyssa/0000-0002-1189-2310; Felger, Ingrid/0000-0003-1255-2606	Swiss National Science Foundation [320030-125316/1, 310030-134889/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (www.snf.ch, grant numbers: 320030-125316/1, 310030-134889/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers MP, 1992, HUMAN BIOL PAPUA NEW, Vxiii; Anderson TJC, 2000, MOL ECOL, V9, P1599, DOI 10.1046/j.1365-294x.2000.01057.x; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Antao T, 2011, EVOL APPL, V4, P144, DOI 10.1111/j.1752-4571.2010.00150.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Ballif M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-270; Barnadas C, 2011, ANTIMICROB AGENTS CH, V55, P4479, DOI 10.1128/AAC.01552-10; Beaumont MA, 1996, P ROY SOC LOND B BIO, V263, P8; Buckee CO, 2010, ADV EXP MED BIOL, V673, P112; Cammack N, 2011, SCIENCE, V333, P705, DOI 10.1126/science.1210875; De Castro MC, 2005, J ARCHAEOL SCI, V32, P4; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hunt P, 2005, MOL BIOCHEM PARASIT, V143, P173, DOI 10.1016/j.molbiopara.2005.05.014; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Iwagami M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-96; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; KOEPFLI C, 2008, J INFECT DIS; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Marfurt J, 2007, AM J TROP MED HYG, V77, P947, DOI 10.4269/ajtmh.2007.77.947; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mueller I, 2002, AM J TROP MED HYG, V67, P459, DOI 10.4269/ajtmh.2002.67.459; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Mueller Ivo, 2004, Papua New Guinea Medical Journal, V47, P159; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Susomboon P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-212; Talisuna AO, 2003, INT J PARASITOL, V33, P1051, DOI 10.1016/S0020-7519(03)00156-5; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WHO, 2011, WORLD MALARIA REPORT 2011, P1	53	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66041	10.1371/journal.pone.0066041	http://dx.doi.org/10.1371/journal.pone.0066041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823758	Green Published, Green Accepted, gold			2022-12-27	WOS:000320576400048
J	Li, ZQ				Li, Zhongqiu			Sex-Age Related Rumination Behavior of Pere David's Deer under Constraints of Feeding Habitat and Rainfall	PLOS ONE			English	Article							BODY-SIZE; PHYSICAL STRUCTURE; CHEWING BEHAVIOR; ACTIVITY BUDGETS; OVIS-CANADENSIS; RUMINANTS; FORAGE; CATTLE; TIME; DIGESTIBILITY	Extensive studies have been conducted on the rumination behavior of domestic herbivores. However, studies on wild animals are limited, particularly wild animals with specific ruminating parameters. In this study, Pere David's deer, a previously extirpated species, was observed to analyze the effects of sex-age, feeding habitat, and rainfall on rumination behavior in the Dafeng Nature Reserve, China. Rumination behavior was investigated based on four parameters: proportion of bedding time spent chewing, bolus processing time (s/bolus), chewing frequency (chews/bolus), and chewing rate (chews/s). Results showed that all three factors affect rumination behavior. The extent of their effects varied based on the four rumination parameters. Chewing rate and frequency decreased based on sex-age levels, i.e., from fawns to juvenile female, juvenile male, adult female, stag, and harem holder. Therefore, body size played a major role in shaping rumination behavior. Deer found in grasslands could chew faster compared with deer found in woodlands. This result might be caused by the effects of dietary composition and sunlight intensity. A deer spends a longer time ruminating while bedding during rainy days compared with rainless days to maximize energy and nutrition intake and compensate for the loss of feeding time during rainy days. Therefore, rumination behavior is plastic and is shaped by intrinsic and extrinsic factors.	Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Li, ZQ (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	lizq0314@gmail.com	Li, Zhong-qiu/A-1748-2011	Li, Zhong-qiu/0000-0003-2004-293X	National Natural Science Foundation of China [31000174, J1103512]; National Nature Reserve Remote Sense Investigation and Assessment [STSN-7]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Reserve Remote Sense Investigation and Assessment; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Financial support for this work was provided by the National Natural Science Foundation of China (numbers 31000174 and J1103512), National Nature Reserve Remote Sense Investigation and Assessment during 2000-2010 (number STSN-7) and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth JAW, 2012, AGR ECOSYST ENVIRON, V155, P105, DOI 10.1016/j.agee.2012.04.005; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; BLACKSHAW JK, 1994, AUST J EXP AGR, V34, P285, DOI 10.1071/EA9940285; Blanchard P, 2005, J ZOOL, V265, P107, DOI 10.1017/S0952836904006077; Blanchard P, 2008, WILDLIFE BIOL, V14, P372, DOI 10.2981/0909-6396(2008)14[372:SVIRPO]2.0.CO;2; BUTRIS GY, 1987, GRASS FORAGE SCI, V42, P259, DOI 10.1111/j.1365-2494.1987.tb02114.x; Chumpawadee S, 2009, J ANIM VET ADV, V8, P2038; Das N, 1999, SMALL RUMINANT RES, V32, P129, DOI 10.1016/S0921-4488(98)00175-8; DEBOEVER JL, 1990, ANIM FEED SCI TECH, V27, P281, DOI 10.1016/0377-8401(90)90143-V; Ding Y, 2004, CHINESE MILU RES, P92; Ding Y, 2004, CHINESE MILU RES, P112; du Toit JT, 2005, OECOLOGIA, V143, P317, DOI 10.1007/s00442-004-1789-7; GORDON JG, 1970, J AGR SCI-CAMBRIDGE, V74, P291, DOI 10.1017/S0021859600022905; GRANT RJ, 1990, J DAIRY SCI, V73, P3158, DOI 10.3168/jds.S0022-0302(90)79005-4; GROSS JE, 1995, FUNCT ECOL, V9, P385, DOI 10.2307/2390001; Hamel S, 2008, ANIM BEHAV, V75, P217, DOI 10.1016/j.anbehav.2007.04.028; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jiang Z, 2011, MILU BIODIVERSITY DA, P75; Jiang ZG, 2000, WILDLIFE SOC B, V28, P681; Jiang Zhi-Gang, 2004, Acta Zoologica Sinica, V50, P706; Julien KC, 1996, ARCH ORAL BIOL, V41, P69, DOI 10.1016/0003-9969(95)00098-4; Li C, 2007, ZOO BIOL, V26, P461, DOI 10.1002/zoo.20132; Li CW, 2001, HORM BEHAV, V40, P518, DOI 10.1006/hbeh.2001.1711; Liang C, 1991, FOREST SCI, V27, P425; Mellado M, 2005, SMALL RUMINANT RES, V57, P105, DOI 10.1016/j.smallrumres.2004.03.009; MEYER RM, 1964, J DAIRY SCI, V47, P1339, DOI 10.3168/jds.S0022-0302(64)88915-3; Moquin P, 2010, ANIM BEHAV, V79, P1047, DOI 10.1016/j.anbehav.2010.01.020; Mysterud A, 1998, OECOLOGIA, V113, P442, DOI 10.1007/s004420050396; OAKES EJ, 1992, CAN J ZOOL, V70, P605, DOI 10.1139/z92-089; Oshiro S, 1996, SMALL RUMINANT RES, V22, P97, DOI 10.1016/S0921-4488(96)00886-3; Pelletier F, 2004, BEHAV ECOL SOCIOBIOL, V56, P546, DOI 10.1007/s00265-004-0820-7; Perez-Barberia FJ, 2008, OECOLOGIA, V157, P21, DOI 10.1007/s00442-008-1056-4; Perez-Barberia FJ, 1998, J ZOOL, V245, P307, DOI 10.1111/j.1469-7998.1998.tb00106.x; Perez-Barberia FJ, 1998, BIOL J LINN SOC, V63, P233, DOI 10.1111/j.1095-8312.1998.tb01516.x; SHIPLEY LA, 1994, AM NAT, V143, P1055, DOI 10.1086/285648; SPALINGER DE, 1986, CAN J ZOOL, V64, P312, DOI 10.1139/z86-051; THOMAS JW, 1961, J DAIRY SCI, V44, P1471, DOI 10.3168/jds.S0022-0302(61)89909-8; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WILSON JR, 1994, J AGR SCI, V122, P173, DOI 10.1017/S0021859600087347; Yu Changqing, 1996, Acta Theriologica Sinica, V16, P19; Yu S, 2011, MILU BIODIVERSITY DA, P18; Zeng Yan, 2004, Acta Theriologica Sinica, V24, P78; Zheng W, 2013, CURR ZOOL, V59, P265, DOI 10.1093/czoolo/59.2.265	43	7	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66261	10.1371/journal.pone.0066261	http://dx.doi.org/10.1371/journal.pone.0066261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823072	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400073
J	Nassim, R; Mansure, JJ; Chevalier, S; Cury, F; Kassouf, W				Nassim, Roland; Mansure, Jose Joao; Chevalier, Simone; Cury, Fabio; Kassouf, Wassim			Combining mTOR Inhibition with Radiation Improves Antitumor Activity in Bladder Cancer Cells In Vitro and In Vivo: A Novel Strategy for Treatment	PLOS ONE			English	Article							CONCURRENT CISPLATIN; IONIZING-RADIATION; MAMMALIAN TARGET; KINASE-ACTIVITY; BREAST-CANCER; DNA-DAMAGE; HELA-CELLS; X-RAY; PATHWAY; CYCLE	Purpose: Radiation therapy for invasive bladder cancer allows for organ preservation but toxicity and local control remain problematic. As such, improving efficacy of treatment requires radiosensitization of tumor cells. The aim of study is to investigate if the mammalian Target of Rapamycin (mTOR), a downstream kinase of the phosphatidylinositol 3-kinase (PI3K)/AKT survival pathway, may be a target for radiation sensitization. Experimental Design: Clonogenic assays were performed using 6 bladder cancer cell lines (UM-UC3, UM-UC5, UM-UC6, KU7, 253J-BV, and 253-JP) in order to examine the effects of ionizing radiation (IR) alone and in combination with RAD001, an mTOR inhibitor. Cell cycle analysis was performed using flow cytometry. In vivo, athymic mice were subcutaneously injected with 2 bladder cancer cell lines. Treatment response with RAD001 (1.5 mg/kg, daily), fractionated IR (total 9Gy = 3Gyx3), and combination of RAD001 and IR was followed over 4 weeks. Tumor weight was measured at experimental endpoint. Results: Clonogenic assays revealed that in all bladder cell lines tested, an additive effect was observed in the combined treatment when compared to either treatment alone. Our data indicates that this effect is due to arrest in both G1 and G2 phases of cell cycle when treatments are combined. Furthermore, our data show that this arrest is primarily regulated by changes in levels of cyclin D1, p27 and p21 following treatments. In vivo, a significant decrease in tumor weight was observed in the combined treatment compared to either treatment alone or control. Conclusions: Altering cell cycle by inhibiting the mTOR signaling pathway in combination with radiation have favorable outcomes and is a promising therapeutic modality for bladder cancer.	[Nassim, Roland; Mansure, Jose Joao; Chevalier, Simone; Kassouf, Wassim] McGill Univ, Div Urol, McGill Urol Oncol Res, Montreal, PQ, Canada; [Cury, Fabio] McGill Univ, Ctr Hlth, Med Phys Unit, Montreal, PQ, Canada; [Cury, Fabio] Res Inst, Montreal, PQ, Canada	McGill University; McGill University	Kassouf, W (corresponding author), McGill Univ, Div Urol, McGill Urol Oncol Res, Montreal, PQ, Canada.	wassim.kassouf@muhc.mcgill.ca	Cury, Fabio L./AAW-5633-2020	Cury, Fabio L./0000-0003-1293-0822	Canadian Institute of Health Research (CIHR) [MOP 89796]; Fonds de recherche du Quebec-Sante (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante (FRSQ)	This project is being funded by a grant from the Canadian Institute of Health Research (CIHR) grant MOP 89796. Dr. W. Kassouf is a recipient of a clinical research scholar award from the Fonds de recherche du Quebec-Sante (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2006, MOL CANCER THER, V5, P1183, DOI 10.1158/1535-7163.MCT-05-0400; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chen WC, 2003, INT J RADIAT ONCOL, V56, P726, DOI 10.1016/S0360-3016(03)00124-X; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Deng R, 2011, ONCOGENE, V30, P944, DOI 10.1038/onc.2010.467; Diaz De Stahl T, 2008, Minerva Urol Nefrol, V60, P205; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gorshtein A, 2009, ENDOCR RELAT CANC; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Jones JM, 1999, CELL GROWTH DIFFER, V10, P213; Kaufmann WK, 1996, FASEB J, V10, P238, DOI 10.1096/fasebj.10.2.8641557; Konety BR, 2007, J UROLOGY, V177, P1636, DOI 10.1016/j.juro.2007.01.055; Law M, 2006, CANCER RES, V66, P1070, DOI 10.1158/0008-5472.CAN-05-1672; Li HF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-43; Lieberman HB, 2008, CURR MED CHEM, V15, P360, DOI 10.2174/092986708783497328; Mansure JJ, 2009, CANCER BIOL THER, V8, P2339, DOI 10.4161/cbt.8.24.9987; MATTSSON A, 1993, J NATL CANCER I, V85, P1679, DOI 10.1093/jnci/85.20.1679; Milosevic M, 2007, UROLOGY, V69, P80, DOI 10.1016/j.urology.2006.05.060; Morgensztern D, 2005, ANTI-CANCER DRUG, V16, P797, DOI 10.1097/01.cad.0000173476.67239.3b; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Ram R, 2009, CLIN CANCER RES, V15, P914, DOI 10.1158/1078-0432.CCR-08-0792; Rho JK, 2009, ONCOL REP, V21, P801, DOI 10.3892/or_00000287; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Samuel T, 2002, CELL CYCLE, V1, P162, DOI 10.4161/cc.1.3.118; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SINCLAIR WK, 1968, RADIAT RES, V33, P620, DOI 10.2307/3572419; SINCLAIR WK, 1965, BIOPHYS J, V5, P1, DOI 10.1016/S0006-3495(65)86700-5; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Xia S, 2010, CANCER BIOTHER RADIO, V25, P317, DOI 10.1089/cbr.2009.0707; Zhan M, 2004, HISTOL HISTOPATHOL, V19, P915, DOI 10.14670/HH-19.915; Zietman AL, 1998, J UROLOGY, V160, P1673, DOI 10.1016/S0022-5347(01)62379-6	42	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65257	10.1371/journal.pone.0065257	http://dx.doi.org/10.1371/journal.pone.0065257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799002	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800003
J	Johnson, I; Liu, HN				Johnson, Ian; Liu, Huinan			A Study on Factors Affecting the Degradation of Magnesium and a Magnesium-Yttrium Alloy for Biomedical Applications	PLOS ONE			English	Article							IN-VITRO EVALUATION; CORROSION; BEHAVIOR; DISSOLUTION; CHLORIDE	Controlling degradation of magnesium or its alloys in physiological saline solutions is essential for their potential applications in clinically viable implants. Rapid degradation of magnesium-based materials reduces the mechanical properties of implants prematurely and severely increases alkalinity of the local environment. Therefore, the objective of this study is to investigate the effects of three interactive factors on magnesium degradation, specifically, the addition of yttrium to form a magnesium-yttrium alloy versus pure magnesium, the metallic versus oxide surfaces, and the presence versus absence of physiological salt ions in the immersion solution. In the immersion solution of phosphate buffered saline (PBS), the magnesium-yttrium alloy with metallic surface degraded the slowest, followed by pure magnesium with metallic or oxide surfaces, and the magnesium-yttrium alloy with oxide surface degraded the fastest. However, in deionized (DI) water, the degradation rate showed a different trend. Specifically, pure magnesium with metallic or oxide surfaces degraded the slowest, followed by the magnesium-yttrium alloy with oxide surface, and the magnesium-yttrium alloy with metallic surface degraded the fastest. Interestingly, only magnesium-yttrium alloy with metallic surface degraded slower in PBS than in DI water, while all the other samples degraded faster in PBS than in DI water. Clearly, the results showed that the alloy composition, presence or absence of surface oxide layer, and presence or absence of physiological salt ions in the immersion solution all influenced the degradation rate and mode. Moreover, these three factors showed statistically significant interactions. This study revealed the complex interrelationships among these factors and their respective contributions to degradation for the first time. The results of this study not only improved our understanding of magnesium degradation in physiological environment, but also presented the key factors to consider in order to satisfy the degradation requirements for next-generation biodegradable implants and devices.	[Johnson, Ian; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Liu, HN (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	huinan.liu@ucr.edu	Liu, Huinan H/N-2891-2015	Liu, Huinan H/0000-0001-9366-6204	U.S. National Science Foundation [CBET BRIGE 1125801]; Hellman Faculty Fellowship; Burroughs Wellcome Fund; University of California Regent's Faculty Fellowship	U.S. National Science Foundation(National Science Foundation (NSF)); Hellman Faculty Fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of California Regent's Faculty Fellowship(University of California System)	The authors thank the U.S. National Science Foundation (CBET BRIGE 1125801), Hellman Faculty Fellowship, Burroughs Wellcome Fund, and the University of California Regent's Faculty Fellowship for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghion E, 2008, J MATER SCI, V43, P4870, DOI 10.1007/s10853-008-2708-9; Ambat R, 2000, J APPL ELECTROCHEM, V30, P865, DOI 10.1023/A:1004011916609; Brar HS, 2009, JOM-US, V61, P31, DOI 10.1007/s11837-009-0129-0; Davenport AJ, 2007, ELECTROCHEM SOLID ST, V10, pC5, DOI 10.1149/1.2400727; FERRANDO WA, 1989, J MATER ENG, V11, P299, DOI 10.1007/BF02834140; Ghali E, 2004, J MATER ENG PERFORM, V13, P7, DOI 10.1361/10599490417533; Guan RG, 2012, J BIOMED MATER RES A, V100A, P999, DOI 10.1002/jbm.a.34042; Gunde P, 2010, J BIOMED MATER RES A, V92A, P409, DOI 10.1002/jbm.a.32350; Hanzi AC, 2009, ACTA BIOMATER, V5, P162, DOI 10.1016/j.actbio.2008.07.034; He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014; Heakal FET, 2009, ELECTROCHIM ACTA, V54, P1545, DOI 10.1016/j.electacta.2008.09.055; Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037; Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290; Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004; Lindstrom R, 2004, CORROS SCI, V46, P1141, DOI 10.1016/j.corsci.2003.09.010; Liu M, 2010, CORROS SCI, V52, P3687, DOI 10.1016/j.corsci.2010.07.019; MILLER PL, 1995, CORROSION, V51, P922, DOI 10.5006/1.3293568; Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106; Rettig R, 2009, J BIOMED MATER RES A, V88A, P359, DOI 10.1002/jbm.a.31887; Socjusz-Podosek M, 2003, MATER CHEM PHYS, V80, P472, DOI 10.1016/S0254-0584(02)00549-7; Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5; Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013; Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Wu BL, 2010, MAT SCI ENG A-STRUCT, V527, P4334, DOI 10.1016/j.msea.2010.03.054; Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014; Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9; Yao HB, 2003, ELECTROCHIM ACTA, V48, P4197, DOI 10.1016/S0013-4686(03)00605-4; Zhang JH, 2009, J ALLOY COMPD, V471, P322, DOI 10.1016/j.jallcom.2008.03.089	29	53	54	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65603	10.1371/journal.pone.0065603	http://dx.doi.org/10.1371/journal.pone.0065603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799028	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300028
J	LeBlanc, AG; Chaput, JP; McFarlane, A; Colley, RC; Thivel, D; Biddle, SJH; Maddison, R; Leatherdale, ST; Tremblay, MS				LeBlanc, Allana G.; Chaput, Jean-Philippe; McFarlane, Allison; Colley, Rachel C.; Thivel, David; Biddle, Stuart J. H.; Maddison, Ralph; Leatherdale, Scott T.; Tremblay, Mark S.			Active Video Games and Health Indicators in Children and Youth: A Systematic Review	PLOS ONE			English	Review							PROMOTE PHYSICAL-ACTIVITY; DANCE DANCE REVOLUTION; ENERGY-EXPENDITURE; YOUNG-ADULTS; SCREEN TIME; WII; ADOLESCENTS; OVERWEIGHT; PILOT; RESPONSES	Background: Active video games (AVGs) have gained interest as a way to increase physical activity in children and youth. The effect of AVGs on acute energy expenditure (EE) has previously been reported; however, the influence of AVGs on other health-related lifestyle indicators remains unclear. Objective: This systematic review aimed to explain the relationship between AVGs and nine health and behavioural indicators in the pediatric population (aged 0-17 years). Data sources: Online databases (MEDLINE, EMBASE, psycINFO, SPORTDiscus and Cochrane Central Database) and personal libraries were searched and content experts were consulted for additional material. Data selection: Included articles were required to have a measure of AVG and at least one relevant health or behaviour indicator: EE (both habitual and acute), adherence and appeal (i.e., participation and enjoyment), opportunity cost (both time and financial considerations, and adverse events), adiposity, cardiometabolic health, energy intake, adaptation (effects of continued play), learning and rehabilitation, and video game evolution (i.e., sustainability of AVG technology). Results: 51 unique studies, represented in 52 articles were included in the review. Data were available from 1992 participants, aged 3-17 years, from 8 countries, and published from 2006-2012. Overall, AVGs are associated with acute increases in EE, but effects on habitual physical activity are not clear. Further, AVGs show promise when used for learning and rehabilitation within special populations. Evidence related to other indicators was limited and inconclusive. Conclusions: Controlled studies show that AVGs acutely increase light- to moderate-intensity physical activity; however, the findings about if or how AVG lead to increases in habitual physical activity or decreases in sedentary behaviour are less clear. Although AVGs may elicit some health benefits in special populations, there is not sufficient evidence to recommend AVGs as a means of increasing daily physical activity.	[LeBlanc, Allana G.; Chaput, Jean-Philippe; McFarlane, Allison; Colley, Rachel C.; Thivel, David; Tremblay, Mark S.] Childrens Hosp Eastern Ontario, Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON K1H 8L1, Canada; [Chaput, Jean-Philippe; Colley, Rachel C.; Tremblay, Mark S.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Biddle, Stuart J. H.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Biddle, Stuart J. H.] NIHR Leicester Loughborough Diet, Lifestyle & Phys Act Biomed Res Unit, Leicester, Leics, England; [Maddison, Ralph] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand; [Leatherdale, Scott T.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Loughborough University; University of Auckland; University of Waterloo	Chaput, JP (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON K1H 8L1, Canada.	jpchaput@cheo.on.ca	Biddle, Stuart/AAE-9395-2019; Tremblay, Mark/AAF-2981-2019; Chaput, Jean-Philippe/ABE-6307-2020; LeBlanc, Allana/AAX-1651-2021; Leatherdale, Scott Thomas/AAE-4515-2022; Tremblay, Mark/ABI-5477-2020; Maddison, Ralph/K-3418-2019	Biddle, Stuart/0000-0002-7663-6895; Chaput, Jean-Philippe/0000-0002-5607-5736; LeBlanc, Allana/0000-0002-4468-6783; Maddison, Ralph/0000-0001-8564-5518	Active Healthy Kids Canada	Active Healthy Kids Canada	This study was supported by funds from Active Healthy Kids Canada. The organization had no role in the design and conduct of the study; the collection, management, analysis and interpretation of the data; or the preparation, review and approval of the manuscript.	Adamo KB, 2010, APPL PHYSIOL NUTR ME, V35, P805, DOI 10.1139/H10-078; Bailey BW, 2011, ARCH PEDIAT ADOL MED, V165, P597, DOI 10.1001/archpediatrics.2011.15; Baranowski T, 2012, PEDIATRICS, V129, pE636, DOI 10.1542/peds.2011-2050; Barnett A, 2011, J PHYS ACT HEALTH, V8, P724, DOI 10.1123/jpah.8.5.724; Berg P, 2012, PEDIATR PHYS THER, V24, P78, DOI 10.1097/PEP.0b013e31823e05e6; Bethea TC, 2012, GAMES HEALTH J, V1, P29, DOI 10.1089/g4h.2011.0005; Biddiss E, 2010, ARCH PEDIAT ADOL MED, V164, P664, DOI 10.1001/archpediatrics.2010.104; Chang YJ, 2011, RES DEV DISABIL, V32, P2566, DOI 10.1016/j.ridd.2011.07.002; Daley AJ, 2009, PEDIATRICS, V124, P763, DOI 10.1542/peds.2008-2357; Deutsch JE, 2008, PHYS THER, V88, P1196, DOI 10.2522/ptj.20080062; Dixon R, 2010, J CHILD HEALTH CARE, V14, P189, DOI 10.1177/1367493509359173; Duncan M. J., 2011, Medicina Sportiva, V15, P81, DOI 10.2478/v10036-011-0014-0; Duncan MJ, 2010, HUM MOV, V11, P95, DOI DOI 10.2478/V10038-009-0023-1; Epstein LH, 2007, ANN BEHAV MED, V33, P124, DOI 10.1007/BF02879893; Errickson SP, 2012, GAMES HEALTH J, V1, P45, DOI 10.1089/g4h.2011.0028; Fawkner SG, 2010, J SPORT SCI, V28, P61, DOI 10.1080/02640410903369935; Fogel VA, 2010, J APPL BEHAV ANAL, V43, P591, DOI 10.1901/jaba.2010.43-591; Foley L, 2012, PEDIAT EXERC SCI, V22, P7; Fremeaux AE, 2011, INT J OBESITY, V35, P1277, DOI 10.1038/ijo.2011.52; Gao Z, 2011, RES Q EXERCISE SPORT, V82, P536, DOI 10.1080/02701367.2011.10599786; Getchell N, 2012, GAMES HEALTH J, V1, P58, DOI 10.1089/g4h.2011.0019; Graf DL, 2009, PEDIATRICS, V124, P534, DOI 10.1542/peds.2008-2851; Graves L, 2008, BRIT J SPORT MED, V42, P592, DOI 10.1136/bmj.39415.632951.80; Graves LEF, 2008, EUR J APPL PHYSIOL, V104, P617, DOI 10.1007/s00421-008-0813-8; Graves LEF, 2010, PEDIATR EXERC SCI, V22, P535, DOI 10.1123/pes.22.4.535; Graves LEF, 2010, J PHYS ACT HEALTH, V7, P393, DOI 10.1123/jpah.7.3.393; Guy S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/179124; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Hallal PC, 2012, LANCET, pS20; Jannink MJ, CYBERPSYCHOL BEHAV, V11, P27; Jones C, 2009, PHYSICIAN SPORTSMED, V37, P138, DOI 10.3810/psm.2009.04.1695; King NA, 2007, OBESITY, V15, P1373, DOI 10.1038/oby.2007.164; Lam JWK, 2011, J EXERC SCI FIT, V9, P24, DOI 10.1016/S1728-869X(11)60003-8; Lanningham-Foster L, 2006, PEDIATRICS, V118, pE1831, DOI 10.1542/peds.2006-1087; Lanningham-Foster L, 2009, J PEDIATR-US, V154, P819, DOI 10.1016/j.jpeds.2009.01.009; Leatherdale ST, 2011, CHRON DIS INJ CAN, V31, P141; Maddison R, 2007, PEDIATR EXERC SCI, V19, P334, DOI 10.1123/pes.19.3.334; Maddison R, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-54; Maddison R, 2011, AM J CLIN NUTR, V94, P156, DOI 10.3945/ajcn.110.009142; Madsen KA, 2007, ARCH PEDIAT ADOL MED, V161, P105, DOI 10.1001/archpedi.161.1.105-c; Maloney AE, 2008, OBESITY, V16, P2074, DOI 10.1038/oby.2008.295; Maloney AE, 2012, GAMES HEALTH J, V1, P96, DOI 10.1089/g4h.2011.0009; Mellecker RR, 2008, ARCH PEDIAT ADOL MED, V162, P886, DOI 10.1001/archpedi.162.9.886; Mellecker RR, 2010, APPETITE, V55, P343, DOI 10.1016/j.appet.2010.07.008; Mhurchu CN, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-8; Mitre N, 2011, J PEDIATR ENDOCR MET, V24, P689, DOI 10.1515/JPEM.2011.013; Murphy ECS, 2009, INT J PEDIATR OBES, V4, P205, DOI 10.3109/17477160902846187; Owens SG, 2011, J STRENGTH COND RES, V25, P3191, DOI 10.1519/JSC.0b013e3182132d55; Paez S, 2009, PEDIATR PHYS THER, V21, P245, DOI 10.1097/PEP.0b013e3181b13a82; Paw MJMCA, 2008, J SCI MED SPORT, V11, P163, DOI 10.1016/j.jsams.2007.06.001; Peng W, 2013, HEALTH EDUC BEHAV, V40, P171, DOI 10.1177/1090198112444956; Peng W, 2011, CYBERPSYCH BEH SOC N, V14, P681, DOI 10.1089/cyber.2010.0578; Penko AL, 2010, ANN BEHAV MED, V39, P162, DOI 10.1007/s12160-010-9164-x; Perron Rachel M, 2011, Int J Exerc Sci, V4, P257; Roemmich JN, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-16; Rubin D, 2010, J CHIROPR MED, V9, P84, DOI 10.1016/j.jcm.2010.02.003; Shih CH, 2011, RES DEV DISABIL, V32, P2780, DOI 10.1016/j.ridd.2011.05.031; Shih CH, 2011, RES DEV DISABIL, V32, P2005, DOI 10.1016/j.ridd.2011.04.008; Sit CHF, 2010, J PHYS ACT HEALTH, V7, P484, DOI 10.1123/jpah.7.4.484; Smallwood SR, 2012, ARCH PEDIAT ADOL MED, V166, P1005, DOI 10.1001/archpediatrics.2012.1271; Straker LM, 2007, PEDIATR EXERC SCI, V19, P459, DOI 10.1123/pes.19.4.459; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; White K, 2011, J SCI MED SPORT, V14, P130, DOI 10.1016/j.jsams.2010.07.005; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Widman LM, 2006, J SPINAL CORD MED, V29, P363, DOI 10.1080/10790268.2006.11753884; Wuang YP, 2011, RES DEV DISABIL, V32, P312, DOI 10.1016/j.ridd.2010.10.002	66	188	190	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65351	10.1371/journal.pone.0065351	http://dx.doi.org/10.1371/journal.pone.0065351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799008	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000320363300015
J	Thwe, AA; Kim, JK; Li, XH; Kim, YB; Uddin, MR; Kim, SJ; Suzuki, T; Park, NI; Park, SU				Thwe, Aye Aye; Kim, Jae Kwang; Li, Xiaohua; Kim, Yeon Bok; Uddin, Md Romij; Kim, Sun Ju; Suzuki, Tatsuro; Park, Nam Il; Park, Sang Un			Metabolomic Analysis and Phenylpropanoid Biosynthesis in Hairy Root Culture of Tartary Buckwheat Cultivars	PLOS ONE			English	Article							AGROBACTERIUM-RHIZOGENES; FLAVONOID BIOSYNTHESIS; HIGHER-PLANTS; GROWTH; RUTIN; ACCUMULATION; ACID; TRANSFORMATION; METABOLITES; EXPRESSION	Buckwheat, Fagopyrum tataricum Gaertn., is an important medicinal plant, which contains several phenolic compounds, including one of the highest content of rutin, a phenolic compound with anti-inflammatory properties. An experiment was conducted to investigate the level of expression of various genes in the phenylpropanoid biosynthetic pathway to analyze in vitro production of anthocyanin and phenolic compounds from hairy root cultures derived from 2 cultivars of tartary buckwheat (Hokkai T8 and T10). A total of 47 metabolites were identified by gas chromatography-time-of-flight mass spectrometry (GC-TOFMS) and subjected to principal component analysis (PCA) in order to fully distinguish between Hokkai T8 and T10 hairy roots. The expression levels of phenylpropanoid biosynthetic pathway genes, through qRT-PCR, showed higher expression for almost all the genes in T10 than T8 hairy root except for FtF3'H-2 and FtFLS-2. Rutin, quercetin, gallic acid, caffeic acid, ferulic acid, 4-hydroxybenzoic acid, and 2 anthocyanin compounds were identified in Hokkai T8 and T10 hairy roots. The concentration of rutin and anthocyanin in Hokkai T10 hairy roots of tartary buckwheat was several-fold higher compared with that obtained from Hokkai T8 hairy root. This study provides useful information on the molecular and physiological dynamic processes that are correlated with phenylpropanoid biosynthetic gene expression and phenolic compound content in F. tataricum species.	[Thwe, Aye Aye; Li, Xiaohua; Kim, Yeon Bok; Uddin, Md Romij; Park, Sang Un] Chungnam Natl Univ, Dept Crop Sci, Taejon, South Korea; [Kim, Jae Kwang] Rural Dev Adm, Natl Acad Agr Sci, Suwon, South Korea; [Kim, Sun Ju] Chungnam Natl Univ, Dept Bio Environm Chem, Taejon, South Korea; [Suzuki, Tatsuro] Natl Agr Res Ctr Hokkaido Reg, Sapporo, Hokkaido, Japan; [Park, Nam Il] Wildlife Genet Resources Ctr, Natl Inst Biol Resources, Inchon, South Korea	Chungnam National University; Rural Development Administration (RDA); Chungnam National University; National Agriculture & Food Research Organization - Japan; National Institute of Biological Resources	Park, NI (corresponding author), Wildlife Genet Resources Ctr, Natl Inst Biol Resources, Inchon, South Korea.	parknamil@korea.kr; supark@cnu.ac.kr		Kim, Sun-Ju/0000-0003-4872-9637	Korea Institute of Oriental Medicine (KIOM) [K11101]; Korea government	Korea Institute of Oriental Medicine (KIOM); Korea government(Korean Government)	This work (K11101) was supported by the Korea Institute of Oriental Medicine (KIOM) grant funded by the Korea government. The funder took part in the role of conceiving and designing the experiment.	Bettini P, 2003, THEOR APPL GENET, V107, P831, DOI 10.1007/s00122-003-1322-0; Christey MC, 2005, METH MOL B, V286, P47; Christey MC, 2001, IN VITRO CELL DEV-PL, V37, P687; FILETICI P, 1987, PLANT MOL BIOL, V9, P19, DOI 10.1007/BF00017983; Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152; Gaberscik A, 2002, J PHOTOCH PHOTOBIO B, V66, P30, DOI 10.1016/S1011-1344(01)00272-X; Georgiev MI, 2007, APPL MICROBIOL BIOT, V74, P1175, DOI 10.1007/s00253-007-0856-5; Giri A, 2000, BIOTECHNOL ADV, V18, P1, DOI 10.1016/S0734-9750(99)00016-6; Gong GH, 2010, EUR J PHARMACOL, V628, P27, DOI 10.1016/j.ejphar.2009.11.028; Guillon S, 2006, TRENDS BIOTECHNOL, V24, P403, DOI 10.1016/j.tibtech.2006.07.002; Guillon S, 2006, CURR OPIN PLANT BIOL, V9, P341, DOI 10.1016/j.pbi.2006.03.008; Guo X, 2007, J AGR FOOD CHEM, V55, P6958, DOI 10.1021/jf071032+; Gupta N, 2011, J PLANT PHYSIOL, V168, P2117, DOI 10.1016/j.jplph.2011.06.018; Hagels H, 1995, CURR ADV BUCKWHEAT R, V115, P801; HAMILL JD, 1987, BIO-TECHNOL, V5, P800, DOI 10.1038/nbt0887-800; Kayashita J, 1997, J NUTR, V127, P1395, DOI 10.1093/jn/127.7.1395; Kim JK, 2013, J CEREAL SCI, V57, P14, DOI 10.1016/j.jcs.2012.09.012; Kim JK, 2013, PLANT BIOTECHNOL REP, V7, P121, DOI 10.1007/s11816-012-0231-6; Kim Yong Kyoung, 2009, Journal of Crop Science and Biotechnology, V12, P53; Kobayashi S, 2012, J BIOSCI BIOENG, V114, P86, DOI 10.1016/j.jbiosc.2012.02.015; Kok EJ, 2008, REGUL TOXICOL PHARM, V50, P98, DOI 10.1016/j.yrtph.2007.09.007; Kuntic V, 2011, MOLECULES, V16, P1378, DOI 10.3390/molecules16021378; Lachman J., 2000, Scientia Agriculturae Bohemica, V31, P89; Landberg R, 2011, J NUTR, V141, P618, DOI 10.3945/jn.110.133843; Lee SY, 2007, PREP BIOCHEM BIOTECH, V37, P239, DOI 10.1080/10826060701386729; Li XH, 2010, J AGR FOOD CHEM, V58, P12176, DOI 10.1021/jf103310g; Liu CL, 2008, J AGR FOOD CHEM, V56, P173, DOI 10.1021/jf072347s; Mandal S, 2008, BIOTECHNOL LETT, V30, P1253, DOI 10.1007/s10529-008-9666-9; Messerli G, 2007, PLANT PHYSIOL, V143, P1484, DOI 10.1104/pp.106.090795; Moriguchi K, 2001, J MOL BIOL, V307, P771, DOI 10.1006/jmbi.2001.4488; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Park NI, 2011, J AGR FOOD CHEM, V59, P2356, DOI 10.1021/jf200020b; PETIT A, 1983, MOL GEN GENET, V190, P204, DOI 10.1007/BF00330641; Pongsuwan W, 2007, J AGR FOOD CHEM, V55, P231, DOI 10.1021/jf062330u; RUSSELL DW, 1971, J BIOL CHEM, V246, P3870; Sircar D, 2007, J PLANT PHYSIOL, V164, P1358, DOI 10.1016/j.jplph.2006.08.002; Srivastava S, 2007, CRIT REV BIOTECHNOL, V27, P29, DOI 10.1080/07388550601173918; Suzuki T, 2009, J AGR FOOD CHEM, V57, P259, DOI 10.1021/jf802731d; Tarachiwin L, 2008, J AGR FOOD CHEM, V56, P5827, DOI 10.1021/jf800418u; TEPFER D, 1984, CELL, V37, P959, DOI 10.1016/0092-8674(84)90430-6; Timotijevic GS, 2010, J PLANT PHYSIOL, V167, P61, DOI 10.1016/j.jplph.2009.06.017; TSUZUKI E, 1987, Bulletin of the Faculty of Agriculture Miyazaki University, V34, P289; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yao Y, 2008, J AGR FOOD CHEM, V56, P10027, DOI 10.1021/jf801879m	45	38	41	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65349	10.1371/journal.pone.0065349	http://dx.doi.org/10.1371/journal.pone.0065349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799007	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300014
J	Zhang, Z; Xu, YW; Liu, J; Wong, DWK; Kwoh, CK; Saw, SM; Wong, TY				Zhang, Zhuo; Xu, Yanwu; Liu, Jiang; Wong, Damon Wing Kee; Kwoh, Chee Keong; Saw, Seang-Mei; Wong, Tien Yin			Automatic Diagnosis of Pathological Myopia from Heterogeneous Biomedical Data	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POPULATION; BLINDNESS; LINKAGE; PREVALENCE; REGION; SCAN; EYE	Pathological myopia is one of the leading causes of blindness worldwide. The condition is particularly prevalent in Asia. Unlike myopia, pathological myopia is accompanied by degenerative changes in the retina, which if left untreated can lead to irrecoverable vision loss. The accurate diagnosis of pathological myopia will enable timely intervention and facilitate better disease management to slow down the progression of the disease. Current methods of assessment typically consider only one type of data, such as that from retinal imaging. However, different kinds of data, including that of genetic, demographic and clinical information, may contain different and independent information, which can provide different perspectives on the visually observable, genetic or environmental mechanisms for the disease. The combination of these potentially complementary pieces of information can enhance the understanding of the disease, providing a holistic appreciation of the multiple risks factors as well as improving the detection outcomes. In this study, we propose a computer-aided diagnosis framework for Pathological Myopia diagnosis through Biomedical and Image Informatics(PM-BMII). Through the use of multiple kernel learning (MKL) methods, PM-BMII intelligently fuses heterogeneous biomedical information to improve the accuracy of disease diagnosis. Data from 2,258 subjects of a population-based study, in which demographic and clinical information, retinal fundus imaging data and genotyping data were collected, are used to evaluate the proposed framework. The experimental results show that PM-BMII achieves an AUC of 0.888, outperforming the detection results from the use of demographic and clinical information 0.607 (increase 46.3%, p < 0.005), genotyping data 0.774 (increase 14.7%, p < 0.005) or imaging data 0.852 (increase 4.2%, p = 0.19) alone. The accuracy of the results obtained demonstrates the feasibility of using heterogeneous data for improved disease diagnosis through our proposed PM-BMII framework.	[Zhang, Zhuo; Xu, Yanwu; Liu, Jiang; Wong, Damon Wing Kee] Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore; [Zhang, Zhuo; Kwoh, Chee Keong] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wong, Tien Yin] Singapore Eye Res Inst, Dept Ophthalmol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Singapore National Eye Center	Zhang, Z (corresponding author), Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore.	zzhang@i2r.a-star.edu.sg	Xu, Yanwu/AAK-8156-2020; Wong, Tien Yin/AAC-9724-2020	Xu, Yanwu/0000-0002-1779-931X; Wong, Tien Yin/0000-0002-8448-1264; liu, jiang/0000-0001-6281-6505; Wong, Damon/0000-0003-4601-9121	Agency for Science, Technology and Research, Singapore, under Science and Engineering Research Council [092-148-0073]	Agency for Science, Technology and Research, Singapore, under Science and Engineering Research Council	This work was supported in part by the Agency for Science, Technology and Research, Singapore, under Science and Engineering Research Council grant 092-148-0073. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONL MEND INH MAN OM; Bach F.R., 2004, P 21 INT C MACH LEAR, P6, DOI DOI 10.1145/1015330.1015424; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cheng J, 2011, LECT NOTES COMPUT SC, V6893, P91, DOI 10.1007/978-3-642-23626-6_12; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GREEN JS, 1986, BRIT J OPHTHALMOL, V70, P696, DOI 10.1136/bjo.70.9.696; Hindorff LA, CATALOG PUBLISHED GE; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Krumpaszky HG, 1999, OPHTHALMOLOGICA, V213, P176, DOI 10.1159/000027415; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Li ZQ, 2011, HUM MOL GENET, V20, P2861, DOI 10.1093/hmg/ddr169; Liu J, 2010, J HEALTHC ENG, V1, P1, DOI 10.1260/2040-2295.1.1.1; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Shih YF, 2006, BRIT J OPHTHALMOL, V90, P546, DOI 10.1136/bjo.2005.081992; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Stambolian D, 2004, AM J HUM GENET, V75, P448, DOI 10.1086/423789; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wojciechowski R, 2006, HUM GENET, V119, P389, DOI 10.1007/s00439-006-0153-x; Xu YW, 2012, LECT NOTES COMPUT SC, V7510, P58, DOI 10.1007/978-3-642-33415-3_8; Xu YW, 2011, LECT NOTES COMPUT SC, V6893, P1, DOI 10.1007/978-3-642-23626-6_1; Xu Z., 2010, P 27 INT C MACHINE L, P1175; Young TL, 2004, ARCH OPHTHALMOL-CHIC, V122, P897, DOI 10.1001/archopht.122.6.897; Zhuo Zhang, 2012, 2012 7th IEEE Conference on Industrial Electronics and Applications (ICIEA 2012). Proceedings, P1742, DOI 10.1109/ICIEA.2012.6361007	39	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65736	10.1371/journal.pone.0065736	http://dx.doi.org/10.1371/journal.pone.0065736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799040	Green Published, gold			2022-12-27	WOS:000320363300036
J	Glatzer, S; Merten, NJ; Dierks, C; Wohlke, A; Philipp, U; Distl, O				Glatzer, Sabrina; Merten, Nina Johanna; Dierks, Claudia; Woehlke, Anne; Philipp, Ute; Distl, Ottmar			A Single Nucleotide Polymorphism within the Interferon Gamma Receptor 2 Gene Perfectly Coincides with Polledness in Holstein Cattle	PLOS ONE			English	Article							BOVINE CHROMOSOME-1; HORN; INHERITANCE; ASSOCIATION; MICRORNAS; SELECTION; BREEDS; PART	Polledness is a high impact trait in modern milk and beef production to meet the demands of animal welfare and work safety. Previous studies have mapped the polled-locus to the proximal region of the bovine chromosome 1 (BTA1) and narrowed it down to approximately 1 Mb. Sequencing of the positional candidate genes within the 1 Mb polled region and whole genome sequencing of Holsteins revealed a single nucleotide polymorphism (SNP) AC000158: g. 1390292G>A within intron 3 of the interferon gamma receptor 2 gene (IFNGR2) in perfect co-segregation with polledness in Holsteins. This complete association was validated in 443 animals of the same breed. This SNP allows reliable genotyping of horned, heterozygous and homozygous polled Holsteins, even in animals that could not be resolved using the previously published haplotype for Holstein.	[Glatzer, Sabrina; Merten, Nina Johanna; Dierks, Claudia; Woehlke, Anne; Philipp, Ute; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Dierks, Claudia/0000-0003-1299-6063	German Research Community (Deutsche Forschungsgemeinschaft, DFG), Bonn, Germany [DI333/15-2]	German Research Community (Deutsche Forschungsgemeinschaft, DFG), Bonn, Germany	This work has been funded by the German Research Community (Deutsche Forschungsgemeinschaft, DFG), Bonn, Germany (DI333/15-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brem G., 1982, Bayerisches Landwirtschaftliches Jahrbuch, V59, P688; Chowdhary BP, 1996, MAMM GENOME, V7, P297, DOI 10.1007/s003359900086; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Drogemuller C, 2002, ANIM GENET, V33, P271, DOI 10.1046/j.1365-2052.2002.00866.x; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; Kim KS, 2009, FEBS J, V276, P2140, DOI 10.1111/j.1742-4658.2009.06932.x; Lange H, 1989, THESIS VET FACULTY L; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Ma C, 2009, SCI CHINA SER C, V52, P323, DOI 10.1007/s11427-009-0056-x; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Quadros L, 2008, HAEMOPHILIA, V14, P628, DOI 10.1111/j.1365-2516.2008.01704.x; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; THREADGILL DS, 1991, P NATL ACAD SCI USA, V88, P154, DOI 10.1073/pnas.88.1.154; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500	20	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67992	10.1371/journal.pone.0067992	http://dx.doi.org/10.1371/journal.pone.0067992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805331	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500159
J	Inoue, Y; Hasegawa, S; Yamada, T; Date, Y; Mizutani, H; Nakata, S; Akamatsu, H				Inoue, Yu; Hasegawa, Seiji; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru; Akamatsu, Hirohiko			Lignin Induces ES Cells to Differentiate into Neuroectodermal Cells through Mediation of the Wnt Signaling Pathway	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DOPAMINERGIC-NEURONS; RETINOIC ACID; GENERATION; CULTURE; MOUSE; MOLECULE; MODEL; LIF	Embryonic stem cells (ES cells) are characterized by their pluripotency and infinite proliferation potential. Ever since ES cells were first established in 1981, there have been a growing number of studies aimed at clinical applications of ES cells. In recent years, various types of differentiation inducement systems using ES cells have been established. Further studies have been conducted to utilize differentiation inducement systems in the field of regenerative medicine. For cellular treatments using stem cells including ES cells, differentiation induction should be performed in a sufficient manner to obtain the intended cell lineages. Lignin is a high-molecular amorphous material that forms plants together with cellulose and hemicelluloses, in which phenylpropane fundamental units are complexly condensed. Lignin derivatives have been shown to have several bioactive functions. In spite of these findings, few studies have focused on the effects of lignin on stem cells. Our study aimed to develop a novel technology using lignin to effectively induce ES cells to differentiate into neuroectodermal cells including ocular cells and neural cells. Since lignin can be produced at a relatively low cost in large volumes, its utilization is expected for more convenient differentiation induction technologies and in the field of regenerative medicine in the future.	[Inoue, Yu; Hasegawa, Seiji; Yamada, Takaaki; Date, Yasushi; Mizutani, Hiroshi; Nakata, Satoru] Nippon Menard Cosmet Co Ltd, Res Labs, Aichi, Japan; [Hasegawa, Seiji; Yamada, Takaaki] Fujita Hlth Univ, Sch Med, Dept Dermatol, Aichi, Japan; [Akamatsu, Hirohiko] Fujita Hlth Univ, Sch Med, Dept Appl Cell & Regenerat Med, Aichi, Japan	Fujita Health University; Fujita Health University	Inoue, Y (corresponding author), Nippon Menard Cosmet Co Ltd, Res Labs, Aichi, Japan.	inoue.yuu@menard.co.jp	Date, Yasushi/C-5349-2016; Hasegawa, Seiji/A-3514-2016	Hasegawa, Seiji/0000-0001-9797-1900; Inoue, Yu/0000-0002-7540-6940	Nippon Menard Cosmetic Co., Ltd.	Nippon Menard Cosmetic Co., Ltd.	This work was supported by Nippon Menard Cosmetic Co., Ltd. (http://www.menard.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Yu Inoue, Seiji Hasegawa, Takaaki Yamada, Yasushi Date, Hiroshi Mizutani and Satoru Nakata are employed by Nippon Menard Cosmetic Co., Ltd, the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GOUGH NM, 1989, REPROD FERT DEVELOP, V1, P281, DOI 10.1071/RD9890281; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; Inoue Y, 2012, PIGM CELL MELANOMA R, V25, P299, DOI 10.1111/j.1755-148X.2012.00988.x; Ito Y, 2006, J PHARMACOL SCI, V102, P196, DOI 10.1254/jphs.FP0060711; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kim YY, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/167376; Lu JF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-57; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Prelle K, 2002, ANAT HISTOL EMBRYOL, V31, P169, DOI 10.1046/j.1439-0264.2002.00388.x; Reynertson KA, 2011, EXP CELL RES, V317, P82, DOI 10.1016/j.yexcr.2010.10.010; Swistowska AM, 2010, STEM CELLS DEV, V19, P71, DOI 10.1089/scd.2009.0107; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Teraoka ME, 2009, DEV BIOL, V330, P389, DOI 10.1016/j.ydbio.2009.04.008; Ulloa-Montoya F, 2005, J BIOSCI BIOENG, V100, P12, DOI 10.1263/jbb.100.12; Vazin T, 2008, STEM CELLS, V26, P1517, DOI 10.1634/stemcells.2008-0039; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Yamane T, 1999, DEV DYNAM, V216, P450, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0	24	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66376	10.1371/journal.pone.0066376	http://dx.doi.org/10.1371/journal.pone.0066376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805217	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500045
J	Jiang, Y; Li, BQ; Zhang, Y; Feng, YM; Gao, YF; Zhang, N; Cai, YD				Jiang, Yang; Li, Bi-Qing; Zhang, Yuchao; Feng, Yuan-Ming; Gao, Yu-Fei; Zhang, Ning; Cai, Yu-Dong			Prediction and Analysis of Post-Translational Pyruvoyl Residue Modification Sites from Internal Serines in Proteins	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; TARGETING POLYAMINE METABOLISM; ACID PAIRING PREFERENCES; ARGININE DECARBOXYLASE; BETA-STRANDS; PHOSPHORYLATION; GLYCOSYLATION; DISORDER; CANCER; IDENTIFICATION	Most of pyruvoyl-dependent proteins observed in prokaryotes and eukaryotes are critical regulatory enzymes, which are primary targets of inhibitors for anti-cancer and anti-parasitic therapy. These proteins undergo an autocatalytic, intramolecular self-cleavage reaction in which a covalently bound pyruvoyl group is generated on a conserved serine residue. Traditional detections of the modified serine sites are performed by experimental approaches, which are often labor-intensive and time-consuming. In this study, we initiated in an attempt for the computational predictions of such serine sites with Feature Selection based on a Random Forest. Since only a small number of experimentally verified pyruvoyl-modified proteins are collected in the protein database at its current version, we only used a small dataset in this study. After removing proteins with sequence identities >60%, a non-redundant dataset was generated and was used, which contained only 46 proteins, with one pyruvoyl serine site for each protein. Several types of features were considered in our method including PSSM conservation scores, disorders, secondary structures, solvent accessibilities, amino acid factors and amino acid occurrence frequencies. As a result, a pretty good performance was achieved in our dataset. The best 100.00% accuracy and 1.0000 MCC value were obtained from the training dataset, and 93.75% accuracy and 0.8441 MCC value from the testing dataset. The optimal feature set contained 9 features. Analysis of the optimal feature set indicated the important roles of some specific features in determining the pyruvoyl-group-serine sites, which were consistent with several results of earlier experimental studies. These selected features may shed some light on the in-depth understanding of the mechanism of the post-translational self-maturation process, providing guidelines for experimental validation. Future work should be made as more pyruvoyl-modified proteins are found and the method should be evaluated on larger datasets. At last, the predicting software can be downloaded from http://www.nkbiox.com/sub/pyrupred/index.html.	[Jiang, Yang; Gao, Yu-Fei] Jilin Univ, China Japan Union Hosp, Dept Surg, Changchun 130023, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Zhang, Yuchao] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Zhang, Yuchao] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Feng, Yuan-Ming; Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab Biomed Engn Measurement, Tianjin 300072, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tianjin University; Shanghai University	Gao, YF (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Surg, Changchun 130023, Peoples R China.	gaoyufei1975@sina.cn; zhni@tju.edu.cn; cai_yud@yahoo.com.cn		Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; National Science Foundation of China [81171342, 81201148]; Innovation Program of Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; grant of "The First-class Discipline of Universities in Shanghai''; Natural science fund projects of Jilin province [201215059]; development of science and technology plan projects of Jilin province [20100733, 201101074]; SRF for ROCS; SEM [2009-36]; Scientific Research Foundation (Jilin Department of Science Technology) [20100733, 200705314, 20090175]; Scientific Research Foundation (Jilin Department of Health) [2010Z068]; SRF for ROCS (Jilin Department of Human Resource & Social Security)	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); grant of "The First-class Discipline of Universities in Shanghai''; Natural science fund projects of Jilin province; development of science and technology plan projects of Jilin province; SRF for ROCS(Scientific Research Foundation for the Returned Overseas Chinese Scholars); SEM; Scientific Research Foundation (Jilin Department of Science Technology); Scientific Research Foundation (Jilin Department of Health); SRF for ROCS (Jilin Department of Human Resource & Social Security)	This contribution is supported by National Basic Research Program of China (2011CB510102, 2011CB510101), National Science Foundation of China (81171342, 81201148), Innovation Program of Shanghai Municipal Education Commission (No. 12YZ120, No. 12ZZ087), the grant of "The First-class Discipline of Universities in Shanghai''. Natural science fund projects of Jilin province (201215059), development of science and technology plan projects of Jilin province (20100733, 201101074), SRF for ROCS, SEM (2009-36), Scientific Research Foundation (Jilin Department of Science & Technology, 200705314, 20090175, 20100733), Scientific Research Foundation (Jilin Department of Health, 2010Z068), SRF for ROCS (Jilin Department of Human Resource & Social Security, 2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert A, 1998, NAT STRUCT BIOL, V5, P289, DOI 10.1038/nsb0498-289; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bale S, 2010, AMINO ACIDS, V38, P451, DOI 10.1007/s00726-009-0404-y; Basu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-210; Bednarski B, 2001, EUR J BIOCHEM, V268, P3538, DOI 10.1046/j.1432-1327.2001.02257.x; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Ekstrom JL, 2001, BIOCHEMISTRY-US, V40, P9495, DOI 10.1021/bi010736o; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fooks HM, 2006, J MOL BIOL, V356, P32, DOI 10.1016/j.jmb.2005.11.008; GALLAGHER T, 1989, J BIOL CHEM, V264, P12737; Gerner EW, 2007, AMINO ACIDS, V33, P189, DOI 10.1007/s00726-007-0515-2; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Giles TN, 2008, J BIOL CHEM, V283, P25829, DOI 10.1074/jbc.M802674200; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; HUGO ER, 1993, BIOCHEM J, V295, P203, DOI 10.1042/bj2950203; Jia SC, 2011, PROTEIN PEPTIDE LETT, V18, P609, DOI 10.2174/092986611795222777; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; LI QX, 1990, J BIOL CHEM, V265, P4111; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Lonvaud-Funel A, 2001, FEMS MICROBIOL LETT, V199, P9, DOI 10.1016/S0378-1097(01)00157-4; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Rogers J, 2006, LECT NOTES COMPUT SC, V3940, P173; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Shameer K, 2011, PROTEIN PEPTIDE LETT, V18, P1010, DOI 10.2174/092986611796378729; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Smith CB, 2008, J BACTERIOL, V190, P7431, DOI 10.1128/JB.00652-08; Toms AV, 2004, J BIOL CHEM, V279, P33837, DOI 10.1074/jbc.M403369200; Trip H, 2011, MOL MICROBIOL, V79, P861, DOI 10.1111/j.1365-2958.2010.07492.x; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wada M, 2010, BIOL PHARM BULL, V33, P891, DOI 10.1248/bpb.33.891; Webb ME, 2012, ACTA CRYSTALLOGR F, V68, P414, DOI 10.1107/S1744309112009487; Witten I.H., 2005, DATA MINING PRACTICA; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; You Liwen, 2006, Comput Syst Bioinformatics Conf, P249; Zhang N, 2012, MOL BIOSYST, V8, P2946, DOI 10.1039/c2mb25185j; Zhang N, 2010, J THEOR BIOL, V263, P360, DOI 10.1016/j.jtbi.2009.12.019; Zhang N, 2009, BIOCHEM BIOPH RES CO, V386, P537, DOI 10.1016/j.bbrc.2009.06.072	56	1	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66678	10.1371/journal.pone.0066678	http://dx.doi.org/10.1371/journal.pone.0066678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805260	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500088
J	Lee, HJ; Jang, M; Kim, H; Kwak, W; Park, W; Hwang, JY; Lee, CK; Jang, GW; Park, MN; Kim, HC; Jeong, JY; Seo, KS; Kim, H; Cho, S; Lee, BY				Lee, Hyun-Jeong; Jang, Mi; Kim, Hyeongmin; Kwak, Woori; Park, WonCheoul; Hwang, Jae Yeon; Lee, Chang-Kyu; Jang, Gul Won; Park, Mi Na; Kim, Hyeong-Cheol; Jeong, Jin Young; Seo, Kang Seok; Kim, Heebal; Cho, Seoae; Lee, Bo-Young			Comparative Transcriptome Analysis of Adipose Tissues Reveals that ECM-Receptor Interaction Is Involved in the Depot-Specific Adipogenesis in Cattle	PLOS ONE			English	Article							INTRAMUSCULAR FAT-CONTENT; GENE-EXPRESSION; PREADIPOCYTE DIFFERENTIATION; PROMOTES ADIPOGENESIS; LONGISSIMUS-LUMBORUM; KEY REGULATOR; UP-REGULATION; HIGH-STARCH; PPAR-GAMMA; SITE	Adipocytes mainly function as energy storage and endocrine cells. Adipose tissues showed the biological and genetic difference based on their depots. The difference of adipocytes between depots might be influenced by the inherent genetic programing for adipogenesis. We used RNA-seq technique to investigate the transcriptomes in 3 adipose tissues of omental (O), subcutaneous (S) and intramuscular (I) fats in cattle. Sequence reads were obtained from Illumina HiSeq2000 and mapped to the bovine genome using Tophat2. Differentially expressed genes (DEG) between adipose tissues were detected by EdgeR. We identified 5797, 2156, and 5455 DEGs in the comparison between OI, OS, and IS respectively and also found 5657 DEGs in the comparison between the intramuscular and the combined omental and subcutaneous fats (C) (FDR<0.01). Depot specifically up-and down-regulated DEGs were 853 in S, 48 in I, and 979 in O. The numbers of DEGs and functional annotation studies suggested that I had the different genetic profile compared to other two adipose tissues. In I, DEGs involved in the developmental process (eg. EGR2, FAS, and KLF7) were up-regulated and those in the immune system process were down-regulated. Many DEGs from the adipose tissues were enriched in the various GO terms of developmental process and KEGG pathway analysis showed that the ECM-receptor interaction was one of commonly enriched pathways in all of the 3 adipose tissues and also functioned as a sub-pathway of other enriched pathways. However, genes involved in the ECM-receptor interaction were differentially regulated depending on the depots. Collagens, main ECM constituents, were significantly up-regulated in S and integrins, transmembrane receptors, were up-regulated in I. Different laminins were up-regulated in the different depots. This comparative transcriptome analysis of three adipose tissues suggested that the interactions between ECM components and transmembrane receptors of fat cells depend on the depot specific adipogenesis.	[Lee, Hyun-Jeong; Jang, Mi; Jang, Gul Won; Park, Mi Na; Kim, Hyeong-Cheol; Jeong, Jin Young] Rural Dev Adm, Natl Inst Anim Sci, Div Anim Genom & Bioinformat, Suwon, South Korea; [Kim, Hyeongmin; Park, WonCheoul; Hwang, Jae Yeon; Lee, Chang-Kyu; Kim, Heebal; Lee, Bo-Young] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Hyeongmin; Park, WonCheoul; Hwang, Jae Yeon; Lee, Chang-Kyu; Kim, Heebal; Lee, Bo-Young] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kwak, Woori] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kwak, Woori; Cho, Seoae] Seoul Natl Univ Res Pk, C&K Genom, Seoul, South Korea; [Jang, Mi; Seo, Kang Seok] Sunchon Natl Univ, Coll Life Sci & Nat Resources, Dept Anim Sci & Technol, Jeollanam Do, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sunchon National University	Cho, S (corresponding author), Seoul Natl Univ Res Pk, C&K Genom, Seoul, South Korea.	seoae@cnkgenomics.com; bylee613@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Hwang, Jae Yeon/0000-0002-6493-4182; Park, WonCheoul/0000-0003-3140-5628	National Livestock Research Institute [PJ008487]; BioGreen 21 Project of Rural Development Administration, Republic of Korea [PJ00819101]	National Livestock Research Institute; BioGreen 21 Project of Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by Project (PJ008487) of the National Livestock Research Institute and BioGreen 21 Project (PJ00819101) of Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Akerblad P, 2002, MOL CELL BIOL, V22, P8015, DOI 10.1128/MCB.22.22.8015-8025.2002; Alterovitz G., 2011, KNOWL BAS BIOINF AN; Ament Z, 2012, GENOME MED, V4, DOI 10.1186/gm331; Arner P, 1997, J ENDOCRINOL, V155, P191, DOI 10.1677/joe.0.1550191; Basu U, 2012, J GENOMICS, V1, P22; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Brooks MA, 2011, J ANIM SCI, V89, P2556, DOI 10.2527/jas.2010-3369; Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Chui PC, 2005, J CLIN INVEST, V115, P2244, DOI 10.1172/JCI24130; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhar M, 2008, J LIPID RES, V49, P612, DOI 10.1194/jlr.M700450-JLR200; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Ditlecadet D, 2011, AM J PHYSIOL-REG I, V300, pR674, DOI 10.1152/ajpregu.00700.2010; DJIAN P, 1983, J CLIN INVEST, V72, P1200, DOI 10.1172/JCI111075; Dodson MV, 2010, J FOOD SCI, V75, pR1, DOI 10.1111/j.1750-3841.2009.01396.x; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; EDENS NK, 1993, AM J PHYSIOL, V265, pE374, DOI 10.1152/ajpendo.1993.265.3.E374; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; FRIED SK, 1993, J CLIN INVEST, V92, P2191, DOI 10.1172/JCI116821; Gardan D, 2006, AM J PHYSIOL-ENDOC M, V291, pE372, DOI 10.1152/ajpendo.00482.2005; Gondret F, 2008, J ANIM SCI, V86, P2115, DOI 10.2527/jas.2007-0750; Graugnard DE, 2010, BRIT J NUTR, V103, P953, DOI 10.1017/S0007114509992789; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; HARTMAN AD, 1985, LIPIDS, V20, P255, DOI 10.1007/BF02534256; HAUNER H, 1991, INT J OBESITY, V15, P121; Helledie T, 2002, MOL CELL BIOCHEM, V239, P157, DOI 10.1023/A:1020538404612; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hong YH, 2005, BIOSCI BIOTECH BIOCH, V69, P2117, DOI 10.1271/bbb.69.2117; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463; Huang H, 2005, BIOCHEMISTRY-US, V44, P10282, DOI 10.1021/bi0477891; Hube F, 1996, HORM METAB RES, V28, P690, DOI 10.1055/s-2007-979879; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; Jin W, 2012, J ANIM SCI, V90, P171, DOI 10.2527/jas.2011-4229; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kanazawa A, 2005, DIABETOLOGIA, V48, P1315, DOI 10.1007/s00125-005-1797-0; Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kirkland J. L., 1997, OBESITY RES S1, V5, p22S; KIRKLAND JL, 1984, J AM GERIATR SOC, V32, P219, DOI 10.1111/j.1532-5415.1984.tb02006.x; Kirkland JL, 1996, INT J OBESITY, V20, pS102; Kunej T, 2007, OBESITY, V15, P2896, DOI 10.1038/oby.2007.344; LEE YB, 1974, J ANIM SCI, V38, P532, DOI 10.2527/jas1974.383532x; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Li P, 2012, J DAIRY SCI, V95, P1759, DOI 10.3168/jds.2011-4580; Li RW, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-114; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo S., 2007, NOVART FDN SYMP, V286, P196; Lobo Sandra, 2007, Novartis Found Symp, V286, P113; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Michal JJ, 2006, ANIM GENET, V37, P400, DOI 10.1111/j.1365-2052.2006.01464.x; MILLER MF, 1991, J ANIM SCI, V69, P162; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Niesler CU, 1998, DIABETES, V47, P1365, DOI 10.2337/diabetes.47.8.1365; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Radler U, 2011, ANN NUTR METAB, V58, P133, DOI 10.1159/000327150; Randhawa M, 2009, FASEB J, V23, P835, DOI 10.1096/fj.08-116327; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Toyoda M, 2009, CELL BIOCHEM FUNCT, V27, P440, DOI 10.1002/cbf.1591; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Yang YZ, 2004, BIOCHEM BIOPH RES CO, V320, P1204, DOI 10.1016/j.bbrc.2004.06.069	79	39	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66267	10.1371/journal.pone.0066267	http://dx.doi.org/10.1371/journal.pone.0066267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805208	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500036
J	Davino, S; Willemsen, A; Panno, S; Davino, M; Catara, A; Elena, SF; Rubio, L				Davino, Salvatore; Willemsen, Anouk; Panno, Stefano; Davino, Mario; Catara, Antonino; Elena, Santiago F.; Rubio, Luis			Emergence and Phylodynamics of Citrus tristeza virus in Sicily, Italy	PLOS ONE			English	Article							MOSAIC-VIRUS; PHYLOGENETIC ANALYSES; MOLECULAR EVOLUTION; GENETIC-VARIATION; POPULATION; RECOMBINATION; SEQUENCE; CTV; SUPERINFECTION; EPIDEMIOLOGY	Citrus tristeza virus (CTV) outbreaks were detected in Sicily island, Italy for the first time in 2002. To gain insight into the evolutionary forces driving the emergence and phylogeography of these CTV populations, we determined and analyzed the nucleotide sequences of the p20 gene from 108 CTV isolates collected from 2002 to 2009. Bayesian phylogenetic analysis revealed that mild and severe CTV isolates belonging to five different clades (lineages) were introduced in Sicily in 2002. Phylogeographic analysis showed that four lineages co-circulated in the main citrus growing area located in Eastern Sicily. However, only one lineage (composed of mild isolates) spread to distant areas of Sicily and was detected after 2007. No correlation was found between genetic variation and citrus host, indicating that citrus cultivars did not exert differential selective pressures on the virus. The genetic variation of CTV was not structured according to geographical location or sampling time, likely due to the multiple introduction events and a complex migration pattern with intense co- and recirculation of different lineages in the same area. The phylogenetic structure, statistical tests of neutrality and comparison of synonymous and nonsynonymous substitution rates suggest that weak negative selection and genetic drift following a rapid expansion may be the main causes of the CTV variability observed today in Sicily. Nonetheless, three adjacent amino acids at the p20 N-terminal region were found to be under positive selection, likely resulting from adaptation events.	[Davino, Salvatore; Panno, Stefano] Univ Palermo, Palermo, Italy; [Davino, Salvatore] IEMEST, Palermo, Italy; [Willemsen, Anouk; Elena, Santiago F.] CSIC UPV, IBMCP, Valencia, Spain; [Davino, Mario] Univ Catania, Catania, Italy; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Rubio, Luis] IVIA, Valencia, Spain	University of Palermo; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Catania; The Santa Fe Institute	Rubio, L (corresponding author), IVIA, Valencia, Spain.	lrubio@ivia.es	Elena, Santiago F./A-4191-2011; Rubio, Luis/H-7810-2012; Panno, Stefano/ABG-8552-2020; Davino, Salvatore/AAI-3858-2020; Willemsen, Anouk/H-7892-2012	Elena, Santiago F./0000-0001-8249-5593; Rubio, Luis/0000-0002-7964-3062; Panno, Stefano/0000-0002-8941-7050; Davino, Salvatore/0000-0002-5926-6300; Willemsen, Anouk/0000-0002-8511-3244	Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BFU2012-30805]; John Templeton Foundation [22371]	Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion; John Templeton Foundation	A.W. and S.F.E. were supported by grant BFU2012-30805 from the Spanish Secretaria de Estado de Investigacion, Desarrollo e Innovacion and by a grant 22371 from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Kubaa R, 2012, PHYTOPATHOL MEDITERR, V51, P496; Albiach-Marti MR, 2000, J VIROL, V74, P6856, DOI 10.1128/JVI.74.15.6856-6865.2000; Ayllon MA, 2006, VIRUS GENES, V32, P119, DOI 10.1007/s11262-005-6866-4; Ayllon MA, 1999, VIROLOGY, V255, P32, DOI 10.1006/viro.1998.9566; BARJOSEPH M, 1989, ANNU REV PHYTOPATHOL, V27, P291, DOI 10.1146/annurev.py.27.090189.001451; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; D'Urso F, 2003, MOL ECOL, V12, P517, DOI 10.1046/j.1365-294X.2000.01747.x; Davino S, 2005, EUR J PLANT PATHOL, V111, P289, DOI 10.1007/s10658-003-2815-z; Davino S, 2003, PLANT DIS, V87, DOI 10.1094/PDIS.2003.87.3.314A; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Febres VJ, 1996, PHYTOPATHOLOGY, V86, P1331; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Folimonova SY, 2010, J VIROL, V84, P1314, DOI 10.1128/JVI.02075-09; FU YX, 1993, GENETICS, V134, P1261; Gomez P, 2012, EUR J PLANT PATHOL, V134, P445, DOI 10.1007/s10658-012-0019-0; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Kimura M, 1985, NEUTRAL THEORY MOL E; Kong P, 2000, VIRUS GENES, V21, P139, DOI 10.1023/A:1008198311398; Lam TTY, 2012, MOL ECOL, V21, P3062, DOI 10.1111/j.1365-294X.2012.05577.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin S, 2009, J GEN VIROL, V90, P1527, DOI 10.1099/vir.0.008193-0; Matos LA, 2013, PLANT DIS, V97, P339, DOI 10.1094/PDIS-05-12-0421-RE; Mawassi M, 1996, J GEN VIROL, V77, P2359, DOI 10.1099/0022-1317-77-9-2359; Moreno P, 2008, MOL PLANT PATHOL, V9, P251, DOI 10.1111/J.1364-3703.2007.00455.X; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Ott M, 2007, P 19 ACM IEEE C SUP; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Powell CA, 2003, PLANT DIS, V87, P1116, DOI 10.1094/PDIS.2003.87.9.1116; Puigbo P, 2007, BIOINFORMATICS, V23, P1556, DOI 10.1093/bioinformatics/btm135; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Reed JC, 2003, VIROLOGY, V306, P203, DOI 10.1016/S0042-6822(02)00051-X; ROISTACHER CN, 1993, P 12 C INT ORG CITR, P00100; Roossinck MJ, 1999, J VIROL, V73, P6752, DOI 10.1128/JVI.73.8.6752-6758.1999; Rubio L, 1996, ANN APPL BIOL, V129, P479, DOI 10.1111/j.1744-7348.1996.tb05770.x; Rubio L, 2001, J VIROL, V75, P8054, DOI 10.1128/JVI.75.17.8054-8062.2001; Sambade A, 2002, PLANT PATHOL, V51, P257, DOI 10.1046/j.1365-3059.2002.00720.x; Sentandreu V, 2006, ARCH VIROL, V151, P875, DOI 10.1007/s00705-005-0683-x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silva G, 2012, J GEN VIROL, V93, P419, DOI 10.1099/vir.0.036574-0; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Sorrentino G., 2005, P 16 C INT ORG CITR, V16, P173; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAJIMA F, 1989, GENETICS, V123, P585; Talbi C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001166; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatineni S, 2011, P NATL ACAD SCI USA, V108, P17366, DOI 10.1073/pnas.1113227108; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Vives MC, 2005, VIROLOGY, V331, P232, DOI 10.1016/j.virol.2004.10.037; Vives MC, 1999, J GEN VIROL, V80, P811, DOI 10.1099/0022-1317-80-3-811; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016896	62	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66700	10.1371/journal.pone.0066700	http://dx.doi.org/10.1371/journal.pone.0066700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818960	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800097
J	Tseng, HH; Chen, SH; Liu, CM; Howes, O; Huang, YL; Hsieh, MH; Liu, CC; Shan, JC; Lin, YT; Hwu, HG				Tseng, Huai-Hsuan; Chen, Sue-Huei; Liu, Chih-Min; Howes, Oliver; Huang, Yu-Lien; Hsieh, Ming H.; Liu, Chen-Chung; Shan, Jia-Chi; Lin, Yi-Ting; Hwu, Hai-Gwo			Facial and Prosodic Emotion Recognition Deficits Associate with Specific Clusters of Psychotic Symptoms in Schizophrenia	PLOS ONE			English	Article							AUDITORY-VERBAL HALLUCINATIONS; NEGATIVE-SYNDROME-SCALE; CARD SORTING TEST; DIAGNOSTIC-ANALYSIS; PSYCHOPATHOLOGY; EXPRESSIONS; RELATIVES; COGNITION; DISORDER; TAIWAN	Background: Patients with schizophrenia perform significantly worse on emotion recognition tasks than healthy participants across several sensory modalities. Emotion recognition abilities are correlated with the severity of clinical symptoms, particularly negative symptoms. However, the relationships between specific deficits of emotion recognition across sensory modalities and the presentation of psychotic symptoms remain unclear. The current study aims to explore how emotion recognition ability across modalities and neurocognitive function correlate with clusters of psychotic symptoms in patients with schizophrenia. Methods: 111 participants who met the DSM-IV diagnostic criteria for schizophrenia and 70 healthy participants performed on a dual-modality emotion recognition task, the Diagnostic Analysis of Nonverbal Accuracy 2-Taiwan version (DANVA-2-TW), and selected subscales of WAIS-III. Of all, 92 patients received neurocognitive evaluations, including CPT and WCST. These patients also received the PANSS for clinical evaluation of symptomatology. Results: The emotion recognition ability of patients with schizophrenia was significantly worse than healthy participants in both facial and vocal modalities, particularly fearful emotion. An inverse correlation was noted between PANSS total score and recognition accuracy for happy emotion. The difficulty of happy emotion recognition and earlier age of onset, together with the perseveration error in WCST predicted total PANSS score. Furthermore, accuracy of happy emotion and the age of onset were the only two significant predictors of delusion/hallucination. All the associations with happy emotion recognition primarily concerned happy prosody. Discussion: Deficits in emotional processing in specific categories, i.e. in happy emotion, together with deficit in executive function, may reflect dysfunction of brain systems underlying severity of psychotic symptoms, in particular the positive dimension.	[Tseng, Huai-Hsuan; Howes, Oliver] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England; [Tseng, Huai-Hsuan; Liu, Chih-Min; Hsieh, Ming H.; Liu, Chen-Chung; Shan, Jia-Chi; Hwu, Hai-Gwo] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10764, Taiwan; [Tseng, Huai-Hsuan; Liu, Chih-Min; Hsieh, Ming H.; Liu, Chen-Chung; Shan, Jia-Chi; Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Sue-Huei; Huang, Yu-Lien] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Shan, Jia-Chi] Cathay Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Lin, Yi-Ting] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Psychiat, Dou Liou City, Yun Lin, Taiwan	University of London; King's College London; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Cathay General Hospital; National Taiwan University; National Taiwan University Hospital	Chen, SH (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.	shchen@ntu.edu.tw	Howes, Oliver/E-7156-2010; Tseng, Huai-Hsuan/D-2034-2009; Hsieh, Ming H./B-2970-2010	Howes, Oliver/0000-0002-2928-1972; Tseng, Huai-Hsuan/0000-0002-5213-1585; Chen, Sue-Huie/0000-0001-6737-2966; LIU, CHIH-MIN/0000-0001-7016-8990; Shan, Jia-Chi/0000-0002-2852-8224; Lin, Yi-Ting/0000-0003-3821-4744; Hsieh, Ming H./0000-0002-3585-7843; HWU, HAI-GWO/0000-0002-2582-2807; LIU, CHEN-CHUNG/0000-0002-9290-110X	National Science Council, Taiwan [NSC-98-2314-B-002- 047-MY3, NSC-96-3112-B-002-039-, NSC-96-2413-H-002-012-MY3, NSC-99-2628-B-002-060-MY2]; MRC [G0700995] Funding Source: UKRI; Medical Research Council [MC_U120097115, 1116129, G0700995] Funding Source: researchfish	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Science Council, Taiwan (NSC-98-2314-B-002- 047-MY3, NSC-96-3112-B-002-039-, NSC-96-2413-H-002-012-MY3, NSC-99-2628-B-002-060-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 1998, SCHIZOPHR RES, V32, P171, DOI 10.1016/S0920-9964(98)00042-5; Alba-Ferrara L, 2012, CLIN PSYCHOL REV, V32, P244, DOI 10.1016/j.cpr.2012.02.003; Bediou B, 2005, PSYCHIAT RES, V133, P149, DOI 10.1016/j.psychres.2004.08.008; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Bozikas VP, 2004, J INT NEUROPSYCH SOC, V10, P549, DOI 10.1017/S1355617704104074; Chan RCK, 2010, PSYCHIAT RES, V178, P381, DOI 10.1016/j.psychres.2009.03.035; Chang CJ, 2002, SCHIZOPHRENIA BULL, V28, P379, DOI 10.1093/oxfordjournals.schbul.a006947; Chen S, 2006, SERIOUS GAMES GAMES; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Cheng J. J., 1996, CHINESE PSYCHIAT, V10, P251; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Edwards J, 2001, SCHIZOPHR RES, V48, P235, DOI 10.1016/S0920-9964(00)00099-2; GOLDBERG TE, 1987, ARCH GEN PSYCHIAT, V44, P1008; Hoekert M, 2007, SCHIZOPHR RES, V96, P135, DOI 10.1016/j.schres.2007.07.023; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; Jack RE, 2012, P NATL ACAD SCI; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Kohler CG, 2000, BIOL PSYCHIAT, V48, P127, DOI 10.1016/S0006-3223(00)00847-7; Koren D, 1998, NEUROPSYCHOLOGY, V12, P289, DOI 10.1037/0894-4105.12.2.289; Laroi F, 2010, J NERV MENT DIS, V198, P79, DOI 10.1097/NMD.0b013e3181c84cb0; Lee SJ, 2009, PSYCHIAT INVEST, V6, P156, DOI 10.4306/pi.2009.6.3.156; Leitman DI, 2010, SCHIZOPHRENIA BULL, V36, P545, DOI 10.1093/schbul/sbn115; Lien YJ, 2010, GENES BRAIN BEHAV, V9, P695, DOI 10.1111/j.1601-183X.2010.00599.x; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Pan YJ, 2009, COMPR PSYCHIAT, V50, P443, DOI 10.1016/j.comppsych.2008.11.003; Park SH, 2011, PSYCHIAT RES, V187, P18, DOI 10.1016/j.psychres.2010.11.007; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Poole JH, 2000, J INT NEUROPSYCH SOC, V6, P649, DOI 10.1017/S135561770066602X; Rossell SL, 2005, SCHIZOPHR RES, V78, P95, DOI 10.1016/j.schres.2005.06.002; SCHNEIDER F, 1995, SCHIZOPHR RES, V17, P67, DOI 10.1016/0920-9964(95)00031-G; Shea TL, 2007, SCHIZOPHR RES, V90, P214, DOI 10.1016/j.schres.2006.09.021; Silver H, 2002, SCHIZOPHR RES, V55, P171, DOI 10.1016/S0920-9964(01)00208-0; Tseng HH, 2012, TAIWANESE J PSYCHIAT, V26; Tseng HH, 2008, INT J PSYCHOL, V43, P478; Tsoi DT, 2008, SCHIZOPHR RES, V99, P263, DOI 10.1016/j.schres.2007.11.006; van der Gaag M, 2006, SCHIZOPHR RES, V85, P273, DOI 10.1016/j.schres.2006.04.001; Wickline VB, 2012, J NONVERBAL BEHAV, V36, P59, DOI 10.1007/s10919-011-0125-2; Wickline VB, 2009, J GENET PSYCHOL, V170, P5, DOI 10.3200/GNTP.170.1.5-30; Yip JTH, 2003, BRAIN COGNITION, V51, P169	43	32	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66571	10.1371/journal.pone.0066571	http://dx.doi.org/10.1371/journal.pone.0066571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23818944	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800080
J	Su, CX; Duan, XG; Zheng, J; Liang, LJ; Wang, F; Guo, L				Su, Chunxia; Duan, Xiangguo; Zheng, Jie; Liang, Lijun; Wang, Feng; Guo, Lin			IFN-alpha as an Adjuvant for Adenovirus-Vectored FMDV Subunit Vaccine through Improving the Generation of T Follicular Helper Cells	PLOS ONE			English	Article							B-CELL; I INTERFERONS; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; CUTTING EDGE; FH CELLS; EXPRESSION; INFECTION; ANTIGEN; VIVO	IFN-alpha exhibits either direct antiviral effects or distinct immunomodulatory properties, which was identified as a 'natural immune adjuvant' for both the innate and the adaptive immune responses. Here we have investigated the effects of IFN-alpha as an adjuvant on the generation of T follicular helper (Tfh) cells and antigen-specific antibody responses. The data showed that adenoviral vectors co-expressing FMDV VP1 proteins and porcine IFN-alpha potently enhanced the generation of Tfh cells, the secretion of IL-21 protein and the expression of Bcl-6 mRNA, compared with adenoviral vectors sole expressing VP1 alone. Additionally, IFN-alpha substantial increased the number of germinal-center (GC) B cells and formation of GCs. Furthermore, IFN-alpha enhanced the antibody response, as shown by increased production of all IgG and subclasses of IgG1 and IgG2a. Thus, our results revealed the potent adjuvant activity of IFN-alpha which enhanced the generation of Tfh cells and regulated the humoral immunity by promoting germinal-center reactions and antibody responses.	[Su, Chunxia; Zheng, Jie; Wang, Feng; Guo, Lin] Ningxia Med Univ, Sch Basic Med Sci, Ningxia, Peoples R China; [Duan, Xiangguo] Ningxia Med Univ, Lab Examinat Coll, Ningxia, Peoples R China; [Liang, Lijun] Ningxia Med Univ, Gen Hosp, Ningxia, Peoples R China	Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Su, CX (corresponding author), Ningxia Med Univ, Sch Basic Med Sci, Ningxia, Peoples R China.	chunxiasu@yahoo.com.cn			National Natural Science Foundations of China [31001064, 81260678]; Natural Science Foundations of Ningxia, China [NZ11178]; department of education project in Ningxia, China [NGY2012065]; Ningxia medical university start project, China [200906]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Ningxia, China; department of education project in Ningxia, China; Ningxia medical university start project, China	This work was funded by National Natural Science Foundations of China (31001064 and 81260678), Natural Science Foundations of Ningxia, China (NZ11178), department of education project in Ningxia, China (NGY2012065), and Ningxia medical university start project, China (200906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Bayer W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-75; Bracci L, 2005, VACCINE, V23, P2994, DOI 10.1016/j.vaccine.2004.12.006; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Chen PY, 2010, J NINGXIA MED U, V32, P947; Chen PY, 2009, J NINGXIA MED U, V31, P566; Chu Jia-Qi, 2012, Journal of Bacteriology and Virology, V42, P224; Couch RB, 2009, VACCINE, V27, P5344, DOI 10.1016/j.vaccine.2009.06.084; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Holl EK, 2011, J IMMUNOL, V186, P5603, DOI 10.4049/jimmunol.1003464; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Segundo FDS, 2010, J VIROL, V84, P2063, DOI 10.1128/JVI.01874-09; Su CX, 2007, DISCUSSION RECOMBINA; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Thompson AL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/289597; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zhu JG, 2007, J IMMUNOL, V178, P3505, DOI 10.4049/jimmunol.178.6.3505	38	18	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66134	10.1371/journal.pone.0066134	http://dx.doi.org/10.1371/journal.pone.0066134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823532	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400056
J	Belonogova, NM; Svishcheva, GR; van Duijn, CM; Aulchenko, YS; Axenovich, TI				Belonogova, Nadezhda M.; Svishcheva, Gulnara R.; van Duijn, Cornelia M.; Aulchenko, Yurii S.; Axenovich, Tatiana I.			Region-Based Association Analysis of Human Quantitative Traits in Related Individuals	PLOS ONE			English	Article							MISSING HERITABILITY; HUMAN HEIGHT; KERNEL; REGRESSION; VARIANTS; TESTS; LOCI	Regional-based association analysis instead of individual testing of each SNP was introduced in genome-wide association studies to increase the power of gene mapping, especially for rare genetic variants. For regional association tests, the kernel machine-based regression approach was recently proposed as a more powerful alternative to collapsing-based methods. However, the vast majority of existing algorithms and software for the kernel machine-based regression are applicable only to unrelated samples. In this paper, we present a new method for the kernel machine-based regression association analysis of quantitative traits in samples of related individuals. The method is based on the GRAMMAR+ transformation of phenotypes of related individuals, followed by use of existing kernel machine-based regression software for unrelated samples. We compared the performance of kernel-based association analysis on the material of the Genetic Analysis Workshop 17 family sample and real human data by using our transformation, the original untransformed trait, and environmental residuals. We demonstrated that only the GRAMMAR+ transformation produced type I errors close to the nominal value and that this method had the highest empirical power. The new method can be applied to analysis of related samples by using existing software for kernel-based association analysis developed for unrelated samples.	[Belonogova, Nadezhda M.; Svishcheva, Gulnara R.; Aulchenko, Yurii S.; Axenovich, Tatiana I.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Erasmus University Rotterdam; Erasmus MC	Axenovich, TI (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	aks@bionet.nsc.ru	Svishcheva, Gulnara/AAD-2881-2022; Aulchenko, Yurii/M-8270-2013; Axenovich, Tatiana I/AAD-2595-2022	Svishcheva, Gulnara/0000-0001-9478-267X; Aulchenko, Yurii/0000-0002-7899-1575; Axenovich, Tatiana I/0000-0002-4318-4458; Van Duijn, Cornelia/0000-0002-2374-9204	Russian Foundation for Basic Research [11-04-00098-a, 12-04-33182]; Programs of Russian Academy of Sciences and RFBR-Helmholtz Joint Research Groups program [12-04-91322-CHGamma_ a]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Programs of Russian Academy of Sciences and RFBR-Helmholtz Joint Research Groups program	This work was supported by grants from the Russian Foundation for Basic Research (11-04-00098-a, 12-04-33182), Programs of Russian Academy of Sciences and RFBR-Helmholtz Joint Research Groups program (12-04-91322-CH Gamma_ a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Almasy L, 2011, BMC P S9; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2009, EUR J HUM GENET, V17, P1070, DOI 10.1038/ejhg.2009.5; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Lun, 2011, BMC Proc, V5 Suppl 9, pS117, DOI 10.1186/1753-6561-5-S9-S117; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Perola M, 2011, BEST PRACT RES CL EN, V25, P19, DOI 10.1016/j.beem.2010.10.013; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Schifano ED, 2012, GENET EPIDEMIOL, DOI [10.1002/gepi.21676, DOI 10.1002/GEPI.21676.[]; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Vineis P, 2010, NAT REV GENET, V11, DOI 10.1038/nrg2809-c2; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57; Zhang Qunyuan, 2011, BMC Proc, V5 Suppl 9, pS35, DOI 10.1186/1753-6561-5-S9-S35; Zhu HJ, 2012, BIOINFORMATICS, V28, pI375, DOI 10.1093/bioinformatics/bts406	34	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65395	10.1371/journal.pone.0065395	http://dx.doi.org/10.1371/journal.pone.0065395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799013	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800005
J	Gatschenberger, H; Azzami, K; Tautz, J; Beier, H				Gaetschenberger, Heike; Azzami, Klara; Tautz, Juergen; Beier, Hildburg			Antibacterial Immune Competence of Honey Bees (Apis mellifera) Is Adapted to Different Life Stages and Environmental Risks	PLOS ONE			English	Article							PAENIBACILLUS-LARVAE; DEVELOPMENTAL-STAGES; BACTERIAL-INFECTION; AMERICAN FOULBROOD; DEFENSE-MECHANISMS; INSECT IMMUNITY; PARALYSIS VIRUS; PROTEINS; PEPTIDE; GENES	The development of all honey bee castes proceeds through three different life stages all of which encounter microbial infections to a various extent. We have examined the immune strength of honey bees across all developmental stages with emphasis on the temporal expression of cellular and humoral immune responses upon artificial challenge with viable Escherichia coli bacteria. We employed a broad array of methods to investigate defence strategies of infected individuals: (a) fate of bacteria in the haemocoel; (b) nodule formation and (c) induction of antimicrobial peptides (AMPs). Newly emerged adult worker bees and drones were able to activate efficiently all examined immune reactions. The number of viable bacteria circulating in the haemocoel of infected bees declined rapidly by more than two orders of magnitude within the first 4-6 h post-injection (p.i.), coinciding with the occurrence of melanised nodules. Antimicrobial activity, on the other hand, became detectable only after the initial bacterial clearance. These two temporal patterns of defence reactions very likely represent the constitutive cellular and the induced humoral immune response. A unique feature of honey bees is that a fraction of worker bees survives the winter season in a cluster mostly engaged in thermoregulation. We show here that the overall immune strength of winter bees matches that of young summer bees although nodulation reactions are not initiated at all. As expected, high doses of injected viable E. coli bacteria caused no mortality in larvae or adults of each age. However, drone and worker pupae succumbed to challenge with E. coli even at low doses, accompanied by a premature darkening of the pupal body. In contrast to larvae and adults, we observed no fast clearance of viable bacteria and no induction of AMPs but a rapid proliferation of E. coli bacteria in the haemocoel of bee pupae ultimately leading to their death.	[Gaetschenberger, Heike; Azzami, Klara; Tautz, Juergen; Beier, Hildburg] Univ Wurzburg, BEEgrp, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Beier, H (corresponding author), Univ Wurzburg, BEEgrp, Bioctr, D-97070 Wurzburg, Germany.	h.beier@biozentrum.uni-wuerzburg.de			Bundesministerium fur Bildung und Forschung, BMBF [FKZ 0315125B]; Deutsche Forschungsgemeinschaft [SFB 567, Part A9]	Bundesministerium fur Bildung und Forschung, BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was financially supported by Bundesministerium fur Bildung und Forschung, BMBF, FKZ 0315125B (Fugapis) to JT and HG and by a grant from the "Deutsche Forschungsgemeinschaft'', SFB 567, Part A9 to HB, JT, KA and HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2011, INSECT BIOCHEM MOLEC, V41, P968, DOI 10.1016/j.ibmb.2011.09.006; Aumeier P, 2001, APIDOLOGIE, V32, P491; Azzami K, 2009, APIDOLOGIE, V40, P660; Azzami K, 2012, ARCH VIROL, V157, P689, DOI 10.1007/s00705-012-1223-0; BAMRICK JF, 1961, J INSECT PATHOL, V3, P381; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; Bedick JC, 2001, COMP BIOCHEM PHYS C, V130, P107, DOI 10.1016/S1532-0456(01)00226-5; Behrends A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00015; Bilikova K, 2001, APIDOLOGIE, V32, P275, DOI 10.1051/apido:2001129; BOMAN HG, 1974, INFECT IMMUN, V10, P136, DOI 10.1128/IAI.10.1.136-145.1974; Brodsgaard CJ, 1998, APIDOLOGIE, V29, P569, DOI 10.1051/apido:19980609; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Doums C, 2002, ECOL ENTOMOL, V27, P138, DOI 10.1046/j.1365-2311.2002.00388.x; DUNN PE, 1983, J INVERTEBR PATHOL, V41, P77, DOI 10.1016/0022-2011(83)90238-0; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; FAYE I, 1975, INFECT IMMUN, V12, P1426, DOI 10.1128/IAI.12.6.1426-1438.1975; Fedorova AA, 2011, ANTIVIR RES, V91, P267, DOI 10.1016/j.antiviral.2011.06.011; FLURI P, 1977, EXPERIENTIA, V33, P1240, DOI 10.1007/BF01922354; Fluri P, 1993, SCHWEIZ BIENENZEIT, V116, P624; Fujita T, 2013, J PROTEOME RES, V12, P404, DOI 10.1021/pr300700e; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Gaetschenberger H, 2012, J EXP BIOL, V215, P1313, DOI 10.1242/jeb.065276; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; HOROHOV DW, 1983, J INVERTEBR PATHOL, V41, P203, DOI 10.1016/0022-2011(83)90220-3; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Huszart T, 2008, ADV VIRUS RES, V72, P227, DOI 10.1016/S0065-3527(08)00406-5; Ivanova E., 2007, J CELL MOL BIOL, V6, P129; JAY S. CAMERON, 1962, BEE WORLD, V43, P119; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kanbar G, 2003, PARASITOL RES, V90, P349, DOI 10.1007/s00436-003-0827-4; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Korner P, 2004, J INVERTEBR PATHOL, V87, P59, DOI 10.1016/j.jip.2004.07.004; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kraus FB, 2003, J EVOLUTION BIOL, V16, P914, DOI 10.1046/j.1420-9101.2003.00593.x; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laughton AM, 2011, J INSECT PHYSIOL, V57, P1023, DOI 10.1016/j.jinsphys.2011.04.020; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schluns H, 2007, INSECT MOL BIOL, V16, P753, DOI 10.1111/j.1365-2583.2007.00768.x; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Siede R, 2012, J APICULT RES, V51, P320, DOI 10.3896/IBRA.1.51.4.05; Stabentheiner A, 2003, J EXP BIOL, V206, P353, DOI 10.1242/jeb.00082; Stanley D, 2011, J APPL ENTOMOL, V135, P534, DOI 10.1111/j.1439-0418.2010.01612.x; Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x; STANLEYSAMUELSON DW, 1991, P NATL ACAD SCI USA, V88, P1064, DOI 10.1073/pnas.88.3.1064; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Szymas B, 2003, APIDOLOGIE, V34, P97, DOI 10.1051/apido:2003012; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Tautz J, 2008, BUZZ BEES; Trenczek T, 1998, ZOOL-ANAL COMPLEX SY, V101, P298; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Winston M.L., 1991, BIOL HONEY BEE; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x	83	62	63	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66415	10.1371/journal.pone.0066415	http://dx.doi.org/10.1371/journal.pone.0066415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799099	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800031
J	Yang, WP; Li, Q; Ochi, T; Yang, JJ; Gao, YL; Tang, XY; Takahashi, S; Wu, JL				Yang, Weiping; Li, Qi; Ochi, Tatsuya; Yang, Jingjing; Gao, Yulin; Tang, Xiaoyu; Takahashi, Satoshi; Wu, Jinglong			Effects of Auditory Stimuli in the Horizontal Plane on Audiovisual Integration: An Event-Related Potential Study	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; VISUAL INTERACTIONS; SELECTIVE ATTENTION; SPEECH-PERCEPTION; HUMANS; CORTEX; SOUND; ACTIVATION; DYNAMICS; SIGNALS	This article aims to investigate whether auditory stimuli in the horizontal plane, particularly originating from behind the participant, affect audiovisual integration by using behavioral and event-related potential (ERP) measurements. In this study, visual stimuli were presented directly in front of the participants, auditory stimuli were presented at one location in an equidistant horizontal plane at the front (0 degrees, the fixation point), right (90 degrees), back (180 degrees), or left (270 degrees) of the participants, and audiovisual stimuli that include both visual stimuli and auditory stimuli originating from one of the four locations were simultaneously presented. These stimuli were presented randomly with equal probability; during this time, participants were asked to attend to the visual stimulus and respond promptly only to visual target stimuli (a unimodal visual target stimulus and the visual target of the audiovisual stimulus). A significant facilitation of reaction times and hit rates was obtained following audiovisual stimulation, irrespective of whether the auditory stimuli were presented in the front or back of the participant. However, no significant interactions were found between visual stimuli and auditory stimuli from the right or left. Two main ERP components related to audiovisual integration were found: first, auditory stimuli from the front location produced an ERP reaction over the right temporal area and right occipital area at approximately 160-200 milliseconds; second, auditory stimuli from the back produced a reaction over the parietal and occipital areas at approximately 360-400 milliseconds. Our results confirmed that audiovisual integration was also elicited, even though auditory stimuli were presented behind the participant, but no integration occurred when auditory stimuli were presented in the right or left spaces, suggesting that the human brain might be particularly sensitive to information received from behind than both sides.	[Yang, Weiping; Ochi, Tatsuya; Yang, Jingjing; Gao, Yulin; Tang, Xiaoyu; Takahashi, Satoshi; Wu, Jinglong] Okayama Univ, Biomed Engn Lab, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Li, Qi] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun, Peoples R China	Okayama University; Changchun University of Science & Technology	Wu, JL (corresponding author), Okayama Univ, Biomed Engn Lab, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	wu@mech.okayama-u.ac.jp	Takahashi, Satoshi/ABG-8262-2021; Yang, Wei/HIA-0360-2022	Takahashi, Satoshi/0000-0002-3535-1535; Yang, Weiping/0000-0001-8839-2173	National Natural Science Foundation of China [61203362]; JSPS; VINNOVA under the Japan-Sweden Research Cooperative Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry;  [25303013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); VINNOVA under the Japan-Sweden Research Cooperative Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); 	A part of this work was supported by the Grant-in-Aid for Scientific Research (B) 25303013 and JSPS and VINNOVA under the Japan-Sweden Research Cooperative Program. A part of the study was also financially supported by the National Natural Science Foundation of China (61203362) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bernstein LE, 2008, NEUROIMAGE, V39, P423, DOI 10.1016/j.neuroimage.2007.08.035; Berryhill M, 2007, PERCEPT PSYCHOPHYS, V69, P628, DOI 10.3758/BF03193920; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Besle J, 2004, COGN PROCESS, V5, P189, DOI DOI 10.1007/S10339-004-0026-Y; Callan A, 2013, NEUROIMAGE, V66, P22, DOI 10.1016/j.neuroimage.2012.10.057; Colonius H, 2009, BRAIN TOPOGR, V21, P177, DOI 10.1007/s10548-009-0091-8; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; Fort A, 2002, CEREB CORTEX, V12, P1031, DOI 10.1093/cercor/12.10.1031; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gondan M, 2005, PERCEPT PSYCHOPHYS, V67, P713, DOI 10.3758/BF03193527; Harrington LK, 1998, EXP BRAIN RES, V122, P247, DOI 10.1007/s002210050512; Jones JA, 2006, EXP BRAIN RES, V174, P588, DOI 10.1007/s00221-006-0634-0; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Li Q, 2010, NEUROREPORT, V21, P173, DOI 10.1097/WNR.0b013e3283345f08; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; MILLER J, 1986, ATTEN PERCEPT PSYCHO, V40, P331, DOI DOI 10.3758/BF03203025; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Morimoto M, 2001, J ACOUST SOC AM, V109, P1596, DOI 10.1121/1.1352084; MUSICANT AD, 1984, J ACOUST SOC AM, V75, P1195, DOI 10.1121/1.390770; PAULESU E, 1995, BRAIN, V118, P661, DOI 10.1093/brain/118.3.661; Raij T, 2000, NEURON, V28, P617, DOI 10.1016/S0896-6273(00)00138-0; RUGG MD, 1995, J COGNITIVE NEUROSCI, V7, P209, DOI 10.1162/jocn.1995.7.2.209; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE, 1993, J COGNITIVE NEUROSCI, V5, P373; Stevenson RA, 2012, EXP BRAIN RES, V219, P121, DOI 10.1007/s00221-012-3072-1; Stevenson RA, 2010, NEUROIMAGE, V49, P3308, DOI 10.1016/j.neuroimage.2009.12.001; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Tuomainen J, 2005, COGNITION, V96, pB13, DOI 10.1016/j.cognition.2004.10.004; Turatto M, 2005, COGNITION, V96, pB55, DOI 10.1016/j.cognition.2004.12.001; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; WIGHTMAN FL, 1995, PERCEPTION SPACE MOT, P365; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Wu JL, 2009, J CLIN NEUROPHYSIOL, V26, P407, DOI 10.1097/WNP.0b013e3181c298b1; Wyk BCV, 2010, BRAIN COGNITION, V74, P97, DOI 10.1016/j.bandc.2010.07.002; Zampini M, 2007, NEUROPSYCHOLOGIA, V45, P1869, DOI 10.1016/j.neuropsychologia.2006.12.004	47	11	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66402	10.1371/journal.pone.0066402	http://dx.doi.org/10.1371/journal.pone.0066402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799097	gold, Green Published, Green Submitted			2022-12-27	WOS:000321397800029
J	Barrs, VR; van Doorn, TM; Houbraken, J; Kidd, SE; Martin, P; Pinheiro, MD; Richardson, M; Varga, J; Samson, RA				Barrs, Vanessa R.; van Doorn, Tineke M.; Houbraken, Jos; Kidd, Sarah E.; Martin, Patricia; Pinheiro, Maria Dolores; Richardson, Malcolm; Varga, Janos; Samson, Robert A.			Aspergillus felis sp nov., an Emerging Agent of Invasive Aspergillosis in Humans, Cats, and Dogs	PLOS ONE			English	Article							EPIDEMIOLOGIC CUTOFF VALUES; SPECIES RECOGNITION; POLYPHASIC TAXONOMY; MIC DISTRIBUTIONS; SECTION FUMIGATI; INFECTIONS; UDAGAWAE; LENTULUS; PATIENT	We describe a novel heterothallic species in Aspergillus section Fumigati, namely A. felis (neosartorya-morph) isolated from three host species with invasive aspergillosis including a human patient with chronic invasive pulmonary aspergillosis, domestic cats with invasive fungal rhinosinusitis and a dog with disseminated invasive aspergillosis. Disease in all host species was often refractory to aggressive antifungal therapeutic regimens. Four other human isolates previously reported as A. viridinutans were identified as A. felis on comparative sequence analysis of the partial beta-tubulin and/or calmodulin genes. A. felis is a heterothallic mold with a fully functioning reproductive cycle, as confirmed by mating-type analysis, induction of teleomorphs within 7 to 10 days in vitro and ascospore germination. Phenotypic analyses show that A. felis can be distinguished from the related species A. viridinutans by its ability to grow at 45 degrees C and from A. fumigatus by its inability to grow at 50 degrees C. Itraconazole and voriconazole cross-resistance was common in vitro.	[Barrs, Vanessa R.; Martin, Patricia] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [van Doorn, Tineke M.; Houbraken, Jos; Samson, Robert A.] Cent Bur Schimmelcultures Koninklijke Nederlandse, Dept Appl & Ind Mycol, Utrecht, Netherlands; [Kidd, Sarah E.] Womens & Childrens Hosp, Mycol Unit, SA Pathol, Adelaide, SA, Australia; [Pinheiro, Maria Dolores] Hosp Sao Joao, Microbiol Lab, Serv Clin Pathol, Oporto, Portugal; [Richardson, Malcolm] Univ S Manchester Hosp, Educ & Res Ctr, Mycol Reference Ctr Manchester, Manchester M20 8LR, Lancs, England; [Richardson, Malcolm] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Varga, Janos] Univ Szeged, Fac Sci, Dept Microbiol, Szeged, Hungary	University of Sydney; SA Pathology; Sao Joao Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Szeged University	Barrs, VR (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	vanessa.barrs@sydney.edu.au	Kidd, Sarah E./A-1731-2009; Houbraken, Jos/AAE-7955-2019; Samson, Robert/ABE-6704-2020; Barrs, Vanessa/K-3755-2012	Kidd, Sarah E./0000-0002-5957-4178; Houbraken, Jos/0000-0003-4893-4438; Barrs, Vanessa/0000-0001-6761-8022; Richardson, Malcolm/0000-0001-5672-9552; Pinheiro, Dolores/0000-0002-5525-0213; Samson, Robert A./0000-0002-2979-3097	Endeavour Research Fellowship; Australian Government; Australian Companion Animal Health Foundation; Centraalbureau voor Schimmelcultures-Koninklijke Nederlandse Akademie van Wetenschappen (CBS-KNAW) Fungal Biodiversity Centre, Utrecht, The Netherlands	Endeavour Research Fellowship; Australian Government(Australian GovernmentCGIAR); Australian Companion Animal Health Foundation; Centraalbureau voor Schimmelcultures-Koninklijke Nederlandse Akademie van Wetenschappen (CBS-KNAW) Fungal Biodiversity Centre, Utrecht, The Netherlands(Netherlands Government)	This study was funded by an Endeavour Research Fellowship awarded by the Australian Government to one of the authors (VRB) (http://www.australiaawards.gov.au/), The Australian Companion Animal Health Foundation and the Centraalbureau voor Schimmelcultures-Koninklijke Nederlandse Akademie van Wetenschappen (CBS-KNAW) Fungal Biodiversity Centre, Utrecht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fuoli L, 2008, ANTIMICROB AGENTS CH, V52, P1244, DOI 10.1128/AAC.00942-07; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2005, J CLIN MICROBIOL, V43, P5996, DOI 10.1128/JCM.43.12.5996-5999.2005; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Barrs VR, 2012, VET J, V191, P58, DOI 10.1016/j.tvjl.2011.02.009; Castro C, 2004, J CLIN MICROBIOL, V42, P4358, DOI 10.1128/JCM.42.9.4358-4360.2004; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Coelho D, 2011, MED MYCOL, V49, P755, DOI 10.3109/13693786.2011.556672; Day MJ, 2009, MED MYCOL, V47, pS315, DOI 10.1080/13693780802056038; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P5150, DOI 10.1128/AAC.00686-11; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P2855, DOI 10.1128/AAC.01730-10; Garcia-Solache MA, 2010, MBIO, V1, DOI 10.1128/mBio.00061-10; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; Giordano C, 2010, J FELINE MED SURG, V12, P714, DOI 10.1016/j.jfms.2010.07.015; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Kano R, 2013, J VET MED SCI, V75, P7, DOI 10.1292/jvms.12-0119; Katz ME, 2005, J CLIN MICROBIOL, V43, P551, DOI 10.1128/JCM.43.2.551-555.2005; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Montenegro G, 2009, J MED MICROBIOL, V58, P391, DOI 10.1099/jmm.0.005942-0; Nei M., 2000, MOL EVOLUTION PHYLOG; Norvell LL, 2011, MYCOTAXON, V116, P481, DOI 10.5248/116.481; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Pelaez T, 2013, J MED MICROBIOL, V62, P474, DOI 10.1099/jmm.0.044867-0; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3142, DOI 10.1128/JCM.00940-09; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Sugui JA, 2010, J CLIN MICROBIOL, V48, P220, DOI 10.1128/JCM.01556-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Van Der Linden JWM, 2011, MED MYCOL, V49, pS82, DOI 10.3109/13693786.2010.499916; Vinh DC, 2009, CLIN INFECT DIS, V49, P102, DOI 10.1086/599345; Vinh DC, 2009, EMERG INFECT DIS, V15, P1292, DOI 10.3201/eid1508.090251; Yaguchi Takashi, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P37, DOI 10.3314/jjmm.48.37	40	74	75	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64871	10.1371/journal.pone.0064871	http://dx.doi.org/10.1371/journal.pone.0064871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798996	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300005
J	Currie, S; Sinclair, M; Murphy, MH; Madden, E; Dunwoody, L; Liddle, D				Currie, Sinead; Sinclair, Marlene; Murphy, Marie H.; Madden, Elaine; Dunwoody, Lynn; Liddle, Dianne			Reducing the Decline in Physical Activity during Pregnancy: A Systematic Review of Behaviour Change Interventions	PLOS ONE			English	Review							GESTATIONAL WEIGHT-GAIN; LIFE-STYLE; ACTIVITY PATTERNS; SELF-EFFICACY; EXERCISE; WOMEN; PREVENTION; RISK; DIET; DETERMINANTS	Purpose: Physical activity (PA) typically declines throughout pregnancy. Low levels of PA are associated with excessive weight gain and subsequently increase risk of pre-eclampsia, gestational diabetes mellitus, hypertension disorders, delivery by caesarean section and stillbirth. Systematic reviews on PA during pregnancy have not explored the efficacy of behaviour change techniques or related theory in altering PA behaviour. This systematic review evaluated the content of PA interventions to reduce the decline of PA in pregnant women with a specific emphasis on the behaviour change techniques employed to elicit this change. Search and Review Methodology: Literature searches were conducted in eight databases. Strict inclusion and exclusion criteria were employed. Two reviewers independently evaluated each intervention using the behaviour change techniques (BCT) taxonomy to identify the specific behaviour change techniques employed. Two reviewers independently assessed the risk of bias using the guidelines from the Cochrane Collaboration. Overall quality was determined using the GRADE approach. Findings: A total of 1140 potentially eligible papers were identified from which 14 studies were selected for inclusion. Interventions included counselling (n = 6), structured exercise (n = 6) and education (n = 2). Common behaviour change techniques employed in these studies were goal setting and planning, feedback, repetition and substitution, shaping knowledge and comparison of behaviours. Regular face-to-face meetings were also commonly employed. PA change over time in intervention groups ranged from increases of 28% to decreases of 25%. In 8 out of 10 studies, which provided adequate data, participants in the intervention group were more physically active post intervention than controls. Conclusions and Implications: Physical activity interventions incorporating behaviour change techniques help reduce the decline in PA throughout pregnancy. Range of behaviour change techniques can be implemented to reduce this decline including goals and planning, shaping knowledge and comparison of outcomes. A lack of high quality interventions hampers conclusions of intervention effectiveness.	[Currie, Sinead; Sinclair, Marlene; Liddle, Dianne] Univ Ulster, Inst Nursing & Hlth Res, Maternal Fetal & Infant Res Ctr, Newtownabbey, North Ireland; [Murphy, Marie H.] Univ Ulster, Sport & Exercise Sci Res Inst, Ctr Phys Activ & Hlth Res, Newtownabbey, North Ireland; [Madden, Elaine] South Eastern Hlth & Social Care Trust, Belfast, Antrim, North Ireland; [Dunwoody, Lynn] Univ Ulster, Psychol Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University; Ulster University; Ulster University	Currie, S (corresponding author), Univ Ulster, Inst Nursing & Hlth Res, Maternal Fetal & Infant Res Ctr, Newtownabbey, North Ireland.	Currie-S4@email.ulster.ac.uk	; Liddle, Sarah Dianne/O-4686-2015	sinclair, marlene/0000-0003-4444-1505; Liddle, Sarah Dianne/0000-0001-8151-641X	Department of Education and Learning, Northern Ireland	Department of Education and Learning, Northern Ireland	This work was supported by the Department of Education and Learning, Northern Ireland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2002, OBSTET GYNECOL, V99, P171; Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299; Armstrong L, 2006, ACSMS GUID EX TEST P; Artal R, 2003, BRIT J SPORT MED, V37, P6, DOI 10.1136/bjsm.37.1.6; Asbee SM, 2009, OBSTET GYNECOL, V113, P305, DOI 10.1097/AOG.0b013e318195baef; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bassett DR, 2010, PHYS THER REV, V15, P135, DOI 10.1179/1743288X10Y.0000000004; Borodulin KM, 2008, MED SCI SPORT EXER, V40, P1901, DOI 10.1249/MSS.0b013e31817f1957; Brown MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039503; Brug Johannes, 2005, Int J Behav Nutr Phys Act, V2, P2, DOI 10.1186/1479-5868-2-2; Callaway LK, 2010, DIABETES CARE, V33, P1457, DOI 10.2337/dc09-2336; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chasan-Taber L, 2011, J PHYS ACT HEALTH, V8, pS228, DOI 10.1123/jpah.8.s2.s228; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Department of Health, 2011, UK PHYS ACT GUID; Evenson KR, 2011, PREV MED, V53, P39, DOI 10.1016/j.ypmed.2011.04.014; Evenson KR, 2004, PAEDIATR PERINAT EP, V18, P400, DOI 10.1111/j.1365-3016.2004.00595.x; Foxcroft KF, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-4; Foy R, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-207; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; Gaston A, 2011, J SCI MED SPORT, V14, P299, DOI 10.1016/j.jsams.2011.02.006; Gaston A, 2009, HEALTH PSYCHOL, V28, P726, DOI 10.1037/a0016702; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Haakstad LAH, 2011, EUR J CONTRACEP REPR, V16, P116, DOI 10.3109/13625187.2011.560307; Hausenblas H, 2011, J REPROD INFANT PSYC, V29, P308, DOI 10.1080/02646838.2011.629993; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hinton P S, 2001, Matern Child Health J, V5, P7, DOI 10.1023/A:1011315616694; Huang TT, 2011, MIDWIFERY, V27, P257, DOI 10.1016/j.midw.2009.06.009; Hui HL., 2006, CAN J DIABETES, V30, P169, DOI DOI 10.1016/S1499-2671(06)02010-7; Jackson RA, 2011, PATIENT EDUC COUNS, V83, P203, DOI 10.1016/j.pec.2010.05.019; Kramer MS, 2006, COCHRANE DATABASE SY, V3; Lawlor DA, 2006, INT J EPIDEMIOL, V35, P3, DOI 10.1093/ije/dyi309; Lee CF, 2011, INT J OBESITY, V35, P1079, DOI 10.1038/ijo.2010.225; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; MADDUX JE, 1983, J EXP SOC PSYCHOL, V19, P469, DOI 10.1016/0022-1031(83)90023-9; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; Michie S, BEHAV CHANGE T UNPUB; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Institute for Health and Clinical Excellence, 2006, 4 COMM US METH INCRE; NHS Information Centre, 2010, STAT OB PHYS ACT DIE; Ong MJ, 2009, DIABETES METAB, V35, P418, DOI 10.1016/j.diabet.2009.04.008; Oostdam N, 2012, BJOG-INT J OBSTET GY, V119, P1098, DOI 10.1111/j.1471-0528.2012.03366.x; Organisation for Economic Co-operation and Development, 2010, HLTH GLANC EUR 2010; Phelan S, 2010, AM J OBSTET GYNECOL, V202, DOI [10.1016/j.ajog.2009.06.008, 10.1016/j.ajog.2010.06.051]; Polley BA, 2002, INT J OBESITY, V26, P1494, DOI 10.1038/sj.ijo.0802130; Poudevigne MS, 2006, SPORTS MED, V36, P19, DOI 10.2165/00007256-200636010-00003; Prochaska J. O., 1984, TRANSTHEORETICAL APP; Rankin J, 2002, EFFECTS ANTENATAL EX; Ronnberg AK, 2010, BJOG-INT J OBSTET GY, V117, P1327, DOI 10.1111/j.1471-0528.2010.02619.x; Royal College of Obstetricians and Gynaecologists, 2006, EX PREGN; Sui ZX, 2012, ACTA OBSTET GYN SCAN, V91, P538, DOI 10.1111/j.1600-0412.2012.01357.x; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Walsh JM, 2007, BRIT MED J, V335, P169, DOI 10.1136/bmj.39267.518808.80; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Williams SL, 2011, HEALTH EDUC RES, V26, P308, DOI 10.1093/her/cyr005; Wolfe LA, 2002, PARMED X PREGNANCY, P1; Yeo S, 2009, RES NURS HEALTH, V32, P379, DOI 10.1002/nur.20328	65	80	82	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66385	10.1371/journal.pone.0066385	http://dx.doi.org/10.1371/journal.pone.0066385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799096	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300079
J	McGahon, MK; Yarham, JM; Daly, A; Guduric-Fuchs, J; Ferguson, LJ; Simpson, DA; Collins, A				McGahon, Mary K.; Yarham, Janet M.; Daly, Aideen; Guduric-Fuchs, Jasenka; Ferguson, Lyndsey J.; Simpson, David A.; Collins, Anthony			Distinctive Profile of IsomiR Expression and Novel MicroRNAs in Rat Heart Left Ventricle	PLOS ONE			English	Article							TRANSIENT OUTWARD CURRENT; MICROVASCULAR ENDOTHELIAL-CELLS; CARDIAC-HYPERTROPHY; MYOCARDIAL-INFARCTION; TRANSMURAL HETEROGENEITY; REGIONAL DIFFERENCES; CANINE VENTRICLE; ANGIOTENSIN-II; ELECTRICAL HETEROGENEITY; DIFFERENTIAL EXPRESSION	MicroRNAs (miRNAs) are single-stranded non-coding RNAs that negatively regulate target gene expression through mRNA cleavage or translational repression. There is mounting evidence that they play critical roles in heart disease. The expression of known miRNAs in the heart has been studied at length by microarray and quantitative PCR but it is becoming evident that microRNA isoforms (isomiRs) are potentially physiologically important. It is well known that left ventricular (patho)physiology is influenced by transmural heterogeneity of cardiomyocyte phenotype, and this likely reflects underlying heterogeneity of gene expression. Given the significant role of miRNAs in regulating gene expression, knowledge of how the miRNA profile varies across the ventricular wall will be crucial to better understand the mechanisms governing transmural physiological heterogeneity. To determinine miRNA/isomiR expression profiles in the rat heart we investigated tissue from different locations across the left ventricular wall using deep sequencing. We detected significant quantities of 145 known rat miRNAs and 68 potential novel orthologs of known miRNAs, in mature, mature* and isomiR formation. Many isomiRs were detected at a higher frequency than their canonical sequence in miRBase and have different predicted targets. The most common miR-133a isomiR was more effective at targeting a construct containing a sequence from the gelsolin gene than was canonical miR-133a, as determined by dual-fluorescence assay. We identified a novel rat miR-1 homolog from a second miR-1 gene; and a novel rat miRNA similar to miR-676. We also cloned and sequenced the rat miR-486 gene which is not in miRBase (v18). Signalling pathways predicted to be targeted by the most highly detected miRNAs include Ubiquitin-mediated Proteolysis, Mitogen-Activated Protein Kinase, Regulation of Actin Cytoskeleton, Wnt signalling, Calcium Signalling, Gap junctions and Arrhythmogenic Right Ventricular Cardiomyopathy. Most miRNAs are not expressed in a gradient across the ventricular wall, with exceptions including miR-10b, miR-21, miR-99b and miR-486.	[McGahon, Mary K.; Yarham, Janet M.; Daly, Aideen; Guduric-Fuchs, Jasenka; Ferguson, Lyndsey J.; Simpson, David A.; Collins, Anthony] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Collins, A (corresponding author), Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland.	anthony.collins@qub.ac.uk	Daly, Aideen/AAF-3537-2021	Daly, Aideen/0000-0001-5003-9630; Simpson, David/0000-0003-0157-1211	British Heart Foundation (BHF) [PG110/039/28365]; Biotechnology and Biological Sciences Research Council (BBSRC [BB/H005498/1]; Science Foundation Ireland; Trinity Centre for High Performance Computing; BBSRC [BB/H005498/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H005498/1] Funding Source: researchfish; British Heart Foundation [PG/10/39/28365] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); Biotechnology and Biological Sciences Research Council (BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Trinity Centre for High Performance Computing; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This research was partly supported by a British Heart Foundation (BHF; http://www.bhf.org.uk) grant to AC (PI) and DAS (Co-I) (PG110/039/28365); and partly supported by a Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk) grant to DAS (BB/H005498/1). The Trinity Genome Sequencing Laboratory is a core facility funded by Science Foundation Ireland and supported by the Trinity Centre for High Performance Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bierhuizen MFA, 2008, J MOL CELL CARDIOL, V45, P373, DOI 10.1016/j.yjmcc.2008.06.011; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bryant SM, 1997, CARDIOVASC RES, V35, P315, DOI 10.1016/S0008-6363(97)00111-9; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Busk PK, 2010, BIOCHEM BIOPH RES CO, V396, P989, DOI 10.1016/j.bbrc.2010.05.039; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carrillo ED, 2011, J CARDIOVASC PHARM, V58, P470, DOI 10.1097/FJC.0b013e31822a789b; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Chan YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058169; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; CLARK RB, 1993, CARDIOVASC RES, V27, P1795, DOI 10.1093/cvr/27.10.1795; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cordeiro JM, 2008, AM J PHYSIOL-HEART C, V295, pH154, DOI 10.1152/ajpheart.01327.2007; Cordeiro JM, 2004, AM J PHYSIOL-HEART C, V286, pH1471, DOI 10.1152/ajpheart.00748.2003; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; D'Alessandra Y, 2012, CURR OPIN CARDIOL, V27, P228, DOI 10.1097/HCO.0b013e3283522052; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Da Silva ND, 2012, MED SCI SPORT EXER, V44, P1453, DOI 10.1249/MSS.0b013e31824e8a36; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Dong D, 2003, CARDIOVASC RES, V57, P320, DOI 10.1016/S0008-6363(02)00661-2; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Dosenko VE, 2012, EXP CLIN CARDIOL, V17, P84; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; FEDIDA D, 1991, J PHYSIOL-LONDON, V442, P191, DOI 10.1113/jphysiol.1991.sp018789; Fernandes T, 2012, HYPERTENSION, V59, P513, DOI 10.1161/HYPERTENSIONAHA.111.185801; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Fu J, 2012, ENVIRON TOXICOL PHAR, V33, P312, DOI 10.1016/j.etap.2011.12.023; Fu MG, 1999, HEART VESSELS, V14, P283, DOI 10.1007/BF03257240; FURUKAWA T, 1990, CIRC RES, V67, P1287, DOI 10.1161/01.RES.67.5.1287; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Ge YZ, 2013, BBA-MOL BASIS DIS, V1832, P1, DOI 10.1016/j.bbadis.2012.09.004; Giunta Simona, 2009, Acta Biomed, V80, P187; Gladka MM, 2012, J MOL CELL CARDIOL, V52, P74, DOI 10.1016/j.yjmcc.2011.09.015; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Glukhov AV, CIRC RES, V106, P981; Goldoni D, 2012, BIOCHEM J, V448, P103, DOI 10.1042/BJ20120578; Gong NL, 2006, J BIOL CHEM, V281, P38498, DOI 10.1074/jbc.M607774200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grubb S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00118; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Hatcher CJ, 2000, DEV DYNAM, V219, P90, DOI 10.1002/1097-0177(200009)219:1<90::AID-DVDY1033>3.0.CO;2-L; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; He W, 2009, CARDIOVASC RES, V81, P64, DOI 10.1093/cvr/cvn259; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Honen BN, 2002, CLIN EXP PHARMACOL P, V29, P161, DOI 10.1046/j.1440-1681.2002.03620.x; Hou YL, 2012, MED SCI MONITOR, V18, pBR309, DOI 10.12659/MSM.883263; Humphreys DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030933; Katanosaka Y, 2005, J BIOL CHEM, V280, P5764, DOI 10.1074/jbc.M410240200; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kumarswamy R, 2012, EUR HEART J, V33, P1067, DOI 10.1093/eurheartj/ehs043; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laurita KR, 2003, CIRC RES, V92, P668, DOI 10.1161/01.RES.0000062468.25308.27; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Li RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044907; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; LITOVSKY SH, 1988, CIRC RES, V62, P116, DOI 10.1161/01.RES.62.1.116; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Liu HB, 2010, TRENDS CARDIOVAS MED, V20, P148, DOI 10.1016/j.tcm.2010.12.003; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Maier LS, 2011, HEART RHYTHM, V8, P474, DOI 10.1016/j.hrthm.2010.09.080; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mishra PK, 2010, CELL BIOCHEM BIOPHYS, V57, P67, DOI 10.1007/s12013-010-9084-1; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Mukhopadhyay P, 2012, J CELL MOL MED, V16, P2504, DOI 10.1111/j.1582-4934.2011.01480.x; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Munch G, 2002, J MOL CELL CARDIOL, V34, P321, DOI 10.1006/jmcc.2001.1515; Nabauer M, 1996, CIRCULATION, V93, P168, DOI 10.1161/01.CIR.93.1.168; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Ohanian M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-18; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Pan ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032571; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poelzing S, 2004, AM J PHYSIOL-HEART C, V286, pH2001, DOI 10.1152/ajpheart.00987.2003; Portbury AL, 2012, J MOL CELL CARDIOL, V52, P526, DOI 10.1016/j.yjmcc.2011.10.023; Prasad AM, 2011, AM J PHYSIOL-HEART C, V300, pH173, DOI 10.1152/ajpheart.00841.2010; Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rosati B, 2006, J MOL CELL CARDIOL, V40, P295, DOI 10.1016/j.yjmcc.2005.11.002; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rossow CF, 2006, CIRC RES, V98, P1306, DOI 10.1161/01.RES.0000222028.92993.10; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Schipper MEI, 2008, J HEART LUNG TRANSPL, V27, P1282, DOI 10.1016/j.healun.2008.09.005; Shan HL, 2009, BRIT J PHARMACOL, V158, P1227, DOI 10.1111/j.1476-5381.2009.00377.x; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; Shigekawa M, 2007, ANN NY ACAD SCI, V1099, P53, DOI 10.1196/annals.1387.059; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Stelzer JE, 2008, J PHYSIOL-LONDON, V586, P5203, DOI 10.1113/jphysiol.2008.160390; Stones R, 2008, PROG BIOPHYS MOL BIO, V97, P268, DOI 10.1016/j.pbiomolbio.2008.02.010; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Suh JH, 2012, BIOCHEM BIOPH RES CO, V423, P404, DOI 10.1016/j.bbrc.2012.05.138; Szabo G, 2005, PFLUG ARCH EUR J PHY, V450, P307, DOI 10.1007/s00424-005-1445-z; Tan JHC, 2004, EXP PHYSIOL, V89, P237, DOI 10.1113/expphysiol.2003.027052; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Vacchi-Suzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052442; Vacchi-Suzzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040395; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; White Michel, 2012, Ther Adv Cardiovasc Dis, V6, P5, DOI 10.1177/1753944711432901; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Xiao J, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-35; Xiong W, 2005, CIRC RES, V97, P207, DOI 10.1161/01.RES.0000175935.08283.27; Xu L, 2012, MOL BIOL REP, V39, P3847, DOI 10.1007/s11033-011-1163-x; Xu L, 2011, MOL CELL BIOCHEM, V352, P239, DOI 10.1007/s11010-011-0759-8; Xu M, 2012, CIRC RES, V111, P837, DOI 10.1161/CIRCRESAHA.112.277418; Xu XD, 2012, J CELL PHYSIOL, V227, P1391, DOI 10.1002/jcp.22852; Yang KC, 2012, J MOL CELL CARDIOL, V53, P101, DOI 10.1016/j.yjmcc.2012.04.012; Yang ZK, 1996, J PHYSIOL-LONDON, V492, P789, DOI 10.1113/jphysiol.1996.sp021346; Zhang Y, 2010, CELL PHYSIOL BIOCHEM, V26, P991, DOI 10.1159/000324012; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014736; Zuker M., 1999, RNA BIOCH BIOTECHNOL; Zygmunt AC, 2001, AM J PHYSIOL-HEART C, V281, pH689, DOI 10.1152/ajpheart.2001.281.2.H689; Zygmunt AC, 2000, AM J PHYSIOL-HEART C, V278, pH1671, DOI 10.1152/ajpheart.2000.278.5.H1671	154	27	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65809	10.1371/journal.pone.0065809	http://dx.doi.org/10.1371/journal.pone.0065809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799049	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300044
J	Rangel, DE; Marin-Medina, N; Castro, JE; Gonzalez-Mancera, A; Forero-Shelton, M				Rangel, Dilia E.; Marin-Medina, Nathaly; Castro, Jaime E.; Gonzalez-Mancera, Andres; Forero-Shelton, Manu			Observation of Bacterial Type I Pili Extension and Contraction under Fluid Flow	PLOS ONE			English	Article							COLI P-PILI; FIMBRIATED ESCHERICHIA-COLI; URINARY-TRACT INFECTIONS; MUSSEL BYSSAL THREAD; OPTICAL TWEEZERS; MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES; FORCE SPECTROSCOPY; ADHESION; FIMH	Type I pili are proteinaceous tethers that mediate bacterial adhesion of uropathogenic Escherichia coli to surfaces and are thought to help bacteria resist drag forces imparted by fluid flow via uncoiling of their quaternary structure. Uncoiling and recoiling have been observed in force spectroscopy experiments, but it is not clear if and how this process occurs under fluid flow. Here we developed an assay to study the mechanical properties of pili in a parallel plate flow chamber. We show that pili extend when attached E. coli bacteria are exposed to increasing shear stresses, that pili can help bacteria move against moderate fluid flows, and characterize two dynamic regimes of this displacement. The first regime is consistent with entropic contraction as modeled by a freely jointed chain, and the second with coiling of the quaternary structure of pili. These results confirm that coiling and uncoiling happen under flow but the observed dynamics are different from those reported previously. Using these results and those from previous studies, we review the mechanical properties of pili in the context of other elastic proteins such as the byssal threads of mussels. It has been proposed that the high extensibility of pili may help recruit more pili into tension and lower the force acting on each one by damping changes in force due to fluid flow. Our analysis of the mechanical properties suggests additional functions of pili; in particular, their extensibility may reduce tension by aligning pili with the direction of flow, and the uncoiled state of pili may complement uncoiling in regulating the force of the terminal adhesin.	[Rangel, Dilia E.; Castro, Jaime E.; Gonzalez-Mancera, Andres] Univ Los Andes, Dept Mech Engn, Bogota, Colombia; [Marin-Medina, Nathaly; Forero-Shelton, Manu] Univ Los Andes, Dept Phys, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Forero-Shelton, M (corresponding author), Univ Los Andes, Dept Phys, Bogota, Colombia.	anforero@uniandes.edu.co		Forero-Shelton, Manu/0000-0002-7989-0311; Gonzalez-Mancera, Andres/0000-0002-0663-2653	Faculty of Sciences (Fondo de Investigaciones); Faculty of Engineering (CIFI)	Faculty of Sciences (Fondo de Investigaciones); Faculty of Engineering (CIFI)	Funding for this project was obtained from two internal research grants of the Faculty of Sciences (Fondo de Investigaciones - DER and NM), one internal research grant of the Faculty of Engineering (CIFI) and an inter-faculties research grant, all of them at Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, BIOPHYS J, V90, P1521, DOI 10.1529/biophysj.105.074674; Andersson M, 2008, CHEMPHYSCHEM, V9, P221, DOI 10.1002/cphc.200700389; Andersson M, 2007, BIOPHYS J, V93, P3008, DOI 10.1529/biophysj.107.110643; Andersson M, 2006, BIOPHYS J, V91, P2717, DOI 10.1529/biophysj.106.087429; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Axner O, 2011, ADV EXP MED BIOL, V715, P301, DOI 10.1007/978-94-007-0940-9_19; Axner O, 2010, SPRINGER SER CHEM PH, V96, P337, DOI 10.1007/978-3-642-02597-6_18; Bell EC, 1996, J EXP BIOL, V199, P1005; Bjornham O, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3148027; Bjornham O, 2010, BIOPHYS J, V99, P1331, DOI 10.1016/j.bpj.2010.06.003; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Carrington E, 2004, AM MALACOL BULL, V18, P135; Carrington E, 2002, INTEGR COMP BIOL, V42, P846, DOI 10.1093/icb/42.4.846; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Connell I, 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; DOMINGUE GJ, 1985, J UROLOGY, V133, P983, DOI 10.1016/S0022-5347(17)49341-4; EDEN CS, 1977, INFECT IMMUN, V18, P767, DOI 10.1128/IAI.18.3.767-774.1977; Fallman E, 2004, PROC SPIE, V5514, P763, DOI 10.1117/12.579893; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; Gonzalez R. C., 2013, DIGITAL IMAGE PROCES, V2nd; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gossert AD, 2008, J MOL BIOL, V375, P752, DOI 10.1016/j.jmb.2007.10.059; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Haralick R. M., 2002, COMPUTER ROBOT VISIO; Howard J., 2001, MECH MOTOR PROTEINS; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; KALLENIUS G, 1981, LANCET, V2, P1369; KLEMM P, 1984, EUR J BIOCHEM, V143, P395, DOI 10.1111/j.1432-1033.1984.tb08386.x; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Moeser GM, 2006, J EXP BIOL, V209, P1996, DOI 10.1242/jeb.02234; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Trong IL, 2010, J STRUCT BIOL, V172, P380, DOI [10.1016/j.jsb.2010.06.002, DOI 10.1016/J.JSB.2010.06.002]; Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514; Vahidi B, 2012, J THEOR BIOL, V298, P42, DOI 10.1016/j.jtbi.2011.12.019; Whitfield M, 2010, BIOPHYS J, V99, P2470, DOI 10.1016/j.bpj.2010.08.045; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Zakrisson J., 2012, EUR BIOPHYS J, P1	47	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65563	10.1371/journal.pone.0065563	http://dx.doi.org/10.1371/journal.pone.0065563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799025	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300024
J	Vashist, P; Gupta, N; Rathore, AS; Shah, A; Singh, S				Vashist, Praveen; Gupta, Noopur; Rathore, Abhilakh S.; Shah, Anita; Singh, Suman			Rapid Assessment of Trachoma in Underserved Population of Car-Nicobar Island, India	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; DISTRICT	Purpose: To determine the burden of trachoma and its related risk factors amongst the native population of Car-Nicobar Island in India. Methods: Rapid assessment for trachoma was conducted in ten villages of Car-Nicobar Island according to standard WHO guidelines. An average of 50 children aged 1-9 years were assessed clinically for signs of active trachoma and facial cleanliness in each village. Additionally, all adults above 15 years of age in these households were examined for evidence of trachomatous trichiasis and corneal opacity. Environmental risk factors contributing to trachoma like limited access to potable water & functional latrine, presence of animal pen and garbage within the Nicobari hut were also noted in all villages. Results: Out of a total of fifteen villages in Car-Nicobar Island, ten villages were selected for trachoma survey depending on evidence of socio-developmental indicators like poverty and decreased access to water, sanitation and healthcare facilities. The total population of the selected clusters was 7277 in the ten villages. Overall, 251 of 516 children (48.6%; CI: 46.5-55.1) had evidence of follicular stage of trachoma and 11 children (2.1%; CI: 1.0-3.4) had evidence of inflammatory stage of trachoma. Nearly 15%(CI: 12.1-18.3) children were noted to have unclean faces in the ten villages. Trachomatous trichiasis was noted in 73 adults (1.0%; CI: 0.8-1.2). The environmental sanitation was not found to be satisfactory in the surveyed villages mainly due to the co-habitance of Nicobari people with domestic animals like pigs, hens, goats, dogs, cats etc in most (96.4%) of the households. Conclusion: Active trachoma and trachomatous trichiasis was observed in all the ten villages surveyed, wherein trachoma control measures are needed.	[Vashist, Praveen; Gupta, Noopur] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi 110029, India; [Rathore, Abhilakh S.; Singh, Suman] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, New Delhi, India; [Shah, Anita] Govind Ballabh Pant Hosp, Port Blair, Andaman & Nicob, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; Govind Ballabh Pant Institute of Postgraduate Medical Education & Research	Vashist, P (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi 110029, India.	praveenvashist@yahoo.com	GUPTA, NOOPUR/AAX-5043-2021	GUPTA, NOOPUR/0000-0001-8022-6656	Ministry of Health & Family Welfare, Govt of India	Ministry of Health & Family Welfare, Govt of India	Funding was provided by the Ministry of Health & Family Welfare, Govt of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amza A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001586; Baggaley RF, 2006, TROP MED INT HEALTH, V11, P220, DOI 10.1111/j.1365-3156.2005.01553.x; Census of India, 2011, PROV POP TOT FIG GLA; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Goldschmidt P, 2006, OPHTHAL EPIDEMIOL, V13, P335, DOI 10.1080/09286580600943796; Harding-Esch EM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000861; Kalua K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009067; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mariotti SP, 2003, AM J TROP MED HYG, V69, P33; Mariotti SP, 2000, 136WHOPBDGET007, V1, P36; Mpyet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040421; Negrel A D, 1999, Community Eye Health, V12, P51; Negrel AD, 2001, WHOPBDGET008, P1; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Polack S, 2003, B WORLD HEALTH ORGAN, V83, P913; PREOBRAGENSKI V V, 1964, J All India Ophthalmol Soc, V12, P68; Pruss A, 2000, B WORLD HEALTH ORGAN, V78, P258; Rabiu M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004003.pub4; Rapid Assessment of Trachoma in India, 2006, RAPID ASSESSMENT TRA, P1; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; *WHO, 2007, 11 M WHO ALL GLOB EL	22	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65918	10.1371/journal.pone.0065918	http://dx.doi.org/10.1371/journal.pone.0065918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799063	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300054
J	Kasahara, AK; Singh, RJ; Noymer, A				Kasahara, Amy K.; Singh, Ravinder J.; Noymer, Andrew			Vitamin D (25OHD) Serum Seasonality in the United States	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; D DEFICIENCY; CIRCULATING 25-HYDROXYVITAMIN-D; SOLAR-RADIATION; HIGH PREVALENCE; BREAST-CANCER; SUN EXPOSURE; ASSOCIATION; POPULATION; PREVENTION	Background: Vitamin D is an important micronutrient for health. Hypovitaminosis D is thought to play a role in the seasonality of a number of diseases and adverse health conditions. To refine hypotheses about the links between vitamin D and seasonal diseases, good estimates of the cyclicality of serum vitamin D are necessary. Objectives: The objective of this study is to describe quantitatively the cyclicality of 25-hydroxyvitamin D (25OHD) in the United States. We provide a statistical analysis with weekly time resolution, in comparison to the quarterly (winter/spring/summer/fall) estimates already in the literature. Methods: We analyzed time series data on 25OHD, spanning 287 consecutive weeks. The pooled data set comes from 3.44 million serum samples from the United States. We statistically analyzed the proportion of sera that were vitamin D sufficient, defined as 25OHD >= 25 ng/mL, as a function of date. Results: In the United States, serum 25OHD follows a lagged pattern relative to the astronomical seasons, peaking in late summer (August) and troughing in late winter (February). Airmass, which is a function of solar altitude, fits the 25OHD data very well when lagged by 8 weeks. Conclusions: Serum vitamin D levels can be modeled as a function of date, working through a double-log transformation of minimal solar airmass (easily calculated from solar altitude, retrievable from an online solar altitude/azimuth table).	[Kasahara, Amy K.] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Singh, Ravinder J.] Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN USA; [Noymer, Andrew] Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA	University of California System; University of California Irvine; Mayo Clinic; University of California System; University of California Irvine	Noymer, A (corresponding author), Univ Calif Irvine, Dept Populat Hlth & Dis Prevent, Irvine, CA 92717 USA.	noymer@uci.edu						Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Antico A, 2012, CLIN REV ALLERG IMMU, V42, P355, DOI 10.1007/s12016-011-8255-1; Azizi E, 2009, PHOTOCHEM PHOTOBIOL, V85, P1240, DOI 10.1111/j.1751-1097.2009.00569.x; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bozzetto S, 2012, ALLERGY, V67, P10, DOI 10.1111/j.1398-9995.2011.02711.x; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; DEVGUN MS, 1981, AM J CLIN NUTR, V34, P1501, DOI 10.1093/ajcn/34.8.1501; DEVGUN MS, 1983, CLIN PHYSIOL BIOCH, V1, P300; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Holick MF, 1977, VITAMIN D BIOCH CHEM, P135; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2004, J CLIN ENDOCR METAB, V89, P3149, DOI 10.1210/jc.2004-0682; Itoh H, 2011, IND HEALTH, V49, P475, DOI 10.2486/indhealth.MS1255; John EM, 2007, AM J EPIDEMIOL, V166, P1409, DOI 10.1093/aje/kwm259; Juzeniene A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/6/066701; Juzeniene A, 2010, INT J INFECT DIS, V14, pE1099, DOI 10.1016/j.ijid.2010.09.002; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; MAXWELL JD, 1994, P NUTR SOC, V53, P533, DOI 10.1079/PNS19940063; McCullagh P, 1989, GEN LINEAR MODELS; McNally JD, 2012, PEDIATRICS, V130, P429, DOI 10.1542/peds.2011-3059; Modarres R, 2012, BONE, V50, P909, DOI 10.1016/j.bone.2012.01.004; Moore C, 2004, J AM DIET ASSOC, V104, P980, DOI 10.1016/j.jada.2004.03.028; National Weather Service, 2012, OC NIN IND ONI DAT; Paul G, 2012, AM J RESP CRIT CARE, V185, P124, DOI 10.1164/rccm.201108-1502CI; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Reusch J, 2009, HORM METAB RES, V41, P402, DOI 10.1055/s-0028-1128131; Schwartz GG, 2007, CURR OPIN CLIN NUTR, V10, P6; Shaman J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020743; Shaw WN, 1901, P R SOC LONDON, V69, P61, DOI 10.1098/rspl.1901.0084; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Tucker MA, 2007, NUTR REV, V65, pS84, DOI 10.1111/j.1753-4887.2007.tb00347.x; Tukey JW, 1977, EXPLORATORY DATA ANA; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; US Naval Observatory, 2012, SUN MOON ALT AZ TABL; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; WEBB AR, 1990, AM J CLIN NUTR, V51, P1075, DOI 10.1093/ajcn/51.6.1075; YOUNG AT, 1994, APPL OPTICS, V33, P1108, DOI 10.1364/AO.33.001108; Zerwekh JE, 2004, ANN CLIN BIOCHEM, V41, P272, DOI 10.1258/0004563041201464; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	45	100	103	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65785	10.1371/journal.pone.0065785	http://dx.doi.org/10.1371/journal.pone.0065785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805188	Green Published, gold			2022-12-27	WOS:000320846500016
J	Vinogradova, MV; Malanina, GG; Waitzman, JS; Rice, SE; Fletterick, RJ				Vinogradova, Maia V.; Malanina, Galina G.; Waitzman, Joshua S.; Rice, Sarah E.; Fletterick, Robert J.			Plant Kinesin-Like Calmodulin Binding Protein Employs Its Regulatory Domain for Dimerization	PLOS ONE			English	Article							TRICHOME MORPHOGENESIS; CRYSTAL-STRUCTURE; MOTOR; ARABIDOPSIS; MICROTUBULES; MOTILITY	Kinesin-like calmodulin binding protein (KCBP), a Kinesin-14 family motor protein, is involved in the structural organization of microtubules during mitosis and trichome morphogenesis in plants. The molecular mechanism of microtubule bundling by KCBP remains unknown. KCBP binding to microtubules is regulated by Ca2+ - binding proteins that recognize its C-terminal regulatory domain. In this work, we have discovered a new function of the regulatory domain. We present a crystal structure of an Arabidopsis KCBP fragment showing that the C-terminal regulatory domain forms a dimerization interface for KCBP. This dimerization site is distinct from the dimerization interface within the N-terminal domain. Side chains of hydrophobic residues of the calmodulin binding helix of the regulatory domain form the C-terminal dimerization interface. Biochemical experiments show that another segment of the regulatory domain located beyond the dimerization interface, its negatively charged coil, is unexpectedly and absolutely required to stabilize the dimers. The strong microtubule bundling properties of KCBP are unaffected by deletion of the C-terminal regulatory domain. The slow minus-end directed motility of KCBP is also unchanged in vitro. Although the C-terminal domain is not essential for microtubule bundling, we suggest that KCBP may use its two independent dimerization interfaces to support different types of bundled microtubule structures in cells. Two distinct dimerization sites may provide a mechanism for microtubule rearrangement in response to Ca2+ signaling since Ca2+- binding proteins can disengage KCBP dimers dependent on its C-terminal dimerization interface.	[Vinogradova, Maia V.; Malanina, Galina G.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Waitzman, Joshua S.; Rice, Sarah E.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Northwestern University	Fletterick, RJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	Robert.Fletterick@ucsf.edu	Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798; Waitzman, Joshua/0000-0003-3364-6281	NIH [R01GM072656]; Myhrvold Family Fellowship from the Fannie and John Hertz Foundation; Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Northwestern's Cellular and Molecular Basis of Disease training grant [GM08061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myhrvold Family Fellowship from the Fannie and John Hertz Foundation; Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Northwestern's Cellular and Molecular Basis of Disease training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The following funds partially supported this work: NIH grant R01GM072656 awarded to Sarah E. Rice; Myhrvold Family Fellowship from the Fannie and John Hertz Foundation, the Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Northwestern's Cellular and Molecular Basis of Disease training grant (GM08061) awarded to Joshua Waitzman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P1711, DOI 10.1104/pp.105.060913; Bowser J, 1997, PLANT J, V12, P1429, DOI 10.1046/j.1365-313x.1997.12061429.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Kao YL, 2000, BIOCHEM BIOPH RES CO, V267, P201, DOI 10.1006/bbrc.1999.1896; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Larson AG, 2009, PHYS CHEM CHEM PHYS, V11, P4890, DOI 10.1039/b900968j; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Naber N, 2011, J MOL BIOL, V408, P628, DOI 10.1016/j.jmb.2011.01.001; Oppenheimer DG, 1997, P NATL ACAD SCI USA, V94, P6261, DOI 10.1073/pnas.94.12.6261; Preuss ML, 2003, PLANT PHYSIOL, V132, P154, DOI 10.1104/pp.103.020339; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; Reddy VS, 1999, BIOINFORMATICS, V15, P1055; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Song H, 1997, P NATL ACAD SCI USA, V94, P322, DOI 10.1073/pnas.94.1.322; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vinogradova MV, 2008, J STRUCT BIOL, V163, P76, DOI 10.1016/j.jsb.2008.04.004; Vinogradova MV, 2009, P NATL ACAD SCI USA, V106, P8175, DOI 10.1073/pnas.0811131106; Vinogradova MV, 2004, J BIOL CHEM, V279, P23504, DOI 10.1074/jbc.M400741200; Vos JW, 2000, PLANT CELL, V12, P979, DOI 10.1105/tpc.12.6.979; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0	21	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66669	10.1371/journal.pone.0066669	http://dx.doi.org/10.1371/journal.pone.0066669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805258	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500086
J	Song, XZ; Peng, CH; Jiang, H; Zhu, QA; Wang, WF				Song, Xinzhang; Peng, Changhui; Jiang, Hong; Zhu, Qiuan; Wang, Weifeng			Direct and Indirect Effects of UV-B Exposure on Litter Decomposition: A Meta-Analysis	PLOS ONE			English	Article							PLANT LITTER; LEAF-LITTER; ULTRAVIOLET-RADIATION; NITROGEN; GRASSLAND; CARBON; RATES; QUALITY; FIELD; PHOTODEGRADATION	Ultraviolet-B (UV-B) exposure in the course of litter decomposition may have a direct effect on decomposition rates via changing states of photodegradation or decomposer constitution in litter while UV-B exposure during growth periods may alter chemical compositions and physical properties of plants. Consequently, these changes will indirectly affect subsequent litter decomposition processes in soil. Although studies are available on both the positive and negative effects (including no observable effects) of UV-B exposure on litter decomposition, a comprehensive analysis leading to an adequate understanding remains unresolved. Using data from 93 studies across six biomes, this introductory meta-analysis found that elevated UV-B directly increased litter decomposition rates by 7% and indirectly by 12% while attenuated UV-B directly decreased litter decomposition rates by 23% and indirectly increased litter decomposition rates by 7%. However, neither positive nor negative effects were statistically significant. Woody plant litter decomposition seemed more sensitive to UV-B than herbaceous plant litter except under conditions of indirect effects of elevated UV-B. Furthermore, levels of UV-B intensity significantly affected litter decomposition response to UV-B (P<0.05). UV-B effects on litter decomposition were to a large degree compounded by climatic factors (e. g., MAP and MAT) (P<0.05) and litter chemistry (e. g., lignin content) (P<0.01). Results suggest these factors likely have a bearing on masking the important role of UV-B on litter decomposition. No significant differences in UV-B effects on litter decomposition were found between study types (field experiment vs. laboratory incubation), litter forms (leaf vs. needle), and decay duration. Indirect effects of elevated UV-B on litter decomposition significantly increased with decay duration (P<0.001). Additionally, relatively small changes in UV-B exposure intensity (30%) had significant direct effects on litter decomposition (P<0.05). The intent of this meta-analysis was to improve our understanding of the overall effects of UV-B on litter decomposition.	[Song, Xinzhang; Jiang, Hong] Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Linan, Peoples R China; [Song, Xinzhang; Jiang, Hong] Zhejiang A&F Univ, Zhejiang Prov Key Lab Carbon Cycling & Carbon Seq, Linan, Peoples R China; [Peng, Changhui; Wang, Weifeng] Univ Quebec, Dept Sci Biol, Inst Environm Sci, Montreal, PQ H3C 3P8, Canada; [Peng, Changhui; Zhu, Qiuan] Northwest Agr & Forest Univ, Lab Ecol Forecasting & Global Change, Coll Forestry, Yangling, Peoples R China	Zhejiang A&F University; Zhejiang A&F University; University of Quebec; University of Quebec Montreal; Northwest A&F University - China	Song, XZ (corresponding author), Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Linan, Peoples R China.	songxinzhang@gmail.com; peng.changhui@uqam.ca	Wang, Weifeng/H-5642-2011	Wang, Weifeng/0000-0002-9752-6185	National Nature Science Foundation of China [31070440, 31270517]; State Key Fundamental Science Funds of China [2011CB302705]; China QianRen Program; NSERC; Zhejiang Provincial Natural Science Foundation of China [Y5090007]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Fundamental Science Funds of China(State Key Development Program for Basic Research of China); China QianRen Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was funded by the National Nature Science Foundation of China (31070440; 31270517), the State Key Fundamental Science Funds of China (2011CB302705), the China QianRen Program as well as the NSERC discovery grant, and the Zhejiang Provincial Natural Science Foundation of China (Y5090007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Bancroft BA, 2007, ECOL LETT, V10, P332, DOI 10.1111/j.1461-0248.2007.01022.x; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; Berg B., 2008, PLANT LITTER DECOMPO, P1; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Brandt LA, 2007, GLOBAL CHANGE BIOL, V13, P2193, DOI 10.1111/j.1365-2486.2007.01428.x; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cybulski WJ, 2000, ENVIRON EXP BOT, V44, P231, DOI 10.1016/S0098-8472(00)00070-8; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Day TA, 2007, PLANT ECOL, V193, P185, DOI 10.1007/s11258-006-9257-6; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Dormann CF, 2002, FUNCT ECOL, V16, P4, DOI 10.1046/j.0269-8463.2001.00596.x; Duguay KJ, 2000, APPL SOIL ECOL, V14, P157, DOI 10.1016/S0929-1393(00)00049-4; Flint SD, 2003, AGR FOREST METEOROL, V120, P177, DOI 10.1016/j.agrformet.2003.08.014; Gallo ME, 2006, APPL SOIL ECOL, V34, P82, DOI 10.1016/j.apsoil.2005.12.006; Henry HAL, 2008, ECOSYSTEMS, V11, P545, DOI 10.1007/s10021-008-9141-4; Herman JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012219; Hoorens B, 2004, GLOBAL CHANGE BIOL, V10, P200, DOI 10.1111/j.1529-8817.2003.00735.x; Hungate BA, 2009, GLOBAL CHANGE BIOL, V15, P2020, DOI 10.1111/j.1365-2486.2009.01866.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; JOHANSON U, 1995, AMBIO, V24, P106; Kirschbaum MUF, 2011, SOIL BIOL BIOCHEM, V43, P1300, DOI 10.1016/j.soilbio.2011.03.001; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li FR, 2010, ACTA OECOL, V36, P1, DOI 10.1016/j.actao.2009.09.002; Liski J, 2003, GLOBAL CHANGE BIOL, V9, P575, DOI 10.1046/j.1365-2486.2003.00605.x; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Lu M, 2011, NEW PHYTOL, V189, P1040, DOI 10.1111/j.1469-8137.2010.03563.x; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Moody SA, 2001, PLANT ECOL, V154, P27, DOI 10.1023/A:1012965610170; Moore TR, 1999, GLOB CHANGE BIOL, V5, P75, DOI 10.1046/j.1365-2486.1998.00224.x; Newsham KK, 2009, GLOBAL CHANGE BIOL, V15, P2574, DOI 10.1111/j.1365-2486.2009.01944.x; Newsham KK, 2001, GLOBAL CHANGE BIOL, V7, P479, DOI 10.1046/j.1365-2486.2001.00423.x; Newsham KK, 1999, GLOBAL CHANGE BIOL, V5, P403, DOI 10.1046/j.1365-2486.1999.00231.x; Niemi R, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI [10.1046/j.1365-2486.2002.00451.x, DOI 10.1046/J.1365-2486.2002.00451.X]; Pancotto VA, 2005, GLOBAL CHANGE BIOL, V11, P1982, DOI 10.1111/j.1365-2486.2005.01027.x; Pancotto VA, 2003, GLOBAL CHANGE BIOL, V9, P1465, DOI 10.1046/j.1365-2486.2003.00667.x; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Rosenberg M. S., 2000, META WIN STAT SOFTWA; Rozema J, 1997, PLANT ECOL, V128, P284; Searles PS, 2001, OECOLOGIA, V127, P1, DOI 10.1007/s004420000592; Smith W. Kolby, 2009, Frontiers of Earth Science in China, V3, P34, DOI 10.1007/s11707-009-0011-y; Smith WK, 2010, GLOBAL CHANGE BIOL, V16, P484, DOI 10.1111/j.1365-2486.2009.01973.x; Song XZ, 2011, EUR J SOIL BIOL, V47, P343, DOI 10.1016/j.ejsobi.2011.08.008; Uselman SM, 2011, SOIL BIOL BIOCHEM, V43, P1254, DOI 10.1016/j.soilbio.2011.02.016; van Groenigen KJ, 2011, NATURE, V475, P214, DOI 10.1038/nature10176; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Verhoef HA, 2000, BIOL FERT SOILS, V31, P366, DOI 10.1007/s003749900181; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Zepp RG, 2011, PHOTOCH PHOTOBIO SCI, V10, P261, DOI 10.1039/c0pp90037k	53	43	44	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68858	10.1371/journal.pone.0068858	http://dx.doi.org/10.1371/journal.pone.0068858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818993	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800150
J	Ferreira, RD; Zhou, DW; Ferreira, JG; Silva, MCC; Silva-Lucca, RA; Mentele, R; Paredes-Gamero, EJ; Bertolin, TC; Correia, MTD; Paiva, PMG; Gustchina, A; Wlodawer, A; Oliva, MLV				Ferreira, Rodrigo da Silva; Zhou, Dongwen; Ferreira, Joana Gasperazzo; Cabral Silva, Mariana Cristina; Silva-Lucca, Rosemeire Aparecida; Mentele, Reinhard; Paredes-Gamero, Edgar Julian; Bertolin, Thiago Carlos; dos Santos Correia, Maria Tereza; Guedes Paiva, Patricia Maria; Gustchina, Alla; Wlodawer, Alexander; Vilela Oliva, Maria Luiza			Crystal Structure of Crataeva tapia Bark Protein (CrataBL) and Its Effect in Human Prostate Cancer Cell Lines	PLOS ONE			English	Article							TRYPSIN-INHIBITOR; SERINE RESIDUE; REACTIVE SITE; LECTIN; BINDING; MECHANISM; DU145; REPLACEMENT; ACTIVATION; REFINEMENT	A protein isolated from the bark of Crataeva tapia (CrataBL) is both a Kunitz-type plant protease inhibitor and a lectin. We have determined the amino acid sequence and three-dimensional structure of CrataBL, as well as characterized its selected biochemical and biological properties. We found two different isoforms of CrataBL isolated from the original source, differing in positions 31 (Pro/Leu); 92 (Ser/Leu); 93 (Ile/Thr); 95 (Arg/Gly) and 97 (Leu/Ser). CrataBL showed relatively weak inhibitory activity against trypsin (K-iapp = 43 mu M) and was more potent against Factor Xa (K-iapp = 8.6 mu M), but was not active against a number of other proteases. We have confirmed that CrataBL contains two glycosylation sites and forms a dimer at high concentration. The high-resolution crystal structures of two different crystal forms of isoform II verified the beta-trefoil fold of CrataBL and have shown the presence of dimers consisting of two almost identical molecules making extensive contacts (similar to 645 angstrom(2)). The structure differs from those of the most closely related proteins by the lack of the N-terminal beta-hairpin. In experiments aimed at investigating the biological properties of CrataBL, we have shown that addition of 40 mM of the protein for 48 h caused maximum growth inhibition in MTT assay (47% of DU145 cells and 43% of PC3 cells). The apoptosis of DU145 and PC3 cell lines was confirmed by flow cytometry using Annexin V/FITC and propidium iodide staining. Treatment with CrataBL resulted in the release of mitochondrial cytochrome c and in the activation of caspase-3 in DU145 and PC3 cells.	[Ferreira, Rodrigo da Silva; Ferreira, Joana Gasperazzo; Cabral Silva, Mariana Cristina; Paredes-Gamero, Edgar Julian; Vilela Oliva, Maria Luiza] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Zhou, Dongwen; Gustchina, Alla; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Silva-Lucca, Rosemeire Aparecida] Univ Estadual Oeste Parana, Ctr Engn & Ciencias Exatas, Toledo, Parana, Brazil; [Mentele, Reinhard] Max Planck Inst Biochem, Inst Clin Neuroimmunol LMU, Munich, Germany; [Mentele, Reinhard] Max Planck Inst Biochem, Dept Prot Analyt, Munich, Germany; [Bertolin, Thiago Carlos] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [dos Santos Correia, Maria Tereza; Guedes Paiva, Patricia Maria] Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil	Universidade Federal de Sao Paulo (UNIFESP); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Estadual do Oeste do Parana; Max Planck Society; University of Munich; Max Planck Society; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Pernambuco	Wlodawer, A (corresponding author), NCI, Macromol Crystallog Lab, Ctr Canc Res, Frederick, MD 21701 USA.	wlodawer@nih.gov; olivaml.bioq@epm.br	Zhou, Dongwen/O-1889-2019; Vilela Oliva, Maria Luiza/AGI-6283-2022; Silva, Mariana/B-9530-2012; Paredes-Gamero, Edgar J/C-4791-2012; Ferreira, Rodrigo S./C-1763-2013; Paiva, Patricia Maria Guedes/S-4038-2019; Oliva, Maria Luiza V/B-9537-2012; de Lucca, Rosemeire Aparecida da Silva/AAQ-2489-2021	Paredes-Gamero, Edgar J/0000-0003-3686-8402; Ferreira, Rodrigo S./0000-0003-4103-6870; Paiva, Patricia Maria Guedes/0000-0003-3467-708X; Oliva, Maria Luiza/0000-0002-5822-0060	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Sao Paulo Research Foundation (FAPESP) [09/53766-5]; Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. W-31-109-Eng-38. The authors are grateful to CAPES, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Sao Paulo Research Foundation (FAPESP) (Process 09/53766-5) for providing financial support. This project was also supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; de Paula CAA, 2012, J BIOL CHEM, V287, P170, DOI 10.1074/jbc.M111.263996; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Arab Mohammad Reza, 2010, Acta Med Iran, V48, P209; Araujo RMS, 2011, NAT PRODUCT BIOPROSP, V1, P97, DOI 10.1007/s13659-011-0014-8; Azarkan M, 2006, BBA-PROTEINS PROTEOM, V1764, P1063, DOI 10.1016/j.bbapap.2006.02.014; Birk Y, 2005, PLANT PROTEASE INHIB; Bok RA, 2003, PROSTATE CANCER P D, V6, P272, DOI 10.1038/sj.pcan.4500676; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burke PA, 2006, INT J ONCOL, V29, P49; CAGAN RH, 1973, SCIENCE, V181, P32, DOI 10.1126/science.181.4094.32; Colella R, 2002, CANCER LETT, V185, P163, DOI 10.1016/S0304-3835(02)00275-6; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; de Araujo RMS, 2011, THROMB RES, V128, P395, DOI 10.1016/j.thromres.2011.06.005; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; DEKLERK DP, 1984, J UROLOGY, V131, P1008, DOI 10.1016/S0022-5347(17)50750-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EDMAN P, 1950, ACTA CHEM SCAND, V4, P277, DOI 10.3891/acta.chem.scand.04-0277; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang EF, 2012, ARCH TOXICOL, V86, P293, DOI 10.1007/s00204-011-0751-9; FISCHER J, 1983, CANCER DETECT PREV, V6, P137; Gahloth D, 2010, ARCH BIOCHEM BIOPHYS, V494, P15, DOI 10.1016/j.abb.2009.11.008; Gozzo AJ, 2006, BIOL CHEM, V387, P1129, DOI 10.1515/BC.2006.139; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jow GM, 2004, CANCER LETT, V216, P165, DOI 10.1016/j.canlet.2004.06.005; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim EJ, 2008, FOOD CHEM TOXICOL, V46, P3651, DOI 10.1016/j.fct.2008.08.038; KUROKAWA T, 1987, J BIOCHEM-TOKYO, V102, P621, DOI 10.1093/oxfordjournals.jbchem.a122096; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJNO G, 1995, AM J PATHOL, V146, P3; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meulenbroek EM, 2012, ACTA CRYSTALLOGR D, V68, P794, DOI 10.1107/S090744491201222X; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nascimento CO, 2008, PROCESS BIOCHEM, V43, P779, DOI 10.1016/j.procbio.2008.02.021; ODANI S, 1978, J BIOCHEM-TOKYO, V84, P1; Oliva MLV, 2010, BIOCHIMIE, V92, P1667, DOI 10.1016/j.biochi.2010.03.021; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Pohleven J, 2012, J BIOL CHEM, V287, P10602, DOI 10.1074/jbc.M111.317263; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rayon C, 1998, J EXP BOT, V49, P1463, DOI 10.1093/jexbot/49.326.1463; Renko M, 2012, BIOL CHEM, V393, P1043, DOI 10.1515/hsz-2012-0159; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Saitoh E, 2005, COMP BIOCHEM PHYS B, V141, P103, DOI 10.1016/j.cbpc.2005.02.002; Salvesen, 1986, PROTEINASE INHIBITOR, P23; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sharon N, 2002, J AGR FOOD CHEM, V50, P6586, DOI 10.1021/jf020190s; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Smith JA, 2001, BIOCHEM PHARMACOL, V62, P469, DOI 10.1016/S0006-2952(01)00690-6; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; de Araujo RMS, 2012, PLANT SCI, V183, P20, DOI 10.1016/j.plantsci.2011.10.018; Sulzenbacher G, 2010, J MOL BIOL, V400, P715, DOI 10.1016/j.jmb.2010.05.038; Talwar GP, 2001, PROSTATE, V46, P207; Troncoso MF, 2003, ARCH BIOCHEM BIOPHYS, V411, P93, DOI 10.1016/S0003-9861(02)00726-9; VANOOSTRUM J, 1991, J STRUCT BIOL, V107, P189; Verma A, 2010, J MICROBIOL METH, V81, P175, DOI 10.1016/j.mimet.2010.03.001; Oliva MLV, 2011, CURR PROTEIN PEPT SC, V12, P348; Yan QJ, 2010, FOOD CHEM, V122, P589, DOI 10.1016/j.foodchem.2010.03.015; Zhang FM, 2013, BIOCHEMISTRY-US, V52, P2148, DOI 10.1021/bi400077b	69	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e64426	10.1371/journal.pone.0064426	http://dx.doi.org/10.1371/journal.pone.0064426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823708	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400001
J	de Oliveira, APL; Peron, JPS; Franco, ALS; Golega, BA; Vieira, RP; Ibanez, OCM; Ribeiro, OG; Cabrera, WHK; De Franco, M; Oliveira, RM; Rizzo, LV; Vargaftig, BB; de Lima, WT				Ligeiro de Oliveira, Ana Paula; Schatzmann Peron, Jean Pierre; Santos Franco, Adriana Lino; Golega, Beatriz Acceturi; Vieira, Rodolfo Paula; Martinez Ibanez, Olga Celia; Ribeiro, Orlando Garcia; Koury Cabrera, Wafa Hanna; De Franco, Marcelo; Oliveira-Filho, Ricardo Martins; Rizzo, Luiz Vicente; Vargaftig, Bernardo Boris; de Lima, Wothan Tavares			Ovariectomized OVA-Sensitized Mice Display Increased Frequency of CD4(+)Foxp3(+) T Regulatory Cells in the Periphery	PLOS ONE			English	Article							ROR-GAMMA-T; MENSTRUAL-CYCLE; TH17 CELLS; DIFFERENTIATION; ASTHMA; CD4(+)CD25(+); T(H)17; PHASE; INFLAMMATION; LYMPHOCYTES	It is well established that female sex hormones have a pivotal role in inflammation. For instance, our group has previously reported that estradiol has proinflammatory actions during allergic lung response in animal models. Based on these findings, we have decided to further investigate whether T regulatory cells are affected by female sex hormones absence after ovariectomy. We evaluated by flow cytometry the frequencies of CD4(+) Foxp3(+) T regulatory cells (Tregs) in central and peripheral lymphoid organs, such as the thymus, spleen and lymph nodes. Moreover, we have also used the murine model of allergic lung inflammation a to evaluate how female sex hormones would affect the immune response in vivo. To address that, ovariectomized or sham operated female Balb/c mice were sensitized or not with ovalbumin 7 and 14 days later and subsequently challenged twice by aerosolized ovalbumin on day 21. Besides the frequency of CD4(+) Foxp3(+) T regulatory cells, we also measured the cytokines IL-4, IL-5, IL-10, IL-13 and IL-17 in the bronchoalveolar lavage from lungs of ovalbumine challenged groups. Our results demonstrate that the absence of female sex hormones after ovariectomy is able to increase the frequency of Tregs in the periphery. As we did not observe differences in the thymus-derived natural occurring Tregs, our data may indicate expansion or conversion of peripheral adaptive Tregs. In accordance with Treg suppressive activity, ovariectomized and ovalbumine-sensitized and challenged animals had significantly reduced lung inflammation. This was observed after cytokine analysis of lung explants showing significant reduction of pro-inflammatory cytokines, such as IL-4, IL-5, IL-13 and IL-17, associated to increased amount of IL-10. In summary, our data clearly demonstrates that OVA sensitization 7 days after ovariectomy culminates in reduced lung inflammation, which may be directly correlated with the expansion of Tregs in the periphery and further higher IL-10 secretion in the lungs.	[Ligeiro de Oliveira, Ana Paula; Vieira, Rodolfo Paula] Univ Nove de Julho UNINOVE, Programa Posgrad Biofoton Aplicada Ciencias Saude, Sao Paulo, Brazil; [Schatzmann Peron, Jean Pierre] ICB USP, Dept Immunol, Sao Paulo, Brazil; [Santos Franco, Adriana Lino; Golega, Beatriz Acceturi; Oliveira-Filho, Ricardo Martins; Vargaftig, Bernardo Boris; de Lima, Wothan Tavares] ICB USP, Dept Pharmacol, Sao Paulo, Brazil; [Martinez Ibanez, Olga Celia; Ribeiro, Orlando Garcia; Koury Cabrera, Wafa Hanna; De Franco, Marcelo] Butantan Inst, Immunogenet Lab, Sao Paulo, Brazil; [Rizzo, Luiz Vicente] HIAE, Inst Ensino & Pesquisa, Sao Paulo, Brazil	Universidade Nove de Julho; Instituto Butantan; Hospital Israelita Albert Einstein	de Lima, WT (corresponding author), ICB USP, Dept Pharmacol, Sao Paulo, Brazil.	wtavares@usp.br	Cabrera, Wafa HK/F-7189-2016; Oliveira-Filho, Ricardo/F-9287-2015; Ribeiro, Orlando Garcia/AAY-9424-2020; Ibañez, Olga CM/B-9627-2015; Ribeiro, Orlando Garcia/B-5241-2016; Vargaftig, Bernardo Boris B.B.J./C-3323-2013; Rizzo, Luiz Vicente/B-4458-2009; Peron, Jean Pierre S/F-9248-2012; Franco, Adriana Lino dos Santos/AAA-7081-2019; DE FRANCO, MARCELO/S-5870-2019; de Paula Vieira, Rodolfo/E-9315-2011	Ribeiro, Orlando Garcia/0000-0003-2117-2402; Ibañez, Olga CM/0000-0002-2672-4758; Franco, Adriana Lino dos Santos/0000-0002-7854-2833; DE FRANCO, MARCELO/0000-0002-0417-8215; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	CAPES (PNPD) [02610/09-4, 0188085]; FAPESP [09/07208-0, 09/51886-3, 2006/5595-0, 2007/55631, 2011/18703-2]	CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by CAPES (PNPD number 02610/09-4 and 0188085) and FAPESP ( number 09/07208-0, 09/51886-3, 2006/5595-0, 2007/55631 and 2011/18703-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Battaglia M, 2009, ANN NY ACAD SCI, V1029, P142; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen ML, 2008, J IMMUNOL, V180, P7327, DOI 10.4049/jimmunol.180.11.7327; Chhabra S K, 2005, Indian J Chest Dis Allied Sci, V47, P109; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; de Oliveira APL, 2004, NEUROIMMUNOMODULAT, V11, P20, DOI 10.1159/000072965; Derbinski G, 2005, JEM, V202, P33; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Huang TJ, 2001, J IMMUNOL, V166, P207, DOI 10.4049/jimmunol.166.1.207; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jamieson PM, 1999, J ENDOCRINOL, V160, P103, DOI 10.1677/joe.0.1600103; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keller AC, 2006, J ALLERGY CLIN IMMUN, V117, P283, DOI 10.1016/j.jaci.2005.10.019; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krug N, 1996, AM J RESP CELL MOL, V14, P319, DOI 10.1165/ajrcmb.14.4.8600935; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lewkowich IP, 2005, AM J RESP CELL MOL, V25, P125; de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006; Matthews J, 2007, BIOCHEM J, V406, P343, DOI 10.1042/BJ20070585; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rhodes L, 2005, J ASTHMA, V42, P777, DOI 10.1080/02770900500308387; Riffo-Vasquez Y, 2007, CLIN EXP ALLERGY, V37, P459, DOI 10.1111/j.1365-2222.2007.02670.x; Scariano JK, 2008, J RECEPT SIG TRANSD, V28, P285, DOI [10.1080/10799890802084614, 10.1080/10799890802084614 ]; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shevach E, 2002, J IMMUNOL, V188, P287; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Stanford KI, 2006, EUR J APPL PHYSIOL, V96, P703, DOI 10.1007/s00421-005-0067-7; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Takeda K, 2009, CURR OPIN IMMUNOL, V21, P660, DOI 10.1016/j.coi.2009.09.005; Wong CK, 2009, IMMUNOL INVEST, V38, P652, DOI 10.1080/08820130903062756; Yang KY, 2009, J AUTOIMMUN, V32, P94, DOI 10.1016/j.jaut.2008.12.004; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L., 2007, NAT IMMUNOL, V8, P1	47	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65674	10.1371/journal.pone.0065674	http://dx.doi.org/10.1371/journal.pone.0065674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799034	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800013
J	Liu, X; Zhu, RX; Li, L; Deng, SM; Li, Q; He, ZY				Liu, Xu; Zhu, Ruixia; Li, Lei; Deng, Shumin; Li, Qu; He, Zhiyi			Genetic Polymorphism in PDE4D Gene and Risk of Ischemic Stroke in Chinese Population: A Meta-Analysis	PLOS ONE			English	Article							PHOSPHODIESTERASE 4D GENE; ASSOCIATION; SURVIVAL; NEURONS; SUSCEPTIBILITY; DEFINITIONS; PROMOTE	Background: Stroke is the second most common cause of death and major cause of disability worldwide. The SNP 83 in PDE4D gene has been suggested as a risk factor in ischemic stroke, but direct evidence from genetic association studies remains inconclusive even in Chinese population. Methods: Meta-analysis of case-control studies on the relationship between SNP 83 in PDE4D gene and susceptibility to ischemic stroke in Chinese population published domestically and abroad from January 2003 to September 2012. Results: 9 case-control studies were selected. Meta-analysis results showed that the significant association between SNP 83 and ischemic stroke was found under the dominant model (OR = 1.34, 95% CI: 1.20-1.49) and recessive model (OR = 1.45, 95% CI: 1.19-1.76) in Chinese population. In subgroup meta-analysis, SNP 83 and atherothrombotic stroke, rather than lacunar stroke, showed the significant association under the dominant model (OR = 1.69, 95% CI: 1.41-2.01) and recessive model (OR = 1.47, 95% CI: 1.04-2.06). Conclusions: The results suggest that SNP 83 in PDE4D gene is significantly associated with susceptibility to ischemic stroke in Chinese population.	[Liu, Xu; Zhu, Ruixia; Li, Lei; Deng, Shumin; Li, Qu; He, Zhiyi] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Peoples R China	China Medical University	He, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Peoples R China.	hezhiyi0301@sina.com		Liu, Xu/0000-0002-3956-946X	National Natural Science Foundation of China [30971018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number: 30971018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bevan S, 2008, STROKE, V39, P1966, DOI 10.1161/STROKEAHA.107.509992; Cheng H, 2011, NEURAL REGEN RES, V6, P935, DOI 10.3969/j.issn.1673-5374.2011.12.010; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2005, TRENDS MOL MED, V11, P217, DOI 10.1016/j.molmed.2005.03.001; Hanson MG, 1998, J NEUROSCI, V18, P7361; Kuhlenbaumer G, 2006, J NEUROL NEUROSUR PS, V77, P521, DOI 10.1136/jnnp.2005.073577; Li C, 2012, ACTA ACAD MED QINDAO, V48, P304; Li N, 2010, BRAIN RES BULL, V81, P38, DOI 10.1016/j.brainresbull.2009.09.009; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin HF, 2007, J THROMB HAEMOST, V5, P436, DOI 10.1111/j.1538-7836.2007.02350.x; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Matsushita T, 2009, STROKE, V40, P1245, DOI 10.1161/STROKEAHA.108.527408; Meschia JF, 2011, NAT REV NEUROL, V7, P369, DOI 10.1038/nrneurol.2011.80; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Munshi A, 2008, INT J STROKE, V3, P188, DOI 10.1111/j.1747-4949.2008.00199.x; Munshi A, 2009, J NEUROL SCI, V285, P142, DOI 10.1016/j.jns.2009.06.024; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nakayama T, 2007, CURR MED CHEM, V14, P3171, DOI 10.2174/092986707782793871; Quarta G, 2009, EUR J HUM GENET, V17, P1448, DOI 10.1038/ejhg.2009.71; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Saleheen D, 2005, STROKE, V36, P2275, DOI 10.1161/01.STR.0000182242.59466.ee; Sasaki T, 2007, STROKE, V38, P1597, DOI 10.1161/STROKEAHA.106.476754; Staton JM, 2006, J NEUROL NEUROSUR PS, V77, P1067, DOI 10.1136/jnnp.2006.092106; Sun Y, 2009, CLIN SCI, V117, P265, DOI 10.1042/CS20080471; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; Wang HM, 2012, J MED RES, V41, P134; Xu SL, 2008, J CLIN NEUROL, V21, P249; Xu XW, 2010, NEUROGENETICS, V11, P327, DOI 10.1007/s10048-010-0235-8; Xue H, 2009, CLIN SCI, V116, P335, DOI 10.1042/CS20080162; Zhang HL, 2009, J CHIN MICROCIRC, V13, P624	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66374	10.1371/journal.pone.0066374	http://dx.doi.org/10.1371/journal.pone.0066374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799094	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800028
J	Komatsu, S; Makino, T; Yasue, H				Komatsu, Setsuko; Makino, Takahiro; Yasue, Hiroshi			Proteomic and Biochemical Analyses of the Cotyledon and Root of Flooding-Stressed Soybean Plants	PLOS ONE			English	Article							CALCIUM-OXALATE; SEEDLINGS; TOLERANCE; MECHANISM	Background: Flooding significantly reduces the growth and grain yield of soybean plants. Proteomic and biochemical techniques were used to determine whether the function of cotyledon and root is altered in soybean under flooding stress. Results: Two-day-old soybean plants were flooded for 2 days, after which the proteins from root and cotyledon were extracted for proteomic analysis. In response to flooding stress, the abundance of 73 and 28 proteins was significantly altered in the root and cotyledon, respectively. The accumulation of only one protein, 70 kDa heat shock protein (HSP70) (Glyma17g08020.1), increased in both organs following flooding. The ratio of protein abundance of HSP70 and biophoton emission in the cotyledon was higher than those detected in the root under flooding stress. Computed tomography and elemental analyses revealed that flooding stress decreases the number of calcium oxalate crystal the cotyledon, indicating calcium ion was elevated in the cotyledon under flooding stress. Conclusion: These results suggest that calcium might play one role through HSP70 in the cotyledon under flooding stress.	[Komatsu, Setsuko] NARO, Natl Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Makino, Takahiro] Grad Sch Creat New Photon Ind, Hamamatsu, Shizuoka, Japan; [Yasue, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan	Komatsu, S (corresponding author), NARO, Natl Inst Crop Sci, Tsukuba, Ibaraki, Japan.	skomatsu@affrc.go.jp			Japan Society for the Promotion of Science [23658063]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-In-Aid for Challenging Exploratory Research (23658063) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bennett M, 2005, MOL PLANT MICROBE IN, V18, P95, DOI 10.1094/MPMI-18-0095; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; Cha JY, 2012, PLANT PHYSIOL BIOCH, V58, P29, DOI 10.1016/j.plaphy.2012.06.006; Chiera JM, 2007, J EXP BOT, V58, P2261, DOI 10.1093/jxb/erm101; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Githiri SM, 2006, PLANT BREEDING, V125, P613, DOI 10.1111/j.1439-0523.2006.01291.x; Hashiguchi A, 2009, J PROTEOME RES, V8, P2058, DOI 10.1021/pr801051m; Hossain Z, 2012, J PROTEOMICS, V75, P4151, DOI 10.1016/j.jprot.2012.05.037; Ilarslan H, 2001, ANN BOT-LONDON, V88, P243, DOI 10.1006/anbo.2001.1453; Kausar R, 2012, MOL BIOL REP, V39, P10573, DOI 10.1007/s11033-012-1945-9; Khatoon A, 2012, AMINO ACIDS, V43, P2513, DOI 10.1007/s00726-012-1333-8; Khatoon A, 2012, J PROTEOMICS, V75, P5706, DOI 10.1016/j.jprot.2012.07.031; Kobayashi M, 1997, PHOTOCHEM PHOTOBIOL, V65, P535, DOI 10.1111/j.1751-1097.1997.tb08600.x; Komatsu S, 2013, J PROTEOMICS; Komatsu S, 2013, J PROTEOMICS, V79, P231, DOI 10.1016/j.jprot.2012.12.023; Komatsu S, 2012, J PROTEOME RES, V11, P68, DOI 10.1021/pr2008863; Komatsu S, 2011, PLANT MOL BIOL, V77, P309, DOI 10.1007/s11103-011-9812-y; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Komatsu S, 2010, AMINO ACIDS, V38, P729, DOI 10.1007/s00726-009-0277-0; Makino T, 1996, PHOTOCHEM PHOTOBIOL, V64, P953, DOI 10.1111/j.1751-1097.1996.tb01860.x; Mathesius U, 2011, PROTEOMICS, V11, P1707, DOI 10.1002/pmic.201000619; Nanjo Y, 2011, PLANT MOL BIOL, V77, P129, DOI 10.1007/s11103-011-9799-4; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Subbaiah CC, 2003, ANN BOT-LONDON, V91, P119, DOI 10.1093/aob/mcf210; Suri SS, 2008, PLANT CELL ENVIRON, V31, P218, DOI 10.1111/j.1365-3040.2007.01754.x; Webb MA, 1999, PLANT CELL, V11, P751, DOI 10.1105/tpc.11.4.751; Yanagawa Y, 2012, PLANT SCI, V185, P250, DOI 10.1016/j.plantsci.2011.11.014	33	38	41	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65301	10.1371/journal.pone.0065301	http://dx.doi.org/10.1371/journal.pone.0065301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799004	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300011
J	Richter, S; Morrison, S; Connor, T; Su, JC; Print, CG; Ronimus, RS; Mcgee, SL; Wilson, WR				Richter, Susan; Morrison, Shona; Connor, Tim; Su, Jiechuang; Print, Cristin G.; Ronimus, Ron S.; Mcgee, Sean L.; Wilson, William R.			Zinc Finger Nuclease Mediated Knockout of ADP-Dependent Glucokinase in Cancer Cell Lines: Effects on Cell Survival and Mitochondrial Oxidative Metabolism	PLOS ONE			English	Article							GENE KNOCKOUT; GENOME; HYPOXIA; HEXOKINASE; GENERATION; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; GLYCOLYSIS; EXPRESSION	Zinc finger nucleases (ZFN) are powerful tools for editing genes in cells. Here we use ZFNs to interrogate the biological function of ADPGK, which encodes an ADP-dependent glucokinase (ADPGK), in human tumour cell lines. The hypothesis we tested is that ADPGK utilises ADP to phosphorylate glucose under conditions where ATP becomes limiting, such as hypoxia. We characterised two ZFN knockout clones in each of two lines (H460 and HCT116). All four clones had frameshift mutations in all alleles at the target site in exon 1 of ADPGK, and were ADPGK-null by immunoblotting. ADPGK knockout had little or no effect on cell proliferation, but compromised the ability of H460 cells to survive siRNA silencing of hexokinase-2 under oxic conditions, with clonogenic survival falling from 21 +/- 3% for the parental line to 6.4 +/- 0.8% (p = 0.002) and 4.3 +/- 0.8% (p = 0.001) for the two knockouts. A similar increased sensitivity to clonogenic cell killing was observed under anoxia. No such changes were found when ADPGK was knocked out in HCT116 cells, for which the parental line was less sensitive than H460 to anoxia and to hexokinase-2 silencing. While knockout of ADPGK in HCT116 cells caused few changes in global gene expression, knockout of ADPGK in H460 cells caused notable up-regulation of mRNAs encoding cell adhesion proteins. Surprisingly, we could discern no consistent effect on glycolysis as measured by glucose consumption or lactate formation under anoxia, or extracellular acidification rate (Seahorse XF analyser) under oxic conditions in a variety of media. However, oxygen consumption rates were generally lower in the ADPGK knockouts, in some cases markedly so. Collectively, the results demonstrate that ADPGK can contribute to tumour cell survival under conditions of high glycolytic dependence, but the phenotype resulting from knockout of ADPGK is cell line dependent and appears to be unrelated to priming of glycolysis in these lines.	[Richter, Susan; Su, Jiechuang; Wilson, William R.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, New Zealand Bioinformat Inst, Auckland 1, New Zealand; [Morrison, Shona; Connor, Tim; Mcgee, Sean L.] Deakin Univ, Sch Med, Metab Res Unit, Geelong, Vic 3217, Australia; [Ronimus, Ron S.] AgResearch, Palmerston North, New Zealand	University of Auckland; University of Auckland; University of Auckland; Deakin University; AgResearch - New Zealand	Wilson, WR (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.	wr.wilson@auckland.ac.nz	Richter, Susan/AAP-1767-2020	Richter, Susan/0000-0002-3549-2477; Ronimus, Ron/0000-0001-8669-5840; Print, Cristin/0000-0001-8345-7812; McGee, Sean/0000-0001-6953-106X	Royal Society of New Zealand Marsden Fund; National Health and Medical Research Council (NHMRC) [1027226, 1027227]	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Royal Society of New Zealand Marsden Fund (www.royalsociety.org.nz/programmes/funds/marsden/). SLM is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship and project grants from the NHMRC (1027226 and 1027227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2012, FEBS OPEN B IN PRESS; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carroll D, 2011, CURR GENE THER, V11, P2, DOI 10.2174/156652311794520076; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Doberstein K, 2011, CARCINOGENESIS, V32, P262, DOI 10.1093/carcin/bgq249; Fan LC, 2012, BIOTECHNOL BIOENG, V109, P1007, DOI 10.1002/bit.24365; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li K, 2009, WORLD J GASTROENTERO, V15, P697, DOI 10.3748/wjg.15.697; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; MacLeod RAF, 2007, NAT PROTOC, V2, P372, DOI 10.1038/nprot.2007.29; Mailloux RJ, 2011, BIOCHEM J, V437, P301, DOI 10.1042/BJ20110571; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Nelson EA, 2006, J BIOL CHEM, V281, P26216, DOI 10.1074/jbc.M605001200; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Palpant NJ, 2012, GENE THER, pe1; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; SEABRIGHT M, 1972, CHROMOSOMA, V36, P204; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Warburg O, 1924, BIOCHEM Z, V152, P309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wong AW, 2010, BIOTECHNOL BIOENG, V106, P751, DOI 10.1002/bit.22749; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yoneda M, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-27; Zhang PQ, 2012, GLYCOBIOLOGY, V22, P897, DOI 10.1093/glycob/cws064	55	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65267	10.1371/journal.pone.0065267	http://dx.doi.org/10.1371/journal.pone.0065267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799003	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300010
J	Viswanathan, S; Muthu, V; Iqbal, N; Remalayam, B; George, T				Viswanathan, Stalin; Muthu, Vivekanandan; Iqbal, Nayyar; Remalayam, Bhavith; George, Tarun			Scrub Typhus Meningitis in South India - A Retrospective Study	PLOS ONE			English	Article							TUBERCULOUS MENINGITIS; ORIENTIA-TSUTSUGAMUSHI; CLINICAL-MANIFESTATIONS; ADENOSINE-DEAMINASE; LABORATORY FINDINGS; RISK-FACTORS; DIAGNOSIS; MENINGOENCEPHALITIS; OUTBREAK; PALSY	Background: Scrub typhus is prevalent in India although definite statistics are not available. There has been only one study on scrub typhus meningitis 20 years ago. Most reports of meningitis/meningoencephalitis in scrub typhus are case reports Methods: A retrospective study done in Pondicherry to extract cases of scrub typhus admitted to hospital between February 2011 and January 2012. Diagnosis was by a combination of any one of the following in a patient with an acute febrile illness-a positive scrub IgM ELISA, Weil-Felix test, and an eschar. Lumbar puncture was performed in patients with headache, nuchal rigidity, altered sensorium or cranial nerve deficits. Results: Sixty five cases of scrub typhus were found, and 17 (17/65) had meningitis. There were 33 males and 32 females. Thirteen had an eschar. Median cerebrospinal fluid (CSF) cell count, lymphocyte percentage, CSF protein, CSF glucose/blood glucose, CSF ADA were 54 cells/mu L, 98%, 88 mg/dL, 0.622 and 3.5 U/mL respectively. Computed tomography was normal in patients with altered sensorium and cranial nerve deficits. Patients with meningitis had lesser respiratory symptoms and signs and higher urea levels. All patients had received doxycycline except one who additionally received chloramphenicol. Conclusion: Meningitis in scrub typhus is mild with quick and complete recovery. Clinical features and CSF findings can mimic tuberculous meningitis, except for ADA levels. In the Indian context where both scrub typhus and tuberculosis are endemic, ADA and scrub IgM may be helpful in identifying patients with scrub meningitis and in avoiding prolonged empirical antituberculous therapy in cases of lymphocytic meningitis.	[Viswanathan, Stalin; Muthu, Vivekanandan] Indira Gandhi Med Coll, Dept Gen Med, Pondicherry, India; [Iqbal, Nayyar; Remalayam, Bhavith; George, Tarun] Pondicherry Inst Med Sci, Dept Internal Med, Pondicherry, India	Pondicherry Institute of Medical Sciences	Viswanathan, S (corresponding author), Indira Gandhi Med Coll, Dept Gen Med, Pondicherry, India.	stalinviswanathan@ymail.com	Viswanathan, Stalin/H-3019-2019	Viswanathan, Stalin/0000-0001-5861-5161				Boorugu Harikishan, 2010, J Assoc Physicians India, V58, P520; Chen Pei-Hao, 2006, Acta Neurol Taiwan, V15, P251; Garg RK, 2010, ACTA NEUROL SCAND, V122, P75, DOI 10.1111/j.1600-0404.2009.01316.x; Harden V.A., 1993, CAMBRIDGE WORLD HIST, V153, P355; Hayakawa K, 2012, J MED MICROBIOL, V61, P291, DOI 10.1099/jmm.0.034678-0; Iqbal N, 2012, TROPICAL MED HLTH, V40; Isaac R, 2004, CLIN INFECT DIS, V39, P1395, DOI 10.1086/424748; Jeong YJ, 2007, RADIOGRAPHICS, V27, P161, DOI 10.1148/rg.271065074; Jim WT, 2009, PEDIATR NEONATOL, V50, P96, DOI 10.1016/S1875-9572(09)60043-7; Kamarasu K, 2007, INDIAN J MED RES, V126, P128; Kang JI, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-173; Khan SA, 2012, INT J INFECT DIS; Kim DM, 2011, DIAGN MICR INFEC DIS, V69, P271, DOI 10.1016/j.diagmicrobio.2010.10.005; Kim DM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-108; Kim JH, 2008, J CLIN NEUROL, V4, P36, DOI 10.3988/jcn.2008.4.1.36; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Kularatne SA, 2012, INT J INFECT DIS; Lai CH, 2009, EMERG INFECT DIS, V15, P1659, DOI 10.3201/eid1510.090007; Lee CS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-216; Lee CS, 2009, AM J TROP MED HYG, V81, P484, DOI 10.4269/ajtmh.2009.81.484; Lee KL, 2008, DIAGN MICR INFEC DIS, V60, P237, DOI 10.1016/j.diagmicrobio.2007.09.015; Lee SH, 2007, SCAND J INFECT DIS, V39, P826, DOI 10.1080/00365540701266755; Lee YH, 2010, J AAPOS, V14, P460, DOI 10.1016/j.jaapos.2010.06.016; Lin WR, 2011, KAOHSIUNG J MED SCI, V27, P573, DOI 10.1016/j.kjms.2011.10.003; Liu YX, 2006, EMERG INFECT DIS, V12, P1109; Liu YX, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-82; Mahajan SK, 2010, EMERG INFECT DIS, V16, P1641, DOI 10.3201/eid1610.100456; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; Moghtaderi A, 2009, SCAND J INFECT DIS, V41, P188, DOI 10.1080/00365540902721384; Murthy JMK, 2010, NEUROL INDIA, V58, P716, DOI 10.4103/0028-3886.72178; Oaks JSC, 1983, BULLETIN, P1; PAPEZ JW, 1949, ARCH NEURO PSYCHIATR, V61, P545, DOI 10.1001/archneurpsyc.1949.02310110080004; Parola P, 2006, CLIN DERMATOL, V24, P191, DOI 10.1016/j.clindermatol.2005.11.007; Premaratna R, 2006, CLIN INFECT DIS, V42; Rajapakse S, 2012, ASIAN PAC J TROP MED, V5, P261, DOI 10.1016/S1995-7645(12)60036-4; Remalayam B, 2011, J POSTGRAD MED, V57, P262, DOI 10.4103/0022-3859.85231; Saifudheen K, 2012, ANN INDIAN ACAD NEUR, V15, P141, DOI 10.4103/0972-2327.95002; Seong SY, 2001, MICROBES INFECT, V3, P11, DOI 10.1016/S1286-4579(00)01352-6; Sharma PK, 2009, T ROY SOC TROP MED H, V103, P1153, DOI 10.1016/j.trstmh.2009.02.006; SILPAPOJAKUL K, 1991, ARCH INTERN MED, V151, P1753, DOI 10.1001/archinte.151.9.1753; Silpapojakul K, 2004, T ROY SOC TROP MED H, V98, P354, DOI 10.1016/j.trstmh.2003.10.011; Sittiwangkul R, 2008, ANN TROP PAEDIATR, V28, P149, DOI 10.1179/146532808X302189; Sun Q, 2012, AM J MED SCI, V344, P116, DOI 10.1097/MAJ.0b013e318238fee3; Suntharasaj T, 1997, J Obstet Gynaecol Res, V23, P75; Thakur JS, 2011, J LARYNGOL OTOL, V125, P567, DOI 10.1017/S0022215111000107; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Ting K S, 1992, J Formos Med Assoc, V91, P110; Tsay RW, 2002, QJM-INT J MED, V95, P126, DOI 10.1093/qjmed/95.2.126; Tuon FF, 2010, SCAND J INFECT DIS, V42, P198, DOI 10.3109/00365540903428158; Varghese GM, 2006, J INFECTION, V52, P56, DOI 10.1016/j.jinf.2005.02.001; Vivekanandan M, 2010, J Assoc Physicians India, V58, P24; Yang S-H, 2005, TZU CHI MED J, V17, P111; Yum KS, 2011, CLIN NEUROL NEUROSUR, V113, P250, DOI 10.1016/j.clineuro.2010.11.007	53	75	79	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66595	10.1371/journal.pone.0066595	http://dx.doi.org/10.1371/journal.pone.0066595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799119	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300091
J	Groen, B; Links, TP; Lefrandt, JD; van den Berg, PP; de Vos, P; Faas, MM				Groen, Bart; Links, Thera P.; Lefrandt, Joop D.; van den Berg, Paul P.; de Vos, Paul; Faas, Marijke M.			Aberrant Pregnancy Adaptations in the Peripheral Immune Response in Type 1 Diabetes: A Rat Model	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RECURRENT SPONTANEOUS-ABORTION; RHEUMATOID-ARTHRITIS; CYTOKINE PRODUCTION; T-CELLS; BB RATS; WOMEN; PREECLAMPSIA; LYMPHOCYTES; MONOCYTES	Introduction: Despite tight glycemic control, pregnancy complication rate in type 1 diabetes patients is higher than in normal pregnancy. Other etiological factors may be responsible for the development of adverse pregnancy outcome. Acceptance of the semi-allogeneic fetus is accompanied by adaptations in the maternal immune-response. Maladaptations of the immune-response has been shown to contribute to pregnancy complications. We hypothesized that type 1 diabetes, as an autoimmune disease, may be associated with maladaptations of the immune-response to pregnancy, possibly resulting in pregnancy complications. Methods: We studied pregnancy outcome and pregnancy-induced immunological adaptations in a normoglycemic rat-model of type 1 diabetes, i.e. biobreeding diabetes-prone rats (BBDP; 5 non-pregnant rats, 7 pregnant day 10 rats and 6 pregnant day 18 rats), versus non-diabetic control rats (i.e. congenic non-diabetic biobreeding diabetes-resistant (BBDR; 6 non-pregnant rats, 6 pregnant day 10 rats and 6 pregnant day 18 rats) and Wistar-rats (6 non-pregnant, 6 pregnant day 10 rats and 5 pregnant day 18 rats)). Results: We observed reduced litter size, lower fetal weight of viable fetuses and increased numbers of resorptions versus control rats. These complications are accompanied by various differences in the immune-response between BBDP and control rats in both pregnant and non-pregnant animals. The immune-response in non-pregnant BBDP-rats was characterized by decreased percentages of lymphocytes, increased percentages of effector T-cells, regulatory T-cells and natural killer cells, an increased Th1/Th2-ratio and activated monocytes versus Wistar and BBDR-rats. Furthermore, pregnancy-induced adaptations in BBDP-rats coincided with an increased Th1/Th2-ratio, a decreased mean fluorescence intensity CD161a/NKR-P1b ratio and no further activation of monocytes versus non-diabetic control rats. Conclusion: This study suggests that even in the face of strict normoglycemia, pregnancy complications still occur in type 1 diabetic pregnancies. This adverse pregnancy outcome may be related to the aberrant immunological adaptations to pregnancy in diabetic rats.	[Groen, Bart; Links, Thera P.] Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Groen, Bart; Links, Thera P.; Lefrandt, Joop D.; van den Berg, Paul P.; de Vos, Paul; Faas, Marijke M.] Univ Groningen, NL-9700 AB Groningen, Netherlands; [Lefrandt, Joop D.] Univ Groningen, Univ Med Ctr Groningen, Div Vasc Med, Dept Internal Med, Groningen, Netherlands; [van den Berg, Paul P.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [de Vos, Paul; Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Div Med Biol, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Faas, MM (corresponding author), Univ Med Ctr Groningen, Div Med Biol, Dept Pathol & Med Biol, Groningen, Netherlands.	m.m.faas@umcg.nl	de Vos, Paul/A-3170-2013	de vos, paul/0000-0001-9618-2408				AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baer AN, 2011, OBSTET GYNECOL SURV, V66, P639, DOI 10.1097/OGX.0b013e318239e1ee; Csorba TR, 2010, CRIT REV CL LAB SCI, V47, P51, DOI 10.3109/10408361003787171; Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006; de Man YA, 2009, ARTHRITIS RHEUM-US, V60, P3196, DOI 10.1002/art.24914; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Diabet Control Complications Trial Res Grp, 1996, AM J OBSTET GYNECOL, V174, P1343; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hawthorne G, 1997, BRIT MED J, V315, P279, DOI 10.1136/bmj.315.7103.279; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hillebrands JL, 2006, J IMMUNOL, V177, P7820, DOI 10.4049/jimmunol.177.11.7820; HUSSAIN MJ, 1987, DIABETOLOGIA, V30, P907, DOI 10.1007/BF00295872; Karami N, 2012, J REPROD IMMUNOL, V95, P87, DOI 10.1016/j.jri.2012.06.005; KNOPP RH, 1986, BIOL NEONATE, V50, P297, DOI 10.1159/000242614; Kuhnert M, 1998, EUR J OBSTET GYN R B, V76, P147, DOI 10.1016/S0301-2115(97)00180-2; Laresgoiti-Servitje E, 2010, HUM REPROD UPDATE, V16, P510, DOI 10.1093/humupd/dmq007; Lee SK, 2012, AM J REPROD IMMUNOL, V67, P311, DOI 10.1111/j.1600-0897.2012.01116.x; Leibowitz A, 2011, CURR HYPERTENS REP, V13, P465, DOI 10.1007/s11906-011-0224-9; Li J, 2003, INT IMMUNOL, V15, P411, DOI 10.1093/intimm/dxg046; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Loke YW, 2000, J REPROD FERTIL, P83; Lopez-Soldado Iliana, 2003, Exp Diabesity Res, V4, P107, DOI 10.1155/EDR.2003.107; Mahmoud Fadia, 2003, J Obstet Gynaecol, V23, P20, DOI 10.1080/0144361021000043163; Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Murphy HR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1680; Norgaard M, 2010, J INTERN MED, V268, P329, DOI 10.1111/j.1365-2796.2010.02239.x; Orsi NM, 2008, J NEUROENDOCRINOL, V20, P462, DOI 10.1111/j.1365-2826.2008.01668.x; Poehlmann H, 2009, CRIT CARE, V13, DOI 10.1186/cc7969; Poussier P, 2005, J IMMUNOL, V174, P4081, DOI 10.4049/jimmunol.174.7.4081; Raghupathy R, 2000, HUM REPROD, V15, P713, DOI 10.1093/humrep/15.3.713; Raghupathy R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/734865; Rossol M, 2012, ARTHRITIS RHEUM-US, V64, P671, DOI 10.1002/art.33418; Sacks G, 1999, IMMUNOL TODAY, V20, P114, DOI 10.1016/S0167-5699(98)01393-0; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saito S, 2007, J REPROD IMMUNOL, V76, P30, DOI 10.1016/j.jri.2007.08.002; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sargent Ian L, 2007, Reprod Biomed Online, V14 Spec No 1, P111, DOI 10.1016/S1472-6483(10)61465-4; Scriba A, 1997, J LEUKOCYTE BIOL, V62, P741, DOI 10.1002/jlb.62.6.741; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Taylor R, 2007, BMJ-BRIT MED J, V334, P742, DOI 10.1136/bmj.39154.700417.BE; van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026; van Nieuwenhoven ALV, 2002, FERTIL STERIL, V77, P1032, DOI 10.1016/S0015-0282(02)02976-X; van Nieuwenhoven ALV, 2008, HYPERTENS PREGNANCY, V27, P207, DOI 10.1080/10641950701885006; Visser J, 2004, LAB ANIM-UK, V38, P371, DOI 10.1258/0023677041958936; WILSON RG, 1986, BRIT MED J, V293, P244, DOI 10.1136/bmj.293.6541.244; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	51	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65490	10.1371/journal.pone.0065490	http://dx.doi.org/10.1371/journal.pone.0065490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805184	Green Published, gold			2022-12-27	WOS:000320846500012
J	Xie, Y; Matsumoto, H; Nalbantoglu, I; Kerr, TA; Luo, JY; Rubin, DC; Kennedy, S; Davidson, NO				Xie, Yan; Matsumoto, Hitoshi; Nalbantoglu, ILKe; Kerr, Thomas A.; Luo, Jianyang; Rubin, Deborah C.; Kennedy, Susan; Davidson, Nicholas O.			Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; HIGH-FAT DIET; GUT-LYMPH HYPOTHESIS; EPIREGULIN EXPRESSION; MOUSE MODEL; INHIBITOR; JTT-130; GLUCOSE; INJURY; MICE	Background: Gut derived lipid factors have been implicated in systemic injury and inflammation but the precise pathways involved are unknown. In addition, dietary fat intake and obesity are independent risk factors for the development of colorectal cancer. Here we studied the severity of experimental colitis and the development of colitis associated cancer (CAC) in mice with an inducible block in chylomicron secretion and fat malabsorption, following intestine-specific deletion of microsomal triglyceride transfer protein (Mttp-IKO). Methodology/Principal Findings: Mttp-IKO mice exhibited more severe injury with similar to 90% mortality following dextran sodium sulfate (DSS) induced colitis, compared to,20% in controls. Intestinal permeability was increased in Mttp-IKO mice compared to controls, both at baseline and after DSS administration, in association with increased circulating levels of TNF alpha. DSS treatment increased colonic mRNA expression of IL-1 beta and IL-17A as well as inflammasome expression in both genotypes, but the abundance of TNF alpha was selectively increased in DSS treated Mttp-IKO mice. There was a 2-fold increase in colonic tumor burden in Mttp-IKO mice following azoxymethane/DSS treatment, which was associated with increased colonic inflammation as well as alterations in cytokine expression. To examine the pathways by which alterations in fatty acid abundance might interact with cytokine signaling to regulate colonic epithelial growth, we used primary murine myofibroblasts to demonstrate that palmitate induced expression of amphiregulin and epiregulin and augmented the increase in both of these growth mediators when added to IL-1 beta or to TNF alpha. Conclusions: These studies demonstrate that Mttp-IKO mice, despite absorbing virtually no dietary fat, exhibit augmented fatty acid dependent signaling that in turn exacerbates colonic injury and increases tumor formation.	[Xie, Yan; Matsumoto, Hitoshi; Kerr, Thomas A.; Luo, Jianyang; Rubin, Deborah C.; Kennedy, Susan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Nalbantoglu, ILKe] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	nod@dom.wustl.edu		Rubin, Deborah/0000-0002-4192-909X	National Institutes of Health [HL-38180, DK-56260]; National Institutes of Health (Washington University Digestive Disease Research Core Center) [DK-52574];  [DK-46122];  [DK-61216]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (Washington University Digestive Disease Research Core Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work was supported by funding from the National Institutes of Health (HL-38180, DK-56260 and the Washington University Digestive Disease Research Core Center DK-52574, particularly the murine and morphology cores) to NOD. DR was supported by grants DK-46122 and DK-61216. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shali K, 2003, CLIN GENET, V63, P135, DOI 10.1046/j.0009-9163.2002.00175.x; Aleksandrova Krasimira, 2013, Curr Nutr Rep, V2, P1; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Fasano A, 2012, CLIN GASTROENTEROL H, V10, P1096, DOI 10.1016/j.cgh.2012.08.012; Fung TT, 2012, CANCER CAUSE CONTROL, V23, P959, DOI 10.1007/s10552-012-9969-y; Ghoshal S, 2009, J LIPID RES, V50, P90, DOI 10.1194/jlr.M800156-JLR200; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hata T, 2011, DIABETES OBES METAB, V13, P629, DOI 10.1111/j.1463-1326.2011.01387.x; Hata T, 2011, DIABETES OBES METAB, V13, P446, DOI 10.1111/j.1463-1326.2011.01368.x; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Inatomi O, 2006, INT J MOL MED, V18, P497; Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102; Kerr TA, 2012, INFLAMM BOWEL DIS, V18, P344, DOI 10.1002/ibd.21763; Kim E, 2011, J PHARMACOL EXP THER, V337, P775, DOI 10.1124/jpet.110.177527; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Levy E, 2001, AM J PHYSIOL-GASTR L, V280, pG563, DOI 10.1152/ajpgi.2001.280.4.G563; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Mera Y, 2011, J PHARMACOL EXP THER, V336, P321, DOI 10.1124/jpet.110.173807; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Nishimura T, 2008, ONCOL REP, V19, P105; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Pendyala S, 2011, AM J CLIN NUTR, V93, P234, DOI 10.3945/ajcn.110.002683; Plateroti M, 1998, AM J PHYSIOL-GASTR L, V274, pG945, DOI 10.1152/ajpgi.1998.274.5.G945; Rachmilewitz D, 2002, GASTROENTEROLOGY, V122, P1428, DOI 10.1053/gast.2002.32994; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Swift LL, 2005, HISTOCHEM CELL BIOL, V123, P475, DOI 10.1007/s00418-005-0772-7; van Diepen JA, 2013, J LIPID RES, V54, P448, DOI 10.1194/jlr.M031963; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Wang YH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008442; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2007, J BIOL CHEM, V282, P33043, DOI 10.1074/jbc.M705386200; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67819	10.1371/journal.pone.0067819	http://dx.doi.org/10.1371/journal.pone.0067819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805328	gold, Green Published			2022-12-27	WOS:000320846500156
J	Gong, P; Zhang, MY; Zhao, H; Tang, ZR; Hua, R; Mei, X; Cui, J; Li, CS				Gong, Ping; Zhang, Ming-Yue; Zhao, Hong; Tang, Zi-Ren; Hua, Rong; Mei, Xue; Cui, Juan; Li, Chun-Sheng			Effect of Mild Hypothermia on the Coagulation-Fibrinolysis System and Physiological Anticoagulants after Cardiopulmonary Resuscitation in a Porcine Model	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; COAGULOPATHY; INFLAMMATION; COMPRESSIONS; ACTIVATION; MECHANISMS; HEART; CARE	The aim of this study was to evaluate the effect of mild hypothermia on the coagulation-fibrinolysis system and physiological anticoagulants after cardiopulmonary resuscitation (CPR). A total of 20 male Wuzhishan miniature pigs underwent 8 min of untreated ventricular fibrillation and CPR. Of these, 16 were successfully resuscitated and were randomized into the mild hypothermia group (MH, n = 8) or the control normothermia group (CN, n = 8). Mild hypothermia (33 degrees C) was induced intravascularly, and this temperature was maintained for 12 h before pigs were actively rewarmed. The CN group received normothermic post-cardiac arrest (CA) care for 72 h. Four animals were in the sham operation group (SO). Blood samples were taken at baseline, and 0.5, 6, 12, 24, and 72 h after ROSC. Whole-body mild hypothermia impaired blood coagulation during cooling, but attenuated blood coagulation impairment at 72 h after ROSC. Mild hypothermia also increased serum levels of physiological anticoagulants, such as PRO C and AT-III during cooling and after rewarming, decreased EPCR and TFPI levels during cooling but not after rewarming, and inhibited fibrinolysis and platelet activation during cooling and after rewarming. Finally, mild hypothermia did not affect coagulation-fibrinolysis, physiological anticoagulants, or platelet activation during rewarming. Thus, our findings indicate that mild hypothermia exerted an anticoagulant effect during cooling, which may have inhibitory effects on microthrombus formation. Furthermore, mild hypothermia inhibited fibrinolysis and platelet activation during cooling and attenuated blood coagulation impairment after rewarming. Slow rewarming had no obvious adverse effects on blood coagulation.	[Gong, Ping] Dalian Med Univ, Hosp Affiliated 1, Dept Emergency, Dalian, Liaoning, Peoples R China; [Zhang, Ming-Yue; Zhao, Hong; Tang, Zi-Ren; Hua, Rong; Mei, Xue; Cui, Juan; Li, Chun-Sheng] Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China	Dalian Medical University; Capital Medical University	Li, CS (corresponding author), Capital Med Univ, Dept Emergency, Beijing Chaoyang Hosp, Beijing, Peoples R China.	lcscyyy@163.com	Gong, Ping/AAV-1936-2021	Gong, Ping/0000-0001-9910-7948	National Natural Science Foundation of China [30972863]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30972863, http://159.226.244.22/portal/proj_search.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2005, J AM COLL CARDIOL, V46, P21, DOI 10.1016/j.jacc.2005.03.046; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Adrie Christophe, 2004, Curr Opin Crit Care, V10, P208, DOI 10.1097/01.ccx.0000126090.06275.fe; Andre P, 2004, BRIT J HAEMATOL, V126, P298, DOI 10.1111/j.1365-2141.2004.05032.x; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bottiger B W, 2001, Curr Opin Crit Care, V7, P176; BOTTIGER BW, 1995, CIRCULATION, V92, P2572, DOI 10.1161/01.CIR.92.9.2572; Bottiger BW, 2002, CRIT CARE MED, V30, P2473, DOI 10.1097/01.CCM.0000034689.78033.E2; Esmon CT, 2003, J ENDOTOXIN RES, V9, P192, DOI 10.1179/096805103125001603; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Fischer M, 1996, INTENS CARE MED, V22, P1214; Gando S, 1997, THROMB HAEMOSTASIS, V77, P278; Gong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035313; Green David, 2006, Hemodial Int, V10 Suppl 2, pS2, DOI 10.1111/j.1542-4758.2006.00119.x; Hekimian G, 2004, SHOCK, V22, P116, DOI 10.1097/01.shk.0000132489.79498.c7; Hu CL, 2011, AM J EMERG MED, V29, P1103, DOI 10.1016/j.ajem.2010.07.016; Hua R, 2012, AM J EMERG MED, V30, P1420, DOI 10.1016/j.ajem.2011.10.022; Ji XF, 2012, RESUSCITATION, V83, P640, DOI 10.1016/j.resuscitation.2011.11.014; Ji XF, 2011, SHOCK, V35, P530, DOI 10.1097/SHK.0b013e31820e2058; Ji XF, 2010, RESUSCITATION, V81, P1031, DOI 10.1016/j.resuscitation.2010.04.023; Kazanskaya GM, 1999, MICROVASC RES, V58, P250, DOI 10.1006/mvre.1999.2181; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Meybohm P, 2010, CRIT CARE, V14, DOI 10.1186/cc8879; Meybohm P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007588; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Nozza S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037032; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schochl H, 2013, RESUSCITATION, V84, P454, DOI 10.1016/j.resuscitation.2012.08.318; Staikou C, 2011, J SURG RES, V167, P125, DOI 10.1016/j.jss.2009.07.037; Su ZY, 2011, AM J EMERG MED, V29, P913, DOI 10.1016/j.ajem.2010.04.001; Tang ZR, 2013, AM J EMERG MED, V31, P86, DOI 10.1016/j.ajem.2012.06.008; VALERI CR, 1995, CRIT CARE MED, V23, P698, DOI 10.1097/00003246-199504000-00019; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; van der Spuy WJ, 2012, REV NEUROSCIENCE, V23, P269, DOI 10.1515/revneuro-2012-0028; Wang S, 2010, CRIT CARE MED, V38, P2024, DOI 10.1097/CCM.0b013e3181eed90a; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; Wu JY, 2009, AM J EMERG MED, V27, P823, DOI 10.1016/j.ajem.2008.07.001; Zhao H, 2012, RESUSCITATION, V83, P913, DOI 10.1016/j.resuscitation.2012.01.001	40	17	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67476	10.1371/journal.pone.0067476	http://dx.doi.org/10.1371/journal.pone.0067476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818980	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800137
J	Kreth, J; Lengeler, JW; Jahreis, K				Kreth, Jens; Lengeler, Joseph W.; Jahreis, Knut			Characterization of Pyruvate Uptake in Escherichia coli K-12	PLOS ONE			English	Article							TRANSPORT-SYSTEM; L-LACTATE; GENE; PHOSPHOENOLPYRUVATE; PHOSPHOTRANSFERASE; DEHYDROGENASE; METABOLISM; SUCCINATE; MUTATIONS; MUTANTS	The monocarboxylate pyruvate is an important metabolite and can serve as sole carbon source for Escherichia coli. Although specific pyruvate transporters have been identified in two bacterial species, pyruvate transport is not well understood in E. coli. In the present study, pyruvate transport was investigated under different growth conditions. The transport of pyruvate shows specific activities depending on the growth substrate used as sole carbon source, suggesting the existence of at least two systems for pyruvate uptake: i) one inducible system and probably highly specific for pyruvate and ii) one system active under non-induced conditions. Using the toxic pyruvate analog 3-fluoropyruvate, a mutant was isolated unable to grow on and transport pyruvate. Further investigation revealed that a revertant selected for growth on pyruvate regained the inducible pyruvate transport activity. Characterization of pyruvate excretion showed that the pyruvate transport negative mutant accumulated pyruvate in the growth medium suggesting an additional transport system for pyruvate excretion. The here presented data give valuable insight into the pyruvate metabolism and transport of E. coli suggesting the presence of at least two uptake systems and one excretion system to balance the intracellular level of pyruvate.	[Kreth, Jens] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK USA; [Lengeler, Joseph W.; Jahreis, Knut] Univ Osnabruck, Arbeitsgruppe Genet Fachbereich Biol Chem, Osnabruck, Germany	University of Oklahoma System; University of Oklahoma Health Sciences Center; University Osnabruck	Kreth, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK USA.	JKreth@ouhsc.edu	Kreth, Jens/AAU-7833-2021	Kreth, Jens/0000-0002-8599-8310				BOCKMANN J, 1992, MOL GEN GENET, V235, P22, DOI 10.1007/BF00286177; Boeck A, 1996, ESCHERICHAI COLI SAL, P217; BRICKMAN E, 1973, J BACTERIOL, V116, P582, DOI 10.1128/JB.116.2.582-587.1973; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; FIETHEN L, 1970, MOL GEN GENET, V108, P322, DOI 10.1007/BF00267769; GUEST JR, 1973, J GEN MICROBIOL, V75, P197, DOI 10.1099/00221287-75-1-197; Hosie AHF, 2002, J BACTERIOL, V184, P5436, DOI 10.1128/JB.184.19.5436-5448.2002; Jolkver E, 2009, J BACTERIOL, V191, P940, DOI 10.1128/JB.01155-08; KODAKI T, 1981, J BIOCHEM-TOKYO, V90, P1437, DOI 10.1093/oxfordjournals.jbchem.a133610; KORNBERG HL, 1967, BIOCHIM BIOPHYS ACTA, V148, P591, DOI 10.1016/0304-4165(67)90167-5; LANG VJ, 1987, J BACTERIOL, V169, P380, DOI 10.1128/jb.169.1.380-385.1987; LOW KB, 1972, BACTERIOL REV, V36, P587, DOI 10.1128/MMBR.36.4.587-607.1972; MATIN A, 1973, EUR J BIOCHEM, V34, P58, DOI 10.1111/j.1432-1033.1973.tb02728.x; Nunez MF, 2002, BIOCHEM BIOPH RES CO, V290, P824, DOI 10.1006/bbrc.2001.6255; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; SCHMID K, 1982, J BACTERIOL, V151, P68, DOI 10.1128/JB.151.1.68-76.1982; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Zeppenfeld T, 2000, J BACTERIOL, V182, P4443, DOI 10.1128/JB.182.16.4443-4452.2000	19	26	26	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67125	10.1371/journal.pone.0067125	http://dx.doi.org/10.1371/journal.pone.0067125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818977	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800120
J	Xia, YH; McLaughlin, MM; Chen, W; Ling, L; Tucker, JD				Xia, Ying-Hua; McLaughlin, Megan M.; Chen, Wen; Ling, Li; Tucker, Joseph D.			HIV and Hepatitis C Virus Testing Delays at Methadone Clinics in Guangdong Province, China	PLOS ONE			English	Article							INJECTING DRUG-USERS; MISSED OPPORTUNITIES; LATE DIAGNOSIS; ANTIRETROVIRAL THERAPY; MAINTENANCE TREATMENT; RISK-FACTORS; INFECTION; INITIATION; BARRIERS; IMPACT	In China, injection drug use is a major transmission route for HIV and hepatitis C virus (HCV) infection. Timely HIV and HCV testing among drug users is vital to earlier diagnosis, linkage to care, and retention. This study aimed to examine HIV and hepatitis C virus (HCV) testing delays at methadone clinics in Guangdong Province, China, and identify individual-level and clinic-level factors associated with delayed testing. Data from 13,270 individuals at 45 methadone clinics in Guangdong were abstracted from a national web-based surveillance database. A two-level binomial logit model was used to examine the association between individual-and clinic-level factors and delayed HIV and HCV testing, defined as receiving a test seven or more days after initial entry into the methadone system. Among 10,046 patients tested for HIV, 1882 (18.7%) had delayed testing; among 10,404 patients tested for HCV, 1542 (14.8%) had delayed testing. Among delayed testers, the median time to HCV testing was significantly longer than the median time to HIV testing (73 vs. 54 days, p<0.05). In the multivariate analysis, the likelihood of delayed HIV testing was higher among individuals with high school or greater education (adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.02-1.72) and individuals enrolled at clinics with more patients (aOR 1.41, 95% CI 1.05-1.91, for each increase in 100). The likelihood of delayed HCV testing was higher among women (aOR 1.51, 95% CI 1.11-2.06) and employed individuals (aOR 1.21, 95% CI 1.02-1.43). Delayed testing for HIV and HCV is common among patients at methadone clinics in Guangdong, with many patients experiencing delays of two or more months. Structural interventions are needed to expedite testing once individuals enter the methadone maintenance program.	[Xia, Ying-Hua; Chen, Wen; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Ying-Hua; McLaughlin, Megan M.; Chen, Wen; Ling, Li; Tucker, Joseph D.] Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China; [McLaughlin, Megan M.; Tucker, Joseph D.] UNC Project China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ling, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn	Xia, Yinghua/H-3451-2018	Xia, Yinghua/0000-0002-3073-0747; Tucker, Joseph/0000-0003-2804-1181	National Natural Science Foundation of China [71173245, 30972552]; Guangdong Natural Science Foundation [9151008901000023]; Global Fund AIDS China Program Round Six (GF6); U.S. Fulbright Student Program; NIH Fogarty Career Development Award [US NIH 1K01TW008200-01A1]; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER [K01TW008200, D43TW009532] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Global Fund AIDS China Program Round Six (GF6); U.S. Fulbright Student Program; NIH Fogarty Career Development Award; UNC Center for AIDS Research; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support for this research came from the National Natural Science Foundation of China (grant 71173245, grant 30972552), Guangdong Natural Science Foundation (grant 9151008901000023), the Global Fund AIDS China Program Round Six (GF6), the U.S. Fulbright Student Program, a NIH Fogarty Career Development Award (US NIH 1K01TW008200-01A1), and the UNC Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Che YH, 2011, AM J DRUG ALCOHOL AB, V37, P148, DOI 10.3109/00952990.2010.535578; Chen Ang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1230; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Du J, 2012, AM J DRUG ALCOHOL AB, V38, P228, DOI 10.3109/00952990.2011.643974; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Hayashida T, 2012, INT J INFECT DIS, V16, pE172, DOI 10.1016/j.ijid.2011.11.003; Hepatotogy Branch Infectious and Parasitology branch Chinese Medical Association, 2004, Zhonghua Yu Fang Yi Xue Za Zhi, V38, P210; Ivers Louise C, 2007, AIDS Res Ther, V4, P28, DOI 10.1186/1742-6405-4-28; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Kuo AM, 2005, AIDS PATIENT CARE ST, V19, P239, DOI 10.1089/apc.2005.19.239; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Lin CQ, 2010, INT J DRUG POLICY, V21, P173, DOI 10.1016/j.drugpo.2009.09.002; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Ministry of Health of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Ministry of Health of China Ministry of Public Security of China State Food and Drug Administration, 2006, WORK PLAN COMM BAS M; Nhac-Vu HT, 2010, INT J STD AIDS, V21, P802, DOI 10.1258/ijsa.2010.010045; Shoptaw S, 2000, J SUBST ABUSE TREAT, V19, P117, DOI 10.1016/S0740-5472(99)00106-3; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Swan D, 2010, AIDS PATIENT CARE ST, V24, P753, DOI 10.1089/apc.2010.0142; Tucker JD, 2011, JAIDS-J ACQ IMM DEF, V57, pE106, DOI 10.1097/QAI.0b013e31821d3694; Wang AX, 2006, CHINESE MED J-PEKING, V119, P1589; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Ward JW, 2013, CLIN LIVER DIS, V17, P1, DOI 10.1016/j.cld.2012.09.011; Wen Y, 2011, AIDS CARE, V23, P1226, DOI 10.1080/09540121.2011.555748; Witteck A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13193; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	35	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66787	10.1371/journal.pone.0066787	http://dx.doi.org/10.1371/journal.pone.0066787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23818964	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800101
J	Chen, YYM; Shieh, HR; Chang, YC				Chen, Yi-Ywan M.; Shieh, Hui-Ru; Chang, Ya-Ching			The Expression of the fim Operon Is Crucial for the Survival of Streptococcus parasanguinis FW213 within Macrophages but Not Acid Tolerance	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; ENDOCARDITIS VIRULENCE; ABC TRANSPORTER; PROTEIN; MANGANESE; ENCODES; CLONING; MUTANS; GENE; GORDONII	The acquisition of transition metal ions is essential for the viability and in some cases the expression of virulence genes in bacteria. The fimCBA operon of Streptococcus parasanguinis FW213 encodes a Mn2+/Fe2+-specific ATP-binding cassette transporter. FimA, a lipoprotein in the system, is essential for the development of endocarditis, presumably by binding to fibrin monolayers on the damaged heart tissue. Recent sequence analysis revealed that Spaf_0344 was homologous to Streptococcus gordonii scaR, encoding a metalloregulatory protein for the Sca Mn2+-specific transporter. Based on the homology, Spaf_0344 was designated fimR. By using various fim promoter (p(fim)) derivatives fused with a promoterless chloramphenicol acetyltransferase gene, the functions of the cis-elements of p(fim) were analyzed in the wild-type and fimR-deficient hosts. The result indicated that FimR represses the expression of p(fim) and the palindromic sequences 5' to fimC are involved in repression of p(fim). A direct interaction between FimR and the palindromic sequences was further confirmed by in vitro electrophoresis gel mobility shift assay and in vivo chromatin immunoprecipitation assay (ChIP)-quantitative real-time PCR (qPCR). The result of the ChIP-qPCR analysis also indicated that FimR is activated by Mn2+ and, to a lesser degree, Fe2+. Functional analysis indicated that the expression of FimA in S. parasanguinis was critical for wild-type levels of survival against oxidative stress and within phagocytes, but not for acid tolerance. Taken together, in addition to acting as an adhesin (FimA), the expression of the fim operon is critical for the pathogenic capacity of S. parasanguinis.	[Chen, Yi-Ywan M.; Shieh, Hui-Ru] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan; [Chen, Yi-Ywan M.; Chang, Ya-Ching] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University	Chen, YYM (corresponding author), Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan.	mchen@mail.cgu.edu.tw		Chen, Yi-Ywan/0000-0002-8727-9811	National Science Council of Taiwan [NSC-982320-B182-031]; Chang Gung Memorial Hospital of Taiwan [CMRPD1B0063]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital of Taiwan(Chang Gung Memorial Hospital)	This work was supported by the National Science Council of Taiwan, grant NSC-982320-B182-031 and Chang Gung Memorial Hospital of Taiwan, grant CMRPD1B0063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; BADDOUR LM, 1994, INFECT IMMUN, V62, P2143, DOI 10.1128/IAI.62.6.2143-2148.1994; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Bruno-Barcena JM, 2010, APPL ENVIRON MICROB, V76, P2747, DOI 10.1128/AEM.02718-09; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; CARLSSON J, 1970, Archives of Oral Biology, V15, P1143, DOI 10.1016/0003-9969(70)90005-1; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Chen YYM, 1998, J BACTERIOL, V180, P5769, DOI 10.1128/JB.180.21.5769-5775.1998; Chen YYM, 2002, MICROBIOL-SGM, V148, P3599, DOI 10.1099/00221287-148-11-3599; COLE RM, 1976, J DENT RES, V55, pA142, DOI 10.1177/002203457605500106011; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; FENNO JC, 1993, GENE, V130, P81, DOI 10.1016/0378-1119(93)90349-8; FENNO JC, 1995, MOL MICROBIOL, V15, P849, DOI 10.1111/j.1365-2958.1995.tb02355.x; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; GANESHKUMAR N, 1991, INFECT IMMUN, V59, P1093, DOI 10.1128/IAI.59.3.1093-1099.1991; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Geng JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034769; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Hanks TS, 2006, INFECT IMMUN, V74, P5132, DOI 10.1128/IAI.00176-06; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Janulczyk R, 1999, MOL MICROBIOL, V34, P596, DOI 10.1046/j.1365-2958.1999.01626.x; Jenkinson HF, 1997, CRIT REV ORAL BIOL M, V8, P175, DOI 10.1177/10454411970080020601; Kim JS, 2005, J BACTERIOL, V187, P5984, DOI 10.1128/JB.187.17.5984-5995.2005; Kinkel TL, 2008, INFECT IMMUN, V76, P3451, DOI 10.1128/IAI.00343-08; Kitten T, 2000, INFECT IMMUN, V68, P4441, DOI 10.1128/IAI.68.8.4441-4451.2000; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; KOLENBRANDER PE, 1994, INFECT IMMUN, V62, P4469, DOI 10.1128/IAI.62.10.4469-4480.1994; Kolenbrander PE, 1998, J BACTERIOL, V180, P290, DOI 10.1128/JB.180.2.290-295.1998; LEBLANC DJ, 1991, ANTIMICROB AGENTS CH, V35, P1804, DOI 10.1128/AAC.35.9.1804; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Martin-Galiano AJ, 2005, MICROBIOL-SGM, V151, P3935, DOI 10.1099/mic.0.28238-0; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Oetjen J, 2002, INFECT IMMUN, V70, P5706, DOI 10.1128/IAI.70.10.5706-5714.2002; Paik S, 2003, J BACTERIOL, V185, P5967, DOI 10.1128/JB.185.20.5967-5975.2003; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002; Rolerson E, 2006, J BACTERIOL, V188, P5033, DOI 10.1128/JB.00155-06; SAMPSON JS, 1994, INFECT IMMUN, V62, P319, DOI 10.1128/IAI.62.1.319-324.1994; Shaw W V, 1975, Methods Enzymol, V43, P737; Spatafora G, 2002, MICROBIOL-SGM, V148, P755, DOI 10.1099/00221287-148-3-755; Stoll KE, 2009, BIOCHEMISTRY-US, V48, P10308, DOI 10.1021/bi900980g; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; XU T, 1992, J BIOL CHEM, V267, P21761	55	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66163	10.1371/journal.pone.0066163	http://dx.doi.org/10.1371/journal.pone.0066163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823757	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400061
J	Liu, HX; Fang, YP; Hu, Y; Gonzalez, FJ; Fang, JW; Wan, YJY				Liu, Hui-Xin; Fang, Yaping; Hu, Ying; Gonzalez, Frank J.; Fang, Jianwen; Wan, Yu-Jui Yvonne			PPAR beta Regulates Liver Regeneration by Modulating Akt and E2f Signaling	PLOS ONE			English	Article							ACTIVATED RECEPTOR-DELTA; LIGAND ACTIVATION; PEROXISOME; ALPHA; PROLIFERATION; EXPRESSION; GROWTH; TRANSCRIPTION; BETA/DELTA; METABOLISM	The current study tests the hypothesis that peroxisome proliferator-activated receptor beta (PPAR beta) has a role in liver regeneration due to its effect in regulating energy homeostasis and cell proliferation. The role of PPARb in liver regeneration was studied using two-third partial hepatectomy (PH) in Wild-type (WT) and PPARb-null (KO) mice. In KO mice, liver regeneration was delayed and the number of Ki-67 positive cells reached the peak at 60 hr rather than at 36-48 hr after PH shown in WT mice. RNA-sequencing uncovered 1344 transcriptomes that were differentially expressed in regenerating WT and KO livers. About 70% of those differentially expressed genes involved in glycolysis and fatty acid synthesis pathways failed to induce during liver regeneration due to PPAR beta deficiency. The delayed liver regeneration in KO mice was accompanied by lack of activation of phosphoinositide-dependent kinase 1 (PDK1)/Akt. In addition, cell proliferation-associated increase of genes encoding E2f transcription factor (E2f) 1-2 and E2f7-8 as well as their downstream target genes were not noted in KO livers 36-48 hr after PH. E2fs have dual roles in regulating metabolism and proliferation. Moreover, transient steatosis was only found in WT, but not in KO mice 36 hr after PH. These data suggested that PPAR beta-regulated PDK1/Akt and E2f signaling that controls metabolism and proliferation is involved in the normal progression of liver regeneration.	[Liu, Hui-Xin; Hu, Ying; Wan, Yu-Jui Yvonne] Calif State Univ Sacramento, Dept Med Pathol & Lab Med, Sacramento, CA 95819 USA; [Fang, Yaping; Fang, Jianwen] Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	California State University System; California State University Sacramento; University of Kansas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wan, YJY (corresponding author), Calif State Univ Sacramento, Dept Med Pathol & Lab Med, Sacramento, CA 95819 USA.	yjywan@ucdavis.edu		Fang, Yaping/0000-0001-6075-0768	National Institutes of Health [CA53596, DK092100]; NATIONAL CANCER INSTITUTE [ZIABC005708, R01CA053596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by grants funded by National Institutes of Health CA53596 and DK092100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Borland MG, 2008, MOL PHARMACOL, V74, P1429, DOI 10.1124/mol.108.050609; Burdick AD, 2007, CELL SIGNAL, V19, P1163, DOI 10.1016/j.cellsig.2006.12.007; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cicenas J, 2005, BREAST CANCER RES, V7, pR394, DOI 10.1186/bcr1015; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Gazit V, 2012, HEPATOLOGY, V56, P1489, DOI 10.1002/hep.25880; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Huang Tom Hsun-Wei, 2012, Curr Mol Pharmacol, V5, P241; Kostadinova R, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-34; Leclercq IA, 2003, GASTROENTEROLOGY, V124, P1451, DOI 10.1016/S0016-5085(03)00270-1; Lukas ER, 1999, MOL CARCINOGEN, V25, P295, DOI 10.1002/(SICI)1098-2744(199908)25:4<295::AID-MC8>3.0.CO;2-9; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Qu AJ, 2010, TOXICOL SCI, V118, P404, DOI 10.1093/toxsci/kfq259; Rao MS, 2002, HEPATOL RES, V22, P52, DOI 10.1016/S1386-6346(01)00119-X; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Shan W, 2008, TOXICOL SCI, V105, P418, DOI 10.1093/toxsci/kfn142; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Skrtic S, 2005, LIVER INT, V25, P33, DOI 10.1111/j.1478-3231.2004.0998.x; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuji K, 2008, FEBS J, V275, P3815, DOI 10.1111/j.1742-4658.2008.06527.x; Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025; Vosper H, 2001, J BIOL CHEM, V276, P44258, DOI 10.1074/jbc.M108482200; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wheeler MD, 2003, AM J PHYSIOL-GASTR L, V284, pG302, DOI 10.1152/ajpgi.00175.2002; Yamamoto Y, 2008, J GASTROEN HEPATOL, V23, P930, DOI 10.1111/j.1440-1746.2008.05370.x; Yang XX, 2010, AM J PATHOL, V176, P733, DOI 10.2353/ajpath.2010.090524; Yuan X, 2011, J PROTEOME RES, V10, P1179, DOI 10.1021/pr100960h; Zhou YF, 2008, AM J PHYSIOL-RENAL, V295, pF662, DOI 10.1152/ajprenal.00046.2008; Zingarelli B, 2010, AM J PATHOL, V177, P1834, DOI 10.2353/ajpath.2010.091010	41	37	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65644	10.1371/journal.pone.0065644	http://dx.doi.org/10.1371/journal.pone.0065644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823620	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400016
J	Bijar, A; Khayati, R; Benavent, AP				Bijar, Ahmad; Khayati, Rasoul; Penalver Benavent, Antonio			Increasing the Contrast of the Brain MR FLAIR Images Using Fuzzy Membership Functions and Structural Similarity Indices in Order to Segment MS Lesions	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; FULLY-AUTOMATIC SEGMENTATION; PROBABILISTIC SEGMENTATION	Segmentation is an important step for the diagnosis of multiple sclerosis (MS). This paper presents a new approach to the fully automatic segmentation of MS lesions in Fluid Attenuated Inversion Recovery (FLAIR) Magnetic Resonance (MR) images. With the aim of increasing the contrast of the FLAIR MR images with respect to the MS lesions, the proposed method first estimates the fuzzy memberships of brain tissues (i.e., the cerebrospinal fluid (CSF), the normal-appearing brain tissue (NABT), and the lesion). The procedure for determining the fuzzy regions of their member functions is performed by maximizing fuzzy entropy through Genetic Algorithm. Research shows that the intersection points of the obtained membership functions are not accurate enough to segment brain tissues. Then, by extracting the structural similarity (SSIM) indices between the FLAIR MR image and its lesions membership image, a new contrast-enhanced image is created in which MS lesions have high contrast against other tissues. Finally, the new contrast-enhanced image is used to segment MS lesions. To evaluate the result of the proposed method, similarity criteria from all slices from 20 MS patients are calculated and compared with other methods, which include manual segmentation. The volume of segmented lesions is also computed and compared with Gold standard using the Intraclass Correlation Coefficient (ICC) and paired samples t test. Similarity index for the patients with small lesion load, moderate lesion load and large lesion load was 0.7261, 0.7745 and 0.8231, respectively. The average overall similarity index for all patients is 0.7649. The t test result indicates that there is no statistically significant difference between the automatic and manual segmentation. The validated results show that this approach is very promising.	[Bijar, Ahmad; Khayati, Rasoul] Shahed Univ, Dept Biomed Engn, Tehran, Iran; [Penalver Benavent, Antonio] Miguel Hernandez Univ Elche, Ctr Operat Res Univ Inst, Elche, Spain	Shahed University; Universidad Miguel Hernandez de Elche	Bijar, A (corresponding author), Shahed Univ, Dept Biomed Engn, Tehran, Iran.	bijar@shahed.ac.ir		Penalver Benavent, Antonio/0000-0002-3775-2623				Admasu F, 2003, 2003 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL 2, PROCEEDINGS, P1081; Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Akselrod-Ballin A, 2009, IEEE T BIO-MED ENG, V56, P2461, DOI 10.1109/TBME.2008.926671; Alfano B, 2000, J MAGN RESON IMAGING, V12, P799, DOI 10.1002/1522-2586(200012)12:6<799::AID-JMRI2>3.0.CO;2-#; Anbeek P, 2005, NEUROIMAGE, V27, P795, DOI 10.1016/j.neuroimage.2005.05.046; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Anbeek P, 2008, MIDAS J, P1; BARTKO JJ, 1991, SCHIZOPHRENIA BULL, V17, P483, DOI 10.1093/schbul/17.3.483; Bedell BJ, 1998, MAGNET RESON MED, V39, P935, DOI 10.1002/mrm.1910390611; Bijar A., 2011, J BIOMED SCI ENG, V4, P552, DOI DOI 10.4236/JBISE.2011.48071; Boudraa AO, 2000, COMPUT BIOL MED, V30, P23, DOI 10.1016/S0010-4825(99)00019-0; Bricq S, 2008, GRAND CHALLENGE WORK, P1; Datta S, 2006, NEUROIMAGE, V29, P467, DOI 10.1016/j.neuroimage.2005.07.042; Datta S, 2007, J MAGN RESON IMAGING, V25, P932, DOI 10.1002/jmri.20896; Edelman RR, 2006, CLIN MAGNETIC RESONA, P1571; Freifeld O, 2007, I S BIOMED IMAGING, P596, DOI 10.1109/ISBI.2007.356922; Garcia-Lorenzo D., 2008, MICCAI WORKSH MED IM, P82; Garcia-Lorenzo D, 2008, GOURMET HLTH PROMOTI, P1; Garcia-Lorenzo D., 2008, WORK MED IM AN MULT, P104; Garcia-Lorenzo D, 2011, IEEE T MED IMAGING, V30, P1455, DOI 10.1109/TMI.2011.2114671; Gawne-Cain ML, 1998, J NEUROL NEUROSUR PS, V64; Goldberg-Zimring D, 1998, MAGN RESON IMAGING, V16, P311, DOI 10.1016/S0730-725X(97)00300-7; Goodman A., 2001, CNS NEWS SPECIAL EDI; He RJ, 2002, MED PHYS, V29, P1536, DOI 10.1118/1.1487422; Holland J.H., 1975, ADAPTATION NATURAL A; KAMBER M, 1995, IEEE T MED IMAGING, V14, P442, DOI 10.1109/42.414608; Khayati R, 2006, THESIS AMIRKBIR U TE; Khayati R, 2008, COMPUT BIOL MED, V38, P379, DOI 10.1016/j.compbiomed.2007.12.005; Lecoeur J, 2009, WORK MED IMAGE ANAL, P5; Li S. Z., 2001, COMP SCI W; Llado X, 2012, INFORM SCIENCES, V186, P164, DOI 10.1016/j.ins.2011.10.011; Martinez WL., 2002, COMPUTATIONAL STAT H; Morra J, 2008, GRAND CHALLENGE WORK, P1; Mortazavi D, 2012, NEURORADIOLOGY, V54, P299, DOI 10.1007/s00234-011-0886-7; Pahm DL, 1999, IEEE T MED IMAGING, V18, P731; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Prastawa M., 2008, GRAND CHALLENGE WORK, P1; Saha S, 2009, INFORM SCIENCES, V179, P3230, DOI 10.1016/j.ins.2009.06.013; Sahraian M. A., 2008, MRI ATLAS MS LESIONS; Sajja BR, 2006, ANN BIOMED ENG, V34, P142, DOI 10.1007/s10439-005-9009-0; Shiee N, 2008, WORK MED IMAGE ANAL, P71; Shiee N, 2010, NEUROIMAGE, V49, P1524, DOI 10.1016/j.neuroimage.2009.09.005; Shiee Navid, 2008, GRAND CHALLENGE WORK, P1; Slump K., 2008, GRAND CHALLENGE WORK, P1; Souplet JC, 2008, GRAND CHALLENGE WORK, P1; Stokking R, 2000, NEUROIMAGE, V12, P726, DOI 10.1006/nimg.2000.0661; Styner M., 2008, MIDAS J, P1; Subbanna N, 2009, MS LESION SEGMENTATI, P15; Tao WB, 2003, PATTERN RECOGN LETT, V24, P3069, DOI 10.1016/S0167-8655(03)00166-1; Tomas X, 2009, WORK MED IMAGE ANAL, P5; Van Leemput K, 2001, IEEE T MED IMAGING, V20, P677, DOI 10.1109/42.938237; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wellner PD., 1993, EPC1993110, pp. 1; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Wu Y, 2006, NEUROIMAGE, V32, P1205, DOI 10.1016/j.neuroimage.2006.04.211; Zavaljevski A, 2000, COMPUT MED IMAG GRAP, V24, P87, DOI 10.1016/S0895-6111(99)00042-7; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; ZIJDENBOS AP, 1994, IEEE T MED IMAGING, V13, P716, DOI 10.1109/42.363096	58	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65469	10.1371/journal.pone.0065469	http://dx.doi.org/10.1371/journal.pone.0065469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799015	gold, Green Submitted, Green Published			2022-12-27	WOS:000321397800007
J	Hu, T; Hu, LX; Zhang, XZ; Zhang, PP; Zhao, ZJ; Fu, JM				Hu, Tao; Hu, Longxing; Zhang, Xunzhong; Zhang, Pingping; Zhao, Zhuangjun; Fu, Jinmin			Differential Responses of CO2 Assimilation, Carbohydrate Allocation and Gene Expression to NaCl Stress in Perennial Ryegrass with Different Salt Tolerance	PLOS ONE			English	Article							SUCROSE-FRUCTAN 6-FRUCTOSYLTRANSFERASE; SIGNAL-TRANSDUCTION; PHOTOSYSTEM-II; PHOTOSYNTHETIC CAPACITY; STOMATAL CONDUCTANCE; SEEDLING GROWTH; SOLUBLE SUGAR; KEY ENZYME; IN-VIVO; SALINITY	Little is known about the effects of NaCl stress on perennial ryegrass (Lolium perenne L.) photosynthesis and carbohydrate flux. The objective of this study was to understand the carbohydrate metabolism and identify the gene expression affected by salinity stress. Seventy-four days old seedlings of two perennial ryegrass accessions (salt-sensitive 'PI 538976' and salt-tolerant 'Overdrive') were subjected to three levels of salinity stress for 5 days. Turf quality in all tissues (leaves, stems and roots) of both grass accessions negatively and significantly correlated with GFS (Glu+Fru+Suc) content, except for 'Overdrive' stems. Relative growth rate (RGR) in leaves negatively and significantly correlated with GFS content in 'Overdrive' (P < 0.01) and 'PI 538976' (P < 0.05) under salt stress. 'Overdrive' had higher CO2 assimilation and F-v/F-m than 'PI 538976'. Intercellular CO2 concentration, however, was higher in 'PI 538976' treated with 400 mM NaCl relative to that with 200 mM NaCl. GFS content negatively and significantly correlated with RGR in 'Overdrive' and 'PI 538976' leaves and in 'PI 538976' stems and roots under salt stress. In leaves, carbohydrate allocation negatively and significantly correlated with RGR (r(2) = 0.83, P < 0.01) and turf quality (r(2) = 0.88, P < 0.01) in salt-tolerant 'Overdrive', however, the opposite trend for salt-sensitive 'PI 538976' (r(2) = 0.71, P < 0.05 for RGR; r(2) = 0.62, P > 0.05 for turf quality). A greater up-regulation in the expression of SPS, SS, SI, 6-SFT gene was observed in 'Overdrive' than 'PI 538976'. A higher level of SPS and SS expression in leaves was found in 'PI 538976' relative to 'Overdrive'. Accumulation of hexoses in roots, stems and leaves can induce a feedback repression to photosynthesis in salt-stressed perennial ryegrass and the salt tolerance may be changed with the carbohydrate allocation in leaves and stems.	[Hu, Tao; Hu, Longxing; Zhang, Pingping; Zhao, Zhuangjun; Fu, Jinmin] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Zhang, Xunzhong] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Virginia Polytechnic Institute & State University	Fu, JM (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China.	jfu@wbgcas.cn	Campos, Gustavo R C Ribeiro/O-3981-2017; Hu, Longxing/AAS-8287-2020		National Natural Science Foundation of China [31071822/C150302]; Chinese Academy of Sciences [KSCX2-YW-N-068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported by National Natural Science Foundation of China (Grant: 31071822/C150302) and Innovative Program of The Chinese Academy of Sciences (Project #: KSCX2-YW-N-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Amiard V, 2003, PLANT PHYSIOL, V132, P2218, DOI 10.1104/pp.103.022335; BAKER NR, 1991, PHYSIOL PLANTARUM, V81, P563, DOI 10.1111/j.1399-3054.1991.tb05101.x; BALL MC, 1988, AUST J PLANT PHYSIOL, V15, P447, DOI 10.1071/PP9880447; Bernstein N, 2010, FREE RADICAL BIO MED, V49, P1161, DOI 10.1016/j.freeradbiomed.2010.06.032; BETHKE PC, 1992, PLANT PHYSIOL, V99, P219, DOI 10.1104/pp.99.1.219; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; BURCHETT MD, 1989, PHYSIOL PLANTARUM, V75, P299, DOI 10.1111/j.1399-3054.1989.tb06185.x; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Debez A, 2004, PLANT SOIL, V262, P179, DOI 10.1023/B:PLSO.0000037034.47247.67; Delfine S, 1999, PLANT PHYSIOL, V119, P1101, DOI 10.1104/pp.119.3.1101; Dionisio-Sese ML, 2000, J PLANT PHYSIOL, V157, P54, DOI 10.1016/S0176-1617(00)80135-2; DUCHATEAU N, 1995, PLANT PHYSIOL, V107, P1249, DOI 10.1104/pp.107.4.1249; ELSE MA, 1995, PLANT PHYSIOL, V109, P1017, DOI 10.1104/pp.109.3.1017; EVERARD JD, 1994, PLANT PHYSIOL, V106, P281, DOI 10.1104/pp.106.1.281; Farrar J, 2000, PLANT SCI, V154, P1, DOI 10.1016/S0168-9452(99)00260-5; Felix J. de M., 2009, Tropical Plant Biology, V2, P98, DOI 10.1007/s12042-009-9031-8; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; FOYER C, 1990, PHOTOSYNTH RES, V25, P83, DOI 10.1007/BF00035457; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; GOLDSCHMIDT EE, 1992, PLANT PHYSIOL, V99, P1443, DOI 10.1104/pp.99.4.1443; GREEN PB, 1968, PLANT PHYSIOL, V43, P1169, DOI 10.1104/pp.43.8.1169; Griffin KL, 1996, CHEM BIOL, V3, P245, DOI 10.1016/S1074-5521(96)90104-0; Gutierrez D, 2009, PHYSIOL PLANTARUM, V137, P86, DOI 10.1111/j.1399-3054.2009.01256.x; Han S, 2009, PLANT SCI, V176, P143, DOI 10.1016/j.plantsci.2008.10.004; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; HAVAUX M, 1992, PLANT PHYSIOL, V100, P424, DOI 10.1104/pp.100.1.424; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Hoagland DR, 1950, 247 CAL AGR EXP, V247; Hu T, 2011, ECOTOX ENVIRON SAFE, V74, P2050, DOI 10.1016/j.ecoenv.2011.07.013; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; KOCH KE, 1992, PLANT CELL, V4, P59, DOI 10.1105/tpc.4.1.59; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Liu H, 2008, PLANT CELL ENVIRON, V31, P1325, DOI 10.1111/j.1365-3040.2008.01838.x; Lu CM, 1999, NEW PHYTOL, V141, P231, DOI 10.1046/j.1469-8137.1999.00340.x; Lutts S, 1996, PLANT GROWTH REGUL, V19, P207, DOI 10.1007/BF00037793; Macias-Rodriguez L, 2002, J AGR FOOD CHEM, V50, P3317, DOI 10.1021/jf011491p; MARCAR NE, 1987, AUST J AGR RES, V38, P297, DOI 10.1071/AR9870297; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; MOING A, 1992, PLANT PHYSIOL, V100, P1878, DOI 10.1104/pp.100.4.1878; MORALES F, 1992, PHYSIOL PLANTARUM, V86, P419, DOI 10.1111/j.1399-3054.1992.tb01338.x; Morvan-Bertrand A, 2001, PLANTA, V213, P109, DOI 10.1007/s004250000478; Moya JL, 2003, J EXP BOT, V54, P825, DOI 10.1093/jxb/erg064; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Neves-Piestun BG, 2001, PLANT PHYSIOL, V125, P1419, DOI 10.1104/pp.125.3.1419; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Nizam I, 2011, AFR J BIOTECHNOL, V10, P10418; Parida AK, 2003, PHOTOSYNTHETICA, V41, P191, DOI 10.1023/B:PHOT.0000011951.37231.69; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; Pollock C, 2003, J EXP BOT, V54, P489, DOI 10.1093/jxb/erg037; Prado FE, 2000, BOT BULL ACAD SINICA, V41, P27; Ramon M., 2008, ARABIDOPSIS BOOK; RHOADES J D, 1990, P1089; Roitsch T, 1999, CURR OPIN PLANT BIOL, V2, P198, DOI 10.1016/S1369-5266(99)80036-3; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; Savitch LV, 2002, PLANT CELL ENVIRON, V25, P761, DOI 10.1046/j.1365-3040.2002.00861.x; Seckin B, 2010, ENVIRON EXP BOT, V69, P76, DOI 10.1016/j.envexpbot.2010.02.013; SEEMANN JR, 1986, PLANT PHYSIOL, V82, P555, DOI 10.1104/pp.82.2.555; SEEMANN JR, 1985, PLANTA, V164, P151, DOI 10.1007/BF00396077; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Smeekens S, 1997, PLANT PHYSIOL, V115, P7, DOI 10.1104/pp.115.1.7; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; SMILLIE RM, 1982, PLANT PHYSIOL, V70, P1049, DOI 10.1104/pp.70.4.1049; SPRENGER N, 1995, P NATL ACAD SCI USA, V92, P11652, DOI 10.1073/pnas.92.25.11652; STOREY R, 1995, AUST J PLANT PHYSIOL, V22, P101, DOI 10.1071/PP9950101; Sudhir PR, 2005, J BIOCHEM MOL BIOL, V38, P481; Takemura T, 2000, AQUAT BOT, V68, P15, DOI 10.1016/S0304-3770(00)00106-6; Trapp S, 2004, ENVIRON SCI POLLUT R, V11, P327, DOI 10.1007/BF02979647; Turgeon A.J., 2002, TURFGRASS MANAGEMENT; Wei JZ, 2001, J PLANT PHYSIOL, V158, P1203, DOI 10.1078/0176-1617-00241; Wu W, 2005, BIOCHEM SYST ECOL, V33, P1141, DOI 10.1016/j.bse.2005.02.010; Xiong YW, 2007, MOL BREEDING, V19, P125, DOI 10.1007/s11032-006-9050-1; Ye Y, 2005, AQUAT BOT, V83, P193, DOI 10.1016/j.aquabot.2005.06.006; Yu XZ, 2008, ECOTOX ENVIRON SAFE, V71, P609, DOI 10.1016/j.ecoenv.2008.05.007; Zhang T, 2010, J PLANT PHYSIOL, V167, P951, DOI 10.1016/j.jplph.2009.12.020; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	82	26	27	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66090	10.1371/journal.pone.0066090	http://dx.doi.org/10.1371/journal.pone.0066090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799072	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300061
J	Shen, CP; Liu, ST; Zhou, WZ; Lin, FS; Lam, AYY; Sung, HY; Chen, W; Lin, JW; Chiu, MJ; Pan, MK; Kao, JH; Wu, JM; Lai, FP				Shen, Chia-Ping; Liu, Shih-Ting; Zhou, Wei-Zhi; Lin, Feng-Seng; Lam, Andy Yan-Yu; Sung, Hsiao-Ya; Chen, Wei; Lin, Jeng-Wei; Chiu, Ming-Jang; Pan, Ming-Kai; Kao, Jui-Hung; Wu, Jin-Ming; Lai, Feipei			A Physiology- Based Seizure Detection System for Multichannel EEG	PLOS ONE			English	Article							AUTOMATIC SPIKE DETECTION; NEURAL-NETWORK; POLARITY; EPILEPSY	Background: Epilepsy is a common chronic neurological disorder characterized by recurrent unprovoked seizures. Electroencephalogram (EEG) signals play a critical role in the diagnosis of epilepsy. Multichannel EEGs contain more information than do single-channel EEGs. Automatic detection algorithms for spikes or seizures have traditionally been implemented on single-channel EEG, and algorithms for multichannel EEG are unavailable. Methodology: This study proposes a physiology-based detection system for epileptic seizures that uses multichannel EEG signals. The proposed technique was tested on two EEG data sets acquired from 18 patients. Both unipolar and bipolar EEG signals were analyzed. We employed sample entropy (SampEn), statistical values, and concepts used in clinical neurophysiology (e.g., phase reversals and potential fields of a bipolar EEG) to extract the features. We further tested the performance of a genetic algorithm cascaded with a support vector machine and post-classification spike matching. Principal Findings: We obtained 86.69% spike detection and 99.77% seizure detection for Data Set I. The detection system was further validated using the model trained by Data Set I on Data Set II. The system again showed high performance, with 91.18% detection of spikes and 99.22% seizure detection. Conclusion: We report a de novo EEG classification system for seizure and spike detection on multichannel EEG that includes physiology-based knowledge to enhance the performance of this type of system.	[Shen, Chia-Ping; Liu, Shih-Ting; Zhou, Wei-Zhi; Lam, Andy Yan-Yu; Chen, Wei; Kao, Jui-Hung; Wu, Jin-Ming; Lai, Feipei] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Lin, Feng-Seng; Sung, Hsiao-Ya; Lai, Feipei] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei 10764, Taiwan; [Lin, Jeng-Wei] Tunghai Univ, Dept Informat Management, Taichung 40704, Taiwan; [Chiu, Ming-Jang; Pan, Ming-Kai] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Chiu, Ming-Jang; Pan, Ming-Kai] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Chiu, Ming-Jang; Pan, Ming-Kai] Natl Taiwan Univ, Coll Sci, Dept Psychol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Tunghai University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Chiu, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan.	mjchiu@ntu.edu.tw	Chiu, Ming-Jang/AAR-3940-2020; Wu, Jin-Ming/D-9370-2013	Chiu, Ming-Jang/0000-0002-4158-4423; Wu, Jin-Ming/0000-0002-1821-239X; Pan, Ming-Kai/0000-0003-1485-3154; Pan, Ming-Kai/0000-0001-5535-2714				Acir N, 2004, COMPUT BIOL MED, V34, P561, DOI 10.1016/j.compbiomed.2003.08.003; Blume WT, 2001, EPILEPSIA, V42, P508, DOI 10.1046/j.1528-1157.2001.02700.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaovalitwongse WA, 2011, IEEE T SYST MAN CY A, V41, P977, DOI 10.1109/TSMCA.2011.2106118; Chen L, 2009, IEEE T INF TECHNOL B, V13, P405, DOI 10.1109/TITB.2008.2012164; Chia-Ping Shen, 2011, 2011 IEEE 11th International Conference on Bioinformatics & Bioengineering, P39, DOI 10.1109/BIBE.2011.13; Cortes C., 1995, SUPPORT VECTOR NETWO; DAVEY BLK, 1989, MED BIOL ENG COMPUT, V27, P365, DOI 10.1007/BF02441427; De Lucia M, 2008, MED BIOL ENG COMPUT, V46, P263, DOI 10.1007/s11517-007-0289-4; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fitzpatrick W, 2007, CAN J NEUROL SCI, V34, P443, DOI 10.1017/S0317167100007332; Ghosh-Dastidar S, 2008, IEEE T BIO-MED ENG, V55, P512, DOI 10.1109/TBME.2007.905490; Guler I, 2005, J NEUROSCI METH, V148, P113, DOI 10.1016/j.jneumeth.2005.04.013; Holland, 1975, ADAPTATION NATURAL A; Inan ZH, 2007, COMPUT BIOL MED, V37, P1160, DOI 10.1016/j.compbiomed.2006.10.010; Indiradevi KP, 2008, COMPUT BIOL MED, V38, P805, DOI 10.1016/j.compbiomed.2008.04.010; Ji ZF, 2011, IEEE T BIO-MED ENG, V58, P2478, DOI 10.1109/TBME.2011.2157917; KNOTT JR, 1985, J CLIN NEUROPHYSIOL, V2, P63, DOI 10.1097/00004691-198501000-00004; Ko CW, 2000, CLIN NEUROPHYSIOL, V111, P477, DOI 10.1016/S1388-2457(99)00284-9; LESSER RP, 1985, J CLIN NEUROPHYSIOL, V2, P45, DOI 10.1097/00004691-198501000-00003; Logesparan L, 2011, IEEE T BIO-MED ENG, V58, P2825, DOI 10.1109/TBME.2011.2160639; Nonclercq A, 2009, NEUROPHYSIOL CLIN, V39, P123, DOI 10.1016/j.neucli.2008.12.001; Oikonomou VP, 2007, COMPUT METH PROG BIO, V85, P101, DOI 10.1016/j.cmpb.2006.10.003; Olejniczak P, 2006, J CLIN NEUROPHYSIOL, V23, P186, DOI 10.1097/01.wnp.0000220079.61973.6c; Pedley T. A., 1980, American Journal of EEG Technology, V20, P101; Sackellares JC, 2012, EPILEPSY BEHAV, V22, P69; Shen CP, 2013, CLIN EEG NE IN PRESS; Shen CP, 2012, INT S NETW EN HLTH I, P797; Tzallas AT, 2009, IEEE T INF TECHNOL B, V13, P703, DOI 10.1109/TITB.2009.2017939; Ubeyli ED, 2007, PATTERN RECOGN LETT, V28, P592, DOI 10.1016/j.patrec.2006.10.004; Valderrama M, 2012, BIOMED SIGNAL PROCES, V7, P237, DOI 10.1016/j.bspc.2011.05.005; Witte H, 2003, IEEE T BIO-MED ENG, V50, P537, DOI 10.1109/TBME.2003.810708; Xia YS, 2006, IEEE T NEURAL NETWOR, V17, P975, DOI 10.1109/TNN.2006.875985; Yadav R, 2012, IEEE T BIO-MED ENG, V59, P1419, DOI 10.1109/TBME.2012.2188399; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091	35	21	22	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65862	10.1371/journal.pone.0065862	http://dx.doi.org/10.1371/journal.pone.0065862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799053	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300047
J	Chiang, HL; Ngo, ST; Chen, CJ; Hu, CK; Li, MS				Chiang, Hsin-Lin; Ngo, Son Tung; Chen, Chun-Jung; Hu, Chin-Kun; Li, Mai Suan			Oligomerization of Peptides LVEALYL and RGFFYT and Their Binding Affinity to Insulin	PLOS ONE			English	Article							EXCHANGE MOLECULAR-DYNAMICS; AMYLOID PEPTIDES; PROTEIN; AGGREGATION; MECHANISM; DISEASE; INHIBITION; FIBRILS; FIBRILLATION; SIMULATIONS	Recently it has been proposed a model for fibrils of human insulin in which the fibril growth proceeds via stacking LVEALYL (fragment 11-17 from chain B of insulin) into pairs of tightly interdigitated beta-sheets. The experiments have also shown that LVEALYL has high propensity to self-assembly and binding to insulin. This necessitates study of oligomerization of LVEALYL and its binding affinity to full-length insulin. Using the all-atom simulations with Gromos96 43a1 force field and explicit water it is shown that LVEALYL can aggregate. Theoretical estimation of the binding free energy of LVEALYL to insulin by the molecular mechanic Poisson-Boltzmann surface area method reveals its strong binding affinity to chain B, implying that, in agreement with the experiments, LVEALYL can affect insulin aggregation via binding mechanism. We predict that, similar to LVEALYL, peptide RGFFYT (fragment B22-27) can self-assemble and bind to insulin modulating its fibril growth process. The binding affinity of RGFFYT is shown to be comparable with that of LVEALYL.	[Chiang, Hsin-Lin; Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan; [Chiang, Hsin-Lin; Hu, Chin-Kun] Acad Sinica, Inst Phys, Taipei, Taiwan; [Ngo, Son Tung] Inst Computat Sci & Technol, Ho Chi Minh City, Vietnam; [Ngo, Son Tung; Li, Mai Suan] Polish Acad Sci, Inst Phys, Warsaw, Poland; [Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Life Sci Grp, Sci Res Div, Hsinchu, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; National Synchrotron Radiation Research Center; National Cheng Kung University	Hu, CK (corresponding author), Acad Sinica, Inst Phys, Taipei, Taiwan.	huck@phys.sinica.edu.tw; masli@ifpan.edu.pl	Ngo, Son Tung/M-4518-2014; Ngo, Son Tung/F-8964-2013; Li, Mai Suan/D-6304-2015; Chen, Chun-Jung/A-6880-2011	Ngo, Son Tung/0000-0003-1034-1768; Ngo, Son Tung/0000-0003-1034-1768; Li, Mai Suan/0000-0001-7021-7916; Chen, Chun-Jung/0000-0002-5157-4288; Hu, Chin-Kun/0000-0002-3620-8319	Narodowe Centrum Nauki in Poland [2011/01/B/NZ1/01622]; Department of Science and Technology at Ho Chi Minh city, Vietnam; Poland-Taiwan NSC [100-2911-I-001-507]; National Science Council in Taiwan [NSC-100-2923-M-001-003-MY3]; National Center for Theoretical Sciences in Taiwan	Narodowe Centrum Nauki in Poland; Department of Science and Technology at Ho Chi Minh city, Vietnam; Poland-Taiwan NSC; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); National Center for Theoretical Sciences in Taiwan	The work was supported by Narodowe Centrum Nauki in Poland (grant No 2011/01/B/NZ1/01622), Department of Science and Technology at Ho Chi Minh city, Vietnam, and Poland-Taiwan NSC grant 100-2911-I-001-507. CKH and HLC are also supported by National Science Council in Taiwan under grant number NSC-100-2923-M-001-003-MY3 and National Center for Theoretical Sciences in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERENDSEN HJC, 1996, INTERMOLECULAR FORCE; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cecchini M, 2004, J CHEM PHYS, V121, P10748, DOI 10.1063/1.1809588; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Devlin GL, 2006, J MOL BIOL, V360, P497, DOI 10.1016/j.jmb.2006.05.007; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Favrin G, 2004, BIOPHYS J, V87, P3657, DOI 10.1529/biophysj.104.046839; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2; Hong DP, 2005, BIOCHEMISTRY-US, V44, P16701, DOI 10.1021/bi051658y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Li MS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218101; Lin YF, 2011, J TAIWAN INST CHEM E, V42, P394, DOI 10.1016/j.jtice.2010.08.010; MacDonald ME, 1996, CURR OPIN NEUROBIOL, V6, P638, DOI 10.1016/S0959-4388(96)80097-3; Viet MH, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4730410; Viet MH, 2011, J PHYS CHEM B, V115, P7433, DOI 10.1021/jp1116728; Matthes D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019129; Nam HB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3415372; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nguyen PH, 2005, PROTEINS, V61, P795, DOI 10.1002/prot.20696; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nguyen PH, 2011, PHYS CHEM CHEM PHYS, V13, P9778, DOI 10.1039/c1cp20323a; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pease LF, 2010, BIOPHYS J, V99, P3979, DOI 10.1016/j.bpj.2010.10.010; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schrodinger L., 2020, PYMOL; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; SHANNO DF, 1970, MATH COMPUT, V24, P647, DOI 10.2307/2004840; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; STORKEL S, 1983, LAB INVEST, V48, P108; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Timofeev VI, 2010, ACTA CRYSTALLOGR F, V66, P259, DOI 10.1107/S1744309110000461; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tzotzos S, 2010, PROTEIN SCI, V19, P327, DOI 10.1002/pro.314; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wilhelm KR, 2007, EUR J NEUROL, V14, P327, DOI 10.1111/j.1468-1331.2006.01667.x; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	58	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65358	10.1371/journal.pone.0065358	http://dx.doi.org/10.1371/journal.pone.0065358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805182	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500010
J	Nakamura, Y; Ishii, J; Kondo, A				Nakamura, Yasuyuki; Ishii, Jun; Kondo, Akihiko			Rapid, Facile Detection of Heterodimer Partners for Target Human G-Protein-Coupled Receptors Using a Modified Split-Ubiquitin Membrane Yeast Two-Hybrid System	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; TIME-RESOLVED FRET; IN-VIVO; GPCR OLIGOMERIZATION; TERMINAL DOMAIN; DRUG DISCOVERY; COMPLEXES; HOMODIMERS; CEREVISIAE; SUBTYPE-5	Potentially immeasurable heterodimer combinations of human G-protein-coupled receptors (GPCRs) result in a great deal of physiological diversity and provide a new opportunity for drug discovery. However, due to the existence of numerous combinations, the sets of GPCR dimers are almost entirely unknown and thus their dominant roles are still poorly understood. Thus, the identification of GPCR dimer pairs has been a major challenge. Here, we established a specialized method to screen potential heterodimer partners of human GPCRs based on the split-ubiquitin membrane yeast two-hybrid system. We demonstrate that the mitogen-activated protein kinase (MAPK) signal-independent method can detect ligand-induced conformational changes and rapidly identify heterodimer partners for target GPCRs. Our data present the abilities to apply for the intermolecular mapping of interactions among GPCRs and to uncover potential GPCR targets for the development of new therapeutic agents.	[Nakamura, Yasuyuki; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan; [Ishii, Jun] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Kondo, A (corresponding author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan.	akondo@kobe-u.ac.jp	Ishii, Jun/D-7670-2016; Kondo, Akihiko/A-2130-2015	Ishii, Jun/0000-0003-2568-515X; Nakamura, Yasuyuki/0000-0002-0093-3754	Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science; Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science, the Naito Foundation, and Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe; iBioK) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; Ishii J, 2008, J BIOCHEM, V143, P667, DOI 10.1093/jb/mvn018; Ishii J, 2006, BIOTECHNOL PROGR, V22, P954, DOI 10.1021/bp0601387; Ishii J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037136; Ishii J, 2010, FEBS J, V277, P1982, DOI 10.1111/j.1742-4658.2010.07625.x; Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Iyer K., 2005, SCI STKE, V2005, P13; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Kokkola T, 1998, BIOCHEM BIOPH RES CO, V249, P531, DOI 10.1006/bbrc.1998.9182; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; Matsushita S, 2010, J BIOL CHEM, V285, P10291, DOI 10.1074/jbc.M109.077990; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Panetta R, 2008, DRUG DISCOV TODAY, V13, P1059, DOI 10.1016/j.drudis.2008.09.002; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Togawa S, 2010, J BIOCHEM, V147, P867, DOI 10.1093/jb/mvq022	36	12	12	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66793	10.1371/journal.pone.0066793	http://dx.doi.org/10.1371/journal.pone.0066793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805278	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500106
J	Tyler, AF; Mendoza, JP; Firan, M; Karandikar, NJ				Tyler, Andrew F.; Mendoza, Jason P.; Firan, Mihail; Karandikar, Nitin J.			CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MHC CLASS-I; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; TRYPTOPHAN CATABOLISM; INTERFERON-GAMMA; MEDICAL PROGRESS; COPOLYMER 1; IFN-GAMMA; ENCEPHALOMYELITIS	The exact mechanism of glatiramer acetate (GA, Copaxone (R)), an FDA-approved immunomodulatory therapy for multiple sclerosis (MS), remains unclear after decades of research. Previously, we have shown that GA therapy of MS induces CD8(+) T cell responses that can potentially suppress pathogenic CD4(+) T cell responses. Using a murine model of MS, experimental autoimmune encephalomyelitis (EAE), we now demonstrate that CD8(+) T cells are necessary in mediating the therapeutic effects of GA. Further, adoptive transfer of GA-induced CD8(+) T cells resulted in amelioration of EAE, establishing a role as a viable immunotherapy in demyelinating disease. Generation of these cells required indoleamine-2,3-dioxygenase (IDO), while suppressive function depended on non-classical MHC class I, IFN-gamma, and perforin expression. GA-induced regulatory myeloid cells, previously shown to activate CD4(+) regulatory T cells in an antigen-independent manner, required CD8(+) T cells for disease suppression in vivo. These studies demonstrate an essential role for CD8(+) T cells in GA therapy and identify their potential as an adoptive immunotherapeutic agent.	[Tyler, Andrew F.; Mendoza, Jason P.; Firan, Mihail; Karandikar, Nitin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Karandikar, NJ (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.	nitin-karandikar@uiowa.edu		Karandikar, Nitin/0000-0002-6867-6950; Mendoza, Jason/0000-0003-2526-5542	NIH [F31, R01, K24]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092106, K24AI079272] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by grant awards from the NIH (Ruth L. Kirschstein National Research Service F31 Award to AT and R01 and K24 awards to NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aharoni R, 2005, INT IMMUNOPHARMACOL, V5, P23, DOI 10.1016/j.intimp.2004.09.007; Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Aharoni R, 1998, J NEUROIMMUNOL, V91, P135, DOI 10.1016/S0165-5728(98)00166-0; Baughman EJ, 2011, J AUTOIMMUN, V36, P115, DOI 10.1016/j.jaut.2010.12.003; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Beeston T, 2010, J NEUROIMMUNOL, V229, P91, DOI 10.1016/j.jneuroim.2010.07.007; Biegler BW, 2006, J NEUROIMMUNOL, V180, P159, DOI 10.1016/j.jneuroim.2006.07.015; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Farina C, 2001, BRAIN, V124, P705, DOI 10.1093/brain/124.4.705; Fridkis-Hareli M, 1998, P NATL ACAD SCI USA, V95, P12528, DOI 10.1073/pnas.95.21.12528; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gajewski TF, 2006, J IMMUNOTHER, V29, P233, DOI 10.1097/01.cji.0000199193.29048.56; Gianfrani C, 2006, J IMMUNOL, V177, P4178, DOI 10.4049/jimmunol.177.6.4178; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hong J, 2005, P NATL ACAD SCI USA, V102, P6449, DOI 10.1073/pnas.0502187102; Hurgin V, 2007, P NATL ACAD SCI USA, V104, P5044, DOI 10.1073/pnas.0611608104; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Illes Z, 2005, EUR J IMMUNOL, V35, P3683, DOI 10.1002/eji.200526121; Jee Y, 2006, INT IMMUNOL, V18, P537, DOI 10.1093/intimm/dxh394; Jung S, 2004, J NEUROIMMUNOL, V148, P63, DOI 10.1016/j.jneuroim.2003.11.014; Kala M, 2010, EXP NEUROL, V221, P136, DOI 10.1016/j.expneurol.2009.10.015; Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380; Kim HJ, 2010, NATURE; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Miller S. D., 2010, CURR PROTOC IMMUNOL; Mitne S, 2011, CLIN OPHTHALMOL, V5, P991, DOI 10.2147/OPTH.S22964; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Najafian N, 2003, J CLIN INVEST; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Sand KL, 2009, CELL MOL LIFE SCI, V66, P1446, DOI 10.1007/s00018-009-8726-1; Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sellebjerg F, 2012, MULT SCLER; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; TEITELBAUM D, 1971, European Journal of Immunology, V1, P242, DOI 10.1002/eji.1830010406; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Theil DJ, 2008, J NEUROIMMUNOL, V204, P92, DOI 10.1016/j.jneuroim.2008.07.005; Toker A, 2011, SCAND J IMMUNOL, V74, P235, DOI 10.1111/j.1365-3083.2011.02575.x; Tonkin DR, 2009, EUR J IMMUNOL, V39, P1313, DOI 10.1002/eji.200838916; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; York NR, 2010, J AUTOIMMUN, V35, P33, DOI 10.1016/j.jaut.2010.01.003; Ziemssen T, 2007, INT REV NEUROBIOL, V79, P537, DOI 10.1016/S0074-7742(07)79024-4	48	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66772	10.1371/journal.pone.0066772	http://dx.doi.org/10.1371/journal.pone.0066772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805274	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500102
J	Tan, WH; Popel, AS; Mac Gabhann, F				Wan Hua Tan; Popel, Aleksander S.; Mac Gabhann, Feilim			Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation	PLOS ONE			English	Article							ENDOTHELIAL-CELL MIGRATION; SIGNAL-TRANSDUCTION; CROSS-TALK; SENSITIVITY-ANALYSIS; QUANTITATIVE MODEL; SYSTEMS BIOLOGY; GAB2; PHOSPHORYLATION; SURVIVAL; QUANTIFICATION	Vascular endothelial growth factor (VEGF) signal transduction is central to angiogenesis in development and in pathological conditions such as cancer, retinopathy and ischemic diseases. However, no detailed mass-action models of VEGF receptor signaling have been developed. We constructed and validated the first computational model of VEGFR2 trafficking and signaling, to study the opposing roles of Gab1 and Gab2 in regulation of Akt phosphorylation in VEGF-stimulated endothelial cells. Trafficking parameters were optimized against 5 previously published in vitro experiments, and the model was validated against six independent published datasets. The model showed agreement at several key nodes, involving scaffolding proteins Gab1, Gab2 and their complexes with Shp2. VEGFR2 recruitment of Gab1 is greater in magnitude, slower, and more sustained than that of Gab2. As Gab2 binds VEGFR2 complexes more transiently than Gab1, VEGFR2 complexes can recycle and continue to participate in other signaling pathways. Correspondingly, the simulation results show a log-linear relationship between a decrease in Akt phosphorylation and Gab1 knockdown while a linear relationship was observed between an increase in Akt phosphorylation and Gab2 knockdown. Global sensitivity analysis demonstrated the importance of initial-concentration ratios of antagonistic molecular species (Gab1/Gab2 and PI3K/Shp2) in determining Akt phosphorylation profiles. It also showed that kinetic parameters responsible for transient Gab2 binding affect the system at specific nodes. This model can be expanded to study multiple signaling contexts and receptor crosstalk and can form a basis for investigation of therapeutic approaches, such as tyrosine kinase inhibitors (TKIs), overexpression of key signaling proteins or knockdown experiments.	[Wan Hua Tan; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA; [Mac Gabhann, Feilim] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Mac Gabhann, F (corresponding author), Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA.	feilim@jhu.edu	Popel, Aleksander S/A-6724-2009	Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health (NIH) [R01 HL101200, R01 CA138264, U54 CA143868, R00 HL093219]; NATIONAL CANCER INSTITUTE [U54CA143868, R01CA138264] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101200, R00HL093219] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) grants R01 HL101200, R01 CA138264, and U54 CA143868 (ASP) and R00 HL093219 (FMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Andersen J, 2010, DANCING TIMES, V100, P55; [Anonymous], 2012, BLOOD PREPUBLICA; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Brummer T, 2008, EMBO J, V27, P2305, DOI 10.1038/emboj.2008.159; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Caron C, 2009, CELL SIGNAL, V21, P943, DOI 10.1016/j.cellsig.2009.02.004; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Jain HV, 2009, MOL CANCER THER, V8, P2926, DOI 10.1158/1535-7163.MCT-08-1223; Jayson GC, 2012, NAT REV CLIN ONCOL; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Meng SS, 2005, BIOCHEM J, V391, P143, DOI 10.1042/BJ20050229; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 1998, COMPUT STAT DATA AN, V26, P445, DOI 10.1016/S0167-9473(97)00043-1; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schneeweis C, 2010, J ATHEROSCLER THROMB, V17, P203, DOI 10.5551/jat.3004; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Tugues S, 2011, MOL ASPECTS MED, V32, P88, DOI 10.1016/j.mam.2011.04.004; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	59	26	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67438	10.1371/journal.pone.0067438	http://dx.doi.org/10.1371/journal.pone.0067438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805312	gold, Green Submitted, Green Published			2022-12-27	WOS:000320846500140
J	Zhang, C; Ni, J; Li, BL; Gao, F; Liu, H; Liu, W; Huang, YJ; Cai, JM				Zhang, Chao; Ni, Jin; Li, Bai-Long; Gao, Fu; Liu, Hu; Liu, Wen; Huang, Yi-Juan; Cai, Jian-Ming			CpG-Oligodeoxynucleotide Treatment Protects against Ionizing Radiation-Induced Intestine Injury	PLOS ONE			English	Article								Background: the bone marrow and the intestine are the major sites of ionizing radiation (IR)-induced injury. Our previous study demonstrated that CpG-oligodeoxynucleotide (ODN) treatment mitigated IR-induced bone marrow injury, but its effect on the intestine is not known. In this study, we sought to determine if CpG-ODN have protective effect on IR-induced intestine injury, and if so, to determine the mechanism of its effect. Methods and Findings: Mice were treated with CpG-ODN after IR. The body weight and survival were daily monitored for 30 days consecutively after exposure. The number of surviving intestinal crypt was assessed by the microcolony survival assay. The number and the distribution of proliferating cell in crypt were evaluated by TUNEL assay and BrdU assay. The expression of Bcl-2, Bax and caspase-3 in crypt were analyzed by Immunohistochemistry assay. The findings showed that the treatment for irradiated mice with CpG-ODN diminished body weight loss, improved 30 days survival, enhanced intestinal crypts survival and maintained proliferating cell population and regeneration in crypt. The reason might involve that CpG-ODN up-regulated the expression of Bcl-2 protein and down-regulated the expression of Bax protein and caspase-3 protein. Conclusion: CpG-ODN was effective in protection of IR-induced intestine injury by enhancing intestinal crypts survival and maintaining proliferating cell population and regeneration in crypt. The mechanism might be that CpG-ODN inhibits proliferating cell apoptosis through regulating the expression of apoptosis-related protein, such as Bax, Bcl-2 and caspase-3.	[Zhang, Chao; Ni, Jin; Li, Bai-Long; Gao, Fu; Liu, Hu; Liu, Wen; Huang, Yi-Juan; Cai, Jian-Ming] Second Mil Med Univ, Sect Radiat Med, Dept Naval Med, Shanghai, Peoples R China	Naval Medical University	Cai, JM (corresponding author), Second Mil Med Univ, Sect Radiat Med, Dept Naval Med, Shanghai, Peoples R China.	cjm882003@gmail.com	li, bz/GVR-7133-2022		National Natural Science Foundation of China [31070762]; National Natural Science Foundation of Shanghai [10ZR1437500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shanghai	This work is supported in part by the National Natural Science Foundation of China (No.31070762) and the National Natural Science Foundation of Shanghai (No. 10ZR1437500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SC, 2005, HISTOCHEM CELL BIOL, V123, P249, DOI 10.1007/s00418-005-0765-6; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367; Coopersmith CM, 1997, ONCOGENE, V15, P131, DOI 10.1038/sj.onc.1201176; Diego A, 2001, DIGEST DIS SCI, V46, P2608; Eric JH, 2012, RADIOBIOLOGY RADIOLO; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Jurk M, 2004, IMMUNOBIOLOGY, V209, P141, DOI 10.1016/j.imbio.2004.02.006; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Lee JD, 2007, CURR OPIN GASTROEN, V23, P27, DOI 10.1097/MOG.0b013e3280118272; Luka M., 2004, CANCER RES, V64, P5074; Mason KA, 2006, RADIOTHER ONCOL, V80, P192, DOI 10.1016/j.radonc.2006.07.024; Monti PWJ, 2005, BJR S27, P27; Payel B, 2009, PLOS ONE, V4, P8041; Pedersen G, 2005, CLIN EXP IMMUNOL, V141, P298, DOI 10.1111/j.1365-2249.2005.02848.x; Pritchard DM, 1999, ONCOGENE, V18, P7287, DOI 10.1038/sj.onc.1203150; Przemeck SMC, 2006, AM J PHYSIOL-GASTR L, V292, P620; Riehl T, 2000, GASTROENTEROLOGY, V118, P1106, DOI 10.1016/S0016-5085(00)70363-5; Salakou S, 2007, IN VIVO, V21, P123; Subhrajit S, 2012, PLOS ONE, V7, P29357; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Wang YH, 2008, J BIOL CHEM, V283, P9454, DOI 10.1074/jbc.M707962200; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Zhang C, 2011, BASIC CLIN PHARMACOL, V109, P11, DOI 10.1111/j.1742-7843.2011.00695.x	25	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66586	10.1371/journal.pone.0066586	http://dx.doi.org/10.1371/journal.pone.0066586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805241	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500069
J	Chen, Y; Fan, JX; Zhang, ZL; Wang, G; Cheng, X; Chuai, ML; Lee, KKH; Yang, XS				Chen, Yao; Fan, Jian-xia; Zhang, Zhao-long; Wang, Guang; Cheng, Xin; Chuai, Manli; Lee, Kenneth Ka Ho; Yang, Xuesong			The Negative Influence of High-Glucose Ambience on Neurogenesis in Developing Quail Embryos	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; OXIDATIVE STRESS; VITAMIN-C; DIABETES-MELLITUS; POLYOL PATHWAY; CREST CELLS; IN-VITRO; MOUSE; CHICK; RAT	Gestational diabetes is defined as glucose intolerance during pregnancy and it is presented as high blood glucose levels during the onset pregnancy. This condition has an adverse impact on fetal development but the mechanism involved is still not fully understood. In this study, we investigated the effects of high glucose on the developing quail embryo, especially its impact on the development of the nervous system. We established that high glucose altered the central nervous system mophologically, such that neural tube defects (NTDs) developed. In addition, we found that high glucose impaired nerve differentiation at dorsal root ganglia and in the developing limb buds, as revealed by neurofilament (NF) immunofluorescent staining. The dorsal root ganglia are normally derived from neural crest cells (NCCs), so we examine the delamination of NCCs from dorsal side of the neural tube. We established that high glucose was detrimental to the NCCs, in vivo and in vitro. High glucose also negatively affected neural differentiation by reducing the number and length of neurites emanating from neurons in culture. We established that high glucose exposure caused an increase in reactive oxidative species (ROS) generation by primary cultured neurons. We hypothesized that excess ROS was the factor responsible for impairing neuron development and differentiation. We provided evidence for our hypothesis by showing that the addition of vitamin C (a powerful antioxidant) could rescue the damaging effects of high glucose on cultured neurons.	[Chen, Yao; Zhang, Zhao-long; Wang, Guang; Cheng, Xin; Yang, Xuesong] Jinan Univ, Div Histol & Embryol, Coll Med, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China; [Fan, Jian-xia] Shanghai Jiao Tong Univ, Sch Med, Dept Gynecol & Obstet, Int Peace Matern & Child Hlth Hosp, Shanghai 200030, Peoples R China; [Chuai, Manli] Univ Dundee, Div Cell & Dev Biol, Dundee, Scotland; [Lee, Kenneth Ka Ho] Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China; [Yang, Xuesong] Jinan Univ, Inst Fetal Preterm Labor Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Shanghai Jiao Tong University; University of Dundee; Chinese University of Hong Kong; Jinan University	Lee, KKH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Stem Cell & Regenerat Themat Res Programme, Shatin, Hong Kong, Peoples R China.	kaholee@cuhk.edu.hk; yang_xuesong@126.com	Wang, Guang/AAC-4624-2019; Lee, Kenneth Ka Ho/H-6698-2013	Lee, Kenneth Ka Ho/0000-0002-6520-304X	NSFC [31071054, 30971493]; "973 Project'' [2010CB529702]	NSFC(National Natural Science Foundation of China (NSFC)); "973 Project''(National Basic Research Program of China)	This study was supported by NSFC grant (31071054); "973 Project'' (2010CB529702) and NSFC grant (30971493) to X Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpak YK, 2012, MED GLAS, V9, P262; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bate M, 1999, CURR OPIN NEUROBIOL, V9, P670, DOI 10.1016/S0959-4388(99)00031-8; Betancor MB, 2012, LIPIDS, V47, P1193, DOI 10.1007/s11745-012-3730-x; BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775; Cheng X, 2012, NEUROTOXICOLOGY, V33, P1239, DOI 10.1016/j.neuro.2012.07.005; Cheng Y, 2000, J CELL SCI, V113, P3161; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Dagher Z, 2004, DIABETES, V53, P2404, DOI 10.2337/diabetes.53.9.2404; Datar Savita, 2005, Rev Diabet Stud, V2, P221, DOI 10.1900/RDS.2005.2.221; Desoye G, 2002, J Matern Fetal Neonatal Med, V11, P258, DOI 10.1080/713605520; Doblado Manuel, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P488, DOI 10.1097/MED.0b013e3282f1cb92; Etchevers H, 2011, NAT PROTOC, V6, P1568, DOI 10.1038/nprot.2011.398; GOLDENBERG H, 1994, J BIOENERG BIOMEMBR, V26, P359, DOI 10.1007/BF00762776; Hadden DR, 2008, DIABETIC MED, V25, P1, DOI [10.1111/j.1464-5491.2008.02387.x, 10.1111/j.1464-5491.2007.02331.x]; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957; Kanwar YS, 2005, PEDIATR NEPHROL, V20, P858, DOI 10.1007/s00467-005-1888-7; Kuan CYK, 2004, MECH DEVELOP, V121, P1055, DOI 10.1016/j.mod.2004.05.001; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Leal EC, 2009, EXP EYE RES, V88, P983, DOI 10.1016/j.exer.2008.12.010; Ma ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034278; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MOASE CE, 1992, J MED GENET, V29, P145, DOI 10.1136/jmg.29.3.145; Morgan SC, 2008, BIRTH DEFECTS RES A, V82, P453, DOI 10.1002/bdra.20457; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; Retnakaran R, 2012, CAN MED ASSOC J, V184, P1353, DOI 10.1503/cmaj.111154; Ruhrberg C, 2010, CELL ADHES MIGR, V4, P622, DOI 10.4161/cam.4.4.13502; Schwarz Q, 2009, DEVELOPMENT, V136, P1785, DOI 10.1242/dev.034322; Siman CM, 1997, DIABETOLOGIA, V40, P1416, DOI 10.1007/s001250050844; Tonge DA, 2004, DEV BIOL, V265, P169, DOI 10.1016/j.ydbio.2003.09.016; Wada H, 1997, DEV BIOL, V187, P240, DOI 10.1006/dbio.1997.8626; Wentzel P, 2005, DIABETES, V54, P546, DOI 10.2337/diabetes.54.2.546; Wentzel P, 2011, BIRTH DEFECTS RES B, V92, P487, DOI 10.1002/bdrb.20321; Wikstrom AK, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.024; Zou Yan, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P139	37	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66646	10.1371/journal.pone.0066646	http://dx.doi.org/10.1371/journal.pone.0066646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818954	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800090
J	Giannandrea, M; Guarnieri, FC; Gehring, NH; Monzani, E; Benfenati, F; Kulozik, AE; Valtorta, F				Giannandrea, Maila; Guarnieri, Fabrizia C.; Gehring, Niels H.; Monzani, Elena; Benfenati, Fabio; Kulozik, Andreas E.; Valtorta, Flavia			Nonsense-Mediated mRNA Decay and Loss-of-Function of the Protein Underlie the X-Linked Epilepsy Associated with the W356x Mutation in Synapsin I	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; I/II/III KNOCKOUT MICE; HIPPOCAMPAL-NEURONS; INHIBITORY SYNAPSES; DEFICIENT MICE; OUT MICE; DOMAIN E; F-ACTIN; PHOSPHORYLATION; IMPAIRMENT	Synapsins are a family of neuronal phosphoproteins associated with the cytosolic surface of synaptic vesicles. Experimental evidence suggests a role for synapsins in synaptic vesicle clustering and recycling at the presynaptic terminal, as well as in neuronal development and synaptogenesis. Synapsin knock-out (Syn1(-/-)) mice display an epileptic phenotype and mutations in the SYN1 gene have been identified in individuals affected by epilepsy and/or autism spectrum disorder. We investigated the impact of the c. 1067G>A nonsense transition, the first mutation described in a family affected by X-linked syndromic epilepsy, on the expression and functional properties of the synapsin I protein. We found that the presence of a premature termination codon in the human SYN1 transcript renders it susceptible to nonsense-mediated mRNA decay (NMD). Given that the NMD efficiency is highly variable among individuals and cell types, we investigated also the effects of expression of the mutant protein and found that it is expressed at lower levels compared to wild-type synapsin I, forms perinuclear aggregates and is unable to reach presynaptic terminals in mature hippocampal neurons grown in culture. Taken together, these data indicate that in patients carrying the W356x mutation the function of synapsin I is markedly impaired, due to both the strongly decreased translation and the altered function of the NMD-escaped protein, and support the value of Syn1(-/-) mice as an experimental model mimicking the human pathology.	[Giannandrea, Maila; Guarnieri, Fabrizia C.; Monzani, Elena; Valtorta, Flavia] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Giannandrea, Maila; Guarnieri, Fabrizia C.; Monzani, Elena; Valtorta, Flavia] Univ Vita Salute San Raffaele, Milan, Italy; [Gehring, Niels H.] Univ Cologne, Inst Genet, Cologne, Germany; [Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Benfenati, Fabio] Univ Genoa, Dept Expt Med, Genoa, Italy; [Kulozik, Andreas E.] Heidelberg Univ, Med Ctr, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Kulozik, Andreas E.] EMBL, Mol Med Partnership Unit, Heidelberg, Germany; [Kulozik, Andreas E.] Heidelberg Univ, Heidelberg, Germany	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Cologne; Istituto Italiano di Tecnologia - IIT; University of Genoa; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Valtorta, F (corresponding author), Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy.	valtorta.flavia@hsr.it	Kulozik, Andreas/AAO-2432-2020; Guarnieri, Fabrizia Claudia/AAN-2483-2020; Monzani, Elena/AAN-2505-2020; Flavia, Valtorta/F-3450-2012	Guarnieri, Fabrizia Claudia/0000-0002-9589-4662; Flavia, Valtorta/0000-0001-9556-4746	Italian Ministry of University and Research (PRIN); Jerome Lejeune Foundation; Telethon-Italy [GGP09134]	Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Jerome Lejeune Foundation; Telethon-Italy(Fondazione Telethon)	This work was supported by research grants from the Italian Ministry of University and Research (PRIN to FB and FV; http://prin.miur.it/) and the Jerome Lejeune Foundation (to FV; http://www.fondationlejeune.org/). The support of Telethon-Italy (grant GGP09134 to FB and FV; http://www.telethon.it/) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NEURON; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BAITINGER C, 1987, J NEUROSCI, V7, P3723; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENFENATI F, 1989, CELL BIOL INT REP, V13, P1007, DOI 10.1016/0309-1651(89)90016-7; Bhuvanagiri M, 2010, BIOCHEM J, V430, P365, DOI 10.1042/BJ20100699; Bogen IL, 2009, NEUROSCIENCE, V158, P231, DOI 10.1016/j.neuroscience.2008.05.055; Boido D, 2010, NEUROSCIENCE, V171, P268, DOI 10.1016/j.neuroscience.2010.08.046; Brautigam CA, 2004, J BIOL CHEM, V279, P11948, DOI 10.1074/jbc.M312015200; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cambiaghi M, 2013, EPILEPSY RES, V103, P153, DOI 10.1016/j.eplepsyres.2012.07.012; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Cheetham JJ, 2001, BIOCHEM J, V354, P57, DOI 10.1042/0264-6021:3540057; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; Etholm L, 2011, BRAIN RES, V1383, P270, DOI 10.1016/j.brainres.2011.01.070; Farisello P, 2013, CEREB CORTEX, V23, P581, DOI 10.1093/cercor/bhs041; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Fornasiero EF, 2012, J NEUROSCI, V32, P12214, DOI 10.1523/JNEUROSCI.1554-12.2012; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Greco B, 2013, BEHAV BRAIN RES, V251, P65, DOI 10.1016/j.bbr.2012.12.015; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilfiker S, 2005, J NEUROSCI, V25, P2658, DOI 10.1523/JNEUROSCI.4278-04.2005; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hurley SL, 2004, BIOCHEM BIOPH RES CO, V317, P16, DOI 10.1016/j.bbrc.2004.03.008; Janz R, 1999, NEURON, V24; Josefsen K, 2011, METHODS MOL BIOL, V703, P87, DOI 10.1007/978-1-59745-248-9_7; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Ketzef M, 2011, NEUROSCIENCE, V189, P108, DOI 10.1016/j.neuroscience.2011.05.030; Kingston Robert E, 2003, Curr Protoc Cell Biol, VChapter 20, DOI 10.1002/0471143030.cb2003s19; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakhan R, 2010, SYNAPSE, V64, P403, DOI 10.1002/syn.20740; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lignani G, 2013, HUM MOL GEN IN PRESS; Lotti F, 2002, J VIROL, V76, P3996, DOI 10.1128/JVI.76.8.3996-4007.2002; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Monaldi I, 2010, BIOCHEM J, V426, P55, DOI 10.1042/BJ20090762; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Neu-Yilik G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-218; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Nicita F, 2012, SEIZURE-EUR J EPILEP, V21, P3, DOI 10.1016/j.seizure.2011.08.007; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Orenbuch A, 2012, J NEUROSCI, V32, P3969, DOI 10.1523/JNEUROSCI.5058-11.2012; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; PETRUCCI TC, 1991, BIOCHEMISTRY-US, V30, P413, DOI 10.1021/bi00216a016; Rees MI, 2010, SEIZURE-EUR J EPILEP, V19, P680, DOI 10.1016/j.seizure.2010.10.029; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Turnbull J, 2005, HUM MOL GENET, V14, P2491, DOI 10.1093/hmg/ddi250; VALTORTA F, 1992, J BIOL CHEM, V267, P7195; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3	69	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67724	10.1371/journal.pone.0067724	http://dx.doi.org/10.1371/journal.pone.0067724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818987	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800144
J	Ou, DL; Lee, BS; Chang, YC; Lin, LI; Liou, JY; Hsu, C; Cheng, AL				Ou, Da-Liang; Lee, Bin-Shyun; Chang, Ya-Chi; Lin, Liang-In; Liou, Jun-Yang; Hsu, Chiun; Cheng, Ann-Lii			Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway	PLOS ONE			English	Article							FACTOR-I RECEPTOR; ANTITUMOR-ACTIVITY; HUMAN HEPATOMA; PROSTATE-CANCER; FACTOR AXIS; IGF-I; RESISTANCE; KINASE; TRANSCRIPTION; ACTIVATION	Insulin-like growth factor (IGF) signaling pathway is an important regulatory mechanism of tumorigenesis and drug resistance in many cancers. The present study explored the potential synergistic effects between IGF receptor (IGFR) inhibition and other molecular targeted agents (MTA) in HCC cells. HCC cell lines (Hep3B, PLC5, and SK-Hep1) and HUVECs were tested. The MTA tested included sorafenib, sunitinib, and the IGFR kinase inhibitor NVP-AEW541. The potential synergistic antitumor effects were tested by median dose effect analysis and apoptosis assay in vitro and by xenograft models in vivo. The activity and functional significance of pertinent signaling pathways and expression of apoptosis-related proteins were measured by RNA interference and Western blotting. We found that IGF can activate IGFR and downstream AKT signaling activities in all the HCC cells tested, but the growth-stimulating effect of IGF was most prominent in Hep3B cells. NVP-AEW541 can abrogate IGF-induced activation of IGFR and AKT signaling in HCC cells. IGF can increase the resistance of HCC cells to sunitinib. The apoptosis-inducing effects of sunitinib, but not sorafenib, were enhanced when IGFR signaling activity was inhibited by NVP-AEW541 or IGFR knockdown. Chk2 kinase activation was found contributory to the synergistic anti-tumor effects between sunitinib and IGFR inhibition. Our data indicate that the apoptosis-potentiating effects of IGFR inhibition for HCC may be drug-specific. Combination therapy of IGFR inhibitors with other MTA may improve the therapeutic efficacy in HCC.	[Ou, Da-Liang; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Ou, Da-Liang; Lee, Bin-Shyun; Chang, Ya-Chi] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Lee, Bin-Shyun; Chang, Ya-Chi; Hsu, Chiun; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Lin, Liang-In] Natl Taiwan Univ Hosp, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan; [Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan; [Hsu, Chiun; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Toxicol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Hsu, C (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.	hsuchiun@gmail.com	Liou, Jun-Yang/B-1065-2010; Lin, Liang-In/K-4600-2019	LIN, LIANG-IN/0000-0002-3561-1093; OU, DA-LIANG/0000-0002-8368-1141; Cheng, Ann-Lii/0000-0002-9152-6512; Hsu, Chiun/0000-0002-1122-0055	Department of Health, Taiwan [DOH99-TD-B-111-001, DOH100-TD-B-111-001]; National Health Research Institute, Taiwan [NHRI-EX99-9911BC, NHRI-EX100-10011BC]	Department of Health, Taiwan; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants DOH99-TD-B-111-001, DOH100-TD-B-111-001 from the Department of Health, Taiwan; NHRI-EX99-9911BC, NHRI-EX100-10011BC from the National Health Research Institute, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.4043; Alexia C, 2004, BIOCHEM PHARMACOL, V68, P1003, DOI 10.1016/j.bcp.2004.05.029; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Boucher J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001173; CARO JF, 1988, J CLIN INVEST, V81, P976, DOI 10.1172/JCI113451; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Faivre S, 2011, J CLIN ONCOL S4, V29; Floc'h N, 2012, CANCER RES, V72, P4483, DOI 10.1158/0008-5472.CAN-12-0283; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao J, 2012, CANCER RES, V72, P3, DOI 10.1158/0008-5472.CAN-11-0550; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Kim SO, 1996, CANCER RES, V56, P3831; Lee OH, 2000, BRIT J CANCER, V82, P385; Lee YI, 1998, ONCOGENE, V16, P2367, DOI 10.1038/sj.onc.1201760; Lee YI, 2000, ONCOGENE, V19, P3717, DOI 10.1038/sj.onc.1203694; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Maloney EK, 2003, CANCER RES, V63, P5073; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Ou DL, 2009, CLIN CANCER RES, V15, P5820, DOI 10.1158/1078-0432.CCR-08-3294; Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Scharf JG, 1998, CARCINOGENESIS, V19, P2121, DOI 10.1093/carcin/19.12.2121; SELL C, 1995, CANCER RES, V55, P303; Shao YY, 2012, ANTICANCER RES, V32, P4865; Shen YC, 2010, J GASTROENTEROL, V45, P794, DOI 10.1007/s00535-010-0270-0; Squatrito M, 2011, CANCER RES, V71, P5945, DOI 10.1158/0008-5472.CAN-11-1245; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Tai WT, 2011, J HEPATOL, V55, P1041, DOI 10.1016/j.jhep.2011.06.005; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; TSAI TF, 1988, BIOCHEM BIOPH RES CO, V153, P39, DOI 10.1016/S0006-291X(88)81186-0; Yao XM, 2003, CLIN CANCER RES, V9, P2719	42	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66589	10.1371/journal.pone.0066589	http://dx.doi.org/10.1371/journal.pone.0066589			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818948	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800084
J	Solberg, R; Escobar, J; Arduini, A; Torres-Cuevas, I; Lahoz, A; Sastre, J; Saugstad, OD; Vento, M; Kuligowski, J; Quintas, G				Solberg, Ronnaug; Escobar, Javier; Arduini, Alessandro; Torres-Cuevas, Isabel; Lahoz, Agustin; Sastre, Juan; Saugstad, Ola Didrik; Vento, Maximo; Kuligowski, Julia; Quintas, Guillermo			Metabolomic Analysis of the Effect of Postnatal Hypoxia on the Retina in a Newly Born Piglet Model	PLOS ONE			English	Article							CDP-CHOLINE; BRAIN; RESUSCITATION; GLUTATHIONE; PLASMA; DAMAGE	The availability of reliable biomarkers of brain injury secondary to birth asphyxia could substantially improve clinical grading, therapeutic intervention strategies, and prognosis. In this study, changes in the metabolome of retinal tissue caused by profound hypoxia in an established neonatal piglet model were investigated using an ultra performance liquid chromatography - quadrupole time of flight mass spectrometry (UPLC-QTOFMS) untargeted metabolomic approach, which included Partial Least Squares - Discriminant Analysis (PLSDA) multivariate data analysis. The initial identification of a set of discriminant metabolites from UPLC-QTOFMS data was confirmed by target UPLC-MS/MS and allowed the selection of endogenous CDP-choline as a promising candidate biomarker for hypoxia-derived brain damage assessing intensity of retinal hypoxia. Results from this study will foster further research on CDP-choline changes occurring during resuscitation.	[Solberg, Ronnaug; Saugstad, Ola Didrik] Univ Oslo, Rikshosp, Inst Surg Res, Dept Pediat Res,Oslo Univ Hosp, N-0027 Oslo, Norway; [Escobar, Javier; Torres-Cuevas, Isabel; Vento, Maximo; Kuligowski, Julia] Hosp La Fe, Hlth Res Inst, Neonatal Res Grp, E-46009 Valencia, Spain; [Arduini, Alessandro; Sastre, Juan] Univ Valencia, Fac Pharm, Dept Physiol, Valencia, Spain; [Lahoz, Agustin] Hosp La Fe, Hlth Res Inst, E-46009 Valencia, Spain; [Vento, Maximo] Univ & Polytech Hosp La Fe, Div Neonatol, Valencia, Spain; [Quintas, Guillermo] Leitat Technol Ctr, Bio In Vitro Div, Barcelona, Spain	University of Oslo; National Hospital Norway; Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Universitari i Politecnic La Fe	Quintas, G (corresponding author), Leitat Technol Ctr, Bio In Vitro Div, Barcelona, Spain.	guira@uv.es	Quintas, Guillermo/AAS-1138-2020; Vento, Maximo/F-3596-2015; Torres-Cuevas, Isabel/T-8140-2017; Quintas, Guillermo/G-8953-2017; Lahoz, Agustin/B-8048-2014; Kuligowski, Julia/M-3285-2017; Saugstad, Ola/AAS-9041-2021	Quintas, Guillermo/0000-0002-4240-9846; Vento, Maximo/0000-0003-0061-4742; Torres-Cuevas, Isabel/0000-0002-8098-1106; Lahoz, Agustin/0000-0001-7232-0626; Kuligowski, Julia/0000-0001-6979-2235; Saugstad, Ola/0000-0002-3166-5254; Arduini, Alessandro/0000-0002-0038-8741; Escobar, Javier/0000-0002-5044-991X	Miguel Servet grant [CP08/00125]; Instituto Carlos III (Ministry of Economy and Competitiveness, Spain) [FISPI11/02942]; Instituto Carlos III [FISPI11/0313]; Ministry of Economy and Competitiveness [SAF2012-39948]; South-Eastern Norway Regional Health Authority;  [CD11/00154];  [CD12/00667];  [PFIS FI12/00109]	Miguel Servet grant; Instituto Carlos III (Ministry of Economy and Competitiveness, Spain); Instituto Carlos III(Instituto de Salud Carlos III); Ministry of Economy and Competitiveness; South-Eastern Norway Regional Health Authority; ; ; 	JE, JK and ITC acknowledge their personal grants (Sara Borrell CD11/00154, CD12/00667 and PFIS FI12/00109). AL acknowledges for a Miguel Servet grant (CP08/00125) and FISPI11/02942 grant from the Instituto Carlos III (Ministry of Economy and Competitiveness, Spain). MV acknowledges the FISPI11/0313 grant from the Instituto Carlos III. GQ acknowledges financial support from the Ministry of Economy and Competitiveness (SAF2012-39948). Financial support was also provided by the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony ML, 1999, J BIOL CHEM, V274, P19686, DOI 10.1074/jbc.274.28.19686; Aquilina K, 2007, J NEUROSURG, V107, P126, DOI 10.3171/PED-07/08/126; Bennet L, 2010, SEMIN FETAL NEONAT M, V15, P253, DOI 10.1016/j.siny.2010.05.007; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Butter A, 2005, J PEDIATR SURG, V40, P826, DOI 10.1016/j.jpedsurg.2005.01.058; Connolly JJ, 2012, PEDIATRICS, V129, P1150, DOI 10.1542/peds.2011-3636; Desvergne B, 2010, PHYSIOL REV, V86, P465; Esbensen KH, 2010, J CHEMOMETR, V24, P168, DOI 10.1002/cem.1310; Fanos V, 2013, SEMIN FETAL NEONAT M, V18, P3, DOI 10.1016/j.siny.2012.10.014; Fiedorowicz M, 2008, ACTA NEUROBIOL EXP, V68, P389; Fokkelman K, 2007, EUR J PHARMACOL, V562, P132, DOI 10.1016/j.ejphar.2007.01.057; Gibellini F, 2012, IUBMB LIFE, V2, P414; Hardy P, 2005, PHARMACOL REP, V57, P169; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Harwood DT, 2009, J CHROMATOGR B, V877, P3393, DOI 10.1016/j.jchromb.2009.04.018; Hendriks MMWB, 2011, TRAC-TREND ANAL CHEM, V30, P1685, DOI 10.1016/j.trac.2011.04.019; Hunsucker Stephen W, 2007, Adv Pediatr, V54, P9, DOI 10.1016/j.yapd.2007.03.003; Jain KK, 2010, HANDBOOK OF BIOMARKERS, P1, DOI 10.1007/978-1-60761-685-6_1; Kaur C, 2012, J NEUROIMMUNE PHARM; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Koluman A, 2009, ANAL BIOANAL CHEM, V94, P663; Lange CAK, 2012, OPHTHALMOLOGICA, V227, P115, DOI 10.1159/000331418; Lindon J. C., 2007, HDB METABONOMICS MET; Liu JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015322; Mami A, 2006, NEUROCHEM RES, V31, P63, DOI 10.1007/s11064-005-9076-5; Massaro AN, 2012, J PEDIATR-US, V161, P434, DOI 10.1016/j.jpeds.2012.02.047; Ogunrinu TA, 2010, J BIOL CHEM, V285, P37716, DOI 10.1074/jbc.M110.161190; Pederzolli CD, 2010, METAB BRAIN DIS, V25, P145, DOI 10.1007/s11011-010-9190-1; Pedreschi R, 2008, PROTEOMICS, V8, P1371, DOI 10.1002/pmic.200700975; Quintas G, 2012, METABOLOMICS, V8, P86, DOI 10.1007/s11306-011-0292-5; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Savorani F, 2012, FOOD RES INT, DOI DOI 10.1016/J.F00DRES.2012.12.025; Shankaran S, 2012, CURR TREAT OPTIONS N; Smit S, 2007, ANAL CHIM ACTA, V592, P210, DOI 10.1016/j.aca.2007.04.043; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; SVARDAL AM, 1990, ANAL BIOCHEM, V184, P338, DOI 10.1016/0003-2697(90)90691-2; Syggelou A, 2012, PEDIATR CLIN N AM, V59, P1039, DOI 10.1016/j.pcl.2012.07.002; Tenorio V, 2011, AN PEDIAT BARC, V75, pe1; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Toet MC, 2009, EARLY HUM DEV, V85, P77, DOI 10.1016/j.earlhumdev.2008.11.007; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vento M, 2010, SEMIN FETAL NEONAT M, V15, P216, DOI 10.1016/j.siny.2010.03.008; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T; Westerhuis JA, 2008, METABOLOMICS, V4, P293, DOI 10.1007/s11306-008-0126-2; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wongravee K, 2009, METABOLOMICS, V5, P387, DOI 10.1007/s11306-009-0164-4	48	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66540	10.1371/journal.pone.0066540	http://dx.doi.org/10.1371/journal.pone.0066540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823578	gold, Green Submitted, Green Published			2022-12-27	WOS:000320576400124
J	Varnava, A; Dervinis, M; Chambers, CD				Varnava, Alice; Dervinis, Martynas; Chambers, Christopher D.			The Predictive Nature of Pseudoneglect for Visual Neglect: Evidence from Parietal Theta Burst Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LINE-BISECTION JUDGMENTS; UNILATERAL SPATIAL NEGLECT; RIGHT-HEMISPHERE DAMAGE; VISUOSPATIAL ATTENTION; MOTOR THRESHOLD; INDIVIDUAL VARIATION; HEMISPATIAL NEGLECT; HORIZONTAL LINE; REPETITIVE TMS	Following parietal damage most patients with visual neglect bisect horizontal lines significantly away from the true centre. Neurologically intact individuals also misbisect lines; a phenomenon referred to as 'pseudoneglect'. In this study we examined the relationship between neglect and pseudoneglect by testing how patterns of pre-existing visuospatial asymmetry predict asymmetry caused by parietal interference. Twenty-four participants completed line bisection and Landmark tasks before receiving continuous theta burst stimulation to the left or right angular gyrus. Results showed that a pre-existing pattern of left pseudoneglect (i.e. right bias), but not right pseudoneglect, predicts left neglect-like behaviour during line bisection following right parietal cTBS. This correlation is consistent with the view that neglect and pseudoneglect arise via a common or linked neural mechanism.	[Varnava, Alice] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales; [Varnava, Alice; Dervinis, Martynas; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Swansea University; Cardiff University	Varnava, A (corresponding author), Swansea Univ, Dept Psychol, Swansea, W Glam, Wales.	VarnavaA@Cardiff.ac.uk	Chambers, Chris/E-7827-2010	Varnava, Alice/0000-0002-5090-9541; Chambers, Chris/0000-0001-6058-4114	Wales Institute of Cognitive Neuroscience; Biotechnology and Biological Sciences Research Council (BBSRC)David Phillips Fellowship; Biotechnology and BBSRC grant [BB/E020291/1]; BBSRC [BB/C519854/1, BB/C519854/2, BB/E020291/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E020291/2, BB/C519854/2, BB/C519854/1] Funding Source: researchfish	Wales Institute of Cognitive Neuroscience; Biotechnology and Biological Sciences Research Council (BBSRC)David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wales Institute of Cognitive Neuroscience (AV & CC), a Biotechnology and Biological Sciences Research Council (BBSRC)David Phillips Fellowship (CC), and Biotechnology and BBSRC grant BB/E020291/1 (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beis JM, 2004, NEUROLOGY, V63, P1600, DOI 10.1212/01.WNL.0000142967.60579.32; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; Bisiach E, 1983, Brain Cogn, V2, P32, DOI 10.1016/0278-2626(83)90027-1; BISIACH E, 1994, NEUROPSYCHOLOGIA, V32, P1431, DOI 10.1016/0028-3932(94)00070-0; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Braun JB, 1999, NEUROLOGY, V53, P527, DOI 10.1212/WNL.53.3.527; BRIGGS G G, 1975, Cortex, V11, P230; Chambers CD, 2006, BRAIN RES, V1097, P149, DOI 10.1016/j.brainres.2006.04.084; Cowie R, 1998, PERCEPT MOTOR SKILL, V86, P834, DOI 10.2466/pms.1998.86.3.834; Dafotakis M, 2008, J NEURAL TRANSM, V115, P1269, DOI 10.1007/s00702-008-0064-1; Daini R, 2002, EXP BRAIN RES, V144, P224, DOI 10.1007/s00221-002-1034-8; Doricchi F, 1999, NEUROLOGY, V52, P1845, DOI 10.1212/WNL.52.9.1845; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Eshel N, 2010, NEUROPSYCHOLOGIA, V48, P3470, DOI 10.1016/j.neuropsychologia.2010.07.031; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Fink GR, 2002, NEUROPSYCHOLOGIA, V40, P119, DOI 10.1016/S0028-3932(01)00087-2; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Fink GR, 2001, NEUROIMAGE, V14, pS59, DOI 10.1006/nimg.2001.0819; Foxe JJ, 2003, NEUROIMAGE, V19, P710, DOI 10.1016/S1053-8119(03)00057-0; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; HALLIGAN PW, 1995, PSYCHOLOGIST, V8, P257; HALLIGAN PW, 1990, NEUROPSYCHOLOGIA, V28, P1043, DOI 10.1016/0028-3932(90)90139-F; HALLIGAN PW, 1992, CORTEX, V28, P525, DOI 10.1016/S0010-9452(13)80225-0; Harvey M, 2002, NEUROPSYCHOLOGIA, V40, P1387, DOI 10.1016/S0028-3932(01)00202-0; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; Ishiai S, 1998, BRAIN COGNITION, V36, P239, DOI 10.1006/brcg.1998.0980; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kinsbourne M, 1977, Adv Neurol, V18, P41; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Leibovitch FS, 1998, NEUROLOGY, V50, P901, DOI 10.1212/WNL.50.4.901; Loo CK, 2000, BIOL PSYCHIAT, V47, P325, DOI 10.1016/S0006-3223(99)00285-1; LUH KE, 1995, NEUROPSYCHOLOGY, V9, P435, DOI 10.1037/0894-4105.9.4.435; Macdonald-Nethercott EM, 2000, PERCEPT MOTOR SKILL, V91, P217, DOI 10.2466/PMS.91.5.217-226; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P1794, DOI 10.1016/S0028-3932(02)00035-0; MANNING L, 1990, NEUROPSYCHOLOGIA, V28, P647, DOI 10.1016/0028-3932(90)90119-9; MARSHALL JC, 1989, CORTEX, V25, P503, DOI 10.1016/S0010-9452(89)80065-6; MARSHALL JC, 1994, CORTEX, V30, P509, DOI 10.1016/S0010-9452(13)80346-2; McCourt ME, 2001, NEUROPSYCHOLOGIA, V39, P1065, DOI 10.1016/S0028-3932(01)00044-6; McCourt ME, 1999, NEUROPSYCHOLOGIA, V37, P843, DOI 10.1016/S0028-3932(98)00140-7; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Mozer MC, 1997, J COGNITIVE NEUROSCI, V9, P171, DOI 10.1162/jocn.1997.9.2.171; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; Oliveri M, 2009, J NEUROPSYCHOL, V3, P201, DOI 10.1348/174866408X388197; Porac C, 2006, BRAIN COGNITION, V61, P305, DOI 10.1016/j.bandc.2006.01.003; REUTERLORENZ PA, 1990, NEUROPSYCHOLOGIA, V28, P327, DOI 10.1016/0028-3932(90)90059-W; Robertson IH, 1999, TRENDS COGN SCI, V3, P385, DOI 10.1016/S1364-6613(99)01378-9; Rorden C, 2006, BRAIN RES, V1080, P17, DOI 10.1016/j.brainres.2004.10.071; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Seki K, 1999, NEUROPSYCHOLOGIA, V37, P75; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Toba MN, 2011, NEUROPSYCHOLOGIA, V49, P238, DOI 10.1016/j.neuropsychologia.2010.11.022; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822; Varnava A, 2008, APPL NEUROPSYCHOL, V15, P107, DOI 10.1080/09084280802083889; Varnava A, 2011, J NEUROSCI METH, V201, P327, DOI 10.1016/j.jneumeth.2011.08.016; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Vossel S, 2010, NEUROPSYCHOLOGIA, V48, P3949, DOI 10.1016/j.neuropsychologia.2010.09.022; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	69	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65851	10.1371/journal.pone.0065851	http://dx.doi.org/10.1371/journal.pone.0065851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823975	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400025
J	Nan, JF; Liu, JX; Li, GY; Xiong, SW; Yan, XM; Yin, Q; Zeng, F; von Deneen, KM; Liang, FR; Gong, QY; Qin, W; Tian, J				Nan, Jiaofen; Liu, Jixin; Li, Guoying; Xiong, Shiwei; Yan, Xuemei; Yin, Qing; Zeng, Fang; von Deneen, Karen M.; Liang, Fanrong; Gong, Qiyong; Qin, Wei; Tian, Jie			Whole-Brain Functional Connectivity Identification of Functional Dyspepsia	PLOS ONE			English	Article							QUALITY-OF-LIFE; IRRITABLE-BOWEL-SYNDROME; GASTRIC DISTENSION; NEPEAN DYSPEPSIA; GASTROINTESTINAL DISORDERS; PSYCHOSOCIAL FACTORS; PREFRONTAL CORTEX; INDEX; PATHOPHYSIOLOGY; DEPRESSION	Recent neuroimaging studies have shown local brain aberrations in functional dyspepsia (FD) patients, yet little attention has been paid to the whole-brain resting-state functional network abnormalities. The purpose of this study was to investigate whether FD disrupts the patterns of whole-brain networks and the abnormal functional connectivity could reflect the severity of the disease. The dysfunctional interactions between brain regions at rest were investigated in FD patients as compared with 40 age-and gender-matched healthy controls. Multivariate pattern analysis was used to evaluate the discriminative power of our results for classifying patients from controls. In our findings, the abnormal brain functional connections were mainly situated within or across the limbic/paralimbic system, the prefrontal cortex, the tempo-parietal areas and the visual cortex. About 96% of the subjects among the original dataset were correctly classified by a leave one-out cross-validation approach, and 88% accuracy was also validated in a replication dataset. The classification features were significantly associated with the patients' dyspepsia symptoms, the self-rating depression scale and self-rating anxiety scale, but it was not correlated with duration of FD patients (p>0.05). Our results may indicate the effectiveness of the altered brain functional connections reflecting the disease pathophysiology underling FD. These dysfunctional connections may be the epiphenomena or causative agents of FD, which may be affected by clinical severity and its related emotional dimension of the disease rather than the clinical course.	[Nan, Jiaofen; Liu, Jixin; Li, Guoying; Xiong, Shiwei; Yan, Xuemei; Yin, Qing; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Zeng, Fang; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Peoples R China; [Gong, Qiyong] Sichuan Univ, West China Hosp, HMRRC, Dept Radiol,Ctr Med Imaging, Chengdu 610064, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Sichuan University	Liu, JX (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	liujixin@life.xidian.edu.cn; lfr@cdutcm.edu.cn; wqin@xidian.edu.cn	Gong, Qiyong/W-3052-2019; Tian, Jie/H-1190-2011; Life, PAM/M-9552-2013; tian, jie/M-6336-2013; 秦, 伟/J-9770-2016	Gong, Qiyong/0000-0002-5912-4871; Tian, Jie/0000-0003-0498-0432; 秦, 伟/0000-0003-4583-0406; Liang, Fanrong/0000-0003-2210-2027	Project for the National Key Basic Research and Development Program (973) [2012CB518501, 2011CB707702]; National Natural Science Foundation of China [81227901, 81271644, 30930112, 81030027, 81000640, 81000641, 81101036, 81101108, 31200837]; Fundamental Research Funds for the Central Universities; Knowledge Innovation Program of the Chinese Academy of Sciences [KGCX2-YW-129]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the Project for the National Key Basic Research and Development Program (973) under grant numbers 2012CB518501 and 2011CB707702, the National Natural Science Foundation of China under grant numbers 81227901, 81271644, 30930112, 81030027, 81000640, 81000641, 81101036, 81101108 and 31200837, and the Fundamental Research Funds for the Central Universities and the Knowledge Innovation Program of the Chinese Academy of Sciences under grant number KGCX2-YW-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Aziz Q, 2000, J NEUROSCI, V20, P2657; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Camilleri M, 2006, GUT, V55, P909, DOI 10.1136/gut.2005.086355; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Derbyshire Stuart W G, 2003, ScientificWorldJournal, V3, P1065; Derbyshire SWG, 2003, AM J GASTROENTEROL, V98, P12, DOI 10.1111/j.1572-0241.2003.07168.x; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Elsenbruch S, 2010, GASTROENTEROLOGY, V139, P1310, DOI 10.1053/j.gastro.2010.06.054; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frith C, 1996, COGNITIVE BRAIN RES, V5, P175, DOI 10.1016/S0926-6410(96)00054-7; Hall GB, 2009, NEUROGASTROENT MOTIL, V22, P276; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Jones M, 2009, AM J GASTROENTEROL, V104, P1483, DOI 10.1038/ajg.2009.136; Jones MP, 2006, NEUROGASTROENT MOTIL, V18, P91, DOI 10.1111/j.1365-2982.2005.00730.x; Keohane J, 2006, WORLD J GASTROENTERO, V12, P2672, DOI 10.3748/wjg.v12.i17.2672; Ladabaum U, 2001, GASTROENTEROLOGY, V120, P369, DOI 10.1053/gast.2001.21201; Ladabaum U, 2007, NEUROIMAGE, V34, P724, DOI 10.1016/j.neuroimage.2006.07.033; Lee KJ, 2004, BEST PRACT RES CL GA, V18, P707, DOI 10.1016/j.bpg.2004.04.007; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027049; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Locke GR, 2004, AM J GASTROENTEROL, V99, P350, DOI 10.1111/j.1572-0241.2004.04043.x; Lu HC, 2010, PAIN, V148, P75, DOI 10.1016/j.pain.2009.10.012; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Min DK, 2011, NEUROSCIENCE, V179, P151, DOI 10.1016/j.neuroscience.2011.01.051; Miwa H, 2011, J GASTROEN HEPATOL, V26, P53, DOI 10.1111/j.1440-1746.2011.06633.x; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Olafsdottir LB, 2012, DIGEST LIVER DIS, V44, P211, DOI 10.1016/j.dld.2011.10.009; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phillips ML, 2003, BRAIN, V126, P669, DOI 10.1093/brain/awg065; Ringel Y, 2006, DIGEST DIS, V24, P278, DOI 10.1159/000092881; Salet GAM, 1998, GUT, V42, P823, DOI 10.1136/gut.42.6.823; Sanjiv M, 2009, HLTH QUAL LIFE OUT, V7, P45; Sass K, 2012, HUM BRAIN MAPP; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Song GH, 2006, PAIN, V126, P79, DOI 10.1016/j.pain.2006.06.017; Tack J, 2001, GASTROENTEROLOGY, V121, P526, DOI 10.1053/gast.2001.27180; Tack J, 2005, J CLIN GASTROENTEROL, V39, pS211, DOI 10.1097/01.mcg.0000156109.97999.d1; Tack J, 2004, GASTROENTEROLOGY, V127, P1239, DOI 10.1053/j.gastro.2004.05.030; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Talley NJ, 2006, GUT, V55, P933, DOI 10.1136/gut.2005.078634; Talley NI, 1999, ALIMENT PHARM THERAP, V13, P225; Talley NJ, 1999, AM J GASTROENTEROL, V94, P2390; Talley NJ, 2001, ALIMENT PHARM THERAP, V15, P207, DOI 10.1046/j.1365-2036.2001.00900.x; Thumshirn M, 2002, GUT, V51, pI63, DOI 10.1136/gut.51.suppl_1.i63; Tian XP, 2009, WORLD J GASTROENTERO, V15, P3173, DOI 10.3748/wjg.15.3173; Tillisch K, 2011, GASTROENTEROLOGY, V140, P407, DOI 10.1053/j.gastro.2010.12.014; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Van Oudenhove L, 2008, GUT, V57, P1666, DOI 10.1136/gut.2008.158162; Van Oudenhove L, 2004, BEST PRACT RES CL GA, V18, P663, DOI 10.1016/j.bpg.2004.04.010; Van Oudenhove L, 2007, WORLD J GASTROENTERO, V13, P3438, DOI 10.3748/wjg.v13.i25.3438; Van Oudenhove L, 2013, NAT REV GASTRO HEPAT, V10, P158, DOI 10.1038/nrgastro.2013.10; Van Oudenhove L, 2010, GASTROENTEROLOGY, V139, P36, DOI 10.1053/j.gastro.2010.04.015; Van Oudenhove L, 2010, AM J GASTROENTEROL, V105, P913, DOI 10.1038/ajg.2010.39; Vandenbergh J, 2005, GASTROENTEROLOGY, V128, P564, DOI 10.1053/j.gastro.2004.11.054; Vandenberghe J, 2007, GASTROENTEROLOGY, V132, P1684, DOI 10.1053/j.gastro.2007.03.037; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeng F, 2011, GASTROENTEROLOGY, V141, P499, DOI 10.1053/j.gastro.2011.05.003; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	67	20	21	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65870	10.1371/journal.pone.0065870	http://dx.doi.org/10.1371/journal.pone.0065870			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799056	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800019
J	Yi, J; Zheng, YJ; Miao, CH; Tang, JG; Zhu, B				Yi, Juan; Zheng, Yijun; Miao, Changhong; Tang, Jianguo; Zhu, Biao			Desflurane Preconditioning Induces Oscillation of NF-kappa B in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; REDUCES INFLAMMATION; MYOCARDIAL-ISCHEMIA; SIGNALING PATHWAY; RENAL ISCHEMIA; INHIBITION; ACTIVATION; PROTECTION; ISOFLURANE; MECHANISM	Background: Nuclear factor kappa B (NF-kappa B) has been implicated in anesthetic preconditioning (APC) induced protection against anoxia and reoxygenation (A/R) injury. The authors hypothesized that desflurane preconditioning would induce NF kappa B oscillation and prevent endothelial cells apoptosis. Methods: A human umbilical vein endothelial cells (HUVECs) A/R injury model was used. A 30 minute desflurane treatment was initiated before anoxia. NF-kappa B inhibitor BAY11-7082 was administered in some experiments before desflurane preconditioning. Cells apoptosis was analyzed by flow cytometry using annexin V-fluorescein isothiocyanate staining and cell viability was evaluated by modified tertrozalium salt (MTT) assay. The cellular superoxide dismutases (SOD) activitiy were tested by water-soluble tetrazolium salt (WST-1) assay. NF-kappa B p65 subunit nuclear translocation was detected by immunofluorescence staining. Expression of inhibitor of NF-kappa B-alpha (IkB alpha), NF-kappa B p65 and cellular inhibitor of apoptosis 1 (c-IAP1), B-cell leukemia/lymphoma 2 (Bcl-2), cysteine containing aspartate specific protease 3 (caspases-3) and second mitochondrial-derived activator of caspase (SMAC/DIABLO) were determined by western blot. Results: Desflurane preconditioning caused phosphorylation and nuclear translocation of NF-kappa B before anoxia, on the contrary, induced the synthesis of I kappa B alpha and inhibition of NF-kappa B after reoxygenation. Desflurane preconditioning upregulated the expression of c-IAP1 and Bcl-2, blocked the cleavage of caspase-3 and reduced SMAC release, and decreased the cell death of HUVECs after A/R. The protective effect was abolished by BAY11-7082 administered before desflurane. Conclusions: The results demonstrated that desflurane activated NF-kappa B during the preconditioning period and inhibited excessive activation of NF-kappa B in reperfusion. And the oscillation of NF-kappa B induced by desflurane preconditioning finally upregulated antiapoptotic proteins expression and protected endothelial cells against A/R.	[Yi, Juan; Zheng, Yijun; Zhu, Biao] Fudan Univ, Zhongshan Hosp, Dept Anesthesiol & Crit Care, Shanghai 200433, Peoples R China; [Miao, Changhong] Fudan Univ, Shanghai Canc Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Tang, Jianguo] Fudan Univ, Peoples Hosp Shanghai 5, Dept Emergency, Shanghai 200433, Peoples R China; [Tang, Jianguo] Fudan Univ, Peoples Hosp Shanghai 5, Crit Care Unit, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Zhu, B (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Anesthesiol & Crit Care, Shanghai 200433, Peoples R China.	zhubiaozs@gmail.com			National Natural Science Foundation of China [30972838/C160201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding game from the National Natural Science Foundation of China Grant number:30972838/C160201 http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour J, 2009, ANESTHESIOLOGY, V110, P317, DOI 10.1097/ALN.0b013e3181942cb4; Annecke T, 2010, BRIT J ANAESTH, V104, P414, DOI 10.1093/bja/aeq019; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Chen CH, 2008, SHOCK, V30, P241, DOI [10.1097/SHK.0b013e318162ad19, 10.1097/SHK.0b013e31816ad19]; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Donnahoo KK, 2000, J UROLOGY, V163, P1328, DOI 10.1016/S0022-5347(05)67772-5; Espinosa I, 2008, HISTOPATHOLOGY, V53, P441, DOI 10.1111/j.1365-2559.2008.03139.x; Feng JF, 2011, J PHARM PHARMACOL, V63, P106, DOI 10.1111/j.2042-7158.2010.01198.x; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Hunter AL, 2005, VASC PHARMACOL, V43, P213, DOI 10.1016/j.vph.2005.07.005; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kandilci HB, 2006, LIFE SCI, V79, P2172, DOI 10.1016/j.lfs.2006.07.011; Kersten JR, 1996, ANESTHESIOLOGY, V85, P794, DOI 10.1097/00000542-199610000-00015; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Li Y, 2008, ANESTH ANALG, V106, P1473, DOI 10.1213/ane.0b013e318168b3f2; Lu XY, 2009, AM J PHYSIOL-HEART C, V296, pH1296, DOI 10.1152/ajpheart.01282.2008; Lucchinetti E, 2007, ANESTHESIOLOGY, V106, P262, DOI 10.1097/00000542-200702000-00013; Lucchinetti E, 2009, ANESTH ANALG, V109, P1117, DOI 10.1213/ANE.0b013e3181b5a277; Maier CM, 2006, ANN NEUROL, V59, P929, DOI 10.1002/ana.20850; Masini E, 2002, BRIT J PHARMACOL, V136, P905, DOI 10.1038/sj.bjp.0704774; Mengel B, 2010, CURR OPIN GENET DEV, V20, P656, DOI 10.1016/j.gde.2010.08.008; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Sun Jun, 2009, J Mol Signal, V4, P4, DOI 10.1186/1750-2187-4-4; Sun SX, 2011, CELL BIOCHEM BIOPHYS, V61, P123, DOI 10.1007/s12013-011-9168-6; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Wang C, 2010, EUR J ANAESTH, V27, P747, DOI 10.1097/EJA.0b013e32833bb3ba; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Wei Z, 2009, TRANSPL P, V41, P4120, DOI 10.1016/j.transproceed.2009.09.054; Zhong CY, 2004, ANESTHESIOLOGY, V100, P540, DOI 10.1097/00000542-200403000-00012	33	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66576	10.1371/journal.pone.0066576	http://dx.doi.org/10.1371/journal.pone.0066576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799118	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800039
J	Bromke, MA; Giavalisco, P; Willmitzer, L; Hesse, H				Bromke, Mariusz A.; Giavalisco, Patrick; Willmitzer, Lothar; Hesse, Holger			Metabolic Analysis of Adaptation to Short-Term Changes in Culture Conditions of the Marine Diatom Thalassiosira pseudonana	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; TROPICAL AUSTRALIAN MICROALGAE; FATTY-ACID-COMPOSITION; PHAEODACTYLUM-TRICORNUTUM; CHEMICAL-COMPOSITION; BATCH CULTURES; HIGHER-PLANTS; WORLD OCEAN; NUTRIENT; PHYTOPLANKTON	This report describes the metabolic and lipidomic profiling of 97 low-molecular weight compounds from the primary metabolism and 124 lipid compounds of the diatom Thalassiosira pseudonana. The metabolic profiles were created for diatoms perturbed for 24 hours with four different treatments: (I) removal of nitrogen, (II) lower iron concentration, (III) addition of sea salt, (IV) addition of carbonate to their growth media. Our results show that as early as 24 hours after nitrogen depletion significant qualitative and quantitative change in lipid composition as well as in the primary metabolism of Thalassiosira pseudonana occurs. So we can observe the accumulation of several storage lipids, namely triacylglycerides, and TCA cycle intermediates, of which citric acid increases more than 10-fold. These changes are positively correlated with expression of TCA enzymes genes. Next to the TCA cycle intermediates and storage lipid changes, we have observed decrease in N-containing lipids and primary metabolites such as amino acids. As a measure of counteracting nitrogen starvation, we have observed elevated expression levels of nitrogen uptake and amino acid biosynthetic genes. This indicates that diatoms can fast and efficiently adapt to changing environment by altering the metabolic fluxes and metabolite abundances. Especially, the accumulation of proline and the decrease of dimethylsulfoniopropionate suggest that the proline is the main osmoprotectant for the diatom in nitrogen rich conditions.	[Bromke, Mariusz A.; Giavalisco, Patrick; Willmitzer, Lothar; Hesse, Holger] Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam, Germany	Max Planck Society	Bromke, MA (corresponding author), Max Planck Inst Mol Plant Physiol, Dept Mol Physiol, Potsdam, Germany.	bromke@mpimp-golm.mpg.de	Bromke, Mariusz A./AAZ-4519-2020	Bromke, Mariusz A./0000-0002-0806-6608	DFG;  [HE3088/4-1]	DFG(German Research Foundation (DFG)); 	This work was supported by grant number HE3088/4-1, funded by DFG (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bender SJ, 2012, PROTIST, V163, P232, DOI 10.1016/j.protis.2011.07.008; BERGES JA, 1995, J PHYCOL, V31, P85, DOI 10.1111/j.0022-3646.1995.00085.x; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gage DA, 1997, NATURE, V387, P891, DOI 10.1038/43160; Gaude N, 2007, PLANT J, V49, P729, DOI 10.1111/j.1365-313X.2006.02992.x; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; Granum E, 2005, CAN J BOT, V83, P898, DOI 10.1139/B05-077; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hummel J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00054; Keller MD, 1999, MAR BIOL, V135, P237, DOI 10.1007/s002270050621; KLOPFENSTEIN WE, 1983, J AM OIL CHEM SOC, V60, P1596, DOI 10.1007/BF02666592; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Li YT, 2011, BIORESOURCE TECHNOL, V102, P123, DOI 10.1016/j.biortech.2010.06.036; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Milligan AJ, 2000, J PHYCOL, V36, P78, DOI 10.1046/j.1529-8817.2000.99013.x; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; MOREL FMM, 1987, J PHYCOL, V23, P137; Nappo M, 2009, J APPL PHYCOL, V21, P295, DOI 10.1007/s10811-008-9367-8; Niki T, 2004, J OCEANOGR, V60, P913, DOI 10.1007/s10872-005-5783-4; ORCUTT DM, 1975, COMP BIOCHEM PHYS B, V50, P579, DOI 10.1016/0305-0491(75)90093-0; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Renaud SM, 1999, AQUACULTURE, V170, P147, DOI 10.1016/S0044-8486(98)00399-8; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; ROBERTS BA, 1986, CAN J BOT, V64, P455, DOI 10.1139/b86-060; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Strong AL, 2009, OCEANOGRAPHY, V22, P236, DOI 10.5670/oceanog.2009.83; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Team RC, 2012, R LANG ENV STAT COMP; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Vidoudez C, 2012, METABOLOMICS, V8, P654, DOI 10.1007/s11306-011-0356-6; Zendejas FJ, 2012, BIOTECHNOL BIOENG, V109, P1146, DOI 10.1002/bit.24395	47	43	43	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67340	10.1371/journal.pone.0067340	http://dx.doi.org/10.1371/journal.pone.0067340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799147	Green Submitted, gold, Green Published			2022-12-27	WOS:000320363300110
J	Cunneen, MM; Liu, B; Wang, L; Reeves, PR				Cunneen, Monica M.; Liu, Bin; Wang, Lei; Reeves, Peter R.			Biosynthesis of UDP-GlcNAc, UndPP-GlcNAc and UDP-GlcNAcA Involves Three Easily Distinguished 4-Epimerase Enzymes, Gne, Gnu and GnaB	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE 4-EPIMERASE; ANTIGEN GENE CLUSTERS; PSEUDOMONAS-AERUGINOSA; SUBSTRATE-SPECIFICITY; BIOCHEMICAL-CHARACTERIZATION; POLYSACCHARIDE SYNTHESIS; GALACTOSE 4-EPIMERASE; STRUCTURAL-ANALYSIS; C4 EPIMERASE; VIRULENCE	We have undertaken an extensive survey of a group of epimerases originally named Gne, that were thought to be responsible for inter-conversion of UDP-N-acetylglucosamine (UDP-GlcNAc) and UDP-N-acetylgalactosamine (UDP-GalNAc). The analysis builds on recent work clarifying the specificity of some of these epimerases. We find three well defined clades responsible for inter-conversion of the gluco- and galacto-configuration at C4 of different N-acetylhexosamines. Their major biological roles are the formation of UDP-GalNAc, UDP-N-acetylgalactosaminuronic acid (UDP-GalNAcA) and undecaprenyl pyrophosphate-N-acetylgalactosamine (UndPP-GalNAc) from the corresponding glucose forms. We propose that the clade of UDP-GlcNAcA epimerase genes be named gnaB and the clade of UndPP-GlcNAc epimerase genes be named gnu, while the UDP-GlcNAc epimerase genes retain the name gne. The Gne epimerases, as now defined after exclusion of those to be named GnaB or Gnu, are in the same clade as the GalE 4-epimerases for inter-conversion of UDP-glucose (UDP-Glc) and UDP-galactose (UDP-Gal). This work brings clarity to an area that had become quite confusing. The identification of distinct enzymes for epimerisation of UDP-GlcNAc, UDP-GlcNAcA and UndPP-GlcNAc will greatly facilitate allocation of gene function in polysaccharide gene clusters, including those found in bacterial genome sequences. A table of the accession numbers for the 295 proteins used in the analysis is provided to enable the major tree to be regenerated with the inclusion of additional proteins of interest. This and other suggestions for annotation of 4-epimerase genes will facilitate annotation.	[Cunneen, Monica M.; Reeves, Peter R.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Liu, Bin; Wang, Lei] Nankai Univ, TEDA, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Liu, Bin; Wang, Lei] TEDA, Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China; [Wang, Lei] Nankai Univ, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China	University of Sydney; Nankai University; Nankai University	Reeves, PR (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	peter.reeves@sydney.edu.au	Reeves, Peter R/A-6064-2008; Wang, Lei/C-5176-2009	Reeves, Peter R/0000-0003-4479-7974; Wang, Lei/0000-0003-4427-0881	National Natural Science Foundation of China (NSFC) Key Program Grant [31030002]; National 973 program of China [2011CB504900]; Australian Research Council	National Natural Science Foundation of China (NSFC) Key Program Grant(National Natural Science Foundation of China (NSFC)); National 973 program of China(National Basic Research Program of China); Australian Research Council(Australian Research Council)	The work for this paper was supported in part by the National Natural Science Foundation of China (NSFC) Key Program Grant 31030002 and the National 973 program of China (2011CB504900), and preliminary work in the area was supported by grants from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Bhatt VS, 2011, PROTEIN SCI, V20, P856, DOI 10.1002/pro.611; Canals R, 2007, J BACTERIOL, V189, P540, DOI 10.1128/JB.01260-06; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Cunneen MM, 2011, GLYCOBIOLOGY, V21, P1140, DOI 10.1093/glycob/cwr010; De Castro C, 2013, GLYCOBIOLOGY, V23, P346, DOI 10.1093/glycob/cws145; De Castro C, 2011, INNATE IMMUN-LONDON, V17, P183, DOI 10.1177/1753425910364425; De Castro C, 2009, INNATE IMMUN-LONDON, V15, P351, DOI 10.1177/1753425909105319; deHenestrosa ARF, 1997, FEMS MICROBIOL LETT, V154, P311, DOI 10.1016/S0378-1097(97)00347-9; ESTRELA AI, 1991, J GEN MICROBIOL, V137, P943, DOI 10.1099/00221287-137-4-943; Guo HJ, 2007, BIOCHEM BIOPH RES CO, V356, P604, DOI 10.1016/j.bbrc.2007.03.015; Hao YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P195, DOI 10.1007/978-3-7091-0733-1_7; HASHIMOTO Y, 1993, J BACTERIOL, V175, P4456, DOI 10.1128/JB.175.14.4456-4465.1993; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Knirel YA, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P41, DOI 10.1007/978-3-7091-0733-1_3; Lopez AB, 2007, J EUKARYOT MICROBIOL, V54, P154, DOI 10.1111/j.1550-7408.2007.00246.x; METZGER M, 1994, J BACTERIOL, V176, P450, DOI 10.1128/JB.176.2.450-459.1994; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; Reeves PR, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P319; Reeves PR, 2003, ADV EXP MED BIOL, V529, P199; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Roodt Y, 2007, DNA SEQUENCE, V18, P265, DOI 10.1080/10425170701207067; Rush JS, 2010, J BIOL CHEM, V285, P1671, DOI 10.1074/jbc.M109.061630; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200; Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200; Thoden JB, 2001, J BIOL CHEM, V276, P20617, DOI 10.1074/jbc.M101304200; Wang L, 2002, J BACTERIOL, V184, P2620, DOI 10.1128/JB.184.10.2620-2625.2002; Wetter M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045609; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Zhao X, 2000, J BIOL CHEM, V275, P33252, DOI 10.1074/jbc.M004191200	33	32	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67646	10.1371/journal.pone.0067646	http://dx.doi.org/10.1371/journal.pone.0067646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799153	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300115
J	Moisello, C; Meziane, HB; Kelly, S; Perfetti, B; Kvint, S; Voutsinas, N; Blanco, D; Quartarone, A; Tononi, G; Ghilardi, MF				Moisello, Clara; Meziane, Hadj Boumediene; Kelly, Simon; Perfetti, Bernardo; Kvint, Svetlana; Voutsinas, Nicholas; Blanco, Daniella; Quartarone, Angelo; Tononi, Giulio; Ghilardi, Maria Felice			Neural Activations during Visual Sequence Learning Leave a Trace in Post-Training Spontaneous EEG	PLOS ONE			English	Article							WORKING-MEMORY TASK; PARKINSONS-DISEASE; PHASE SYNCHRONIZATION; ALPHA OSCILLATIONS; THETA OSCILLATIONS; MOTOR CORTEX; PERFORMANCE; MODULATION; SLEEP; INHIBITION	Recent EEG studies have shown that implicit learning involving specific cortical circuits results in an enduring local trace manifested as local changes in spectral power. Here we used a well characterized visual sequence learning task and high density-(hd-)EEG recording to determine whether also declarative learning leaves a post-task, local change in the resting state oscillatory activity in the areas involved in the learning process. Thus, we recorded hd-EEG in normal subjects before, during and after the acquisition of the order of a fixed spatial target sequence (VSEQ) and during the presentation of targets in random order (VRAN). We first determined the temporal evolution of spectral changes during VSEQ and compared it to VRAN. We found significant differences in the alpha and theta bands in three main scalp regions, a right occipito-parietal (ROP), an anterior-frontal (AFr), and a right frontal (RFr) area. The changes in frontal theta power during VSEQ were positively correlated with the learning rate. Further, post-learning EEG recordings during resting state revealed a significant increase in alpha power in ROP relative to a pre-learning baseline. We conclude that declarative learning is associated with alpha and theta changes in frontal and posterior regions that occur during the task, and with an increase of alpha power in the occipito-parietal region after the task. These post-task changes may represent a trace of learning and a hallmark of use-dependent plasticity.	[Moisello, Clara; Meziane, Hadj Boumediene; Perfetti, Bernardo; Kvint, Svetlana; Voutsinas, Nicholas; Blanco, Daniella; Ghilardi, Maria Felice] CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA; [Kelly, Simon] CUNY, Dept Biomed Engn, New York, NY 10021 USA; [Quartarone, Angelo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol Sci, Messina, Italy; [Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; University of Messina; University of Wisconsin System; University of Wisconsin Madison	Ghilardi, MF (corresponding author), CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA.	lice.mg79@gmail.com	; QUARTARONE, Angelo/G-3264-2017	Meziane, Hadj Boumediene/0000-0001-9284-5016; QUARTARONE, Angelo/0000-0003-1485-6590; Kelly, Simon/0000-0001-9983-3595	McDonnell Foundation; National Parkinson Foundation; National Institute of Health [NS-054864, NS-055185]; Rudin Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054864, R01NS055185] Funding Source: NIH RePORTER	McDonnell Foundation; National Parkinson Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rudin Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	McDonnell Foundation to MFG and GT, National Parkinson Foundation to MFG, National Institute of Health (NS-054864 to MFG, NS-055185 to GT) and Rudin Fellowship to SvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaansen MCM, 2002, CLIN NEUROPHYSIOL, V113, P1882, DOI 10.1016/S1388-2457(02)00303-6; BEATTY J, 1974, SCIENCE, V183, P871, DOI 10.1126/science.183.4127.871; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; Buschkuehl M, 2012, DEV COGN NEUROS-NETH, V2, pS167, DOI 10.1016/j.dcn.2011.10.001; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Crupi D, 2013, J MOTOR BEHAV, V45, P127, DOI 10.1080/00222895.2012.760514; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J., 2005, EVENT RELATED POTENT, P189; Gallasch E, 2009, EUR J APPL PHYSIOL, V105, P47, DOI 10.1007/s00421-008-0871-y; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Ghilardi MF, 2007, PARKINSONISM RELAT D, V13, P146, DOI 10.1016/j.parkreldis.2006.08.006; Ghilardi MF, 2003, ANN NEUROL, V54, P102, DOI 10.1002/ana.10610; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hung CS, 2013, SLEEP, V36, P59, DOI 10.5665/sleep.2302; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Keller A, 2002, TRENDS NEUROSCI, V25, P541, DOI 10.1016/S0166-2236(02)02260-9; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W., 1993, Brain Topography, V5, P241, DOI 10.1007/BF01128991; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Kvint S, 2011, ARCH ITAL BIOL, V149, P303, DOI 10.4449/aib.v149i3.1244; Landsness EC, 2011, CLIN NEUROPHYSIOL, V122, P2418, DOI 10.1016/j.clinph.2011.05.001; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001; Moisello C, 2009, EXP BRAIN RES, V194, P143, DOI 10.1007/s00221-008-1681-5; Nakamura T, 2001, HUM BRAIN MAPP, V12, P42, DOI 10.1002/1097-0193(200101)12:1<42::AID-HBM40>3.0.CO;2-D; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perfetti B, 2010, ARCH ITAL BIOL, V148, P279; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pignatelli M, 2012, J PHYSIOL-PARIS, V106, P81, DOI 10.1016/j.jphysparis.2011.09.007; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Tanaka S, 2011, NEUROPSYCHOL REHABIL, V21, P650, DOI 10.1080/09602011.2011.605589; Vanni S, 1997, J NEUROSCI, V17, P7141; Vyazovskiy VV, 2011, PROG BRAIN RES, V193, P17, DOI 10.1016/B978-0-444-53839-0.00002-8; White T.P, 2012, HUM BRAIN MAPP	50	24	25	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65882	10.1371/journal.pone.0065882	http://dx.doi.org/10.1371/journal.pone.0065882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799058	gold, Green Published			2022-12-27	WOS:000320363300050
J	Schwarzinger, M; Sagaon-Teyssier, L; Cabaret, O; Bretagne, S; Cordonnier, C				Schwarzinger, Michael; Sagaon-Teyssier, Luis; Cabaret, Odile; Bretagne, Stephane; Cordonnier, Catherine		PREVERT Investigators	Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model	PLOS ONE			English	Article								Background: The performance of serum biomarkers for the early detection of invasive aspergillosis expectedly depends on the timing of test results relative to the empirical administration of antifungal therapy during neutropenia, although a dynamic evaluation framework is lacking. Methods: We developed a multi-state model describing simultaneously the likelihood of empirical antifungal therapy and the risk of invasive aspergillosis during neutropenia. We evaluated whether the first positive test result with a biomarker is an independent predictor of invasive aspergillosis when both diagnostic information used to treat and risk factors of developing invasive aspergillosis are taken into account over time. We applied the multi-state model to a homogeneous cohort of 185 high-risk patients with acute myeloid leukemia. Patients were prospectively screened for galactomannan antigenemia twice a week for immediate treatment decision; 2,214 serum samples were collected on the same days and blindly assessed for (1->3)- beta-D-glucan antigenemia and a quantitative PCR assay targeting a mitochondrial locus. Results: The usual evaluation framework of biomarker performance was unable to distinguish clinical benefits of beta-glucanor PCR assays. The multi-state model evidenced that the risk of invasive aspergillosis is a complex time function of neutropenia duration and risk management. The quantitative PCR assay accelerated the early detection of invasive aspergillosis (P = .010), independently of other diagnostic information used to treat, while beta-glucan assay did not (P = .53). Conclusions: The performance of serum biomarkers for the early detection of invasive aspergillosis is better apprehended by the evaluation of time-varying predictors in a multi-state model. Our results provide strong rationale for prospective studies testing a preemptive antifungal therapy, guided by clinical, radiological, and bi-weekly blood screening with galactomannan antigenemia and a standardized quantitative PCR assay.	[Schwarzinger, Michael] INSERM, UMR 738, Equipe ATIP AVENIR, Paris, France; [Schwarzinger, Michael] Univ Paris Diderot, Sorbonne Paris Cite, UMR 738, Paris, France; [Schwarzinger, Michael] Translat Hlth Econ Network, Paris, France; [Schwarzinger, Michael] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Sagaon-Teyssier, Luis] INSERM, SESSTIM UMR912, Marseille, France; [Sagaon-Teyssier, Luis] Univ Aix Marseille, UMR S912, IRD, Marseille, France; [Sagaon-Teyssier, Luis] Observ Reg Sante Provence Alpes Cote Azur, ORS PACA, Marseille, France; [Cabaret, Odile; Bretagne, Stephane] Henri Mondor Teaching Hosp, AP HP, Parasitol Mycol Dept, Creteil, France; [Bretagne, Stephane; Cordonnier, Catherine] Univ Paris Est Creteil, UMR 956, Creteil, France; [Bretagne, Stephane] Inst Pasteur, Ctr Natl Reference Mycoses Invas & Antifong, Paris, France; [Cordonnier, Catherine] Henri Mondor Teaching Hosp, AP HP, Hematol Dept, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Schwarzinger, M (corresponding author), INSERM, UMR 738, Equipe ATIP AVENIR, Paris, France.	michael.schwarzinger@inserm.fr	BRETAGNE, Stephane/H-6655-2019; maury, sebastien/Q-6573-2018; Cornet, Muriel/M-6563-2014; Schwarzinger, Michael/F-7367-2011; BRETAGNE, Stephane/GLT-8879-2022	BRETAGNE, Stephane/0000-0001-6870-3800; maury, sebastien/0000-0002-1170-8683; Cornet, Muriel/0000-0003-4155-3675; Schwarzinger, Michael/0000-0002-0573-6856; Paugam, Andre/0000-0003-1451-3029; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192; Sagaon-Teyssier, Luis/0000-0001-7318-6596	French Ministry of Health [PHRC 2002 AOR02028]	French Ministry of Health	Financial support French Ministry of Health (PHRC 2002 AOR02028). The study sponsor had no involvement in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Alberti C, 2001, J HOSP INFECT, V48, P198, DOI 10.1053/jhin.2001.0998; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Barnes RA, 2009, J CLIN PATHOL, V62, P64, DOI 10.1136/jcp.2008.058354; Botterel F, 2008, TRANSPL INFECT DIS, V10, P333, DOI 10.1111/j.1399-3062.2008.00323.x; Cordonnier C, 2009, CLIN INFECT DIS, V48, P1042, DOI 10.1086/597395; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; Cornet M, 1999, INFECT CONT HOSP EP, V20, P508, DOI 10.1086/501661; Costa C, 2002, J CLIN MICROBIOL, V40, P2224, DOI 10.1128/JCM.40.6.2224-2227.2002; Costa JM, 2001, PRENATAL DIAG, V21, P85, DOI 10.1002/1097-0223(200102)21:2&lt;85::AID-PD18&gt;3.0.CO;2-1; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Desmet S, 2009, J CLIN MICROBIOL, V47, P3871, DOI 10.1128/JCM.01756-09; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; Gotzsche PC, 1997, BMJ-BRIT MED J, V314, P1238, DOI 10.1136/bmj.314.7089.1238; Heckman J J, 1994, Stat Methods Med Res, V3, P279, DOI 10.1177/096228029400300306; Kami M, 2001, CLIN INFECT DIS, V33, P1504, DOI 10.1086/323337; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Kawazu M, 2004, J CLIN MICROBIOL, V42, P2733, DOI 10.1128/JCM.42.6.2733-2741.2004; Koo S, 2009, CLIN INFECT DIS, V49, P1650, DOI 10.1086/647942; Lamoth F, 2012, CLIN INFECT DIS, V54, P633, DOI 10.1093/cid/cir897; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; Maertens J, 2005, CLIN INFECT DIS, V41, P1242, DOI 10.1086/496927; Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175; Maertens J, 2001, BLOOD, V97, P1604, DOI 10.1182/blood.V97.6.1604; Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178; Marino P, 2013, J CLIN ONCOL, V31, P1277, DOI 10.1200/JCO.2011.38.5401; Marr KA, 2005, CLIN INFECT DIS, V41, pS381, DOI 10.1086/430920; Marr KA, 2005, CLIN INFECT DIS, V40, P1762, DOI 10.1086/429921; Marr KA, 2004, J INFECT DIS, V190, P641, DOI 10.1086/422009; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; MEYER BD, 1990, ECONOMETRICA, V58, P757, DOI 10.2307/2938349; Miceli MH, 2008, CLIN INFECT DIS, V46, P1412, DOI 10.1086/528714; Muhlemann K, 2005, LEUKEMIA, V19, P545, DOI 10.1038/sj.leu.2403674; Nouer SA, 2011, CLIN INFECT DIS, V53, P671, DOI 10.1093/cid/cir441; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Segal BH, 2007, CLIN INFECT DIS, V44, P402, DOI 10.1086/510677; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; White PL, 2011, J CLIN MICROBIOL, V49, P3842, DOI 10.1128/JCM.05316-11; White PL, 2010, J CLIN MICROBIOL, V48, P1231, DOI 10.1128/JCM.01767-09; Yokoe D, 2009, BONE MARROW TRANSPL, V44, P495, DOI 10.1038/bmt.2009.261	40	24	29	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65776	10.1371/journal.pone.0065776	http://dx.doi.org/10.1371/journal.pone.0065776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V71EU	23799048	gold, Green Published, Green Submitted			2022-12-27	WOS:000211558300001
J	Steele, AM; Wensley, KJ; Ellard, S; Murphy, R; Shepherd, M; Colclough, K; Hattersley, AT; Shields, BM				Steele, Anna M.; Wensley, Kirsty J.; Ellard, Sian; Murphy, Rinki; Shepherd, Maggie; Colclough, Kevin; Hattersley, Andrew T.; Shields, Beverley M.			Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; YOUNG; SENSITIVITY; DIAGNOSIS; INDIVIDUALS; PREVALENCE; SUBTYPES; CHILDREN; MODY	Aims: HaemoglobinA1c (HbA1c) is recommended for diabetes diagnosis but fasting plasma glucose (FPG) has been useful for identifying patients with glucokinase (GCK) mutations which cause lifelong persistent fasting hyperglycaemia. We aimed to derive age-related HbA1c reference ranges for these patients to determine how well HbA1c can discriminate patients with a GCK mutation from unaffected family members and young-onset type 1 (T1D) and type 2 diabetes (T2D) and to investigate the proportion of GCK mutation carriers diagnosed with diabetes using HbA1c and/or FPG diagnostic criteria. Methods: Individuals with inactivating GCK mutations (n = 129), familial controls (n = 100), T1D (n = 278) and T2D (n = 319) aged >= 18years were recruited. Receiver Operating Characteristic (ROC) analysis determined effectiveness of HbA1c and FPG to discriminate between groups. Results: HbA1c reference ranges in subjects with GCK mutations were: 38-56 mmol/mol (5.6-7.3%) if aged <= 40years; 41-60 mmol/mol (5.9-7.6%) if >40years. All patients (123/123) with a GCK mutation were above the lower limit of the HbA1c age-appropriate reference ranges. 69% (31/99) of controls were below these lower limits. HbA1c was also effective in discriminating those with a GCK mutation from those with T1D/T2D. Using the upper limit of the age-appropriate reference ranges to discriminate those with a mutation from those with T1D/T2D correctly identified 97% of subjects with a mutation. The majority (438/597 (73%)) with other types of young-onset diabetes had an HbA1c above the upper limit of the age-appropriate GCK reference range. HbA1c >= 48 mmol/mol classified more people with GCK mutations as having diabetes than FPG >= 7 mmol/l (68% vs. 48%, p = 0.0009). Conclusions: Current HbA1c diagnostic criteria increase diabetes diagnosis in patients with a GCK mutation. We have derived age-related HbA1c reference ranges that can be used for discriminating hyperglycaemia likely to be caused by a GCK mutation and aid identification of probands and family members for genetic testing.	[Steele, Anna M.; Wensley, Kirsty J.; Shepherd, Maggie; Hattersley, Andrew T.; Shields, Beverley M.] Univ Exeter, NIHR Exeter Clin Res Facil, Exeter, Devon, England; [Steele, Anna M.; Wensley, Kirsty J.; Shepherd, Maggie] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Ellard, Sian; Colclough, Kevin] Royal Devon & Exeter NHS Fdn Trust, Dept Mol Genet, Exeter, Devon, England; [Murphy, Rinki] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1, New Zealand	University of Exeter; University of Exeter; University of Exeter; University of Auckland	Steele, AM (corresponding author), Univ Exeter, NIHR Exeter Clin Res Facil, Exeter, Devon, England.	anna.steele@pms.ac.uk		Ellard, Sian/0000-0002-7620-5526; Hattersley, Andrew/0000-0001-5620-473X	Diabetes United Kingdom [BDA:RD07/0003473]; National Institute of Health Research (NIHR); NIHR; European Community's Seventh Framework Programme (FP7) [223211]; Diabetes UK [07/0003473] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/098, RDA/03/07/073, NF-SI-0611-10219] Funding Source: researchfish	Diabetes United Kingdom(Diabetes UK); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); European Community's Seventh Framework Programme (FP7); Diabetes UK(Diabetes UK); National Institute for Health Research(National Institute for Health Research (NIHR))	AMS is funded by the Diabetes United Kingdom (grant number BDA:RD07/0003473) and the National Institute of Health Research (NIHR). AMS, BS, KJW, ATH and SE are employed as core members of staff within the NIHR funded Peninsula Clinical Research Facility and ATH is an NIHR Senior Investigator. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no223211, CEED3. The funders had no role in study design, data collection and analysis, decision to publish or prepration of the manuscript.	ADA, 2012, DIABETES CARE S1, V35, pS4; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Feigerlova E, 2006, EUR J PEDIATR, V165, P446, DOI 10.1007/s00431-006-0106-3; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Gloyn AL, 2009, DIABETOLOGIA, V52, P172, DOI 10.1007/s00125-008-1188-4; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Horn PS, 2001, CLIN CHEM, V47, P2137; Massa O, 2001, DIABETOLOGIA, V44, P898; McDonald TJ, 2011, DIABETES CARE, V34, P1860, DOI 10.2337/dc11-0323; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Organisation W, 2011, US GLYC HAEM HBA1C D; Organization WH, 1999, DEF DIAGN CLASS DIAB; Owen KR, 2010, DIABETES CARE, V33, P1919, DOI 10.2337/dc10-0288; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; Pal A, 2010, DIABETES CARE, V33, P252, DOI 10.2337/dc09-1246; Pearson ER, 2001, DIABETES, V50, pS101, DOI 10.2337/diabetes.50.2007.S101; Sagen JV, 2008, PEDIAT DIABETES; Shields BM, 2012, DIABETOLOGIA, V55, P1265, DOI 10.1007/s00125-011-2418-8; Steele AM, 2011, DIABETIC MED J BRI S, V28, pA77; Steele AM, 2010, DIABETIC MED J BR S1, V27, pSD22; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; Thanabalasingham G, 2011, DIABETOLOGIA, V54, P2801, DOI 10.1007/s00125-011-2261-y; Thanabalasingham G, 2012, DIABETES CARE, V35, P1206, DOI 10.2337/dc11-1243; Velho G, 1998, EUR J ENDOCRINOL, V138, P233, DOI 10.1530/eje.0.1380233; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Velho G, 1996, DIABETES CARE, V19, P915, DOI 10.2337/diacare.19.9.915	26	78	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65326	10.1371/journal.pone.0065326	http://dx.doi.org/10.1371/journal.pone.0065326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799006	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300013
J	Wong, KS; Cheung, MK; Au, CH; Kwan, HS				Wong, Kin-Sing; Cheung, Man-Kit; Au, Chun-Hang; Kwan, Hoi-Shan			A Novel Lentinula edodes Laccase and Its Comparative Enzymology Suggest Guaiacol-Based Laccase Engineering for Bioremediation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; CRYSTAL-STRUCTURE; DIRECTED EVOLUTION; FUNGAL LACCASES; EXPRESSION; OXIDATION; BIODEGRADATION; DEGRADATION; DYES; THERMOSTABILITY	Laccases are versatile biocatalysts for the bioremediation of various xenobiotics, including dyes and polyaromatic hydrocarbons. However, current sources of new enzymes, simple heterologous expression hosts and enzymatic information (such as the appropriateness of common screening substrates on laccase engineering) remain scarce to support efficient engineering of laccase for better "green'' applications. To address the issue, this study began with cloning the laccase family of Lentinula edodes. Three laccases perfectio sensu stricto (Lcc4A, Lcc5, and Lcc7) were then expressed from Pichia pastoris, characterized and compared with the previously reported Lcc1A and Lcc1B in terms of kinetics, stability, and degradation of dyes and polyaromatic hydrocarbons. Lcc7 represented a novel laccase, and it exhibited both the highest catalytic efficiency (assayed with 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) [ABTS]) and thermostability. However, its performance on "green'' applications surprisingly did not match the activity on the common screening substrates, namely, ABTS and 2,6-dimethoxyphenol. On the other hand, correlation analyses revealed that guaiacol is much better associated with the decolorization of multiple structurally different dyes than are the two common screening substrates. Comparison of the oxidation chemistry of guaiacol and phenolic dyes, such as azo dyes, further showed that they both involve generation of phenoxyl radicals in laccase-catalyzed oxidation. In summary, this study concluded a robust expression platform of L. edodes laccases, novel laccases, and an indicative screening substrate, guaiacol, which are all essential fundamentals for appropriately driving the engineering of laccases towards more efficient "green'' applications.	[Wong, Kin-Sing; Cheung, Man-Kit; Au, Chun-Hang; Kwan, Hoi-Shan] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Kwan, HS (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	hoishankwan@cuhk.edu.hk	Cheung, Man Kit/E-5696-2012; Kwan, Hoi Shan/GOV-6863-2022; Cheung, Man Kit/M-6972-2019	Cheung, Man Kit/0000-0002-2764-2113; Cheung, Man Kit/0000-0002-2764-2113; Kwan, Hoi Shan/0000-0002-7943-2513	Innovation & Technology Fund in Hong Kong [ITS/047/08]; GeneHarbor (Hong Kong) Technologies Limited [ITS/047/08]; Research Grants Council of Hong Kong [CUHK467810]	Innovation & Technology Fund in Hong Kong; GeneHarbor (Hong Kong) Technologies Limited; Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Innovation & Technology Fund in Hong Kong (ITS/047/08; http://www.itf.gov.hk/) and GeneHarbor (Hong Kong) Technologies Limited (ITS/047/08; http://www.geneharbortech.com/), and was partially supported by the Research Grants Council of Hong Kong (CUHK467810; http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2002, J BIOMOL SCREEN, V7, P547, DOI 10.1177/1087057102238629; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; Call HP, 1997, J BIOTECHNOL, V53, P163, DOI 10.1016/S0168-1656(97)01683-0; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Campos R, 2001, J BIOTECHNOL, V89, P131, DOI 10.1016/S0168-1656(01)00303-0; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chhabra M, 2009, J BIOTECHNOL, V143, P69, DOI 10.1016/j.jbiotec.2009.06.011; CHIVUKULA M, 1995, APPL ENVIRON MICROB, V61, P4374, DOI 10.1128/AEM.61.12.4374-4377.1995; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Doerge DR, 1997, ANAL BIOCHEM, V250, P10, DOI 10.1006/abio.1997.2191; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Farinas ET, 2001, CURR OPIN BIOTECH, V12, P545, DOI 10.1016/S0958-1669(01)00261-0; Festa G, 2008, PROTEINS, V72, P25, DOI 10.1002/prot.21889; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadibarata T, 2012, WATER AIR SOIL POLL, V223, P933, DOI 10.1007/s11270-011-0914-6; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hilden K, 2009, BIOTECHNOL LETT, V31, P1117, DOI 10.1007/s10529-009-9998-0; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hu XK, 2009, BIORESOURCE TECHNOL, V100, P4963, DOI 10.1016/j.biortech.2009.03.089; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kimata K, 2012, J BIOSCI BIOENG, V113, P154, DOI 10.1016/j.jbiosc.2011.10.007; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li KC, 1999, APPL ENVIRON MICROB, V65, P2654; Majeau JA, 2010, BIORESOURCE TECHNOL, V101, P2331, DOI 10.1016/j.biortech.2009.10.087; Mate D, 2010, CHEM BIOL, V17, P1030, DOI 10.1016/j.chembiol.2010.07.010; Miele A, 2010, MOL BIOTECHNOL, V46, P149, DOI 10.1007/s12033-010-9289-y; Nagai M, 2003, MICROBIOL-SGM, V149, P2455, DOI 10.1099/mic.0.26414-0; Nagai M, 2002, APPL MICROBIOL BIOT, V60, P327, DOI 10.1007/s00253-002-1109-2; Pardo I, 2012, BIOTECHNOL BIOENG, V109, P2978, DOI 10.1002/bit.24588; Pereira L, 2009, ADV SYNTH CATAL, V351, P1857, DOI 10.1002/adsc.200900271; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Sakamoto Y, 2008, APPL MICROBIOL BIOT, V79, P971, DOI 10.1007/s00253-008-1507-1; Simmons KE, 1987, ENVIRON SCI TECHNOL, V23, P115; SRINIVASAN C, 1995, APPL ENVIRON MICROB, V61, P4274, DOI 10.1128/AEM.61.12.4274-4277.1995; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Strong PJ, 2011, CRIT REV ENV SCI TEC, V41, P373, DOI 10.1080/10643380902945706; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tilli S, 2011, ENZYME MICROB TECH, V49, P465, DOI 10.1016/j.enzmictec.2011.08.002; Wong KS, 2012, BIORESOURCE TECHNOL, V104, P157, DOI 10.1016/j.biortech.2011.10.097; Xu F, 2000, APPL ENVIRON MICROB, V66, P2052, DOI 10.1128/AEM.66.5.2052-2056.2000; Yano A, 2009, MICROBIOL RES, V164, P642, DOI 10.1016/j.micres.2008.12.001; Zhao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038817; Zhao J, 1999, APPL ENVIRON MICROB, V65, P4908	51	24	27	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66426	10.1371/journal.pone.0066426	http://dx.doi.org/10.1371/journal.pone.0066426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799101	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300080
J	Wu, CW; Ivanova, E; Zhang, Y; Pan, ZH				Wu, Chaowen; Ivanova, Elena; Zhang, Yi; Pan, Zhuo-Hua			rAAV-Mediated Subcellular Targeting of Optogenetic Tools in Retinal Ganglion Cells In Vivo	PLOS ONE			English	Article							RESTORES VISUAL RESPONSES; ECTOPIC EXPRESSION; PHOTORECEPTOR DEGENERATION; CONGENITAL AMAUROSIS; HIPPOCAMPAL-NEURONS; MAMMALIAN RETINA; GENE-TRANSFER; DENDRITES; CHANNELS; RESTORATION	Expression of optogenetic tools in surviving inner retinal neurons to impart retinal light sensitivity has been a new strategy for restoring vision after photoreceptor degeneration. One potential approach for restoring retinal light sensitivity after photoreceptor degeneration is to express optogenetic tools in retinal ganglion cells (RGCs). For this approach, restoration of ON and OFF center-surround receptive fields in RGCs, a key feature of visual information processing, may be important. A possible solution is to differentially express depolarizing and hyperpolarizing optogenetic tools, such as channelrhodopsin-2 and halorhodopsin, to the center and peripheral regions of the RGC dendritic field by using protein targeting motifs. Recombinant adeno-associated virus (rAAV) vectors have proven to be a powerful vehicle for in vitro and in vivo gene delivery, including in the retina. Therefore, the search for protein targeting motifs that can achieve rAAV-mediated subcellular targeted expression would be particularly valuable for developing therapeutic applications. In this study, we identified two protein motifs that are suitable for rAAV-mediated subcellular targeting for generating center-surround receptive fields while reducing the axonal expression in RGCs. Resulting morphological dendritic field and physiological response field by center-targeting were significantly smaller than those produced by surround-targeting. rAAV motif-mediated protein targeting could also be a valuable tool for studying physiological function and clinical applications in other areas of the central nervous system.	[Wu, Chaowen; Ivanova, Elena; Zhang, Yi; Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Dept Anat Cell Biol, Detroit, MI 48202 USA; [Pan, Zhuo-Hua] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Sch Med, Dept Anat Cell Biol, Detroit, MI 48202 USA.	zhpan@med.wayne.edu			NIH [EY17130]; Wayne State University (WSU);  [EY04068]; NATIONAL EYE INSTITUTE [R01EY017130, P30EY004068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University (WSU); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY17130 (Z.-H. P.), the Wayne State University (WSU) MD/PhD program (C. W.), and core grant EY04068 to Department of Anatomy and Cell Biology at Wayne State University, the Ligon Research Center of Vision, and Research to Prevent Blindness to Department of Ophthalmology at Wayne State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P299, DOI 10.1113/jphysiol.1978.sp012234; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Chow BY, 2012, PROG BRAIN RES, V196, P49, DOI 10.1016/B978-0-444-59426-6.00003-3; Doroudchi MM, 2011, MOL THER, V19, P1220, DOI 10.1038/mt.2011.69; Flotte TR, 2004, GENE THER, V11, P805, DOI 10.1038/sj.gt.3302233; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Greenberg KP, 2011, NEURON, V69, P713, DOI 10.1016/j.neuron.2011.01.024; Grubb MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013761; Ivanova E, 2010, NEUROSCIENCE, V165, P233, DOI 10.1016/j.neuroscience.2009.10.021; Ivanova E, 2013, J COMP NEUROL, V521, P2165, DOI 10.1002/cne.23279; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; MANGEL SC, 1991, J PHYSIOL-LONDON, V442, P211, DOI 10.1113/jphysiol.1991.sp018790; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mitsui S, 2005, J NEUROSCI, V25, P1122, DOI 10.1523/JNEUROSCI.3853-04.2005; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; Polosukhina A, 2012, NEURON, V75, P271, DOI 10.1016/j.neuron.2012.05.022; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Rosales CR, 2005, EUR J NEUROSCI, V22, P2381, DOI 10.1111/j.1460-9568.2005.04400.x; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Sucrace E, 2003, PROG RETIN EYE RES, V22, P705; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	42	44	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66332	10.1371/journal.pone.0066332	http://dx.doi.org/10.1371/journal.pone.0066332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799092	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300076
J	Bunprajun, T; Henriksen, TI; Scheele, C; Pedersen, BK; Green, CJ				Bunprajun, Tipwadee; Henriksen, Tora Ida; Scheele, Camilla; Pedersen, Bente Klarlund; Green, Charlotte Jane			Lifelong Physical Activity Prevents Aging-Associated Insulin Resistance in Human Skeletal Muscle Myotubes via Increased Glucose Transporter Expression	PLOS ONE			English	Article							NATURAL-HISTORY; SATELLITE CELL; EXERCISE; PROTEIN; GLUT4; ACTIVATION; TOLERANCE; DIFFERENTIATION; HYPERTROPHY; PROGRESSION	Both aging and physical inactivity are associated with increased development of insulin resistance whereas physical activity has been shown to promote increased insulin sensitivity. Here we investigated the effects of physical activity level on aging-associated insulin resistance in myotubes derived from human skeletal muscle satellite cells. Satellite cells were obtained from young (22 yrs) normally active or middle-aged (56.6 yrs) individuals who were either lifelong sedentary or lifelong active. Both middle-aged sedentary and middle-aged active myotubes had increased p21 and myosin heavy chain protein expression. Interestingly MHCIIa was increased only in myotubes from middle-aged active individuals. Middle-aged sedentary cells had intact insulin-stimulated Akt phosphorylation however, the same cell showed ablated insulin-stimulated glucose uptake and GLUT4 translocation to the plasma membrane. On the other hand, middle-aged active cells retained both insulin-stimulated increases in glucose uptake and GLUT4 translocation to the plasma membrane. Middle-aged active cells also had significantly higher mRNA expression of GLUT1 and GLUT4 compared to middle-aged sedentary cells, and significantly higher GLUT4 protein. It is likely that physical activity induces a number of stable adaptations, including increased GLUT4 expression that are retained in cells ex vivo and protect, or delay the onset of middle-aged-associated insulin resistance. Additionally, a sedentary lifestyle has an impact on the metabolism of human myotubes during aging and may contribute to aging-associated insulin resistance through impaired GLUT4 localization.	[Bunprajun, Tipwadee; Henriksen, Tora Ida; Scheele, Camilla; Pedersen, Bente Klarlund; Green, Charlotte Jane] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Infect Dis,Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Bunprajun, Tipwadee] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10700, Thailand	Rigshospitalet; University of Copenhagen; Mahidol University	Green, CJ (corresponding author), Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Infect Dis,Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark.	cjgreen30@gmail.com	Pedersen, Bente Klarlund/AGR-3217-2022; Scheele, Camilla/S-6401-2017; Scheele, Camilla/AAA-3599-2020; GREEN, Charlotte/B-9742-2014; Henriksen, Tora/AGK-6018-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Scheele, Camilla/0000-0002-6055-9709; Scheele, Camilla/0000-0002-6055-9709; GREEN, Charlotte/0000-0003-1631-3186; Henriksen, Tora/0000-0003-1568-8920; Bunprajun, Tipwadee/0000-0003-4972-7246	Danish National Research Foundation [02-512-55]; Danish Council for Independent Research - Medical Sciences; Commission of the European Communities [223576 - MYOAGE]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0042/2550]	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Commission of the European Communities(European Commission); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Centre of Inflammation and Metabolism (CIM) is supported by a grant from the Danish National Research Foundation (#02-512-55). This study was supported by the Danish Council for Independent Research - Medical Sciences, the Commission of the European Communities (Grant Agreement no. 223576 - MYOAGE) and by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant PHD/0042/2550).	Alfaro LAS, 2011, STEM CELLS, V29, P2030, DOI 10.1002/stem.759; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, pE203, DOI 10.1152/ajpendo.2001.280.2.E203; Bamman MM, 2003, J GERONTOL A-BIOL, V58, P108; Booth FW, 2011, J APPL PHYSIOL, V111, P1497, DOI 10.1152/japplphysiol.00420.2011; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Broholm C, 2012, AM J PHYSIOL-ENDOC M, V303, pE283, DOI 10.1152/ajpendo.00586.2011; CARMELI E, 1994, P SOC EXP BIOL MED, V206, P103; Carrascosa JM, 2011, CURR PROTEIN PEPT SC, V12, P305; Christ-Roberts CY, 2004, METABOLISM, V53, P1233, DOI 10.1016/j.metabol.2004.03.022; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P352, DOI 10.1210/jc.2004-0516; DELA F, 1994, DIABETES, V43, P862, DOI 10.2337/diabetes.43.7.862; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1191, DOI 10.1152/ajpendo.2000.279.5.E1191; Gjovaag TF, 2009, MED SCI SPORT EXER, V41, P129, DOI 10.1249/MSS.0b013e3181844e42; GOODYEAR LJ, 1992, DIABETES, V41, P1091, DOI 10.2337/diabetes.41.9.1091; Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200; Green CJ, 2011, DIABETES, V60, P2810, DOI 10.2337/db11-0263; GUILLETDENIAU I, 1994, J CELL SCI, V107, P487; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Harber MP, 2012, J APPL PHYSIOL, V113, P1495, DOI 10.1152/japplphysiol.00786.2012; Holloszy J O, 2000, Mayo Clin Proc, V75 Suppl, pS3; KAHN SE, 1990, AM J PHYSIOL, V258, pE937, DOI 10.1152/ajpendo.1990.258.6.E937; Liu Y, 2008, BRIT J SPORT MED, V42, P989, DOI 10.1136/bjsm.2007.045518; MacKrell JG, 2012, J GERONTOL A-BIOL, V67, P1286, DOI 10.1093/gerona/gls194; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Nakatani A, 1997, J APPL PHYSIOL, V82, P711, DOI 10.1152/jappl.1997.82.2.711; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; Robson LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027116; RODNICK KJ, 1990, DIABETES, V39, P1425, DOI 10.2337/diabetes.39.11.1425; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Scheele C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039657; SEALS DR, 1984, J APPL PHYSIOL, V56, P1521, DOI 10.1152/jappl.1984.56.6.1521; Stuart CA, 2010, MED SCI SPORT EXER, V42, P96, DOI 10.1249/MSS.0b013e3181ad7f36; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231	46	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66628	10.1371/journal.pone.0066628	http://dx.doi.org/10.1371/journal.pone.0066628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805253	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500081
J	Chang, ML; Lin, YJ; Chang, CJ; Yeh, C; Chen, TC; Yeh, TS; Lee, WC; Yeh, CT				Chang, Ming-Ling; Lin, Yu-Jr; Chang, Chee-Jen; Yeh, Charisse; Chen, Tse-Ching; Yeh, Ta-Sen; Lee, Wei-Chen; Yeh, Chau-Ting			Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; C VIRUS; SURFACE-ANTIGEN; LIVER-TISSUE; INFECTION; DNA; RISK; MUTATIONS; INTERFERENCE; EPIDEMIOLOGY	Objective and Background: The roles of chronic hepatitis B virus (HBV) co-infection (CI) in carcinogenesis of hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) remained controversial. To gain new insights into this issue, we investigated the postoperative prognostic value of HBVCI in HCV-associated HCC. Methods: A study cohort of 115 liver tissues obtained from the noncancerous parts of surgically removed HCV-associated HCCs were subjected to virological analysis in a tertiary care setting. Assayed factors included clinicopathological variables, tissue amounts of viral genomes, genotypic characterization of viruses, as well as the presence of overt (serum HBsAg positive) or occult (serum HBsAg negative but tissue HBV-DNA positive) HBVCI. Cox proportional hazard model was used to estimate postoperative survivals. Results: Of the 115 patients, overt and occult HBVCIs were detected in 35 and 16 patients, respectively. Multivariate analysis revealed that tumor size >3 cm (adjusted hazard ratio (AHR), 2.079 [95% confidence interval, 1.149 similar to 3.761]), alpha-fetoprotein >8 ng/mL (AHR, 5.976 [2.007 similar to 17.794]) albumin <4 g/dL(AHR, 2.539 [1.399 similar to 4.606]), ALT>50 U/L (AHR, 1.086 [1.006 similar to 1.172]), presence of occult HBVCI (AHR, 2.708 [1.317 similar to 5.566]), and absence of overt HBVCI (AHR, 2.216 [1.15 similar to 4.269]) were independently associated with unfavorable disease-free survival. Patients with occult HBVCI had a shorter disease-free (P = 0.002), a shorter overall survival (P = 0.026), a higher bilirubin level (P = 0.003) and a higher prevalence of precore G1896A mutation (P = 0.006) compared with those with overt HBVCI. Conclusion: Occult and overt HBVCI served as independent predictors for postoperative survival in HCV-associated HCC.	[Chang, Ming-Ling; Yeh, Chau-Ting] Chang Gung Mem Hosp, Liver Res Ctr, Linkou, Taiwan; [Chang, Ming-Ling; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Linkou, Taiwan; [Chang, Ming-Ling] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Linkou, Taiwan; [Lin, Yu-Jr; Chang, Chee-Jen] Chang Gung Mem Hosp, Resource Ctr Clin Res, Linkou, Taiwan; [Yeh, Charisse] Flintridge Sacred Heart Acad, Flintridge, CA USA; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Taipei 10591, Taiwan; [Yeh, Ta-Sen; Lee, Wei-Chen] Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Taipei 10591, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yeh, CT (corresponding author), Chang Gung Mem Hosp, Liver Res Ctr, Linkou, Taiwan.	chautingy@gmail.com			Chang Gung Medical Research Program [CLRPG 370695, CMRPG3B1251]	Chang Gung Medical Research Program	This study was supported by grants from Chang Gung Medical Research Program (CLRPG 370695 and CMRPG3B1251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; Bouchard MJ, 2011, CANCER LETT, V305, P123, DOI 10.1016/j.canlet.2010.11.014; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; Chisari FV, 2000, AM J PATHOL, V156, P1117, DOI 10.1016/S0002-9440(10)64980-2; Cho LY, 2011, INT J CANCER, V128, P176, DOI 10.1002/ijc.25321; Chu CM, 1997, J CLIN MICROBIOL, V35, P102, DOI 10.1128/JCM.35.1.102-105.1997; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; El Chaar M, 2010, HEPATOLOGY, V52, P1600, DOI 10.1002/hep.23886; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Eyre NS, 2009, J HEPATOL, V51, P446, DOI 10.1016/j.jhep.2009.04.025; Fujiwara Y, 2010, ANTICANCER RES, V30, P5129; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; Jardi R, 2001, HEPATOLOGY, V34, P404, DOI 10.1053/jhep.2001.26511; KAKLAMANI E, 1991, JAMA-J AM MED ASSOC, V265, P1974, DOI 10.1001/jama.265.15.1974; Kensler TW, 2004, GASTROENTEROLOGY, V127, pS310, DOI 10.1053/j.gastro.2004.09.046; Lai MY, 2005, INTERVIROLOGY, V49, P91, DOI 10.1159/000087269; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; LIAW YF, 1995, HEPATOLOGY, V22, P1101, DOI 10.1016/0270-9139(95)90615-0; Liu CJ, 2006, J INFECT DIS, V193, P1258, DOI 10.1086/502978; Lok AS, 2011, HEPATOLOGY, V54, P434, DOI 10.1002/hep.24257; Lu SN, 1998, PEDIATR INFECT DIS J, V17, P142, DOI 10.1097/00006454-199802000-00012; Matsuzaki Y, 1997, CANCER LETT, V119, P53, DOI 10.1016/S0304-3835(97)00249-8; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; Obika M, 2008, INTERVIROLOGY, V51, P59, DOI 10.1159/000121363; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Raimondo C, 2001, J HEPATOL, V34, P471, DOI 10.1016/S0168-8278(01)00016-2; Ryu SH, 2008, HEPATOLOGY, V47, P929, DOI 10.1002/hep.22124; Talwalkar JA, 2004, GASTROENTEROLOGY, V127, pS126, DOI 10.1053/j.gastro.2004.09.026; TaylorRobinson SD, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63789-0; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; YAMAMOTO K, 1994, J VIROL, V68, P2671, DOI 10.1128/JVI.68.4.2671-2676.1994; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yeh CT, 1997, HEPATOL RES, V7, P159; Yotsuyanagi H, 1998, HEPATOLOGY, V27, P1377, DOI 10.1002/hep.510270526	39	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64891	10.1371/journal.pone.0064891	http://dx.doi.org/10.1371/journal.pone.0064891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805180	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500008
J	Hass, J; Walton, E; Kirsten, H; Liu, JY; Priebe, L; Wolf, C; Karbalai, N; Gollub, R; White, T; Roessner, V; Muller, KU; Paus, T; Smolka, MN; Schumann, G; Scholz, M; Cichon, S; Calhoun, V; Ehrlich, S				Hass, Johanna; Walton, Esther; Kirsten, Holger; Liu, Jingyu; Priebe, Lutz; Wolf, Christiane; Karbalai, Nazanin; Gollub, Randy; White, Tonya; Roessner, Veit; Mueller, Kathrin U.; Paus, Tomas; Smolka, Michael N.; Schumann, Gunter; Scholz, Markus; Cichon, Sven; Calhoun, Vince; Ehrlich, Stefan		IMAGEN Consortium	A Genome-Wide Association Study Suggests Novel Loci Associated with a Schizophrenia-Related Brain-Based Phenotype	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; DATA QUALITY-CONTROL; HIPPOCAMPAL ATROPHY; PSYCHOTIC DISORDERS; ALZHEIMERS-DISEASE; QUANTITATIVE TRAIT; BIPOLAR DISORDER; STRUCTURAL MRI; VERBAL MEMORY; GENE	Patients with schizophrenia and their siblings typically show subtle changes of brain structures, such as a reduction of hippocampal volume. Hippocampal volume is heritable, may explain a variety of cognitive symptoms of schizophrenia and is thus considered an intermediate phenotype for this mental illness. The aim of our analyses was to identify single-nucleotide polymorphisms (SNP) related to hippocampal volume without making prior assumptions about possible candidate genes. In this study, we combined genetics, imaging and neuropsychological data obtained from the Mind Clinical Imaging Consortium study of schizophrenia (n = 328). A total of 743,591 SNPs were tested for association with hippocampal volume in a genome-wide association study. Gene expression profiles of human hippocampal tissue were investigated for gene regions of significantly associated SNPs. None of the genetic markers reached genome-wide significance. However, six highly correlated SNPs (rs4808611, rs35686037, rs12982178, rs1042178, rs10406920, rs8170) on chromosome 19p13.11, located within or in close proximity to the genes NR2F6, USHBP1, and BABAM1, as well as four SNPs in three other genomic regions (chromosome 1, 2 and 10) had p-values between 6.75x10(-6) and 8.3x10(-7). Using existing data of a very recently published GWAS of hippocampal volume and additional data of a multicentre study in a large cohort of adolescents of European ancestry, we found supporting evidence for our results. Furthermore, allelic differences in rs4808611 and rs8170 were highly associated with differential mRNA expression in the cis-acting region. Associations with memory functioning indicate a possible functional importance of the identified risk variants. Our findings provide new insights into the genetic architecture of a brain structure closely linked to schizophrenia. In silico replication, mRNA expression and cognitive data provide additional support for the relevance of our findings. Identification of causal variants and their functional effects may unveil yet unknown players in the neurodevelopment and the pathogenesis of neuropsychiatric disorders.	[Hass, Johanna; Walton, Esther; Roessner, Veit; Ehrlich, Stefan] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Child & Adolescent Psychiat, Dresden, Germany; [Kirsten, Holger; Scholz, Markus] Univ Leipzig, IMISE, D-04109 Leipzig, Germany; [Kirsten, Holger; Scholz, Markus] Univ Leipzig, LIFE Leipzig Interdisciplinary Res Cluster Genet, D-04109 Leipzig, Germany; [Liu, Jingyu; Calhoun, Vince] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Liu, Jingyu; Calhoun, Vince] MIND Res Network, Albuquerque, NM USA; [Priebe, Lutz] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Priebe, Lutz; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Wolf, Christiane; Karbalai, Nazanin; Cichon, Sven] Max Planck Inst Psychiat, RG Stat Genet, D-80804 Munich, Germany; [Gollub, Randy] Massachusetts Gen Hosp, MGH MIT HMS Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Gollub, Randy; Ehrlich, Stefan] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [White, Tonya; Ehrlich, Stefan] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [White, Tonya; Ehrlich, Stefan] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Mueller, Kathrin U.; Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Nottingham, Brain & Body Ctr, Nottingsham, England; [Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Schumann, Gunter] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Leipzig University; Leipzig University; University of New Mexico; Lovelace Respiratory Research Institute; University of Bonn; University of Bonn; Max Planck Society; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Toronto; University Toronto Affiliates; Baycrest; University of Nottingham; McGill University; University of London; King's College London; Helmholtz Association; Research Center Julich	Ehrlich, S (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Child & Adolescent Psychiat, Dresden, Germany.	transden.lab@uniklinikum-dresden.de	Walton, Esther/P-9832-2019; Smolka, Michael/B-4865-2011; Mirza-Schreiber, Nazanin/AAD-1558-2022; Calhoun, Vince D./ACN-9399-2022; Roessner, Veit/AAQ-8760-2020; Vollstädt-Klein, Sabine/C-6744-2012; Cichon, Sven/H-8803-2013; Mirza-Schreiber, Nazanin/AAD-1563-2022; Kirsten, Holger/AAP-7250-2020; Ehrlich, Stefan/ABB-4650-2020; Walton, Esther/GSN-8429-2022; Cichon, Sven/B-9618-2014; White, Tonya/AAU-2226-2021	Walton, Esther/0000-0002-0935-2200; Smolka, Michael/0000-0001-5398-5569; Calhoun, Vince D./0000-0001-9058-0747; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Cichon, Sven/0000-0002-9475-086X; Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Kirsten, Holger/0000-0002-3126-7950; Ehrlich, Stefan/0000-0003-2132-4445; Cichon, Sven/0000-0002-9475-086X; White, Tonya/0000-0003-0271-1896; Liu, Jingyu/0000-0002-1724-7523; Roessner, Veit/0000-0002-1873-7081; Gollub, Randy L./0000-0002-9434-4044	National Institutes of Health [NIH/NCRR P41RR14075]; Department of Energy [DE-FG02-99ER62764]; MIND Research Network; Morphometry Biomedical Informatics Research Network (BIRN) [1U24, RR021382A]; Function BIRN [U24RR021992-01, NIH.NCRR MO1 RR025758-01]; NARSAD; Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network plus (NGFNplus) [PtJ-Bio 0313909]; German Federal Ministry of Education and Research (BMBF), within the Integrated Genome Research Network (IG) MooDS [01GS08144]; Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig); European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative; European Commission Framework Programme 6 (FP-6) Integrated Project IMAGEN [PL037286]; European Commission Framework Programme 7 (FP-7) Project Alzheimer's Disease, Alcoholism, Memory, Schizophrenia (ADAMS); FP-7 Innovative Medicine Initiative Project European Autism Interventions (AIMS); UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre Mental Health program; MRC programme grant Developmental Pathways into Adolescent Substance Abuse [93558]; Eli Lilly; Janssen-Cilag; Medice; Novartis; MRC [G0901858] Funding Source: UKRI; Medical Research Council [G9817803B, G0901858] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021992, U24RR021382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); MIND Research Network; Morphometry Biomedical Informatics Research Network (BIRN); Function BIRN; NARSAD(NARSAD); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network plus (NGFNplus)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF), within the Integrated Genome Research Network (IG) MooDS(Federal Ministry of Education & Research (BMBF)); Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig); European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative; European Commission Framework Programme 6 (FP-6) Integrated Project IMAGEN; European Commission Framework Programme 7 (FP-7) Project Alzheimer's Disease, Alcoholism, Memory, Schizophrenia (ADAMS); FP-7 Innovative Medicine Initiative Project European Autism Interventions (AIMS); UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre Mental Health program; MRC programme grant Developmental Pathways into Adolescent Substance Abuse(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Eli Lilly(Eli Lilly); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medice; Novartis(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health (NIH/NCRR P41RR14075), Department of Energy (DE-FG02-99ER62764), MIND Research Network, Morphometry Biomedical Informatics Research Network (BIRN) (1U24, RR021382A), Function BIRN (U24RR021992-01, NIH.NCRR MO1 RR025758-01), NARSAD Young Investigator Grant (SE), and the Deutsche Forschungsgemeinschaft (Research Fellowship to SE). Further funding came from the German Federal Ministry of Education and Research (BMBF, grant PtJ-Bio 0313909 to HK), within the context of the National Genome Research Network plus (NGFNplus), and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to SC). HK and MS are supported by the Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment (LIFE Center, Universitat Leipzig). LIFE is funded by the European Union, the European Regional Development Fund (ERDF) and the Free State of Saxony within the framework of the excellence initiative. IMAGEN is funded by the European Commission Framework Programme 6 (FP-6) Integrated Project IMAGEN (PL037286), the European Commission Framework Programme 7 (FP-7) Project Alzheimer's Disease, Alcoholism, Memory, Schizophrenia (ADAMS), the FP-7 Innovative Medicine Initiative Project European Autism Interventions (AIMS), the UK Department of Health National Institute of Health Research (NIHR)-Biomedical Research Centre Mental Health program and the MRC programme grant Developmental Pathways into Adolescent Substance Abuse (93558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Veit Roessner has received lecture fees from Eli Lilly, Janssen-Cilag, Medice, and Novartis and was a member of advisory boards of Eli Lilly, Novartis. All other authors declare no biomedical financial interests or other potential conflict of interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Andreasen N. C., 1987, PSYCHIAT SYMPTOMS YO; Andreasen N. C., 1984, SCALE ASSESSMENT POS; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Andreasen NC, 1983, SCALE ASSESSMENT NEG; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cannon TD, 1998, ARCH GEN PSYCHIAT, V55, P67, DOI 10.1001/archpsyc.55.1.67; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Cohen NJ, 1993, NEUROPSYCHOLOGY MEMO; Correll CU, 2010, J CHILD PSYCHOL PSYC, V51, P390, DOI 10.1111/j.1469-7610.2010.02235.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ehrlich S, 2010, NEUROIMAGE, V53, P992, DOI 10.1016/j.neuroimage.2009.12.046; First MB, 2002, STRUCTURED CLIN INTE; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Furney SJ, 2011, MOL PSYCHIATR, V16, P1130, DOI 10.1038/mp.2010.123; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Heckers S, 2001, HIPPOCAMPUS, V11, P520, DOI 10.1002/hipo.1068; HECKERS S, 1991, ARCH GEN PSYCHIAT, V48, P1002; Highley JR, 2003, BRIT J PSYCHIAT, V183, P414, DOI 10.1192/bjp.183.5.414; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Joreskog K., 1986, LISREL 6 ANAL LINEAR; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kaymaz N, 2009, INT REV NEUROBIOL, V89, P85, DOI 10.1016/S0074-7742(09)89005-3; Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622; Kohtz JD, 2010, PHYSIOL BEHAV, V100, P250, DOI 10.1016/j.physbeh.2010.01.015; Krebs MO, 2009, TRENDS MOL MED, V15, P562, DOI 10.1016/j.molmed.2009.10.001; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lawrie SM, 2008, SCHIZOPHRENIA BULL, V34, P330, DOI 10.1093/schbul/sbm158; Le Hellard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007534; Lee AL, 2002, BIPOLAR DISORD, V4, P117, DOI 10.1034/j.1399-5618.2002.01144.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Mistry M, 2012, MOL PSYCHIAT; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Muller DJ, 2011, BIPOLAR DISORD, V13, P198, DOI 10.1111/j.1399-5618.2011.00905.x; Novak NM, 2012, TWIN RES HUM GENET, V15, P414, DOI 10.1017/thg.2012.17; Orellana C, 2009, CYTOGENET GENOME RES, V127, P5, DOI 10.1159/000279261; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; Phillips LJ, 2006, AUST NZ J PSYCHIAT, V40, P725, DOI 10.1080/j.1440-1614.2006.01877.x; Poot M, 2011, CYTOGENET GENOME RES, V135, P228, DOI 10.1159/000334064; Potkin Steven G, 2009, Cogn Neuropsychiatry, V14, P391, DOI 10.1080/13546800903059829; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajeevan MS, 2007, GENES BRAIN BEHAV, V6, P167, DOI 10.1111/j.1601-183X.2006.00244.x; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SASS KJ, 1992, J CLIN EXP NEUROPSYC, V14, P662, DOI 10.1080/01688639208402854; SASS KJ, 1990, NEUROLOGY, V40, P1694, DOI 10.1212/WNL.40.11.1694; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Sim K, 2006, SCHIZOPHRENIA BULL, V32, P332, DOI 10.1093/schbul/sbj030; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Squire L.R., 2002, NEUROPSYCHOLOGY MEMO; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Teo YY, 2008, CURR OPIN LIPIDOL, V19, P133, DOI 10.1097/MOL.0b013e3282f5dd77; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; White T, 2011, SCHIZOPHRENIA BULL, V37, P222, DOI 10.1093/schbul/sbp088; Wilcke A, 2011, EUROPEAN J HUMAN GEN; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhu XG, 2000, MOL CELL BIOL, V20, P2604, DOI 10.1128/MCB.20.7.2604-2618.2000; Zobel A, 2008, AM J MED GENET B, V147B, P836, DOI 10.1002/ajmg.b.30709	83	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64872	10.1371/journal.pone.0064872	http://dx.doi.org/10.1371/journal.pone.0064872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805179	Green Published, gold			2022-12-27	WOS:000320846500007
J	Haussig, JM; Matuschewski, K; Kooij, TWA				Haussig, Joana M.; Matuschewski, Kai; Kooij, Taco W. A.			Experimental Genetics of Plasmodium berghei NFU in the Apicoplast Iron-Sulfur Cluster Biogenesis Pathway	PLOS ONE			English	Article							MALARIA PARASITE; FOSMIDOMYCIN-CLINDAMYCIN; PROTEIN; FE; SUFB; TRANSFECTION; EVOLUTION; SYSTEM	Eukaryotic pathogens of the phylum Apicomplexa contain a non-photosynthetic plastid, termed apicoplast. Within this organelle distinct iron-sulfur [Fe-S] cluster proteins are likely central to biosynthesis pathways, including generation of isoprenoids and lipoic acid. Here, we targeted a nuclear-encoded component of the apicoplast [Fe-S] cluster biosynthesis pathway by experimental genetics in the murine malaria parasite Plasmodium berghei. We show that ablation of the gene encoding a nitrogen fixation factor U (NifU)-like domain containing protein (NFUapi) resulted in parasites that were able to complete the entire life cycle indicating redundant or non-essential functions. nfu(-) parasites displayed reduced merosome formation in vitro, suggesting that apicoplast NFUapi plays an auxiliary role in establishing a blood stage infection. NFUapi fused to a combined fluorescent protein-epitope tag delineates the Plasmodium apicoplast and was tested to revisit inhibition of liver stage development by azithromycin and fosmidomycin. We show that the branched apicoplast signal is entirely abolished by azithromycin treatment, while fosmidomycin had no effect on apicoplast morphology. In conclusion, our experimental genetics analysis supports specialized and/or redundant role(s) for NFUapi in the [Fe-S] cluster biosynthesis pathway in the apicoplast of a malarial parasite.	[Haussig, Joana M.; Matuschewski, Kai; Kooij, Taco W. A.] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany	Max Planck Society	Kooij, TWA (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.	kooij@mpiib-berlin.mpg.de	Kooij, Taco W.A./L-5623-2015	Kooij, Taco W.A./0000-0002-8547-7523; Matuschewski, Kai/0000-0001-6147-8591; Haussig, Joana M./0000-0002-5216-3472	Max Planck Society; European Union [242095]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was supported by the Max Planck Society and partly by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no242095: EVIMalaR - Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Baumeister S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019334; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Borrmann S, 2005, ANTIMICROB AGENTS CH, V49, P3749, DOI 10.1128/AAC.49.9.3749-3754.2005; Borrmann S, 2004, J INFECT DIS, V190, P1534, DOI 10.1086/424603; Borrmann S, 2004, J INFECT DIS, V189, P901, DOI 10.1086/381785; Borrmann S, 2006, ANTIMICROB AGENTS CH, V50, P2713, DOI 10.1128/AAC.00392-06; Chahal HK, 2012, J INORG BIOCHEM, V116, P126, DOI 10.1016/j.jinorgbio.2012.06.008; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Cilingir G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036598; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Ellis KES, 2001, MOL MICROBIOL, V41, P973, DOI 10.1046/j.1365-2958.2001.02588.x; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Haussig JM, 2011, MOL MICROBIOL, V81, P1511, DOI 10.1111/j.1365-2958.2011.07787.x; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kenthirapalan S, 2012, INT J PARASITOL, V42, P1185, DOI 10.1016/j.ijpara.2012.10.006; Kooij TWA, 2012, MOL BIOCHEM PARASIT, V185, P19, DOI 10.1016/j.molbiopara.2012.06.001; Kumar B, 2011, INT J PARASITOL, V41, P991, DOI 10.1016/j.ijpara.2011.05.006; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Missinou MA, 2002, LANCET, V360, P1941, DOI 10.1016/S0140-6736(02)11860-5; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rangachari K, 2002, FEBS LETT, V514, P225, DOI 10.1016/S0014-5793(02)02369-4; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wiesner J, 2003, PARASITOL RES, V90, pS71, DOI 10.1007/s00436-002-0770-9; Xu XM, 2011, ANTIOXID REDOX SIGN, V15, P271, DOI 10.1089/ars.2010.3259; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200	44	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67269	10.1371/journal.pone.0067269	http://dx.doi.org/10.1371/journal.pone.0067269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805304	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500132
J	Pajon, R; Fergus, AM; Granoff, DM				Pajon, Rolando; Fergus, Andrew M.; Granoff, Dan M.			Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa	PLOS ONE			English	Article							H-BINDING-PROTEIN; NEISSERIA-MENINGITIDIS; GLYCOCONJUGATE VACCINE; BACTERICIDAL ANTIBODY; GROUP-A; MONOCLONAL-ANTIBODIES; CONTROLLED-TRIAL; IMMUNE MEMORY; PORA GENE; IMMUNOGENICITY	Background: The meningococcal serogroup A (MenA) polysaccharide conjugate vaccine used in Sub-Saharan Africa does not prevent disease caused by MenW or MenX strains, which also cause epidemics in the region. We investigated the vaccine-potential of native outer membrane vesicles with over-expressed factor H-binding protein (NOMV-fHbp), which targeted antigens in African meningococcal strains, and was combined with a MenA polysaccharide conjugate vaccine. Methodology/Principal Findings: The NOMV-fHbp vaccine was prepared from a mutant African MenW strain with PorA P1.5,2, attenuated endotoxin (Delta LpxL1), deleted capsular genes, and over-expressed fHbp in variant group 1. The NOMV-fHbp was adsorbed with Al(OH)(3) and used to reconstitute a lyophilized MenA conjugate vaccine, which normally is reconstituted with liquid MenC, Y and W conjugates in a meningococcal quadrivalent conjugate vaccine (MCV4-CRM, Novartis). Mice immunized with the NOMV-fHbp vaccine alone developed serum bactericidal (human complement) activity against 13 of 15 African MenA strains tested; 10 of 10 African MenX strains, 7 of 7 African MenW strains, and 6 of 6 genetically diverse MenB strains with fHbp variant group 1 (including 1 strain from The Gambia). The combination NOMV-fHbp/MenA conjugate vaccine elicited high serum bactericidal titers against the two MenA strains tested that were resistant to bactericidal antibodies elicited by the NOMV-fHbp alone; the combination elicited higher titers against the MenA and MenW strains than those elicited by a control MCV4-CRM vaccine (P<0.05); and high titers against MenX and MenB strains. For most strains, the titers elicited by a control NOMV-fHbp knock out vaccine were <1:10 except when the strain PorA matched the vaccine (titers >1:000). Conclusion/Significance: The NOMV-fHbp/MenA conjugate vaccine provided similar or higher coverage against MenA and MenW strains than a quadrivalent meningococcal conjugate vaccine, and extended protection against MenX strains responsible for epidemics in Africa, and MenB strains with fHbp in variant group 1.	[Pajon, Rolando; Fergus, Andrew M.; Granoff, Dan M.] Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Granoff, DM (corresponding author), Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, 747 52nd St, Oakland, CA 94609 USA.	dgranoff@chori.org			Public Health Service from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [R01 AI 046464, AI 082263]; Clorox Company; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR 016226]; Novartis Vaccines and Diagnostics; Sanofi Pasteur; Novartis; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046464] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Clorox Company; Research Facilities Improvement Program from the National Center for Research Resources, NIH; Novartis Vaccines and Diagnostics; Sanofi Pasteur; Novartis(Novartis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 AI 046464 and AI 082263 (to D.M.G.) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH). D.M.G. also is supported in part by an endowment established by the Clorox Company. The laboratory work at Children's Hospital Oakland Research Institute was performed in a facility funded by Research Facilities Improvement Program grant C06 RR 016226 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dan M. Granoff is principal investigator of laboratory research conducted on behalf of Children's Hospital Oakland Research Institute that is funded by grants from Novartis Vaccines and Diagnostics, and Sanofi Pasteur. D.M.G. is also supported in part by an endowment established by the Clorox Company. He also held a paid consultancy from Novartis. DMG and Rolando Pajon are inventors on patents or patent applications in the area of meningococcal vaccine. The patent applications relevant to the vaccine described in the manuscript are listed below. Andrew Fergus declares no conflicts. These competing interests do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Ctr : US Publication Number : 20120288517 Title : Factor H Binding proteins (FHBP) with altered properties and methods of use thereof Pub Date: Nov. 15, 2012 Organization : Children's Hospital Oakland California Inventor : Peter Beernink, Rolando Pajon and Dan M Granoff link: http://www.patentbuddy.com/Patent/20120288517 Ctr : US Publication Number : 20120093867 Title : GNA1870-Based Vesicle Vaccines for Broad Protection Against Diseases Caused by Neisseria meningitidis Pub Date: Apr. 19, 2012 Organization: Children's Hospital Oakland California Inventor : Dan M Granoff and Victor Hou link: http://patent.ipexl.com/U2S/20120093867.html	Beernink PT, 2009, J INFECT DIS, V199, P1360, DOI 10.1086/597806; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002688; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Beernink PT, 2009, MOL IMMUNOL, V46, P1647, DOI 10.1016/j.molimm.2009.02.021; Ibarz-Pavon AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019717; Bishai DM, 2011, HEALTH AFFAIR, V30, P1058, DOI 10.1377/hlthaff.2011.0295; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Brunelli B, 2011, VACCINE, V29, P1072, DOI 10.1016/j.vaccine.2010.11.064; Caugant DA, 2007, VACCINE, V25, pA8, DOI 10.1016/j.vaccine.2007.04.033; Caugant DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046019; Chiavolini D, 2008, CLIN VACCINE IMMUNOL, V15, P1322, DOI 10.1128/CVI.00125-08; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026; DEMPSEY JAF, 1995, J BACTERIOL, V177, P6390, DOI 10.1128/jb.177.22.6390-6400.1995; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; FEAVERS IM, 1992, MOL MICROBIOL, V6, P489, DOI 10.1111/j.1365-2958.1992.tb01493.x; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Findlow H, 2011, CLIN VACCINE IMMUNOL, V18, P1492, DOI 10.1128/CVI.05020-11; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; FINNE J, 1983, LANCET, V2, P355; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Gasparini R, 2011, HUM VACCINES, V7, P170, DOI 10.4161/hv.7.2.13717; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuntini S, 2011, INFECT IMMUN, V79, P3751, DOI 10.1128/IAI.05182-11; Granoff DM, 2013, PEDIATR INFECT DIS J, V32, P372, DOI 10.1097/INF.0b013e318282942f; Granoff DM, 1998, CLIN DIAGN LAB IMMUN, V5, P479, DOI 10.1128/CDLI.5.4.479-485.1998; Gray-Owen SD, 2003, SCAND J INFECT DIS, V35, P614, DOI 10.1080/00365540310016042; Greenwood B, 2007, EPIDEMIOL INFECT, V135, P703, DOI 10.1017/S0950268807008825; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison LH, 2008, JAMA-J AM MED ASSOC, V299, P217, DOI 10.1001/jama.2007.57-c; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2010, NAT REV DRUG DISCOV, V9, P429, DOI 10.1038/nrd3194; Harrison LH, 2010, CLIN INFECT DIS, V50, pS37, DOI 10.1086/648963; Jackson LA, 2009, PEDIATR INFECT DIS J, V28, P86, DOI 10.1097/INF.0b013e31818a0237; Jelfs J, 2000, CLIN DIAGN LAB IMMUN, V7, P390, DOI 10.1128/CDLI.7.3.390-395.2000; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Koeberling O, 2008, J INFECT DIS, V198, P262, DOI 10.1086/589308; Koeberling O, 2011, VACCINE, V29, P4728, DOI 10.1016/j.vaccine.2011.04.095; Koeberling O, 2011, CLIN VACCINE IMMUNOL, V18, P736, DOI 10.1128/CVI.00542-10; Koeberling O, 2009, CLIN VACCINE IMMUNOL, V16, P156, DOI 10.1128/CVI.00403-08; Kogan G, 1997, CARBOHYD RES, V298, P191, DOI 10.1016/S0008-6215(96)00305-9; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marshall HS, 2012, PEDIATR INFECT DIS J, V31, P1061, DOI 10.1097/INF.0b013e31826327e4; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Mothibeli KM, 2011, VACCINE, V29, P2187, DOI 10.1016/j.vaccine.2010.11.072; Mueller JE, 2006, EXPERT REV VACCINES, V5, P319, DOI 10.1586/14760584.5.3.319; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Nokleby H, 2007, VACCINE, V25, P3080, DOI 10.1016/j.vaccine.2007.01.022; Norheim G, 2006, J CLIN MICROBIOL, V44, P861, DOI 10.1128/JCM.44.3.861-871.2006; Norheim G, 2012, SCAND J IMMUNOL, V76, P99, DOI 10.1111/j.1365-3083.2012.02709.x; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Pace D, 2009, CURR OPIN MOL THER, V11, P692; Pajon R, 2012, INFECT IMMUN, V80, P2667, DOI 10.1128/IAI.00103-12; Pajon R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001302; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Perrett KP, 2009, PEDIATR INFECT DIS J, V28, P186, DOI 10.1097/INF.0b013e31818e037d; POOLMAN JT, 1995, CLIN DIAGN LAB IMMUN, V2, P69, DOI 10.1128/CDLI.2.1.69-72.1995; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Richmond PC, 2012, VACCINE, V30, P6163, DOI 10.1016/j.vaccine.2012.07.065; Richmond PC, 2012, LANCET INFECT DIS, V12, P597, DOI 10.1016/S1473-3099(12)70087-7; Scarselli M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002234; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; Smith H, 1995, MICROB PATHOGENESIS, V19, P365, DOI 10.1006/mpat.1995.0071; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Steeghs L, 2004, J ENDOTOXIN RES, V10, P113, DOI 10.1179/096805104225004059; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Tsang RSW, 2001, FEMS MICROBIOL LETT, V199, P203, DOI 10.1111/j.1574-6968.2001.tb10675.x; Vu DM, 2011, VACCINE, V29, P1968, DOI 10.1016/j.vaccine.2010.12.075; WANG JF, 1992, INFECT IMMUN, V60, P5267, DOI 10.1128/IAI.60.12.5267-5282.1992; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Welsch JA, 2008, VACCINE, V26, pI40, DOI 10.1016/j.vaccine.2008.11.060; Wetzler LM, 2010, FUTURE MICROBIOL, V5, P749, DOI 10.2217/FMB.10.41; Xie O, 2012, VACCINE, V30, P5812, DOI 10.1016/j.vaccine.2012.07.032; Zollinger WD, 2010, VACCINE, V28, P5057, DOI 10.1016/j.vaccine.2010.05.006; Zughaier S, 2007, VACCINE, V25, P4401, DOI 10.1016/j.vaccine.2007.03.029	94	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66536	10.1371/journal.pone.0066536	http://dx.doi.org/10.1371/journal.pone.0066536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805230	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500058
J	Trung, VN; Yamamoto, H; Furukawa, A; Yamaguchi, T; Murata, S; Yoshimura, M; Murakami, Y; Sato, S; Otani, H; Ugi, S; Morino, K; Maegawa, H; Tani, T				Vo Nguyen Trung; Yamamoto, Hiroshi; Furukawa, Akira; Yamaguchi, Tsuyoshi; Murata, Satoshi; Yoshimura, Masahiro; Murakami, Yoko; Sato, Shigetaka; Otani, Hideji; Ugi, Satoshi; Morino, Katsutaro; Maegawa, Hiroshi; Tani, Tohru			Enhanced Intestinal Motility during Oral Glucose Tolerance Test after Laparoscopic Sleeve Gastrectomy: Preliminary Results Using Cine Magnetic Resonance Imaging	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; SMALL-BOWEL MOTILITY; STATE FREE PRECESSION; BARIATRIC SURGERY; GASTRIC BYPASS; GASTROINTESTINAL MOTILITY; OBESE-PATIENTS; WEIGHT-LOSS; TIME; ENTEROCLYSIS	Background: Enhanced secretion of glucagon-like peptide-1 (GLP-1) has been suggested as a possible mechanism underlying the improvement in type 2 diabetes mellitus (T2DM) after laparoscopic sleeve gastrectomy (LSG). However, the reason for enhanced GLP-1 secretion during glucose challenge after LSG remains unclear because LSG does not include intestinal bypass. In this study, we focused on the effects of LSG on GLP-1 secretion and intestinal motility during the oral glucose tolerance test (OGTT) using cine magnetic resonance imaging (MRI) before and 3 months after LSG. Methods: LSG was performed in 12 obese patients with a body mass index >35 kg/m(2). Six patients had T2DM. OGTT was performed before and 3 months after the surgery. Body weight, hemoglobin A1c (HbA1c), and GLP-1 levels during OGTT were examined, and intestinal motility during OGTT was assessed using cine MRI. Results: Body weight was significantly decreased after surgery in all the cases. HbA1c was markedly decreased in all the diabetic subjects. In all cases, GLP-1 secretion during OGTT was enhanced and cine MRI showed markedly increased intestinal motility at 15 and 30 min during OGTT after LSG. Conclusions: LSG leads to accelerated intestinal motility and reduced intestinal transit time, which may be involved in the mechanism underlying enhanced GLP-1 secretion during OGTT after LSG.	[Vo Nguyen Trung; Yamamoto, Hiroshi; Yamaguchi, Tsuyoshi; Murata, Satoshi; Tani, Tohru] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 52021, Japan; [Furukawa, Akira; Yoshimura, Masahiro; Murakami, Yoko; Sato, Shigetaka; Otani, Hideji] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga 52021, Japan; [Ugi, Satoshi; Morino, Katsutaro; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 52021, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Yamamoto, H (corresponding author), Shiga Univ Med Sci, Dept Surg, Seta Tsukinowa Cho, Otsu, Shiga 52021, Japan.	yhiroshi@belle.shiga-med.ac.jp	MORINO, KATSUTARO/I-3207-2019	MORINO, KATSUTARO/0000-0003-2420-3817; Maegawa, Hiroshi/0000-0002-4611-8149	Grants-in-Aid for Scientific Research [25461839] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ailiani AC, 2009, MAGN RESON MED, V62, P116, DOI 10.1002/mrm.21982; Bernstine H, 2009, OBES SURG, V19, P293, DOI 10.1007/s11695-008-9791-5; Braghetto I, 2009, OBES SURG, V19, P1515, DOI 10.1007/s11695-009-9954-z; Chambers AP, 2013, GASTROENTEROLOGY, V144, P50, DOI 10.1053/j.gastro.2012.09.009; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Cremonini F, 2002, ALIMENT PHARM THER, V16, P1781, DOI 10.1046/j.1365-2036.2002.01344.x; de Zwart IM, 2002, RADIOLOGY, V224, P592, DOI 10.1148/radiol.2242011412; Dimitriadis E, 2013, ANN SURG, V257, P647, DOI 10.1097/SLA.0b013e31826e1846; EVANS DF, 1993, GUT, V34, P848, DOI 10.1136/gut.34.6.848; Fidler JL, 2009, RADIOGRAPHICS, V29, P1811, DOI 10.1148/rg.296095507; Froehlich JM, 2005, J MAGN RESON IMAGING, V21, P370, DOI 10.1002/jmri.20284; Froehlich JM, 2009, EUR RADIOL, V19, P1387, DOI 10.1007/s00330-008-1293-2; Furukawa A, 2004, RADIOGRAPHICS, V24, P689, DOI 10.1148/rg.243035120; Gao C, 2002, NEUROGASTROENT MOTIL, V14, P365, DOI 10.1046/j.1365-2982.2002.00341.x; Gumbs AA, 2005, OBES SURG, V15, P462, DOI 10.1381/0960892053723367; Hansen MB, 2003, PHYSIOL RES, V52, P1; Hansen MB, 2002, PHYSIOL RES, V51, P541; Hellstrom PM, 2010, VITAM HORM, V84, P319, DOI [10.1016/S0083-6729(10)84006-3, 10.1016/B978-0-12-381517-0.00012-6]; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Husebye E, 1999, NEUROGASTROENT MOTIL, V11, P141; Ichikawa Y, 2003, J CARDIOVASC MAGN R, V5, P333, DOI 10.1081/JCMR-120019422; Iida M, 2000, J GASTROEN HEPATOL, V15, P381, DOI 10.1046/j.1440-1746.2000.02076.x; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Kasama K, 2008, OBES SURG, V18, P1473, DOI 10.1007/s11695-008-9492-0; Kiely JM, 2005, J SURG RES, V124, P98, DOI 10.1016/j.jss.2004.10.005; Klinaki I, 2012, ANN SURG IN PRESS; Lauenstein TC, 2003, AM J ROENTGENOL, V180, P1305, DOI 10.2214/ajr.180.5.1801305; Lee WJ, 2011, ARCH SURG-CHICAGO, V146, P143, DOI 10.1001/archsurg.2010.326; Lee WJ, 2010, SURGERY, V147, P664, DOI 10.1016/j.surg.2009.10.059; MADSEN JL, 1991, SCAND J GASTROENTERO, V26, P1263, DOI 10.3109/00365529108998623; Mayer APT, 2002, INTENS CARE MED, V28, P336, DOI 10.1007/s00134-002-1224-7; Michalsky D, 2013, OBES SURG, V23, P567, DOI 10.1007/s11695-012-0850-6; Mingrone G, 2009, DIABETES METAB, V35, P518, DOI 10.1016/S1262-3636(09)73459-7; Nishino M, 2005, EUR J RADIOL, V53, P263, DOI 10.1016/j.ejrad.2004.04.002; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Peterli R, 2009, ANN SURG, V250, P234, DOI 10.1097/SLA.0b013e3181ae32e3; Pilichiewicz AN, 2007, AM J PHYSIOL-ENDOC M, V293, pE743, DOI 10.1152/ajpendo.00159.2007; Rocca AS, 1999, ENDOCRINOLOGY, V140, P1687, DOI 10.1210/en.140.4.1687; Rubino F, 2013, OBESITY SIL IN PRESS; Salehi M, 2008, J CLIN ENDOCR METAB, V93, P4909, DOI 10.1210/jc.2008-0605; Sandoval DA, 2013, DIABETES IN PRESS; Savoye-Collet C, 2002, AM J ROENTGENOL, V179, P435, DOI 10.2214/ajr.179.2.1790435; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schnoor J, 2003, LAB ANIM-UK, V37, P145, DOI 10.1258/00236770360563796; Shah S, 2010, SURG OBES RELAT DIS, V6, P152, DOI 10.1016/j.soard.2009.11.019; Shen SH, 2007, J MAGN RESON IMAGING, V26, P672, DOI 10.1002/jmri.21054; Simren M, 2000, DIGEST DIS SCI, V45, P2151, DOI 10.1023/A:1010770302403; Slavin GS, 2002, MAGN RESON MED, V48, P934, DOI 10.1002/mrm.10321; Stefater MA, 2010, GASTROENTEROLOGY, V138, P2426, DOI 10.1053/j.gastro.2010.02.059; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; THOENI RF, 1991, RADIOLOGY, V178, P659, DOI 10.1148/radiology.178.3.1994398; Wakamiya M, 2011, J MAGN RESON IMAGING, V33, P1235, DOI 10.1002/jmri.22529; Wiarda BM, 2006, AM J ROENTGENOL, V187, P522, DOI 10.2214/AJR.05.0511; Yehoshua RT, 2008, OBES SURG, V18, P1083, DOI 10.1007/s11695-008-9576-x	54	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65739	10.1371/journal.pone.0065739	http://dx.doi.org/10.1371/journal.pone.0065739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823622	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400020
J	Bao, W; Jin, L; Fu, HJ; Shen, YN; Lu, GX; Mei, H; Cao, XZ; Wang, HS; Liu, WD				Bao, Wei; Jin, Lei; Fu, Hai-jing; Shen, Yong-nian; Lu, Gui-xia; Mei, Huan; Cao, Xin-zhi; Wang, Hong-sheng; Liu, Wei-da			Interleukin-22 Mediates Early Host Defense against Rhizomucor pusilluscan Pathogens	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; CANDIDA-ALBICANS; IMMUNITY; CELLS; DIFFERENTIATION; IL-22; CYTOKINE; MICE; TH17	Background: In recent years, the fungal infectious disease zygomycosis has increased in incidence worldwide, especially among the immunodeficient population. Despite the rates of zygomycosis-related death and deformation being very high, the mechanism(s) by which the fungal pathogens cause these severe manifestations remain unknown. Methods: Using the associated Rhizomucor variabilis species, which can selectively induce cutaneous zygomycosis in otherwise healthy individuals, we investigated the host mechanisms of infection-related responses, including cytokine and chemokine expression as well as contributions of particular T cell subsets. siRNA specifically targeting IL-22, IL-17 and IFN-gamma were used to down-regulate expression of those molecules. Results: In mouse models of infection, IL-22 was implicated in development of Rhizomucor spp.-induced skin lesions. In cultured human peripheral blood monocytes, R. pusilluscan, which is often found in immunodeficient patients, induced the production of IL-22, while R. variabilis did not. Moreover, Rhizomucor spp.-induced secretion of Il-22 from CCR6(+)CCR4(+)CCR10(+) cells was down-regulated by knockdown of IL-22 related signaling receptors, RORC and ARH. Conclusion: Our data strongly suggest that avoidance of IL-22 may be one mechanism by which mucor species produce morbidity and mortality in infected individuals.	[Bao, Wei; Shen, Yong-nian; Lu, Gui-xia; Mei, Huan; Wang, Hong-sheng; Liu, Wei-da] Chinese Acad Med Sci, Inst Dermatol, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Dept Mycol, Nanjing, Jiangsu, Peoples R China; [Bao, Wei; Shen, Yong-nian; Lu, Gui-xia; Mei, Huan; Wang, Hong-sheng; Liu, Wei-da] Peking Union Med Coll, Nanjing, Jiangsu, Peoples R China; [Jin, Lei] Nanjing Univ, Jinling Hosp, Dept Stomatol, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Bao, Wei] Nanjing Univ, Jinling Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Fu, Hai-jing] Nanjing Univ, Jinling Hosp, Sch Med, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Bao, Wei] Bayi Hosp, Nanjing, Jiangsu, Peoples R China; [Cao, Xin-zhi] Nanjing Univ, Jinling Hosp, Sch Clin, Dept Med Imaging,Med Coll, Nanjing 210008, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing University; Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Liu, WD (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Jiangsu Key Lab Mol Biol Skin Dis & STIs, Dept Mycol, Nanjing, Jiangsu, Peoples R China.	liumyco@hotmail.com			Ministry of Science and Technology of Major Projects [2008ZX1004-002]; Clinical Subjects' Key Project of the Ministry of Health [125]; National Natural Sciences Foundation of China [81000717]; China Postdoctoral Science Special Foundation [201104072]; China Postdoctoral Science Foundation [20100480233]; Natural Sciences Foundation of Jiangsu [BK2010134]	Ministry of Science and Technology of Major Projects; Clinical Subjects' Key Project of the Ministry of Health; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Sciences Foundation of Jiangsu	This work was supported by grants from the Ministry of Science and Technology of Major Projects (No. 2008ZX1004-002), the 2010-2012 Clinical Subjects' Key Project of the Ministry of Health (No. 125), the National Natural Sciences Foundation of China (No. 81000717), the China Postdoctoral Science Special Foundation (No. 201104072), the China Postdoctoral Science Foundation (No. 20100480233), and the Natural Sciences Foundation of Jiangsu (No. BK2010134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavani A, 2012, CHEM IMMUNOL ALLERGY, V96, P39, DOI 10.1159/000331870; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Enoch DA, 2011, INT J ANTIMICROB AG, V38, P465, DOI 10.1016/j.ijantimicag.2011.05.010; Eyerich S, 2011, EUR J IMMUNOL, V41, P1894, DOI 10.1002/eji.201041197; Gessner MA, 2012, INFECT IMMUN, V80, P410, DOI 10.1128/IAI.05939-11; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaushik R, 2012, SURG INFECT, V13, P125, DOI 10.1089/sur.2010.078; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kontoyiannis DP, 2012, AM J MED, V125, pS25, DOI 10.1016/j.amjmed.2011.10.009; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Liu Y, 2009, EUR J IMMUNOL, V39, P1472, DOI 10.1002/eji.200838811; Lu XL, 2009, CLIN INFECT DIS, V49, pE39, DOI 10.1086/600817; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McAleer JP, 2011, J LEUKOCYTE BIOL, V90, P263, DOI 10.1189/jlb.0211099; Muhl H, 2011, CELL MICROBIOL, V13, P340, DOI 10.1111/j.1462-5822.2010.01559.x; Page AV, 2008, TRANSPL INFECT DIS, V10, P419, DOI 10.1111/j.1399-3062.2008.00324.x; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Xiong N, 2012, PROTEIN CELL, V3, P571, DOI 10.1007/s13238-012-2927-3; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	30	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65065	10.1371/journal.pone.0065065	http://dx.doi.org/10.1371/journal.pone.0065065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23798999	Green Submitted, Green Published, gold			2022-12-27	WOS:000321397800002
J	Boudarham, J; Roche, N; Pradon, D; Bonnyaud, C; Bensmail, D; Zory, R				Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Bonnyaud, Celine; Bensmail, Djamel; Zory, Raphael			Variations in Kinematics during Clinical Gait Analysis in Stroke Patients	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; STIFF-LEGGED GAIT; OLDER-ADULTS; COMMUNITY AMBULATION; RECTUS FEMORIS; CAUTIOUS GAIT; FATIGUE; PEOPLE; INDIVIDUALS; FALLS	In addition to changes in spatio-temporal and kinematic parameters, patients with stroke exhibit fear of falling as well as fatigability during gait. These changes could compromise interpretation of data from gait analysis. The aim of this study was to determine if the gait of hemiplegic patients changes significantly over successive gait trials. Forty two stroke patients and twenty healthy subjects performed 9 gait trials during a gait analysis session. The mean and variability of spatio-temporal and kinematic joint parameters were analyzed during 3 groups of consecutive gait trials (1-3, 4-6 and 7-9). Principal component analysis was used to reduce the number of variables from the joint kinematic waveforms and to identify the parts of the gait cycle which changed during the gait analysis session. The results showed that i) spontaneous gait velocity and the other spatio-temporal parameters significantly increased, and ii) gait variability decreased, over the last 6 gait trials compared to the first 3, for hemiplegic patients but not healthy subjects. Principal component analysis revealed changes in the sagittal waveforms of the hip, knee and ankle for hemiplegic patients after the first 3 gait trials. These results suggest that at the beginning of the gait analysis session, stroke patients exhibited phase of adaptation, characterized by a "cautious gait'' but no fatigue was observed.	[Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Bonnyaud, Celine; Bensmail, Djamel; Zory, Raphael] CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Boudarham, J (corresponding author), CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France.	julien.boudarham@yahoo.fr	roche, nicolas/R-6080-2018; Bonnyaud, Celine/AGK-7246-2022; Bensmail, Djamel/R-6035-2018	Bensmail, Djamel/0000-0001-9360-9330				Balash Y, 2007, J NEURAL TRANSM, V114, P1309, DOI 10.1007/s00702-007-0771-z; Barak Y, 2006, PHYS THER, V86, P1501, DOI 10.2522/ptj.20050387; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; BOHANNON RW, 1987, ARCH PHYS MED REHAB, V68, P777; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Carin-Levy G, 2006, CEREBROVASC DIS, V21, P201, DOI 10.1159/000090792; Carriero A, 2009, GAIT POSTURE, V29, P71, DOI 10.1016/j.gaitpost.2008.06.011; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Duncan F, 2012, INT J STROKE, V7, P157, DOI 10.1111/j.1747-4949.2011.00741.x; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P1138, DOI 10.1053/apmr.2002.33644; Giladi N, 2005, J NEUROL, V252, P300, DOI 10.1007/s00415-005-0641-2; Goldberg SR, 2003, J BIOMECH, V36, P1111, DOI 10.1016/S0021-9290(03)00106-4; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Hausdorff J. M., 2005, J NEUROENG REHABIL, V2, P2; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hill Keith, 1997, Aust J Physiother, V43, P173; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hutin E, 2012, GAIT POSTURE, V36, P205, DOI 10.1016/j.gaitpost.2012.02.016; Hutin E, 2010, NEUROREHAB NEURAL RE, V24, P442, DOI 10.1177/1545968309354535; Hyngstrom AS, 2012, AM J PHYS MED REHAB, V91, P33, DOI 10.1097/PHM.0b013e31823caac0; Iosa M, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/810415; JACKSON JE, 1991, USERS GUIDE PRINCIPL; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; KERRIGAN DC, 1991, AM J PHYS MED REHAB, V70, P294; Kesar TM, 2011, GAIT POSTURE, V33, P314, DOI 10.1016/j.gaitpost.2010.11.024; Kirkwood RN, 2011, BRAZ J PHYS THER, V15, P52, DOI 10.1590/S1413-35552011000100007; Lam R, 2011, CAN FAM PHYSICIAN, V57, P765; Lerdal A, 2009, J PAIN SYMPTOM MANAG, V38, P928, DOI 10.1016/j.jpainsymman.2009.04.028; Lewis SJ, 2011, ARCH PHYS MED REHAB, V92, P295, DOI 10.1016/j.apmr.2010.10.030; Lord SE, 2005, STROKE, V36, P1457, DOI 10.1161/01.STR.0000170698.20376.2e; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Maynard V, 2003, GAIT POSTURE, V17, P59, DOI 10.1016/S0966-6362(02)00051-6; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Morris ME, 2002, J NEUROL NEUROSUR PS, V72, P361, DOI 10.1136/jnnp.72.3.361; Muniz AMS, 2009, GAIT POSTURE, V29, P31, DOI 10.1016/j.gaitpost.2008.05.015; Nagai K, 2012, AGING CLIN EXP RES, V24, P157, DOI 10.3275/7716; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Oken O, 2008, GAIT POSTURE, V27, P506, DOI 10.1016/j.gaitpost.2007.06.007; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Patla AE, 1999, J AGING PHYS ACTIV, V7, P7, DOI 10.1123/japa.7.1.7; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Perry J., 1992, GAIT ANAL NORMAL PAT; Reid SM, 2010, GAIT POSTURE, V31, P197, DOI 10.1016/j.gaitpost.2009.10.005; Robertson JVG, 2009, GAIT POSTURE, V29, P108, DOI 10.1016/j.gaitpost.2008.07.005; Schmid AA, 2011, AM J OCCUP THER, V65, P125, DOI 10.5014/ajot.2011.000737; Schwartz MH, 2004, GAIT POSTURE, V20, P196, DOI 10.1016/j.gaitpost.2003.09.011; Sehle A, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-59; Sibley KM, 2008, GAIT POSTURE, V27, P387, DOI 10.1016/j.gaitpost.2007.05.007; Sibley KM, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-27; Straudi S, 2009, EUR J PHYS REHAB MED, V45, P341; Sung DH, 2000, ARCH PHYS MED REHAB, V81, P910, DOI 10.1053/apmr.2000.5615; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; WINTER DA, 1974, J BIOMECH, V7, P157, DOI 10.1016/0021-9290(74)90056-6; Yavuzer G, 2008, GAIT POSTURE, V27, P31, DOI 10.1016/j.gaitpost.2006.12.016	59	85	92	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66421	10.1371/journal.pone.0066421	http://dx.doi.org/10.1371/journal.pone.0066421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799100	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800032
J	Gu, L; Bai, WL; Li, S; Zhang, YQ; Han, Y; Gu, Y; Meng, GL; Xie, LP; Wang, J; Xiao, YJ; Shan, LY; Zhou, SM; Wei, L; Ferro, A; Ji, Y				Gu, Lei; Bai, Wenli; Li, Sha; Zhang, Yuqing; Han, Yi; Gu, Yue; Meng, Guoliang; Xie, Liping; Wang, Jing; Xiao, Yujiao; Shan, Liyang; Zhou, Suming; Wei, Lei; Ferro, Albert; Ji, Yong			Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress	PLOS ONE			English	Article							NF-KAPPA-B; LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; APOE KNOCKOUT MICE; OXIDIZED-LDL; RECEPTOR LOX-1; UP-REGULATION; NUDE-MICE	Celastrol is a triterpenoid compound extracted from the Chinese herb Tripterygium wilfordii Hook F. Previous research has revealed its anti-oxidant, anti-inflammatory, anti-cancer and immunosuppressive properties. Here, we investigated whether celastrol inhibits oxidized low-density lipoprotein (oxLDL) induced oxidative stress in RAW 264.7 cells. In addition, the effect of celastrol on atherosclerosis in vivo was assessed in apolipoprotein E knockout (apoE(-/-)) mouse fed a high-fat/high-cholesterol diet (HFC). We found that celastrol significantly attenuated oxLDL-induced excessive expression of lectin-like oxidized low density lipoprotein receptor-1(LOX-1) and generation of reactive oxygen species (ROS) in cultured RAW264.7 macrophages. Celastrol also decreased I kappa B phosphorylation and degradation and reduced production of inducible nitric oxide synthase (iNOS), nitric oxide (NO) and proinflammatory cytokines such as tumor necrosis factor (TNF)-alpha and IL-6. Celastrol reduced atherosclerotic plaque size in apoE(-/-) mice. The expression of LOX-1 within the atherosclerotic lesions and generation of superoxide in mouse aorta were also significantly reduced by celastrol while the lipid profile was not improved. In conclusion, our results show that celastrol inhibits atherosclerotic plaque developing in apoE(-/-) mice via inhibiting LOX-1 and oxidative stress.	[Gu, Lei; Bai, Wenli; Li, Sha; Gu, Yue; Meng, Guoliang; Xie, Liping; Wang, Jing; Xiao, Yujiao; Shan, Liyang; Ji, Yong] Nanjing Med Univ, Atherosclerosis Res Ctr, State Key Lab Reprod Med, Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Zhang, Yuqing; Zhou, Suming] Nanjing Med Univ, Affiliated Jiangning Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Han, Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China; [Wei, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London WC2R 2LS, England	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University of London; King's College London	Ji, Y (corresponding author), Nanjing Med Univ, Atherosclerosis Res Ctr, State Key Lab Reprod Med, Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	yongji@njmu.edu.cn	Gu, Lei/GWQ-6785-2022	Ferro, Albert/0000-0002-5486-9145; Shan, Liyang/0000-0003-0431-4376	National Basic Research Program (973) [2011CB503903]; National Natural Science Foundation of China [81170083, 81200196]; Universities Natural Science Research Project of Jiangsu Province [10KJA310033]; PAPD	National Basic Research Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Universities Natural Science Research Project of Jiangsu Province; PAPD	This work was supported by grants from National Basic Research Program (973) (No. 2011CB503903), the National Natural Science Foundation of China (No. 81170083, 81200196), Universities Natural Science Research Project of Jiangsu Province (No. 10KJA310033) and PAPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2004, THORAX, V59, P483, DOI 10.1136/thx.2003.017640; Aoyama T, 2000, FEBS LETT, V467, P217, DOI 10.1016/S0014-5793(00)01154-6; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Buttery LDK, 1996, LAB INVEST, V75, P77; Cheng J, 2011, AFR J PHARM PHARMACO, V5, P1247, DOI 10.5897/AJPP11.458; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Dhar A, 2003, MOL CANCER THER, V2, P1285; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; Feng XY, 2010, ATHEROSCLEROSIS, V208, P396, DOI 10.1016/j.atherosclerosis.2009.07.035; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; GAMBLE W, 1978, J LIPID RES, V19, P1068; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Hashizume M, 2012, CYTOKINE, V58, P424, DOI 10.1016/j.cyto.2012.02.010; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hofnagel O, 2006, ARTERIOSCL THROM VAS, V26, P604, DOI 10.1161/01.ATV.0000201073.45862.8b; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Ishiyama J, 2010, ATHEROSCLEROSIS, V209, P118, DOI 10.1016/j.atherosclerosis.2009.09.004; Itabe H, 2003, BIOL PHARM BULL, V26, P1, DOI 10.1248/bpb.26.1; Jang SY, 2011, CANCER LETT, V300, P57, DOI 10.1016/j.canlet.2010.09.006; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Kim DH, 2009, EUR J CLIN INVEST, V39, P819, DOI 10.1111/j.1365-2362.2009.02186.x; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li DY, 2001, CARDIOVASC RES, V52, P130, DOI 10.1016/S0008-6363(01)00371-6; Li L, 2004, CIRC RES, V94, P892, DOI 10.1161/01.RES.0000124920.09738.26; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; SASSA H, 1990, BIOCHEM BIOPH RES CO, V172, P890, DOI 10.1016/0006-291X(90)90759-G; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schmitz G, 2007, ANTIOXID REDOX SIGN, V9, P1499, DOI 10.1089/ars.2007.1663; Scott J, 2007, NEW ENGL J MED, V357, P2195, DOI 10.1056/NEJMcibr075951; SIES H, 1989, NATURWISSENSCHAFTEN, V76, P57, DOI 10.1007/BF00396705; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Sukhanov S, 2006, CIRC RES, V99, P191, DOI 10.1161/01.RES.0000232319.02303.8c; Taye A, 2010, EUR J PHARMACOL, V627, P42, DOI 10.1016/j.ejphar.2009.10.045; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Wang Y, 2011, BIOCHEM BIOPH RES CO, V411, P543, DOI 10.1016/j.bbrc.2011.06.177; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; White SJ, 2011, CARDIOVASC PATHOL, V20, P369, DOI 10.1016/j.carpath.2010.08.007; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P871, DOI 10.1161/01.ATV.0000259358.31234.37; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yu XA, 2010, AM J HYPERTENS, V23, P895, DOI 10.1038/ajh.2010.75	55	70	74	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65477	10.1371/journal.pone.0065477	http://dx.doi.org/10.1371/journal.pone.0065477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799016	gold, Green Published, Green Submitted			2022-12-27	WOS:000321397800008
J	Heinrichs, D; Berres, ML; Nellen, A; Fischer, P; Scholten, D; Trautwein, C; Wasmuth, HE; Sahin, H				Heinrichs, Daniel; Berres, Marie-Luise; Nellen, Andreas; Fischer, Petra; Scholten, David; Trautwein, Christian; Wasmuth, Hermann E.; Sahin, Hacer			The Chemokine CCL3 Promotes Experimental Liver Fibrosis in Mice	PLOS ONE			English	Article							T-CELLS; LYMPHOCYTES; CHEMOTAXIS; EXPRESSION; PROTEIN-1; HEPATITIS; RECEPTOR; DISEASE; INJURY; GAMMA	Liver fibrosis is associated with infiltrating immune cells and activation of hepatic stellate cells. We here aimed to investigate the effects of the CC chemokine CCL3, also known as macrophage inflammatory protein-1a, in two different fibrosis models. To this end, we treated mice either with carbon tetrachloride or with a methionine-and choline-deficient diet to induce fibrosis in CCL3 deficient and wild-type mice. The results show that the protein expression of CCL3 is increased in wild-type mice after chronic liver injury. Deletion of CCL3 exhibited reduced liver fibrosis compared to their wild-type counterparts. We could validate these results by treating the two mouse groups with either carbon tetrachloride or by feeding a methionine-and choline-deficient diet. In these models, lack of CCL3 is functionally associated with reduced stellate cell activation and liver immune cell infiltration. In vitro, we show that CCL3 leads to increased proliferation and migration of hepatic stellate cells. In conclusion, our results define the chemokine CCL3 as a mediator of experimental liver fibrosis. Thus, therapeutic modulation of CCL3 might be a promising target for chronic liver diseases.	[Heinrichs, Daniel; Berres, Marie-Luise; Nellen, Andreas; Fischer, Petra; Scholten, David; Trautwein, Christian; Wasmuth, Hermann E.; Sahin, Hacer] Univ Hosp Aachen, Dept Med 3, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Sahin, H (corresponding author), Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	hasahin@ukaachen.de	Berres, Marie-Luise/AAN-5351-2021		Deutsche Forschungsgemeinschaft [WA2557/2-1, SFB/TRR 57]; Else Kroner-Fresenius Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (WA2557/2-1 and SFB/TRR 57) and the Else Kroner-Fresenius Stiftung to H.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2004, EUR J PHARMACOL, V497, P343, DOI 10.1016/j.ejphar.2004.07.005; Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berkman N, 1995, J IMMUNOL; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bonecchi R, 1999, J IMMUNOL, V162, P474; Colobran R, 2010, CLIN EXP IMMUNOL, V162, P41, DOI 10.1111/j.1365-2249.2010.04224.x; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Holt AP, 2008, CLIN LIVER DIS, V12, P861, DOI 10.1016/j.cld.2008.07.002; Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020; Ishikawa S, 2011, J HEPATOL, V54, P1195, DOI 10.1016/j.jhep.2010.08.022; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Marra F, 2009, SEMIN IMMUNOPATHOL, V31, P345, DOI 10.1007/s00281-009-0169-0; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Nellen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036614; Park O, 2009, HEPATOLOGY, V49, P1683, DOI 10.1002/hep.22813; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; Roth SJ, 1995, EUR J IMMUNOL, V25, P3482, DOI 10.1002/eji.1830251241; Sahin H, 2012, BIOCH BIOPHYS ACTA; Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Stock MK, 2013, INT J CLIN EXP PATHO, V6, P678; Takahashi H, 2002, J LEUKOCYTE BIOL, V72, P1190; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Vicente CP, 1998, MOL CELL BIOCHEM, V187, P11, DOI 10.1023/A:1006886308490; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Yang XB, 2011, AM J RESP CELL MOL, V45, P127, DOI 10.1165/rcmb.2010-0265OC	29	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66106	10.1371/journal.pone.0066106	http://dx.doi.org/10.1371/journal.pone.0066106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799074	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800023
J	Gao, C; Lan, X; Zhang, XG; Deng, Y				Gao, Cai; Lan, Xin; Zhang, Xiaoge; Deng, Yong			A Bio-Inspired Methodology of Identifying Influential Nodes in Complex Networks	PLOS ONE			English	Article							CENTRALITY; MODEL	How to identify influential nodes is a key issue in complex networks. The degree centrality is simple, but is incapable to reflect the global characteristics of networks. Betweenness centrality and closeness centrality do not consider the location of nodes in the networks, and semi-local centrality, leaderRank and pageRank approaches can be only applied in unweighted networks. In this paper, a bio-inspired centrality measure model is proposed, which combines the Physarum centrality with the K-shell index obtained by K-shell decomposition analysis, to identify influential nodes in weighted networks. Then, we use the Susceptible-Infected (SI) model to evaluate the performance. Examples and applications are given to demonstrate the adaptivity and efficiency of the proposed method. In addition, the results are compared with existing methods.	[Gao, Cai; Lan, Xin; Zhang, Xiaoge; Deng, Yong] Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China; [Deng, Yong] Vanderbilt Univ, Sch Engn, Nashville, TN 37235 USA	Southwest University - China; Vanderbilt University	Deng, Y (corresponding author), Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China.	ydeng@swu.edu.cn	Deng, Yong/A-9193-2015; Zhang, Xiaoge/D-8969-2013	Zhang, Xiaoge/0000-0001-6831-3175; Deng, Yong/0000-0001-9286-2123				Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2012, J INFORM COMPUTATION; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy M, 2004, EUR PHYS J B, V38, P163, DOI 10.1140/epjb/e2004-00111-4; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Cheng Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022123; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Gao Y, 2013, PHYSICA A, DOI [10.1016/j.bbr.2011.03.031, DOI 10.1016/J.BBR.2011.03.031]; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Jiang LL, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/40001; Jordan F, 2007, ECOL MODEL, V205, P270, DOI 10.1016/j.ecolmodel.2007.02.032; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kolaczyk ED, 2009, SOC NETWORKS, V31, P190, DOI 10.1016/j.socnet.2009.02.003; Liu WP, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/58007; Lu LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01082; Lu LY, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066119; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Masuda N, 2013, PLOS ONE, V8; Miorandi Daniele, 2010, 2010 8th International Symposium on Modeling and Optimization in Mobile, Ad Hoc and Wireless Networks (WiOpt), P488; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Page Lawrence, 1999, 199966 STANF INFOLAB; Pathak PH, 2012, COMPUT COMMUN, V35, P1074, DOI 10.1016/j.comcom.2012.01.023; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Szolnoki A, 2013, J THEORETICAL BIOL; Szolnoki A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042805; Tero A, 2006, PHYSICA A, V363, P115, DOI 10.1016/j.physa.2006.01.053; Tero A, 2008, THEOR BIOSCI, V127, P89, DOI 10.1007/s12064-008-0037-9; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; Wang FH, 2011, J TRANSP GEOGR, V19, P285, DOI 10.1016/j.jtrangeo.2010.01.004; Wei DJ, 2013, PHYSICA A, V392, P2564, DOI 10.1016/j.physa.2013.01.054; Yan G, 2005, CHINESE PHYS LETT, V22, P510, DOI 10.1088/0256-307X/22/2/068; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang H, 2011, J BIOMED INFORM, V44, P830, DOI 10.1016/j.jbi.2011.05.001; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zhang XG, 2013, INT J PROD RES, V51, P5100, DOI 10.1080/00207543.2013.793425; Zhang XG, 2013, APPL MATH COMPUT, V219, P9959, DOI 10.1016/j.amc.2013.04.023; Zhang YJ, 2013, APPL SOFT COMPUT, V13, P2356, DOI 10.1016/j.asoc.2012.12.035; Zhou T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.056109; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zio E, 2011, RISK ANAL, V31, P1196, DOI 10.1111/j.1539-6924.2011.01584.x	56	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66732	10.1371/journal.pone.0066732	http://dx.doi.org/10.1371/journal.pone.0066732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799129	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300094
J	Li, J; Yang, LJ; Qin, WJ; Zhang, G; Yuan, JL; Wang, FL				Li, Jun; Yang, Lijun; Qin, Weijun; Zhang, Geng; Yuan, Jianlin; Wang, Fuli			Adaptive Induction of Growth Differentiation Factor 15 Attenuates Endothelial Cell Apoptosis in Response to High Glucose Stimulus	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; BETA SUPERFAMILY MEMBER; JUN NH2-TERMINAL KINASE; NF-KAPPA-B; CANCER CELLS; GENE-EXPRESSION; REACTIVE OXYGEN; P53; PROLIFERATION; DYSFUNCTION	Growth differentiation factor 15 (GDF15), a direct target gene of p53, is a multifunctional member of the TGF-beta/BMP superfamily. GDF15 can be induced and is implicated as a key secretory cytokine in response to multiple cellular stimuli. Accumulating evidence indicates that GDF15 is associated with the development and prognosis of diabetes mellitus, while whether GDF15 can be induced by high glucose is unknown. In the present study, we revealed that high glucose could induce GDF15 expression and secretion in cultured human umbilical vein endothelial cells in a ROS-and p53-dependent manner. Inhibition of high glucose-induced GDF15 expression by siRNA demonstrated that adaptively induced GDF15 played a protective role against high glucose-induced human umbilical vein endothelial cell apoptosis via maintaining the active state of PI3K/Akt/eNOS pathway and attenuating NF-kappa B/JNK pathway activation. The protective effects of GDF15 were probably achieved by inhibiting ROS overproduction in high glucose-treated human umbilical vein endothelial cells in a negative feedback manner. Our results suggest that high glucose can promote GDF15 expression and secretion in human umbilical vein endothelial cells, which in turn attenuates high glucose-induced endothelial cell apoptosis.	[Li, Jun] Fourth Mil Med Univ, Dept Burns & Cutaneous Surg, Xijing Hosp, Xian 710032, Peoples R China; [Yang, Lijun; Qin, Weijun; Zhang, Geng; Yuan, Jianlin; Wang, Fuli] Fourth Mil Med Univ, Dept Urol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Wang, FL (corresponding author), Fourth Mil Med Univ, Dept Urol, Xijing Hosp, Xian 710032, Peoples R China.	wangfuli98@gmail.com		Li, Jun/0000-0001-8702-8054	National Natural Science Foundation of China [81072116, 30872583]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by two grants from the National Natural Science Foundation of China: #81072116 (http://159.226.244.22/portal/Proj_List. asp); #30872583 (http://159.226.244.22/portal/Proj_List.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2010, OXID MED CELL LONGEV, V3, P361, DOI 10.4161/oxim.3.6.14415; Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610; Appierto V, 2009, CARCINOGENESIS, V30, P824, DOI 10.1093/carcin/bgp067; Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Chao CL, 2009, BRIT J NUTR, V101, P1165, DOI 10.1017/S0007114508073637; Dostalova I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417; Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9; Funk SD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/569654; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Ho FM, 2006, CELL SIGNAL, V18, P391, DOI 10.1016/j.cellsig.2005.05.009; Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Kelly JA, 2009, CANCER LETT, V277, P38, DOI 10.1016/j.canlet.2008.11.013; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kim JS, 2005, MOL CANCER THER, V4, P487; Kim KK, 2008, CARCINOGENESIS, V29, P704, DOI 10.1093/carcin/bgn031; Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Li HS, 2005, J CLIN ENDOCR METAB, V90, P3045, DOI 10.1210/jc.2004-0808; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu T, 2003, CANCER RES, V63, P5034; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Mraz M, 2011, J CLIN ENDOCR METAB, V96, pE606, DOI 10.1210/jc.2010-1858; Nickel N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-62; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Pang RP, 2007, CANCER LETT, V251, P268, DOI 10.1016/j.canlet.2006.11.032; Paralkar VM, 1998, J BIOL CHEM, V273, P13760, DOI 10.1074/jbc.273.22.13760; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; Wadham C, 2007, DIABETES, V56, P2715, DOI 10.2337/db06-1294; Wollert KC, 2007, BASIC RES CARDIOL, V102, P412, DOI 10.1007/s00395-007-0662-3; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; YokoyamaKobayashi M, 1997, J BIOCHEM-TOKYO, V122, P622; Zanetti M, 2008, J MOL MED-JMM, V86, P185, DOI 10.1007/s00109-007-0257-3; Zhang L, 2009, ORAL ONCOL, V45, P627, DOI 10.1016/j.oraloncology.2008.07.017	53	66	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65549	10.1371/journal.pone.0065549	http://dx.doi.org/10.1371/journal.pone.0065549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799024	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300023
J	Lipnicki, DM; Sachdev, PS; Crawford, J; Reppermund, S; Kochan, NA; Trollor, JN; Draper, B; Slavin, MJ; Kang, K; Lux, O; Mather, KA; Brodaty, H				Lipnicki, Darren M.; Sachdev, Perminder S.; Crawford, John; Reppermund, Simone; Kochan, Nicole A.; Trollor, Julian N.; Draper, Brian; Slavin, Melissa J.; Kang, Kristan; Lux, Ora; Mather, Karen A.; Brodaty, Henry			Risk Factors for Late-Life Cognitive Decline and Variation with Age and Sex in the Sydney Memory and Ageing Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; PHYSICAL-ACTIVITY; IMPAIRED OLFACTION; ALZHEIMERS-DISEASE; APOE GENOTYPE; DEMENTIA; PROGRESSION; PROFILES; IMPACT; IDENTIFICATION	Introduction: An aging population brings increasing burdens and costs to individuals and society arising from late-life cognitive decline, the causes of which are unclear. We aimed to identify factors predicting late-life cognitive decline. Methods: Participants were 889 community-dwelling 70-90-year-olds from the Sydney Memory and Ageing Study with comprehensive neuropsychological assessments at baseline and a 2-year follow-up and initially without dementia. Cognitive decline was considered as incident mild cognitive impairment (MCI) or dementia, as well as decreases in attention/processing speed, executive function, memory, and global cognition. Associations with baseline demographic, lifestyle, health and medical factors were determined. Results: All cognitive measures showed decline and 14% of participants developed incident MCI or dementia. Across all participants, risk factors for decline included older age and poorer smelling ability most prominently, but also more education, history of depression, being male, higher homocysteine, coronary artery disease, arthritis, low health status, and stroke. Protective factors included marriage, kidney disease, and antidepressant use. For some of these factors the association varied with age or differed between men and women. Additional risk and protective factors that were strictly age- and/or sex-dependent were also identified. We found salient population attributable risks (8.7-49.5%) for older age, being male or unmarried, poor smelling ability, coronary artery disease, arthritis, stroke, and high homocysteine. Discussion: Preventing or treating conditions typically associated with aging might reduce population-wide late-life cognitive decline. Interventions tailored to particular age and sex groups may offer further benefits.	[Lipnicki, Darren M.; Sachdev, Perminder S.; Crawford, John; Reppermund, Simone; Kochan, Nicole A.; Trollor, Julian N.; Draper, Brian; Slavin, Melissa J.; Kang, Kristan; Lux, Ora; Mather, Karen A.; Brodaty, Henry] Univ New S Wales, Fac Med, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW 2052, Australia; [Sachdev, Perminder S.; Kochan, Nicole A.; Mather, Karen A.] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia; [Sachdev, Perminder S.; Draper, Brian; Slavin, Melissa J.; Brodaty, Henry] Univ New S Wales, Fac Med, Sch Psychiat, Primary Dementia Collaborat Res Ctr, Sydney, NSW 2052, Australia; [Trollor, Julian N.] Univ New S Wales, Fac Med, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW 2052, Australia; [Draper, Brian; Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Sydney, NSW, Australia; [Lux, Ora] Prince Wales Hosp, South Eastern Area Lab Serv, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Sachdev, PS (corresponding author), Univ New S Wales, Fac Med, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW 2052, Australia.	p.sachdev@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Karen, Mather A/O-9795-2016	Sachdev, Perminder/0000-0002-9595-3220; Karen, Mather A/0000-0003-4143-8941; Kang, Kristan/0000-0002-2057-1033; Trollor, Julian/0000-0002-7685-2977	National Health & Medical Research Council of Australia Program Grant [ID 350833]; Capacity Building Grant [ID568940]; Eli Lilly; Pfizer; Janssen; Novartis; Sanofi; Medivation	National Health & Medical Research Council of Australia Program Grant; Capacity Building Grant; Eli Lilly(Eli Lilly); Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Sanofi; Medivation	National Health & Medical Research Council of Australia Program Grant (ID 350833) and Capacity Building Grant (ID568940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Perminder Sachdev has received payment for lectures by Eli Lilly and Pfizer. Henry Brodaty has received payment for lectures by Pfizer, Janssen, and Novartis, is on the Alzheimer's Advisory Boards of these companies and Lunbeck, consults for Wyeth, and has received institutional grants for an Alzheimer's drug trial from Sanofi and Medivation. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alley D, 2007, RES AGING, V29, P73, DOI 10.1177/0164027506294245; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Arntzen KA, 2011, EUR J NEUROL, V18, P737, DOI 10.1111/j.1468-1331.2010.03263.x; Artero S, 2008, J NEUROL NEUROSUR PS, V79, P979, DOI 10.1136/jnnp.2007.136903; Barnes BBE, 2011, CANCER EPIDEMIOL, V35, P345, DOI 10.1016/j.canep.2010.11.003; Batterham PJ, 2011, PSYCHOL AGING, V26, P339, DOI 10.1037/a0021845; Benton AL, 1996, BENTON TEST; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Bunce D, 2004, NEUROLOGY, V63, P816, DOI 10.1212/01.WNL.0000137041.86153.42; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; Dahl AK, 2013, INT J OBESITY, V37, P296, DOI 10.1038/ijo.2012.37; Dash SK, 2013, RECENT PATENTS ENDOC, V7, P155, DOI 10.2174/1872214811307020009; Dominguez RO, 2012, DIABETES RES CLIN PR, V98, P68, DOI 10.1016/j.diabres.2012.05.013; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Graves AB, 1999, NEUROLOGY, V53, P1480, DOI 10.1212/WNL.53.7.1480; Hasselbalch BJ, 2012, NEUROPSYCHOLOGY, V26, P642, DOI 10.1037/a0029301; Hendrie Hugh C, 2006, Alzheimers Dement, V2, P12, DOI 10.1016/j.jalz.2005.11.004; Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195; Kaplan E, 2001, BOSTON NAMING TEST; Kuljis RO, 2011, J ALZHEIMERS DIS, V25, P29, DOI 10.3233/JAD-2011-101392; Lim YY, 2012, NEUROLOGY, V79, P1645, DOI 10.1212/WNL.0b013e31826e9ae6; Middleton LE, 2011, ARCH INTERN MED, V171, P1251, DOI 10.1001/archinternmed.2011.277; Millan-Calenti JC, 2012, ARCH GERONTOL GERIAT, V54, P197, DOI 10.1016/j.archger.2011.02.010; Mitchell AJ, 2008, J NEUROL NEUROSUR PS, V79, P1386, DOI 10.1136/jnnp.2007.142679; Musicco M, 2009, J NEUROL, V256, P1288, DOI 10.1007/s00415-009-5116-4; Packard CJ, 2007, J AM GERIATR SOC, V55, P1777, DOI 10.1111/j.1532-5415.2007.01415.x; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Ratey JJ, 2011, REV NEUROSCIENCE, V22, P171, DOI 10.1515/RNS.2011.017; Royall DR, 2002, NEUROEPIDEMIOLOGY, V21, P68, DOI 10.1159/000048619; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Sachdev PS, 2012, AM J GERIAT PSYCHIAT, V20, P854, DOI 10.1097/JGP.0b013e31825461b0; Sachdev PS, 2012, J AM GERIATR SOC, V60, P24, DOI 10.1111/j.1532-5415.2011.03774.x; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strauss E, 2006, COMPENDIUM NEUROPSYC; Swan GE, 2002, NEUROEPIDEMIOLOGY, V21, P58, DOI 10.1159/000048618; Tyas SL, 2006, ANN EPIDEMIOL, V16, P477, DOI 10.1016/j.annepidem.2005.09.006; Waite LM, 2001, J NEUROL NEUROSUR PS, V71, P296, DOI 10.1136/jnnp.71.3.296; Wang HX, 2013, J GERONTOL A-BIOL, V68, P205, DOI 10.1093/gerona/gls153; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V26, P61, DOI 10.1159/000090250; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	51	76	78	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65841	10.1371/journal.pone.0065841	http://dx.doi.org/10.1371/journal.pone.0065841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163UV	23799051	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300045
J	Sivro, A; McKinnon, LR; Ji, HZ; Kimani, J; Jaoko, W; Plummer, FA; Su, RC; Ball, TB				Sivro, Aida; McKinnon, Lyle R.; Ji, Hezhao; Kimani, Joshua; Jaoko, Walter; Plummer, Francis A.; Su, Ruey-Chyi; Ball, T. Blake			Interferon Regulatory Factor 1 Polymorphisms Previously Associated with Reduced HIV Susceptibility Have No Effect on HIV Disease Progression	PLOS ONE			English	Article							RESISTANCE; INFECTION; IDENTIFICATION; NAIROBI	Introduction: Interferon regulatory factor 1 (IRF1) is induced by HIV early in the infection process and serves two functions: transactivation of the HIV-1 genome and thus replication, and eliciting antiviral innate immune responses. We previously described three IRF1 polymorphisms that correlate with reduced IRF1 expression and reduced HIV susceptibility. Objective: To determine whether IRF1 polymorphisms previously associated with reduced HIV susceptibility play a role in HIV pathogenesis and disease progression in HIV-infected ART-naive individuals. Methods: IRF1 genotyping for polymorphisms (619, MS and 6516) was performed by PCR in 847 HIV positive participants from a sex worker cohort in Nairobi, Kenya. Rates of CD4+ T cell decline and viral loads (VL) were analyzed using linear mixed models. Results: Three polymorphisms in the IRF1, located at 619, microsatellite region and 6516 of the gene, previously associated with decreased susceptibility to HIV infection show no effect on disease progression, either measured by HIV-1 RNA levels or the slopes of CD4 decline before treatment initiation. Conclusion: Whereas these three polymorphisms in the IRF1 gene protect against HIV-1 acquisition, they appear to exert no discernable effects once infection is established.	[Sivro, Aida; Kimani, Joshua; Plummer, Francis A.; Su, Ruey-Chyi; Ball, T. Blake] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [McKinnon, Lyle R.; Kimani, Joshua; Jaoko, Walter; Ball, T. Blake] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [McKinnon, Lyle R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ji, Hezhao; Plummer, Francis A.; Ball, T. Blake] Publ Hlth Agcy Canada, Natl Microbiol Labs, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Nairobi; University of Toronto; Public Health Agency of Canada	Ball, TB (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	tball@cc.umanitoba.ca	Jaoko, Walter/AAN-5048-2020	Sivro, Aida/0000-0001-9215-5285; Ji, Hezhao/0000-0002-5451-6294; McKinnon, Lyle/0000-0002-7157-0700; Jaoko, Walter/0000-0002-7134-6581	Canadian Institute of Health Research (CIHR) [103231]; CIHR; International Infectious Diseases and Global Health Training Program (IIDGHTP)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); International Infectious Diseases and Global Health Training Program (IIDGHTP)	This work was supported by the Canadian Institute of Health Research (CIHR - 103231). A. S. and L. R. M. are supported by CIHR Research Fellowships and the International Infectious Diseases and Global Health Training Program (IID&GHTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Haase, 2005, NAT REV IMMUNOL; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Burgener A, 2011, J PROTEOME; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Fowke K, 1996, LANCET; Harman A, 2011, HIV INFECT DENDRITIC; Harman AN, 2011, BLOOD, V118, P298, DOI 10.1182/blood-2010-07-297721; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Ji HZ, 2010, SCAND J INFECT DIS, V42, P389, DOI 10.3109/00365540903496536; Ji HZ, 2004, J HUM GENET, V49, P528, DOI 10.1007/s10038-004-0185-9; Kaul R, 2001, J CLIN INVEST, V107, P341, DOI 10.1172/JCI10714; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lipsitz SR, 2000, J ROY STAT SOC C-APP, V49, P287, DOI 10.1111/1467-9876.00192; MacDonald KS, 2000, J INFECT DIS, V181, P1581, DOI 10.1086/315472; Marsili G, 2004, ANN NY ACAD SCI, V1030, P636, DOI 10.1196/annals.1329.074; Marsili G, 2012, CYTOKINE GROWTH F R, V23, P255, DOI 10.1016/j.cytogfr.2012.06.001; McKinnon LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049797; McNeil AJ, 1997, STAT MED, V16, P2555, DOI 10.1002/(SICI)1097-0258(19971130)16:22&lt;2555::AID-SIM690&gt;3.0.CO;2-Y; Plummer FA, 1999, IMMUNOL LETT, V66, P27, DOI 10.1016/S0165-2478(98)00182-5; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sgarbanti M, 2002, J EXP MED, V195, P1359, DOI 10.1084/jem.20010753; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Su RC, 2011, BLOOD, V117, P2649, DOI 10.1182/blood-2010-10-312462; World Health Organization, 2010, ANTIRETROVIRAL THERA; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379	26	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66253	10.1371/journal.pone.0066253	http://dx.doi.org/10.1371/journal.pone.0066253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799084	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300069
J	Zheng, SS; Chen, XH; Yin, X; Zhang, BH				Zheng, Su-Su; Chen, Xiao-Hong; Yin, Xin; Zhang, Bo-Heng			Prognostic Significance of HIF-1 alpha Expression in Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RISK-FACTORS; HYPOXIA; RECURRENCE; RESECTION; IMPACT	Aim: Pilot studies have evaluated the correlation between hypoxia-inducible factor-1 alpha (HIF-1 alpha) overexpression and clinical outcome in hepatocellular carcinoma (HCC) patients. However, the results remain inconclusive. To comprehensively and quantitatively summarize the evidence on the suitability of HIF-1 alpha to predict the prognosis of patients with HCC, a meta-analysis was carried out. Methods: Systematic literature searches were applied to PubMed, Elsevier and Web of Science databases until Feb. 2013. Seven studies (953 patients) were included in this meta-analysis. Pooled measure was calculated from the available data to evaluate the association between tissue -based HIF-1 alpha level and overall survival (OS) and disease-free survival (DFS) in HCC patients. The relation between HIF-1 alpha expression and vascular invasion was also assessed. Data were synthesized with fixed or random effect model, hazard ration (HR) or odds ratio (OR) with its 95% confidence interval (CI) was used as the effect size estimate. Result: The combined data suggested that HIF-1 alpha overexpression in HCC correlated with poor OS [HR = 1.65 (95% (CI): 1.38, 1.97)] and DFS [HR = 2.14 (95% CI: 1.39, 3.29)]. And high HIF-1 alpha expression tended to be associated with vascular invasion [OR = 2.21 (95% CI: 1.06, 4.57)]. Conclusion: HIF-1 alpha overexpression indicates a poor prognosis for patients with HCC, it may also have predictive potential for HCC invasion and metastasis.	[Zheng, Su-Su; Chen, Xiao-Hong; Yin, Xin; Zhang, Bo-Heng] Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China; [Zheng, Su-Su; Chen, Xiao-Hong; Yin, Xin; Zhang, Bo-Heng] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Zhang, Bo-Heng] Fudan Univ, Ctr Evidence Based Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, BH (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200032, Peoples R China.	zhang.boheng@zs-hospital.sh.cn						Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Dai Chen-Xin, 2009, BMC Cancer, V9, P418, DOI 10.1186/1471-2407-9-418; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong Zhi-zhen, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P506, DOI 10.3760/cma.j.issn.1007-3418.2010.07.009; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; Filmus Jorge, 2004, Mol Diagn, V8, P207, DOI 10.2165/00066982-200408040-00002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Huang GW, 2005, WORLD J GASTROENTERO, V11, P1705; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kimura S, 2004, EUR J CANCER, V40, P1904, DOI 10.1016/j.ejca.2004.04.035; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Lu XG, 2006, CLIN COLORECTAL CANC, V5, P350, DOI 10.3816/CCC.2006.n.005; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mao C, 2012, MOL BIOL REP, V39, P1113, DOI 10.1007/s11033-011-0839-6; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Wada H, 2006, LIVER INT, V26, P414, DOI 10.1111/j.1478-3231.2006.01243.x; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Xiang ZL, 2012, MOL BIOL REP, V39, P2021, DOI 10.1007/s11033-011-0949-1; Xie HH, 2008, DIGEST DIS SCI, V53, P3225, DOI 10.1007/s10620-008-0296-9; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301	22	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65753	10.1371/journal.pone.0065753	http://dx.doi.org/10.1371/journal.pone.0065753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799043	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300038
J	Chen, P; Wang, C; Ma, XJ; Zhang, YZ; Liu, Q; Qiu, S; Liu, Q; Tian, J; Ni, JZ				Chen, Ping; Wang, Chao; Ma, Xiaojie; Zhang, Yizhe; Liu, Qing; Qiu, Shi; Liu, Qiong; Tian, Jing; Ni, Jiazuan			Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer's Disease	PLOS ONE			English	Article							METHIONINE SULFOXIDE REDUCTASE; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; CLUSTERIN/APOLIPOPROTEIN-J; IDENTIFIES VARIANTS; APOPTOSIS; PROTEIN; CLU; METABOLISM; SELENIUM	Selenoprotein R (SelR) plays an important role in maintaining intracellular redox balance by reducing the R-form of methionine sulfoxide to methionine. As SelR is highly expressed in brain and closely related to Alzheimer's disease (AD), its biological functions in human brain become a research focus. In this paper, the selenocysteine-coding TGA of SelR gene was mutated to cysteine-coding TGC and used to screen the human fetal brain cDNA library with a yeast two-hybrid system. Our results demonstrated that SelR interacts with clusterin (Clu), a chaperone protein. This protein interaction was further verified by fluorescence resonance energy transfer (FRET), coimmunoprecipitation (co-IP), and pull-down assays. The interacting domain of Clu was determined by co-IP to be a dynamic, molten globule structure spanning amino acids 315 to 381 with an amphipathic-helix. The interacting domain of SelR was investigated by gene manipulation, ligand replacement, protein over-expression, and enzyme activity measurement to be a tetrahedral complex consisting of a zinc ion binding with four Cys residues. Study on the mutual effect of SelR and Clu showed synergic property between the two proteins. Cell transfection with SelR gene increased the expression of Clu, while cell transfection with Clu promoted the enzyme activity of SelR. Co-overexpression of SelR and Clu in N2aSW cells, an AD model cell line, significantly decreased the level of intracellular reactive oxygen species. Furthermore, FRET and co-IP assays demonstrated that Clu interacted with beta-amyloid peptide, a pathological protein of AD, which suggested a potential effect of SelR and A beta with the aid of Clu. The interaction between SelR and Clu provides a novel avenue for further study on the mechanism of SelR in AD prevention.	[Wang, Chao; Ni, Jiazuan] Chinese Acad Sci, Changchun Inst Appl Chem, Changchun 130022, Peoples R China; [Chen, Ping; Ma, Xiaojie; Zhang, Yizhe; Liu, Qing; Qiu, Shi; Liu, Qiong; Tian, Jing; Ni, Jiazuan] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China; [Wang, Chao] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Ping] Shenzhen Univ, Coll Optoelect Engn, Shenzhen, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Shenzhen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shenzhen University	Liu, Q (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China.	liuqiong@szu.edu.cn; jzni@szu.edu.cn	Liu, Qiong/AAK-1556-2021		National Natural Science Foundation of China [31070731, 21271131]; Natural Science Foundation of Guangdong Province [10151806001000023]; Grants of Shenzhen Municipal Science and Technology Industry and Information Technology Commission Research [CXB201005240008A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Grants of Shenzhen Municipal Science and Technology Industry and Information Technology Commission Research	This work was financially supported by the National Natural Science Foundation of China (No. 31070731 and 21271131), the Natural Science Foundation of Guangdong Province (No. 10151806001000023), and the Grants of Shenzhen Municipal Science and Technology Industry and Information Technology Commission Research (No. CXB201005240008A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachmann FL, 2010, J BIOL CHEM, V285, P33315, DOI 10.1074/jbc.M110.132308; Atkins JF, 2000, NATURE, V407, P463, DOI 10.1038/35035189; Bailey RW, 2001, BIOCHEMISTRY-US, V40, P11828, DOI 10.1021/bi010135x; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655; Chen P, 2013, INT J MOL SCI, V14, P4385, DOI 10.3390/ijms14034385; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Dobrovolska O, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/586539; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hatfield D.L., 2011, SELENIUM ITS MOL BIO; Huang K., 2009, SELENIUM ITS CHEM BI; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Keskanokwong T, 2011, EUR HEART J, V32, P305, DOI 10.1093/eurheartj/ehq469; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; Kim N, 2012, J CELL PHYSIOL, V227, P1157, DOI 10.1002/jcp.22836; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liu L, 2009, NANO LETT, V9, P4066, DOI 10.1021/nl902256b; Loef M, 2011, J ALZHEIMERS DIS, V26, P81, DOI 10.3233/JAD-2011-110414; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Marchetti MA, 2005, INVEST OPHTH VIS SCI, V46, P2007; MINETTI G, 1994, ITAL J BIOCHEM, V43, P273; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sagher D, 2006, J BIOL CHEM, V281, P31184, DOI 10.1074/jbc.M606962200; Sala A, 2009, ADV CANCER RES, V105, P115, DOI 10.1016/S0065-230X(09)05007-6; Shen LM, 2009, CHEM-BIOL INTERACT, V181, P455, DOI 10.1016/j.cbi.2009.07.013; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tian J, 2010, ANAL BIOCHEM, V406, P83, DOI 10.1016/j.ab.2010.06.018; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Vandepoele K, 2010, EXP CELL RES, V316, P1225, DOI 10.1016/j.yexcr.2010.01.019; Xu F, 2008, BBA-MOL BASIS DIS, V1782, P615, DOI 10.1016/j.bbadis.2008.08.004; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zhang YZ, 2011, J SHENZHEN U SCI ENG, V28, P400	43	16	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66384	10.1371/journal.pone.0066384	http://dx.doi.org/10.1371/journal.pone.0066384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805218	gold, Green Submitted, Green Published			2022-12-27	WOS:000320846500046
J	Gulati, S; Smith, DF; Cummings, RD; Couch, RB; Griesemer, SB; George, KS; Webster, RG; Air, GM				Gulati, Shelly; Smith, David F.; Cummings, Richard D.; Couch, Robert B.; Griesemer, Sara B.; George, Kirsten St.; Webster, Robert G.; Air, Gillian M.			Human H3N2 Influenza Viruses Isolated from 1968 To 2012 Show Varying Preference for Receptor Substructures with No Apparent Consequences for Disease or Spread	PLOS ONE			English	Article							AMINO-ACID CHANGE; BINDING SPECIFICITY; SIALIC-ACID; HEMAGGLUTININ; CELLS; OLIGOSACCHARIDES; NEURAMINIDASE; AGGLUTINATION; RECOGNITION; SEQUENCES	It is generally accepted that human influenza viruses bind glycans containing sialic acid linked alpha 2-6 to the next sugar, that avian influenza viruses bind glycans containing the alpha 2-3 linkage, and that mutations that change the binding specificity might change the host tropism. We noted that human H3N2 viruses showed dramatic differences in their binding specificity, and so we embarked on a study of representative human H3N2 influenza viruses, isolated from 1968 to 2012, that had been isolated and minimally passaged only in mammalian cells, never in eggs. The 45 viruses were grown in MDCK cells, purified, fluorescently labeled and screened on the Consortium for Functional Glycomics Glycan Array. Viruses isolated in the same season have similar binding specificity profiles but the profiles show marked year-to-year variation. None of the 610 glycans on the array (166 sialylated glycans) bound to all viruses; the closest was Neu5Ac alpha 2-6(Gal beta 1-4GlcNAc)(3) in either a linear or biantennary form, that bound 42 of the 45 viruses. The earliest human H3N2 viruses preferentially bound short, branched sialylated glycans while recent viruses bind better to long polylactosamine chains terminating in sialic acid. Viruses isolated in 1996, 2006, 2010 and 2012 bind glycans with alpha 2-3 linked sialic acid; for 2006, 2010 and 2012 viruses this binding was inhibited by oseltamivir, indicating binding of alpha 2-3 sialylated glycans by neuraminidase. More significantly, oseltamivir inhibited virus entry of 2010 and 2012 viruses into MDCK cells. All of these viruses were representative of epidemic strains that spread around the world, so all could infect and transmit between humans with high efficiency. We conclude that the year-to-year variation in receptor binding specificity is a consequence of amino acid sequence changes driven by antigenic drift, and that viruses with quite different binding specificity and avidity are equally fit to infect and transmit in the human population.	[Gulati, Shelly; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Smith, David F.; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Couch, Robert B.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Griesemer, Sara B.; George, Kirsten St.] Wadsworth Ctr, New York State Dept Hlth, Albany, NY USA; [Webster, Robert G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Emory University; Baylor College of Medicine; State University of New York (SUNY) System; Wadsworth Center; St Jude Children's Research Hospital	Air, GM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	gillian-air@ouhsc.edu		Air, Gillian/0000-0001-5724-3108	NIH through a bridge grant from the Consortium for Functional Glycomics [GM62116]; American Lebanese Syrian Associated Charities;  [GM098791];  [AI18203];  [HHSN272200900007C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM098791] Funding Source: NIH RePORTER	NIH through a bridge grant from the Consortium for Functional Glycomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH through a bridge grant from the Consortium for Functional Glycomics (GM62116, P.I. James Paulson), GM098791 (RDC), AI18203 (GMA), HHSN272200900007C (RGW) and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich U, 2011, FEBS J, V278, P1699, DOI 10.1111/j.1742-4658.2011.08096.x; Amonsen M, 2007, J VIROL, V81, P8341, DOI 10.1128/JVI.00718-07; Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Asaoka N, 2006, MICROBES INFECT, V8, P511, DOI 10.1016/j.micinf.2005.08.006; Cholleti SR, 2012, OMICS, V16, P497, DOI 10.1089/omi.2012.0013; Fazekas de St Groth S, 1977, INFL HEM S BAD NEAR; Ghate AA, 1998, EUR J BIOCHEM, V258, P320, DOI 10.1046/j.1432-1327.1998.2580320.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulati S, DIS MARKERS IN PRESS; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Heimburg-Molinaro J, 2012, METHODS MOL BIOL, V808, P251, DOI 10.1007/978-1-61779-373-8_18; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; KATZ JM, 1990, J VIROL, V64, P1808, DOI 10.1128/JVI.64.4.1808-1811.1990; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040422; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; LAVER WG, 1981, J MOL BIOL, V145, P339, DOI 10.1016/0022-2836(81)90209-6; LAVER WG, 1981, VIROLOGY, V111, P538, DOI 10.1016/0042-6822(81)90355-X; LEE EU, 1989, J BIOL CHEM, V264, P13848; Li D, 2009, J CLIN MICROBIOL, V47, P466, DOI 10.1128/JCM.00892-08; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Meisen I, 2012, GLYCOBIOLOGY, V22, P1055, DOI 10.1093/glycob/cws077; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Nobusawa E, 2012, MICROBIOL IMMUNOL, V56, P99, DOI 10.1111/j.1348-0421.2012.00412.x; Nycholat CM, 2012, ANGEW CHEM INT EDIT, V51, P4860, DOI 10.1002/anie.201200596; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Popova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041895; PRIETO PA, 1985, ARCH BIOCHEM BIOPHYS, V241, P281, DOI 10.1016/0003-9861(85)90384-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Sato K, 2004, EPIDEMIOL INFECT, V132, P399, DOI 10.1017/S0950268803001821; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Tappert MM, 2011, J VIROL, V85, P12146, DOI 10.1128/JVI.05537-11; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; Zhu XY, 2012, J VIROL, V86, P13371, DOI 10.1128/JVI.01426-12	43	76	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66325	10.1371/journal.pone.0066325	http://dx.doi.org/10.1371/journal.pone.0066325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805213	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500041
J	He, XL; Ding, CQ; Han, JL				He, Xue-Lian; Ding, Chang-Qing; Han, Jian-Lin			Lack of Structural Variation but Extensive Length Polymorphisms and Heteroplasmic Length Variations in the Mitochondrial DNA Control Region of Highly Inbred Crested Ibis, Nipponia nippon	PLOS ONE			English	Article							MTDNA CONTROL REGION; MICROSATELLITE LOCI; STURGEON ACIPENSER; SEQUENCE VARIATION; RAPID SEGREGATION; GENETIC DIVERSITY; MUTATION-RATES; TANDEM REPEATS; SIZE VARIATION; TRANSMISSION	The animal mitochondrial DNA (mtDNA) length polymorphism and heteroplasmy are accepted to be universal. Here we report the lack of structural variation but the presence of length polymorphism as well as heteroplasmy in mtDNA control region of an endangered avian species - the Crested Ibis (Nipponia nippon). The complete control region was directly sequenced while the distribution pattern and inheritance of the length variations were examined using both direct sequencing and genotyping of the PCR fragments from captive birds with pedigrees, wild birds and a historical specimen. Our results demonstrated that there was no structural variation in the control region, however, different numbers of short tandem repeats with an identical motif of CA(3)CA(2)CA(3) at the 3'-end of the control region determined the length polymorphisms among and heteroplasmy within individual birds. There were one to three predominant fragments in every bird; nevertheless multiple minor fragments coexist in all birds. These extremely high polymorphisms were suggested to have derived from the 'replication slippage' of a perfect microsatellite evolution following the step-wise mutational model. The patterns of heteroplasmy were found to be shifted between generations and among siblings but rather stable between blood and feather samples. This study provides the first evidence of a very extensive mtDNA length polymorphism and heteroplasmy in the highly inbred Crested Ibis which carries an mtDNA genome lack of structural genetic diversity. The analysis of pedigreed samples also sheds light on the transmission of mtDNA length heteroplasmy in birds following the genetic bottleneck theory. Further research focusing on the generation and transmission of particular mtDNA heteroplasmy patterns in single germ line of Crested Ibis is encouraged by this study.	[He, Xue-Lian; Ding, Chang-Qing] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [He, Xue-Lian; Han, Jian-Lin] CAAS, Inst Anim Sci, CAAS ILRI Joint Lab Livestock & Forage Genet Reso, Beijing, Peoples R China; [Han, Jian-Lin] ILRI, Nairobi, Kenya	Beijing Forestry University; CGIAR; International Livestock Research Institute (ILRI); Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; CGIAR; International Livestock Research Institute (ILRI)	Ding, CQ (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	cqding@bjfu.edu.cn; h.jianlin@cgiar.org		He, Xuelian/0000-0001-5968-1486	National Natural Science Foundation of China [30870314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (#30870314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald GW, 1978, P 1978 C COL WAT GRO, P1; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; AVISE JC, 1988, AUK, V105, P516, DOI 10.1093/auk/105.3.516; BALL RM, 1992, AUK, V109, P626; BERG T, 1995, CURR GENET, V27, P257, DOI 10.1007/BF00326158; Berger C, 2011, FORENSIC SCI INT-GEN, V5, P142, DOI 10.1016/j.fsigen.2010.10.002; Bergstrom CT, 1998, GENETICS, V149, P2135; BirdLife International, 2012, IUCN 2012 IUCN RED L; BOYCE TM, 1989, GENETICS, V123, P825; Brown JR, 1996, GENETICS, V142, P525; BROWN JR, 1992, GENETICS, V132, P221; BUROKER NE, 1990, GENETICS, V124, P157; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; Chen W, 2006, LETT BIOTECHNOLOGY, V17, P651; Cho HJ, 2009, GENES GENET SYST, V84, P297, DOI 10.1266/ggs.84.297; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Coskun PE, 2003, P NATL ACAD SCI USA, V100, P2174, DOI 10.1073/pnas.0630589100; Crochet PA, 2000, MOL BIOL EVOL, V17, P1797, DOI 10.1093/oxfordjournals.molbev.a026280; DENSMORE LD, 1985, GENETICS, V110, P689; Ding C., 2004, RES CRESTED IBIS; Ding Changqing, 2010, Chinese Birds, V1, P156; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Forster L, 2010, INT J LEGAL MED, V124, P133, DOI 10.1007/s00414-009-0385-0; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Genovart M, 2003, IBIS, V145, P448, DOI 10.1046/j.1474-919X.2003.00187.x; Gill F, 2013, IOC WORLD BIRD LIST; HALE LR, 1986, P NATL ACAD SCI USA, V83, P8813, DOI 10.1073/pnas.83.22.8813; Haring E, 2001, MOL BIOL EVOL, V18, P1892, DOI 10.1093/oxfordjournals.molbev.a003730; HARRISON RG, 1985, SCIENCE, V228, P1446, DOI 10.1126/science.228.4706.1446; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; He LP, 2006, CONSERV GENET, V7, P157, DOI 10.1007/s10592-005-6790-0; HOELZEL AR, 1993, J MOL EVOL, V37, P190, DOI 10.1007/BF02407355; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Ji YJ, 2004, MOL ECOL NOTES, V4, P615, DOI 10.1111/j.1471-8286.2004.00754.x; Kan XZ, 2010, GENET MOL RES, V9, P1204, DOI 10.4238/vol9-2gmr820; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; Kidd MG, 1998, MOL BIOL EVOL, V15, P61, DOI 10.1093/oxfordjournals.molbev.a025848; KOEHLER CM, 1991, GENETICS, V129, P247; KONDO R, 1990, GENETICS, V126, P657; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Lei CZ, 2004, ANIM BIOTECHNOL, V9, P181; Liu Yin Zeng, 1981, Acta Zoologica Sinica, V27, P273; Ludwig A, 2000, GENETICS, V156, P1933; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; Lutz-Bonengel S, 2004, INT J LEGAL MED, V118, P274, DOI 10.1007/s00414-004-0457-0; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Munwes I, 2011, MOL ECOL, V20, P2878, DOI 10.1111/j.1365-294X.2011.05134.x; Nesbo CL, 1998, GENETICS, V148, P1907; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; RAND DM, 1986, GENETICS, V114, P955; RAND DM, 1989, GENETICS, V121, P551; Ritchie PA, 2000, GENOME, V43, P613, DOI 10.1139/gen-43-4-613; Roques S, 2004, J HERED, V95, P332, DOI 10.1093/jhered/esh047; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sekiguchi K, 2003, MITOCHONDRION, V2, P401, DOI 10.1016/S1567-7249(03)00028-X; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; [万君兴 Wan Junxing], 2010, [甘肃农业大学学报, Journal of Gansu Agricultural University], V45, P16; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; White DJ, 2009, MOL BIOL EVOL, V26, P1435, DOI 10.1093/molbev/msp073; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Wolff JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020522; Yamashina Y, 1983, NIPPONIA NIPPON; Zhang B, 2004, BIRD CONSERV INT, V14, P183, DOI 10.1017/S0959270904000231; Zhang B, 2005, THESIS ZHEJIANG U ZH; Zhang YD, 2004, THESIS NW SCI TECH U; [张智 ZHANG Zhi], 2008, [科技导报, Science & Technology Review], V26, P48	78	11	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66324	10.1371/journal.pone.0066324	http://dx.doi.org/10.1371/journal.pone.0066324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805212	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500040
J	Pietrocola, G; Geoghegan, JA; Rindi, S; Di Poto, A; Missineo, A; Consalvi, V; Foster, TJ; Speziale, P				Pietrocola, Giampiero; Geoghegan, Joan A.; Rindi, Simonetta; Di Poto, Antonella; Missineo, Antonino; Consalvi, Valerio; Foster, Timothy J.; Speziale, Pietro			Molecular Characterization of the Multiple Interactions of SpsD, a Surface Protein from Staphylococcus pseudintermedius, with Host Extracellular Matrix Proteins	PLOS ONE			English	Article							MSCRAMM CLUMPING FACTOR; TANDEM BETA-ZIPPER; HUMAN-FIBRINOGEN; CANINE CORNEOCYTES; PLATELET RECEPTOR; MEDIATE ADHERENCE; ATOPIC-DERMATITIS; BINDING DOMAIN; GAMMA-CHAIN; FACTOR-B	Staphylococcus pseudintermedius, a commensal and pathogen of dogs and occasionally of humans, expresses surface proteins potentially involved in host colonization and pathogenesis. Here, we describe the cloning and characterization of SpsD, a surface protein of S. pseudintermedius reported as interacting with extracellular matrix proteins and corneocytes. A ligand screen and Western immunoblotting revealed that the N-terminal A domain of SpsD bound fibrinogen, fibronectin, elastin and cytokeratin 10. SpsD also interfered with thrombin-induced fibrinogen coagulation and blocked ADP-induced platelet aggregation. The binding site for SpsD was mapped to residues 395-411 in the fibrinogen gamma-chain, while binding sites in fibronectin were localized to the N- and C-terminal regions. SpsD also bound to glycine-and serine-rich omega loops within the C-terminal tail region of cytokeratin 10. Ligand binding studies using SpsD variants lacking the C-terminal segment or containing an amino-acid substitution in the putative ligand binding site provided insights into interaction mechanism of SpsD with the different ligands. Together these data demonstrate the multi-ligand binding properties of SpsD and illustrate some interesting differences in the variety of ligands bound by SpsD and related proteins from S. aureus.	[Pietrocola, Giampiero; Rindi, Simonetta; Di Poto, Antonella; Missineo, Antonino; Speziale, Pietro] Inst Biochem, Dept Mol Med, Pavia, Italy; [Geoghegan, Joan A.; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin, Ireland; [Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem Sci Rossi Fanelli, I-00185 Rome, Italy	University of Pavia; Trinity College Dublin; Sapienza University Rome	Speziale, P (corresponding author), Inst Biochem, Dept Mol Med, Pavia, Italy.	pspeziale@unipv.it	consalvi, valerio/F-1918-2011	PIETROCOLA, GIAMPIERO/0000-0002-7069-8155; Geoghegan, Joan/0000-0002-3788-0668	Fondazione CARIPLO [Vaccines 2009-3546]; Science Foundation Ireland [08/IN.1/B1845]	Fondazione CARIPLO(Fondazione Cariplo); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The support by Fondazione CARIPLO '[Vaccines 2009-3546]' to P. Speziale is acknowledged. TJF acknowledges the support of Science Foundation Ireland [grant number 08/IN.1/B1845]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2012, VET DERMATOL, V23, DOI 10.1111/j.1365-3164.2011.01021.x; Bannoehr J, 2011, INFECT IMMUN, V79, P3074, DOI 10.1128/IAI.00137-11; Ben Zakour NL, 2011, J BACTERIOL, V193, P2363, DOI 10.1128/JB.00137-11; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Burke FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-160; Campanile F, 2007, MICROB DRUG RESIST, V13, P7, DOI 10.1089/mdr.2006.9991; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Geoghegan JA, 2009, VET MICROBIOL, V138, P345, DOI 10.1016/j.vetmic.2009.03.030; Gerstadt K, 1999, CLIN INFECT DIS, V29, P218, DOI 10.1086/520168; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; HAWIGER J, 1989, BIOCHEMISTRY-US, V28, P2909, DOI 10.1021/bi00433a024; Jirouskova M, 2001, THROMB HAEMOSTASIS, V86, P1047; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Keane FM, 2007, BIOCHEMISTRY-US, V46, P7226, DOI 10.1021/bi700454x; Kempker R, 2009, AM J MED SCI, V338, P425, DOI 10.1097/MAJ.0b013e3181b0baa9; KLOCZEWIAK M, 1983, THROMB RES, V29, P249, DOI 10.1016/0049-3848(83)90147-0; Laarhoven LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027788; Liu CZ, 2005, THROMB HAEMOSTASIS, V94, P286, DOI 10.1160/TH05-03-0205; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; McEwan NA, 2000, RES VET SCI, V68, P279, DOI 10.1053/rvsc.2000.0378; McEwan NA, 2005, RES VET SCI, V78, P193, DOI 10.1016/j.rvsc.2004.09.002; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; Onuma K, 2012, VET DERMATOL, V23, P17, DOI 10.1111/j.1365-3164.2011.00995.x; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Speziale P, 2008, NAT PROTOC, V3, P525, DOI 10.1038/nprot.2008.12; Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241; Tse H, 2011, J BACTERIOL, V193, P1783, DOI 10.1128/JB.00023-11; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Walsh EJ, 2008, MICROBIOL-SGM, V154, P550, DOI 10.1099/mic.0.2007/010868-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; ZARDI L, 1985, EUR J BIOCHEM, V146, P571, DOI 10.1111/j.1432-1033.1985.tb08690.x	46	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66901	10.1371/journal.pone.0066901	http://dx.doi.org/10.1371/journal.pone.0066901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805283	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500111
J	Flores-Moreno, H; Thomson, FJ; Warton, DI; Moles, AT				Flores-Moreno, Habacuc; Thomson, Fiona J.; Warton, David I.; Moles, Angela T.			Are Introduced Species Better Dispersers Than Native Species? A Global Comparative Study of Seed Dispersal Distance	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; PLANT INVASIVENESS; ENEMY RELEASE; ALIEN; PATTERNS; ECOLOGY; TRAITS; DETERMINANTS; CONSERVATION; DEMOGRAPHY	We provide the first global test of the idea that introduced species have greater seed dispersal distances than do native species, using data for 51 introduced and 360 native species from the global literature. Counter to our expectations, there was no significant difference in mean or maximum dispersal distance between introduced and native species. Next, we asked whether differences in dispersal distance might have been obscured by differences in seed mass, plant height and dispersal syndrome, all traits that affect dispersal distance and which can differ between native and introduced species. When we included all three variables in the model, there was no clear difference in dispersal distance between introduced and native species. These results remained consistent when we performed analyses including a random effect for site. Analyses also showed that the lack of a significant difference in dispersal distance was not due to differences in biome, taxonomic composition, growth form, nitrogen fixation, our inclusion of non-invasive introduced species, or our exclusion of species with human-assisted dispersal. Thus, if introduced species do have higher spread rates, it seems likely that these are driven by differences in post-dispersal processes such as germination, seedling survival, and survival to reproduction.	[Flores-Moreno, Habacuc; Moles, Angela T.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Kensington, NSW 2033, Australia; [Thomson, Fiona J.] Landcare Res, Lincoln, NE, New Zealand; [Warton, David I.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Math & Stat, Sydney, NSW, Australia	University of New South Wales Sydney; Landcare Research - New Zealand; University of New South Wales Sydney	Flores-Moreno, H (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, POB 1, Kensington, NSW 2033, Australia.	h.floresmoreno@unsw.edu.au	Warton, David/B-5791-2009; Moles, Angela T/C-3083-2008	Warton, David/0000-0001-9441-6645; Moles, Angela T/0000-0003-2041-7762	Evolution & Ecology Research Centre at UNSW; Australian Research Council [DP 0984222]	Evolution & Ecology Research Centre at UNSW; Australian Research Council(Australian Research Council)	H.F.M. was supported by a scholarship from the Evolution & Ecology Research Centre at UNSW. A. T. M. was supported by funding from the Australian Research Council (DP 0984222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2001, ECOSCIENCE, V8, P471, DOI 10.1080/11956860.2001.11682677; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; Cadotte MW, 2001, ECOSCIENCE, V8, P230, DOI 10.1080/11956860.2001.11682649; Chrobock T, 2011, BASIC APPL ECOL, V12, P244, DOI 10.1016/j.baae.2011.03.001; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Core R Team, 2012, R LANG ENV STAT COMP; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Daws MI, 2007, S AFR J BOT, V73, P138, DOI 10.1016/j.sajb.2006.09.003; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; Dostal P, 2013, J ECOL, V101, P388, DOI 10.1111/1365-2745.12037; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hawkes CV, 2007, AM NAT, V170, P832, DOI 10.1086/522842; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; HONIG MA, 1992, AUST J ECOL, V17, P305, DOI 10.1111/j.1442-9993.1992.tb00812.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Jongejans E, 2008, J ECOL, V96, P687, DOI 10.1111/j.1365-2745.2008.01367.x; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Knapp S, 2012, ECOL LETT, V15, P696, DOI 10.1111/j.1461-0248.2012.01787.x; Kuster EC, 2010, BIOL INVASIONS, V12, P2001, DOI 10.1007/s10530-009-9603-4; Lake JC, 2004, BIOL CONSERV, V117, P215, DOI 10.1016/S0006-3207(03)00294-5; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lord J, 1997, J BIOGEOGR, V24, P205, DOI 10.1046/j.1365-2699.1997.00126.x; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Martin PH, 2010, OIKOS, V119, P807, DOI 10.1111/j.1600-0706.2009.17941.x; Mason RAB, 2008, GLOBAL ECOL BIOGEOGR, V17, P633, DOI 10.1111/j.1466-8238.2008.00402.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Moravcova L, 2010, PRESLIA, V82, P365; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Murray BR, 2010, BIOL INVASIONS, V12, P2265, DOI 10.1007/s10530-009-9637-7; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Ordonez A, 2013, GLOBAL ECOL BIOGEOGR, V22, P648, DOI 10.1111/geb.12019; Ordonez A, 2010, FUNCT ECOL, V24, P1353, DOI 10.1111/j.1365-2435.2010.01739.x; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Preacher K.J., 2001, CALCULATION CHI SQUA; Prinzing A, 2002, EVOL ECOL RES, V4, P385; Pysek P, 2005, ECOSCIENCE, V12, P302, DOI 10.2980/i1195-6860-12-3-302.1; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; Pysek Petr, 2007, V193, P97; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Royal Botanic Gardens Kew, 2020, SEED INF DAT SID VER; Saumel I, 2010, LANDSCAPE URBAN PLAN, V94, P244, DOI 10.1016/j.landurbplan.2009.10.009; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Thebaud C, 2001, AM NAT, V157, P231, DOI 10.1086/318635; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; Thompson K, 2008, J ECOL, V96, P853, DOI 10.1111/j.1365-2745.2008.01383.x; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Thomson FJ, 2010, J ECOL, V98, P1310, DOI 10.1111/j.1365-2745.2010.01724.x; Tummers B, 2006, DATATHEIF 3; Van Kleunen M, 2007, J ECOL, V95, P674, DOI 10.1111/j.1365-2745.2007.01250.x; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; Vila M, 2005, OECOLOGIA, V142, P474, DOI 10.1007/s00442-004-1731-z; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; WESTOBY M, 1992, TRENDS ECOL EVOL, V7, P368, DOI 10.1016/0169-5347(92)90006-W; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0	69	19	19	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e68541	10.1371/journal.pone.0068541	http://dx.doi.org/10.1371/journal.pone.0068541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818991	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800148
J	Goldin, MA; Alonso, LM; Alliende, JA; Goller, F; Mindlin, GB				Goldin, Matias A.; Alonso, Leandro M.; Alliende, Jorge A.; Goller, Franz; Mindlin, Gabriel B.			Temperature Induced Syllable Breaking Unveils Nonlinearly Interacting Timescales in Birdsong Motor Pathway	PLOS ONE			English	Article							GENERATION; DYNAMICS; CORTEX; MECHANISM; WHISKING	The nature of telencephalic control over premotor and motor circuits is debated. Hypotheses range from complete usurping of downstream circuitry to highly interactive mechanisms of control. We show theoretically and experimentally, that telencephalic song motor control in canaries is consistent with a highly interactive strategy. As predicted from a theoretical model of respiratory control, mild cooling of a forebrain nucleus (HVC) led to song stretching, but further cooling caused progressive restructuring of song, consistent with the hypothesis that respiratory gestures are subharmonic responses to a timescale present in the output of HVC. This interaction between a life-sustaining motor function (respiration) and telencephalic song motor control suggests a more general mechanism of how nonlinear integration of evolutionarily new brain structures into existing circuitry gives rise to diverse, new behavior.	[Goldin, Matias A.; Alonso, Leandro M.; Alliende, Jorge A.; Mindlin, Gabriel B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Lab Sistemas Dinam, RA-1428 Buenos Aires, DF, Argentina; [Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	University of Buenos Aires; Utah System of Higher Education; University of Utah	Goldin, MA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Lab Sistemas Dinam, RA-1428 Buenos Aires, DF, Argentina.	mgoldin@df.uba.ar	Alonso, Leandro/O-2553-2019; Alonso, Leandro/F-8685-2015	Alonso, Leandro/0000-0001-8211-2855; Mindlin, Gabo/0000-0002-7808-5708; Goldin, Matias/0000-0002-5151-3637	Conicet; University of Buenos Aires; NIH [DC-06876]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006876] Funding Source: NIH RePORTER	Conicet(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Conicet, University of Buenos Aires and NIH DC-06876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens KF, 2004, J NEUROPHYSIOL, V92, P1700, DOI 10.1152/jn.00020.2004; Alliende JA, 2010, DEV NEUROBIOL, V70, P943, DOI 10.1002/dneu.20835; Alonso LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041929; Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Andalman AS, 2011, PLOS ONE, V6, pe2546, DOI [10.1371/journal.pone.0025461., DOI 10.1371/J0URNAL.P0NE.0025461]; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Cramer NP, 2006, J NEUROPHYSIOL, V96, P209, DOI 10.1152/jn.00071.2006; Dunsheath P, 1927, NATURE, V120, P363, DOI 10.1038/120363a0; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Friedman WA, 2006, J NEUROPHYSIOL, V95, P1274, DOI 10.1152/jn.00945.2005; Friedman WA, 2012, J NEUROPHYSIOL, V107, P551, DOI 10.1152/jn.01132.2010; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; GUCKENHEIMER J, 1997, NONLINEAR OSCILLATIO; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mendez JM, 2012, J NEUROPHYSIOL, V107, P2971, DOI 10.1152/jn.00646.2011; Mindlin GB, 2005, PHYS BIRDSONG; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2008, NEUROSCIENCE BIRDSON, P115; Smotherman M, 2006, J NEUROSCI, V26, P4860, DOI 10.1523/JNEUROSCI.4607-05.2006; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Trevisan MA, 2007, EUR PHYS J-SPEC TOP, V146, P199, DOI 10.1140/epjst/e2007-00180-1; Trevisan MA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058103; Zeigler HP, 2008, NEUROSCIENCE BIRDSON	28	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67814	10.1371/journal.pone.0067814	http://dx.doi.org/10.1371/journal.pone.0067814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818988	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800145
J	Hernandez-Bartolome, A; Lopez-Rodriguez, R; Rodriguez-Munoz, Y; Martin-Vilchez, S; Borque, MJ; Garcia-Buey, L; Gonzalez-Moreno, L; Real, Y; Moreno-Otero, R; Sanz-Cameno, P				Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Jesus Borque, Maria; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma			Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; INFLAMMATORY LIVER-DISEASE; PRIMARY BILIARY-CIRRHOSIS; VIRUS-INFECTION; TUMOR ANGIOGENESIS; EXPRESSION; MARKERS; INDEX; MECHANISMS; BIOPSY	Aims: Accurate liver fibrosis staging is crucial for the management of chronic hepatitis C (CHC). The invasiveness and cost burden of liver biopsy have driven the search for new noninvasive biomarkers of fibrosis. Based on the link between serum angiopoietin-1 and 2 levels and CHC progression, we aimed to determine the value of these angiogenic factors as noninvasive biomarkers of liver fibrosis. Methods: Serum levels of angiopoietin-1 and -2 were measured by ELISA in 108 CHC patients who underwent pretreatment liver biopsy. The correlation between angiopoietins and clinical and demographic variables with liver fibrosis was analyzed by univariate regression. Significant factors were then subjected to multivariate analysis, from which we constructed a novel noninvasive liver fibrosis index (AngioScore), whose performance was validated in an independent series of 71 CHC patients. The accuracy of this model was compared with other documented fibrosis algorithms by De Long test. Results: Angiopoietins correlated significantly with hepatic fibrosis; however, only angiopoietin-2 was retained in the final model, which also included age, platelets, AST, INR, and GGT. The model was validated and behaved considerably better than other fibrosis indices in discriminating all, significant, moderate and severe liver fibrosis (0.886, 0.920, 0.923). Using clinically relevant cutoffs, we classified CHC patients by discarding significant fibrosis and diagnosing moderate and severe fibrosis with greater accuracy, sensitivity, and specificity. Conclusions: Our novel noninvasive liver fibrosis model, based on serum angiopoietin-2 levels, outperforms other indices and should help substantially in managing CHC and monitoring long-term follow-up prognosis.	[Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Univ Autonoma Madrid, Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Gastroenterol Serv,Liver Unit, Madrid, Spain; [Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Garcia-Buey, Luisa; Gonzalez-Moreno, Leticia; Real, Yolanda; Moreno-Otero, Ricardo; Sanz-Cameno, Paloma] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Hernandez-Bartolome, Angel; Lopez-Rodriguez, Rosario; Rodriguez-Munoz, Yolanda; Martin-Vilchez, Samuel; Jesus Borque, Maria; Sanz-Cameno, Paloma] Hosp Univ La Princesa, Mol Biol Unit, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital de La Princesa	Moreno-Otero, R (corresponding author), Univ Autonoma Madrid, Hosp Univ La Princesa, Inst Invest Sanitaria Princesa, Gastroenterol Serv,Liver Unit, Madrid, Spain.	rmoreno.hlpr@salud.madrid.org	Martin-Vilchez, Samuel/AFV-2112-2022; Sanz, Paloma/C-7799-2014; Lopez-Rodriguez, Rosario/M-3381-2014; Chaparro, María/I-2500-2016; López-Rodríguez, Rosario/AAB-2290-2022	Martin-Vilchez, Samuel/0000-0003-0557-7653; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; Chaparro, María/0000-0002-9275-4242; López-Rodríguez, Rosario/0000-0002-4713-0633	Ministerio de Ciencia e Innovacion (SAF) [2010/21805]; CIBERehd (Instituto de Salud Carlos III, Madrid); Fundacion Mutua Madrilena to Ricardo Moreno-Otero; Paloma Sanz-Cameno; Asociacion Espanola Contra el Cancer (AIO)	Ministerio de Ciencia e Innovacion (SAF); CIBERehd (Instituto de Salud Carlos III, Madrid)(Instituto de Salud Carlos III); Fundacion Mutua Madrilena to Ricardo Moreno-Otero; Paloma Sanz-Cameno; Asociacion Espanola Contra el Cancer (AIO)	This work was partially supported by the Ministerio de Ciencia e Innovacion (SAF: 2010/21805), CIBERehd (Instituto de Salud Carlos III, Madrid) and Fundacion Mutua Madrilena to Ricardo Moreno-Otero and Paloma Sanz-Cameno. Paloma Sanz-Cameno has a grant from Asociacion Espanola Contra el Cancer (AIO 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gebo KA, 2002, HEPATOLOGY, V36, pS161, DOI 10.1053/jhep.2002.36989; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kobayashi H, 2005, FRONT BIOSCI-LANDMRK, V10, P666, DOI 10.2741/1561; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Medina J, 2004, HEPATOLOGY, V39, P1185, DOI 10.1002/hep.20193; Melgar-Lesmes P, 2009, GUT, V58, P285, DOI 10.1136/gut.2008.155028; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Paradis V, 2003, GASTROENTEROLOGY, V124, P651, DOI 10.1053/gast.2003.50104; Poordad FF, 2004, EXPERT REV MOL DIAGN, V4, P593, DOI 10.1586/14737159.4.5.593; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Salcedo X, 2005, HEPATOLOGY, V42, P696, DOI 10.1002/hep.20828; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sanz-Cameno P, 2002, J HEPATOL, V37, P723, DOI 10.1016/S0168-8278(02)00266-0; Sanz-Cameno P, 2006, AM J PATHOL, V169, P1215, DOI 10.2353/ajpath.2006.051246; Sanz-Cameno P, 2010, J ONCOL, V2010, DOI 10.1155/2010/272170; Scholz A, 2007, AM J GASTROENTEROL, V102, P2471, DOI 10.1111/j.1572-0241.2007.01377.x; Sebastiani G, 2012, J VIRAL HEPATITIS, V19, P18, DOI 10.1111/j.1365-2893.2011.01518.x; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sugimachi K, 2003, J CLIN PATHOL, V56, P854, DOI 10.1136/jcp.56.11.854; Tanaka S, 1999, J CLIN INVEST, V103, P341, DOI 10.1172/JCI4891; Tanaka S, 2003, J GASTROENTEROL, V38, P93; Tanaka S, 2002, HEPATOLOGY, V35, P861, DOI 10.1053/jhep.2002.32535; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Tugues S, 2007, HEPATOLOGY, V46, P1919, DOI 10.1002/hep.21921; Vespasiani-Gentilucci U, 2011, J INTERF CYTOK RES, V31, P207, DOI 10.1089/jir.2010.0040; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Westin J, 2008, SCAND J GASTROENTERO, V43, P73, DOI 10.1080/00365520701514461; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670	55	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66143	10.1371/journal.pone.0066143	http://dx.doi.org/10.1371/journal.pone.0066143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823085	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400057
J	Inderbitzin, P; Davis, RM; Bostock, RM; Subbarao, KV				Inderbitzin, Patrik; Davis, R. Michael; Bostock, Richard M.; Subbarao, Krishna V.			Identification and Differentiation of Verticillium Species and V. longisporum Lineages by Simplex and Multiplex PCR Assays	PLOS ONE			English	Article							REAL-TIME PCR; RIBOSOMAL INTERGENIC SEQUENCES; WINTER OILSEED RAPE; ALBO-ATRUM; QUANTITATIVE PCR; BRASSICA-NAPUS; DAHLIAE; SOIL; WILT; DNA	Accurate species identification is essential for effective plant disease management, but is challenging in fungi including Verticillium sensu stricto (Ascomycota, Sordariomycetes, Plectosphaerellaceae), a small genus of ten species that includes important plant pathogens. Here we present fifteen PCR assays for the identification of all recognized Verticillium species and the three lineages of the diploid hybrid V. longisporum. The assays were based on DNA sequence data from the ribosomal internal transcribed spacer region, and coding and non-coding regions of actin, elongation factor 1-alpha, glyceraldehyde-3-phosphate dehydrogenase and tryptophan synthase genes. The eleven single target (simplex) PCR assays resulted in amplicons of diagnostic size for V. alfalfae, V. albo-atrum, V. dahliae including V. longisporum lineage A1/D3, V. isaacii, V. klebahnii, V. nonalfalfae, V. nubilum, V. tricorpus, V. zaregamsianum, and Species A1 and Species D1, the two undescribed ancestors of V. longisporum. The four multiple target (multiplex) PCR assays simultaneously differentiated the species or lineages within the following four groups: Verticillium albo-atrum, V. alfalfae and V. nonalfalfae; Verticillium dahliae and V. longisporum lineages A1/D1, A1/D2 and A1/D3; Verticillium dahliae including V. longisporum lineage A1/D3, V. isaacii, V. klebahnii and V. tricorpus; Verticillium isaacii, V. klebahnii and V. tricorpus. Since V. dahliae is a parent of two of the three lineages of the diploid hybrid V. longisporum, no simplex PCR assay is able to differentiate V. dahliae from all V. longisporum lineages. PCR assays were tested with fungal DNA extracts from pure cultures, and were not evaluated for detection and quantification of Verticillium species from plant or soil samples. The DNA sequence alignments are provided and can be used for the design of additional primers.	[Inderbitzin, Patrik; Davis, R. Michael; Bostock, Richard M.; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Subbarao, KV (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835	California Leafy Greens Board [2011-05, 2011-06]; United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2010-51181-21069]	California Leafy Greens Board; United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA))	Financial support for this research was provided by the California Leafy Greens Board (www.caleafygreens.ca.gov/) (contracts 2011-05 and 2011-06) and the United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) (www.csrees.usda.gov/fo/specialtycropresearchinitiative. cfm) (grant# 2010-51181-21069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2007, Bulletin OEPP/EPPO Bulletin, V37, P528, DOI 10.1111/j.1365-2338.2007.01160.x; [Anonymous], 2004, PHYTOPATHOL MEDITERR, V43, P273; Atallah ZK, 2007, PHYTOPATHOLOGY, V97, P865, DOI 10.1094/PHYTO-97-7-0865; Babadoost M, 2004, PLANT PATHOL, V53, P669, DOI 10.1111/j.1365-3059.2004.01070.x; Banno S, 2011, J GEN PLANT PATHOL, V77, P282, DOI 10.1007/s10327-011-0335-9; Bilodeau GJ, 2012, PHYTOPATHOLOGY, V102, P331, DOI 10.1094/PHYTO-05-11-0130; CARDER JH, 1994, MODERN ASSAYS FOR PLANT PATHOGENIC FUNGI: IDENTIFICATION, DETECTION AND QUANTIFICATION, P91; Dan H, 2001, PLANT DIS, V85, P700, DOI 10.1094/PDIS.2001.85.7.700; Debode J, 2011, PLANT DIS, V95, P1571, DOI 10.1094/PDIS-04-11-0267; Drummond A.J., 2010, GENEIOUS V4 8 5; Du XH, 2012, MYCOLOGIA, V104, P1351, DOI 10.3852/12-056; Dunker S, 2008, J PHYTOPATHOL, V156, P698, DOI 10.1111/j.1439-0434.2008.01429.x; Duressa D, 2012, PHYTOPATHOLOGY, V102, P443, DOI 10.1094/PHYTO-10-11-0280; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Gams W, 2001, NOVA HEDWIGIA, V72, P329; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gayoso C, 2007, EUR J PLANT PATHOL, V118, P199, DOI 10.1007/s10658-007-9134-8; Grafenhan T, 2011, STUD MYCOL, P79, DOI 10.3114/sim.2011.68.04; Harris DC, 1996, PLANT PATHOL, V45, P106, DOI 10.1046/j.1365-3059.1996.d01-96.x; HAWKSWORTH DL, 1970, CMI DESCRIPTIONS PAT, V256; HAWKSWORTH DL, 1970, CMI DESCRIPTIONS PAT, V255; HEALE JB, 1963, ANN APPL BIOL, V52, P439, DOI 10.1111/j.1744-7348.1963.tb03768.x; Hodge KT, 2005, TAXON, V54, P485, DOI 10.2307/25065318; Inderbitzin P, 2001, AM J BOT, V88, P52, DOI 10.2307/2657126; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; ISAAC IVOR, 1953, TRANS BRIT MYCOL SOC, V36, P180; ISAAC IVOR, 1949, TRANS BRIT MYCOL SOC, V32, P137; Kageyama Koji, 2003, Journal of General Plant Pathology, V69, P153; Karajeh MR, 2006, J PHYTOPATHOL, V154, P496, DOI 10.1111/j.1439-0434.2006.01138.x; Karapapa VK, 2001, CURR MICROBIOL, V42, P217, DOI 10.1007/s002840010207; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Kuchta Paulina, 2008, Journal of Fruit and Ornamental Plant Research, V16, P295; KWOK S, 1994, PCR METH APPL, V3, pS39; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen RC, 2007, PHYTOPATHOLOGY, V97, P1519, DOI 10.1094/PHYTO-97-11-1519; Li KN, 1999, MYCOL RES, V103, P1361, DOI 10.1017/S0953756299008357; Lievens B, 2006, PLANT SCI, V171, P155, DOI 10.1016/j.plantsci.2006.03.009; Mahuku GS, 2002, AM J POTATO RES, V79, P107, DOI 10.1007/BF02881519; MOUKHAMEDOV R, 1994, PHYTOPATHOLOGY, V84, P256, DOI 10.1094/Phyto-84-256; Nagao H, 1997, MICROB ENV, V12, P15; NAZAR RN, 1991, PHYSIOL MOL PLANT P, V39, P1, DOI 10.1016/0885-5765(91)90027-F; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Piel William H., 2002, Research Report from the National Institute for Environmental Studies Japan, V171, P41; Platt HW, 2000, ADVANCES IN VERTICILLIUM: RESEARCH AND DISEASE MANAGEMENT, P140; Platt HW, 2000, ADVANCES IN VERTICILLIUM: RESEARCH AND DISEASE MANAGEMENT, P59; Pramateftaki PV, 2000, FUNGAL GENET BIOL, V29, P19, DOI 10.1006/fgbi.1999.1178; Qin QM, 2008, PLANT DIS, V92, P69, DOI 10.1094/PDIS-92-1-0069; Radisek S, 2006, EUR J PLANT PATHOL, V116, P301, DOI 10.1007/s10658-006-9061-0; ROBB J, 1994, MODERN ASSAYS FOR PLANT PATHOGENIC FUNGI: IDENTIFICATION, DETECTION AND QUANTIFICATION, P83; Sambrook J., 2001, MOL CLONING; Steventon LA, 2002, MYCOL RES, V106, P570, DOI 10.1017/S0953756202005865; Subbarao K. V., 1997, COMPENDIUM LETTUCE D, P26; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Usami T, 2011, J GEN PLANT PATHOL, V77, P17, DOI 10.1007/s10327-010-0282-x; VOLOSSIOUK T, 1995, APPL ENVIRON MICROB, V61, P3972, DOI 10.1128/AEM.61.11.3972-3976.1995; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WILHELM S, 1955, PHYTOPATHOLOGY, V45, P180; Zare R, 2007, NOVA HEDWIGIA, V85, P463, DOI 10.1127/0029-5035/2007/0085-0463; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x	66	58	62	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65990	10.1371/journal.pone.0065990	http://dx.doi.org/10.1371/journal.pone.0065990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823707	gold, Green Published, Green Submitted			2022-12-27	WOS:000320576400043
J	Kumar, V; Nadda, G; Kumar, S; Yadav, SK				Kumar, Vinay; Nadda, Gireesh; Kumar, Sanjay; Yadav, Sudesh Kumar			Transgenic Tobacco Overexpressing Tea cDNA Encoding Dihydroflavonol 4-Reductase and Anthocyanidin Reductase Induces Early Flowering and Provides Biotic Stress Tolerance	PLOS ONE			English	Article							PROANTHOCYANIDIN BIOSYNTHESIS; TRANSCRIPTION FACTOR; ECTOPIC EXPRESSION; CAMELLIA-SINENSIS; GENE; FLAVAN-3-OLS; PATHWAYS; ENZYMES; PROTEIN; ACID	Flavan-3-ols contribute significantly to flavonoid content of tea (Camellia sinensis L.). Dihydroflavonol 4-reductase (DFR) and anthocyanidin reductase (ANR) are known to be key regulatory enzymes of flavan-3-ols biosynthesis. In this study, we have generated the transgenic tobacco overexpressing individually tea cDNA CsDFR and CsANR encoding for DFR and ANR to evaluate their influence on developmental and protective abilities of plant against biotic stress. The transgenic lines of CsDFR and CsANR produced early flowering and better seed yield. Both types of transgenic tobacco showed higher content of flavonoids than control. Flavan-3-ols such as catechin, epicatechin and epicatechingallate were found to be increased in transgenic lines. The free radical scavenging activity of CsDFR and CsANR transgenic lines was improved. Oxidative stress was observed to induce lesser cell death in transgenic lines compared to control tobacco plants. Transgenic tobacco overexpressing CsDFR and CsANR also showed resistance against infestation by a tobacco leaf cutworm Spodoptera litura. Results suggested that the overexpression of CsDFR and CsANR cDNA in tobacco has improved flavonoids content and antioxidant potential. These attributes in transgenic tobacco have ultimately improved their growth and development, and biotic stress tolerance.	[Kumar, Vinay; Kumar, Sanjay; Yadav, Sudesh Kumar] CSIR, CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India; [Nadda, Gireesh] CSIR, CSIR Inst Himalayan Bioresource Technol, HATS Div, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Yadav, SK (corresponding author), CSIR, CSIR Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India.	sudeshkumar@ihbt.res.in		Nadda, Gireesh/0000-0002-7321-7951	Council of Scientific and Industrial Research (CSIR), GOI under NMITLI program [TLP003]	Council of Scientific and Industrial Research (CSIR), GOI under NMITLI program	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR), GOI under NMITLI program (TLP003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137; Auger B, 2009, PLANTA, V230, P1167, DOI 10.1007/s00425-009-1017-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Filippo I, 2006, PHYTOCHEMISTRY ADV R, pa23; Goldberg-Moeller R, 2013, PLANT SCI, V198, P46, DOI 10.1016/j.plantsci.2012.09.012; Han YP, 2012, J EXP BOT, V63, P2437, DOI 10.1093/jxb/err415; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hong LL, 2012, PLANTA, V236, P141, DOI 10.1007/s00425-012-1598-x; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Joshi R, 2011, SCI HORTIC-AMSTERDAM, V130, P266, DOI 10.1016/j.scienta.2011.06.007; Kelen M, 2004, TURK J CHEM, V28, P603; Koseki M, 2005, PLANT CELL PHYSIOL, V46, P1879, DOI 10.1093/pcp/pci192; Koskimaki JJ, 2009, EUR J PLANT PATHOL, V125, P629, DOI 10.1007/s10658-009-9511-6; Kovinich N, 2012, T RES, DOI [10.1007/s11248-011-9566-y, DOI 10.1007/S1]; Kumar V, 2013, MOL BIOTECHNOL, V53, P118, DOI 10.1007/s12033-012-9495-x; Li HH, 2012, MOL BIOL REP, V39, P2991, DOI 10.1007/s11033-011-1061-2; Lo Piero AR, 2006, PHYTOCHEMISTRY, V67, P684, DOI 10.1016/j.phytochem.2006.01.025; Lukaszewicz M, 2004, J AGR FOOD CHEM, V52, P1526, DOI 10.1021/jf034482k; Mahajan M, 2012, PLANT BIOLOGY, V14, P725, DOI 10.1111/j.1438-8677.2011.00550.x; Mahajan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028315; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Reddy AM, 2007, METAB ENG, V9, P95, DOI 10.1016/j.ymben.2006.09.003; Sharma SB, 2005, PLANT J, V44, P62, DOI 10.1111/j.1365-313X.2005.02510.x; Shen GA, 2006, J PLANT PHYSIOL, V163, P224, DOI 10.1016/j.jplph.2005.06.012; Shimada A, 2005, Z NATURFORSCH C, V60, P572; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; Singh K, 2004, ANAL BIOCHEM, V335, P330, DOI 10.1016/j.ab.2004.08.030; Singh K, 2008, TREE PHYSIOL, V28, P1349, DOI 10.1093/treephys/28.9.1349; Singh K, 2009, TREE PHYSIOL, V29, P837, DOI 10.1093/treephys/tpp022; Singh K, 2009, PLANT BIOTECHNOL REP, V3, P95, DOI 10.1007/s11816-008-0079-y; Takahashi H, 2006, ANN BOT-LONDON, V98, P819, DOI 10.1093/aob/mcl162; Tian Li, 2008, Phytochemistry Reviews, V7, P445, DOI 10.1007/s11101-007-9076-y; Uefuji H, 2005, PLANT MOL BIOL, V59, P221, DOI 10.1007/s11103-005-8520-x; Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.02655.x; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946	48	23	28	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65535	10.1371/journal.pone.0065535	http://dx.doi.org/10.1371/journal.pone.0065535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823500	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400008
J	Chang, SX; Li, GW; Chen, Y; Bao, H; Zhou, L; Yuan, J; Wu, DM; Dai, YM				Chang, Shi-Xin; Li, Guan-Wu; Chen, Yao; Bao, Hong; Zhou, Lei; Yuan, Jun; Wu, Dong-Mei; Dai, Yong-Ming			Characterizing Venous Vasculatures of Hepatocellular Carcinoma Using a Multi-Breath-Hold Two-Dimensional Susceptibility Weighted Imaging	PLOS ONE			English	Article							CONTRAST; MRI; ANGIOGENESIS; ARCHITECTURE; TARGETS; LIVER	The aim of our study is to characterize the venous vasculatures of hepatocellular carcinoma (HCC) using a multi-breath-hold two-dimensional (2D) susceptibility weighted imaging (SWI) in comparison with conventional Magnetic Resonance Imaging (MRI) sequences. Twenty-nine patients with pathologically confirmed HCC underwent MR examination at a 3.0 T scanner. The number of venous vascularity in or around the lesion was counted and the image quality was subjectively evaluated by two experienced radiologists independently based on four image sets: 1) SWI, 2) T1-weighted sequence, 3) T2-weighted sequence, and 4) T1-weighted dynamic contrast-enhanced (DCE) sequence. Of the 29 patients, a total of 33 liver lesions were detected by both SWI and conventional MR sequences. In the evaluation of the conspicuity of venous vascularity, a mean of 10.7 tumor venous vessels per mass was detected by the SWI and 3.9 tumor vasculatures were detected by T1-weighted DCE (P < 0.0001), while none was detected by T1-, T2-weighted sequences. The Pearson correlation coefficients between the lesion sizes and the number of tumor vasculatures detected by T1-weighted DCE was 0.708 (P < 0.001), and 0.883 by SWI (P < 0.001). Our data suggest that SWI appears to be a more sensitive tool compared to T1-weighted DCE sequence to characterize venous vasculature in liver lesions.	[Chang, Shi-Xin; Li, Guan-Wu; Chen, Yao; Bao, Hong; Zhou, Lei; Yuan, Jun] Shanghai Univ Tradit Chinese Med, Dept Radiol, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China; [Wu, Dong-Mei] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Dai, Yong-Ming] Siemens Healthcare China, MR Collaborat NE Asia, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; East China Normal University; Siemens AG	Dai, YM (corresponding author), Siemens Healthcare China, MR Collaborat NE Asia, Shanghai, Peoples R China.	dymdym118@gmail.com		Li, Guanwu/0000-0003-0840-9022	Foundation of Shanghai Science and Technology Commission, China [10JC1414600]	Foundation of Shanghai Science and Technology Commission, China	This study was supported by grants from the Foundation of Shanghai Science and Technology Commission, China (No. 10JC1414600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An C, 2012, EUR RADIOL, V22, P1701, DOI 10.1007/s00330-012-2421-6; Bosman FT, 2010, WHO CLASSIFICATION T, P211; d'Assignies G, 2009, RADIOLOGY, V250, P407, DOI 10.1148/radiol.2501080291; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Ishii Y, 2010, J SURG RES, V158, P69, DOI 10.1016/j.jss.2008.09.015; Kanematsu M, 2005, AM J ROENTGENOL, V184, P832, DOI 10.2214/ajr.184.3.01840832; Kao HW, 2012, EUR RADIOL, V22, P1397, DOI 10.1007/s00330-012-2387-4; Kim H, 2011, MOL IMAGING, V10, P153, DOI 10.2310/7290.2010.00040; Kim Myeong-Jin, 2008, Oncology, V75 Suppl 1, P72, DOI 10.1159/000173427; Li RK, 2012, J MAGN RESON IMAGING, V36, P900, DOI 10.1002/jmri.23734; Matsubara T, 2013, HEPATOLOGY, V57, P1416, DOI 10.1002/hep.25965; Mie MB, 2010, Z MED PHYS, V20, P143, DOI 10.1016/j.zemedi.2010.02.004; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nagy JA, 2012, CLIN EXP METASTAS, V29, P657, DOI 10.1007/s10585-012-9500-6; Nanashima A, 2009, ANN SURG ONCOL, V16, P2130, DOI 10.1245/s10434-009-0459-8; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; Rauscher A, 2005, MAGNET RESON MED, V54, P87, DOI 10.1002/mrm.20520; Robinson RJ, 2011, J NEUROIMAGING, V21, pE189, DOI 10.1111/j.1552-6569.2010.00516.x; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Steingoetter A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026366; Tao R, 2012, CLIN RADIOL, V67, pE91, DOI 10.1016/j.crad.2012.08.015; Witjes CDM, 2012, J MAGN RESON IMAGING, V36, P641, DOI 10.1002/jmri.23681; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	26	12	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65895	10.1371/journal.pone.0065895	http://dx.doi.org/10.1371/journal.pone.0065895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799060	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300052
J	Omae, M; Takada, N; Yamamoto, S; Nakajima, H; Sato, TN				Omae, Madoka; Takada, Norio; Yamamoto, Shohei; Nakajima, Hiroyuki; Sato, Thomas N.			Identification of Inter-Organ Vascular Network: Vessels Bridging between Organs	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ENDOTHELIAL-CELLS; TRANSGENIC ZEBRAFISH; IN-VIVO; PANCREAS DEVELOPMENT; ANGIOCRINE SIGNALS; SELF-RENEWAL; LIVER; VASCULOGENESIS; REGENERATION	Development and homeostasis of organs and whole body is critically dependent on the circulatory system. In particular, the circulatory system, the railways shuttling oxygen and nutrients among various organs, is indispensible for inter-organ humoral communication. Since the modern view of the anatomy and mechanics of the circulatory system was established in 17th century, it has been assumed that humoral factors are carried to and from organs via vascular branches of the central arteries and veins running along the body axis. Over the past few decades, major advances have been made in understanding molecular and cellular mechanisms underlying the vascularization of organs. However, very little is known about how each organ is linked by vasculature (i.e., inter-organ vascular networks). In fact, the exact anatomy of inter-organ vascular networks has remained obscure. Herein, we report the identification of four distinct vessels, V1(LP), V2(LP), V3(LP) and V4(LP), that bridge between two organs, liver and pancreas in developing zebrafish. We found that these inter-organ vessels can be classified into two types: direct and indirect types. The direct type vessels are those that bridge between two organs via single distinct vessel, to which V1(LP) and V2(LP) vessels belong. The indirect type bridges between two organs via separate branches that emanate from a stem vessel, and V3(LP) and V4(LP) vessels belong to this type. Our finding of V1(LP), V2(LP), V3(LP) and V4(LP) vessels provides the proof of the existence of inter-organ vascular networks. These and other yet-to-be-discovered inter-organ vascular networks may facilitate the direct exchange of humoral factors that are necessary for the coordinated growth, differentiation and homeostasis of the connected organs. It is also possible that the inter-organ vessels serve as tracks for their connected organs to follow during their growth to establish their relative positions and size differences.	[Omae, Madoka; Takada, Norio; Yamamoto, Shohei; Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Nakajima, Hiroyuki] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, Osaka, Japan; [Sato, Thomas N.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Sato, Thomas N.] Centenary Inst, Sydney, NSW, Australia	Nara Institute of Science & Technology; National Cerebral & Cardiovascular Center - Japan; Cornell University; University of Sydney; Centenary Institute	Sato, TN (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	island1005@bs.naist.jp	Nakajima, Hiroyuki/Z-1243-2019	Nakajima, Hiroyuki/0000-0003-4139-2779; Yamamoto, Shohei/0000-0001-8898-4603	JSPS KAKENHI S [22229007]; Takeda Science Foundation	JSPS KAKENHI S(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI S Grant Number 22229007 (TNS) and Takeda Science Foundation (NT, TNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Gabella G., 1995, GRAYS ANATOMY, P1451; Harvey William, 1628, EXCERCITATIO ANATOMI; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65720	10.1371/journal.pone.0065720	http://dx.doi.org/10.1371/journal.pone.0065720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799039	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300035
J	Prieto, M; Wedin, M				Prieto, Maria; Wedin, Mats			Dating the Diversification of the Major Lineages of Ascomycota (Fungi)	PLOS ONE			English	Article							DIVERGENCE TIMES; MOLECULAR CLOCK; PHYLOGENETIC-RELATIONSHIPS; CALIBRATION UNCERTAINTY; FOSSIL CALIBRATIONS; EVOLUTION; LIFE; ORIGIN; MODEL; TREE	Establishing the dates for the origin and main diversification events in the phylogeny of Ascomycota is among the most crucial remaining goals in understanding the evolution of Fungi. There have been several analyses of divergence times in the fungal tree of life in the last two decades, but most have yielded contrasting results for the origin of the major lineages. Moreover, very few studies have provided temporal estimates for a large set of clades within Ascomycota. We performed molecular dating to estimate the divergence times of most of the major groups of Ascomycota. To account for paleontological uncertainty, we included alternative fossil constraints as different scenarios to enable a discussion of the effect of selection of fossils. We used data from 6 molecular markers and 121 extant taxa within Ascomycota. Our various 'relaxed clock' scenarios suggest that the origin and diversification of the Pezizomycotina occurred in the Cambrian. The main lineages of lichen-forming Ascomycota originated at least as early as the Carboniferous, with successive radiations in the Jurassic and Cretaceous generating the diversity of the main modern groups. Our study provides new information about the timing of the main diversification events in Ascomycota, including estimates for classes, orders and families of both lichenized and non-lichenized Ascomycota, many of which had not been previously dated.	[Prieto, Maria; Wedin, Mats] Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden; [Prieto, Maria] Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain	Swedish Museum of Natural History; Universidad Rey Juan Carlos	Prieto, M (corresponding author), Swedish Museum Nat Hist, Dept Bot, S-10405 Stockholm, Sweden.	maria.prieto@nrm.se	Prieto, Maria/Q-5033-2017	Prieto, Maria/0000-0002-1692-9821; Wedin, Mats/0000-0002-8295-5198	Swedish Research Council [VR 621-2009-5372]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was funded by the Swedish Research Council (grant VR 621-2009-5372 to MW). The authors thank the Swedish Museum of Natural History for providing complementary facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paz GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039683; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Baloch E, 2010, TAXON, V59, P1483, DOI 10.1002/tax.595013; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; BERBEE ML, 1993, CAN J BOT, V71, P1114, DOI 10.1139/b93-131; Blair J.E, 2009, TIMETREE LIFE, P213; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012759; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Donoghue PCJ, 2009, BIOESSAYS, V31, P178, DOI 10.1002/bies.200800128; Dorfelt H, 2005, MYCOL RES, V109, P956, DOI 10.1017/S0953756205003497; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Gazis R, 2012, MOL PHYLOGENET EVOL, V65, P294, DOI 10.1016/j.ympev.2012.06.019; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11; Gueidan C, 2011, FUNGAL BIOL-UK, V115, P987, DOI 10.1016/j.funbio.2011.04.002; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; HASEGAWA M, 1989, JPN J GENET, V64, P243, DOI 10.1266/jjg.64.243; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedges SB, 2004, TRENDS GENET, V20, P242, DOI 10.1016/j.tig.2004.03.004; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lumbsch HT, 2007, MYCOL RES, V111, P1133, DOI 10.1016/j.mycres.2007.06.016; MAGDEFRAU KARL, 1957, BER DUTCH BOT GES, V70, P433; Miller M.A., 2010, P GAT COMP ENV WORKS; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; Padovan ACB, 2005, J MOL EVOL, V60, P726, DOI 10.1007/s00239-004-0164-y; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Peterson EB, 2000, LICHENOLOGIST, V32, P298, DOI 10.1006/lich.1999.0257; Peterson Kristin R., 2004, Harvard Papers in Botany, V8, P141; Poinar GO, 2000, LICHENOLOGIST, V32, P263, DOI 10.1006/lich.1999.0258; Poinar GO., 1992, LIFE AMBER; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prieto M, 2013, CLADISTICS, V29, P296, DOI 10.1111/j.1096-0031.2012.00429.x; Pryer KM, 2009, TIMETREE LIFE, P153; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; Rambaut A., 2007, TRACER V1 4; RENNER SS, 2009, TIMETREE LIFE, P157; Rikkinen J, 2003, MYCOLOGIA, V95, P1032, DOI 10.2307/3761911; Rikkinen J, 2000, MYCOL RES, V104, P7, DOI 10.1017/S0953756299001884; Rikkinen J, 2002, KARSTENIA, V42, P29, DOI DOI 10.29203/KA.2002.384; Rikkinen J, 2008, J EXP BOT, V59, P1007, DOI 10.1093/jxb/ern004; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schmidt AR, 2010, P NATL ACAD SCI USA, V107, P7329, DOI 10.1073/pnas.1000948107; Schmitt I., 2010, MYCOLOGY, V1, P75, DOI DOI 10.1080/21501201003631540; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Spatafora JW, 1998, AM J BOT, V85, P1569, DOI 10.2307/2446483; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor Paul D., 2004, P1, DOI 10.1017/CBO9780511607370.002; Taylor TN, 2005, MYCOLOGIA, V97, P269, DOI 10.3852/mycologia.97.1.269; Taylor TN, 1996, REV PALAEOBOT PALYNO, V90, P249, DOI 10.1016/0034-6667(95)00086-0; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Tuovila H, 2013, FUNGAL DIVERS, V58, P199, DOI 10.1007/s13225-012-0210-9; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Yang EC, 2012, P NATL ACAD SCI USA, V109, P10960, DOI 10.1073/pnas.1120915109; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; ZUCKERKANDL EMILE, 1965, P97	79	122	124	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65576	10.1371/journal.pone.0065576	http://dx.doi.org/10.1371/journal.pone.0065576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799026	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300026
J	Sabri, F; Sebelik, ME; Meacham, R; Boughter, JD; Challis, MJ; Leventis, N				Sabri, Firouzeh; Sebelik, Merry E.; Meacham, Ryan; Boughter, John D., Jr.; Challis, Mitchell J.; Leventis, Nicholas			In Vivo Ultrasonic Detection of Polyurea Crosslinked Silica Aerogel Implants	PLOS ONE			English	Article							ACOUSTIC PROPERTIES; SCAFFOLDS; POROSITY	Background: Polyurea crosslinked silica aerogels are highly porous, lightweight, and mechanically strong materials with great potential for in vivo applications. Recent in vivo and in vitro studies have demonstrated the biocompatibility of this type of aerogel. The highly porous nature of aerogels allows for exceptional thermal, electric, and acoustic insulating capabilities that can be taken advantage of for non-invasive external imaging techniques. Sound-based detection of implants is a low cost, non-invasive, portable, and rapid technique that is routinely used and readily available in major clinics and hospitals. Methodology: In this study the first in vivo ultrasound response of polyurea crosslinked silica aerogel implants was investigated by means of a GE Medical Systems LogiQe diagnostic ultrasound machine with a linear array probe. Aerogel samples were inserted subcutaneously and sub-muscularly in a) fresh animal model and b) cadaveric human model for analysis. For comparison, samples of polydimethylsiloxane (PDMS) were also imaged under similar conditions as the aerogel samples. Conclusion/significance: Polyurea crosslinked silica aerogel (X-Si aerogel) implants were easily identified when inserted in either of the regions in both fresh animal model and cadaveric model. The implant dimensions inferred from the images matched the actual size of the implants and no apparent damage was sustained by the X-Si aerogel implants as a result of the ultrasonic imaging process. The aerogel implants demonstrated hyperechoic behavior and significant posterior shadowing. Results obtained were compared with images acquired from the PDMS implants inserted at the same location.	[Sabri, Firouzeh] Univ Memphis, Dept Phys, Memphis, TN 38152 USA; [Sebelik, Merry E.; Meacham, Ryan; Challis, Mitchell J.] Univ Tennessee, Ctr Hlth Sci, Dept Otolaryngol Head & Neck Surg, Memphis, TN 38163 USA; [Boughter, John D., Jr.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Leventis, Nicholas] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO USA	University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; Missouri University of Science & Technology	Sabri, F (corresponding author), Univ Memphis, Dept Phys, Memphis, TN 38152 USA.	fsabri@memphis.edu			FedEx Institute of Technology, University of Memphis	FedEx Institute of Technology, University of Memphis	The first author would like to thank the FedEx Institute of Technology, University of Memphis, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD JF, 1994, REV SCI INSTRUM, V65, P754, DOI 10.1063/1.1145097; BRINKER CJ, 1994, J MEMBRANE SCI, V94, P85, DOI 10.1016/0376-7388(93)E0129-8; Caponi S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214204; Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7; Cujat MO, 2008, J PROSTHET DENT, V99, P218, DOI 10.1016/S0022-3913(08)60046-3; FRICKE J, 1992, INT J HEAT MASS TRAN, V35, P2305, DOI 10.1016/0017-9310(92)90073-2; Fricke J., 1986, SPRINGER P PHYS; Fullerton BA, 2008, ARCH PHYS MED REHAB, V89, P377, DOI 10.1016/j.apmr.2007.09.017; Gibbon WW, 2002, J CLIN ULTRASOUND, V30, P288, DOI 10.1002/jcu.10065; GIBIAT V, 1995, J NON-CRYST SOLIDS, V186, P244, DOI 10.1016/0022-3093(95)00049-6; GRONAUER M, 1986, ACUSTICA, V59, P177; Hong SJ, 2009, ACTA BIOMATER, V5, P1725, DOI 10.1016/j.actbio.2008.12.006; Huynh NT, 2011, PROC SPIE, V7897, DOI 10.1117/12.873302; Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI 10.1016/j.biomaterials.2007.12.031; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Katti A, 2006, CHEM MATER, V18, P285, DOI 10.1021/cm0513841; Kherlopian AR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-74; Laugier P, 2011, BONE QUANTITATIVE ULTRASOUND, P1, DOI 10.1007/978-94-007-0017-8; Leventis N, 2011, AEROGELS HDB ADV SOL; Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005; Lyons L, 1999, 76 ANN M SE SECT APS, V54; Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0; McNally EG, 2008, SKELETAL RADIOL, V37, P99, DOI 10.1007/s00256-007-0356-9; Meacham RK, 2012, OTOLARYNG HEAD NECK, V147, P864, DOI 10.1177/0194599812446677; Middleton WD, 2004, AM J ROENTGENOL, V183, P1449, DOI 10.2214/ajr.183.5.1831449; Park J., 2010, BIOMATERIALS INTRO; Power M, 2001, J NON-CRYST SOLIDS, V285, P303, DOI 10.1016/S0022-3093(01)00471-9; Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0; Sabri F, 2011, ADV SPACE RES, V47, P419, DOI 10.1016/j.asr.2010.09.014; Sabri F, 2011, P 3 ANN ORNL BIOM SC; Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050686; Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033242; Silverstein Michael S., POROUS POLYM; Smith NB., 2010, INTRO MED IMAGING PH; Suetens Paul, 2009, FUNDAMENTALS MED IMA; Thomas V, 2006, CURR NANOSCI, V2, P155; Wells PNT, 1999, REP PROG PHYS, V62, P671, DOI 10.1088/0034-4885/62/5/201; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645	38	32	32	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66348	10.1371/journal.pone.0066348	http://dx.doi.org/10.1371/journal.pone.0066348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799093	Green Published, gold, Green Submitted			2022-12-27	WOS:000320363300077
J	Bales, PM; Renke, EM; May, SL; Shen, Y; Nelson, DC				Bales, Patrick M.; Renke, Emilija Miljkovic; May, Sarah L.; Shen, Yang; Nelson, Daniel C.			Purification and Characterization of Biofilm-Associated EPS Exopolysaccharides from ESKAPE Organisms and Other Pathogens	PLOS ONE			English	Article							POLYMERIC SUBSTANCES EPS; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-EPIDERMIDIS; CAPSULAR POLYSACCHARIDE; ESCHERICHIA-COLI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BIOCHEMICAL-CHARACTERIZATION; INFECTIOUS-DISEASES; BACTERIAL BIOFILMS; COLANIC ACID	In bacterial biofilms, high molecular weight, secreted exopolysaccharides can serve as a scaffold to which additional carbohydrates, proteins, lipids, and nucleic acids adhere, forming the matrix of the developing biofilm. Here we report methods to extract and purify high molecular weight (>15 kDa) exopolysaccharides from biofilms of eight human pathogens, including species of Staphylcococcus, Klebsiella, Acinetobacter, Pseudomonas, and a toxigenic strain of Escherichia coli O157:H7. Glycosyl composition analysis indicated a high total mannose content across all strains with P. aeruginosa and A. baumannii exopolysaccharides comprised of 80-90% mannose, K. pneumoniae and S. epidermidis strains containing 40-50% mannose, and E. coli with similar to 10% mannose. Galactose and glucose were also present in all eight strains, usually as the second and third most abundant carbohydrates. N-acetyl-glucosamine and galacturonic acid were found in 6 of 8 strains, while arabinose, fucose, rhamnose, and xylose were found in 5 of 8 strains. For linkage analysis, 33 distinct residue-linkage combinations were detected with the most abundant being mannose-linked moieties, in line with the composition analysis. The exopolysaccharides of two P. aeruginosa strains analyzed were consistent with the Psl carbohydrate, but not Pel or alginate. The S. epidermidis strain had a composition rich in mannose and glucose, which is consistent with the previously described slime associated antigen (SAA) and the extracellular slime substance (ESS), respectively, but no polysaccharide intracellular adhesion (PIA) was detected. The high molecular weight exopolysaccharides from E. coli, K. pneumoniae, and A. baumannii appear to be novel, based on composition and/or ratio analysis of carbohydrates.	[Bales, Patrick M.; Renke, Emilija Miljkovic; May, Sarah L.; Shen, Yang; Nelson, Daniel C.] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Nelson, Daniel C.] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Nelson, DC (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD USA.	nelsond@umd.edu	Shen, Yang/X-2665-2018; Nelson, Daniel C./I-2198-2012	Shen, Yang/0000-0003-4278-1477; Nelson, Daniel C./0000-0003-3248-4831	U.S. Department of Defense [DM102823]; Cosmos Club Foundation's Young Scholars Grant Program; Howard Hughes Medical Institute Undergraduate Science Education Program	U.S. Department of Defense(United States Department of Defense); Cosmos Club Foundation's Young Scholars Grant Program; Howard Hughes Medical Institute Undergraduate Science Education Program(Howard Hughes Medical Institute)	This work was supported by a grant from the U.S. Department of Defense (DM102823) to DCN. PMB acknowledges support from the Cosmos Club Foundation's Young Scholars Grant Program. Support for EMR was provided by a grant to the University of Maryland from the Howard Hughes Medical Institute Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S., 2009, CHARACTERIZATION BAC; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Azeredo J, 1999, WATER SCI TECHNOL, V39, P243, DOI 10.2166/wst.1999.0365; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906, DOI 10.1128/IAI.58.9.2906-2911.1990; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Comte S, 2007, J HAZARD MATER, V140, P129, DOI 10.1016/j.jhazmat.2006.06.058; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELSASSERBEILE U, 1978, CARBOHYD RES, V65, P245, DOI 10.1016/S0008-6215(00)84316-5; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hughes KA, 1998, MICROBIOL-UK, V144, P3039, DOI 10.1099/00221287-144-11-3039; JUNKINS AD, 1992, CURR MICROBIOL, V25, P9, DOI 10.1007/BF01570076; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; KAPLAN N, 1985, EUR J BIOCHEM, V152, P453, DOI 10.1111/j.1432-1033.1985.tb09218.x; Kives J, 2006, COLLOID SURFACE B, V52, P123, DOI 10.1016/j.colsurfb.2006.04.018; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Liu H, 2002, J BIOTECHNOL, V95, P249, DOI 10.1016/S0168-1656(02)00025-1; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; National Institutes of Health, 2002, PA03047 NIH; Oliveira R, 1999, BIOTECHNOL TECH, V13, P391, DOI 10.1023/A:1008954301470; Pan XL, 2010, WATER SA, V36, P111; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; PETERS G, 1987, ZENTRALBLATT BAKTE S, V16, P15; Ratto M, 2001, APPL MICROBIOL BIOT, V57, P182; Revdiwala S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/945805; Sandal I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-186; Seo MJ, 2011, J MICROBIOL BIOTECHN, V21, P1287, DOI 10.4014/jmb.1106.06046; Shemesh M, 2007, J MED MICROBIOL, V56, P1528, DOI 10.1099/jmm.0.47146-0; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5; SUTHERLAND IW, 1969, BIOCHEM J, V115, P935, DOI 10.1042/bj1150935; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2; SUTHERLAND IW, 1965, J GEN MICROBIOL, V39, P373, DOI 10.1099/00221287-39-3-373; TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Yadav KK, 2012, APPL BIOCHEM BIOTECH, V168, P1621, DOI 10.1007/s12010-012-9883-5; YORK WS, 1986, METHOD ENZYMOL, V118, P3; YUREWICZ EC, 1971, J BIOL CHEM, V246, P5607	55	128	136	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67950	10.1371/journal.pone.0067950	http://dx.doi.org/10.1371/journal.pone.0067950			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805330	Green Submitted, gold, Green Published			2022-12-27	WOS:000320846500158
J	Wang, YM; Liu, ZW; Guo, JB; Wang, XF; Zhao, XX; Zheng, X				Wang, Yu-Mei; Liu, Zu-Wang; Guo, Jing-Bo; Wang, Xiao-Fang; Zhao, Xin-Xin; Zheng, Xuan			ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-Analysis	PLOS ONE			English	Review							ESTROGEN-RECEPTOR-ALPHA; ANDROGEN RECEPTOR; PSA LEVELS; ASSOCIATION; BETA; HETEROGENEITY; CYP17	Background: Many published data on the association between single nucleotide polymorphisms (SNPs) in the ESR1 gene and prostate cancer susceptibility are inconclusive. The aim of this Human Genome Epidemiology (HuGE) review and meta-analysis is to derive a more precise estimation of this relationship. Methods: A literature search of PubMed, Embase, Web of Science and Chinese Biomedical (CBM) databases was conducted from their inception through July 1st, 2012. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the strength of association. Results: Twelve case-control studies were included with a total 2,165 prostate cancer cases and 3,361 healthy controls. When all the eligible studies were pooled into the meta-analysis, ESR1 PvuII (C>T) and XbaI (A>G) polymorphisms showed no association with the risk of prostate cancer. However, in the stratified analyses based on ethnicity and country, the results indicated that ESR1 PvuII (C>T) polymorphism was significantly associated with increased risk of prostate cancer among Asian populations, especially among Indian population; while ESR1 XbaI (A>G) polymorphism may significantly increase the risk of prostate cancer among American population. Furthermore, we also performed a pooled analysis for all eligible case-control studies to explore the role of codon 10 (T>C), codon 325 (C>G), codon 594 (G>A) and +261G>C polymorphisms in prostate cancer risk. Nevertheless, no significant associations between these polymorphisms and the risk of prostate cancer were observed. Conclusion: Results from the current meta-analysis indicate that ESR1 PvuII (C>T) polymorphism may be a risk factor for prostate cancer among Asian populations, especially among Indian population; while ESR1 XbaI (A>G) polymorphism may increase the risk of prostate cancer among American population.	[Wang, Yu-Mei; Liu, Zu-Wang; Guo, Jing-Bo; Wang, Xiao-Fang; Zhao, Xin-Xin; Zheng, Xuan] China Med Univ, Shengjing Hosp, Dept Hosp, Shenyang, Peoples R China	China Medical University	Wang, YM (corresponding author), China Med Univ, Shengjing Hosp, Dept Hosp, Shenyang, Peoples R China.	cmu2h_wym@126.com			Foundation of the Science and Technology Research Project of the Higher Education Department of Liaoning Province [L2011192]	Foundation of the Science and Technology Research Project of the Higher Education Department of Liaoning Province	This was funded by the Foundation of the Science and Technology Research Project of the Higher Education Department of Liaoning Province (No. L2011192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker N, 2011, RADIOLOGE, V51, P922, DOI 10.1007/s00117-011-2183-1; Bonkhoff H, 2009, EUR UROL, V55, P533, DOI 10.1016/j.eururo.2008.10.035; Cancel-Tassin G, 2003, EUR UROL, V44, P487, DOI 10.1016/S0302-2838(03)00319-1; Chae YK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006523; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; Fukatsu T, 2004, ANTICANCER RES, V24, P2431; Gupta L, 2010, MOL CELL BIOCHEM, V335, P255, DOI 10.1007/s11010-009-0275-2; Hernandez J, 2006, J UROLOGY, V175, P523, DOI 10.1016/S0022-5347(05)00240-5; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Imamov O, 2005, BIOL REPROD, V73, P866, DOI 10.1095/biolreprod.105.043497; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kjaergaard AD, 2007, CIRCULATION, V115, P861, DOI 10.1161/CIRCULATIONAHA.106.615567; Langley RE, 2008, BJU INT, V102, P442, DOI 10.1111/j.1464-410X.2008.07583.x; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Lee KM, 2009, CARCINOGENESIS, V30, P621, DOI 10.1093/carcin/bgp028; Li LC, 2004, BIOCHEM BIOPH RES CO, V321, P455, DOI 10.1016/j.bbrc.2004.06.164; Low YL, 2006, NUTR CANCER, V56, P31, DOI 10.1207/s15327914nc5601_5; McIntyre MH, 2007, CANCER EPIDEM BIOMAR, V16, P2233, DOI 10.1158/1055-9965.EPI-07-0481; Modugno F, 2001, CLIN CANCER RES, V7, P3092; Nelles JL, 2011, EXPERT REV ENDOCRINO, V6, P437, DOI 10.1586/EEM.11.20; Nicolaiew N, 2009, EUR J ENDOCRINOL, V160, P101, DOI 10.1530/EJE-08-0321; Onsory K, 2008, MOL CELL BIOCHEM, V314, P25, DOI 10.1007/s11010-008-9761-1; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Risbridger GP, 2001, ENDOCRINOLOGY, V142, P2443, DOI 10.1210/en.142.6.2443; Royuela M, 2001, J ENDOCRINOL, V168, P447, DOI 10.1677/joe.0.1680447; Safarinejad MR, 2012, MOL CARCINOG; Shibata A, 1997, PROSTATE, V32, P65; Sissung TM, 2011, J CLIN ENDOCR METAB, V96, pE368, DOI 10.1210/jc.2010-2070; Sivonova MK, 2012, MOL BIOL REP, V39, P7871, DOI 10.1007/s11033-012-1631-y; Sobti RC, 2008, CANCER GENET CYTOGEN, V185, P78, DOI 10.1016/j.cancergencyto.2008.04.022; Sonoda T, 2010, EUR J CANCER PREV, V19, P131, DOI 10.1097/CEJ.0b013e328333fbe2; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sun T, 2010, CANCER EPIDEM BIOMAR, V19, P1871, DOI 10.1158/1055-9965.EPI-10-0216; Suzuki K, 2003, CANCER LETT, V195, P177, DOI 10.1016/S0304-3835(03)00182-4; Tanaka Y, 2003, MOL CARCINOGEN, V37, P202, DOI 10.1002/mc.10138; Wang F, 2011, PROSTATE, V71, P1167, DOI 10.1002/pros.21332; Wang LZ, 2003, CANCER LETT, V202, P53, DOI 10.1016/j.canlet.2003.08.001; Zhao ZY, 2012, BIOORG MED CHEM LETT, V22, P129, DOI 10.1016/j.bmcl.2011.11.053; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66999	10.1371/journal.pone.0066999	http://dx.doi.org/10.1371/journal.pone.0066999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805288	Green Submitted, Green Published, gold			2022-12-27	WOS:000320846500116
J	Martini, S; Al Ali, B; Garel, M; Nerini, D; Grossi, V; Pacton, M; Casalot, L; Cuny, P; Tamburini, C				Martini, Severine; Al Ali, Badr; Garel, Marc; Nerini, David; Grossi, Vincent; Pacton, Muriel; Casalot, Laurence; Cuny, Philippe; Tamburini, Christian			Effects of Hydrostatic Pressure on Growth and Luminescence of a Moderately-Piezophilic Luminous Bacteria Photobacterium phosphoreum ANT-2200	PLOS ONE			English	Article							MEMBRANE-LIPIDS; SEA; BIOLUMINESCENCE; CARBON; SNOW; GENE; TEMPERATURE; CONSUMPTION; EXPRESSION; SEDIMENT	Bacterial bioluminescence is commonly found in the deep sea and depends on environmental conditions. Photobacterium phosphoreum ANT-2200 has been isolated from the NW Mediterranean Sea at 2200-m depth (in situ temperature of 13 degrees C) close to the ANTARES neutrino telescope. The effects of hydrostatic pressure on its growth and luminescence have been investigated under controlled laboratory conditions, using a specifically developed high-pressure bioluminescence system. The growth rate and the maximum population density of the strain were determined at different temperatures (from 4 to 37 degrees C) and pressures (from 0.1 to 40 MPa), using the logistic model to define these two growth parameters. Indeed, using the growth rate only, no optimal temperature and pressure could be determined. However, when both growth rate and maximum population density were jointly taken into account, a cross coefficient was calculated. By this way, the optimum growth conditions for P. phosphoreum ANT-2200 were found to be 30 degrees C and, 10 MPa defining this strain as mesophile and moderately piezophile. Moreover, the ratio of unsaturated vs. saturated cellular fatty acids was found higher at 22 MPa, in agreement with previously described piezophile strains. P. phosphoreum ANT-2200 also appeared to respond to high pressure by forming cell aggregates. Its maximum population density was 1.2 times higher, with a similar growth rate, than at 0.1 MPa. Strain ANT-2200 grown at 22 MPa produced 3 times more bioluminescence. The proposed approach, mimicking, as close as possible, the in situ conditions, could help studying deep-sea bacterial bioluminescence and validating hypotheses concerning its role into the carbon cycle in the deep ocean.	[Martini, Severine; Al Ali, Badr; Garel, Marc; Nerini, David; Casalot, Laurence; Cuny, Philippe; Tamburini, Christian] Aix Marseille Univ, CNRS INSU, IRD, Mediterranean Inst Oceanog,UM 110, Marseille, France; [Martini, Severine; Al Ali, Badr; Garel, Marc; Nerini, David; Casalot, Laurence; Cuny, Philippe; Tamburini, Christian] Univ Sud Toulon Var, CNRS INSU, IRD, Mediterranean Inst Oceanog,UM 110, La Garde, France; [Grossi, Vincent] Univ Lyon 1, CNRS, Lab Geol Lyon, UMR5276, F-69622 Villeurbanne, France; [Pacton, Muriel] ETH, Inst Geol, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tamburini, C (corresponding author), Aix Marseille Univ, CNRS INSU, IRD, Mediterranean Inst Oceanog,UM 110, Marseille, France.	christian.tamburini@univ-amu.fr	Casalot, Laurie/B-7536-2013; Casalot, Laurie/ABB-7062-2021; Tamburini, Christian/I-7821-2012; Tamburini, Christian/AAO-8577-2020; Grossi, Vincent/G-6493-2010	Casalot, Laurie/0000-0002-4191-6889; Casalot, Laurie/0000-0002-4191-6889; Tamburini, Christian/0000-0003-3752-7423; Tamburini, Christian/0000-0003-3752-7423; Grossi, Vincent/0000-0001-6263-3813; martini, severine/0000-0001-9471-1708; NERINI, DAVID/0000-0002-7995-1364; Garel, Marc/0000-0002-4374-5905	ANR-POTES [ANR-05-BLAN-0161-01]; Agence Nationale de la Recherche; Aix-Marseille Universite; CNRS; Ministry of Education, Research and Technology, France; Syria Ministry of Higher Education	ANR-POTES(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Aix-Marseille Universite; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministry of Education, Research and Technology, France; Syria Ministry of Higher Education	This work was funded by the ANR-POTES program (ANR-05-BLAN-0161-01) supported by the Agence Nationale de la Recherche, by the AAMIS program (Aix-Marseille Universite) and by EC2CO BIOLUX program (CNRS). SM was granted a MERNT fellowship (Ministry of Education, Research and Technology, France). BAA was supported by a fellowship funded by the Syria Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe F, 1999, TRENDS MICROBIOL, V7, P447, DOI 10.1016/S0966-842X(99)01608-X; Abe F, 1999, BAROPHYSIOLOGY EXTRE, P227; Al Ali B, 2010, CHEM ECOL, V26, P57, DOI 10.1080/02757540903513766; ALLDREDGE AL, 1987, SCIENCE, V235, P689, DOI 10.1126/science.235.4789.689; ANDREWS CC, 1984, NATURE, V307, P539, DOI 10.1038/307539a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; BARTLETT D, 1989, NATURE, V342, P572, DOI 10.1038/342572a0; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; BARTLETT DH, 1992, SCI PROG, V76, P479; BARTLETT DH, 1995, RES MICROBIOL, V146, P697, DOI 10.1016/0923-2508(96)81066-7; Bartlett DH, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P333; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bourgois JJ, 2001, J BIOENERG BIOMEMBR, V33, P353, DOI 10.1023/A:1010615508916; Campbell RW, 2003, MAR ECOL PROG SER, V263, P93, DOI 10.3354/meps263093; Christie WW, 1989, GAS CHROMATOGRAPHY L, P64; Czyz A, 2000, MICROBIOL-UK, V146, P283, DOI 10.1099/00221287-146-2-283; DELONG EF, 1985, SCIENCE, V228, P1101, DOI 10.1126/science.3992247; DeLong EF, 1997, APPL ENVIRON MICROB, V63, P2105, DOI 10.1128/AEM.63.5.2105-2108.1997; Dunlap PV, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P863, DOI 10.1007/0-387-30742-7_27; Eloe EA, 2011, APPL ENVIRON MICROB, V77, P8145, DOI 10.1128/AEM.05204-11; FANG J, 2010, DISCOVER, V31, P18; Gentile G, 2009, DEEP-SEA RES PT II, V56, P763, DOI 10.1016/j.dsr2.2008.07.023; GROGAN DW, 1984, ARCH MICROBIOL, V137, P159, DOI 10.1007/BF00414459; Grossi V, 2010, ENVIRON MICROBIOL, V12, P2020, DOI 10.1111/j.1462-2920.2010.02213.x; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; HASTINGS JW, 1983, B MAR SCI, V33, P818; Herring P.J., 1987, Journal of Bioluminescence and Chemiluminescence, V1, P147, DOI 10.1002/bio.1170010303; Hmelo LR, 2011, ENV MICROBIOL REP, V3, P682, DOI 10.1111/j.1758-2229.2011.00281.x; KAMIMURA K, 1993, APPL ENVIRON MICROB, V59, P924, DOI 10.1128/AEM.59.3.924-926.1993; KATO C, 1994, FEMS MICROBIOL LETT, V122, P91, DOI 10.1111/j.1574-6968.1994.tb07149.x; Kato C, 1995, JAMSTECR, V32, P7; Kato C, 2008, PROTEIN ADAPTATION E, P167; Kita-Tsukamoto K, 2006, FEMS MICROBIOL LETT, V256, P298, DOI 10.1111/j.1574-6968.2006.00129.x; Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; NEALSON KH, 1977, ARCH MICROBIOL, V112, P9, DOI 10.1007/BF00446648; Nealson KH, 1978, METHOD ENZYMOL, V57, P153; Ploug H, 2000, LIMNOL OCEANOGR, V45, P1467, DOI 10.4319/lo.2000.45.7.1467; Pooley DT, 2011, PHOTOCHEM PHOTOBIOL, V87, P324, DOI 10.1111/j.1751-1097.2010.00864.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; R Core Team, 2012, R LANG ENV STAT COMP; RUBY EG, 1979, APPL ENVIRON MICROB, V38, P406, DOI 10.1128/AEM.38.3.406-411.1979; RUBY EG, 1980, APPL ENVIRON MICROB, V39, P302, DOI 10.1128/AEM.39.2.302-306.1980; Schweitzer B, 2001, APPL ENVIRON MICROB, V67, P632, DOI 10.1128/AEM.67.2.632-645.2001; Shively JM, 2001, BACTERIAL ARCHAEAL I; Tamburini C, 2009, DEEP-SEA RES PT II, V56, P1533, DOI 10.1016/j.dsr2.2008.12.035; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; Yamada M, 2000, J BACTERIOL, V182, P2945, DOI 10.1128/JB.182.10.2945-2952.2000; Yanagibayashi M, 1999, FEMS MICROBIOL LETT, V170, P271, DOI 10.1016/S0378-1097(98)00556-4; Yano Y, 1998, APPL ENVIRON MICROB, V64, P479; YAYANOS AA, 1995, ANNU REV MICROBIOL, V49, P777, DOI 10.1146/annurev.mi.49.100195.004021; YAYANOS AA, 1986, P NATL ACAD SCI USA, V83, P9542, DOI 10.1073/pnas.83.24.9542; Zarubin M, 2012, P NATL ACAD SCI USA, V109, P853, DOI 10.1073/pnas.1116683109; ZOBELL CE, 1949, J BACTERIOL, V57, P179, DOI 10.1128/JB.57.2.179-189.1949	58	24	25	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66580	10.1371/journal.pone.0066580	http://dx.doi.org/10.1371/journal.pone.0066580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818946	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800082
J	Schmidt, JH; Gorn, TS				Schmidt, Joshua H.; Gorn, Tony S.			Possible Secondary Population-Level Effects of Selective Harvest of Adult Male Muskoxen	PLOS ONE			English	Article							MOOSE ALCES-ALCES; SEX-RATIO; BODY CONDITION; MULE DEER; DYNAMICS; AGE; MANAGEMENT; NUTRITION; HISTORY; CALVES	Selective harvest regimes are often focused on males resulting in skewed sex-ratios, and for many ungulate species this strategy is sustainable. However, muskoxen (Ovibos moschatus) are very social and mature bulls (>= 4 years old), particularly prime-age bulls (6-10 years old), play important roles in predator defense and recruitment. A year-round social structure incorporating large males into mixed-sex groups could make this species more susceptible to the effects of selective harvest if population composition and sex-ratios influence overall survival and reproductive success. Using detailed data collected on the muskox population occupying the Seward Peninsula, Alaska during 2002-2012, we formulated the hypothesis that the selective harvest of mature bulls may be related to documented changes in population composition and growth rates in this species. In addition, we reviewed existing published information from two other populations in Alaska, the Cape Thompson and Northeastern populations, to compare population growth rates among the three areas under differential harvest rates relative to our hypothesis. We found that on the Seward Peninsula, mature bull: adult cow ratios declined 4-12%/ year and short-yearling: adult cow ratios (i.e., recruitment) declined 8-9%/year in the most heavily harvested areas. Growth rates in all 3 populations decreased disproportionately after increases in the number of bulls harvested, and calf: cow ratios declined in the Northeastern population as harvest increased. While lack of appropriate data prevented us from excluding other potential causes such as density dependent effects and changes in predator densities, our results did align with our hypothesis, suggesting that in the interest of conservation, harvest of mature males should be restricted until causal factors can be more definitively identified. If confirmed by additional research, our findings would have important implications for harvest management and conservation of muskoxen and other ungulate species with similar life-histories.	[Schmidt, Joshua H.] Natl Pk Serv, Cent Alaska Network, Fairbanks, AK USA; [Gorn, Tony S.] Alaska Dept Fish & Game, Div Wildlife Conservat, Nome, AK USA	United States Department of the Interior; Alaska Department of Fish & Game	Schmidt, JH (corresponding author), Natl Pk Serv, Cent Alaska Network, Fairbanks, AK USA.	joshua_schmidt@nps.gov			Federal Aid in Wildlife Restoration; Alaska Department of Fish and Game, Western Arctic Parklands; U.S. National Park Service Inventory and Monitoring Program	Federal Aid in Wildlife Restoration; Alaska Department of Fish and Game, Western Arctic Parklands; U.S. National Park Service Inventory and Monitoring Program	Support for this project was provided by Federal Aid in Wildlife Restoration, the Alaska Department of Fish and Game, Western Arctic Parklands, and the U.S. National Park Service Inventory and Monitoring Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LG, 1995, J WILDLIFE MANAGE, V59, P584, DOI 10.2307/3802467; Allen J. A., 1912, Science New York Ser 2, V36, DOI 10.1126/science.36.934.720; [Anonymous], 1965, CANADIAN WILDLIFE SE, V2; Barboza PS, 2004, INT CONGR SER, V1275, P327, DOI 10.1016/j.ics.2004.09.040; Bishop CJ, 2005, WILDLIFE SOC B, V33, P662, DOI 10.2193/0091-7648(2005)33[662:EOLAHO]2.0.CO;2; Boertje RD, 2009, J WILDLIFE MANAGE, V73, P314, DOI 10.2193/2007-591; Buckland S.T., 2001, pi; CARBYN LN, 1988, ARCTIC, V41, P297; Conroy M.J., 2009, QUANTITATIVE CONSERV; Czaplewski R.L., 1983, Wildlife Society Bulletin, V11, P121; Dau J, 2001, MUSKOX MANAGEMENT RE, P31; Dau J, 2007, MUSKOX MANAGEMENT RE, P35; Dobson A, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P193; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gorn TS., 2011, MUSKOX MANAGEMENT RE, P16; Gray DR, 1974, MUSK OX, V14, P25; Gray DR, 1987, MUSKOXEN POLAR BEAR; GUNN A, 1982, ARCTIC, V35, P545; GUNN A, 1991, ARCTIC, V44, P188; Gunn A., 1982, P1021; Gunn A., 2003, WILD MAMMALS N AM BI, V2nd, P1076; Harper P, 2009, MUSKOX MANAGEMENT RE; Hone E., 1934, Special Publications of the American Committee on International Wild Life Protection, Vno. 5, P1; Hunter CM, 2004, J WILDLIFE MANAGE, V68, P585, DOI 10.2193/0022-541X(2004)068[0585:TIOEVA]2.0.CO;2; Ihl C, 2011, J MAMMAL, V92, P819, DOI 10.1644/10-MAMM-A-109.1; Jenkins D.A., 2011, 1 GOV NUN DEP ENV; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; KOMERS PE, 1992, BEHAV ECOL SOCIOBIOL, V31, P195; Laurian C, 2000, J APPL ECOL, V37, P515, DOI 10.1046/j.1365-2664.2000.00520.x; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Lenart EA, 2001, MUSKOX MANAGEMENT RE, P39; Lenart EA., 2011, MUSKOX MANAGEMENT RE, P63; LENT P C, 1988, Mammalian Species, P1, DOI 10.2307/3504280; Lent P.C., 1999, MUSKOXEN THEIR HUNTE, V5; MILLER FL, 1980, CAN FIELD NAT, V94, P52; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Mysterud A, 2011, J APPL ECOL, V48, P827, DOI 10.1111/j.1365-2664.2011.02006.x; OLESEN CR, 1989, CAN J ZOOL, V67, P1116, DOI 10.1139/z89-159; Persons K, 2001, MUSKOX MANAGEMENT RE, P13; PRINS HHT, 1989, BEHAVIOUR, V108, P297, DOI 10.1163/156853989X00349; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reynolds PE, 1998, J WILDLIFE MANAGE, V62, P734, DOI 10.2307/3802350; Reynolds PE, 2002, URSUS, V13, P79; Reynolds PE, 1991, RANGIFER, V13, P83; Rowell JE, 2007, CAN J ANIM SCI, V87, P535, DOI 10.4141/CJAS06036; Rowell JE, 2003, J ANIM SCI, V81, P2669; Royle J. A., 2008, HIERARCHICAL MODELIN; Saether BE, 2009, ANIM CONSERV, V12, P488, DOI 10.1111/j.1469-1795.2009.00278.x; Saether BE, 2003, J WILDLIFE MANAGE, V67, P455, DOI 10.2307/3802703; Saether BE, 2001, WILDLIFE BIOL, V7, P171, DOI 10.2981/wlb.2001.021; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Smith, 1976, THESIS U ALASKA FAIR; SMITH TE, 1989, CAN J ZOOL, V67, P1096, DOI 10.1139/z89-155; Smith TE, 1984, BIOL PAPERS U ALASKA; Smith TE, 1987, 161R AL DEP FISH GAM; Solberg EJ, 2002, WILDLIFE BIOL, V8, P117, DOI 10.2981/wlb.2002.016; Spiegelhalter DJ, 2004, WINBUGS VERSION 1 4; Testa JW, 2000, J MAMMAL, V81, P162, DOI 10.1644/1545-1542(2000)081<0162:TPITSO>2.0.CO;2; Westing C, 2011, MUSKOX MANAGEMENT RE, P48; White GC, 2001, J WILDLIFE MANAGE, V65, P543, DOI 10.2307/3803107; White RG, 1997, J ZOOL, V243, P13, DOI 10.1111/j.1469-7998.1997.tb05752.x; WHITE RG, 1989, CAN J ZOOL, V67, P1125, DOI 10.1139/z89-162; Williams B. K., 2002, ANAL MANAGEMENT ANIM; [No title captured]	65	11	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67493	10.1371/journal.pone.0067493	http://dx.doi.org/10.1371/journal.pone.0067493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818982	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800139
J	Jia, YF; Jiao, SW; Zhang, YM; Zhou, Y; Lei, GC; Liu, GH				Jia, Yifei; Jiao, Shengwu; Zhang, Yamian; Zhou, Yan; Lei, Guangchun; Liu, Guanhua			Diet Shift and Its Impact on Foraging Behavior of Siberian Crane (Grus Leucogeranus) in Poyang Lake	PLOS ONE			English	Article							HABITAT SELECTION; CHINA; CONSERVATION	The study of habitat selection and diet has a long history in ecology. This is often used to assess the functional roles of wetland in biodiversity conservation. Shifting habitat and diet may be one of the survival strategies during extremely adverse conditions. Therefore, sudden changes in habitat selection may indicate the deterioration of the habitat quality, and management interventions are necessary. Siberian crane (Grus leucogeranus) became critically endangered due to loss of habitat, and is currently a global conservation focus. Every winter, more than 95% of the species' global population congregates at Poyang Lake, and feeds on tubers of Vallisneria spiralis in shallow water and mudflat habitat. In this study, we reported the first sighting of large numbers of Siberian cranes foraging at wet meadows, where they fed on a different plant, Potentilla limprichtii due to extreme scarcity of their preferred tuber. To understand how well the cranes adapted to such unusual habitat, field surveys to assess the distribution of cranes across different habitats, and food availability in each habitat were carried out in the winter of 2011. Field observations on crane behaviors at different habitats were also conducted. Results show that cranes displayed significantly different behavior patterns when using the wet meadow, compared to the crane's optimal habitat - shallow water and mudflat. Both juveniles and adults spent significantly less time foraging, and more time alerting in meadows than in shallow waters and mudflats. These results indicated that the meadow might be a suboptimal wintering ground for Siberian crane, which helped the cranes survive from extreme unfavorable conditions. To some degree, this finding alleviates the general concern over the fluctuating of its food resources which was caused by hydrological disturbances. However, more studies are needed to assess the consequences of such diet and habitat shift for crane survival.	[Jia, Yifei; Jiao, Shengwu; Zhang, Yamian; Zhou, Yan; Lei, Guangchun] Beijing Forestry Univ, Beijing, Peoples R China; [Liu, Guanhua] Jiangxi Poyang Lake Natl Nat Reserve Author, Nanchang, Jiangxi, Peoples R China	Beijing Forestry University	Lei, GC (corresponding author), Beijing Forestry Univ, Beijing, Peoples R China.	leiguangchunbjfu@gmail.com	Guangchun, Lei/ABC-8081-2021		Key National Basic Research Development Program of China (973 Program) [2012CB417005, 2009CB421103]	Key National Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This study was supported by a grant from the Key National Basic Research Development Program of China (973 Program) (No. 2012CB417005 & No. 2009CB421103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2006, WATERBIRD SURVEY MID; Aviles JM, 2003, CAN J ZOOL, V81, P1233, DOI 10.1139/Z03-105; Bystrom P, 2003, J ANIM ECOL, V72, P156, DOI 10.1046/j.1365-2656.2003.00681.x; Chen B, 1991, P 1987 INT CRAN WORK, P109; Davis CA, 1998, CONDOR, V100, P266, DOI 10.2307/1370267; Deng G, 2007, J JIANGXI NORMAL U N, V2, P12; Drickamer LC., 1996, ANIMAL BEHAV MECH EC, V4; Ellis DH, 1998, BEHAV PROCESS, V43, P125, DOI 10.1016/S0376-6357(98)00008-4; Ge C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026447; Guo HF, 2008, 2008 INTERNATIONAL CONFERENCE ON MULTIMEDIA AND INFORMATION TECHNOLOGY, PROCEEDINGS, P741, DOI 10.1109/MMIT.2008.27; International Wetland, 2012, WATERBIRD POPULATION; IUCN, 2012, IUCN RED LIST; JANUS C, 1988, ANIM BEHAV, V36, P1400, DOI 10.1016/S0003-3472(88)80210-0; Ji W., 2007, GEORG INF SCI, V13, P51, DOI [10.1080/10824000709480632, DOI 10.1080/10824000709480632]; Johnsgard P, 1983, CRANES OF THE WORLD; Kanai Y, 2002, BIOL CONSERV, V106, P339, DOI 10.1016/S0006-3207(01)00259-2; KIMBER A, 1995, REGUL RIVER, V11, P167, DOI 10.1002/rrr.3450110206; Kong DJ, 2011, ORYX, V45, P258, DOI 10.1017/S0030605310000888; Krebs J.R., 1978, P23; Lewis AC, 1986, SCIENCE; Ma RH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045514; Ma ZJ, 2003, ECOL RES, V18, P321, DOI 10.1046/j.1440-1703.2003.00557.x; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Meine C.D., 1996, CRANES STATUS SURVEY, P294; MILLIKEN GA, 1992, ANAL MESSY DATA DESI, V1; Morris DW, 2012, OIKOS, V121, P975, DOI 10.1111/j.1600-0706.2011.20492.x; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; Potapov E., 1992, Bird Conservation International, V2, P149; [RDevelopment C TEAM], 2008, R LANG ENV STAT COMP; Rosenberger A, 2003, FRESHWATER BIOL, V48, P1563, DOI 10.1046/j.1365-2427.2003.01109.x; Shankman D, 2006, INT J CLIMATOL, V26, P1255, DOI 10.1002/joc.1307; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Stephens DW, 1987, FORAGING THEORY; van Dijk J, 2008, J ANIM ECOL, V77, P1183, DOI 10.1111/j.1365-2656.2008.01445.x; Wu GF, 2008, INT J REMOTE SENS, V29, P2183, DOI 10.1080/01431160701422254; Wu GF, 2009, HYDROBIOLOGIA, V623, P213, DOI 10.1007/s10750-008-9659-7; Wu J, 2010, MONITORING ANN REPOR, P100; Wu Z.Y., 1994, FLORA CHINA; Xiong B, 2002, ACTA HYDROBIOL, V26, P24; Zar JH, 2009, BIOSTAT ANAL, V110, P92	43	44	63	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e65843	10.1371/journal.pone.0065843	http://dx.doi.org/10.1371/journal.pone.0065843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823943	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400024
J	Zheng, WW; Rasmussen, U; Zheng, SP; Bao, XD; Chen, B; Gao, Y; Guan, X; Larsson, J; Bergman, B				Zheng, Weiwen; Rasmussen, Ulla; Zheng, Siping; Bao, Xiaodong; Chen, Bin; Gao, Yuan; Guan, Xiong; Larsson, John; Bergman, Birgitta			Multiple Modes of Cell Death Discovered in a Prokaryotic (Cyanobacterial) Endosymbiont	PLOS ONE			English	Article							AZOLLA-ANABAENA SYMBIOSIS; SEQUENCE ALIGNMENT; APOPTOTIC CELLS; AUTOPHAGY; CLEARANCE; CYCLE; DIE	Programmed cell death (PCD) is a genetically-based cell death mechanism with vital roles in eukaryotes. Although there is limited consensus on similar death mode programs in prokaryotes, emerging evidence suggest that PCD events are operative. Here we present cell death events in a cyanobacterium living endophytically in the fern Azolla microphylla, suggestive of PCD. This symbiosis is characterized by some unique traits such as a synchronized development, a vertical transfer of the cyanobacterium between plant generations, and a highly eroding cyanobacterial genome. A combination of methods was used to identify cell death modes in the cyanobacterium. Light- and electron microscopy analyses showed that the proportion of cells undergoing cell death peaked at 53.6% (average 20%) of the total cell population, depending on the cell type and host developmental stage. Biochemical markers used for early and late programmed cell death events related to apoptosis (Annexin V-EGFP and TUNEL staining assays), together with visualization of cytoskeleton alterations (FITC-phalloidin staining), showed that all cyanobacterial cell categories were affected by cell death. Transmission electron microscopy revealed four modes of cell death: apoptotic-like, autophagic-like, necrotic-like and autolytic-like. Abiotic stresses further enhanced cell death in a dose and time dependent manner. The data also suggest that dynamic changes in the peptidoglycan cell wall layer and in the cytoskeleton distribution patterns may act as markers for the various cell death modes. The presence of a metacaspase homolog (domain p20) further suggests that the death modes are genetically programmed. It is therefore concluded that multiple, likely genetically programmed, cell death modes exist in cyanobacteria, a finding that may be connected with the evolution of cell death in the plant kingdom.	[Zheng, Weiwen; Gao, Yuan; Guan, Xiong] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Rasmussen, Ulla; Larsson, John; Bergman, Birgitta] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Zheng, Weiwen; Zheng, Siping; Chen, Bin] Fujian Acad Agr Sci, Biotech Inst, Fuzhou, Peoples R China; [Bao, Xiaodong] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA	Fujian Agriculture & Forestry University; Stockholm University; Fujian Academy of Agricultural Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bergman, B (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	bergmanb@botan.su.se			Swedish Research Council Formas; Swedish Energy Agency; Swedish Research Council Link program; National Natural Science Foundation of China [31071745]; Science and Technology Foundation of Fujian Province, China [2010R1021-8]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Swedish Research Council Link program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Fujian Province, China	The financial support from the Swedish Research Council Formas and the Swedish Energy Agency (to B.B.), the Swedish Research Council Link program (to U.R. and W.W.Z.), the National Natural Science Foundation of China (Grant 31071745 to X.G. and W.W.Z.), and the Science and Technology Foundation of Fujian Province, China (Grant 2010R1021-8; to S.P.Z.) is gratefully acknowledged. The authors also thank K. and A. Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund-Samuelsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049888; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Bursch W, 2000, J CELL SCI, V113, P1189; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekman M, 2008, J EXP BOT, V59, P1023, DOI 10.1093/jxb/erm282; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Guljamow A, 2012, PLOS ONE, V7, P221, DOI 10.1371/journal.pone.0029926; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Jiang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-198; Jimenez C, 2009, J EXP BOT, V60, P815, DOI 10.1093/jxb/ern330; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Laporte C, 2007, CELL DEATH DIFFER, V14, P266, DOI 10.1038/sj.cdd.4401994; Larsson J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-187; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Melino G, 2005, CELL DEATH DIFFER, V12, P1457, DOI 10.1038/sj.cdd.4401781; Ning SB, 2002, J APPL MICROBIOL, V93, P15, DOI 10.1046/j.1365-2672.2002.01651.x; PERKINS SK, 1993, NEW PHYTOL, V123, P53; PETERS GA, 1989, ANNU REV PLANT PHYS, V40, P193, DOI 10.1146/annurev.pp.40.060189.001205; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Reyes-Prieto A, 2007, MOL PHYLOGENET EVOL, V45, P384, DOI 10.1016/j.ympev.2007.02.026; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Tang YZ, 2007, APPL ENVIRON MICROB, V73, P2306, DOI 10.1128/AEM.01741-06; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; van Heerde WL, 2000, CARDIOVASC RES, V45, P549, DOI 10.1016/S0008-6363(99)00396-X; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; VERNET T, 1991, J BIOL CHEM, V266, P21451; Watanabe I., 1977, UTILIZATION AZOLLA A; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zheng WW, 2009, MICROBIOL MONOGR, V8, P235, DOI 10.1007/7171_2008_120; Zheng WW, 2009, NEW PHYTOL, V181, P53, DOI 10.1111/j.1469-8137.2008.02644.x	46	23	25	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66147	10.1371/journal.pone.0066147	http://dx.doi.org/10.1371/journal.pone.0066147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23822984	Green Published, Green Submitted, gold			2022-12-27	WOS:000320576400058
J	Holtta, M; Hansson, O; Andreasson, U; Hertze, J; Minthon, L; Nagga, K; Andreasen, N; Zetterberg, H; Blennow, K				Holtta, Mikko; Hansson, Oskar; Andreasson, Ulf; Hertze, Joakim; Minthon, Lennart; Nagga, Katarina; Andreasen, Niels; Zetterberg, Henrik; Blennow, Kaj			Evaluating Amyloid-beta Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; LONG-TERM POTENTIATION; A-BETA; IN-VIVO; NATURAL OLIGOMERS; CSF BIOMARKERS; SYNAPSE LOSS; MOUSE MODEL; PROTEIN; PEPTIDE	The current study evaluated amyloid-beta oligomers (A beta o) in cerebrospinal fluid as a clinical biomarker for Alzheimer's disease (AD). We developed a highly sensitive A beta o ELISA using the same N-terminal monoclonal antibody (82E1) for capture and detection. CSF samples from patients with AD, mild cognitive impairment (MCI), and healthy controls were examined. The assay was specific for oligomerized A beta with a lower limit of quantification of 200 fg/ml, and the assay signal showed a tight correlation with synthetic A beta o levels. Three clinical materials of well characterized AD patients (n = 199) and cognitively healthy controls (n = 148) from different clinical centers were included, together with a clinical material of patients with MCI (n = 165). A beta o levels were elevated in the all three AD-control comparisons although with a large overlap and a separation from controls that was far from complete. Patients with MCI who later converted to AD had increased A beta o levels on a group level but several samples had undetectable levels. These results indicate that presence of high or measurable A beta o levels in CSF is clearly associated with AD, but the overlap is too large for the test to have any diagnostic potential on its own.	[Holtta, Mikko; Andreasson, Ulf; Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Hansson, Oskar; Hertze, Joakim; Minthon, Lennart; Nagga, Katarina] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden; [Andreasen, Niels] Karolinska Univ Hosp, Geriatr Med Sect, Dept Clin Neurosci & Family Med, Stockholm, Sweden; [Zetterberg, Henrik] UCL, UCL Inst Neurol, London, England	University of Gothenburg; Lund University; Karolinska Institutet; Karolinska University Hospital; University of London; University College London	Holtta, M (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden.	mikko.holtta@neuro.gu.se	Hansson, Oskar/A-7134-2013	Hansson, Oskar/0000-0001-8467-7286; Nagga, Katarina/0000-0003-0194-8402; Holtta, Mikko/0000-0001-6024-3686	Stiftelsen Gamla tjanarinnor; Gun och Bertil Stohnes stiftelse; Demensfonden; Kungliga och Hvitfeldtska stiftelsen; Stiftelsen Greta Johansson och Brita Anderssons Minnesfond; Adlerbertska stiftelsen	Stiftelsen Gamla tjanarinnor; Gun och Bertil Stohnes stiftelse; Demensfonden; Kungliga och Hvitfeldtska stiftelsen; Stiftelsen Greta Johansson och Brita Anderssons Minnesfond; Adlerbertska stiftelsen	This work was supported by Stiftelsen Gamla tjanarinnor, Gun och Bertil Stohnes stiftelse, Demensfonden, Kungliga och Hvitfeldtska stiftelsen, Stiftelsen Greta Johansson och Brita Anderssons Minnesfond, Adlerbertska stiftelsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N, 1999, NEUROSCI LETT, V273, P5, DOI 10.1016/S0304-3940(99)00617-5; Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bjerke M, 2010, INT J ALZHEIMERS DIS, V2010; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; El-Agnaf OMA, 2000, BIOCHEM BIOPH RES CO, V273, P1003, DOI 10.1006/bbrc.2000.3051; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Flirski Marcin, 2005, Current Alzheimer Research, V2, P47, DOI 10.2174/1567205052772704; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Funke SA, 2007, BIOCHEM BIOPH RES CO, V364, P902, DOI 10.1016/j.bbrc.2007.10.085; Gao CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015725; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mustafiz T, 2011, NEURODEGENER DIS, V8, P352, DOI 10.1159/000323871; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Santos AN, 2012, J ALZHEIMERS DIS, V29, P171, DOI 10.3233/JAD-2012-111361; Sehlin D, 2010, J ALZHEIMERS DIS, V21, P1295, DOI 10.3233/JAD-2010-100609; Sepulveda FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011820; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565	50	92	93	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66381	10.1371/journal.pone.0066381	http://dx.doi.org/10.1371/journal.pone.0066381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799095	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300078
J	Schubert, M; Spahn, M; Kneitz, S; Scholz, CJ; Joniau, S; Stroebel, P; Riedmiller, H; Kneitz, B				Schubert, Maria; Spahn, Martin; Kneitz, Susanne; Scholz, Claus Juergen; Joniau, Steven; Stroebel, Philipp; Riedmiller, Hubertus; Kneitz, Burkhard			Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GROUP PROTEIN I(Y); RADICAL PROSTATECTOMY; MYC EXPRESSION; LUNG-CANCER; CELLS; HMGA1; OVEREXPRESSION; IDENTIFICATION; METASTASIS	Background: The identification of additional prognostic markers to improve risk stratification and to avoid overtreatment is one of the most urgent clinical needs in prostate cancer (PCa). MicroRNAs, being important regulators of gene expression, are promising biomarkers in various cancer entities, though the impact as prognostic predictors in PCa is poorly understood. The aim of this study was to identify specific miRNAs as potential prognostic markers in high-risk PCa and to validate their clinical impact. Methodology and Principal Findings: We performed miRNA-microarray analysis in a high-risk PCa study group selected by their clinical outcome (clinical progression free survival (CPFS) vs. clinical failure (CF)). We identified seven candidate miRNAs (let-7a/b/c, miR-515-3p/5p, -181b, -146b, and -361) that showed differential expression between both groups. Further qRT-PCR analysis revealed down-regulation of members of the let-7 family in the majority of a large, well-characterized high-risk PCa cohort (n = 98). Expression of let-7a/b/and -c was correlated to clinical outcome parameters of this group. While let-7a showed no association or correlation with clinical relevant data, let-7b and let-7c were associated with CF in PCa patients and functioned partially as independent prognostic marker. Validation of the data using an independent high-risk study cohort revealed that let-7b, but not let-7c, has impact as an independent prognostic marker for BCR and CF. Furthermore, we identified HMGA1, a non-histone protein, as a new target of let-7b and found correlation of let-7b down-regulation with HMGA1 over-expression in primary PCa samples. Conclusion: Our findings define a distinct miRNA expression profile in PCa cases with early CF and identified let-7b as prognostic biomarker in high-risk PCa. This study highlights the importance of let-7b as tumor suppressor miRNA in high-risk PCa and presents a basis to improve individual therapy for high-risk PCa patients.	[Schubert, Maria; Riedmiller, Hubertus; Kneitz, Burkhard] Univ Hosp, Dept Urol & Pediat Urol, Comprehens Canc Ctr CCC Mainfranken, Wurzburg, Germany; [Spahn, Martin] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland; [Kneitz, Susanne] Univ Wurzburg, Dept Physiol Chem, D-97070 Wurzburg, Germany; [Scholz, Claus Juergen] Univ Wurzburg, D-97070 Wurzburg, Germany; [Joniau, Steven] Katholieke Univ Leuven Hosp, Dept Urol, Louvain, Belgium; [Stroebel, Philipp] Univ Hosp, Dept Pathol, Gottingen, Germany	University of Wurzburg; University of Bern; University Hospital of Bern; University of Wurzburg; University of Wurzburg; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Gottingen	Schubert, M (corresponding author), Univ Hosp, Dept Urol & Pediat Urol, Comprehens Canc Ctr CCC Mainfranken, Wurzburg, Germany.	Schubert_M@klinik.uni-wuerzburg.de; Kneitz_B@klinik.uni-wuerzburg.de	Scholz, Claus Jürgen/H-3202-2019; Spahn, Martin/A-9128-2015; Joniau, Steven/K-7655-2013	Scholz, Claus Jürgen/0000-0002-6406-7859; Spahn, Martin/0000-0002-5770-9489; Joniau, Steven/0000-0003-3195-9890	German Research Foundation (DFG); University of Wuerzburg [Z-3/14]; Ferdinand Eisenberger grant of the Deutsche Gesellschaft fur Urologie (German Society of Urology) [ScM1/FE-11]; IZKF (Interdisciplinary Center for Clinical Research)	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Ferdinand Eisenberger grant of the Deutsche Gesellschaft fur Urologie (German Society of Urology); IZKF (Interdisciplinary Center for Clinical Research)	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing, a Ferdinand Eisenberger grant of the Deutsche Gesellschaft fur Urologie (German Society of Urology), grant ID ScM1/FE-11; and IZKF (Interdisciplinary Center for Clinical Research), University of Wurzburg, grant ID Z-3/14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Fedele M, 1996, CANCER RES, V56, P1896; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Garg Minal, 2012, World J Stem Cells, V4, P62; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hulf T, 2012, ONCOGENE; Ji JF, 2010, J HEPATOL, V53, P974, DOI 10.1016/j.jhep.2010.07.001; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033729; Larne O, 2012, INT J CANC; Liau SS, 2007, BRIT J CANCER, V96, P993, DOI 10.1038/sj.bjc.6603654; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Man YG, 2011, CANCER GENOM PROTEOM, V8, P235; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Petrovich Z, 2002, BJU INT, V89, P604, DOI 10.1046/j.1464-410X.2002.02698.x; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Rahman MM, 2009, BRIT J CANCER, V100, P501, DOI 10.1038/sj.bjc.6604883; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Sokol L, 2011, BRIT J HAEMATOL, V153, P24, DOI 10.1111/j.1365-2141.2011.08581.x; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Spahn M, 2010, EUR UROL, V58, P1, DOI 10.1016/j.eururo.2010.03.001; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takeuchi I, 2012, PROSTATE, V72, P1124, DOI 10.1002/pros.22460; Tamimi Y, 1996, BRIT J CANCER, V74, P573, DOI 10.1038/bjc.1996.403; TAMIMI Y, 1993, CANCER RES, V53, P5512; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wei JJ, 2011, CLIN CANCER RES, V17, P1297, DOI 10.1158/1078-0432.CCR-10-0993; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388	48	67	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65064	10.1371/journal.pone.0065064	http://dx.doi.org/10.1371/journal.pone.0065064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798998	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300007
J	Tandon, A; Sharma, A; Rodier, JT; Klibanov, AM; Rieger, FG; Mohan, RR				Tandon, Ashish; Sharma, Ajay; Rodier, Jason T.; Klibanov, Alexander M.; Rieger, Frank G.; Mohan, Rajiv R.			BMP7 Gene Transfer via Gold Nanoparticles into Stroma Inhibits Corneal Fibrosis In Vivo	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; CHRONIC KIDNEY-DISEASE; MITOMYCIN-C; PHOTOREFRACTIVE KERATECTOMY; MYOFIBROBLAST DIFFERENTIATION; PTERYGIUM SURGERY; HAZE; EXPRESSION; CELLS; PROLIFERATION	This study examined the effects of BMP7 gene transfer on corneal wound healing and fibrosis inhibition in vivo using a rabbit model. Corneal haze in rabbits was produced with the excimer laser performing -9 diopters photorefractive keratectomy. BMP7 gene was introduced into rabbit keratocytes by polyethylimine-conjugated gold nanoparticles (PEI2-GNPs) transfection solution single 5-minute topical application on the eye. Corneal haze and ocular health in live animals was gauged with stereo-and slit-lamp biomicroscopy. The levels of fibrosis [alpha-smooth muscle actin (alpha SMA), F-actin and fibronectin], immune reaction (CD11b and F4/80), keratocyte apoptosis (TUNEL), calcification (alizarin red, vonKossa and osteocalcin), and delivered-BMP7 gene expression in corneal tissues were quantified with immunofluorescence, western blotting and/or real-time PCR. Human corneal fibroblasts (HCF) and in vitro experiments were used to characterize the molecular mechanism mediating BMP7's anti-fibrosis effects. PEI2-GNPs showed substantial BMP7 gene delivery into rabbit keratocytes in vivo (2x10(4) gene copies/mu g DNA). Localized BMP7 gene therapy showed a significant corneal haze decrease (1.68 +/- 0.31 compared to 3.2 +/- 0.43 in control corneas; p<0.05) in Fantes grading scale. Immunostaining and immunoblot analyses detected significantly reduced levels of alpha SMA (46 +/- 5% p<0.001) and fibronectin proteins (48 +/- 5% p<0.01). TUNEL, CD11b, and F4/80 assays revealed that BMP7 gene therapy is nonimmunogenic and nontoxic for the cornea. Furthermore, alizarin red, vonKossa and osteocalcin analyses revealed that localized PEI2-GNP-mediated BMP7 gene transfer in rabbit cornea does not cause calcification or osteoblast recruitment. Immunofluorescence of BMP7-transefected HCFs showed significantly increased pSmad-1/5/8 nuclear localization (>88%; p<0.0001), and immunoblotting of BMP7-transefected HCFs grown in the presence of TGF beta demonstrated significantly enhanced pSmad-1/5/8 (95%; p<0.001) and Smad6 (53%, p<0.001), and decreased alpha SMA (78%; p<0.001) protein levels. These results suggest that localized BMP7 gene delivery in rabbit cornea modulates wound healing and inhibits fibrosis in vivo by counter balancing TGF beta 1-mediated profibrotic Smad signaling.	[Tandon, Ashish; Sharma, Ajay; Rodier, Jason T.; Rieger, Frank G.; Mohan, Rajiv R.] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Tandon, Ashish; Sharma, Ajay; Rodier, Jason T.; Mohan, Rajiv R.] Univ Missouri, Sch Med, Mason Eye Inst, Columbia, MO USA; [Klibanov, Alexander M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Klibanov, Alexander M.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Mohan, Rajiv R.] Univ Missouri, Coll Vet Med, Columbia, MO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Missouri System; University of Missouri Columbia	Mohan, RR (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	mohanr@health.missouri.edu			Veteran Health Affairs Merit [1I01BX000357-01]; National Eye Institute, National Institutes of Health [RO1EY17294]; National Institutes of Health [RO1EB000244]; Research to Prevent Blindness Unrestricted (Mason Eye Institute) grants; NATIONAL EYE INSTITUTE [R01EY017294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244] Funding Source: NIH RePORTER	Veteran Health Affairs Merit; National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Unrestricted (Mason Eye Institute) grants; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by 1I01BX000357-01Veteran Health Affairs Merit (RRM), RO1EY17294 National Eye Institute, National Institutes of Health (RRM), RO1EB000244 National Institutes of Health (AMK), and Research to Prevent Blindness Unrestricted (Mason Eye Institute) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedei A, 2006, EUR J OPHTHALMOL, V16, P229, DOI 10.1177/112067210601600206; Buijs JT, 2010, CURR PHARM DESIGN, V16, P1291; Camellin M, 2004, J REFRACT SURG, V20, pS693; Campolongo MJ, 2010, ADV DRUG DELIVER REV, V62, P606, DOI 10.1016/j.addr.2010.03.004; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cho YK, 2012, INVEST OPHTH VIS SCI, V53, P2328, DOI 10.1167/iovs.11-8393; Davies MR, 2003, J AM SOC NEPHROL, V14, P1559, DOI 10.1097/01.ASN.0000068404.57780.DD; Dougherty PJ, 1996, CORNEA, V15, P537; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Hung FC, 2002, VISION RES, V42, P427, DOI 10.1016/S0042-6989(01)00242-5; Irache JM, 2011, VET PARASITOL, V180, P47, DOI 10.1016/j.vetpar.2011.05.028; Jang JW, 2009, INVEST OPHTHALMOL VI, V50; Jani PD, 2007, INVEST OPHTH VIS SCI, V48, P2030, DOI 10.1167/iovs.06-0853; Jester JV, 2012, MOL VIS, V18, P1828; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619; Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460; Mitu G, 2008, FRONT BIOSCI-LANDMRK, V13, P4726, DOI 10.2741/3035; Mohan RR, 2011, CURR MOL MED, V11, P110; Mohan RR, 2012, PROG RETIN EYE RES, V31, P43, DOI 10.1016/j.preteyeres.2011.09.001; Mohan RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018771; Mohan RR, 2010, EXP EYE RES, V91, P238, DOI 10.1016/j.exer.2010.05.013; Mohan RR, 1998, INVEST OPHTH VIS SCI, V39, P2626; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Mohan RR, 2007, IOVS, V48; Murray LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004039; Netto MV, 2006, J REFRACT SURG, V22, P562; Nien CJ, 2011, J CATARACT REFR SURG, V37, P937, DOI 10.1016/j.jcrs.2010.11.035; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; RUBINFELD RS, 1992, OPHTHALMOLOGY, V99, P1647; Safianik B, 2002, BRIT J OPHTHALMOL, V86, P357, DOI 10.1136/bjo.86.3.357; Saika S, 2005, LAB INVEST, V85, P474, DOI 10.1038/labinvest.3700247; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sharma A, 2011, NANOMED-NANOTECHNOL, V7, P505, DOI 10.1016/j.nano.2011.01.006; Sharma A, 2009, INVEST OPHTH VIS SCI, V50, P2695, DOI 10.1167/iovs.08-2919; Srinivasan M, 2012, ARCH OPHTHALMOL-CHIC, V130, P143, DOI 10.1001/archophthalmol.2011.315; Tandon A, 2010, CURR MOL MED, V10, P565; Tandon A, 2012, J REFRACT SURG, V28, P285, DOI 10.3928/1081597X-20120210-01; Teli MK, 2010, CURR PHARM DESIGN, V16, P1882; Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100; Thornton I, 2008, J REFRACT SURG, V24, P68, DOI 10.3928/1081597X-20080101-13; Vega E, 2012, INT J NANOMED, V7, P1357, DOI 10.2147/IJN.S28481; Vesaluoma M, 1997, CURR EYE RES, V16, P19, DOI 10.1076/ceyr.16.1.19.5119; WALL NA, 1993, J CELL BIOL, V120, P493, DOI 10.1083/jcb.120.2.493; Wei Y, 2006, CYTOTHERAPY, V8, P570, DOI 10.1080/14653240600987690; Wesselinova D, 2011, CURR CANCER DRUG TAR, V11, P164, DOI 10.2174/156800911794328484; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Wu KY, 1999, J OCUL PHARMACOL TH, V15, P401, DOI 10.1089/jop.1999.15.401; Yeh LCC, 2002, J CELL BIOCHEM, V87, P292, DOI 10.1002/jcb.10315; You LT, 2002, INVEST OPHTH VIS SCI, V43, P72; You LT, 1999, INVEST OPHTH VIS SCI, V40, P296; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz	55	73	75	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66434	10.1371/journal.pone.0066434	http://dx.doi.org/10.1371/journal.pone.0066434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799103	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300082
J	Huang, C; Wang, J; Chen, Z; Wang, YZ; Zhang, W				Huang, Chao; Wang, Jia; Chen, Zhuo; Wang, Yuzhe; Zhang, Wei			2-phenylethynesulfonamide Prevents Induction of Pro-inflammatory Factors and Attenuates LPS-induced Liver Injury by Targeting NHE1-Hsp70 Complex in Mice	PLOS ONE			English	Article							NF-KAPPA-B; HEAT-SHOCK-PROTEIN; NA+/H+ EXCHANGE; HSP70; LIPOPOLYSACCHARIDE; HEAT-SHOCK-PROTEIN-70; ACTIVATION; APOPTOSIS; APAF-1; RAT	The endotoxin-mediated production of pro-inflammatory cytokines plays an important role in the pathogenesis of liver disorders. Heat shock protein (Hsp70) overexpression has established functions in lipopolysaccharide (LPS)-mediated inflammatory response. However, little is known about the role of Hsp70 activity in LPS signaling. We hypothesized that inhibition of Hsp70 substrate binding activity can ameliorate LPS-induced liver injury by decreasing induction of pro-inflammatory factors. In this study, C57/BL6 mice were injected intraperitoneally with LPS and 2-phenylethynesulfonamide (PES), an inhibitor of Hsp70 substrate binding activity. We found that i. PES prevented LPS-induced increase in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, infiltration of inflammatory cells, and liver cell apoptosis; ii. PES reduced inducible nitric oxide synthase (iNOS) protein expression as well as serum nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) content in LPS-stimulated mice; iii. PES reduced the mRNA level of iNOS, TNF-alpha, and IL-6 in LPS-stimulated liver. iiii. PES attenuated the degradation of inhibitor of kappa beta-alpha (I kappa B-alpha) as well as the phosphorylation and nuclear translocation of nuclear factor-kappa B (NF-kappa B) in LPS-stimulated liver. Similar changes in the protein expression of inflammatory markers, IkB-alpha degradation, and NF-kappa B phosphorylation and nuclear translocation were observed in RAW 264.7 cells. Further mechanistic studies revealed that PES remarkably reduced the elevation of [Ca2+] i and intracellular pH value (pHi) in LPS-stimulated RAW 264.7 cells. Furthermore, PES significantly reduced the increase in Na+/H+ exchanger 1 (NHE1) association to Hsp70 in LPS-stimulated macrophages and liver, suggesting that NHE1-Hsp70 interaction is required for the involvement of NHE1 in the inflammation response. In conclusion, inhibition of Hsp70 substrate binding activity in vivo reduces the induction of pro-inflammatory factors and prevents LPS-induced liver injury likely by disrupting NHE1-Hsp70 interaction which consequently reduces the activation of I kappa B-alpha-NF-kappa B pathway in liver.	[Huang, Chao; Wang, Jia; Wang, Yuzhe; Zhang, Wei] Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Jiangsu, Peoples R China; [Chen, Zhuo] Nantog First Peoples Hosp, Invas Technol Dept, Nantong, Jiangsu, Peoples R China	Nantong University	Zhang, W (corresponding author), Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Jiangsu, Peoples R China.	asicampa@yahoo.com.cn			National Natural Science Foundation of China [81102428]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China to Dr. Chao Huang (No. 81102428) and also supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Ambade A, 2012, HEPATOLOGY, V55, P1585, DOI 10.1002/hep.24802; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Boeri D, 2003, EUR J CLIN INVEST, V33, P500, DOI 10.1046/j.1365-2362.2003.01157.x; Colletti LM, 2001, SHOCK, V16, P312, DOI 10.1097/00024382-200116040-00014; El Kasmi KC, 2012, HEPATOLOGY, V55, P1518, DOI 10.1002/hep.25500; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; HEMING TA, 1995, J LEUKOCYTE BIOL, V57, P609, DOI 10.1002/jlb.57.4.609; Hsu HY, 2007, MOL PHARMACOL, V71, P344, DOI 10.1124/mol.106.024240; Huang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049954; Huang C, 2010, GLIA, V58, P1415, DOI 10.1002/glia.21017; Jinwal Umesh K, 2010, Mol Cell Pharmacol, V2, P43; Josephs MD, 2000, AM J PHYSIOL-REG I, V278, pR1196, DOI 10.1152/ajpregu.2000.278.5.R1196; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kaiser M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.28; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Luo SX, 2011, AM J PHYSIOL-CELL PH, V301, pC227, DOI 10.1152/ajpcell.00493.2010; Macfarlane SR, 2005, BRIT J PHARMACOL, V145, P535, DOI 10.1038/sj.bjp.0706204; Mamelak D, 2001, J BIOL CHEM, V276, P449, DOI 10.1074/jbc.M006732200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; ROTSTEIN OD, 1987, FEBS LETT, V215, P223, DOI 10.1016/0014-5793(87)80150-3; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; Tando Y, 1999, AM J PHYSIOL-GASTR L, V277, pG678, DOI 10.1152/ajpgi.1999.277.3.G678; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Tung D, 2013, PHARMACOLOGY, V91, P29, DOI 10.1159/000343762; Weiland TJ, 2005, PEPTIDES, V26, P447, DOI 10.1016/j.peptides.2004.10.006; Xue J, 2007, AM J PHYSIOL-REG I, V292, pR2406, DOI 10.1152/ajpregu.00859.2006; Yeh CH, 2010, LEUKEMIA RES, V34, P605, DOI 10.1016/j.leukres.2009.09.014; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502	40	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67582	10.1371/journal.pone.0067582	http://dx.doi.org/10.1371/journal.pone.0067582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805318	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500146
J	Lin, XJ; Shang, XY; Manorek, G; Howell, SB				Lin, Xinjian; Shang, Xiying; Manorek, Gerald; Howell, Stephen B.			Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4	PLOS ONE			English	Article							SEROUS OVARIAN CARCINOGENESIS; DIFFERENTIAL GENE-EXPRESSION; JUNCTION PROTEINS CLAUDIN-3; E-CADHERIN EXPRESSION; CELL-CELL ADHESION; TIGHT JUNCTION; BREAST-CANCER; TUMOR PROGRESSION; FALLOPIAN-TUBE; METASTASIS	The mechanisms that control intracellular adhesion are central to the process of invasion and metastasis. Claudin-3 (CLDN3) and claudin-4 (CLDN4) are major structural molecules of the tight junctions that link epithelial cells. Our prior work has demonstrated that knockdown of the expression of either CLDN3 or CLDN4 produces marked changes in the phenotype of ovarian carcinoma cells including increases in growth rate in vivo, migration, invasion, metastasis, and drug resistance, similar to those produced by the epithelial-to-mesenchymal transition (EMT). We postulated that these changes may result from the ability of CLDN3 or CLDN4 to suppress EMT. In this study we found that knockdown of either CLDN3 or CLDN4 increased cell size and resulted in flattened morphology. While knockdown of CLDN3 or CLDN4 did not alter the expression of vimentin, it significantly down-regulated the level of E-cadherin and up-regulated N-cadherin expression. Conversely, over-expression of CLDN3 or CLDN4 in a cell line that does not express endogenous CLDN3 or CLDN4 decreased N-cadherin expression. Re-expression of E-cadherin in the CLDN3 or CLDN4 knockdown cells reduced migration, invasion and tumor growth in vivo. Loss of either CLDN3 or CLDN4 resulted in activation of the PI3K pathway as evidenced by increased Akt phosphorylation, elevated cellular PIP3 content and PI3K activity as well as up-regulation of the mRNA and protein levels of the transcription factor Twist. Taken together, these findings suggest that CLDN3 and CLDN4 function to sustain an epithelial phenotype and that their loss promotes EMT.	[Lin, Xinjian] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Lin, XJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	xlin@ucsd.edu; showell@ucsd.edu			NIH [P30 CA23100, P30 NS047101]; Clayton Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Clayton Medical Research Foundation. The authors thank Dr. Kersi Pestonjamasp for sharing expertise on confocal microscopy. NIH grants P30 CA23100 and P30 NS047101 provided support for imaging resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; BUICK RN, 1985, CANCER RES, V45, P3668; Cheng TC, 2006, CANCER CHEMOTH PHARM, V58, P384, DOI 10.1007/s00280-005-0171-8; Choi YL, 2007, HISTOL HISTOPATHOL, V22, P1185, DOI 10.14670/HH-22.1185; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Ersoz S, 2011, PATHOL RES PRACT, V207, P285, DOI 10.1016/j.prp.2011.01.011; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Grille SJ, 2003, CANCER RES, V63, P2172; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Hough CD, 2000, CANCER RES, V60, P6281; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Itoh M, 2003, J MAMMARY GLAND BIOL, V8, P449, DOI 10.1023/B:JOMG.0000017431.45314.07; Iwanicki MP, 2011, CANC DISCOVERY; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karreth F, 2004, CANCER BIOL THER, V3, P1058, DOI 10.4161/cbt.3.11.1302; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kohler K, 2005, BIOL CELL, V97, P659; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Martin TA, 2001, HISTOL HISTOPATHOL, V16, P1183, DOI 10.14670/HH-16.1183; Matsuoka T, 2011, J SURG ONCOL, V103, P674, DOI 10.1002/jso.21854; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mullin J M, 2004, Sci STKE, V2004, ppe2, DOI 10.1126/stke.2162004pe2; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ouban A, 2010, HISTOL HISTOPATHOL, V25, P83, DOI 10.14670/HH-25.83; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; SELBY PJ, 1980, BRIT J CANCER, V41, P52, DOI 10.1038/bjc.1980.7; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Shang X, 2012, MOL PHARM; Shang XY, 2012, NEOPLASIA, V14, P974, DOI 10.1593/neo.12942; Szasz AM, 2011, CANCER SCI, V102, P2248, DOI 10.1111/j.1349-7006.2011.02085.x; Tassi RA, 2008, INT J GYNECOL CANCER, V18, P1262, DOI 10.1111/j.1525-1438.2008.01194.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsutsumi K, 2012, ANN SURG ONCOL, V19, pS491, DOI 10.1245/s10434-011-1970-2; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Wittekind C, 2005, ONCOLOGY-BASEL, V69, P14, DOI 10.1159/000086626; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yoshida J, 2009, MED MOL MORPHOL, V42, P82, DOI 10.1007/s00795-008-0436-5; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3; Yuan XQ, 2009, MOL CANCER THER, V8, P1906, DOI 10.1158/1535-7163.MCT-09-0106; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	75	70	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e67496	10.1371/journal.pone.0067496	http://dx.doi.org/10.1371/journal.pone.0067496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805314	gold, Green Published, Green Submitted			2022-12-27	WOS:000320846500142
J	Montemurro, MA; Zanette, DH				Montemurro, Marcelo A.; Zanette, Damian H.			Keywords and Co-Occurrence Patterns in the Voynich Manuscript: An Information-Theoretic Analysis	PLOS ONE			English	Article							WORDS; HOAX	The Voynich manuscript has remained so far as a mystery for linguists and cryptologists. While the text written on medieval parchment -using an unknown script system- shows basic statistical patterns that bear resemblance to those from real languages, there are features that suggested to some researches that the manuscript was a forgery intended as a hoax. Here we analyse the long-range structure of the manuscript using methods from information theory. We show that the Voynich manuscript presents a complex organization in the distribution of words that is compatible with those found in real language sequences. We are also able to extract some of the most significant semantic word-networks in the text. These results together with some previously known statistical features of the Voynich manuscript, give support to the presence of a genuine message inside the book.	[Montemurro, Marcelo A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Zanette, Damian H.] Consejo Nacl Invest Cient & Tecn, Ctr Atom Bariloche, San Carlos De Bariloche, Ro Negro, Argentina; [Zanette, Damian H.] Inst Balseiro, San Carlos De Bariloche, Ro Negro, Argentina	University of Manchester; Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Montemurro, MA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	m.montemurro@manchester.ac.uk		Montemurro, Marcelo/0000-0003-0893-8530				Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; Bennett W.R, 1976, SCI ENG PROBLEM SOLV; Carpena P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.035102; Ferrer i Cancho R., 2002, ADV COMPLEX SYST, V5, P1, DOI [10.1142/S0219525902000468, DOI 10.1142/S0219525902000468]; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; HARTER SP, 1975, J AM SOC INFORM SCI, V26, P197, DOI 10.1002/asi.4630260402; Herrera JP, 2008, EUR PHYS J B, V63, P135, DOI 10.1140/epjb/e2008-00206-x; Landini G, 2001, CRYPTOLOGIA, V25, P275, DOI 10.1080/0161-110191889932; LUHN HP, 1958, IBM J RES DEV, V2, P159, DOI 10.1147/rd.22.0159; Montemurro MA, 2010, ADV COMPLEX SYST, V13, P135, DOI 10.1142/S0219525910002530; Ortuno M, 2002, EUROPHYS LETT, V57, P759, DOI 10.1209/epl/i2002-00528-3; Reddy S., 2011, 5 ACL WORKSH LANG TE; Rugg G, 2004, CRYPTOLOGIA, V28, P31, DOI 10.1080/0161-110491892755; Schinner A, 2007, CRYPTOLOGIA, V31, P95, DOI 10.1080/01611190601133539; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Thomas MC, 2006, ELEMENTS INFORM THEO; ZANETTE DH, 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293	18	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66344	10.1371/journal.pone.0066344	http://dx.doi.org/10.1371/journal.pone.0066344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805215	Green Accepted, gold, Green Published			2022-12-27	WOS:000320846500043
J	Chuan, W; Chen, MY; Fu, FM; Huang, M				Wang, Chuan; Chen, Minyan; Fu, Fangmeng; Huang, Meng			Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							CYCLOPHOSPHAMIDE; AGONIST; WOMEN; TRIPTORELIN; MENOPAUSE	Objective: To determine by meta-analysis whether gonadotropin-releasing hormone analog (GnRHa) cotreatment accompanying chemotherapy for breast cancer protects ovarian function. Methods: Randomized controlled trials (RCTs) comparing GnRH cotreatment with chemotherapy alone in premenopausal women were collected by electronic and manual searches of Pubmed, MEDLINE (OVID), CENTRAL (The Coehrane Central Register of Controlled Trials), CBM, CNKI, VIP and Wanfang data bases. All the data was analyzed by Stata 11.2. Results: Seven studies with a total of 677 participants met the inclusion criteria. The outcome of meta-analysis implied that, compared with adjuvant chemotherapy alone, the number of patients with resumption of spontaneous menstruation was statistically greater in the GnRH cotreatment patients (OR 2.83; 95% CI, 1.52-5.25). Conclusions: Evidence from RCTs suggests a potential benefit of GnRH cotreatment with chemotherapy in premenopausal women, producing higher rates of spontaneous resumption of menses.	[Wang, Chuan; Fu, Fangmeng] Fujian Med Univ, Union Hosp, Dept Gen Surg, Fuzhou, Peoples R China; [Chen, Minyan] Fujian Med Univ, Union Clin Sch, Fuzhou, Peoples R China; [Huang, Meng] Fujian Ctr Dis Control & Prevent, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University	Chuan, W (corresponding author), Fujian Med Univ, Union Hosp, Dept Gen Surg, Fuzhou, Peoples R China.	chuanwang6858@yahoo.cn						ATAYA K, 1995, BIOL REPROD, V52, P365, DOI 10.1095/biolreprod52.2.365; ATAYA K, 1993, REPROD TOXICOL, V7, P229, DOI 10.1016/0890-6238(93)90229-Z; Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044; [柏建岭 BAI Jianling], 2007, [循证医学, The Journal of Evidence-Based Medicine], V7, P363; Bedaiwy MA, 2011, FERTIL STERIL, V95, P906, DOI 10.1016/j.fertnstert.2010.11.017; Blumenfeld Z, 2003, CURR OPIN OBSTET GYN, V15, P359, DOI 10.1097/00001703-200310000-00003; Blumenfeld Z, 2002, ANN ONCOL, V13, P138, DOI 10.1093/annonc/13.S1.138; BOKSER L, 1990, BRIT J CANCER, V61, P861, DOI 10.1038/bjc.1990.192; Clowse MEB, 2009, J WOMENS HEALTH, V18, P311, DOI 10.1089/jwh.2008.0857; Decanter C, 2011, GYNECOL OBSTET FERTI, V39, P501, DOI 10.1016/j.gyobfe.2011.07.011; Del Mastro L, 2011, JAMA-J AM MED ASSOC, V306, P269, DOI 10.1001/jama.2011.991; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerber B, 2011, J CLIN ONCOL, V29, P2334, DOI 10.1200/JCO.2010.32.5704; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Klimm B, 2005, HAEMATOLOGICA, V90, P1680; [李明毅 LI Mingyi], 2008, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V35, P905; MANTEL N, 1959, J NATL CANCER I, V22, P719; Munster PN, 2012, J CLIN ONCOL, V30, P533, DOI 10.1200/JCO.2011.34.6890; Olopade OI, 2008, CLIN CANCER RES, V14, P7988, DOI 10.1158/1078-0432.CCR-08-1211; Partridge A, 2007, EUR J CANCER, V43, P1646, DOI 10.1016/j.ejca.2007.04.006; Shenns RJ, 1993, CANC PRINCIPLES PRAC; Sun J, 2011, CHINA DISABIL MED, V19, P15; SUTCLIFFE SB, 1979, JAMA-J AM MED ASSOC, V242, P1898, DOI 10.1001/jama.242.17.1898; Suzuki Nao, 2012, Gan To Kagaku Ryoho, V39, P151; Sverrisdottir A, 2009, BREAST CANCER RES TR, V117, P561, DOI 10.1007/s10549-009-0313-5	27	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e66360	10.1371/journal.pone.0066360	http://dx.doi.org/10.1371/journal.pone.0066360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805216	Green Published, gold, Green Submitted			2022-12-27	WOS:000320846500044
J	Godoy, MS; Castro-Vasquez, A; Vega, IA				Godoy, Martin S.; Castro-Vasquez, Alfredo; Vega, Israel A.			Endosymbiotic and Host Proteases in the Digestive Tract of the Invasive Snail Pomacea canaliculata: Diversity, Origin and Characterization	PLOS ONE			English	Article							APPLE-SNAILS; MIDGUT GLAND; PURIFICATION; MOLLUSCA; ENZYMES; ABALONE; CAENOGASTROPODA; GASTROPODA; SLUG; GUT	Digestive proteases of the digestive tract of the apple snail Pomacea canaliculata were studied. Luminal protease activity was found in the crop, the style sac and the coiled gut and was significantly higher in the coiled gut. Several protease bands and their apparent molecular weights were identified in both tissue extracts and luminal contents by gel zymography: (1) a 125 kDa protease in salivary gland extracts and in the crop content; (2) a 30 kDa protease throughout all studied luminal contents and in extracts of the midgut gland and of the endosymbionts isolated from this gland; (3) two proteases of 145 and 198 kDa in the coiled gut content. All these proteases were inhibited by aprotinin, a serine-protease inhibitor, and showed maximum activity between 30 degrees C and 35 degrees C and pH between 8.5 and 9.5. Tissue L-alanine-N-aminopeptidase activity was determined in the wall of the crop, the style sac and the coiled gut and was significantly higher in the coiled gut. Our findings show that protein digestion in P. canaliculata is carried out through a battery of diverse proteases originated from the salivary glands and the endosymbionts lodged in the midgut gland and by proteases of uncertain origin that occur in the coiled gut lumen.	[Godoy, Martin S.; Castro-Vasquez, Alfredo; Vega, Israel A.] Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina; [Godoy, Martin S.; Castro-Vasquez, Alfredo; Vega, Israel A.] Consejo Nacl Invest Cient & Tecn, Inst Histol & Embriol Dr Mario H Burgos, Mendoza, Argentina; [Castro-Vasquez, Alfredo; Vega, Israel A.] Univ Nacl Cuyo, Inst Ciencias Basicas, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Vega, IA (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina.	israel.vega7@gmail.com	Vega, Israel Aníbal/ABB-1303-2020	Vega, Israel Aníbal/0000-0002-1398-3611	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Fondo Nacional de Ciencia y Tecnica (Argentina)	Universidad Nacional de Cuyo; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo Nacional de Ciencia y Tecnica (Argentina)	This work was supported by grants from the Universidad Nacional de Cuyo, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Fondo Nacional de Ciencia y Tecnica (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews E. B., 1965, Proceedings of the Zoological Society of London, V145, P19; Balti R, 2012, FOOD CHEM, V130, P475, DOI 10.1016/j.foodchem.2011.07.019; BARLOCHER F, 1989, OECOLOGIA, V80, P39, DOI 10.1007/BF00789929; BECKSTEAD JH, 1995, J HISTOCHEM CYTOCHEM, V43, P345, DOI 10.1177/43.3.7868864; BISWAS AK, 1968, J ZOOL, V156, P325; Castro-Vazquez A, 2002, BIOCELL, V26, P101; CHARNEY J, 1947, J BIOL CHEM, V171, P501; Charrier M, 2003, CAN J ZOOL, V81, P928, DOI [10.1139/z03-071, 10.1139/Z03-071]; Ciminari ME, 2005, REV CHIL HIST NAT, V78, P267; COCKBURN TC, 1980, COMP BIOCHEM PHYS B, V65, P275, DOI 10.1016/0305-0491(80)90013-9; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Cueto JA, 2011, MOLLUSCAN RES, V31, P57; DEVI CU, 1981, P INDIAN AS-ANIM SCI, V90, P307, DOI 10.1007/BF03186005; EVANS WAL, 1962, COMP BIOCHEM PHYSIOL, V5, P223, DOI 10.1016/0010-406X(62)90108-1; Garcia-Esquivel Z, 2006, AQUACULTURE, V261, P615, DOI 10.1016/j.aquaculture.2006.08.022; GHOSE KRISHNA CHANDRA, 1961, PROC ZOOL SOC LONDON, V137, P127; Guionie O, 2003, COMP BIOCHEM PHYS B, V135, P503, DOI 10.1016/S1096-4959(03)00115-5; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; Hernandez-Santoyo A, 1998, AQUACULTURE, V159, P203, DOI 10.1016/S0044-8486(97)00172-5; Hirata K, 1998, BIOSCI BIOTECH BIOCH, V62, P2242, DOI 10.1271/bbb.62.2242; Hirata K, 1998, J FAC AGR KYUSHU U, V42, P463; Hirata K, 1998, BIOSCI BIOTECH BIOCH, V62, P807, DOI 10.1271/bbb.62.807; Imjongjirak C, 2008, DNA SEQUENCE, V19, P224, DOI 10.1080/10425170701517911; James R, 1997, COMP BIOCHEM PHYS B, V118, P275, DOI 10.1016/S0305-0491(97)00058-8; Koch E, 2006, VELIGER, V48, P17; LECHEVALIER P, 1995, COMP BIOCHEM PHYS B, V110, P777, DOI 10.1016/0305-0491(94)00211-C; Leung D, 2000, J MED CHEM, V43, P305, DOI 10.1021/jm990412m; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macey BM, 2006, MAR BIOTECHNOL, V8, P246, DOI 10.1007/s10126-005-0113-9; Martin GG, 2011, COMP BIOCHEM PHYS A, V160, P365, DOI 10.1016/j.cbpa.2011.07.003; Martinez R, 2011, AQUACULT INT, V19, P445, DOI 10.1007/s10499-010-9360-5; MEENAKSHI V. R., 1954, JOUR ANIMAL MORPHOL AND PHYSIOL, V1, P35; MEENAKSHI V. R., 1955, J ANIMAL MORPHOLOGY, V3, P75; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Moura KRS, 2004, J MOLLUS STUD, V70, P21, DOI 10.1093/mollus/70.1.21; Oscoz J, 2010, AQUAT INVASIONS, V5, P263, DOI 10.3391/ai.2010.5.3.04; Picos-Garcia C, 2000, AQUACULTURE, V181, P157, DOI 10.1016/S0044-8486(99)00223-9; RAGSTER LE, 1981, PLANT PHYSIOL, V67, P104, DOI 10.1104/pp.67.1.104; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; REID RGB, 1972, COMP BIOCHEM PHYSIOL, V41, P887, DOI 10.1016/0300-9629(72)90352-0; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANG QX, 1990, BIOL REPROD, V43, P946, DOI 10.1095/biolreprod43.6.946; Seuffert ME, 2010, J THERM BIOL, V35, P77, DOI 10.1016/j.jtherbio.2009.11.003; Teo SS, 2004, J MOLLUSCAN RES, V24, P139; Vega IA, 2006, BIOCELL, V30, P367; Vega IA, 2005, SYMBIOSIS, V39, P37; Vega IA, 2012, ENVIRON SCI POLLUT R, V19, P3307, DOI 10.1007/s11356-012-0848-6; Voltzow J, 1994, MICROSCOPIC ANATOMY, P111; Walker AJ, 1999, SOIL BIOL BIOCHEM, V31, P1387, DOI 10.1016/S0038-0717(99)00054-1; Yamaura I, 1997, BIOSCI BIOTECH BIOCH, V61, P615, DOI 10.1271/bbb.61.615; Zhao J, 2012, AQUACULTURE, V338, P147, DOI 10.1016/j.aquaculture.2012.01.016	53	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66689	10.1371/journal.pone.0066689	http://dx.doi.org/10.1371/journal.pone.0066689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23818959	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800096
J	Lindner, G; Pfortmueller, CA; Funk, GC; Leichtle, AB; Fiedler, GM; Exadaktylos, AK				Lindner, Gregor; Pfortmueller, Carmen A.; Funk, Georg-Christian; Leichtle, Alexander B.; Fiedler, Georg Martin; Exadaktylos, Aristomenis K.			High-Sensitive Troponin Measurement in Emergency Department Patients Presenting with Syncope: A Retrospective Analysis	PLOS ONE			English	Article							HEART-FAILURE; DIAGNOSIS; MANAGEMENT; ASSAY	Objective: To study the relevance of high-sensitive troponin measurements in the acute workup in patients admitted to the emergency department of a large university hospital due to syncope. Methods: In this retrospective study all patients admitted to the emergency department because of syncope of the Inselspital, University Hospital Bern between 01 August 2010 and 31 October 2012, with serial determination of highsensitive troponin (baseline and three hours control) were included. Of all identified patients we obtained data on demographics, laboratory data, ECG as well as on outcome. A change in high-sensitive troponin in the three hours control of +/-30% compared to baseline was considered significant. Results: A total of 121 patients with a mean age of 67 years (SD 16) were included in the study. 79 patients (65%) were male and 42 (35%) were female. There was no significant difference in the median high sensitive-troponin level at baseline and in the three hours control (0.01 mcg/L [0.003 to 0.022] versus 0.011 mcg/L [0.003 to 0.022], p = 0.47). Median percent change in high-sensitive troponin level between baseline and control was 0% (29.1 to 5). 51 patients (42%) had elevated highsensitive troponin levels at baseline with 7 patients (6%) showing a dynamic of +/230% change from the baseline measurement in the 3 hours control. 3 of these patients received coronary angiography due to the dynamic in highsensitive troponin, none of whom needed intervention for coronary revascularization. Conclusions: On basis of the current study, where no single patient took benefit from determination of high-sensitive troponin, measurement of cardiac troponins should be reserved for patients with syncope presenting with symptoms suggestive for the presence of an acute cardiac syndrome.	[Lindner, Gregor; Pfortmueller, Carmen A.; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Lindner, Gregor; Pfortmueller, Carmen A.] Univ Hosp Bern, Inselspital, Dept Internal Med, CH-3010 Bern, Switzerland; [Funk, Georg-Christian] Otto Wagner Spital Vienna, Dept Resp & Crit Care Med, Vienna, Austria; [Funk, Georg-Christian] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria; [Leichtle, Alexander B.; Fiedler, Georg Martin] Univ Hosp Bern, Inselspital, Ctr Lab Med, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Ludwig Boltzmann Institute; University of Bern; University Hospital of Bern	Lindner, G (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	lindner.gregor@gmail.com	Lindner, Gregor/AAR-6761-2020; Fiedler, Georg Martin/C-8341-2011; Leichtle, Alexander/C-7262-2011	Lindner, Gregor/0000-0001-5551-8227; Fiedler, Georg Martin/0000-0001-5689-4574; Pfortmueller, Carmen/0000-0003-0326-2770				Aarones M, 2011, AM HEART J, V161, P1031, DOI 10.1016/j.ahj.2010.09.021; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; Kapoor WN, 2000, NEW ENGL J MED, V343, P1856, DOI 10.1056/NEJM200012213432507; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Korff S, 2006, HEART, V92, P987, DOI 10.1136/hrt.2005.071282; Mendu ML, 2009, ARCH INTERN MED, V169, P1299, DOI 10.1001/archinternmed.2009.204; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Pascual-Figal DA, 2012, AM HEART J, V163, P1002, DOI 10.1016/j.ahj.2012.03.015; Reed MJ, 2012, EMERG MED J, V29, P1001, DOI 10.1136/emermed-2012-201332; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163; Sun BC, 2009, ANN EMERG MED, V54, P769, DOI 10.1016/j.annemergmed.2009.07.027; Sutton R, 2012, NAT REV CARDIOL, V9, P590, DOI 10.1038/nrcardio.2012.102	12	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2013	8	6							e66470	10.1371/journal.pone.0066470	http://dx.doi.org/10.1371/journal.pone.0066470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166SA	23823330	Green Published, gold, Green Submitted			2022-12-27	WOS:000320576400113
J	Oppenheim, JN; Isakov, P; Magnasco, MO				Oppenheim, Jacob N.; Isakov, Pavel; Magnasco, Marcelo O.			Degraded Time-Frequency Acuity to Time-Reversed Notes	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; NATURAL SOUNDS; REPRESENTATIONS; REASSIGNMENT; VOCALIZATION; STATISTICS; RESPONSES; SPECTRUM; STIMULI; NEURONS	Time-reversal symmetry breaking is a key feature of many classes of natural sounds, originating in the physics of sound production. While attention has been paid to the response of the auditory system to "natural stimuli," very few psychophysical tests have been performed. We conduct psychophysical measurements of time-frequency acuity for stylized representations of "natural"-like notes (sharp attack, long decay) and the time-reversed versions of these notes (long attack, sharp decay). Our results demonstrate significantly greater precision, arising from enhanced temporal acuity, for such sounds over their time-reversed versions, without a corresponding decrease in frequency acuity. These data inveigh against models of auditory processing that include tradeoffs between temporal and frequency acuity, at least in the range of notes tested and suggest the existence of statistical priors for notes with a sharp-attack and a long-decay. We are additionally able to calculate a minimal theoretical bound on the sophistication of the nonlinearities in auditory processing. We find that among the best studied classes of nonlinear time-frequency representations, only matching pursuit, spectral derivatives, and reassigned spectrograms are able to satisfy this criterion.	[Oppenheim, Jacob N.; Isakov, Pavel; Magnasco, Marcelo O.] Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA	Rockefeller University	Magnasco, MO (corresponding author), Rockefeller Univ, Phys Math Lab, 1230 York Ave, New York, NY 10021 USA.	magnasco@rockefeller.edu			National Science Foundation (NSF) [EF-0928723]; Emerging Frontiers [0928723] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation (NSF) grant EF-0928723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, TIME FREQUENCY ANAL; Attias H, 1997, ADV NEUR IN, V9, P27; AUGER F, 1994, INT CONF ACOUST SPEE, P317; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; ChassandeMottin E, 1997, IEEE SIGNAL PROC LET, V4, P293, DOI 10.1109/97.633772; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fulop SA, 2006, J ACOUST SOC AM, V119, P360, DOI 10.1121/1.2133000; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Gardner TJ, 2006, P NATL ACAD SCI USA, V103, P6094, DOI 10.1073/pnas.0601707103; Geffen M, 2011, FRONTIERS INTEGRATIV, P5; Ghazanfar AA, 2001, CURR OPIN NEUROBIOL, V11, P712, DOI 10.1016/S0959-4388(01)00274-4; GORDON JW, 1987, J ACOUST SOC AM, V82, P88, DOI 10.1121/1.395441; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; KODERA K, 1978, IEEE T ACOUST SPEECH, V26, P64, DOI 10.1109/TASSP.1978.1163047; Magnasco MO, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.058101; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Oppenheim JN, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.044301; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rodriguez FA, 2010, J NEUROSCI, V30, P15969, DOI 10.1523/JNEUROSCI.0966-10.2010; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tkacik G, 2008, BIOSYSTEMS, V93, P90, DOI 10.1016/j.biosystems.2008.04.011; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e65386	10.1371/journal.pone.0065386	http://dx.doi.org/10.1371/journal.pone.0065386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799012	Green Published, gold, Green Submitted			2022-12-27	WOS:000321397800004
J	Chung, FH; Lee, HHC; Lee, HC				Chung, Feng-Hsiang; Lee, Henry Hsin-Chung; Lee, Hoong-Chien			ToP: A Trend-of-Disease-Progression Procedure Works Well for Identifying Cancer Genes from Multi-State Cohort Gene Expression Data for Human Colorectal Cancer	PLOS ONE			English	Article							TGF-BETA; HUMAN BREAST; NETWORK; COMPLEX; CELLS; COLON; DISCOVERY; INFORMATION; MICROARRAYS; METASTASIS	Significantly expressed genes extracted from microarray gene expression data have proved very useful for identifying genetic biomarkers of diseases, including cancer. However, deriving a disease related inference from a list of differentially expressed genes has proven less than straightforward. In a systems disease such as cancer, how genes interact with each other should matter just as much as the level of gene expression. Here, in a novel approach, we used the network and disease progression properties of individual genes in state-specific gene-gene interaction networks (GGINs) to select cancer genes for human colorectal cancer (CRC) and obtain a much higher hit rate of known cancer genes when compared with methods not based on network theory. We constructed GGINs by integrating gene expression microarray data from multiple states - healthy control (Nor), adenoma (Ade), inflammatory bowel disease (IBD) and CRC - with protein-protein interaction database and Gene Ontology. We tracked changes in the network degrees and clustering coefficients of individual genes in the GGINs as the disease state changed from one to another. From these we inferred the state sequences Nor-Ade-CRC and Nor-IBD-CRC both exhibited a trend of (disease) progression (ToP) toward CRC, and devised a ToP procedure for selecting cancer genes for CRC. Of the 141 candidates selected using ToP, similar to 50% had literature support as cancer genes, compared to hit rates of 20% to 30% for standard methods using only gene expression data. Among the 16 candidate cancer genes that encoded transcription factors, 13 were known to be tumorigenic and three were novel: CDK1, SNRPF, and ILF2. We identified 13 of the 141 predicted cancer genes as candidate markers for early detection of CRC, 11 and 2 at the Ade and IBD states, respectively.	[Chung, Feng-Hsiang; Lee, Henry Hsin-Chung; Lee, Hoong-Chien] Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan; Chung Yuan Christian Univ, Dept Phys, Zhongli, Taiwan; [Chung, Feng-Hsiang] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Zhongli, Taiwan; [Lee, Henry Hsin-Chung; Lee, Hoong-Chien] Cathay Gen Hosp, Cathay Med Res Inst, Taipei, Taiwan	National Central University; Chung Yuan Christian University; National Central University; Cathay General Hospital	Chung, FH (corresponding author), Natl Cent Univ, Inst Syst Biol & Bioinformat, Zhongli, Taiwan.	fabian415@gmail.com; hclee12345@gmail.com	Lee, Henry/GVS-2114-2022		National Science Council (ROC) [NSC 100-2911-I-008-001, NSC 99-2911-I-008-100]; Cathy General Hospital-National Central University Grant [99CGH-NCU-A3]	National Science Council (ROC)(Ministry of Science and Technology, Taiwan); Cathy General Hospital-National Central University Grant	This work was supported by the National Science Council (ROC) grants NSC 100-2911-I-008-001 (for the Center for Dynamical Biomarkers and Translational Medicine, National Central University) and NSC 99-2911-I-008-100, and the Cathy General Hospital-National Central University Grant 99CGH-NCU-A3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anderson GR, 2001, CURR SCI, V81, P101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Butte A J, 2000, Pac Symp Biocomput, P418; Cardoso J, 2007, BBA-REV CANCER, V1775, P103, DOI 10.1016/j.bbcan.2006.08.004; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dudaronek JM, 2007, J IMMUNOL, V179, P7262, DOI 10.4049/jimmunol.179.11.7262; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Garcia O, 2007, BIOINFORMATICS, V23, P394, DOI 10.1093/bioinformatics/btl605; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gu CC, 2002, GENET EPIDEMIOL, V23, P37, DOI 10.1002/gepi.220; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hwang T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-128; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Kendall M.G., 1973, ADV THEORY STAT, V2; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liang S, 1998, Pac Symp Biocomput, P18; Lin CC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-138; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Linderman GC, 2012, NUCLEIC ACIDS RES, V40, pW152, DOI 10.1093/nar/gks526; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Park T, 2003, BIOINFORMATICS, V19, P694, DOI 10.1093/bioinformatics/btg068; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rabbani SA, 1998, INT J ONCOL, V12, P911; RAMBALDI A, 1990, BLOOD, V76, P2565; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shibayama Masaki, 2011, Cancers (Basel), V3, P2858, DOI 10.3390/cancers3032858; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vucic EA, 2008, PHARMACOGENOMICS, V9, P215, DOI 10.2217/14622416.9.2.215; Watanabe T, 2009, DIS COLON RECTUM, V52, P1941, DOI 10.1007/DCR.0b013e3181b53684; WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie YY, 2012, BBA-MOL BASIS DIS, V1822, P875, DOI 10.1016/j.bbadis.2012.02.019; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020124; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	68	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65683	10.1371/journal.pone.0065683	http://dx.doi.org/10.1371/journal.pone.0065683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799036	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300033
J	Dobrijevic, D; Di Liberto, G; Tanaka, K; de Wouters, T; Dervyn, R; Boudebbouze, S; Binesse, J; Blottiere, HM; Jamet, A; Maguin, E; van de Guchte, M				Dobrijevic, Dragana; Di Liberto, Gaetana; Tanaka, Kosei; de Wouters, Tomas; Dervyn, Rozenn; Boudebbouze, Samira; Binesse, Johan; Blottiere, Herve M.; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten			High-Throughput System for the Presentation of Secreted and Surface-Exposed Proteins from Gram-Positive Bacteria in Functional Metagenomics Studies	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NF-KAPPA-B; BACILLUS-SUBTILIS; HETEROLOGOUS PROTEIN; ESCHERICHIA-COLI; TRANSFORMATION; OPTIMIZATION; EXPRESSION; MATURATION; MICROBIOTA	Complex microbial ecosystems are increasingly studied through the use of metagenomics approaches. Overwhelming amounts of DNA sequence data are generated to describe the ecosystems, and allow to search for correlations between gene occurrence and clinical (e. g. in studies of the gut microbiota), physico-chemical (e. g. in studies of soil or water environments), or other parameters. Observed correlations can then be used to formulate hypotheses concerning microbial gene functions in relation to the ecosystem studied. In this context, functional metagenomics studies aim to validate these hypotheses and to explore the mechanisms involved. One possible approach is to PCR amplify or chemically synthesize genes of interest and to express them in a suitable host in order to study their function. For bacterial genes, Escherichia coli is often used as the expression host but, depending on the origin and nature of the genes of interest and the test system used to evaluate their putative function, other expression systems may be preferable. In this study, we developed a system to evaluate the role of secreted and surface-exposed proteins from Gram-positive bacteria in the human gut microbiota in immune modulation. We chose to use a Gram-positive host bacterium, Bacillus subtilis, and modified it to provide an expression background that behaves neutral in a cell-based immune modulation assay, in vitro. We also adapted an E. coli - B. subtilis shuttle expression vector for use with the Gateway high-throughput cloning system. Finally, we demonstrate the functionality of this host-vector system through the cloning and expression of a flagellin-coding sequence, and show that the expression-clone elicits an inflammatory response in a human intestinal epithelial cell line. The expression host can easily be adapted to assure neutrality in other assay systems, allowing the use of the presented presentation system in functional metagenomics of the gut and other ecosystems.	[Dobrijevic, Dragana; Di Liberto, Gaetana; Tanaka, Kosei; de Wouters, Tomas; Dervyn, Rozenn; Boudebbouze, Samira; Binesse, Johan; Blottiere, Herve M.; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten] INRA, Micalis UMR1319, Jouy En Josas, France; [Dobrijevic, Dragana; Di Liberto, Gaetana; Tanaka, Kosei; de Wouters, Tomas; Dervyn, Rozenn; Boudebbouze, Samira; Binesse, Johan; Blottiere, Herve M.; Jamet, Alexandre; Maguin, Emmanuelle; van de Guchte, Maarten] AgroParisTech, UMR Micalis, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	van de Guchte, M (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	maarten.vandeguchte@jouy.inra.fr	BLOTTIERE, Hervé M/C-6120-2011	BLOTTIERE, Hervé M/0000-0002-8390-0607; Dobrijevic, Dragana/0000-0001-7591-8105	European Community [215553-2, HEALTH-F4-2007-201052]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements no215553-2 ("Crosstalk") and HEALTH-F4-2007-201052 ("MetaHIT"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Bermudez-Humaran LG, 2004, J MED MICROBIOL, V53, P427, DOI 10.1099/jmm.0.05472-0; Bermudez-Humaran LG, 2002, APPL ENVIRON MICROB, V68, P917, DOI 10.1128/AEM.68.2.917-922.2002; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; CANOSI U, 1978, MOL GEN GENET, V166, P259, DOI 10.1007/BF00267617; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Douillard FP, 2011, PLASMID, V66, P129, DOI 10.1016/j.plasmid.2011.07.001; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Fasehee H, 2011, PROTEOMICS, V11, P3905, DOI 10.1002/pmic.201100174; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; GRUNDY FJ, 1994, J BACTERIOL, V176, P2108, DOI 10.1128/jb.176.7.2108-2110.1994; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Nguyen HD, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-22; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; JENKINSON HF, 1983, J GEN MICROBIOL, V129, P1945; Kaci G, 2011, APPL ENVIRON MICROB, V77, P4681, DOI 10.1128/AEM.03021-10; Kodama T, 2007, J BIOSCI BIOENG, V104, P135, DOI 10.1263/jbb.104.135; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lakhdari O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013092; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravn P, 2003, MICROBIOL-SGM, V149, P2193, DOI 10.1099/mic.0.26299-0; Rocha CS, 2012, INFLAMM BOWEL DIS, V18, P657, DOI 10.1002/ibd.21834; Rondon MR, 1999, P NATL ACAD SCI USA, V96, P6451, DOI 10.1073/pnas.96.11.6451; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Zweers JC, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-10	45	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65956	10.1371/journal.pone.0065956	http://dx.doi.org/10.1371/journal.pone.0065956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799065	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300055
J	Galeazzi, JM; Mender, BMW; Paredes, M; Tromans, JM; Evans, BD; Minini, L; Stringer, SM				Galeazzi, Juan M.; Mender, Bedeho M. W.; Paredes, Mariana; Tromans, James M.; Evans, Benjamin D.; Minini, Loredana; Stringer, Simon M.			A Self-Organizing Model of the Visual Development of Hand-Centred Representations	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; INVARIANT OBJECT RECOGNITION; LATERAL INTRAPARIETAL AREA; SACCADE-RELATED ACTIVITY; NEURONAL REPRESENTATION; PREMOTOR CORTEX; POSITION; SYSTEM; INFORMATION; FEEDBACK	We show how hand-centred visual representations could develop in the primate posterior parietal and premotor cortices during visually guided learning in a self-organizing neural network model. The model incorporates trace learning in the feed-forward synaptic connections between successive neuronal layers. Trace learning encourages neurons to learn to respond to input images that tend to occur close together in time. We assume that sequences of eye movements are performed around individual scenes containing a fixed hand-object configuration. Trace learning will then encourage individual cells to learn to respond to particular hand-object configurations across different retinal locations. The plausibility of this hypothesis is demonstrated in computer simulations.	[Galeazzi, Juan M.; Mender, Bedeho M. W.; Paredes, Mariana; Tromans, James M.; Evans, Benjamin D.; Minini, Loredana; Stringer, Simon M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, Oxon, England	University of Oxford	Galeazzi, JM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, Oxon, England.	juan.galeazzigonzalez@psy.ox.ac.uk		Minini, Loredana/0000-0001-7713-403X; Evans, Benjamin/0000-0002-1734-6070; Galeazzi, Juan M/0000-0003-4221-6988	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [214673, 309944]; Instituto Jalisciense de la Juventud (IJJ) [2011B-1286]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto Jalisciense de la Juventud (IJJ)	This research was supported in part by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Scholar: 214673 grant no. 309944, http://www.conacyt.gob.mx) and by the Instituto Jalisciense de la Juventud (IJJ, Grant 2011B-1286, http://www.ijj.gob.mx) via a studentship awarded to J. M. Galeazzi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1987, EXP BRAIN RES, V67, P316; [Anonymous], 1998, NEURAL NETWORKS BRAI; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Blohm G, 2009, NEURON, V64, P598, DOI 10.1016/j.neuron.2009.11.022; Blohm G, 2009, CEREB CORTEX, V19, P1372, DOI 10.1093/cercor/bhn177; Bosco A, 2010, J NEUROSCI, V30, P14773, DOI 10.1523/JNEUROSCI.2313-10.2010; Bremner LR, 2012, NEURON, V75, P342, DOI 10.1016/j.neuron.2012.03.041; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Buneo CA, 2012, J NEUROPHYSIOL, V108, P187, DOI 10.1152/jn.00137.2011; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; Chang SWC, 2010, P NATL ACAD SCI USA, V107, P7951, DOI 10.1073/pnas.0913209107; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Desmurget M, 1997, EXP BRAIN RES, V115, P180, DOI 10.1007/PL00005680; Filimon F, 2009, J NEUROSCI, V29, P2961, DOI 10.1523/JNEUROSCI.3211-08.2009; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hertz J., 1991, INTRO THEORY NEURAL, V1; Holmes NP, 2005, EXP BRAIN RES, V166, P489, DOI 10.1007/s00221-005-2389-4; Makin TR, 2012, EXP BRAIN RES, V219, P421, DOI 10.1007/s00221-012-3089-5; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Prevosto V, 2011, EUR J NEUROSCI, V33, P444, DOI 10.1111/j.1460-9568.2010.07541.x; Rolls ET, 1990, NETWORK-COMP NEURAL, V1, P407, DOI 10.1088/0954-898X/1/4/002; Rolls ET, 2007, NEURAL COMPUT, V19, P139, DOI 10.1162/neco.2007.19.1.139; ROLLS ET, 1992, PHILOS T R SOC B, V335, P11, DOI 10.1098/rstb.1992.0002; Rolls ET, 2000, NEURAL COMPUT, V12, P2547, DOI 10.1162/089976600300014845; Rolls ET, 2001, NETWORK-COMP NEURAL, V12, P111, DOI 10.1088/0954-898X/12/2/302; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; ROLLS ET, 1997, EXPT BRAIN RES, V114, P177; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; Sarlegna FR, 2009, ADV EXP MED BIOL, V629, P317, DOI 10.1007/978-0-387-77064-2_16; Saunders JA, 2005, EXP BRAIN RES, V162, P458, DOI 10.1007/s00221-004-2064-1; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Stringer SM, 2000, NEURAL NETWORKS, V13, P305, DOI 10.1016/S0893-6080(00)00017-4; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	58	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66272	10.1371/journal.pone.0066272	http://dx.doi.org/10.1371/journal.pone.0066272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799086	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000320363300070
J	Kawahara, H; Naito, H; Takara, K; Wakabayashi, T; Kidoya, H; Takakura, N				Kawahara, Hiroki; Naito, Hisamichi; Takara, Kazuhiro; Wakabayashi, Taku; Kidoya, Hiroyasu; Takakura, Nobuyuki			Tumor Endothelial Cell-Specific Drug Delivery System Using Apelin-Conjugated Liposomes	PLOS ONE			English	Article							BLOOD-VESSELS; GROWTH-FACTOR; THERAPY; TIE2	Background: A drug delivery system specifically targeting endothelial cells (ECs) in tumors is required to prevent normal blood vessels from being damaged by angiogenesis inhibitors. The purpose of this study was to investigate whether apelin, a ligand for APJ expressed in ECs when angiogenesis is taking place, can be used for targeting drug delivery to ECs in tumors. Methods and Results: Uptake of apelin via APJ stably expressed in NIH-3T3 cells was investigated using TAMRA (fluorescent probe)-conjugated apelin. Both long and short forms of apelin (apelin 36 and apelin 13) were taken up, the latter more effectively. To improve efficacy of apelin-liposome conjugates, we introduced cysteine, with its sulfhydryl group, to the C terminus of apelin 13, resulting in the generation of apelin 14. In turn, apelin 14 was conjugated to rhodamine-encapsulating liposomes and administered to tumor-bearing mice. In the tumor microenvironment, we confirmed that liposomes were incorporated into the cytoplasm of ECs. In contrast, apelin non-conjugated liposomes were rarely found in the cytoplasm of ECs. Moreover, non-specific uptake of apelin-conjugated liposomes was rarely detected in other normal organs. Conclusions: ECs in normal organs express little APJ; however, upon hypoxic stimulation, such as in tumors, ECs start to express APJ. The present study suggests that apelin could represent a suitable tool to effectively deliver drugs specifically to ECs within tumors.	[Kawahara, Hiroki; Naito, Hisamichi; Takara, Kazuhiro; Wakabayashi, Taku; Kidoya, Hiroyasu; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Takakura, Nobuyuki] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan.	ntakaku@biken.osaka-u.ac.jp		Naito, Hisamichi/0000-0002-0750-1743	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Fukami A, 2002, BIOCHEM BIOPH RES CO, V291, P1065, DOI 10.1006/bbrc.2002.6572; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gerber HP, 2005, CANCER RES, V65, P671; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kidoya H, 2012, ONCOGENE, V31, P3254, DOI 10.1038/onc.2011.489; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kidoya H, 2010, BLOOD, V115, P3166, DOI 10.1182/blood-2009-07-232306; Lee DK, 2010, BIOCHEM BIOPH RES CO, V395, P185, DOI 10.1016/j.bbrc.2010.03.151; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Presta LG, 1997, CANCER RES, V57, P4593; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Shibuya M, 2006, EXP CELL RES, V10, P49; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8	25	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e65499	10.1371/journal.pone.0065499	http://dx.doi.org/10.1371/journal.pone.0065499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799018	Green Submitted, gold, Green Published			2022-12-27	WOS:000320363300019
J	Liu, HY; Zhao, K; Liu, JX				Liu, Hongyun; Zhao, Ke; Liu, Jianxin			Effects of Glucose Availability on Expression of the Key Genes Involved in Synthesis of Milk Fat, Lactose and Glucose Metabolism in Bovine Mammary Epithelial Cells	PLOS ONE			English	Article							GRADED DUODENAL INFUSIONS; FED DAIRY-COWS; GRASS-SILAGE; LACTATION; GLAND; TRANSPORT; SURVIVAL; YIELD; MODEL; ACID	As the main precursor for lactose synthesis, large amounts of glucose are required by lactating dairy cows. Milk yield greatly depends on mammary lactose synthesis due to its osmoregulatory property for mammary uptake of water. Thus, glucose availability to the mammary gland could be a potential regulator of milk production. In the present study, the effect of glucose availability on expression of the key genes involved in synthesis of milk fat, lactose and glucose metabolism in vitro was investigated. Bovine mammary epithelial cells (BMEC) were treated for 12 h with various concentrations of glucose (2.5, 5, 10 or 20 mmol/L). The higher concentrations of glucose (10-20 mmol/L) did not affect the mRNA expression of acetylCoA carboxylase, diacyl glycerol acyl transferase, glycerol-3 phosphate acyl transferase and a-lactalbumin, whereas fatty acid synthase, sterol regulatory element binding protein-1 and beta-1, 4-galactosyl transferase mRNA expression increased at 10 mmol/L and then decreased at 20 mmol/L. The content of lactose synthase increased with increasing concentration of glucose, with addition of highest value at 20 mmol/L of glucose. Moreover, the increased glucose concentration stimulated the activities of pyruvate kinase and glucose-6-phosphate dehydrogenase, and elevated the energy status of the BMEC. Therefore, it was deduced that after increasing glucose availability, the extra absorbed glucose was partitioned to entering the synthesis of milk fat and lactose by the regulation of the mRNA expression of key genes, promoting glucose metabolism by glycolysis and pentose phosphate pathway as well as energy status. These results indicated that the sufficient availability of glucose in BMEC may promote glucose metabolism, and affect the synthesis of milk composition.	[Liu, Hongyun; Zhao, Ke; Liu, Jianxin] Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Liu, JX (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Mol Anim Nutr, Inst Dairy Sci, Hangzhou 310003, Zhejiang, Peoples R China.	hyliu@zju.edu.cn			China Ministry of Science and Technology [2011CB100801]; earmarked fund for China Agriculture Research System [CARS-37]; National Natural Science Foundation of China [30901034]	China Ministry of Science and Technology(Ministry of Science and Technology, China); earmarked fund for China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of the China Ministry of Science and Technology (No. 2011CB100801), the earmarked fund for China Agriculture Research System (CARS-37) and the National Natural Science Foundation of China (No. 30901034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM S, 1954, J BIOL CHEM, V211, P31; Al-Trad B, 2009, J DAIRY SCI, V92, P5645, DOI 10.3168/jds.2009-2264; ANNISON EF, 1964, J PHYSIOL-LONDON, V175, P372, DOI 10.1113/jphysiol.1964.sp007522; Bauman DE, 2008, J NUTR, V138, P403, DOI 10.1093/jn/138.2.403; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bernard L, 2008, ADV EXP MED BIOL, V606, P67, DOI 10.1007/978-0-387-74087-4_2; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Farrell HM, 2004, J DAIRY SCI, V87, P1641, DOI 10.3168/jds.S0022-0302(04)73319-6; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Hammerman PS, 2004, TRENDS BIOCHEM SCI, V29, P586, DOI 10.1016/j.tibs.2004.09.008; Han L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027074; Harvatine KJ, 2009, ANIMAL, V3, P40, DOI 10.1017/S1751731108003133; Humphrey BD, 2008, J NUTR, V138, P1153, DOI 10.1093/jn/138.6.1153; Hurtaud C, 2000, J DAIRY SCI, V83, P2952, DOI 10.3168/jds.S0022-0302(00)75195-2; Hurtaud C, 1998, J DAIRY SCI, V81, P3239, DOI 10.3168/jds.S0022-0302(98)75888-6; JUDSON GJ, 1973, BRIT J NUTR, V29, P175, DOI 10.1079/BJN19730093; Kahn CM, 2010, MERCK VET MANUAL, DOI DOI 10.1071/RD9910501; KIMMICH GA, 1975, ANAL BIOCHEM, V69, P187, DOI 10.1016/0003-2697(75)90580-1; KLEIBER M, 1955, BIOCHIM BIOPHYS ACTA, V17, P252, DOI 10.1016/0006-3002(55)90357-7; Lemosquet S, 2004, J DAIRY SCI, V87, P1767, DOI 10.3168/jds.S0022-0302(04)73332-9; Lemosquet S, 1997, J DAIRY SCI, V80, P2854, DOI 10.3168/jds.S0022-0302(97)76250-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mellenberger R W, 1974, Biochem J, V142, P659; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Oldick BS, 1997, J DAIRY SCI, V80, P1315, DOI 10.3168/jds.S0022-0302(97)76060-0; Ramakrishnan B, 2001, J MOL BIOL, V310, P205, DOI 10.1006/jmbi.2001.4757; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; RENNER ED, 1972, J BIOL CHEM, V247, P5765; Rigout S, 2002, J DAIRY SCI, V85, P595, DOI 10.3168/jds.S0022-0302(02)74113-1; Rulquin H, 2004, J DAIRY SCI, V87, P340, DOI 10.3168/jds.S0022-0302(04)73173-2; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Xiao CT, 2005, J DAIRY SCI, V88, P2794, DOI 10.3168/jds.S0022-0302(05)72959-3; Zhao K, 2012, ANIMAL, V6, P488, DOI 10.1017/S1751731111001893; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023	36	38	43	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e66092	10.1371/journal.pone.0066092	http://dx.doi.org/10.1371/journal.pone.0066092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799073	Green Submitted, Green Published, gold			2022-12-27	WOS:000320363300062
J	Novotny, LA; Amer, AO; Brockson, ME; Goodman, SD; Bakaletz, LO				Novotny, Laura A.; Amer, Amal O.; Brockson, M. Elizabeth; Goodman, Steven D.; Bakaletz, Lauren O.			Structural Stability of Burkholderia cenocepacia Biofilms Is Reliant on eDNA Structure and Presence of a Bacterial Nucleic Acid Binding Protein	PLOS ONE			English	Article							SECRETION SYSTEM ACTIVITY; CYSTIC-FIBROSIS PATIENTS; ANTIBIOTIC SUSCEPTIBILITY; LUNG TRANSPLANTATION; RESPONSE REGULATOR; CEPACIA-COMPLEX; DNA; INFLAMMATION; IHF	Cystic fibrosis (CF) is the most common lethal inherited genetic disorder affection Caucasians. Even with medical advances, CF is life-shortening with patients typically surviving only to age 38. Infection of the CF lung by Burkholderia cenocepacia presents exceptional challenges to medical management of these patients as clinically this microbe is resistant to virtually all antibiotics, is highly transmissible and infection of CF patients with this microbe renders them ineligible for lung transplant, often the last lifesaving option. Here we have targeted two abundant components of the B. cenocepacia biofilm for immune intervention: extracellular DNA and DNABII proteins, the latter of which are bacterial nucleic acid binding proteins. Treatment of B. cenocepacia biofilms with antiserum directed at one of these DNABII proteins (integration host factor or IHF) resulted in significant disruption of the biofilm. Moreover, when anti-IHF mediated destabilization of a B. cenocepacia biofilm was combined with exposure to traditional antibiotics, B. cenocepacia resident within the biofilm and thereby typically highly resistant to the action of antibiotics, were now rendered susceptible to killing. Pre-incubation of B. cenocepacia with anti-IHF serum prior to exposure to murine CF macrophages, which are normally unable to effectively degrade ingested B. cenocepacia, resulted in a statistically significant increase in killing of phagocytized B. cenocepacia. Collectively, these findings support further development of strategies that target DNABII proteins as a novel approach for treatment of CF patients, particularly those whose lungs are infected with B. cenocepacia.	[Novotny, Laura A.; Brockson, M. Elizabeth; Goodman, Steven D.; Bakaletz, Lauren O.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Novotny, Laura A.; Brockson, M. Elizabeth; Goodman, Steven D.; Bakaletz, Lauren O.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Amer, Amal O.] Ctr Microbial Interface Biol, Dept Microbial Infect & Immun, Columbus, OH USA; [Amer, Amal O.] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Amer, Amal O.] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Goodman, SD (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA.	Steven.Goodman@NationwideChildrens.org; Lauren.Bakaletz@NationwideChildrens.org	Amer, Amal/E-2643-2011; Bakaletz, Lauren/GMW-8490-2022; Goodman, Steven/C-5732-2013		NIDCD/NIH [R01DC011818];  [R01HL094586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011818] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from NIDCD/NIH to LOB and SDG (R01DC011818). Studies in Dr. Amal Amer's laboratory were supported by grant R01HL094586. www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Boleij A, 2009, INFECT IMMUN, V77, P5519, DOI 10.1128/IAI.00384-09; Browning DF, 2010, CURR OPIN MICROBIOL, V13, P773, DOI 10.1016/j.mib.2010.09.013; BUTLER SL, 1995, J CLIN MICROBIOL, V33, P1001, DOI 10.1128/JCM.33.4.1001-1004.1995; Campana Silvia, 2004, J Cyst Fibros, V3, P159, DOI 10.1016/j.jcf.2004.03.010; CASTELLANI C, 1995, ARCH DIS CHILD, V73, P276, DOI 10.1136/adc.73.3.276; Dawson KG, 1999, PEDIATR INFECT DIS J, V18, P816, DOI 10.1097/00006454-199902000-00015; De Soyza A, 2010, J HEART LUNG TRANSPL, V29, P1395, DOI 10.1016/j.healun.2010.06.007; Dubarry N, 2010, APPL ENVIRON MICROB, V76, P1095, DOI 10.1128/AEM.02123-09; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gao Q, 2000, THESIS U SO CALIFORN; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; Golini G, 2006, EUR J CLIN MICROBIOL, V25, P175, DOI 10.1007/s10096-006-0099-x; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Graindorge A, 2010, DIAGN MICR INFEC DIS, V66, P29, DOI 10.1016/j.diagmicrobio.2009.06.008; Gustave JE, 2013, J CYST FIBROS, V12, P384, DOI 10.1016/j.jcf.2012.10.011; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hopkins PM, 2009, AM J RESP CRIT CARE, V179, P257, DOI 10.1164/ajrccm.179.3.257; Hung DCI, 2011, J BACTERIOL, V193, P3642, DOI 10.1128/JB.00155-11; Jimenez Luis, 2007, PDA J Pharm Sci Technol, V61, P383; Jones EA, 2012, J INNATE IMMUN; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Jurcisek JA, 2011, JOVE-J VIS EXP, DOI 10.3791/2481; Justice SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048349; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Lechtzin N, 2006, RESPIRATION, V73, P27, DOI 10.1159/000087686; LIPUMA JJ, 1995, NEW ENGL J MED, V332, P820; Lucero CA, 2011, AM J INFECT CONTROL, V39, P775, DOI 10.1016/j.ajic.2010.12.005; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lunsford RD, 1996, CURR MICROBIOL, V32, P95, DOI 10.1007/s002849900017; Nash EF, 2010, TRANSPL INFECT DIS, V12, P551, DOI 10.1111/j.1399-3062.2010.00525.x; Peeters E, 2008, J HOSP INFECT, V70, P361, DOI 10.1016/j.jhin.2008.08.015; Post J Christopher, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P347, DOI 10.1097/MOO.0b013e3282b97327; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; SIMPSON IN, 1994, J ANTIMICROB CHEMOTH, V34, P353, DOI 10.1093/jac/34.3.353; Slinger R, 2006, DIAGN MICR INFEC DIS, V56, P247, DOI 10.1016/j.diagmicrobio.2006.04.012; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1188, DOI 10.1099/00207713-47-4-1188; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; WINTERS BD, 1993, INFECT IMMUN, V61, P3259, DOI 10.1128/IAI.61.8.3259-3264.1993; Zhang LP, 1999, INFECT IMMUN, V67, P6473	49	61	72	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e67629	10.1371/journal.pone.0067629	http://dx.doi.org/10.1371/journal.pone.0067629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23799151	gold, Green Published, Green Submitted			2022-12-27	WOS:000320363300114
J	Sampaio-Silva, F; Magalhaes, T; Carvalho, F; Dinis-Oliveira, RJ; Silvestre, R				Sampaio-Silva, Fernanda; Magalhaes, Teresa; Carvalho, Felix; Dinis-Oliveira, Ricardo Jorge; Silvestre, Ricardo			Profiling of RNA Degradation for Estimation of Post Morterm Interval	PLOS ONE			English	Article							REAL-TIME PCR; MESSENGER-RNA; GENE-EXPRESSION; POSTMORTEM INTERVAL; HOUSEKEEPING GENES; QUALITY-CONTROL; HUMAN BRAIN; RT-PCR; QUANTIFICATION; IDENTIFICATION	An estimation of the post mortem interval (PMI) is frequently touted as the Holy Grail of forensic pathology. During the first hours after death, PMI estimation is dependent on the rate of physical observable modifications including algor, rigor and livor mortis. However, these assessment methods are still largely unreliable and inaccurate. Alternatively, RNA has been put forward as a valuable tool in forensic pathology, namely to identify body fluids, estimate the age of biological stains and to study the mechanism of death. Nevertheless, the attempts to find correlation between RNA degradation and PMI have been unsuccessful. The aim of this study was to characterize the RNA degradation in different post mortem tissues in order to develop a mathematical model that can be used as coadjuvant method for a more accurate PMI determination. For this purpose, we performed an eleven-hour kinetic analysis of total extracted RNA from murine's visceral and muscle tissues. The degradation profile of total RNA and the expression levels of several reference genes were analyzed by quantitative real-time PCR. A quantitative analysis of normalized transcript levels on the former tissues allowed the identification of four quadriceps muscle genes (Actb, Gapdh, Ppia and Srp72) that were found to significantly correlate with PMI. These results allowed us to develop a mathematical model with predictive value for estimation of the PMI (confidence interval of +/-51 minutes at 95%) that can become an important complementary tool for traditional methods.	[Sampaio-Silva, Fernanda; Silvestre, Ricardo] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Sampaio-Silva, Fernanda; Dinis-Oliveira, Ricardo Jorge; Silvestre, Ricardo] Adv Inst Hlth Sci North, Dept Sci, CESPU, CRL, Gandra, Portugal; [Magalhaes, Teresa; Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Med, Dept Legal Med & Forens Sci, P-4100 Oporto, Portugal; [Magalhaes, Teresa; Dinis-Oliveira, Ricardo Jorge] Ctr Forens Sci CENCIFOR, Coimbra, Portugal; [Carvalho, Felix; Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Pharm, Dept Biol Sci, REQUIMTE,Lab Toxicol, P-4100 Oporto, Portugal; [Dinis-Oliveira, Ricardo Jorge] Polytech Hlth Inst North, Dept Diagnost & Therapeut Technol, CESPU, CRL, Vila Nova De Famalicao, Portugal; [Magalhaes, Teresa] Natl Inst Legal Med & Forens Sci, North Branch, Oporto, Portugal; [Magalhaes, Teresa] Univ Porto, Biomed Sci Inst Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Instituto Nacional de Medicina Legal e Ciencias Forenses, IP; Universidade do Porto	Silvestre, R (corresponding author), Univ Porto, Inst Mol & Cell Biol IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	rleal@ibmc.up.pt	Magalhães, Teresa/J-7897-2013; Silvestre, Ricardo/C-7243-2011; Carvalho, Félix/D-4914-2013; Dinis-Oliveira, Ricardo Jorge/D-9186-2013	Silvestre, Ricardo/0000-0002-9270-2717; Carvalho, Félix/0000-0003-3858-3494; Dinis-Oliveira, Ricardo Jorge/0000-0001-7430-6297; Magalhaes, Teresa/0000-0002-8098-8076; Sampaio Silva, Fernanda/0000-0002-7936-5154	FCT [SFRH/BPD/36865/2007]; Programa Ciencia; Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Ciencia(Spanish Government); Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	Ricardo Jorge Dinis-Oliveira acknowledges FCT for his Post-Doc grant (SFRH/BPD/36865/2007). Ricardo Silvestre was supported by Programa Ciencia, financed by Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico, co-funded by Fundo Social Europeu and National funding from Ministry of Science, Technology and Higher Education (MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2005, FORENSIC SCI INT, V148, P37, DOI 10.1016/j.forsciint.2004.04.071; Bahar B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-108; Bauer M, 2007, FORENSIC SCI INT-GEN, V1, P69, DOI 10.1016/j.fsigen.2006.11.002; Bauer M, 2003, FORENSIC SCI INT, V138, P94, DOI 10.1016/j.forsciint.2003.09.008; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Courts C, 2010, FORENSIC SCI INT, V203, P106, DOI 10.1016/j.forsciint.2010.07.002; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dinis-Oliveira RJ, 2010, TOXICOL MECH METHOD, V20, P363, DOI 10.3109/15376516.2010.497976; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Heinrich M, 2007, INT J LEGAL MED, V121, P136, DOI 10.1007/s00414-006-0131-9; Heinrich M, 2007, FORENSIC SCI INT-GEN, V1, P163, DOI 10.1016/j.fsigen.2007.01.002; Henssge C, 2007, FORENSIC SCI INT, V165, P182, DOI 10.1016/j.forsciint.2006.05.017; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; HUMPHREYS-BEHER M G, 1986, Biotechnology and Applied Biochemistry, V8, P392; Juusola J, 2005, FORENSIC SCI INT, V152, P1, DOI 10.1016/j.forsciint.2005.02.020; Juusola J, 2007, J FORENSIC SCI, V52, P1252, DOI 10.1111/j.1556-4029.2007.00550.x; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Koppelkamm A, 2010, INT J LEGAL MED, V124, P371, DOI 10.1007/s00414-010-0433-9; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Liu LJ, 2007, J HUAZHONG U SCI-MED, V27, P362, DOI 10.1007/s11596-007-0404-7; MADEA B, 1994, FORENSIC SCI INT, V69, P221, DOI 10.1016/0379-0738(94)90386-7; Madea B, 2005, FORENSIC SCI INT, V151, P139, DOI 10.1016/j.forsciint.2005.01.013; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Partemi S, 2010, FORENSIC SCI INT, V203, P99, DOI 10.1016/j.forsciint.2010.07.005; Prahlow J, 2010, FORENSIC PATHOLOGY FOR POLICE, DEATH INVESTIGATORS, ATTORNEYS, AND FORENSIC SCIENTISTS, P1, DOI 10.1007/978-1-59745-404-9; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Sieger J, 2000, ENCY FORENSIC SCI; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vennemann M, 2010, FORENSIC SCI INT, V203, P71, DOI 10.1016/j.forsciint.2010.07.006; Vennemann M, 2010, FORENSIC SCI INT, V203, P76, DOI 10.1016/j.forsciint.2010.07.007; Weis S, 2007, J NEUROSCI METH, V165, P198, DOI 10.1016/j.jneumeth.2007.06.001; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhao Dong, 2006, Legal Medicine, V8, P132, DOI 10.1016/j.legalmed.2005.09.001	46	89	93	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56507	10.1371/journal.pone.0056507	http://dx.doi.org/10.1371/journal.pone.0056507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437149	Green Published, gold			2022-12-27	WOS:000315184200087
J	Xiao, Y; Xia, W; Yang, YD; Mason, AS; Lei, XT; Ma, ZL				Xiao, Yong; Xia, Wei; Yang, Yaodong; Mason, Annaliese S.; Lei, Xintao; Ma, Zilong			Characterization and Evolution of Conserved MicroRNA through Duplication Events in Date Palm (Phoenix dactylifera)	PLOS ONE			English	Article							GENOME SEQUENCE; BLACK COTTONWOOD; PLANT MICRORNAS; ORIGINS; BIOGENESIS; DIVERGENCE; BIRTH	MicroRNAs (miRNAs) are important regulators of gene expression at the post-transcriptional level in a wide range of species. Highly conserved miRNAs regulate ancestral transcription factors common to all plants, and control important basic processes such as cell division and meristem function. We selected 21 conserved miRNA families to analyze the distribution and maintenance of miRNAs. Recently, the first genome sequence in Palmaceae was released: date palm (Phoenix dactylifera). We conducted a systematic miRNA analysis in date palm, computationally identifying and characterizing the distribution and duplication of conserved miRNAs in this species compared to other published plant genomes. A total of 81 miRNAs belonging to 18 miRNA families were identified in date palm. The majority of miRNAs in date palm and seven other well-studied plant species were located in intergenic regions and located 4 to 5 kb away from the nearest protein-coding genes. Sequence comparison showed that 67% of date palm miRNA members were present in duplicated segments, and that 135 pairs of miRNA-containing segments were duplicated in Arabidopsis, tomato, orange, rice, apple, poplar and soybean with a high similarity of non coding sequences between duplicated segments, indicating genomic duplication was a major force for expansion of conserved miRNAs. Duplicated miRNA pairs in date palm showed divergence in pre-miRNA sequence and in number of promoters, implying that these duplicated pairs may have undergone divergent evolution. Comparisons between date palm and the seven other plant species for the gain/loss of miR167 loci in an ancient segment shared between monocots and dicots suggested that these conserved miRNAs were highly influenced by and diverged as a result of genomic duplication events.	[Xiao, Yong; Xia, Wei; Yang, Yaodong; Lei, Xintao] Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconuts Res Inst, Wenchang, Hainan, Peoples R China; [Mason, Annaliese S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Mason, Annaliese S.] Univ Queensland, Ctr Integrat Legume Res, Brisbane, Qld, Australia; [Ma, Zilong] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; University of Queensland; University of Queensland; Chinese Academy of Tropical Agricultural Sciences	Yang, YD (corresponding author), Chinese Acad Trop Agr Sci, Hainan Key Lab Trop Oil Crops Biol, Coconuts Res Inst, Wenchang, Hainan, Peoples R China.	ydyang@tocri.com	Xiao, Yang/N-5021-2017; Mason, Annaliese S/B-8809-2011; HUI, Xiaoyan Hannah/M-5175-2019; Yang, Yaodong/L-8445-2019	Xiao, Yang/0000-0003-3927-1839; Mason, Annaliese S/0000-0003-2701-7964; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Yang, Yaodong/0000-0002-6599-5665; Zhou, Zhiguang/0000-0002-0374-1838	National Natural Science Foundation of China [31101179]; Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute [CATAS- ITBB120506]; Australian Research Council Early Career Researcher Award [DE120100668]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China; National Nonprofit Institute; Australian Research Council Early Career Researcher Award(Australian Research Council)	This work was supported by grants from the National Natural Science Foundation of China (No. 31101179), the Project for High-Level Returned Scholar of Ministry of Human Resources and Social Security of P.R. China (2011), the National Nonprofit Institute Research Grant of CATAS- ITBB120506, and Australian Research Council Early Career Researcher Award (DE120100668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Djerbi S, 2005, PLANTA, V221, P739, DOI 10.1007/s00425-005-1498-4; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Garcia D, 2008, SEMIN CELL DEV BIOL, V19, P586, DOI 10.1016/j.semcdb.2008.07.013; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kozik A, 2002, BIOINFORMATICS, V18, P335, DOI 10.1093/bioinformatics/18.2.335; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nozawa M, 2012, GENOME BIOL EVOL, V4, P230, DOI 10.1093/gbe/evs002; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Sun J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034092; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Turner M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-169; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028073	40	68	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e71435	10.1371/journal.pone.0071435	http://dx.doi.org/10.1371/journal.pone.0071435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23799122	Green Submitted, gold, Green Published			2022-12-27	WOS:000323124000057
J	Xiao, Y; Xu, AM; Hui, XY; Zhou, PC; Li, X; Zhong, H; Tang, WL; Huang, G; Zhou, ZG				Xiao, Yang; Xu, Aimin; Hui, Xiaoyan; Zhou, Pengcheng; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang			Circulating Lipocalin-2 and Retinol-Binding Protein 4 Are Associated with Intima-Media Thickness and Subclinical Atherosclerosis in Patients with Type 2 Diabetes	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; INSULIN-RESISTANCE; RETINOL-BINDING-PROTEIN-4; INFLAMMATION; OBESITY; EXPRESSION; FAMILY	Background: The lipocalin family proteins, including lipocalin-2 and retinol-binding protein 4 (RBP4), are adipokines closely associated with obesity-related metabolic disorders. In this study, we evaluated the association of serum lipocalin-2 and RBP4 with intima-media thickness (IMT) and subclinical atherosclerosis in type 2 diabetic patients. Methods and Results: Serum levels of lipocalin-2 and RBP4 were measured in 284 type 2 diabetic patients. Subclinical atherosclerosis was assessed by IMT at carotid, femoral and iliac arteries with ultrasound. Patients with subclinical atherosclerosis showed significantly higher circulating concentrations of lipocalin-2 and RBP4 when compared to those without [112.9 (86.4 to 202.1) mu g/L versus 77.2(55.0-150.4) mu g/L, 37.1(32.3-40.8) mg/L versus 23.2(20.1-29.2) mg/L, respectively; P = 0.002, P<0.001, respectively]. Moreover, positive correlations were observed between carotid IMT and lipocalin-2 (r = 0.170, P = 0.018) or RBP4 (r = 0.132, P = 0.040), femoral IMT and lipocalin-2 (r = 0.160, P = 0.027), as well as between iliac IMT and RBP4 (r = 0.241, P<0.001). Multiple logistic regression analysis further demonstrated that these two adipokines were independent risk factors for subclinical atherosclerosis in type 2 diabetes. Conclusion: Circulating levels of lipocalin-2 and RBP4 are positively correlated with carotid IMT and subclinical atherosclerosis in type 2 diabetes, which suggests a potential role of these two lipid-binding chaperones in the pathogenesis of vascular complications of diabetes.	[Xiao, Yang; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang] Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Hunan Key Lab Med Epigen, Changsha, Hunan, Peoples R China; [Xiao, Yang; Li, Xing; Zhong, Hui; Tang, Weili; Huang, Gan; Zhou, Zhiguang] Cent S Univ, Inst Metab & Endocrinol, Key Lab Diabet Immunol, Hunan Key Lab Med Epigen,Minist Educ, Changsha, Hunan, Peoples R China; [Xu, Aimin; Hui, Xiaoyan; Zhou, Pengcheng] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Xiao, Yang; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	Central South University; Central South University; University of Hong Kong; University of Hong Kong; University of Hong Kong	Zhou, ZG (corresponding author), Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Hunan Key Lab Med Epigen, Changsha, Hunan, Peoples R China.	zhouzg@hotmail.com	Xiao, Yang/N-5021-2017; Mason, Annaliese S/B-8809-2011; HUI, Xiaoyan Hannah/M-5175-2019; Yang, Yaodong/L-8445-2019	Xiao, Yang/0000-0003-3927-1839; Mason, Annaliese S/0000-0003-2701-7964; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Yang, Yaodong/0000-0002-6599-5665; Zhou, Zhiguang/0000-0002-0374-1838	National key technology RD program [2012BAI02B04]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1195]; Hunan Provincial Natural Science Foundation of China [11JJ7005]; National Natural Science Foundation of China [81170725, 81200600]; Hong Kong Collaborative Research Fund [HKU/CRF/10]; Research Fund for the Doctoral Program of Higher Education of China [20110162120014]; Fundamental Research Funds for the Central University [2011QNZT176]	National key technology RD program(National Key Technology R&D Program); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Collaborative Research Fund; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central University	This work is supported by the National key technology R&D program (2012BAI02B04), Program for Changjiang Scholars and Innovative Research Team in University (IRT1195), Hunan Provincial Natural Science Foundation of China (11JJ7005), the National Natural Science Foundation of China (Grant No. 81170725, to Z.Z.), Hong Kong Collaborative Research Fund (HKU/CRF/10, to A.X.), the National Natural Science Foundation of China (Grant No. 81200600), the Research Fund for the Doctoral Program of Higher Education of China (20110162120014), and the Fundamental Research Funds for the Central University (2011QNZT176, to Y.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Balagopal P, 2007, J CLIN ENDOCR METAB, V92, P1971, DOI 10.1210/jc.2006-2712; Balbarini A, 2000, ANGIOLOGY, V51, P269; Barazzoni R, 2011, CLIN ENDOCRINOL OXF; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bobbert T, 2010, ATHEROSCLEROSIS, V213, P549, DOI 10.1016/j.atherosclerosis.2010.07.063; Bratt T, 1999, BBA-GEN SUBJECTS, V1472, P262, DOI 10.1016/S0304-4165(99)00131-2; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Choi KM, 2008, EUR J ENDOCRINOL, V158, P203, DOI 10.1530/EJE-07-0633; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Jaffer FA, 2006, J AM COLL CARDIOL, V47, P1328, DOI 10.1016/j.jacc.2006.01.029; Kardys I, 2006, ARTERIOSCL THROM VAS, V26, P631, DOI 10.1161/01.ATV.0000201289.83256.cf; Kotliar Carol, 2008, J Cardiometab Syndr, V3, P60, DOI 10.1111/j.1559-4572.2008.07957.x; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu JT, 2011, BR J PHARM; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Park SE, 2009, ATHEROSCLEROSIS, V204, P23, DOI 10.1016/j.atherosclerosis.2008.08.012; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solini A, 2009, AM J HYPERTENS, V22, P1001, DOI 10.1038/ajh.2009.116; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816	36	68	74	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2013	8	6							e66607	10.1371/journal.pone.0066607	http://dx.doi.org/10.1371/journal.pone.0066607			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177TH	23799122	Green Published, Green Submitted, gold			2022-12-27	WOS:000321397800042
J	Ren, GL; Huang, GY; Zheng, H; Fang, Y; Ma, HH; Xu, MC; Zhang, HB; Zhang, WY; Zhao, YG; Sun, DY; Hu, WK; Liu, J				Ren, Guang-Li; Huang, Guang-Yu; Zheng, Hong; Fang, Ying; Ma, Heng-Hao; Xu, Man-Chun; Zhang, Hong-Bin; Zhang, Wei-Yun; Zhao, Ya-Gang; Sun, Da-Yong; Hu, Wen-Kui; Liu, Jian			Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and lLong-Term-siRNA Treatment	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SHORT HAIRPIN RNA; NONPARENCHYMAL LIVER-CELLS; DENDRITIC CELLS; POLYMERASE-II; EXPRESSION; REPLICATION; INFECTION; INTERFERENCE; INHIBITION	Background: Currently, no licensed therapy can thoroughly eradicate hepatitis B virus (HBV) from the body, including interferon alpha and inhibitors of HBV reverse-transcription. Small interfering RNA (siRNA) seem to be a promising tool for treating HBV, but had no effect on the pre-existing HBV covalently closed circular DNA. Because it is very difficult to thoroughly eradicate HBV with unique siRNAs, upgrading the immune response is the best method for fighting HBV infection. Here, we aim to explore the immune response of transgenic mice to HBV vaccination after long-term treatment with siRNAs and develop a therapeutic approach that combines siRNAs with immunopotentiators. Methodology/Principal Findings: To explore the response of transgenic mice to hepatitis B vaccine, innate and acquired immunity were detected after long-term treatment with siRNAs and vaccination. Antiviral cytokines and level of anti-hepatitis B surface antigen antibody (HBsAg-Ab) were measured after three injections of hepatitis B vaccine. Results: Functional analyses indicated that toll-like receptor-mediated innate immune responses were reinforced, and antiviral cytokines were significantly increased, especially in the pSilencer4.1/HBV groups. Analysis of CD80+/CD86+ dendritic cells in the mouse liver indicated that dendritic cell antigen presentation was strengthened. Furthermore, the siRNA-treated transgenic mice could produce detectable HBsAg-Ab after vaccination, especially in the CpG oligonucleotide vaccine group. Conclusions/Significance: For the first time, our studies demonstrate that siRNAs with CpG HBV vaccine could strengthen the immune response and break the immune tolerance status of transgenic mice to HBV. Thus, siRNAs and HBV vaccine could provide a sharp double-edged sword against chronic HBV infection.	[Ren, Guang-Li; Ma, Heng-Hao; Xu, Man-Chun; Zhang, Hong-Bin; Zhang, Wei-Yun; Hu, Wen-Kui; Liu, Jian] Gen Hosp GuangZhou Mil Command PLA, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Ren, Guang-Li] S China Univ Technol, Inst Biochem, Guangzhou, Guangdong, Peoples R China; [Ren, Guang-Li] HuaBo Biopharmceut Inst GuangZhou, Guangzhou, Guangdong, Peoples R China; [Huang, Guang-Yu] Third Mil Med Univ, Dept Infect Dis, Southwest Hosp, Chongqing, Peoples R China; [Zheng, Hong] Fourth Mil Med Univ, Dent Hosp, Dept Oral Orthopaed, Xian 710032, Peoples R China; [Fang, Ying] Guangzhou Med Univ, Dept Stomatol, Guangzhou, Guangdong, Peoples R China; [Zhao, Ya-Gang; Sun, Da-Yong] Gen Hosp GuangZhou Mil Command PLA, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Hu, Wen-Kui; Liu, Jian] Gen Hosp GuangZhou Mil Command PLA, Dept Gerontol & Deanery, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; South China University of Technology; Army Medical University; Air Force Military Medical University; Guangzhou Medical University; Southern Theater Command General Hospital; Southern Theater Command General Hospital	Ren, GL (corresponding author), Gen Hosp GuangZhou Mil Command PLA, Dept Pediat, Guangzhou, Guangdong, Peoples R China.	guangliren@hotmail.com			China postdoctoral Science Foundation [20100470917, 201003353]; Natural Science Foundation of Guangzhou province [8451001002000762]; Guangdong province & GuangZhou Science and Technology Program Funds [12C19732961131678, 20120314]	China postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangzhou province; Guangdong province & GuangZhou Science and Technology Program Funds	This research was funded by China postdoctoral Science Foundation [20100470917; 201003353]; Natural Science Foundation of Guangzhou province [8451001002000762]; and Guangdong province & GuangZhou Science and Technology Program Funds [12C19732961131678, 20120314]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carmona S, 2009, MOL PHARMACEUT, V6, P706, DOI 10.1021/mp800157x; Chen CC, 2009, MOL THER, V17, P352, DOI 10.1038/mt.2008.245; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Durantel D, 2012, J HEPATOL, V57, P486, DOI 10.1016/j.jhep.2012.06.019; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Nassanian H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000767; Park SG, 2005, GASTROENTEROLOGY, V128, P2042, DOI 10.1053/j.gastro.2005.03.002; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Ren GL, 2005, BIOCHEM BIOPH RES CO, V335, P1051, DOI 10.1016/j.bbrc.2005.07.170; Ren GL, 2007, ANTIVIR THER, V12, P865; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Starkey JL, 2009, J GEN VIROL, V90, P115, DOI 10.1099/vir.0.004408-0; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Wen WH, 2007, HEPATOLOGY, V46, P84, DOI 10.1002/hep.21663; Wu J, 2007, HEPATOLOGY, V46, P1769, DOI 10.1002/hep.21897; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu Zhe, 2007, J Infect, V55, pe1, DOI 10.1016/j.jinf.2007.01.003; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhang JC, 2009, J VIROL METHODS, V161, P30, DOI 10.1016/j.jviromet.2009.05.009	31	25	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2013	8	3							e57525	10.1371/journal.pone.0057525	http://dx.doi.org/10.1371/journal.pone.0057525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099RC	23472088	gold, Green Published, Green Submitted			2022-12-27	WOS:000315637900027
J	Haupt, VJ; Daminelli, S; Schroeder, M				Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael			Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key	PLOS ONE			English	Article							MOLECULAR COMPLEXITY; DATABASE; PHARMACOLOGY; ALGORITHM; MECHANISM; BIOLOGY; UPDATE; ALIGN	Drug repositioning applies established drugs to new disease indications with increasing success. A pre-requisite for drug repurposing is drug promiscuity (polypharmacology) - a drug's ability to bind to several targets. There is a long standing debate on the reasons for drug promiscuity. Based on large compound screens, hydrophobicity and molecular weight have been suggested as key reasons. However, the results are sometimes contradictory and leave space for further analysis. Protein structures offer a structural dimension to explain promiscuity: Can a drug bind multiple targets because the drug is flexible or because the targets are structurally similar or even share similar binding sites? We present a systematic study of drug promiscuity based on structural data of PDB target proteins with a set of 164 promiscuous drugs. We show that there is no correlation between the degree of promiscuity and ligand properties such as hydrophobicity or molecular weight but a weak correlation to conformational flexibility. However, we do find a correlation between promiscuity and structural similarity as well as binding site similarity of protein targets. In particular, 71% of the drugs have at least two targets with similar binding sites. In order to overcome issues in detection of remotely similar binding sites, we employed a score for binding site similarity: LigandRMSD measures the similarity of the aligned ligands and uncovers remote local similarities in proteins. It can be applied to arbitrary structural binding site alignments. Three representative examples, namely the anticancer drug methotrexate, the natural product quercetin and the anti-diabetic drug acarbose are discussed in detail. Our findings suggest that global structural and binding site similarity play a more important role to explain the observed drug promiscuity in the PDB than physicochemical drug properties like hydrophobicity or molecular weight. Additionally, we find ligand flexibility to have a minor influence.	[Haupt, V. Joachim; Daminelli, Simone; Schroeder, Michael] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany	Technische Universitat Dresden	Schroeder, M (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany.	michael.schroeder@biotec.tu-dresden.de	Schroeder, Michael/A-3040-2010	Weller, Aron/0000-0002-0663-4384; Schroeder, Mariana/0000-0002-9517-4243	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	EU project "Ponte"; German Federal Ministry of Economics and Technology project "GeneCloud"	Funding by the EU project "Ponte" (http://www.ponte-project.eu) and the German Federal Ministry of Economics and Technology project "GeneCloud" (http://transinsight.com/genecloud) is kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; Bottegoni G, 2006, BIOINFORMATICS, V22, pE58, DOI 10.1093/bioinformatics/btl212; Brandt W, 2010, CURR TOP MED CHEM, V10, P1361, DOI 10.2174/156802610792232060; Daminelli S, 2012, INTEGR BIOL-UK, V4, P778, DOI 10.1039/c2ib00154c; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Gunther S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-293; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Haupt VJ, 2011, BRIEF BIOINFORM, V12, P312, DOI 10.1093/bib/bbr011; Heinrich JC, 2011, J CANCER RES CLIN, V137, P1349, DOI 10.1007/s00432-011-1005-1; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kalinina OV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002043; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kellenberger E, 2008, CURR COMPUT-AID DRUG, V4, P209, DOI 10.2174/157340908785747401; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konc J, 2012, J CHEM INF MODEL, V52, P604, DOI 10.1021/ci2005687; Kroeze W. K., 2012, POLYPHARMACOLOGY DRU, P133, DOI [10.1002/9781118098141.ch7, DOI 10.1002/9781118098141.CH7]; Leach AR, 2011, CURR OPIN CHEM BIOL, V15, P489, DOI 10.1016/j.cbpa.2011.05.008; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Liu TY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002326; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mencher Simon K, 2005, BMC Clin Pharmacol, V5, P3, DOI 10.1186/1472-6904-5-3; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; O'Connor KA, 2005, NAT REV DRUG DISCOV, V4, P1005, DOI 10.1038/nrd1900; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Painter J, 2004, J APPL CRYSTALLOGR, V37, P174, DOI 10.1107/S0021889803025639; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Rahman SA, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-12; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; [No title captured]	64	109	109	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e65894	10.1371/journal.pone.0065894	http://dx.doi.org/10.1371/journal.pone.0065894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23805191	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500019
J	Zhang, Y; Zhang, WN; Lu, K; Ji, RR; Wang, FL; Liu, T				Zhang, Yu; Zhang, Wei-Nan; Lu, Ke; Ji, Rongrong; Wang, Fanglin; Liu, Ting			Phrasal Paraphrase Based Question Reformulation for Archived Question Retrieval	PLOS ONE			English	Article								Lexical gap in cQA search, resulted by the variability of languages, has been recognized as an important and widespread phenomenon. To address the problem, this paper presents a question reformulation scheme to enhance the question retrieval model by fully exploring the intelligence of paraphrase in phrase-level. It compensates for the existing paraphrasing research in a suitable granularity, which either falls into fine-grained lexical-level or coarse-grained sentence-level. Given a question in natural language, our scheme first detects the involved key-phrases by jointly integrating the corpus-dependent knowledge and question-aware cues. Next, it automatically extracts the paraphrases for each identified key-phrase utilizing multiple online translation engines, and then selects the most relevant reformulations from a large group of question rewrites, which is formed by full permutation and combination of the generated paraphrases. Extensive evaluations on a real world data set demonstrate that our model is able to characterize the complex questions and achieves promising performance as compared to the state-of-the-art methods.	[Zhang, Yu; Zhang, Wei-Nan; Liu, Ting] Harbin Inst Technol, Res Ctr Social Comp & Informat Retrieval, Harbin, Heilongjiang, Peoples R China; [Lu, Ke] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China; [Wang, Fanglin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	Harbin Institute of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University; National University of Singapore	Ji, RR (corresponding author), Xiamen Univ, Dept Cognit Sci, Xiamen, Fujian, Peoples R China.	rrji@ee.columbia.edu; hardegg@gmail.com		zhang, longxian/0000-0002-5706-131X; ling, hong/0000-0002-1886-1242; Liu, Jun/0000-0002-0522-6733				[Anonymous], 2006, P LREC; [Anonymous], 2012, P 2012 JOINT C EMP M; Bannard Colin, 2005, P 43 ANN M ASS COMP, P597, DOI [10.3115/1219840.1219914, DOI 10.3115/1219840.1219914]; Barzilay R, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P16; Bendersky M, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P605; Bendersky M, 2012, SIGIR 2012: PROCEEDINGS OF THE 35TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P941, DOI 10.1145/2348283.2348408; Bendersky Michael, 2010, P 3 ACM INT C WEB SE, P31, DOI [10.1145/1718487.1718492, DOI 10.1145/1718487.1718492]; Bendersky Michael, 2008, P 31 ANN INT ACM SIG, P491, DOI DOI 10.1145/1390334.1390419; Buscaldi D, 2005, CROSS LANG EV FOR CL; CALLAN JP, 1995, INFORM PROCESS MANAG, V31, P327, DOI 10.1016/0306-4573(94)00050-D; Callison-Burch Chris, 2008, P C EMP METH NAT LAN, P196; Chakrabarti D., 2011, P 5 INT AAAI C WEBL, V11, P66; Dinh D, 2011, LECT NOTES COMPUT SC, V6611, P375, DOI 10.1007/978-3-642-20161-5_38; Duclaye F, 2003, P EACL WORKSH NAT LA, P35; Gao Y., 2017, ACM MULTIMEDIA, P1517; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Gao Yue, 2010, P INT C MULT, P123; Gehler P, 2009, IEEE I CONF COMP VIS, P221, DOI 10.1109/ICCV.2009.5459169; Grineva Maria, 2009, P 18 INT C WORLD WID, P661, DOI DOI 10.1145/1526709.1526798; Harabagiu S, 2001, P TEXT RETR C QUEST; Harman D., 1988, 11th International Conference on Research and Development in Information Retrieval, P321; Hovy E., 2001, P 10 TEXT RETRIEVAL; Jianfeng Gao, 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P170; Jinxi Xu, 1996, SIGIR Forum, P4; Kai Wang, 2010, P 23 INT C COMP LING, P1155; Lam-Adesina A. M., 2001, SIGIR Forum, P1; Mihalcea R., 2004, P 2004 C EMP METH NA, P404, DOI DOI 10.3115/1219044.1219064; Ponte J. M., 1998, P 21 ANN INT ACM SIG, P275, DOI DOI 10.1145/290941.291008; Riezler S, 2007, P 45 ANN M ASS COMP, V45, P464; Robertson S, 2002, INFORM RETRIEVAL, V5, P239, DOI 10.1023/A:1015702129514; Robertson S. E., 1995, Text REtrieval Conference (TREC-3) (NIST SP 500-225), P109; Robertson SE, 1999, TREC 99, V8; Sang J., 2012, P 20 ACM INT C MULT, P19; Sang JT, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037687; Song F, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P279, DOI 10.1145/312624.312698; Srikanth M., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P425; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang K, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P187, DOI 10.1145/1571941.1571975; Xu J, 2011, P 20 INT C COMP WORL, P153, DOI [10.1145/1963192.1963270, DOI 10.1145/1963192.1963270]; Xue X., 2008, P 31 ANN INT ACM SIG, P475, DOI 10.1145/1390334.1390416; Yang H, 2005, PDCAT 2005: SIXTH INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED COMPUTING, APPLICATIONS AND TECHNOLOGIES, PROCEEDINGS, P40; Yonggang Qiu, 1993, SIGIR Forum, P160; Zhang ST, 2012, LECT NOTES COMPUT SC, V7573, P660, DOI 10.1007/978-3-642-33709-3_47; Zhang ST, 2012, IEEE T SYST MAN CY B, V42, P838, DOI 10.1109/TSMCB.2011.2179533; Zhao S, 2008, P ACL 08, P1021; Zhao SQ, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1795; Zhao Shiqi, 2010, P COL 2010, P1326; Zhao Shiqi, 2009, P JOINT C 47 ANN M A, V2, P834	48	100	109	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2013	8	6							e64601	10.1371/journal.pone.0064601	http://dx.doi.org/10.1371/journal.pone.0064601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170JP	23977002	Green Published, Green Submitted, gold			2022-12-27	WOS:000320846500006
J	Wang, MH; Li, JX; Lim, GE; Johnson, JD				Wang, Minghu; Li, Jiaxu; Lim, Gareth E.; Johnson, James D.			Is Dynamic Autocrine Insulin Signaling Possible? A Mathematical Model Predicts Picomolar Concentrations of Extracellular Monomeric Insulin within Human Pancreatic Islets	PLOS ONE			English	Article							BETA-CELL MASS; INJECTED SOLUBLE INSULIN; SUBCUTANEOUS INJECTION; PHARMACOKINETIC MODEL; ENDOGENOUS INSULIN; GLUCOSE; RECEPTOR; SECRETION; APOPTOSIS; ANALOGS	Insulin signaling is essential for beta-cell survival and proliferation in vivo. Insulin also has potent mitogenic and anti-apoptotic actions on cultured beta-cells, with maximum effect in the high picomolar range and diminishing effect at high nanomolar doses. In order to understand whether these effects of insulin are constitutive or can be subjected to physiological modulation, it is essential to estimate the extracellular concentration of monomeric insulin within an intact islet. Unfortunately, the in vivo concentration of insulin monomers within the islet cannot be measured directly with current technology. Here, we present the first mathematical model designed to estimate the levels of monomeric insulin within the islet extracellular space. Insulin is released as insoluble crystals that exhibit a delayed dissociation into hexamers, dimers, and eventually monomers, which only then can act as signaling ligands. The rates at which different forms of insulin dissolve in vivo have been estimated from studies of peripheral insulin injection sites. We used this and other information to formulate a mathematical model to estimate the local insulin concentration within a single islet as a function of glucose. Model parameters were estimated from existing literature. Components of the model were validated using experimental data, if available. Model analysis predicted that the majority of monomeric insulin in the islet is that which has been returned from the periphery, and the concentration of intra-islet monomeric insulin varies from similar to 50-300 pM when glucose is in the physiological range. Thus, our results suggest that the local concentration of monomeric insulin within the islet is in the picomolar 'sweet spot' range of insulin doses that activate the insulin receptor and have the most potent effects on beta-cells in vitro. Together with experimental data, these estimations support the concept that autocrine/ paracrine insulin signalling within the islet is dynamic, rather than constitutive and saturated.	[Wang, Minghu; Li, Jiaxu] Univ Louisville, Dept Math, Louisville, KY 40292 USA; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Lim, Gareth E.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of Louisville; University of British Columbia; University of British Columbia	Li, JX (corresponding author), Univ Louisville, Dept Math, Louisville, KY 40292 USA.	jiaxu.li@louisville.edu; jimjohn@mail.ubc.ca	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	DOE (Department of Energy's) [DE-EM000197]; National Institutes of Health/National Institute of Dental and Craniofacial Research grant [R01-DE019243]; National Institutes of Health/National Institute of Environmental Health Sciences [P30-ES014443]; Canadian Institutes for Health Research; Juvenile Diabetes Research Foundation; Michael Smith Foundation for Health Research; Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	DOE (Department of Energy's); National Institutes of Health/National Institute of Dental and Craniofacial Research grant; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Diabetes Association; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Minghu Wang and Jiaxu Li were supported in part by DOE (Department of Energy's) grant DE-EM000197. Jiaxu Li is also supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grant R01-DE019243, and National Institutes of Health/National Institute of Environmental Health Sciences grant P30-ES014443. James D. Johnson and Gareth E. Lim were supported by the Canadian Institutes for Health Research, the Juvenile Diabetes Research Foundation, the Michael Smith Foundation for Health Research, and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Engelborghs K, 2001, J MATH BIOL, V42, P361, DOI 10.1007/s002850000072; Evert M, 2004, CANCER RES, V64, P8093, DOI 10.1158/0008-5472.CAN-04-2040; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; Gullo L, 1999, ANN ONCOL, V10, P79, DOI 10.1023/A:1008349122106; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; HORUK R, 1979, NATURE, V279, P439, DOI 10.1038/279439a0; HORUK R, 1980, NATURE, V286, P822, DOI 10.1038/286822a0; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Johnson JD, 2008, CELL CYCLE, V7, P1343, DOI 10.4161/cc.7.10.5865; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Jones CNO, 1997, J CLIN ENDOCR METAB, V82, P1834, DOI 10.1210/jc.82.6.1834; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Li JX, 2006, J THEOR BIOL, V242, P722, DOI 10.1016/j.jtbi.2006.04.002; Li JX, 2012, MATH BIOSCI, V235, P128, DOI 10.1016/j.mbs.2011.11.005; Li JX, 2009, DISCRETE CONT DYN-B, V12, P401, DOI 10.3934/dcdsb.2009.12.401; Li J, 2009, MATH BIOSCI ENG, V6, P41, DOI 10.3934/mbe.2009.6.41; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lim GE, 2013, DIABETOLOGIA; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; MATTHEWS DR, 1985, CLIN ENDOCRINOL, V23, P71, DOI 10.1111/j.1365-2265.1985.tb00185.x; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; MILES KA, 1995, BRIT J RADIOL, V68, P471, DOI 10.1259/0007-1285-68-809-471; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; MOSEKILDE E, 1989, J PHARMACOKINET BIOP, V17, P67, DOI 10.1007/BF01059088; Nyman LR, 2008, J CLIN INVEST; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Palumbo P, 2007, DISCRETE CONT DYN-B, V7, P399; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; POLONSKY KS, 1988, J CLIN INVEST, V81, P435, DOI 10.1172/JCI113338; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Smith H.L., 1995, MATH SURVEYS MONOGR; Soeborg T, 2009, EUR J PHARM SCI, V36, P78, DOI 10.1016/j.ejps.2008.10.018; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801; Tarin C, 2005, IEEE T BIO-MED ENG, V52, P1994, DOI 10.1109/TBME.2005.857681; TRAJANOSKI Z, 1993, BIOMED TECH, V38, P224, DOI 10.1515/bmte.1993.38.9.224; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Ueki K, 2003, DIABETES, V52, pA42; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h	58	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2013	8	6							e64860	10.1371/journal.pone.0064860	http://dx.doi.org/10.1371/journal.pone.0064860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163UV	23798995	Green Published, Green Submitted, gold			2022-12-27	WOS:000320363300004
J	Yu, HC; Hou, DR; Liu, CY; Lin, CS; Shiau, CW; Cheng, AL; Chen, KF				Yu, Hui-Chuan; Hou, Duen-Ren; Liu, Chun-Yu; Lin, Chen-Si; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Kuen-Feng			Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-SUPPRESSOR; CIP2A EXPRESSION; CELL-SURVIVAL; PP2A; UBIQUITIN; AKT; APOPTOSIS; PHOSPHORYLATION	Previously, we reported that cancerous inhibitor of protein phosphatase 2A (CIP2A) mediates the apoptotic effect of bortezomib in hepatocellular carcinoma (HCC). Here, we report a proteasome-independent mechanism by which bortezomib induces autophagy in HCC. Our data indicate that bortezomib activated autophagy in a dose-and time-dependent manner in HCC cell lines including Huh-7, Sk-Hep1, and Hep3B. Bortezomib downregulated CIP2A, phospho-Akt (P-Akt) and phospho-4EBP1 (P-4EBP1) in a dose-and time-dependent manner in all tested HCC cells. Ectopic expression of CIP2A abolished the effect of bortezomib on autophagy. Co-treatment of bortezomib and calyculin A, a PP2A inhibitor, reduced the effect of bortezomib on P-Akt, P-4EBP1, and autophagy. Increased phosphorylation of either Akt or 4EBP1 by ectopic overexpression protected cells from bortezomib-induced autophagy. Furthermore, we examined the effect of Delta Btz, a bortezomib derivative that closely resembles bortezomib structurally but has no proteasome activity, in HCC. Interestingly, Delta Btz demonstrated similar effects to bortezomib on autophagy, CIP2A, P-Akt and P-4EBP1, suggesting that the effect of bortezomib on autophagy is independent of proteasome inhibition. Moreover, our in vivo data showed that both bortezomib and Delta Btz inhibited tumor growth, downregulated CIP2A, P-Akt and induced autophagy in Huh-7 tumors. In conclusion, bortezomib induces autophagy in HCC through a CIP2A-PP2A-Akt-4EBP1 pathway.	[Yu, Hui-Chuan; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yu, Hui-Chuan; Cheng, Ann-Lii; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Lin, Chen-Si; Chen, Kuen-Feng] Natl Taiwan Univ, Sch Vet Med, Taipei 10764, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Hou, Duen-Ren] Natl Cent Univ, Dept Chem, Tao Yuan, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Shiau, Chung-Wai] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, KF (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.	kfchen1970@ntu.edu.tw	Lin, Chen-Si/AAD-3733-2019	Lin, Chen-Si/0000-0003-2254-8344; Chen, Kuen-Feng/0000-0002-4686-7019; HOU, Duen-Ren/0000-0003-1072-2915; Yu, Hongbo/0000-0002-3384-7772; Liu, Jinting/0000-0003-2136-8560; Cheng, Ann-Lii/0000-0002-9152-6512; Suiyi, Zhu/0000-0002-9784-2698	National Taiwan University Hospital [NTUH 101P01]; National Science Council, Taiwan [NSC99-2314-B-002-017-MY2, NSC100-2325-B- 002-036]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by grants, NTUH 101P01 (KFC) from National Taiwan University Hospital; NSC99-2314-B-002-017-MY2 (KFC), and NSC100-2325-B- 002-036 (KFC) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eskelinen EL, 2005, CELL DEATH DIFFER, V12, P1468, DOI 10.1038/sj.cdd.4401721; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Ling YH, 2002, MOL CANCER THER, V1, P841; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Qu W, 2010, MED ONCOL; Richardson Paul G, 2003, Cancer Control, V10, P361; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Verslype C, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp281; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhu Keyi, 2009, Proceedings of the American Association for Cancer Research Annual Meeting, V50, P451, DOI 10.1038/onc.2009.343	50	88	89	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55705	10.1371/journal.pone.0055705	http://dx.doi.org/10.1371/journal.pone.0055705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23799106	Green Submitted, gold, Green Published			2022-12-27	WOS:000314597900052
J	Wang, MJ; Yuan, DJ; Gao, WH; Li, Y; Tan, JF; Zhang, XL				Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong			A Comparative Genome Analysis of PME and PMEI Families Reveals the Evolution of Pectin Metabolism in Plant Cell Walls	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; METHYLESTERASE; GENE; SEQUENCE; DUPLICATION; POLYPLOIDY; INHIBITORS; KNOWLEDGE; DISPLAY	Pectins are fundamental polysaccharides in the plant primary cell wall. Pectins are synthesized and secreted to cell walls as highly methyl-esterified polymers and then demethyl-esterified by pectin methylesterases (PMEs), which are spatially regulated by pectin methylesterase inhibitors (PMEIs). Although PME and PMEI genes are pivotal in plant cell wall formation, few studies have focused on the evolutionary patterns of the PME and PMEI gene families. In this study, the gene origin, evolution, and expression diversity of these two families were systematically analyzed using 11 representative species, including algae, bryophytes, lycophytes and flowering land plants. The results show that 1) for the two subfamilies (PME and proPME) of PME, the origin of the PME subfamily is consistent with the appearance of pectins in early charophyte cell walls, 2) Whole genome duplication (WGD) and tandem duplication contribute to the expansion of proPME and PMEI families in land plants, 3) Evidence of selection pressure shows that the proPME and PMEI families have rapidly evolved, particularly the PMEI family in vascular plants, and 4) Comparative expression profile analysis of the two families indicates that the eudicot Arabidopsis and monocot rice have different expression patterns. In addition, the gene structure and sequence analyses show that the origin of the PMEI domain may be derived from the neofunctionalization of the pro domain after WGD. This study will advance the evolutionary understanding of the PME and PMEI families and plant cell wall development.	[Wang, Maojun; Yuan, Daojun; Gao, Wenhui; Li, Yang; Tan, Jiafu; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yuan, DJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	robert@mail.hzau.edu.cn; xlzhang@mail.hzau.edu.cn	Tan, Jiafu/A-9980-2016; Yuan, Daojun/R-6048-2016; Tan, Jiafu/J-2422-2013; Yuan, Daojun/D-5555-2011; Wang, Maojun/M-2587-2019; Li, Jiaxu/AAE-7065-2021; Lim, Gareth/G-9143-2017	Yuan, Daojun/0000-0001-6007-5571; Tan, Jiafu/0000-0002-6498-7495; Wang, Maojun/0000-0002-4791-3742; Lim, Gareth/0000-0003-3850-3757; Cheng, Xiaoqian/0000-0002-2544-4260	National Natural Science Foundation of China [31230056]; National Basic Research Program [2010CB126001]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was financially supported by the National Natural Science Foundation of China (NO. 31230056) and National Basic Research Program (2010CB126001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cao Jun, 2012, PLoS One, V7, pe46944, DOI 10.1371/journal.pone.0046944; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; de Freitas ST, 2012, PLANT J, V71, P824, DOI 10.1111/j.1365-313X.2012.05034.x; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fangel JU, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00152; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Giovane A, 2004, BBA-PROTEINS PROTEOM, V1696, P245, DOI 10.1016/j.bbapap.2003.08.011; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li C, 2012, MOL BIOL EVOL, V29, P3227, DOI 10.1093/molbev/mss131; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Sterling JD, 2001, PLANT PHYSIOL, V127, P360, DOI 10.1104/pp.127.1.360; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Timme RE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-96; Wang CM, 2012, PLANT PHYSIOL, V158, P1523, DOI 10.1104/pp.111.192203; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028150; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yadav S, 2009, PROCESS BIOCHEM, V44, P1, DOI 10.1016/j.procbio.2008.09.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu ZL, 2009, PLANT PHYSIOL, V151, P1943, DOI 10.1104/pp.109.142984; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6; Zuccolo A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r48	66	388	397	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e72082	10.1371/journal.pone.0072082	http://dx.doi.org/10.1371/journal.pone.0072082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	23798995	Green Published, gold, Green Submitted			2022-12-27	WOS:000323097300177
J	Wang, JB; Zhu, TC; Ni, HW; Zhong, HX; Fu, XL; Wang, JF				Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng			Effects of Elevated CO2 and Nitrogen Deposition on Ecosystem Carbon Fluxes on the Sanjiang Plain Wetland in Northeast China	PLOS ONE			English	Article							NET ECOSYSTEM; SOIL RESPIRATION; EXCHANGE; FOREST; SEQUESTRATION; LIMITATION; GRASSLAND; RESPONSES; DIOXIDE; ENRICHMENT	Background: Increasing atmospheric CO2 and nitrogen (N) deposition across the globe may affect ecosystem CO2 exchanges and ecosystem carbon cycles. Additionally, it remains unknown how increased N deposition and N addition will alter the effects of elevated CO2 on wetland ecosystem carbon fluxes. Methodology/Principal Findings: Beginning in 2010, a paired, nested manipulative experimental design was used in a temperate wetland of northeastern China. The primary factor was elevated CO2, accomplished using Open Top Chambers, and N supplied as NH4NO3 was the secondary factor. Gross primary productivity (GPP) was higher than ecosystem respiration (ER), leading to net carbon uptake (measured by net ecosystem CO2 exchange, or NEE) in all four treatments over the growing season. However, their magnitude had interannual variations, which coincided with air temperature in the early growing season, with the soil temperature and with the vegetation cover. Elevated CO2 significantly enhanced GPP and ER but overall reduced NEE because the stimulation caused by the elevated CO2 had a greater impact on ER than on GPP. The addition of N stimulated ecosystem C fluxes in both years and ameliorated the negative impact of elevated CO2 on NEE. Conclusion/Significance: In this ecosystem, future elevated CO2 may favor carbon sequestration when coupled with increasing nitrogen deposition.	[Wang, Jianbo; Zhu, Tingcheng; Ni, Hongwei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Wang, Jianbo; Ni, Hongwei; Zhong, Haixiu; Fu, Xiaoling; Wang, Jifeng] Heilongjiang Acad Sci, Inst Nat Resources & Ecol, Harbin, Heilongjiang Pr, Peoples R China	Northeast Normal University - China	Ni, HW (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	nihongwei2000@163.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30970452]; Heilongjiang Province Funds for Distinguished Young Scientists [JC03-09]; Fundamental Research Funds for the Finance Department of Heilongjiang Province [2012EFA-02]; Natural Science Foundation of Heilongjiang Province [C201032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Province Funds for Distinguished Young Scientists; Fundamental Research Funds for the Finance Department of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This research was supported by the National Natural Science Foundation of China (30970452), the Heilongjiang Province Funds for Distinguished Young Scientists (JC03-09), Fundamental Research Funds for the Finance Department of Heilongjiang Province (2012EFA-02), and the Natural Science Foundation of Heilongjiang Province (C201032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2011, GLOBAL CHANGE BIOL, V17, P3546, DOI 10.1111/j.1365-2486.2011.02484.x; Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Bachman S, 2010, OECOLOGIA, V162, P791, DOI 10.1007/s00442-009-1511-x; Bonneville MC, 2008, AGR FOREST METEOROL, V148, P69, DOI 10.1016/j.agrformet.2007.09.004; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Hymus GJ, 2003, GLOBAL CHANGE BIOL, V9, P1802, DOI 10.1111/j.1365-2486.2003.00675.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Jasoni RL, 2005, GLOBAL CHANGE BIOL, V11, P749, DOI 10.1111/j.1365-2486.2005.00948.x; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Kivimaki SK, 2013, ENVIRON EXP BOT, V90, P53, DOI 10.1016/j.envexpbot.2012.09.003; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu De-yan, 2008, Ying Yong Sheng Tai Xue Bao, V19, P2599; [刘德燕 LIU Deyan], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P305; Lovell RD, 1997, BIOL FERT SOILS, V26, P28, DOI 10.1007/s003740050338; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Milchunas DG, 2005, PLANT SOIL, V268, P111, DOI 10.1007/s11104-004-0230-7; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pendall E, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001821; Randerson JT, 2002, ECOL APPL, V12, P937, DOI 10.1890/1051-0761(2002)012[0937:NEPACM]2.0.CO;2; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, AGR FOREST METEOROL, V151, P1131, DOI 10.1016/j.agrformet.2011.04.001; Sowerby A, 2000, SOIL BIOL BIOCHEM, V32, P1359, DOI 10.1016/S0038-0717(00)00045-6; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; [孙志高 SUN Zhigao], 2007, [水科学进展, Advances in Water Science], V18, P182; Welp LR, 2007, AGR FOREST METEOROL, V147, P172, DOI 10.1016/j.agrformet.2007.07.010; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhao GuangYing, 2008, Research of Environmental Sciences, V21, P134; Zhou XP, 2012, J ENVIRON SCI, V24, P2104, DOI 10.1016/S1001-0742(11)61057-7	46	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66563	10.1371/journal.pone.0066563	http://dx.doi.org/10.1371/journal.pone.0066563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800079
J	Wang, JH; Sharma, A; Ghamande, SA; Bush, S; Ferris, D; Zhi, WB; He, MF; Wang, MY; Wang, XX; Miller, E; Hopkins, D; Macfee, M; Guan, RL; Tang, JH; She, JX				Wang, Jinhua; Sharma, Ashok; Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Macfee, Michael; Guan, Ruili; Tang, Jinhai; She, Jin-Xiong			Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer	PLOS ONE			English	Article							BIOMARKER PANELS; DIAGNOSIS; PROGRESSION; MARKERS; INFLAMMATION; VALIDATION; CA-125; CA125; ASSAY	Background: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeutic outcome and recurrence of cancer. Previous biomarker research on ovarian cancer (OC) has mostly focused on the discovery and validation of diagnostic biomarkers. The primary purpose of this study is to identify serum biomarkers for prognosis and therapeutic outcomes of ovarian cancer. Experimental Design: Forty serum proteins were analyzed in 70 serum samples from healthy controls (HC) and 101 serum samples from serous OC patients at three different disease phases: post diagnosis (PD), remission (RM) and recurrence (RC). The utility of serum proteins as OC biomarkers was evaluated using a variety of statistical methods including survival analysis. Results: Ten serum proteins (PDGF-AB/BB, PDGF-AA, CRP, sFas, CA125, SAA, sTNFRII, sIL-6R, IGFBP6 and MDC) have individually good area-under-the-curve (AUC) values (AUC = 0.69-0.86) and more than 10 three-marker combinations have excellent AUC values (0.91-0.93) in distinguishing active cancer samples (PD & RC) from HC. The mean serum protein levels for RM samples are usually intermediate between HC and OC patients with active cancer (PD & RC). Most importantly, five proteins (sICAM1, RANTES, sgp130, sTNFR-II and sVCAM1) measured at remission can classify, individually and in combination, serous OC patients into two subsets with significantly different overall survival (best HR = 17, p <10(-3)). Conclusion: We identified five serum proteins which, when measured at remission, can accurately predict the overall survival of serous OC patients, suggesting that they may be useful for monitoring the therapeutic outcomes for ovarian cancer.	[Wang, Jinhua; Sharma, Ashok; Zhi, Wenbo; He, Mingfang; Wang, Meiyao; Wang, Xiaoxiao; Miller, Eric; Hopkins, Diane; Guan, Ruili; She, Jin-Xiong] Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Wang, Jinhua; He, Mingfang; Tang, Jinhai; She, Jin-Xiong] Nanjing Univ Technol, Sino Amer Canc Res Inst, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Wang, Meiyao; Tang, Jinhai; She, Jin-Xiong] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Jinhua; He, Mingfang; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Ghamande, Sharad A.; Bush, Stephen; Ferris, Daron; Macfee, Michael] Georgia Hlth Sci Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Guan, Ruili] Beijing Univ, Inst Urol Surg, Hosp 1, Beijing 100871, Peoples R China	University System of Georgia; Augusta University; Nanjing Tech University; Nanjing Medical University; Nanjing Medical University; Nanjing Tech University; University System of Georgia; Augusta University; Peking University	She, JX (corresponding author), Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@gru.edu	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure [RC2011091]; Jiangsu Government Scholarship; "333" Plan	Georgia Cancer Coalition; Georgia Research Alliance as an eminent scholar; Jiangsu Medical key Figure; Jiangsu Government Scholarship; "333" Plan	This work was partly supported by a grant from the Georgia Cancer Coalition to DF and JXS. JXS was supported by the Georgia Research Alliance as an eminent scholar. JW was supported by Jiangsu Medical key Figure (RC2011091) and Jiangsu Government Scholarship and "333" Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amonkar SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004599; Antovska S V, 2011, Klin Onkol, V24, P435; Autelitano DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-45; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Ben-Hamo R, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-3; Burger RA, 2004, CANCER-AM CANCER SOC, V101, P106, DOI 10.1002/cncr.20314; Burger RA, 2011, GYNECOL ONCOL, V121, P230, DOI 10.1016/j.ygyno.2010.11.035; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Das PM, 2008, BIOMARK MED, V2, P291, DOI 10.2217/17520363.2.3.291; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Havrilesky LJ, 2008, GYNECOL ONCOL, V110, P374, DOI 10.1016/j.ygyno.2008.04.041; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Hogdall C, 2011, GYNECOL ONCOL, V123, P308, DOI 10.1016/j.ygyno.2011.07.018; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim K, 2009, CLIN LAB MED, V29, P47, DOI 10.1016/j.cll.2009.02.001; Langmar Z, 2011, EUR J GYNAECOL ONCOL, V32, P605; Lee CK, 2011, J NATL CANCER I, V103, P1338, DOI 10.1093/jnci/djr282; Lu D, 2011, GYNECOL ONCOL, V122, P560, DOI 10.1016/j.ygyno.2011.05.039; Lundin E, 2009, CANCER CAUSE CONTROL, V20, P1151, DOI 10.1007/s10552-009-9330-2; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mury D, 2011, J CANCER RES CLIN, V137, P1131, DOI 10.1007/s00432-011-0977-1; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Rahbari NN, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-286; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skaznik-Wikiel ME, 2011, INT J GYNECOL CANCER, V21, P1013, DOI 10.1097/IGC.0b013e31821ce903; Steffensen KD, 2011, INT J GYNECOL CANCER, V21, P1040, DOI 10.1097/IGC.0b013e31821e052e; Tang A, 2012, GYNECOL ONCOL; Toriola AT, 2011, ANN ONCOL, V22, P1916, DOI 10.1093/annonc/mdq694; van Altena AM, 2010, GYNECOL ONCOL, V119, P265, DOI 10.1016/j.ygyno.2010.07.025; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Yip P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029533; Yurkovetsky Z, 2007, GYNECOL ONCOL, V107, P58, DOI 10.1016/j.ygyno.2007.05.041; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	42	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e78393	10.1371/journal.pone.0078393	http://dx.doi.org/10.1371/journal.pone.0078393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24244307	Green Submitted, Green Published, gold			2022-12-27	WOS:000327221600026
J	Wang, JL; Hu, Y; Kong, X; Wang, ZH; Chen, HY; Xu, J; Fang, JY				Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan			Candidate microRNA Biomarkers in Human Gastric Cancer: A Systematic Review and Validation Study	PLOS ONE			English	Review							CELL-PROLIFERATION; POTENTIAL BIOMARKERS; SERUM MIR-21; EXPRESSION; INVASION; PROGRESSION; MIR-17-5P; MIGRATION; MIR-18A; DYSREGULATION	Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is therefore a clear need to search for more sensitive early diagnostic biomarkers. We performed a systematic review of eight published miRNA profiling studies that compared GC tissues with adjacent noncancerous tissues. A miRNA ranking system was used that took the frequency of comparisons, direction of differential expression and total sample size into consideration. We identified five miRNAs that were most consistently reported to be upregulated (miR-21, miR-106b, miR-17, miR-18a and miR-20a) and two miRNAs that were downregulated (miR-378 and miR-638). Six of these were further validated in 32 paired sets of GC and adjacent noncancerous tissue samples using real-time PCR. MiR-21, miR-106b, miR-17, miR-18a and miR-20a were confirmed to be upregulatedin GC tissues, while the expression of miR-378 was decreased. Moreover, we found a significant association between expression levels of miR-21, miR-106b, miR-17, miR-18a and miR-20a and clinicopathological features of GC. These miRNAs may be used for diagnostic and/or prognostic biomarkers for GC and therefore warrant further investigation.	[Wang, Ji-Lin; Hu, Ye; Kong, Xuan; Wang, Zhen-Hua; Chen, Hao-Yan; Xu, Jie; Fang, Jing-Yuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China; [Fang, Jing-Yuan] Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai, Peoples R China; [Fang, Jing-Yuan] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Dis, Div Gastroenterol & Hepatol,Renji Hosp, Shanghai 200030, Peoples R China.	xujieletter@gmail.com; jingyuanfang@yahoo.com	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of Key Program [30830055]; Ministry of Public Health, China [200802094]; Ministry of Education [20090073110077]; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine [BXJ201219]	National Natural Science Foundation of Key Program; Ministry of Public Health, China; Ministry of Education; Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine	This work was supported by grants from the National Natural Science Foundation of Key Program (No. 30830055), the Ministry of Public Health, China (No. 200802094), the Ministry of Education (No. 20090073110077) to Fang JY, and the Doctor Innovation Foundation of Shanghai Jiao-Tong University School Of Medicine (No. BXJ201219) to Wang JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder H, 2012, CARCINOGENESIS, V33, P1736, DOI 10.1093/carcin/bgs204; Ang TL, 2010, SINGAP MED J, V51, P93; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cao Z, 2012, J CANCER RES CLIN, V138, P611, DOI 10.1007/s00432-011-1140-8; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chen LT, 2012, MED ONCOL, V29, P1673, DOI 10.1007/s12032-011-0083-x; Cui L, 2013, CANCER, DOI [10.1002/cncr.27903, DOI 10.1002/CNCR.27903.PMID:23335180]; Deng H, 2013, GENE; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Faltejskova P, 2012, CANCER BIOMARK, V12, P199, DOI 10.3233/CBM-130308; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo L, 2012, MOL BIOL REP; Han ML, 2012, CANCER SCI, V103, P1058, DOI 10.1111/j.1349-7006.2012.02281.x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Li LH, 2012, DIGEST DIS SCI, V57, P2910, DOI 10.1007/s10620-012-2317-y; Li X, 2012, CANCER BIOL THER, V13, P890, DOI 10.4161/cbt.20841; Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Nguyen HCN, 2013, PROSTATE, V73, P346, DOI 10.1002/pros.22572; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Saito Y, 2013, INT J CANCER, V132, P1751, DOI 10.1002/ijc.27862; Shen G, 2013, CARCINOGENESIS, V34, P211, DOI 10.1093/carcin/bgs320; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang J, 2012, EUR J CANCER, V48, P1904, DOI 10.1016/j.ejca.2011.11.026; Wang M, 2013, EUR J CANC; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Wohrer SS, 2004, ANN ONCOL, V15, P1585, DOI 10.1093/annonc/mdh422; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Wu W, 2013, BRIT J CANCER, V108, P653, DOI 10.1038/bjc.2012.587; Xu YJ, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/640168; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yu J, 2010, CANCER BIOL THER, V10, P748, DOI 10.4161/cbt.10.8.13083; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	56	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2013	8	9							e73683	10.1371/journal.pone.0073683	http://dx.doi.org/10.1371/journal.pone.0073683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244QV	24244307	Green Published, Green Submitted, gold			2022-12-27	WOS:000326405300110
J	Wang, JG; Han, J; Jia, YX; Zeng, W; Hou, XT; Meng, X				Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu			Outcome of Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Valvular Surgery	PLOS ONE			English	Article							POSTCARDIOTOMY CARDIOGENIC-SHOCK; ADULT PATIENTS; LIFE-SUPPORT; SURVIVAL; EXPERIENCE; FAILURE; RESCUE; RISK	Background: We evaluated retrospectively the early and midterm results of using veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in patients undergoing valvular surgery. Methods: A total of 87 patients undergoing valvular surgery received VA-ECMO due to refractory postcardiotomy cardiogenic shock (PCS), who were eligible for inclusion were enrolled in this study. Preoperative, perioperative, and postoperative variables were assessed and analyzed for possible associations with mortality in hospital and after discharge. Results: The mean age, additive EuroSCORE, and left ventricular ejection fraction (LVEF) for all patients was 65 +/- 7 years, 6.1 +/- 1.9 points, and 46% +/- 12%, respectively. The mean duration of VA-ECMO support was 61 +/- 37 hours. Intra-aortic balloon pumps (IABP) were implanted in 47.1% of patients. Weaning from VA-ECMO was successful in 59% of patients, and 49% were discharged. Multivariate analysis revealed that being >65 years old (odds ratio [OR], 2.75), receiving postoperative renal replacement treatment (OR, 2.47), having a peak lactate level >= 12 mmol L-1 (OR, 2.18), and receiving VA-ECMO for >60 hours (OR, 3.2) were independent predictors of in-hospital mortality. IABP support (OR, 0.46) was protective. In addition, persistent heart failure with an LVEF <40% was an independent predictor of mortality after discharge. Conclusions: VA-ECMO is an acceptable technique for the treatment of PCS in patients undergoing valvular surgery, who would otherwise die. It is justified by the good long-term outcomes of hospital survivors, but the use of VA-ECMO must be decided on an individual risk profile basis because of high morbidity and mortality rates.	[Wang, Jian-Gang; Han, Jie; Jia, Yi-Xin; Zeng, Wen; Hou, Xiao-Tong; Meng, Xu] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China	Capital Medical University	Wang, JG (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	wangjiangang7545@126.com; mxu@263.net	wang, jian/GVS-0711-2022; Xu, Jie/C-4283-2016; Xu, Jie/K-3712-2019; Takahashi, Ken/B-1622-2011	Xu, Jie/0000-0001-9163-3898; Xu, Jie/0000-0001-9163-3898; naruse, keiji/0000-0003-4100-6444; Takahashi, Ken/0000-0002-7580-8691; Sharma, Ashok/0000-0001-9597-4374	National Natural Science Foundation of China [30900629]; Beijing Novo Program [2010B047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Novo Program	This work was supported by the National Natural Science Foundation of China [Grant No. 30900629] and the Beijing Novo Program [Grant No. 2010B047]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt M, EUR J CARDIOTHORAC S, V40, P689; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Aziz TA, 2010, J HEART LUNG TRANSPL, V29, P66, DOI 10.1016/j.healun.2009.08.025; Bakhtiary F, 2008, J THORAC CARDIOV SUR, V135, P382, DOI 10.1016/j.jtcvs.2007.08.007; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Doll N, 2004, ANN THORAC SURG, V77, P151, DOI 10.1016/S0003-4975(03)01329-8; GOLDING LAR, 1992, ANN THORAC SURG, V54, P1059, DOI 10.1016/0003-4975(92)90070-K; Gupta P, 2012, ANN THORAC SURG, V93, P1584, DOI 10.1016/j.athoracsur.2012.01.008; Hsu PS, 2010, EUR J CARDIO-THORAC, V37, P328, DOI 10.1016/j.ejcts.2009.07.033; Ko WJ, 2002, ANN THORAC SURG, V73, P538, DOI 10.1016/S0003-4975(01)03330-6; Lin JW, 2010, RESUSCITATION, V81, P796, DOI 10.1016/j.resuscitation.2010.03.002; Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009; MUEHRCKE DD, 1995, J THORAC CARDIOV SUR, V110, P843, DOI 10.1016/S0022-5223(95)70119-2; RASTAN AJ, 2010, J THORAC CARDIOVASC, V139; Rastan AJ, 2010, J THORAC CARDIOV SUR, V139, P302, DOI 10.1016/j.jtcvs.2009.10.043; Smedira NG, 2001, J THORAC CARDIOV SUR, V122, P92, DOI 10.1067/mtc.2001.114351; Wang JG, 2009, ANN THORAC SURG, V88, P1897, DOI 10.1016/j.athoracsur.2009.08.009; Wu MY, 2010, RESUSCITATION, V81, P1111, DOI 10.1016/j.resuscitation.2010.04.031	18	224	237	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e63924	10.1371/journal.pone.0063924	http://dx.doi.org/10.1371/journal.pone.0063924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24244307	Green Published, gold, Green Submitted			2022-12-27	WOS:000319435600036
J	Li, YY; Xie, J; Wu, SY; Xia, J; Zhang, PF; Liu, C; Zhang, P; Huang, X				Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi			Protein Kinase Regulated by dsRNA Downregulates the Interferon Production in Dengue Virus- and dsRNA-Stimulated Human Lung Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; PKR-DEPENDENT ACTIVATION; CELLULAR ACTIVATOR; RIG-I; BINDING PROTEIN; ADAPTER IPS-1; INDUCTION; INFECTION; TRANSLATION	Background: Dengue virus (DENV) is found in the tropical and subtropical regions and affects millions of people annually. Currently, no specific vaccine or antiviral treatment against dengue virus is available. Innate immunity has been shown to be important for host resistance to DENV infection. Although protein kinase regulated by double-stranded RNA (PKR) has been found to promote the innate signaling in response to infection by several viruses, its role in the innate response to DENV infection is still unclear. Our study aimed to investigate the role of PKR in DENV-induced innate immune responses. Methodology/Principal Findings: By RNAi, silencing of PKR significantly enhanced the expression of interferon (IFN)-beta in DENV infected human lung epithelial A549 cells. Western blot and immunofluorescence microscopy data showed that PKR knockdown upregulated the activation of innate signaling cascades including p38 and JNK mitogen-activated protein kinases (MAPKs), interferon regulatory factor-3 and NF-kappa B, following DENV2 infection. Likewise, a negative regulatory effect of PKR on the IFN production was also observed in poly(IC) challenged cells. Moreover, the PKR knockdown-mediated IFN induction was attenuated by RIG-I or IPS-1 silencing. Finally, overexpression of a catalytically inactive PKR mutant (K296R), but not of a mutant lacking dsRNA binding activity (K64E) or the double mutant (K64EK296R), reversed the IFN induction mediated by PKR knockdown, suggesting that the dsRNA binding activity is required for PKR to downregulate IFN production. Conclusions/Significance: PKR acts as a negative regulator of IFN induction triggered by DENVs and poly(IC), and this regulation relies on its dsRNA binding activity. These findings reveal a novel regulatory role for PKR in innate immunity, suggesting that PKR might be a promising target for anti-DENV treatments.	[Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Yuye; Xie, Jiong; Wu, Siyu; Xia, Jun; Zhang, Peifen; Liu, Chao; Zhang, Ping; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, P (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510275, Guangdong, Peoples R China.	zhangp36@mail.sysu.edu.cn; huangxi6@mail.sysu.edu.cn	Liu, Hongliang/P-3444-2014; Scott, Colin/A-4682-2009; Oakeshott, John/B-5365-2009; Teese, Mark George/B-4307-2008; Chen, Huaping/O-3096-2014	Liu, Hongliang/0000-0001-7639-0904; Scott, Colin/0000-0001-6110-6982; Oakeshott, John/0000-0001-8324-7874; Tollefsbol, Trygve/0000-0002-0284-1511; Li, Yong/0000-0002-3595-6673; Li, Yongwen/0000-0001-6102-2949; Teese, Mark George/0000-0002-8003-4918; HUANG, XI/0000-0002-4829-8390; Song, Yajun/0000-0002-6628-2747; Chen, Huaping/0000-0002-9835-5138; Yang, Xianwei/0000-0003-4388-9674	National Natural Science Foundation of China [30972763, 81261160323, 81171576, 30901345, U0832006]; Guangdong innovative research team program [2009010058]; Guangdong Province Universities and Colleges Pearl River School Funded Scheme [2009]; Guangdong Natural Science Foundation [10251008901000013]; National Basic Research Program of China [2010CB530004]; Doctoral Fund of Ministry of Education of China [20100171110047]; Fundamental Research Funds for the Central Universities of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong innovative research team program; Guangdong Province Universities and Colleges Pearl River School Funded Scheme; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Basic Research Program of China(National Basic Research Program of China); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (30972763, 81261160323, 81171576, 30901345, U0832006), Guangdong innovative research team program (NO. 2009010058), Guangdong Province Universities and Colleges Pearl River School Funded Scheme (NO. 2009), Guangdong Natural Science Foundation (10251008901000013), National Basic Research Program of China (2010CB530004), Doctoral Fund of Ministry of Education of China (20100171110047), Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Bonnet MC, 2006, CELL SIGNAL, V18, P1865, DOI 10.1016/j.cellsig.2006.02.010; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055; Cheung BKW, 2005, J IMMUNOL, V175, P7218, DOI 10.4049/jimmunol.175.11.7218; COLTHURST DR, 1987, EUR J BIOCHEM, V166, P357, DOI 10.1111/j.1432-1033.1987.tb13523.x; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ito T, 1999, J BIOL CHEM, V274, P15427, DOI 10.1074/jbc.274.22.15427; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Nakayama Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000966; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Pereira RMS, 2010, FASEB J, V24, P617, DOI 10.1096/fj.09-140053; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Porterfield J S, 1980, Med Trop (Mars), V40, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; RUSSELL PK, 1967, J IMMUNOL, V99, P291; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sen A, 2011, J VIROL, V85, P3717, DOI 10.1128/JVI.02634-10; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; Weber F, 2006, J INTERF CYTOK RES, V26, P1, DOI 10.1089/jir.2006.26.1; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	63	321	342	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2013	8	1							e55108	10.1371/journal.pone.0055108	http://dx.doi.org/10.1371/journal.pone.0055108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093RV	23342141	Green Published, Green Submitted, gold			2022-12-27	WOS:000315210400065
